PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Dawes, M				Dawes, Martin			Identifying sick children in primary care	LANCET			English	Editorial Material							PARENTS		McGill Univ, Montreal, PQ H2W 1S4, Canada	McGill University	Dawes, M (corresponding author), McGill Univ, Montreal, PQ H2W 1S4, Canada.	martin.dawes@mcgill.ca	dawes, martin/B-1750-2013	Dawes, Martin/0000-0003-3624-2477				Barry CA, 2000, BRIT MED J, V320, P1246, DOI 10.1136/bmj.320.7244.1246; Crocetti M, 2001, PEDIATRICS, V107, P1241, DOI 10.1542/peds.107.6.1241; HALLIDAY JL, 1925, LANCET, V205, P763; Kai J, 1996, BRIT MED J, V313, P987; Li SF, 2000, PEDIATR EMERG CARE, V16, P394, DOI 10.1097/00006565-200012000-00003; Neighbour R, 2004, INNER CONSULTATION, V2nd; Van den Bruel Ann, 2006, BMC Fam Pract, V7, P23, DOI 10.1186/1471-2296-7-23; VANDENBRUEL A, 2010, LANCET	8	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 6	2010	375	9717					784	785		10.1016/S0140-6736(09)62166-8	http://dx.doi.org/10.1016/S0140-6736(09)62166-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	570MO	20132978				2022-12-28	WOS:000275682600007
J	Bard, E; Hamelin, B; Delanghe-Sabatier, D				Bard, Edouard; Hamelin, Bruno; Delanghe-Sabatier, Doriane			Deglacial Meltwater Pulse 1B and Younger Dryas Sea Levels Revisited with Boreholes at Tahiti	SCIENCE			English	Article							ANTARCTIC ICE-SHEET; U-TH AGES; LAST DEGLACIATION; MASS-SPECTROMETRY; REEF GROWTH; RECORD; BARBADOS; CALIBRATION; CLIMATE; CORALS	Reconstructing sea-level changes during the last deglaciation provides a way of understanding the ice dynamics that can perturb large continental ice sheets. The resolution of the few sea-level records covering the critical time interval between 14,000 and 9,000 calendar years before the present is still insufficient to draw conclusions about sea-level changes associated with the Younger Dryas cold event and the meltwater pulse 1B (MWP-1B). We used the uranium-thorium method to date shallow-living corals from three new cores drilled onshore in the Tahiti barrier reef. No significant discontinuity can be detected in the sea-level rise during the MWP-1B period. The new Tahiti sea-level record shows that the sea-level rise slowed down during the Younger Dryas before accelerating again during the Holocene.	[Bard, Edouard; Hamelin, Bruno; Delanghe-Sabatier, Doriane] Univ Aix Marseille, Inst Rech Dev, Coll France, CEREGE,UMR 6635,CNRS, F-13545 Aix En Provence 4, France	UDICE-French Research Universities; PSL Research University Paris; College de France; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD)	Bard, E (corresponding author), Univ Aix Marseille, Inst Rech Dev, Coll France, CEREGE,UMR 6635,CNRS, BP 80, F-13545 Aix En Provence 4, France.	bard@cerege.fr	delanghe, doriane/AAN-3167-2020; Bard, Edouard/G-7717-2014	delanghe, doriane/0000-0001-6050-4823; 	Gary Comer Foundation for Science and Education; European Science Foundation (EuroMARC); CNRS; College de France	Gary Comer Foundation for Science and Education; European Science Foundation (EuroMARC)(European Science Foundation (ESF)); CNRS(Centre National de la Recherche Scientifique (CNRS)); College de France	The authors thank G. Cabioch for help with coring and sampling; G. Menot and W. Barthelemy for help with U-Th analyses; D. Borschneck for help with x-ray diffraction analyses; P. Deschamps for age calculations and drafting Fig. 1; P. Dussouillez and J.-J. Motte for help with maps; and F. Antonioli, G. Cabioch, P. Clark, P. Deschamps, and F. Taylor for useful technical and scientific discussions. Numerical data are available in table S1 and also at the National Oceanic and Atmospheric Administration's National Geophysical Data Center public data repository. Paleoclimate work at CEREGE is supported by grants from the Gary Comer Foundation for Science and Education, the European Science Foundation (EuroMARC), the CNRS, and the College de France.	ANDERSEN BG, 1995, QUATERN INT, V28, P147, DOI 10.1016/1040-6182(95)00037-J; BARD E, 1990, NATURE, V345, P405, DOI 10.1038/345405a0; Bard E, 1996, NATURE, V382, P241, DOI 10.1038/382241a0; BARD E, 1990, NATURE, V346, P456, DOI 10.1038/346456a0; BARD E, 1993, RADIOCARBON, V35, P191, DOI 10.1017/S0033822200013886; Bassett SE, 2005, SCIENCE, V309, P925, DOI 10.1126/science.1111575; Cabioch G, 2003, QUATERNARY SCI REV, V22, P1771, DOI 10.1016/S0277-3791(03)00170-7; Cabioch G, 1999, SEDIMENTOLOGY, V46, P985; Clark PU, 2002, SCIENCE, V295, P2438; Clark PU, 2002, NATURE, V415, P863, DOI 10.1038/415863a; Cutler KB, 2003, EARTH PLANET SC LETT, V206, P253, DOI 10.1016/S0012-821X(02)01107-X; DESCHAMPS P, 2009, GEOPH RES ABSTR, V11; EDWARDS RL, 1993, SCIENCE, V260, P962, DOI 10.1126/science.260.5110.962; Fairbanks RG, 2005, QUATERNARY SCI REV, V24, P1781, DOI 10.1016/j.quascirev.2005.04.007; FAIRBANKS RG, 1989, NATURE, V342, P637, DOI 10.1038/342637a0; Hanebuth T, 2000, SCIENCE, V288, P1033, DOI 10.1126/science.288.5468.1033; Kanfoush SL, 2000, SCIENCE, V288, P1815, DOI 10.1126/science.288.5472.1815; Liu Z, 2009, SCIENCE, V325, P310, DOI 10.1126/science.1171041; Milne GA, 2009, NAT GEOSCI, V2, P471, DOI 10.1038/ngeo544; Milne GA, 2008, QUATERNARY SCI REV, V27, P2292, DOI 10.1016/j.quascirev.2008.08.018; Mitrovica JX, 2009, SCIENCE, V323, P753, DOI 10.1126/science.1166510; Montaggioni LF, 1997, GEOLOGY, V25, P555, DOI 10.1130/0091-7613(1997)025<0555:CRORGO>2.3.CO;2; Okuno J, 1999, PALAEOGEOGR PALAEOCL, V146, P283, DOI 10.1016/S0031-0182(98)00136-9; Peltier WR, 2006, QUATERNARY SCI REV, V25, P3322, DOI 10.1016/j.quascirev.2006.04.010; Pfeffer WT, 2008, SCIENCE, V321, P1340, DOI 10.1126/science.1159099; Philippon G, 2006, EARTH PLANET SC LETT, V248, P750, DOI 10.1016/j.epsl.2006.06.017; Rasmussen SO, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006079; Renssen H, 2009, NAT GEOSCI, V2, P410, DOI 10.1038/NGEO513; Rinterknecht VR, 2006, SCIENCE, V311, P1449, DOI 10.1126/science.1120702; Shennan I, 1999, J QUATERNARY SCI, V14, P715, DOI 10.1002/(SICI)1099-1417(199912)14:7<715::AID-JQS511>3.0.CO;2-G; Stanford JD, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2006PA001340; Svendsen JI, 2004, DEV QUA SCI, V2, P369; TAYLOR FW, 1991, GEOLOGY, V19, P103, DOI 10.1130/0091-7613(1991)019<0103:LQFOCR>2.3.CO;2; Weaver AJ, 2003, SCIENCE, V299, P1709, DOI 10.1126/science.1081002; Webster JM, 2004, GEOLOGY, V32, P249, DOI 10.1130/G20170.1	35	250	255	3	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 5	2010	327	5970					1235	1237		10.1126/science.1180557	http://dx.doi.org/10.1126/science.1180557			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563VD	20075212				2022-12-28	WOS:000275162100033
J	Garcia, V; Bibes, M; Bocher, L; Valencia, S; Kronast, F; Crassous, A; Moya, X; Enouz-Vedrenne, S; Gloter, A; Imhoff, D; Deranlot, C; Mathur, ND; Fusil, S; Bouzehouane, K; Barthelemy, A				Garcia, V.; Bibes, M.; Bocher, L.; Valencia, S.; Kronast, F.; Crassous, A.; Moya, X.; Enouz-Vedrenne, S.; Gloter, A.; Imhoff, D.; Deranlot, C.; Mathur, N. D.; Fusil, S.; Bouzehouane, K.; Barthelemy, A.			Ferroelectric Control of Spin Polarization	SCIENCE			English	Article							ELECTRIC-FIELD CONTROL; TUNNEL-JUNCTIONS; FERROMAGNETISM	A current drawback of spintronics is the large power that is usually required for magnetic writing, in contrast with nanoelectronics, which relies on "zero-current," gate-controlled operations. Efforts have been made to control the spin-relaxation rate, the Curie temperature, or the magnetic anisotropy with a gate voltage, but these effects are usually small and volatile. We used ferroelectric tunnel junctions with ferromagnetic electrodes to demonstrate local, large, and nonvolatile control of carrier spin polarization by electrically switching ferroelectric polarization. Our results represent a giant type of interfacial magnetoelectric coupling and suggest a low-power approach for spin-based information control.	[Garcia, V.; Bibes, M.; Deranlot, C.; Fusil, S.; Bouzehouane, K.; Barthelemy, A.] CNRS Thales, Unite Mixte Phys, F-91767 Palaiseau, France; [Bocher, L.; Gloter, A.; Imhoff, D.] Univ Paris 11, CNRS, UMR 8502, Phys Solides Lab, F-91405 Orsay, France; [Valencia, S.; Kronast, F.] Berliner Elekt Speicherring Gesell Synchrotronstr, Helmholtz Zentrum Berlin, D-12489 Berlin, Germany; [Moya, X.; Mathur, N. D.] Univ Cambridge, Dept Mat Sci, Cambridge CB2 3QZ, England; [Enouz-Vedrenne, S.] Thales Res & Technol, F-91767 Palaiseau, France; [Fusil, S.] Univ Evry Val dEssonne, F-91025 Evry, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universite Paris Saclay; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB); University of Cambridge; Thales Group; UDICE-French Research Universities; Universite Paris Saclay	Bibes, M (corresponding author), CNRS Thales, Unite Mixte Phys, 1 Ave Augustin Fresnel,Campus Ecole Polytech, F-91767 Palaiseau, France.	manuel.bibes@thalesgroup.com	Bibes, Manuel/C-5899-2013; Bocher, Laura/F-9024-2017; Valencia, Sergio/D-3615-2015; BARTHELEMY, Agnès/ABB-5522-2020; Gloter, Alexandre/ABE-2539-2020; Bibes, Manuel/AAC-5764-2019; GLOTER, Alexandre/F-7130-2017; Garcia, Vincent/C-9359-2012	Bibes, Manuel/0000-0002-6704-3422; Bocher, Laura/0000-0002-9589-8743; Valencia, Sergio/0000-0002-3912-5797; Gloter, Alexandre/0000-0002-4813-3799; Bibes, Manuel/0000-0002-6704-3422; Garcia, Vincent/0000-0002-7230-8130; Kronast, Florian/0000-0001-6048-480X; Moya, Xavier/0000-0003-0276-1981	France-U. K. Partenariat Hubert Curien Alliance program; French Reseau Thematique de Recherche Avancee Triangle de la Physique; European Union (EU); U. K. Engineering and Physical Sciences Research Council [EP/E026206/I]; French C-Nano Ile de France; French Agence Nationale de la Recherche (ANR) Oxitronics; French ANR Alicante; European Enabling Science and Technology; French Microscopie Electronique et Sonde Atomique network; Comissionat per a Universitats i Recerca (Generalitat de Catalunya)	France-U. K. Partenariat Hubert Curien Alliance program; French Reseau Thematique de Recherche Avancee Triangle de la Physique; European Union (EU)(CGIAREuropean Commission); U. K. Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); French C-Nano Ile de France; French Agence Nationale de la Recherche (ANR) Oxitronics(French National Research Agency (ANR)); French ANR Alicante(French National Research Agency (ANR)); European Enabling Science and Technology; French Microscopie Electronique et Sonde Atomique network; Comissionat per a Universitats i Recerca (Generalitat de Catalunya)(Generalitat de Catalunya)	We thank R. Guillemet, C. Israel, M. E. Vickers, R. Mattana, J.-M. George, and P. Seneor for technical assistance, and C. Colliex for fruitful discussions on the microscopy measurements. This study was partially supported by the France-U. K. Partenariat Hubert Curien Alliance program, the French Reseau Thematique de Recherche Avancee Triangle de la Physique, the European Union (EU) Specific Targeted Research Project (STReP) Manipulating the Coupling in Multiferroic Films, EU STReP Controlling Mesoscopic Phase Separation, U. K. Engineering and Physical Sciences Research Council grant EP/E026206/I, French C-Nano Ile de France, French Agence Nationale de la Recherche (ANR) Oxitronics, French ANR Alicante, the European Enabling Science and Technology through European Elelctron Microscopy program, and the French Microscopie Electronique et Sonde Atomique network. X. M. acknowledges support from Comissionat per a Universitats i Recerca (Generalitat de Catalunya).	ABBATE M, 1991, PHYS REV B, V44, P5419, DOI 10.1103/PhysRevB.44.5419; Bihler C, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.045203; Bouzehouane K, 2003, NANO LETT, V3, P1599, DOI 10.1021/nl034610j; Bowen M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.137203; Bowen M, 2003, APPL PHYS LETT, V82, P233, DOI 10.1063/1.1534619; Burton JD, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.174406; Chappert C, 2007, NAT MATER, V6, P813, DOI 10.1038/nmat2024; Chiba D, 2008, NATURE, V455, P515, DOI 10.1038/nature07318; Choi KJ, 2004, SCIENCE, V306, P1005, DOI 10.1126/science.1103218; Chu YH, 2008, NAT MATER, V7, P478, DOI 10.1038/nmat2184; Duan CG, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.047201; Eerenstein W, 2007, NAT MATER, V6, P348, DOI 10.1038/nmat1886; Fechner M, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.212406; Gajek M, 2007, NAT MATER, V6, P296, DOI 10.1038/nmat1860; Garcia V, 2009, NATURE, V460, P81, DOI 10.1038/nature08128; Hollmann N, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.085111; JULLIERE M, 1975, PHYS LETT A, V54, P225, DOI 10.1016/0375-9601(75)90174-7; Kanki T, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2405861; Kohlstedt H, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.125341; Lee J., PREPRINT; Maruyama T, 2009, NAT NANOTECHNOL, V4, P158, DOI [10.1038/nnano.2008.406, 10.1038/NNANO.2008.406]; Niranjan MK, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.104405; Nitta J, 1997, PHYS REV LETT, V78, P1335, DOI 10.1103/PhysRevLett.78.1335; Ohno H, 2000, NATURE, V408, P944, DOI 10.1038/35050040; Overby M, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2917481; Regan TJ, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevLett.87.214422; Riester SWE, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3076107; Sahoo S, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.092108; Scott JF, 2007, SCIENCE, V315, P954, DOI 10.1126/science.1129564; Slonczewski JC, 1996, J MAGN MAGN MATER, V159, pL1, DOI 10.1016/0304-8853(96)00062-5; Stolichnov I, 2008, NAT MATER, V7, P464, DOI 10.1038/nmat2185; Thiele C, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.054408; Tsymbal EY, 2006, SCIENCE, V313, P181, DOI 10.1126/science.1126230; Velev JP, 2009, NANO LETT, V9, P427, DOI 10.1021/nl803318d; Weisheit M, 2007, SCIENCE, V315, P349, DOI 10.1126/science.1136629; Yamauchi K, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2767776; Yang F, 2007, J APPL PHYS, V102, DOI 10.1063/1.2768075; Zhuravlev MY, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.169901; Zhuravlev MY, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.246802; Zutic I, 2004, REV MOD PHYS, V76, P323, DOI 10.1103/RevModPhys.76.323	40	561	578	21	541	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2010	327	5969					1106	1110		10.1126/science.1184028	http://dx.doi.org/10.1126/science.1184028			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560KJ	20075211				2022-12-28	WOS:000274901100029
J	Gegear, RJ; Foley, LE; Casselman, A; Reppert, SM				Gegear, Robert J.; Foley, Lauren E.; Casselman, Amy; Reppert, Steven M.			Animal cryptochromes mediate magnetoreception by an unconventional photochemical mechanism	NATURE			English	Article							BLUE-LIGHT PHOTORECEPTOR; DROSOPHILA; CLOCK; MODEL; ORIENTATION; DEFINE; PERIOD; BIRDS	Understanding the biophysical basis of animal magnetoreception has been one of the greatest challenges in sensory biology. Recently it was discovered that the light-dependent magnetic sense of Drosophila melanogaster is mediated by the ultraviolet (UV)-A/blue light photoreceptor cryptochrome (Cry)(1). Here we show, using a transgenic approach, that the photoreceptive, Drosophila-like type 1 Cry and the transcriptionally repressive, vertebrate-like type 2 Cry of the monarch butterfly (Danaus plexippus) can both function in the magnetoreception system of Drosophila and require UV-A/blue light (wavelength below 420 nm) to do so. The lack of magnetic responses for both Cry types at wavelengths above 420 nm does not fit the widely held view that tryptophan triad-generated radical pairs mediate the ability of Cry to sense a magnetic field. We bolster this assessment by using a mutant form of Drosophila and monarch type 1 Cry and confirm that the tryptophan triad pathway is not crucial in magnetic transduction. Together, these results suggest that animal Crys mediate light-dependent magnetoreception through an unconventional photochemical mechanism. This work emphasizes the utility of Drosophila transgenesis for elucidating the precise mechanisms of Cry-mediated magnetosensitivity in insects and also in vertebrates such as migrating birds.	[Gegear, Robert J.; Foley, Lauren E.; Casselman, Amy; Reppert, Steven M.] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Reppert, SM (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, 364 Plantat St, Worcester, MA 01605 USA.	robert.gegear@umassmed.edu; steven.reppert@umassmed.edu		Gegear, Robert/0000-0001-9886-1324	National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086794] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Q. Yuan for performing the assays in Fig. 3d and the cryptochrome alignments in Supplementary Fig. 1, and P. Emery, C. Merlin and D. R. Weaver for discussions. This work was supported by a grant from the National Institutes of Health.	Berndt A, 2007, J BIOL CHEM, V282, P13011, DOI 10.1074/jbc.M608872200; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Gegear RJ, 2008, NATURE, V454, P1014, DOI 10.1038/nature07183; Hoang N, 2008, PLOS BIOL, V6, P1559, DOI 10.1371/journal.pbio.0060160; Hogben HJ, 2009, CHEM PHYS LETT, V480, P118, DOI 10.1016/j.cplett.2009.08.051; Kaneko M, 2000, J COMP NEUROL, V422, P66, DOI 10.1002/(SICI)1096-9861(20000619)422:1<66::AID-CNE5>3.0.CO;2-2; Lohmann KJ, 2007, J EXP BIOL, V210, P3697, DOI 10.1242/jeb.001313; Maeda K, 2008, NATURE, V453, P387, DOI 10.1038/nature06834; Mouritsen H, 2005, CURR OPIN NEUROBIOL, V15, P406, DOI 10.1016/j.conb.2005.06.003; Ozturk N, 2007, COLD SPRING HARB SYM, V72, P119, DOI 10.1101/sqb.2007.72.015; Ozturk N, 2008, J BIOL CHEM, V283, P3256, DOI 10.1074/jbc.M708612200; PHILLIPS JB, 1992, ETHOL ECOL EVOL, V4, P33, DOI 10.1080/08927014.1992.9525348; Reppert SM, 2006, CELL, V124, P233, DOI 10.1016/j.cell.2006.01.009; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; Ritz T, 2002, NEURON, V34, P503, DOI 10.1016/S0896-6273(02)00707-9; Rodgers CT, 2009, P NATL ACAD SCI USA, V106, P353, DOI 10.1073/pnas.0711968106; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; Sheeba V, 2008, J NEUROPHYSIOL, V99, P976, DOI 10.1152/jn.00930.2007; Solov'yov IA, 2009, BIOPHYS J, V96, P4804, DOI 10.1016/j.bpj.2009.03.048; Song SH, 2007, J BIOL CHEM, V282, P17608, DOI 10.1074/jbc.M702874200; Stanewsky R, 2003, J NEUROBIOL, V54, P111, DOI 10.1002/neu.10164; Tu DC, 2004, SCIENCE, V306, P129, DOI 10.1126/science.1101484; vanVickle-Chavez SJ, 2007, J BIOL CHEM, V282, P10561, DOI 10.1074/jbc.M609314200; Wiltschko R, 2005, CURR BIOL, V15, P1518, DOI 10.1016/j.cub.2005.07.037; Wiltschko W, 2005, J COMP PHYSIOL A, V191, P675, DOI 10.1007/s00359-005-0627-7; Yoshii T, 2009, PLOS BIOL, V7, P813, DOI 10.1371/journal.pbio.1000086; Yuan Q, 2007, MOL BIOL EVOL, V24, P948, DOI 10.1093/molbev/msm011; Zhu HS, 2008, PLOS BIOL, V6, P138, DOI 10.1371/journal.pbio.0060004; Zhu HS, 2005, CURR BIOL, V15, pR953, DOI 10.1016/j.cub.2005.11.030	29	184	198	2	138	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 11	2010	463	7282					804	U114		10.1038/nature08719	http://dx.doi.org/10.1038/nature08719			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	553VG	20098414	Green Accepted, Green Submitted			2022-12-28	WOS:000274394300039
J	Claeys, M				Claeys, Magda			Comment on "Unexpected Epoxide Formation in the Gas-Phase Photooxidation of Isoprene"	SCIENCE			English	Editorial Material							SECONDARY ORGANIC AEROSOL; OXIDATION	Paulot et al. (Reports, 7 August 2009, p. 730) reported that the photooxidation of isoprene under low-nitrogen oxides (NO(x)) conditions produces epoxides that can facilitate the formation of secondary organic aerosol (SOA). However, another pathway involving the formation of methyl-butenediol intermediates can also lead to isoprene-derived SOA formation. Further research is needed to clarify the fate of isoprene in the atmosphere.	Univ Antwerp, Dept Pharmaceut Sci, Antwerp, Belgium	University of Antwerp	Claeys, M (corresponding author), Univ Antwerp, Dept Pharmaceut Sci, Antwerp, Belgium.	magda.claeys@ua.ac.be						Boge O, 2006, ATMOS ENVIRON, V40, P2501, DOI 10.1016/j.atmosenv.2005.12.025; Claeys M, 2004, SCIENCE, V303, P1173, DOI 10.1126/science.1092805; Guenther A, 2006, ATMOS CHEM PHYS, V6, P3181, DOI 10.5194/acp-6-3181-2006; Kleindienst TE, 2009, ATMOS CHEM PHYS, V9, P6541, DOI 10.5194/acp-9-6541-2009; Paulot F, 2009, SCIENCE, V325, P730, DOI 10.1126/science.1172910; Ruppert L, 2000, ATMOS ENVIRON, V34, P1529, DOI 10.1016/S1352-2310(99)00408-2; Surratt JD, 2006, J PHYS CHEM A, V110, P9665, DOI 10.1021/jp061734m; TURNER JO, 1971, TETRAHEDRON LETT, V12, P887	8	4	4	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 5	2010	327	5966								10.1126/science.1180942	http://dx.doi.org/10.1126/science.1180942			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551ZD	20133556				2022-12-28	WOS:000274251800018
J	Scita, G; Di Fiore, PP				Scita, Giorgio; Di Fiore, Pier Paolo			The endocytic matrix	NATURE			English	Review							ASYMMETRIC CELL-DIVISION; TGF-BETA RECEPTOR; ANCHORED GROWTH-FACTOR; CLATHRIN HEAVY-CHAIN; FYVE DOMAIN PROTEIN; P53-MEDIATED TRANSCRIPTION; ENDOSOMAL COMPARTMENT; ALPHA-ADAPTIN; MAP KINASE; STEM-CELLS	Endocytosis has long been thought of as simply a way for cells to internalize nutrients and membrane-associated molecules. But an explosive growth in knowledge has given a new dimension to our understanding of this process. It now seems that endocytosis is a master organizer of signalling circuits, with one of its main roles being the resolution of signals in space and time. Many of the functions of endocytosis that are emerging from recent research cannot yet be reconciled with the canonical view of intracellular trafficking but, instead, point to endocytosis being integrated at a deeper level in the cellular 'master plan' (the cellular network of signalling circuits that lie at the base of the cell's make-up). Deconvolution of this level, which we call the 'endocytic matrix', might uncover a fundamental aspect of how a cell is built.	[Scita, Giorgio; Di Fiore, Pier Paolo] FIRC Inst Mol Oncol Fdn, IFOM, I-20139 Milan, Italy; [Scita, Giorgio; Di Fiore, Pier Paolo] Univ Milan, Dept Med Surg & Dent, I-20122 Milan, Italy; [Di Fiore, Pier Paolo] European Inst Oncol, Dept Expt Oncol, I-20139 Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; University of Milan; IRCCS European Institute of Oncology (IEO)	Di Fiore, PP (corresponding author), FIRC Inst Mol Oncol Fdn, IFOM, IFOM IEO Campus,Via Adamello 16, I-20139 Milan, Italy.	giorgio.scita@ifom-ieo-campus.it; pierpaolo.difiore@ifom-ieo-campus.it	Scita, Giorgio/J-9670-2012; Di Fiore, Pier Paolo/K-2130-2012	Di Fiore, Pier Paolo/0000-0002-2252-0950; Scita, Giorgio/0000-0001-7984-1889	Italian Association for Cancer Research (AIRC); Italian Ministry of Education, University and Scientific Research (MIUR); Association for International Cancer Research; Italian Ministry of Health; European Community; European Research Council; Cariplo Foundation; Ferrari Foundation; Monzino Foundation	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Education, University and Scientific Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); Association for International Cancer Research; Italian Ministry of Health(Ministry of Health, Italy); European Community(European Commission); European Research Council(European Research Council (ERC)European Commission); Cariplo Foundation(Fondazione Cariplo); Ferrari Foundation; Monzino Foundation	We apologize to those colleagues whose primary research papers or important discoveries could not be properly acknowledged because of space constraints. We thank A. Sorkin and M. von Zastrow for sharing, ahead of publication, their excellent review on endocytosis and signalling. We also thank P. R. Romano for critically editing the manuscript. Work in the authors' laboratories is supported by grants from the following: the Italian Association for Cancer Research (AIRC) and the Italian Ministry of Education, University and Scientific Research (MIUR) (to G. S. and P. P. D. F.); the Association for International Cancer Research (G. S.); and the Italian Ministry of Health, the European Community, the European Research Council, the Cariplo Foundation, the Ferrari Foundation and the Monzino Foundation (P. P. D. F.).	Altschuler SJ, 2008, NATURE, V454, P886, DOI 10.1038/nature07119; Andrews R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000493; Balasubramanian N, 2007, NAT CELL BIOL, V9, P1381, DOI 10.1038/ncb1657; Baluska F, 2006, DEV BIOL, V294, P1, DOI 10.1016/j.ydbio.2006.02.047; Beckmann J, 2007, BLOOD, V109, P5494, DOI 10.1182/blood-2006-11-055921; Berdnik D, 2002, DEV CELL, V3, P221, DOI 10.1016/S1534-5807(02)00215-0; Birtwistle MR, 2009, MOL ONCOL, V3, P308, DOI 10.1016/j.molonc.2009.05.009; Boucrot E, 2007, P NATL ACAD SCI USA, V104, P7939, DOI 10.1073/pnas.0702511104; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Caswell PT, 2007, DEV CELL, V13, P496, DOI 10.1016/j.devcel.2007.08.012; Chen YG, 2007, J BIOL CHEM, V282, P9688, DOI 10.1074/jbc.M611704200; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Colaluca IN, 2008, NATURE, V451, P76, DOI 10.1038/nature06412; Coumailleau F, 2009, NATURE, V458, P1051, DOI 10.1038/nature07854; del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Disanza A, 2009, MOL ONCOL, V3, P280, DOI 10.1016/j.molonc.2009.05.008; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Donaldson JG, 2005, BIOCHEM SOC T, V33, P1276, DOI 10.1042/BST0331276; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; Enari M, 2006, GENE DEV, V20, P1087, DOI 10.1101/gad.1381906; Fehrenbacher N, 2009, MOL ONCOL, V3, P297, DOI 10.1016/j.molonc.2009.06.004; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Furthauer M, 2009, MOL ONCOL, V3, P339, DOI 10.1016/j.molonc.2009.05.006; Gillette JM, 2009, NAT CELL BIOL, V11, P303, DOI 10.1038/ncb1838; Grande-Garcia A, 2007, J CELL BIOL, V177, P683, DOI 10.1083/jcb.200701006; Hayes S, 2002, J CELL BIOL, V158, P1239, DOI 10.1083/jcb.200204088; Hieda M, 2008, J CELL BIOL, V180, P763, DOI 10.1083/jcb.200710022; Hutterer A, 2005, EMBO REP, V6, P836, DOI 10.1038/sj.embor.7400500; Irion U, 2007, NATURE, V445, P554, DOI 10.1038/nature05503; Isokane M, 2008, J CELL SCI, V121, P3608, DOI 10.1242/jcs.031443; Jekely G, 2005, DEV CELL, V9, P197, DOI 10.1016/j.devcel.2005.06.004; Jekely G, 2007, ADV EXP MED BIOL, V607, P38; Kholodenko BN, 2003, J EXP BIOL, V206, P2073, DOI 10.1242/jeb.00298; Lanzetti L, 2008, TRAFFIC, V9, P2011, DOI 10.1111/j.1600-0854.2008.00816.x; Lehtonen S, 2008, MOL BIOL CELL, V19, P2949, DOI 10.1091/mbc.E07-05-0521; Maeder CI, 2007, NAT CELL BIOL, V9, P1319, DOI 10.1038/ncb1652; Markevich NI, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100108; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; McGill MA, 2009, J BIOL CHEM, V284, P26427, DOI 10.1074/jbc.M109.014845; Meyers J, 2006, CURR BIOL, V16, P1685, DOI 10.1016/j.cub.2006.07.056; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Mills IG, 2007, SEMIN CELL DEV BIOL, V18, P459, DOI 10.1016/j.semcdb.2007.07.001; Mills IG, 2005, J CELL BIOL, V170, P191, DOI 10.1083/jcb.200503106; Miserey-Lenkei S, 2006, EMBO J, V25, P278, DOI 10.1038/sj.emboj.7600929; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Nada S, 2009, EMBO J, V28, P477, DOI 10.1038/emboj.2008.308; Nilsson L, 2008, GENETICS, V179, P375, DOI 10.1534/genetics.108.087247; Ohmori K, 2008, ONCOGENE, V27, P2215, DOI 10.1038/sj.onc.1210854; Ohya T, 2009, NATURE, V459, P1091, DOI 10.1038/nature08107; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Pasternak SH, 2003, J BIOL CHEM, V278, P26687, DOI 10.1074/jbc.M304009200; Pawson T, 2007, CURR OPIN CELL BIOL, V19, P112, DOI 10.1016/j.ceb.2007.02.013; Pei ZF, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-4; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; Pyrzynska B, 2009, MOL ONCOL, V3, P321, DOI 10.1016/j.molonc.2009.06.001; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Royle SJ, 2005, NATURE, V434, P1152, DOI 10.1038/nature03502; Santolini E, 2000, J CELL BIOL, V151, P1345, DOI 10.1083/jcb.151.6.1345; Schenck A, 2008, CELL, V133, P486, DOI 10.1016/j.cell.2008.02.044; Schweitzer JK, 2005, J BIOL CHEM, V280, P41628, DOI 10.1074/jbc.M504497200; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Stauffer DR, 2001, J CELL SCI, V114, P2383; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Thompson HM, 2004, NAT CELL BIOL, V6, P335, DOI 10.1038/ncb1112; Traynor D, 2007, J CELL SCI, V120, P2318, DOI 10.1242/jcs.007732; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; Vaccari T, 2008, J CELL BIOL, V180, P755, DOI 10.1083/jcb.200708127; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wilkin M, 2008, DEV CELL, V15, P762, DOI 10.1016/j.devcel.2008.09.002; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104; Yamamoto H, 2008, DEV CELL, V15, P37, DOI 10.1016/j.devcel.2008.04.015; Yu X, 2009, FEBS J, V276, P2201, DOI 10.1111/j.1742-4658.2009.06949.x; Zhao C, 2007, NAT CELL BIOL, V9, P706, DOI 10.1038/ncb1594; Zoncu R, 2009, CELL, V136, P1110, DOI 10.1016/j.cell.2009.01.032	82	350	357	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 28	2010	463	7280					464	473		10.1038/nature08910	http://dx.doi.org/10.1038/nature08910			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	548QK	20110990				2022-12-28	WOS:000273981100038
J	Okamoto, N; Furusawa, Y; Sakamoto, K; Yamamoto, T; Kondo, Y; Nagafusa, Y; Higuchi, T				Okamoto, Nagahisa; Furusawa, Yoshihiko; Sakamoto, Kota; Yamamoto, Toshiyuki; Kondo, Yoshiyuki; Nagafusa, Yuko; Higuchi, Teruhiko			Major depression: what caused the crisis?	LANCET			English	Editorial Material							MYASTHENIA-GRAVIS		[Okamoto, Nagahisa; Sakamoto, Kota; Nagafusa, Yuko; Higuchi, Teruhiko] Natl Ctr Hosp Neurol & Psychiat, Dept Psychiat, Kodaira, Tokyo 1878551, Japan; [Furusawa, Yoshihiko; Yamamoto, Toshiyuki; Kondo, Yoshiyuki] Natl Ctr Hosp Neurol & Psychiat, Dept Neurol, Kodaira, Tokyo 1878551, Japan	National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan	Okamoto, N (corresponding author), Natl Ctr Hosp Neurol & Psychiat, Dept Psychiat, 4-1-1 Ogawahigashi, Kodaira, Tokyo 1878551, Japan.	okamoton@ncnp.go.jp						Kohler W, 2007, J NEUROL, V254, P90, DOI 10.1007/s00415-007-2022-5; Kulaksizoglu IB, 2007, CNS DRUGS, V21, P473, DOI 10.2165/00023210-200721060-00004; PANDE AC, 1990, CONVULSIVE THER, V6, P172; ROHR W, 1992, PSYCHIAT PRAX, V19, P157; Shinkai K, 2001, J NEUROPSYCH CLIN N, V13, P116, DOI 10.1176/appi.neuropsych.13.1.116-a	5	3	4	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 23	2010	375	9711					346	346		10.1016/S0140-6736(09)61718-9	http://dx.doi.org/10.1016/S0140-6736(09)61718-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	549QS	20109962				2022-12-28	WOS:000274069300037
J	Spiegel, PB; Checchi, F; Colombo, S; Paik, E				Spiegel, Paul B.; Checchi, Francesco; Colombo, Sandra; Paik, Eugene			Health-care needs of people affected by conflict: future trends and changing frameworks	LANCET			English	Editorial Material							MIDDLE-INCOME COUNTRIES; PREVENTION		[Spiegel, Paul B.; Paik, Eugene] United Nations High Commissioner Refugees, Publ Hlth & HIV Sect, Geneva, Switzerland; [Checchi, Francesco] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; [Colombo, Sandra] Int Rescue Comm, Hlth Unit, New York, NY USA	University of London; London School of Hygiene & Tropical Medicine	Spiegel, PB (corresponding author), United Nations High Commissioner Refugees, Publ Hlth & HIV Sect, Case Postale 2500, Geneva, Switzerland.	spiegel@unhcr.org	Spiegel, Paul/AAL-3238-2021	Spiegel, Paul/0000-0002-6158-6661; Checchi, Francesco/0000-0001-9030-5382				[Anonymous], GLOB STAT IDP COUNTR; Austin J, 2008, REPROD HEALTH MATTER, V16, P10, DOI 10.1016/S0968-8080(08)31351-2; Beaglehole R, 2008, LANCET, V372, P940, DOI 10.1016/S0140-6736(08)61404-X; BURKHOLDER BT, 1995, LANCET, V346, P1012, DOI 10.1016/S0140-6736(95)91694-6; Chan E Y Y, 2007, Asia Pac J Public Health, V19 Spec No, P45; CHECCHI F, 2007, 61 HPN OV DEV I; *EC INT UN, 2009, SPEC REP MANN BARR W; *HUM SEC CTR, 2006, HUM SEC BRIEF 2006; Mowafi H, 2008, JAMA-J AM MED ASSOC, V299, P1713, DOI 10.1001/jama.299.14.1713; Patel V, 2007, LANCET, V370, P991, DOI 10.1016/S0140-6736(07)61240-9; PAVIGNANI E, ANAL DISRUP IN PRESS; Salama P, 2004, LANCET, V364, P1801, DOI 10.1016/S0140-6736(04)17405-9; *SPHER PROJ, 2004, SPHER HDB SHPER PROJ; Spiegel PB, 2007, LANCET, V369, P2187, DOI 10.1016/S0140-6736(07)61015-0; Spiegel PB, 2000, LANCET, V355, P2204, DOI 10.1016/S0140-6736(00)02404-1; *UN DEV PROGR, HUM DEV REP 1993 200; *UN HIGH COMM REF, STAT YB 1994 2007 UN; *UN HIGH COMM REF, 2009, UNHCR STAT ONL POP D; *UN REL WORKS AG, UNRWA FIG 1997 2008; Walker Peter, 2009, SHAPING HUMANITARIAN	20	158	161	0	23	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 23	2010	375	9711					341	345		10.1016/S0140-6736(09)61873-0	http://dx.doi.org/10.1016/S0140-6736(09)61873-0			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	549QS	20109961				2022-12-28	WOS:000274069300036
J	Dawson, J; Doll, H; Fitzpatrick, R; Jenkinson, C; Carr, AJ				Dawson, Jill; Doll, Helen; Fitzpatrick, Ray; Jenkinson, Crispin; Carr, Andrew J.			The routine use of patient reported outcome measures in healthcare settings	BRITISH MEDICAL JOURNAL			English	Article							HIP; QUESTIONNAIRE; MANAGEMENT; CANCER; TRIAL; INDEX	The use of patient reported outcome measures might seem to be quite straightforward; however, a number of pitfalls await clinicians with limited expertise. Jill Dawson and colleagues provide a guide for individuals keen to use patient reported outcome measures at a local level Patient reported outcome measures (PROMs) are standardised, validated questionnaires that are completed by patients to measure their perceptions of their own functional status and wellbeing. Many such measures were originally designed for assessing treatment effectiveness in the context of clinical trials, 1 but are now used more widely to assess patient perspectives of care outcomes. This outcomes based definition of PROMs distinguishes them from questionnaires used to measure patients' experience of the care process. PROMs are designed to measure either patients' perceptions of their general health ("generic" health status) or their perceptions of their health in relation to specific diseases or conditions. The short form 36 (SF-36) health survey, 2 for example, is a generic questionnaire that assesses self perceived health status by using 36 questions relating to eight broad areas (or "domains") of wellbeing. Examples of condition specific questionnaires include the Parkinson's disease questionnaire (PDQ-39), 3 which assesses quality of life in patients with Parkinson's disease; the visual function questionnaire (VF-14), 4 which uses 14 questions to measure various aspects of visual function affected by cataracts; and the Oxford hip score, 5 which uses 12 questions to assess hip pain and function in relation to outcomes of hip replacement surgery. Patients complete PROMs by rating their health in response to individual questions. These responses are scored (from 0 to 4, for example) according to the level of difficulty or severity reported by the patient. When PROMs are analysed, the individual ratings are combined to produce an overall score to represent an underlying phenomenon or "construct," such as " perceived level of pain" or anxiety. The analysis of PROMs tends to focus on the amount of change that has occurred in the patients' condition or their general health related quality of life, as represented by a change in PROM score following an intervention. To date, PROMs have been used in clinical trials,(6 7) national audits,(8) and registers for joint replacement(9) (10) and other conditions.(11) However, the routine use of PROMs has become widespread in heath care at a local level.(12) Interest is also rapidly growing in the application of PROMs in the context of audit and "registers," to inform individual care and manage the performance of healthcare providers.(12 13 14 15 16) Indeed, in the specific areas of hip and knee replacement, inguinal hernia repair, and varicose vein surgery, the routine collection of PROMs has, since April 2009, been introduced throughout the NHS to measure and improve clinical quality.(17) Government led initiatives such as this are likely to encourage more widespread use of PROMs at both a national and a local level. Specific guidance on methods for collecting baseline PROM data are provided in guidelines for the recent NHS-wide PROMs initiative,(18) in which subsequent data collection and handling are undertaken by private contractors. This article, however, is aimed at individuals who are keen to use PROMs at a local level, who may have limited research experience or access to expertise and advice on relevant research methods, and who may be unaware of a number of pitfalls that could undermine their aim of ultimately producing useful, meaningful data. In addition, there are very few published examples of the application of PROMs in the context of clinical governance and quality assurance,(19) with this form of application being largely unevaluated. Evidence of the impact of using PROMs on routine practice is also lacking.	[Dawson, Jill; Doll, Helen; Fitzpatrick, Ray; Jenkinson, Crispin] Univ Oxford, Dept Publ Hlth, Oxford OX3 7LF, England; [Dawson, Jill] Oxford Brookes Univ, Sch Hlth & Social Care, Oxford OX3 0BP, England; [Carr, Andrew J.] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford OX3 7LD, England	University of Oxford; Oxford Brookes University; University of Oxford	Dawson, J (corresponding author), Univ Oxford, Dept Publ Hlth, Oxford OX3 7LF, England.	jill.dawson@dphpc.ox.ac.uk						Appleby J, 2004, MEASURING SUCCESS NH; Black N, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2495; BRACKEN MB, 1989, BRIT J OBSTET GYNAEC, V96, P383, DOI 10.1111/j.1471-0528.1989.tb02410.x; Dawson J, 1996, J BONE JOINT SURG BR, V78B, P185, DOI 10.1302/0301-620X.78B2.0780185; *DEP HLTH, 2007, OUR NHS OUR FUT NHS; Department of Health, 2009, GUID ROUT COLL PAT R; EDWARDS AWF, SOME QUOTATIONS RA F; Fitzpatrick R, 1998, Health Technol Assess, V2, P1; Ganz PA, 2007, J CLIN ONCOL, V25, P5063, DOI 10.1200/JCO.2007.11.0197; Grant AM, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2664; Greenhalgh J, 2005, SOC SCI MED, V60, P833, DOI 10.1016/j.socscimed.2004.06.022; Haywood K, 2006, PATIENT EDUC COUNS, V63, P12, DOI 10.1016/j.pec.2005.10.005; Jenkinson C, 1997, AGE AGEING, V26, P353, DOI 10.1093/ageing/26.5.353; MALCHAU H, 2005, CLIN ORTHOP REL RES; *MAPI RES TRUST, 2009, PAT REP OUTC QUAL LI; Matthews FE, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-12; New Zealand Joint Registry, 2008, NZ JOINT REG 9 YEAR; Saleh KJ, 2004, CLIN ORTHOP RELAT R, P272, DOI 10.1097/01.blo.0000137589.23853.61; Silverman LR, 2002, J CLIN ONCOL, V20, P2429, DOI 10.1200/JCO.2002.04.117; STEINBERG EP, 1994, ARCH OPHTHALMOL-CHIC, V112, P630, DOI 10.1001/archopht.1994.01090170074026; Timmins N, 2008, BRIT MED J, V336, P1464, DOI 10.1136/bmj.39618.627951.80; Vallance-Owen A, 2004, J PUBLIC HEALTH-UK, V26, P187, DOI 10.1093/pubmed/fdh127; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WASSON J, 1992, MED CARE, V30, pMS42, DOI 10.1097/00005650-199205001-00004; Williams O, 2002, J ARTHROPLASTY, V17, P165, DOI 10.1054/arth.2002.29389; Zanoli G, 2006, ACTA ORTHOP, V77, P662, DOI 10.1080/17453670610012764	26	338	338	1	72	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 18	2010	340								c186	10.1136/bmj.c186	http://dx.doi.org/10.1136/bmj.c186			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	548HM	20083546				2022-12-28	WOS:000273951100003
J	Yecies, JL; Manning, BD				Yecies, Jessica L.; Manning, Brendan D.			Chewing the Fat on Tumor Cell Metabolism	CELL			English	Editorial Material							CANCER		[Yecies, Jessica L.; Manning, Brendan D.] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Manning, BD (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA.	bmanning@hsph.harvard.edu	Manning, Brendan/ABD-6528-2021	Manning, Brendan/0000-0003-3895-5956				Buzzai M, 2005, ONCOGENE, V24, P4165, DOI 10.1038/sj.onc.1208622; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; MEDES G, 1953, CANCER RES, V13, P27; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; ROSE DP, 1991, JNCI-J NATL CANCER I, V83, P1491, DOI 10.1093/jnci/83.20.1491; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268	9	24	29	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 8	2010	140	1					28	30		10.1016/j.cell.2009.12.037	http://dx.doi.org/10.1016/j.cell.2009.12.037			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	541CY	20085702	Bronze			2022-12-28	WOS:000273391900011
J	Seal, MD; Chia, SK				Seal, Melanie D.; Chia, Stephen K.			Challenging the dogma on trastuzumab: a matter of the heart	LANCET			English	Editorial Material							BREAST-CANCER; NEOADJUVANT THERAPY; CHEMOTHERAPY; PACLITAXEL; EPIRUBICIN; ANTIBODY; TRIAL; HER2		[Seal, Melanie D.; Chia, Stephen K.] British Columbia Canc Agcy, Div Med Oncol, Vancouver, BC V5Z 4E6, Canada	British Columbia Cancer Agency	Chia, SK (corresponding author), British Columbia Canc Agcy, Div Med Oncol, Vancouver, BC V5Z 4E6, Canada.	schia@bccancer.bc.ca						Buzdar AU, 2007, CLIN CANCER RES, V13, P228, DOI 10.1158/1078-0432.CCR-06-1345; Buzdar AU, 2005, J CLIN ONCOL, V23, P3676, DOI 10.1200/JCO.2005.07.032; Chia S, 2008, J CLIN ONCOL, V26, P786, DOI 10.1200/JCO.2008.15.0243; Gianni L, 2010, LANCET, V375, P377, DOI 10.1016/S0140-6736(09)61964-4; MIGLIACCIO I, 2009, CANC RES S, V69; Pegram M, 1999, ONCOGENE, V18, P2241, DOI 10.1038/sj.onc.1202526; Perez EA, 2007, J CLIN ONCOL S, V25, p6S; Pritchard KI, 2006, NEW ENGL J MED, V354, P2103, DOI 10.1056/NEJMoa054504; Rastogi P, 2008, J CLIN ONCOL, V26, P778, DOI 10.1200/JCO.2007.15.0235; SLAMON D, 2006, BREAST CANC RES T S1, V100, pS90; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Smith I, 2007, LANCET, V369, P29, DOI 10.1016/S0140-6736(07)60028-2; Suter TM, 2007, J CLIN ONCOL, V25, P3859, DOI 10.1200/JCO.2006.09.1611; UNTCH M, 2009, 6 EUR BREAST CANC C	14	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2010	375	9712					349	350		10.1016/S0140-6736(09)62069-9	http://dx.doi.org/10.1016/S0140-6736(09)62069-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	552PK	20113810				2022-12-28	WOS:000274305500004
J	Sansom, RS; Gabbott, SE; Purnell, MA				Sansom, Robert S.; Gabbott, Sarah E.; Purnell, Mark A.			Non-random decay of chordate characters causes bias in fossil interpretation	NATURE			English	Article							BURGESS SHALE; PRESERVATION; VERTEBRATES; PHYLOGENY; BRANCHIOSTOMA; ORGANISMS; EVOLUTION; TAPHONOMY; BIOLOGY; ORIGIN	Exceptional preservation of soft-bodied Cambrian chordates provides our only direct information on the origin of vertebrates(1,2). Fossil chordates from this interval offer crucial insights into how the distinctive body plan of vertebrates evolved, but reading this pre-biomineralization fossil record is fraught with difficulties, leading to controversial and contradictory interpretations(3,4). The cause of these difficulties is taphonomic: we lack data on when and how important characters change as they decompose, resulting in a lack of constraint on anatomical interpretation and a failure to distinguish phylogenetic absence of characters from loss through decay(3). Here we show, from experimental decay of amphioxus and ammocoetes, that loss of chordate characters during decay is non-random: the more phylogenetically informative are the most labile, whereas plesiomorphic characters are decay resistant. The taphonomic loss of synapomorphies and relatively higher preservation potential of chordate plesiomorphies will thus result in bias towards wrongly placing fossils on the chordate stem. Application of these data to Cathaymyrus (Cambrian period of China) and Metaspriggina (Cambrian period of Canada) highlights the difficulties: these fossils cannot be placed reliably in the chordate or vertebrate stem because they could represent the decayed remains of any non-biomineralized, total-group chordate. Preliminary data suggest that this decay filter also affects other groups of organisms and that 'stem-ward slippage' may be a widespread but currently unrecognized bias in our understanding of the early evolution of a number of phyla.	[Sansom, Robert S.; Gabbott, Sarah E.; Purnell, Mark A.] Univ Leicester, Dept Geol, Leicester LE1 7RH, Leics, England	University of Leicester	Purnell, MA (corresponding author), Univ Leicester, Dept Geol, Leicester LE1 7RH, Leics, England.	mark.purnell@le.ac.uk	Sansom, Robert/H-1902-2012; Purnell, Mark/A-2336-2010	Purnell, Mark/0000-0002-1777-9220; Sansom, Robert/0000-0003-1926-2556	UK Natural Environment Research Council [NE/E015336/1]; Natural Environment Research Council [NE/E015336/1] Funding Source: researchfish; NERC [NE/E015336/1] Funding Source: UKRI	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by UK Natural Environment Research Council grant NE/E015336/1. Specimens were provided by H. Escriva (Banyuls-sur-Mer, France) and B. Morland and S. Morland (Bellflask Ecological Survey), with practical assistance from C. Koch, C. Pratt and P. Griffiths. We thank D. Briggs for his feedback on the submitted manuscript.	Bartolomaeus T, 2005, HYDROBIOLOGIA, V535, P341, DOI 10.1007/s10750-004-1847-5; Briggs DEG, 2003, ANNU REV EARTH PL SC, V31, P275, DOI 10.1146/annurev.earth.31.100901.144746; BRIGGS DEG, 1993, LETHAIA, V26, P275, DOI 10.1111/j.1502-3931.1993.tb01532.x; Briggs DEG, 1995, PALAIOS, V10, P539, DOI 10.2307/3515093; BRIGGS DEG, 1993, PALEOBIOLOGY, V19, P107, DOI 10.1017/S0094837300012343; BUTTERFIELD NJ, 1990, PALEOBIOLOGY, V16, P272, DOI 10.1017/S0094837300009994; Butterfield NJ, 2003, INTEGR COMP BIOL, V43, P166, DOI 10.1093/icb/43.1.166; Delarbre C, 2002, MOL PHYLOGENET EVOL, V22, P184, DOI 10.1006/mpev.2001.1045; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Donoghue PCJ, 2005, TRENDS ECOL EVOL, V20, P312, DOI 10.1016/j.tree.2005.04.008; Donoghue PCJ, 2009, BIOESSAYS, V31, P178, DOI 10.1002/bies.200800128; Eriksson M, 1999, J PALEONTOL, V73, P403, DOI 10.1017/S002233600002792X; Fedewa Luke A., 2005, Journal of Herpetological Medicine and Surgery, V15, P13; Fuentes M, 2004, J EXP ZOOL PART B, V302B, P384, DOI 10.1002/jez.b.20025; Gaines RR, 2008, GEOLOGY, V36, P755, DOI 10.1130/G24961A.1; Gee H, 2008, NATURE, V453, P999, DOI 10.1038/453999a; Holland ND, 2001, BIOESSAYS, V23, P142, DOI 10.1002/1521-1878(200102)23:2<142::AID-BIES1021>3.0.CO;2-5; Janvier P, 1996, PALAEONTOLOGY, V39, P259; Janvier P, 1997, GEOBIOS-LYON, V30, P931, DOI 10.1016/S0016-6995(97)80217-3; Janvier P, 2003, CR PALEVOL, V2, P523, DOI 10.1016/j.crpv.2003.09.002; Mallatt J, 2003, J MORPHOL, V258, P1, DOI 10.1002/jmor.10081; Merz RA, 2006, INTEGR COMP BIOL, V46, P481, DOI 10.1093/icb/icj057; Morris SC, 2008, J PALEONTOL, V82, P424, DOI 10.1666/06-130.1; Richardson MK, 2003, J MORPHOL, V257, P348, DOI 10.1002/jmor.10119; Rouse GW, 1997, ZOOL SCR, V26, P139, DOI 10.1111/j.1463-6409.1997.tb00412.x; Sagemann J, 1999, GEOCHIM COSMOCHIM AC, V63, P1083, DOI 10.1016/S0016-7037(99)00087-3; Shu DG, 1996, NATURE, V384, P157, DOI 10.1038/384157a0; Smith MP, 2001, SYST ASSOC SPEC VOL, V61, P67; Swalla BJ, 2008, PHILOS T R SOC B, V363, P1557, DOI 10.1098/rstb.2007.2246; Yasui K, 2008, ZOOL SCI, V25, P1012, DOI 10.2108/zsj.25.1012	30	137	142	2	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 11	2010	463	7282					797	800		10.1038/nature08745	http://dx.doi.org/10.1038/nature08745			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	553VG	20118914				2022-12-28	WOS:000274394300037
J	Krin, CS; Giannou, C; Seppelt, IM; Walker, S; Mattox, KL; Wigle, RL; Crippen, D				Krin, Charles S.; Giannou, Christos; Seppelt, Ian M.; Walker, Steve; Mattox, Kenneth L.; Wigle, Richard L.; Crippen, David			Disaster management Appropriate response to humanitarian crises	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Seppelt, Ian M.] Nepean Hosp, Dept Intens Care Med, Penrith, NSW, Australia; [Walker, Steve] CareFlight, Sydney, NSW, Australia; [Mattox, Kenneth L.] Ben Taub Gen Hosp, Houston, TX 77030 USA; [Wigle, Richard L.] Louisiana State Univ, Med Ctr, Shreveport, LA USA; [Crippen, David] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA	Nepean Hospital; University of Sydney; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh									0	10	10	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 2	2010	340								c562	10.1136/bmj.c562	http://dx.doi.org/10.1136/bmj.c562			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	553CU	20124565				2022-12-28	WOS:000274343400004
J	Crocker, JC				Crocker, John C.			Turning Away from High Symmetry	SCIENCE			English	Editorial Material							ATTRACTION		Univ Penn, Philadelphia, PA 19104 USA	University of Pennsylvania	Crocker, JC (corresponding author), Univ Penn, 220 S 33rd St, Philadelphia, PA 19104 USA.	jcrocker@seas.upenn.edu	Crocker, John C/D-4991-2012	Crocker, John C/0000-0001-6239-6010				Arkus N, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.118303; Biancaniello PL, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.058302; Crocker JC, 1999, PHYS REV LETT, V82, P4352, DOI 10.1103/PhysRevLett.82.4352; Kim AJ, 2006, LANGMUIR, V22, P1991, DOI 10.1021/la0528955; Lu PJ, 2008, NATURE, V453, P499, DOI 10.1038/nature06931; Manoharan VN, 2003, SCIENCE, V301, P483, DOI 10.1126/science.1086189; Meng GN, 2010, SCIENCE, V327, P560, DOI 10.1126/science.1181263	7	13	13	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 29	2010	327	5965					535	536		10.1126/science.1184457	http://dx.doi.org/10.1126/science.1184457			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549CT	20110493				2022-12-28	WOS:000274020500024
J	Trivedi, AN; Moloo, H; Mor, V				Trivedi, Amal N.; Moloo, Husein; Mor, Vincent			Increased Ambulatory Care Copayments and Hospitalizations among the Elderly	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEALTH MAINTENANCE ORGANIZATION; EMERGENCY-DEPARTMENT; SERVICES; BENEFITS; INSURANCE; PLAN; EVENTS	BACKGROUND When copayments for ambulatory care are increased, elderly patients may forgo important outpatient care, leading to increased use of hospital care. METHODS We compared longitudinal changes in the use of outpatient and inpatient care between enrollees in Medicare plans that increased copayments for ambulatory care and enrollees in matched control plans-similar plans that made no changes in these copayments. The study population included 899,060 beneficiaries enrolled in 36 Medicare plans during the period from 2001 through 2006. RESULTS In plans that increased copayments for ambulatory care, mean copayments nearly doubled for both primary care ($7.38 to $14.38) and specialty care ($12.66 to $22.05). In control plans, mean copayments for primary care and specialty care remained unchanged at $8.33 and $11.38, respectively. In the year after the rise in copayments, plans that increased cost sharing had 19.8 fewer annual outpatient visits per 100 enrollees (95% confidence interval [CI], 16.6 to 23.1), 2.2 additional annual hospital admissions per 100 enrollees (95% CI, 1.8 to 2.6), 13.4 more annual inpatient days per 100 enrollees (95% CI, 10.2 to 16.6), and an increase of 0.7 percentage points in the proportion of enrollees who were hospitalized (95% CI, 0.51 to 0.95), as compared with concurrent trends in control plans. These estimates were consistent among a cohort of continuously enrolled beneficiaries. The effects of increases in copayments for ambulatory care were magnified among enrollees living in areas of lower income and education and among enrollees who had hypertension, diabetes, or a history of myocardial infarction. CONCLUSIONS Raising cost sharing for ambulatory care among elderly patients may have adverse health consequences and may increase total spending on health care.	[Trivedi, Amal N.; Moloo, Husein; Mor, Vincent] Brown Univ, Alpert Med Sch, Dept Community Hlth, Providence, RI 02912 USA; [Trivedi, Amal N.] Providence VA Med Ctr, Res Enhancement Award Program, Providence, RI USA	Brown University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center	Trivedi, AN (corresponding author), Brown Univ, Alpert Med Sch, Dept Community Hlth, Box G-S121, Providence, RI 02912 USA.	amal_trivedi@brown.edu			Veterans Affairs Health Services Research and Development Service	Veterans Affairs Health Services Research and Development Service(US Department of Veterans Affairs)	Dr. Trivedi is the recipient of a Pfizer Health Policy Scholars Award and a career development award from the Veterans Affairs Health Services Research and Development Service.	Agency for Healthcare Research and Quality Healthcare Cost and Utilization Project, HCUPNET; [Anonymous], 2001, INTERSTUDY COMPETITI; BECK RG, 1980, MED CARE, V18, P787, DOI 10.1097/00005650-198008000-00001; Buntin MB, 2004, J HEALTH ECON, V23, P525, DOI 10.1016/j.jhealeco.2003.10.005; CHANDRA A, 2007, 12972 NBER; CHERKIN DC, 1989, MED CARE, V27, P1036, DOI 10.1097/00005650-198911000-00005; Claxton G, 2006, HEALTH AFFAIR, V25, pW476, DOI 10.1377/hlthaff.25.w476; *COMM FUND, 2003, MED CHOIC PLANS CONT; CULYER AJ, 2000, HDB HLTH EC, P409; CUTLER DM, 1997, 6107 NBER; Diehr P, 1999, ANNU REV PUBL HEALTH, V20, P125, DOI 10.1146/annurev.publhealth.20.1.125; Eichner MJ, 1998, AM ECON REV, V88, P117; Freiberg L Jr, 1976, Inquiry, V13, P54; Ginsburg PB, 2007, NEW ENGL J MED, V356, P1201, DOI 10.1056/NEJMp068272; Goldman DP, 2004, JAMA-J AM MED ASSOC, V291, P2344, DOI 10.1001/jama.291.19.2344; GRUBER J, ROLE CONSUMER COPAY; Helms LJ, 1978, COPAYMENTS DEMAND ME; Hsu J, 2006, HEALTH SERV RES, V41, P1801, DOI 10.1111/j.1475-6773.2006.00562.x; Hsu J, 2006, NEW ENGL J MED, V354, P2349, DOI 10.1056/NEJMsa054436; Magid DJ, 1997, NEW ENGL J MED, V336, P1722, DOI 10.1056/NEJM199706123362406; NEWHOUSE JP, 1981, NEW ENGL J MED, V305, P1501, DOI 10.1056/NEJM198112173052504; Rice T, 2004, MED CARE RES REV, V61, P415, DOI 10.1177/1077558704269498; RODDY PC, 1986, MED CARE, V24, P873, DOI 10.1097/00005650-198609000-00009; SCHEFFLER RM, 1984, MED CARE, V22, P247, DOI 10.1097/00005650-198403000-00008; SCITOVSKY AA, 1972, SOC SECUR BULL, V35, P3; Selby JV, 1996, NEW ENGL J MED, V334, P635, DOI 10.1056/NEJM199603073341006; SOUMERAI SB, 1994, NEW ENGL J MED, V331, P650, DOI 10.1056/NEJM199409083311006; Tamblyn R, 2001, JAMA-J AM MED ASSOC, V285, P421, DOI 10.1001/jama.285.4.421; Trivedi AN, 2008, NEW ENGL J MED, V358, P375, DOI 10.1056/NEJMsa070929; Trivedi AN, 2008, JAMA-J AM MED ASSOC, V300, P2879, DOI 10.1001/jama.2008.888; Trivedi AN, 2005, NEW ENGL J MED, V353, P692, DOI 10.1056/NEJMsa051207; Wharam JF, 2007, JAMA-J AM MED ASSOC, V297, P1093, DOI 10.1001/jama.297.10.1093; MEDICARE HEDIS3 0 19; MEDICAID SCHIP STATE	34	118	118	2	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 28	2010	362	4					320	328		10.1056/NEJMsa0904533	http://dx.doi.org/10.1056/NEJMsa0904533			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	548OT	20107218				2022-12-28	WOS:000273975000008
J	Hodge, JG; Courtney, B				Hodge, James G., Jr.; Courtney, Brooke			Assessing the Legal Standard of Care in Public Health Emergencies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PHYSICIANS		[Hodge, James G., Jr.] Arizona State Univ, Sandra Day O'Connor Coll Law, Publ Hlth Law & Policy Program, Tempe, AZ 85287 USA; [Courtney, Brooke] Univ Pittsburgh, Med Ctr, Ctr Biosecur, Baltimore, MD USA	Arizona State University; Arizona State University-Tempe; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Maryland; University of Maryland Baltimore	Hodge, JG (corresponding author), Arizona State Univ, Sandra Day O'Connor Coll Law, Publ Hlth Law & Policy Program, POB 877906,Armstrong Hall,Room 120E, Tempe, AZ 85287 USA.	james.hodge.1@asu.edu						Fink S., 2009, NEW YORK TIMES MAGAZ, pMM28; Gostin LO, 2009, JAMA-J AM MED ASSOC, V302, P2365, DOI 10.1001/jama.2009.1780; Hall Mark A., 2003, HLTH CARE LAW ETHICS; Lewis MH, 2007, JAMA-J AM MED ASSOC, V297, P2633, DOI 10.1001/jama.297.23.2633; Institute of Medicine, 2010, CRISIS STANDARDS CAR, P69; KINNEY ED, 2009, IND HLTH L REV, V6; Powell T, 2008, DISASTER MED PUBLIC, V2, P20, DOI 10.1097/DMP.0b013e3181620794; Studdert DM, 2005, JAMA-J AM MED ASSOC, V293, P2609, DOI 10.1001/jama.293.21.2609; *US DEP HHS, 2009, DET PUBL HLTH EM EX; *WHIT HOUS OFF PRE, 2009, DECL NAT EM RESP 200	10	18	18	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 27	2010	303	4					361	362		10.1001/jama.2010.31	http://dx.doi.org/10.1001/jama.2010.31			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	548IC	20103761				2022-12-28	WOS:000273952800026
J	Robles, MS; Boyault, C; Knutti, D; Padmanabhan, K; Weitz, CJ				Robles, Maria S.; Boyault, Cyril; Knutti, Darko; Padmanabhan, Kiran; Weitz, Charles J.			Identification of RACK1 and Protein Kinase C alpha as Integral Components of the Mammalian Circadian Clock	SCIENCE			English	Article							GENE-EXPRESSION; PHOSPHORYLATION; ACTIVATION; MECHANISM; CRYPTOCHROME; DEGRADATION; OSCILLATION; REVEALS; PERIOD; BMAL1	At the core of the mammalian circadian clock is a negative feedback loop in which the dimeric transcription factor CLOCK-BMAL1 drives processes that in turn suppress its transcriptional activity. To gain insight into the mechanisms of circadian feedback, we analyzed mouse protein complexes containing BMAL1. Receptor for activated C kinase-1 (RACK1) and protein kinase C-alpha (PKC alpha) were recruited in a circadian manner into a nuclear BMAL1 complex during the negative feedback phase of the cycle. Overexpression of RACK1 and PKC alpha suppressed CLOCK-BMAL1 transcriptional activity, and RACK1 stimulated phosphorylation of BMAL1 by PKC alpha in vitro. Depletion of endogenous RACK1 or PKC alpha from fibroblasts shortened the circadian period, demonstrating that both molecules function in the clock oscillatory mechanism. Thus, the classical PKC signaling pathway is not limited to relaying external stimuli but is rhythmically activated by internal processes, forming an integral part of the circadian feedback loop.	[Robles, Maria S.; Boyault, Cyril; Knutti, Darko; Padmanabhan, Kiran; Weitz, Charles J.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Weitz, CJ (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	cweitz@hms.harvard.edu	Robles, Maria/ABH-1497-2020; Boyault, Cyril/K-3593-2014; Robles, Maria S/D-6307-2015; Padmanabhan, Kiran/N-2953-2013	Robles, Maria/0000-0001-9149-8761; Robles, Maria S/0000-0001-9149-8761; Padmanabhan, Kiran/0000-0001-7020-1682; Boyault, Cyril/0000-0001-9614-4292	Edward R. and Anne G. Lefler Center; G. Harold and Leila Y. Mathers Charitable Foundation; Swiss National Science Foundation; EMBO	Edward R. and Anne G. Lefler Center; G. Harold and Leila Y. Mathers Charitable Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EMBO(European Molecular Biology Organization (EMBO))	We thank P. Nakatani (Dana-Farber Cancer Institute) for the FH cassette; P. Sassone-Corsi (University of California, Irvine) for BMAL1 antiserum; M. J. Weber (University of Virginia), D. Mochly-Rosen (Stanford University), P. Blumberg (National Cancer Institute), and M. Grossi (University of Rome), respectively, for RACK1, C2, PKCa, and MYOD cDNAs; M. Liu for expert technical assistance; N. Vujovic for help with transactivation assays; and L. Lande-Diner for comments on the manuscript. Supported by grants from the Edward R. and Anne G. Lefler Center and the G. Harold and Leila Y. Mathers Charitable Foundation (C. J. W.), an Edward R. and Anne G. Lefler Center postdoctoral fellowship (M. S. R.), a Swiss National Science Foundation grant (D. K.), and an EMBO postdoctoral fellowship (C. B.).	Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Dardente H, 2007, BIOCHEM J, V402, P525, DOI 10.1042/BJ20060827; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; Harrisingh MC, 2007, J NEUROSCI, V27, P12489, DOI 10.1523/JNEUROSCI.3680-07.2007; Hu LJ, 2006, J MOL NEUROSCI, V29, P55, DOI 10.1385/JMN:29:1:55; Imaizumi T., 2007, SCI STKE, ppe32; Jakubcakova V, 2007, NEURON, V54, P831, DOI 10.1016/j.neuron.2007.04.031; Lee B, 2007, EUR J NEUROSCI, V26, P451, DOI 10.1111/j.1460-9568.2007.05664.x; Lee HS, 2002, OSTEOARTHR CARTILAGE, V10, P890, DOI 10.1053/joca.2002.0842; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Liu YV, 2007, CELL CYCLE, V6, P656, DOI 10.4161/cc.6.6.3981; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Schak KM, 1999, BRAIN RES, V840, P158, DOI 10.1016/S0006-8993(99)01787-4; Schechtman D, 2001, ONCOGENE, V20, P6339, DOI 10.1038/sj.onc.1204778; Shim HS, 2007, EMBO REP, V8, P366, DOI 10.1038/sj.embor.7400920; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; Sklan EH, 2006, PROG NEUROBIOL, V78, P117, DOI 10.1016/j.pneurobio.2005.12.002; Stebbins EG, 2001, J BIOL CHEM, V276, P29644, DOI 10.1074/jbc.M101044200; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Tamaru T, 2003, GENES CELLS, V8, P973, DOI 10.1046/j.1365-2443.2003.00686.x; Tamaru T, 2009, NAT STRUCT MOL BIOL, V16, P446, DOI 10.1038/nsmb.1578; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yoshitane H, 2009, MOL CELL BIOL, V29, P3675, DOI 10.1128/MCB.01864-08	26	101	109	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 22	2010	327	5964					463	466		10.1126/science.1180067	http://dx.doi.org/10.1126/science.1180067			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546BS	20093473				2022-12-28	WOS:000273783100037
J	Tomlinson, G; Detsky, AS				Tomlinson, George; Detsky, Allan S.			Composite End Points in Randomized Trials There Is No Free Lunch	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ROSIGLITAZONE; OUTCOMES		[Tomlinson, George; Detsky, Allan S.] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Tomlinson, George; Detsky, Allan S.] Univ Hlth Network, Toronto, ON, Canada; [Tomlinson, George; Detsky, Allan S.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Tomlinson, George; Detsky, Allan S.] Univ Toronto, Dept Med, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Detsky, AS (corresponding author), Mt Sinai Hosp, Dept Med, 600 Univ Ave,Ste 429, Toronto, ON M5G 1X5, Canada.	adetsky@mtsinai.on.ca	Tomlinson, George A/L-5432-2016	Tomlinson, George A/0000-0002-9328-6399				Cantor WJ, 2009, NEW ENGL J MED, V360, P2705, DOI 10.1056/NEJMoa0808276; DETSKY AS, 1985, J CHRON DIS, V38, P753, DOI 10.1016/0021-9681(85)90118-3; Ferreira-Gonzalez I, 2007, BRIT MED J, V334, P786, DOI 10.1136/bmj.39136.682083.AE; Ferreira-Gonzalez I, 2007, J CLIN EPIDEMIOL, V60, P651, DOI 10.1016/j.jclinepi.2006.10.020; Freemantle N, 2003, JAMA-J AM MED ASSOC, V289, P2554, DOI 10.1001/jama.289.19.2554; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; Gold MR, 1996, COST EFFECTIVENESS H; Kent DM, 2009, JAMA-J AM MED ASSOC, V302, P2254, DOI 10.1001/jama.2009.1679; Lim E, 2008, ANN INTERN MED, V149, P612, DOI 10.7326/0003-4819-149-9-200811040-00004; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761	10	92	94	1	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 20	2010	303	3					267	268		10.1001/jama.2009.2017	http://dx.doi.org/10.1001/jama.2009.2017			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	544WM	20085955				2022-12-28	WOS:000273690600023
J	Flouris, AD; Oikonomou, DN				Flouris, Andreas D.; Oikonomou, Dimitris N.			Personal View Electronic cigarettes: miracle or menace?	BRITISH MEDICAL JOURNAL			English	Editorial Material							SECONDHAND SMOKE		[Flouris, Andreas D.; Oikonomou, Dimitris N.] Ctr Res & Technol Thessaly, Inst Human Performance & Rehabil, FAME Lab, Volos, Greece		Flouris, AD (corresponding author), Ctr Res & Technol Thessaly, Inst Human Performance & Rehabil, FAME Lab, Volos, Greece.	aflouris@cereteth.gr	Flouris, Andreas/GXG-4893-2022					Flouris AD, 2010, AM J PHYSIOL-LUNG C, V298, pL3, DOI 10.1152/ajplung.00215.2009; Flouris AD, 2009, AM J RESP CRIT CARE, V179, P1029, DOI 10.1164/rccm.200812-1920OC; Laugesen M, 2008, SAFE IS E CIGARETTE; Leondiadis L, 2009, RESULTS CHEM ANAL NO; Pauly J, 2007, TOB CONTROL, V16, P357, DOI 10.1136/tc.2006.019687; Westenberger BJ., 2009, EVALUATION E CIGARET	6	39	39	0	14	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 19	2010	340								c311	10.1136/bmj.c311	http://dx.doi.org/10.1136/bmj.c311			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	548HN	20085989				2022-12-28	WOS:000273951200021
J	Stein, J				Stein, Joel			The Family Business	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												js1165@columbia.edu		Stein, Joel/0000-0001-5527-025X					0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 13	2010	303	2					114	114		10.1001/jama.2009.1905	http://dx.doi.org/10.1001/jama.2009.1905			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	542UI	20068197				2022-12-28	WOS:000273522600001
J	Liese, B; Rosenberg, M; Schratz, A				Liese, Bernhard; Rosenberg, Mark; Schratz, Alexander			Neglected Tropical Diseases 1 Programmes, partnerships, and governance for elimination and control of neglected tropical diseases	LANCET			English	Article							ONCHOCERCIASIS CONTROL; LYMPHATIC FILARIASIS; GLOBAL ELIMINATION; CHAGAS-DISEASE; GUINEA WORM; TRACHOMA; ERADICATION; INTEGRATION; SCHISTOSOMIASIS; PROGRESS	Neglected tropical diseases represent one of the most serious burdens to public health. Many can be treated cost-effectively, yet they have been largely ignored on the global health policy agenda until recently. In this first paper in the Series we review the fragmented structure of elimination and control programmes for these diseases, starting with the ambiguous definition of a neglected tropical disease. We describe selected international control initiatives and present their effect, governance arrangements, and financing mechanisms, including substantial drug-donation programmes. We also discuss efforts to exploit shared features of these diseases by integration of selected control activities within countries, thus creating economies of scope. Finally we address the challenges, resulting from the diversity of disease control approaches and governance structures-both nationally and internationally-and provide some suggestions for the way forward.	[Liese, Bernhard] Georgetown Univ, Dept Int Hlth, SNHS, Washington, DC 20007 USA; [Rosenberg, Mark] Task Force Global Hlth, Decatur, GA USA	Georgetown University	Liese, B (corresponding author), Georgetown Univ, Dept Int Hlth, SNHS, 3700 Reservoir Rd NW, Washington, DC 20007 USA.	bhl6@georgetown.edu						ADDISS DG, 2005, INDIAN J UROL, V7, P12; Alleman Mary M, 2006, Filaria J, V5, P11, DOI 10.1186/1475-2883-5-11; [Anonymous], 2008, GLOB MAL ACT PLAN MA; Austin J.E., 2000, COLLABORATION CHALLE; Bailey R, 2001, B WORLD HEALTH ORGAN, V79, P233; BARRETT D, 2000, PUBLIC PRIVATE PARTN, P41; Barry M, 2007, NEW ENGL J MED, V356, P2561, DOI 10.1056/NEJMp078089; BAYER AG, 2008, SUSTAINABLE DEV REPO; BAYER AG, 2006, SUSTAINABLE DEV REPO; Benton B, 1998, ANN TROP MED PARASIT, V92, pS33, DOI 10.1080/00034989859537; Benton B, 2002, ANN TROP MED PARASIT, V96, P5, DOI 10.1179/000349802125000619; Blackburn BG, 2006, AM J TROP MED HYG, V75, P650, DOI 10.4269/ajtmh.2006.75.650; Blanks J, 1998, Rev Panam Salud Publica, V3, P367, DOI 10.1590/S1020-49891998000600002; Braber KL, 2004, LEPROSY REV, V75, P208; Bump JB, 2006, ATTACKING AFRICA'S POVERTY: EXPERIENCE FROM THE GROUND, P285; CAINES K, 2004, 4 GHP DFID HLTH RES; Colatrella B, 2008, ANN TROP MED PARASIT, V102, P7, DOI 10.1179/136485908X337418; CROMPTON D, 2009, DFID SUPPORT CONTROL; CROSS C, 2002, T R SOC TROP MED HYG, V94, P601; Curtale F, 2008, T ROY SOC TROP MED H, V102, P508, DOI 10.1016/j.trstmh.2008.02.002; Dias JCP, 2002, MEM I OSWALDO CRUZ, V97, P603, DOI 10.1590/S0074-02762002000500002; Dias JCP, 2007, MEM I OSWALDO CRUZ, V102, P11, DOI 10.1590/S0074-02762007005000092; Drameh PS, 2002, TRENDS PARASITOL, V18, P378, DOI 10.1016/S1471-4922(02)02362-0; England R, 2007, BMJ-BRIT MED J, V334, P344, DOI 10.1136/bmj.39113.402361.94; Feenstra P, 2005, LEPROSY REV, V76, P194; Fenwick A, 2006, T ROY SOC TROP MED H, V100, P200, DOI 10.1016/j.trstmh.2005.03.014; Fenwick A, 2009, PARASITOLOGY, V136, P1719, DOI 10.1017/S0031182009990400; Frick KD, 2003, AM J TROP MED HYG, V69, P1; *GLAXOSMITHKLINE P, 2009, OUR RESP CORP RESP R; *GLOB NETW NEGL TR, 2009, AB NTDS; *GLOB NETW NEGL TR, 2009, GLOB NETW REC 34 MIL; Grepin KA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000174; Haddad D, 2008, ANN TROP MED PARASIT, V102, P35, DOI 10.1179/136485908X337472; Henderson D A, 1998, Bull World Health Organ, V76 Suppl 2, P17; *HKI, 2007, 0210321001 HKI RTI; Hopkins DR, 2005, AM J TROP MED HYG, V73, P669, DOI 10.4269/ajtmh.2005.73.669; Hopkins DR, 1998, EMERG INFECT DIS, V4, P414, DOI 10.3201/eid0403.980319; Hopkins DR, 2002, AM J TROP MED HYG, V67, P266; Hotez P, 2007, TRENDS PARASITOL, V23, P511, DOI 10.1016/j.pt.2007.08.015; Hotez P, 2006, ADV EXP MED BIOL, V582, P23; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; Hotez PJ, 2006, PLOS MED, V3, P576, DOI 10.1371/journal.pmed.0030102; Hotez PJ, 2009, LANCET, V373, P1570, DOI 10.1016/S0140-6736(09)60233-6; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000405; HUNT P, 2007, EC BEHAV RES REPORT, V6; *ITI, 2009, BRING LIGHT COM DEF; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; *JOHNS JOHNS, 2008, 2007 WORLDW CONTR PR; KIM A, 1997, 1835 WORLD BANK; Kolaczinski JH, 2007, TRENDS PARASITOL, V23, P485, DOI 10.1016/j.pt.2007.08.007; Kumaresan JA, 2003, AM J TROP MED HYG, V69, P24, DOI 10.4269/ajtmh.2003.69.24; Lammie PJ, 2006, TRENDS PARASITOL, V22, P313, DOI 10.1016/j.pt.2006.05.009; Liese BH, 2009, INT HEALTH, V1, P141, DOI 10.1016/j.inhe.2009.08.004; Mariotti SP, 2003, AM J TROP MED HYG, V69, P33; *MCKINS CO, 2008, IND EXT EV STOP TB P; Mecaskey JW, 2003, LANCET INFECT DIS, V3, P728, DOI 10.1016/S1473-3099(03)00807-7; *MECT DON PROGR, 2008, 2007 ANN HIGHL; *MERCK CO INC, 2008, LIST RESP WORK HEALT; *MERCK GROUP, 2009, COMB TROP DIS SCHIST; Molyneux DH, 2005, PLOS MED, V2, P1064, DOI 10.1371/journal.pmed.0020336; MOLYNEUX DH, 1995, PARASITOL TODAY, V11, P399, DOI 10.1016/0169-4758(95)80016-6; Moran M, 2009, PLOS MED, V6, P137, DOI 10.1371/journal.pmed.1000030; *NEGL TROP DIS CON, NEGL TROP DIS CONTR; *NEGL TROP DIS WOR, 2007, FRAM DES MON EV PLAN; *NOV FDN SUST DEV, 2002, REP 2001 2002 BAS NO; *NOV INT AG, 2007, ANN REP 2007 NOV INT; *PAHO, PAR NEGL DIS PAHO RE; Peters DH, 2004, TROP MED INT HEALTH, V9, pA4, DOI 10.1111/j.1365-3156.2004.01209.x; *PLOS NEGL TROP DI, PLOS NEGL TROP DIS J; Ramaiah KD, 2000, PARASITOL TODAY, V16, P251, DOI 10.1016/S0169-4758(00)01643-4; Reich MR, 2000, NAT MED, V6, P617, DOI 10.1038/76176; Rinaldi A, 2005, PLOS MED, V2, P1222, DOI 10.1371/journal.pmed.0020341; *SAN AV, 2007, ACC MED; Sauerbrey M, 2008, ANN TROP MED PARASIT, V102, P25, DOI 10.1179/136485908X337454; Southgate VR, 2005, J HELMINTHOL, V79, P181, DOI 10.1079/JOH2005307; *STOP TB PARTN, GOV; THYLEFORS B, 2004, TROP MED INT HLTH S4, V9, P1; *US NAT COUNC, 2000, NAT INT EST GLOB INF; *USAID, CONTR NEGL TROP DIS; *WHO, 2004, INT CONTR NEGL DIS; *WHO, 2004, NEGL TROP DIS HIDD S; *WHO, 2006, NEGL TROP DIS HIDD S; WHO, 2007, GLOB PLAN COMB NEGL; WHO, 2006, COORD US ANTH DRUGS; *WHO TDR, 2007, 10 YEAR VIS STRAT FO; *WHO TDR, 2008, COMM DIR INT MAJ HLT; World Bank, 2004, WORLD DEV REP 2004 M; World Health Organization, 2006, STRAT TECHN M INT CO; World Health Organization, 2007, REP GLOB PARTN M NEG	89	92	94	0	24	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 2	2010	375	9708					67	76		10.1016/S0140-6736(09)61749-9	http://dx.doi.org/10.1016/S0140-6736(09)61749-9			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	539BZ	20109865				2022-12-28	WOS:000273229700033
J	Hwang, CS; Shemorry, A; Varshavsky, A				Hwang, Cheol-Sang; Shemorry, Anna; Varshavsky, Alexander			N-Terminal Acetylation of Cellular Proteins Creates Specific Degradation Signals	SCIENCE			English	Article							END RULE PATHWAY; UBIQUITIN LIGASE; MAT-ALPHA-2 REPRESSOR; YEAST; ACETYLTRANSFERASE; PROTEOMICS; RETICULUM; MEMBRANE; SENSOR; GENES	The retained N-terminal methionine (Met) residue of a nascent protein is often N-terminally acetylated (Nt-acetylated). Removal of N-terminal Met by Met-aminopeptidases frequently leads to Nt-acetylation of the resulting N-terminal alanine (Ala), valine (Val), serine (Ser), threonine (Thr), and cysteine (Cys) residues. Although a majority of eukaryotic proteins (for example, more than 80% of human proteins) are cotranslationally Nt-acetylated, the function of this extensively studied modification is largely unknown. Using the yeast Saccharomyces cerevisiae, we found that the Nt-acetylated Met residue could act as a degradation signal (degron), targeted by the Doa10 ubiquitin ligase. Moreover, Doa10 also recognized the Nt-acetylated Ala, Val, Ser, Thr, and Cys residues. Several examined proteins of diverse functions contained these N-terminal degrons, termed N-Ac-degrons, which are a prevalent class of degradation signals in cellular proteins.	[Hwang, Cheol-Sang; Shemorry, Anna; Varshavsky, Alexander] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Varshavsky, A (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	avarsh@caltech.edu	Hwang, Cheol-Sang/Q-7391-2019	Hwang, Cheol-Sang/0000-0002-0105-5957	NIH; March of Dimes Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007616] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Foundation(March of Dimes); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Zhou (Caltech) for MS analyses and C. Brower for comments on the paper. We are grateful to members of the Varshavsky laboratory for their advice in the course of this study and particularly thank O. Batygin for her technical assistance. This work was supported by grants from NIH and the March of Dimes Foundation to A. V.	Arnesen T, 2009, P NATL ACAD SCI USA, V106, P8157, DOI 10.1073/pnas.0901931106; BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; Deng M, 2006, NATURE, V443, P827, DOI 10.1038/nature05170; Frottin F, 2006, MOL CELL PROTEOMICS, V5, P2336, DOI 10.1074/mcp.M600225-MCP200; Gautschi M, 2003, MOL CELL BIOL, V23, P7403, DOI 10.1128/MCB.23.20.7403-7414.2003; Goetze S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000236; Hassink G, 2005, BIOCHEM J, V388, P647, DOI 10.1042/BJ20041241; HOCHSTRASSER M, 1990, CELL, V61, P697, DOI 10.1016/0092-8674(90)90481-S; Hu RG, 2005, NATURE, V437, P981, DOI 10.1038/nature04027; Hu RG, 2008, P NATL ACAD SCI USA, V105, P76, DOI 10.1073/pnas.0710568105; Hwang CS, 2009, P NATL ACAD SCI USA, V106, P2142, DOI 10.1073/pnas.0812316106; Hwang CS, 2008, P NATL ACAD SCI USA, V105, P19188, DOI 10.1073/pnas.0808891105; JOHNSON AD, 1995, CURR OPIN GENET DEV, V5, P552, DOI 10.1016/0959-437X(95)80022-0; JORNVALL H, 1975, J THEOR BIOL, V55, P1, DOI 10.1016/S0022-5193(75)80105-6; MAYER A, 1989, SCIENCE, V244, P1480, DOI 10.1126/science.2544030; Mogk A, 2007, TRENDS CELL BIOL, V17, P165, DOI 10.1016/j.tcb.2007.02.001; MULLEN JR, 1989, EMBO J, V8, P2067, DOI 10.1002/j.1460-2075.1989.tb03615.x; PARK EC, 1992, EMBO J, V11, P2087, DOI 10.1002/j.1460-2075.1992.tb05267.x; Polevoda B, 2003, J MOL BIOL, V325, P595, DOI 10.1016/S0022-2836(02)01269-X; Ravid T, 2006, EMBO J, V25, P533, DOI 10.1038/sj.emboj.7600946; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Tasaki T, 2007, TRENDS BIOCHEM SCI, V32, P520, DOI 10.1016/j.tibs.2007.08.010; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Varshavsky A, 2005, METHOD ENZYMOL, V399, P777, DOI 10.1016/S0076-6879(05)99051-4; Varshavsky A, 2008, J BIOL CHEM, V283, P34469, DOI 10.1074/jbc.X800009200; Wang HQ, 2009, MOL CELL, V34, P686, DOI 10.1016/j.molcel.2009.04.032; Zill OA, 2008, GENE DEV, V22, P1704, DOI 10.1101/gad.1640008	29	442	472	3	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2010	327	5968					973	977		10.1126/science.1183147	http://dx.doi.org/10.1126/science.1183147			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556XE	20110468	Green Accepted			2022-12-28	WOS:000274625800033
J	Pape, JW; Johnson, WD; Fitzgerald, DW				Pape, Jean William; Johnson, Warren D., Jr.; Fitzgerald, Daniel W.			The Earthquake in Haiti - Dispatch from Port-au-Prince	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Fitzgerald, Daniel W.] Weill Cornell Med Coll, GHESKIO Ctr, New York, NY USA; [Fitzgerald, Daniel W.] Weill Cornell Med Coll, Ctr Global Hlth, New York, NY USA	Cornell University; Cornell University					FIC NIH HHS [D43 TW000018] Funding Source: Medline; NIAID NIH HHS [UM1 AI069421, U01 AI069421] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [D43TW000018] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069421, UM1AI069421] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))			0	25	25	1	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 18	2010	362	7					575	577		10.1056/NEJMp1001015	http://dx.doi.org/10.1056/NEJMp1001015			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	556ED	20107209	Bronze			2022-12-28	WOS:000274571200003
J	Karlas, A; Machuy, N; Shin, Y; Pleissner, KP; Artarini, A; Heuer, D; Becker, D; Khalil, H; Ogilvie, LA; Hess, S; Maurer, AP; Muller, E; Wolff, T; Rudel, T; Meyer, TF				Karlas, Alexander; Machuy, Nikolaus; Shin, Yujin; Pleissner, Klaus-Peter; Artarini, Anita; Heuer, Dagmar; Becker, Daniel; Khalil, Hany; Ogilvie, Lesley A.; Hess, Simone; Maeurer, Andre P.; Mueller, Elke; Wolff, Thorsten; Rudel, Thomas; Meyer, Thomas F.			Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication	NATURE			English	Article							ION-CHANNEL PROTEIN; A-VIRUS; GENES; EXPORT; INTERFERENCE; TRANSCRIPTION; INFECTION; COMPLEX; TARGETS; ATPASE	Influenza A virus, being responsible for seasonal epidemics and reoccurring pandemics, represents a worldwide threat to public health(1). High mutation rates facilitate the generation of viral escape mutants, rendering vaccines and drugs directed against virus-encoded targets potentially ineffective(2). In contrast, targeting host cell determinants temporarily dispensable for the host but crucial for virus replication could prevent viral escape. Here we report the discovery of 287 human host cell genes influencing influenza A virus replication in a genome-wide RNA interference (RNAi) screen. Using an independent assay we confirmed 168 hits (59%) inhibiting either the endemic H1N1 (119 hits) or the current pandemic swine-origin (121 hits) influenza A virus strains, with an overlap of 60%. Notably, a subset of these common hits was also essential for replication of a highly pathogenic avian H5N1 strain. In-depth analyses of several factors provided insights into their infection stage relevance. Notably, SON DNA binding protein (SON)(3) was found to be important for normal trafficking of influenza virions to late endosomes early in infection. We also show that a small molecule inhibitor of CDC-like kinase 1 (CLK1)(4) reduces influenza virus replication by more than two orders of magnitude, an effect connected with impaired splicing of the viral M2 messenger RNA. Furthermore, influenza-virus-infected p27(-/-) (cyclin-dependent kinase inhibitor 1B; Cdkn1b) mice accumulated significantly lower viral titres in the lung, providing in vivo evidence for the importance of this gene. Thus, our results highlight the potency of genome-wide RNAi screening for the dissection of virus-host interactions and the identification of drug targets for a broad range of influenza viruses.	[Karlas, Alexander; Machuy, Nikolaus; Shin, Yujin; Artarini, Anita; Heuer, Dagmar; Becker, Daniel; Khalil, Hany; Ogilvie, Lesley A.; Hess, Simone; Maeurer, Andre P.; Mueller, Elke; Rudel, Thomas; Meyer, Thomas F.] Max Planck Inst Infect Biol, Dept Mol Biol, D-10117 Berlin, Germany; [Pleissner, Klaus-Peter] Max Planck Inst Infect Biol, Core Facil Bioinformat, D-10117 Berlin, Germany; [Wolff, Thorsten] Robert Koch Inst, D-13353 Berlin, Germany	Max Planck Society; Max Planck Society; Robert Koch Institute	Meyer, TF (corresponding author), Max Planck Inst Infect Biol, Dept Mol Biol, Charitepl 1, D-10117 Berlin, Germany.	meyer@mpiib-berlin.mpg.de	Khalil, Hany/J-7700-2017; Meyer, Thomas F. F/J-2485-2013	Khalil, Hany/0000-0001-9738-4087; Meyer, Thomas F. F/0000-0002-6120-8679; Artarini, Anita/0000-0002-0235-7973; Ogilvie, Lesley/0000-0001-9794-2915; Karlas, Alexander/0000-0002-2187-2057	EU [LSHB-CT-2004-005276]; ERA-Net Pathogenomics [0313938A]; FCI; RiNA network Berlin; German Government support via BMG; German Government support via BMBF	EU(European Commission); ERA-Net Pathogenomics; FCI(Fonds der Chemischen Industrie); RiNA network Berlin; German Government support via BMG; German Government support via BMBF(Federal Ministry of Education & Research (BMBF))	The authors would like to thank M. Drabkina, G. Heins, D. Khalil and D. Manntz for technical support, and K. Hoffmann and the experimental animal facility, headed by U. Klemm, for supporting mouse experiments. We also thank A. Pekosz for providing the influenza luciferase reporter construct and S. Becker for the pandemic H1N1 influenza strain. This work was supported through the EU FP6 project RIGHT (LSHB-CT-2004-005276), ERA-Net Pathogenomics (grant no. 0313938A) and a grant from FCI to T. F. M., and the RiNA network Berlin to T. R. and T. F. M. T. W. acknowledges German Government support via BMG (FSI program) and BMBF (FluResearchNet). H. K. and A. A. are student fellows of the Egyptian Government and IMPRS-IDI, respectively.	Boutros M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r66; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Brideau C, 2003, J BIOMOL SCREEN, V8, P634, DOI 10.1177/1087057103258285; Bullock AN, 2009, STRUCTURE, V17, P352, DOI 10.1016/j.str.2008.12.023; Cherry S, 2005, GENE DEV, V19, P445, DOI 10.1101/gad.1267905; Cheung TKW, 2005, J GEN VIROL, V86, P1447, DOI 10.1099/vir.0.80727-0; Cullen BR, 2003, TRENDS BIOCHEM SCI, V28, P419, DOI 10.1016/S0968-0004(03)00142-7; Elton D, 2001, J VIROL, V75, P408, DOI 10.1128/JVI.75.1.408-419.2001; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Ge Q, 2003, P NATL ACAD SCI USA, V100, P2718, DOI 10.1073/pnas.0437841100; GUINEA R, 1995, J VIROL, V69, P2306, DOI 10.1128/JVI.69.4.2306-2312.1995; Hagiwara M, 2005, BBA-PROTEINS PROTEOM, V1754, P324, DOI 10.1016/j.bbapap.2005.09.010; Hao LH, 2008, NATURE, V454, P890, DOI 10.1038/nature07151; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Horimoto T, 2005, NAT REV MICROBIOL, V3, P591, DOI 10.1038/nrmicro1208; Huang YQ, 2004, P NATL ACAD SCI USA, V101, P9666, DOI 10.1073/pnas.0403533101; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Josset L, 2008, J CLIN VIROL, V43, P381, DOI 10.1016/j.jcv.2008.08.017; Konig R, 2007, NAT METHODS, V4, P847, DOI 10.1038/NMETH1089; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Ludwig S, 2003, TRENDS MOL MED, V9, P46, DOI 10.1016/S1471-4914(02)00010-2; Lutz A, 2005, J VIROL METHODS, V126, P13, DOI 10.1016/j.jviromet.2005.01.016; Machuy N, 2005, MOL CELL PROTEOMICS, V4, P44, DOI 10.1074/mcp.M400089-MCP200; Muraki M, 2004, J BIOL CHEM, V279, P24246, DOI 10.1074/jbc.M314298200; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Opitz B, 2007, CELL MICROBIOL, V9, P930, DOI 10.1111/j.1462-5822.2006.00841.x; PEREZ L, 1994, J GEN VIROL, V75, P2595, DOI 10.1099/0022-1317-75-10-2595; Salomon R, 2006, J EXP MED, V203, P689, DOI 10.1084/jem.20051938; Satterly N, 2007, P NATL ACAD SCI USA, V104, P1853, DOI 10.1073/pnas.0610977104; SESSIONS OM, 2009, DISCOVERY INSECT HUM, V458, P1047; Shih SR, 1996, EMBO J, V15, P5415, DOI 10.1002/j.1460-2075.1996.tb00925.x; Sun CT, 2001, J BIOL CHEM, V276, P24059, DOI 10.1074/jbc.M101330200	33	521	555	5	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 11	2010	463	7282					818	U132		10.1038/nature08760	http://dx.doi.org/10.1038/nature08760			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	553VG	20081832	Green Published			2022-12-28	WOS:000274394300042
J	Kumagai, A; Shevchenko, A; Shevchenko, A; Dunphy, WG				Kumagai, Akiko; Shevchenko, Anna; Shevchenko, Andrej; Dunphy, William G.			Treslin Collaborates with TopBP1 in Triggering the Initiation of DNA Replication	CELL			English	Article							XENOPUS EGG EXTRACTS; POLYMERASE-ALPHA; S-PHASE; BUDDING YEAST; ATR; CDK; CHROMATIN; COMPLEX; PROTEIN; CDC45	TopBP1 has important roles in both DNA replication and checkpoint regulation in vertebrates. We have identified a protein called Treslin that associates with TopBP1 in Xenopus egg extracts. Depletion of Treslin from egg extracts strongly inhibits chromosomal DNA replication. Binding of Treslin to chromatin in egg extracts occurs independently of TopBP1. However, loading of the initiator protein Cdc45 onto chromatin cannot take place in the absence of Treslin. Prior to the initiation of DNA replication, Treslin associates with TopBP1 in a Cdk2-dependent manner. Ablation of Treslin from human cells also strongly inhibits DNA replication. Taken together, these results indicate that Treslin and TopBP1 collaborate in the Cdk2-mediated loading of Cdc45 onto replication origins. Thus, Treslin regulates a pivotal step in the initiation of DNA replication in vertebrates.	[Kumagai, Akiko; Dunphy, William G.] CALTECH, Div Biol 147 75, Pasadena, CA 91125 USA; [Shevchenko, Anna; Shevchenko, Andrej] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	California Institute of Technology; Max Planck Society	Dunphy, WG (corresponding author), CALTECH, Div Biol 147 75, Pasadena, CA 91125 USA.	dunphy@caltech.edu			National Institutes of Health [GM043974, GM070891]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070891, R01GM043974, R37GM043974] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to laboratory members for comments on the manuscript. We would also like to thank Rochelle Diamond for assistance with the FACS analyses and T.C. Spelsberg (Mayo Clinic) for the U2OS T-REx cells. This work was supported by National Institutes of Health grants GM043974 and GM070891 to W.G.D.	Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Botchan M, 2007, NATURE, V445, P272, DOI 10.1038/445272a; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Garcia V, 2005, DNA REPAIR, V4, P1227, DOI 10.1016/j.dnarep.2005.04.001; Hashimoto Y, 2003, EMBO J, V22, P2526, DOI 10.1093/emboj/cdg238; Hashimoto Y, 2006, GENES CELLS, V11, P993, DOI 10.1111/j.1365-2443.2006.00998.x; Jares P, 2000, GENE DEV, V14, P1528; Junqueira M, 2008, J PROTEOME RES, V7, P3382, DOI 10.1021/pr800140v; Kumagai A, 2000, MOL CELL, V6, P839, DOI 10.1016/S1097-2765(00)00082-4; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Lee J, 2007, J BIOL CHEM, V282, P28036, DOI 10.1074/jbc.M704635200; Matsuno K, 2006, MOL CELL BIOL, V26, P4843, DOI 10.1128/MCB.02267-05; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Mendez J, 2003, BIOESSAYS, V25, P1158, DOI 10.1002/bies.10370; Mimura S, 2000, GENES CELLS, V5, P439, DOI 10.1046/j.1365-2443.2000.00340.x; Mimura S, 1998, EMBO J, V17, P5699, DOI 10.1093/emboj/17.19.5699; Monroe DG, 2003, J CELL BIOCHEM, V90, P315, DOI 10.1002/jcb.10633; Mordes DA, 2008, GENE DEV, V22, P1478, DOI 10.1101/gad.1666208; Pacek M, 2004, EMBO J, V23, P3667, DOI 10.1038/sj.emboj.7600369; Sangrithi MN, 2005, CELL, V121, P887, DOI 10.1016/j.cell.2005.05.015; Sclafani RA, 2007, ANNU REV GENET, V41, P237, DOI 10.1146/annurev.genet.41.110306.130308; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Tanaka S, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-16; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Tercero JA, 2000, EMBO J, V19, P2082, DOI 10.1093/emboj/19.9.2082; Van Hatten RA, 2002, J CELL BIOL, V159, P541, DOI 10.1083/jcb.200207090; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Yan S, 2006, J CELL BIOL, V173, P181, DOI 10.1083/jcb.200601076; Yoo HY, 2009, MOL BIOL CELL, V20, P2351, DOI 10.1091/mbc.E08-12-1190; Yoo HY, 2004, J BIOL CHEM, V279, P53353, DOI 10.1074/jbc.M408026200; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432; Zou L, 1998, SCIENCE, V280, P593, DOI 10.1126/science.280.5363.593	33	168	174	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 5	2010	140	3					349	U59		10.1016/j.cell.2009.12.049	http://dx.doi.org/10.1016/j.cell.2009.12.049			18	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	552ND	20116089	Green Accepted, Bronze			2022-12-28	WOS:000274297700013
J	Sunda, WG				Sunda, William G.			Iron and the Carbon Pump	SCIENCE			English	Editorial Material							OCEAN ACIDIFICATION; SPECIATION; WATERS		NOAA, Beaufort Lab, Natl Ocean Serv, Beaufort, NC 28516 USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA	Sunda, WG (corresponding author), NOAA, Beaufort Lab, Natl Ocean Serv, 101 Pivers Isl Rd, Beaufort, NC 28516 USA.	bill.sunda@noaa.gov						Breitbarth E., 2009, BIOGEOSCI DISCUSS, V6, P6781, DOI DOI 10.5194/BGD-6-6781-2009; Coale KH, 2004, SCIENCE, V304, P408, DOI 10.1126/science.1089778; Falkowski PG, 1997, NATURE, V387, P272, DOI 10.1038/387272a0; Feely RA, 2009, OCEANOGRAPHY, V22, P36, DOI 10.5670/oceanog.2009.95; Fu FX, 2008, LIMNOL OCEANOGR, V53, P2472, DOI 10.4319/lo.2008.53.6.2472; Gledhill M, 1998, MAR CHEM, V59, P283, DOI 10.1016/S0304-4203(97)00097-2; Jickells TD, 2005, SCIENCE, V308, P67, DOI 10.1126/science.1105959; Kleypas JA, 2009, OCEANOGRAPHY, V22, P108, DOI 10.5670/oceanog.2009.101; MARTIN JH, 1988, NATURE, V331, P341, DOI 10.1038/331341a0; MARTIN JH, 1990, NATURE, V345, P156, DOI 10.1038/345156a0; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; Millero FJ, 2009, OCEANOGRAPHY, V22, P72, DOI 10.5670/oceanog.2009.98; Moore JK, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002220; Shi DL, 2010, SCIENCE, V327, P676, DOI 10.1126/science.1183517; Sholkovitz ER, 2009, GEOCHIM COSMOCHIM AC, V73, P3981, DOI 10.1016/j.gca.2009.04.029; Stumm W., 1981, AQUATIC CHEM	16	28	29	4	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 5	2010	327	5966					654	655		10.1126/science.1186151	http://dx.doi.org/10.1126/science.1186151			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551ZD	20133563				2022-12-28	WOS:000274251800027
J	Ecker, AS; Berens, P; Keliris, GA; Bethge, M; Logothetis, NK; Tolias, AS				Ecker, Alexander S.; Berens, Philipp; Keliris, Georgios A.; Bethge, Matthias; Logothetis, Nikos K.; Tolias, Andreas S.			Decorrelated Neuronal Firing in Cortical Microcircuits	SCIENCE			English	Article							PRIMARY VISUAL-CORTEX; AREA MT; NOISE CORRELATIONS; INFORMATION; VARIABILITY; DISCHARGE; ACCURACY; MACAQUE; CONNECTIVITY; SYNAPSES	Correlated trial-to-trial variability in the activity of cortical neurons is thought to reflect the functional connectivity of the circuit. Many cortical areas are organized into functional columns, in which neurons are believed to be densely connected and to share common input. Numerous studies report a high degree of correlated variability between nearby cells. We developed chronically implanted multitetrode arrays offering unprecedented recording quality to reexamine this question in the primary visual cortex of awake macaques. We found that even nearby neurons with similar orientation tuning show virtually no correlated variability. Our findings suggest a refinement of current models of cortical microcircuit architecture and function: Either adjacent neurons share only a few percent of their inputs or, alternatively, their activity is actively decorrelated.	[Ecker, Alexander S.; Berens, Philipp; Tolias, Andreas S.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Ecker, Alexander S.; Berens, Philipp; Keliris, Georgios A.; Bethge, Matthias; Logothetis, Nikos K.] Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany; [Ecker, Alexander S.; Berens, Philipp; Bethge, Matthias] Univ Tubingen, Inst Theoret Phys, D-72076 Tubingen, Germany; [Ecker, Alexander S.; Berens, Philipp; Bethge, Matthias] Univ Tubingen, Ctr Integrat Neurosci, D-72076 Tubingen, Germany; [Logothetis, Nikos K.] Univ Manchester, Div Imaging Sci & Biomed Engn, Manchester M1 7HL, Lancs, England; [Tolias, Andreas S.] Michael E DeBakey Vet Affairs Med Ctr, Houston, TX 77030 USA; [Tolias, Andreas S.] Rice Univ, Dept Computat & Appl Math, Houston, TX 77005 USA	Baylor College of Medicine; Max Planck Society; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; University of Manchester; US Department of Veterans Affairs; Veterans Health Administration (VHA); Michael E DeBakey VA Medical Center; Rice University	Tolias, AS (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	atolias@cns.bcm.edu	Ecker, Alexander S/A-5184-2010; Keliris, Georgios A/B-6692-2008; Berens, Philipp/A-5653-2009; Bethge, Matthias/B-1554-2008; Logothetis, Nikos/U-9282-2019	Ecker, Alexander S/0000-0003-2392-5105; Keliris, Georgios A/0000-0001-6732-1261; Berens, Philipp/0000-0002-0199-4727; 	National Eye Institute, NIH [R01 EY018847]; Max Planck Society; U.S. Department of Defense [W81XWH-08-2-0147]; Department of Veterans Affairs; Arnold and Mabel Beckman Foundation; German Federal Ministry of Education and Research (BMBF) [FKZ:01GQ0601]; NATIONAL EYE INSTITUTE [R01EY018847] Funding Source: NIH RePORTER	National Eye Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Max Planck Society(Max Planck SocietyFoundation CELLEX); U.S. Department of Defense(United States Department of Defense); Department of Veterans Affairs(US Department of Veterans Affairs); Arnold and Mabel Beckman Foundation; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank M. Subramanian, A. Hoenselaar, T. J. Williford, and D. Murray for help with experiments; R. J. Cotton for his contribution in setting up recording equipment; and the Siapas laboratory at Caltech for providing the recording software. We thank R. J. Cotton, P. Dayan, S. Deneve, K. D. Harris, E. V. Lubenov, W. J. Ma, J. H. Macke, A. Renart, J. de la Rocha, A. G. Siapas, and S. M. Smirnakis for comments on the manuscript and discussions. This work was supported by the National Eye Institute, NIH (R01 EY018847), the Max Planck Society, the U.S. Department of Defense (W81XWH-08-2-0147), a VA Merit Award from the Department of Veterans Affairs, and an Arnold and Mabel Beckman Foundation Young Investigator Award to A. S. T., and by the German Federal Ministry of Education and Research (BMBF) through the Bernstein award to M. B. (FKZ:01GQ0601).	Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; Averbeck BB, 2003, J NEUROSCI, V23, P7630; Averbeck BB, 2006, J NEUROPHYSIOL, V95, P3633, DOI 10.1152/jn.00919.2005; BACH M, 1986, EXP BRAIN RES, V61, P451; Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; Braitenberg V, 1991, ANATOMY CORTEX STAT; BRYANT HL, 1973, J NEUROPHYSIOL, V36, P205, DOI 10.1152/jn.1973.36.2.205; Cohen MR, 2008, NEURON, V60, P162, DOI 10.1016/j.neuron.2008.08.007; Constantinidis C, 2002, J NEUROPHYSIOL, V88, P3487, DOI 10.1152/jn.00188.2002; de la Rocha J, 2007, NATURE, V448, P802, DOI 10.1038/nature06028; Gawne TJ, 1996, CEREB CORTEX, V6, P482, DOI 10.1093/cercor/6.3.482; GAWNE TJ, 1993, J NEUROSCI, V13, P2758; Gray CM, 1995, J NEUROSCI METH, V63, P43, DOI 10.1016/0165-0270(95)00085-2; Gutnisky DA, 2008, NATURE, V452, P220, DOI 10.1038/nature06563; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; HELLWIG B, 1994, BIOL CYBERN, V71, P1, DOI 10.1007/BF00198906; Hertz J, 2010, NEURAL COMPUT, V22, P427, DOI 10.1162/neco.2009.06-08-806; Huang X, 2009, J NEUROPHYSIOL, V101, P3012, DOI 10.1152/jn.00010.2009; Kohn A, 2005, J NEUROSCI, V25, P3661, DOI 10.1523/JNEUROSCI.5106-04.2005; Lee D, 1998, J NEUROSCI, V18, P1161; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Reich DS, 2001, SCIENCE, V294, P2566, DOI 10.1126/science.1065839; Renart A, 2010, SCIENCE, V327, P587, DOI 10.1126/science.1179850; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Smith MA, 2008, J NEUROSCI, V28, P12591, DOI 10.1523/JNEUROSCI.2929-08.2008; Sompolinsky H, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051904; Tolias AS, 2007, J NEUROPHYSIOL, V98, P3780, DOI 10.1152/jn.00260.2007; Wilke SD, 2002, NEURAL COMPUT, V14, P155, DOI 10.1162/089976602753284482; Yu YC, 2009, NATURE, V458, P501, DOI 10.1038/nature07722; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	31	430	434	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 29	2010	327	5965					584	587		10.1126/science.1179867	http://dx.doi.org/10.1126/science.1179867			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549CT	20110506				2022-12-28	WOS:000274020500039
J	Wilson, CG; Sherman, PW				Wilson, Christopher G.; Sherman, Paul W.			Anciently Asexual Bdelloid Rotifers Escape Lethal Fungal Parasites by Drying Up and Blowing Away	SCIENCE			English	Article							RED-QUEEN; SEX	Asexuality has major theoretical advantages over sexual reproduction. An important evolutionary puzzle, therefore, is why exclusively asexual metazoan lineages rarely endure. The Red Queen hypothesis posits that asexuality is rapidly extinguished by relentlessly coevolving parasites and pathogens. If so, any long-lasting asexual lineage must have unusual alternative mechanisms to deal with these biotic enemies. Bdelloid rotifers are freshwater invertebrates that abandoned sexual reproduction millions of years ago. Here, we show that cultured populations of bdelloids can rid themselves of a deadly fungal parasite through complete desiccation (anhydrobiosis) and disperse by wind to establish new populations in its absence. In Red Queen models, spatiotemporal escape can decouple and protect asexuals from coevolving enemies. Thus, our results may help to explain the persistence of the anciently asexual Bdelloidea.	[Wilson, Christopher G.; Sherman, Paul W.] Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14850 USA	Cornell University	Wilson, CG (corresponding author), Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14850 USA.	cgw8@cornell.edu		Wilson, Christopher/0000-0001-7649-5255	Sigma Xi; U.S. Department of Agriculture; Cornell University	Sigma Xi; U.S. Department of Agriculture(United States Department of Agriculture (USDA)); Cornell University	We thank D. Slottje, G. Masters, and J. Hue for research assistance; K. Hodge, S. Glockling, D. Fontaneto, and G. Barron for helpful advice; U.S. Agricultural Research Service collection of Entomopathogenic Fungi (ARSEF) for fungal isolates; and T. Seeley, J. Scarl, K. Reeve, R. Raguso, C. Lively, N. Hairston, and R. Booker for useful commentaries. Financial support was provided by Sigma Xi, U.S. Department of Agriculture, and Cornell University (Department of Neurobiology and Behavior and an S. H. Weiss Presidential Fellowship to P. W. S.).	Agrawal AF, 2006, PLOS BIOL, V4, P1364, DOI 10.1371/journal.pbio.0040265; Barraclough TG, 2007, MOL BIOL EVOL, V24, P1952, DOI 10.1093/molbev/msm123; BARRON GL, 1991, CAN J BOT, V69, P494, DOI 10.1139/b91-067; Bell G., 1982, MASTERPIECE NATURE; Caceres CE, 2002, OECOLOGIA, V131, P402, DOI 10.1007/s00442-002-0897-5; Fontaneto D, 2008, MOL ECOL, V17, P3136, DOI 10.1111/j.1365-294X.2008.03806.x; HAMILTON WD, 1980, OIKOS, V35, P282, DOI 10.2307/3544435; HAMILTON WD, 1990, P NATL ACAD SCI USA, V87, P3566, DOI 10.1073/pnas.87.9.3566; Jenkins DG, 1998, HYDROBIOLOGIA, V387, P15, DOI 10.1023/A:1017080029317; Jokela J, 2009, AM NAT, V174, pS43, DOI 10.1086/599080; Judson Olivia P., 1996, Trends in Ecology and Evolution, V11, P41, DOI 10.1016/0169-5347(96)81040-8; Judson OP, 1997, J THEOR BIOL, V186, P33, DOI 10.1006/jtbi.1996.0339; LADLE RJ, 1993, P ROY SOC B-BIOL SCI, V253, P155, DOI 10.1098/rspb.1993.0096; Normark BB, 2003, BIOL J LINN SOC, V79, P69, DOI 10.1046/j.1095-8312.2003.00182.x; Ricci C, 2001, HYDROBIOLOGIA, V446, P1, DOI 10.1023/A:1017548418201; Salathe M, 2008, TRENDS ECOL EVOL, V23, P439, DOI 10.1016/j.tree.2008.04.010; Tunnacliffe A, 2003, PHILOS T ROY SOC B, V358, P1755, DOI 10.1098/rstb.2002.1214; Welch DBM, 2008, P NATL ACAD SCI USA, V105, P5145, DOI 10.1073/pnas.0800972105; West SA, 1999, J EVOLUTION BIOL, V12, P1003	19	51	53	0	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 29	2010	327	5965					574	576		10.1126/science.1179252	http://dx.doi.org/10.1126/science.1179252			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549CT	20110504				2022-12-28	WOS:000274020500036
J	Frank, DC; Esper, J; Raible, CC; Buntgen, U; Trouet, V; Stocker, B; Joos, F				Frank, David C.; Esper, Jan; Raible, Christoph C.; Buentgen, Ulf; Trouet, Valerie; Stocker, Benjamin; Joos, Fortunat			Ensemble reconstruction constraints on the global carbon cycle sensitivity to climate	NATURE			English	Article							NORTHERN-HEMISPHERE TEMPERATURES; ATMOSPHERIC CO2; LAST MILLENNIUM; ANTARCTIC ICE; FEEDBACKS; COMMITMENTS; RESOLUTION; HOLOCENE; CORE	The processes controlling the carbon flux and carbon storage of the atmosphere, ocean and terrestrial biosphere are temperature sensitive(1-4) and are likely to provide a positive feedback leading to amplified anthropogenic warming(3). Owing to this feedback, at time-scales ranging from interannual to the 20-100-kyr cycles of Earth's orbital variations(1,5-7), warming of the climate system causes a net release of CO2 into the atmosphere; this in turn amplifies warming. But the magnitude of the climate sensitivity of the global carbon cycle (termed gamma), and thus of its positive feedback strength, is under debate, giving rise to large uncertainties in global warming projections(8,9). Here we quantify the median gamma as 7.7 p. p. m. v. CO2 per degrees C warming, with a likely range of 1.7-21.4 p. p. m. v. CO2 per degrees C. Sensitivity experiments exclude significant influence of pre-industrial land-use change on these estimates. Our results, based on the coupling of a probabilistic approach with an ensemble of proxy-based temperature reconstructions and pre-industrial CO2 data from three ice cores, provide robust constraints for gamma on the policy-relevant multi-decadal to centennial timescales. By using an ensemble of >200,000 members, quantification of gamma is not only improved, but also likelihoods can be assigned, thereby providing a benchmark for future model simulations. Although uncertainties do not at present allow exclusion of gamma calculated from any of ten coupled carbon-climate models, we find that gamma is about twice as likely to fall in the lowermost than in the uppermost quartile of their range. Our results are incompatibly lower (P < 0.05) than recent pre-industrial empirical estimates of similar to 40 p. p. m. v. CO2 per degrees C (refs 6, 7), and correspondingly suggest similar to 80% less potential amplification of ongoing global warming.	[Frank, David C.; Buentgen, Ulf; Trouet, Valerie] Swiss Fed Res Inst WSL, CH-8903 Birmensdorf, Switzerland; [Frank, David C.; Raible, Christoph C.; Stocker, Benjamin; Joos, Fortunat] Univ Bern, Oeschger Ctr Climate Change Res, CH-3012 Bern, Switzerland; [Esper, Jan] Johannes Gutenberg Univ Mainz, Dept Geog, D-55099 Mainz, Germany; [Raible, Christoph C.; Stocker, Benjamin; Joos, Fortunat] Univ Bern, Inst Phys, CH-3012 Bern, Switzerland	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of Bern; Johannes Gutenberg University of Mainz; University of Bern	Frank, DC (corresponding author), Swiss Fed Res Inst WSL, Zurcherstr 111, CH-8903 Birmensdorf, Switzerland.	david.frank@wsl.ch	Joos, Fortunat/B-4118-2018; Frank, David/C-7764-2013; Trouet, Valerie/AAE-4888-2021; Esper, Jan/O-3127-2018; Raible, Christoph/M-8309-2016; Stocker, Benjamin David/K-3194-2015; buentgen, ulf/J-6952-2013	Joos, Fortunat/0000-0002-9483-6030; Esper, Jan/0000-0003-3919-014X; Raible, Christoph/0000-0003-0176-0602; Stocker, Benjamin David/0000-0003-2697-9096; Trouet, Valerie/0000-0002-2683-8704; Frank, David/0000-0001-5463-5640	Swiss National Science Foundation (NCCR-Climate); European Union [226701, 017008]	Swiss National Science Foundation (NCCR-Climate)(Swiss National Science Foundation (SNSF)); European Union(European Commission)	We thank P. Friedlingstein, R. Knutti and T. Stocker for comments, the C4MIP consortium for use of their model output, and the Swiss National Science Foundation (NCCR-Climate) and the European Union projects Carbo-Extreme (226701) and Millennium (017008) for funding.	Archer D, 2008, CLIMATIC CHANGE, V90, P283, DOI 10.1007/s10584-008-9413-1; Briffa KR, 2000, QUATERNARY SCI REV, V19, P87, DOI 10.1016/S0277-3791(99)00056-6; Brohan P, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006548; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Cook E. R., 1981, Tree-Ring Bulletin, V41, P45; Cox P, 2008, SCIENCE, V321, P1642, DOI 10.1126/science.1158907; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; D'Arrigo R, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006352; Elsig J, 2009, NATURE, V461, P507, DOI 10.1038/nature08393; Esper J, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021236; Esper J, 2002, SCIENCE, V295, P2250, DOI 10.1126/science.1066208; Esper J, 2009, CLIMATIC CHANGE, V94, P267, DOI [10.1007/s10584-008-9492-z, 10.1007/s10584-008-9492-Z]; Etheridge DM, 1996, J GEOPHYS RES-ATMOS, V101, P4115, DOI 10.1029/95JD03410; Frank D, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030571; Frank D, 2007, QUATERNARY SCI REV, V26, P3298, DOI 10.1016/j.quascirev.2007.08.002; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Gerber S, 2003, CLIM DYNAM, V20, P281, DOI 10.1007/s00382-002-0270-8; Hegerl GC, 2007, J CLIMATE, V20, P650, DOI 10.1175/JCLI4011.1; Hegerl GC, 2006, NATURE, V440, P1029, DOI 10.1038/nature04679; Heimann M, 2008, NATURE, V451, P289, DOI 10.1038/nature06591; Huntingford C, 2009, TELLUS B, V61, P355, DOI 10.1111/j.1600-0889.2009.00414.x; Jones C, 2009, NAT GEOSCI, V2, P484, DOI 10.1038/ngeo555; Jones PD, 1998, HOLOCENE, V8, P455, DOI 10.1191/095968398667194956; Joos F, 2004, SCOPE SER, V62, P165; Joos F, 1999, SCIENCE, V284, P464, DOI 10.1126/science.284.5413.464; Joos F, 2008, P NATL ACAD SCI USA, V105, P1425, DOI 10.1073/pnas.0707386105; Juckes MN, 2007, CLIM PAST, V3, P591, DOI 10.5194/cp-3-591-2007; Lee TCK, 2008, CLIM DYNAM, V31, P263, DOI 10.1007/s00382-007-0351-9; MacDonald GM, 2006, SCIENCE, V314, P285, DOI 10.1126/science.1131722; Macfarlane DG, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025005; Mann ME, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017814; Mann ME, 1999, GEOPHYS RES LETT, V26, P759, DOI 10.1029/1999GL900070; Mann ME, 2008, P NATL ACAD SCI USA, V105, P13252, DOI 10.1073/pnas.0805721105; Moberg A, 2005, NATURE, V433, P613, DOI 10.1038/nature03265; Plattner GK, 2008, J CLIMATE, V21, P2721, DOI 10.1175/2007JCLI1905.1; Pongratz J, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2009GB003488; Scheffer M, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025044; Siegenthaler U, 2005, TELLUS B, V57, P51, DOI 10.1111/j.1600-0889.2005.00131.x; Soloman S., 2007, CLIMATE CHANGE 2007; Strassmann KM, 2008, TELLUS B, V60, P583, DOI 10.1111/j.1600-0889.2008.00340.x; Thompson DWJ, 2008, NATURE, V453, P646, DOI 10.1038/nature06982; Thornton PE, 2009, BIOGEOSCIENCES, V6, P2099, DOI 10.5194/bg-6-2099-2009; Trouet V, 2009, SCIENCE, V324, P78, DOI 10.1126/science.1166349; Tschumi J, 2000, J GLACIOL, V46, P45, DOI 10.3189/172756500781833359; von Storch H, 2004, SCIENCE, V306, P679, DOI 10.1126/science.1096109; Woodwell GM, 1998, CLIMATIC CHANGE, V40, P495, DOI 10.1023/A:1005345429236	46	203	210	6	138	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 28	2010	463	7280					527	U143		10.1038/nature08769	http://dx.doi.org/10.1038/nature08769			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	548QK	20110999				2022-12-28	WOS:000273981100048
J	Maynard, A; Bloor, K				Maynard, Alan; Bloor, Karen			Will financial incentives and penalties improve hospital care?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PERFORMANCE; QUALITY; PAY; MEDICARE		[Maynard, Alan] Univ York, York Hlth Policy Grp, York YO10 5DD, N Yorkshire, England	University of York - UK	Maynard, A (corresponding author), Univ York, York Hlth Policy Grp, York YO10 5DD, N Yorkshire, England.	akm3@york.ac.uk		Bloor, Karen/0000-0003-4852-9854				Baker G., 2005, PROVIDER PAY FOR PER; Campbell SM, 2009, NEW ENGL J MED, V361, P368, DOI 10.1056/NEJMsa0807651; *DEP HLTH, IMP ASS COMM QUAL IN; *DEP HLTH, 2009, FIG YOU CAN TRUST BR; Department of Health, 2008, US COMM QUAL INN CQU; Department of Health, 2008, GUID ROUT COLL PAT R; Doran T, 2008, LANCET, V372, P728, DOI 10.1016/S0140-6736(08)61123-X; Fleetcroft Robert, 2006, J Health Serv Res Policy, V11, P27, DOI 10.1258/135581906775094316; Grossbart SR, 2006, MED CARE RES REV, V63, p29S, DOI 10.1177/1077558705283643; *HOUS COMM HLTH CO, 2008, PUBL EXP HLTH PERS S; Hughes D, 1999, SOCIOL HEALTH ILL, V21, P71, DOI 10.1111/1467-9566.00143; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Lindenauer PK, 2007, NEW ENGL J MED, V356, P486, DOI 10.1056/NEJMsa064964; Mehrotra A, 2009, AM J MED QUAL, V24, P19, DOI 10.1177/1062860608326634; Milstein A, 2009, NEW ENGL J MED, V360, P2388, DOI 10.1056/NEJMp0809125; National Patient Safety Agency. National Patient Safety Agency, 2009, NEV EV FRAM 2009 10; *NHS NW, ADV QUAL; *PREM, P4P POND; *PREM, ADV QUAL N W ENGL; Rosenthal MB, 2007, NEW ENGL J MED, V357, P1573, DOI 10.1056/NEJMp078184; Ryan AM, 2009, HEALTH SERV RES, V44, P821, DOI 10.1111/j.1475-6773.2009.00956.x; [No title captured]	22	19	19	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 21	2010	340								c88	10.1136/bmj.c88	http://dx.doi.org/10.1136/bmj.c88			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	548HP	20093280				2022-12-28	WOS:000273951400011
J	Al-Shoaibi, N; Massel, D				Al-Shoaibi, Naeem; Massel, David			Perioperative fluvastatin reduced cardiac events after noncardiac vascular surgery	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Al-Shoaibi, Naeem; Massel, David] London Hlth Sci Ctr, London, ON, Canada	London Health Sciences Centre	Al-Shoaibi, N (corresponding author), London Hlth Sci Ctr, London, ON, Canada.							Aung PP, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000123.pub2; Dunkelgrun M, 2009, ANN SURG, V249, P921, DOI 10.1097/SLA.0b013e3181a77d00; Genest J, 2009, CAN J CARDIOL, V25, P567, DOI 10.1016/S0828-282X(09)70715-9	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 19	2010	152	2							JC1-7	10.7326/0003-4819-152-2-201001190-02007	http://dx.doi.org/10.7326/0003-4819-152-2-201001190-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	548IE	20083822				2022-12-28	WOS:000273953000031
J	Livingston, EH				Livingston, Edward H.			Solutions for Improving Patient Safety	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ACCOUNTABILITY		Univ Texas SW Med Ctr Dallas, Div Gastrointestinal & Endocrine Surg, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Livingston, EH (corresponding author), Univ Texas SW Med Ctr Dallas, Div Gastrointestinal & Endocrine Surg, 5323 Harry Hines Blvd,Room E7-126, Dallas, TX 75390 USA.	edward.livingston@utsouthwestern.edu						BLANKSTEIN A, 2008, LOS ANGELES TIM 1216; Bush RL, 2009, AM J SURG, V198, pS41, DOI 10.1016/j.amjsurg.2009.08.005; IOM Committee on Quality of Health Care in America, 2000, ERR IS HUM BUILD SAF; Leape LL, 2005, JAMA-J AM MED ASSOC, V293, P2384, DOI 10.1001/jama.293.19.2384; Neily J, 2009, ARCH SURG-CHICAGO, V144, P1028, DOI 10.1001/archsurg.2009.126; Pronovost PJ, 2009, JAMA-J AM MED ASSOC, V302, P890, DOI 10.1001/jama.2009.1177; Sax HC, 2009, ARCH SURG-CHICAGO, V144, P1133, DOI 10.1001/archsurg.2009.207; Wachter RM, 2009, NEW ENGL J MED, V361, P1401, DOI 10.1056/NEJMsb0903885; Zarembo A., 2009, LOS ANGELES TIM 1014	9	8	9	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 13	2010	303	2					159	161		10.1001/jama.2009.2010	http://dx.doi.org/10.1001/jama.2009.2010			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	542UI	20073118				2022-12-28	WOS:000273522600026
J	Abrahamsen, B; Masud, T; Avenell, A; Anderson, F; Meyer, HE; Cooper, C; Smith, H; LaCroix, AZ; Torgerson, D; Johansen, A; Jackson, R; Rejnmark, L; Wactawski-Wende, J; Brixen, K; Mosekilde, L; Robbins, JA; Francis, RM				Abrahamsen, B.; Masud, T.; Avenell, A.; Anderson, F.; Meyer, H. E.; Cooper, C.; Smith, H.; LaCroix, A. Z.; Torgerson, D.; Johansen, A.; Jackson, R.; Rejnmark, L.; Wactawski-Wende, J.; Brixen, K.; Mosekilde, L.; Robbins, J. A.; Francis, R. M.		DIPART Vitamin D Individual Patien	Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED-CONTROLLED-TRIALS; PLACEBO-CONTROLLED TRIAL; D SUPPLEMENTATION; DOUBLE-BLIND; OSTEOPOROTIC FRACTURES; ELDERLY-PEOPLE; HIP FRACTURE; OLDER-PEOPLE; D DEFICIENCY; BONE LOSS	Objectives To identify participants' characteristics that influence the anti-fracture efficacy of vitamin D or vitamin D plus calcium with respect to any fracture, hip fracture, and clinical vertebral fracture and to assess the influence of dosing regimens and co-administration of calcium. Design Individual patient data analysis using pooled data from randomised trials. Data sources Seven major randomised trials of vitamin D with calcium or vitamin D alone, yielding a total of 68 517 participants (mean age 69.9 years, range 47-107 years, 14.7% men). Study selection Studies included were randomised studies with at least one intervention arm in which vitamin D was given, fracture as an outcome, and at least 1000 participants. Data synthesis Logistic regression analysis was used to identify significant interaction terms, followed by Cox's proportional hazards models incorporating age, sex, fracture history, and hormone therapy and bisphosphonate use. Results Trials using vitamin D with calcium showed a reduced overall risk of fracture (hazard ratio 0.92, 95% confidence interval 0.86 to 0.99, P=0.025) and hip fracture (all studies: 0.84, 0.70 to 1.01, P=0.07; studies using 10 mu g of vitamin D given with calcium: 0.74, 0.60 to 0.91, P=0.005). For vitamin D alone in daily doses of 10 mu g or 20 mu g, no significant effects were found. No interaction was found between fracture history and treatment response, nor any interaction with age, sex, or hormone replacement therapy. Conclusion This individual patient data analysis indicates that vitamin D given alone in doses of 10-20 mu g is not effective in preventing fractures. By contrast, calcium and vitamin D given together reduce hip fractures and total fractures, and probably vertebral fractures, irrespective of age, sex, or previous fractures.	[Abrahamsen, B.] Copenhagen Univ Hosp Gentofte, Dept Med F, Hellerup, Denmark; [Abrahamsen, B.; Brixen, K.] Univ So Denmark, Inst Clin Res, Odense, Denmark; [Masud, T.] Univ Nottingham Hosp, Nottingham NG7 2UH, England; [Avenell, A.] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen AB9 1FX, Scotland; [Anderson, F.] Univ Southampton, Sch Med, DOHaD Res Div, Southampton SO9 5NH, Hants, England; [Meyer, H. E.] Univ Oslo, Norwegian Inst Publ Hlth, Div Epidemiol, Oslo, Norway; [Meyer, H. E.] Univ Oslo, Prevent Med & Epidemiol Sect, Oslo, Norway; [Cooper, C.] MRC, Epidemiol Resource Ctr, Southampton, Hants, England; [Smith, H.] Brighton & Sussex Med Sch, Brighton, E Sussex, England; [LaCroix, A. Z.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Torgerson, D.] Univ York, York Trials Unit, York YO10 5DD, N Yorkshire, England; [Johansen, A.] Swansea Univ, Dept Publ Hlth, Swansea, W Glam, Wales; [Johansen, A.] Univ Wales Hosp, Acad Dept Geriatr Med, Cardiff CF4 4XW, S Glam, Wales; [Jackson, R.] Ohio State Univ, Columbus, OH 43210 USA; [Rejnmark, L.; Mosekilde, L.] Aarhus Univ Hosp, DK-8000 Aarhus, Denmark; [Wactawski-Wende, J.] SUNY Buffalo, Dept Social & Prevent Med, Buffalo, NY USA; [Wactawski-Wende, J.] SUNY Buffalo, Dept Obstet Gynecol, Buffalo, NY USA; [Brixen, K.] Odense Univ Hosp, DK-5000 Odense, Denmark; [Robbins, J. A.] Calif State Univ Sacramento, Sacramento, CA 95819 USA; [Francis, R. M.] Freeman Rd Hosp, Newcastle Upon Tyne, Tyne & Wear, England	University of Copenhagen; Herlev & Gentofte Hospital; University of Southern Denmark; University of Nottingham; University of Aberdeen; University of Southampton; Norwegian Institute of Public Health (NIPH); University of Oslo; University of Oslo; University of Brighton; University of Sussex; Fred Hutchinson Cancer Center; University of York - UK; Swansea University; Cardiff University; University System of Ohio; Ohio State University; Aarhus University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Southern Denmark; Odense University Hospital; California State University System; California State University Sacramento; Newcastle Freeman Hospital; Newcastle University - UK	Abrahamsen, B (corresponding author), Copenhagen Univ Hosp Gentofte, Dept Internal Med & Endocrinol, Niels Andersensvej 65, DK-2900 Copenhagen, Denmark.	b.abrahamsen@physician.dk	Abrahamsen, Bo/B-8920-2008; Torgerson, David/L-4566-2019; Wactawski-Wende, Jean/AGH-5457-2022; Smith, Helen E/M-2449-2016; Meyer, Haakon E./AAH-9333-2019	Abrahamsen, Bo/0000-0002-2730-6080; Torgerson, David/0000-0002-1667-4275; Wactawski-Wende, Jean/0000-0003-3096-9595; Smith, Helen E/0000-0003-1883-6124; Meyer, Haakon E/0000-0002-3262-8260; Cooper, Cyrus/0000-0003-3510-0709; Rejnmark, Lars/0000-0002-2152-4247	National Heart, Lung, and Blood Institute, National Institutes of Health, US Department of Health and Human Services [N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, 44221]; UK Medical Research Council; Chief Scientist Office of the Scottish Government Health Directorates; Merck; Procter Gamble; Roche; Eli Lilly; Shire; ProStrakan; Servier; Shire Pharmaceuticals; Pfizer; Sanofi-Aventis; Merck Sharp Dohme; Medical Research Council [MC_UP_A620_1014, U1475000001] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10082] Funding Source: researchfish; Chief Scientist Office [HSRU1] Funding Source: researchfish; WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH [N01WH032100, N01WH032122, N01WH022110, N01WH032101, N01WH032113, N01WH042109, N01WH032119, N01WH032118, N01WH042107, N01WH032109, N01WH032112, N01WH042108, N01WH032115, N01WH032108, N01WH042129, N01WH032106, N01WH032102, N01WH042132, N01WH042130, N01WH032111, N01WH032105, N01WH042131] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute, National Institutes of Health, US Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist Office of the Scottish Government Health Directorates; Merck(Merck & Company); Procter Gamble(Procter & Gamble); Roche(Roche Holding); Eli Lilly(Eli Lilly); Shire; ProStrakan; Servier(Servier); Shire Pharmaceuticals; Pfizer(Pfizer); Sanofi-Aventis(Sanofi-Aventis); Merck Sharp Dohme(Merck & Company); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office; WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The WHI program is funded by the National Heart, Lung, and Blood Institute, National Institutes of Health, US Department of Health and Human Services through contracts N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, and 44221. AA acknowledges personal funding from the UK Medical Research Council and Chief Scientist Office of the Scottish Government Health Directorates.; BA receives consulting fees from Novartis, serves on advisory boards for Amgen and Nycomed, and receives lecture fees from Eli Lilly and Procter & Gamble. TM receives research funding and speakers' fees from Merck, Procter & Gamble, Roche, Eli Lilly, Shire, ProStrakan, and Servier. FA has received honorariums for lectures and advisory panels from Shire, Celltech, ProStrakan, and Merck. CC has served in a consultant capacity to the Alliance for Better Bone Health, Eli Lilly, Merck Sharp & Dohme, Amgen, GlaxoSmithKline, Roche, and Servier. DT has received research funding from Shire Pharmaceuticals. ALC serves on advisory boards for studies funded by Pfizer, Procter & Gamble, and Sanofi-Aventis. KB has received consultancy fees from Servier, Novartis, Eli Lilly, Nycomed, and Osteologix, as well as speakers' fees from Eli Lilly, Novartis, and Servier and research grants from Merck Sharp & Dohme. RMF has served as an adviser to Procter & Gamble, Sanofi, Merck Sharp & Dohme, Roche, GlaxoSmithKline, Novartis, Lilly, Servier, Nycomed, Shire, and Prostrakan.	Aspray TJ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afj018; Avenell A, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000227.pub3; Bischoff-Ferrari HA, 2005, JAMA-J AM MED ASSOC, V293, P2257, DOI 10.1001/jama.293.18.2257; Bischoff-Ferrari HA, 2006, AM J CLIN NUTR, V84, P18, DOI 10.1093/ajcn/84.1.18; Bischoff-Ferrari HA, 2009, ARCH INTERN MED, V169, P551, DOI 10.1001/archinternmed.2008.600; Boonen S, 2007, J CLIN ENDOCR METAB, V92, P1415, DOI 10.1210/jc.2006-1404; Brennan J, 2003, OSTEOPOROSIS INT, V14, P515, DOI 10.1007/s00198-003-1404-5; CHAPUY MC, 1992, NEW ENGL J MED, V327, P1637, DOI 10.1056/NEJM199212033272305; Francis RM, 2006, QJM-INT J MED, V99, P355, DOI 10.1093/qjmed/hcl031; Grant AM, 2005, LANCET, V365, P1621, DOI 10.1016/S0140-6736(05)63013-9; Harwood RH, 2004, AGE AGEING, V33, P45, DOI 10.1093/ageing/afh002; Hirani V, 2005, AGE AGEING, V34, P485, DOI 10.1093/ageing/afi153; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holroyd C, 2008, BEST PRACT RES CL EN, V22, P671, DOI 10.1016/j.beem.2008.06.001; Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218; Johansen A, 1997, INJURY, V28, P655, DOI 10.1016/S0020-1383(97)00144-7; Lambert PC, 2002, J CLIN EPIDEMIOL, V55, P86, DOI 10.1016/S0895-4356(01)00414-0; Larsen ER, 2004, J BONE MINER RES, V19, P370, DOI 10.1359/JBMR.0301240; Law M, 2006, AGE AGEING, V35, P482, DOI 10.1093/ageing/afj080; Lips P, 2001, ENDOCR REV, V22, P477, DOI 10.1210/er.22.4.477; Lips P, 1996, ANN INTERN MED, V124, P400, DOI 10.7326/0003-4819-124-4-199602150-00003; Lyons RA, 2007, OSTEOPOROSIS INT, V18, P811, DOI 10.1007/s00198-006-0309-5; Meyer HE, 2002, J BONE MINER RES, V17, P709, DOI 10.1359/jbmr.2002.17.4.709; Porthouse J, 2005, BMJ-BRIT MED J, V330, P1003, DOI 10.1136/bmj.330.7498.1003; Romagnoli E, 2008, J CLIN ENDOCR METAB, V93, P3015, DOI 10.1210/jc.2008-0350; Smith H, 2007, RHEUMATOLOGY, V46, P1852, DOI 10.1093/rheumatology/kem240; Tang BMP, 2007, LANCET, V370, P657, DOI 10.1016/S0140-6736(07)61342-7; Trivedi DP, 2003, BMJ-BRIT MED J, V326, P469, DOI 10.1136/bmj.326.7387.469	29	267	272	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 12	2010	340								b5463	10.1136/bmj.b5463	http://dx.doi.org/10.1136/bmj.b5463			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	545CZ	20068257	Green Accepted, Green Published, Green Submitted, hybrid			2022-12-28	WOS:000273711400004
J	Kyewski, B; Peterson, P				Kyewski, Bruno; Peterson, Paert			Aire, Master of Many Trades	CELL			English	Editorial Material							CENTRAL TOLERANCE; PROTEIN; THYMUS		[Kyewski, Bruno] German Canc Res Ctr, Div Dev Immunol, Tumor Immunol Program, D-69120 Heidelberg, Germany; [Peterson, Paert] Univ Tartu, Inst Gen & Mol Pathol, EE-50090 Tartu, Estonia	Helmholtz Association; German Cancer Research Center (DKFZ); University of Tartu	Kyewski, B (corresponding author), German Canc Res Ctr, Div Dev Immunol, Tumor Immunol Program, D-69120 Heidelberg, Germany.	b.kyewski@dkfz.de; part.peterson@ut.ee	Peterson, Pärt/A-5788-2009	Peterson, Pärt/0000-0001-6755-791X				Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Guerau-De-Arellano M, 2008, P NATL ACAD SCI USA, V105, P14011, DOI 10.1073/pnas.0806616105; Halonen M, 2004, HUM MUTAT, V23, P245, DOI 10.1002/humu.20003; Klein L, 2009, NAT REV IMMUNOL, V9, P833, DOI 10.1038/nri2669; Kyewski B, 2006, ANNU REV IMMUNOL, V24, P571, DOI 10.1146/annurev.immunol.23.021704.115601; Liiv I, 2008, BBA-MOL CELL RES, V1783, P74, DOI 10.1016/j.bbamcr.2007.09.003; Nitiss JL, 2009, NAT REV CANCER, V9, P327, DOI 10.1038/nrc2608; Org T, 2008, EMBO REP, V9, P370, DOI [10.1038/embor.2008.11, 10.1038/sj.embor.2008.11]; Peterson P, 2008, NAT REV IMMUNOL, V8, P948, DOI 10.1038/nri2450	9	30	30	1	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 8	2010	140	1					24	26		10.1016/j.cell.2009.12.036	http://dx.doi.org/10.1016/j.cell.2009.12.036			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	541CY	20085700	Bronze			2022-12-28	WOS:000273391900009
J	Carey, AF; Wang, GR; Su, CY; Zwiebel, LJ; Carlson, JR				Carey, Allison F.; Wang, Guirong; Su, Chih-Ying; Zwiebel, Laurence J.; Carlson, John R.			Odorant reception in the malaria mosquito Anopheles gambiae	NATURE			English	Article							VOLATILE ORGANIC-COMPOUNDS; HUMAN SKIN EMANATIONS; DROSOPHILA-ANTENNA; AEDES-AEGYPTI; MOLECULAR-BASIS; CELLULAR BASIS; IDENTIFICATION; ATTRACTANTS; OLFACTION; BEHAVIOR	The mosquito Anopheles gambiae is the major vector of malaria in sub-Saharan Africa. It locates its human hosts primarily through olfaction, but little is known about the molecular basis of this process. Here we functionally characterize the Anopheles gambiae odorant receptor (AgOr) repertoire. We identify receptors that respond strongly to components of human odour and that may act in the process of human recognition. Some of these receptors are narrowly tuned, and some salient odorants elicit strong responses from only one or a few receptors, suggesting a central role for specific transmission channels in human host-seeking behaviour. This analysis of the Anopheles gambiae receptors permits a comparison with the corresponding Drosophila melanogaster odorant receptor repertoire. We find that odorants are differentially encoded by the two species in ways consistent with their ecological needs. Our analysis of the Anopheles gambiae repertoire identifies receptors that may be useful targets for controlling the transmission of malaria.	[Carey, Allison F.; Su, Chih-Ying; Carlson, John R.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Wang, Guirong; Zwiebel, Laurence J.] Vanderbilt Univ, Global Hlth & Program Dev Biol, Nashville, TN 37235 USA; [Wang, Guirong; Zwiebel, Laurence J.] Vanderbilt Univ, Inst Biol Chem, Ctr Mol Neurosci, Dept Biol Sci, Nashville, TN 37235 USA	Yale University; Vanderbilt University; Vanderbilt University	Carlson, JR (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	john.carlson@yale.edu		Zwiebel, Laurence/0000-0001-6686-7289	Foundation for the National Institutes of Health (NIH); NIH [2T32GM07205]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063364, T32GM007205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002174, R01DC004729] Funding Source: NIH RePORTER	Foundation for the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank W. van der Goes van Naters and C. Yao for help with electrophysiology, E. Hallem, S. Kreher, J. Salzman and T. Emonet for assistance with data analyses, and T.-W. Koh for comments on the manuscript. We thank P. Graham, Z. Berman, A. Rabin, M. Dillon and E. Kelley-Swift for technical assistance. We thank Y.-T. Qiu for assistance in generating Fig. 1b and Supplementary Fig. 1. This work was funded in part by grants from the Foundation for the National Institutes of Health (NIH) through the Grand Challenges in Global Health Initiative to L. J. Z., and from the NIH to L. J. Z. and J. R. C. A. F. C. is supported by an NIH Medical Scientist Training Program grant (2T32GM07205).	Allan SA, 2005, J AM MOSQUITO CONTR, V21, P268, DOI 10.2987/8756-971X(2005)21[268:EOOSAO]2.0.CO;2; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Bernier UR, 2002, J AM MOSQUITO CONTR, V18, P186; Bernier UR, 2000, ANAL CHEM, V72, P747, DOI 10.1021/ac990963k; Blackwell A, 2000, ANN TROP MED PARASIT, V94, P389, DOI 10.1080/00034983.2000.11813554; Cork A, 1996, MED VET ENTOMOL, V10, P269, DOI 10.1111/j.1365-2915.1996.tb00742.x; Curran AM, 2007, J CHROMATOGR B, V846, P86, DOI 10.1016/j.jchromb.2006.08.039; Curran AM, 2005, J CHEM ECOL, V31, P1607, DOI 10.1007/s10886-005-5801-4; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Fox AN, 2001, P NATL ACAD SCI USA, V98, P14693, DOI 10.1073/pnas.261432998; Gallagher M, 2008, BRIT J DERMATOL, V159, P780, DOI 10.1111/j.1365-2133.2008.08748.x; Gaunt MW, 2002, MOL BIOL EVOL, V19, P748, DOI 10.1093/oxfordjournals.molbev.a004133; Gutierrez-Garcia AG, 2007, PHYSIOL BEHAV, V91, P166, DOI 10.1016/j.physbeh.2007.02.006; Haddad R, 2008, NAT METHODS, V5, P425, DOI [10.1038/nmeth.1197, 10.1038/NMETH.1197]; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hallem EA, 2004, NATURE, V427, P212, DOI 10.1038/427212a; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; KOSTELC JG, 1980, J PERIODONTAL RES, V15, P185, DOI 10.1111/j.1600-0765.1980.tb00273.x; Kreher SA, 2005, NEURON, V46, P445, DOI 10.1016/j.neuron.2005.04.007; Kreher SA, 2008, NEURON, V59, P110, DOI 10.1016/j.neuron.2008.06.010; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lindh JM, 2008, J MED ENTOMOL, V45, P1039, DOI 10.1603/0022-2585(2008)45[1039:OROAGS]2.0.CO;2; Logan JG, 2008, J CHEM ECOL, V34, P308, DOI 10.1007/s10886-008-9436-0; Lu T, 2007, CURR BIOL, V17, P1533, DOI 10.1016/j.cub.2007.07.062; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Meijerink J, 2000, J CHEM ECOL, V26, P1367, DOI 10.1023/A:1005475422978; MILLAR JG, 1992, J AM MOSQUITO CONTR, V8, P11; Moore Sarah J., 2007, P3; MORTON ID, 1990, FLAVOUR FRUITS, P57401; Olsen SR, 2008, NATURE, V452, P956, DOI 10.1038/nature06864; Omolo MO, 2004, PHYTOCHEMISTRY, V65, P2797, DOI 10.1016/j.phytochem.2004.08.035; Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016; Schlief ML, 2007, NAT NEUROSCI, V10, P623, DOI 10.1038/nn1881; Su CY, 2009, CELL, V139, P45, DOI 10.1016/j.cell.2009.09.015; Sun HW, 2008, J ENVIRON QUAL, V37, P615, DOI 10.2134/jeq2007.0357; Syed Z, 2009, P NATL ACAD SCI USA, V106, P18803, DOI 10.1073/pnas.0906932106; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; TAKKEN W, 1991, INSECT SCI APPL, V12, P287, DOI 10.1017/S1742758400020816; TANGERMAN A, 1983, CLIN CHIM ACTA, V130, P103, DOI 10.1016/0009-8981(83)90263-2; *TNO, 2004, VOL COMP FOOD QUAL Q; Verhulst NO, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-302; Wilson RI, 2006, ANNU REV NEUROSCI, V29, P163, DOI 10.1146/annurev.neuro.29.051605.112950; World Health Organization, 2008, WORLD MAL REP; Xia YF, 2008, P NATL ACAD SCI USA, V105, P6433, DOI 10.1073/pnas.0801007105; Yao CA, 2005, J NEUROSCI, V25, P8359, DOI 10.1523/JNEUROSCI.2432-05.2005; Zwiebel LJ, 2004, INSECT BIOCHEM MOLEC, V34, P645, DOI 10.1016/j.ibmb.2004.03.017	47	370	393	8	178	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 4	2010	464	7285					66	U77		10.1038/nature08834	http://dx.doi.org/10.1038/nature08834			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563GZ	20130575	Green Accepted			2022-12-28	WOS:000275117500034
J	Christodoulou, F; Raible, F; Tomer, R; Simakov, O; Trachana, K; Klaus, S; Snyman, H; Hannon, GJ; Bork, P; Arendt, D				Christodoulou, Foteini; Raible, Florian; Tomer, Raju; Simakov, Oleg; Trachana, Kalliopi; Klaus, Sebastian; Snyman, Heidi; Hannon, Gregory J.; Bork, Peer; Arendt, Detlev			Ancient animal microRNAs and the evolution of tissue identity	NATURE			English	Article							NEMATOSTELLA-VECTENSIS; SPATIAL EXPRESSION; GENES; LET-7; DROSOPHILA; SYSTEM	The spectacular escalation in complexity in early bilaterian evolution correlates with a strong increase in the number of microRNAs(1,2). To explore the link between the birth of ancient microRNAs and body plan evolution, we set out to determine the ancient sites of activity of conserved bilaterian microRNA families in a comparative approach. We reason that any specific localization shared between protostomes and deuterostomes (the two major superphyla of bilaterian animals) should probably reflect an ancient specificity of that microRNA in their last common ancestor. Here, we investigate the expression of conserved bilaterian microRNAs in Platynereis dumerilii, a protostome retaining ancestral bilaterian features(3,4), in Capitella, another marine annelid, in the sea urchin Strongylocentrotus, a deuterostome, and in sea anemone Nematostella, representing an outgroup to the bilaterians. Our comparative data indicate that the oldest known animal microRNA, miR-100, and the related miR-125 and let-7 were initially active in neurosecretory cells located around the mouth. Other sets of ancient microRNAs were first present in locomotor ciliated cells, specific brain centres, or, more broadly, one of four major organ systems: central nervous system, sensory tissue, musculature and gut. These findings reveal that microRNA evolution and the establishment of tissue identities were closely coupled in bilaterian evolution. Also, they outline a minimum set of cell types and tissues that existed in the protostome-deuterostome ancestor.	[Christodoulou, Foteini; Raible, Florian; Tomer, Raju; Simakov, Oleg; Klaus, Sebastian; Snyman, Heidi; Arendt, Detlev] European Mol Biol Lab, Dev Biol Unit, D-69117 Heidelberg, Germany; [Raible, Florian; Trachana, Kalliopi; Bork, Peer] European Mol Biol Lab, Computat Biol Unit, D-69117 Heidelberg, Germany; [Hannon, Gregory J.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Cold Spring Harbor Laboratory	Arendt, D (corresponding author), European Mol Biol Lab, Dev Biol Unit, D-69117 Heidelberg, Germany.	arendt@embl.de	Hannon, Gregory/AAB-3568-2019; Bork, Peer/F-1813-2013; Tomer, Raju/F-2335-2010; Simakov, Oleg/AAV-2494-2020; Simakov, Oleg/G-4572-2015; Raible, Florian/G-6019-2011	Bork, Peer/0000-0002-2627-833X; Simakov, Oleg/0000-0002-3585-4511; Simakov, Oleg/0000-0002-3585-4511; Klaus, Sebastian/0000-0001-5822-7978; Raible, Florian/0000-0002-4515-6485	NCI NIH HHS [P01 CA013106-39, P01 CA013106-38, P01 CA013106] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aboobaker AA, 2005, P NATL ACAD SCI USA, V102, P18017, DOI 10.1073/pnas.0508823102; Arenas-Mena C, 2000, DEVELOPMENT, V127, P4631; Arendt D, 2001, NATURE, V409, P81, DOI 10.1038/35051075; Caygill EE, 2008, CURR BIOL, V18, P943, DOI 10.1016/j.cub.2008.06.020; Denes AS, 2007, CELL, V129, P277, DOI 10.1016/j.cell.2007.02.040; Deo M, 2006, DEV DYNAM, V235, P2538, DOI 10.1002/dvdy.20847; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; GONZALEZESTEVEZ C, 2009, INT J DEV B IN PRESS; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Harada Y, 2000, MECH DEVELOP, V91, P337, DOI 10.1016/S0925-4773(99)00279-8; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Jekely G, 2007, BIOTECHNIQUES, V42, P751, DOI 10.2144/000112462; Kapsimali M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r173; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lu J, 2008, NAT GENET, V40, P351, DOI 10.1038/ng.73; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Nielsen C, 2012, ANIMAL EVOLUTION: INTERRELATIONSHIPS OF THE LIVING PHYLA, 3RD EDITION, P1; Pall GS, 2008, NAT PROTOC, V3, P1077, DOI 10.1038/nprot.2008.67; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Prochnik SE, 2007, DEV GENES EVOL, V217, P73, DOI 10.1007/s00427-006-0116-1; Raible F, 2005, SCIENCE, V310, P1325, DOI 10.1126/science.1119089; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rentzsch F, 2006, DEV BIOL, V296, P375, DOI 10.1016/j.ydbio.2006.06.003; Scholz CB, 2003, DEV GENES EVOL, V212, P563, DOI 10.1007/s00427-002-0272-x; Shkumatava A, 2009, GENE DEV, V23, P466, DOI 10.1101/gad.1745709; Sokol NS, 2008, GENE DEV, V22, P1591, DOI 10.1101/gad.1671708; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Szafranska AE, 2007, ONCOGENE, V26, P4442, DOI 10.1038/sj.onc.1210228; Tessmar-Raible K, 2007, CELL, V129, P1389, DOI 10.1016/j.cell.2007.04.041; Valoczi A, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh171; Vigh B, 2004, HISTOL HISTOPATHOL, V19, P607, DOI 10.14670/HH-19.607; Wheeler BM, 2009, EVOL DEV, V11, P50, DOI 10.1111/j.1525-142X.2008.00302.x; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519	38	211	221	0	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 25	2010	463	7284					1084	U105		10.1038/nature08744	http://dx.doi.org/10.1038/nature08744			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563DR	20118916	Green Accepted			2022-12-28	WOS:000275108400037
J	Ehre, D; Lavert, E; Lahav, M; Lubomirsky, I				Ehre, David; Lavert, Etay; Lahav, Meir; Lubomirsky, Igor			Water Freezes Differently on Positively and Negatively Charged Surfaces of Pyroelectric Materials	SCIENCE			English	Article							SUPERCOOLED WATER; ICE NUCLEATION; SIMULATION; INTERFACE; CRYSTALS; BATIO3; MODEL	Although ice melts and water freezes under equilibrium conditions at 0 degrees C, water can be supercooled under homogeneous conditions in a clean environment down to -40 degrees C without freezing. The influence of the electric field on the freezing temperature of supercooled water (electrofreezing) is of topical importance in the living and inanimate worlds. We report that positively charged surfaces of pyroelectric LiTaO3 crystals and SrTiO3 thin films promote ice nucleation, whereas the same surfaces when negatively charged reduce the freezing temperature. Accordingly, droplets of water cooled down on a negatively charged LiTaO3 surface and remaining liquid at -11 degrees C freeze immediately when this surface is heated to -8 degrees C, as a result of the replacement of the negative surface charge by a positive one. Furthermore, powder x-ray diffraction studies demonstrated that the freezing on the positively charged surface starts at the solid/water interface, whereas on a negatively charged surface, ice nucleation starts at the air/water interface.	[Ehre, David; Lavert, Etay; Lahav, Meir; Lubomirsky, Igor] Weizmann Inst Sci, Dept Mat & Interfaces, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Lubomirsky, I (corresponding author), Weizmann Inst Sci, Dept Mat & Interfaces, IL-76100 Rehovot, Israel.	Igor.Lubomirsky@weizmann.ac.il	Lubomirsky, Igor/AAU-3353-2020	Lubomirsky, Igor/0000-0002-2359-2059	Israeli Science Foundation; Israel Ministry of Science; Nancy and Stephen Grand Research Center for Sensors and Security	Israeli Science Foundation(Israel Science Foundation); Israel Ministry of Science(Ministry of Science, Technology and Space (MOST), Israel); Nancy and Stephen Grand Research Center for Sensors and Security	The authors acknowledge the Israeli Science Foundation, the Israel Ministry of Science and the Nancy and Stephen Grand Research Center for Sensors and Security for funding this research. M. L. acknowledges the European COST 0703 on system chemistry, the Helen and Milton Kimmelman Center for Biomolecular Structure and Assembly, and the G. M. J. Schmidt Minerva center. The authors thank I. Weissbuch and I. Feldman of the Weizmann Institute for fruitful discussions. This research is made possible in part by the generosity of the Harold Perlman Family.	Dufour L., 1861, POGGENDORFS ANN PHYS, V190, P530; Ehre D, 2007, J MATER RES, V22, P2742, DOI 10.1557/JMR.2007.0342; Ehre D, 2007, ADV MATER, V19, P1515, DOI 10.1002/adma.200602149; Ehre D, 2007, ADV FUNCT MATER, V17, P1204, DOI 10.1002/adfm.200600190; Ehre D, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.184106; GAVISH M, 1992, SCIENCE, V256, P815, DOI 10.1126/science.1589763; Honkimaki V, 2006, J SYNCHROTRON RADIAT, V13, P426, DOI 10.1107/S0909049506031438; Hozumi T, 2003, INT J REFRIG, V26, P537, DOI 10.1016/S0140-7007(03)00008-2; Johari GP, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1900723; LAVERTOFIR E, 2009, THESIS FEINBERG GRAD; Lee R., 1995, BIOL ICE NUCL ITS AP, V1st ed.; Matsumoto M, 2002, NATURE, V416, P409, DOI 10.1038/416409a; Ogasawara H, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.276102; PRUPPACH.HR, 1973, PURE APPL GEOPHYS, V104, P623, DOI 10.1007/BF00875907; RUSSELL AE, 1993, J CHEM SOC FARADAY T, V89, P195, DOI 10.1039/ft9938900195; Shaw RA, 2005, J PHYS CHEM B, V109, P9865, DOI 10.1021/jp0506336; SHICHIRI T, 1981, J CRYST GROWTH, V54, P207, DOI 10.1016/0022-0248(81)90461-9; Svishchev IM, 1996, J CHEM PHYS, V105, P4742, DOI 10.1063/1.472313; TAKAHASHI T, 1982, J CRYST GROWTH, V59, P441, DOI 10.1016/0022-0248(82)90365-7; TONEY MF, 1994, NATURE, V368, P444, DOI 10.1038/368444a0; XIA XF, 1995, PHYS REV LETT, V74, P3193, DOI 10.1103/PhysRevLett.74.3193; Zangi R, 2004, J CHEM PHYS, V120, P7123, DOI 10.1063/1.1687315; Zhang L, 2008, J AM CHEM SOC, V130, P7686, DOI 10.1021/ja8011116; Zheng JM, 2009, J COLLOID INTERF SCI, V332, P511, DOI 10.1016/j.jcis.2009.01.010; ZHU SB, 1991, J CHEM PHYS, V95, P2791, DOI 10.1063/1.460930	25	175	180	7	279	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2010	327	5966					672	675		10.1126/science.1178085	http://dx.doi.org/10.1126/science.1178085			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551ZD	20133568				2022-12-28	WOS:000274251800033
J	Geissmann, F; Manz, MG; Jung, S; Sieweke, MH; Merad, M; Ley, K				Geissmann, Frederic; Manz, Markus G.; Jung, Steffen; Sieweke, Michael H.; Merad, Miriam; Ley, Klaus			Development of Monocytes, Macrophages, and Dendritic Cells	SCIENCE			English	Review							COLONY-STIMULATING FACTOR; HEMATOPOIETIC PROGENITOR CELLS; STEADY-STATE CONDITIONS; BLOOD MONOCYTES; IN-VIVO; BONE-MARROW; FUNCTIONAL-PROPERTIES; LANGERHANS CELLS; STEM-CELLS; RECEPTOR	Monocytes and macrophages are critical effectors and regulators of inflammation and the innate immune response, the immediate arm of the immune system. Dendritic cells initiate and regulate the highly pathogen-specific adaptive immune responses and are central to the development of immunologic memory and tolerance. Recent in vivo experimental approaches in the mouse have unveiled new aspects of the developmental and lineage relationships among these cell populations. Despite this, the origin and differentiation cues for many tissue macrophages, monocytes, and dendritic cell subsets in mice, and the corresponding cell populations in humans, remain to be elucidated.	[Geissmann, Frederic] Kings Coll London, Ctr Mol & Cellular Biol Inflammat, Div Immunol Infect & Inflammatory Dis, London SE1 1UL, England; [Manz, Markus G.] Univ Zurich Hosp, Dept Internal Med, Div Hematol, CH-8091 Zurich, Switzerland; [Jung, Steffen] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Sieweke, Michael H.] Univ Aix Marseille, CIML, F-13288 Marseille 09, France; [Sieweke, Michael H.] INSERM, U631, F-13258 Marseille, France; [Sieweke, Michael H.] CNRS, UMR6102, Marseille, France; [Merad, Miriam] Mt Sinai Sch Med, Icahn Med Inst, Inst Immunol, New York, NY 10029 USA; [Merad, Miriam] Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY 10029 USA; [Ley, Klaus] La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA	University of London; King's College London; University of Zurich; University Zurich Hospital; Weizmann Institute of Science; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; La Jolla Institute for Immunology	Geissmann, F (corresponding author), Kings Coll London, Ctr Mol & Cellular Biol Inflammat, Div Immunol Infect & Inflammatory Dis, Great Maze Pond, London SE1 1UL, England.	frederic.geissmann@kcl.ac.uk; klaus@liai.org	Jung, Steffen/K-1409-2012; Sieweke, Michael/AAR-7515-2020; Manz, Markus G/C-7588-2011	Jung, Steffen/0000-0003-4290-5716; Sieweke, Michael/0000-0002-3228-9537; Manz, Markus/0000-0002-4676-7931; geissmann, frederic/0000-0001-5029-2468	Medical Research Council UK [G0900867]; NIH [R01 HL058108]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058108] Funding Source: NIH RePORTER; MRC [G0900867] Funding Source: UKRI; Medical Research Council [G0900867] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The diagram depicted in Fig. 2 is the result of a collective discussion at a recent workshop: "Monocytes, Macrophages and Dendritic Cell Heterogeneity," 2 to 7 March 2009, Paris, France, organized by the Fondation des Treilles (www.les-treilles.com/newsite/index.html). We thank V. Bronte, I. Charo, J. Van Ginderachter, G. MacPherson, A. Mantovani, E. Pamer, R. Steinman, and F. Swirski for their input into Fig. 1 and for their ideas that we have incorporated into this review. Any misrepresentation is the responsibility of the authors. Work by F. G. and K. L. on the development of monocytes, macrophages, and dendritic cells is funded by Medical Research Council UK grant G0900867 to F. G. and grant NIH R01 HL058108 to K.	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Alder JK, 2008, J IMMUNOL, V180, P5645, DOI 10.4049/jimmunol.180.8.5645; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Auffray C, 2009, J EXP MED, V206, P595, DOI 10.1084/jem.20081385; Aziz A, 2006, MOL CELL BIOL, V26, P6808, DOI 10.1128/MCB.00245-06; Babcock DT, 2008, P NATL ACAD SCI USA, V105, P10017, DOI 10.1073/pnas.0709951105; Bakri Y, 2005, BLOOD, V105, P2707, DOI 10.1182/blood-2004-04-1448; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; CECCHINI MG, 1994, DEVELOPMENT, V120, P1357; Chorro L, 2009, J EXP MED, V206, P3089, DOI 10.1084/jem.20091586; Cisse B, 2008, CELL, V135, P37, DOI 10.1016/j.cell.2008.09.016; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Corcoran L, 2003, J IMMUNOL, V170, P4926, DOI 10.4049/jimmunol.170.10.4926; Cuttell L, 2008, CELL, V135, P524, DOI 10.1016/j.cell.2008.08.033; D'Amico A, 2003, J EXP MED, V198, P293, DOI 10.1084/jem.20030107; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; Dunay IR, 2008, IMMUNITY, V29, P306, DOI 10.1016/j.immuni.2008.05.019; Feinberg MW, 2007, EMBO J, V26, P4138, DOI 10.1038/sj.emboj.7601824; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Geissmann F, 1998, J EXP MED, V187, P961, DOI 10.1084/jem.187.6.961; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2008, IMMUNOL CELL BIOL, V86, P398, DOI 10.1038/icb.2008.19; Gleissner CA, 2010, CIRC RES, V106, P203, DOI 10.1161/CIRCRESAHA.109.199505; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Jaensson E, 2008, J EXP MED, V205, P2139, DOI 10.1084/jem.20080414; Kabashima K, 2005, IMMUNITY, V22, P439, DOI 10.1016/j.immuni.2005.02.007; KAWASAKI ES, 1985, SCIENCE, V230, P291, DOI 10.1126/science.2996129; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Li JC, 2009, J EXP MED, V206, P607, DOI 10.1084/jem.20082232; Lin HS, 2008, SCIENCE, V320, P807, DOI 10.1126/science.1154370; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Manz MG, 2007, IMMUNITY, V26, P537, DOI 10.1016/j.immuni.2007.05.001; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Martinez-Agosto JA, 2007, GENE DEV, V21, P3044, DOI 10.1101/gad.1602607; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Merad M, 2009, BLOOD, V113, P3418, DOI 10.1182/blood-2008-12-180646; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Narni-Mancinelli E, 2007, J EXP MED, V204, P2075, DOI 10.1084/jem.20070204; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Onai N, 2006, J EXP MED, V203, P227, DOI 10.1084/jem.20051645; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Robben PM, 2005, J EXP MED, V201, P1761, DOI 10.1084/jem.20050054; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sarrazin S, 2009, CELL, V138, P300, DOI 10.1016/j.cell.2009.04.057; Sasmono RT, 2003, BLOOD, V101, P1155, DOI 10.1182/blood-2002-02-0569; Scatizzi JC, 2006, AM J PATHOL, V168, P1531, DOI 10.2353/ajpath.2006.050555; Schulz O, 2009, J EXP MED, V206, P3101, DOI 10.1084/jem.20091925; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Shigematsu H, 2004, IMMUNITY, V21, P43, DOI 10.1016/j.immuni.2004.06.011; Sieweke MH, 1998, CURR OPIN GENET DEV, V8, P545, DOI 10.1016/S0959-437X(98)80009-9; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; STEINMAN RM, 1974, J EXP MED, V139, P1431, DOI 10.1084/jem.139.6.1431; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Taylor PR, 2003, IMMUNITY, V19, P2, DOI 10.1016/S1074-7613(03)00178-X; Trogan E, 2002, P NATL ACAD SCI USA, V99, P2234, DOI 10.1073/pnas.042683999; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615; WiktorJedrzejczak W, 1996, PHYSIOL REV, V76, P927, DOI 10.1152/physrev.1996.76.4.927; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Wu L, 2005, SEMIN IMMUNOL, V17, P304, DOI 10.1016/j.smim.2005.05.001; Yrlid U, 2006, J IMMUNOL, V176, P4155, DOI 10.4049/jimmunol.176.7.4155; Zenke M, 2006, TRENDS IMMUNOL, V27, P140, DOI 10.1016/j.it.2005.12.007	81	2023	2125	11	548	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2010	327	5966					656	661		10.1126/science.1178331	http://dx.doi.org/10.1126/science.1178331			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551ZD	20133564	Green Accepted			2022-12-28	WOS:000274251800028
J	Smith, RJ; Okano, JT; Kahn, JS; Bodine, EN; Blower, S				Smith, Robert J.; Okano, Justin T.; Kahn, James S.; Bodine, Erin N.; Blower, Sally			Evolutionary Dynamics of Complex Networks of HIV Drug-Resistant Strains: The Case of San Francisco	SCIENCE			English	Article							ACQUIRED-IMMUNODEFICIENCY-SYNDROME; ACTIVE ANTIRETROVIRAL THERAPY; FAILING THERAPY; MENS HEALTH; ZIDOVUDINE; TRANSMISSION; MUTATIONS; INFECTION; SENSITIVITY; LAMIVUDINE	Over the past two decades, HIV resistance to antiretroviral drugs (ARVs) has risen to high levels in the wealthier countries of the world, which are able to afford widespread treatment. We have gained insights into the evolution and transmission dynamics of ARV resistance by designing a biologically complex multistrain network model. With this model, we traced the evolutionary history of ARV resistance in San Francisco and predict its future dynamics. By using classification and regression trees, we identified the key immunologic, virologic, and treatment factors that increase ARV resistance. Our modeling shows that 60% of the currently circulating ARV-resistant strains in San Francisco are capable of causing self-sustaining epidemics, because each individual infected with one of these strains can cause, on average, more than one new resistant infection. It is possible that a new wave of ARV-resistant strains that pose a substantial threat to global public health is emerging.	[Smith, Robert J.; Okano, Justin T.; Bodine, Erin N.; Blower, Sally] Univ Calif Los Angeles, David Geffen Sch Med, Ctr Biomed Modeling, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA; [Kahn, James S.] Univ Calif San Francisco, Dept Med, Div Aids, San Francisco, CA 94110 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California San Francisco	Blower, S (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Ctr Biomed Modeling, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA.	sblower@mednet.ucla.edu		Smith?, Stacey/0000-0002-6529-3321; Bodine, Erin/0000-0001-7885-1233; Okano, Justin/0000-0002-2476-9370	National Institute of Allergy and Infectious Diseases (NIAID) [RO1 AI041935, P30-AI27763]; Natural Sciences and Engineering Research Council of Canada; Mathematics of Information Technology and Complex Systems; John Simon Guggenheim Foundation; National Academies Keck Foundation; Semel Institute for Neuroscience Human Behavior; NCRR [K24RR024369]; AHRQ [R18-HS017784]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R18HS017784] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K24RR024369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, R01AI041935] Funding Source: NIH RePORTER; AHRQ [5R18HS017784-02] Funding Source: Federal RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Mathematics of Information Technology and Complex Systems; John Simon Guggenheim Foundation; National Academies Keck Foundation; Semel Institute for Neuroscience Human Behavior; NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	R.J.S., J.T.O., E.N.B., and S. B. acknowledge the financial support of the National Institute of Allergy and Infectious Diseases (NIAID) (RO1 AI041935). R.J.S. is supported by a Natural Sciences and Engineering Research Council of Canada discovery grant, an Early Researcher award, and funding from Mathematics of Information Technology and Complex Systems. In addition, S. B. acknowledges the John Simon Guggenheim Foundation, the National Academies Keck Foundation, and the Semel Institute for Neuroscience & Human Behavior. J.S.K. acknowledges NIAID grants P30-AI27763, NCRR K24RR024369, and AHRQ R18-HS017784. We thank R. Breban, D. Freimer, J. Freimer, N. Freimer, N. Jewell, E. Kajita, T. Pylko, V. Supervie, and R. Vardavas for useful discussions throughout the course of this research.	BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Blower SM, 2000, SCIENCE, V287, P650, DOI 10.1126/science.287.5453.650; Booth CL, 2007, J ANTIMICROB CHEMOTH, V59, P1047, DOI 10.1093/jac/dkm082; Breiman L., 1984, CLASSIFICATION REGRE; Darwin C, 2003, ORIGIN SPECIES; ERON JJ, 1995, NEW ENGL J MED, V333, P1662, DOI 10.1056/NEJM199512213332502; Goudsmit J, 2001, AIDS, V15, P2293, DOI 10.1097/00002030-200111230-00011; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Kandathil AJ, 2009, INDIAN J MED MICROBI, V27, P231, DOI 10.4103/0255-0857.53205; Katlama C, 1996, JAMA-J AM MED ASSOC, V276, P118, DOI 10.1001/jama.276.2.118; Kuritzkes DR, 2004, AIDS PATIENT CARE ST, V18, P259, DOI 10.1089/108729104323076007; LANG W, 1987, JAMA-J AM MED ASSOC, V257, P326, DOI 10.1001/jama.257.3.326; LANG W, 1991, J ACQ IMMUN DEF SYND, V4, P713; LANG W, 1993, J ACQ IMMUN DEF SYND, V6, P191; LARDER BA, 1989, SCIENCE, V243, P1731, DOI 10.1126/science.2467383; Louie JK, 2002, J INFECT DIS, V186, P1023, DOI 10.1086/343862; Martinez-Picado J, 2008, VIRUS RES, V134, P104, DOI 10.1016/j.virusres.2007.12.021; Phillips A, 2001, NAT MED, V7, P993, DOI 10.1038/nm0901-993; Powers KA, 2008, LANCET INFECT DIS, V8, P553, DOI 10.1016/S1473-3099(08)70156-7; Ross L, 2008, AIDS RES HUM RETROV, V24, P617, DOI 10.1089/aid.2007.0188; Schmit JC, 1998, AIDS, V12, P2007, DOI 10.1097/00002030-199815000-00012; Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737; Tchetgen E, 2001, J ACQ IMMUN DEF SYND, V26, P118, DOI 10.1097/00126334-200102010-00003; Truong HHA, 2006, AIDS, V20, P2193, DOI 10.1097/01.aids.0000252059.85236.af; Vardavas R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000152; WINKELSTEIN W, 1987, JAMA-J AM MED ASSOC, V257, P321, DOI 10.1001/jama.257.3.321; Zaric GS, 1998, SIMULATION, V71, P262, DOI 10.1177/003754979807100406	28	94	106	4	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2010	327	5966					697	701		10.1126/science.1180556	http://dx.doi.org/10.1126/science.1180556			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551ZD	20075214				2022-12-28	WOS:000274251800040
J	Giovannoni, G; Comi, G; Cook, S; Rammohan, K; Rieckmann, P; Sorensen, PS; Vermersch, P; Chang, P; Hamlett, A; Musch, B; Greenberg, SJ				Giovannoni, Gavin; Comi, Giancarlo; Cook, Stuart; Rammohan, Kottil; Rieckmann, Peter; Sorensen, Per Soelberg; Vermersch, Patrick; Chang, Peter; Hamlett, Anthony; Musch, Bruno; Greenberg, Steven J.		CLARITY Study Grp	A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CELLS; MS; DIAGNOSIS	BACKGROUND Cladribine provides immunomodulation through selective targeting of lymphocyte subtypes. We report the results of a 96-week phase 3 trial of a short-course oral tablet therapy in patients with relapsing-remitting multiple sclerosis. METHODS We randomly assigned 1326 patients in an approximate 1: 1: 1 ratio to receive one of two cumulative doses of cladribine tablets ( either 3.5 mg or 5.25 mg per kilogram of body weight) or matching placebo, given in two or four short courses for the first 48 weeks, then in two short courses starting at week 48 and week 52 ( for a total of 8 to 20 days per year). The primary end point was the rate of relapse at 96 weeks. RESULTS Among patients who received cladribine tablets ( either 3.5 mg or 5.25 mg per kilogram), there was a significantly lower annualized rate of relapse than in the placebo group (0.14 and 0.15, respectively, vs. 0.33; P<0.001 for both comparisons), a higher relapse-free rate (79.7% and 78.9%, respectively, vs. 60.9%; P<0.001 for both comparisons), a lower risk of 3-month sustained progression of disability ( hazard ratio for the 3.5-mg group, 0.67; 95% confidence interval [CI], 0.48 to 0.93; P = 0.02; and hazard ratio for the 5.25-mg group, 0.69; 95% CI, 0.49 to 0.96; P = 0.03), and significant reductions in the brain lesion count on magnetic resonance imaging (MRI) (P<0.001 for all comparisons). Adverse events that were more frequent in the cladribine groups included lymphocytopenia (21.6% in the 3.5-mg group and 31.5% in the 5.25-mg group, vs. 1.8%) and herpes zoster ( 8 patients and 12 patients, respectively, vs. no patients). CONCLUSIONS Treatment with cladribine tablets significantly reduced relapse rates, the risk of disability progression, and MRI measures of disease activity at 96 weeks. The benefits need to be weighed against the risks.	[Giovannoni, Gavin] Queen Mary Univ London, Blizard Inst Cell & Mol Sci, Barts & London Sch Med & Dent, Ctr Neurosci, London E1 2AT, England; [Comi, Giancarlo] Univ Vita Salute San Raffaele, Inst Expt Neurol, Milan, Italy; [Cook, Stuart] Univ Med & Dent, New Jersey Med Sch, Newark, NJ USA; [Rammohan, Kottil] Ohio State Univ, Columbus, OH 43210 USA; [Rieckmann, Peter] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Rieckmann, Peter] Vancouver Coastal Hlth, Vancouver, BC, Canada; [Sorensen, Per Soelberg] Rigshosp, Copenhagen Univ Hosp, DK-2100 Copenhagen, Denmark; [Vermersch, Patrick] Univ Lille Nord France, Lille, France	University of London; Queen Mary University London; Vita-Salute San Raffaele University; Rutgers State University New Brunswick; Rutgers State University Medical Center; University System of Ohio; Ohio State University; University of British Columbia; Vancouver Coastal Health Research Institute; Rigshospitalet; University of Copenhagen; Universite de Lille - ISITE; Universite de Lille	Giovannoni, G (corresponding author), Queen Mary Univ London, Blizard Inst Cell & Mol Sci, Barts & London Sch Med & Dent, Ctr Neurosci, 4 Newark St, London E1 2AT, England.	g.giovannoni@qmul.ac.uk	Laskov, Vitalii B/H-8548-2013; amato, Maria Pia/AAL-5998-2020; LICEND, CEMND/F-1296-2015; Nehrych, Tetyana I/L-7555-2016; Kotov, Sergey V./E-4451-2017; MHIRI, Chokri/O-8801-2014; Milanov, Ivan/D-4318-2015	Laskov, Vitalii B/0000-0002-2391-5823; amato, Maria Pia/0000-0003-3325-3760; Nehrych, Tetyana I/0000-0003-0170-511X; Kotov, Sergey V./0000-0002-8706-7317; Laskov, Vitalii/0000-0003-2870-4547; MHIRI, Chokri/0000-0001-7591-6994; Toomsoo, Toomas/0000-0002-8364-0438; Wiertlewki, Sandrine/0000-0002-8678-3661; Laplaud, David/0000-0001-6113-6938; Sorensen, Per Soelberg/0000-0002-2818-3780; Moskovko, Sergii/0000-0003-3910-2672; Reingold, Stephen/0000-0003-4485-8634; Milanov, Ivan/0000-0002-4522-4070; Pozzilli, Carlo/0000-0002-6360-4798	Merck Serono; Bayer Schering Pharma; Biogen Idec; Novartis; Teva-Aventis; UCB Pharma; Vertex Pharmaceuticals; Ironwood Pharmaceuticals; Merz; Sanofi-Aventis; Biogen-Dompe; Bayer Schering; Bayer Healthcare; Genmab; EMD Serono; Bayer Pharmaceuticals; Pfizer; Teva; Genentech; Acorda; Biogen; Genzyme; MS Society of Canada; Ilich Foundation	Merck Serono(Merck & Company); Bayer Schering Pharma(Bayer AG); Biogen Idec(Biogen); Novartis(Novartis); Teva-Aventis(Teva Pharmaceutical Industries); UCB Pharma(UCB Pharma SA); Vertex Pharmaceuticals(Vertex Pharmaceuticals); Ironwood Pharmaceuticals; Merz; Sanofi-Aventis(Sanofi-Aventis); Biogen-Dompe(Biogen); Bayer Schering(Bayer AG); Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); Genmab(Genmab); EMD Serono; Bayer Pharmaceuticals(Bayer AG); Pfizer(Pfizer); Teva(Teva Pharmaceutical Industries); Genentech(Roche HoldingGenentech); Acorda; Biogen(Biogen); Genzyme(Sanofi-AventisGenzyme Corporation); MS Society of Canada; Ilich Foundation	Supported by Merck Serono, with editorial assistance provided by Acumed, which was funded by Merck Serono.; Dr. Giovannoni reports receiving consulting fees from Bayer Schering Pharma, Biogen Idec, Merck Serono, Novartis, Teva-Aventis, UCB Pharma, and Vertex Pharmaceuticals, lecture fees from Bayer Schering Pharma, Biogen Idec, Merck Serono, and Vertex Pharmaceuticals, and grant support from Bayer Schering Pharma, Biogen Idec, Ironwood Pharmaceuticals, Merck Serono, Merz, Novartis, and Teva-Aventis; Dr. Comi, receiving consulting fees from Novartis, Teva Pharmaceuticals, Sanofi-Aventis, Merck Serono, and Bayer Schering and lecture fees from Novartis, Teva Pharmaceuticals, Sanofi-Aventis, Merck Serono, Biogen-Dompe, and Bayer Schering; Dr. Cook, receiving consulting fees from Merck Serono, Bayer Healthcare, and Genmab and lecture fees from EMD Serono and Bayer Healthcare; Dr. Rammohan, receiving consulting fees from Bayer Pharmaceuticals, EMD Serono, Pfizer, Teva, Genentech, and Novartis, lecture fees from Bayer, EMD Serono, Pfizer, and Teva, and grant support from Bayer, EMD Serono, Pfizer, Teva, Acorda, Biogen, Genzyme, UCB Pharma, and Novartis; Dr. Rieckmann, receiving consulting fees from Merck Serono, Biogen Idec, Teva, Bayer, and Novartis, lecture fees from Merck Serono, Biogen Idec, and Teva, and grant support from Merck Serono, Bayer, Teva, the MS Society of Canada, and the Ilich Foundation; Dr. Soelberg Sorensen, receiving consulting fees from Merck Serono, Biogen Idec, Teva, Bayer Schering, Genmab, and Novartis, lecture fees from Merck Serono, Biogen Idec, and Teva, and grant support from Biogen Idec; Dr. Vermersch, receiving consulting fees from Merck Serono, Bayer Schering, Teva-Aventis, Biogen Idec, and Novartis, lecture fees from Merck Serono, Biogen Idec, Bayer Schering, and Novartis, and grant support from Biogen Idec, Merck Serono, and Teva-Aventis; and Drs. Chang, Hamlett, Musch, and Greenberg, being employees of Merck Serono. No other potential conflict of interest relevant to this article was reported.; We thank Rehan Verjee of Merck Serono and Mary Goodsell of Acumed for their contributions to the preparation of the manuscript.	Bartosik-Psujek H, 2004, ACTA NEUROL SCAND, V109, P390, DOI 10.1111/j.1600-0404.2004.00259.x; BEUTLER E, 1992, LANCET, V340, P952, DOI 10.1016/0140-6736(92)92826-2; Beutler E, 1996, P NATL ACAD SCI USA, V93, P1716, DOI 10.1073/pnas.93.4.1716; Chitnis T, 2007, INT REV NEUROBIOL, V79, P43, DOI 10.1016/S0074-7742(07)79003-7; Cohen BA, 2007, INT J CLIN PRACT, V61, P1922, DOI 10.1111/j.1742-1241.2007.01561..x; Fazekas F, 1999, NEUROLOGY, V53, P448, DOI 10.1212/WNL.53.3.448; Franciotta D, 2008, LANCET NEUROL, V7, P852, DOI 10.1016/S1474-4422(08)70192-3; Guarnaccia JB, 2008, WORLD C TREATM RES M; Janiec K, 2001, Med Sci Monit, V7, P93; Kleinschnitz C., 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P35; Kopadze T, 2009, EUR J NEUROL, V16, P409, DOI 10.1111/j.1468-1331.2008.02433.x; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; LAUGEL B, 2008, WORLD C TREATM RES M; LEIST T, 2009, 23 ANN M CONS MULT S; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Niezgoda A, 2001, Folia Morphol (Warsz), V60, P225; Rice GPA, 2000, NEUROLOGY, V54, P1145, DOI 10.1212/WNL.54.5.1145; Romine JS, 1999, P ASSOC AM PHYSICIAN, V111, P35, DOI 10.1046/j.1525-1381.1999.09115.x; SIPE JC, 1994, LANCET, V344, P9, DOI 10.1016/S0140-6736(94)91046-4	19	566	583	0	35	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 4	2010	362	5					416	426		10.1056/NEJMoa0902533	http://dx.doi.org/10.1056/NEJMoa0902533			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551FV	20089960				2022-12-28	WOS:000274193300007
J	Swensen, SJ; Meyer, GS; Nelson, EC; Hunt, GC; Pryor, DB; Weissberg, JI; Kaplan, GS; Daley, J; Yates, GR; Chassin, MR; James, BC; Berwick, DM				Swensen, Stephen J.; Meyer, Gregg S.; Nelson, Eugene C.; Hunt, Gordon C., Jr.; Pryor, David B.; Weissberg, Jed I.; Kaplan, Gary S.; Daley, Jennifer; Yates, Gary R.; Chassin, Mark R.; James, Brent C.; Berwick, Donald M.			Cottage Industry to Postindustrial Care - The Revolution in Health Care Delivery	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Swensen, Stephen J.] Mayo Clin, Rochester, MN 55905 USA; [Meyer, Gregg S.] Massachusetts Gen Hosp, Ctr Qual & Safety, Boston, MA 02114 USA; [Meyer, Gregg S.] Massachusetts Gen Phys Org, Boston, MA USA; [Nelson, Eugene C.] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA; [Hunt, Gordon C., Jr.] Sutter Hlth, Sacramento, CA USA; [Pryor, David B.] Ascens Hlth, St Louis, MO USA; [Weissberg, Jed I.] Kaiser Permanente, Oakland, CA USA; [Kaplan, Gary S.] Virginia Mason Hlth Syst, Seattle, WA USA; [Daley, Jennifer] Partners Community Healthcare, Boston, MA USA; [Yates, Gary R.] Sentara Healthcare, Norfolk, VA USA; [Chassin, Mark R.] Joint Commiss, Oak Brook Terrace, IL USA; [James, Brent C.] Intermt Healthcare, Salt Lake City, UT USA; [Berwick, Donald M.] Inst Healthcare Improvement, Cambridge, MA USA	Mayo Clinic; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Dartmouth College; Kaiser Permanente; Virginia Mason Medical Center; Sentara Healthcare; Intermountain Healthcare; Intermountain Medical Center; Institute for Healthcare Improvement	Swensen, SJ (corresponding author), Mayo Clin, Rochester, MN 55905 USA.							[Anonymous], IMPR AM HOSP JOINT C; Bohmer R.M.J., 2009, DESIGNING CARE ALIGN, DOI 10.1001/jama.2010.245; Groopman J, 2007, DOCTORS THINK; *JOINT COMM, 2006, IMPR AM HOSP JOINT C; CMS PREMIER HOSP QUA	5	87	90	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 4	2010	362	5								10.1056/NEJMp0911199	http://dx.doi.org/10.1056/NEJMp0911199			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	551FV	20089956				2022-12-28	WOS:000274193300004
J	Shelly, M; Lim, BK; Cancedda, L; Heilshorn, SC; Gao, HF; Poo, MM				Shelly, Maya; Lim, Byung Kook; Cancedda, Laura; Heilshorn, Sarah C.; Gao, Hongfeng; Poo, Mu-ming			Local and Long-Range Reciprocal Regulation of cAMP and cGMP in Axon/Dendrite Formation	SCIENCE			English	Article							DETERMINES NEURONAL POLARITY; AXON FORMATION; HIPPOCAMPAL-NEURONS; SAD KINASES; CYCLIC-AMP; IN-VIVO; POLARIZATION; GROWTH; MODULATION; MECHANISMS	Cytosolic cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) often mediate antagonistic cellular actions of extracellular factors, from the regulation of ion channels to cell volume control and axon guidance. We found that localized cAMP and cGMP activities in undifferentiated neurites of cultured hippocampal neurons promote and suppress axon formation, respectively, and exert opposite effects on dendrite formation. Fluorescence resonance energy transfer imaging showed that alterations of the amount of cAMP resulted in opposite changes in the amount of cGMP, and vice versa, through the activation of specific phosphodiesterases and protein kinases. Local elevation of cAMP in one neurite resulted in cAMP reduction in all other neurites of the same neuron. Thus, local and long-range reciprocal regulation of cAMP and cGMP together ensures coordinated development of one axon and multiple dendrites.	[Shelly, Maya; Lim, Byung Kook; Cancedda, Laura; Heilshorn, Sarah C.; Gao, Hongfeng; Poo, Mu-ming] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Cancedda, Laura] Italian Inst Technol, Dept Neurosci & Brain Technol, I-16163 Genoa, Italy	University of California System; University of California Berkeley; Istituto Italiano di Tecnologia - IIT	Poo, MM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	mpoo@uclink.berkeley.edu		Lim, Byungkook/0000-0002-3766-5415; shelly, maya/0000-0002-2211-1751; Cancedda, Laura/0000-0003-0566-057X; Heilshorn, Sarah/0000-0002-9801-6304	National Institutes of Health [NS-22764]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022764] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. Thakar, S. Li, M. Nasir, and D. Liepmann (University of California at Berkeley) for help with poly(dimethylsiloxane) microfluidic molds; J. Zhang (Johns Hopkins University) for the ICUE and AKAR FRET probes; M. J. Lohse (University of Wurzburg) for the cGES-DE5 FRET probe; M. Feller and S. Pautot (University of California at Berkeley) for advice on FRET imaging and bead coating; and M. Hung for help with culture preparations. This work was supported in part by a grant from the National Institutes of Health (NS-22764).	Adler CE, 2006, NAT NEUROSCI, V9, P511, DOI 10.1038/nn1666; Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Barnes AP, 2008, CURR OPIN NEUROBIOL, V18, P44, DOI 10.1016/j.conb.2008.05.003; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; Buttner N, 2003, J NEUROPHYSIOL, V90, P586, DOI 10.1152/jn.00007.2003; Choi YJ, 2008, GENE DEV, V22, P2485, DOI 10.1101/gad.1685008; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; Da Silva JS, 2005, NAT NEUROSCI, V8, P606, DOI 10.1038/nn1442; de Anda FC, 2005, NATURE, V436, P704, DOI 10.1038/nature03811; DiPilato LM, 2004, P NATL ACAD SCI USA, V101, P16513, DOI 10.1073/pnas.0405973101; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Esch T, 1999, J NEUROSCI, V19, P6417; Fivaz M, 2008, CURR BIOL, V18, P44, DOI 10.1016/j.cub.2007.11.051; Gao Y, 2003, J NEUROSCI, V23, P11770; GOLDBERG DJ, 1987, DEV BIOL, V124, P35, DOI 10.1016/0012-1606(87)90456-8; Goldberg N D, 1975, Adv Cyclic Nucleotide Res, V5, P307; GOSLIN K, 1989, J CELL BIOL, V108, P1507, DOI 10.1083/jcb.108.4.1507; HARTZELL HC, 1986, NATURE, V323, P273, DOI 10.1038/323273a0; Hempel A, 1996, AM J PHYSIOL-HEART C, V270, pH1264, DOI 10.1152/ajpheart.1996.270.4.H1264; Hilliard MA, 2006, DEV CELL, V10, P379, DOI 10.1016/j.devcel.2006.01.013; Hopker VH, 1999, NATURE, V401, P69, DOI 10.1038/43441; Jacobson C, 2006, NEURON, V49, P797, DOI 10.1016/j.neuron.2006.02.005; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Kishi M, 2005, SCIENCE, V307, P929, DOI 10.1126/science.1107403; LOHOF AM, 1992, J NEUROSCI, V12, P1253; Menager C, 2004, J NEUROCHEM, V89, P109, DOI 10.1046/j.1471-4159.2004.02302.x; Menniti FS, 2006, NAT REV DRUG DISCOV, V5, P660, DOI 10.1038/nrd2058; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Nikolaev VO, 2006, NAT METHODS, V3, P23, DOI 10.1038/nmeth816; Nishiyama M, 2003, NATURE, V423, P990, DOI 10.1038/nature01751; Ossipova O, 2003, NAT CELL BIOL, V5, P889, DOI 10.1038/ncb1048; PENARASGADO C, 1994, AM J PHYSIOL-CELL PH, V267, pC1319, DOI 10.1152/ajpcell.1994.267.5.C1319; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Togashi K, 2008, NEURON, V58, P694, DOI 10.1016/j.neuron.2008.03.017; Toriyama M, 2006, J CELL BIOL, V175, P147, DOI 10.1083/jcb.200604160; Wildonger J, 2008, GENE DEV, V22, P2447, DOI 10.1101/gad.1724108; Witte H, 2008, J CELL BIOL, V180, P619, DOI 10.1083/jcb.200707042; Witte H, 2008, CURR OPIN NEUROBIOL, V18, P479, DOI 10.1016/j.conb.2008.09.019; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zaccolo M, 2007, CIRC RES, V100, P1569, DOI 10.1161/CIRCRESAHA.106.144501; Zhang J, 2001, P NATL ACAD SCI USA, V98, P14997, DOI 10.1073/pnas.211566798; ZHENG JQ, 1994, J CELL BIOL, V127, P1693, DOI 10.1083/jcb.127.6.1693	48	184	191	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 29	2010	327	5965					547	552		10.1126/science.1179735	http://dx.doi.org/10.1126/science.1179735			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549CT	20110498				2022-12-28	WOS:000274020500029
J	Brook, RH				Brook, Robert H.			Continuing Medical Education Let the Guessing Begin	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									RAND Hlth, Santa Monica, CA 90407 USA	RAND Corporation	Brook, RH (corresponding author), RAND Hlth, 1776 Main St,POB 2138, Santa Monica, CA 90407 USA.	robert_brook@rand.org						ADAMS ID, 1986, BRIT MED J, V293, P800, DOI 10.1136/bmj.293.6550.800; ALGUIRE PC, 2006, MKSAP, V14; Dean NC, 2001, AM J MED, V110, P451, DOI 10.1016/S0002-9343(00)00744-0; *FARM HEART STUD, BIBL FARM HEART STUD; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Sackett DL, 1985, CLIN EPIDEMIOLOGY BA	6	5	5	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 27	2010	303	4					359	360		10.1001/jama.2010.25	http://dx.doi.org/10.1001/jama.2010.25			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	548IC	20103760				2022-12-28	WOS:000273952800025
J	Degomme, O; Guha-Sapir, D				Degomme, Olivier; Guha-Sapir, Debarati			Patterns of mortality rates in Darfur conflict	LANCET			English	Article							DEATH	Background Several mortality estimates for the Darfur conflict have been reported since 2004, but few accounted for conflict dynamics such as changing displacement and causes of deaths. We analyse changes over time for crude and cause-specific mortality rates, and assess the effect of displacement on mortality rates. Methods Retrospective mortality surveys were gathered from an online database. Quasi-Poisson models were used to assess mortality rates with place and period in which the survey was done, and the proportions of displaced people in the samples were the explanatory variables. Predicted mortality rates for five periods were computed and applied to population data taken from the UN's series about Darfur to obtain the number of deaths. Findings 63 of 107 mortality surveys met all criteria for analysis. Our results show significant reductions in mortality rates from early 2004 to the end of 2008, although rates were higher during deployment of fewer humanitarian aid workers. In general, the reduction in rate was more important for violence-related than for diarrhoea-related mortality. Displacement correlated with increased rates of deaths associated with diarrhoea, but also with reduction in violent deaths. We estimated the excess number of deaths to be 298 271 (95% CI 178 258-461 520). Interpretation Although violence was the main cause of death during 2004, diseases have been the cause of most deaths since 2005, with displaced populations being the most susceptible. Any reduction in humanitarian assistance could lead to worsening mortality rates, as was the case between mid 2006 and mid 2007.	[Degomme, Olivier; Guha-Sapir, Debarati] Univ Catholique Louvain, Ctr Res Epidemiol Disasters, Inst Hlth & Soc, B-1200 Brussels, Belgium	Universite Catholique Louvain	Degomme, O (corresponding author), Univ Catholique Louvain, Ctr Res Epidemiol Disasters, Inst Hlth & Soc, 30-94 Clos Chapelle Aux Champs, B-1200 Brussels, Belgium.	olivier.degomme@uclouvain.be			US Department of State Bureau Of Population, Refugees and Migration; UK Department for International Development; European Commission	US Department of State Bureau Of Population, Refugees and Migration; UK Department for International Development; European Commission(European CommissionEuropean Commission Joint Research Centre)	The US Department of State Bureau Of Population, Refugees and Migration, and the UK Department for International Development funded the complex emergency database project; and the European Commission funded the MICROCON project. We thank the US Department of State Bureau Of Population, Refugees and Migration, and the UK Department for International Development for their continuous support of the complex emergency database project; the European Commission for their support within the MICROCON project; and D Hargitt, O d'Aoust, N Paliakara, M Albela, and our non-governmental partners for their assistance. This report does not necessarily represent the views of the funding source.	Burnham G, 2006, LANCET, V368, P1421, DOI 10.1016/S0140-6736(06)69491-9; COEBERGH J, 2005, PARLIAMENTARY BRIEF, V9, P5; Coghlan B, 2006, LANCET, V367, P44, DOI 10.1016/S0140-6736(06)67923-3; *CTR RES EP DIS, COMPL EM DAT; Degomme O, 2007, EMERG THEMES EPIDEMI, V4, DOI 10.1186/1742-7622-4-11; DEWAAL A, 1989, POP STUD-J DEMOG, V43, P5, DOI 10.1080/0032472031000143826; Geneva Declaration Secretariat, 2008, GLOB BURD ARM VIOL; Government Accountability Office, 2006, DARF CRIS DEATH EST; Guha-Sapir D., 2005, DARFUR COUNTING DEAT; GUHASAPIR D, 2005, DARF COUNT DEATHS MO; Hagan J, 2005, CRIMINOLOGY, V43, P525, DOI 10.1111/j.0011-1348.2005.00016.x; Hagan J, 2006, SCIENCE, V313, P1578, DOI 10.1126/science.1127397; HOLMES J, 2008, 5872 M TUESD 22 APR; *IRIN, 2006, SUD DARF PEAC ACC VE; Nabarro D, 2004, MORTALITY PROJECTION; Petersen Andreas, 2006, SCORCHED EARTH DARFU; Reeves E., 2005, DARFUR MORTALITY UPD; Reeves Eric, 2006, QUANTIFYING GENOCI 1; *REUT, 2005, 180 000 DARF DEATHS; The Sphere Project, 2004, HUM CHART MIN STAND; *UN, DARF HUM PROF SER; *UN, 2006 WORK PLAN SUD; *UNICEF, 2006, DARF FUND CRIS THREA; *US DEP STAT, 2005, SUD DEATH TOLL DARF; *WFP, 2006, SHARP RAT CUTS LEAV; *WORLD BANK, 2003, SUD STAB REC COUNTR, V2; [No title captured]; WORK PLAN 2007; WORK PLAN 2008	29	92	92	0	18	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 23	2010	375	9711					294	300		10.1016/S0140-6736(09)61967-X	http://dx.doi.org/10.1016/S0140-6736(09)61967-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	549QS	20109956				2022-12-28	WOS:000274069300030
J	Horton, R				Horton, Richard			Offline: Who will be our John Hersey?	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.								0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 23	2010	375	9711					266	266		10.1016/S0140-6736(10)60113-4	http://dx.doi.org/10.1016/S0140-6736(10)60113-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	549QS	20109935				2022-12-28	WOS:000274069300010
J	Smitaman, E; Rubinowitz, AN				Smitaman, Edward; Rubinowitz, Ami N.			Extramedullary Hematopoiesis Associated with beta-Thalassemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Smitaman, Edward; Rubinowitz, Ami N.] Yale New Haven Med Ctr, New Haven, CT 06504 USA	Yale University	Smitaman, E (corresponding author), Yale New Haven Med Ctr, 20 York St, New Haven, CT 06504 USA.	edward.smitaman@yale.edu							0	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 21	2010	362	3					253	253		10.1056/NEJMicm0810132	http://dx.doi.org/10.1056/NEJMicm0810132			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	545NE	20089975				2022-12-28	WOS:000273738400011
J	Gilg, O; Yoccoz, NG				Gilg, Olivier; Yoccoz, Nigel G.			Explaining Bird Migration	SCIENCE			English	Editorial Material							CLIMATE-CHANGE; DETERMINANTS; PREDATORS; GREENLAND; PATTERNS; CYCLES		[Gilg, Olivier] Univ Helsinki, Dept Biol & Environm Sci, FIN-00014 Helsinki, Finland; [Gilg, Olivier] Univ Burgundy, Lab Biogeosci, F-21000 Dijon, France; [Yoccoz, Nigel G.] Univ Tromso, Dept Arctic & Marine Biol, N-9037 Tromso, Norway	University of Helsinki; Universite de Bourgogne; UiT The Arctic University of Tromso	Gilg, O (corresponding author), Univ Helsinki, Dept Biol & Environm Sci, FIN-00014 Helsinki, Finland.	olivier.gilg@gmail.com	GILG, Olivier/C-2588-2008; Yoccoz, Nigel/C-8561-2014	GILG, Olivier/0000-0002-9083-4492; Yoccoz, Nigel/0000-0003-2192-1039				Alerstam T, 2003, OIKOS, V103, P247, DOI 10.1034/j.1600-0706.2003.12559.x; B anfield A., 1974, MAMMALS CANADA; Bety J, 2001, OIKOS, V93, P388, DOI 10.1034/j.1600-0706.2001.930304.x; Boertmann David, 1994, Meddelelser om Gronland Bioscience, V38, P1; CAFF (Conservation of Arctic Flora and Fauna), 2001, ARCT FLOR FAUN STAT; Gensbol B., 2004, NATURE WILDLIFE GUID; Gilg O., 2005, ECOPOLARIS TARA 5 EX; Gilg O, 2006, OIKOS, V113, P193, DOI 10.1111/j.2006.0030-1299.14125.x; GODFREY WE, 1986, OISEAUX CANADA; Hayman P., 1986, SHOREBIRDS; Henningsson SS, 2005, J BIOGEOGR, V32, P383, DOI 10.1111/j.1365-2699.2004.01204.x; Ims RA, 2005, BIOSCIENCE, V55, P311, DOI 10.1641/0006-3568(2005)055[0311:TICITE]2.0.CO;2; Kovacs K., 2006, BIRDS MAMMALS SVALBA; Larson S., 1960, Oikos, V11, P276, DOI 10.2307/3564688; Lepage D, 1998, ARCTIC, V51, P125; McKinnon L, 2010, SCIENCE, V327, P326, DOI 10.1126/science.1183010; Piersma T, 1997, OIKOS, V80, P623, DOI 10.2307/3546640; Post E, 2009, SCIENCE, V325, P1355, DOI 10.1126/science.1173113; Sittler B, 2000, ARCTIC, V53, P53; Summers RW, 1998, ECOGRAPHY, V21, P573, DOI 10.1111/j.1600-0587.1998.tb00549.x; ZOCKLER C, ARCTIC BIRD LIB; Zockler Christoph, 1998, WCMC Biodiversity Series, V3, P1	22	29	29	3	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 15	2010	327	5963					276	277		10.1126/science.1184964	http://dx.doi.org/10.1126/science.1184964			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544CM	20075236				2022-12-28	WOS:000273629700023
J	Gyapong, JO; Gyapong, M; Yellu, N; Anakwah, K; Amofah, G; Bockarie, M; Adjei, S				Gyapong, John O.; Gyapong, Margaret; Yellu, Nathaniel; Anakwah, Kwadwo; Amofah, George; Bockarie, Moses; Adjei, Sam			Neglected Tropical Diseases 2 Integration of control of neglected tropical diseases into health-care systems: challenges and opportunities	LANCET			English	Article							COMMUNITY-DIRECTED TREATMENT; LYMPHATIC FILARIASIS; GENITAL SCHISTOSOMIASIS; CONTROL PROGRAMS; ELIMINATION; SERVICES; STRATEGIES; DELIVERY; AFRICA; POLICY	Although progress has been made in the fight against neglected tropical diseases, current financial resources and global political commitments are insufficient to reach the World Health Assembly's ambitious goals. Increased efforts are needed to expand global coverage. These efforts will involve national and international harmonisation and coordination of the activities of partnerships devoted to control or elimination of these diseases. Rational planning and integration into regular health systems is essential to scale up these interventions to achieve complete eradication of these diseases. Programmes with similar delivery strategies and interventions-such as those for onchocerciasis, lymphatic filariasis, and soil-transmitted helminthiasis-could be managed on the same platform and together. Furthermore, better-resourced programmes-such as those for malaria, HIV/AIDS, and tuberculosis-could work closely with those for neglected tropical diseases to their mutual benefit and the benefit of the entire health system.	[Gyapong, John O.; Gyapong, Margaret; Yellu, Nathaniel; Anakwah, Kwadwo] Ghana Hlth Serv, Div Res & Dev, Accra, Ghana; [Bockarie, Moses] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Adjei, Sam] Publ Hlth Consultant, Accra, Ghana	Ghana Health Service; Liverpool School of Tropical Medicine; University of Liverpool	Gyapong, JO (corresponding author), Ghana Hlth Serv, Div Res & Dev, POB MB 190, Accra, Ghana.	gyapong@4u.com.gh	Bockarie, Moses/AAV-4578-2020; Bockarie, Moses/AAW-3130-2021	Gyapong, John/0000-0002-8415-1468; Gyapong, Margaret/0000-0002-4818-3497				Amazigo U, 1998, ANN TROP MED PARASIT, V92, pS23, DOI 10.1080/00034989859528; Amazigo U, 2007, SOC SCI MED, V64, P2070, DOI 10.1016/j.socscimed.2007.01.018; [Anonymous], 1996, World Health Organ Tech Rep Ser, V861, P1; Aylward RB, 2006, ANN TROP MED PARASIT, V100, P401, DOI 10.1179/136485906X97354; Baker MC, 2007, INT J HEALTH PLAN M, V22, P337, DOI 10.1002/hpm.900; Blackburn BG, 2006, AM J TROP MED HYG, V75, P650, DOI 10.4269/ajtmh.2006.75.650; Boatin BA, 2006, ADV PARASIT, V61, P349, DOI 10.1016/S0065-308X(05)61009-3; Brady MA, 2006, TRENDS PARASITOL, V22, P285, DOI 10.1016/j.pt.2006.05.007; Canning D, 2006, T ROY SOC TROP MED H, V100, P499, DOI 10.1016/j.trstmh.2006.02.001; Coulibaly Y, 2008, TROP MED INT HEALTH, V13, P1430, DOI 10.1111/j.1365-3156.2008.02174.x; Diallo I, 1993, World Health Forum, V14, P349; Feenstra P, 2002, LEPROSY REV, V73, P111; FELDMEIER H, 1994, INT J STD AIDS, V5, P368, DOI 10.1177/095646249400500517; Fenwick A, 2005, LANCET, V365, P1029, DOI 10.1016/s0140-6736(05)71134-x; Gyapong JO, 2005, EXPERT OPIN PHARMACO, V6, P179, DOI 10.1517/14656566.6.2.179; Gyapong M, 2001, ANN TROP MED PARASIT, V95, P77, DOI 10.1080/00034980020035942; Henderson D A, 1998, Bull World Health Organ, V76 Suppl 2, P17; Hodgkin C, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000074; Homeida M., 2002, Annals of Tropical Medicine and Parasitology, V96, pS93, DOI 10.1179/000349802125000673; Hotez P, 2006, ADV EXP MED BIOL, V582, P23; Hotez PJ, 2006, PLOS MED, V3, P576, DOI 10.1371/journal.pmed.0030102; Hotez PJ, 2009, LANCET, V373, P1570, DOI 10.1016/S0140-6736(09)60233-6; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000430; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000346; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000405; Katabarwa MN, 2005, TROP MED INT HEALTH, V10, P312, DOI 10.1111/j.1365-3156.2005.01396.x; Kjetland EF, 2006, AIDS, V20, P593, DOI 10.1097/01.aids.0000210614.45212.0a; Kumaresan J, 2005, EYE, V19, P1067, DOI 10.1038/sj.eye.6701963; Lammie PJ, 2006, TRENDS PARASITOL, V22, P313, DOI 10.1016/j.pt.2006.05.009; Laxminarayan R, 2006, LANCET, V367, P1193, DOI 10.1016/S0140-6736(06)68440-7; Massa K, 2009, J BIOSOC SCI, V41, P89, DOI 10.1017/S0021932008002964; Melgaard B, 1998, Bull World Health Organ, V76 Suppl 2, P26; Mills A, 2005, B WORLD HEALTH ORGAN, V83, P315; Molyneux DH, 2008, T ROY SOC TROP MED H, V102, P509, DOI 10.1016/j.trstmh.2008.02.024; Molyneux DH, 2009, LANCET, V373, P296, DOI 10.1016/S0140-6736(09)60089-1; Molyneux DH, 2005, PLOS MED, V2, P1064, DOI 10.1371/journal.pmed.0020336; Molyneux DH, 2006, LANCET, V367, P966, DOI 10.1016/S0140-6736(06)68404-3; Molyneux DH, 2004, LANCET, V364, P380, DOI 10.1016/S0140-6736(04)16728-7; Molyneux DH, 2004, BMJ-BRIT MED J, V328, P1129, DOI 10.1136/bmj.328.7448.1129; Murray CJL, 2000, B WORLD HEALTH ORGAN, V78, P717; Naimoli JF, 2008, HEALTH POLICY PLANN, V23, P379, DOI 10.1093/heapol/czn028; Namadi A, 2002, LEPROSY REV, V73, P138; Oliveira-Cruz V., 2003, J INT DEV, V15, P67, DOI [DOI 10.1002/JID.966, 10.1002/jid.966]; Ottesen EA, 2006, ADV PARASIT, V61, P395, DOI 10.1016/S0065-308X(05)61010-X; Ramaiah KD, 2001, TROP MED INT HEALTH, V6, P1062, DOI 10.1046/j.1365-3156.2001.00813.x; Ruiz-Tiben E, 2006, ADV PARASIT, V61, P275, DOI 10.1016/S0065-308X(05)61007-X; Sachs JD, 2006, SCIENCE, V311, P1521, DOI 10.1126/science.1126851; Schreuder B, 2001, S AFR MED J, V91, P249; Segall M, 2003, INT J HEALTH PLAN M, V18, pS5, DOI 10.1002/hpm.719; Sundewall J, 2006, HEALTH POLICY, V76, P277, DOI 10.1016/j.healthpol.2005.06.009; Thylefors B, 2006, ANN TROP MED PARASIT, V100, P733, DOI 10.1179/136485906X112202; Unger JP, 2003, INT J HEALTH PLAN M, V18, pS27, DOI 10.1002/hpm.723; *WHO, 2008, TDR07 WHO; *WHO, 2005, WKLY EPIDEMIOL REC, V80, P289; *WHO, 1996, TDRAFRRP961 WHO; WHO, 2002, WHO TECHN REP SER, V912; *WHO, 2009, COR HLTH IND 2007 DA	57	95	97	1	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 9	2010	375	9709					160	165		10.1016/S0140-6736(09)61249-6	http://dx.doi.org/10.1016/S0140-6736(09)61249-6			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	544NM	20109893				2022-12-28	WOS:000273664500033
J	Popp, C; Dean, W; Feng, SH; Cokus, SJ; Andrews, S; Pellegrini, M; Jacobsen, SE; Reik, W				Popp, Christian; Dean, Wendy; Feng, Suhua; Cokus, Shawn J.; Andrews, Simon; Pellegrini, Matteo; Jacobsen, Steven E.; Reik, Wolf			Genome-wide erasure of DNA methylation in mouse primordial germ cells is affected by AID deficiency	NATURE			English	Article							EPIGENETIC INHERITANCE; DEMETHYLATION; DEAMINASE; 5-HYDROXYMETHYLCYTOSINE; 5-METHYLCYTOSINE; PLURIPOTENT; DYNAMICS; ELEMENTS	Epigenetic reprogramming including demethylation of DNA occurs in mammalian primordial germ cells (PGCs) and in early embryos, and is important for the erasure of imprints and epimutations, and the return to pluripotency(1-9). The extent of this reprogramming and its molecular mechanisms are poorly understood. We previously showed that the cytidine deaminases AID and APOBEC1 can deaminate 5-methylcytosine in vitro and in Escherichia coli, and in the mouse are expressed in tissues in which demethylation occurs(10). Here we profiled DNA methylation throughout the genome by unbiased bisulphite next generation sequencing(11-13) in wild-type and AID-deficient mouse PGCs at embryonic day (E) 13.5. Wild-type PGCs revealed marked genome-wide erasure of methylation to a level below that of methylation deficient (Np95(-/-), also called Uhrf1(-/-)) embryonic stem cells, with female PGCs being less methylated than male ones. By contrast, AID-deficient PGCs were up to three times more methylated than wild-type ones; this substantial difference occurred throughout the genome, with introns, intergenic regions and transposons being relatively more methylated than exons. Relative hypermethylation in AID-deficient PGCs was confirmed by analysis of individual loci in the genome. Our results reveal that erasure of DNA methylation in the germ line is a global process, hence limiting the potential for transgenerational epigenetic inheritance. AID deficiency interferes with genome-wide erasure of DNA methylation patterns, indicating that AID has a critical function in epigenetic reprogramming and potentially in restricting the inheritance of epimutations in mammals.	[Feng, Suhua; Cokus, Shawn J.; Pellegrini, Matteo; Jacobsen, Steven E.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Popp, Christian; Dean, Wendy; Reik, Wolf] Babraham Inst, Lab Dev Genet & Imprinting, Cambridge CB22 3AT, England; [Popp, Christian; Dean, Wendy; Reik, Wolf] Univ Cambridge, Ctr Trophoblast Res, Cambridge CB2 3EG, England; [Andrews, Simon] Babraham Inst, Bioinformat Grp, Cambridge CB22 3AT, England; [Jacobsen, Steven E.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Howard Hughes Medical Institute; University of California System; University of California Los Angeles	Jacobsen, SE (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	jacobsen@ucla.edu; wolf.reik@bbsrc.ac.uk	Reik, Wolf/I-6794-2012; Dean, Wendy/GSE-3948-2022	Dean, Wendy/0000-0001-9441-5044; Reik, Wolf/0000-0003-0216-9881; Pellegrini, Matteo/0000-0001-9355-9564	BBSRC; MRC; EU NoE The Epigenome; CellCentric; HHMI; NSF; NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM060398] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000M220, BBS/E/B/0000M982] Funding Source: researchfish; Medical Research Council [G0700098, G0300723B] Funding Source: researchfish; BBSRC [BBS/E/B/0000M220] Funding Source: UKRI; MRC [G0700098] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU NoE The Epigenome; CellCentric; HHMI(Howard Hughes Medical Institute); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank H. Morgan for his contributions to some of the early analysis of Aid<SUP>-/-</SUP> mice, A. Segonds-Pichon for help with statistical evaluation, and J. Hetzel for assisting in preparing the Illumina Solexa libraries and their sequencing. We also thank S. Petersen-Mahrt, C. Rada and F. Santos for advice and discussions. C. P. was a Boehringer-Ingelheim predoctoral Fellow. S. F. is a Howard Hughes Medical Institute Fellow of the Life Science Research Foundation. S. E. J. is an investigator of the Howard Hughes Medical Institute. This work was supported by BBSRC, MRC, EU NoE The Epigenome, and CellCentric (to W. R.), and by HHMI, NSF Plant Genome Research Programme, and NIH (to S. E. J.).	BHUTANI N, 2009, NATURE          1221, DOI DOI 10.1038/NATURE08752; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Gehring M, 2009, TRENDS GENET, V25, P82, DOI 10.1016/j.tig.2008.12.001; Gehring M, 2009, SCIENCE, V324, P1447, DOI 10.1126/science.1171609; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; Hsieh TF, 2009, SCIENCE, V324, P1451, DOI [10.1126/science.1172417, 10.1126/science.112417]; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Lane N, 2003, GENESIS, V35, P88, DOI 10.1002/gene.10168; Larijani M, 2005, MOL IMMUNOL, V42, P599, DOI 10.1016/j.molimm.2004.09.007; Lee J, 2002, DEVELOPMENT, V129, P1807; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Neuberger MS, 2003, TRENDS BIOCHEM SCI, V28, P305, DOI 10.1016/S0968-0004(03)00111-7; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Robbiani DF, 2009, MOL CELL, V36, P631, DOI 10.1016/j.molcel.2009.11.007; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Seki Y, 2007, DEVELOPMENT, V134, P2627, DOI 10.1242/dev.005611; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Teixeira FK, 2009, SCIENCE, V323, P1600, DOI 10.1126/science.1165313; Whitelaw NC, 2008, CURR OPIN GENET DEV, V18, P273, DOI 10.1016/j.gde.2008.07.001; Yamazaki Y, 2003, P NATL ACAD SCI USA, V100, P12207, DOI 10.1073/pnas.2035119100; Zvetkova I, 2005, NAT GENET, V37, P1274, DOI 10.1038/ng1663	30	647	676	1	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 25	2010	463	7284					1101	U126		10.1038/nature08829	http://dx.doi.org/10.1038/nature08829			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563DR	20098412	Green Accepted			2022-12-28	WOS:000275108400041
J	Bouadma, L; Luyt, CE; Tubach, F; Cracco, C; Alvarez, A; Schwebel, C; Schortgen, F; Lasocki, S; Veber, B; Dehoux, M; Bernard, M; Pasquet, B; Regnier, B; Brun-Buisson, C; Chastre, J; Wolff, M				Bouadma, Lila; Luyt, Charles-Edouard; Tubach, Florence; Cracco, Christophe; Alvarez, Antonio; Schwebel, Carole; Schortgen, Frederique; Lasocki, Sigismond; Veber, Benoit; Dehoux, Monique; Bernard, Maguy; Pasquet, Blandine; Regnier, Bernard; Brun-Buisson, Christian; Chastre, Jean; Wolff, Michel		PRORATA Trial Grp	Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial	LANCET			English	Article							VENTILATOR-ASSOCIATED PNEUMONIA; RESPIRATORY-TRACT INFECTIONS; COMMUNITY-ACQUIRED PNEUMONIA; CRITICALLY-ILL PATIENTS; GRAM-NEGATIVE BACILLI; ANTIMICROBIAL THERAPY; DISEASES-SOCIETY; GUIDELINES; SEPSIS; MANAGEMENT	Background Reduced duration of antibiotic treatment might contain the emergence of multidrug-resistant bacteria in intensive care units. We aimed to establish the effectiveness of an algorithm based on the biomarker procalcitonin to reduce antibiotic exposure in this setting. Methods In this multicentre, prospective, parallel-group, open-label trial, we used an independent, computer-generated randomisation sequence to randomly assign patients in a 1:1 ratio to procalcitonin (n=311 patients) or control (n=319) groups; investigators were masked to assignment before, but not after, randomisation. For the procalcitonin group, antibiotics were started or stopped based on predefined cut-off ranges of procalcitonin concentrations; the control group received antibiotics according to present guidelines. Drug selection and the final decision to start or stop antibiotics were at the discretion of the physician. Patients were expected to stay in the intensive care unit for more than 3 days, had suspected bacterial infections, and were aged 18 years or older. Primary endpoints were mortality at days 28 and 60 (non-inferiority analysis), and number of days without antibiotics by day 28 (superiority analysis). Analyses were by intention to treat. The margin of non-inferiority was 10%. This trial is registered with ClinicalTrials.gov, number NCT00472667. Findings Nine patients were excluded from the study; 307 patients in the procalcitonin group and 314 in the control group were included in analyses. Mortality of patients in the procalcitonin group seemed to be non-inferior to those in the control group at day 28 (21.2% [65/307] vs 20.4% [64/314]; absolute difference 0.8%, 90% Cl -4.6 to 6.2) and day 60 (30.0% [92/307] vs 26.1% [82/314]; 3.8%, -2.1 to 9.7). Patients in the procalcitonin group had significantly more days without antibiotics than did those in the control group (14.3 days [SD 9.1] vs 11.6 days [SD 8.2]; absolute difference 2.7 days, 95% Cl 1.4 to 4.1, p<0.0001). Interpretation A procalcitonin-guided strategy to treat suspected bacterial infections in non-surgical patients in intensive care units could reduce antibiotic exposure and selective pressure with no apparent adverse outcomes.	[Bouadma, Lila; Regnier, Bernard; Wolff, Michel] Univ Paris 07, Hop Bichat Claude Bernard, Assistance Publ Hop Paris, Serv Reanimat Med, Paris, France; [Tubach, Florence; Pasquet, Blandine] Univ Paris 07, Hop Bichat Claude Bernard, Assistance Publ Hop Paris, Dept Epidemiol Biostat & Rech Clin, Paris, France; [Lasocki, Sigismond] Univ Paris 07, Hop Bichat Claude Bernard, Assistance Publ Hop Paris, Dept Anesthesie & Reanimat, Paris, France; [Dehoux, Monique] Univ Paris 07, Hop Bichat Claude Bernard, Assistance Publ Hop Paris, Biochim Lab, Paris, France; [Luyt, Charles-Edouard; Chastre, Jean] Univ Paris 06, Hop La Pitie Salpetriere, Assistance Publ Hop Paris, Serv Reanimat Med, Paris, France; [Cracco, Christophe] Univ Paris 06, Hop La Pitie Salpetriere, Assistance Publ Hop Paris, Serv Pneumol & Reanimat, Paris, France; [Alvarez, Antonio] Hop Lafontaine, Serv Reanimat Med, St Denis, France; [Schwebel, Carole] CHU Grenoble, Serv Reanimat Med, F-38043 Grenoble, France; [Schortgen, Frederique; Brun-Buisson, Christian] Univ Paris 12, Hop Henri Mondor, Assistance Publ Hop Paris, Serv Reanimat Med, F-94010 Creteil, France; [Veber, Benoit] Ctr Hosp Univ Rouen, Dept Anesthesie & Reanimat, Rouen, France; [Bernard, Maguy] Univ Paris 05, Hop La Pitie Salpetriere, Assistance Publ Hop Paris, Biochim Lab, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU de Rouen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Universite Paris Cite	Wolff, M (corresponding author), Hop Bichat Claude Bernard, Serv Reanimat Med & Malad Infect, 46 Rue Henri Huchard, F-75877 Paris 18, France.	michel.wolff@bch.aphp.fr	schwebel, carole/M-6189-2014; lasocki, sigismond/G-9443-2016	MOURVILLIER, BRUNO/0000-0001-5227-1468; Schortgen, Frederique/0000-0003-1756-7508	Departement a la Recherche Clinique et au Developpement, Assistance Publique-Hopitaux de Paris [PHRC AOR06019]	Departement a la Recherche Clinique et au Developpement, Assistance Publique-Hopitaux de Paris	We thank Isabelle Hoffman, Helene Picard, and Erica Vlachos (Unite de Recherche Clinique, Hopital Bichat-Claude-Bernard), and Jessica Palmyre (Unite de Recherche Clinique, Hopital Pitie-Salpetriere) for their outstanding efforts in monitoring of the study; all the staff members of all the participating hospitals and intensive care units who have been associated with this trial; Aurelie Guimfack. Olivier Chassany, and Francois Lemaire (Departement a la Recherche Clinique et au Developpement, Assistance Publique-Hopitaux de Paris) for their help with undertaking the study; and Janet Jacobson for editorial assistance. This trial was supported by a research grant from the Departement a la Recherche Clinique et au Developpement, Assistance Publique-Hopitaux de Paris, which also sponsored the study (PHRC AOR06019). Brahms, one of the manufacturers of the procalcitonin assay, provided all assay-related materials free of charge for the study (Kryptor machines if not already available on-site, and kits and maintenance required for study-related measurements); Brahms did not provide any further funding for the study.	Annane D, 2003, AM J RESP CRIT CARE, V168, P165, DOI 10.1164/rccm.2201087; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; AUSTRIAN R, 1964, ANN INTERN MED, V60, P759, DOI 10.7326/0003-4819-60-5-759; Becker KL, 2008, CRIT CARE MED, V36, P941, DOI 10.1097/CCM.0B013E318165BABB; BONE RC, 1992, CHEST, V101, P1481, DOI 10.1378/chest.101.6.1481; Briel M, 2008, ARCH INTERN MED, V168, P2000, DOI 10.1001/archinte.168.18.2000; Chastre J, 2003, JAMA-J AM MED ASSOC, V290, P2588, DOI 10.1001/jama.290.19.2588; Christ-Crain M, 2004, LANCET, V363, P600, DOI 10.1016/S0140-6736(04)15591-8; Christ-Crain M, 2006, AM J RESP CRIT CARE, V174, P84, DOI 10.1164/rccm.200512-1922OC; Cremieux AC, 2003, ANTIMICROB AGENTS CH, V47, P2030, DOI 10.1128/AAC.47.6.2030-2035.2003; Dellit TH, 2007, CLIN INFECT DIS, V44, P159, DOI 10.1086/510393; el Moussaoui R, 2006, BMJ-BRIT MED J, V332, P1355, DOI 10.1136/bmj.332.7554.1355; Fagon JY, 2000, ANN INTERN MED, V132, P621, DOI 10.7326/0003-4819-132-8-200004180-00004; Fleming TR, 2008, CLIN INFECT DIS, V47, pS108, DOI 10.1086/591390; Goldmann DA, 1996, JAMA-J AM MED ASSOC, V275, P234, DOI 10.1001/jama.275.3.234; Hanberger H, 1999, JAMA-J AM MED ASSOC, V281, P67, DOI 10.1001/jama.281.1.67; Harbarth S, 2001, AM J RESP CRIT CARE, V164, P396, DOI 10.1164/ajrccm.164.3.2009052; Hochreiter M, 2009, CRIT CARE, V13, DOI 10.1186/cc7903; Iregui M, 2002, CHEST, V122, P262, DOI 10.1378/chest.122.1.262; Kollef MH, 2001, ANN INTERN MED, V134, P298, DOI 10.7326/0003-4819-134-4-200102200-00014; Kollef MH, 1999, CHEST, V115, P462, DOI 10.1378/chest.115.2.462; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Luyt CE, 2005, AM J RESP CRIT CARE, V171, P48, DOI 10.1164/rccm.200406-746Oc; Luyt CE, 2008, INTENS CARE MED, V34, P1434, DOI 10.1007/s00134-008-1112-x; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Masterton RG, 2008, J ANTIMICROB CHEMOTH, V62, P5, DOI 10.1093/jac/dkn162; Micek S, 2004, CHEST, V125, P1791, DOI 10.1378/chest.125.5.1791; Munoz-Price LS, 2008, NEW ENGL J MED, V358, P1271, DOI 10.1056/NEJMra070741; Muscedere J, 2008, J CRIT CARE, V23, P138, DOI 10.1016/j.jcrc.2007.12.008; Neuhauser MM, 2003, JAMA-J AM MED ASSOC, V289, P885, DOI 10.1001/jama.289.7.885; Nobre V, 2008, AM J RESP CRIT CARE, V177, P498, DOI 10.1164/rccm.200708-1238OC; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Schuetz P, 2009, JAMA-J AM MED ASSOC, V302, P1059, DOI 10.1001/jama.2009.1297; Spellberg B, 2008, CLIN INFECT DIS, V47, pS249, DOI 10.1086/591411; Stolz D, 2009, EUR RESPIR J, V34, P1364, DOI 10.1183/09031936.00053209; Stolz D, 2007, CHEST, V131, P9, DOI 10.1378/chest.06-1500; Tang BMP, 2007, LANCET INFECT DIS, V7, P210, DOI 10.1016/S1473-3099(07)70052-X; Teixeira PJZ, 2007, J HOSP INFECT, V65, P361, DOI 10.1016/j.jhin.2006.12.019; *US DEP HHS, GUID IND E 10 CHOIC; Uzzan B, 2006, CRIT CARE MED, V34, P1996, DOI 10.1097/01.CCM.0000226413.54364.36; Vandijck DM, 2008, INT J ANTIMICROB AG, V31, P161, DOI 10.1016/j.ijantimicag.2007.10.015; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	43	756	820	2	79	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 6	2010	375	9713					463	474		10.1016/S0140-6736(09)61879-1	http://dx.doi.org/10.1016/S0140-6736(09)61879-1			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	558PV	20097417				2022-12-28	WOS:000274757900029
J	Burkard, G				Burkard, Guido			Splitting Spin States on a Chip	SCIENCE			English	Editorial Material							SINGLE-ELECTRON SPIN; QUANTUM DOTS		Univ Konstanz, Dept Phys, D-78457 Constance, Germany	University of Konstanz	Burkard, G (corresponding author), Univ Konstanz, Dept Phys, D-78457 Constance, Germany.	guido.burkard@uni-konstanz.de	Burkard, Guido/ABB-9358-2021; Burkard, Guido/A-6949-2008	Burkard, Guido/0000-0001-9053-2200; Burkard, Guido/0000-0001-9053-2200				Foletti S, 2009, NAT PHYS, V5, P903, DOI 10.1038/NPHYS1424; Koppens FHL, 2006, NATURE, V442, P766, DOI 10.1038/nature05065; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; Nowack KC, 2007, SCIENCE, V318, P1430, DOI 10.1126/science.1148092; Petta JR, 2010, SCIENCE, V327, P669, DOI 10.1126/science.1183628; Petta JR, 2005, SCIENCE, V309, P2180, DOI 10.1126/science.1116955; Ribeiro H, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.216802	8	4	4	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 5	2010	327	5966					650	651		10.1126/science.1185548	http://dx.doi.org/10.1126/science.1185548			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551ZD	20133560				2022-12-28	WOS:000274251800024
J	Epstein, RM; Korones, DN; Quill, TE				Epstein, Ronald M.; Korones, David N.; Quill, Timothy E.			Withholding Information from Patients - When Less Is More	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Epstein, Ronald M.] Univ Rochester, Med Ctr, Dept Family Med, Rochester, NY 14642 USA; [Korones, David N.] Univ Rochester, Med Ctr, Dept Pediat, Rochester, NY 14642 USA; [Quill, Timothy E.] Univ Rochester, Med Ctr, Dept Internal Med, Rochester, NY 14642 USA; [Epstein, Ronald M.; Quill, Timothy E.] Univ Rochester, Med Ctr, Dept Psychiat, Rochester, NY 14642 USA; [Epstein, Ronald M.] Univ Rochester, Med Ctr, Dept Oncol, Rochester, NY 14642 USA; [Epstein, Ronald M.; Korones, David N.; Quill, Timothy E.] Univ Rochester, Med Ctr, Rochester Ctr Improve Commun Hlth Care, Rochester, NY 14642 USA; [Epstein, Ronald M.; Korones, David N.; Quill, Timothy E.] Univ Rochester, Med Ctr, Ctr Eth Humanities & Palliat Care, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester	Epstein, RM (corresponding author), Univ Rochester, Med Ctr, Dept Family Med, Rochester, NY 14642 USA.							Crawley Lavera M, 2002, J Palliat Med, V5, P775, DOI 10.1089/109662102320880697; Epstein RM, 1999, JAMA-J AM MED ASSOC, V282, P833, DOI 10.1001/jama.282.9.833; Epstein RM, 2004, JAMA-J AM MED ASSOC, V291, P2359, DOI 10.1001/jama.291.19.2359; Epstein RM, 2009, JAMA-J AM MED ASSOC, V302, P195, DOI 10.1001/jama.2009.984; Surbone A, 2006, LANCET ONCOL, V7, P944, DOI 10.1016/S1470-2045(06)70941-X	5	38	39	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 4	2010	362	5					380	381		10.1056/NEJMp0911835	http://dx.doi.org/10.1056/NEJMp0911835			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	551FV	20130252				2022-12-28	WOS:000274193300002
J	Duncan, JR; Paterson, DS; Hoffman, JM; Mokler, DJ; Borenstein, NS; Belliveau, RA; Krous, HF; Haas, EA; Stanley, C; Nattie, EE; Trachtenberg, FL; Kinney, HC				Duncan, Jhodie R.; Paterson, David S.; Hoffman, Jill M.; Mokler, David J.; Borenstein, Natalia S.; Belliveau, Richard A.; Krous, Henry F.; Haas, Elisabeth A.; Stanley, Christina; Nattie, Eugene E.; Trachtenberg, Felicia L.; Kinney, Hannah C.			Brainstem Serotonergic Deficiency in Sudden Infant Death Syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RECEPTOR-BINDING; MEDULLA-OBLONGATA; NEURONS; ABNORMALITIES; VICTIMS; REGIONS; RISK	Context Sudden infant death syndrome ( SIDS) is postulated to result from abnormalities in brainstem control of autonomic function and breathing during a critical developmental period. Abnormalities of serotonin (5-hydroxytryptamine [5-HT]) receptor binding in regions of the medulla oblongata involved in this control have been reported in infants dying from SIDS. Objective To test the hypothesis that 5-HT receptor abnormalities in infants dying from SIDS are associated with decreased tissue levels of 5-HT, its key biosynthetic enzyme ( tryptophan hydroxylase [TPH2]), or both. Design, Setting, and Participants Autopsy study conducted to analyze levels of 5-HT and its metabolite, 5-hydroxyindoleacetic acid (5-HIAA); levels of TPH2; and 5-HT1A receptor binding. The data set was accrued between 2004 and 2008 and consisted of 41 infants dying from SIDS (cases), 7 infants with acute death from known causes (controls), and 5 hospitalized infants with chronic hypoxia-ischemia. Main Outcome Measures Serotonin and metabolite tissue levels in the raphe obscurus and paragigantocellularis lateralis (PGCL); TPH2 levels in the raphe obscurus; and 5-HT1A binding density in 5 medullary nuclei that contain 5-HT neurons and 5 medullary nuclei that receive 5-HT projections. Results Serotonin levels were 26% lower in SIDS cases (n=35) compared with age-adjusted controls (n=5) in the raphe obscurus(55.4 [95% confidence interval {CI}, 47.2-63.6] vs 75.5 [95% CI, 54.2-96.8] pmol/mg protein, P=.05) and the PGCL (31.4 [ 95% CI, 23.7-39.0] vs 40.0 [95% CI, 20.1-60.0] pmol/mg protein, P=.04). There was no evidence of excessive 5-HT degradation assessed by 5-HIAA levels, 5-HIAA: 5-HT ratio, or both. In the raphe obscurus, TPH2 levels were 22% lower in the SIDS cases (n=34) compared with controls (n=5) (151.2% of standard [ 95% CI, 137.5%-165.0%] vs 193.9% [ 95% CI, 158.6%-229.2%], P=.03). 5-HT1A receptor binding was 29% to 55% lower in 3 medullary nuclei that receive 5-HT projections. In 4 nuclei, 3 of which contain 5-HT neurons, there was a decrease with age in 5-HT1A receptor binding in the SIDS cases but no change in the controls ( age x diagnosis interaction). The profile of 5-HT and TPH2 abnormalities differed significantly between the SIDS and hospitalized groups ( 5-HT in the raphe obscurus: 55.4 [95% CI, 47.2-63.6] vs 85.6 [ 95% CI, 61.8-109.4] pmol/mg protein, P=.02; 5-HT in the PGCL: 31.4 [95% CI, 23.7-39.0] vs 71.1 [95% CI, 49.0-93.2] pmol/mg protein, P=.002; TPH2 in the raphe obscurus: 151.2% [ 95% CI, 137.5%-165.0%] vs 102.6% [ 95% CI, 58.7%-146.4%], P=.04). Conclusion Compared with controls, SIDS was associated with lower 5-HT and TPH2 levels, consistent with a disorder of medullary 5-HT deficiency. JAMA. 2010; 303(5):430-437 www.jama.com	[Duncan, Jhodie R.; Paterson, David S.; Hoffman, Jill M.; Borenstein, Natalia S.; Belliveau, Richard A.; Kinney, Hannah C.] Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; [Duncan, Jhodie R.; Paterson, David S.; Hoffman, Jill M.; Borenstein, Natalia S.; Belliveau, Richard A.; Kinney, Hannah C.] Harvard Univ, Sch Med, Boston, MA USA; [Mokler, David J.] Univ New England, Coll Osteopath Med, Dept Biochem Sci, Biddeford, ME USA; [Krous, Henry F.; Haas, Elisabeth A.] Rady Childrens Hosp San Diego, San Diego, CA USA; [Krous, Henry F.; Haas, Elisabeth A.] Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA; [Stanley, Christina] San Diego Cty Med Examiners Off, San Diego, CA USA; [Nattie, Eugene E.] Dartmouth Med Sch, Dept Physiol, Lebanon, NH USA; [Trachtenberg, Felicia L.] New England Res Inst, Watertown, MA 02172 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of New England - Maine; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; Dartmouth College; HealthCore, Inc	Kinney, HC (corresponding author), Childrens Hosp, Dept Pathol, Enders 1112-1,300 Longwood Ave, Boston, MA 02115 USA.	hannah.kinney@childrens.harvard.edu	Mokler, David J./H-3114-2019	Mokler, David J./0000-0001-7340-3431	National Health and Medical Research Council of Australia; CJ Murphy Foundation; CJ Foundation; National Institute of Child Health and Development [R37-HD20991, PO1-HD036379]; Developmental Disabilities Research Center, Children's Hospital Boston [P30-HD18655]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655, P01HD036379, R01HD020991] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD020991] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); CJ Murphy Foundation; CJ Foundation; National Institute of Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Developmental Disabilities Research Center, Children's Hospital Boston; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by the First Candle/SIDS Alliance, CJ Martin Overseas Fellowship (National Health and Medical Research Council of Australia), CJ Murphy Foundation for Solving the Puzzle of SIDS, CJ Foundation for SIDS, National Institute of Child Health and Development (R37-HD20991 and PO1-HD036379), and Developmental Disabilities Research Center, Children's Hospital Boston (P30-HD18655)	Alenina N, 2009, P NATL ACAD SCI USA, V106, P10332, DOI 10.1073/pnas.0810793106; Cummings KJ, 2009, AM J PHYSIOL-REG I, V296, pR1783, DOI 10.1152/ajpregu.00122.2009; EATON MJ, 1995, DEV BIOL, V170, P169, DOI 10.1006/dbio.1995.1205; FILIANO JJ, 1994, BIOL NEONATE, V65, P194; Hauck FR, 2008, PEDIATRICS, V122, P660, DOI 10.1542/peds.2007-0135; Hodges MR, 2009, J NEUROSCI, V29, P10341, DOI 10.1523/JNEUROSCI.1963-09.2009; Hunt CE, 2005, ARCH DIS CHILD, V90, P48, DOI 10.1136/adc.2004.051458; Kinney HC, 2007, AUTON NEUROSCI-BASIC, V132, P81, DOI 10.1016/j.autneu.2006.11.001; Kinney HC, 2009, NEW ENGL J MED, V361, P795, DOI 10.1056/NEJMra0803836; Kinney HC, 2009, ANNU REV PATHOL-MECH, V4, P517, DOI 10.1146/annurev.pathol.4.110807.092322; Kinney HC, 2003, J NEUROPATH EXP NEUR, V62, P1178, DOI 10.1093/jnen/62.11.1178; Kinney HC, 2001, J NEUROPATH EXP NEUR, V60, P228, DOI 10.1093/jnen/60.3.228; KONTUR PJ, 1994, J NEUROCHEM, V62, P282; KOPP N, 1993, NEUROPEDIATRICS, V24, P25, DOI 10.1055/s-2008-1071508; Krous HF, 2004, PEDIATRICS, V114, P234, DOI 10.1542/peds.114.1.234; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Machaalani R, 2009, ACTA NEUROPATHOL, V117, P257, DOI 10.1007/s00401-008-0468-x; Mansouri J, 2001, J NEUROPATH EXP NEUR, V60, P141, DOI 10.1093/jnen/60.2.141; Moon RY, 2007, LANCET, V370, P1578, DOI 10.1016/S0140-6736(07)61662-6; Nattie E, 2009, BIOESSAYS, V31, P130, DOI 10.1002/bies.200800200; Obonai T, 1998, PEDIATRICS, V101, P285, DOI 10.1542/peds.101.2.285; Olszewski J., 1967, CYTOARCHITECTURE HUM; Ozawa Y, 2002, NEUROPEDIATRICS, V33, P142, DOI 10.1055/s-2002-33678; Panigrahy A, 2000, J NEUROPATH EXP NEUR, V59, P377, DOI 10.1093/jnen/59.5.377; Paterson DS, 2006, JAMA-J AM MED ASSOC, V296, P2124, DOI 10.1001/jama.296.17.2124; Paxinos G., 1995, ATLAS HUMAN BRAINSTE; Poets Christian F, 2004, Paediatr Respir Rev, V5 Suppl A, pS383, DOI 10.1016/S1526-0542(04)90068-1; Sridhar R, 2003, PEDIATR PULM, V36, P113, DOI 10.1002/ppul.10287; TAKASHIMA S, 1991, NEUROPEDIATRICS, V22, P97, DOI 10.1055/s-2008-1071424; Thach B, 2008, EMBO REP, V9, P114, DOI 10.1038/sj.embor.7401163; Weese-Mayer DE, 2007, AM J MED GENET A, V143A, P771, DOI 10.1002/ajmg.a.31722; WILLINGER M, 1994, PEDIATRICS, V93, P814; WILLINGER M, 1991, Pediatric Pathology, V11, P677	33	213	217	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 3	2010	303	5					430	437		10.1001/jama.2010.45	http://dx.doi.org/10.1001/jama.2010.45			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	550QR	20124538	Green Accepted, Bronze			2022-12-28	WOS:000274143600018
J	Chen, MS; White, MC				Chen, Mark S.; White, M. Christina			Combined Effects on Selectivity in Fe-Catalyzed Methylene Oxidation	SCIENCE			English	Article							C-H BONDS; SATURATED-HYDROCARBONS; HYDROGEN-PEROXIDE; HYDROXYLATION; OXYGENATION; OXYFUNCTIONALIZATION; FUNCTIONALIZATION; SCLAREOLIDE; COMPLEXES; MOLECULES	Methylene C-H bonds are among the most difficult chemical bonds to selectively functionalize because of their abundance in organic structures and inertness to most chemical reagents. Their selective oxidations in biosynthetic pathways underscore the power of such reactions for streamlining the synthesis of molecules with complex oxygenation patterns. We report that an iron catalyst can achieve methylene C-H bond oxidations in diverse natural-product settings with predictable and high chemo-, site-, and even diastereoselectivities. Electronic, steric, and stereoelectronic factors, which individually promote selectivity with this catalyst, are demonstrated to be powerful control elements when operating in combination in complex molecules. This small-molecule catalyst displays site selectivities complementary to those attained through enzymatic catalysis.	[Chen, Mark S.; White, M. Christina] Univ Illinois, Dept Chem, Roger Adams Lab, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	White, MC (corresponding author), Univ Illinois, Dept Chem, Roger Adams Lab, Urbana, IL 61801 USA.	white@scs.uiuc.edu	Chen, Mark/AAX-6131-2020	Chen, Mark/0000-0001-5415-4660	A. P. Sloan Foundation; Camille and Henry Dreyfus Foundation; Bristol-Myers Squibb; Pfizer; Abbott; University of Illinois	A. P. Sloan Foundation(Alfred P. Sloan Foundation); Camille and Henry Dreyfus Foundation; Bristol-Myers Squibb(Bristol-Myers Squibb); Pfizer(Pfizer); Abbott(Abbott Laboratories); University of Illinois	Dedicated to Professor Eric N. Jacobsen on his 50th birthday for his inspirational work on selective oxidations. We gratefully acknowledge R. J. Pakula for performing gas chromatography experiments toward elucidating the steric effects on oxidation site selectivity; M. A. Bigi, D. J. Covell, and E. M. Stang for helpful discussions and checking our spectroscopic data; and S. A. Reed for helpful discussions and checking our experimental procedure. M. S. C. was a Harvard University graduate student who completed his doctoral work with M. C. W. at the University of Illinois at Urbana-Champaign. This work was submitted to M. S. C.'s committee as part of his thesis on 28 August 2009 and was presented by M. C. W. at the Welch Symposium on 27 October 2009. We are grateful to the A. P. Sloan Foundation, the Camille and Henry Dreyfus Foundation, Bristol-Myers Squibb, Pfizer, Abbott, and the University of Illinois for financial support. M. S. C. is a 2008 Bristol-Myers Squibb Graduate Fellow in Synthetic Organic Chemistry. A U. S. patent on "Selective Aliphatic C-H Oxidation" is pending (application 12/245,086).	Ata A, 2007, CHEM PHARM BULL, V55, P118, DOI 10.1248/cpb.55.118; BARTON DHR, 1990, TETRAHEDRON, V46, P3743; Brodsky BH, 2005, J AM CHEM SOC, V127, P15391, DOI 10.1021/ja055549i; Chen K, 2009, NATURE, V459, P824, DOI 10.1038/nature08043; Chen MS, 2007, SCIENCE, V318, P783, DOI 10.1126/science.1148597; Chen MS, 2004, J AM CHEM SOC, V126, P1346, DOI 10.1021/ja039107n; Clardy J, 2004, NATURE, V432, P829, DOI 10.1038/nature03194; COLLMAN JP, 1990, J AM CHEM SOC, V112, P3689, DOI 10.1021/ja00165a081; Das S, 2006, SCIENCE, V312, P1941, DOI 10.1126/science.1127899; Davis EM, 2000, TOP CURR CHEM, V209, P53; Desai LV, 2004, J AM CHEM SOC, V126, P9542, DOI 10.1021/ja046831c; ELIEL EL, 1966, J AM CHEM SOC, V88, P3327, DOI 10.1021/ja00966a027; Farooq A, 2000, Z NATURFORSCH C, V55, P341; Fraunhoffer KJ, 2005, ORG LETT, V7, P223, DOI 10.1021/ol047800p; GROVES JT, 1979, J AM CHEM SOC, V101, P5290; Hanson RL, 2002, ORG PROCESS RES DEV, V6, P482, DOI 10.1021/op020028q; Kim C, 1997, J AM CHEM SOC, V119, P5964, DOI 10.1021/ja9642572; Lee JS, 2003, ORG LETT, V5, P2247, DOI 10.1021/ol034551g; Lim MH, 1999, B CHEM SOC JPN, V72, P707, DOI 10.1246/bcsj.72.707; Mas-Balleste R, 2006, SCIENCE, V312, P1885, DOI 10.1126/science.1129814; MELLO R, 1989, J AM CHEM SOC, V111, P6749, DOI 10.1021/ja00199a039; Okuno T, 1997, J CHEM SOC DALTON, P3547, DOI 10.1039/a700030h; OLAH GA, 1992, CHEM REV, V92, P69, DOI 10.1021/cr00009a003; Ortiz de Montellano P. R., 2005, CYTOCHROME P450 STRU; Stang EM, 2009, NAT CHEM, V1, P547, DOI [10.1038/NCHEM.351, 10.1038/nchem.351]; UMBREIT MA, 1977, J AM CHEM SOC, V99, P5526, DOI 10.1021/ja00458a072; Vermeulen NA, 2009, TETRAHEDRON, V65, P3078, DOI 10.1016/j.tet.2008.11.082; Wender PA, 2005, ORG LETT, V7, P79, DOI 10.1021/ol047859w; White MC, 2001, J AM CHEM SOC, V123, P7194, DOI 10.1021/ja015884g; Yang J, 2002, J ORG CHEM, V67, P5057, DOI 10.1021/jo020174u	30	576	580	13	263	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 29	2010	327	5965					566	571		10.1126/science.1183602	http://dx.doi.org/10.1126/science.1183602			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	549CT	20110502				2022-12-28	WOS:000274020500034
J	Madhi, SA; Cunliffe, NA; Steele, D; Witte, D; Kirsten, M; Louw, C; Ngwira, B; Victor, JC; Gillard, PH; Cheuvart, BB; Han, HH; Neuzil, KM				Madhi, Shabir A.; Cunliffe, Nigel A.; Steele, Duncan; Witte, Desiree; Kirsten, Mari; Louw, Cheryl; Ngwira, Bagrey; Victor, John C.; Gillard, Paul H.; Cheuvart, Brigitte B.; Han, Htay H.; Neuzil, Kathleen M.			Effect of Human Rotavirus Vaccine on Severe Diarrhea in African Infants	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EFFICACY; GASTROENTERITIS; PROTECTION; RIX4414; STRAINS; SAFETY; ANTIBODY; CHILDREN	BACKGROUND Rotavirus is the most common cause of severe gastroenteritis among young children worldwide. Data are needed to assess the efficacy of the rotavirus vaccine in African children. METHODS We conducted a randomized, placebo-controlled, multicenter trial in South Africa (3166 infants; 64.1% of the total) and Malawi (1773 infants; 35.9% of the total) to evaluate the efficacy of a live, oral rotavirus vaccine in preventing severe rotavirus gastroenteritis. Healthy infants were randomly assigned in a 1: 1: 1 ratio to receive two doses of vaccine (in addition to one dose of placebo) or three doses of vaccine-the pooled vaccine group-or three doses of placebo at 6, 10, and 14 weeks of age. Episodes of gastroenteritis caused by wild-type rotavirus during the first year of life were assessed through active follow-up surveillance and were graded with the use of the Vesikari scale. RESULTS A total of 4939 infants were enrolled and randomly assigned to one of the three groups; 1647 infants received two doses of the vaccine, 1651 infants received three doses of the vaccine, and 1641 received placebo. Of the 4417 infants included in the per-protocol efficacy analysis, severe rotavirus gastroenteritis occurred in 4.9% of the infants in the placebo group and in 1.9% of those in the pooled vaccine group (vaccine efficacy, 61.2%; 95% confidence interval, 44.0 to 73.2). Vaccine efficacy was lower in Malawi than in South Africa (49.4% vs. 76.9%); however, the number of episodes of severe rotavirus gastroenteritis that were prevented was greater in Malawi than in South Africa (6.7 vs. 4.2 cases prevented per 100 infants vaccinated per year). Efficacy against all-cause severe gastroenteritis was 30.2%. At least one serious adverse event was reported in 9.7% of the infants in the pooled vaccine group and in 11.5% of the infants in the placebo group. CONCLUSIONS Human rotavirus vaccine significantly reduced the incidence of severe rotavirus gastroenteritis among African infants during the first year of life. (ClinicalTrials.gov number, NCT00241644.)	[Cunliffe, Nigel A.] Univ Liverpool, Sch Infect & Host Def, Div Med Microbiol, Liverpool L69 3GA, Merseyside, England; [Madhi, Shabir A.] Univ Witwatersrand, Natl Res Fdn Vaccine Preventable Dis, Dept Sci & Technol, Johannesburg, South Africa; [Kirsten, Mari] Univ Pretoria, Dept Paediat Surg, ZA-0002 Pretoria, South Africa; [Louw, Cheryl] Madibeng Ctr Res, Brits, South Africa; [Louw, Cheryl] Univ Limpopo, Diarrhoeal Pathogens Res Unit, MRC, Limpopo, South Africa; [Witte, Desiree; Ngwira, Bagrey] Univ Malawi, Coll Med, Blantyre, Malawi; [Victor, John C.; Neuzil, Kathleen M.] PATH, Rotavirus Vaccine Program, Seattle, WA USA; [Gillard, Paul H.; Cheuvart, Brigitte B.; Han, Htay H.] GlaxoSmithKline Biol, Rixensart, Belgium	University of Liverpool; National Research Foundation - South Africa; University of Witwatersrand; University of Pretoria; University of Limpopo; University of Malawi; GlaxoSmithKline	Cunliffe, NA (corresponding author), Univ Liverpool, Sch Infect & Host Def, Div Med Microbiol, Daulby St, Liverpool L69 3GA, Merseyside, England.	n.a.cunliffe@liv.ac.uk		Victor, John/0000-0002-7970-6588; Cunliffe, Nigel/0000-0002-5449-4988	GlaxoSmithKline; PATH Rotavirus Vaccine Program; WHO; Centers for Disease Control and Prevention; Global Alliance for Vaccines and Immunization (GAVI); Sanofi Pasteur	GlaxoSmithKline(GlaxoSmithKline); PATH Rotavirus Vaccine Program; WHO(World Health Organization); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Global Alliance for Vaccines and Immunization (GAVI); Sanofi Pasteur	The clinical trials were funded and coordinated by GlaxoSmithKline and the PATH Rotavirus Vaccine Program, a collaboration with the WHO and the Centers for Disease Control and Prevention, with support from the Global Alliance for Vaccines and Immunization (GAVI).; Dr. Madhi reports receiving lecture fees from GlaxoSmithKline and consulting fees from Merck; Dr. Cunliffe, receiving lecture fees and grant support from Sanofi Pasteur and GlaxoSmithKline; Dr. Gillard, owning shares in GlaxoSmithKline; and Dr. Han, owning shares in GlaxoSmithKline. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 2009, Wkly Epidemiol Rec, V84, P220; [Anonymous], 13 INT C INF DIS KUA; [Anonymous], ASS VACC PREV DIS BU; Araujo EC, 2007, J PEDIAT-BRAZIL, V83, P217, DOI [10.2223/JPED.1600, 10.1590/S0021-75572007000400006]; Clark A, 2009, LANCET, V373, P1543, DOI 10.1016/S0140-6736(09)60317-2; Cunliffe NA, 1997, J INFECT DI IN PRESS; Cunliffe NA, 2009, EMERG INFECT DIS, V15, P87, DOI 10.3201/eid1501.080427; De Vos B, 2009, PEDIATR INFECT DIS J, V28, P261, DOI 10.1097/INF.0b013e3181907177; Gentsch JR, 2005, J INFECT DIS, V192, pS146, DOI 10.1086/431499; GEORGESCOURBOT MC, 1991, RES VIROLOGY, V142, P405, DOI 10.1016/0923-2516(91)90008-Q; Glass RI, 2005, J INFECT DIS, V192, pS160, DOI 10.1086/431504; Global Advisory Committee on Vaccine Safety, 2008, WKLY EPIDEMIOL REC, V84, P37; Global Advisory Committee on Vaccine Safety, 2005, WKLY EPIDEMIOL REC, V81, P13; JOHN TJ, 1976, BRIT MED J, V1, P812, DOI 10.1136/bmj.1.6013.812; Murphy TV, 2001, NEW ENGL J MED, V344, P564, DOI 10.1056/NEJM200102223440804; O'Ryan M, 2007, EXPERT REV VACCINES, V6, P11, DOI 10.1586/14760584.6.1.11; PAGE NA, 2009, J MED VIROL, V12, P81; Pang XL, 1999, J CLIN VIROL, V13, P9, DOI 10.1016/S1386-6532(98)00013-4; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; RUUSKA T, 1990, SCAND J INFECT DIS, V22, P259, DOI 10.3109/00365549009027046; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; SIMANJUNTAK CH, 1991, LANCET, V338, P1055, DOI 10.1016/0140-6736(91)91910-M; Steele AD, 2003, VACCINE, V21, P354, DOI 10.1016/S0264-410X(02)00615-1; STEELE AD, 1986, J CLIN MICROBIOL, V23, P992, DOI 10.1128/JCM.23.5.992-994.1986; Steele AD, 2003, VACCINE, V21, P361, DOI 10.1016/S0264-410X(02)00616-3; Steele AD, 2006, 11 AS C DIARRH DIS N; SUHARYONO, 1992, LANCET, V340, P689, DOI 10.1016/0140-6736(92)92231-4; Tregnaghi M, 2008, 13 INT C INF DIS KUA; Velazquez FR, 1996, NEW ENGL J MED, V335, P1022, DOI 10.1056/NEJM199610033351404; Vesikari T, 2007, LANCET, V370, P1757, DOI 10.1016/S0140-6736(07)61744-9; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; WARD RL, 1989, J INFECT DIS, V159, P79, DOI 10.1093/infdis/159.1.79; World Health Organization, 2007, Wkly Epidemiol Rec, V82, P285; World Health Organization, 2008, Weekly Epidemiological Record, V83, P421; Zaman K, 2009, VACCINE, V27, P1333, DOI 10.1016/j.vaccine.2008.12.059; 2006, WKLY EPIDEMIOL REC, V81, P1	36	653	669	0	47	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 28	2010	362	4					289	298		10.1056/NEJMoa0904797	http://dx.doi.org/10.1056/NEJMoa0904797			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	548OT	20107214	Green Published, Green Accepted			2022-12-28	WOS:000273975000004
J	Sattler, A; Parkin, G				Sattler, Aaron; Parkin, Gerard			Cleaving carbon-carbon bonds by inserting tungsten into unstrained aromatic rings	NATURE			English	Article							HETEROCYCLIC NITROGEN-COMPOUNDS; HYDRODENITROGENATION CATALYSIS; METAL; CHEMISTRY; COMPLEX; COORDINATION; ISOCYANIDES; QUINOXALINE; MOLYBDENUM; ACTIVATION	The cleavage of C-H and C-C bonds by transition metal centres is of fundamental interest and plays an important role in the synthesis of complex organic molecules from petroleum feedstocks(1-6). But while there are many examples for the oxidative addition of C-H bonds to a metal centre, transformations that feature oxidative addition of C-C bonds are rare. The paucity of transformations that involve the cleavage of C-C rather than C-H bonds is usually attributed to kinetic factors arising from the greater steric hindrance and the directional nature of the sp(n) hybrids that form the C-C bond, and to thermodynamic factors arising from the fact that M-C bonds are weaker than M-H bonds(2-5). Not surprisingly, therefore, most examples of C-C bond cleavage either avoid the kinetic limitations by using metal compounds in which the C-C bond is held in close proximity to the metal centre, or avoid the thermodynamic limitations by using organic substrates in which the cleavage is accompanied by either a relief of strain energy or the formation of an aromatic system(2-5). Here, we show that a tungsten centre can be used to cleave a strong C-C bond that is a component of an unstrained 6-membered aromatic ring. The cleavage is enabled by the formation of an unusual chelating di(isocyanide) ligand, which suggests that other metal centres with suitable ancillary ligands could also accomplish the cleavage of strong C-C bonds of aromatic substrates and thereby provide new ways of functionalizing such molecules.	[Sattler, Aaron; Parkin, Gerard] Columbia Univ, Dept Chem, New York, NY 10027 USA	Columbia University	Parkin, G (corresponding author), Columbia Univ, Dept Chem, New York, NY 10027 USA.	parkin@columbia.edu			US Department of Energy, Office of Basic Energy Sciences [DE-FG02-93ER14339]; National Science Foundation [CHE-0619638]	US Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF))	We thank the US Department of Energy, Office of Basic Energy Sciences (DE-FG02-93ER14339) for supporting this research. We thank The National Science Foundation (CHE-0619638) for the acquisition of an X-ray diffractometer. We thank W. Sattler for discussions.	Bailey BC, 2006, J AM CHEM SOC, V128, P6798, DOI 10.1021/ja061590p; Bonanno JB, 2003, INORG CHIM ACTA, V345, P173, DOI 10.1016/S0020-1693(02)01308-7; Brennessel WW, 2007, ANGEW CHEM INT EDIT, V46, P598, DOI 10.1002/anie.200603746; Buccella D, 2006, J AM CHEM SOC, V128, P16358, DOI 10.1021/ja066457b; CARNAHAN EM, 1993, ACCOUNTS CHEM RES, V26, P90, DOI 10.1021/ar00027a003; CLAUSS AD, 1984, ORGANOMETALLICS, V3, P619, DOI 10.1021/om00082a020; CRABTREE RH, 1985, CHEM REV, V85, P245, DOI 10.1021/cr00068a002; Cyranski MK, 2005, CHEM REV, V105, P3773, DOI 10.1021/cr0300845; Espinet P, 2000, CHEM COMMUN, P915, DOI 10.1039/b001027h; GRAY SD, 1995, J AM CHEM SOC, V117, P10678, DOI 10.1021/ja00148a010; HAHN FE, 1993, ANGEW CHEM INT EDIT, V32, P650, DOI 10.1002/anie.199306501; Hahn FE, 1996, J ORGANOMET CHEM, V526, P149; HARTWIG JF, 1991, J AM CHEM SOC, V113, P3404, DOI 10.1021/ja00009a028; ITO Y, 1990, J CHEM SOC CHEM COMM, P403, DOI 10.1039/c39900000403; ITO Y, 1988, SYNTHESIS-STUTTGART, P714; JONES WD, 1993, NATURE, V364, P676, DOI 10.1038/364676a0; JONES WD, 2006, COMPREHENSIVE ORGANO, V1; Jun CH, 2004, CHEM SOC REV, V33, P610, DOI 10.1039/b308864m; Kleckley TS, 1997, J AM CHEM SOC, V119, P247, DOI 10.1021/ja9631312; Kuznetsov M.L., 2002, RUSS CHEM REV, V71, P265; Lappert MF, 2005, J ORGANOMET CHEM, V690, P5467, DOI 10.1016/j.jorganchem.2005.07.066; Pombeiro AJL, 2001, COORDIN CHEM REV, V218, P43, DOI 10.1016/S0010-8545(01)80003-5; Rybtchinski B, 1999, ANGEW CHEM INT EDIT, V38, P870, DOI 10.1002/(SICI)1521-3773(19990401)38:7<870::AID-ANIE870>3.0.CO;2-3; Strauch HC, 1999, ORGANOMETALLICS, V18, P3802, DOI 10.1021/om990215l; van der Boom ME, 2003, CHEM REV, V103, P1759, DOI 10.1021/cr960118r; Wagner NL, 2000, J AM CHEM SOC, V122, P10856, DOI 10.1021/ja0018466; Weller KJ, 1998, ORGANOMETALLICS, V17, P322, DOI 10.1021/om970749r; WILKER CN, 1983, NOUV J CHIM, V7, P535; Zhu G, 2002, J AM CHEM SOC, V124, P13658, DOI 10.1021/ja028512w; Zhu G, 2008, J AM CHEM SOC, V130, P1564, DOI 10.1021/ja078102d	30	127	128	6	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 28	2010	463	7280					523	526		10.1038/nature08730	http://dx.doi.org/10.1038/nature08730			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	548QK	20110998				2022-12-28	WOS:000273981100047
J	Nash, KL; Hirschfield, GM				Nash, Kathryn L.; Hirschfield, Gideon M.			Case report A massive haematemesis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ESOPHAGEAL-VARICES; INJECTION SCLEROTHERAPY; ENDOSCOPIC TREATMENT; RANDOMIZED-TRIAL; LIGATION; PREVENTION; CIRRHOSIS; METAANALYSIS; MANAGEMENT; RISK		[Nash, Kathryn L.] Southampton Univ Hosp NHS Trust, Southampton SO16 6YD, Hants, England; [Hirschfield, Gideon M.] Univ Toronto, Dept Med, Toronto Western Hosp, Ctr Liver, Toronto, ON M5T 2S8, Canada	University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Nash, KL (corresponding author), Southampton Univ Hosp NHS Trust, Southampton SO16 6YD, Hants, England.	klnash11@yahoo.co.uk	Hirschfield, Gideon M/M-2143-2015	Hirschfield, Gideon M/0000-0002-6736-2255				Banares R, 2002, HEPATOLOGY, V35, P609, DOI 10.1053/jhep.2002.31354; BLEICHNER G, 1986, BRIT J SURG, V73, P724, DOI 10.1002/bjs.1800730916; Carbonell N, 2004, HEPATOLOGY, V40, P652, DOI 10.1002/hep.20339; DAmico G, 1997, BAILLIERE CLIN GASTR, V11, P243, DOI 10.1016/S0950-3528(97)90038-5; De Ledinghen V, 1999, GUT, V44, P270, DOI 10.1136/gut.44.2.270; DEFRANCHIS R, 1988, NEW ENGL J MED, V319, P983; Garcia-Tsao G, 2007, HEPATOLOGY, V46, P922, DOI 10.1002/hep.21907; GIMSON AES, 1993, LANCET, V342, P391, DOI 10.1016/0140-6736(93)92812-8; HAYES PC, 1990, LANCET, V336, P153, DOI 10.1016/0140-6736(90)91668-Z; Hubmann R, 2006, ENDOSCOPY, V38, P896, DOI 10.1055/s-2006-944662; Ioannou G, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002147; Jenkins SA, 1997, GUT, V41, P526, DOI 10.1136/gut.41.4.526; Khuroo MS, 2005, ALIMENT PHARM THER, V21, P347, DOI 10.1111/j.1365-2036.2005.02346.x; LEBREC D, 1980, GASTROENTEROLOGY, V79, P1139; OHO K, 1995, ENDOSCOPY, V27, P349, DOI 10.1055/s-2007-1005712; PALMER ED, 1956, GASTROENTEROLOGY, V30, P85; PANES J, 1988, DIGEST DIS SCI, V33, P454, DOI 10.1007/BF01536031; Papatheodoridis GV, 1999, HEPATOLOGY, V30, P612, DOI 10.1002/hep.510300316; Soares-Weiser K, 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002907, DOI 10.1002/14651858.CD002907]]; STIEGMANN GV, 1992, NEW ENGL J MED, V326, P1527, DOI 10.1056/NEJM199206043262304; Takeuchi M, 1996, LANCET, V348, P1038, DOI 10.1016/S0140-6736(05)64972-0; Thalheimer U, 2005, GUT, V54, P556, DOI 10.1136/gut.2004.048181; Thomson SJ, 2008, ALCOHOL ALCOHOLISM, V43, P416, DOI 10.1093/alcalc/agn020; Verrill C, 2009, ADDICTION, V104, P768, DOI 10.1111/j.1360-0443.2009.02521.x; Yip WW, 2006, SEMIN DIAGN PATHOL, V23, P149, DOI 10.1053/j.semdp.2006.11.002	25	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 27	2010	340								b5534	10.1136/bmj.b5534	http://dx.doi.org/10.1136/bmj.b5534			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	549YB	20106882				2022-12-28	WOS:000274089300001
J	Becker, T; Loch, G; Beyer, M; Zinke, I; Aschenbrenner, AC; Carrera, P; Inhester, T; Schultze, JL; Hoch, M				Becker, Thomas; Loch, Gerrit; Beyer, Marc; Zinke, Ingo; Aschenbrenner, Anna C.; Carrera, Pilar; Inhester, Therese; Schultze, Joachim L.; Hoch, Michael			FOXO-dependent regulation of innate immune homeostasis	NATURE			English	Article							LIFE-SPAN; DROSOPHILA; HOMOLOG; METABOLISM; EXPRESSION; DROSOMYCIN; INFECTION; MUTANTS; CHICO; TOLL	The innate immune system represents an ancient host defence mechanism that protects against invading microorganisms. An important class of immune effector molecules to fight pathogen infections are antimicrobial peptides (AMPs) that are produced in plants and animals(1). In Drosophila, the induction of AMPs in response to infection is regulated through the activation of the evolutionarily conserved Toll and immune deficiency (IMD) pathways(2). Here we show that AMP activation can be achieved independently of these immunoregulatory pathways by the transcription factor FOXO, a key regulator of stress resistance, metabolism and ageing. In non-infected animals, AMP genes are activated in response to nuclear FOXO activity when induced by starvation, using insulin signalling mutants, or by applying small molecule inhibitors. AMP induction is lost in foxo null mutants but enhanced when FOXO is overexpressed. Expression of AMP genes in response to FOXO activity can also be triggered in animals unable to respond to immune challenges due to defects in both the Toll and IMD pathways. Molecular experiments at the Drosomycin promoter indicate that FOXO directly binds to its regulatory region, thereby inducing its transcription. In vivo studies in Drosophila, but also studies in human lung, gut, kidney and skin cells indicate that a FOXO-dependent regulation of AMPs is evolutionarily conserved. Our results indicate a new mechanism of cross-regulation of metabolism and innate immunity by which AMP genes can be activated under normal physiological conditions in response to the oscillating energy status of cells and tissues. This regulation seems to be independent of the pathogen-responsive innate immunity pathways whose activation is often associated with tissue damage and repair. The sparse production of AMPs in epithelial tissues in response to FOXO may help modulating the defence reaction without harming the host tissues, in particular when animals are suffering from energy shortage or stress.	[Becker, Thomas; Loch, Gerrit; Zinke, Ingo; Aschenbrenner, Anna C.; Carrera, Pilar; Hoch, Michael] Univ Bonn, Dev Genet & Mol Physiol Unit, LIMES Inst, D-53115 Bonn, Germany; [Beyer, Marc; Inhester, Therese; Schultze, Joachim L.] Univ Bonn, Mol Immune & Cell Biol Unit, LIMES Inst, D-53115 Bonn, Germany	University of Bonn; University of Bonn	Hoch, M (corresponding author), Univ Bonn, Dev Genet & Mol Physiol Unit, LIMES Inst, Carl Troll Str 31, D-53115 Bonn, Germany.	m.hoch@uni-bonn.de	Beyer, Marc/ABE-1408-2021; Schultze, Joachim L./ABA-8176-2020; Schultze, Joachim L/D-7794-2011	Beyer, Marc/0000-0001-9704-148X; Schultze, Joachim L./0000-0003-2812-9853; Schultze, Joachim L/0000-0003-2812-9853; Aschenbrenner, Anna/0000-0002-9429-5457	DFG [SFBs 645, 704]	DFG(German Research Foundation (DFG))	For sending flies and constructs, we thank M. Tatar (foxo<SUP>21</SUP>, foxo<SUP>W24</SUP> and UAS foxo TM), B. Lemaitre (Relish<SUP>E20</SUP>, spatzle<SUP>RM7</SUP>), S. Cohen (UAS foxo-GFP) and M. Boutros (luciferase vectors). Thanks to M. Famulok for providing the Steppke inhibitor SecinH3. N. Novak, J. Grell and A. Schmitz assisted with luciferase assays. We thank S. Mario-Wegner for help with transgenic luciferase flies. We thank members of the Famulok, Schultze and Hoch laboratory for discussions. This work was supported by grants from the DFG to M. H. (SFBs 645 and 704).	Bauer M, 2006, PHYSIOL GENOMICS, V25, P393, DOI 10.1152/physiolgenomics.00009.2006; Bischoff V, 2006, PLOS PATHOG, V2, P139, DOI 10.1371/journal.ppat.0020014; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; Dionne MS, 2006, CURR BIOL, V16, P1977, DOI 10.1016/j.cub.2006.08.052; Evans EA, 2008, AGING CELL, V7, P879, DOI 10.1111/j.1474-9726.2008.00435.x; Ferrandon D, 1998, EMBO J, V17, P1217, DOI 10.1093/emboj/17.5.1217; Flatt T, 2008, J EXP BIOL, V211, P2712, DOI 10.1242/jeb.014878; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Fuss B, 2006, NATURE, V444, P945, DOI 10.1038/nature05412; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Hafen E, 2004, SWISS MED WKLY, V134, P711; Hafner M, 2006, NATURE, V444, P941, DOI 10.1038/nature05415; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; LEMAITRE B, 2007, ANNU REV IMMUNOL, V697, P743; Libert S, 2008, MOL IMMUNOL, V45, P810, DOI 10.1016/j.molimm.2007.06.353; Min KJ, 2008, AGING CELL, V7, P199, DOI 10.1111/j.1474-9726.2008.00373.x; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Simon A, 2008, ANTIMICROB AGENTS CH, V52, P1407, DOI 10.1128/AAC.00155-07; Tzou P, 2000, IMMUNITY, V13, P737, DOI 10.1016/S1074-7613(00)00072-8; Uvell H, 2007, TRENDS GENET, V23, P342, DOI 10.1016/j.tig.2007.05.003; Wu JL, 2007, CELL MICROBIOL, V9, P1073, DOI 10.1111/j.1462-5822.2006.00853.x; Zaidman-Remy A, 2006, IMMUNITY, V24, P463, DOI 10.1016/j.immuni.2006.02.012; Zasloff M, 2006, NAT MED, V12, P606, DOI 10.1038/nm0606-607; Zinke I, 2002, EMBO J, V21, P6162, DOI 10.1093/emboj/cdf600	30	243	250	3	59	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 21	2010	463	7279					369	373		10.1038/nature08698	http://dx.doi.org/10.1038/nature08698			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545PM	20090753				2022-12-28	WOS:000273748100047
J	McMurray, JJV				McMurray, John J. V.			Systolic Heart Failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARDIAC-RESYNCHRONIZATION THERAPY; LEFT-VENTRICULAR DYSFUNCTION; CONVERTING-ENZYME-INHIBITOR; RANDOMIZED-TRIAL; EUROPEAN-SOCIETY; ELDERLY-PATIENTS; TASK-FORCE; MORTALITY; MORBIDITY; ASSOCIATION	A 74-year-old man with a history of hypertension and myocardial infarction that occurred 5 years previously presents with breathlessness on exertion. His current medications include a statin and aspirin. On examination, his pulse is 76 beats per minute and regular, and his blood pressure is 121/74 mm Hg. There is jugular venous distention, lateral displacement of the apex beat, and edema in his lower limbs. The lung examination is normal. An echocardiogram shows left ventricular dilatation, globally reduced contractility, and an ejection fraction of 33%. How should his case be managed?	[McMurray, John J. V.] Univ Glasgow, British Heart Fdn, Cardiovasc Res Ctr, Glasgow G12 8TA, Lanark, Scotland; [McMurray, John J. V.] Univ Glasgow, Western Infirm, Glasgow G11 6NT, Lanark, Scotland	University of Glasgow; University of Glasgow	McMurray, JJV (corresponding author), Univ Glasgow, British Heart Fdn, Cardiovasc Res Ctr, 126 Univ Pl, Glasgow G12 8TA, Lanark, Scotland.	j.mcmurray@bio.gla.ac.uk	mcmurray, John/B-2467-2013	mcmurray, John/0000-0002-6317-3975	Bristol-Myers Squibb; Novartis; Amgen; AstraZeneca; F. Hoffmann-La Roche; Pfizer; GlaxoSmithKline; Scios	Bristol-Myers Squibb(Bristol-Myers Squibb); Novartis(Novartis); Amgen(Amgen); AstraZeneca(AstraZeneca); F. Hoffmann-La Roche(Hoffmann-La Roche); Pfizer(Pfizer); GlaxoSmithKline(GlaxoSmithKline); Scios	Dr. McMurray reports receiving consulting fees from the Menarini Group, Bristol-Myers Squibb, Roche, Novocardia (now part of Merck), Boehringer Ingelheim, Novartis, Boston Scientific, and bioMerieux, lecture fees from AstraZeneca, Solvay, Takeda, Novartis, and Bristol-Myers Squibb-Sanofi, and grant support from Bristol-Myers Squibb, Novartis, Amgen, AstraZeneca, F. Hoffmann-La Roche, Pfizer, GlaxoSmithKline, and Scios. No other potential conflict of interest relevant to the article was reported.	Abrahamsson P, 2009, EUR HEART J, V30, P338, DOI 10.1093/eurheartj/ehn503; Aurigemma GP, 2004, NEW ENGL J MED, V351, P1097, DOI 10.1056/NEJMcp022709; BALL SG, 1993, LANCET, V342, P821; Bardy GH, 2005, NEW ENGL J MED, V352, P2146; Beshai JF, 2007, NEW ENGL J MED, V357, P2461, DOI 10.1056/NEJMoa0706695; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; Carson P, 1999, J Card Fail, V5, P178, DOI 10.1016/S1071-9164(99)90001-5; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; COHN JN, 1986, NEW ENGL J MED, V314, P1547, DOI 10.1056/NEJM198606123142404; Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; COHN JN, 1991, NEW ENGL J MED, V325, P303, DOI 10.1056/NEJM199108013250502; Criteria Committee of the New York Heart Association, 1994, NOMENCLATURE CRITERI, V9th, P253; Dickstein K, 2008, EUR J HEART FAIL, V10, P933, DOI 10.1016/j.ejheart.2008.08.005; Exner DV, 2001, NEW ENGL J MED, V344, P1351, DOI 10.1056/NEJM200105033441802; Flather MD, 2005, EUR HEART J, V26, P215, DOI 10.1093/eurheartj/ehi118; FRANCIS GS, 1984, ANN INTERN MED, V101, P370, DOI 10.7326/0003-4819-101-3-370; Granger CB, 2003, LANCET, V362, P772, DOI 10.1016/S0140-6736(03)14284-5; *HEART FAIL SOC AM, ED MOD HEART FAIL; Hjalmarson A, 1999, LANCET, V353, P2001; Hunt SA, 2009, CIRCULATION, V119, pE391, DOI 10.1161/CIRCULATIONAHA.109.192065; Jaarsma T, 2009, EUR J HEART FAIL, V11, P433, DOI 10.1093/eurjhf/hfp041; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; Jhund PS, 2009, CIRCULATION, V119, P515, DOI 10.1161/CIRCULATIONAHA.108.812172; Jondeau G, 2009, EUR HEART J, V30, P2186, DOI 10.1093/eurheartj/ehp323; Jones RH, 2009, NEW ENGL J MED, V360, P1705, DOI 10.1056/NEJMoa0900559; Karamitsos TD, 2009, J AM COLL CARDIOL, V54, P1407, DOI 10.1016/j.jacc.2009.04.094; Kjekshus J, 2007, NEW ENGL J MED, V357, P2248, DOI 10.1056/NEJMoa0706201; KOBER L, 1995, NEW ENGL J MED, V333, P1670, DOI 10.1056/NEJM199512213332503; Kober L, 2008, NEW ENGL J MED, V358, P2678, DOI 10.1056/NEJMoa0800456; Konstam MA, 2009, LANCET, V374, P1840, DOI 10.1016/S0140-6736(09)61913-9; Lechat P, 1999, LANCET, V353, P9; Maisel A, 2008, EUR J HEART FAIL, V10, P824, DOI 10.1016/j.ejheart.2008.07.014; Mant J, 2009, HEALTH TECHNOL ASSES, V13, pIX, DOI 10.3310/hta13320; Maric B, 2009, EUR J HEART FAIL, V11, P506, DOI 10.1093/eurjhf/hfp036; Mark DB, 2008, NEW ENGL J MED, V359, P999, DOI 10.1056/NEJMoa0706719; Massie BM, 2009, CIRCULATION, V119, P1616, DOI 10.1161/CIRCULATIONAHA.108.801753; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; McMurray J, 2005, EUR J HEART FAIL, V7, P710, DOI 10.1016/j.ejheart.2005.07.002; MCMURRAY J, 1992, NEW ENGL J MED, V327, P1768; MCMURRAY J, 1992, NEW ENGL J MED, V327, P685; McMurray JJV, 2003, LANCET, V362, P767, DOI 10.1016/S0140-6736(03)14283-3; McMurray JJV, 2009, EUR J HEART FAIL, V11, P795, DOI 10.1093/eurjhf/hfp098; Moss AJ, 2009, NEW ENGL J MED, V361, P1329, DOI 10.1056/NEJMoa0906431; O'Connor CM, 2009, JAMA-J AM MED ASSOC, V301, P1439, DOI 10.1001/jama.2009.454; Packer M, 1999, CIRCULATION, V100, P2312, DOI 10.1161/01.CIR.100.23.2312; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; Perry G, 1997, NEW ENGL J MED, V336, P525; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Pfisterer M, 2009, JAMA-J AM MED ASSOC, V301, P383, DOI 10.1001/jama.2009.2; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Poole-Wilson PA, 2003, LANCET, V362, P7, DOI 10.1016/S0140-6736(03)13800-7; Rose EA, 2001, NEW ENGL J MED, V345, P1435, DOI 10.1056/NEJMoa012175; Slaughter MS, 2009, NEW ENGL J MED, V361, P2241, DOI 10.1056/NEJMoa0909938; Sochalski J, 2009, HEALTH AFFAIR, V28, P179, DOI 10.1377/hlthaff.28.1.179; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; Tavazzi L, 2008, LANCET, V372, P1223, DOI 10.1016/S0140-6736(08)61239-8; Taylor AL, 2005, NEW ENGL J MED, V352, P1043; Velazquez EJ, 2007, J THORAC CARDIOV SUR, V134, P1540, DOI 10.1016/j.jtcvs.2007.05.069; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501	60	254	278	0	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 21	2010	362	3					228	238		10.1056/NEJMcp0909392	http://dx.doi.org/10.1056/NEJMcp0909392			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	545NE	20089973				2022-12-28	WOS:000273738400009
J	Granwehr, B				Granwehr, Bruno			One or two 7.5-mu g doses of MF59-adjuvanted influenza A (H1N1) 2009 vaccine was immunogenic in adults within 21 days	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Granwehr, B (corresponding author), Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA.		Granwehr, Bruno/S-3997-2019	Granwehr, Bruno/0000-0002-5143-6416				Atmar RL, 2006, CLIN INFECT DIS, V43, P1135, DOI 10.1086/508174; Chan M., WORLD NOW START 2009; Huang Q. S., 2009, Morbidity and Mortality Weekly Report, V58, P918; Mendez IZR, 2007, VACCINE, V25, P825, DOI 10.1016/j.vaccine.2006.09.039; *NAT I ALL INF DIS, PED H1N1 VACC CLIN S; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999	6	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 19	2010	152	2							JC1-8	10.7326/0003-4819-152-2-201001190-02008	http://dx.doi.org/10.7326/0003-4819-152-2-201001190-02008			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	548IE	20083823				2022-12-28	WOS:000273953000032
J	Wolfe, D; Horton, R				Wolfe, David; Horton, Richard			A new era of nuclear disarmament for human security	LANCET			English	Editorial Material									[Wolfe, David] Oppenheimer Inst Sci & Int Cooperat, London NW3 4SY, England; [Horton, Richard] The Lancet, London NW1 7BY, England		Wolfe, D (corresponding author), Oppenheimer Inst Sci & Int Cooperat, London NW3 4SY, England.	dwolfe@oisic.org						Fitzpatrick M, 2006, SURVIVAL, V48, P5, DOI 10.1080/00396330600905494; Holdstock D, 2000, LANCET, V355, P1544, DOI 10.1016/S0140-6736(00)02176-0; 1982, LANCET, V319, P321	3	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 16	2010	375	9710					173	174		10.1016/S0140-6736(10)60054-2	http://dx.doi.org/10.1016/S0140-6736(10)60054-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	546ZH	20109899				2022-12-28	WOS:000273853800004
J	Gong, HX; Shen, B; Flevaris, P; Chow, C; Lam, SCT; Voyno-Yasenetskaya, TA; Kozasa, T; Du, XP				Gong, Haixia; Shen, Bo; Flevaris, Panagiotis; Chow, Christina; Lam, Stephen C. -T.; Voyno-Yasenetskaya, Tatyana A.; Kozasa, Tohru; Du, Xiaoping			G Protein Subunit G alpha(13) Binds to Integrin alpha(IIb)beta(3) and Mediates Integrin "Outside-In" Signaling	SCIENCE			English	Article							SHAPE CHANGE; P115 RHOGEF; ACTIVATION; SRC; PLATELETS; KINASES; SWITCH; ROLES; MODEL	Integrins mediate cell adhesion to the extracellular matrix and transmit signals within the cell that stimulate cell spreading, retraction, migration, and proliferation. The mechanism of integrin outside-in signaling has been unclear. We found that the heterotrimeric guanine nucleotide-binding protein (G protein) G alpha(13) directly bound to the integrin beta(3) cytoplasmic domain and that G alpha(13)-integrin interaction was promoted by ligand binding to the integrin alpha(IIb)beta(3) and by guanosine triphosphate (GTP) loading of G alpha(13). Interference of G alpha(13) expression or a myristoylated fragment of G alpha(13) that inhibited interaction of alpha(IIb)beta(3) with G alpha(13) diminished activation of protein kinase c-Src and stimulated the small guanosine triphosphatase RhoA, consequently inhibiting cell spreading and accelerating cell retraction. We conclude that integrins are noncanonical G alpha(13)-coupled receptors that provide a mechanism for dynamic regulation of RhoA.	[Gong, Haixia; Shen, Bo; Flevaris, Panagiotis; Chow, Christina; Lam, Stephen C. -T.; Voyno-Yasenetskaya, Tatyana A.; Kozasa, Tohru; Du, Xiaoping] Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Du, XP (corresponding author), Univ Illinois, Dept Pharmacol, 835 S Wolcott Ave,Room E403, Chicago, IL 60612 USA.	xdu@uic.edu	Shen, Bo/G-2012-2014	Shen, Bo/0000-0002-5237-6144; Chow, Christina/0000-0003-3944-4234	National Heart, Lung, and Blood Institute [HL080264, HL062350, HL068819]; National Institute of General Medical Sciences [GM061454, GM074001]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080264, R01HL062350, R01HL068819] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074001, R01GM061454] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants HL080264, HL062350, and HL068819 from the National Heart, Lung, and Blood Institute (X. D.) and GM061454 and GM074001 from the National Institute of General Medical Sciences (T. K.). We thank G. Nucifora for help with bone marrow transplantation and K. O'Brien and M. K. Delaney for proofreading.	Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Arthur WT, 2000, CURR BIOL, V10, P719, DOI 10.1016/S0960-9822(00)00537-6; Brass L F, 1991, Prog Hemost Thromb, V10, P127; COLLER BS, 1980, BLOOD, V55, P169; DU XP, 1991, CELL, V65, P409, DOI 10.1016/0092-8674(91)90458-B; Flevaris P, 2007, J CELL BIOL, V179, P553, DOI 10.1083/jcb.200703185; Flevaris P, 2009, BLOOD, V113, P893, DOI 10.1182/blood-2008-05-155978; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; Gu MY, 1999, J CELL BIOL, V147, P1085, DOI 10.1083/jcb.147.5.1085; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Huang JS, 2007, J BIOL CHEM, V282, P10210, DOI 10.1074/jbc.M605678200; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Klages B, 1999, J CELL BIOL, V144, P745, DOI 10.1083/jcb.144.4.745; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Li ZY, 2006, BLOOD, V107, P965, DOI 10.1182/blood-2005-03-1308; Ma YQ, 2007, J THROMB HAEMOST, V5, P1345, DOI 10.1111/j.1538-7836.2007.02537.x; Moers A, 2003, NAT MED, V9, P1418, DOI 10.1038/nm943; Moissoglu K, 2006, BIOL CELL, V98, P547, DOI 10.1042/BC20060025; Obergfell A, 2002, J CELL BIOL, V157, P265, DOI 10.1083/jcb.200112113; Ren XD, 2000, METHOD ENZYMOL, V325, P264; Riobo NA, 2005, TRENDS PHARMACOL SCI, V26, P146, DOI 10.1016/j.tips.2005.01.007; Senyuk V, 2009, CANCER RES, V69, P262, DOI 10.1158/0008-5472.CAN-08-2534; Shattil SJ, 2005, TRENDS CELL BIOL, V15, P399, DOI 10.1016/j.tcb.2005.06.005; Tanabe S, 2004, METHOD ENZYMOL, V390, P285; Vidal C, 2002, BLOOD, V100, P4462, DOI 10.1182/blood.V100.13.4462	25	161	168	2	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 15	2010	327	5963					340	343		10.1126/science.1174779	http://dx.doi.org/10.1126/science.1174779			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544CM	20075254	Green Accepted			2022-12-28	WOS:000273629700046
J	McKinnon, L; Smith, PA; Nol, E; Martin, JL; Doyle, FI; Abraham, KF; Gilchrist, HG; Morrison, RIG; Bety, J				McKinnon, L.; Smith, P. A.; Nol, E.; Martin, J. L.; Doyle, F. I.; Abraham, K. F.; Gilchrist, H. G.; Morrison, R. I. G.; Bety, J.			Lower Predation Risk for Migratory Birds at High Latitudes	SCIENCE			English	Article							LONG-DISTANCE MIGRATION; RED KNOTS; NEST PREDATION; SHOREBIRDS; NORTH; CIRCUMPOLAR; SONGBIRDS; EVOLUTION; PRESSURE; PATTERNS	Quantifying the costs and benefits of migration distance is critical to understanding the evolution of long-distance migration. In migratory birds, life history theory predicts that the potential survival costs of migrating longer distances should be balanced by benefits to lifetime reproductive success, yet quantification of these reproductive benefits in a controlled manner along a large geographical gradient is challenging. We measured a controlled effect of predation risk along a 3350-kilometer south-north gradient in the Arctic and found that nest predation risk declined more than twofold along the latitudinal gradient. These results provide evidence that birds migrating farther north may acquire reproductive benefits in the form of lower nest predation risk.	[McKinnon, L.; Bety, J.] Univ Quebec, Dept Biol, Rimouski, PQ G5L 3A1, Canada; [McKinnon, L.; Bety, J.] Univ Quebec, Ctr Etud Nord, Rimouski, PQ G5L 3A1, Canada; [Smith, P. A.; Morrison, R. I. G.] Environm Canada, Natl Wildlife Res Ctr, Ottawa, ON K1A 0H3, Canada; [Nol, E.] Trent Univ, Environm & Life Sci Grad Program, Ecol & Conservat Grp, Peterborough, ON K9J 7B8, Canada; [Nol, E.] Trent Univ, Dept Biol, Peterborough, ON K9J 7B8, Canada; [Martin, J. L.] CNRS, Ctr Ecol Fonct & Evolut, Dept Dynam Syst Ecol, F-34033 Montpellier, France; [Doyle, F. I.] Wildlife Dynam Consulting, Telkwa, BC V0J 2X0, Canada; [Abraham, K. F.] Ontario Minist Nat Resources, Wildlife Res & Dev Sect, Peterborough, ON K9J 7B8, Canada; [Gilchrist, H. G.] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada; [Gilchrist, H. G.] Carleton Univ, Natl Wildlife Res Ctr, Environm Canada, Ottawa, ON K1S 5B6, Canada	University of Quebec; University of Quebec; Environment & Climate Change Canada; Canadian Wildlife Service; National Wildlife Research Centre - Canada; Trent University; Trent University; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Ministry of Natural Resources & Forestry; Carleton University; Carleton University; Environment & Climate Change Canada; Canadian Wildlife Service; National Wildlife Research Centre - Canada	McKinnon, L (corresponding author), Univ Quebec, Dept Biol, Rimouski, PQ G5L 3A1, Canada.	laura.mckinnon3@gmail.com	Martin, Jean-Louis/E-5059-2010	Bety, Joel/0000-0002-8775-6411	ArcticNet; Environment Canada; Fonds Quebecois de Recherche sur la Nature et les Technologies; Garfield Weston Foundation; Institut Paul Emile Victor; International Polar Year (IPY) Project ArcticWOLVES; Natural Sciences and Engineering Research Council of Canada; Northern Ecosystem Initiatives; Northern Scientific Training Program; Ontario Ministry of Natural Resources	ArcticNet; Environment Canada(CGIAR); Fonds Quebecois de Recherche sur la Nature et les Technologies(FQRNT); Garfield Weston Foundation; Institut Paul Emile Victor; International Polar Year (IPY) Project ArcticWOLVES; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Northern Ecosystem Initiatives; Northern Scientific Training Program; Ontario Ministry of Natural Resources	Funded by ArcticNet, Environment Canada, Fonds Quebecois de Recherche sur la Nature et les Technologies, a Garfield Weston Foundation Award for Northern Research, Institut Paul Emile Victor (formerly Institut Francais de Recherches et Technologies Polaires), International Polar Year (IPY) Project ArcticWOLVES, Natural Sciences and Engineering Research Council of Canada (Northern Internship Program and Discovery Grant), Northern Ecosystem Initiatives, Northern Scientific Training Program, and the Ontario Ministry of Natural Resources. Logistical support was provided by the Ontario Ministry of Natural Resources, the Polar Continental Shelf Project, Parks Canada, and D. Leclerc. We also thank the Department of National Defense and staff of the Environment Canada weather station for logistic support at Alert; Vicky Johnston and crew for support on Prince Charles Island; the many field assistants who monitored artificial nests: A. Blachford, A. Bechet, J. Carrier, M. Cloutier, A.-M. d'Aoust-Messier, E. d'Astous, T. Daufresne, S. Gan, D. Hogan, L. Jolicoeur, C. Juillet, J.-R. Julien, B. Laliberte, P. Y. l'Herault, R. Lopez, P. Meister, M. Nelligan, D. Ootoova, L. Qangug, D. C. Rabouam, G. Reid, N. Ward, and S. Williams; G. Gauthier and D. Berteaux, leaders of the IPY ArcticWOLVES project, for fostering collaboration between the authors; and O. Gilg, C. Juillet, L. P. Nguyen, T. Piersma, D. Reid, and two anonymous reviewers for helpful discussions or comments on early versions of the manuscript.	Alerstam T, 2003, OIKOS, V103, P247, DOI 10.1034/j.1600-0706.2003.12559.x; Baker AJ, 2004, P ROY SOC B-BIOL SCI, V271, P875, DOI 10.1098/rspb.2003.2663; BOLAND JM, 1990, CONDOR, V92, P284, DOI 10.2307/1368226; Butler RW, 2000, AUK, V117, P518, DOI 10.1642/0004-8038(2000)117[0518:SSFSNA]2.0.CO;2; COX DR, 1972, J R STAT SOC B, V34, P187; Ganter B, 2000, ARCTIC, V53, P289; Kis J, 2000, ARDEA, V88, P155; Kvist A, 2001, NATURE, V413, P730, DOI 10.1038/35099556; LAIRD M, 1961, CAN J ZOOLOG, V39, P209, DOI 10.1139/z61-025; LEVEY DJ, 1992, AM NAT, V140, P447, DOI 10.1086/285421; Martin TE, 2000, P ROY SOC B-BIOL SCI, V267, P2287, DOI 10.1098/rspb.2000.1281; MARTIN TE, 1995, ECOL MONOGR, V65, P101, DOI 10.2307/2937160; Martin TE, 2000, SCIENCE, V287, P1482, DOI 10.1126/science.287.5457.1482; Morrison RIG, 2007, J AVIAN BIOL, V38, P479, DOI 10.1111/j.2007.0908-8857.03934.x; Morrison RIG, 2006, ARDEA, V94, P607; Piersma T, 2003, FUNCT ECOL, V17, P356, DOI 10.1046/j.1365-2435.2003.00741.x; Piersma T, 1997, OIKOS, V80, P623, DOI 10.2307/3546640; Schekkerman H, 2003, OECOLOGIA, V134, P332, DOI 10.1007/s00442-002-1124-0; STEARNS SC, 1976, Q REV BIOL, V51, P3, DOI 10.1086/409052; van de Kam J, 2004, SHOREBIRDS ILLUSTRAT; Wikelski M, 2003, NATURE, V423, P704, DOI 10.1038/423704a; Ydenberg RC, 2004, P ROY SOC B-BIOL SCI, V271, P1263, DOI 10.1098/rspb.2004.2713	22	185	193	4	147	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 15	2010	327	5963					326	327		10.1126/science.1183010	http://dx.doi.org/10.1126/science.1183010			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544CM	20075251				2022-12-28	WOS:000273629700041
J	Holbrook, TL; Galarneau, MR; Dye, JL; Quinn, K; Dougherty, AL				Holbrook, Troy Lisa; Galarneau, Michael R.; Dye, Judy L.; Quinn, Kimberly; Dougherty, Amber L.			Morphine Use after Combat Injury in Iraq and Post-Traumatic Stress Disorder	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MENTAL-HEALTH PROBLEMS; MAJOR TRAUMA; RISK-FACTORS; PTSD; AFGHANISTAN; CARE; PHARMACOTHERAPY; INTERVENTION; PREVENTION; SYMPTOMS	BACKGROUND Post-traumatic stress disorder (PTSD) is a common adverse mental health outcome among seriously injured civilians and military personnel who are survivors of trauma. Pharmacotherapy in the aftermath of serious physical injury or exposure to traumatic events may be effective for the secondary prevention of PTSD. METHODS We identified 696 injured U. S. military personnel without serious traumatic brain injury from the Navy-Marine Corps Combat Trauma Registry Expeditionary Medical Encounter Database. Complete data on medications administered were available for all personnel selected. The diagnosis of PTSD was obtained from the Career History Archival Medical and Personnel System and verified in a review of medical records. RESULTS Among the 696 patients studied, 243 received a diagnosis of PTSD and 453 did not. The use of morphine during early resuscitation and trauma care was significantly associated with a lower risk of PTSD after injury. Among the patients in whom PTSD developed, 61% received morphine; among those in whom PTSD did not develop, 76% received morphine (odds ratio, 0.47; P<0.001). This association remained significant after adjustment for injury severity, age, mechanism of injury, status with respect to amputation, and selected injury-related clinical factors. CONCLUSIONS Our findings suggest that the use of morphine during trauma care may reduce the risk of subsequent development of PTSD after serious injury.	[Holbrook, Troy Lisa; Galarneau, Michael R.; Dye, Judy L.; Quinn, Kimberly; Dougherty, Amber L.] Naval Hlth Res Ctr, San Diego, CA 92106 USA; [Holbrook, Troy Lisa] EPI SOAR Consulting, San Diego, CA USA	United States Department of Defense; United States Navy; Naval Medical Research Center (NMRC); Naval Health Research Center (NHRC)	Holbrook, TL (corresponding author), Naval Hlth Res Ctr, 140 Sylvester Rd, San Diego, CA 92106 USA.	troy@epi-soar.com			U.S. Navy Bureau of Medicine and Surgery [60808]	U.S. Navy Bureau of Medicine and Surgery	Supported by U.S. Navy Bureau of Medicine and Surgery under the Wounded, Ill, and Injured-Psychological Health-Traumatic Brain Injury Program (work unit 60808).	[Anonymous], 2000, DIAGNOSTIC STAT MANU, V4th; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BAKER WA, 1976, INORG CHIM ACTA, V16, P5, DOI 10.1016/S0020-1693(00)91684-0; BRAUN P, 1990, J CLIN PSYCHIAT, V51, P236; Bryant RA, 2009, BIOL PSYCHIAT, V65, P438, DOI 10.1016/j.biopsych.2008.10.032; Davidson JRT, 2006, J CLIN PSYCHIAT, V67, P34; Davidson JRT, 2004, J CLIN PSYCHIAT, V65, P44; Ducrocq F, 2005, ENCEPHALE, V31, P212; Erbes C, 2007, MIL MED, V172, P359, DOI 10.7205/MILMED.172.4.359; Galarneau MR, 2006, MIL MED, V171, P691, DOI 10.7205/MILMED.171.8.691; Gelpin E, 1996, J CLIN PSYCHIAT, V57, P390; Gennarelli T., 2005, ABBREVIATED INJURY S; Grieger TA, 2006, AM J PSYCHIAT, V163, P1777, DOI 10.1176/appi.ajp.163.10.1777; Gunderson EKE, 2005, MIL MED, V170, P172; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Holbrook TL, 2001, J TRAUMA, V51, P287, DOI 10.1097/00005373-200108000-00010; Holbrook TL, 2005, J TRAUMA, V58, P764, DOI 10.1097/01.TA.0000159247.48547.7D; Holbrook TL, 2001, J TRAUMA, V50, P270, DOI 10.1097/00005373-200102000-00012; Koren D, 2005, AM J PSYCHIAT, V162, P276, DOI 10.1176/appi.ajp.162.2.276; Marmar CR, 2002, PSYCHIAT QUART, V73, P259, DOI 10.1023/A:1020459916113; MCGAUGH JL, 1988, BRAIN RES, V446, P37, DOI 10.1016/0006-8993(88)91294-2; Michaels AJ, 1998, J TRAUMA, V44, P644, DOI 10.1097/00005373-199804000-00013; Michaels AJ, 1999, J TRAUMA, V47, P867, DOI 10.1097/00005373-199911000-00009; Michaels AJ, 1999, J TRAUMA, V47, P460, DOI 10.1097/00005373-199909000-00005; Morgan CA, 2003, BIOL PSYCHIAT, V53, P834, DOI 10.1016/S0006-3223(03)00116-1; *NAT CTR POSTTR ST, EP FACTS PTSD; Norman SB, 2008, PSYCHOL MED, V38, P533, DOI 10.1017/S0033291707001389; Pitman RK, 2005, CNS SPECTRUMS, V10, P99, DOI 10.1017/S109285290001943X; Saxe G, 2001, J AM ACAD CHILD PSY, V40, P915, DOI 10.1097/00004583-200108000-00013; Schlesselman JJ, 1982, CASE CONTROL STUDIES; Stein MB, 2007, J TRAUMA STRESS, V20, P923, DOI 10.1002/jts.20270; Vaiva G, 2003, BIOL PSYCHIAT, V54, P947, DOI 10.1016/S0006-3223(03)00412-8; Zatzick D, 2006, PSYCHIAT SERV, V57, P1726, DOI 10.1176/appi.ps.57.12.1726; Zatzick Douglas, 2003, Semin Clin Neuropsychiatry, V8, P158, DOI 10.1016/S1084-3612(03)00016-9; Zatzick Douglas, 2003, Semin Clin Neuropsychiatry, V8, P168, DOI 10.1016/S1084-3612(03)00015-7; Zatzick DF, 2007, J TRAUMA STRESS, V20, P401, DOI 10.1002/jts.20256; Zhang W, 2007, EXPERT OPIN PHARMACO, V8, P1861, DOI 10.1517/14656566.8.12.1861	39	287	296	1	35	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 14	2010	362	2					110	117		10.1056/NEJMoa0903326	http://dx.doi.org/10.1056/NEJMoa0903326			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	543FU	20071700				2022-12-28	WOS:000273558500008
J	Brooks, AMS; Paisey, RB; Waterson, MJ; Smith, JC				Brooks, Augustin M. S.; Paisey, Richard B.; Waterson, Michael J.; Smith, Jamie C.			Case Report Diagnostic difficulties with a lipaemic blood sample	BRITISH MEDICAL JOURNAL			English	Editorial Material							ACUTE-PANCREATITIS; HYPERLIPIDEMIC PANCREATITIS; AMYLASE ACTIVITY; HYPERTRIGLYCERIDEMIA; HYPERLIPEMIA		[Brooks, Augustin M. S.; Paisey, Richard B.; Smith, Jamie C.] Torbay Hosp, Dept Endocrinol & Diabet, Torquay TQ2 7AA, Devon, England; [Waterson, Michael J.] Torbay Hosp, Dept Clin Biochem, Torquay TQ2 7AA, Devon, England		Brooks, AMS (corresponding author), Torbay Hosp, Dept Endocrinol & Diabet, Torquay TQ2 7AA, Devon, England.	augustinmarchand@hotmail.com		Brooks, Augustin/0000-0002-8486-4441				BALTHAZAR EJ, 1989, RADIOL CLIN N AM, V27, P19; Banks PA, 2006, AM J GASTROENTEROL, V101, P2379, DOI 10.1111/j.1572-0241.2006.00856.x; FALLAT RW, 1973, JAMA-J AM MED ASSOC, V225, P1331, DOI 10.1001/jama.225.11.1331; Goldacre MJ, 2004, BRIT MED J, V328, P1466, DOI 10.1136/bmj.328.7454.1466; Kemppainen EA, 1997, NEW ENGL J MED, V336, P1788, DOI 10.1056/NEJM199706193362504; Kyriakidis AV, 2006, DIGESTION, V73, P259, DOI 10.1159/000095425; LESSER PB, 1975, ANN INTERN MED, V82, P795, DOI 10.7326/0003-4819-82-6-795; Okura Y, 2004, WORLD J GASTROENTERO, V10, P3691, DOI 10.3748/wjg.v10.i24.3691; Sharma P, 1996, BRIT MED J, V313, P1265, DOI 10.1136/bmj.313.7067.1265; WARSHAW AL, 1975, ANN SURG, V182, P72, DOI 10.1097/00000658-197507000-00014; WICKUS GG, 1982, CLIN CHEM, V28, P2131; Yadav D, 2003, J CLIN GASTROENTEROL, V36, P54, DOI 10.1097/00004836-200301000-00016	12	3	3	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 13	2010	340								b5530	10.1136/bmj.b5530	http://dx.doi.org/10.1136/bmj.b5530			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	545DA	20071437				2022-12-28	WOS:000273711500003
J	Woolf, SH				Woolf, Steven H.			The 2009 Breast Cancer Screening Recommendations of the US Preventive Services Task Force	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Woolf, Steven H.] Virginia Commonwealth Univ, Dept Family Med, Richmond, VA 23298 USA; [Woolf, Steven H.] Virginia Commonwealth Univ, Dept Epidemiol & Community Hlth, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University	Woolf, SH (corresponding author), Virginia Commonwealth Univ, West Hosp, Dept Family Med, 1200 Broad St,POB 980251, Richmond, VA 23298 USA.	swoolf@vcu.edu						Agency for Healthcare Research and Quality, US PREV SERV TASK FO; Berg AO, 2002, ANN INTERN MED, V137, P344, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00011; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; CONDON S, 2009, CBS NEWS        1118; Duffy SW, 2002, CANCER-AM CANCER SOC, V95, P458, DOI 10.1002/cncr.10765; Eggen D, 2009, WASHINGTON POST 1118; Gaus CR, 2003, HLTH AFF MILLWOOD S; Shaneyfelt TM, 2009, JAMA-J AM MED ASSOC, V301, P868, DOI 10.1001/jama.2009.225; Thomas DB, 2002, JNCI-J NATL CANCER I, V94, P1445, DOI 10.1093/jnci/94.19.1445; Woolf SH, 1997, JAMA-J AM MED ASSOC, V278, P2105, DOI 10.1001/jama.278.23.2105	10	55	55	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 13	2010	303	2					162	163		10.1001/jama.2009.1989	http://dx.doi.org/10.1001/jama.2009.1989			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	542UI	20068210				2022-12-28	WOS:000273522600027
J	Kumar, SV; Wigge, PA				Kumar, S. Vinod; Wigge, Philip A.			H2A.Z-Containing Nucleosomes Mediate the Thermosensory Response in Arabidopsis	CELL			English	Article							RNA-POLYMERASE-II; FLOWERING TIME; HIGH-TEMPERATURE; AMBIENT-TEMPERATURE; CIRCADIAN CLOCK; CLIMATE-CHANGE; CHROMATIN; H2A.Z; TRANSCRIPTION; EXPRESSION	Plants are highly sensitive to temperature and can perceive a difference of as little as 1 degrees C. How temperature is sensed and integrated in development is unknown. In a forward genetic screen in Arabidopsis, we have found that nucleosomes containing the alternative histone H2A.Z are essential to perceiving ambient temperature correctly. Genotypes deficient in incorporating H2A.Z into nucleosomes phenocopy warm grown plants, and show a striking constitutive warm temperature transcriptome. We show that nucleosomes containing H2A.Z display distinct responses to temperature in vivo, independently of transcription. Using purified nucleosomes, we are able to show that H2A.Z confers distinct DNA-unwrapping properties on nucleosomes, indicating a direct mechanism for the perception of temperature through DNA-nucleosome fluctuations. Our results show that H2A.Z-containing nucleosomes provide thermosensory information that is used to coordinate the ambient temperature transcriptome. We observe the same effect in budding yeast, indicating that this is an evolutionarily conserved mechanism.	[Kumar, S. Vinod; Wigge, Philip A.] John Innes Ctr, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Wigge, PA (corresponding author), John Innes Ctr, Colney Lane, Norwich NR4 7UH, Norfolk, England.	philip.wigge@bbsrc.ac.uk	Wigge, Philip/B-3333-2010; Wigge, Philip Anthony/ABD-5113-2021	Wigge, Philip Anthony/0000-0003-4822-361X; Kumar, S Vinod/0000-0001-9265-4906	JIC; BBSRC; ERC; Biotechnology and Biological Sciences Research Council [BBS/E/J/00000610] Funding Source: researchfish	JIC; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ERC(European Research Council (ERC)European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was made possible by the unflagging support and encouragement of Chris Lamb, and we dedicate it to his memory. We thank Andrew Maule for the gift of the HSP70::LUC reporter line. Rich Meagher kindly provided the antibody to H2A.Z. We thank all members of the lab for discussions and advice. We are indebted to Katja Jaeger for help in initiating the project. We thank Hugh Pelham, Caroline Dean, Liam Dolan, Judith Irwin, Michael Bevan, and Andrew Maule for discussions. This project was funded by start-up funds from the JIC, BBSRC, and ERC.	Ausin I, 2004, NAT GENET, V36, P162, DOI 10.1038/ng1295; Balasubramanian S, 2006, PLOS GENET, V2, P980, DOI 10.1371/journal.pgen.0020106; Blazquez MA, 2003, NAT GENET, V33, P168, DOI 10.1038/ng1085; Boeger H, 2003, MOL CELL, V11, P1587, DOI 10.1016/S1097-2765(03)00231-4; Boeger H, 2008, CELL, V133, P716, DOI 10.1016/j.cell.2008.02.051; Brand M, 2008, NAT PROTOC, V3, P398, DOI 10.1038/nprot.2008.8; Cerdan PD, 2003, NATURE, V423, P881, DOI 10.1038/nature01636; Choi K, 2005, PLANT CELL, V17, P2647, DOI 10.1105/tpc.105.035485; Creyghton MP, 2008, CELL, V135, P649, DOI 10.1016/j.cell.2008.09.056; Almeida Alex-Alan F. de, 2007, Braz. J. Plant Physiol., V19, P83, DOI 10.1590/S1677-04202007000200001; Deal RB, 2005, PLANT CELL, V17, P2633, DOI 10.1105/tpc.105.035196; Fan JY, 2002, NAT STRUCT BIOL, V9, P172, DOI 10.1038/nsb767; Fitter AH, 2002, SCIENCE, V296, P1689, DOI 10.1126/science.1071617; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gendrel AV, 2002, SCIENCE, V297, P1871, DOI 10.1126/science.1074950; Gould PD, 2006, PLANT CELL, V18, P1177, DOI 10.1105/tpc.105.039990; Gray WM, 1998, P NATL ACAD SCI USA, V95, P7197, DOI 10.1073/pnas.95.12.7197; Halliday KJ, 2003, PLANT J, V33, P875, DOI 10.1046/j.1365-313X.2003.01674.x; Heggie L, 2005, INT J DEV BIOL, V49, P675, DOI 10.1387/ijdb.041926lh; Hodges C, 2009, SCIENCE, V325, P626, DOI 10.1126/science.1172926; Ishibashi T, 2009, BIOCHEMISTRY-US, V48, P5007, DOI 10.1021/bi900196c; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kelly AE, 2008, P NATL ACAD SCI USA, V105, P11823, DOI 10.1073/pnas.0802891105; Kim HJ, 2004, NAT GENET, V36, P167, DOI 10.1038/ng1298; KNEZETIC JA, 1986, CELL, V45, P95, DOI 10.1016/0092-8674(86)90541-6; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; Koini MA, 2009, CURR BIOL, V19, P408, DOI 10.1016/j.cub.2009.01.046; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Lam FH, 2008, NATURE, V453, P246, DOI 10.1038/nature06867; Larkindale J, 2008, PLANT PHYSIOL, V146, P748, DOI 10.1104/pp.107.112060; Lee JH, 2007, GENE DEV, V21, P397, DOI 10.1101/gad.1518407; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Li B, 2005, P NATL ACAD SCI USA, V102, P18385, DOI 10.1073/pnas.0507975102; LORCH Y, 1987, CELL, V49, P203, DOI 10.1016/0092-8674(87)90561-7; Martin-Trillo M, 2006, DEVELOPMENT, V133, P1241, DOI 10.1242/dev.02301; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Michael TP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040014; Mittler R, 2006, TRENDS PLANT SCI, V11, P15, DOI 10.1016/j.tplants.2005.11.002; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Petesch SJ, 2008, CELL, V134, P74, DOI 10.1016/j.cell.2008.05.029; Poethig RS, 2003, SCIENCE, V301, P334, DOI 10.1126/science.1085328; POLACH KJ, 1995, J MOL BIOL, V254, P130, DOI 10.1006/jmbi.1995.0606; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Salome PA, 2005, PLANT CELL, V17, P791, DOI 10.1105/tpc.104.029504; Samach A, 2005, CURR OPIN PLANT BIOL, V8, P483, DOI 10.1016/j.pbi.2005.07.011; Segal E, 2009, NAT REV GENET, V10, P443, DOI 10.1038/nrg2591; Sung DY, 2001, PLANT PHYSIOL, V126, P789, DOI 10.1104/pp.126.2.789; Sung S, 2005, ANNU REV PLANT BIOL, V56, P491, DOI 10.1146/annurev.arplant.56.032604.144307; Thambirajah AA, 2006, J BIOL CHEM, V281, P20036, DOI 10.1074/jbc.M601975200; Tsankov AM, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100106; Whittle CM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000187; Wilczek AM, 2009, SCIENCE, V323, P930, DOI 10.1126/science.1165826; Willis CG, 2008, P NATL ACAD SCI USA, V105, P17029, DOI 10.1073/pnas.0806446105; Zhang CJ, 2005, FLUID PHASE EQUILIBR, V231, P1, DOI 10.1016/j.fluid.2005.03.018; Zilberman D, 2008, NATURE, V456, P125, DOI 10.1038/nature07324	56	618	663	8	223	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 8	2010	140	1					136	147		10.1016/j.cell.2009.11.006	http://dx.doi.org/10.1016/j.cell.2009.11.006			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	541CY	20079334	Bronze			2022-12-28	WOS:000273391900021
J	Singh, KK; Tsai, LH				Singh, Karun K.; Tsai, Li-Huei			MicroTUB(B3)ules and Brain Development	CELL			English	Editorial Material							NEURONAL MIGRATION; MUTATIONS		[Singh, Karun K.; Tsai, Li-Huei] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Singh, Karun K.; Tsai, Li-Huei] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Singh, Karun K.; Tsai, Li-Huei] Broad Inst, Stanley Ctr Psychiat Res, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Northwell Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Tsai, LH (corresponding author), MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA.	lhtsai@mit.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		De Vos KJ, 2008, ANNU REV NEUROSCI, V31, P151, DOI 10.1146/annurev.neuro.31.061307.090711; des Portes V, 1998, CELL, V92, P51; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Jaglin XH, 2009, NAT GENET, V41, P746, DOI 10.1038/ng.380; Keays DA, 2007, CELL, V128, P45, DOI 10.1016/j.cell.2006.12.017; Lewis SA, 1997, TRENDS CELL BIOL, V7, P479, DOI 10.1016/S0962-8924(97)01168-9; Poirier K, 2007, HUM MUTAT, V28, P1055, DOI 10.1002/humu.20572; Yamada K, 2003, NAT GENET, V35, P318, DOI 10.1038/ng1261	8	15	15	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 8	2010	140	1					30	32		10.1016/j.cell.2009.12.038	http://dx.doi.org/10.1016/j.cell.2009.12.038			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	541CY	20085703	Bronze, Green Submitted			2022-12-28	WOS:000273391900012
J	Wensley, BG; Batey, S; Bone, FAC; Chan, ZM; Tumelty, NR; Steward, A; Kwa, LG; Borgia, A; Clarke, J				Wensley, Beth G.; Batey, Sarah; Bone, Fleur A. C.; Chan, Zheng Ming; Tumelty, Nuala R.; Steward, Annette; Kwa, Lee Gyan; Borgia, Alessandro; Clarke, Jane			Experimental evidence for a frustrated energy landscape in a three-helix-bundle protein family	NATURE			English	Article							INTERNAL-FRICTION; TRANSITION-STATE; CONTACT ORDER; DIFFUSION; BARRIER; STABILITY; KINETICS; MODEL; VISCOSITY; DYNAMICS	Energy landscape theory is a powerful tool for understanding the structure and dynamics of complex molecular systems, in particular biological macromolecules(1). The primary sequence of a protein defines its free-energy landscape and thus determines the folding pathway and the rate constants of folding and unfolding, as well as the protein's native structure. Theory has shown that roughness in the energy landscape will lead to slower folding(1), but derivation of detailed experimental descriptions of this landscape is challenging. Simple folding models(2,3) show that folding is significantly influenced by chain entropy; proteins in which the contacts are local fold quickly, owing to the low entropy cost of forming stabilizing, native contacts during folding(4,5). For some protein families, stability is also a determinant of folding rate constants(6). Where these simple metrics fail to predict folding behaviour, it is probable that there are features in the energy landscape that are unusual. Such general observations cannot explain the folding behaviour of the R15, R16 and R17 domains of alpha-spectrin. R15 folds similar to 3,000 times faster than its homologues, although they have similar structures, stabilities and, as far as can be determined, transition-state stabilities(7-10). Here we show that landscape roughness (internal friction) is responsible for the slower folding and unfolding of R16 and R17. We use chimaeric domains to demonstrate that this internal friction is a property of the core, and suggest that frustration in the landscape of the slow-folding spectrin domains may be due to misdocking of the long helices during folding. Theoretical studies have suggested that rugged landscapes will result in slower folding; here we show experimentally that such a phenomenon directly influences the folding kinetics of a 'normal' protein, that is, one with a significant energy barrier that folds on a relatively slow, millisecond-second, timescale.	[Wensley, Beth G.; Batey, Sarah; Bone, Fleur A. C.; Chan, Zheng Ming; Tumelty, Nuala R.; Steward, Annette; Kwa, Lee Gyan; Borgia, Alessandro; Clarke, Jane] Univ Cambridge, Dept Chem, MRC, Ctr Prot Engn, Cambridge CB2 1EW, England	University of Cambridge	Clarke, J (corresponding author), Univ Cambridge, Dept Chem, MRC, Ctr Prot Engn, Lensfield Rd, Cambridge CB2 1EW, England.	jc162@cam.ac.uk	Borgia, Alessandro/AAF-9203-2019	Borgia, Alessandro/0000-0002-4701-8967	Wellcome Trust [064417/Z/01/A]; UK Medical Research Council; MRC [MC_U105485808] Funding Source: UKRI; Medical Research Council [MC_U105485808] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust (grant number 064417/Z/01/A). B. G. W. was supported by a UK Medical Research Council studentship. J.C. is a Wellcome Trust Senior Research Fellow. We thank W. Eaton, P. Wolynes, R. Best and B. Schuler for discussions.	ANSARI A, 1992, SCIENCE, V256, P1796, DOI 10.1126/science.1615323; Bachmann A, 2001, J MOL BIOL, V306, P375, DOI 10.1006/jmbi.2000.4399; BRYNGELSON JD, 1989, J PHYS CHEM-US, V93, P6902, DOI 10.1021/j100356a007; Cellmer T, 2008, P NATL ACAD SCI USA, V105, P18320, DOI 10.1073/pnas.0806154105; CHRUNYK BA, 1990, BIOCHEMISTRY-US, V29, P2149, DOI 10.1021/bi00460a027; Clarke J, 1999, STRUCT FOLD DES, V7, P1145, DOI 10.1016/S0969-2126(99)80181-6; FERSHT AR, 1992, J MOL BIOL, V224, P771, DOI 10.1016/0022-2836(92)90561-W; Frauenfelder H, 2006, P NATL ACAD SCI USA, V103, P15469, DOI 10.1073/pnas.0607168103; Gianni S, 2003, P NATL ACAD SCI USA, V100, P13286, DOI 10.1073/pnas.1835776100; Godoy-Ruiz R, 2008, J PHYS CHEM B, V112, P5938, DOI 10.1021/jp0757715; Gromiha MM, 2001, J MOL BIOL, V310, P27, DOI 10.1006/jmbi.2001.4775; Gruebele M, 2008, RSC BIOMOL SCI, P106, DOI 10.1039/9781847558282-00106; Henry ER, 2004, CHEM PHYS, V307, P163, DOI 10.1016/j.chemphys.2004.06.064; Jacob M, 1997, P NATL ACAD SCI USA, V94, P5622, DOI 10.1073/pnas.94.11.5622; Jas GS, 2001, J PHYS CHEM B, V105, P261, DOI 10.1021/jp0022048; Johnson CP, 2007, BLOOD, V109, P3538, DOI 10.1182/blood-2006-07-038588; KIEFHABER T, 1992, J MOL BIOL, V224, P217, DOI 10.1016/0022-2836(92)90585-8; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; Kusunoki H, 2004, J MOL BIOL, V344, P495, DOI 10.1016/j.jmb.2004.09.019; Ladurner AG, 1999, NAT STRUCT BIOL, V6, P28; Munoz V, 1999, P NATL ACAD SCI USA, V96, P11311, DOI 10.1073/pnas.96.20.11311; Nettels D, 2007, P NATL ACAD SCI USA, V104, P2655, DOI 10.1073/pnas.0611093104; Oliveberg M, 1998, J MOL BIOL, V277, P933, DOI 10.1006/jmbi.1997.1612; Oliveberg M, 2001, CURR OPIN STRUC BIOL, V11, P94, DOI 10.1016/S0959-440X(00)00171-8; Otzen DE, 1999, BIOCHEMISTRY-US, V38, P6499, DOI 10.1021/bi982819j; Pabit SA, 2004, BIOCHEMISTRY-US, V43, P12532, DOI 10.1021/bi048822m; Pace C N, 1986, Methods Enzymol, V131, P266; Plaxco KW, 1998, P NATL ACAD SCI USA, V95, P13591, DOI 10.1073/pnas.95.23.13591; Plaxco KW, 1998, J MOL BIOL, V277, P985, DOI 10.1006/jmbi.1998.1645; Pogorelov TV, 2004, BIOPHYS J, V87, P207, DOI 10.1529/biophysj.104.042861; Pradeep L, 2007, J MOL BIOL, V366, P1016, DOI 10.1016/j.jmb.2006.11.064; Qiu LL, 2005, CHEM PHYS, V312, P325, DOI 10.1016/j.chemphys.2004.12.001; Sanchez IE, 2003, J MOL BIOL, V325, P367, DOI 10.1016/S0022-2836(02)01230-5; Scott KA, 2005, PROTEIN SCI, V14, P1617, DOI 10.1110/ps.051377105; Scott KA, 2004, J MOL BIOL, V344, P207, DOI 10.1016/j.jmb.2004.09.023; Scott KA, 2004, J MOL BIOL, V344, P195, DOI 10.1016/j.jmb.2004.09.037; Scott KA, 2006, J MOL BIOL, V359, P159, DOI 10.1016/j.jmb.2006.03.011; Silow M, 1997, BIOCHEMISTRY-US, V36, P7633, DOI 10.1021/bi970210x; Sutto L, 2007, P NATL ACAD SCI USA, V104, P19825, DOI 10.1073/pnas.0709922104; Szabo Z. G., 1969, COMPREHENSIVE CHEM K, V2, P1; Ternstrom T, 1999, P NATL ACAD SCI USA, V96, P14854, DOI 10.1073/pnas.96.26.14854; Wensley BG, 2009, J MOL BIOL, V390, P1074, DOI 10.1016/j.jmb.2009.05.010; Yang WY, 2003, NATURE, V423, P193, DOI 10.1038/nature01609; ZWANZIG R, 1988, P NATL ACAD SCI USA, V85, P2029, DOI 10.1073/pnas.85.7.2029	44	128	128	0	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 4	2010	463	7281					685	U122		10.1038/nature08743	http://dx.doi.org/10.1038/nature08743			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551GB	20130652	Green Accepted			2022-12-28	WOS:000274193900041
J	Sen, GL; Reuter, JA; Webster, DE; Zhu, L; Khavari, PA				Sen, George L.; Reuter, Jason A.; Webster, Daniel E.; Zhu, Lilly; Khavari, Paul A.			DNMT1 maintains progenitor function in self-renewing somatic tissue	NATURE			English	Article							DNA METHYLATION; STEM-CELLS; GENE-EXPRESSION; DIFFERENTIATION; METHYLTRANSFERASE; GENOME; DEMETHYLATION; PROLIFERATION; KERATINOCYTES; PATTERNS	Progenitor cells maintain self-renewing tissues throughout life by sustaining their capacity for proliferation while suppressing cell cycle exit and terminal differentiation(1,2). DNA methylation(3-5) provides a potential epigenetic mechanism for the cellular memory needed to preserve the somatic progenitor state through repeated cell divisions. DNA methyltransferase 1 (DNMT1)(6,7) maintains DNA methylation patterns after cellular replication. Although dispensable for embryonic stem cell maintenance(8), the role for DNMT1 in maintaining the progenitor state in constantly replenished somatic tissues, such as mammalian epidermis, is unclear. Here we show that DNMT1 is essential for epidermal progenitor cell function. DNMT1 protein was found enriched in undifferentiated cells, where it was required to retain proliferative stamina and suppress differentiation. In tissue, DNMT1 depletion led to exit from the progenitor cell compartment, premature differentiation and eventual tissue loss. Genome-wide analysis showed that a significant portion of epidermal differentiation gene promoters were methylated in self-renewing conditions but were subsequently demethylated during differentiation. Furthermore, UHRF1 (refs 9, 10), a component of the DNA methylation machinery that targets DNMT1 to hemi-methylated DNA, is also necessary to suppress premature differentiation and sustain proliferation. In contrast, Gadd45A(11,12) and B-13, which promote active DNA demethylation, are required for full epidermal differentiation gene induction. These data demonstrate that proteins involved in the dynamic regulation of DNA methylation patterns are required for progenitor maintenance and self-renewal in mammalian somatic tissue.	[Sen, George L.; Reuter, Jason A.; Webster, Daniel E.; Zhu, Lilly; Khavari, Paul A.] Stanford Univ, Program Epithelial Biol, Stanford, CA 94305 USA; [Sen, George L.; Reuter, Jason A.; Webster, Daniel E.; Zhu, Lilly; Khavari, Paul A.] Stanford Univ, Program Canc Biol, Stanford, CA 94305 USA; [Sen, George L.; Reuter, Jason A.; Webster, Daniel E.; Zhu, Lilly; Khavari, Paul A.] Stanford Univ, Stanford Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Khavari, Paul A.] Vet Affairs Palo Alto Healthcare Syst, Palo Alto, CA 94304 USA	Stanford University; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Khavari, PA (corresponding author), Stanford Univ, Program Epithelial Biol, Stanford, CA 94305 USA.	khavari@stanford.edu		Webster, Dan/0000-0001-6874-8451	USVA Office of Research and Development; NIH/NIAMS [AR45192]; LVMH Recherche; NIH [AR055849]; NATIONAL CANCER INSTITUTE [T32CA009302, R01CA142635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR057828, R01AR045192, R01AR049737, F32AR055849] Funding Source: NIH RePORTER	USVA Office of Research and Development; NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); LVMH Recherche; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the USVA Office of Research and Development, NIH/NIAMS AR45192, an unrestricted research gift from LVMH Recherche to P. A. K. and an NIH National Research Service Award AR055849 to G. L. S. We thank M. P. Scott, G. R. Crabtree, M. T. Fuller, J. Wysocka, H. Y. Chang, A. E. Oro, T. W. Ridky, B. J. Zarnegar, M. Kretz, D. Webster, R. Flockhart for critical comments and pre-submission review, X. Bao for help with figures, and G. Lai for informatics.	Andersen B, 1997, GENE DEV, V11, P1873, DOI 10.1101/gad.11.14.1873; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; BESTOR T, 1988, J MOL BIOL, V203, P971, DOI 10.1016/0022-2836(88)90122-2; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Carlson ME, 2008, NATURE, V454, P528, DOI 10.1038/nature07034; Damelin M, 2007, MOL CELL BIOL, V27, P3891, DOI 10.1128/MCB.00036-07; Eckert RL, 1997, J INVEST DERMATOL, V109, P501, DOI 10.1111/1523-1747.ep12336477; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Fuks F, 2005, CURR OPIN GENET DEV, V15, P490, DOI 10.1016/j.gde.2005.08.002; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; He J, 2008, NAT STRUCT MOL BIOL, V15, P1169, DOI 10.1038/nsmb.1499; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Khavari PA, 2006, NAT REV CANCER, V6, P270, DOI 10.1038/nrc1838; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; Lazarov M, 2002, NAT MED, V8, P1105, DOI 10.1038/nm779; Lei H, 1996, DEVELOPMENT, V122, P3195; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Maurelli R, 2006, FASEB J, V20, P1516, DOI 10.1096/fj.05-4480fje; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Motohashi H, 2004, P NATL ACAD SCI USA, V101, P6379, DOI 10.1073/pnas.0305902101; Nakamura Y, 2007, EXP DERMATOL, V16, P143, DOI 10.1111/j.1600-0625.2006.00528.x; *NAT CANC I DCCPS, 2002, SEER INC SURV UNPUB; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Robbins PB, 2001, P NATL ACAD SCI USA, V98, P5193, DOI 10.1073/pnas.091484998; Sen GL, 2008, GENE DEV, V22, P1865, DOI 10.1101/gad.1673508; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Weber M, 2007, CURR OPIN CELL BIOL, V19, P273, DOI 10.1016/j.ceb.2007.04.011; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990	38	322	338	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 28	2010	463	7280					563	U189		10.1038/nature08683	http://dx.doi.org/10.1038/nature08683			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	548QK	20081831	Green Accepted			2022-12-28	WOS:000273981100056
J	Campbell, F; Doull, L				Campbell, Fiona; Doull, Linda			Provision of secondary care in fragile state contexts	LANCET			English	Editorial Material									[Campbell, Fiona; Doull, Linda] Merlin, Hlth & Policy Dept, London EC1V 9NR, England		Campbell, F (corresponding author), Merlin, Hlth & Policy Dept, London EC1V 9NR, England.	Fiona.campbell@merlin.org.uk						*HIGH LEV FOR HLTH, 2004, ACH HLTH MILL DEV GO; *INT STAND COMM, 2009, HLTH RES AV MAPP SYS; World Health Organization, 2008, PRIM HLTH CAR MOR EV; PARTNERSHIP MATERNAL	4	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 23	2010	375	9711					260	261		10.1016/S0140-6736(09)62155-3	http://dx.doi.org/10.1016/S0140-6736(09)62155-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	549QS	20109933				2022-12-28	WOS:000274069300007
J	Rubenstein, LS; Bittle, MD				Rubenstein, Leonard S.; Bittle, Melanie D.			Responsibility for protection of medical workers and facilities in armed conflict	LANCET			English	Article								Assaults on patients and medical personnel, facilities, and transports, denial of access to medical services, and misuse of medical facilities and emblems have become a feature of armed conflict despite their prohibition by the laws of war. Strategies to improve compliance with these laws, protection, and accountability are lacking, and regular reporting of violations is absent. A systematic review of the frequency of reporting and types of violations has not been done for more than 15 years. To gain a better understanding of the scope and extent of the problem, we used uniform search criteria to review three global sources of human rights reports in armed conflicts for 2003-08, and in-depth reports on violations committed in armed conflict during 1989-2008. Findings from this review showed deficiencies in the extent and methods of reporting, but also identified three major trends in such assaults: attacks on medical functions seem to be part of a broad assault on civilians; assaults on medical functions are used to achieve a military advantage; and combatants do not respect the ethical duty of health professionals to provide care to patients irrespective of affiliation. WHO needs to lead robust and systematic documentation of these violations, and countries and the medical community need to take steps to improve compliance, protection, and accountability.	[Rubenstein, Leonard S.] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Bittle, Melanie D.] US Inst Peace, Washington, DC USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Rubenstein, LS (corresponding author), Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, 615 N Wolfe St, Baltimore, MD 21205 USA.	lrubenst@jhsph.edu			US Institute of Peace	US Institute of Peace	The US Institute of Peace provided a fellowship to LSR that enabled this study to be done. The Institute exercised no editorial control whatsoever over the content.	Allhoff F, 2006, CAMB Q HEALTHC ETHIC, V15, P392; *AMN INT, 1999, ISR GAZ OP CAST LEAD; *AMN INT, 2000, HARM HEAL VIOL HUM R; *BRIT MED ASS, 2009, SRI LANK VIOL FUND H; CHECCHI F, 2005, HUMANITARIAN PRACTIC; Cobey AC, 2001, ANN INTERN MED, V134, P421, DOI 10.7326/0003-4819-134-5-200103060-00015; Coghlan B, 2006, LANCET, V367, P44, DOI 10.1016/S0140-6736(06)67923-3; COUPLAND RM, 1991, BMJ-BRIT MED J, V303, P1509, DOI 10.1136/bmj.303.6816.1509; Coupland R, 2007, B WORLD HEALTH ORGAN, V85, P181, DOI 10.2471/BLT.06.037135; *DEP PEAC CONFL RE, UPPS CONFL DAT PROGR; DEVIN J, 1992, VIOLATION MED NEUTRA, P104; DUBOIS M, 2008, HUMANITARIAN EXCHANG; Ewumbue-Monono Churchill, 2006, INT REV RED CROSS, V88, P905; Geiss R., 2006, INT REV RED CROSS, V88, P757; GROSS M, 2006, BIOETHICS ARMED CORI; Harbom L, 2008, J PEACE RES, V45, P697, DOI 10.1177/0022343308094331; HAUSER C, 2004, NY TIMES        0414; Henckaerts Jean-Marie, 2005, CUSTOMARY INT HUMANI; *HUM RIGHTS WATCH, 2009, SRI LANK REP SHELL H; *INT COMM RED CROS, 1949, CONV AM COND WOUND S; *INT COMM RED CROS, 2007, HUM TECHN LEG MIL CH; *INT COMM RED CROS, 1949, CONV 4 REL PROT CIVL; *INT COMM RED CROS, 2009, GAZ ICRC STRIV EV TR; *INT COMM RED CROS, 1949, PROT ADD GEN CONV 12; *INT STAND COMM, GROW SHELT TREE PROT; International Committee of the Red Cross, 2009, GAZ ICRC DEM URG ACC; JAMAIL D, 2005, IRAQI HOSPITALS AILI; KALSHOVEN F, 1992, VIOLATION MED NEUTRA; *OFF HIGH COMM HUM, 2006, 2 PER REP UN HIGH CO; *OFF UN HIGH COMM, 1976, SOC CULT RIGHTS ENT; *OFF UN HIGH COMM, 1976, ENT FORC MARCH 3; Orbinski J, 2007, LANCET, V370, P698, DOI 10.1016/S0140-6736(07)61346-4; *PHYS HUM RIGHTS, 1996, MED SIEG FORM YUG 19, P65; *PHYS HUM RIGHTS, 2009, PER MED LEG OPPR CON; SIMMONDS S, 2004, SUPPORT HLTH SECTOR; Slim Hugo, 2008, KILLING CIVILIANS ME; Taback Nathan, 2005, Med Confl Surviv, V21, P19, DOI 10.1080/1362369042000315032; Taback Nathan, 2006, THINKING OUTSIDE BOX, P191; Taylor-Robinson SD, 2002, J MED ETHICS, V28, P49, DOI 10.1136/jme.28.1.49; TURLAN C, 2006, EXCHANGE MAGAZIN NOV; U.S. Department of State, 2009, REP C INC REC CONFL; *UN, 2004, UN SPEC RAPP RIGHT H; *UN, ROM STAT INT CRIM 2; *UN COMM EC SOC CU, 2000, GEN COMM 14; *US DEP JUST, 2008, BIKR THAP; *US DISTR COURT, 2007, SO DISTR NEW YORK; *WHO, 2006, ENG HLTH 11 GEN PROG; *WHO, 2009, SAV LIV MAK HOSP SAF; WHO, 2009, STRENGTH WHOS I CAP; World Health Organization, 2007, WHO ETHICAL SAFETY R; World Health Organization, 2009, WORLD HLTH STAT IND; *WORLD MED ASS, 2009, WMA URG SRI LANK PRE; *WORLD MED ASS, 2009, WMA URG MED NEUR TIM; *WORLD ORG TORT, 2009, SRI LANK OR STAT 11	54	56	57	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 23	2010	375	9711					329	340		10.1016/S0140-6736(09)61926-7	http://dx.doi.org/10.1016/S0140-6736(09)61926-7			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	549QS	20109960				2022-12-28	WOS:000274069300035
J	Cooper, OR; Parrish, DD; Stohl, A; Trainer, M; Nedelec, P; Thouret, V; Cammas, JP; Oltmans, SJ; Johnson, BJ; Tarasick, D; Leblanc, T; McDermid, IS; Jaffe, D; Gao, R; Stith, J; Ryerson, T; Aikin, K; Campos, T; Weinheimer, A; Avery, MA				Cooper, O. R.; Parrish, D. D.; Stohl, A.; Trainer, M.; Nedelec, P.; Thouret, V.; Cammas, J. P.; Oltmans, S. J.; Johnson, B. J.; Tarasick, D.; Leblanc, T.; McDermid, I. S.; Jaffe, D.; Gao, R.; Stith, J.; Ryerson, T.; Aikin, K.; Campos, T.; Weinheimer, A.; Avery, M. A.			Increasing springtime ozone mixing ratios in the free troposphere over western North America	NATURE			English	Article							LONG-TERM CHANGES; SURFACE OZONE; ASIAN EMISSIONS; UNITED-STATES; AIRCRAFT; CLIMATOLOGY; TRANSPORT; POLLUTION; TRENDS	In the lowermost layer of the atmosphere-the troposphere-ozone is an important source of the hydroxyl radical, an oxidant that breaks down most pollutants and some greenhouse gases(1). High concentrations of tropospheric ozone are toxic, however, and have a detrimental effect on human health and ecosystem productivity(1). Moreover, tropospheric ozone itself acts as an effective greenhouse gas(2). Much of the present tropospheric ozone burden is a consequence of anthropogenic emissions of ozone precursors(3) resulting in widespread increases in ozone concentrations since the late 1800s(3-7). At present, east Asia has the fastest-growing ozone precursor emissions(8). Much of the springtime east Asian pollution is exported eastwards towards western North America(9). Despite evidence that the exported Asian pollution produces ozone(10), no previous study has found a significant increase in free tropospheric ozone concentrations above the western USA since measurements began in the late 1970s(5,11,12). Here we compile springtime ozone measurements from many different platforms across western North America. We show a strong increase in springtime ozone mixing ratios during 1995-2008 and we have some additional evidence that a similar rate of increase in ozone mixing ratio has occurred since 1984. We find that the rate of increase in ozone mixing ratio is greatest when measurements are more heavily influenced by direct transport from Asia. Our result agrees with previous modelling studies, which indicate that global ozone concentrations should be increasing during the early part of the twenty-first century as a result of increasing precursor emissions, especially at northern mid-latitudes(13), with western North America being particularly sensitive to rising Asian emissions(14). We suggest that the observed increase in springtime background ozone mixing ratio may hinder the USA's compliance with its ozone air quality standard.	[Cooper, O. R.; Aikin, K.] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Cooper, O. R.; Parrish, D. D.; Trainer, M.; Oltmans, S. J.; Johnson, B. J.; Gao, R.; Ryerson, T.; Aikin, K.] NOAA, Earth Syst Res Lab, Boulder, CO 80305 USA; [Stohl, A.] Norwegian Inst Air Res, Dept Reg & Global Pollut Issues, N-2027 Kjeller, Norway; [Nedelec, P.; Thouret, V.; Cammas, J. P.] Observ Midi Pyrenees, CNRS, Lab Aerol, F-31400 Toulouse, France; [Tarasick, D.] Environm Canada, Meteorol Serv Canada, Expt Studies Res Div, Downsview, ON M3H 5T4, Canada; [Leblanc, T.; McDermid, I. S.] CALTECH, Jet Prop Lab, Table Mt Facil, Wrightwood, CA 92397 USA; [Jaffe, D.] Univ Washington, Dept Atmospher & Environm Chem, Bothell, WA 98011 USA; [Stith, J.] Natl Ctr Atmospher Res, Res Aviat Facil, Broomfield, CO 80021 USA; [Campos, T.; Weinheimer, A.] Natl Ctr Atmospher Res, Div Atmospher Chem, Boulder, CO 80305 USA; [Avery, M. A.] NASA, Langley Res Ctr, Hampton, VA 23681 USA	University of Colorado System; University of Colorado Boulder; National Oceanic Atmospheric Admin (NOAA) - USA; Norwegian Institute for Air Research; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Environment & Climate Change Canada; Meteorological Service of Canada; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Washington; University of Washington Bothell; National Center Atmospheric Research (NCAR) - USA; National Center Atmospheric Research (NCAR) - USA; National Aeronautics & Space Administration (NASA); NASA Langley Research Center	Cooper, OR (corresponding author), Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA.	owen.r.cooper@noaa.gov	Trainer, Michael/H-5168-2013; Cooper, Owen R/H-4875-2013; Aikin, Kenneth C/I-1973-2013; Ryerson, Thomas/C-9611-2009; Stohl, Andreas/A-7535-2008; Gao, Ru-Shan/H-7455-2013; Oltmans, Samuel/AAC-8987-2022; Parrish, David/E-8957-2010; Ryerson, Tom/AAA-8399-2021	Trainer, Michael/0000-0002-1668-2961; Cooper, Owen R/0000-0001-7391-1161; Aikin, Kenneth C/0000-0001-8540-9291; Ryerson, Thomas/0000-0003-2800-7581; Stohl, Andreas/0000-0002-2524-5755; Gao, Ru-Shan/0000-0001-6985-1637; Parrish, David/0000-0001-6312-2724; Tarasick, David/0000-0001-9869-0692	NOAA; European Communities; EADS; National Science Foundation	NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); European Communities(European Commission); EADS; National Science Foundation(National Science Foundation (NSF))	This work was supported in part by NOAA's Climate Goal Program. We acknowledge the support of MOZAIC by the European Communities, EADS, Airbus and the airlines (Lufthansa, Austrian, Air France) who have carried MOZAIC equipment free of charge since 1994. B. Ridley, NCAR (retired), measured ozone from the NCAR C-130 during TOPSE. G. L. Gregory, NASA (retired), measured ozone from the Convair CV-990 during CITE-1C. M. Proffitt, NOAA (retired) measured ozone from the NASA ER2 during STRAT and POLARIS, and measured ozone from the NASA WB57 during WAM. PACDEX ozone data were provided by NCAR/EOL under sponsorship of the National Science Foundation (http://data.eol.ucar.edu/). EDGAR (http://www.mnp.nl/edgar) is a product of the National Institute for Public Health and the Netherlands Organisation for Applied Scientific Research and is part of the Global Emissions Inventory Activity of IGBP/IGAC. Finally we thank R. Dickerson for providing the mean ozone values for June 1985 and May-June 1986.	Chou CCK, 2006, ATMOS ENVIRON, V40, P3898, DOI 10.1016/j.atmosenv.2006.02.018; Ding AJ, 2008, ATMOS CHEM PHYS, V8, P1, DOI 10.5194/acp-8-1-2008; Fiore AM, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010816; Horowitz LW, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006937; Hudman RC, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004974; *INT PAN CLIM CHAN, 2007, CLIM CHANG 2007 PHYS; Jacob DJ, 1999, GEOPHYS RES LETT, V26, P2175, DOI 10.1029/1999GL900450; Jaffe D, 2007, ATMOS ENVIRON, V41, P5452, DOI 10.1016/j.atmosenv.2007.02.034; Lefohn AS, 2008, ATMOS ENVIRON, V42, P8252, DOI 10.1016/j.atmosenv.2008.07.060; Logan JA, 1999, J GEOPHYS RES-ATMOS, V104, P26373, DOI 10.1029/1999JD900300; LUKE WT, 1992, J GEOPHYS RES-ATMOS, V97, P20647, DOI 10.1029/92JD02127; LUKE WT, 1990, THESIS U MARYLAND; Oltmans SJ, 2006, ATMOS ENVIRON, V40, P3156, DOI 10.1016/j.atmosenv.2006.01.029; Oltmans SJ, 2008, ATMOS ENVIRON, V42, P6020, DOI 10.1016/j.atmosenv.2008.03.034; Parrish DD, 2009, ATMOS CHEM PHYS, V9, P1303, DOI 10.5194/acp-9-1303-2009; Parrish DD, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004978; Poberaj CS, 2009, ATMOS CHEM PHYS, V9, P5343; Royal Society, 2008, GROUND LEVEL OZONE 2; Schultz M. G., 2007, REANALYSIS TROPOSPHE, P1; STAEHELIN J, 1994, ATMOS ENVIRON, V28, P75, DOI 10.1016/1352-2310(94)90024-8; Stevenson DS, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006338; Stohl A, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001396; Tanimoto H, 2009, ATMOS ENVIRON, V43, P1358, DOI 10.1016/j.atmosenv.2008.12.006; Tarasick DW, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD004643; Thouret V, 2006, ATMOS CHEM PHYS, V6, P1033, DOI 10.5194/acp-6-1033-2006; US Environmental Protection Agency, 2009, NAT EM INV NEI AIR P; van der A RJ, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009021; Wang T, 2009, ATMOS CHEM PHYS, V9, P6217, DOI 10.5194/acp-9-6217-2009; Zbinden RM, 2006, ATMOS CHEM PHYS, V6, P1053, DOI 10.5194/acp-6-1053-2006; Zhang L, 2008, ATMOS CHEM PHYS, V8, P6117, DOI 10.5194/acp-8-6117-2008; Zhang Q, 2009, ATMOS CHEM PHYS, V9, P5131, DOI 10.5194/acp-9-5131-2009	31	305	314	8	211	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 21	2010	463	7279					344	348		10.1038/nature08708	http://dx.doi.org/10.1038/nature08708			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545PM	20090751	Green Submitted			2022-12-28	WOS:000273748100041
J	Larson, HJ; Heymann, DL				Larson, Heidi J.; Heymann, David L.			Public Health Response to Influenza A(H1N1) as an Opportunity to Build Public Trust	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Larson, Heidi J.] Univ London Imperial Coll Sci Technol & Med, Inst Global Hlth, Fac Med, London SW7 1NA, England; [Heymann, David L.] London Sch Hyg & Trop Med, London WC1, England; [Heymann, David L.] Ctr Global Hlth Secur Chatham House, London, England	Imperial College London; University of London; London School of Hygiene & Tropical Medicine	Larson, HJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Inst Global Hlth, Fac Med, 15 Princes Gardens, London SW7 1NA, England.	h.larson@imperial.ac.uk	Larson, Heidi J./N-1018-2017	Larson, Heidi J./0000-0002-8477-7583				[Anonymous], 1996, LANCET, V348, P1529; Cooper LZ, 2008, PEDIATRICS, V122, P149, DOI 10.1542/peds.2008-0987; Dorozynski A, 1998, BRIT MED J, V317, P1034; Heymann DL, 2004, NEW ENGL J MED, V351, P1275, DOI 10.1056/NEJMp048204; Jegede AS, 2007, PLOS MED, V4, P417, DOI 10.1371/journal.pmed.0040073; [Anonymous], 2008, Bull World Health Organ, V86, P425; PETERS RG, 1997, DETERMINANTS TRUST C; Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0; World Health Organization, 2009, PAND INFL PREP RESP	9	81	82	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 20	2010	303	3					271	272		10.1001/jama.2009.2023	http://dx.doi.org/10.1001/jama.2009.2023			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	544WM	20085957				2022-12-28	WOS:000273690600025
J	Klein, L				Klein, Liviu			Higher-dose dabigatran reduced stroke, but not major hemorrhage, more than warfarin in atrial fibrillation	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Klein, Liviu] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Klein, L (corresponding author), Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA.							Birman-Deych E, 2006, STROKE, V37, P1070, DOI 10.1161/01.STR.0000208294.46968.a4; Gage BF, 2009, NEW ENGL J MED, V361, P1200, DOI 10.1056/NEJMe0906886; Hylek EM, 2003, NEW ENGL J MED, V349, P1019, DOI 10.1056/NEJMoa022913; WOLF PA, 1987, ARCH INTERN MED, V147, P1561, DOI 10.1001/archinte.147.9.1561	4	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 19	2010	152	2							JC1-2	10.7326/0003-4819-152-2-201001190-02002	http://dx.doi.org/10.7326/0003-4819-152-2-201001190-02002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	548IE	20083817				2022-12-28	WOS:000273953000026
J	Robbins, J				Robbins, John			Review: High-dose oral vitamin D supplements and active vitamin D prevent falls in older persons	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Calif Davis, Sacramento, CA 95817 USA	University of California System; University of California Davis	Robbins, J (corresponding author), Univ Calif Davis, Sacramento, CA 95817 USA.								0	2	2	2	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 19	2010	152	2							JC1-3	10.7326/0003-4819-152-2-201001190-02003	http://dx.doi.org/10.7326/0003-4819-152-2-201001190-02003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	548IE	20083818				2022-12-28	WOS:000273953000027
J	Boehncke, WH; Boehncke, S; Schon, MP				Boehncke, Wolf-Henning; Boehncke, Sandra; Schoen, Michael P.			Managing comorbid disease in patients with psoriasis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							INSULIN-RESISTANCE; CLINICAL-FEATURES; ARTHRITIS; RISK; QUESTIONNAIRE; RECOMMENDATIONS; EPIDEMIOLOGY; MECHANISMS; MORTALITY; CELLS		[Boehncke, Wolf-Henning] Clin Johann Wolfgang Goethe Univ, Dept Dermatol, D-60590 Frankfurt, Germany; [Boehncke, Sandra] Clin Johann Wolfgang Goethe Univ, Endocrinol Sect, Dept Internal Med, D-60590 Frankfurt, Germany; [Schoen, Michael P.] Univ Gottingen, Dept Dermatol Venereol & Allergol, Gottingen, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Gottingen	Boehncke, WH (corresponding author), Clin Johann Wolfgang Goethe Univ, Dept Dermatol, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	Boehncke@em.uni-frankfurt.de		Schon, Michael/0000-0002-0698-4130				Augustin M, 2008, J DTSCH DERMATOL GES, V6, P640, DOI 10.1111/j.1610-0387.2008.06807.x; Boehncke S, 2007, BRIT J DERMATOL, V157, P1249, DOI 10.1111/j.1365-2133.2007.08190.x; Boehncke WH, 2009, HAUTARZT, V60, P116, DOI 10.1007/s00105-008-1663-3; Dominguez PL, 2009, ARCH DERMATOL RES, V301, P573, DOI 10.1007/s00403-009-0981-3; Gelfand JM, 2007, ARCH DERMATOL, V143, P1493, DOI 10.1001/archderm.143.12.1493; Gelfand JM, 2006, JAMA-J AM MED ASSOC, V296, P1735, DOI 10.1001/jama.296.14.1735; Gerdes S, 2008, BRIT J DERMATOL, V159, P1116, DOI 10.1111/j.1365-2133.2008.08786.x; Gladman DD, 2009, ANN RHEUM DIS, V68, P497, DOI 10.1136/ard.2008.089441; Gladman DD, 2005, ANN RHEUM DIS, V64, P14, DOI 10.1136/ard.2004.032482; Gottlieb A, 2009, LANCET, V373, P633, DOI 10.1016/S0140-6736(09)60140-9; Griffiths CEM, 2007, LANCET, V370, P263, DOI 10.1016/S0140-6736(07)61128-3; HENSELER T, 1995, J AM ACAD DERMATOL, V32, P982, DOI 10.1016/0190-9622(95)91336-X; Ibrahim GH, 2009, CLIN EXP RHEUMATOL, V27, P469; Kimball AB, 2008, J AM ACAD DERMATOL, V58, P1031, DOI 10.1016/j.jaad.2008.01.006; Kirby B, 2008, BRIT J DERMATOL, V158, P138, DOI 10.1111/j.1365-2133.2007.08299.x; Li GL, 2007, ENDOCRINOLOGY, V148, P3356, DOI 10.1210/en.2006-1441; Ludwig RJ, 2007, BRIT J DERMATOL, V156, P271, DOI 10.1111/j.1365-2133.2006.07562.x; Mallbris L, 2004, EUR J EPIDEMIOL, V19, P225, DOI 10.1023/B:EJEP.0000020447.59150.f9; Mease PJ, 2004, ARTHRITIS RHEUM-US, V50, P2264, DOI 10.1002/art.20335; Naldi L, 2005, J INVEST DERMATOL, V125, P61, DOI 10.1111/j.0022-202X.2005.23681.x; Nast Alexander, 2007, J Dtsch Dermatol Ges, V5 Suppl 3, P1, DOI 10.1111/j.1610-0387.2007.06172.x; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Neuvonen PJ, 2006, CLIN PHARMACOL THER, V80, P565, DOI 10.1016/j.clpt.2006.09.003; Pathirana D, 2009, J EUR ACAD DERMATOL, V23, P1, DOI 10.1111/j.1468-3083.2009.03389.x; Qureshi AA, 2008, J RHEUMATOL, V35, P1423; Radtke MA, 2009, J EUR ACAD DERMATOL, V23, P683, DOI 10.1111/j.1468-3083.2009.03159.x; Rahman P, 2009, J RHEUMATOL, V36, P137, DOI 10.3899/jrheum.080458; Ritchlin CT, 2009, ANN RHEUM DIS, V68, P1387, DOI 10.1136/ard.2008.094946; Sergeant A, 2008, BRIT J DERMATOL, V158, P417, DOI [10.1111/j.1365-2133.2007.08334.x, 10.1111/j.1365-2133.2007.08322.x]; Smith CH, 2006, BMJ-BRIT MED J, V333, P380, DOI 10.1136/bmj.333.7564.380; Tesmer LA, 2008, IMMUNOL REV, V223, P87, DOI 10.1111/j.1600-065X.2008.00628.x; Wolf N, 2008, J MED GENET, V45, P114, DOI 10.1136/jmg.2007.053595	32	91	94	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 15	2010	340								b5666	10.1136/bmj.b5666	http://dx.doi.org/10.1136/bmj.b5666			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	545DB	20080817	Green Published			2022-12-28	WOS:000273711600001
J	Pospisilik, JA; Schramek, D; Schnidar, H; Cronin, SJF; Nehme, NT; Zhang, XY; Knauf, C; Cani, PD; Aumayr, K; Todoric, J; Bayer, M; Haschemi, A; Puviindran, V; Tar, K; Orthofer, M; Neely, GG; Dietzl, G; Manoukian, A; Funovics, M; Prager, G; Wagner, O; Ferrandon, D; Aberger, F; Hui, CC; Esterbauer, H; Penninger, JM				Pospisilik, J. Andrew; Schramek, Daniel; Schnidar, Harald; Cronin, Shane J. F.; Nehme, Nadine T.; Zhang, Xiaoyun; Knauf, Claude; Cani, Patrice D.; Aumayr, Karin; Todoric, Jelena; Bayer, Martina; Haschemi, Arvand; Puviindran, Vijitha; Tar, Krisztina; Orthofer, Michael; Neely, G. Gregory; Dietzl, Georg; Manoukian, Armen; Funovics, Martin; Prager, Gerhard; Wagner, Oswald; Ferrandon, Dominique; Aberger, Fritz; Hui, Chi-chung; Esterbauer, Harald; Penninger, Josef M.			Drosophila Genome-wide Obesity Screen Reveals Hedgehog as a Determinant of Brown versus White Adipose Cell Fate	CELL			English	Article							TRANSCRIPTIONAL CONTROL; SIGNALING PATHWAY; SONIC HEDGEHOG; ADULT MICE; DIFFERENTIATION; ADIPOGENESIS; METABOLISM; TISSUE; GENE; REGULATOR	Over 1 billion people are estimated to be overweight, placing them at risk for diabetes, cardiovascular disease, and cancer. We performed a systems-level genetic dissection of adiposity regulation using genome-wide RNAi screening in adult Drosophila. As a follow-up, the resulting similar to 500 candidate obesity genes were functionally classified using muscle-, oenocyte-, fat-body-, and neuronal-specific knockdown in vivo and revealed hedgehog signaling as the top-scoring fat-body-specific pathway. To extrapolate these findings into mammals, we generated fat-specific hedgehog-activation mutant mice. Intriguingly, these mice displayed near total loss of white, but not brown, fat compartments. Mechanistically, activation of hedgehog signaling irreversibly blocked differentiation of white adipocytes through direct, coordinate modulation of early adipogenic factors. These findings identify a role for hedgehog signaling in white/brown adipocyte determination and link in vivo RNAi-based scanning of the Drosophila genome to regulation of adipocyte cell fate in mammals.	[Todoric, Jelena; Bayer, Martina; Haschemi, Arvand; Tar, Krisztina; Wagner, Oswald; Esterbauer, Harald] Med Univ Vienna, Dept Med, A-1090 Vienna, Austria; [Todoric, Jelena; Bayer, Martina; Haschemi, Arvand; Tar, Krisztina; Wagner, Oswald; Esterbauer, Harald] Med Univ Vienna, Chem Lab Diagnost, A-1090 Vienna, Austria; [Funovics, Martin] Med Univ Vienna, Dept Radiol, A-1090 Vienna, Austria; [Prager, Gerhard] Med Univ Vienna, Dept Surg, A-1090 Vienna, Austria; [Pospisilik, J. Andrew; Schramek, Daniel; Cronin, Shane J. F.; Aumayr, Karin; Orthofer, Michael; Neely, G. Gregory; Penninger, Josef M.] Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria; [Schnidar, Harald; Aberger, Fritz] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria; [Nehme, Nadine T.; Ferrandon, Dominique] Univ Strasbourg, Equipe Fdn Rech Med, UPR CNRS 9022, Inst Biol Mol & Cellulaire, F-67084 Strasbourg, France; [Zhang, Xiaoyun; Puviindran, Vijitha; Hui, Chi-chung] Univ Toronto, Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5S 1A8, Canada; [Zhang, Xiaoyun; Puviindran, Vijitha; Hui, Chi-chung] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Knauf, Claude] Univ Toulouse 3, INSERM U858, Team 3, Inst Med Mol Rangueil,IFR150,CHU Rangueil, F-31432 Toulouse 4, France; [Cani, Patrice D.] Catholic Univ Louvain, LDRI, Unit PMNT 73 69, B-1200 Brussels, Belgium; [Dietzl, Georg] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Manoukian, Armen] Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Salzburg University; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Catholique Louvain; Howard Hughes Medical Institute; Stanford University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Esterbauer, H (corresponding author), Med Univ Vienna, Dept Med, Waehringer Guertel 18-20, A-1090 Vienna, Austria.	harald.esterbauer@meduniwien.ac.at; josef.penninger@imba.oeaw.ac.at	Schramek, Daniel/J-5792-2014; Schnidar, Harald/C-7049-2009; D., Cani Patrice/M-8055-2016; Penninger, Josef M/I-6860-2013; Schramek, Daniel/AAL-1470-2020; Aberger, Fritz/B-6357-2012; neely, graham/A-6511-2011; Neely, Greg/AAB-4642-2020	D., Cani Patrice/0000-0003-2040-2448; Penninger, Josef M/0000-0002-8194-3777; Schramek, Daniel/0000-0001-9977-2104; Aberger, Fritz/0000-0003-2009-6305; Neely, Greg/0000-0002-1957-9732; Haschemi, Arvand/0000-0001-9532-3205; FERRANDON, Dominique/0000-0001-7680-7773; Esterbauer, Harald/0000-0001-7343-7455; Knauf, Claude/0000-0001-5213-5378	JDRF; Marie-Curie Foundation; WWTF; CIHR; CCSRI; Austrian Academy of Sciences; GEN-AU (Genome Austria); Austrian Ministry of Science and Education; European Union; FRS-FNRS Belgium; CNRS; Programme MIME	JDRF(Juvenile Diabetes Research Foundation); Marie-Curie Foundation(European Commission); WWTF; CIHR(Canadian Institutes of Health Research (CIHR)); CCSRI; Austrian Academy of Sciences; GEN-AU (Genome Austria); Austrian Ministry of Science and Education; European Union(European Commission); FRS-FNRS Belgium(Fonds de la Recherche Scientifique - FNRS); CNRS(Centre National de la Recherche Scientifique (CNRS)); Programme MIME	The authors are indebted to the IMBA and MUW service departments, all members of the VDRC Drosophila library, and Barry Dickson, Pawel Pasierbek, Maria Novatchkova, Patricia Schittenhelm, Helen Damhofer, and Maria Ozsvar-Kozma for excellent technical help. J.A.P. was supported by fellowships from the JDRF and the Marie-Curie Foundation. This project, J. A. P., and H. E. are supported by the WWTF. C.-C. H. was supported by CIHR and CCSRI. J. M. P. is supported by the Austrian Academy of Sciences, GEN-AU (Genome Austria), the Austrian Ministry of Science and Education, and a European Union Advanced ERC grant. P. D. C. is a research associate from the FRS-FNRS Belgium. D. F. is supported by the CNRS and a Droselegans grant from the Programme MIME, and the D. F. laboratory is an "Equipe FRM'' (Fondation pour la Recherche Medicale).	Altarejos JY, 2008, NAT MED, V14, P1112, DOI 10.1038/nm.1866; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Baker KD, 2007, CELL METAB, V6, P257, DOI 10.1016/j.cmet.2007.09.002; Brown LJ, 2002, J BIOL CHEM, V277, P32899, DOI 10.1074/jbc.M202409200; Buhman KK, 2004, J NUTR, V134, P2979, DOI 10.1093/jn/134.11.2979; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; FAN CM, 1995, CELL, V81, P457, DOI 10.1016/0092-8674(95)90398-4; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Farmer SR, 2009, NATURE, V458, P839, DOI 10.1038/458839a; Farooqi IS, 2007, OBES REV, V8, P37, DOI 10.1111/j.1467-789X.2007.00315.x; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Gronke S, 2007, PLOS BIOL, V5, P1248, DOI 10.1371/journal.pbio.0050137; Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; Gutierrez E, 2007, NATURE, V445, P275, DOI 10.1038/nature05382; Hader T, 2003, EMBO REP, V4, P511, DOI 10.1038/sj.embor.embor837; Hebrok M, 2000, DEVELOPMENT, V127, P4905; Heine VM, 2009, J CLIN INVEST, V119, P267, DOI 10.1172/JCI36376; JIANG J, 1995, CELL, V80, P563, DOI 10.1016/0092-8674(95)90510-3; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Leopold P, 2007, NATURE, V450, P186, DOI 10.1038/nature06286; Li Z, 2008, INT J BIOL SCI, V4, P29; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Makino S, 2001, DEV BIOL, V239, P95, DOI 10.1006/dbio.2001.0419; Martin PM, 2006, J NEUROCHEM, V98, P279, DOI 10.1111/j.1471-4159.2006.03878.x; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; Melcher C, 2007, J ENDOCRINOL, V192, P467, DOI 10.1677/JOE-06-0066; Min KT, 1999, SCIENCE, V284, P1985, DOI 10.1126/science.284.5422.1985; Nybakken K, 2005, NAT GENET, V37, P1323, DOI 10.1038/ng1682; Oldham S, 2003, TRENDS CELL BIOL, V13, P79, DOI 10.1016/S0962-8924(02)00042-9; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Ross DA, 2004, MOL CELL BIOL, V24, P3505, DOI 10.1128/MCB.24.8.3505-3513.2004; Schlegel A, 2007, PLOS GENET, V3, P2037, DOI 10.1371/journal.pgen.0030199; Seale P, 2009, GENE DEV, V23, P788, DOI 10.1101/gad.1779209; Speakman J, 2008, LAB ANIM-UK, V42, P413, DOI 10.1258/la.2007.006067; Suh JM, 2006, CELL METAB, V3, P25, DOI 10.1016/j.cmet.2005.11.012; Suzawa M, 2003, NAT CELL BIOL, V5, P224, DOI 10.1038/ncb942; Thomas MK, 2000, DIABETES, V49, P2039, DOI 10.2337/diabetes.49.12.2039; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; *WHO, 2009, GLOB STRAT DIET PHYS; Wu X, 2002, J AM CHEM SOC, V124, P14520, DOI 10.1021/ja0283908; Yan ZJ, 2005, GENE DEV, V19, P1662, DOI 10.1101/gad.1323805; Yu C, 2005, J BIOL CHEM, V280, P13600, DOI 10.1074/jbc.M409468200; Zehentner BK, 2000, DNA CELL BIOL, V19, P275, DOI 10.1089/10445490050021186; ZHANG J, 1995, BIOCHEM J, V306, P205, DOI 10.1042/bj3060205; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	52	282	300	2	41	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 8	2010	140	1					148	160		10.1016/j.cell.2009.12.027	http://dx.doi.org/10.1016/j.cell.2009.12.027			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	541CY	20074523	Bronze			2022-12-28	WOS:000273391900022
J	Kuck, KH; Schaumann, A; Eckardt, L; Willems, S; Ventura, R; Delacretaz, E; Pitschner, HF; Kautzner, J; Schumacher, B; Hansen, PS				Kuck, Karl-Heinz; Schaumann, Anselm; Eckardt, Lars; Willems, Stephan; Ventura, Rodolfo; Delacretaz, Etienne; Pitschner, Heinz-Friedrich; Kautzner, Josef; Schumacher, Burghard; Hansen, Peter S.		VTACH Study Grp	Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial	LANCET			English	Article							SUDDEN CARDIAC DEATH; MYOCARDIAL-INFARCTION; CARDIOVERTER-DEFIBRILLATORS; PREVENTION; ARRHYTHMIA; THERAPY; SHOCKS; RHYTHM	Background In patients with ventricular tachycardia (VT) and a history of myocardial infarction, intervention with an implantable cardioverter defibrillator (ICD) can prevent sudden cardiac death and thereby reduce total mortality. However, ICD shocks are painful and do not provide complete protection against sudden cardiac death. We assessed the potential benefit of catheter ablation before implantation of a cardioverter defibrillator. Methods The Ventricular Tachycardia Ablation in Coronary Heart Disease (VTACH) study was a prospective, open, randomised controlled trial, undertaken in 16 centres in four European countries. Patients aged 18-80 years were eligible for enrolment if they had stable VT, previous myocardial infarction, and reduced left-ventricular ejection fraction (LVEF; <= 50%). 110 patients were randomly allocated in a 1:1 ratio to receive catheter ablation and an ICD (ablation group, n=54) or ICD alone (control group, n=56). Randomisation was done by computer-generated randomly permuted blocks and stratified by Centre and LVEF (<= 30% or >30%). Patients were followed up for at least 1 year. The primary endpoint was the time to first recurrence of VT or ventricular fibrillation (VF). Analysis was by intention to treat (ITT). This study is registered with ClinicalTrials.gov, number NCT00919373. Findings 107 patients were included in the ITT population (ablation group, n=52; control group, n=55). Two patients (one in each group) withdrew consent immediately after randomisation without any follow-up data and one patient (ablation group) was excluded because of a protocol violaton. Mean follow-up was 22.5 months (SD 9.0). Time to recurrence of VT or VF was longer in the ablation group (median 18.6 months [lower quartile 2.4, upper quartile not determinable]) than in the control group (5.9 months [IQR 0.8-26.7]). At 2 years, estimates for survival free from VT or VF were 47% in the ablation group and 29% in the control group (hazard ratio 0.61; 95% CI 0.37-0.99; p=0.045). Complications related to the ablation procedure occurred in two patients; no deaths occurred within 30 days after ablation. 15 device-related complications requiring surgical intervention occurred in 13 patients (ablation group, four; control group, nine). Nine patients died during the study (ablation group, five; control group, four). Interpretation Prophylactic VT ablation before defibrillator implantation seemed to prolong time to recurrence of VT in patients with stable VT, previous myocardial infarction, and reduced LVEF. Prophylactic catheter ablation should therefore be considered before implantation of a cardioverter defibrillator in such patients. Funding St Jude Medical.	[Kuck, Karl-Heinz; Schaumann, Anselm] Asklepios Klin St Georg, Hanseat Herzzentrum, D-20099 Hamburg, Germany; [Eckardt, Lars] Univ Klinikum, Med Klin C, Munster, Germany; [Willems, Stephan; Ventura, Rodolfo] Univ Herzzentrum, Hamburg, Germany; [Delacretaz, Etienne] Univ Klin Inselspital, Bern, Switzerland; [Pitschner, Heinz-Friedrich] Kerckhoff Klin GmbH, Bad Nauheim, Germany; [Kautzner, Josef] Inst Clin & Expt Med, Prague, Czech Republic; [Schumacher, Burghard] Herz & Gefass Klin, Bad Neustadt an der Saale, Germany; [Hansen, Peter S.] Skejby Sygehus, Aarhus Univ Hosp, DK-8200 Aarhus, Denmark	Asklepios Klinik St. Georg; University of Munster; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Bern; University Hospital of Bern; Kerckhoff Clinic; Institute for Clinical & Experimental Medicine (IKEM); Aarhus University	Kuck, KH (corresponding author), Asklepios Klin St Georg, Hanseat Herzzentrum, Lohmuhlenstr 5, D-20099 Hamburg, Germany.	k.kuck@asklepios.com	Kjaerulf Jensen, Henrik/A-7980-2018	Kjaerulf Jensen, Henrik/0000-0003-1802-4302	St Jude Medical GmbH, Germany	St Jude Medical GmbH, Germany	We thank And M Sinha and Jochen Michaelsen for the review of the ICD episodes, Birgit Schmidtmann for statistical analysis, and Frederike Troster for the contribution to this report. This study was presented in part as an abstract at the 2007 Annual Scientific Sessions of the Heart Rhythm Society, Boston, MA, USA, May 9-12, 2007 This trial was supported by fees from St Jude Medical GmbH, Germany, for data acquisition and documentation.; Funding St Jude Medical.	Aliot EM, 2009, EUROPACE, V11, P771, DOI 10.1093/europace/eup098; Anderson KP, 2005, J INTERV CARD ELECTR, V14, P71, DOI 10.1007/s10840-005-4547-9; BOCKER D, 1995, BRIT HEART J, V73, P158; Calkins H, 2000, J AM COLL CARDIOL, V35, P1905, DOI 10.1016/S0735-1097(00)00615-X; Carbucicchio C, 2008, CIRCULATION, V117, P462, DOI 10.1161/CIRCULATIONAHA.106.686534; Connolly SJ, 2000, CIRCULATION, V101, P1297, DOI 10.1161/01.CIR.101.11.1297; Connolly SJ, 2006, JAMA-J AM MED ASSOC, V295, P165, DOI 10.1001/jama.295.2.165; Della Bella P, 2004, EUR HEART J, V25, P1127, DOI 10.1016/j.ehj.2004.01.021; DELUNA AB, 1989, AM HEART J, V117, P151, DOI 10.1016/0002-8703(89)90670-4; GONSKA BD, 1994, J AM COLL CARDIOL, V24, P1506, DOI 10.1016/0735-1097(94)90147-3; Irvine J, 2002, AM HEART J, V144, P282, DOI 10.1067/mhj.2002.124049; KIM YH, 1994, CIRCULATION, V89, P1094, DOI 10.1161/01.CIR.89.3.1094; Kuck KH, 2000, CIRCULATION, V102, P748, DOI 10.1161/01.CIR.102.7.748; Marchlinski FE, 2000, CIRCULATION, V101, P1288, DOI 10.1161/01.CIR.101.11.1288; McAnulty J, 1997, NEW ENGL J MED, V337, P1576; Menz V, 1997, PACE, V20, P173, DOI 10.1111/j.1540-8159.1997.tb04837.x; Mitchell LB, 2002, J AM COLL CARDIOL, V39, P1323, DOI 10.1016/S0735-1097(02)01784-9; Mont L, 1999, J AM COLL CARDIOL, V34, P351, DOI 10.1016/S0735-1097(99)00206-5; MORADY F, 1993, CIRCULATION, V87, P363, DOI 10.1161/01.CIR.87.2.363; Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Poole JE, 2008, NEW ENGL J MED, V359, P1009, DOI 10.1056/NEJMoa071098; Raitt MH, 2001, CIRCULATION, V103, P244; Reddy VY, 2007, NEW ENGL J MED, V357, P2657, DOI 10.1056/NEJMoa065457; Rothman SA, 1997, CIRCULATION, V96, P3499; Soejima K, 2001, CIRCULATION, V104, P664, DOI 10.1161/hc3101.093764; Stevenson WG, 1998, CIRCULATION, V98, P308, DOI 10.1161/01.CIR.98.4.308; Stevenson WG, 2008, CIRCULATION, V118, P2773, DOI 10.1161/CIRCULATIONAHA.108.788604; Tanner H, 2010, J CARDIOVASC ELECTR, V21, P47, DOI 10.1111/j.1540-8167.2009.01563.x; Zipes DP, 2006, J AM COLL CARDIOL, V48, pe247, DOI [10.1016/j.jacc.2006.07.010, DOI 10.1016/J.JACC.2006.07.010]	30	457	469	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 2	2010	375	9708					31	40		10.1016/S0140-6736(09)61755-4	http://dx.doi.org/10.1016/S0140-6736(09)61755-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	539BZ	20109864				2022-12-28	WOS:000273229700029
J	Walley, T; Davidson, P				Walley, Tom; Davidson, Peter			Research funding in a pandemic	LANCET			English	Editorial Material									[Walley, Tom] Univ Liverpool, The Infirm, Dept Pharmacol & Therapeut, Liverpool L69 3GF, Merseyside, England; [Davidson, Peter] Univ Southampton, NIHR Evaluat Trials & Studies Coordinating Ctr, Southampton, Hants, England	University of Liverpool; University of Southampton	Walley, T (corresponding author), Univ Liverpool, The Infirm, Dept Pharmacol & Therapeut, Liverpool L69 3GF, Merseyside, England.	twalley@liv.ac.uk						Department of Health, 2006, BEST RES BEST HLTH N; DoHSC (Department of Health & Social Care), 2021, NHS CONST ENGL; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5106; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; *NAT I HLTH RES, 2009, IMPL PLAN 4 1C BUR B; *NAT I HLTH RES, 2009, DEL HLTH RES PROGR R; *NAT I HLTH RES, NIHR EV TRIALS STUD; Pollard AJ, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4652; Tran TH, 2009, LANCET, V373, P2085, DOI 10.1016/S0140-6736(09)61131-4; INTEGRATED RES APPL	10	11	11	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR-APR	2010	375	9720					1063	1065		10.1016/S0140-6736(10)60068-2	http://dx.doi.org/10.1016/S0140-6736(10)60068-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	578ZB	20096451				2022-12-28	WOS:000276334600009
J	Luco, RF; Pan, Q; Tominaga, K; Blencowe, BJ; Pereira-Smith, OM; Misteli, T				Luco, Reini F.; Pan, Qun; Tominaga, Kaoru; Blencowe, Benjamin J.; Pereira-Smith, Olivia M.; Misteli, Tom			Regulation of Alternative Splicing by Histone Modifications	SCIENCE			English	Article							BINDING; EXON; TRANSCRIPTION; RECOGNITION; PTB	Alternative splicing of pre-mRNA is a prominent mechanism to generate protein diversity, yet its regulation is poorly understood. We demonstrated a direct role for histone modifications in alternative splicing. We found distinctive histone modification signatures that correlate with the splicing outcome in a set of human genes, and modulation of histone modifications causes splice site switching. Histone marks affect splicing outcome by influencing the recruitment of splicing regulators via a chromatin-binding protein. These results outline an adaptor system for the reading of histone marks by the pre-mRNA splicing machinery.	[Luco, Reini F.; Misteli, Tom] NCI, NIH, Bethesda, MD 20892 USA; [Pan, Qun; Blencowe, Benjamin J.] Univ Toronto, Banting & Best Dept Med Res, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Tominaga, Kaoru; Pereira-Smith, Olivia M.] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, Dept Cellular & Struct Biol, San Antonio, TX 78245 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Toronto; University of Texas System; University of Texas Health San Antonio	Misteli, T (corresponding author), NCI, NIH, Bethesda, MD 20892 USA.	mistelit@mail.nih.gov	Pillay, Nischalan/F-9536-2012; Tominaga, Kaoru/AAL-4250-2020; Luco, Reini/E-9855-2018	Tominaga, Kaoru/0000-0001-8799-528X; Luco, Reini/0000-0002-9086-6507	NIH; National Cancer Institute; Center for Cancer Research; National Cancer Institute of Canada; Canadian Institutes of Health Research [MOP-67011]; Genome Canada; NIA/NIH [RO1 AGO32134]; American Heart Association [0765084Y]; NATIONAL CANCER INSTITUTE [ZIABC010309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032134] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada(Genome Canada); NIA/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank J. Patton, D. Skalnik, B. Strahl, J. Steitz, D. Black, M. Garcia-Blanco, and H. Kimura for reagents; P. Scaffidi for discussions; J. Calarco for validations; C. Misquitta for technical assistance; H. Kosucu and Q. Morris for advice on statistical analysis; and E. Tominaga for cell culture. This research was supported by the Intramural Research Program of NIH, the National Cancer Institute, the Center for Cancer Research (T. M.), grants from the National Cancer Institute of Canada, Canadian Institutes of Health Research (grant MOP-67011) and Genome Canada (administered through the Ontario Genomics Institute) to B. B., NIA/NIH grant RO1 AGO32134 (OMPS) to O.P.S., and American Heart Association grant 0765084Y to K. T. Complete RNA deep-sequencing data are available at the Gene Expression Omnibus (accession no. GSE19373).	Allo M, 2009, NAT STRUCT MOL BIOL, V16, P717, DOI 10.1038/nsmb.1620; Andersson R, 2009, GENOME RES, V19, P1732, DOI 10.1101/gr.092353.109; Batsche E, 2006, NAT STRUCT MOL BIOL, V13, P22, DOI 10.1038/nsmb1030; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Carstens RP, 2000, MOL CELL BIOL, V20, P7388, DOI 10.1128/MCB.20.19.7388-7400.2000; de la Mata M, 2003, MOL CELL, V12, P525, DOI 10.1016/j.molcel.2003.08.001; Hayakawa T, 2007, GENES CELLS, V12, P811, DOI 10.1111/j.1365-2443.2007.01089.x; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Kornblihtt AR, 2004, RNA, V10, P1489, DOI 10.1261/rna.7100104; Loomis RJ, 2009, MOL CELL, V33, P450, DOI 10.1016/j.molcel.2009.02.003; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Munoz MJ, 2009, CELL, V137, P708, DOI 10.1016/j.cell.2009.03.010; Nogues G, 2002, J BIOL CHEM, V277, P43110, DOI 10.1074/jbc.M208418200; Pan Q, 2004, MOL CELL, V16, P929, DOI 10.1016/j.molcel.2004.12.004; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Ray D, 2009, NAT BIOTECHNOL, V27, P667, DOI 10.1038/nbt.1550; Robson-Dixon ND, 2004, J BIOL CHEM, V279, P29075, DOI 10.1074/jbc.M312747200; Schor IE, 2009, P NATL ACAD SCI USA, V106, P4325, DOI 10.1073/pnas.0810666106; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Spellman R, 2007, MOL CELL, V27, P420, DOI 10.1016/j.molcel.2007.06.016; Spies N, 2009, MOL CELL, V36, P245, DOI 10.1016/j.molcel.2009.10.008; Tilgner H, 2009, NAT STRUCT MOL BIOL, V16, P996, DOI 10.1038/nsmb.1658; Wagner EJ, 2002, MOL CELL, V10, P943, DOI 10.1016/S1097-2765(02)00645-7; WANG ET, 2008, NATURE, V27, P456; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; Zhang P, 2006, NUCLEIC ACIDS RES, V34, P6621, DOI 10.1093/nar/gkl989	28	729	754	4	147	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2010	327	5968					996	1000		10.1126/science.1184208	http://dx.doi.org/10.1126/science.1184208			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556XE	20133523	Green Accepted			2022-12-28	WOS:000274625800040
J	Alcock, F; Clements, A; Webb, C; Lithgow, T				Alcock, Felicity; Clements, Abigail; Webb, Chaille; Lithgow, Trevor			Tinkering Inside the Organelle	SCIENCE			English	Editorial Material							MITOCHONDRIAL; EVOLUTION; PROTEIN; IMPORT; ORIGIN; TRANSLOCASE; EUKARYOTES; MEMBRANE		[Alcock, Felicity; Clements, Abigail; Webb, Chaille; Lithgow, Trevor] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3800, Australia	Monash University	Alcock, F (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton Campus, Melbourne, Vic 3800, Australia.	trevor.lithgow@med.monash.edu.au	Lithgow, Trevor J/H-5925-2017; Alcock, Felicity/T-4073-2019	Lithgow, Trevor J/0000-0002-0102-7884; Alcock, Felicity/0000-0002-3983-6097; Clements, Abigail/0000-0003-2285-777X				BAKER A, 1987, P NATL ACAD SCI USA, V84, P3117, DOI 10.1073/pnas.84.10.3117; BOORSTEIN WR, 1994, J MOL EVOL, V38, P1; Cavalier-Smith T, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-19; Cavalier-Smith T, 2006, P ROY SOC B-BIOL SCI, V273, P1943, DOI 10.1098/rspb.2006.3531; Clements A, 2009, P NATL ACAD SCI USA, V106, P15791, DOI 10.1073/pnas.0908264106; Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895; Gross J, 2009, NAT REV GENET, V10, P495, DOI 10.1038/nrg2610; Haferkamp I, 2002, EUR J BIOCHEM, V269, P3172, DOI 10.1046/j.1432-1033.2002.02991.x; Herrmann JM, 2003, TRENDS MICROBIOL, V11, P74, DOI 10.1016/S0966-842X(02)00033-1; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Kurland CG, 2000, MICROBIOL MOL BIOL R, V64, P786, DOI 10.1128/MMBR.64.4.786-820.2000; Lucattini R, 2004, MOL BIOL EVOL, V21, P652, DOI 10.1093/molbev/msh058; Mokranjac D, 2003, EMBO J, V22, P4945, DOI 10.1093/emboj/cdg485; Rassow J, 1999, J MOL BIOL, V286, P105, DOI 10.1006/jmbi.1998.2455; Williams BAP, 2008, J MOL BIOL, V375, P1249, DOI 10.1016/j.jmb.2007.11.005; Zimmer C, 2009, SCIENCE, V325, P666, DOI 10.1126/science.325_666	16	36	37	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 5	2010	327	5966					649	650		10.1126/science.1182129	http://dx.doi.org/10.1126/science.1182129			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551ZD	20133559				2022-12-28	WOS:000274251800023
J	Schnoll, RA; Patterson, F; Wileyto, EP; Heitjan, DF; Shields, AE; Asch, DA; Lerman, C				Schnoll, Robert A.; Patterson, Freda; Wileyto, E. Paul; Heitjan, Daniel F.; Shields, Alexandra E.; Asch, David A.; Lerman, Caryn			Effectiveness of Extended-Duration Transdermal Nicotine Therapy A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							SUSTAINED-RELEASE BUPROPION; RECEPTOR PARTIAL AGONIST; SMOKING-CESSATION; REPLACEMENT THERAPY; COST-EFFECTIVENESS; PATCH; INTERVENTIONS; VARENICLINE; ABSTINENCE; PLACEBO	Background: Tobacco dependence is a chronic, relapsing condition that may require extended treatment. Objective: To assess whether extended-duration transdermal nicotine therapy increases abstinence from tobacco more than standard-duration therapy in adult smokers. Design: Parallel randomized, placebo-controlled trial from September 2004 to February 2008. Participants and all research personnel except the database manager were blinded to randomization. (ClinicalTrials.gov registration number: NCT00364156) Setting: Academic center. Participants: 568 adult smokers. Intervention: In an unstratified small block-randomization scheme, participants were randomly assigned to standard therapy (Nicoderm CQ [GlaxoSmithKline, Research Triangle Park, North Carolina], 21 mg, for 8 weeks and placebo for 16 weeks) or extended therapy (Nicoderm CQ, 21 mg, for 24 weeks). Measurements: The primary outcome was biochemically confirmed point-prevalence abstinence at weeks 24 and 52. Secondary outcomes were continuous and prolonged abstinence, lapse and recovery events, cost per additional quitter, and side effects and adherence. Results: At week 24, extended therapy produced higher rates of point-prevalence abstinence (31.6% vs. 20.3%; odds ratio, 1.81 95% CI, 1.23 to 2.66]; P = 0.002), prolonged abstinence (41.5% vs. 26.9%; odds ratio, 1.97 [CI, 1.38 to 2.82]; P = 0.001), and continuous abstinence (19.2% vs. 12.6%; odds ratio, 1.64 [CI, 1.04 to 2.60]; P = 0.032) versus standard therapy. Extended therapy reduced the risk for lapse (hazard ratio, 0.77 [CI, 0.63 to 0.95]; P = 0.013) and increased the chances of recovery from lapses (hazard ratio, 1.47 [CI, 1.17 to 1.84]; P = 0.001). Time to relapse was slower with extended versus standard therapy (hazard ratio, 0.50 [CI, 0.35 to 0.73]; P < 0.001). At week 52, extended therapy produced higher quit rates for prolonged abstinence only (P = 0.027). No differences in side effects and adverse events between groups were found at the extended-treatment assessment. Limitation: The generalizability of the findings may be limited because participants were smokers without medical comorbid conditions who were seeking treatment, and differences in adherence across treatment groups were detected. Conclusion: Transdermal nicotine for 24 weeks increased biochemically confirmed point-prevalence abstinence and continuous abstinence at week 24, reduced the risk for smoking lapses, and increased the likelihood of recovery to abstinence after a lapse compared with 8 weeks of transdermal nicotine therapy.	[Schnoll, Robert A.] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA	University of Pennsylvania; Harvard University; Massachusetts General Hospital	Schnoll, RA (corresponding author), Univ Penn, Dept Psychiat, 3535 Market St,Suite 4100, Philadelphia, PA 19104 USA.	schnoll@mail.med.upenn.edu	Lerman, Caryn/AHC-5180-2022; Patterson, Freda/T-9389-2019	Asch, David/0000-0002-7970-286X; Patterson, Freda/0000-0001-6561-3092	National Cancer Institute; National Institute on Drug Abuse [P50 CA/DA84718, P50 CA143187]; NATIONAL CANCER INSTITUTE [P50CA143187, P50CA084718] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Grant Support: By a Transdisciplinary Tobacco Use Research Center Grant from the National Cancer Institute and the National Institute on Drug Abuse (P50 CA/DA84718 and P50 CA143187).	Alterman AI, 1999, DRUG ALCOHOL DEPEN, V53, P159, DOI 10.1016/S0376-8716(98)00124-0; Bansal MA, 2004, NICOTINE TOB RES, V6, P303, DOI 10.1080/14622200412331320707; Benowitz NL, 2004, AM J MED, V116, P203, DOI 10.1016/j.amjmed.2003.11.009; Brown RA, 1998, PSYCHOL ADDICT BEHAV, V12, P101, DOI 10.1037/0893-164X.12.2.101; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P1194; Curry SJ, 1998, NEW ENGL J MED, V339, P673, DOI 10.1056/NEJM199809033391006; Fiore M C, 2000, Respir Care, V45, P1196; First MB, 2002, STRUCTURED CLIN INTE; Gonzales D, 2006, JAMA-J AM MED ASSOC, V296, P47, DOI 10.1001/jama.296.1.47; Hall SM, 2004, AM J PSYCHIAT, V161, P2100, DOI 10.1176/appi.ajp.161.11.2100; Hatsukami D, 2007, PHARMACOL BIOCHEM BE, V86, P132, DOI 10.1016/j.pbb.2006.12.017; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Heitjan DF, 2000, HEALTH ECON, V9, P327; HOSMER D, 1999, APPL SURVIVAL ANAL R, V1; Hougaard, 2000, ANAL MULTIVARIATE SU; Hughes JR, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000031.pub4, 10.1002/14651858.CD000031.pub3]; Hughes JR, 2003, NICOTINE TOB RES, V5, P13, DOI 10.1080/1462220031000070552; HUGHES JR, 1992, J CONSULT CLIN PSYCH, V60, P689, DOI 10.1037/0022-006X.60.5.689; Jonk YC, 2005, AM J MANAG CARE, V11, P77; Jorenby DE, 2006, JAMA-J AM MED ASSOC, V296, P56, DOI 10.1001/jama.296.1.56; Kozlowski LT, 2007, ADDICT BEHAV, V32, P2140, DOI 10.1016/j.addbeh.2007.01.030; Lerman C, 2004, ANN INTERN MED, V140, P426, DOI 10.7326/0003-4819-140-6-200403160-00009; McKay JR, 2005, ADDICTION, V100, P1594, DOI 10.1111/j.1360-0443.2005.01208.x; McPhillips-Tangum Carol, 2004, Prev Chronic Dis, V1, pA04; Medioni J, 2005, ADDICTION, V100, P247, DOI 10.1111/j.1360-0443.2004.00961.x; Partin MR, 2006, AM J PREV MED, V31, P293, DOI 10.1016/j.amepre.2006.06.021; Pierce JP, 2002, JAMA-J AM MED ASSOC, V288, P1260, DOI 10.1001/jama.288.10.1260; Rose JE, 2009, NICOTINE TOB RES, V11, P1067, DOI 10.1093/ntr/ntp103; RUSSELL MAH, 1993, BRIT MED J, V306, P1308, DOI 10.1136/bmj.306.6888.1308; Shiffman S, 2006, J CONSULT CLIN PSYCH, V74, P276, DOI 10.1037/0022-006X.74.2.276; Shiffman S, 2006, PSYCHOPHARMACOLOGY, V184, P608, DOI 10.1007/s00213-005-0175-4; Shiffman S, 2006, ADDICTION, V101, P1822, DOI 10.1111/j.1360-0443.2006.01635.x; Song FJ, 2002, MED DECIS MAKING, V22, pS26, DOI 10.1107/027298902237708; SRNT Subcommittee on Biochemical Verification, 2002, Nicotine Tob Res, V4, P149, DOI 10.1080/14622200210123581; Stead LF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000146.pub3; Tilson L, 2004, Ir Med J, V97, P270; Tonnesen P, 1999, EUR RESPIR J, V13, P238, DOI 10.1034/j.1399-3003.1999.13b04.x; West R, 2005, TOB CONTROL, V14, P166, DOI 10.1136/tc.2004.008649; Wileyto EP, 2005, NICOTINE TOB RES, V7, P257, DOI 10.1080/14622200500055673; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x; Wooltorton JRA, 2003, J NEUROSCI, V23, P3176	41	97	97	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 2	2010	152	3					144	U4		10.7326/0003-4819-152-3-201002020-00005	http://dx.doi.org/10.7326/0003-4819-152-3-201002020-00005			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	552WN	20124230	Green Accepted			2022-12-28	WOS:000274324600002
J	Grol, R				Grol, R.			Has guideline development gone astray? Yes	BRITISH MEDICAL JOURNAL			English	Editorial Material							CLINICAL GUIDELINES; CARE; QUALITY		Radboud Univ Nijmegen, Med Ctr, Sci Inst Qual Hlth Care, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen	Grol, R (corresponding author), Radboud Univ Nijmegen, Med Ctr, Sci Inst Qual Hlth Care, POB 9101,114, NL-6500 HB Nijmegen, Netherlands.	r.grol@iq.umcn.nl	Grol, Richard/C-8523-2013					BOIVIN A, 2009, MED CARE        0618; Burgers JS, 2003, INT J TECHNOL ASSESS, V19, P148, DOI 10.1017/S026646230300014X; Burgers JS, 2002, DIABETES CARE, V25, P1933, DOI 10.2337/diacare.25.11.1933; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Grol R, 2001, JAMA-J AM MED ASSOC, V286, P2578, DOI 10.1001/jama.286.20.2578; Grol R, 1998, BRIT MED J, V317, P858, DOI 10.1136/bmj.317.7162.858; Hegarty K, 2009, BRIT J GEN PRACT, V59, P322, DOI 10.3399/bjgp09X420581; *IGZ, 2009, BEH GEN VATB BEINVL; Institute of Medicine, 2009, CONFL INT MED RES ED; Kraemer JD, 2009, JAMA-J AM MED ASSOC, V301, P665, DOI 10.1001/jama.301.6.665; Krahn M, 2008, JAMA-J AM MED ASSOC, V300, P436, DOI 10.1001/jama.300.4.436; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Tricoci P, 2009, JAMA-J AM MED ASSOC, V301, P831, DOI 10.1001/jama.2009.205; van Weel C, 2006, LANCET, V367, P550, DOI 10.1016/S0140-6736(06)68198-1; Wollersheim H, 2009, NETH J MED, V67, P39	15	33	33	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 29	2010	340								c306	10.1136/bmj.c306	http://dx.doi.org/10.1136/bmj.c306			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	549YD	20118175	Green Submitted			2022-12-28	WOS:000274089500001
J	Pomerantz, RT; O'Donnell, M				Pomerantz, Richard T.; O'Donnell, Mike			Direct Restart of a Replication Fork Stalled by a Head-On RNA Polymerase	SCIENCE			English	Article							REPAIR COUPLING FACTOR; DNA-REPLICATION; TRANSCRIPTION; STRAND; COMPLEXES; CONFLICTS; REVEALS; BINDING	In vivo studies suggest that replication forks are arrested by encounters with head-on transcription complexes. Yet, the fate of the replisome and RNA polymerase (RNAP) after a head-on collision is unknown. We found that the Escherichia coli replisome stalls upon collision with a head-on transcription complex, but instead of collapsing, the replication fork remains highly stable and eventually resumes elongation after displacing the RNAP from DNA. We also found that the transcription-repair coupling factor Mfd promotes direct restart of the fork after the collision by facilitating displacement of the RNAP. These findings demonstrate the intrinsic stability of the replication apparatus and a previously unknown role for the transcription-coupled repair pathway in promoting replication past a RNAP block.	[Pomerantz, Richard T.; O'Donnell, Mike] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	O'Donnell, M (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10021 USA.	odonnell@mail.rockefeller.edu		O'Donnell, Michael/0000-0001-9002-4214	NIH; Marie-Josee and Henry Kravis Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038839] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marie-Josee and Henry Kravis Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to S. Darst for providing RNAP and Mfd proteins and expression vectors. We also thank S. Borukhov for providing GreB and D. Zhang for technical support. This work was supported by a grant from the NIH (M. O. D.) and by a Marie-Josee and Henry Kravis Fellowship at the Rockefeller University (R. T. P.).	Bidnenko V, 2002, EMBO J, V21, P3898, DOI 10.1093/emboj/cdf369; Deaconescu AM, 2006, CELL, V124, P507, DOI 10.1016/j.cell.2005.11.045; GEORGE DL, 1974, MOL GEN GENET, V133, P283, DOI 10.1007/BF00332704; HANAWALT PC, 1994, SCIENCE, V266, P1957, DOI 10.1126/science.7801121; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Heller RC, 2006, NATURE, V439, P557, DOI 10.1038/nature04329; HINKLE DC, 1972, J MOL BIOL, V70, P197, DOI 10.1016/0022-2836(72)90533-5; Kaplan DL, 2004, MOL CELL, V15, P453, DOI 10.1016/j.molcel.2004.06.039; Labib K, 2007, EMBO REP, V8, P346, DOI 10.1038/sj.embor.7400940; LIU B, 1995, SCIENCE, V267, P1131, DOI 10.1126/science.7855590; McGlynn P, 2000, CELL, V101, P35, DOI 10.1016/S0092-8674(00)80621-2; McGlynn P, 2008, J MOL BIOL, V381, P249, DOI 10.1016/j.jmb.2008.05.053; Park JS, 2002, CELL, V109, P757, DOI 10.1016/S0092-8674(02)00769-9; Pomerantz RT, 2007, TRENDS MICROBIOL, V15, P156, DOI 10.1016/j.tim.2007.02.007; Pomerantz RT, 2008, NATURE, V456, P762, DOI 10.1038/nature07527; Rudolph CJ, 2007, DNA REPAIR, V6, P981, DOI 10.1016/j.dnarep.2007.02.017; SELBY CP, 1995, J BIOL CHEM, V270, P4882, DOI 10.1074/jbc.270.9.4882; Trautinger BW, 2005, MOL CELL, V19, P247, DOI 10.1016/j.molcel.2005.06.004; Vilette D, 1996, MOL GEN GENET, V252, P398, DOI 10.1007/BF02173004; Yuzhakov A, 1996, CELL, V86, P877, DOI 10.1016/S0092-8674(00)80163-4	20	118	120	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 29	2010	327	5965					590	592		10.1126/science.1179595	http://dx.doi.org/10.1126/science.1179595			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549CT	20110508	Green Accepted			2022-12-28	WOS:000274020500041
J	Cruciat, CM; Ohkawara, B; Acebron, SP; Karaulanov, E; Reinhard, C; Ingelfinger, D; Boutros, M; Niehrs, C				Cruciat, Cristina-Maria; Ohkawara, Bisei; Acebron, Sergio P.; Karaulanov, Emil; Reinhard, Carmen; Ingelfinger, Dierk; Boutros, Michael; Niehrs, Christof			Requirement of Prorenin Receptor and Vacuolar H+-ATPase-Mediated Acidification for Wnt Signaling	SCIENCE			English	Article							(PRO)RENIN RECEPTOR; ACTIVATION; PROTEIN; LRP6; IDENTIFICATION; MEMBRANE; PATHWAY; COMPLEX; KINASE; GENES	Wnt/beta-catenin signaling is important in stem cell biology, embryonic development, and disease, including cancer. However, the mechanism of Wnt signal transmission, notably how the receptors are activated, remains incompletely understood. We found that the prorenin receptor (PRR) is a component of the Wnt receptor complex. PRR functions in a renin-independent manner as an adaptor between Wnt receptors and the vacuolar H+-adenosine triphosphatase (V-ATPase) complex. Moreover, PRR and V-ATPase were required to mediate Wnt signaling during antero-posterior patterning of Xenopus early central nervous system development. The results reveal an unsuspected role for the prorenin receptor, V-ATPase activity, and acidification during Wnt/beta-catenin signaling.	[Cruciat, Cristina-Maria; Ohkawara, Bisei; Acebron, Sergio P.; Karaulanov, Emil; Reinhard, Carmen; Niehrs, Christof] Deutsch Krebsforschungszentrum, DKFZ ZMBH Alliance, Div Mol Embryol, D-69120 Heidelberg, Germany; [Ingelfinger, Dierk; Boutros, Michael] Deutsch Krebsforschungszentrum, Div Signaling & Funct Genom, D-69120 Heidelberg, Germany; [Ingelfinger, Dierk; Boutros, Michael] Heidelberg Univ, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Niehrs, C (corresponding author), Deutsch Krebsforschungszentrum, DKFZ ZMBH Alliance, Div Mol Embryol, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	niehrs@dkfz-heidelberg.de	Boutros, Michael/C-3566-2008	Boutros, Michael/0000-0002-9458-817X; Ohkawara, Bisei/0000-0002-1987-458X	Deutsche Forschungsgemeinschaft; European Commission; Gobierno Vasco	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre); Gobierno Vasco(Basque Government)	We thank H. Clevers, R. Grosschedl, X. He, R. Moon, J. Nathans, R. Nusse, M. Levin, G. Miesenbock, Y. M. Chan, M. A. Skinner, and M. Lorizate for reagents; Y. L. Huang for confocal microscopy; A. Glinka for recombinant Wnt3a-V5; and T. Buchling and K. Bartscherer for sharing data before publication and discussion. This work was supported by the Deutsche Forschungsgemeinschaft and the European Commission (Endotrack and Marie-Curie Program). S. P. A. is a recipient of a fellowship from Gobierno Vasco.	Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Blitzer JT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-28; Campbell DJ, 2008, HYPERTENSION, V51, P1259, DOI 10.1161/HYPERTENSIONAHA.108.110924; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Contrepas A, 2009, AM J PHYSIOL-REG I, V297, pR250, DOI 10.1152/ajpregu.90832.2008; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; George A, 2007, NEUROBIOL DIS, V26, P125, DOI 10.1016/j.nbd.2006.12.004; Huang Y, 2007, KIDNEY INT, V72, P45, DOI 10.1038/sj.ki.5002243; Kiecker C, 2001, DEVELOPMENT, V128, P4189; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu M, 2002, J BIOL CHEM, V277, P38409, DOI 10.1074/jbc.M203521200; Ludwig J, 1998, J BIOL CHEM, V273, P10939, DOI 10.1074/jbc.273.18.10939; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; McGrew LL, 1999, MECH DEVELOP, V87, P21, DOI 10.1016/S0925-4773(99)00136-7; MCMAHON AP, 1992, CELL, V69, P581, DOI 10.1016/0092-8674(92)90222-X; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Nguyen G, 2002, J CLIN INVEST, V109, P1417, DOI 10.1172/JCI200214276; Polakis P, 2000, GENE DEV, V14, P1837; Ramser J, 2005, HUM MOL GENET, V14, P1019, DOI 10.1093/hmg/ddi094; Sakoda M, 2007, HYPERTENS RES, V30, P1139, DOI 10.1291/hypres.30.1139; Saris JJ, 2006, HYPERTENSION, V48, P564, DOI 10.1161/01.HYP.0000240064.19301.1b; Simons M, 2009, NAT CELL BIOL, V11, P286, DOI 10.1038/ncb1836; Yamamoto H, 2006, DEV CELL, V11, P213, DOI 10.1016/j.devcel.2006.07.003; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540	31	417	427	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 22	2010	327	5964					459	463		10.1126/science.1179802	http://dx.doi.org/10.1126/science.1179802			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546BS	20093472				2022-12-28	WOS:000273783100036
J	Schaer, BA; Schneider, C; Jick, SS; Conen, D; Osswald, S; Meier, CR				Schaer, Beat A.; Schneider, Cornelia; Jick, Susan S.; Conen, David; Osswald, Stefan; Meier, Christoph R.			Risk for Incident Atrial Fibrillation in Patients Who Receive Antihypertensive Drugs A Nested Case-Control Study	ANNALS OF INTERNAL MEDICINE			English	Article							PRACTICE RESEARCH DATABASE; CONVERTING-ENZYME-INHIBITION; LEFT-VENTRICULAR DYSFUNCTION; II RECEPTOR BLOCKADE; GENERAL-PRACTICE; RANDOMIZED-TRIAL; HEART-FAILURE; PREVENTION; HYPERTENSION; REDUCTION	Background: Different antihypertensive drug classes may alter risk for atrial fibrillation. Some studies suggest that drugs that interfere with the renin-angiotensin system may be favorable because of their effect on atrial remodeling. Objective: To assess and compare the relative risk for incident atrial fibrillation among hypertensive patients who receive antihypertensive drugs from different classes. Design: Nested case-control analysis. Setting: The United Kingdom-based General Practice Research Database, a well-validated primary care database comprising approximately 5 million patient records. Patients: 4661 patients with atrial fibrillation and 18 642 matched control participants from a population of 682 993 patients treated for hypertension. Measurements: A comparison of the risk for atrial fibrillation among hypertensive users of angiotensin-converting enzyme (ACE) inhibitors, angiotensin II-receptor blockers (ARBs), or beta-blockers with the reference group of users of calcium-channel blockers. Patients with clinical risk factors for atrial fibrillation were excluded. Results: Current exclusive long-term therapy with ACE inhibitors (odds ratio [OR], 0.75 [95% CI, 0.65 to 0.87]), ARBs (OR, 0.71 [CI, 0.57 to 0.89]), or beta-blockers (OR, 0.78 [CI, 0.67 to 0.92]) was associated with a lower risk for atrial fibrillation than current exclusive therapy with calcium-channel blockers. Limitation: Blood pressure changes during treatment courses could not be evaluated, and risk for bias by indication cannot be fully excluded in an observational study. Conclusion: In hypertensive patients, long-term receipt of ACE inhibitors, ARBs, or beta-blockers reduces the risk for atrial fibrillation compared with receipt of calcium-channel blockers.	[Meier, Christoph R.] Univ Basel Hosp, Hosp Pharm, CH-4031 Basel, Switzerland; Boston Univ, Med Ctr, Lexington, MA USA	University of Basel; Boston University	Meier, CR (corresponding author), Univ Basel Hosp, Hosp Pharm, Spitalstr 26, CH-4031 Basel, Switzerland.	meierch@uhbs.ch	Osswald, Stefan/A-6904-2018	Osswald, Stefan/0000-0002-9240-6731; Jick, Susan/0000-0002-2215-1067; Schneider, Cornelia/0000-0001-9628-691X				Alsheikh-Ali AA, 2004, AM HEART J, V147, P1061, DOI 10.1016/j.ahj.2003.12.033; Boldt A, 2004, HEART, V90, P400, DOI 10.1136/hrt.2003.015347; Burke TA, 2007, PHARMACOEPIDEM DR S, V16, P979, DOI 10.1002/pds.1444; Dorian P, 2008, EUR HEART J SUPPL, V10, pH11, DOI 10.1093/eurheartj/sun033; Ducharme A, 2006, AM HEART J, V152, P86, DOI 10.1016/j.ahj.2005.06.036; Ehrlich JR, 2006, EUR HEART J, V27, P512, DOI 10.1093/eurheartj/ehi668; Epstein AE, 2002, AM HEART J, V143, P991, DOI 10.1067/mhj.2002.122875; FEINBERG WM, 1995, ARCH INTERN MED, V155, P469, DOI 10.1001/archinte.155.5.469; Gasse C, 2005, THROMB HAEMOSTASIS, V94, P537, DOI 10.1160/TH05-03-0166; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Hansson L, 1999, LANCET, V353, P611, DOI 10.1016/S0140-6736(98)05012-0; Hansson L, 1999, LANCET, V354, P1751, DOI 10.1016/S0140-6736(99)10327-1; Healey JS, 2005, J AM COLL CARDIOL, V45, P1832, DOI 10.1016/j.jacc.2004.11.070; Jick H, 1997, LANCET, V350, P1045, DOI 10.1016/S0140-6736(05)70451-7; JICK H, 1991, BRIT MED J, V302, P766, DOI 10.1136/bmj.302.6779.766; Jick SS, 2003, PHARMACOTHERAPY, V23, P686, DOI 10.1592/phco.23.5.686.32205; Kumagai K, 2003, J AM COLL CARDIOL, V41, P2197, DOI 10.1016/S0735-1097(03)00464-9; L'Allier PL, 2004, J AM COLL CARDIOL, V44, P159, DOI 10.1016/j.jacc.2004.03.056; Lawson DH, 1998, QJM-MON J ASSOC PHYS, V91, P445, DOI 10.1093/qjmed/91.6.445; Maggioni AP, 2005, AM HEART J, V149, P548, DOI 10.1016/j.ahj.2004.09.033; Mitchell GF, 2007, JAMA-J AM MED ASSOC, V297, P709, DOI 10.1001/jama.297.7.709; Okazaki H, 2006, HYPERTENS RES, V29, P277, DOI 10.1291/hypres.29.277; Ruigomez A, 2002, J CLIN EPIDEMIOL, V55, P358, DOI 10.1016/S0895-4356(01)00478-4; Ruigomez Ana, 2005, BMC Cardiovasc Disord, V5, P20, DOI 10.1186/1471-2261-5-20; Schauerte P, 2001, J CARDIOVASC ELECTR, V12, P592, DOI 10.1046/j.1540-8167.2001.00592.x; Schlienger RG, 2004, JAMA-J AM MED ASSOC, V292, P1326, DOI 10.1001/jama.292.11.1326; Schmieder RE, 2008, J HYPERTENS, V26, P403, DOI 10.1097/HJH.0b013e3282f35c67; Turnbull F, 2003, LANCET, V362, P1527; Vermes E, 2003, CIRCULATION, V107, P2926, DOI 10.1161/01.CIR.0000072793.81076.D4; Wachtell K, 2005, J AM COLL CARDIOL, V45, P712, DOI 10.1016/j.jacc.2004.10.068; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Wood L, 2004, DRUG SAFETY, V27, P871, DOI 10.2165/00002018-200427120-00004; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317	33	78	85	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 19	2010	152	2					78	+		10.7326/0003-4819-152-2-201001190-00005	http://dx.doi.org/10.7326/0003-4819-152-2-201001190-00005			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	548IE	20083826				2022-12-28	WOS:000273953000002
J	Nienaber, CA				Nienaber, Christoph A.			Everolimus or paclitaxel stents in real life: go COMPARE	LANCET			English	Editorial Material							BARE-METAL STENTS; DRUG-ELUTING STENTS; RANDOMIZED-TRIALS; METAANALYSIS; THROMBOSIS; OUTCOMES; MORTALITY		Univ Hosp Rostock, Rostock Sch Med, Dept Cardiol & Angiol, D-18057 Rostock, Germany	University of Rostock	Nienaber, CA (corresponding author), Univ Hosp Rostock, Rostock Sch Med, Dept Cardiol & Angiol, D-18057 Rostock, Germany.	nienaber@med.uni-rostock.de						Caixeta A, 2009, J AM COLL CARDIOL, V54, P894, DOI 10.1016/j.jacc.2009.04.077; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; Kedhi E, 2010, LANCET, V375, P201, DOI 10.1016/S0140-6736(09)62127-9; Kirtane AJ, 2009, CIRCULATION, V119, P3198, DOI 10.1161/CIRCULATIONAHA.108.826479; Lagerqvist B, 2009, CIRC-CARDIOVASC INTE, V2, P401, DOI 10.1161/CIRCINTERVENTIONS.108.844985; Marroquin OC, 2008, NEW ENGL J MED, V358, P342, DOI 10.1056/NEJMoa0706258; Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731; Morrow DA, 2009, CIRCULATION, V119, P2758, DOI 10.1161/CIRCULATIONAHA.108.833665; Nienaber CA, 2009, AM J CARDIOL, V104, P1362, DOI 10.1016/j.amjcard.2009.06.058; Nordmann AJ, 2006, EUR HEART J, V27, P2784, DOI 10.1093/eurheartj/ehl282; Onuma Y, 2009, J AM COLL CARDIOL, V54, P269, DOI 10.1016/j.jacc.2009.05.016; Shishehbor MH, 2008, J AM COLL CARDIOL, V52, P1041, DOI 10.1016/j.jacc.2008.06.030; Stettler C, 2007, LANCET, V370, P937, DOI 10.1016/S0140-6736(07)61444-5; Turco MA, 2007, J AM COLL CARDIOL, V49, P1676, DOI 10.1016/j.jacc.2007.01.069; Wiviott SD, 2008, LANCET, V371, P1353, DOI 10.1016/S0140-6736(08)60422-5	15	2	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 16	2010	375	9710					174	176		10.1016/S0140-6736(10)60005-0	http://dx.doi.org/10.1016/S0140-6736(10)60005-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	546ZH	20109900				2022-12-28	WOS:000273853800005
J	Rehwinkel, J; Sousa, CRE				Rehwinkel, Jan; Reis e Sousa, Caetano			RIGorous Detection: Exposing Virus Through RNA Sensing	SCIENCE			English	Editorial Material							DOUBLE-STRANDED-RNA; RIG-I HELICASE; INNATE IMMUNITY; 5'-TRIPHOSPHATE RNA; RECOGNITION; INTERFERON; INDUCTION; RESPONSES; SENSOR	Virus infection in mammals elicits a variety of defense responses that are initiated by signals from virus-sensing receptors expressed by the host. These receptors include the ubiquitously expressed RIG-I-like receptor (RLR) family of RNA helicases. RLRs are cytoplasmic proteins that act in cell-intrinsic antiviral defense by recognizing RNAs indicative of virus presence. Here, we highlight recent progress in understanding how RLRs discriminate between the RNA content of healthy versus virus-infected cells, functioning as accurate sensors of virus invasion.	[Rehwinkel, Jan; Reis e Sousa, Caetano] Canc Res UK, London Res Inst, Immunobiol Lab, London WC2A 3PX, England	Cancer Research UK	Sousa, CRE (corresponding author), Canc Res UK, London Res Inst, Immunobiol Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	caetano@cancer.org.uk	Rehwinkel, Jan/CAG-1436-2022; Reis e Sousa, Caetano/O-1657-2014; Reis e Sousa, Caetano/ABD-7322-2021	Rehwinkel, Jan/0000-0003-3841-835X; Reis e Sousa, Caetano/0000-0001-7392-2119; Reis e Sousa, Caetano/0000-0001-7392-2119	Cancer Research UK Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Habjan M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002032; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Knipe DM, 2007, FIELDS VIROLOGY; Maines TR, 2008, IMMUNOL REV, V225, P68, DOI 10.1111/j.1600-065X.2008.00690.x; Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042; Myong S, 2009, SCIENCE, V323, P1070, DOI 10.1126/science.1168352; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pichlmair A, 2009, J VIROL, V83, P10761, DOI 10.1128/JVI.00770-09; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Ranjith-Kumar CT, 2009, J BIOL CHEM, V284, P1155, DOI 10.1074/jbc.M806219200; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Schmidt A, 2009, P NATL ACAD SCI USA, V106, P12067, DOI 10.1073/pnas.0900971106; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028	20	131	137	3	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 15	2010	327	5963					284	286		10.1126/science.1185068	http://dx.doi.org/10.1126/science.1185068			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544CM	20075242				2022-12-28	WOS:000273629700029
J	Woloshin, S; Schwartz, LM				Woloshin, Steven; Schwartz, Lisa M.			The Benefits and Harms of Mammography Screening Understanding the Trade-offs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BREAST-CANCER		VA Outcomes Grp, White River Jct, VT USA; Dartmouth Inst Hlth Policy & Clin Practice, Hanover, NH USA	VA Outcomes Group; Dartmouth College	Schwartz, LM (corresponding author), VA Med Ctr, VA Outcomes Grp 111B, White River Jct, VT 05009 USA.	lisa.schwartz@dartmouth.edu						Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Elmore G, 1998, NEW ENGL J MED, V338, P1089, DOI 10.1056/NEJM199804163381601; Esserman L, 2009, JAMA-J AM MED ASSOC, V302, P1685, DOI 10.1001/jama.2009.1498; Gotzsche PC, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub3; Mandelblatt JS, 2009, ANN INTERN MED, V151, P738, DOI 10.7326/0003-4819-151-10-200911170-00010; PEAR R, 2009, NY TIMES        1203; Schwartz LM, 2007, BRIT MED J, V335, P731, DOI 10.1136/bmj.39350.590625.80; Schwartz LM, 2000, BMJ-BRIT MED J, V320, P1635, DOI 10.1136/bmj.320.7250.1635; Schwartz LM, 2004, JAMA-J AM MED ASSOC, V291, P71, DOI 10.1001/jama.291.1.71; Zackrisson S, 2006, BRIT MED J, V332, P689, DOI 10.1136/bmj.38764.572569.7C	10	49	50	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 13	2010	303	2					164	165		10.1001/jama.2009.2007	http://dx.doi.org/10.1001/jama.2009.2007			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	542UI	20068211				2022-12-28	WOS:000273522600028
J	Bongaarts, J; Pelletier, F; Gerland, P				Bongaarts, John; Pelletier, Francois; Gerland, Patrick			How many more AIDS deaths?	LANCET			English	Editorial Material									[Bongaarts, John] Populat Council, New York, NY 10017 USA; [Pelletier, Francois; Gerland, Patrick] UN, Populat Div, New York, NY 10017 USA	Population Council	Bongaarts, J (corresponding author), Populat Council, New York, NY 10017 USA.	jbongaarts@popcouncil.org	Gerland, Patrick/F-7390-2013	Gerland, Patrick/0000-0002-2082-3122				[Anonymous], 2005, UPDATED PROJECTIONS; BONGAARTS J, INT HDB ADU IN PRESS; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; *UNAIDS, 2004, REP GLOB AIDS EP; *UNAIDS, 2008, AIDS EP UPD DEC 2007; *UNAIDS, 2008, 2008 REP GLOB AIDS E; UNAIDS, 2006, REP GLOB AIDS EP; [United Nations Department of Economics and Social Affairs Population division], 2009, WORLD POP PROSP 2008; World Health Organization, 2008, GLOB BURD DIS 2004 U	9	6	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 9	2010	375	9709					103	104		10.1016/S0140-6736(09)61756-6	http://dx.doi.org/10.1016/S0140-6736(09)61756-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	544NM	20109872				2022-12-28	WOS:000273664500008
J	Horton, R				Horton, Richard			Offline: Dear editors, I love you	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.								0	1	1	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 9	2010	375	9709					106	106		10.1016/S0140-6736(10)60001-3	http://dx.doi.org/10.1016/S0140-6736(10)60001-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	544NM	20109874				2022-12-28	WOS:000273664500010
J	Ryan, DP; da Silva, MRD; Soong, TW; Fontaine, B; Donaldson, MR; Kung, AWC; Jongjaroenprasert, W; Liang, MC; Khoo, DHC; Cheah, JS; Ho, SC; Bernstein, HS; Maciel, RMB; Brown, RH; Ptacek, LJ				Ryan, Devon P.; da Silva, Magnus R. Dias; Soong, Tuck Wah; Fontaine, Bertrand; Donaldson, Matt R.; Kung, Annie W. C.; Jongjaroenprasert, Wallaya; Liang, Mui Cheng; Khoo, Daphne H. C.; Cheah, Jin Seng; Ho, Su Chin; Bernstein, Harold S.; Maciel, Rui M. B.; Brown, Robert H., Jr.; Ptacek, Louis J.			Mutations in Potassium Channel Kir2.6 Cause Susceptibility to Thyrotoxic Hypokalemic Periodic Paralysis	CELL			English	Article							RECTIFYING K+ CHANNEL; FUNCTIONAL EXPRESSION; CARDIOMYOCYTES; TRAFFICKING; REVEALS; CLONING	Thyrotoxic hypokalemic periodic paralysis (TPP) is characterized by acute attacks of weakness, hypokalemia, and thyrotoxicosis of various etiologies. These transient attacks resemble those of patients with familial hypokalemic periodic paralysis (hypoKPP) and resolve with treatment of the underlying hyperthyroidism. Because of the phenotypic similarity of these conditions, we hypothesized that TPP might also be a channelopathy. While sequencing candidate genes, we identified a previously unreported gene (not present in human sequence databases) that encodes an inwardly rectifying potassium (Kir) channel, Kir2.6. This channel, nearly identical to Kir2.2, is expressed in skeletal muscle and is transcriptionally regulated by thyroid hormone. Expression of Kir2.6 in mammalian cells revealed normal Kir currents in whole-cell and single-channel recordings. Kir2.6 mutations were present in up to 33% of the unrelated TPP patients in our collection. Some of these mutations clearly alter a variety of Kir2.6 properties, all altering muscle membrane excitability leading to paralysis.	[Ryan, Devon P.; Ptacek, Louis J.] Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94158 USA; [Ryan, Devon P.; da Silva, Magnus R. Dias; Donaldson, Matt R.; Ptacek, Louis J.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Ptacek, Louis J.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Soong, Tuck Wah] Natl Inst Neurosci, Ion Channel & Transporter Lab, Singapore 308433, Singapore; [Fontaine, Bertrand] Univ Paris 06, INSERM, UMRS 546, F-75013 Paris, France; [Fontaine, Bertrand] Grp Hosp Pitie Salpetriere, AP HP, Ctr Reference Canalopathies Musculaires, F-75013 Paris, France; [Kung, Annie W. C.] Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Jongjaroenprasert, Wallaya] Mahidol Univ, Ramathibodi Hosp, Dept Med, Bangkok 10400, Thailand; [Soong, Tuck Wah; Liang, Mui Cheng] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 308433, Singapore; [Cheah, Jin Seng] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 308433, Singapore; [Khoo, Daphne H. C.; Ho, Su Chin] Singapore Gen Hosp, Dept Clin Res, Singapore 169608, Singapore; [Bernstein, Harold S.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Maciel, Rui M. B.] Univ Fed Sao Paulo, Div Endocrinol, Dept Med, BR-04039032 Sao Paulo, Brazil; [Brown, Robert H., Jr.] Massachusetts Gen Hosp, Charlestown, MA 02129 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; National Neuroscience Institute (NNI); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Hong Kong; Mahidol University; National University of Singapore; National University of Singapore; Singapore General Hospital; University of California System; University of California San Francisco; Universidade Federal de Sao Paulo (UNIFESP); Harvard University; Massachusetts General Hospital	Ptacek, LJ (corresponding author), Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94158 USA.	ljp@ucsf.edu	da Silva, Magnus R Dias/B-9132-2012; da Silva, Magnus R. Dias/AAG-7540-2019; Maciel, Rui M. B./A-9826-2013; da Silva, Magnus R. Dias/AAO-3942-2020	da Silva, Magnus R Dias/0000-0002-8516-966X; da Silva, Magnus R. Dias/0000-0002-8516-966X; Maciel, Rui M. B./0000-0002-6123-6098; da Silva, Magnus R. Dias/0000-0002-8516-966X; Ryan, Devon/0000-0002-8549-0971; Liang, Mui Cheng/0000-0003-1208-0733; Soong, Tuck Wah/0000-0002-0876-0325	Muscular Dystrophy Association; National Institutes of Health [U54 RR19481]; CAPES Foundation [2284/01-4]; FAPESP (Sao Paulo State Research Foundation) [2000/03442-4, 1999/03688-4]; INSERM; AFM; C.B. Day Foundation; NINDS	Muscular Dystrophy Association(Muscular Dystrophy Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CAPES Foundation(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP (Sao Paulo State Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); AFM(Association Francaise contre les Myopathies); C.B. Day Foundation; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Lily Jan, Friederike Haas, and Carol Vandenburg for helpful discussions and advice and all the patients for their participation. We also thank Kathleen Giacomini for additional DNA controls. This work was supported by the Muscular Dystrophy Association, National Institutes of Health grant U54 RR19481, CAPES Foundation grant 2284/01-4 (MRDS), and FAPESP (Sao Paulo State Research Foundation) grants 2000/03442-4 (MRDS) and 1999/03688-4 (RMBM). B. F. is supported by INSERM, AFM, and ANR Maladies Rares and acknowledges patient referral and fruitful discussions of members of the clinical and research French network Resocanaux. R. Brown received generous support from the C.B. Day Foundation and the NINDS L.J.P. is an Investigator of the Howard Hughes Medical Institute.	Abraham MR, 1999, FASEB J, V13, P1901; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Bassett JHD, 2003, MOL CELL ENDOCRINOL, V213, P1, DOI 10.1016/j.mce.2003.10.033; Bulman DE, 1999, NEUROLOGY, V53, P1932, DOI 10.1212/WNL.53.9.1932; Donaldson MR, 2003, NEUROLOGY, V60, P1811, DOI 10.1212/01.WNL.0000072261.14060.47; Eichler EE, 2004, NAT REV GENET, V5, P345, DOI 10.1038/nrg1322; Hugnot JP, 1997, GENOMICS, V39, P113, DOI 10.1006/geno.1996.4450; Karle CA, 2002, CIRCULATION, V106, P1493, DOI 10.1161/01.CIR.0000029747.53262.5C; Kavok NS, 2001, BMC CELL BIOL, V2, DOI 10.1186/1471-2121-2-5; KELLEY DE, 1989, ARCH INTERN MED, V149, P2597, DOI 10.1001/archinte.149.11.2597; Krapivinsky G, 1998, NEURON, V20, P995, DOI 10.1016/S0896-6273(00)80480-8; Kung AWC, 2006, J CLIN ENDOCR METAB, V91, P2490, DOI 10.1210/jc.2006-0356; KUNG AWC, 2002, OXFORD TXB ENDOCRINO, P427; Le Bouter S, 2003, CIRC RES, V92, P234, DOI 10.1161/01.RES.0000053185.75505.8E; Leonoudakis D, 2004, J BIOL CHEM, V279, P22331, DOI 10.1074/jbc.M400285200; Leonoudakis D, 2004, J BIOL CHEM, V279, P19051, DOI 10.1074/jbc.M400284200; Lin HY, 1999, AM J PHYSIOL-CELL PH, V276, pC1014, DOI 10.1152/ajpcell.1999.276.5.C1014; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Lu Z, 2004, ANNU REV PHYSIOL, V66, P103, DOI 10.1146/annurev.physiol.66.032102.150822; Namba N, 1996, FEBS LETT, V386, P211, DOI 10.1016/0014-5793(96)00445-0; Namba N, 1997, CYTOGENET CELL GENET, V79, P85, DOI 10.1159/000134688; NEMZEK JA, 1994, J AM VET MED ASSOC, V205, P65; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Plaster NM, 2001, CELL, V105, P511, DOI 10.1016/S0092-8674(01)00342-7; Preisig-Muller R, 2002, P NATL ACAD SCI USA, V99, P7774, DOI 10.1073/pnas.102609499; PTACEK LJ, 1994, CELL, V77, P863; Ryan DP, 2007, MOL GENETIC BASIS NE, P550; Silva Magnus R Dias da, 2004, Arq Bras Endocrinol Metabol, V48, P196; Soom M, 2001, FEBS LETT, V490, P49, DOI 10.1016/S0014-5793(01)02136-6; TAKAHASHI N, 1994, J BIOL CHEM, V269, P23274; Tinker A, 1996, CELL, V87, P857, DOI 10.1016/S0092-8674(00)81993-5; WIBLE BA, 1995, CIRC RES, V76, P343, DOI 10.1161/01.RES.76.3.343; Zaritsky JJ, 2001, J PHYSIOL-LONDON, V533, P697, DOI 10.1111/j.1469-7793.2001.t01-1-00697.x; Zaritsky JJ, 2000, CIRC RES, V87, P160, DOI 10.1161/01.RES.87.2.160; Zobel C, 2003, J PHYSIOL-LONDON, V550, P365, DOI 10.1113/jphysiol.2002.036400	35	173	186	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 8	2010	140	1					88	98		10.1016/j.cell.2009.12.024	http://dx.doi.org/10.1016/j.cell.2009.12.024			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	541CY	20074522	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000273391900017
J	Licht, RW				Licht, Rasmus W.			A new BALANCE in bipolar I disorder	LANCET			English	Editorial Material							LITHIUM; MAINTENANCE; DIVALPROEX; EFFICACY; PLACEBO; CARBAMAZEPINE; LAMOTRIGINE; TRIALS		Aarhus Univ Hosp, Mood Disorders Res Unit, DK-8240 Risskov, Denmark	Aarhus University	Licht, RW (corresponding author), Aarhus Univ Hosp, Mood Disorders Res Unit, DK-8240 Risskov, Denmark.	rasmus.licht@ps.rm.dk		Licht, Rasmus W./0000-0001-8095-3490				Bendz H, 2001, EUR PSYCHIAT, V16, P199, DOI 10.1016/S0924-9338(01)00565-X; Bowden CL, 2000, ARCH GEN PSYCHIAT, V57, P481, DOI 10.1001/archpsyc.57.5.481; BOWDEN CL, 1994, JAMA-J AM MED ASSOC, V271, P918, DOI 10.1001/jama.271.12.918; Geddes JR, 2010, LANCET, V375, P385, DOI 10.1016/S0140-6736(09)61828-6; Geddes JR, 2005, EPIDEMIOL PSICHIAT S, V14, P122, DOI 10.1017/S1121189X00006357; Goodwin GM, 2004, J CLIN PSYCHIAT, V65, P432; Greil W, 1997, J AFFECT DISORDERS, V43, P151, DOI 10.1016/S0165-0327(96)01427-9; Hartong EGTM, 2003, J CLIN PSYCHIAT, V64, P144, DOI 10.4088/JCP.v64n0206; Licht RW, 2008, BIPOLAR DISORD, V10, P27; McElroy SL, 2008, J AFFECT DISORDERS, V107, P127, DOI 10.1016/j.jad.2007.08.014; Tohen M, 2004, BRIT J PSYCHIAT, V184, P337, DOI 10.1192/bjp.184.4.337; Vieta E, 2008, J AFFECT DISORDERS, V109, P251, DOI 10.1016/j.jad.2008.06.001	12	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2010	375	9712					350	352		10.1016/S0140-6736(09)61970-X	http://dx.doi.org/10.1016/S0140-6736(09)61970-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	552PK	20092883				2022-12-28	WOS:000274305500005
J	Chen, DD; Xiao, H; Zhang, K; Wang, B; Gao, ZY; Jian, YL; Qi, XY; Sun, JW; Miao, L; Yang, CL				Chen, Didi; Xiao, Hui; Zhang, Kai; Wang, Bin; Gao, Zhiyang; Jian, Youli; Qi, Xiaying; Sun, Jianwei; Miao, Long; Yang, Chonglin			Retromer Is Required for Apoptotic Cell Clearance by Phagocytic Receptor Recycling	SCIENCE			English	Article							GOLGI RETROGRADE TRANSPORT; WNT-PRODUCING CELLS; CAENORHABDITIS-ELEGANS; C-ELEGANS; MAMMALIAN RETROMER; COMPLEX; ENGULFMENT; SECRETION; ENDOSOME; MIG-14/WNTLESS	The cell surface receptor CED-1 mediates apoptotic cell recognition by phagocytic cells, enabling cell corpse clearance in Caenorhabditis elegans. Here, we found that the C. elegans intracellular protein sorting complex, retromer, was required for cell corpse clearance by mediating the recycling of CED-1. Retromer was recruited to the surfaces of phagosomes containing cell corpses, and its loss of function caused defective cell corpse removal. The retromer probably acted through direct interaction with CED-1 in the cell corpse recognition pathway. In the absence of retromer function, CED-1 associated with lysosomes and failed to recycle from phagosomes and cytosol to the plasma membrane. Thus, retromer is an essential mediator of apoptotic cell clearance by regulating phagocytic receptor(s) during cell corpse engulfment.	[Chen, Didi; Xiao, Hui; Gao, Zhiyang; Jian, Youli; Qi, Xiaying; Sun, Jianwei; Yang, Chonglin] Chinese Acad Sci, Key Lab Mol & Dev Biol, Inst Genet & Dev Biol, Beijing 100101, Peoples R China; [Chen, Didi; Xiao, Hui; Sun, Jianwei] Chinese Acad Sci, Grad Sch, Beijing 100039, Peoples R China; [Zhang, Kai; Wang, Bin; Miao, Long] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS	Yang, CL (corresponding author), Chinese Acad Sci, Key Lab Mol & Dev Biol, Inst Genet & Dev Biol, Datun Rd, Beijing 100101, Peoples R China.	clyang@genetics.ac.cn	Zhang, Kai/M-9831-2017; XIAO, HUI/H-2342-2013; Qi, Xiaying/D-2640-2017; xiao, hui/O-8437-2014; chen, didi/P-7934-2015	Zhang, Kai/0000-0003-2962-3976; Qi, Xiaying/0000-0002-1793-1974; xiao, hui/0000-0001-5709-3365; chen, didi/0000-0002-1453-6899; Miao, Long/0000-0002-0562-6681	Chinese government [2007CB947201, 30871266, KSCX1-YW-R-70]; Chinese Academy of Sciences 100-Talents Program	Chinese government; Chinese Academy of Sciences 100-Talents Program(Chinese Academy of Sciences)	We thank S. Mitani, X. Wang, D. Xue, H. Fares, and C. elegans Genetic Center (CGC) for strains; X. Wang and H. Zhang for critically reading the manuscript; and I. Hanson for proofreading services. This research was supported by grants 2007CB947201, 30871266, and KSCX1-YW-R-70 from the Chinese government. C.Y. is supported by the Chinese Academy of Sciences 100-Talents Program.	Arighi CN, 2004, J CELL BIOL, V165, P123, DOI 10.1083/jcb.200312055; Belenkaya TY, 2008, DEV CELL, V14, P120, DOI 10.1016/j.devcel.2007.12.003; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Collins BM, 2008, TRAFFIC, V9, P1811, DOI 10.1111/j.1600-0854.2008.00777.x; Coudreuse DYM, 2006, SCIENCE, V312, P921, DOI 10.1126/science.1124856; Cullen PJ, 2008, NAT REV MOL CELL BIO, V9, P574, DOI 10.1038/nrm2427; Franch-Marro X, 2008, NAT CELL BIOL, V10, P170, DOI 10.1038/ncb1678; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kritikou EA, 2006, GENE DEV, V20, P2279, DOI 10.1101/gad.384506; Pan CL, 2008, DEV CELL, V14, P132, DOI 10.1016/j.devcel.2007.12.001; Port F, 2008, NAT CELL BIOL, V10, P178, DOI 10.1038/ncb1687; Prasad BC, 2006, DEVELOPMENT, V133, P1757, DOI 10.1242/dev.02357; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P193, DOI 10.1146/annurev.cellbio.20.022003.114619; Seaman MNJ, 1998, J CELL BIOL, V142, P665, DOI 10.1083/jcb.142.3.665; Shi AB, 2009, EMBO J, V28, P3290, DOI 10.1038/emboj.2009.272; Strochlic TI, 2007, J CELL BIOL, V177, P115, DOI 10.1083/jcb.200609161; Verges M, 2004, NAT CELL BIOL, V6, P763, DOI 10.1038/ncb1153; Wassmer T, 2009, DEV CELL, V17, P110, DOI 10.1016/j.devcel.2009.04.016; Yang PT, 2008, DEV CELL, V14, P140, DOI 10.1016/j.devcel.2007.12.004; Yu XM, 2006, DEV CELL, V10, P743, DOI 10.1016/j.devcel.2006.04.007; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	22	93	116	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 5	2010	327	5970					1261	1264		10.1126/science.1184840	http://dx.doi.org/10.1126/science.1184840			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563VD	20133524				2022-12-28	WOS:000275162100041
J	Stone, DH				Stone, David H.			Long-term survival of children born with congenital anomalies	LANCET			English	Editorial Material							DOWNS-SYNDROME; SPINA-BIFIDA; POPULATION; INFANTS		Univ Glasgow, Fac Med, PEACH Unit, Glasgow G3 8SJ, Lanark, Scotland	University of Glasgow	Stone, DH (corresponding author), Univ Glasgow, Fac Med, PEACH Unit, Glasgow G3 8SJ, Lanark, Scotland.	d.h.stone@clinmed.gla.ac.uk						Agha MM, 2006, BIRTH DEFECTS RES A, V76, P46, DOI 10.1002/bdra.20218; BAMFORTH SJ, 1989, AM J HUM GENET, V44, P225; *CHIEF MED OFF, 2005, CMO ANN REP 2004 GAS; Dastgiri S, 2003, ARCH DIS CHILD, V88, P391, DOI 10.1136/adc.88.5.391; *EUROCAT, 2005, EUROCAT GUID 1 3 REF; Frid C, 1999, J INTELL DISABIL RES, V43, P234, DOI 10.1046/j.1365-2788.1999.00198.x; Leonard S, 2000, PAEDIATR PERINAT EP, V14, P163; Reefhuis Jennita, 2002, Community Genet, V5, P13, DOI 10.1159/000064628; TENNANT PWG, 2010, LANCET; Wong LYC, 2001, PAEDIATR PERINAT EP, V15, P374, DOI 10.1046/j.1365-3016.2001.00371.x	10	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 20	2010	375	9715					614	616		10.1016/S0140-6736(09)62030-4	http://dx.doi.org/10.1016/S0140-6736(09)62030-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	564JT	20092885				2022-12-28	WOS:000275210900005
J	Ivers, LC; Cullen, K				Ivers, Louise C.; Cullen, Kimberly			Coordinating and Prioritizing Aid in Haiti	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Partners Hlth, Port au Prince, Haiti				Ivers, Louise C/Q-4164-2018	Ivers, Louise C/0000-0003-2314-9230	NIAID NIH HHS [K23 AI063998] Funding Source: Medline; NICHD NIH HHS [R01 HD057627] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI063998] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))			0	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 18	2010	362	7								10.1056/NEJMpv1001326	http://dx.doi.org/10.1056/NEJMpv1001326			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	556ED	20130247				2022-12-28	WOS:000274571200036
J	Lumbiganon, P; Laopaiboon, M; Gulmezoglu, AM; Souza, JP; Taneepanichskul, S; Pang, RY; Attygalle, DE; Shrestha, N; Mori, R; Hinh, ND; Bang, HT; Rathavy, T; Kang, CY; Cheang, K; Festin, M; Udomprasertgul, V; Germar, MJV; Gao, YQ; Roy, M; Carroli, G; Ba-Thike, K; Filatova, E; Villar, J				Lumbiganon, Pisake; Laopaiboon, Malinee; Guelmezoglu, A. Metin; Souza, Joao Paulo; Taneepanichskul, Surasak; Pang Ruyan; Attygalle, Deepika Eranjanie; Shrestha, Naveen; Mori, Rintaro; Hinh, Nguyen Duc; Bang, Hoang Thi; Rathavy, Tung; Kang Chuyun; Cheang, Kannitha; Festin, Mario; Udomprasertgul, Venus; Germar, Maria Julieta V.; Gao Yanqiu; Roy, Malabika; Carroli, Guillermo; Ba-Thike, Katherine; Filatova, Ekaterina; Villar, Jose		World Hlth Org Global Survey	Method of delivery and pregnancy outcomes in Asia: the WHO global survey on maternal and perinatal health 2007-08	LANCET			English	Article							CESAREAN DELIVERY; LATIN-AMERICA; RATES; OBSTETRICIANS; MORTALITY; SECTIONS	Background There has been concern about rising rates of Caesarean section worldwide. This Article reports the third phase of the WHO global survey, which aimed to estimate the rate of different methods of delivery and to examine the relation between method of delivery and maternal and perinatal outcomes in selected facilities in Africa and Latin America in 2004-05, and in Asia in 2007-08. Methods Nine countries participated in the Asia global survey: Cambodia, China, India, Japan, Nepal, Philippines, Sri Lanka, Thailand, and Vietnam. in each country, the capital city and two other regions or provinces were randomly selected. We studied all women admitted for delivery during 3 months in institutions with 6000 or fewer expected deliveries per year and during 2 months in those with more than 6000 deliveries. We gathered data for institutions to obtain a detailed description of the health facility and its resources for obstetric care. We obtained data from women's medical records to summarise obstetric and perinatal events. Findings We obtained data for 109101 of 112152 deliveries reported in 122 recruited facilities (97% coverage), and analysed 107 950 deliveries. The overall rate of Caesarean section was 27.3% (n=29 428) and of operative vaginal delivery was 3.2% (n=3465). Risk of maternal mortality and morbidity index (at least one of maternal mortality, admission to intensive care unit [ICU], blood transfusion, hysterectomy, or internal iliac artery ligation) was increased for operative vaginal delivery (adjusted odds ratio 2.1, 95% CI 1.7-2.6) and all types of Caesarean section (antepartum without indication 2.7, 1.4-5.5; antepartum with indication 10.6, 9.3-12.0; intrapartum without indication 14.2, 9.8-20.7; intrapartum. with indication 14.5, 13.2-16.0). For breech presentation, Caesarean section, either antepartum (0.2, 0.1-0.3) or intrapartum (0.3, 0.2-0.4), was associated with improved perinatal outcomes, but also with increased risk of stay in neonatal ICU (2.0, 1.1-3.6; and 2.1, 1.2-3.7, respectively). Interpretation To improve maternal and perinatal outcomes, Caesarean section should be done only when there is a medical indication.	[Guelmezoglu, A. Metin] WHO, Dept Reprod Hlth & Res, World Bank Special Programme Res Dev & Res Traini, UNDP,UNFPA, CH-1211 Geneva 27, Switzerland; [Lumbiganon, Pisake] Khon Kaen Univ, Fac Med, Dept Obstet & Gynaecol, Khon Kaen, Thailand; [Laopaiboon, Malinee] Khon Kaen Univ, Fac Publ Hlth, Dept Biostat & Demog, Khon Kaen, Thailand; [Taneepanichskul, Surasak; Udomprasertgul, Venus] Chulalongkorn Univ, Coll Publ Hlth Sci, Bangkok, Thailand; [Pang Ruyan; Kang Chuyun; Gao Yanqiu] Peking Univ, Sch Publ Hlth, Dept Maternal & Child Hlth, Beijing 100871, Peoples R China; [Attygalle, Deepika Eranjanie] Minist Hlth, Family Hlth Bur, Colombo, Sri Lanka; [Shrestha, Naveen] Pokhara Univ, Fac Sci & Technol, Sch Pharmaceut & Biomed Sci, Kaski, Nepal; [Mori, Rintaro] Osaka Med Ctr & Res Inst Maternal & Child Hlth, Osaka, Japan; [Hinh, Nguyen Duc] Natl Obstet & Gynaecol Hosp, Hanoi, Vietnam; [Bang, Hoang Thi] WHO Country Off, Hanoi, Vietnam; [Rathavy, Tung] Natl Maternal & Child Hlth Ctr, Phnom Penh, Cambodia; [Cheang, Kannitha] WHO Country Off, Phnom Penh, Cambodia; [Festin, Mario; Germar, Maria Julieta V.] Univ Philippines, Coll Med, Manila, Philippines; [Roy, Malabika] Indian Council Med Res, New Delhi, India; [Carroli, Guillermo] Ctr Rosarino Estudios Perinatales Rosario, Rosario, Santa Fe, Argentina	The World Bank; United Nations Population Fund; World Health Organization; Khon Kaen University; Khon Kaen University; Chulalongkorn University; Peking University; University of the Philippines System; University of the Philippines Manila; Indian Council of Medical Research (ICMR)	Gulmezoglu, AM (corresponding author), WHO, Dept Reprod Hlth & Res, World Bank Special Programme Res Dev & Res Traini, UNDP,UNFPA, Ave Appia 20, CH-1211 Geneva 27, Switzerland.	gulmezoglum@who.int	Souza, João Paulo/G-1982-2010; Lumbiganon, Pisake/E-8634-2010; Festin, Mario Philip/GQQ-9749-2022; Withinunthakit, Siriporn/E-6131-2010	Souza, João Paulo/0000-0002-2288-4244; Lumbiganon, Pisake/0000-0001-9372-0071; Mori, Rintaro/0000-0001-7656-6156; Shrestha, Naveen/0000-0002-9325-598X	United States Agency for International Development (USAID); UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), WHO, Geneva, Switzerland; Ministry of Health, Labour and Welfare of Japan; Ministry of Public Health, Beijing, China; Indian Council of Medical Research, Delhi, India	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), WHO, Geneva, Switzerland; Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Public Health, Beijing, China; Indian Council of Medical Research, Delhi, India(Indian Council of Medical Research (ICMR))	We thank Nirun Intarut for support during the data monitoring and analysis; Mary Ellen Stanton of USAID for her support and technical input to the project: Mai Fujii who assisted the implementation of the survey; S Marthinsson who developed the online data entry system and assisted in the training of country personnel; Leiv Bakketeig who assisted die first training meeting; Daniel Wojdyla and Liana Campodonico at Centro Rosarino de Estudios Perinatales, Rosario, Argentina for providing relevant information from the earlier surveys and methodological support; the WHO South-East Asia and Western Pacific Regional Office Staff at Delhi and Manila for their support to the operationalisation of the survey: and WHO country office staff and the Counterparts at die ministries of health for providing permissions and administrative Support to the project. The study was financially supported by the United States Agency for International Development (USAID); UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), WHO, Geneva, Switzerland; Ministry of Health, Labour and Welfare of Japan; Ministry of Public Health, Beijing, China; and Indian Council of Medical Research, Delhi, India.	AlMufti R, 1997, EUR J OBSTET GYN R B, V73, P1, DOI 10.1016/S0301-2115(96)02692-9; Althabe F, 2002, BRIT MED J, V324, P945, DOI 10.1136/bmj.324.7343.945; Behague DP, 2002, BMJ-BRIT MED J, V324, P942, DOI 10.1136/bmj.324.7343.942; Belizan JM, 1999, BMJ-BRIT MED J, V319, P1397, DOI 10.1136/bmj.319.7222.1397; Deneux-Tharaux C, 2006, OBSTET GYNECOL, V108, P541, DOI 10.1097/01.AOG.0000233154.62729.24; Hofmeyr GJ, 2000, COCHRANE DB SYST REV, V2; HOFMEYR GJ, 2003, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD000166; Langer A, 2002, BRIT MED J, V324, P928, DOI 10.1136/bmj.324.7343.928; Lavender T, 2005, BMJ-BRIT MED J, V331, P490, DOI 10.1136/bmj.38560.572639.3A; Maine D, 2007, LANCET, V370, P1380, DOI 10.1016/S0140-6736(07)61580-3; National Collaborating Centre for Women's and Children's Health, 2004, CAES SECT CLIN GUID; Shah A, 2008, B WORLD HEALTH ORGAN, V86, P126, DOI 10.2471/BLT.06.039842; Tita ATN, 2009, NEW ENGL J MED, V360, P111, DOI 10.1056/NEJMoa0803267; Villar J, 2007, BRIT MED J, V335, P1025, DOI 10.1136/bmj.39363.706956.55; Villar J, 2006, LANCET, V367, P1819, DOI 10.1016/S0140-6736(06)68704-7	15	619	788	0	116	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 6	2010	375	9713					490	499		10.1016/S0140-6736(09)61870-5	http://dx.doi.org/10.1016/S0140-6736(09)61870-5			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	558PV	20071021				2022-12-28	WOS:000274757900032
J	Sittig, DF; Classen, DC				Sittig, Dean F.; Classen, David C.			Safe Electronic Health Record Use Requires a Comprehensive Monitoring and Evaluation Framework	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							LESSONS; SYSTEMS		[Sittig, Dean F.] Univ Texas Houston, Sch Hlth Informat Sci, Mem Hermann Ctr Healthcare Qual & Safety, Houston, TX 77030 USA; [Classen, David C.] Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT USA; [Classen, David C.] CSC, Salt Lake City, UT USA	University of Texas System; University of Texas Health Science Center Houston; Utah System of Higher Education; University of Utah	Sittig, DF (corresponding author), Univ Texas Houston, Sch Hlth Informat Sci, Mem Hermann Ctr Healthcare Qual & Safety, 6410 Fannin St,UTPB 1100-43, Houston, TX 77030 USA.	dean.f.sittig@uth.tmc.edu	Sittig, Dean F./D-2471-2009	Sittig, Dean F./0000-0001-5811-8915	NLM NIH HHS [R01 LM006942, R01 LM006942-07A2, R56 LM006942, R01-LM006942] Funding Source: Medline; NATIONAL LIBRARY OF MEDICINE [R01LM006942] Funding Source: NIH RePORTER	NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		BHANSALI PV, UNIVERSAL SOFTWARE S; Kilbridge PM, 2006, QUAL SAF HEALTH CARE, V15, P81, DOI 10.1136/qshc.2005.014969; Koppel R, 2009, JAMA-J AM MED ASSOC, V301, P1276, DOI 10.1001/jama.2009.398; Leveson Nancy G., 1995, APPENDIX SAFEWARE SY; Pronovost PJ, 2009, HEALTH AFFAIR, V28, pW479, DOI 10.1377/hlthaff.28.3.w479; Sanghvi Amita A, 2009, J Med Assoc Ga, V98, P53; Sittig DF, 2006, PEDIATRICS, V118, P797, DOI 10.1542/peds.2005-3132; Sittig DF, 2009, JAMA-J AM MED ASSOC, V302, P1111, DOI 10.1001/jama.2009.1311; Sittig DF, 2009, CLIN INFORM SYSTEMS; Walker JM, 2008, J AM MED INFORM ASSN, V15, P272, DOI 10.1197/jamia.M2618	10	49	49	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 3	2010	303	5					450	451		10.1001/jama.2010.61	http://dx.doi.org/10.1001/jama.2010.61			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	550QR	20124542	Green Accepted			2022-12-28	WOS:000274143600022
J	Garg, S; Ahnen, DJ				Garg, Samita; Ahnen, Dennis J.			Is Computed Tomographic Colonography Being Held to a Higher Standard?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							COLONOSCOPIC MISS RATES; CT COLONOGRAPHY; EXTRACOLONIC FINDINGS; COLORECTAL-CANCER; ADENOMAS; ADULTS	Recent guidelines for colorectal cancer screening have reached different conclusions on whether computed tomographic colonography (CTC) is an acceptable screening option, and the Centers for Medicare & Medicaid Services recently decided not to cover CTC screening. The rationale against recommending or covering CTC screening includes concerns about radiation exposure, false-negative rates for small polyps, the discovery of extracolonic findings, variability in performance, a lack of targeted studies, a higher adenoma rate in the Medicare-eligible age group, and an absence of evidence that covering CTC would increase overall screening rates. Similar concerns can be raised for other recommended and covered colon cancer screening tests, but it seems that CTC is being held to a new and higher standard.	Univ Colorado, Ctr Canc, Denver Vet Affairs Med Ctr, Denver, CO 80262 USA; Univ Colorado Denver, Sch Med, Denver, CO USA	University of Colorado System; University of Colorado Denver; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Ahnen, DJ (corresponding author), Denver Vet Affairs Med Ctr 111E, 1055 Clermont St, Denver, CO 80220 USA.	dennis.ahnen@ucdenver.edu						Amis E Stephen Jr, 2007, J Am Coll Radiol, V4, P272, DOI 10.1016/j.jacr.2007.03.002; Barclay RL, 2006, NEW ENGL J MED, V355, P2533, DOI 10.1056/NEJMoa055498; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Bressler B, 2004, GASTROENTEROLOGY, V127, P452, DOI 10.1053/j.gastro.2004.05.032; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; *CTR MED MED SERV, MED COV DAT DEC MEM; Dhruva SS, 2009, NEW ENGL J MED, V360, P2699, DOI 10.1056/NEJMp0904408; Hara AK, 2000, RADIOLOGY, V215, P353, DOI 10.1148/radiology.215.2.r00ap33353; Johnson CD, 2008, NEW ENGL J MED, V359, P1207, DOI 10.1056/NEJMoa0800996; Kemerink GJ, 2001, BRIT J RADIOL, V74, P420, DOI 10.1259/bjr.74.881.740420; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Levin TR, 2006, ANN INTERN MED, V145, P880, DOI 10.7326/0003-4819-145-12-200612190-00004; Pickhardt PJ, 2006, AM J ROENTGENOL, V186, P718, DOI 10.2214/AJR.04.1748; Pickhardt PJ, 2004, ANN INTERN MED, V141, P352, DOI 10.7326/0003-4819-141-5-200409070-00009; Pickhardt PJ, 2003, NEW ENGL J MED, V349, P2191, DOI 10.1056/NEJMoa031618; Pignone M, 2002, ANN INTERN MED, V137, P132, DOI 10.7326/0003-4819-137-2-200207160-00015; Prakash C, 2000, GASTROENTEROLOGY, V118, pA191, DOI 10.1016/S0016-5085(00)82840-1; Rex DK, 1997, GASTROENTEROLOGY, V112, P24, DOI 10.1016/S0016-5085(97)70214-2; Rex DK, 2008, NEW ENGL J MED, V358, P88, DOI 10.1056/NEJMc073084; Urquhart J, 2009, GASTROINTEST ENDOSC, V69, P271, DOI 10.1016/j.gie.2008.04.063; Wiesner R, 2003, GASTROENTEROLOGY, V124, P91, DOI 10.1053/gast.2003.50016; Winawer SJ, 1997, GASTROENTEROLOGY, V112, P594, DOI 10.1053/gast.1997.v112.agast970594; Yee J, 2005, RADIOLOGY, V236, P519, DOI 10.1148/radiol.2362040166; Zauber AG, COST EFFECTIVENESS C	24	8	8	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 2	2010	152	3					178	181		10.7326/0003-4819-152-3-201002020-00009	http://dx.doi.org/10.7326/0003-4819-152-3-201002020-00009			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	552WN	20124234				2022-12-28	WOS:000274324600006
J	Robock, A; Bunzl, M; Kravitz, B; Stenchikov, GL				Robock, Alan; Bunzl, Martin; Kravitz, Ben; Stenchikov, Georgiy L.			A Test for Geoengineering?	SCIENCE			English	Editorial Material									[Robock, Alan; Kravitz, Ben] Rutgers State Univ, Dept Environm Sci, New Brunswick, NJ 08901 USA; [Bunzl, Martin] Rutgers State Univ, Dept Philosophy, New Brunswick, NJ 08901 USA; [Stenchikov, Georgiy L.] 4700 King Abdullah Univ Sci & Technol, Div Phys Sci & Engn, Thuwal 239556900, Saudi Arabia	Rutgers State University New Brunswick; Rutgers State University New Brunswick; King Abdullah University of Science & Technology	Robock, A (corresponding author), Rutgers State Univ, Dept Environm Sci, 14 Coll Farm Rd, New Brunswick, NJ 08901 USA.	robock@envsci.rutgers.edu	Robock, Alan/B-6385-2016; Georgiy, Stenchikov/J-8569-2013; Kravitz, Ben/P-7925-2014; Stenchikov, Georgiy/AAA-4371-2022	Kravitz, Ben/0000-0001-6318-1150; Stenchikov, Georgiy Lvovich/0000-0001-9033-4925; Robock, Alan/0000-0002-6319-5656				Blackstock JJ, 2010, SCIENCE, V327, P527, DOI 10.1126/science.1183877; BLUTH GJS, 1992, GEOPHYS RES LETT, V19, P151, DOI 10.1029/91GL02792; Caldeira K, 2008, PHILOS T R SOC A, V366, P4039, DOI 10.1098/rsta.2008.0132; Heckendorn P, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/4/045108; Hegerl GC, 2009, SCIENCE, V325, P955, DOI 10.1126/science.1178530; *NSF, ATM0730452 NSF; Robock A, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1175/2779.1; Robock A, 2008, B ATOM SCI, V64, P14, DOI 10.1080/00963402.2008.11461140; Robock A, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039209; Solomon S, 1999, REV GEOPHYS, V37, P275, DOI 10.1029/1999RG900008; Trenberth KE, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030524; Wigley TML, 2006, SCIENCE, V314, P452, DOI 10.1126/science.1131728	12	95	98	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 29	2010	327	5965					530	531		10.1126/science.1186237	http://dx.doi.org/10.1126/science.1186237			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549CT	20110490				2022-12-28	WOS:000274020500021
J	Bayer, R; Kelly, M				Bayer, Ronald; Kelly, Matthew			Tobacco Control and Free Speech - An American Dilemma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bayer, Ronald; Kelly, Matthew] Columbia Univ, Mailman Sch Publ Hlth, Ctr Hist & Eth Publ Hlth, New York, NY 10027 USA	Columbia University	Bayer, R (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Ctr Hist & Eth Publ Hlth, New York, NY 10027 USA.			Kelly, Matthew/0000-0001-6272-0247				*C RES SERV, 2009, FDA TOB REG HHIST 19; Lynch BS., 1994, GROWING TOBACCO FREE; Richard JBonnie, 2007, ENDING TOBACCO PROBL	3	13	13	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 28	2010	362	4					281	283		10.1056/NEJMp0909626	http://dx.doi.org/10.1056/NEJMp0909626			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	548OT	20071696	Bronze			2022-12-28	WOS:000273975000001
J	Richardson, V; Hernandez-Pichardo, J; Quintanar-Solares, M; Esparza-Aguilar, M; Johnson, B; Gomez-Altamirano, CM; Parashar, U; Patel, M				Richardson, Vesta; Hernandez-Pichardo, Joselito; Quintanar-Solares, Manjari; Esparza-Aguilar, Marcelino; Johnson, Brian; Misael Gomez-Altamirano, Cesar; Parashar, Umesh; Patel, Manish			Effect of Rotavirus Vaccination on Death from Childhood Diarrhea in Mexico	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							1ST 2 YEARS; DOUBLE-BLIND; EFFICACY; SAFETY; GASTROENTERITIS; MORTALITY; VACCINES; CHILDREN; INFANTS; LIFE	BACKGROUND A phased introduction of a monovalent rotavirus vaccine occurred in Mexico from February 2006 through May 2007. We assessed the effect of vaccination on deaths from diarrhea in Mexican children in 2008 and 2009. METHODS We obtained data on deaths from diarrhea, regardless of cause, from January 2003 through May 2009 in Mexican children under 5 years of age. We compared diarrhea-related mortality in 2008 and during the 2008 and 2009 rotavirus seasons with the mortality at baseline (2003-2006), before the introduction of the rotavirus vaccine. Vaccine coverage was estimated from administrative data. RESULTS By December 2007, an estimated 74% of children who were 11 months of age or younger had received one dose of rotavirus vaccine. In 2008, there were 1118 diarrhea-related deaths among children younger than 5 years of age, a reduction of 675 from the annual median of 1793 deaths during the 2003-2006 period. Diarrhea-related mortality fell from an annual median of 18.1 deaths per 100,000 children at baseline to 11.8 per 100,000 children in 2008 (rate reduction, 35%; 95% confidence interval [CI], 29 to 39; P<0.001). Among infants who were 11 months of age or younger, diarrhea-related mortality fell from 61.5 deaths per 100,000 children at baseline to 36.0 per 100,000 children in 2008 (rate reduction, 41%; 95% CI, 36 to 47; P<0.001). As compared with baseline, diarrhea-related mortality was 29% lower for children between the ages of 12 and 23 months, few of whom were age-eligible for vaccination. Mortality among unvaccinated children between the ages of 24 and 59 months was not significantly reduced. The reduction in the number of diarrhea-related deaths persisted through two full rotavirus seasons (2008 and 2009). CONCLUSIONS After the introduction of a rotavirus vaccine, a significant decline in diarrhea-related deaths among Mexican children was observed, suggesting a potential benefit from rotavirus vaccination.	[Johnson, Brian; Parashar, Umesh; Patel, Manish] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Richardson, Vesta; Hernandez-Pichardo, Joselito; Quintanar-Solares, Manjari; Esparza-Aguilar, Marcelino; Misael Gomez-Altamirano, Cesar] Minist Hlth, Natl Ctr Child & Adolescent Hlth, Mexico City, DF, Mexico	Centers for Disease Control & Prevention - USA	Patel, M (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, 1600 Clifton Rd,MS A-47, Atlanta, GA 30333 USA.	mpatel@cdc.gov		/0000-0003-1486-3651; Quintanar-Solares, Manjari/0000-0003-0894-9192				Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Burton A, 2009, B WORLD HEALTH ORGAN, V87, P535, DOI 10.2471/BLT.08.053819; de Oliveira LH, 2008, EXPERT REV VACCINES, V7, P345, DOI 10.1586/14760584.7.3.345; Glass RI, 2006, LANCET, V368, P323, DOI 10.1016/S0140-6736(06)68815-6; Gonzalez-Cossio T, 2003, SALUD PUBLICA MEXICO, V45, pS477; Linhares AC, 2008, LANCET, V371, P1181, DOI 10.1016/S0140-6736(08)60524-3; Parashar UD, 2006, EMERG INFECT DIS, V12, P304; Parashar UD, 2009, J INFECT DIS, V200, pS9, DOI 10.1086/605025; Parashar UD, 2009, NEW ENGL J MED, V360, P1063, DOI 10.1056/NEJMp0810154; Patel M, 2009, JAMA-J AM MED ASSOC, V301, P2243, DOI 10.1001/jama.2009.756; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; *SECR SAL INEGI, DIR GEN INF SAL; Tate JE, 2009, PEDIATRICS, V124, P465, DOI 10.1542/peds.2008-3528; Velazquez F Raul, 2004, Pediatr Infect Dis J, V23, pS149, DOI 10.1097/01.inf.0000142463.72442.91; Vesikari T, 2007, LANCET, V370, P1757, DOI 10.1016/S0140-6736(07)61744-9; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; Villa S, 1999, B WORLD HEALTH ORGAN, V77, P375; WHO, 2009, WHO TECH REP SER, V958, P1	18	256	270	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 28	2010	362	4					299	305		10.1056/NEJMoa0905211	http://dx.doi.org/10.1056/NEJMoa0905211			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	548OT	20107215				2022-12-28	WOS:000273975000005
J	Mesirov, JP				Mesirov, Jill P.			Accessible Reproducible Research	SCIENCE			English	Editorial Material									[Mesirov, Jill P.] MIT, Broad Inst, Cambridge, MA 02142 USA; [Mesirov, Jill P.] Harvard Univ, Cambridge, MA 02142 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Mesirov, JP (corresponding author), MIT, Broad Inst, Cambridge, MA 02142 USA.	mesirov@broad.mit.edu	Mesirov, Jill/AGF-7626-2022		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074024] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM074024-08, R01 GM074024] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDREESSEN M, 1993, NCSA MOSAIC TECHNICA; APPEL K, 1976, DISCRETE MATH, V16, P179, DOI 10.1016/0012-365X(76)90147-3; BERNERSLEE T, 1994, COMMUN ACM, V37, P76, DOI 10.1145/179606.179671; BUCKHEIT J, 1995, WAVELETS STAT, P55, DOI DOI 10.1007/978-1-4612-2544-75; [Committee on Science Engineering and Public Policy (US) Committee on Ensuring the Utility and Integrity of Research Data in a Digital Age], 2009, ENS INT ACC STEW RES; FELDMAN SI, 1979, SOFTWARE PRACT EXPER, V9, P255, DOI 10.1002/spe.4380090402; Gentleman R, 2007, J COMPUT GRAPH STAT, V16, P1, DOI 10.1198/106186007X178663; Gentleman R, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1034; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; King G, 2006, PS-POLIT SCI POLIT, V39, P119; KNUTH D. E., 1979, TEX METAFONT NEW DIR; KNUTH DE, 1984, COMPUT J, V27, P97, DOI 10.1093/comjnl/27.2.97; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Schwab M, 2000, COMPUT SCI ENG, V2, P61, DOI 10.1109/5992.881708; 2009, COMPUT SCI ENG, V11, P3	15	154	155	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 22	2010	327	5964					415	416		10.1126/science.1179653	http://dx.doi.org/10.1126/science.1179653			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	546BS	20093459	Green Accepted			2022-12-28	WOS:000273783100020
J	Katz, R; Shah, P				Katz, Ruth; Shah, Priti			The Patient Who Falls Challenges for Families, Clinicians, and Communities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Katz, Ruth] Off Assistant Secretary Planning & Evaluat, Off Disabil Aging & Long Term Care Policy, Washington, DC 20201 USA; [Shah, Priti] US Adm Aging, Dept Hlth & Human Serv, Washington, DC USA		Katz, R (corresponding author), Off Assistant Secretary Planning & Evaluat, Off Disabil Aging & Long Term Care Policy, 200 Independence Ave SW,Room 424-E-3, Washington, DC 20201 USA.	ruth.katz@hhs.gov						COHEN MA, 2006, SERVICE USE TRANSITI; DOTY P, 2009, FED PARTN CAR MAY 16; Spillman Brenda, 2007, DOES HIGH CAREGIVER; Stevens JA, 2006, INJURY PREV, V12, P290, DOI 10.1136/ip.2005.011015; *US DEP HHS, EFF RED FALLS LONG T; *US DEP HHS, NAT FAM CAR SUPP PRO	6	9	9	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 20	2010	303	3					273	274		10.1001/jama.2009.2016	http://dx.doi.org/10.1001/jama.2009.2016			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	544WM	20085958				2022-12-28	WOS:000273690600026
J	Temperley, R; Richter, R; Dennerlein, S; Lightowlers, RN; Chrzanowska-Lightowlers, ZM				Temperley, Richard; Richter, Ricarda; Dennerlein, Sven; Lightowlers, Robert N.; Chrzanowska-Lightowlers, Zofia M.			Hungry Codons Promote Frameshifting in Human Mitochondrial Ribosomes	SCIENCE			English	Article							TRANSLATION		[Temperley, Richard; Richter, Ricarda; Dennerlein, Sven; Lightowlers, Robert N.; Chrzanowska-Lightowlers, Zofia M.] Univ Newcastle, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Chrzanowska-Lightowlers, ZM (corresponding author), Univ Newcastle, Inst Ageing & Hlth, Mitochondrial Res Grp, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	Z.Chrzanowska-Lightowlers@ncl.ac.uk		Chrzanowska-Lightowlers, Zofia/0000-0002-0045-3152	Wellcome Trust [074454/Z/04/Z]; Biotechnology and Biological Sciences Research Council [BB/F011520/1]; BBSRC [BB/F011520/1] Funding Source: UKRI; Medical Research Council [G0700718B] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust (074454/Z/04/Z) and Biotechnology and Biological Sciences Research Council (BB/F011520/1). We thank K. Gerdes for kindly providing the clone and antibodies to bacterial RelE.	GESTELAND RF, 1992, SCIENCE, V257, P1640, DOI 10.1126/science.1529352; Russell RD, 2008, J MOL EVOL, V67, P682, DOI 10.1007/s00239-008-9179-0; Soleimanpour-Lichaei HR, 2007, MOL CELL, V27, P745, DOI 10.1016/j.molcel.2007.06.031	3	114	119	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 15	2010	327	5963					301	301		10.1126/science.1180674	http://dx.doi.org/10.1126/science.1180674			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544CM	20075246				2022-12-28	WOS:000273629700033
J	Governato, F; Brook, C; Mayer, L; Brooks, A; Rhee, G; Wadsley, J; Jonsson, P; Willman, B; Stinson, G; Quinn, T; Madau, P				Governato, F.; Brook, C.; Mayer, L.; Brooks, A.; Rhee, G.; Wadsley, J.; Jonsson, P.; Willman, B.; Stinson, G.; Quinn, T.; Madau, P.			Bulgeless dwarf galaxies and dark matter cores from supernova-driven outflows	NATURE			English	Article							STELLAR FEEDBACK; RADIATIVE-TRANSFER; STAR-FORMATION; DISK GALAXIES; SIMULATIONS; UNIVERSE; RESOLUTION; ROTATION; ORIGIN; HALOES	For almost two decades the properties of 'dwarf' galaxies have challenged the cold dark matter (CDM) model of galaxy formation(1). Most observed dwarf galaxies consist of a rotating stellar disk(2) embedded in a massive dark-matter halo with a near-constant-density core(3). Models based on the dominance of CDM, however, invariably form galaxies with dense spheroidal stellar bulges and steep central dark-matter profiles(4-6), because low-angular-momentum baryons and dark matter sink to the centres of galaxies through accretion and repeated mergers(7). Processes that decrease the central density of CDM halos(8) have been identified, but have not yet reconciled theory with observations of present-day dwarfs. This failure is potentially catastrophic for the CDM model, possibly requiring a different dark-matter particle candidate(9). Here we report hydrodynamical simulations (in a framework(10) assuming the presence of CDM and a cosmological constant) in which the inhomogeneous interstellar medium is resolved. Strong outflows from supernovae remove low-angular-momentum gas, which inhibits the formation of bulges and decreases the dark-matter density to less than half of what it would otherwise be within the central kiloparsec. The analogues of dwarf galaxies-bulgeless and with shallow central dark-matter profiles-arise naturally in these simulations.	[Governato, F.; Quinn, T.] Univ Washington, Dept Astron, Seattle, WA 98195 USA; [Brook, C.] Univ Cent Lancashire, Jeremiah Horrocks Inst, Preston PR1 2HE, Lancs, England; [Mayer, L.] Univ Zurich, Inst Theoret Phys, CH-8057 Zurich, Switzerland; [Brooks, A.] CALTECH, Pasadena, CA 91125 USA; [Rhee, G.] Univ Nevada, Dept Phys & Astron, Las Vegas, NV 89154 USA; [Wadsley, J.; Stinson, G.] McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada; [Jonsson, P.] Univ Calif Santa Cruz, Inst Particle Phys, Santa Cruz, CA 95064 USA; [Madau, P.] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Willman, B.] Haverford Coll, Dept Astron, Haverford, PA 19041 USA	University of Washington; University of Washington Seattle; University of Central Lancashire; University of Zurich; California Institute of Technology; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; McMaster University; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Haverford College	Governato, F (corresponding author), Univ Washington, Dept Astron, Seattle, WA 98195 USA.	fabio@astro.washington.edu	Brooks, Alyson/AGP-7576-2022; Brook, Christopher B/E-4234-2010	Brooks, Alyson/0000-0002-0372-3736; Madau, Piero/0000-0002-6336-3293; Quinn, Thomas/0000-0001-5510-2803; Brook, Christopher B/0000-0002-0534-4115				Abadi MG, 2003, ASTROPHYS J, V591, P499, DOI 10.1086/375512; Barnes JE, 1996, ASTROPHYS J, V471, P115, DOI 10.1086/177957; Binney J, 2001, MON NOT R ASTRON SOC, V321, P471, DOI 10.1046/j.1365-8711.2001.04024.x; Brooks AM, 2007, ASTROPHYS J, V655, pL17, DOI 10.1086/511765; Ceverino D, 2009, ASTROPHYS J, V695, P292, DOI 10.1088/0004-637X/695/1/292; Coles P, 2005, NATURE, V433, P248, DOI 10.1038/nature03282; de Blok WJG, 2008, ASTRON J, V136, P2648, DOI 10.1088/0004-6256/136/6/2648; FALL SM, 1980, MON NOT R ASTRON SOC, V193, P189, DOI 10.1093/mnras/193.2.189; Geha M, 2006, ASTROPHYS J, V653, P240, DOI 10.1086/508604; Governato F, 2007, MON NOT R ASTRON SOC, V374, P1479, DOI 10.1111/j.1365-2966.2006.11266.x; Haardt F, 1996, ASTROPHYS J, V461, P20, DOI 10.1086/177035; Jonsson P, 2006, MON NOT R ASTRON SOC, V372, P2, DOI 10.1111/j.1365-2966.2006.10884.x; Lee JC, 2009, ASTROPHYS J, V692, P1305, DOI 10.1088/0004-637X/692/2/1305; Maller AH, 2002, MON NOT R ASTRON SOC, V335, P487, DOI 10.1046/j.1365-8711.2002.05646.x; Mashchenko S, 2008, SCIENCE, V319, P174, DOI 10.1126/science.1148666; Mashchenko S, 2006, NATURE, V442, P539, DOI 10.1038/nature04944; Mo HJ, 2004, MON NOT R ASTRON SOC, V353, P829, DOI 10.1111/j.1365-2966.2004.08114.x; Moore B, 1999, MON NOT R ASTRON SOC, V310, P1147, DOI 10.1046/j.1365-8711.1999.03039.x; Pontzen A, 2008, MON NOT R ASTRON SOC, V390, P1349, DOI 10.1111/j.1365-2966.2008.13782.x; Primack JR, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/10/105029; Robertson BE, 2008, ASTROPHYS J, V680, P1083, DOI 10.1086/587796; Simon JD, 2005, ASTROPHYS J, V621, P757, DOI 10.1086/427684; Spergel DN, 2003, ASTROPHYS J SUPPL S, V148, P175, DOI 10.1086/377226; Swaters RA, 2003, ASTROPHYS J, V587, pL19, DOI 10.1086/375045; Valenzuela O, 2007, ASTROPHYS J, V657, P773, DOI 10.1086/508674; van den Bosch FC, 2001, MON NOT R ASTRON SOC, V326, P1205, DOI 10.1046/j.1365-8711.2001.04656.x; Walter F, 1999, ASTRON J, V118, P273, DOI 10.1086/300906; Wilman RJ, 2005, NATURE, V436, P227, DOI 10.1038/nature03718	30	777	780	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 14	2010	463	7278					203	206		10.1038/nature08640	http://dx.doi.org/10.1038/nature08640			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543MQ	20075915	Green Accepted, Green Submitted			2022-12-28	WOS:000273582700029
J	Murphy, AM				Murphy, Anne M.			Mammography Screening for Breast Cancer A View From 2 Worlds	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Johns Hopkins Univ, Sch Med, Dept Pediat, Div Cardiol, Baltimore, MD 21205 USA	Johns Hopkins University	Murphy, AM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat, Div Cardiol, 720 Rutland Ave,Ross Bldg 1144, Baltimore, MD 21205 USA.	amurphy2@jhmi.edu						Burke W, 2009, AM J MED GENET A, V149A, P349, DOI 10.1002/ajmg.a.32643; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Nelson HD, 2009, ANN INTERN MED, V151, pW237, DOI DOI 10.7326/0003-4819-151-10-200911170-00009; Nelson HD, 2009, ANN INTERN MED, V151, P727, DOI 10.7326/0003-4819-151-10-200911170-00009; Pisano ED, 2005, NEW ENGL J MED, V353, P1773, DOI 10.1056/NEJMoa052911; Qaseem A, 2007, ANN INTERN MED, V146, P511, DOI 10.7326/0003-4819-146-7-200704030-00007; Smith-Bindman R, 2003, JAMA-J AM MED ASSOC, V290, P2129, DOI 10.1001/jama.290.16.2129; Taplin S, 2008, J NATL CANCER I, V100, P876, DOI 10.1093/jnci/djn172; Thomas DB, 2002, JNCI-J NATL CANCER I, V94, P1445, DOI 10.1093/jnci/94.19.1445; US Cancer Statistics Working Group US Department of Health and Human Services Centers for Disease Control and Prevention National Cancer Institute, 2012, US CANC STAT 1999 20; Weitzel JN, 2007, JAMA-J AM MED ASSOC, V297, P2587, DOI 10.1001/jama.297.23.2587	11	22	22	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 13	2010	303	2					166	167		10.1001/jama.2009.1991	http://dx.doi.org/10.1001/jama.2009.1991			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	542UI	20068212				2022-12-28	WOS:000273522600029
J	Grosset, DG; Macphee, GJA; Nairn, M				Grosset, D. G.; Macphee, G. J. A.; Nairn, M.		Guideline Dev Grp	Guidelines Diagnosis and pharmacological management of Parkinson's disease: summary of SIGN guidelines	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EXCESSIVE DAYTIME SLEEPINESS; CHOLINESTERASE-INHIBITORS; DEPRESSION; DEMENTIA; COMMUNITY; SCALE		[Nairn, M.] Scottish Intercollegiate Guidelines Network, Edinburgh EH7 5EA, Midlothian, Scotland; [Grosset, D. G.; Macphee, G. J. A.] So Gen Hosp, Dept Neurol, Glasgow G51 4TF, Lanark, Scotland	University of Glasgow	Nairn, M (corresponding author), Scottish Intercollegiate Guidelines Network, Edinburgh EH7 5EA, Midlothian, Scotland.	moray.nairn@nhs.net		Grosset, Donald/0000-0002-2757-8203; Nairn, Moray/0000-0001-6474-4410	BI; UCB Pharma	BI; UCB Pharma(UCB Pharma SA)	All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare that (1) No authors have support from any company for the submitted work; (2) DGG has received honorariums for talks from Boehringer-Ingelheim (BI), GE Healthcare, GlaxoSmithKline (GSK), Teva, and Union Chimique Belge (UCB); has been reimbursed for conference attendance from Teva and UCB; and has received grant support for research staff from GSK and GE Healthcare. GM has participated in advisory boards for BI, GSK, Teva, and Solvay Pharmaceuticals; has received speaker fees from BI, GSK, Orion, and Solvay; and has received travel grants from BI and UCB Pharma. MN has no relationships with any company that might have an interest in the submitted work in the previous three years; (3) their spouses, partners, or children have no financial relationships that may be relevant to the submitted work; and (4) DGG chaired the SIGN guideline development group on diagnosis and pharmacological management of Parkinson's disease. GM and MN have no non-financial interests that may be relevant to the submitted work.	Aarsland D, 2004, J GERIATR PSYCH NEUR, V17, P164, DOI 10.1177/0891988704267463; Aarsland D, 2005, MOVEMENT DISORD, V20, P1255, DOI 10.1002/mds.20527; Ahlskog JE, 2001, MOVEMENT DISORD, V16, P448, DOI 10.1002/mds.1090; Chaudhuri KR, 2006, MOVEMENT DISORD, V21, P916, DOI 10.1002/mds.20844; Devos D, 2008, MOVEMENT DISORD, V23, P850, DOI 10.1002/mds.21966; General Register Office for Scotland, 2009, PROJ POP SCOTL 2008; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Gjerstad MD, 2006, NEUROLOGY, V67, P853, DOI 10.1212/01.wnl.0000233980.25978.9d; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Lang AE, 2009, NEUROLOGY, V72, pS39, DOI 10.1212/WNL.0b013e318198e177; Leroi I, 2006, J NEUROL SCI, V248, P104, DOI 10.1016/j.jns.2006.05.021; Maidment ID, 2005, ACTA PSYCHIAT SCAND, V111, P403, DOI 10.1111/j.1600-0447.2005.00516.x; Miyasaki JM, 2006, NEUROLOGY, V66, P996, DOI 10.1212/01.wnl.0000215428.46057.3d; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Schrag A, 2002, J NEUROL NEUROSUR PS, V73, P529, DOI 10.1136/jnnp.73.5.529; Schrag A, 2007, MOVEMENT DISORD, V22, P1077, DOI 10.1002/mds.21333; *SCOTT INT GUID NE, 2010, SIGN PUBL, V113; Sellbach AN, 2006, PARKINSONISM RELAT D, V12, P399, DOI 10.1016/j.parkreldis.2006.03.002; Starkstein SE, 2008, MOVEMENT DISORD, V23, P538, DOI 10.1002/mds.21866; Tan EK, 2002, NEUROLOGY, V58, P465, DOI 10.1212/WNL.58.3.465; Tandberg E, 1999, MOVEMENT DISORD, V14, P922, DOI 10.1002/1531-8257(199911)14:6<922::AID-MDS1003>3.0.CO;2-7; Weintraub D, 2005, MOVEMENT DISORD, V20, P1161, DOI 10.1002/mds.20555	22	22	22	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 12	2010	340								b5614	10.1136/bmj.b5614	http://dx.doi.org/10.1136/bmj.b5614			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	545CZ	20068048				2022-12-28	WOS:000273711400007
J	Barker, R				Barker, Richard			A flexible blueprint for the future of drug development	LANCET			English	Editorial Material									Assoc British Pharmaceut Ind, London SW1A 2DY, England		Barker, R (corresponding author), Assoc British Pharmaceut Ind, 12 Whitehall, London SW1A 2DY, England.	rbarker@abpi.org.uk						Berry DA, 1996, BAYESIAN BIOSTATISTI; Cooksey D., 2006, REV UK HLTH RES FUND; DiMasi JA, 2001, CLIN PHARMACOL THER, V69, P297, DOI 10.1067/mcp.2001.115446; Rawlins M, 2008, LANCET, V372, P2152, DOI 10.1016/S0140-6736(08)61930-3; US Food and Drug Administration, 2009, CRIT PATH IN	5	15	15	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN-FEB	2010	375	9712					357	359		10.1016/S0140-6736(10)60141-9	http://dx.doi.org/10.1016/S0140-6736(10)60141-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	552PK	20113813				2022-12-28	WOS:000274305500009
J	Kaski, D; Mead, S; Hyare, H; Cooper, S; Jampana, R; Overell, J; Knight, R; Collinge, J; Rudge, P				Kaski, Diego; Mead, Simon; Hyare, Harpreet; Cooper, Sarah; Jampana, Ravi; Overell, James; Knight, Richard; Collinge, John; Rudge, Peter			Variant CJD in an individual heterozygous for PRNP codon 129	LANCET			English	Editorial Material							PHENOTYPE; DISEASE		[Kaski, Diego; Mead, Simon; Hyare, Harpreet; Collinge, John; Rudge, Peter] UCL, Inst Neurol, MRC, Prion Unit, London WC1N 3BG, England; [Kaski, Diego; Mead, Simon; Hyare, Harpreet; Collinge, John; Rudge, Peter] UCL, Inst Neurol, Natl Prion Clin, London WC1N 3BG, England; [Kaski, Diego; Mead, Simon; Hyare, Harpreet; Collinge, John; Rudge, Peter] Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England; [Cooper, Sarah; Jampana, Ravi; Overell, James] Univ Glasgow, Inst Neurol Sci, Glasgow, Lanark, Scotland; [Knight, Richard] Western Gen Hosp, Natl CJD Surveillance Unit, Edinburgh EH4 2XU, Midlothian, Scotland	University of London; University College London; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of Glasgow; University of Edinburgh	Collinge, J (corresponding author), UCL, Inst Neurol, MRC, Prion Unit, Queen Sq, London WC1N 3BG, England.	j.collinge@prion.ucl.ac.uk	Kaski, Diego/GQY-5716-2022; Mead, Simon/E-9414-2011	Mead, Simon/0000-0002-4326-1468; Kaski, Diego/0000-0002-0591-646X	MRC [MC_U123160657] Funding Source: UKRI; Medical Research Council [MC_U123160657] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Asante EA, 2006, P NATL ACAD SCI USA, V103, P10759, DOI 10.1073/pnas.0604292103; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Collinge J, 2006, LANCET, V367, P2068, DOI 10.1016/S0140-6736(06)68930-7; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; Wadsworth JDF, 2004, SCIENCE, V306, P1793, DOI 10.1126/science.1103932	5	76	76	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC-JAN	2009	374	9707					2128	2128		10.1016/S0140-6736(09)61568-3	http://dx.doi.org/10.1016/S0140-6736(09)61568-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	537OO	20109837				2022-12-28	WOS:000273122900038
J	Hare, S; Gupta, SS; Valkov, E; Engelman, A; Cherepanov, P				Hare, Stephen; Gupta, Saumya Shree; Valkov, Eugene; Engelman, Alan; Cherepanov, Peter			Retroviral intasome assembly and inhibition of DNA strand transfer	NATURE			English	Article							AUTOMATED STRUCTURE SOLUTION; HIV-1 INTEGRASE; CRYSTAL-STRUCTURE; ACTIVE-SITE; TERMINAL DOMAINS; STRUCTURAL BASIS; VIRUS INTEGRASE; BINDING DOMAIN; PROTEIN; MECHANISM	Integrase is an essential retroviral enzyme that binds both termini of linear viral DNA and inserts them into a host cell chromosome. The structure of full-length retroviral integrase, either separately or in complex with DNA, has been lacking. Furthermore, although clinically useful inhibitors of HIV integrase have been developed, their mechanism of action remains speculative. Here we present a crystal structure of full-length integrase from the prototype foamy virus in complex with its cognate DNA. The structure shows the organization of the retroviral intasome comprising an integrase tetramer tightly associated with a pair of viral DNA ends. All three canonical integrase structural domains are involved in extensive protein-DNA and protein-protein interactions. The binding of strand-transfer inhibitors displaces the reactive viral DNA end from the active site, disarming the viral nucleoprotein complex. Our findings define the structural basis of retroviral DNA integration, and will allow modelling of the HIV-1 intasome to aid in the development of antiretroviral drugs.	[Hare, Stephen; Gupta, Saumya Shree; Valkov, Eugene; Cherepanov, Peter] Univ London Imperial Coll Sci Technol & Med, Div Med, London W2 1PG, England; [Engelman, Alan] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA	Imperial College London; Harvard University; Dana-Farber Cancer Institute	Cherepanov, P (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Med, St Marys Campus,Norfolk Pl, London W2 1PG, England.	p.cherepanov@imperial.ac.uk	Cherepanov, Peter P/F-6859-2010; Valkov, Eugene/AAA-1735-2020; Valkov, Eugene/C-1554-2010	Cherepanov, Peter P/0000-0002-0634-538X; Valkov, Eugene/0000-0002-3721-1739; Hare, Stephen/0000-0003-2951-1595	UK Medical Research Council; US National Institutes of Health; MRC [G0900116] Funding Source: UKRI; Medical Research Council [G0900116] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, R01AI070042] Funding Source: NIH RePORTER	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank F. Dyda for critical reading of the manuscript, R. Clayton and M. Cummings for the generous gift of InSTIs and helpful discussions, T. Sorensen and the staff of the I02 and I04 beamlines of the Diamond Light Source for assistance with X-ray data collection. P. C. and co-workers are funded by the UK Medical Research Council, and A. E. by the US National Institutes of Health.	Alian A, 2009, P NATL ACAD SCI USA, V106, P8192, DOI 10.1073/pnas.0811919106; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bujacz G, 1997, J BIOL CHEM, V272, P18161, DOI 10.1074/jbc.272.29.18161; Cai ML, 1997, NAT STRUCT BIOL, V4, P567, DOI 10.1038/nsb0797-567; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; Chen ZG, 2000, J MOL BIOL, V296, P521, DOI 10.1006/jmbi.1999.3451; Cherepanov P, 2007, NUCLEIC ACIDS RES, V35, P113, DOI 10.1093/nar/gkl885; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Craigie R, 2002, MOBILE DNA, P613; Davies DR, 2000, SCIENCE, V289, P77, DOI 10.1126/science.289.5476.77; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; EIJKELENBOOM APAM, 1995, NAT STRUCT BIOL, V2, P807, DOI 10.1038/nsb0995-807; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGELMAN A, 1994, J VIROL, V68, P5911, DOI 10.1128/JVI.68.9.5911-5917.1994; ENGELMAN A, 1991, CELL, V67, P1211, DOI 10.1016/0092-8674(91)90297-C; Espeseth AS, 2000, P NATL ACAD SCI USA, V97, P11244, DOI 10.1073/pnas.200139397; Esposito D, 1998, EMBO J, V17, P5832, DOI 10.1093/emboj/17.19.5832; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Grobler JA, 2008, ANTIVIR THER, V13, pA41; Grobler JA, 2002, P NATL ACAD SCI USA, V99, P6661, DOI 10.1073/pnas.092056199; Hare S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000515; Jaskolski M, 2009, FEBS J, V276, P2926, DOI 10.1111/j.1742-4658.2009.07009.x; Jenkins TM, 1997, EMBO J, V16, P6849, DOI 10.1093/emboj/16.22.6849; Buzon MJ, 2010, AIDS, V24, P17, DOI 10.1097/QAD.0b013e328331c81e; Langley DR, 2008, BIOCHEMISTRY-US, V47, P13481, DOI 10.1021/bi801372d; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Lewinski MK, 2005, ADV GENET, V55, P147, DOI 10.1016/S0065-2660(05)55005-3; Li M, 2006, EMBO J, V25, P1295, DOI 10.1038/sj.emboj.7601005; Luscombe NM, 1997, NUCLEIC ACIDS RES, V25, P4940, DOI 10.1093/nar/25.24.4940; Marchand C, 2009, CURR TOP MED CHEM, V9, P1016, DOI 10.2174/156802609789630910; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Michel F, 2009, EMBO J, V28, P980, DOI 10.1038/emboj.2009.41; MILLER MD, 1995, CURR BIOL, V5, P1047, DOI 10.1016/S0960-9822(95)00209-0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nowal MG, 2009, VIROLOGY, V389, P141, DOI 10.1016/j.virol.2009.04.014; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; Nowotny M, 2009, EMBO REP, V10, P144, DOI 10.1038/embor.2008.256; Richardson JM, 2009, CELL, V138, P1096, DOI 10.1016/j.cell.2009.07.012; Sato M, 2006, J MED CHEM, V49, P1506, DOI 10.1021/jm0600139; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Steiniger-White M, 2004, CURR OPIN STRUC BIOL, V14, P50, DOI 10.1016/j.sbi.2004.01.008; Summa V, 2008, J MED CHEM, V51, P5843, DOI 10.1021/jm800245z; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Valkov E, 2009, NUCLEIC ACIDS RES, V37, P243, DOI 10.1093/nar/gkn938; Wang JY, 2001, EMBO J, V20, P7333, DOI 10.1093/emboj/20.24.7333; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yang ZN, 2000, J MOL BIOL, V296, P535, DOI 10.1006/jmbi.1999.3463; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	50	521	540	3	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 11	2010	464	7286					232	U108		10.1038/nature08784	http://dx.doi.org/10.1038/nature08784			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	566JO	20118915	Green Submitted, Green Accepted			2022-12-28	WOS:000275366100037
J	Reed, C; Katz, JM				Reed, Carrie; Katz, Jacqueline M.			Serological surveys for 2009 pandemic influenza A H1N1	LANCET			English	Editorial Material							VIRUSES		[Reed, Carrie; Katz, Jacqueline M.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Reed, C (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30333 USA.	ggj2@cdc.gov						Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; CDC, 2009, FIST GLOB EST 2009 H; Chen HL, 2009, EMERG INFECT DIS, V15, P1849, DOI 10.3201/eid1511.090868; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Health Protection Agency, 2009, PAND H1N1 2009 INFL; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Reed C, 2009, EMERG INFECT DIS, V15, P2004, DOI 10.3201/eid1512.091413; Turbelin C, 2009, EURO SURVEILL, V14; Xing Z, 2009, EMERG INFECT DIS, V15, P1847, DOI 10.3201/eid1511.090685; Zhu FC, 2009, NEW ENGL J MED, V361, P2414, DOI 10.1056/NEJMoa0908535	13	20	23	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR-APR	2010	375	9720					1062	1063		10.1016/S0140-6736(09)62194-2	http://dx.doi.org/10.1016/S0140-6736(09)62194-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	578ZB	20096449				2022-12-28	WOS:000276334600008
J	Zielke, O; Arrowsmith, JR; Ludwig, LG; Akciz, SO				Zielke, Olaf; Arrowsmith, J. Ramon; Ludwig, Lisa Grant; Akciz, Sinan O.			Slip in the 1857 and Earlier Large Earthquakes Along the Carrizo Plain, San Andreas Fault	SCIENCE			English	Article							CALIFORNIA; RUPTURE	The moment magnitude (M-w) 7.9 Fort Tejon earthquake of 1857, with a similar to 350-kilometer-long surface rupture, was the most recent major earthquake along the south-central San Andreas Fault, California. Based on previous measurements of its surface slip distribution, rupture along the similar to 60-kilometer-long Carrizo segment was thought to control the recurrence of 1857-like earthquakes. New high-resolution topographic data show that the average slip along the Carrizo segment during the 1857 event was 5.3 +/- 1.4 meters, eliminating the core assumption for a linkage between Carrizo segment rupture and recurrence of major earthquakes along the south-central San Andreas Fault. Earthquake slip along the Carrizo segment may recur in earthquake clusters with cumulative slip of similar to 5 meters.	[Zielke, Olaf; Arrowsmith, J. Ramon] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; [Ludwig, Lisa Grant; Akciz, Sinan O.] Univ Calif Irvine, Program Publ Hlth, Irvine, CA 92697 USA	Arizona State University; Arizona State University-Tempe; University of California System; University of California Irvine	Zielke, O (corresponding author), Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA.	olaf.zielke@asu.edu	Ludwig, Lisa Grant/G-6442-2012	Ludwig, Lisa Grant/0000-0001-6538-8067; Akciz, Sinan/0000-0003-3142-5215; zielke, olaf/0000-0002-4797-0034	NSF [EAR-0529922]; Southern California Earthquake Center (SCEC); U.S. Geological Survey [07HQAG0008]; Directorate For Geosciences [0930643] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Southern California Earthquake Center (SCEC); U.S. Geological Survey(United States Geological Survey); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was supported by the NSF Tectonics Program and the Southern California Earthquake Center (SCEC). SCEC is funded by NSF Cooperative Agreement EAR-0529922 and U.S. Geological Survey Cooperative Agreement 07HQAG0008. The SCEC contribution number for this paper is 1310. We thank T. Jordan, D. Schwartz, and anonymous reviewers for constructive comments.	*2007 WORK GROUP C, 2008, 20071437 USGS 2007 W; Akciz SO, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2007JB005285; Arrowsmith JR, 2009, GEOMORPHOLOGY, V113, P70, DOI 10.1016/j.geomorph.2009.01.002; Ben-Zion Y, 2008, REV GEOPHYS, V46, DOI 10.1029/2008RG000260; CANE MA, 1985, SCIENCE, V228, P1085, DOI 10.1126/science.228.4703.1085; GRANT LB, 1993, B SEISMOL SOC AM, V83, P619; GRANT LB, 1994, J GEOPHYS RES-SOL EA, V99, P6819, DOI 10.1029/94JB00125; Haeussler PJ, 2004, B SEISMOL SOC AM, V94, pS23, DOI 10.1785/0120040626; Knopoff L, 2000, P NATL ACAD SCI USA, V97, P11880, DOI 10.1073/pnas.190241297; Lin AM, 2002, SCIENCE, V296, P2015, DOI 10.1126/science.1070879; Liu-Zeng J, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2004JB003601; Ludwig LG, 2010, SCIENCE, V327, P1117, DOI 10.1126/science.1182837; Rockwell TK, 2002, B SEISMOL SOC AM, V92, P79, DOI 10.1785/0120000809; Schimmelmann A, 2003, HOLOCENE, V13, P763, DOI 10.1191/0959683603hl661rp; SCHWARTZ DP, 1984, J GEOPHYS RES, V89, P5681, DOI 10.1029/JB089iB07p05681; SIEH KE, 1984, GEOL SOC AM BULL, V95, P883, DOI 10.1130/0016-7606(1984)95<883:HAOTSA>2.0.CO;2; SIEH KE, 1978, B SEISMOL SOC AM, V68, P1421; *US GEOL SURV, QUAT FAULT FOLD DAT; Wallace R. E., 1968, PROF C GEOLOGIC PROB, VXI, P6; WESNOUSKY SG, 1994, B SEISMOL SOC AM, V84, P1940; Wesnousky SG, 2008, B SEISMOL SOC AM, V98, P1609, DOI 10.1785/0120070111; Xu XW, 2009, GEOLOGY, V37, P515, DOI 10.1130/G25462A.1; Zielke O, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL036249	23	190	233	4	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2010	327	5969					1119	1122		10.1126/science.1182781	http://dx.doi.org/10.1126/science.1182781			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560KJ	20093436				2022-12-28	WOS:000274901100033
J	Bryce, J; Gilroy, K; Jones, G; Hazel, E; Black, RE; Victora, CG				Bryce, Jennifer; Gilroy, Kate; Jones, Gareth; Hazel, Elizabeth; Black, Robert E.; Victora, Cesar G.			The Accelerated Child Survival and Development programme in west Africa: a retrospective evaluation	LANCET			English	Article								Background UNICEF implemented the Accelerated Child Survival and Development (ACSD) programme in 11 west African countries between 2001 and 2005 to reduce child mortality by at least 25% by the end of 2006. We undertook a retrospective evaluation of the programme in Benin, Ghana, and Mali. Methods We used data from Demographic and Health Surveys and Multiple Indicator Cluster Surveys to compare changes in coverage for 14 ACSD interventions, nutritional status (stunting and wasting), and mortality in children younger than 5 years in the ACSD focus districts with those in the remainder of every country (comparison areas), after excluding major metropolitan areas. Findings Mortality in children younger than 5 years decreased in ACSD areas by 13% in Benin (absolute decrease 18 deaths per 1000 livebirths, p=0.12), 20% in Ghana (21 per 1000 livebirths, p=0.10), and 24% in Mali (63 per 1000 livebirths, p<0.0001), but these decreases were not greater than those in comparison areas in Benin (25%; absolute decrease 36 deaths per 1000 livebirths, p=0.15) or Mali (31%; 76 per 1000 livebirths, p=0.30; comparison data not available for Ghana). ACSD districts showed significantly greater increases than did comparison areas in coverage for preventive interventions delivered through outreach and campaign strategies in Ghana and Mali, but not Benin. Coverage in ACSD areas for correct treatment of childhood pneumonia, diarrhoea, and malaria did not differ significantly from before to after programme implementation in Benin and Mali, but decreased significantly in Ghana for malaria (from 78% to 53%, p<0.0001) and diarrhoea (from 39% to 28%, p=0.05). We recorded no significant improvements in nutritional status attributable to ACSD in the three countries. Interpretation The ACSD project did not accelerate child survival in Benin and Mali focus districts relative to comparison areas, probably because coverage for effective treatment interventions for malaria and pneumonia were not accelerated, causes of neonatal deaths and undernutrition were not addressed, and stock shortages of insecticide-treated nets restricted the potential effect of this intervention. Changes in policy and nationwide programme strengthening may have benefited from inputs by UNICEF and other partners, making an acceleration effect in the ACSD focus districts difficult to capture. Funding UNICEF, Canadian International Development Agency, Coordenacao de Aperfeicoamento de Pessoal do Nivel Superior (Brazil), and Fulbright Fellowship.	[Bryce, Jennifer; Gilroy, Kate; Jones, Gareth; Hazel, Elizabeth; Black, Robert E.; Victora, Cesar G.] Johns Hopkins Bloomberg Sch Publ Hlth, Inst Int Programs, Baltimore, MD 21205 USA; [Victora, Cesar G.] Univ Fed Pelotas, Pelotas, Brazil	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Universidade Federal de Pelotas	Bryce, J (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Inst Int Programs, 615 N Wolfe St, Baltimore, MD 21205 USA.	jbryce@jhsph.edu	Victora, Cesar Gomes/Y-2455-2019; Victora, Cesar G/D-4476-2013	Victora, Cesar Gomes/0000-0002-2465-2180; Victora, Cesar G/0000-0002-2465-2180; Hazel, Elizabeth A./0000-0002-9176-3278; Black, Robert/0000-0001-9926-7984	UNICEF; Canadian International Development Agency; Coordenacao de Aperfeicoamento de Pessoal do Nivel Superior (Brazil); Fulbright Fellowship	UNICEF; Canadian International Development Agency; Coordenacao de Aperfeicoamento de Pessoal do Nivel Superior (Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fulbright Fellowship	Funding UNICEF, Canadian International Development Agency, Coordenacao de Aperfeicoamento de Pessoal do Nivel Superior (Brazil), and Fulbright Fellowship.; We thank the staff of the Ministries of Health and National Statistics offices in Benin, Ghana, and Mali, and the UNICEF national, regional and headquarters staff and leadership for their active collaboration and participation in this evaluation effort; Easmon Otupiri and Seydou Doumbia who led teams that documented ACSD implementation and contextual factors in Ghana and Mali; Trevor Croft who helped with mortality data processing and analysis; Agbessi Amouzou who helped with mortality and equity analyses; Jeremy Schiefen who helped with administrative coordination; and the staff of Macro, International for assistance with the Supplemental surveys. UNICEF supported the evaluation through funds provided by Canadian CIDA and UNICEF country offices provided financial support for the supplemental surveys and advanced technical assistance from Macro, International.	Aker J.C., 2008, CAN WE AVOID ANOTHER; Arifeen SE, 2009, LANCET, V374, P393, DOI 10.1016/S0140-6736(09)60828-X; Athey S, 2006, ECONOMETRICA, V74, P431, DOI 10.1111/j.1468-0262.2006.00668.x; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; BRYCE J, 2008, TRACK PROGR MAT NEWB; Bryce J, 2006, LANCET, V368, P1067, DOI 10.1016/S0140-6736(06)69339-2; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; *GHAN HLTH SERV, REG DET HLTH STAT; Ghana Statistical Service. Noguchi Memorial Institute of Medical Research, 2004, GHAN DEM HLTH SURV 2; *J HOPK BLOOMB SCH, LIST EV BAS DEC MAK; Kish L, 1965, SURVEY SAMPLING; *MIN HLTH PLANN ST, 2008, DEM HLTH SURV MAL 20; Quinn VJ, 2005, J HUM LACT, V21, P345, DOI 10.1177/0890334405278383; RAO J, 2005, INTERPLAY SAMPLE SUR; Rutstein SO, 2006, GUIDE DHS STAT; *STATACORP, 2005, SURV DAT REF MAN; Tulloch J, 1999, LANCET, V354, pS16; *UN CHILDR FUND, 2004, UNICEF WHO M CHILD S; *UN CHILDR FUND, 2005, ACC CHILD SURV DEV R; United Nations Children's Fund, 2005, MULT IND CLUST SURV; Victora CG, 2009, B WORLD HEALTH ORGAN, V87, P83, DOI 10.2471/BLT.09.062828; Victora CG, 2005, HEALTH POLICY PLANN, V20, pI18, DOI 10.1093/heapol/czi050; Wolter KM, 2007, STAT SOC BEHAV SC, P1, DOI 10.1007/978-0-387-35099-8	24	62	62	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 13	2010	375	9714					572	582		10.1016/S0140-6736(09)62060-2	http://dx.doi.org/10.1016/S0140-6736(09)62060-2			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	560YO	20071020				2022-12-28	WOS:000274941900031
J	Gao, X; Zhou, LJ; Jiao, XY; Lu, FR; Yan, CY; Zeng, X; Wang, JW; Shi, YG				Gao, Xiang; Zhou, Lijun; Jiao, Xuyao; Lu, Feiran; Yan, Chuangye; Zeng, Xin; Wang, Jiawei; Shi, Yigong			Mechanism of substrate recognition and transport by an amino acid antiporter	NATURE			English	Article							AGMATINE ANTIPORTER; BACTERIAL HOMOLOG; CRYSTAL-STRUCTURE; RESISTANCE; PUTRESCINE; EXCRETION; ARGININE; SITE; IDENTIFICATION; CADAVERINE	In extremely acidic environments, enteric bacteria such as Escherichia coli rely on the amino acid antiporter AdiC to expel protons by exchanging intracellular agmatine (Agm(2+)) for extracellular arginine (Arg(+))(1-3). AdiC is a representative member of the amino acid-polyamine-organocation (APC) superfamily of membrane transporters(4,5). The structure of substrate-free AdiC revealed a homodimeric assembly, with each protomer containing 12 transmembrane segments and existing in an outward-open conformation(6,7). The overall folding of AdiC is similar to that of the Na+-coupled symporters(8-11). Despite these advances, it remains unclear how the substrate (arginine or agmatine) is recognized and transported by AdiC. Here we report the crystal structure of an E. coli AdiC variant bound to Arg at 3.0 angstrom resolution. The positively charged Arg is enclosed in an acidic binding chamber, with the head groups of Arg hydrogen-bonded to main chain atoms of AdiC and the aliphatic portion of Arg stacked by hydrophobic side chains of highly conserved residues. Arg binding induces pronounced structural rearrangement in transmembrane helix 6 (TM6) and, to a lesser extent, TM2 and TM10, resulting in an occluded conformation. Structural analysis identified three potential gates, involving four aromatic residues and Glu 208, which may work in concert to differentially regulate the upload and release of Arg and Agm.	[Gao, Xiang; Zeng, Xin; Shi, Yigong] Tsinghua Univ, Minist Educ, Prot Sci Lab, Beijing 100084, Peoples R China; [Zhou, Lijun; Jiao, Xuyao; Lu, Feiran; Yan, Chuangye; Wang, Jiawei] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Struct Biol Ctr, Sch Life Sci, Beijing 100084, Peoples R China; [Zhou, Lijun; Jiao, Xuyao; Lu, Feiran; Yan, Chuangye; Wang, Jiawei] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Jiao, Xuyao] Shandong Univ, Sch Life Sci, Jinan 250100, Shandong, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; Shandong University	Shi, YG (corresponding author), Tsinghua Univ, Minist Educ, Prot Sci Lab, Beijing 100084, Peoples R China.	shi-lab@tsinghua.edu.cn	Wang, Jiawei/D-1144-2010; Yan, Chuangye/AAJ-5832-2021	Wang, Jiawei/0000-0001-9893-8539; Yan, Chuangye/0000-0001-9338-8048; gao, xiang/0000-0001-6397-5639; Shi, Yigong/0000-0003-2030-168X; Lu, Feiran/0000-0002-1757-2895; Zhou, Lijun/0000-0002-0393-4787	Ministry of Science and Technology [2009CB918801]; Tsinghua University; National Natural Science Foundation; Beijing Municipal Commissions of Education and Science and Technology	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Tsinghua University; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Beijing Municipal Commissions of Education and Science and Technology	We thank C. Miller and Y. Xiong for discussion and exchange of information, N. Shimizu, T. Kumasaka and S. Baba at the Spring-8 beamline BL41XU for on-site assistance, and N. Yan for discussion and comments on the manuscript. This work was supported by the Ministry of Science and Technology (grant no. 2009CB918801), Tsinghua University 985 Phase II funds, National Natural Science Foundation, and Beijing Municipal Commissions of Education and Science and Technology.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Casagrande F, 2008, J BIOL CHEM, V283, P33240, DOI 10.1074/jbc.M806917200; Castanie-Cornet MP, 1999, J BACTERIOL, V181, P3525, DOI 10.1128/JB.181.11.3525-3535.1999; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Fang YL, 2007, J BIOL CHEM, V282, P176, DOI 10.1074/jbc.M610075200; Fang YL, 2009, NATURE, V460, P1040, DOI 10.1038/nature08201; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; Gong S, 2003, J BACTERIOL, V185, P4402, DOI 10.1128/JB.185.15.4402-4409.2003; Hersh BM, 1996, J BACTERIOL, V178, P3978, DOI 10.1128/jb.178.13.3978-3981.1996; Iyer R, 2003, J BACTERIOL, V185, P6556, DOI 10.1128/JB.185.22.6556-6561.2003; Jack DL, 2000, MICROBIOL-SGM, V146, P1797, DOI 10.1099/00221287-146-8-1797; Kashiwagi K, 2000, J BIOL CHEM, V275, P36007, DOI 10.1074/jbc.M006083200; Kashiwagi K, 1997, J BIOL CHEM, V272, P6318, DOI 10.1074/jbc.272.10.6318; KASHIWAGI K, 1992, P NATL ACAD SCI USA, V89, P4529, DOI 10.1073/pnas.89.10.4529; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Soksawatmaekhin W, 2004, MOL MICROBIOL, V51, P1401, DOI 10.1046/j.1365-2958.2003.03913.x; Soksawatmaekhin W, 2006, J BIOL CHEM, V281, P29213, DOI 10.1074/jbc.M600754200; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614	31	157	157	6	137	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 11	2010	463	7282					828	U143		10.1038/nature08741	http://dx.doi.org/10.1038/nature08741			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	553VG	20090677				2022-12-28	WOS:000274394300044
J	Harrison, T				Harrison, Terry			Apes Among the Tangled Branches of Human Origins	SCIENCE			English	Editorial Material							MIOCENE GREAT APE; MIDDLE MIOCENE; ARDIPITHECUS-RAMIDUS; CHIMPANZEE; KENYA		NYU, Dept Anthropol, Ctr Study Human Origins, New York, NY 10003 USA	New York University	Harrison, T (corresponding author), NYU, Dept Anthropol, Ctr Study Human Origins, New York, NY 10003 USA.	terry.harrison@nyu.edu						Agusti J, 2003, J HUM EVOL, V45, P145, DOI 10.1016/S0047-2484(03)00091-5; Andrews Peter, 2005, P103; Begun D. R., 2007, HDB PALAEOANTHROPOLO, V2, P921; Begun David R., 2003, Deinsea (Rotterdam), V10, P23; Gibbons A, 2009, SCIENCE, V326, P1598, DOI 10.1126/science.326.5960.1598-a; Gibbons A, 2009, SCIENCE, V326, P36, DOI 10.1126/science.326_36; Harrison T, 2002, CAM S BIO EVOL ANTHR, V33, P311; HARRISON T, 1989, J HUM EVOL, V18, P537, DOI 10.1016/0047-2484(89)90017-1; Kumar S, 2005, P NATL ACAD SCI USA, V102, P18842, DOI 10.1073/pnas.0509585102; Kunimatsu Y, 2007, P NATL ACAD SCI USA, V104, P19220, DOI 10.1073/pnas.0706190104; McCrossin ML, 1998, PRIMATE LOCOMOTION, P353; Moya-Sola S, 2004, SCIENCE, V306, P1339, DOI 10.1126/science.1103094; Moya-Sola S, 2009, P NATL ACAD SCI USA, V106, P9601, DOI 10.1073/pnas.0811730106; Pickford M, 2005, ANTHROPOL SCI, V113, P95, DOI 10.1537/ase.04S014; Pickford M, 2009, CR PALEVOL, V8, P413, DOI 10.1016/j.crpv.2008.11.003; Stewart CB, 1998, CURR BIOL, V8, pR582, DOI 10.1016/S0960-9822(07)00367-3; Suwa G, 2007, NATURE, V448, P921, DOI 10.1038/nature06113; White TD, 2009, SCIENCE, V326, P75, DOI 10.1126/science.1175802	18	69	71	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 29	2010	327	5965					532	534		10.1126/science.1184703	http://dx.doi.org/10.1126/science.1184703			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	549CT	20110491	Green Submitted			2022-12-28	WOS:000274020500022
J	Li, LH; Clevers, H				Li, Linheng; Clevers, Hans			Coexistence of Quiescent and Active Adult Stem Cells in Mammals	SCIENCE			English	Review							HEMATOPOIETIC PROGENITOR CELLS; SELF-RENEWAL; CAENORHABDITIS-ELEGANS; ENDOTHELIAL-CELLS; SMALL-INTESTINE; IN-VIVO; NICHE; PROLIFERATION; ACTIVATION; SKIN	Adult stem cells are crucial for physiological tissue renewal and regeneration after injury. Prevailing models assume the existence of a single quiescent population of stem cells residing in a specialized niche of a given tissue. Emerging evidence indicates that both quiescent (out of cell cycle and in a lower metabolic state) and active (in cell cycle and not able to retain DNA labels) stem cell subpopulations may coexist in several tissues, in separate yet adjoining locations. Here, we summarize these findings and propose that quiescent and active stem cell populations have separate but cooperative functional roles.	[Li, Linheng] SIMR, Kansas City, MO 64110 USA; [Li, Linheng] Univ Kansas, Med Ctr, Dept Pathol, Kansas City, KS 66160 USA; [Clevers, Hans] Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Clevers, Hans] Univ Med Ctr, NL-3584 CT Utrecht, Netherlands	University of Kansas; University of Kansas Medical Center; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Li, LH (corresponding author), SIMR, Kansas City, MO 64110 USA.	lil@stowers.org; h.clevers@hubrecht.eu			SIMR; National Institute of Diabetes and Digestive and Kidney Diseases [U01DK085507]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK085507] Funding Source: NIH RePORTER	SIMR; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J. Kimble and E. Fuchs for their critical reading and very valuable comments; colleagues, including J. Grindley, D. Scoville, X. He, J. Haug, V. Greco, etc., for suggestions and discussions; and J. Perry and K. Tannen for proofreading. We regret that we are unable to cite other relevant studies because of space constraints. L. L. was supported by SIMR and by grant U01DK085507 from National Institute of Diabetes and Digestive and Kidney Diseases.	ABKOWITZ JL, 1990, P NATL ACAD SCI USA, V87, P9062, DOI 10.1073/pnas.87.22.9062; Antoine M, 2005, GROWTH FACTORS, V23, P87, DOI 10.1080/08977190500096004; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Barker N, 2007, GASTROENTEROLOGY, V133, P1755, DOI 10.1053/j.gastro.2007.10.029; Barker N, 2008, GENE DEV, V22, P1856, DOI 10.1101/gad.1674008; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Crittenden SL, 2006, MOL BIOL CELL, V17, P3051, DOI 10.1091/mbc.E06-03-0170; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Fuchs E, 2000, CELL, V100, P143, DOI 10.1016/S0092-8674(00)81691-8; Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; Haug JS, 2008, CELL STEM CELL, V2, P367, DOI 10.1016/j.stem.2008.01.017; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Kiel MJ, 2007, NATURE, V449, P238, DOI 10.1038/nature06115; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; KIMBLE JE, 1981, DEV BIOL, V81, P208, DOI 10.1016/0012-1606(81)90284-0; Kohler A, 2009, BLOOD, V114, P290, DOI 10.1182/blood-2008-12-195644; Kollet O, 2006, NAT MED, V12, P657, DOI 10.1038/nm1417; Kosinski C, 2007, P NATL ACAD SCI USA, V104, P15418, DOI 10.1073/pnas.0707210104; Lee G, 2009, P NATL ACAD SCI USA, V106, P4701, DOI 10.1073/pnas.0900751106; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; McKenzie JL, 2006, NAT IMMUNOL, V7, P1225, DOI 10.1038/ni1393; Narbonne P, 2006, DEVELOPMENT, V133, P611, DOI 10.1242/dev.02232; Niemann C, 2002, TRENDS CELL BIOL, V12, P185, DOI 10.1016/S0962-8924(02)02263-8; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Potten CS, 1997, INT J EXP PATHOL, V78, P219, DOI 10.1046/j.1365-2613.1997.280362.x; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Scoville DH, 2008, GASTROENTEROLOGY, V134, P849, DOI 10.1053/j.gastro.2008.01.079; Song XQ, 2007, DEVELOPMENT, V134, P1071, DOI 10.1242/dev.003392; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Waghmare SK, 2008, EMBO J, V27, P1309, DOI 10.1038/emboj.2008.72; Wechezak AR, 2003, EXP CELL RES, V288, P335, DOI 10.1016/S0014-4827(03)00232-5; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639; Yokota T, 2008, J IMMUNOL, V181, P6061, DOI 10.4049/jimmunol.181.9.6061; Zhang JW, 2006, STEM CELLS, V24, P2826, DOI 10.1634/stemcells.2005-0544; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhang YV, 2009, CELL STEM CELL, V5, P267, DOI 10.1016/j.stem.2009.06.004	49	870	908	1	133	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 29	2010	327	5965					542	545		10.1126/science.1180794	http://dx.doi.org/10.1126/science.1180794			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549CT	20110496	Green Accepted			2022-12-28	WOS:000274020500027
J	Stark, LA; Pompei, K				Stark, Louisa A.; Pompei, Kevin			Making Genetics Easy to Understand	SCIENCE			English	Editorial Material									[Stark, Louisa A.; Pompei, Kevin] Univ Utah, Genet Sci Learning Ctr, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Stark, LA (corresponding author), Univ Utah, Genet Sci Learning Ctr, Salt Lake City, UT 84112 USA.	louisa.stark@utah.edu		Stark, Louisa/0000-0002-2978-7279	Howard Hughes Medical Institute Funding Source: Medline; NCRR NIH HHS [R25 RR016291, R25 RR023288] Funding Source: Medline; NIDA NIH HHS [R25 DA015461] Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; Dunn R., 1978, TEACHING STUDENTS TH; Gardner H., 1993, FRAMES MIND THEORY M; Mayer R. E., 2002, NEW DIRECTIONS TEACH, P55, DOI DOI 10.1002/TL.47; National Research Council (NRC), 1996, NAT SCI ED STAND; NISSELLE AE, 2009, THESIS U MELBOURNE	6	6	6	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 29	2010	327	5965					538	539		10.1126/science.1183029	http://dx.doi.org/10.1126/science.1183029			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	549CT	20110495	Green Accepted			2022-12-28	WOS:000274020500026
J	Boger-Megiddo, I; Heckbert, SR; Weiss, NS; McKnight, B; Furberg, CD; Wiggins, KL; Delaney, JAC; Siscovick, DS; Larson, EB; Lemaitre, RN; Smith, NL; Rice, KM; Glazer, NL; Psaty, BM				Boger-Megiddo, Inbal; Heckbert, Susan R.; Weiss, Noel S.; McKnight, Barbara; Furberg, Curt D.; Wiggins, Kerri L.; Delaney, Joseph A. C.; Siscovick, David S.; Larson, Eric B.; Lemaitre, Rozenn N.; Smith, Nicholas L.; Rice, Kenneth M.; Glazer, Nicole L.; Psaty, Bruce M.			Myocardial infarction and stroke associated with diuretic based two drug antihypertensive regimens: population based case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ANTI HYPERTENSIVE DRUGS; CARDIOVASCULAR MORBIDITY; CALCIUM-ANTAGONISTS; RANDOMIZED-TRIAL; ELDERLY-PATIENTS; HEART-FAILURE; OUTCOMES; AMLODIPINE; MORTALITY; RISK	Objective To examine the association of myocardial infarction and stroke incidence with several commonly used two drug antihypertensive treatment regimens. Design Population based case-control study. Setting Group Health Cooperative, Seattle, WA, USA. Participants Cases (n=353) were aged 30-79 years, had pharmacologically treated hypertension, and were diagnosed with a first fatal or non-fatal myocardial infarction or stroke between 1989 and 2005. Controls (n=952) were a random sample of Group Health members who had pharmacologically treated hypertension. We excluded individuals with heart failure, evidence of coronary heart disease, diabetes, or chronic kidney disease. Exposures One of three common two drug combinations: diuretics plus beta blockers; diuretics plus calcium channel blockers; and diuretics plus angiotensin converting enzyme inhibitors or angiotensin receptor blockers. Main outcome measures Myocardial infarction or stroke. Results Compared with users of diuretics plus beta blockers, users of diuretics plus calcium channel blockers had an increased risk of myocardial infarction (adjusted odds ratio (OR) 1.98, 95% confidence interval 1.37 to 2.87) but not of stroke (OR 1.02, 95% CI 0.63 to 1.64). The risks of myocardial infarction and stroke in users of diuretics plus angiotensin converting enzyme inhibitors or angiotensin receptor blockers were slightly but not significantly lower than in users of diuretics plus beta blockers (myocardial infarction: OR 0.76, 95% CI 0.52 to 1.11; stroke: OR 0.71, 95% CI 0.46 to 1.10). Conclusions In patients with hypertension, diuretics plus calcium channel blockers were associated with a higher risk of myocardial infarction than other common two drug treatment regimens. A large trial of second line antihypertensive treatments in patients already on low dose diuretics is required to provide a solid basis for treatment recommendations.	[Heckbert, Susan R.; Wiggins, Kerri L.; Siscovick, David S.; Lemaitre, Rozenn N.; Smith, Nicholas L.; Glazer, Nicole L.; Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; [Weiss, Noel S.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [McKnight, Barbara; Rice, Kenneth M.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Furberg, Curt D.] Wake Forest Univ, Bowman Gray Sch Med, Dept Publ Hlth Sci, Winston Salem, NC 27157 USA; [Larson, Eric B.] Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Wake Forest University; Wake Forest Baptist Medical Center; Group Health Cooperative	Psaty, BM (corresponding author), Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA.	psaty@u.washington.edu	Rice, Kenneth M/A-4150-2013; Delaney, Joseph A/J-8204-2019	Rice, Kenneth M/0000-0001-5779-4495; Delaney, Joseph A/0000-0003-1771-1776; Wiggins, Kerri L/0000-0003-2749-1279; Glazer, Nicole/0000-0002-6397-609X	National Heart, Lung, and Blood Institute [HL43201, HL40628, HL60739, HL68639, HL68986, HL73410, HL74745, HL085251, HL007902]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL040628, R01HL074745, R01HL043201, R01HL073410, R01HL060739, T32HL007902, R29HL040628, R01HL068639, R01HL068986, R01HL085251] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported in part by grants HL43201 (BMP), HL40628 (BMP), HL60739 (BMP), HL68639 (BMP), HL68986 (SRH), HL73410 (NLS), HL74745 (BMP), HL085251 (BMP), and HL007902 (DSS) from the National Heart, Lung, and Blood Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Heart, Lung, and Blood Institute or the National Institutes of Health.	Alderman MH, 2005, HYPERTENSION, V46, P1, DOI 10.1161/01.HYP.0000168924.37091.58; BEARD K, 1992, BMJ-BRIT MED J, V304, P412, DOI 10.1136/bmj.304.6824.412; Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; Casas JP, 2005, LANCET, V366, P2026, DOI 10.1016/S0140-6736(05)67814-2; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Elliott WJ, 2007, LANCET, V369, P201, DOI 10.1016/S0140-6736(07)60108-1; Flather MD, 2000, LANCET, V355, P1575, DOI 10.1016/S0140-6736(00)02212-1; Furberg CD, 2000, JAMA-J AM MED ASSOC, V283, P1967; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Hansson L, 1999, LANCET, V353, P611, DOI 10.1016/S0140-6736(98)05012-0; Hansson L, 1999, LANCET, V354, P1751, DOI 10.1016/S0140-6736(99)10327-1; Heidenreich PA, 1999, JAMA-J AM MED ASSOC, V281, P1927, DOI 10.1001/jama.281.20.1927; Horton NJ, 2007, AM STAT, V61, P79, DOI 10.1198/000313007X172556; Jamerson K, 2008, NEW ENGL J MED, V359, P2417, DOI 10.1056/NEJMoa0806182; Julius S, 2004, LANCET, V363, P2022, DOI 10.1016/S0140-6736(04)16451-9; Laragh J, 2001, AM J HYPERTENS, V14, P491, DOI 10.1016/S0895-7061(01)02097-0; Lechat P, 1998, CIRCULATION, V98, P1184, DOI 10.1161/01.CIR.98.12.1184; Lindholm LH, 2002, LANCET, V359, P1004, DOI 10.1016/S0140-6736(02)08090-X; *NAT COLL CTR CHRO, 2006, HYP MAN AD PRIM CAR; Neal B, 2000, LANCET, V356, P1955; *NIH, 2008, SYST BLOOD PRESS INT; Pepine CJ, 2003, JAMA-J AM MED ASSOC, V290, P2805, DOI 10.1001/jama.290.21.2805; Psaty BM, 2006, JAMA-J AM MED ASSOC, V295, P1704, DOI 10.1001/jama.295.14.1704; PSATY BM, 1995, JAMA-J AM MED ASSOC, V274, P620, DOI 10.1001/jama.274.8.620; Psaty BN, 2003, JAMA-J AM MED ASSOC, V289, P2534, DOI 10.1001/jama.289.19.2534; The AO, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981	29	13	15	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 25	2010	340								c103	10.1136/bmj.c103	http://dx.doi.org/10.1136/bmj.c103			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	549XZ	20100777	Green Published, hybrid			2022-12-28	WOS:000274089100001
J	Cohen, SP; Brown, C; Kurihara, C; Plunkett, A; Nguyen, C; Strassels, SA				Cohen, Steven P.; Brown, Charlie; Kurihara, Connie; Plunkett, Anthony; Nguyen, Conner; Strassels, Scott A.			Diagnoses and factors associated with medical evacuation and return to duty for service members participating in Operation Iraqi Freedom or Operation Enduring Freedom: a prospective cohort study	LANCET			English	Article							LOW-BACK-PAIN; NECK PAIN; GULF-WAR; MILITARY; MANAGEMENT; CASUALTIES; DISORDERS; INJURY	Background Anticipation of the types of injuries that occur in modem warfare is essential to plan operations and maintain a healthy military. We aimed to identify the diagnoses that result in most medical evacuations, and ascertain which demographic and clinical variables were associated with return to duty. Methods Demographic and clinical data were prospectively obtained for US military personnel who had been medically evacuated from Operation Iraqi Freedom or Operation Enduring Freedom (January, 2004-December, 2007). Diagnoses were categorised post hoc according to the International Classification of Diseases codes that were recorded at the time of transfer. The primary outcome measure was return to duty within 2 weeks. Findings 34006 personnel were medically evacuated, of whom 89% were men, 91% were enlisted, 82% were in the army, and 86% sustained an injury in Iraq. The most common reasons for medical evacuation were: musculoskeletal and connective tissue disorders (n=8104 service members, 24%), combat injuries (n=4713, 14%), neurological disorders (n=3502, 10%), psychiatric diagnoses (n=3108, 9%), and spinal pain (n=2445, 7%). The factors most strongly associated with return to duty were being a senior officer (adjusted OR 2.01, 95% Cl 1.71-2.35, p<0.0001), having a non-battle-related injury or disease (3.18, 2.77-3.67, p<0.0001), and presenting with chest or abdominal pain (2.48, 1.61-3.81, p<0.0001), a gastrointestinal disorder (non-surgical 2.32, 1.51-3.56, p=0.0001; surgical 2.62, 1.69-4.06, p<0.0001), or a genitourinary disorder (2.19, 1.43-3.36, p=0.0003). Covariates associated with a decreased probability of return to duty were serving in the navy or coast guard (0.59, 0.45-0.78, p=0.0002), or marines (0.86,0.77-0.96, p=0.0083); and presenting with a combat injury (0.27, 0.17-0.44, p<0.0001), a psychiatric disorder (0.28, 0.18-0.43, p<0.0001), musculoskeletal or connective tissue disorder (0.46, 0.30-0.71, p=0.0004), spinal pain (0.41, 0.26-0.63, p=0.0001), or other wound (0.54, 0.34-0.84, p=0.0069). Interpretation Implementation of preventive measures for service members who are at highest risk of evacuation, forward-deployed treatment, and therapeutic interventions could reduce the effect of non-battle-related injuries and disease on military readiness.	[Cohen, Steven P.] Johns Hopkins Sch Med, Pain Management Div, Baltimore, MD USA; [Brown, Charlie] Johns Hopkins Sch Med, Dept Anesthesiol, Baltimore, MD USA; [Cohen, Steven P.; Kurihara, Connie; Plunkett, Anthony] Walter Reed Army Med Ctr, Pain Management Div, Anesthesia Serv, Dept Surg, Washington, DC 20307 USA; [Nguyen, Conner] Landstuhl Reg Med Ctr, Dept Surg, Landstuhl, Germany; [Strassels, Scott A.] Univ Texas Austin, Div Pharm Practice, Austin, TX 78712 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; United States Department of Defense; United States Army; Walter Reed National Military Medical Center; Landstuhl Regional Medical Center; University of Texas System; University of Texas Austin	Cohen, SP (corresponding author), 550 North Broadway,Suite 301, Baltimore, MD 21029 USA.	scohen40@jhmi.edu			John P Murtha Neuroscience and Pain Institute, Johnstown, PA, USA; US Army Regional Anesthesia and Pain Management Initiative, Washington, DC, USA	John P Murtha Neuroscience and Pain Institute, Johnstown, PA, USA; US Army Regional Anesthesia and Pain Management Initiative, Washington, DC, USA	Funded by a Congressional grant from the John P Murtha Neuroscience and Pain Institute, Johnstown, PA, USA; and the US Army Regional Anesthesia and Pain Management Initiative, Washington, DC, USA. The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting the views of the Department of the Army or the Department of Defense.	[Anonymous], 2014, INT CLASS DIS 9 REV; Ariens GAM, 2001, AM J IND MED, V39, P180, DOI 10.1002/1097-0274(200102)39:2<180::AID-AJIM1005>3.0.CO;2-#; Barrett DH, 2002, PSYCHOSOMATICS, V43, P195, DOI 10.1176/appi.psy.43.3.195; Bellamy RF, 1996, ANESTHESIA PERIOPERA; Carroll LJ, 2008, SPINE, V33, pS93, DOI 10.1097/BRS.0b013e31816445d4; Cohen SP, 2005, ANESTH ANALG, V101, P1098, DOI 10.1213/01.ane.0000169332.45209.cf; COHEN SP, SPINE IN PRESS; Cohen SP, 2009, ARCH INTERN MED, V169, P1916, DOI 10.1001/archinternmed.2009.380; Cohen SP, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2718; Croft AM, 1999, MIL MED, V164, P460, DOI 10.1093/milmed/164.7.460; HOEFFLER DF, 1981, MIL MED, V146, P776; Holcomb JB, 2006, J TRAUMA, V60, P397, DOI 10.1097/01.ta.0000203581.75241.f1; Leclerc A, 1999, SPINE, V24, P1455, DOI 10.1097/00007632-199907150-00011; Peake JB, 2000, AM J PREV MED, V18, P4, DOI 10.1016/S0749-3797(00)00104-5; Pincus Tamar, 2002, Spine (Phila Pa 1976), V27, pE109, DOI 10.1097/00007632-200203010-00017; Pransky G, 2002, SPINE, V27, P864, DOI 10.1097/00007632-200204150-00017; SHANE L, 2005, STARS STRIPES W 1209; SONGTAG D, 2008, NY TIMES NEW YO 0113; TYSON AS, 2006, WASHINGTON POST 1220; *US DEP VET AFF, HOM VET OV HOM; White RL, 2007, ANESTHESIOLOGY, V107, P1003, DOI 10.1097/01.anes.0000290605.55736.e1; Writer JV, 2000, AM J PREV MED, V18, P64, DOI 10.1016/S0749-3797(00)00115-X; Young Richard S K, 2008, Conn Med, V72, P13; ZOROYA G, 2008, US TODAY WASHIN 1020	24	131	141	0	18	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 23	2010	375	9711					301	309		10.1016/S0140-6736(09)61797-9	http://dx.doi.org/10.1016/S0140-6736(09)61797-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	549QS	20109957				2022-12-28	WOS:000274069300031
J	Giacaman, R; Rabaia, Y; Nguyen-Gillham, V				Giacaman, Rita; Rabaia, Yoke; Nguyen-Gillham, Viet			Domestic and political violence: the Palestinian predicament	LANCET			English	Editorial Material							INTIMATE-PARTNER VIOLENCE; TERRITORY; HEALTH		[Giacaman, Rita; Rabaia, Yoke; Nguyen-Gillham, Viet] Birzeit Univ, Inst Community & Publ Hlth, Birzeit, Israel	Birzeit University	Giacaman, R (corresponding author), Birzeit Univ, Inst Community & Publ Hlth, Birzeit, Israel.	rita@birzeit.edu						Brown RM, 2002, AGGRESS VIOLENT BEH, V7, P499, DOI 10.1016/S1359-1789(01)00077-5; Clark CJ, 2010, LANCET, V375, P310, DOI 10.1016/S0140-6736(09)61827-4; Das V, 2007, LIFE AND WORDS: VIOLENCE AND THE DESCENT INTO THE ORDINARY, P1; FANON F, 2004, VIOLENCE WRETCHED EA, P1; Giacaman R, 2009, LANCET, V373, P837, DOI 10.1016/S0140-6736(09)60107-0; Gilligan James, 2001, PREVENTING VIOLENCE; Goodman LA, 2009, TRAUMA VIOLENCE ABUS, V10, P306, DOI 10.1177/1524838009339754; JOHNSON P, 2008, DYNAMICS, V20, P119; Palestinian Central Bureau of Statistics, 2006, PRESS C PREL RES DOM	9	6	6	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 23	2010	375	9711					259	260		10.1016/S0140-6736(09)62005-5	http://dx.doi.org/10.1016/S0140-6736(09)62005-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	549QS	20109932				2022-12-28	WOS:000274069300006
J	Bienvenu, F; Jirawatnotai, S; Elias, JE; Meyer, CA; Mizeracka, K; Marson, A; Frampton, GM; Cole, MF; Odom, DT; Odajima, J; Geng, Y; Zagozdzon, A; Jecrois, M; Young, RA; Liu, XS; Cepko, CL; Gygi, SP; Sicinski, P				Bienvenu, Frederic; Jirawatnotai, Siwanon; Elias, Joshua E.; Meyer, Clifford A.; Mizeracka, Karolina; Marson, Alexander; Frampton, Garrett M.; Cole, Megan F.; Odom, Duncan T.; Odajima, Junko; Geng, Yan; Zagozdzon, Agnieszka; Jecrois, Marie; Young, Richard A.; Liu, X. Shirley; Cepko, Constance L.; Gygi, Steven P.; Sicinski, Piotr			Transcriptional role of cyclin D1 in development revealed by a genetic-proteomic screen	NATURE			English	Article							KINASE-INDEPENDENT MECHANISM; CELL-CYCLE; ESTROGEN-RECEPTOR; MOUSE RETINA; BREAST; TRANSFORMATION; RECRUITMENT; EXPRESSION; REPRESSES; CANCER	Cyclin D1 belongs to the core cell cycle machinery, and it is frequently overexpressed in human cancers(1,2). The full repertoire of cyclin D1 functions in normal development and oncogenesis is unclear at present. Here we developed Flag-and haemagglutinin-tagged cyclin D1 knock-in mouse strains that allowed a high-throughput mass spectrometry approach to search for cyclin D1-binding proteins in different mouse organs. In addition to cell cycle partners, we observed several proteins involved in transcription. Genome-wide location analyses (chromatin immunoprecipitation coupled to DNA microarray; ChIP-chip) showed that during mouse development cyclin D1 occupies promoters of abundantly expressed genes. In particular, we found that in developing mouse retinas-an organ that critically requires cyclin D1 function(3,4)-cyclin D1 binds the upstream regulatory region of the Notch1 gene, where it serves to recruit CREB binding protein (CBP) histone acetyltransferase. Genetic ablation of cyclin D1 resulted in decreased CBP recruitment, decreased histone acetylation of the Notch1 promoter region, and led to decreased levels of the Notch1 transcript and protein in cyclin D1-null (Ccnd1(-/-)) retinas. Transduction of an activated allele of Notch1 into Ccnd1(-/-) retinas increased proliferation of retinal progenitor cells, indicating that upregulation of Notch1 signalling alleviates the phenotype of cyclin D1-deficiency. These studies show that in addition to its well-established cell cycle roles, cyclin D1 has an in vivo transcriptional function in mouse development. Our approach, which we term 'genetic-proteomic', can be used to study the in vivo function of essentially any protein.	[Bienvenu, Frederic; Jirawatnotai, Siwanon; Odajima, Junko; Geng, Yan; Zagozdzon, Agnieszka; Jecrois, Marie; Sicinski, Piotr] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Bienvenu, Frederic; Jirawatnotai, Siwanon; Odajima, Junko; Geng, Yan; Zagozdzon, Agnieszka; Jecrois, Marie; Sicinski, Piotr] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Elias, Joshua E.; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Meyer, Clifford A.; Liu, X. Shirley] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Meyer, Clifford A.; Liu, X. Shirley] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Mizeracka, Karolina; Cepko, Constance L.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Jirawatnotai, Siwanon] Mahidol Univ, Inst Mol Biosci, Salaya 73170, Nakhon Prathom, Thailand; [Marson, Alexander; Frampton, Garrett M.; Cole, Megan F.; Young, Richard A.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Marson, Alexander; Frampton, Garrett M.; Cole, Megan F.; Young, Richard A.] MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Odom, Duncan T.] Canc Res UK, Cambridge Res Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Mahidol University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Sicinski, P (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, 44 Binney St, Boston, MA 02115 USA.	Peter_Sicinski@dfci.harvard.edu	Pillay, Nischalan/F-9536-2012; Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647; Odom, Duncan/0000-0001-6201-5599; Frampton, Garrett/0000-0002-2361-2750	Cancer Research UK; European Research Council; EMBO Young Investigator Award;  [R01 CA108420];  [P01 CA080111];  [P01 CA109901];  [HG3456];  [R01 EYO9676];  [HG004069]; Cancer Research UK [15603] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA108420, P01CA080111, P01CA109901] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY008064, R01EY009676] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668, R01HG004069, R01HG003456] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); European Research Council(European Research Council (ERC)European Commission); EMBO Young Investigator Award(European Molecular Biology Organization (EMBO)); ; ; ; ; ; ; Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank T. Liu, Y. Ndassa-Colday, J. Marto, R. Bronson, B. Smith, E. Jacobsen, M. Brown and members of the Brown laboratory for help at different stages of the project, M. Ewen for p-Babe-puro-Cyclin D1 and cyclin D1(K112E) plasmids, G. Seigel for R28 cells, T. Volkert, J. Love and E. Fox for help with arrays, P. White and O. Smirnova for help with BCBC arrays. This work was supported by grants R01 CA108420, P01 CA080111 and P01 CA109901 (to P. S.), HG3456 (to S. P. G.), R01 EYO9676 (to C. L. C.), HG004069 (to X. S. L.), Cancer Research UK, European Research Council Starting Grant, and an EMBO Young Investigator Award (all to D. T. O.). P. S. is a Leukemia and Lymphoma Society Scholar.	Adnane J, 1999, ONCOGENE, V18, P239, DOI 10.1038/sj.onc.1202297; Alexson TO, 2006, DEV NEUROSCI-BASEL, V28, P34, DOI 10.1159/000090751; Blackshaw S, 2004, PLOS BIOL, V2, P1411, DOI 10.1371/journal.pbio.0020247; Coqueret O, 2002, GENE, V299, P35, DOI 10.1016/S0378-1119(02)01055-7; Das G, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-15; FANTL V, 1995, GENE DEV, V9, P2364, DOI 10.1101/gad.9.19.2364; Flora A, 2007, P NATL ACAD SCI USA, V104, P15382, DOI 10.1073/pnas.0707456104; Fu MF, 2005, J BIOL CHEM, V280, P16934, DOI 10.1074/jbc.M500403200; Fu MF, 2005, J BIOL CHEM, V280, P29728, DOI 10.1074/jbc.M503188200; Hatakeyama J, 2004, SEMIN CELL DEV BIOL, V15, P83, DOI 10.1016/j.semcdb.2003.09.005; Heine P, 2008, DEVELOPMENT, V135, P805, DOI 10.1242/dev.012088; Inoue K, 1998, MOL CELL BIOL, V18, P1590, DOI 10.1128/MCB.18.3.1590; Jadhav AR, 2006, DEVELOPMENT, V133, P913, DOI 10.1242/dev.02245; Jadhav AP, 2006, P NATL ACAD SCI USA, V103, P18998, DOI 10.1073/pnas.0608155103; Lindsay J, 2008, CTS-CLIN TRANSL SCI, V1, P107, DOI 10.1111/j.1752-8062.2008.00041.x; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; McMahon C, 1999, P NATL ACAD SCI USA, V96, P5382, DOI 10.1073/pnas.96.10.5382; McManus KJ, 2003, MOL CELL BIOL, V23, P7611, DOI 10.1128/MCB.23.21.7611-7627.2003; Musgrove EA, 2006, GROWTH FACTORS, V24, P13, DOI 10.1080/08977190500361812; Ratineau C, 2002, J BIOL CHEM, V277, P8847, DOI 10.1074/jbc.M110747200; Ronchini C, 2001, MOL CELL BIOL, V21, P5925, DOI 10.1128/MCB.21.17.5925-5934.2001; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Seigel GM, 1996, IN VITRO CELL DEV-AN, V32, P66; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; SICINSKI P, 1995, CELL, V82, P621, DOI 10.1016/0092-8674(95)90034-9; Yaron O, 2006, DEVELOPMENT, V133, P1367, DOI 10.1242/dev.02311; Yeung SC, 2005, NEUROREPORT, V16, P673, DOI 10.1097/00001756-200505120-00004; Yu QY, 2001, NATURE, V411, P1017, DOI 10.1038/35082500; Zwijsen RML, 1998, GENE DEV, V12, P3488, DOI 10.1101/gad.12.22.3488	30	211	217	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 21	2010	463	7279					374	378		10.1038/nature08684	http://dx.doi.org/10.1038/nature08684			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545PM	20090754	Green Submitted, Green Accepted			2022-12-28	WOS:000273748100048
J	Grayling, AC				Grayling, A. C.			Philosophically Speaking End libel law's chilling effect on science	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London Birkbeck Coll, London WC1E 7HX, England	University of London; Birkbeck University London	Grayling, AC (corresponding author), Univ London Birkbeck Coll, London WC1E 7HX, England.	a.grayling@bbk.ac.uk						2010, BRIT MED J, V340, pC110	1	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 20	2010	340								c339	10.1136/bmj.c339	http://dx.doi.org/10.1136/bmj.c339			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	548HO	20089580				2022-12-28	WOS:000273951300015
J	Feig, D				Feig, Denice			Treatment of mild gestational diabetes did not prevent neonatal complications but reduced fetal overgrowth	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Toronto, Toronto, ON, Canada	University of Toronto	Feig, D (corresponding author), Univ Toronto, Toronto, ON, Canada.		Feig, Denice/C-4606-2015					Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973	1	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 19	2010	152	2							JC1-6	10.7326/0003-4819-152-2-201001190-02006	http://dx.doi.org/10.7326/0003-4819-152-2-201001190-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	548IE	20083821				2022-12-28	WOS:000273953000030
J	Banerjee, A; Hollis, A; Pogge, T				Banerjee, Amitava; Hollis, Aidan; Pogge, Thomas			The Health Impact Fund: incentives for improving access to medicines	LANCET			English	Editorial Material							PATENTS		[Banerjee, Amitava] Univ Oxford, Stroke Prevent Res Unit, Oxford OX3 9DU, England; [Pogge, Thomas] Yale Univ, Dept Philosophy, New Haven, CT USA; [Hollis, Aidan] Univ Calgary, Dept Econ, Calgary, AB T2N 1N4, Canada	University of Oxford; Yale University; University of Calgary	Banerjee, A (corresponding author), Univ Oxford, John Radcliffe Hosp, Stroke Prevent Res Unit, Level 6,West Wing, Oxford OX3 9DU, England.	amitava.banerjee@clneuro.ox.ac.uk	Banerjee, Amitava/D-4381-2014	Banerjee, Amitava/0000-0001-8741-3411; Hollis, Aidan/0000-0001-5125-2193				[Anonymous], 2009, LANCET, V373, P693, DOI 10.1016/S0140-6736(09)60410-4; Attaran A, 2004, HEALTH AFFAIR, V23, P155, DOI 10.1377/hlthaff.23.3.155; Attaran A, 2001, JAMA-J AM MED ASSOC, V286, P1886, DOI 10.1001/jama.286.15.1886; BACIU A, 2007, FUTURE DRUG SAFETY P; CHEN S, 2008, 4703 WPS WORLD BANK; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Garber AM, 2009, NEW ENGL J MED, V360, P1169, DOI 10.1056/NEJMp0808414; Gemmill MC, 2007, HEALTH ECON, V16, P627, DOI 10.1002/hec.1190; HOLLIS A, 2007, WHO PUBL HEAR UNPUB; HOLLIS A, HLTH IMPACT FUND MAK; Horton R, 2002, LANCET, V359, P1605, DOI 10.1016/S0140-6736(02)08523-9; OLIVEIRA MA, 2004, B WORLD HEALTH ORGAN, V82, P8150; PEDERSEN TR, 1994, LANCET, V344, P1383; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; *UN MILL DEV GOALS, GAT UN SYST WORK MDG; von Schirnding Y, 2005, GLOBALIZATION HEALTH, V1, DOI 10.1186/1744-8603-1-8; *WHO, 2005, CHRON DIS REP 2005, pCH2; WHO (World Health Organization), 1988, WORLD DRUG SIT; WITTY A, 2009, BIG PHARMA CATALYST; World Trade Organization, TRAD REL ASP INT PRO; 2000, GLOBAL POVERTY REPOR	21	49	50	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 9	2010	375	9709					166	169		10.1016/S0140-6736(09)61296-4	http://dx.doi.org/10.1016/S0140-6736(09)61296-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	544NM	20109894				2022-12-28	WOS:000273664500034
J	Eron, JJ; Young, B; Cooper, DA; Youle, M; DeJesus, E; Andrade-Villanueva, J; Workman, C; Zajdenverg, R; Fatkenheuer, G; Berger, DS; Kumar, PN; Rodgers, AJ; Shaughnessy, MA; Walker, ML; Barnard, RJO; Miller, MD; DiNubile, MJ; Nguyen, BY; Leavitt, R; Xu, X; Sklar, P				Eron, Joseph J.; Young, Benjamin; Cooper, David A.; Youle, Michael; DeJesus, Edwin; Andrade-Villanueva, Jaime; Workman, Cassy; Zajdenverg, Roberto; Faetkenheuer, Gerd; Berger, Daniel S.; Kumar, Princy N.; Rodgers, Anthony J.; Shaughnessy, Melissa A.; Walker, Monica L.; Barnard, Richard J. O.; Miller, Michael D.; DiNubile, Mark J.; Nguyen, Bach-Yen; Leavitt, Randi; Xu, Xia; Sklar, Peter		SWITCHMRK 1 Investigator; SWITCHMRK 2 Investigator	Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials	LANCET			English	Article							TREATMENT-NAIVE PATIENTS; INTEGRASE INHIBITOR RALTEGRAVIR; COMBINATION THERAPY; ANTIRETROVIRAL THERAPY; DAILY LOPINAVIR/RITONAVIR; 2008 RECOMMENDATIONS; SAFETY; EFFICACY; MONOTHERAPY; ATAZANAVIR	Background To reduce lipid abnormalities and other side-effects associated with antiretroviral regimens containing lopinavir-ritonavir, patients might want to switch one or more components of their regimen. We compared substitution of raltegravir for lopinavir-ritonavir with continuation of lopinavir-ritonavir in HIV-infected patients with stable viral suppression on lopinavir-ritonavir-based combination therapy. Methods The SWITCHMRK I and 2 studies were multicentre, double-blind, double-dummy, phase 3, randomised controlled trials. HIV-infected patients aged 18 years or older were eligible if they had documented viral RNA (vRNA) concentration below the limit of assay quantification for at least 3 months while on a lopinavir-ritonavir-based regimen. 707 eligible patients were randomly allocated by interactive voice response system in a 1:1 ratio to switch from lopinavir-ritonavir to raltegravir (400 mg twice daily; n=353) or to remain on lopinavir-ritonavir (two 200 mg/50 mg tablets twice daily; n=354), while continuing background therapy consisting of at least two nucleoside or nucleotide reverse transcriptase inhibitors. Primary endpoints were the mean percentage change in serum lipid concentrations from baseline to week 12; the proportion of patients with vRNA concentration less than 50 copies per mL at week 24 (with all treated patients who did not complete the study counted as failures) with a prespecified non-inferiority margin of -12% for each study; and the frequency of adverse events up to 24 weeks. Analyses were done according to protocol. These trials are registered with ClinicalTrials.gov, numbers NCT00443703 and NCT00443729. Findings 702 patients received at least one dose of study drug and were included in the efficacy and safety analyses for the combined trials (raltegravir, n=350; lopinavir-ritonavir, n=352). Percentage changes in lipid concentrations from baseline to week 12 were significantly greater (p<0.0001) in the raltegravir group than in the lopinavir-ritonavir group in each study, yielding combined results for total cholesterol -12.6% vs 1.0%, non-HDL cholesterol -15.0% vs 2.6%, and triglycerides -42.2% vs 6.2%. At week 24, 293 (84.4%, 95% CI 80.2-88.1) of 347 patients in the raltegravir group had vRNA concentration less than 50 copies per mL compared with 319 (90.6%, 87.1-93.5) of 352 patients in the lopinavir-ritonavir group (treatment difference -6.2%, -11.2 to -1.3). Clinical and laboratory adverse events occur-red at similar frequencies in the treatment groups. There were no serious drug-related adverse events or deaths. The only drug-related clinical adverse event of moderate to severe intensity reported in 1% or more of either treatment group was diarrhoea, which occurred in ten patients in the lopinavir-ritonavir group (3%) and no patients in the raltegravir group. The studies were terminated at week 24 because of lower than expected virological efficacy in the raltegravir group compared with the lopinavir-ritonavir group. Interpretation Although switching to raltegravir was associated with greater reductions in serum lipid concentrations than was continuation of lopinavir-ritonavir, efficacy results did not establish non-inferiority of raltegravir to lopinavir-ritonavir.	[Eron, Joseph J.] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Young, Benjamin] Denver Infect Dis Consultants, Denver, CO USA; [Cooper, David A.] Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia; [Youle, Michael] Garrett Anderson Ward Royal Free Hosp, London, England; [DeJesus, Edwin] Orlando Immunol Ctr, Orlando, FL USA; [Andrade-Villanueva, Jaime] Antigua Hosp Civil Guadalajara, Guadalajara, Jalisco, Mexico; [Workman, Cassy] AIDS Res Initiat, Darlinghurst, NSW, Australia; [Zajdenverg, Roberto] Univ Fed Rio de Janeiro, Projeto Praca Onze, Rio De Janeiro, Brazil; [Faetkenheuer, Gerd] Univ Cologne, Dept Internal Med, Cologne, Germany; [Berger, Daniel S.] Univ Illinois, Northstar Med Ctr, Chicago, IL USA; [Kumar, Princy N.] Georgetown Univ, Med Ctr, Washington, DC 20007 USA; [Rodgers, Anthony J.; Shaughnessy, Melissa A.; Walker, Monica L.; Barnard, Richard J. O.; Miller, Michael D.; DiNubile, Mark J.; Nguyen, Bach-Yen; Leavitt, Randi; Xu, Xia; Sklar, Peter] Merck Res Labs, N Wales, PA 19454 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of New South Wales Sydney; Kirby Institute; Orlando Immunology Center; Universidade Federal do Rio de Janeiro; University of Cologne; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Georgetown University; Merck & Company	Sklar, P (corresponding author), Merck Res Labs, POB 1000,UG3D-56, N Wales, PA 19454 USA.	peter_sklar@merck.com	Garcia-Diaz, Julia/D-3555-2011; Andrade-Villanueva, Jaime Federico/GPK-6845-2022	Garcia-Diaz, Julia/0000-0002-4476-4147; Andrade-Villanueva, Jaime Federico/0000-0003-1948-655X; Alvarez-Moreno, Carlos Arturo/0000-0001-5419-4494	Merck	Merck(Merck & Company)	We thank all the patients and their caregivers who participated in these studies. We recognise the important contributions of the investigators who enrolled their patients in these stitches. In particular, we are grateful for the collaboration of Steven Andrews, who died during the course of the studies. We thank Robin Isaacs for thoughtful advice and Joann DiLullo and Karyn Davis for expert technical assistance. These studies were sponsored and funded by Merck, which manufactures raltegravir under the name Isentress.	Cameron DW, 2008, J INFECT DIS, V198, P234, DOI 10.1086/589622; Cooper DA, 2008, NEW ENGL J MED, V359, P355, DOI 10.1056/NEJMoa0708978; *DAIDS, TOX GUID AD; De Castro N, 2009, CLIN INFECT DIS, V49, P1259, DOI 10.1086/605674; Delfraissy JFO, 2008, AIDS, V22, P385, DOI 10.1097/QAD.0b013e3282f3f16d; *DHHS PAN OFF AIDS, GUID US ANT AG HIV 1; Joseph E, 2006, LANCET, V368, P476, DOI 10.1016/S0140-6736(06)69155-1; Freeman RC, 2001, WOMEN HEALTH, V34, P31, DOI 10.1300/J013v34n04_03; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; Gatell J, 2007, CLIN INFECT DIS, V44, P1484, DOI 10.1086/517497; Gathe J, 2009, JAIDS-J ACQ IMM DEF, V50, P474, DOI 10.1097/QAI.0b013e31819c2937; Grinsztejn B, 2007, LANCET, V369, P1261, DOI 10.1016/S0140-6736(07)60597-2; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Harris M, 2008, AIDS, V22, P1224, DOI 10.1097/QAD.0b013e328302f3b5; Hatano H, 2006, CLIN INFECT DIS, V43, P1329, DOI 10.1086/508655; Hicks C, 2009, CLIN INFECT DIS, V48, P931, DOI 10.1086/597290; Hirsch MS, 2008, CLIN INFECT DIS, V47, P266, DOI 10.1086/589297; Jahn A, 2008, LANCET, V371, P1603, DOI 10.1016/S0140-6736(08)60693-5; Lennox JL, 2009, LANCET, V374, P796, DOI 10.1016/S0140-6736(09)60918-1; Madruga JV, 2007, LANCET, V370, P49, DOI 10.1016/S0140-6736(07)61049-6; Mallolas J, 2009, JAIDS-J ACQ IMM DEF, V51, P29, DOI 10.1097/QAI.0b013e31819a226f; Markowitz M, 2007, JAIDS-J ACQ IMM DEF, V46, P125, DOI 10.1097/QAI.0b013e318157131c; Markowitz M, 2009, JAIDS-J ACQ IMM DEF, V52, P350, DOI 10.1097/QAI.0b013e3181b064b0; Martinez E, 2003, NEW ENGL J MED, V349, P1036, DOI 10.1056/NEJMoa021589; *MED DICT REG ACT, MEDDRA VERS 11 0; MIETTINEN O, 1985, STAT MED, V4, P213, DOI 10.1002/sim.4780040211; Molina JM, 2008, LANCET, V372, P646, DOI 10.1016/S0140-6736(08)61081-8; Pulido F, 2008, AIDS, V22, pF1, DOI 10.1097/QAD.0b013e3282f4243b; Riddler SA, 2008, JAIDS-J ACQ IMM DEF, V48, P281, DOI 10.1097/QAI.0b013e31817bbbf0; Sabin CA, 2008, LANCET, V371, P1417, DOI 10.1016/S0140-6736(08)60423-7; Sax Paul E, 2008, AIDS Clin Care, V20, P104; Soriano V, 2008, J ANTIMICROB CHEMOTH, V61, P200, DOI 10.1093/jac/dkm413; Steigbigel RT, 2008, NEW ENGL J MED, V359, P339, DOI 10.1056/NEJMoa0708975; Towner W, 2009, JAIDS-J ACQ IMM DEF, V51, P367, DOI 10.1097/QAI.0b013e3181ae35de; Walensky RP, 2006, J INFECT DIS, V194, P11, DOI 10.1086/505147; Walmsley S, 2002, NEW ENGL J MED, V346, P2039, DOI 10.1056/NEJMoa012354	36	247	258	0	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2010	375	9712					396	407		10.1016/S0140-6736(09)62041-9	http://dx.doi.org/10.1016/S0140-6736(09)62041-9			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	552PK	20074791				2022-12-28	WOS:000274305500027
J	Kilby, JM				Kilby, J. Michael			Switching HIV therapies: competing host and viral factors	LANCET			English	Editorial Material							IMMUNODEFICIENCY-VIRUS-INFECTION; INTEGRASE INHIBITOR RALTEGRAVIR; RANDOMIZED CONTROLLED-TRIAL; TREATMENT-NAIVE PATIENTS; SOCIETY-USA PANEL; 2008 RECOMMENDATIONS; COMBINATION THERAPY; EFFICACY; SAFETY		Med Univ S Carolina, Charleston, SC 29425 USA	Medical University of South Carolina	Kilby, JM (corresponding author), Med Univ S Carolina, Charleston, SC 29425 USA.	mkilby@musc.edu		Kilby, J. Michael/0000-0003-3222-1003				ELMERDEWITT P, 1996, TIME            1230, P54; Eron JJ, 2010, LANCET, V375, P396, DOI 10.1016/S0140-6736(09)62041-9; Grinsztejn B, 2007, LANCET, V369, P1261, DOI 10.1016/S0140-6736(07)60597-2; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Hirsch MS, 2008, CLIN INFECT DIS, V47, P266, DOI 10.1086/589297; Lennox JL, 2009, LANCET, V374, P796, DOI 10.1016/S0140-6736(09)60918-1; Markowitz M, 2007, JAIDS-J ACQ IMM DEF, V46, P125, DOI 10.1097/QAI.0b013e318157131c; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Riddler SA, 2008, NEW ENGL J MED, V358, P2095, DOI 10.1056/NEJMoa074609; Shlay JC, 2007, JAIDS-J ACQ IMM DEF, V44, P506, DOI 10.1097/QAI.0b013e31804216cf	11	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN-FEB	2010	375	9712					352	354		10.1016/S0140-6736(10)60067-0	http://dx.doi.org/10.1016/S0140-6736(10)60067-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	552PK	20074790				2022-12-28	WOS:000274305500006
J	McCormack, MP; Young, LF; Vasudevan, S; de Graaf, CA; Codrington, R; Rabbitts, TH; Jane, SM; Curtis, DJ				McCormack, Matthew P.; Young, Lauren F.; Vasudevan, Sumitha; de Graaf, Carolyn A.; Codrington, Rosalind; Rabbitts, Terence H.; Jane, Stephen M.; Curtis, David J.			The Lmo2 Oncogene Initiates Leukemia in Mice by Inducing Thymocyte Self-Renewal	SCIENCE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; T-CELL LEUKEMIA; GENE-THERAPY; CHROMOSOMAL TRANSLOCATIONS; RETROVIRAL INSERTION; PROTEIN RBTN2; SCID-X1; HEMATOPOIESIS; TRANSCRIPTION; ACTIVATION	The LMO2 oncogene causes a subset of human T cell acute lymphoblastic leukemias (T-ALL), including four cases that arose as adverse events in gene therapy trials. To investigate the cellular origin of LMO2-induced leukemia, we used cell fate mapping to study mice in which the Lmo2 gene was constitutively expressed in the thymus. Lmo2 induced self-renewal of committed T cells in the mice more than 8 months before the development of overt T-ALL. These self-renewing cells retained the capacity for T cell differentiation but expressed several genes typical of hematopoietic stem cells (HSCs), suggesting that Lmo2 might reactivate an HSC-specific transcriptional program. Forced expression of one such gene, Hhex, was sufficient to initiate self-renewal of thymocytes in vivo. Thus, Lmo2 promotes the self-renewal of preleukemic thymocytes, providing a mechanism by which committed T cells can then accumulate additional genetic mutations required for leukemic transformation.	[McCormack, Matthew P.; Young, Lauren F.; Vasudevan, Sumitha; Jane, Stephen M.; Curtis, David J.] Royal Melbourne Hosp, Rotary Bone Marrow Res Labs, Parkville, Vic 3050, Australia; [McCormack, Matthew P.; Jane, Stephen M.; Curtis, David J.] Univ Melbourne, Dept Med, Parkville, Vic 3010, Australia; [de Graaf, Carolyn A.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [de Graaf, Carolyn A.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia; [Codrington, Rosalind; Rabbitts, Terence H.] St James Univ Hosp, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England	Royal Melbourne Hospital; University of Melbourne; Walter & Eliza Hall Institute; University of Melbourne; Saint James's University Hospital; University of Leeds	McCormack, MP (corresponding author), Royal Melbourne Hosp, Rotary Bone Marrow Res Labs, Grattan St, Parkville, Vic 3050, Australia.	mccormack@wehi.edu.au	Curtis, David/H-4996-2014; Jane, Stephen/D-6659-2011; Rabbitts, Terence/D-6262-2016	Curtis, David/0000-0001-9497-0996; McCormack, Matthew/0000-0003-1536-5611; Jane, Stephen Marsden/0000-0002-1045-0481; Rabbitts, Terence/0000-0002-4982-2609	Cancer Council of Victoria; National Health and Medical Research Council of Australia (NHMRC) [382901]; Leukaemia Foundation; Medical Research Council UK [G0600914]; Leukaemia Research UK [07036]; Medical Research Council [G0600914] Funding Source: researchfish; MRC [G0600914] Funding Source: UKRI	Cancer Council of Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Leukaemia Foundation; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Leukaemia Research UK; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank C. Talora and I. Screpanti for Lck-Notch3-IC transgenic mice; D. Izon for the MIG-Hhex retroviral vector; A. Strasser for comments on the manuscript; G. Smyth for advice on bioinformatics; and L. Ta, R. Bowyer, L. Mizhiritzky, and J. Davis for animal husbandry. This work was supported by grants (to M. P. M., S. M. J., and D. J. C.) from the Cancer Council of Victoria and National Health and Medical Research Council of Australia (NHMRC) (project grant 382901); a grant-in-aid (to M. P. M. and D.J.C.) from the Leukaemia Foundation; and grants (to T. H. R.) from the Medical Research Council UK (programme grant G0600914) and Leukaemia Research UK (programme grant 07036). D.J.C. is an R. D. Wright Biomedical Research Fellow, and S.M.J. is a Principal Research Fellow of the NHMRC.	Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Hall MA, 2003, P NATL ACAD SCI USA, V100, P992, DOI 10.1073/pnas.0237324100; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; LARSON RC, 1995, ONCOGENE, V11, P853; LARSON RC, 1994, ONCOGENE, V9, P3675; McCormack MP, 2004, NEW ENGL J MED, V350, P913, DOI 10.1056/NEJMra032207; McCormack MP, 2003, MOL CELL BIOL, V23, P9003, DOI 10.1128/MCB.23.24.9003-9013.2003; Nam CH, 2006, MOL THER, V13, P15, DOI 10.1016/j.ymthe.2005.09.010; Patterson LJ, 2007, BLOOD, V109, P2389, DOI 10.1182/blood-2006-02-003087; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Rabbitts TH, 1998, GENE DEV, V12, P2651, DOI 10.1101/gad.12.17.2651; Schwarz BA, 2006, IMMUNOL REV, V209, P47, DOI 10.1111/j.0105-2896.2006.00350.x; Van Vlierberghe P, 2006, BLOOD, V108, P3520, DOI 10.1182/blood-2006-04-019927; WARREN AJ, 1994, CELL, V78, P45, DOI 10.1016/0092-8674(94)90571-1; Yamada Y, 1998, P NATL ACAD SCI USA, V95, P3890, DOI 10.1073/pnas.95.7.3890	18	167	174	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 12	2010	327	5967					879	883		10.1126/science.1182378	http://dx.doi.org/10.1126/science.1182378			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554AQ	20093438				2022-12-28	WOS:000274408300066
J	Iglehart, JK				Iglehart, John K.			Press Ahead or Scale Back? The Reform Effort after the GOP Victory in Massachusetts	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		AARON HJ, 2010, COMMUNICATION   0122; BALZ D, 2010, WASH POST       0217, pA1; Blumenthal David, 2009, HEART POWER HLTH POL; Pear Robert, 2010, N Y TIMES; 2010, WALL STREET J   0123, pA14	5	0	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 11	2010	362	6								10.1056/NEJMp1000939	http://dx.doi.org/10.1056/NEJMp1000939			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	553WJ	20107210				2022-12-28	WOS:000274397200004
J	Brochard, L				Brochard, Laurent			Less sedation in intensive care: the pendulum swings back	LANCET			English	Editorial Material							CRITICALLY-ILL PATIENTS		[Brochard, Laurent] Ctr Hosp Albert Chenevier Henri Mondor, AP HP, Med Intens Care Unit, F-94000 Creteil, France; [Brochard, Laurent] Hop Henri Mondor, INSERM, U955, F-94010 Creteil, France; [Brochard, Laurent] Univ Paris Est, Creteil, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Brochard, L (corresponding author), Ctr Hosp Albert Chenevier Henri Mondor, AP HP, Med Intens Care Unit, F-94000 Creteil, France.	laurent.brochard@hmn.aphp.fr						Girard TD, 2008, LANCET, V371, P126, DOI 10.1016/S0140-6736(08)60105-1; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; Payen JF, 2007, ANESTHESIOLOGY, V106, P687, DOI 10.1097/01.anes.0000264747.09017.da; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Strom T, 2010, LANCET, V375, P475, DOI 10.1016/S0140-6736(09)62072-9	5	14	15	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 6	2010	375	9713					436	438		10.1016/S0140-6736(10)60103-1	http://dx.doi.org/10.1016/S0140-6736(10)60103-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	558PV	20116840				2022-12-28	WOS:000274757900005
J	Grant, R				Grant, Ronald			An Oath to My Grandfather	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												rgrant9751@aol.com							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 3	2010	303	5					397	397		10.1001/jama.2010.44	http://dx.doi.org/10.1001/jama.2010.44			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	550QR	20124528				2022-12-28	WOS:000274143600001
J	Anderson, T				Anderson, Tatum			Medicine in Developing Countries How can child and maternal mortality be cut?	BRITISH MEDICAL JOURNAL			English	Editorial Material												tatum.anderson@tiscali.co.uk						*ACT GLOB HLTH, 2009, ZAMB AID EFF HLTH SE; *COUNTD 2015, 2008 REP; *DEP INT DEV, ANN REP 2009 DEP INT; Human Rights Watch, 2009, NO TALL ANG; *INT GROUP CHILD M, STAT AR CHILD SURV H; *SAF MOTH IN, SAF MOTH REV; Unicef, 2009, STAT WORLDS CHILDR	7	3	3	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 26	2010	340								c431	10.1136/bmj.c431	http://dx.doi.org/10.1136/bmj.c431			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	549YA	20103527				2022-12-28	WOS:000274089200004
J	Boos, WR; Kuang, ZM				Boos, William R.; Kuang, Zhiming			Dominant control of the South Asian monsoon by orographic insulation versus plateau heating	NATURE			English	Article							SUMMER MONSOON; QUASI-EQUILIBRIUM; INDIAN MONSOON; UPLIFT; VARIABILITY; SIMULATION; MOUNTAINS; EVOLUTION; CLIMATE; ONSET	The Tibetan plateau, like any landmass, emits energy into the atmosphere in the form of dry heat and water vapour, but its mean surface elevation is more than 5km above sea level. This elevation is widely held to cause the plateau to serve as a heat source that drives the South Asian summer monsoon, potentially coupling uplift of the plateau to climate changes on geologic timescales(1-5). Observations of the present climate, however, do not clearly establish the Tibetan plateau as the dominant thermal forcing in the region: peak upper-tropospheric temperatures during boreal summer are located over continental India, south of the plateau. Here we show that, although Tibetan plateau heating locally enhances rainfall along its southern edge in an atmospheric model, the large-scale South Asian summer monsoon circulation is otherwise unaffected by removal of the plateau, provided that the narrow orography of the Himalayas and adjacent mountain ranges is preserved. Additional observational and model results suggest that these mountains produce a strong monsoon by insulating warm, moist air over continental India from the cold and dry extratropics. These results call for both a reinterpretation of how South Asian climate may have responded to orographic uplift, and a re-evaluation of how this climate may respond to modified land surface and radiative forcings in coming decades.	[Boos, William R.; Kuang, Zhiming] Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; [Kuang, Zhiming] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Boos, WR (corresponding author), Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA.	billboos@alum.mit.edu	Boos, William/C-6467-2014	Boos, William/0000-0001-9076-3551	Department of Earth and Planetary Sciences at Harvard University; Harvard University Center for the Environment; NSF [ATM-0754332]	Department of Earth and Planetary Sciences at Harvard University; Harvard University Center for the Environment; NSF(National Science Foundation (NSF))	We thank P. Molnar for conversations motivating this work. Computing time was provided by the NCAR, which is sponsored by the NSF. W. R. B. was supported by the Reginald A. Daly Postdoctoral Fellowship in the Department of Earth and Planetary Sciences at Harvard University, and the John and Elaine French Environmental Fellowship at the Harvard University Center for the Environment. Z.K. was supported by NSF grant ATM-0754332.	Abe M, 2003, J METEOROL SOC JPN, V81, P909, DOI 10.2151/jmsj.81.909; An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; Boos WR, 2009, Q J ROY METEOR SOC, V135, P319, DOI 10.1002/qj.388; Chakraborty A, 2006, ANN GEOPHYS-GERMANY, V24, P2075, DOI 10.5194/angeo-24-2075-2006; Chakraborty A, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015522; Chou C, 2001, Q J ROY METEOR SOC, V127, P1869, DOI 10.1002/qj.49712757602; Durre I, 2006, J CLIMATE, V19, P53, DOI 10.1175/JCLI3594.1; EMANUEL KA, 1994, Q J ROY METEOR SOC, V120, P1111, DOI 10.1256/smsqj.51901; Flohn H., 1953, ARCH METEOROLOGIE A, V5, P265, DOI DOI 10.1007/BF02247771; Flohn H., 1968, 130 COL STAT U, P120; HAHN DG, 1975, J ATMOS SCI, V32, P1515, DOI 10.1175/1520-0469(1975)032<1515:TROMIT>2.0.CO;2; Held IM, 2002, J CLIMATE, V15, P2125, DOI 10.1175/1520-0442(2002)015<2125:NWSWTA>2.0.CO;2; Holloway CE, 2007, J ATMOS SCI, V64, P1467, DOI 10.1175/JAS3907.1; Huffman GJ, 2007, J HYDROMETEOROL, V8, P38, DOI 10.1175/JHM560.1; Li CF, 1996, J CLIMATE, V9, P358, DOI 10.1175/1520-0442(1996)009<0358:TOAIVO>2.0.CO;2; Liang XZ, 1998, Q J ROY METEOR SOC, V124, P2597, DOI 10.1002/qj.49712455204; Lin JL, 2008, J CLIMATE, V21, P4541, DOI 10.1175/20O8JCLI1816.1; Molnar P, 1999, J GEOPHYS RES-ATMOS, V104, P24265, DOI 10.1029/1999JD900485; MOLNAR P, 1993, REV GEOPHYS, V31, P357, DOI 10.1029/93RG02030; MURAKAMI T, 1981, J METEOR SOC JAPAN, V59, P66; PRELL WL, 1992, NATURE, V360, P647, DOI 10.1038/360647a0; Qiu J, 2008, NATURE, V454, P393, DOI 10.1038/454393a; RAYMO ME, 1992, NATURE, V359, P117, DOI 10.1038/359117a0; RUDDIMAN WF, 1989, J GEOPHYS RES-ATMOS, V94, P18409, DOI 10.1029/JD094iD15p18409; SARACHIK ES, 1978, DYNAM ATMOS OCEANS, V2, P455; Uppala SM, 2005, Q J ROY METEOR SOC, V131, P2961, DOI 10.1256/qj.04.176; Xie SP, 2006, J CLIMATE, V19, P3420, DOI 10.1175/JCLI3777.1; Yanai M, 2006, ASIAN MONSOON, P513, DOI [DOI 10.1007/3-540-37722-0_13, 10.1007/3-540-37722-0_13]; Yasunari T, 2006, J HYDROMETEOROL, V7, P626, DOI 10.1175/JHM515.1; Zhou Y, 2004, J METEOROL SOC JPN, V82, P1565, DOI 10.2151/jmsj.82.1565	32	595	639	17	242	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 14	2010	463	7278					218	U102		10.1038/nature08707	http://dx.doi.org/10.1038/nature08707			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543MQ	20075917				2022-12-28	WOS:000273582700033
J	Liu, CM; Young, AL; Starling-Windhof, A; Bracher, A; Saschenbrecker, S; Rao, BV; Rao, KV; Berninghausen, O; Mielke, T; Hartl, FU; Beckmann, R; Hayer-Hartl, M				Liu, Cuimin; Young, Anna L.; Starling-Windhof, Amanda; Bracher, Andreas; Saschenbrecker, Sandra; Rao, Bharathi Vasudeva; Rao, Karnam Vasudeva; Berninghausen, Otto; Mielke, Thorsten; Hartl, F. Ulrich; Beckmann, Roland; Hayer-Hartl, Manajit			Coupled chaperone action in folding and assembly of hexadecameric Rubisco	NATURE			English	Article							RIBULOSE-BISPHOSPHATE CARBOXYLASE; PHOTO-CROSS-LINKING; ESCHERICHIA-COLI; RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; 1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; SMALL SUBUNITS; AMINO-ACID; RBCX GENE; IN-VIVO; PROTEIN	Form I Rubisco (ribulose 1,5-bisphosphate carboxylase/oxygenase), a complex of eight large (RbcL) and eight small (RbcS) subunits, catalyses the fixation of atmospheric CO2 in photosynthesis. The limited catalytic efficiency of Rubisco has sparked extensive efforts to re-engineer the enzyme with the goal of enhancing agricultural productivity. To facilitate such efforts we analysed the formation of cyanobacterial form I Rubisco by in vitro reconstitution and cryo-electron microscopy. We show that RbcL subunit folding by the GroEL/GroES chaperonin is tightly coupled with assembly mediated by the chaperone RbcX(2). RbcL monomers remain partially unstable and retain high affinity for GroEL until captured by RbcX(2). As revealed by the structure of a RbcL(8)-(RbcX2)(8) assembly intermediate, RbcX(2) acts as a molecular staple in stabilizing the RbcL subunits as dimers and facilitates RbcL(8) core assembly. Finally, addition of RbcS results in RbcX(2) release and holoenzyme formation. Specific assembly chaperones may be required more generally in the formation of complex oligomeric structures when folding is closely coupled to assembly.	[Liu, Cuimin; Starling-Windhof, Amanda; Bracher, Andreas; Saschenbrecker, Sandra; Rao, Bharathi Vasudeva; Rao, Karnam Vasudeva; Hartl, F. Ulrich; Hayer-Hartl, Manajit] Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany; [Young, Anna L.; Berninghausen, Otto; Beckmann, Roland] Univ Munich, Dept Chem & Biochem, Ctr Integrated Prot Sci CIPSM, D-81377 Munich, Germany; [Young, Anna L.; Berninghausen, Otto; Beckmann, Roland] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Mielke, Thorsten] Max Planck Inst Mol Genet, USN, D-14195 Berlin, Germany; [Mielke, Thorsten] Charite, Inst Med Phys & Biophys, D-10098 Berlin, Germany	Max Planck Society; University of Munich; University of Munich; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Hayer-Hartl, M (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, Klopferspitz 18, D-82152 Martinsried, Germany.	uhartl@biochem.mpg.de; beckmann@lmb.uni-muenchen.de; mhartl@biochem.mpg.de	Hayer-Hartl, Manajit/V-8078-2017; Hartl, F. Ulrich/Y-8206-2019	Hayer-Hartl, Manajit/0000-0001-8213-6742; , Amanda/0000-0003-2483-3886; Saschenbrecker, Sandra/0000-0002-4769-915X	Deutsche Forschungsgemeinschaft [SFB 594]; Ernst-Jung Foundation; Korber Foundation; European Union and the Center for Integrated Protein Science Munich (CIPSM)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ernst-Jung Foundation; Korber Foundation; European Union and the Center for Integrated Protein Science Munich (CIPSM)	Assistance by K. Valer and J. Basquin in the MPIB crystallization facility, by C. Ungewickell in the Gene Center cryo-EM facility as well as by the staff at SLS-beamline X10SA-PX-II is acknowledged. We thank the Deutsche Forschungsgemeinschaft (SFB 594), the Ernst-Jung Foundation, the Korber Foundation, the European Union and the Center for Integrated Protein Science Munich (CIPSM) for financial support.	Andersson I, 2003, ARCH BIOCHEM BIOPHYS, V414, P130, DOI 10.1016/S0003-9861(03)00164-4; Andersson I, 2008, J EXP BOT, V59, P1555, DOI 10.1093/jxb/ern091; Andrews T.J., 1987, BIOCH PLANTS, P131, DOI 10.1016/B978-0-12-675410-0.50009-9; Andrews TJ, 2003, ARCH BIOCHEM BIOPHYS, V414, P159, DOI 10.1016/S0003-9861(03)00100-0; ANDREWS TJ, 1988, J BIOL CHEM, V263, P12213; BARRACLOUGH R, 1980, BIOCHIM BIOPHYS ACTA, V608, P19, DOI 10.1016/0005-2787(80)90129-X; Brinker A, 2001, CELL, V107, P223, DOI 10.1016/S0092-8674(01)00517-7; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Chin JW, 2002, CHEMBIOCHEM, V3, P1135, DOI 10.1002/1439-7633(20021104)3:11<1135::AID-CBIC1135>3.0.CO;2-M; Emlyn-Jones D, 2006, PLANT CELL PHYSIOL, V47, P1630, DOI 10.1093/pcp/pcl028; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans W, 1997, CHEM BRIT, V33, P22; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; GOLOUBINOFF P, 1989, NATURE, V337, P44, DOI 10.1038/337044a0; GUTTERIDGE S, 1995, PLANT CELL, V7, P809, DOI 10.1105/tpc.7.7.809; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; HayerHartl MK, 1996, EMBO J, V15, P6111, DOI 10.1002/j.1460-2075.1996.tb00999.x; Lakshmipathy SK, 2007, J BIOL CHEM, V282, P12186, DOI 10.1074/jbc.M609871200; LANGER T, 1992, EMBO J, V11, P4757, DOI 10.1002/j.1460-2075.1992.tb05581.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie A. G. W., 1992, JOINT CCP4 ESF EACBM, V26; Li LA, 1997, J BACTERIOL, V179, P3793, DOI 10.1128/jb.179.11.3793-3796.1997; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; MARTIN J, 1993, NATURE, V366, P228, DOI 10.1038/366228a0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NEWMAN J, 1993, J BIOL CHEM, V268, P25876; NEWMAN J, 1993, ACTA CRYSTALLOGR D, V49, P548, DOI 10.1107/S090744499300530X; Onizuka T, 2004, PLANT CELL PHYSIOL, V45, P1390, DOI 10.1093/pcp/pch160; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; ROESSNER D, 1994, J CHROMATOGR A, V687, P249, DOI 10.1016/0021-9673(94)00818-3; Ryu YH, 2006, NAT METHODS, V3, P263, DOI 10.1038/NMETH864; Saschenbrecker S, 2007, CELL, V129, P1189, DOI 10.1016/j.cell.2007.04.025; SCHNEIDER G, 1990, J MOL BIOL, V211, P989, DOI 10.1016/0022-2836(90)90088-4; Spreitzer RJ, 2005, P NATL ACAD SCI USA, V102, P17225, DOI 10.1073/pnas.0508042102; Spreitzer RJ, 2002, ANNU REV PLANT BIOL, V53, P449, DOI 10.1146/annurev.arplant.53.100301.135233; Tabita FR, 2007, MICROBIOL MOL BIOL R, V71, P576, DOI 10.1128/MMBR.00015-07; Tabita FR, 1999, PHOTOSYNTH RES, V60, P1, DOI 10.1023/A:1006211417981; Tanaka S, 2007, ACTA CRYSTALLOGR D, V63, P1109, DOI 10.1107/S090744490704228X; Tang YC, 2006, CELL, V125, P903, DOI 10.1016/j.cell.2006.04.027; Tarnawski M, 2008, ACTA BIOCHIM POL, V55, P777; THOW G, 1994, BIOCHEMISTRY-US, V33, P5109, DOI 10.1021/bi00183a014; Vagin AA, 2001, ACTA CRYSTALLOGR D, V57, P1451, DOI 10.1107/S0907444901012409; VANDERVIES SM, 1986, EMBO J, V5, P2439, DOI 10.1002/j.1460-2075.1986.tb04519.x; VANDERVIES SM, 1992, BIOCHEMISTRY-US, V31, P3635, DOI 10.1021/bi00129a012; WEINER MP, 1994, GENE, V151, P119, DOI 10.1016/0378-1119(94)90641-6; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; Whitney SM, 2008, J EXP BOT, V59, P1909, DOI 10.1093/jxb/erm311; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3	50	129	142	5	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 14	2010	463	7278					197	U81		10.1038/nature08651	http://dx.doi.org/10.1038/nature08651			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543MQ	20075914				2022-12-28	WOS:000273582700028
J	McMahon, GT; Blake, MA; Wu, CL				McMahon, Graham T.; Blake, Michael A.; Wu, Chin-Lee			A Man with Hypertension, Hyperglycemia, and Edema Secondary Cushing's syndrome due to metastatic small-cell carcinoma of prostatic origin	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ECTOPIC ACTH; MANAGEMENT; THERAPY; CANCER		[McMahon, Graham T.] Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Dept Med, Boston, MA 02115 USA; [Blake, Michael A.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Wu, Chin-Lee] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [McMahon, Graham T.] Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; [Blake, Michael A.] Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; [Wu, Chin-Lee] Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University	McMahon, GT (corresponding author), Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Dept Med, Boston, MA 02115 USA.		McMahon, Graham/D-3740-2009	McMahon, Graham/0000-0003-4288-6535				Alwani RA, 2009, PITUITARY, V12, P280, DOI 10.1007/s11102-008-0100-z; Anthoney DA, 1995, EUR J CANCER, V31A, P2109, DOI 10.1016/0959-8049(95)00388-6; Blake Michael A, 2002, Curr Probl Diagn Radiol, V31, P67, DOI 10.1016/S0363-0188(02)90009-5; Brown WH, 1928, LANCET, V2, P1022; BUCHFELDER M, 1993, AM J NEURORADIOL, V14, P1183; Chiong Jun R, 2008, Int J Cardiol, V124, P6, DOI 10.1016/j.ijcard.2007.01.119; de Bruin C, 2009, REV ENDOCR METAB DIS, V10, P91, DOI 10.1007/s11154-008-9082-4; DeLellis RA, 2003, ENDOCR PATHOL, V14, P303, DOI 10.1385/EP:14:4:303; Hansson J, 2003, SCAND J UROL NEPHROL, V37, P28, DOI 10.1080/03008880310006922; Isidori AM, 2007, ARQ BRAS ENDOCRINOL, V51, P1217, DOI 10.1590/S0004-27302007000800007; Kataoka K, 2007, INT J UROL, V14, P436, DOI 10.1111/j.1442-2042.2006.01710.x; Liddle G W, 1969, Recent Prog Horm Res, V25, P283; MURE A, 1995, J ENDOCRINOL INVEST, V18, P180, DOI 10.1007/BF03347800; Nieman LK, 2005, AM J MED, V118, P1340, DOI 10.1016/j.amjmed.2005.01.059; Nieman Lynnette K, 2002, Pituitary, V5, P77, DOI 10.1023/A:1022308429992; Nimalasena S, 2008, BJU INT, V101, P424, DOI 10.1111/j.1464-410X.2007.07294.x; OESTERLING JE, 1992, J UROLOGY, V147, P804, DOI 10.1016/S0022-5347(17)37390-1; Ray D, 2006, INT J IMMUNOGENET, V33, P237, DOI 10.1111/j.1744-313X.2006.00604.x; Rickman T, 2001, AM J KIDNEY DIS, V37, P838, DOI 10.1016/S0272-6386(01)80134-7; Schteingart DE, 2007, NEW ENGL J MED, V356, P2415, DOI 10.1056/NEJMe078087; Sciarra A, 2006, INT J CLIN PRACT, V60, P462, DOI 10.1111/j.1742-1241.2006.00750.x; Shalet S, 2008, CURR OPIN ENDOCRINOL, V15, P234, DOI 10.1097/MED.0b013e3282fc7025; SONINO N, 1987, NEW ENGL J MED, V317, P812, DOI 10.1056/NEJM198709243171307; Stambaugh J E Jr, 1978, J Med Soc N J, V75, P925; STATHAM BN, 1981, POSTGRAD MED J, V57, P467, DOI 10.1136/pgmj.57.669.467; Suzuki N, 1993, Nihon Hinyokika Gakkai Zasshi, V84, P2027; Terzolo M, 2007, NEW ENGL J MED, V356, P2372, DOI 10.1056/NEJMoa063360; TETU B, 1987, CANCER, V59, P1803, DOI 10.1002/1097-0142(19870515)59:10<1803::AID-CNCR2820591019>3.0.CO;2-X; Wang W, 2008, AM J SURG PATHOL, V32, P65, DOI 10.1097/PAS.0b013e318058a96b; WENK RE, 1977, CANCER, V40, P773, DOI 10.1002/1097-0142(197708)40:2<773::AID-CNCR2820400226>3.0.CO;2-I; Yao JL, 2006, AM J SURG PATHOL, V30, P705, DOI 10.1097/00000478-200606000-00005	31	9	10	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 14	2010	362	2					156	166		10.1056/NEJMcpc0905546	http://dx.doi.org/10.1056/NEJMcpc0905546			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	543FU	20071706				2022-12-28	WOS:000273558500015
J	Khraiwesh, B; Arif, MA; Seumel, GI; Ossowski, S; Weigel, D; Reski, R; Frank, W				Khraiwesh, Basel; Arif, M. Asif; Seumel, Gotelinde I.; Ossowski, Stephan; Weigel, Detlef; Reski, Ralf; Frank, Wolfgang			Transcriptional Control of Gene Expression by MicroRNAs	CELL			English	Article							DIRECTED DNA METHYLATION; DEPENDENT RNA-POLYMERASE; TRANS-ACTING SIRNAS; PHYSCOMITRELLA-PATENS; ARABIDOPSIS-THALIANA; C-ELEGANS; MAMMALIAN-CELLS; MESSENGER-RNAS; DICER HOMOLOG; PLANTS	MicroRNAs (miRNAs) control gene expression in animals and plants. Like another class of small RNAs, siRNAs, they affect gene expression posttranscriptionally. While siRNAs in addition act in transcriptional gene silencing, a role of miRNAs in transcriptional regulation has been less clear. We show here that in moss Physcomitrella patens mutants without a DICER-LIKE1b gene, maturation of miRNAs is normal but cleavage of target RNAs is abolished and levels of these transcripts are drastically reduced. These mutants accumulate miRNA: target-RNA duplexes and show hypermethylation of the genes encoding target RNAs, leading to gene silencing. This pathway occurs also in the wild-type upon hormone treatment. We propose that initiation of epigenetic silencing by DNA methylation depends on the ratio of the miRNA and its target RNA.	[Khraiwesh, Basel; Arif, M. Asif; Seumel, Gotelinde I.; Reski, Ralf; Frank, Wolfgang] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Ossowski, Stephan; Weigel, Detlef] Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany; [Seumel, Gotelinde I.; Reski, Ralf; Frank, Wolfgang] Freiburg Initiat Syst Biol, D-79104 Freiburg, Germany; [Khraiwesh, Basel; Reski, Ralf] Ctr Biol Signalling Studies, D-79104 Freiburg, Germany	University of Freiburg; Max Planck Society	Reski, R (corresponding author), Univ Freiburg, Fac Biol, Schaenzlestr 1, D-79104 Freiburg, Germany.	ralf.reski@biologie.uni-freiburg.de; wolfgang.frank@biologie.uni-freiburg.de	Weigel, Detlef/C-1418-2008; Weigel, Detlef/GSJ-0799-2022; Weigel, Detlef/AAR-3312-2021; Ossowski, Stephan/E-2139-2011; Khraiwesh, Basel/G-7509-2015	Weigel, Detlef/0000-0002-2114-7963; Weigel, Detlef/0000-0002-2114-7963; Ossowski, Stephan/0000-0002-7416-9568; Khraiwesh, Basel/0000-0001-7026-1263; Reski, Ralf/0000-0002-5496-6711; Arif, M Asif/0000-0003-3237-7796	Landesstiftung Baden-Wurttemberg [P-LS-RNS/40]; German Federal Ministry of Education and Research [FRISYS 0313921]; Excellence Initiative of the German Federal and State Governments [EXC 294]; European Community [LSHG-CT-2006-037900]; German Academic Exchange Service	Landesstiftung Baden-Wurttemberg; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Excellence Initiative of the German Federal and State Governments; European Community(European Commission); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by Landesstiftung Baden-Wurttemberg (P-LS-RNS/40 to D. W., W. F., and R. R.), the German Federal Ministry of Education and Research (FRISYS 0313921 to W. F. and R. R.), the Excellence Initiative of the German Federal and State Governments (EXC 294 to R. R.), the European Community FP6 IP SIROCCO (LSHG-CT-2006-037900 to D. W.), and the German Academic Exchange Service (DAAD to M. A. A.). We thank G. Gierga and R. Haas for technical assistance, K. M. Folta for advice on nuclear runons, and T. Laux, W. R. Hess, R. Baumeister, and P. Beyer for comments on the manuscript.	Arazi T, 2005, PLANT J, V43, P837, DOI 10.1111/j.1365-313X.2005.02499.x; Axtell MJ, 2007, PLANT CELL, V19, P1750, DOI 10.1105/tpc.107.051706; Axtell MJ, 2006, CELL, V127, P565, DOI 10.1016/j.cell.2006.09.032; Bao N, 2004, DEV CELL, V7, P653, DOI 10.1016/j.devcel.2004.10.003; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Bender J, 2004, CURR OPIN PLANT BIOL, V7, P521, DOI 10.1016/j.pbi.2004.07.003; Boyko A, 2008, ENVIRON MOL MUTAGEN, V49, P61, DOI 10.1002/em.20347; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Cao XF, 2002, P NATL ACAD SCI USA, V99, P16491, DOI 10.1073/pnas.162371599; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Doi N, 2003, CURR BIOL, V13, P41, DOI 10.1016/S0960-9822(02)01394-5; Duchaine TF, 2006, CELL, V124, P343, DOI [10.1016/j.cell.2005.11.036, 10.1016/j.cel.2005.11.036]; Dunoyer P, 2005, NAT GENET, V37, P1356, DOI 10.1038/ng1675; Dyachenko OV, 2006, BIOCHEMISTRY-MOSCOW+, V71, P461, DOI 10.1134/S000629790604016X; Egener Tanja, 2002, BMC Plant Biology, V2, DOI 10.1186/1471-2229-2-6; Fattash I, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-13; Floyd SK, 2004, NATURE, V428, P485, DOI 10.1038/428485a; Folta KM, 2006, NAT PROTOC, V1, P3094, DOI 10.1038/nprot.2006.471; Frank W, 2005, PLANT BIOLOGY, V7, P220, DOI 10.1055/s-2005-865645; Frank W, 2005, PLANTA, V220, P384, DOI 10.1007/s00425-004-1351-1; Gasciolli V, 2005, CURR BIOL, V15, P1494, DOI 10.1016/j.cub.2005.07.024; Golden TA, 2002, PLANT PHYSIOL, V130, P808, DOI 10.1104/pp.003491; Gonzalez S, 2008, CELL CYCLE, V7, P2601, DOI 10.4161/cc.7.16.6541; Henderson IR, 2008, GENE DEV, V22, P1597, DOI 10.1101/gad.1667808; Henderson IR, 2006, NAT GENET, V38, P721, DOI 10.1038/ng1804; Henderson IR, 2004, DEVELOPMENT, V131, P3829, DOI 10.1242/dev.01294; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Howell MD, 2007, PLANT CELL, V19, P926, DOI 10.1105/tpc.107.050062; Kanno T, 2005, NAT GENET, V37, P761, DOI 10.1038/ng1580; Khraiwesh B, 2008, PLANT PHYSIOL, V148, P684, DOI 10.1104/pp.108.128025; Kim DH, 2008, P NATL ACAD SCI USA, V105, P16230, DOI 10.1073/pnas.0808830105; Koprivova A, 2003, PLANT BIOLOGY, V5, P582, DOI 10.1055/s-2003-44721; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Luo QJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000457; MacRae IJ, 2008, P NATL ACAD SCI USA, V105, P512, DOI 10.1073/pnas.0710869105; Matzke M, 2007, CURR OPIN PLANT BIOL, V10, P512, DOI 10.1016/j.pbi.2007.06.007; Mlotshwa S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001755; Moissiard G, 2007, RNA, V13, P1268, DOI 10.1261/rna.541307; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Pontier D, 2005, GENE DEV, V19, P2030, DOI 10.1101/gad.348405; Qi Y, 2005, MOL CELL, V19, P421, DOI 10.1016/j.molcel.2005.06.014; Richardt S, 2010, PLANT MOL BIOL, V72, P27, DOI 10.1007/s11103-009-9550-6; Ronemus M, 2006, PLANT CELL, V18, P1559, DOI 10.1105/tpc.106.042127; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Strepp R, 1998, P NATL ACAD SCI USA, V95, P4368, DOI 10.1073/pnas.95.8.4368; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Talmor-Neiman M, 2006, PLANT J, V48, P511, DOI 10.1111/j.1365-313X.2006.02895.x; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Vaistij FE, 2002, PLANT CELL, V14, P857, DOI 10.1105/tpc.010480; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Xie ZX, 2005, P NATL ACAD SCI USA, V102, P12984, DOI 10.1073/pnas.0506426102; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Zilberman D, 2004, CURR BIOL, V14, P1214, DOI 10.1016/j.cub.2004.06.055	62	333	374	3	104	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 8	2010	140	1					111	122		10.1016/j.cell.2009.12.023	http://dx.doi.org/10.1016/j.cell.2009.12.023			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	541CY	20085706	Bronze			2022-12-28	WOS:000273391900019
J	Nomura, DK; Long, JZ; Niessen, S; Hoover, HS; Ng, SW; Cravatt, BF				Nomura, Daniel K.; Long, Jonathan Z.; Niessen, Sherry; Hoover, Heather S.; Ng, Shu-Wing; Cravatt, Benjamin F.			Monoacylglycerol Lipase Regulates a Fatty Acid Network that Promotes Cancer Pathogenesis	CELL			English	Article							ENZYME-ACTIVITY PROFILES; LYSOPHOSPHATIDIC ACID; BREAST-CANCER; MONOGLYCERIDE LIPASE; CELL-PROLIFERATION; TRANSFORMED-CELLS; METABOLISM; PROTEIN; KINASE; GROWTH	Tumor cells display progressive changes in metabolism that correlate with malignancy, including development of a lipogenic phenotype. How stored fats are liberated and remodeled to support cancer pathogenesis, however, remains unknown. Here, we show that the enzyme monoacylglycerol lipase (MAGL) is highly expressed in aggressive human cancer cells and primary tumors, where it regulates a fatty acid network enriched in oncogenic signaling lipids that promotes migration, invasion, survival, and in vivo tumor growth. Overexpression of MAGL in nonaggressive cancer cells recapitulates this fatty acid network and increases their pathogenicity-phenotypes that are reversed by an MAGL inhibitor. Impairments in MAGL-dependent tumor growth are rescued by a high-fat diet, indicating that exogenous sources of fatty acids can contribute to malignancy in cancers lacking MAGL activity. Together, these findings reveal how cancer cells can co-opt a lipolytic enzyme to translate their lipogenic state into an array of protumorigenic signals.	[Nomura, Daniel K.; Long, Jonathan Z.; Cravatt, Benjamin F.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Nomura, Daniel K.; Long, Jonathan Z.; Cravatt, Benjamin F.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Niessen, Sherry; Hoover, Heather S.] Scripps Res Inst, Ctr Physiol Prote, La Jolla, CA 92037 USA; [Ng, Shu-Wing] Harvard Univ, Sch Med, Brigham & Womens Hosp, Lab Gynecol Oncol, Boston, MA 02115 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Cravatt, BF (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	cravatt@scripps.edu		Long, Jonathan/0000-0003-2631-7463	National Institutes of Health [CA132630, CA087660]; Skaggs Institute for Chemical Biology; NATIONAL CANCER INSTITUTE [R01CA132630, R01CA087660, R37CA087660] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute for Chemical Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the members of the Cravatt laboratory for helpful discussion and critical reading of the manuscript. In particular, we acknowledge Gabriel M. Simon for assistance with data analysis, Michele K. McKinney, and Jacqueline L. Blankman for technical assistance. This work was supported by the National Institutes of Health (CA132630, CA087660) and the Skaggs Institute for Chemical Biology.	Ahn K, 2008, CHEM REV, V108, P1687, DOI 10.1021/cr0782067; Bektas M, 2005, J CELL BIOL, V169, P801, DOI 10.1083/jcb.200407123; Blankman JL, 2007, CHEM BIOL, V14, P1347, DOI 10.1016/j.chembiol.2007.11.006; Buzzai M, 2005, ONCOGENE, V24, P4165, DOI 10.1038/sj.onc.1208622; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Chiang KP, 2006, CHEM BIOL, V13, P1041, DOI 10.1016/j.chembiol.2006.08.008; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; De Schrijver E, 2003, CANCER RES, V63, P3799; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; DeBerardinis RJ, 2006, J BIOL CHEM, V281, P37372, DOI 10.1074/jbc.M608372200; Dinh TP, 2002, CHEM PHYS LIPIDS, V121, P149, DOI 10.1016/S0009-3084(02)00150-0; Endsley MP, 2007, INT J CANCER, V121, P984, DOI 10.1002/ijc.22761; Fackler OT, 2008, J CELL BIOL, V181, P879, DOI 10.1083/jcb.200802081; Gao XX, 2008, MOL BIOL CELL, V19, P4366, DOI 10.1091/mbc.E08-05-0449; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gjerstorff MF, 2006, INT J ONCOL, V28, P1327; Gschwind A, 2002, CANCER RES, V62, P6329; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Jessani N, 2005, NAT METHODS, V2, P691, DOI 10.1038/NMETH778; Jessani N, 2004, P NATL ACAD SCI USA, V101, P13756, DOI 10.1073/pnas.0404727101; Jessani N, 2002, P NATL ACAD SCI USA, V99, P10335, DOI 10.1073/pnas.162187599; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Kalaany NY, 2009, NATURE, V458, P725, DOI 10.1038/nature07782; Karlsson M, 2001, GENE, V272, P11, DOI 10.1016/S0378-1119(01)00559-5; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Kuhajda FP, 2000, P NATL ACAD SCI USA, V97, P3450, DOI 10.1073/pnas.050582897; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Liu Y, 2006, PROSTATE CANCER P D, V9, P230, DOI 10.1038/sj.pcan.4500879; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; Long JZ, 2009, CHEM BIOL, V16, P744, DOI 10.1016/j.chembiol.2009.05.009; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Mackie K, 2006, AAPS J, V8, pE298, DOI 10.1007/BF02854900; MARNETT LJ, 1992, CANCER RES, V52, P5575; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; McMahon B, 2007, PATHOPHYSIOL HAEMO T, V36, P184, DOI 10.1159/000175156; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Nomura DK, 2008, NAT CHEM BIOL, V4, P373, DOI 10.1038/nchembio.86; Patricelli MP, 2001, PROTEOMICS, V1, P1067, DOI 10.1002/1615-9861(200109)1:9<1067::AID-PROT1067>3.0.CO;2-4; Prentki M, 2008, ENDOCR REV, V29, P647, DOI 10.1210/er.2008-0007; Przybytkowski E, 2007, BIOCHEM CELL BIOL, V85, P301, DOI 10.1139/O07-001; Puustinen P, 2009, CANCER RES, V69, P2870, DOI 10.1158/0008-5472.CAN-08-2760; Ren J, 2006, CANCER RES, V66, P3006, DOI 10.1158/0008-5472.CAN-05-1292; Saghatelian A, 2004, BIOCHEMISTRY-US, V43, P14332, DOI 10.1021/bi0480335; Sarnataro D, 2006, MOL PHARMACOL, V70, P1298, DOI 10.1124/mol.106.025601; Seftor EA, 2002, CLIN EXP METASTAS, V19, P233, DOI 10.1023/A:1015591624171; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Stylli SS, 2008, J CLIN NEUROSCI, V15, P725, DOI 10.1016/j.jocn.2008.03.003; Vazquez-Martin A, 2008, CELL PROLIFERAT, V41, P59, DOI 10.1111/j.1365-2184.2007.00498.x; Wang DZ, 2008, CANCER RES, V68, P6468, DOI 10.1158/0008-5472.CAN-08-0896; WELCH DR, 1991, INT J CANCER, V47, P227, DOI 10.1002/ijc.2910470211; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zechner R, 2005, CURR OPIN LIPIDOL, V16, P333, DOI 10.1097/01.mol.0000169354.20395.1c; Zhao Q, 2005, J BIOL CHEM, V280, P26735, DOI 10.1074/jbc.M412828200; Zhou WB, 2007, CANCER RES, V67, P2964, DOI 10.1158/0008-5472.CAN-06-3439; Zunder ER, 2008, CANCER CELL, V14, P180, DOI 10.1016/j.ccr.2008.06.014	61	689	725	4	133	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 8	2010	140	1					49	61		10.1016/j.cell.2009.11.027	http://dx.doi.org/10.1016/j.cell.2009.11.027			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	541CY	20079333	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000273391900014
J	Stevenson, WG; Tedrow, U				Stevenson, William G.; Tedrow, Usha			Preventing ventricular tachycardia with catheter ablation	LANCET			English	Editorial Material							DEFIBRILLATORS; ANTIARRHYTHMICS; IMPLANTATION; THERAPY; SHOCKS; RHYTHM		[Stevenson, William G.; Tedrow, Usha] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Stevenson, WG (corresponding author), Brigham & Womens Hosp, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA.	wstevenson@partners.org	Tedrow, Usha/AFV-2528-2022					Aliot EM, 2009, EUROPACE, V11, P771, DOI 10.1093/europace/eup098; Connolly SJ, 2006, JAMA-J AM MED ASSOC, V295, P165, DOI 10.1001/jama.295.2.165; Della Bella P, 2002, EUR HEART J, V23, P414, DOI 10.1053/euhj.2001.2804; Epstein AE, 2008, CIRCULATION, V117, P2820, DOI 10.1161/CIRCUALTIONAHA.108.189741; Kuck KH, 2010, LANCET, V375, P31, DOI 10.1016/S0140-6736(09)61755-4; Moss AJ, 2004, CIRCULATION, V110, P3760, DOI 10.1161/01.CIR.0000150390.04704.B7; Poole JE, 2008, NEW ENGL J MED, V359, P1009, DOI 10.1056/NEJMoa071098; Raitt MH, 2001, CIRCULATION, V103, P244; Reddy VY, 2007, NEW ENGL J MED, V357, P2657, DOI 10.1056/NEJMoa065457; Schron EB, 2002, CIRCULATION, V105, P589, DOI 10.1161/hc0502.103330; Stevenson WG, 2008, CIRCULATION, V118, P2773, DOI 10.1161/CIRCULATIONAHA.108.788604; Zipes DP, 2006, J AM COLL CARDIOL, V48, pe247, DOI [10.1016/j.jacc.2006.07.010, DOI 10.1016/J.JACC.2006.07.010]	12	7	7	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 2	2010	375	9708					4	6		10.1016/S0140-6736(09)61915-2	http://dx.doi.org/10.1016/S0140-6736(09)61915-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	539BZ	20109841				2022-12-28	WOS:000273229700005
J	West, KP; Black, RE				West, Keith P., Jr.; Black, Robert E.			Rajiv Shah at USAID: reviving nutrition for the world's poor	LANCET			English	Editorial Material							INTERVENTIONS		[West, Keith P., Jr.; Black, Robert E.] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Human Nutr, Dept Int Hlth, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	West, KP (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Human Nutr, Dept Int Hlth, Baltimore, MD 21205 USA.	kwest@jhsph.edu		Black, Robert/0000-0001-9926-7984				[Anonymous], 2004, CLIN MAN AC DIARRH; [Anonymous], 2008, LANCET, DOI DOI 10.1016/S0140-6736(07)61693-6; Christian P, 2009, AM J EPIDEMIOL, V170, P1127, DOI 10.1093/aje/kwp253; Dewey KG, 2008, MATERN CHILD NUTR, V4, P24, DOI 10.1111/j.1740-8709.2007.00124.x; FAO, 2005, FAO AGR SER, V36, P211, DOI DOI 10.18356/7EE6B494-EN; G8 Summi, 2009, CHAIRS SUMM; Horton S., 2008, BEST PRACTICE PAPER; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	14	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2010	375	9712					355	357		10.1016/S0140-6736(10)60100-6	http://dx.doi.org/10.1016/S0140-6736(10)60100-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	552PK	20113812				2022-12-28	WOS:000274305500008
J	Pauly, MV				Pauly, Mark V.			Avoiding Side Effects in Implementing Health Insurance Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Penn, Wharton Sch, Hlth Care Management Dept, Philadelphia, PA 19104 USA	University of Pennsylvania	Pauly, MV (corresponding author), Univ Penn, Wharton Sch, Hlth Care Management Dept, Philadelphia, PA 19104 USA.							BUNDORF MK, 2005, 11677 NBER; Herring B, 2006, J HEALTH ECON, V25, P395, DOI 10.1016/j.jhealeco.2005.09.008; Pauly MV, 2007, HEALTH AFFAIR, V26, P770, DOI 10.1377/hlthaff.26.3.770	3	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 25	2010	362	8					671	673		10.1056/NEJMp0912181	http://dx.doi.org/10.1056/NEJMp0912181			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	559SA	20107211				2022-12-28	WOS:000274845600002
J	Balkin, JM				Balkin, Jack M.			The Constitutionality of the Individual Mandate for Health Insurance	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Yale Univ, Sch Law, New Haven, CT 06520 USA	Yale University	Balkin, JM (corresponding author), Yale Univ, Sch Law, New Haven, CT 06520 USA.								0	17	17	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 11	2010	362	6					482	483		10.1056/NEJMp1000087	http://dx.doi.org/10.1056/NEJMp1000087			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	553WJ	20071697	Green Published			2022-12-28	WOS:000274397200003
J	Fisher, HS; Hoekstra, HE				Fisher, Heidi S.; Hoekstra, Hopi E.			Competition drives cooperation among closely related sperm of deer mice	NATURE			English	Article							NATURAL-POPULATIONS; SWIMMING SPEED; PEROMYSCUS; FERTILITY; VELOCITY; EVOLUTION; RODENT; SIZE; GENE	Among the extraordinary adaptations driven by sperm competition is the cooperative behaviour of spermatozoa(1). By forming cooperative groups, sperm can increase their swimming velocity and thereby gain an advantage in intermale sperm competition(1,2). Accordingly, selection should favour cooperation of the most closely related sperm to maximize fitness(3). Here we show that sperm of deer mice (genus Peromyscus) form motile aggregations, then we use this system to test predictions of sperm cooperation. We find that sperm aggregate more often with conspecific than heterospecific sperm, suggesting that individual sperm can discriminate on the basis of genetic relatedness. Next, we provide evidence that the cooperative behaviour of closely related sperm is driven by sperm competition. In a monogamous species lacking sperm competition, Peromyscus polionotus, sperm indiscriminately group with unrelated conspecific sperm. In contrast, in the highly promiscuous deer mouse, Peromyscus maniculatus, sperm are significantly more likely to aggregate with those obtained from the same male than with sperm from an unrelated conspecific donor. Even when we test sperm from sibling males, we continue to see preferential aggregations of related sperm in P. maniculatus. These results suggest that sperm from promiscuous deer mice discriminate among relatives and thereby cooperate with the most closely related sperm, an adaptation likely to have been driven by sperm competition.	[Fisher, Heidi S.; Hoekstra, Hopi E.] Harvard Univ, Museum Comparat Zool, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Fisher, Heidi S.; Hoekstra, Hopi E.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Fisher, HS (corresponding author), Harvard Univ, Museum Comparat Zool, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	hfisher@oeb.harvard.edu	Hoekstra, Hopi E/I-6690-2012	Hoekstra, Hopi E/0000-0003-1431-1769; Fisher, Heidi S./0000-0001-5622-4335	NIH; Arnold and Mabel Beckman Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM084719] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arnold and Mabel Beckman Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Manceau and J. Gros for technical assistance and R. Lewontin for statistical advice. S. Immler, K. Foster and D. Haig provided comments and discussion on the manuscript. H. S. F. is supported by an NIH Ruth Kirschstein National Research Service Award. Research was funded by an Arnold and Mabel Beckman Foundation Young Investigator Award to H. E. H.	BIRDSALL DA, 1973, EVOLUTION, V27, P106, DOI 10.1111/j.1558-5646.1973.tb05922.x; Birkhead TR, 1999, P ROY SOC B-BIOL SCI, V266, P1759, DOI 10.1098/rspb.1999.0843; Breed WG, 2005, J MORPHOL, V265, P271, DOI 10.1002/jmor.10357; Burness G, 2004, BEHAV ECOL SOCIOBIOL, V56, P65, DOI 10.1007/s00265-003-0752-7; DAWSON WD, 1965, EVOLUTION, V19, P44, DOI 10.2307/2406294; Dewsbury D.A., 1981, Biologist (Charleston), V63, P138; DEWSBURY DA, 1985, ANIM BEHAV, V33, P1266, DOI 10.1016/S0003-3472(85)80186-X; DEWSBURY DA, 1981, J COMP PHYSIOL PSYCH, V95, P880, DOI 10.1037/h0077842; Donoghue AM, 1999, BIOL REPROD, V61, P422, DOI 10.1095/biolreprod61.2.422; FOLTZ DW, 1981, AM NAT, V117, P665, DOI 10.1086/283751; Gage MJG, 2004, CURR BIOL, V14, P44, DOI 10.1016/j.cub.2003.12.028; Gomendio M, 2008, INT J DEV BIOL, V52, P439, DOI 10.1387/ijdb.082595mg; Holt WV, 2009, REPROD DOMEST ANIM, V44, P31, DOI 10.1111/j.1439-0531.2009.01363.x; HOLT WV, 1989, HUM REPROD, V4, P292, DOI 10.1093/oxfordjournals.humrep.a136891; Howard DJ, 1999, ANNU REV ECOL SYST, V30, P109, DOI 10.1146/annurev.ecolsys.30.1.109; Immler S, 2008, REPRODUCTION, V135, P275, DOI 10.1530/REP-07-0482; Immler S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000170; JD Biggers, 1971, METHODS MAMMALIAN EM; Joseph SB, 2004, TRENDS ECOL EVOL, V19, P592, DOI 10.1016/j.tree.2004.08.004; Linzey A.V., 1974, American Museum Novitates, VNo. 2532, P1; Malo AF, 2005, BIOL REPROD, V72, P822, DOI 10.1095/biolreprod.104.036368; Moore H, 2002, NATURE, V418, P174, DOI 10.1038/nature00832; Moore HDM, 1996, J ANDROL, V17, P50; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; PARKER GA, 1988, SPERM COMPETITION SE, P3; Pizzari T, 2008, PLOS BIOL, V6, P925, DOI 10.1371/journal.pbio.0060130; Queller DC, 2003, SCIENCE, V299, P105, DOI 10.1126/science.1077742; Ramm SA, 2005, P ROY SOC B-BIOL SCI, V272, P949, DOI 10.1098/rspb.2004.3048; Smukalla S, 2008, CELL, V135, P726, DOI 10.1016/j.cell.2008.09.037; Snook RR, 2005, TRENDS ECOL EVOL, V20, P46, DOI 10.1016/j.tree.2004.10.011; Stickel L. F., 1968, P373	31	89	91	2	190	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 11	2010	463	7282					801	803		10.1038/nature08736	http://dx.doi.org/10.1038/nature08736			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	553VG	20090679	Green Accepted			2022-12-28	WOS:000274394300038
J	Celum, C; Wald, A; Lingappa, JR; Magaret, AS; Wang, RS; Mugo, N; Mujugira, A; Baeten, JM; Mullins, JI; Hughes, JP; Bukusi, EA; Cohen, CR; Katabira, E; Ronald, A; Kiarie, J; Farquhar, C; Stewart, GJ; Makhema, J; Essex, M; Were, E; Fife, KH; de Bruyn, G; Gray, GE; McIntyre, JA; Manongi, R; Kapiga, S; Coetzee, D; Allen, S; Inambao, M; Kayitenkore, K; Karita, E; Kanweka, W; Delany, S; Rees, H; Vwalika, B; Stevens, W; Campbell, MS; Thomas, KK; Coombs, RW; Morrow, R; Whittington, WLH; McElrath, MJ; Barnes, L; Ridzon, R; Corey, L				Celum, C.; Wald, A.; Lingappa, J. R.; Magaret, A. S.; Wang, R. S.; Mugo, N.; Mujugira, A.; Baeten, J. M.; Mullins, J. I.; Hughes, J. P.; Bukusi, E. A.; Cohen, C. R.; Katabira, E.; Ronald, A.; Kiarie, J.; Farquhar, C.; Stewart, G. J.; Makhema, J.; Essex, M.; Were, E.; Fife, K. H.; de Bruyn, G.; Gray, G. E.; McIntyre, J. A.; Manongi, R.; Kapiga, S.; Coetzee, D.; Allen, S.; Inambao, M.; Kayitenkore, K.; Karita, E.; Kanweka, W.; Delany, S.; Rees, H.; Vwalika, B.; Stevens, W.; Campbell, M. S.; Thomas, K. K.; Coombs, R. W.; Morrow, R.; Whittington, W. L. H.; McElrath, M. J.; Barnes, L.; Ridzon, R.; Corey, L.		Partners Prevention HSV HIV Transm	Acyclovir and Transmission of HIV-1 from Persons Infected with HIV-1 and HSV-2	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HERPES-SIMPLEX-VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; PLACEBO-CONTROLLED TRIAL; DISCORDANT COUPLES; CLINICAL-TRIALS; DOUBLE-BLIND; TYPE-1; WOMEN; SUPPRESSION; PLASMA	BACKGROUND Most persons who are infected with human immunodeficiency virus type 1 (HIV-1) are also infected with herpes simplex virus type 2 (HSV-2), which is frequently reactivated and is associated with increased plasma and genital levels of HIV-1. Therapy to suppress HSV-2 reduces the frequency of reactivation of HSV-2 as well as HIV-1 levels, suggesting that suppression of HSV-2 may reduce the risk of transmission of HIV-1. METHODS We conducted a randomized, placebo-controlled trial of suppressive therapy for HSV-2 (acyclovir at a dose of 400 mg orally twice daily) in couples in which only one of the partners was seropositive for HIV-1 (CD4 count, >= 250 cells per cubic millimeter) and that partner was also infected with HSV-2 and was not taking antiretroviral therapy at the time of enrollment. The primary end point was transmission of HIV-1 to the partner who was not initially infected with HIV-1; linkage of transmissions was assessed by means of genetic sequencing of viruses. RESULTS A total of 3408 couples were enrolled at 14 sites in Africa. Of the partners who were infected with HIV-1, 68% were women, and the baseline median CD4 count was 462 cells per cubic millimeter. Of 132 HIV-1 seroconversions that occurred after randomization ( an incidence of 2.7 per 100 person-years), 84 were linked within couples by viral sequencing: 41 in the acyclovir group and 43 in the placebo group ( hazard ratio with acyclovir, 0.92, 95% confidence interval [CI], 0.60 to 1.41; P = 0.69). Suppression with acyclovir reduced the mean plasma concentration of HIV-1 by 0.25 log(10) copies per milliliter (95% CI, 0.22 to 0.29; P<0.001) and the occurrence of HSV-2-positive genital ulcers by 73% (risk ratio, 0.27; 95% CI, 0.20 to 0.36; P<0.001). A total of 92% of the partners infected with HIV-1 and 84% of the partners not infected with HIV-1 remained in the study for 24 months. The level of adherence to the dispensed study drug was 96%. No serious adverse events related to acyclovir were observed. CONCLUSIONS Daily acyclovir therapy did not reduce the risk of transmission of HIV-1, despite a reduction in plasma HIV-1 RNA of 0.25 log10 copies per milliliter and a 73% reduction in the occurrence of genital ulcers due to HSV-2.	[Celum, C.] Univ Washington, Harborview Med Ctr, Dept Global Hlth, Seattle, WA 98104 USA; [Celum, C.; Wald, A.; Farquhar, C.; Stewart, G. J.] Univ Washington, Dept Epidemiol, Seattle, WA 98104 USA; [Celum, C.; Wald, A.; Lingappa, J. R.; Baeten, J. M.; Mullins, J. I.; Farquhar, C.; Stewart, G. J.; Campbell, M. S.; Thomas, K. K.; Coombs, R. W.; Whittington, W. L. H.; McElrath, M. J.; Corey, L.] Univ Washington, Dept Med, Seattle, WA 98104 USA; [Wald, A.; Magaret, A. S.; Mullins, J. I.; Coombs, R. W.; Morrow, R.; Corey, L.] Univ Washington, Dept Lab Med, Seattle, WA 98104 USA; [Mullins, J. I.] Univ Washington, Dept Microbiol, Seattle, WA 98104 USA; [Lingappa, J. R.] Univ Washington, Dept Pediat, Seattle, WA 98104 USA; [Hughes, J. P.] Univ Washington, Dept Biostat, Seattle, WA 98104 USA; [Wald, A.; Magaret, A. S.; McElrath, M. J.; Corey, L.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Inst, Seattle, WA 98104 USA; [Ridzon, R.] Fred Hutchinson Canc Res Ctr, Bill & Melinda Gates Fdn, Seattle, WA 98104 USA; [Mugo, N.; Bukusi, E. A.; Kiarie, J.] Univ Nairobi, Dept Obstet & Gynecol, Nairobi, Kenya; [Mugo, N.; Bukusi, E. A.; Kiarie, J.] Kenyatta Natl Hosp, Nairobi, Kenya; [Bukusi, E. A.] Kenya Govt Med Res Ctr, Ctr Microbiol Res, Nairobi, Kenya; [Were, E.] Moi Univ, Dept Reprod Hlth, Eldoret, Kenya; [Cohen, C. R.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; [Katabira, E.] Makerere Univ, Infect Dis Inst, Kampala, Uganda; [Ronald, A.] Univ Manitoba, Dept Med, Winnipeg, MB, Canada; [Makhema, J.] Botswana Harvard Partnership, Gaborone, Botswana; [Essex, M.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Fife, K. H.] Indiana Univ, Dept Med, Indianapolis, IN USA; [de Bruyn, G.; Gray, G. E.; McIntyre, J. A.] Univ Witwatersrand, Perinatal HIV Res Unit, Johannesburg, South Africa; [Delany, S.; Rees, H.] Univ Witwatersrand, Reprod Hlth & HIV Res Unit, Johannesburg, South Africa; [Stevens, W.] Univ Witwatersrand, Contract Lab Serv, Johannesburg, South Africa; [Coetzee, D.] Univ Cape Town, Infect Dis Epidemiol Unit, ZA-7925 Cape Town, South Africa; [Manongi, R.; Kapiga, S.] Kilimanjaro Christian Med Ctr, Moshi, Tanzania; [Kapiga, S.] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London, England; [Allen, S.; Inambao, M.; Kayitenkore, K.; Karita, E.; Kanweka, W.; Vwalika, B.] Rwanda Zambia HIV Res Grp, Atlanta, GA USA; [Allen, S.; Inambao, M.; Kayitenkore, K.; Karita, E.; Kanweka, W.; Vwalika, B.] Emory Univ, Sch Med, Atlanta, GA USA; [Allen, S.; Inambao, M.; Kayitenkore, K.; Karita, E.; Kanweka, W.; Vwalika, B.] Emory Univ, Sch Publ Hlth, Atlanta, GA USA	Harborview Medical Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Bill & Melinda Gates Foundation; Fred Hutchinson Cancer Center; University of Nairobi; Kenyatta National Hospital; Kenya Medical Research Institute; Moi University; University of California System; University of California San Francisco; Makerere University; University of Manitoba; Harvard University; Harvard T.H. Chan School of Public Health; Indiana University System; Indiana University-Purdue University Indianapolis; University of Witwatersrand; University of Witwatersrand; University of Witwatersrand; University of Cape Town; Kilimanjaro Christian Medical Centre; University of London; London School of Hygiene & Tropical Medicine; Emory University; Emory University	Celum, C (corresponding author), Univ Washington, Harborview Med Ctr, Dept Global Hlth, 325 9th Ave,Box 359927, Seattle, WA 98104 USA.		John-Stewart, Grace/U-3351-2019; Lingappa, Jairam/N-7760-2017; Wilson, David P/G-4614-2013; Moyo, Sikhulile/E-1464-2015; McIntyre, James/V-7115-2019; John-Stewart, Grace/L-3650-2019; Corey, Lawrence/AAE-1796-2020; de Bruyn, Guy/E-5574-2010; Wald, Anna/B-6272-2012	Moyo, Sikhulile/0000-0003-3821-4592; Corey, Lawrence/0000-0002-2179-2436; Wald, Anna/0000-0003-3486-6438; Thomas, Katherine K/0000-0002-7024-468X; Joloba, Moses/0000-0002-0334-9983; Rees, Helen/0000-0003-1442-6734; Mujugira, Andrew/0000-0001-6646-6733; Ndung'u, Thumbi/0000-0003-2962-3992; de Bruyn, Guy/0000-0002-8028-4474; Rono, Bernard/0000-0001-6553-8491; Kapiga, Saidi/0000-0003-1753-4060; Gichuhi, Stephen/0000-0002-7062-4869; kiarie, james/0000-0003-4180-7858; Were, Edwin/0000-0002-4783-0795; Ronald, Allan/0000-0002-5746-3490	Bill and Melinda Gates Foundation [26469]; University of Washington [AI-27757, AI-38858]; NIAID [P01 AI30731]; National Institute of Mental Health (NIMH) [R01 MH66767]; GlaxoSmithKline; Immune Design; AiCuris; Astellas Pharma US; MediGene; Merck Vaccines; Cepheid; Merck; Novartis; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI038858, P30AI027757, P01AI030731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066767] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); University of Washington(University of Washington); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); GlaxoSmithKline(GlaxoSmithKline); Immune Design; AiCuris; Astellas Pharma US(Astellas Pharmaceuticals); MediGene; Merck Vaccines; Cepheid; Merck(Merck & Company); Novartis(Novartis); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Supported by a grant (26469) from the Bill and Melinda Gates Foundation. HIV-1 RNA testing and some computational analyses were also supported by a grant (AI-27757) from the University of Washington Center for AIDS Research Clinical Retrovirology and Computational Biology Cores. Roche HIV-1 RNA quality-assessment panels were obtained under the auspices of the University of Washington AIDS Clinical Trials Group Virology Support Laboratory (AI-38858). Herpes laboratory support was provided in part through a grant (NIAID P01 AI30731) from the Herpes Program Project. Dr. Whittington received support from Gen-Probe to undertake testing for this project. The community outreach recruitment strategy used by some sites was adapted from the Influence Network Agent model developed by Emory collaborators under a grant (NIMH R01 MH66767) from the National Institute of Mental Health, and the couples' voluntary HIV counseling and testing procedures were based on the CDC/NIMH/Liverpool School of Tropical Medicine procedure manual, which was developed in part through support from a grant (R01 MH66767) from the NIMH. Dr. Celum reports receiving grant support from and serving on an advisory board for GlaxoSmithKline; Dr. Wald, receiving consulting fees from Immune Design, AiCuris, Astellas Pharma US, and MediGene and speaking fees from Merck Vaccines; Dr. Fife, receiving grant support from Astellas Pharma US and GlaxoSmithKline; Dr. Coombs, serving on an advisory board for Merck; Dr. Morrow, serving on an advisory board for Abbott Molecular, Biokit USA, and Roche Diagnostics; Dr. Whittington, receiving grant support from Cepheid; Dr. Ronald, receiving lecture fees from Merck; Dr. Essex, receiving royalties from Harvard University for use of the HIV gp 120/160 protein for diagnostics; and Dr. Corey, receiving consulting fees from AiCuris and GenPhar, receiving fees and equity shares (<1% ownership) for heading the scientific advisory board of Immune Design, and being named as a coinventor on several patents describing antigens and epitopes to which T-cell responses to HSV2 are directed. The University of Washington Virology Division Laboratories have received grant funding from GlaxoSmithKline and Novartis to perform serologic assays for herpes simplex virus and polymerase-chain-reaction assays for studies funded by the companies; Dr. Corey directs these laboratories but receives no salary support from these grants. No other potential conflicts of interest relevant to this article were reported.; We thank the couples who participated in this study and the referral partners, community advisory groups, institutions, and communities that collaborated with the study sites; the members of the data safety and monitoring board (Drs. Richard Whitley [chair], Ann Arvin, Francis Kasolo, Alejandros Llanos, Jonathan Matenga, James Neaton, and David Serwadda) for their oversight and expertise; the members of the Endpoint Adjudication Committee (Drs. Jan Albert, Thomas Leitner, and Francine McCutchan) for their expertise and time in reviewing sequencing data and determining linkages; Toni Maddox for assistance with the preparation of an earlier version of the manuscript; and Drs. Deborah Donnell and Patrick Ndase for their contributions to the study and insightful comments on the analysis and on an earlier version of the manuscript.	Baeten JM, 2008, J INFECT DIS, V198, P1804, DOI 10.1086/593214; Baeten JM, 2004, J INFECT DIS, V189, P1466, DOI 10.1086/383049; CAMERON DW, 1989, LANCET, V2, P403; Delany S, 2009, AIDS, V23, P461, DOI 10.1097/QAD.0b013e32831db217; Diaz JJ, 1996, NATURE, V379, P273, DOI 10.1038/379273a0; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Dunne EF, 2008, JAIDS-J ACQ IMM DEF, V49, P77, DOI 10.1097/QAI.0b013e3181831832; Fideli OS, 2001, AIDS RES HUM RETROV, V17, P901, DOI 10.1089/088922201750290023; Gilbert PB, 2003, J INFECT DIS, V188, P179, DOI 10.1086/376449; Glynn JR, 2009, AIDS, V23, P1595, DOI 10.1097/QAD.0b013e32832e15e8; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Gupta R, 2004, J INFECT DIS, V190, P1374, DOI 10.1086/424519; HENG MCY, 1994, LANCET, V343, P255, DOI 10.1016/S0140-6736(94)91110-X; KUCERA LS, 1990, AIDS RES HUM RETROV, V6, P641, DOI 10.1089/aid.1990.6.641; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Lingappa JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005272; Lingappa JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001411; Lisco A, 2008, CELL HOST MICROBE, V4, P260, DOI 10.1016/j.chom.2008.07.008; Mbopi-Keou FX, 2000, J INFECT DIS, V182, P1090, DOI 10.1086/315836; McMahon MA, 2008, J BIOL CHEM, V283, P31289, DOI 10.1074/jbc.C800188200; Mole L, 1997, J INFECT DIS, V176, P766, DOI 10.1086/517297; MOSCA JD, 1987, NATURE, V325, P67, DOI 10.1038/325067a0; Nagot N, 2007, NEW ENGL J MED, V356, P790, DOI 10.1056/NEJMoa062607; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Schacker T, 2002, J INFECT DIS, V186, P1718, DOI 10.1086/345771; Schacker T, 1998, JAMA-J AM MED ASSOC, V280, P61, DOI 10.1001/jama.280.1.61; SIEGAL FP, 1981, NEW ENGL J MED, V305, P1439, DOI 10.1056/NEJM198112103052403; Strick LB, 2006, CLIN INFECT DIS, V43, P347, DOI 10.1086/505496; Walson JL, 2008, AIDS, V22, P1601, DOI 10.1097/QAD.0b013e32830a502e; Weiss H, 2004, HERPES S, V11, p24A; Zuckerman RA, 2007, J INFECT DIS, V196, P1500, DOI 10.1086/522523	33	374	375	0	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 4	2010	362	5					427	439		10.1056/NEJMoa0904849	http://dx.doi.org/10.1056/NEJMoa0904849			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551FV	20089951	Green Accepted, Green Published			2022-12-28	WOS:000274193300008
J	Alderman, MH				Alderman, Michael H.			Reducing Dietary Sodium The Case for Caution	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARDIOVASCULAR-DISEASE; FOLLOW-UP; HYPERTENSION		Yeshiva Univ Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Alderman, MH (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Room 1315 Belfer Bldg,1300 Morris Pk Ave, Bronx, NY 10461 USA.	michael.alderman@einstein.yu.edu						Alderman MH, 2007, J HYPERTENS, V25, P903, DOI 10.1097/HJH.0b013e3280c14394; Cohen HW, 2008, J GEN INTERN MED, V23, P1297, DOI 10.1007/s11606-008-0645-6; Cook NR, 2007, BMJ-BRIT MED J, V334, P885, DOI 10.1136/bmj.39147.604896.55; Cook NR, 2009, ARCH INTERN MED, V169, P32, DOI 10.1001/archinternmed.2008.523; Graudal NA, 1998, JAMA-J AM MED ASSOC, V279, P1383, DOI 10.1001/jama.279.17.1383; Jessup M, 2009, CIRCULATION, V119, P1977, DOI 10.1161/CIRCULATIONAHA.109.192064; Marantz PR, 2008, AM J PREV MED, V34, P234, DOI 10.1016/j.amepre.2007.11.017; Paterna S, 2009, AM J CARDIOL, V103, P93, DOI 10.1016/j.amjcard.2008.08.043; Sacco RL, 2006, CIRCULATION, V113, pE409, DOI 10.1161/circ.113.10.e409; Strazzullo P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4567	10	82	82	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 3	2010	303	5					448	449		10.1001/jama.2010.69	http://dx.doi.org/10.1001/jama.2010.69			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	550QR	20124541				2022-12-28	WOS:000274143600021
J	Nilsen, TW; Graveley, BR				Nilsen, Timothy W.; Graveley, Brenton R.			Expansion of the eukaryotic proteome by alternative splicing	NATURE			English	Review							RNA-BINDING PROTEIN; MESSENGER-RNAS; DSCAM; VARIANTS; GENE; SITE; TRANSCRIPTOME; REGULATORS; GENOME; EXONS	The collection of components required to carry out the intricate processes involved in generating and maintaining a living, breathing and, sometimes, thinking organism is staggeringly complex. Where do all of the parts come from? Early estimates stated that about 100,000 genes would be required to make up a mammal; however, the actual number is less than one-quarter of that, barely four times the number of genes in budding yeast. It is now clear that the 'missing' information is in large part provided by alternative splicing, the process by which multiple different functional messenger RNAs, and therefore proteins, can be synthesized from a single gene.	[Nilsen, Timothy W.] Case Western Reserve Univ, Sch Med, Dept Biochem, Ctr RNA Mol Biol, Cleveland, OH 44106 USA; [Graveley, Brenton R.] Univ Connecticut, Ctr Hlth, Stem Cell Inst, Dept Genet & Dev Biol, Farmington, CT 06030 USA	Case Western Reserve University; University of Connecticut	Nilsen, TW (corresponding author), Case Western Reserve Univ, Sch Med, Dept Biochem, Ctr RNA Mol Biol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	twn@case.edu; graveley@neuron.uchc.edu	Graveley, Brenton R/C-3108-2013	Graveley, Brenton/0000-0001-5777-5892	National Institutes of Health; Raymond and Beverly Sackler Fund for the Arts and Sciences; State of Connecticut's Stem Cell Research Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067842, R01GM062516] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Raymond and Beverly Sackler Fund for the Arts and Sciences; State of Connecticut's Stem Cell Research Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We apologize to the many authors whose publications are not cited directly because of space limitations. Research in our laboratories is supported by grants from the National Institutes of Health (T. W. N. and B. R. G.), the Raymond and Beverly Sackler Fund for the Arts and Sciences (B. R. G.) and the State of Connecticut's Stem Cell Research Fund (B. R. G.).	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Allo M, 2009, NAT STRUCT MOL BIOL, V16, P717, DOI 10.1038/nsmb.1620; ALT FW, 1980, CELL, V20, P293, DOI 10.1016/0092-8674(80)90615-7; Anastassiou D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-1-r2; Beye M, 2003, CELL, V114, P419, DOI 10.1016/S0092-8674(03)00606-8; Blanchette M, 2009, MOL CELL, V33, P438, DOI 10.1016/j.molcel.2009.01.022; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Boutz PL, 2007, GENE DEV, V21, P71, DOI 10.1101/gad.1500707; BUCKANOVICH RJ, 1993, NEURON, V11, P657, DOI 10.1016/0896-6273(93)90077-5; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Calarco JA, 2007, GENE DEV, V21, P2963, DOI 10.1101/gad.1606907; Calarco JA, 2009, CELL, V138, P898, DOI 10.1016/j.cell.2009.06.012; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Chen HJ, 2009, J NEUROSCI, V29, P5654, DOI 10.1523/JNEUROSCI.5978-08.2009; Clamp M, 2007, P NATL ACAD SCI USA, V104, P19428, DOI 10.1073/pnas.0709013104; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Dorn R, 2001, P NATL ACAD SCI USA, V98, P9724, DOI 10.1073/pnas.151268698; Dye MJ, 2006, MOL CELL, V21, P849, DOI 10.1016/j.molcel.2006.01.032; EARLY P, 1980, CELL, V20, P313, DOI 10.1016/0092-8674(80)90617-0; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Fox-Walsh KL, 2005, P NATL ACAD SCI USA, V102, P16176, DOI 10.1073/pnas.0508489102; Fu XD, 2004, CELL, V119, P736, DOI 10.1016/j.cell.2004.11.039; Gabut M, 2008, CELL, V133, P192, DOI 10.1016/j.cell.2008.03.010; Giles KE, 2005, MOL CELL BIOL, V25, P4397, DOI 10.1128/MCB.25.11.4397-4405.2005; Goodman SJ, 2003, DEVELOPMENT, V130, P3757, DOI 10.1242/dev.00604; Goren A, 2006, MOL CELL, V22, P769, DOI 10.1016/j.molcel.2006.05.008; Graveley BR, 2005, CELL, V123, P65, DOI 10.1016/j.cell.2005.07.028; Graveley BR, 2008, TRENDS GENET, V24, P5, DOI 10.1016/j.tig.2007.10.004; Hasselmann M, 2008, NATURE, V454, P519, DOI 10.1038/nature07052; Hillier LW, 2009, GENOME RES, V19, P657, DOI 10.1101/gr.088112.108; House AE, 2006, NAT STRUCT MOL BIOL, V13, P937, DOI 10.1038/nsmb1149; Jin Y, 2003, EMBO J, V22, P905, DOI 10.1093/emboj/cdg089; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Kornblihtt AR, 2007, ADV EXP MED BIOL, V623, P175, DOI 10.1007/978-0-387-77374-2_11; Kwon SY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000574; Labrador M, 2001, NATURE, V409, P1000, DOI 10.1038/35059000; Lin SR, 2007, ADV EXP MED BIOL, V623, P107, DOI 10.1007/978-0-387-77374-2_7; Lynch KW, 2007, ADV EXP MED BIOL, V623, P161, DOI 10.1007/978-0-387-77374-2_10; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Markovtsov V, 2000, MOL CELL BIOL, V20, P7463, DOI 10.1128/MCB.20.20.7463-7479.2000; Martinez-Contreras R, 2006, PLOS BIOL, V4, P172, DOI 10.1371/journal.pbio.0040021; Martinez-Contreras R, 2007, ADV EXP MED BIOL, V623, P123, DOI 10.1007/978-0-387-77374-2_8; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Modrek B, 2003, NAT GENET, V34, P177, DOI 10.1038/ng1159; Muriel JM, 2005, DEVELOPMENT, V132, P4223, DOI 10.1242/dev.02007; Navaratnam DS, 1997, NEURON, V19, P1077, DOI 10.1016/S0896-6273(00)80398-0; Nern A, 2005, P NATL ACAD SCI USA, V102, P12944, DOI 10.1073/pnas.0502888102; Neves G, 2004, NAT GENET, V36, P240, DOI 10.1038/ng1299; Ohler U, 2005, PLOS COMPUT BIOL, V1, P113, DOI 10.1371/journal.pcbi.0010015; Olson S, 2007, NAT STRUCT MOL BIOL, V14, P1134, DOI 10.1038/nsmb1339; Ono K, 2008, J CELL SCI, V121, P2662, DOI 10.1242/jcs.034215; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Park JW, 2004, P NATL ACAD SCI USA, V101, P15974, DOI 10.1073/pnas.0407004101; Pleiss JA, 2007, PLOS BIOL, V5, P745, DOI 10.1371/journal.pbio.0050090; Polydorides AD, 2000, P NATL ACAD SCI USA, V97, P6350, DOI 10.1073/pnas.110128397; Rosenblatt KP, 1997, NEURON, V19, P1061, DOI 10.1016/S0896-6273(00)80397-9; ROSENFELD MG, 1982, P NATL ACAD SCI-BIOL, V79, P1717, DOI 10.1073/pnas.79.6.1717; Sanchez L, 2008, INT J DEV BIOL, V52, P837, DOI 10.1387/ijdb.072396ls; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Sharma S, 2008, NAT STRUCT MOL BIOL, V15, P183, DOI 10.1038/nsmb.1375; Shepard PJ, 2008, RNA, V14, P1463, DOI 10.1261/rna.1069408; Shin C, 2004, NAT REV MOL CELL BIO, V5, P727, DOI 10.1038/nrm1467; SIEBEL CW, 1992, GENE DEV, V6, P1386, DOI 10.1101/gad.6.8.1386; Smith DJ, 2008, MOL CELL, V30, P657, DOI 10.1016/j.molcel.2008.04.013; Sorek R, 2003, GENOME RES, V13, P1631, DOI 10.1101/gr.1208803; Sorensen JB, 2003, CELL, V114, P75, DOI 10.1016/S0092-8674(03)00477-X; Stolc V, 2004, SCIENCE, V306, P655, DOI 10.1126/science.1101312; Sugnet CW, 2003, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2004, P66; Tilgner H, 2009, NAT STRUCT MOL BIOL, V16, P996, DOI 10.1038/nsmb.1658; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; Underwood JG, 2005, MOL CELL BIOL, V25, P10005, DOI 10.1128/MCB.25.22.10005-10016.2005; VALCARCEL J, 1993, NATURE, V362, P171, DOI 10.1038/362171a0; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; Wojtowicz WM, 2007, CELL, V130, P1134, DOI 10.1016/j.cell.2007.08.026; Xie JY, 2001, NATURE, V410, P936, DOI 10.1038/35073593; Xing Y, 2006, NAT REV GENET, V7, P499, DOI 10.1038/nrg1896; Yu Y, 2008, CELL, V135, P1224, DOI 10.1016/j.cell.2008.10.046; Zhang XHF, 2006, P NATL ACAD SCI USA, V103, P13427, DOI 10.1073/pnas.0603042103; Zhang XHF, 2009, RNA, V15, P367, DOI 10.1261/rna.1498509; Zuo P, 1996, GENE DEV, V10, P1356, DOI 10.1101/gad.10.11.1356	84	1322	1365	8	264	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 28	2010	463	7280					457	463		10.1038/nature08909	http://dx.doi.org/10.1038/nature08909			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	548QK	20110989	Green Submitted, Green Accepted			2022-12-28	WOS:000273981100037
J	Paragi, Z; Taylor, GB; Kouveliotou, C; Granot, J; Ramirez-Ruiz, E; Bietenholz, M; van der Horst, AJ; Pidopryhora, Y; van Langevelde, HJ; Garrett, MA; Szomoru, A; Argo, MK; Bourke, S; Paczynski, B				Paragi, Z.; Taylor, G. B.; Kouveliotou, C.; Granot, J.; Ramirez-Ruiz, E.; Bietenholz, M.; van der Horst, A. J.; Pidopryhora, Y.; van Langevelde, H. J.; Garrett, M. A.; Szomoru, A.; Argo, M. K.; Bourke, S.; Paczynski, B.			A mildly relativistic radio jet from the otherwise normal type Ic supernova 2007gr	NATURE			English	Article							GAMMA-RAY BURSTS; SN 2007GR; EMISSION	The class of type Ic supernovae have drawn increasing attention since 1998 owing to their sparse association (only four so far) with long duration gamma-ray bursts (GRBs)(1-4). Although both phenomena originate from the core collapse of a massive star, supernovae emit mostly at optical wavelengths, whereas GRBs emit mostly in soft gamma-rays or hard X-rays. Though the GRB central engine generates ultra-relativistic jets, which beam the early emission into a narrow cone, no relativistic outflows have hitherto been found in type Ib/c supernovae explosions, despite theoretical expectations(5-7) and searches(8). Here we report radio (interferometric) observations that reveal a mildly relativistic expansion in a nearby type Ic supernova, SN 2007gr. Using two observational epochs 60 days apart, we detect expansion of the source and establish a conservative lower limit for the average apparent expansion velocity of 0.6c. Independently, a second mildly relativistic supernova has been reported(9). Contrary to the radio data, optical observations(10-13) of SN 2007gr indicate a typical type Ic supernova with ejecta velocities similar to 6,000 km s(-1), much lower than in GRB-associated supernovae. We conclude that in SN 2007gr a small fraction of the ejecta produced a low-energy mildly relativistic bipolar radio jet, while the bulk of the ejecta were slower and, as shown by optical spectropolarimetry(14), mildly aspherical.	[Paragi, Z.; Pidopryhora, Y.; van Langevelde, H. J.; Szomoru, A.; Bourke, S.] JIVE, NL-7990 AA Dwingeloo, Netherlands; [Paragi, Z.] MTA Res Grp Phys Geodesy & Geodynam, H-1521 Budapest, Hungary; [Taylor, G. B.] Univ New Mexico, Dept Phys & Astron, Albuquerque, NM 87131 USA; [Kouveliotou, C.; van der Horst, A. J.] NASA, George C Marshall Space Flight Ctr, Space Sci Off, Huntsville, AL 35812 USA; [Granot, J.] Univ Hertfordshire, Ctr Astrophys Res, Hatfield AL10 9AB, Herts, England; [Ramirez-Ruiz, E.] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Bietenholz, M.] Hartebeesthoek Radio Observ, ZA-1740 Krugersdorp, South Africa; [Bietenholz, M.] York Univ, Dept Phys & Astron, Toronto, ON M3J 1P3, Canada; [Garrett, M. A.] Netherlands Inst Radio Astron ASTRON, NL-7990 AA Dwingeloo, Netherlands; [van Langevelde, H. J.; Garrett, M. A.] Leiden Univ, Leiden Observ, NL-2300 RA Leiden, Netherlands; [Garrett, M. A.] Swinburne Univ Technol, Ctr Astrophys & Supercomp, Hawthorn, Vic 3122, Australia; [Argo, M. K.] Curtin Univ Technol, Curtin Inst Radio Astron, Perth, WA 6845, Australia	University of New Mexico; National Aeronautics & Space Administration (NASA); NASA Marshall Space Flight Center; University of Hertfordshire; University of California System; University of California Santa Cruz; National Research Foundation - South Africa; Hartebeesthoek Radio Astronomy Observatory; York University - Canada; Leiden University; Leiden University - Excl LUMC; Swinburne University of Technology; Curtin University	Paragi, Z (corresponding author), JIVE, Postbus 2, NL-7990 AA Dwingeloo, Netherlands.	zparagi@jive.nl		Taylor, Greg/0000-0001-6495-7731; Granot, Jonathan/0000-0001-8530-8941; Argo, Megan/0000-0003-3594-0214; van Langevelde, Huib Jan/0000-0002-0230-5946; van der Horst, Alexander/0000-0001-9149-6707; Paragi, Zsolt/0000-0002-5195-335X	Hungarian Scientific Research Fund (OTKA) [K72515]; EC [02662]; national research councils; Netherlands Foundation for Scientific Research (NWO); European Community [R113CT 2003 5058187]; Royal Society; NASA; Science and Technology Facilities Council [ST/G002630/1] Funding Source: researchfish; STFC [ST/G002630/1] Funding Source: UKRI	Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); EC(European CommissionEuropean Commission Joint Research Centre); national research councils; Netherlands Foundation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Community(European Commission); Royal Society(Royal Society of London); NASA(National Aeronautics & Space Administration (NASA)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	Z. P. acknowledges support from the Hungarian Scientific Research Fund (OTKA, grant K72515). We are grateful to A. Soderberg for providing the VLA coordinates of SN 2007gr in August 2007, which helped us to confirm our initial e-VLBI detection and thus enabled our follow-up VLBI observations. e-VLBI development in Europe is supported by the EC DG-INFSO funded Communication Network Developments project 'EXPReS', contract no. 02662. The EVN is a joint facility of European, Chinese, South African and other radio astronomy institutes funded by their national research councils. The WSRT is operated by ASTRON (Netherlands Institute for Radio Astronomy) with support from the Netherlands Foundation for Scientific Research (NWO). ParselTounge was developed in the context of the ALBIUS project, funded by the European Community's sixth Framework Programme under RadioNet R113CT 2003 5058187. J. G. acknowledges a Royal Society Wolfson Research Merit Award. A. J. v. d. H. was supported by the NASA Postdoctoral Program at the MSFC, administered by Oak Ridge Associated Universities through a contract with NASA.	CHORNOCK R, 2007, CENT BUR ELECT TELEG, V1036; Crockett RM, 2008, ASTROPHYS J LETT, V672, pL99, DOI 10.1086/527299; Galama TJ, 1998, NATURE, V395, P670, DOI 10.1038/27150; Granot J, 2004, ASTROPHYS J, V609, pL9, DOI 10.1086/422516; Granot J, 2003, ASTROPHYS J, V593, pL81, DOI 10.1086/378262; Hjorth J, 2003, NATURE, V423, P847, DOI 10.1038/nature01750; Hunter DJ, 2009, ASTRON ASTROPHYS, V508, P371, DOI 10.1051/0004-6361/200912896; Kaneko Y, 2007, ASTROPHYS J, V654, P385, DOI 10.1086/508324; MADISON D, 2007, CENT BUR ELECT TELEG, V1034; Paczynski B, 2001, ACTA ASTRONOM, V51, P1; Pilyugin LS, 2004, ASTRON ASTROPHYS, V425, P849, DOI 10.1051/0004-6361:20034522; SODERBERG A, 2007, ASTRON TELEGR, V1187; Soderberg AM, 2006, ASTROPHYS J, V638, P930, DOI 10.1086/499121; Stanek KZ, 2003, ASTROPHYS J, V591, pL17, DOI 10.1086/376976; Tanaka M, 2008, ASTROPHYS J, V689, P1191, DOI 10.1086/592325; Valenti S, 2008, ASTROPHYS J LETT, V673, pL155, DOI 10.1086/527672; Weiler KW, 2002, ANNU REV ASTRON ASTR, V40, P387, DOI 10.1146/annurev.astro.40.060401.093744	17	45	45	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 28	2010	463	7280					516	518		10.1038/nature08713	http://dx.doi.org/10.1038/nature08713			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	548QK	20110996	Green Submitted			2022-12-28	WOS:000273981100045
J	Harris, SR; Feil, EJ; Holden, MTG; Quail, MA; Nickerson, EK; Chantratita, N; Gardete, S; Tavares, A; Day, N; Lindsay, JA; Edgeworth, JD; de Lencastre, H; Parkhill, J; Peacock, SJ; Bentley, SD				Harris, Simon R.; Feil, Edward J.; Holden, Matthew T. G.; Quail, Michael A.; Nickerson, Emma K.; Chantratita, Narisara; Gardete, Susana; Tavares, Ana; Day, Nick; Lindsay, Jodi A.; Edgeworth, Jonathan D.; de Lencastre, Herminia; Parkhill, Julian; Peacock, Sharon J.; Bentley, Stephen D.			Evolution of MRSA During Hospital Transmission and Intercontinental Spread	SCIENCE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; IDENTIFICATION; CLONES; TRIMETHOPRIM; MUTATION; STRAIN	Current methods for differentiating isolates of predominant lineages of pathogenic bacteria often do not provide sufficient resolution to define precise relationships. Here, we describe a high-throughput genomics approach that provides a high-resolution view of the epidemiology and microevolution of a dominant strain of methicillin-resistant Staphylococcus aureus (MRSA). This approach reveals the global geographic structure within the lineage, its intercontinental transmission through four decades, and the potential to trace person-to-person transmission within a hospital environment. The ability to interrogate and resolve bacterial populations is applicable to a range of infectious diseases, as well as microbial ecology.	[Harris, Simon R.; Holden, Matthew T. G.; Quail, Michael A.; Parkhill, Julian; Bentley, Stephen D.] Wellcome Trust Sanger Inst, Cambridge CB10 15A, England; [Feil, Edward J.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Nickerson, Emma K.; Chantratita, Narisara; Day, Nick; Peacock, Sharon J.] Mahidol Univ, Fac Trop Med, Bangkok, Thailand; [Nickerson, Emma K.; Peacock, Sharon J.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 0QQ, England; Univ Nova Lisboa, Inst Tecnol Quim & Biol, Mol Genet Lab, P-2780156 Oeiras, Portugal; [Gardete, Susana; Tavares, Ana; de Lencastre, Herminia] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Mol Genet Lab, P-2780156 Oeiras, Portugal; [Gardete, Susana; de Lencastre, Herminia] Rockefeller Univ, Microbiol Lab, New York, NY 10065 USA; [Day, Nick] Univ Oxford, Nuffield Dept Clin Med, Ctr Clin Vaccinol & Trop Med, Oxford OX3 7LJ, England; [Lindsay, Jodi A.] Univ London, Dept Cellular & Mol Med, Ctr Infect, London SW17 0RE, England; [Edgeworth, Jonathan D.] Guys Hosp, Guys Kings & St Thomas Med Sch, Kings Coll London, Dept Infect Dis, London SE1 9RT, England; [Edgeworth, Jonathan D.] Guys & St Thomas Natl Hlth Serv Fdn Trust, Directorate Infect, London SE1 7EH, England	Wellcome Trust Sanger Institute; University of Bath; Mahidol University; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Universidade Nova de Lisboa; Universidade Nova de Lisboa; Rockefeller University; University of Oxford; University of London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust	Bentley, SD (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 15A, England.	sdb@sanger.ac.uk	Peacock, Sharon J/ABE-6331-2020; Weinstock, George M/C-6314-2013; Harris, Simon R/K-1318-2013; Parkhill, Julian/G-4703-2011; Lindsay, Jodi/B-9565-2008; Chantratita, Narisara/P-2169-2019; Quail, michael/ABE-6131-2020; Holden, Matthew TG/K-6449-2014; Lindsay, Jodi/ABH-8205-2020	Weinstock, George M/0000-0002-2997-4592; Harris, Simon R/0000-0003-1512-6194; Parkhill, Julian/0000-0002-7069-5958; Lindsay, Jodi/0000-0002-5219-1625; Holden, Matthew TG/0000-0002-4958-2166; Lindsay, Jodi/0000-0002-5219-1625; Peacock, Sharon/0000-0002-1718-2782; Tavares, Ana/0000-0002-2221-4785; /0000-0001-6816-8932	Wellcome Trust; Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BPD/25403/2005, SFRH/BD/44220/2008]; Guy's and St. Thomas' Charity; Department of Health via the National Institute for Health Research's comprehensive Biomedical Research Centre	Wellcome Trust(Wellcome TrustEuropean Commission); Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Guy's and St. Thomas' Charity; Department of Health via the National Institute for Health Research's comprehensive Biomedical Research Centre	The Sanger Institute is core funded by the Wellcome Trust. We thank C. Milheirico and J. D. Cockfield for preparation of genomic DNA and G. Dougan and the Sanger Institute Sequencing and Informatics groups for general support. S. G. and A. T. were supported by grants SFRH/BPD/25403/2005 and SFRH/BD/44220/2008, respectively, from Fundacao para a Ciencia e Tecnologia, Portugal. E.K.N., N.C., N.D., and S. J. P. were funded by the Wellcome Trust. Funding for the sequencing of the TW20 genome was provided by Guy's and St. Thomas' Charity. J. D. E. receives funding from the Department of Health via the National Institute for Health Research's comprehensive Biomedical Research Centre award to Guy's and St. Thomas' National Health Service Foundation Trust in partnership with King's College London. The Illumina Genome Analyzer reads are deposited in the Short Read Archive (National Center for Biotechnology Information) under the accession no. ERA000102. The annotated chromosome of TW20 has been submitted to European Molecular Biology Laboratory with the accession number FN433596.	Alp E, 2009, J INFECTION, V58, P433, DOI 10.1016/j.jinf.2009.04.006; Bartels MD, 2008, EUR J CLIN MICROBIOL, V27, P757, DOI 10.1007/s10096-008-0500-z; Besier S, 2003, MOL MICROBIOL, V47, P463, DOI 10.1046/j.1365-2958.2003.03307.x; Dale GE, 1997, J MOL BIOL, V266, P23, DOI 10.1006/jmbi.1996.0770; de Lencastre Herminia, 2008, P333; Edgeworth JD, 2007, CLIN INFECT DIS, V44, P493, DOI 10.1086/511034; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Falush D, 2001, P NATL ACAD SCI USA, V98, P15056, DOI 10.1073/pnas.251396098; Feil EJ, 2008, J CLIN MICROBIOL, V46, P1520, DOI 10.1128/JCM.02238-07; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Hurdle JG, 2004, J ANTIMICROB CHEMOTH, V53, P102, DOI 10.1093/jac/dkh020; Ko KS, 2005, J CLIN MICROBIOL, V43, P421, DOI 10.1128/JCM.43.1.421-426.2005; Lindsay JA, 2004, TRENDS MICROBIOL, V12, P378, DOI 10.1016/j.tim.2004.06.004; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Melter O, 2003, J CLIN MICROBIOL, V41, P4998, DOI 10.1128/JCM.41.11.4998-5005.2003; Moran NA, 2009, SCIENCE, V323, P379, DOI 10.1126/science.1167140; Nubel U, 2008, P NATL ACAD SCI USA, V105, P14130, DOI 10.1073/pnas.0804178105; Ochman H, 1999, P NATL ACAD SCI USA, V96, P12638, DOI 10.1073/pnas.96.22.12638; Oliveira DC, 2001, MICROB DRUG RESIST, V7, P349, DOI 10.1089/10766290152773365; Rocha EPC, 2006, J THEOR BIOL, V239, P226, DOI 10.1016/j.jtbi.2005.08.037; Szczepanik A, 2007, EUR J CLIN MICROBIOL, V26, P29, DOI 10.1007/s10096-006-0237-5; Tanaka M, 2000, J Infect Chemother, V6, P131, DOI 10.1007/s101560070010; Vickers AA, 2009, J ANTIMICROB CHEMOTH, V63, P1112, DOI 10.1093/jac/dkp090; Vivoni AM, 2006, J CLIN MICROBIOL, V44, P1686, DOI 10.1128/JCM.44.5.1686-1691.2006; Wichelhaus TA, 2002, ANTIMICROB AGENTS CH, V46, P3381, DOI 10.1128/AAC.46.11.3381-3385.2002; Xu BL, 2009, J HOSP INFECT, V71, P245, DOI 10.1016/j.jhin.2008.10.029	26	829	862	5	216	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 22	2010	327	5964					469	474		10.1126/science.1182395	http://dx.doi.org/10.1126/science.1182395			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546BS	20093474	Green Accepted			2022-12-28	WOS:000273783100039
J	Lam, JKY; Lam, KSL; Tan, KCB; Chow, WS; Tso, AWK; Kung, AWC				Lam, Joanne K. Y.; Lam, Karen S. L.; Tan, Kathryn C. B.; Chow, Wing-Sun; Tso, Annette W. K.; Kung, Annie W. C.			Case report A woman with hypophosphataemia and raised alkaline phosphatase	BRITISH MEDICAL JOURNAL			English	Editorial Material							VITAMIN-D INSUFFICIENCY; PRIMARY HYPERPARATHYROIDISM; 25-HYDROXYVITAMIN-D; DEFICIENCY		[Lam, Joanne K. Y.; Lam, Karen S. L.; Tan, Kathryn C. B.; Chow, Wing-Sun; Tso, Annette W. K.; Kung, Annie W. C.] Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Kung, AWC (corresponding author), Queen Mary Hosp, 102 Pok Fu Lam Rd, Hong Kong, Hong Kong, Peoples R China.	awckung@hku.hk						Barger-Lux MJ, 1998, OSTEOPOROSIS INT, V8, P222, DOI 10.1007/s001980050058; Bilezikian JP, 2009, J CLIN ENDOCR METAB, V94, P335, DOI 10.1210/jc.2008-1763; Bischoff-Ferrari HA, 2006, AM J CLIN NUTR, V84, P18, DOI 10.1093/ajcn/84.1.18; Chiu B, 2006, ARCH SURG-CHICAGO, V141, P483, DOI 10.1001/archsurg.141.5.483; Civelek AC, 2002, SURGERY, V131, P149, DOI 10.1067/msy.2002.119817; HUNSEN RV, 2004, WORLD J SURG, V28, P1122; ISIDRO ML, 2009, ENDOCRINE; PARISIEN M, 1990, ENDOCRIN METAB CLIN, V19, P19, DOI 10.1016/S0889-8529(18)30337-2; Prentice A, 2008, NUTR REV, V66, pS153, DOI 10.1111/j.1753-4887.2008.00100.x; Rao DS, 2000, J CLIN ENDOCR METAB, V85, P1054, DOI 10.1210/jc.85.3.1054; Silverberg SJ, 1999, AM J MED, V107, P561, DOI 10.1016/S0002-9343(99)00294-6; Stewart ZA, 2005, SURGERY, V138, P1018, DOI 10.1016/j.surg.2005.09.018; Wat WZM, 2007, ANN NUTR METAB, V51, P59, DOI 10.1159/000100822	13	0	0	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 20	2010	340								b5564	10.1136/bmj.b5564	http://dx.doi.org/10.1136/bmj.b5564			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	548HO	20089574				2022-12-28	WOS:000273951300002
J	Siefermann, KR; Abel, B				Siefermann, Katrin R.; Abel, Bernd			Ion Chemistry Mediated by Water Networks	SCIENCE			English	Editorial Material							MOLECULAR-ORBITAL CALCULATIONS; NITROUS-ACID FORMATION; CLUSTER IONS; GAS-PHASE		[Siefermann, Katrin R.; Abel, Bernd] Univ Gottingen, Inst Phys Chem, D-37077 Gottingen, Germany; [Abel, Bernd] Univ Leipzig, Ostwald Inst Phys & Theoret Chem, D-04103 Leipzig, Germany	University of Gottingen; Leipzig University	Siefermann, KR (corresponding author), Univ Gottingen, Inst Phys Chem, Tammannstr 6, D-37077 Gottingen, Germany.	bernd.abel@uni-leipzig.de						FEHSENFE.FC, 1969, J GEOPHYS RES, V74, P2217, DOI 10.1029/JA074i009p02217; FEHSENFELD FC, 1971, J CHEM PHYS, V55, P2120, DOI 10.1063/1.1676383; HAMILTON EJ, 1975, J CHEM PHYS, V63, P3682, DOI 10.1063/1.431772; Hammam E, 2001, J PHYS CHEM A, V105, P5528, DOI 10.1021/jp003847q; Hammam E, 2000, J PHYS CHEM A, V104, P4571, DOI 10.1021/jp994278t; NARCISI RS, 1965, J GEOPHYS RES, V70, P3687, DOI 10.1029/JZ070i015p03687; PUCKETT LJ, 1971, J CHEM PHYS, V54, P2564, DOI 10.1063/1.1675213; Relph RA, 2010, SCIENCE, V327, P308, DOI 10.1126/science.1177118; TROE J, 1994, J CHEM SOC FARADAY T, V90, P2303, DOI 10.1039/ft9949002303; Vohringer-Martinez E, 2007, SCIENCE, V315, P497, DOI 10.1126/science.1134494	10	11	11	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 15	2010	327	5963					280	281		10.1126/science.1184555	http://dx.doi.org/10.1126/science.1184555			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544CM	20075239				2022-12-28	WOS:000273629700026
J	Wittstock, A; Zielasek, V; Biener, J; Friend, CM; Baumer, M				Wittstock, A.; Zielasek, V.; Biener, J.; Friend, C. M.; Baeumer, M.			Nanoporous Gold Catalysts for Selective Gas-Phase Oxidative Coupling of Methanol at Low Temperature	SCIENCE			English	Article							MOLECULAR-TRANSFORMATIONS; AEROBIC OXIDATION; POROUS GOLD; OXYGEN; AU; EFFICIENT; ALCOHOLS; ETHANOL	Gold (Au) is an interesting catalytic material because of its ability to catalyze reactions, such as partial oxidations, with high selectivities at low temperatures; but limitations arise from the low O-2 dissociation probability on Au. This problem can be overcome by using Au nanoparticles supported on suitable oxides which, however, are prone to sintering. Nanoporous Au, prepared by the dealloying of AuAg alloys, is a new catalyst with a stable structure that is active without any support. It catalyzes the selective oxidative coupling of methanol to methyl formate with selectivities above 97% and high turnover frequencies at temperatures below 80 degrees C. Because the overall catalytic characteristics of nanoporous Au are in agreement with studies on Au single crystals, we deduced that the selective surface chemistry of Au is unaltered but that O-2 can be readily activated with this material. Residual silver is shown to regulate the availability of reactive oxygen.	[Wittstock, A.; Zielasek, V.; Baeumer, M.] Univ Bremen, Inst Appl & Phys Chem, D-28359 Bremen, Germany; [Biener, J.] Lawrence Livermore Natl Lab, Nanoscale Synth & Characterizat Lab, Livermore, CA 94550 USA; [Friend, C. M.] Harvard Univ, Dept Chem, Cambridge, MA 02138 USA	University of Bremen; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Harvard University	Biener, J (corresponding author), Univ Bremen, Inst Appl & Phys Chem, D-28359 Bremen, Germany.	biener2@llnl.gov; cfriend@seas.harvard.edu; mbaeumer@uni-bremen.de	Bäumer, Marcus/S-5441-2016; Wittstock, Arne/ABI-3292-2020; Baeumer, Marcus/AAC-2802-2019; SHANG, Jintang/A-3715-2012	Bäumer, Marcus/0000-0002-8620-1764; Baeumer, Marcus/0000-0002-8620-1764; 	Alexander von Humboldt Foundation; HanseWissenschaftskolleg in Germany; U.S. DOE [DE-FG02-84-ER13289]; University of Bremen	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); HanseWissenschaftskolleg in Germany; U.S. DOE(United States Department of Energy (DOE)); University of Bremen	We are grateful to R. Schlogl (Fritz-Haber-Institute, Berlin) for critically reading the manuscript. Work at LLNL was performed under the auspices of the U.S. Department of Energy (DOE) by LLNL under contract DE-AC52-07NA27344. C. M. F. acknowledges a Senior Research Award from the Alexander von Humboldt Foundation and a fellowship from the HanseWissenschaftskolleg in Germany as well as research support from the U.S. DOE under contract DE-FG02-84-ER13289. M. B. acknowledges financial support from the University of Bremen.	Abad A, 2005, ANGEW CHEM INT EDIT, V44, P4066, DOI 10.1002/anie.200500382; Bond GC, 2000, GOLD BULL, V33, P41, DOI 10.1007/BF03216579; Deng XY, 2005, J AM CHEM SOC, V127, P9267, DOI 10.1021/ja050144j; Falsig H, 2008, ANGEW CHEM INT EDIT, V47, P4835, DOI 10.1002/anie.200801479; Gewin V, 2006, NATURE, V443, P137, DOI 10.1038/443137a; Gong J, 2008, J PHYS CHEM C, V112, P5501, DOI 10.1021/jp0763735; HARUTA M, 1987, CHEM LETT, P405, DOI 10.1246/cl.1987.405; Haruta M, 2007, CHEMPHYSCHEM, V8, P1911, DOI 10.1002/cphc.200700325; Hughes MD, 2005, NATURE, V437, P1132, DOI 10.1038/nature04190; Hutchings GJ, 2005, CATAL TODAY, V100, P55, DOI 10.1016/j.cattod.2004.12.016; Hvolbaek B, 2007, NANO TODAY, V2, P14, DOI 10.1016/S1748-0132(07)70113-5; Ishida T, 2007, ANGEW CHEM INT EDIT, V46, P7154, DOI 10.1002/anie.200701622; Jorgensen B, 2007, J CATAL, V251, P332, DOI 10.1016/j.jcat.2007.08.004; Liu XY, 2008, CHEM SOC REV, V37, P2243, DOI 10.1039/b800309m; Liu XY, 2009, J AM CHEM SOC, V131, P5757, DOI 10.1021/ja900822r; MADIX RJ, 1986, SCIENCE, V233, P1159, DOI 10.1126/science.233.4769.1159; Mallat T, 2004, CHEM REV, V104, P3037, DOI 10.1021/cr0200116; Marko IE, 1996, SCIENCE, V274, P2044, DOI 10.1126/science.274.5295.2044; Nyce GW, 2007, CHEM MATER, V19, P344, DOI 10.1021/cm062569q; Poliakoff M, 2007, NATURE, V450, P810, DOI 10.1038/450810a; SCHWANK J, 1980, J CATAL, V63, P415, DOI 10.1016/0021-9517(80)90095-0; SIM WS, 1995, J PHYS CHEM-US, V99, P16002, DOI 10.1021/j100043a046; Sinha AK, 2004, TOP CATAL, V29, P95, DOI 10.1023/B:TOCA.0000029791.69935.53; United Nations World Commission on Environment and Development (UN WCED), 1987, A42427 UN WCED; Wang CB, 1999, J PHYS CHEM B, V103, P5645, DOI 10.1021/jp984363l; Wittstock A, 2009, J PHYS CHEM C, V113, P5593, DOI 10.1021/jp808185v; Xu BJ, 2010, NAT CHEM, V2, P61, DOI [10.1038/NCHEM.467, 10.1038/nchem.467]; Xu BJ, 2009, ANGEW CHEM INT EDIT, V48, P4206, DOI 10.1002/anie.200805404; Yin HM, 2008, J PHYS CHEM C, V112, P9673, DOI 10.1021/jp8019864; Zeis R, 2008, J CATAL, V253, P132, DOI 10.1016/j.jcat.2007.10.017; Zhang JT, 2007, J PHYS CHEM C, V111, P10382, DOI 10.1021/jp072333p; Zielasek V, 2006, ANGEW CHEM INT EDIT, V45, P8241, DOI 10.1002/anie.200602484; 2009, ULLMANS ENCY IND CHE	33	934	964	7	859	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 15	2010	327	5963					319	322		10.1126/science.1183591	http://dx.doi.org/10.1126/science.1183591			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	544CM	20075249				2022-12-28	WOS:000273629700039
J	Cane, MA				Cane, Mark A.			CLIMATE A moist model monsoon	NATURE			English	Editorial Material									Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA	Columbia University	Cane, MA (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA.		Cane, Mark/I-8086-2012	Cane, Mark/0000-0001-5408-2388				Ashfaq M, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036500; Blanford HF., 1886, MEM INDIA MET DEP, V2, P217; Boos WR, 2010, NATURE, V463, P218, DOI 10.1038/nature08707; Chakraborty A, 2006, ANN GEOPHYS-GERMANY, V24, P2075, DOI 10.5194/angeo-24-2075-2006; EMANUEL KA, 1994, Q J ROY METEOR SOC, V120, P1111, DOI 10.1256/smsqj.51901; Gadgil S, 2003, ANNU REV EARTH PL SC, V31, P429, DOI 10.1146/annurev.earth.31.100901.141251; SARACHIK ES, 1978, DYNAM ATMOS OCEANS, V2, P455	7	15	17	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 14	2010	463	7278					163	164		10.1038/463163a	http://dx.doi.org/10.1038/463163a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543MQ	20075905				2022-12-28	WOS:000273582700018
J	Griffiths, CEM; Strober, BE; van de Kerkhof, P; Ho, V; Fidelus-Gort, R; Yeilding, N; Guzzo, C; Xia, YC; Zhou, B; Li, S; Dooley, LT; Goldstein, NH; Menter, A				Griffiths, Christopher E. M.; Strober, Bruce E.; van de Kerkhof, Peter; Ho, Vincent; Fidelus-Gort, Roseanne; Yeilding, Newman; Guzzo, Cynthia; Xia, Yichuan; Zhou, Bei; Li, Shu; Dooley, Lisa T.; Goldstein, Neil H.; Menter, Alan		ACCEPT Study Grp	Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTERLEUKIN-12/23 MONOCLONAL-ANTIBODY; CHRONIC PLAQUE PSORIASIS; RANDOMIZED-CONTROLLED-TRIAL; DOUBLE-BLIND; TNF INHIBITION; EFFICACY; PLACEBO; SAFETY; METHOTREXATE; INDUCTION	BACKGROUND Biologic agents offer a range of new therapeutic options for patients with psoriasis; however, the relative benefit-risk profiles of such therapies are not well known. We compared two biologic agents, ustekinumab (an interleukin-12 and interleukin-23 blocker) and etanercept (an inhibitor of tumor necrosis factor a), for the treatment of psoriasis. METHODS We randomly assigned 903 patients with moderate-to-severe psoriasis to receive subcutaneous injections of either 45 or 90 mg of ustekinumab (at weeks 0 and 4) or high-dose etanercept (50 mg twice weekly for 12 weeks). The primary end point was the proportion of patients with at least 75% improvement in the psoriasis area-and-severity index (PASI) at week 12; a secondary end point was the proportion with cleared or minimal disease on the basis of the physician's global assessment. Assessors were unaware of the treatment assignments. The efficacy and safety of a crossover from etanercept to ustekinumab were evaluated after week 12. RESULTS There was at least 75% improvement in the PASI at week 12 in 67.5% of patients who received 45 mg of ustekinumab and 73.8% of patients who received 90 mg, as compared with 56.8% of those who received etanercept (P=0.01 and P<0.001, respectively). Similarly, 65.1% of patients who received 45 mg of ustekinumab and 70.6% of patients who received 90 mg of ustekinumab had cleared or minimal disease according to the physician's global assessment, as compared with 49.0% of those who received etanercept (P<0.001 for both comparisons). Among patients who did not have a response to etanercept, 48.9% had at least 75% improvement in the PASI within 12 weeks after crossover to ustekinumab. One or more adverse events occurred through week 12 in 66.0% of patients who received 45 mg of ustekinumab and 69.2% of patients who received 90 mg of ustekinumab and in 70.0% who received etanercept; 1.9%, 1.2%, and 1.2%, respectively, had serious adverse events. Safety patterns were similar before and after crossover from etanercept to ustekinumab. CONCLUSIONS The efficacy of ustekinumab at a dose of 45 or 90 mg was superior to that of high-dose etanercept over a 12-week period in patients with psoriasis. (ClinicalTrials.gov number, NCT00454584.)	[Griffiths, Christopher E. M.] Univ Manchester, Salford Royal Hosp, Dermatol Ctr, Manchester Acad Hlth Sci Ctr, Manchester M6 8HD, Lancs, England; [Strober, Bruce E.] NYU Med Ctr, New York, NY 10016 USA; [van de Kerkhof, Peter] Univ Nijmegen Hosp, NL-6500 HB Nijmegen, Netherlands; [Ho, Vincent] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Fidelus-Gort, Roseanne] Incyte Corp, Wilmington, DE USA; [Yeilding, Newman; Guzzo, Cynthia; Xia, Yichuan; Zhou, Bei; Li, Shu; Dooley, Lisa T.] Centocor Res & Dev, Malvern, PA USA; [Goldstein, Neil H.] Precis Res, Malvern, PA USA; [Menter, Alan] Baylor Univ, Med Ctr, Psoriasis Res Unit, Dallas, TX USA	Salford Royal NHS Foundation Trust; Salford Royal Hospital; University of Manchester; New York University; Radboud University Nijmegen; University of British Columbia; Incyte; Johnson & Johnson; Johnson & Johnson USA; Baylor University; Baylor University Medical Center	Griffiths, CEM (corresponding author), Univ Manchester, Salford Royal Hosp, Dermatol Ctr, Manchester Acad Hlth Sci Ctr, Manchester M6 8HD, Lancs, England.	christopher.griffiths@manchester.ac.uk	Griffiths, Christopher E.M./P-5448-2014; Strober, Bruce/AAQ-6953-2020	Griffiths, Christopher E.M./0000-0001-5371-4427; Strober, Bruce/0000-0002-8394-2057	Centocor Research and Development; Merck Serono; Amgen and Abbott Laboratories; Centocor; Abbott; Amgen; Wyeth; National Institute for Health Research, Manchester Biomedical Research Centre	Centocor Research and Development; Merck Serono(Merck & Company); Amgen and Abbott Laboratories; Centocor; Abbott(Abbott Laboratories); Amgen(Amgen); Wyeth(Wyeth); National Institute for Health Research, Manchester Biomedical Research Centre(National Institute for Health Research (NIHR))	We thank C. Arnold of Centocor Ortho Biotech Services Research and Development for her writing support and editorial assistance, J. Krueger of Rockefeller University and J. Benson of Centocor Research and Development for their critical review of an earlier version of the manuscript, Y. You of Centocor Research and Development for her programming support, and the National Institute for Health Research, Manchester Biomedical Research Centre, for support to Dr. Griffiths.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Caproni M, 2009, J CLIN IMMUNOL, V29, P210, DOI 10.1007/s10875-008-9233-0; FREDRIKSSON T, 1978, DERMATOLOGICA, V157, P238, DOI 10.1159/000250839; Gordon KB, 2006, J AM ACAD DERMATOL, V55, P598, DOI 10.1016/j.jaad.2006.05.027; Gottlieb AB, 2005, J IMMUNOL, V175, P2721, DOI 10.4049/jimmunol.175.4.2721; Griffiths CEM, 2007, LANCET, V370, P263, DOI 10.1016/S0140-6736(07)61128-3; Hehlgans T, 2005, IMMUNOLOGY, V115, P1, DOI 10.1111/j.1365-2567.2005.02143.x; Heydendael VMR, 2003, NEW ENGL J MED, V349, P658, DOI 10.1056/NEJMoa021359; Kimball AB, 2008, ARCH DERMATOL, V144, P200, DOI 10.1001/archdermatol.2007.63; Krueger GG, 2007, NEW ENGL J MED, V356, P580, DOI 10.1056/NEJMoa062382; Kryczek I, 2008, J IMMUNOL, V181, P4733, DOI 10.4049/jimmunol.181.7.4733; Lebwohl M, 2003, NEW ENGL J MED, V349, P2004, DOI 10.1056/NEJMoa030002; Lebwohl M, 2003, ARCH DERMATOL, V139, P719, DOI 10.1001/archderm.139.6.719; Leonardi CL, 2003, NEW ENGL J MED, V349, P2014, DOI 10.1056/NEJMoa030409; Leonardi CL, 2008, LANCET, V371, P1665, DOI 10.1016/S0140-6736(08)60725-4; Liu H, 2008, J IMMUNOL, V180, P7948, DOI 10.4049/jimmunol.180.12.7948; Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Menter A, 2007, J AM ACAD DERMATOL, V56, pe1; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Papp KA, 2008, LANCET, V371, P1675, DOI 10.1016/S0140-6736(08)60726-6; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Reich K, 2005, LANCET, V366, P1367, DOI 10.1016/S0140-6736(05)67566-6; Saurat JH, 2008, BRIT J DERMATOL, V158, P558, DOI 10.1111/j.1365-2133.2007.08315.x; Schon MP, 2005, NEW ENGL J MED, V352, P1899, DOI 10.1056/NEJMra041320; Steinman L, 2008, J EXP MED, V205, P1517, DOI 10.1084/jem.20072066; Vanden Eijnden S, 2005, EUR J IMMUNOL, V35, P469, DOI 10.1002/eji.200425677; Zaba LC, 2007, J EXP MED, V204, P3183, DOI 10.1084/jem.20071094	28	634	672	2	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 14	2010	362	2					118	128		10.1056/NEJMoa0810652	http://dx.doi.org/10.1056/NEJMoa0810652			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	543FU	20071701				2022-12-28	WOS:000273558500009
J	van der Gaag, NA; Rauws, EAJ; van Eijck, CHJ; Bruno, MJ; van der Harst, E; Kubben, FJGM; Gerritsen, JJGM; Greve, JW; Gerhards, MF; de Hingh, IHJT; Klinkenbijl, JH; Nio, CY; de Castro, SMM; Busch, ORC; van Gulik, TM; Bossuyt, PMM; Gouma, DJ				van der Gaag, Niels A.; Rauws, Erik A. J.; van Eijck, Casper H. J.; Bruno, Marco J.; van der Harst, Erwin; Kubben, Frank J. G. M.; Gerritsen, Josephus J. G. M.; Greve, Jan Willem; Gerhards, Michael F.; de Hingh, Ignace H. J. T.; Klinkenbijl, Jean H.; Nio, Chung Y.; de Castro, Steve M. M.; Busch, Olivier R. C.; van Gulik, Thomas M.; Bossuyt, Patrick M. M.; Gouma, Dirk J.			Preoperative Biliary Drainage for Cancer of the Head of the Pancreas	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GEMCITABINE-BASED CHEMORADIATION; POSTOPERATIVE COMPLICATIONS; RESECTABLE ADENOCARCINOMA; ENDOSCOPIC SPHINCTEROTOMY; OBSTRUCTIVE-JAUNDICE; SURGICAL-TREATMENT; PANCREATICODUODENECTOMY; PERIAMPULLARY; METAANALYSIS; MANAGEMENT	BACKGROUND The benefits of preoperative biliary drainage, which was introduced to improve the postoperative outcome in patients with obstructive jaundice caused by a tumor of the pancreatic head, are unclear. METHODS In this multicenter, randomized trial, we compared preoperative biliary drainage with surgery alone for patients with cancer of the pancreatic head. Patients with obstructive jaundice and a bilirubin level of 40 to 250 mu mol per liter (2.3 to 14.6 mg per deciliter) were randomly assigned to undergo either preoperative biliary drainage for 4 to 6 weeks, followed by surgery, or surgery alone within 1 week after diagnosis. Preoperative biliary drainage was attempted primarily with the placement of an endoprosthesis by means of endoscopic retrograde cholangiopancreatography. The primary outcome was the rate of serious complications within 120 days after randomization. RESULTS We enrolled 202 patients; 96 were assigned to undergo early surgery and 106 to undergo preoperative biliary drainage; 6 patients were excluded from the analysis. The rates of serious complications were 39% (37 patients) in the early-surgery group and 74% (75 patients) in the biliary-drainage group (relative risk in the early-surgery group, 0.54; 95% confidence interval [CI], 0.41 to 0.71; P<0.001). Preoperative biliary drainage was successful in 96 patients (94%) after one or more attempts, with complications in 47 patients (46%). Surgery-related complications occurred in 35 patients (37%) in the early-surgery group and in 48 patients (47%) in the biliary-drainage group (relative risk, 0.79; 95% CI, 0.57 to 1.11; P=0.14). Mortality and the length of hospital stay did not differ significantly between the two groups. CONCLUSIONS Routine preoperative biliary drainage in patients undergoing surgery for cancer of the pancreatic head increases the rate of complications. (Current Controlled Trials number, ISRCTN31939699.)	[van der Gaag, Niels A.; de Castro, Steve M. M.; Busch, Olivier R. C.; van Gulik, Thomas M.; Gouma, Dirk J.] Univ Amsterdam, Acad Med Ctr, Dept Surg, NL-1105 AZ Amsterdam, Netherlands; [Rauws, Erik A. J.] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol, NL-1105 AZ Amsterdam, Netherlands; [Nio, Chung Y.] Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands; [Bossuyt, Patrick M. M.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol & Biostat, NL-1105 AZ Amsterdam, Netherlands; [van Eijck, Casper H. J.] Erasmus MC, Dept Surg, Rotterdam, Netherlands; [Bruno, Marco J.] Erasmus MC, Dept Gastroenterol, Rotterdam, Netherlands; [van der Harst, Erwin] Maasstad Hosp, Dept Surg, Rotterdam, Netherlands; [Kubben, Frank J. G. M.] Maasstad Hosp, Dept Gastroenterol, Rotterdam, Netherlands; [Gerritsen, Josephus J. G. M.] Med Spectrum Twente, Dept Surg, Enschede, Netherlands; [Greve, Jan Willem] Univ Hosp Maastricht, Dept Surg, Maastricht, Netherlands; [Gerhards, Michael F.] Onze Lieve Vrouw Hosp, Dept Surg, Amsterdam, Netherlands; [de Hingh, Ignace H. J. T.] Catharina Hosp, Dept Surg, Eindhoven, Netherlands; [Klinkenbijl, Jean H.] Rijnstate Hosp, Dept Surg, Arnhem, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Maasstad Hospital; Maasstad Hospital; Medical Spectrum Twente; Maastricht University; Maastricht University Medical Centre (MUMC); Onze Lieve Vrouwe Gasthuis Hospital; Catharina Hospital; Rijnstate Hospital	Gouma, DJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Surg, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	d.j.gouma@amc.uva.nl	van Eijck, casper/K-5983-2019; Busch, Olivier/AAC-3650-2020; Bossuyt, Patrick M/AAR-1183-2021; Bossuyt, Patrick M./B-4557-2016; Van Eijck, Casper/ABD-1655-2020	Bossuyt, Patrick M/0000-0003-4427-0128; Bossuyt, Patrick M./0000-0003-4427-0128; De Hingh, Ignace/0000-0003-3491-4268	Netherlands Organization for Health Research and Development	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development)	Supported by the Netherlands Organization for Health Research and Development.; Dr. Bruno reports receiving lecture fees from Boston Scientific; and Dr. Greve, consulting fees from GI Dynamics and lecture fees from Covidien and Johnson & Johnson. No other potential conflict of interest relevant to this article was reported.; We thank Huug Obertop (formerly of the Academic Medical Center in Amsterdam and more recently of the Erasmus Medical Center in Rotterdam); Paul Fockens, Sapphire Phoa, and Otto van Delden of the Academic Medical Center in Amsterdam; Ernst Kuipers of the Erasmus Medical Center in Rotterdam; and the patients and their families for their contributions to the study.	Balcom JH, 2001, ARCH SURG-CHICAGO, V136, P391, DOI 10.1001/archsurg.136.4.391; Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; Cameron JL, 2006, ANN SURG, V244, P10, DOI 10.1097/01.sla.0000217673.04165.ea; Christensen M, 2004, GASTROINTEST ENDOSC, V60, P721, DOI 10.1016/S0016-5107(04)02169-8; COTTON PB, 1991, GASTROINTEST ENDOSC, V37, P383, DOI 10.1016/S0016-5107(91)70740-2; DAVIDS PHP, 1992, LANCET, V340, P1488, DOI 10.1016/0140-6736(92)92752-2; de Castro SMM, 2005, J GASTROINTEST SURG, V9, P1163, DOI 10.1016/j.gassur.2005.08.010; de Castro SMM, 2005, BRIT J SURG, V92, P1117, DOI 10.1002/bjs.5047; de Castro SMM, 2005, ANN SURG, V241, P85, DOI 10.1097/01.sla.0000150169.22834.13; de Groen PC, 1999, NEW ENGL J MED, V341, P1368, DOI 10.1056/NEJM199910283411807; Diener MK, 2007, ANN SURG, V245, P187, DOI 10.1097/01.sla.0000242711.74502.a9; Evans DB, 2008, J CLIN ONCOL, V26, P3496, DOI 10.1200/JCO.2007.15.8634; Freeman Martin L, 2003, Curr Gastroenterol Rep, V5, P145, DOI 10.1007/s11894-003-0084-9; Gouma DJ, 1999, EUR J SURG ONCOL, V25, P113, DOI 10.1053/ejso.1998.0612; Gouma DJ, 2000, ANN SURG, V232, P786, DOI 10.1097/00000658-200012000-00007; Henegouwen MIV, 1997, GUT, V41, P758, DOI 10.1136/gut.41.6.758; Huibregtse K, 1996, NEW ENGL J MED, V335, P961, DOI 10.1056/NEJM199609263351309; Johnson CD, 2005, GUT, V54, DOI 10.1136/gut.2004.057059; Karsten TM, 1996, EUR J SURG, V162, P881; Katz MHG, 2008, J AM COLL SURGEONS, V206, P833, DOI 10.1016/j.jamcollsurg.2007.12.020; Kimmings AN, 2000, GUT, V46, P725, DOI 10.1136/gut.46.5.725; KLINKENBIJL JHG, 1993, BRIT J SURG, V80, P1575, DOI 10.1002/bjs.1800801227; LILLEMOE KD, 1993, ANN SURG, V217, P447, DOI 10.1097/00000658-199305010-00004; Lillemoe KD, 1999, ANN SURG, V230, P143, DOI 10.1097/00000658-199908000-00002; Moss AC, 2007, CANCER TREAT REV, V33, P213, DOI 10.1016/j.ctrv.2006.10.006; Mullen JT, 2005, J GASTROINTEST SURG, V9, P1094, DOI 10.1016/j.gassur.2005.08.006; Phoa SSKS, 1999, BRIT J SURG, V86, P789, DOI 10.1046/j.1365-2168.1999.01138.x; Pisters PWT, 2001, ANN SURG, V234, P47, DOI 10.1097/00000658-200107000-00008; Schnelldorfer T, 2008, ANN SURG, V247, P456, DOI 10.1097/SLA.0b013e3181613142; Sewnath ME, 2002, ANN SURG, V236, P17, DOI 10.1097/00000658-200207000-00005; Sewnath ME, 2001, J AM COLL SURGEONS, V192, P726, DOI 10.1016/S1072-7515(01)00819-5; TREDE M, 1988, ANN SURG, V207, P39, DOI 10.1097/00000658-198801000-00009; van der Gaag NA, 2009, J GASTROINTEST SURG, V13, P814, DOI 10.1007/s11605-008-0618-4; van der Gaag Niels A, 2007, BMC Surg, V7, P3; van Geenen RCI, 2001, SURGERY, V129, P158, DOI 10.1067/msy.2001.110221; Van Heek NT, 2003, ANN SURG, V238, P894, DOI 10.1097/01.sla.0000098617.21801.95; Varadhachary GR, 2008, J CLIN ONCOL, V26, P3487, DOI 10.1200/JCO.2007.15.8642; WANG Q, 2008, COCHRANE DB SYST REV, V3; Williams PT, 2007, MED SCI SPORT EXER, V39, P801, DOI 10.1249/mss.0b013e31803349b1	39	633	643	0	57	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 14	2010	362	2					129	137		10.1056/NEJMoa0903230	http://dx.doi.org/10.1056/NEJMoa0903230			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	543FU	20071702				2022-12-28	WOS:000273558500010
J	Williams, D; Gutierrez, JM; Harrison, R; Warrell, DA; White, J; Winkel, KD; Gopalakrishnakone, P				Williams, David; Maria Gutierrez, Jose; Harrison, Robert; Warrell, David A.; White, Julian; Winkel, Kenneth D.; Gopalakrishnakone, Ponnampalam		Global Snake Bite Initiative Worki	The Global Snake Bite Initiative: an antidote for snake bite	LANCET			English	Editorial Material							NEGLECTED TROPICAL DISEASES; BURDEN		[Williams, David; Warrell, David A.; Winkel, Kenneth D.] Univ Melbourne, Australian Venom Res Unit, Dept Pharmacol, Parkville, Vic 3010, Australia; [Williams, David] Univ Melbourne, Nossal Inst Global Hlth, Parkville, Vic 3010, Australia; [Maria Gutierrez, Jose] Univ Costa Rica, Inst Clodomiro Picado, San Jose, Costa Rica; [Harrison, Robert] Univ Liverpool, Liverpool Sch Trop Med, Alistair Reid Venom Res Unit, Liverpool L3 5QA, Merseyside, England; [Warrell, David A.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England; [White, Julian] Womens & Childrens Hosp, Toxinol Dept, Adelaide, SA, Australia; [Gopalakrishnakone, Ponnampalam] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117595, Singapore	University of Melbourne; University of Melbourne; Universidad Costa Rica; Liverpool School of Tropical Medicine; University of Liverpool; University of Oxford; Womens & Childrens Hospital Australia; National University of Singapore	Williams, D (corresponding author), Univ Melbourne, Australian Venom Res Unit, Dept Pharmacol, Grattan St, Parkville, Vic 3010, Australia.	d.williams4@pgrad.unimelb.edu.au	Winkel, Kenneth D./K-8489-2013; Gutiérrez, José/GSJ-1846-2022	Winkel, Kenneth D./0000-0001-8282-6938; Williams, David/0000-0002-6838-4632; Gutierrez, Jose Maria/0000-0001-8385-3081				[Anonymous], 2006, Wkly Epidemiol Rec, V81, P317; [Anonymous], 2008, Wkly Epidemiol Rec, V83, P269; [Anonymous], WORLD HLTH REP 2004; Branche C., 2008, WORLD REPORT CHILD I; Chippaux JP, 1998, B WORLD HEALTH ORGAN, V76, P515; DECOCK KM, 1988, LANCET, V1, P630; GATES W, 2007, COMMUNICATION; Kasturiratne A, 2008, PLOS MED, V5, P1591, DOI 10.1371/journal.pmed.0050218; Mathers CD, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000114; *MELB C MAN, 2008, P 1 GLOB ISS CLIN TO; MION G, 1997, REANIMATION TROPICAL, P349; Molyneux DH, 2009, LANCET, V373, P296, DOI 10.1016/S0140-6736(09)60089-1; NASIDI A, 1989, T ROY SOC TROP MED H, V83, P401, DOI 10.1016/0035-9203(89)90518-X; SWAROOP S, 1954, Bull World Health Organ, V10, P35; WHO, 2009, GUID PROD CONTR REG; World Health Organization, 2008, Weekly Epidemiological Record, V83, P69	16	220	227	0	23	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 2	2010	375	9708					89	91		10.1016/S0140-6736(09)61159-4	http://dx.doi.org/10.1016/S0140-6736(09)61159-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	539BZ	20109867				2022-12-28	WOS:000273229700035
J	Yuan, J; Luo, KT; Zhang, LZ; Cheville, JC; Lou, ZK				Yuan, Jian; Luo, Kuntian; Zhang, Lizhi; Cheville, John C.; Lou, Zhenkun			USP10 Regulates p53 Localization and Stability by Deubiquitinating p53	CELL			English	Article							ATM-DEPENDENT PHOSPHORYLATION; UBIQUITIN-SPECIFIC PROTEASE; RING-FINGER DOMAIN; DNA-DAMAGE; NUCLEAR EXPORT; P53-MDM2 PATHWAY; MDM2; DEGRADATION; HAUSP; ACTIVATION	Stability and localization of p53 is essential for its tumor suppressor function. Ubiquitination by the E3 ubiquitin ligase Mdm2 is the major regulatory mechanism of p53, which induces p53 nuclear export and degradation. However, it is unclear whether ubiquitinated cytoplasmic p53 can be recycled. Here, we report that USP10, a cytoplasmic ubiquitin-specific protease, deubiquitinates p53, reversing Mdm2-induced p53 nuclear export and degradation. After DNA damage, USP10 is stabilized, and a fraction of USP10 translocates to the nucleus to activate p53. The translocation and stabilization of USP10 is regulated by ATM -mediated phosphorylation of USP10 at Thr42 and Ser337. Finally, USP10 suppresses tumor cell growth in cells with wild-type p53, with USP10 expression downregulated in a high percentage of clear cell carcinomas, known to have few p53 mutations. These findings reveal USP10 to be a novel regulator of p53, providing an alternative mechanism of p53 inhibition in cancers with wildtype p53.	[Yuan, Jian; Luo, Kuntian; Lou, Zhenkun] Mayo Clin, Dept Oncol, Div Oncol Res, Rochester, MN 55905 USA; [Zhang, Lizhi; Cheville, John C.] Mayo Clin, Dept Pathol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Lou, ZK (corresponding author), Mayo Clin, Dept Oncol, Div Oncol Res, Rochester, MN 55905 USA.	lou.zhenkun@mayo.edu	高, 雨莉/HGU-8187-2022; Yuan, Jian/B-1310-2012	Yuan, Jian/0000-0002-2801-8849	Richard Schulze Family Foundation and Research; National Institutes of Health [CA130996]; NATIONAL CANCER INSTITUTE [R01CA148940, R01CA130996] Funding Source: NIH RePORTER	Richard Schulze Family Foundation and Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Bert Vogelstein (Johns Hopkins University), Thomas Roberts (Dana-Farber Cancer Institute and Harvard Medical School), Peter Howley (National Cancer Institute), and Tyler Jacks (MIT Center for Cancer Research) for providing reagents used in this study. This work was supported in part by grants from the Richard Schulze Family Foundation and Research Grant and the National Institutes of Health (CA130996).	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Boyd SD, 2000, NAT CELL BIOL, V2, P563, DOI 10.1038/35023500; Brooks CL, 2007, ONCOGENE, V26, P7262, DOI 10.1038/sj.onc.1210531; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Chehab NH, 2000, GENE DEV, V14, P278; Cummins JM, 2004, NATURE, V428, DOI 10.1038/nature02501; Deng SS, 2007, BREAST CANCER RES TR, V104, P21, DOI 10.1007/s10549-006-9393-7; Everett RD, 1997, EMBO J, V16, P1519, DOI 10.1093/emboj/16.7.1519; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; Geyer RK, 2000, NAT CELL BIOL, V2, P569, DOI 10.1038/35023507; Grunda JM, 2006, J NEURO-ONCOL, V80, P261, DOI 10.1007/s11060-006-9191-4; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Hu M, 2006, PLOS BIOL, V4, P228, DOI 10.1371/journal.pbio.0040027; Khosravi R, 1999, P NATL ACAD SCI USA, V96, P14973, DOI 10.1073/pnas.96.26.14973; Kubbutat MHG, 1997, MOL CELL BIOL, V17, P460, DOI 10.1128/MCB.17.1.460; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Lohrum MAE, 2001, MOL CELL BIOL, V21, P8521, DOI 10.1128/MCB.21.24.8521-8532.2001; Marchenko ND, 2007, CELL CYCLE, V6, P1718, DOI 10.4161/cc.6.14.4503; Maya R, 2001, GENE DEV, V15, P1067, DOI 10.1101/gad.886901; Meulmeester E, 2005, MOL CELL, V18, P565, DOI 10.1016/j.molcel.2005.04.024; Nikolaev AY, 2003, CELL, V112, P29, DOI 10.1016/S0092-8674(02)01255-2; Pereg Y, 2005, P NATL ACAD SCI USA, V102, P5056, DOI 10.1073/pnas.0408595102; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Sheng Y, 2006, NAT STRUCT MOL BIOL, V13, P285, DOI 10.1038/nsmb1067; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Shieh SY, 2000, GENE DEV, V14, P289; Shim H, 1997, P NATL ACAD SCI USA, V94, P6658, DOI 10.1073/pnas.94.13.6658; Shirangi TR, 2002, FASEB J, V16, P420, DOI 10.1096/fj.01-0617fje; Soncini C, 2001, ONCOGENE, V20, P3869, DOI 10.1038/sj.onc.1204553; Song MS, 2008, NATURE, V455, P813, DOI 10.1038/nature07290; Soussi T, 2000, HUM MUTAT, V15, P105, DOI 10.1002/(SICI)1098-1004(200001)15:1<105::AID-HUMU19>3.0.CO;2-G; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Stommel JM, 2004, EMBO J, V23, P1547, DOI 10.1038/sj.emboj.7600145; Terzian T, 2008, GENE DEV, V22, P1337, DOI 10.1101/gad.1662908; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Xirodimas DP, 2001, EXP CELL RES, V270, P66, DOI 10.1006/excr.2001.5314	44	367	392	3	57	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 5	2010	140	3					384	U121		10.1016/j.cell.2009.12.032	http://dx.doi.org/10.1016/j.cell.2009.12.032			21	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	552ND	20096447	Green Accepted, Bronze			2022-12-28	WOS:000274297700016
J	Schuetz, GM; Zacharopoulou, NM; Schlattmann, P; Dewey, M				Schuetz, Georg M.; Zacharopoulou, Niki Maria; Schlattmann, Peter; Dewey, Marc			Meta-analysis: Noninvasive Coronary Angiography Using Computed Tomography Versus Magnetic Resonance Imaging	ANNALS OF INTERNAL MEDICINE			English	Review							DUAL-SOURCE CT; LEFT-VENTRICULAR FUNCTION; HEART-RATE-VARIABILITY; MULTIDETECTOR ROW CT; X-RAY ANGIOGRAPHY; DIAGNOSTIC-ACCURACY; ARTERY-DISEASE; PREDICTIVE-VALUE; CLINICAL-VALUE; HIGH-RISK	Background: Two imaging techniques, multislice computed tomography (CT) and magnetic resonance imaging (MRI), have evolved for noninvasive coronary angiography. Purpose: To compare CT and MRI for ruling out clinically significant coronary artery disease (CAD) in adults with suspected or known CAD. Data Sources: MEDLINE, EMBASE, and ISI Web of Science searches from inception through 2 June 2009 and bibliographies of reviews. Study Selection: Prospective English-or German-language studies that compared CT or MRI with conventional coronary angiography in all patients and included sufficient data for compilation of 2 x 2 tables. Data Extraction: 2 investigators independently extracted patient and study characteristics; differences were resolved by consensus. Data Synthesis: 89 and 20 studies (comprising 7516 and 989 patients) assessed CT and MRI, respectively. Bivariate analysis of data yielded a mean sensitivity and specificity of 97.2% (95% CI, 96.2% to 98.0%) and 87.4% (CI, 84.5% to 89.8%) for CT and 87.1% (CI, 83.0% to 90.3%) and 70.3% (CI, 58.8% to 79.7%) for MRI. In studies that included only patients with suspected CAD, sensitivity and specificity of CT were 97.6% (CI, 96.1% to 98.5%) and 89.2% (CI, 86.0% to 91.8%). Covariate analysis yielded a significantly higher sensitivity for CT scanners with more than 16 rows (98.1% [CI, 97.0% to 99.0%]; P < 0.050) than for older-generation scanners (95.6% [CI, 94.0% to 97.0%]). Heart rates less than 60 beats/min during CT yielded significantly better values for sensitivity than did higher heart rates (P < 0.001). Limitations: Few studies investigated coronary angiography with MRI. Only 5 studies were direct head-to-head comparisons of CT and MRI. Covariate analyses explained only part of the observed heterogeneity. Conclusion: For ruling out CAD, CT is more accurate than MRI. Scanners with more than 16 rows improve sensitivity, as do slowed heart rates.	[Dewey, Marc] Free Univ Berlin, Humboldt Univ, Charite Med Sch, Dept Radiol, D-10117 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Dewey, M (corresponding author), Free Univ Berlin, Humboldt Univ, Charite Med Sch, Dept Radiol, Charitepl 1, D-10117 Berlin, Germany.	marc.dewey@charite.de	Schlattmann, Peter/B-5289-2008	Dewey, Marc/0000-0002-4402-2733				Abdulla J, 2007, EUR HEART J, V28, P3042, DOI 10.1093/eurheartj/ehm466; Achenbach S, 2005, EUR HEART J, V26, P1978, DOI 10.1093/eurheartj/ehi326; Achenbach S, 2010, J CARDIOVASC COMPUT, V4, P110, DOI 10.1016/j.jcct.2010.01.013; Alkadhi H, 2008, EUR HEART J, V29, P766, DOI 10.1093/eurheartj/ehn044; Andreini D, 2007, J AM COLL CARDIOL, V49, P2044, DOI 10.1016/j.jacc.2007.01.086; Austen W G, 1975, Circulation, V51, P5; Bayrak F, 2008, ACTA CARDIOL, V63, P11, DOI 10.2143/AC.63.1.2025326; Bedaux WLF, 2002, J CARDIOV MAGN RESON, V4, P273, DOI 10.1081/JCMR-120003953; Bellenger NG, 2000, EUR HEART J, V21, P1387, DOI 10.1053/euhj.2000.2011; Bellenger NG, 2000, HERZ, V25, P392, DOI 10.1007/s000590050031; Bogaert J, 2003, RADIOLOGY, V226, P707, DOI 10.1148/radiol.2263011750; Bonmassari R, 2006, J CARDIOVASC MED, V7, P817, DOI 10.2459/01.JCM.0000250870.55907.75; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Botnar RM, 2003, J CARDIOV MAGN RESON, V5, P589, DOI 10.1081/JCMR-120025232; Brodoefel H, 2008, RADIOLOGY, V247, P346, DOI 10.1148/radiol.2472070906; Budoff MJ, 2008, J AM COLL CARDIOL, V52, P1724, DOI 10.1016/j.jacc.2008.07.031; Cademartiri F, 2007, RADIOL MED, V112, P969, DOI 10.1007/s11547-007-0198-5; Carrascosa Patricia, 2007, J Cardiovasc Comput Tomogr, V1, P86, DOI 10.1016/j.jcct.2007.06.003; Cheng LQ, 2006, J MAGN RESON IMAGING, V23, P669, DOI 10.1002/jmri.20567; Chow BJW, 2007, CAN J CARDIOL, V23, P801, DOI 10.1016/S0828-282X(07)70831-0; Chu HT, 2006, J CLIN EPIDEMIOL, V59, P1331, DOI 10.1016/j.jclinepi.2006.06.011; Coles DR, 2007, INT J CARDIOVAS IMAG, V23, P603, DOI 10.1007/s10554-006-9193-5; Cornily JC, 2007, EUR J RADIOL, V61, P84, DOI 10.1016/j.ejrad.2006.08.010; d'Othee BJ, 2008, EUR J RADIOL, V65, P449, DOI 10.1016/j.ejrad.2007.05.003; Danias PG, 2004, J AM COLL CARDIOL, V44, P1867, DOI 10.1016/j.jacc.2004.07.051; Davin L, 2007, ACTA CARDIOL, V62, P339, DOI 10.2143/AC.62.4.2022276; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; Deetjen AG, 2007, CLIN CARDIOL, V30, P118, DOI 10.1002/clc.20059; Dewey M, 2007, ROFO-FORTSCHR RONTG, V179, P581, DOI 10.1055/s-2007-963112; Dewey M, 2007, ROFO-FORTSCHR RONTG, V179, P246, DOI 10.1055/s-2007-962830; DEWEY M, 2009, CORONARY CT ANGIOGRA; Dewey M, 2007, J MAGN RESON IMAGING, V26, P1322, DOI 10.1002/jmri.21147; Dewey M, 2007, EUR RADIOL, V17, P2829, DOI 10.1007/s00330-007-0685-z; Dewey M, 2007, EUR RADIOL, V17, P1301, DOI 10.1007/s00330-006-0439-3; Dewey M, 2006, ANN INTERN MED, V145, P407, DOI 10.7326/0003-4819-145-6-200609190-00004; Dewey M, 2009, CIRCULATION, V120, P867, DOI 10.1161/CIRCULATIONAHA.109.859280; Earls JP, 2008, RADIOLOGY, V246, P742, DOI 10.1148/radiol.2463070989; Egger E, 1997, LANCET, V350, P326, DOI 10.1016/S0140-6736(97)02419-7; Ehara M, 2006, CIRC J, V70, P564, DOI 10.1253/circj.70.564; Einstein AJ, 2007, CIRCULATION, V116, P1290, DOI 10.1161/CIRCULATIONAHA.107.688101; Einstein AJ, 2007, JAMA-J AM MED ASSOC, V298, P317, DOI 10.1001/jama.298.3.317; Erdogan N, 2006, HEART VESSELS, V21, P278, DOI 10.1007/s00380-005-0903-z; Flohr TG, 2006, EUR RADIOL, V16, P256, DOI 10.1007/s00330-005-2919-2; Garcia MJ, 2006, JAMA-J AM MED ASSOC, V296, P403, DOI 10.1001/jama.296.4.403; Gaudio C, 2009, INT J CARDIOL, V135, P280, DOI 10.1016/j.ijcard.2008.03.091; Gerber BL, 2005, RADIOLOGY, V234, P98, DOI 10.1148/radiol.2341031325; Ghersin E, 2006, AM J ROENTGENOL, V186, P177, DOI 10.2214/AJR.04.1232; Ghostine S, 2006, J AM COLL CARDIOL, V48, P1929, DOI 10.1016/j.jacc.2006.04.103; Gilard M, 2006, J AM COLL CARDIOL, V47, P2020, DOI 10.1016/j.jacc.2005.11.085; GOLDBERG RK, 1990, AM HEART J, V119, P178, DOI 10.1016/S0002-8703(05)80098-5; Grosse C, 2007, ACTA RADIOL, V48, P36, DOI 10.1080/02841850601045096; Hackenbroch M, 2004, ROFO-FORTSCHR RONTG, V176, P1133, DOI 10.1055/s-2004-813187; Hacker M, 2007, NUKLEARMED-NUCL MED, V46, P29; Halon DA, 2007, CARDIOLOGY, V108, P200, DOI 10.1159/000096778; Hamon M, 2007, RADIOLOGY, V245, P720, DOI 10.1148/radiol.2453061899; Hamon M, 2006, J AM COLL CARDIOL, V48, P1896, DOI 10.1016/j.jacc.2006.08.028; Hausleiter J, 2007, EUR HEART J, V28, P3034, DOI 10.1093/eurheartj/ehm150; Henneman MM, 2006, HEART, V92, P1779, DOI 10.1136/hrt.2006.087874; Henneman MM, 2008, J AM COLL CARDIOL, V52, P216, DOI 10.1016/j.jacc.2008.04.012; Herzog BA, 2008, EUR HEART J, V29, P3037, DOI 10.1093/eurheartj/ehn485; Herzog C, 2007, RADIOLOGY, V244, P112, DOI 10.1148/radiol.2441060332; Herzog C, 2007, RADIOLOGY, V244, P121, DOI 10.1148/radiol.2441060004; Hoffmann H, 2007, ACAD RADIOL, V14, P901, DOI 10.1016/j.acra.2007.05.005; Hoffmann MHK, 2005, JAMA-J AM MED ASSOC, V293, P2471, DOI 10.1001/jama.293.20.2471; Hoffmann U, 2004, CIRCULATION, V110, P2638, DOI 10.1161/01.CIR.0000145614.07427.9F; Ichikawa Y, 2007, CIRCULATION, V116, P510; Ikonen AEJ, 2003, ACTA RADIOL, V44, P583, DOI 10.1046/j.1600-0455.2003.00152.x; Itagaki MW, 2009, RADIOLOGY, V252, P468, DOI 10.1148/radiol.2523081241; Johnson TRC, 2007, INVEST RADIOL, V42, P684, DOI 10.1097/RLI.0b013e31806907d0; Kaiser C, 2005, EUR HEART J, V26, P1987, DOI 10.1093/eurheartj/ehi384; Kefer J, 2005, J AM COLL CARDIOL, V46, P92, DOI 10.1016/j.jacc.2005.03.057; Kim RJ, 2000, NEW ENGL J MED, V343, P1445, DOI 10.1056/NEJM200011163432003; Kim WY, 2001, NEW ENGL J MED, V345, P1863, DOI 10.1056/NEJMoa010866; Klein C, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-45; Kolnes K, 2006, ACTA RADIOL, V47, P680, DOI 10.1080/02841850600806332; Kroft LJM, 2007, AM J ROENTGENOL, V189, P581, DOI 10.2214/AJR.07.2138; Laissy JP, 2007, HEART, V93, P1121, DOI 10.1136/hrt.2006.107284; Langer C, 2009, J COMPUT ASSIST TOMO, V33, P179, DOI 10.1097/RCT.0b013e3181839624; Leber AW, 2007, EUR HEART J, V28, P2354, DOI 10.1093/eurheartj/ehm294; Leeflang MMG, 2008, ANN INTERN MED, V149, P889, DOI 10.7326/0003-4819-149-12-200812160-00008; Leschka S, 2008, HEART, V94, P1154, DOI 10.1136/hrt.2007.124800; Leschka S, 2005, EUR HEART J, V26, P1482, DOI 10.1093/eurheartj/ehi261; Leschka S, 2008, AM J ROENTGENOL, V190, P1583, DOI 10.2214/AJR.07.2000; Lord SJ, 2006, ANN INTERN MED, V144, P850, DOI 10.7326/0003-4819-144-11-200606060-00011; Maintz D, 2007, ACTA RADIOL, V48, P967, DOI 10.1080/02841850701630292; Manghat NE, 2007, CLIN RADIOL, V62, P632, DOI 10.1016/j.crad.2007.01.014; Marano R, 2009, EUR RADIOL, V19, P1114, DOI 10.1007/s00330-008-1239-8; Martuscelli E, 2004, EUR HEART J, V25, P1043, DOI 10.1016/j.ehj.2004.03.024; Maruyama T, 2008, J AM COLL CARDIOL, V52, P1450, DOI 10.1016/j.jacc.2008.07.048; McCarthy RM, 2007, INVEST RADIOL, V42, P665, DOI 10.1097/RLI.0b013e3180661a77; Meijboom WB, 2008, J AM COLL CARDIOL, V52, P2135, DOI 10.1016/j.jacc.2008.08.058; Meijboom WB, 2007, HEART, V93, P1386, DOI 10.1136/hrt.2006.112771; Meijboom WB, 2006, J AM COLL CARDIOL, V48, P1658, DOI 10.1016/j.jacc.2006.06.054; Meijer AB, 2008, AM J ROENTGENOL, V191, P1667, DOI 10.2214/AJR.07.4022; Miller JM, 2008, NEW ENGL J MED, V359, P2324, DOI 10.1056/NEJMoa0806576; Mir-Akbari H, 2009, ACTA RADIOL, V50, P174, DOI 10.1080/02841850802647013; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Mollet NR, 2004, J AM COLL CARDIOL, V43, P2265, DOI 10.1016/j.jacc.2004.03.032; Mollet NR, 2005, J AM COLL CARDIOL, V45, P128, DOI 10.1016/j.jacc.2004.09.074; Mollet NR, 2005, CIRCULATION, V112, P2318, DOI 10.1161/CIRCULATIONAHA.105.533471; Moon JY, 2005, YONSEI MED J, V46, P86, DOI 10.3349/ymj.2005.46.1.86; Morgan-Hughes GJ, 2005, HEART, V91, P308, DOI 10.1136/hrt.2004.034892; Mowatt G, 2008, HEALTH TECHNOL ASSES, V12, P1; Nikolaou K, 2006, AM J ROENTGENOL, V186, P1659, DOI 10.2214/AJR.05.0726; Nikolaou K, 2006, AM J ROENTGENOL, V187, P111, DOI 10.2214/AJR.05.1697; NOTO TJ, 1991, CATHETER CARDIO DIAG, V24, P75, DOI 10.1002/ccd.1810240202; Olivetti L, 2006, RADIOL MED, V111, P1054, DOI 10.1007/s11547-006-0104-6; Oncel D, 2007, RADIOLOGY, V245, P703, DOI 10.1148/radiol.2453070094; Oncel D, 2007, EUR J RADIOL, V62, P394, DOI 10.1016/j.ejrad.2007.01.009; Plein S, 2002, RADIOLOGY, V225, P300, DOI 10.1148/radiol.2243011436; PLEIN S, 2008, EUR HEART J; Pontone G, 2007, CLIN RADIOL, V62, P978, DOI 10.1016/j.crad.2007.02.022; Pontone G, 2007, CORONARY ARTERY DIS, V18, P265, DOI 10.1097/MCA.0b013e328035f8ae; Postel Thomas, 2007, Exp Clin Cardiol, V12, P149; Pouleur AC, 2008, CIRC-CARDIOVASC IMAG, V1, P114, DOI 10.1161/CIRCIMAGING.107.756304; Pugliese F, 2006, EUR RADIOL, V16, P575, DOI 10.1007/s00330-005-0041-0; Pundziute G, 2008, HEART, V94, P48, DOI 10.1136/hrt.2007.116715; Raff GL, 2005, J AM COLL CARDIOL, V46, P552, DOI 10.1016/j.jacc.2005.05.056; Reant P, 2006, AM J CARDIOL, V97, P1506, DOI 10.1016/j.amjcard.2005.12.039; Regenfus M, 2000, J AM COLL CARDIOL, V36, P44, DOI 10.1016/S0735-1097(00)00672-0; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Riley RD, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-3; Rixe J, 2009, CIRC J, V73, P316, DOI 10.1253/circj.CJ-08-0534; Rodevand O, 2006, SCAND CARDIOVASC J, V40, P76, DOI 10.1080/14017430600686969; Romeo F, 2007, AM J CARDIOL, V99, P325, DOI 10.1016/j.amjcard.2006.08.029; Ropers D, 2006, AM J CARDIOL, V97, P343, DOI 10.1016/j.amjcard.2005.08.050; Ropers D, 2003, CIRCULATION, V107, P664, DOI 10.1161/01.CIR.0000055738.31551.A9; Ropers U, 2007, J AM COLL CARDIOL, V50, P2393, DOI 10.1016/j.jacc.2007.09.017; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Rybicki FJ, 2008, INT J CARDIOVAS IMAG, V24, P535, DOI 10.1007/s10554-008-9308-2; Sakuma H, 2006, J AM COLL CARDIOL, V48, P1946, DOI 10.1016/j.jacc.2006.07.055; Sandstede J, 1999, ROFO-FORTSCHR RONTG, V170, P269; Scanlon PJ, 1999, CIRCULATION, V99, P2345, DOI 10.1161/01.CIR.99.17.2345; Scheffel H, 2008, HEART, V94, P1132, DOI 10.1136/hrt.2008.149971; Scheffel H, 2007, AM J CARDIOL, V100, P701, DOI 10.1016/j.amjcard.2007.03.087; Scheffel H, 2006, EUR RADIOL, V16, P2739, DOI 10.1007/s00330-006-0474-0; Schonenberger E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000246; Schuijf JD, 2006, AM HEART J, V151, P404, DOI 10.1016/j.ahj.2005.03.022; Schuijf JD, 2006, AM J CARDIOL, V98, P145, DOI 10.1016/j.amjcard.2006.01.092; Schwitter J, 2008, EUR HEART J, V29, P480, DOI 10.1093/eurheartj/ehm617; Shabestari AA, 2007, AM J CARDIOL, V99, P1656, DOI 10.1016/j.amjcard.2007.01.040; Stein PD, 2006, AM J MED, V119, P203, DOI 10.1016/j.amjmed.2005.06.071; Stengel D, 2003, J MED SCREEN, V10, P47, DOI 10.1258/096914103321610806; Stolzmann P, 2008, AM J ROENTGENOL, V191, P1684, DOI 10.2214/AJR.07.4040; Sun ZH, 2006, EUR J RADIOL, V60, P279, DOI 10.1016/j.ejrad.2006.06.009; Tsai IC, 2007, J COMPUT ASSIST TOMO, V31, P258, DOI 10.1097/01.rct.0000237808.03499.e4; Turkvattan A, 2008, ACTA RADIOL, V49, P400, DOI 10.1080/02841850701870922; Ulimoen GR, 2008, ACTA RADIOL, V49, P1140, DOI 10.1080/02841850802452083; van der Zaag-Loonen HJ, 2006, EUR RADIOL, V16, P2748, DOI 10.1007/s00330-006-0312-4; van Houwelingen HC, 2002, STAT MED, V21, P589, DOI 10.1002/sim.1040; Vanhoenacker Piet K, 2007, BMC Cardiovasc Disord, V7, P39, DOI 10.1186/1471-2261-7-39; Vanhoenacker PK, 2007, RADIOLOGY, V244, P419, DOI 10.1148/radiol.2442061218; VANHOUWELINGEN HC, 1993, STAT MED, V12, P2273, DOI 10.1002/sim.4780122405; Walker MJ, 2009, INT J CARDIOVAS IMAG, V25, P189, DOI 10.1007/s10554-009-9444-3; Watkins MW, 2007, AM J CARDIOL, V99, P175, DOI 10.1016/j.amjcard.2006.07.081; Weustink AC, 2007, J AM COLL CARDIOL, V50, P786, DOI 10.1016/j.jacc.2007.04.068; Whiting Penny, 2005, BMC Med Res Methodol, V5, P19, DOI 10.1186/1471-2288-5-19; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Whiting Penny F, 2006, BMC Med Res Methodol, V6, P9, DOI 10.1186/1471-2288-6-9; Yang Q, 2009, J AM COLL CARDIOL, V54, P69, DOI 10.1016/j.jacc.2009.03.016	160	191	198	0	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 2	2010	152	3					167	U12		10.7326/0003-4819-152-3-201002020-00008	http://dx.doi.org/10.7326/0003-4819-152-3-201002020-00008			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	552WN	20124233				2022-12-28	WOS:000274324600005
J	Daniel, R; Mallen, CD; Cooper, J				Daniel, Rebecca; Mallen, Christian David; Cooper, Jason			10-minute consultation Female stress urinary incontinence	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Mallen, Christian David] Keele Univ, Arthrit Res Campaign Natl Primary Care Ctr, Keele ST5 5BG, Staffs, England; [Cooper, Jason] Univ Hosp N Staffordshire, Stoke On Trent ST4 6QG, Staffs, England	Keele University; Keele University		r.daniel@cphc.keele.ac.uk		Mallen, Christian/0000-0002-2677-1028					0	2	2	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 1	2010	340								b5533	10.1136/bmj.b5533	http://dx.doi.org/10.1136/bmj.b5533			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	553CT	20123833				2022-12-28	WOS:000274343300008
J	Choiniere, JN; Xu, X; Clark, JM; Forster, CA; Guo, Y; Han, FL				Choiniere, Jonah N.; Xu, Xing; Clark, James M.; Forster, Catherine A.; Guo, Yu; Han, Fenglu			A Basal Alvarezsauroid Theropod from the Early Late Jurassic of Xinjiang, China	SCIENCE			English	Article							LONG FEATHERS; MANIRAPTORAN; DINOSAURIA; AGE	The fossil record of Jurassic theropod dinosaurs closely related to birds remains poor. A new theropod from the earliest Late Jurassic of western China represents the earliest diverging member of the enigmatic theropod group Alvarezsauroidea and confirms that this group is a basal member of Maniraptora, the clade containing birds and their closest theropod relatives. It extends the fossil record of Alvarezsauroidea by 63 million years and provides evidence for maniraptorans earlier in the fossil record than Archaeopteryx. The new taxon confirms extreme morphological convergence between birds and derived alvarezsauroids and illuminates incipient stages of the highly modified alvarezsaurid forelimb.	[Choiniere, Jonah N.; Clark, James M.; Forster, Catherine A.] George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA; [Xu, Xing; Guo, Yu; Han, Fenglu] Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Evolutionary Systemat Vertebrates, Beijing 100044, Peoples R China	George Washington University; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Choiniere, JN (corresponding author), George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA.	jonah.choiniere@gmail.com		Choiniere, Jonah/0000-0002-1008-0687	National Science Foundation Division of Earth Sciences and Office of International Science and Engineering of the USA; National Natural Sciences Foundation of China; Chinese Academy of Sciences; GWU; Jurassic Foundation; Hilmar Sallee bequest; George Washington University; Directorate For Geosciences [0922187] Funding Source: National Science Foundation	National Science Foundation Division of Earth Sciences and Office of International Science and Engineering of the USA; National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); GWU; Jurassic Foundation; Hilmar Sallee bequest; George Washington University; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank W. Ding and T. Yu for finding the specimen, and the crew of the 2004 Sino-American field expedition for excavating the specimen; H.-j. Wang, X. Ding, and L. Xiang for preparing the fossil; A. Buscalioni, C. Mehling, and M. Norell for specimen access; and P. Barrett, H. Cameron, J. Conrad, M. Ellison, D. Hone, C. Sullivan, and A. Turner for discussions. Support for this research was provided by the National Science Foundation Division of Earth Sciences and Office of International Science and Engineering of the USA, the National Natural Sciences Foundation of China, and the Chinese Academy of Sciences; and the GWU Facilitating Fund, the Jurassic Foundation, the Hilmar Sallee bequest, and the George Washington University.	Bonaparte JF., 1991, REV MUSEO ARGENTINO, V4, P17; Chiappe LM, 1998, NATURE, V392, P275, DOI 10.1038/32642; Chiappe Luis M., 2002, P87; Clark James M., 2006, P26; Clark JM, 2004, DINOSAURIA, 2ND EDITION, P151; Clark James M., 2002, P31; Feduccia A, 2002, AUK, V119, P1187, DOI 10.1642/0004-8038(2002)119[1187:BADSAT]2.0.CO;2; GOLOBOFF PA, 2003, TNT VERSION 1 1; Gradstein F.M., 2004, GEOLOGIC TIME SCALE; HOLTZ TR, 1994, J VERTEBR PALEONTOL, V14, P480, DOI 10.1080/02724634.1995.10011574; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Hutchinson JR, 1998, J VERTEBR PALEONTOL, V18, P447, DOI 10.1080/02724634.1998.10011073; Karhu AA., 1996, PALEONTOL J, V30, P583; Kessler E., 2005, ACTA PALAEONTOL ROMA, V5, P349; Li RH., 2003, JURASSIC SYSTEM N CH; Liu YQ, 2006, CHINESE SCI BULL, V51, P2634, DOI 10.1007/s11434-006-2165-2; Longrich NR, 2009, CRETACEOUS RES, V30, P239, DOI 10.1016/j.cretres.2008.07.005; MADSEN JH, 1976, B UTAH GEOLOGICAL MI, V109, P1; Makovicky PJ, 2004, DINOSAURIA, 2ND EDITION, P184; Martinelli AG, 2007, ZOOTAXA, P1; Naish D, 2004, NEUES JAHRB GEOL P-M, P385; NORELL MA, 1993, AM J SCI, V293A, P407, DOI 10.2475/ajs.293.A.407; Novas FE, 1997, J VERTEBR PALEONTOL, V17, P137, DOI 10.1080/02724634.1997.10010959; Novas Fernando E., 2002, P121; Novas Fernando E., 1996, Memoirs of the Queensland Museum, V39, P675; OSTROM JH, 1969, PEABODY MUS NAT HIST, V30; PEREZMORENO BP, 1994, NATURE, V370, P363, DOI 10.1038/370363a0; PERLE A, 1993, NATURE, V362, P623, DOI DOI 10.1038/362623A0; Perle A., 1994, AM MUS NOVIT, V3105, P1; Pol D, 2001, CLADISTICS, V17, P285, DOI 10.1111/j.1096-0031.2001.tb00125.x; Pol D, 2006, SYST BIOL, V55, P512, DOI 10.1080/10635150600755446; Sereno PC, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P69; Suzuki Shigeru, 2002, Contributions in Science (Los Angeles), V494, P1; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; Turner AH, 2009, AM MUS NOVIT, P1; Xu X, 2005, NATURWISSENSCHAFTEN, V92, P173, DOI 10.1007/s00114-004-0604-y; Zhang FC, 2002, NATURWISSENSCHAFTEN, V89, P394, DOI 10.1007/s00114-002-0353-8; Zhang FC, 2008, NATURE, V455, P1105, DOI 10.1038/nature07447	38	101	108	3	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 29	2010	327	5965					571	574		10.1126/science.1182143	http://dx.doi.org/10.1126/science.1182143			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549CT	20110503				2022-12-28	WOS:000274020500035
J	Annane, D; Cariou, A; Maxime, V; Azoulay, E; D'honneur, G; Timsit, JF; Cohen, Y; Wolf, M; Fartoukh, M; Adrie, C; Santre, C; Bollaert, PE; Mathonet, A; Amathieu, R; Tabah, A; Clec'h, C; Mayaud, J; Lejeune, J; Chevret, S				Annane, Djillali; Cariou, Alain; Maxime, Virginie; Azoulay, Elie; D'honneur, Gilles; Timsit, Jean Francois; Cohen, Yves; Wolf, Michel; Fartoukh, Muriel; Adrie, Christophe; Santre, Charles; Bollaert, Pierre Edouard; Mathonet, Armelle; Amathieu, Roland; Tabah, Alexis; Clec'h, Christophe; Mayaud, Julien; Lejeune, Julie; Chevret, Sylvie		COIITSS Study Investigators	Corticosteroid Treatment and Intensive Insulin Therapy for Septic Shock in Adults A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; CRITICALLY-ILL; ACUTE PHYSIOLOGY; GLUCOSE CONTROL; SEVERE SEPSIS; MORTALITY; CARE; HYDROCORTISONE; CLASSIFICATION; POPULATION	Context Corticosteroid therapy induces potentially detrimental hyperglycemia in septic shock. In addition, the benefit of adding fludrocortisone in this setting is unclear. Objectives To test the efficacy of intensive insulin therapy in patients whose septic shock was treated with hydrocortisone and to assess, as a secondary objective, the benefit of fludrocortisone. Design, Setting, and Patients A multicenter, 2 x 2 factorial, randomized trial, involving 509 adults with septic shock who presented with multiple organ dysfunction, as defined by a Sequential Organ Failure Assessment score of 8 or more, and who had received hydrocortisone treatment was conducted from January 2006 to January 2009 in 11 intensive care units in France. Interventions Patients were randomly assigned to 1 of 4 groups: continuous intravenous insulin infusion with hydrocortisone alone, continuous intravenous insulin infusion with hydrocortisone plus fludrocortisone, conventional insulin therapy with hydrocortisone alone, or conventional insulin therapy with intravenous hydrocortisone plus fludrocortisone. Hydrocortisone was administered in a 50-mg bolus every 6 hours, and fludrocortisone was administered orally in 50-mu g tablets once a day, each for 7 days. Main Outcome Measure In-hospital mortality. Results Of the 255 patients treated with intensive insulin, 117 (45.9%), and 109 of 254 (42.9%) treated with conventional insulin therapy died (relative risk [RR], 1.07; 95% confidence interval [CI], 0.88-1.30; P = .50). Patients treated with intensive insulin experienced significantly more episodes of severe hypoglycemia (<40 mg/dL) than those in the conventional-treatment group, with a difference in mean number of episodes per patient of 0.15 (95% CI, 0.02-0.28; P = .003). At hospital discharge, 105 of 245 patients treated with fludrocortisone (42.9%) died and 121 of 264 (45.8%) in the control group died (RR, 0.94; 95% CI, 0.77-1.14; P = .50). Conclusions Compared with conventional insulin therapy, intensive insulin therapy did not improve in-hospital mortality among patients who were treated with hydrocortisone for septic shock. The addition of oral fludrocortisone did not result in a statistically significant improvement in in-hospital mortality.	[Annane, Djillali] Univ Versailles SQY, Crit Care Dept, Hop Raymond Poincare, AP HP,Gen ICU, F-92380 Garches, France; [Cariou, Alain; Mathonet, Armelle] Hop Cochin, AP HP, Gen ICU, Paris, France; [Azoulay, Elie; Mayaud, Julien] Hop St Louis, AP HP, Gen ICU, Paris, France; [D'honneur, Gilles; Amathieu, Roland] Hop Jean Verdier, AP HP, Dept Anesthesiol, Bondy, France; [Timsit, Jean Francois; Tabah, Alexis] Hop A Michallon, Gen ICU, Grenoble, France; [Cohen, Yves; Clec'h, Christophe] Hop Avicenne, Gen ICU, AP HP, F-93009 Bobigny, France; [Wolf, Michel] Hop Bichat Claude Bernard, Gen ICU, AP HP, F-75877 Paris, France; [Fartoukh, Muriel] Hop Tenon, ICU, AP HP, F-75970 Paris, France; [Adrie, Christophe] Hop Delafontaine, Gen ICU, St Denis, France; [Santre, Charles] Ctr Hosp dAnnecy, Gen ICU, Annecy, France; [Bollaert, Pierre Edouard] Cent Hosp, Gen ICU, Nancy, France; [Lejeune, Julie; Chevret, Sylvie] Med Hop St Louis, Dept Biostat & Informat, AP HP, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Jean-Verdier - APHP; CHU Grenoble Alpes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre Hospitalier Annecy Genevois; CHU de Nancy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP	Annane, D (corresponding author), Univ Versailles SQY, Crit Care Dept, Hop Raymond Poincare, AP HP,Gen ICU, 104 Blvd Raymond Poincare, F-92380 Garches, France.	djillali.annane@rpc.aphop.fr	Annane, Djillali/R-7947-2019; Tabah, Alexis/B-6982-2014	Tabah, Alexis/0000-0003-3513-2778; chevret, sylvie/0000-0001-6449-4730	Assistance Publique-Hopitaux de Paris	Assistance Publique-Hopitaux de Paris	Assistance Publique-Hopitaux de Paris was the study sponsor.	Aardal-Eriksson E, 1999, BIOL PSYCHIAT, V46, P850, DOI 10.1016/S0006-3223(98)00381-3; Annane D, 2005, LANCET, V365, P63, DOI 10.1016/S0140-6736(04)17667-8; Annane D, 2003, JAMA-J AM MED ASSOC, V289, P43, DOI 10.1001/jama.289.1.43-b; Annane D, 2000, JAMA-J AM MED ASSOC, V283, P1038, DOI 10.1001/jama.283.8.1038; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; Annane D, 2009, JAMA-J AM MED ASSOC, V301, P2362, DOI 10.1001/jama.2009.815; Azoulay E, 2003, INTENS CARE MED, V29, P1498, DOI 10.1007/s00134-003-1904-y; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Brady K, 2000, JAMA-J AM MED ASSOC, V283, P1837, DOI 10.1001/jama.283.14.1837; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Finney SJ, 2003, JAMA-J AM MED ASSOC, V290, P2041, DOI 10.1001/jama.290.15.2041; GAIL M, 1985, BIOMETRICS, V41, P361, DOI 10.2307/2530862; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Jordhoy MS, 2001, J CLIN ONCOL, V19, P3884, DOI 10.1200/JCO.2001.19.18.3884; KNAUS WA, 1981, CRIT CARE MED, V9, P591, DOI 10.1097/00003246-198108000-00008; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Leplege A, 1998, J CLIN EPIDEMIOL, V51, P1013, DOI 10.1016/S0895-4356(98)00093-6; Leynaert B, 2000, AM J RESP CRIT CARE, V162, P1391, DOI 10.1164/ajrccm.162.4.9912033; MATHIEU J, 1992, NEUROLOGY, V42, P203, DOI 10.1212/WNL.42.1.203; Mayou RA, 2000, BRIT J PSYCHIAT, V176, P589, DOI 10.1192/bjp.176.6.589; MCCABE WR, 1962, ARCH INTERN MED, V110, P847, DOI 10.1001/archinte.1962.03620240029006; Pochard F, 2001, CRIT CARE MED, V29, P1893, DOI 10.1097/00003246-200110000-00007; Russell JA, 2008, NEW ENGL J MED, V358, P877, DOI 10.1056/NEJMoa067373; Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366; Sundin EC, 2002, BRIT J PSYCHIAT, V180, P205, DOI 10.1192/bjp.180.3.205; Umpierrez GE, 2002, J CLIN ENDOCR METAB, V87, P978, DOI 10.1210/jc.87.3.978; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; VENKATESH B, 2007, INTENS CARE MED, V33, P1432; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	37	209	222	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 27	2010	303	4					341	348		10.1001/jama.2010.2	http://dx.doi.org/10.1001/jama.2010.2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	548IC	20103758				2022-12-28	WOS:000273952800022
J	Richardson, JD; Sareen, J; Elhai, JD				Richardson, J. Don; Sareen, Jitender; Elhai, Jon D.			Psychiatric problems in medically evacuated service members	LANCET			English	Editorial Material							POSTTRAUMATIC-STRESS-DISORDER; MENTAL-HEALTH PROBLEMS; PEACEKEEPING VETERANS; MILITARY; PTSD; CARE; AFGHANISTAN; DEPRESSION; INJURY; IRAQ		[Richardson, J. Don] London Parkwood Hosp, St Josephs Hlth Care, Operat Stress Injury Clin, London, ON N6C 5J1, Canada; [Richardson, J. Don] Vet Affairs Canada, Natl Ctr Operat Stress Injuries, Montreal, PQ, Canada; [Richardson, J. Don] Univ Western Ontario, Dept Psychiat, London, ON N6A 3K7, Canada; [Sareen, Jitender] Operat Stress Injury Clin, Winnipeg, MB, Canada; [Sareen, Jitender] Univ Manitoba, Dept Psychiat, Winnipeg, MB R3T 2N2, Canada; [Elhai, Jon D.] Univ Toledo, Dept Psychol, Toledo, OH 43606 USA	Western University (University of Western Ontario); Western University (University of Western Ontario); University of Manitoba; University System of Ohio; University of Toledo	Richardson, JD (corresponding author), London Parkwood Hosp, St Josephs Hlth Care, Operat Stress Injury Clin, London, ON N6C 5J1, Canada.	Don.Richardson@sjhc.london.on.ca	Richardson, J Don/X-5123-2018; Elhai, Jon D/U-1901-2017	Richardson, J Don/0000-0002-2927-6735; Elhai, Jon D/0000-0001-5205-9010; Sareen, Jitender/0000-0001-8573-6495				Bauer MS, 2004, AM J PSYCHIAT, V161, P3, DOI 10.1176/appi.ajp.161.1.3; Boscarino JA, 1997, PSYCHOSOM MED, V59, P605, DOI 10.1097/00006842-199711000-00008; Cohen SP, 2010, LANCET, V375, P301, DOI 10.1016/S0140-6736(09)61797-9; Creamer M, 2004, PSYCHOTHERAPY, V41, P388, DOI 10.1037/0033-3204.41.4.388; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Iversen AC, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-68; Koren D, 2005, AM J PSYCHIAT, V162, P276, DOI 10.1176/appi.ajp.162.2.276; MCFARLANE AC, 1994, J PSYCHOSOM RES, V38, P715, DOI 10.1016/0022-3999(94)90024-8; Richardson JD, 2006, J CLIN PSYCHIAT, V67, P1240, DOI 10.4088/JCP.v67n0810; Richardson JD, 2009, AUST NZ J PSYCHIAT, V43, P366, DOI 10.1080/00048670902721061; Sareen J, 2007, PSYCHOSOM MED, V69, P242, DOI 10.1097/PSY.0b013e31803146d8; Schoenfeld FB, 2004, PSYCHIAT SERV, V55, P519, DOI 10.1176/appi.ps.55.5.519; Zatzick D, 2008, ANN SURG, V248, P429, DOI 10.1097/SLA.0b013e318185a6b8	14	0	0	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 23	2010	375	9711					257	259		10.1016/S0140-6736(10)60004-9	http://dx.doi.org/10.1016/S0140-6736(10)60004-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	549QS	20109931				2022-12-28	WOS:000274069300005
J	Stone, GW				Stone, Gregg W.			Ticagrelor in ACS: redefining a new standard of care?	LANCET			English	Editorial Material							ACUTE CORONARY SYNDROMES; ACUTE MYOCARDIAL-INFARCTION; ST-SEGMENT-ELEVATION; CLOPIDOGREL; INTERVENTION; METAANALYSIS; ASPIRIN; THERAPY; TRIAL; PCI		Columbia Univ, Med Ctr, Cardiovasc Res Fdn, New York, NY 10022 USA	Cardiovascular Research Foundation (CRF); Columbia University	Stone, GW (corresponding author), Columbia Univ, Med Ctr, Cardiovasc Res Fdn, New York, NY 10022 USA.	gstone@crf.org						Bavry AA, 2006, J AM COLL CARDIOL, V48, P1319, DOI 10.1016/j.jacc.2006.06.050; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Brar SS, 2009, J AM COLL CARDIOL, V53, P1677, DOI 10.1016/j.jacc.2009.03.013; Cannon CP, 2010, LANCET, V375, P283, DOI 10.1016/S0140-6736(09)62191-7; Eikelboom JW, 2006, CIRCULATION, V114, P774, DOI 10.1161/CIRCULATIONAHA.106.612812; Ferguson JJ, 2004, JAMA-J AM MED ASSOC, V292, P45; Forman MB, 2006, CARDIOVASC DRUG REV, V24, P116, DOI 10.1111/j.1527-3466.2006.00116.x; Gurbel PA, 2009, CIRCULATION, V120, P2577, DOI 10.1161/CIRCULATIONAHA.109.912550; Mehran R, 2009, EUR HEART J, V30, P1457, DOI 10.1093/eurheartj/ehp110; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P2908, DOI 10.1001/jama.293.23.2908; MEHTA SR, 2009, CURRENT STEMI PCI DO; Pocock SJ, 2010, CIRCULATION, V121, P43, DOI 10.1161/CIRCULATIONAHA.109.878017; Sabatine MS, 2005, JAMA-J AM MED ASSOC, V294, P1224, DOI 10.1001/jama.294.10.1224; Stone GW, 2008, CIRCULATION, V118, P538, DOI 10.1161/CIRCULATIONAHA.107.756494; Stone GW, 2008, NEW ENGL J MED, V358, P2218, DOI 10.1056/NEJMoa0708191; Stone GW, 2006, NEW ENGL J MED, V355, P2203, DOI 10.1056/NEJMoa062437; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wiviott SD, 2007, CIRCULATION, V116, P2923, DOI 10.1161/CIRCULATIONAHA.107.740324; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Yusuf S, 2006, NEW ENGL J MED, V354, P1464; Yusuf S, 2001, NEW ENGL J MED, V345, P494	22	15	17	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 23	2010	375	9711					263	265		10.1016/S0140-6736(10)60070-0	http://dx.doi.org/10.1016/S0140-6736(10)60070-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	549QS	20079529				2022-12-28	WOS:000274069300009
J	Bender, MA; Knutson, TR; Tuleya, RE; Sirutis, JJ; Vecchi, GA; Garner, ST; Held, IM				Bender, Morris A.; Knutson, Thomas R.; Tuleya, Robert E.; Sirutis, Joseph J.; Vecchi, Gabriel A.; Garner, Stephen T.; Held, Isaac M.			Modeled Impact of Anthropogenic Warming on the Frequency of Intense Atlantic Hurricanes	SCIENCE			English	Article							TROPICAL CYCLONE ACTIVITY; NORTH-ATLANTIC; CLIMATE-CHANGE; VARIABILITY; SIMULATIONS	Several recent models suggest that the frequency of Atlantic tropical cyclones could decrease as the climate warms. However, these models are unable to reproduce storms of category 3 or higher intensity. We explored the influence of future global warming on Atlantic hurricanes with a downscaling strategy by using an operational hurricane-prediction model that produces a realistic distribution of intense hurricane activity for present-day conditions. The model projects nearly a doubling of the frequency of category 4 and 5 storms by the end of the 21st century, despite a decrease in the overall frequency of tropical cyclones, when the downscaling is based on the ensemble mean of 18 global climate-change projections. The largest increase is projected to occur in the Western Atlantic, north of 20 degrees N.	[Bender, Morris A.; Knutson, Thomas R.; Sirutis, Joseph J.; Vecchi, Gabriel A.; Garner, Stephen T.; Held, Isaac M.] NOAA, Geophys Fluid Dynam Lab, Princeton, NJ 08540 USA; [Tuleya, Robert E.] Old Dominion Univ, Ctr Coastal Phys Oceanog, Norfolk, VA 23508 USA	National Oceanic Atmospheric Admin (NOAA) - USA; Old Dominion University	Bender, MA (corresponding author), NOAA, Geophys Fluid Dynam Lab, 201 Forrestal Rd, Princeton, NJ 08540 USA.	Morris.Bender@noaa.gov	Knutson, Thomas/G-7457-2019; Knutson, Thomas/P-7225-2019; Vecchi, Gabriel/A-2413-2008	Knutson, Thomas/0000-0003-4541-519X; Knutson, Thomas/0000-0003-4541-519X; Vecchi, Gabriel/0000-0002-5085-224X	Office of Science, U. S. Department of Energy	Office of Science, U. S. Department of Energy(United States Department of Energy (DOE))	We wish to thank T. Marchok, R. Stouffer, A. Wittenburg, and three Science reviewers for their helpful comments and suggestions on earlier versions of the manuscript. We are also grateful to T. Marchok for his assistance in the preparation of several figures and to S. Sellars for assistance with some statistical calculations. Special appreciation goes to the current director of GFDL, V. Ramaswamy, for his support and encouragement. We thank the CMIP3 modeling groups, the Program for Climate Model Diagnosis and Intercomparison (PCMDI), and the World Climate Research Programme's (WCRP) Working Group on Coupled Modelling (WGCM) for their roles in making available the WCRP CMIP3 multi-model dataset. Support of this dataset is provided by the Office of Science, U. S. Department of Energy.	Bender MA, 2000, MON WEATHER REV, V128, P917, DOI 10.1175/1520-0493(2000)128<0917:RCSOHO>2.0.CO;2; Bender MA, 2007, MON WEATHER REV, V135, P3965, DOI 10.1175/2007MWR2032.1; Bengtsson L, 2007, TELLUS A, V59, P539, DOI 10.1111/j.1600-0870.2007.00251.x; Elsner JB, 2008, NATURE, V455, P92, DOI 10.1038/nature07234; Emanuel K, 2005, NATURE, V436, P686, DOI 10.1038/nature03906; Emanuel K, 2007, J CLIMATE, V20, P5497, DOI 10.1175/2007JCLI1571.1; Evan AT, 2009, SCIENCE, V324, P778, DOI 10.1126/science.1167404; Gillett NP, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033670; Gualdi S, 2008, J CLIMATE, V21, P5204, DOI 10.1175/2008JCLI1921.1; Holland GJ, 2007, PHILOS T R SOC A, V365, P2695, DOI 10.1098/rsta.2007.2083; Knutson TR, 2008, NAT GEOSCI, V1, P359, DOI 10.1038/ngeo202; Knutson TR, 2007, B AM METEOROL SOC, V88, P1549, DOI 10.1175/BAMS-88-10-1549; Mann M.E., 2006, EOS, V87, P233, DOI 10.1029/2006EO240001; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Santer BD, 2006, P NATL ACAD SCI USA, V103, P13905, DOI 10.1073/pnas.0602861103; Solomon S., 2007, PHYS SCI BASIS WORKI; Vecchi GA, 2008, SCIENCE, V322, P687, DOI 10.1126/science.1164396; Vecchi GA, 2008, J CLIMATE, V21, P3580, DOI 10.1175/2008JCLI2178.1; Vecchi GA, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028905; Zhang R, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026267; Zhao M, 2009, J CLIMATE, V22, P6653, DOI 10.1175/2009JCLI3049.1	22	678	696	8	321	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 22	2010	327	5964					454	458		10.1126/science.1180568	http://dx.doi.org/10.1126/science.1180568			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546BS	20093471	Green Submitted			2022-12-28	WOS:000273783100035
J	Dunn, KM; Saunders, KW; Rutter, CM; Banta-Green, CJ; Merrill, JO; Sullivan, MD; Weisner, CM; Silverberg, MJ; Campbell, CI; Psaty, BM; Von Korff, M				Dunn, Kate M.; Saunders, Kathleen W.; Rutter, Carolyn M.; Banta-Green, Caleb J.; Merrill, Joseph O.; Sullivan, Mark D.; Weisner, Constance M.; Silverberg, Michael J.; Campbell, Cynthia I.; Psaty, Bruce M.; Von Korff, Michael			Opioid Prescriptions for Chronic Pain and Overdose A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							CHRONIC NONCANCER PAIN; MUSCULOSKELETAL PAIN; ANALGESICS; THERAPY; DEATHS; TRENDS; PHYSICIANS; MORTALITY; EFFICACY; ABUSE	Background: Long-term opioid therapy for chronic noncancer pain is becoming increasingly common in community practice. Concomitant with this change in practice, rates of fatal opioid overdose have increased. The extent to which overdose risks are elevated among patients receiving medically prescribed long-term opioid therapy is unknown. Objective: To estimate rates of opioid overdose and their association with an average prescribed daily opioid dose among patients receiving medically prescribed, long-term opioid therapy. Design: Cox proportional hazards models were used to estimate overdose risk as a function of average daily opioid dose (morphine equivalents) received at the time of overdose. Setting: HMO. Patients: 9940 persons who received 3 or more opioid prescriptions within 90 days for chronic noncancer pain between 1997 and 2005. Measurements: Average daily opioid dose over the previous 90 days from automated pharmacy data. Primary outcomes-nonfatal and fatal overdoses-were identified through diagnostic codes from inpatient and outpatient care and death certificates and were confirmed by medical record review. Results: 51 opioid-related overdoses were identified, including 6 deaths. Compared with patients receiving 1 to 20 mg/d of opioids (0.2% annual overdose rate), patients receiving 50 to 99 mg/d had a 3.7-fold increase in overdose risk (95% CI, 1.5 to 9.5) and a 0.7% annual overdose rate. Patients receiving 100 mg/d or more had an 8.9-fold increase in overdose risk (CI, 4.0 to 19.7) and a 1.8% annual overdose rate. Limitations: Increased overdose risk among patients receiving higher dose regimens may be due to confounding by patient differences and by use of opioids in ways not intended by prescribing physicians. The small number of overdoses in the study cohort is also a limitation. Conclusion: Patients receiving higher doses of prescribed opioids are at increased risk for overdose, which underscores the need for close supervision of these patients.	[Von Korff, Michael] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA 98101 USA; Univ Washington, Seattle, WA 98195 USA; Keele Univ, Arthrit Res Campaign Natl Primary Care Ctr, Keele, Staffs, England; No Calif Kaiser Permanente, Oakland, CA USA; Univ Calif San Francisco, San Francisco, CA 94143 USA	Group Health Cooperative; University of Washington; University of Washington Seattle; Keele University; Kaiser Permanente; University of California System; University of California San Francisco	Von Korff, M (corresponding author), Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, 1730 Minor Ave,Suite 1600, Seattle, WA 98101 USA.	vonkorff.m@ghc.org	Rutter, Carolyn/AAZ-3677-2021	VonKorff, Michael/0000-0001-5386-8477; Banta-Green, Caleb/0000-0003-4084-6943	National Institute of Drug Abuse [DA022557]; Wellcome Trust [083572]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA022557] Funding Source: NIH RePORTER	National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Grant Support: This research was supported by a grant to Dr. Von Korff from the National Institute of Drug Abuse (DA022557). Dr. Dunn participated in this work with Dr. Von Korff at the Group Health Research Institute through a grant from the Wellcome Trust (083572).	Ballantyne JC, 2008, CLIN J PAIN, V24, P469, DOI 10.1097/AJP.0b013e31816b2f26; Ballantyne Jane C, 2007, Pain Physician, V10, P479; Ballantyne JC, 2003, NEW ENGL J MED, V349, P1943, DOI 10.1056/NEJMra025411; BOUDREAU D, 2009, PHARMACOEPIDEMIOL DR; Breivik H, 2005, EUR J PAIN, V9, P127, DOI 10.1016/j.ejpain.2004.05.013; Caudill-Slosberg MA, 2004, PAIN, V109, P514, DOI 10.1016/j.pain.2004.03.006; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Eriksen J, 2006, PAIN, V125, P172, DOI 10.1016/j.pain.2006.06.009; Fernandez W, 2006, J SUBST ABUSE TREAT, V31, P151, DOI 10.1016/j.jsat.2006.04.008; Fishman PA, 2003, MED CARE, V41, P84, DOI 10.1097/00005650-200301000-00011; Fishman SM, 2006, PHARMACOEPIDEM DR S, V15, P628, DOI 10.1002/pds.1292; Franklin GM, 2005, AM J IND MED, V48, P91, DOI 10.1002/ajim.20191; Furlan AD, 2006, CAN MED ASSOC J, V174, P1589, DOI 10.1503/cmaj.051528; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Hall AJ, 2008, JAMA-J AM MED ASSOC, V300, P2613, DOI 10.1001/jama.2008.802; Hartung DM, 2007, ANN PHARMACOTHER, V41, P921, DOI 10.1345/aph.1K066; Kuehn BM, 2009, JAMA-J AM MED ASSOC, V301, P1213, DOI 10.1001/jama.2009.367; Martell BA, 2007, ANN INTERN MED, V146, P116, DOI 10.7326/0003-4819-146-2-200701160-00006; McLellan AT, 2008, JAMA-J AM MED ASSOC, V300, P2672, DOI 10.1001/jama.2008.793; Paulozzi LJ, 2006, PHARMACOEPIDEM DR S, V15, P618, DOI 10.1002/pds.1276; Paulozzi LJ, 2006, AM J PREV MED, V31, P506, DOI 10.1016/j.amepre.2006.08.017; Reidenberg MM, 2007, CLIN PHARMACOL THER, V81, P903, DOI 10.1038/sj.clpt.6100127; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1085, DOI 10.1016/0895-4356(93)90106-B; SAS/STAT, 2008, SAS STAT 9 2 US GUID; Saunders KW, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P223; Shah NG, 2008, ADDICTION, V103, P126, DOI 10.1111/j.1360-0443.2007.02054.x; Therneau TM, 2000, MODELING SURVIVAL DA; Trescot AM, 2008, PAIN PHYSICIAN, V11, pS5; Von Korff M, 2004, PAIN, V109, P207, DOI 10.1016/j.pain.2004.02.019; Von Korff M, 2008, CLIN J PAIN, V24, P521, DOI 10.1097/AJP.0b013e318169d03b; Washington State Department of Health, 2007, HLTH WASH STAT 2007; Won A, 2006, J GERONTOL A-BIOL, V61, P165, DOI 10.1093/gerona/61.2.165; Wysowski DK, 2007, DRUG SAFETY, V30, P533, DOI 10.2165/00002018-200730060-00007	33	934	943	1	74	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 19	2010	152	2					85	+		10.7326/0003-4819-152-2-201001190-00006	http://dx.doi.org/10.7326/0003-4819-152-2-201001190-00006			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	548IE	20083827	Green Accepted			2022-12-28	WOS:000273953000003
J	Baker, MC; Mathieu, E; Fleming, FM; Deming, M; King, JD; Garba, A; Koroma, JB; Bockarie, M; Kabore, A; Sankara, DP; Molyneux, DH				Baker, M. C.; Mathieu, E.; Fleming, F. M.; Deming, M.; King, J. D.; Garba, A.; Koroma, J. B.; Bockarie, M.; Kabore, A.; Sankara, D. P.; Molyneux, D. H.			Neglected Tropical Diseases 3 Mapping, monitoring, and surveillance of neglected tropical diseases: towards a policy framework	LANCET			English	Article							CIRCULATING CATHODIC ANTIGEN; SUB-SAHARAN AFRICA; LOA-LOA INFECTION; LYMPHATIC FILARIASIS; BANCROFTIAN FILARIASIS; RAPID ASSESSMENT; URINARY SCHISTOSOMIASIS; ONCHOCERCIASIS CONTROL; COST-EFFECTIVENESS; SPATIAL-ANALYSIS	As national programmes respond to the new opportunities presented for scaling up preventive chemotherapy programmes for the coadministration of drugs to target lymphatic filariasis, onchocerciasis, schistosomiasis, soil-transmitted helminthiasis, and trachoma, possible synergies between existing disease-specific policies and protocols need to be examined. In this report we compare present policies for mapping, monitoring, and surveillance for these diseases, drawing attention to both the challenges and opportunities for integration. Although full integration of all elements of mapping, monitoring, and surveillance strategies might not be feasible for the diseases targeted through the preventive chemotherapy approach, there are opportunities for integration, and we present examples of integrated strategies. Finally, if advantage is to be taken of scaled up interventions to address neglected tropical diseases, efforts to develop rapid, inexpensive, and easy-to-use methods, whether disease-specific or integrated, should be increased. We present a framework for development of an integrated monitoring and evaluation system that combines both integrated and disease-specific strategies.	[Baker, M. C.] RTI Int, Ctr Int Hlth, Washington, DC 20005 USA; [Mathieu, E.; Deming, M.] Ctr Dis Control & Prevent, Div Parasit Dis, Parasit Dis Branch, Atlanta, GA USA; [Fleming, F. M.] Univ London Imperial Coll Sci Technol & Med, Schistosomiasis Control Initiat, London, England; [King, J. D.] Emory Univ, Carter Ctr, Atlanta, GA 30322 USA; [Garba, A.] RISEAL, NTD Control Program, Niamey, Niger; [Koroma, J. B.] Minist Hlth & Sanitat, Natl Onchocerciasis Neglected Trop Dis Control Pr, Freetown, Sierra Leone; [Bockarie, M.; Molyneux, D. H.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Kabore, A.] Liverpool Associates Hlth, Liverpool, Merseyside, England	Research Triangle Institute; Centers for Disease Control & Prevention - USA; Imperial College London; Emory University; Ministry of Health & Sanitation Sierra Leone; Liverpool School of Tropical Medicine; University of Liverpool	Baker, MC (corresponding author), RTI Int, Ctr Int Hlth, 805 15th St NW,Suite 601, Washington, DC 20005 USA.	mcb93@georgetown.edu	Bockarie, Moses/AAV-4578-2020; Bockarie, Moses/AAW-3130-2021	Garba, Amadou/0000-0002-6298-8259	USAID	USAID(United States Agency for International Development (USAID))	We thank Annie Baridjord for her administrative supporting in preparing this report. The views of the authors are their own and do not necessarily represent those of the US Centers for Disease Control and Prevention. This study is made possible by the generous support of the American people through USAID. The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the US Government.	Amazigo U, 2007, SOC SCI MED, V64, P2070, DOI 10.1016/j.socscimed.2007.01.018; [Anonymous], DEM HLTH SURV; [Anonymous], 2006, PREV CHEM HUM HELM C; Ansell J, 2002, ANN TROP MED PARASIT, V96, P145, DOI 10.1179/000349802125000682; *APOC, 2002, COMM SELF MON IV TRE; *APOC WHO, 1998, COMM DIR TREATM INV; *APOC WHO, 2002, IND PART MON CDTI PR; Baker MC, 2007, INT J HEALTH PLAN M, V22, P337, DOI 10.1002/hpm.900; BAKER MC, 2008, ASTMH 57 ANN M NEW O; Boatin BA, 2006, ADV PARASIT, V61, P349, DOI 10.1016/S0065-308X(05)61009-3; Bockarie MJ, 2007, AM J TROP MED HYG, V77, P591, DOI 10.4269/ajtmh.2007.77.591; Bockarie MJ, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1686; Boussinesq M, 1997, ANN TROP MED PARASIT, V91, P573, DOI 10.1080/00034989760671; Bradley M, 2001, T ROY SOC TROP MED H, V95, P72, DOI 10.1016/S0035-9203(01)90338-4; Brooker S, 2000, PARASITOL TODAY, V16, P303, DOI 10.1016/S0169-4758(00)01687-2; Brooker S, 2005, TROP MED INT HEALTH, V10, P647, DOI 10.1111/j.1365-3156.2005.01446.x; Brooker S, 2007, T ROY SOC TROP MED H, V101, P1, DOI 10.1016/j.trstmh.2006.08.004; Brooks M, 2009, J VET EMERG CRIT CAR, V19, P1, DOI 10.1111/j.1476-4431.2009.00385.x; Butler D, 2009, NATURE, V457, P772, DOI 10.1038/457772a; Clements ACA, 2008, INT J PARASITOL, V38, P401, DOI 10.1016/j.ijpara.2007.08.001; De Rochars MVEB, 2004, AM J TROP MED HYG, V71, P598, DOI 10.4269/ajtmh.2004.71.598; Diawara L, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000497; DUKE BOL, 1993, PROCEDURAL MANUAL IV; Emerson PM, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000197; Gardon J, 1997, LANCET, V350, P18, DOI 10.1016/S0140-6736(96)11094-1; Gonzalez RJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000404; Gyapong JO, 2001, T ROY SOC TROP MED H, V95, P681, DOI 10.1016/S0035-9203(01)90115-4; Gyapong JO, 2002, ANN TROP MED PARASIT, V96, P695, DOI 10.1179/000349802125001735; Helmy H, 2006, T ROY SOC TROP MED H, V100, P656, DOI 10.1016/j.trstmh.2005.08.015; Homeida M, 2002, ANN TROP MED PARASIT, V96, P93, DOI 10.1179/000349802125000673; Hotez PJ, 2006, PLOS MED, V3, P576, DOI 10.1371/journal.pmed.0030102; KING JD, 2009, AM J TROP M IN PRESS; Koukounari A, 2006, AM J TROP MED HYG, V75, P278, DOI 10.4269/ajtmh.2006.75.278; Legesse M, 2007, T ROY SOC TROP MED H, V101, P668, DOI 10.1016/j.trstmh.2006.11.009; Lengeler C, 2002, B WORLD HEALTH ORGAN, V80, P235; Mabey DCW, 2003, LANCET, V362, P223, DOI 10.1016/S0140-6736(03)13914-1; Mariotti SP, 2009, BRIT J OPHTHALMOL, V93, P563, DOI 10.1136/bjo.2008.148494; Michel CEC, 2006, LANCET, V367, P1585, DOI 10.1016/S0140-6736(06)68695-9; Miller K, 2004, OPHTHAL EPIDEMIOL, V11, P255, DOI 10.1080/09286580490514577; Mohammed KA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000171; Molyneux DH, 2009, T ROY SOC TROP MED H, V103, P338, DOI 10.1016/j.trstmh.2008.12.016; Molyneux DH, 2005, PLOS MED, V2, P1064, DOI 10.1371/journal.pmed.0020336; Montresor A., 1998, WORLD HLTH ORG; Montresor A., 2002, HELMINTH CONTROL SCH; Murdoch ME, 2002, ANN TROP MED PARASIT, V96, P283, DOI 10.1179/000349802125000826; Ngondi J, 2009, T ROY SOC TROP MED H, V103, P1001, DOI 10.1016/j.trstmh.2008.11.023; NGOUMOU P, 1994, ANN TROP MED PARASIT, V88, P463, DOI 10.1080/00034983.1994.11812893; Ngoumou P., 1993, MANUAL RAPID EPIDEMI; Njenga SM, 2007, ANN TROP MED PARASIT, V101, P161, DOI 10.1179/136485907X156933; Noma M, 2002, ANN TROP MED PARASIT, V96, P29, DOI 10.1179/000349802125000637; Onapa AW, 2005, ANN TROP MED PARASIT, V99, P141, DOI 10.1179/136485905X19829; Osei-Atweneboano MY, 2007, LANCET, V369, P2021, DOI 10.1016/S0140-6736(07)60942-8; Ottesen EA, 2006, ADV PARASIT, V61, P395, DOI 10.1016/S0065-308X(05)61010-X; Ramzy RMR, 2006, LANCET, V367, P992, DOI 10.1016/S0140-6736(06)68426-2; REMME JHF, 1995, PARASITOL TODAY, V11, P403, DOI 10.1016/0169-4758(95)80017-4; RESNIKOFF S, 2007, REV INT TRACHOME PAT, V84, P59; Richards FO, 2001, TRENDS PARASITOL, V17, P558, DOI 10.1016/S1471-4922(01)02112-2; Richards FO, 2006, B WORLD HEALTH ORGAN, V84, P673, DOI 10.2471/BLT.06.029652; Richter J., 2000, ULTRASOUND SCHISTOSO; Savioli L, 1999, MONITORING HELMINTH; STINGL P, 1984, T ROY SOC TROP MED H, V78, P254, DOI 10.1016/0035-9203(84)90291-8; Stothard JR, 2006, ACTA TROP, V97, P219, DOI 10.1016/j.actatropica.2005.11.004; Takougang I, 2002, B WORLD HEALTH ORGAN, V80, P852; Taylor MJ, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-7; Thomson MC, 2000, LANCET, V356, P1077, DOI 10.1016/S0140-6736(00)02733-1; Thylefors B, 2006, ANN TROP MED PARASIT, V100, P733, DOI 10.1179/136485906X112202; THYLEFORS B, 1987, B WORLD HEALTH ORGAN, V65, P477; United Nations Children's Fund (UNICEF), MULT IND CLUST SURV; Utzinger J, 2006, PLOS MED, V3, P585, DOI 10.1371/journal.pmed.0030112; Wanji Samuel, 2005, Filaria J, V4, P2, DOI 10.1186/1475-2883-4-2; Weil GJ, 2007, TRENDS PARASITOL, V23, P78, DOI 10.1016/j.pt.2006.12.001; Weil GJ, 2000, J INFECT DIS, V182, P1796, DOI 10.1086/317629; WHITE GB, 2002, ANN TROP MED PARA S2, V96, pS3; WHO, 1995, ONCH ITS CONTR REP W; WHO, 2006, TRACH CONTR GUID PRO; WHO, 2005, WHOCDSCPECEE200550; World Health Organization, 2008, Weekly Epidemiological Record, V83, P333; World Health Organization, 2008, Weekly Epidemiological Record, V83, P237; World Health Organization, 2004, MIDL MAN COURS EPI M; World Health Organization, 1987, WHO TECHN REP SER, V752; World Health Organization, 2002, WHO TECHN REP SER; 2007, WKLY EPIDEMIOL REC, V29, P256	82	53	54	1	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 16	2010	375	9710					231	238		10.1016/S0140-6736(09)61458-6	http://dx.doi.org/10.1016/S0140-6736(09)61458-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	546ZH	20109924				2022-12-28	WOS:000273853800033
J	Milhous, WK; Weina, PJ				Milhous, Wilbur K.; Weina, Peter J.			The Botanical Solution for Malaria	SCIENCE			English	Editorial Material							ANTIMALARIAL-DRUG; ARTEMISININ; ARTEETHER		[Milhous, Wilbur K.] Univ S Florida, Coll Publ Hlth, Tampa, FL 33612 USA; [Weina, Peter J.] Walter Reed Army Inst Res, Silver Spring, MD 20910 USA	State University System of Florida; University of South Florida; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Milhous, WK (corresponding author), Univ S Florida, Coll Publ Hlth, Tampa, FL 33612 USA.	wmilhous@health.usf.edu						BREWER TG, 1994, T ROY SOC TROP MED H, V88, P33, DOI 10.1016/0035-9203(94)90469-3; Carothers JM, 2009, CURR OPIN BIOTECH, V20, P498, DOI 10.1016/j.copbio.2009.08.001; Genovese RE, 2000, PHARMACOL BIOCHEM BE, V67, P37, DOI 10.1016/S0091-3057(00)00309-9; Graham IA, 2010, SCIENCE, V327, P328, DOI 10.1126/science.1182612; KLAYMAN DL, 1985, SCIENCE, V228, P1049, DOI 10.1126/science.3887571; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Vennerstrom JL, 2004, NATURE, V430, P900, DOI 10.1038/nature02779; Wells TNC, 2009, NAT REV DRUG DISCOV, V8, P879, DOI 10.1038/nrd2972	8	15	15	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 15	2010	327	5963					279	280		10.1126/science.1184780	http://dx.doi.org/10.1126/science.1184780			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544CM	20075238				2022-12-28	WOS:000273629700025
J	Delaere, P; Vranckx, J; Verleden, G; De Leyn, P; Van Raemdonck, D				Delaere, Pierre; Vranckx, Jan; Verleden, Geert; De Leyn, Paul; Van Raemdonck, Dirk		Leuven Tracheal Transplant Grp	Tracheal Allotransplantation after Withdrawal of Immunosuppressive Therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ARTICULAR-CARTILAGE; TRANSPLANTATION; ALLOGRAFT; SURGERY; CANCER	Reconstruction of long-segment tracheal defects requires a vascularized allograft. We report successful tracheal allotransplantation after indirect revascularization of the graft in a heterotopic position. Immunosuppressive therapy was administered before the operation, and the tracheal allograft was wrapped in the recipient's forearm fascia. Once revascularization was achieved, the mucosal lining was replaced progressively with buccal mucosa from the recipient. At 4 months, the tracheal chimera was fully lined with mucosa, which consisted of respiratory epithelium from the donor and buccal mucosa from the recipient. After withdrawal of immunosuppressive therapy, the tracheal allograft was moved to its correct anatomical position with an intact blood supply. No treatment-limiting adverse effects occurred.	[Delaere, Pierre] Univ Hosp Leuven, Ctr Larynx Trachea & Hypopharynx Reconstruct, Dept Otolaryngol & Head & Neck Surg, B-3000 Louvain, Belgium; [Vranckx, Jan] Univ Hosp Leuven, Dept Plast & Reconstruct Surg, B-3000 Louvain, Belgium; [Verleden, Geert] Univ Hosp Leuven, Dept Internal Med, Div Pneumol, B-3000 Louvain, Belgium; [De Leyn, Paul; Van Raemdonck, Dirk] Univ Hosp Leuven, Dept Thorac Surg, B-3000 Louvain, Belgium	KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven	Delaere, P (corresponding author), Univ Hosp Leuven, Ctr Larynx Trachea & Hypopharynx Reconstruct, Dept Otolaryngol & Head & Neck Surg, Kapucijnenvoer 33, B-3000 Louvain, Belgium.	pierre.delaere@med.kuleuven.be	Van Raemdonck, Dirk/AAL-4147-2020	Roskams, Tania/0000-0002-2816-1530; Van Raemdonck, Dirk/0000-0003-1261-0992	GlaxoSmithKline Belgium; AstraZeneca Belgium	GlaxoSmithKline Belgium(GlaxoSmithKline); AstraZeneca Belgium(AstraZeneca)	Dr. Verleden reports receiving consulting fees from GlaxoSmithKline Belgium, AstraZeneca Belgium, and MSD Belgium and lecture fees and research grants from GlaxoSmithKline Belgium and AstraZeneca Belgium. No other potential conflict of interest relevant to this article was reported.	Buckwalter JA, 1997, J BONE JOINT SURG AM, V79A, P612, DOI 10.2106/00004623-199704000-00022; Delaere P, 1999, PLAST RECONSTR SURG, V104, P1635, DOI 10.1097/00006534-199911000-00004; Delaere P, 2007, LARYNGOSCOPE, V117, P1764, DOI 10.1097/MLG.0b013e3181238397; Delaere PR, 2009, LANCET, V373, P717, DOI 10.1016/S0140-6736(09)60429-3; Delaere PR, 1996, ARCH OTOLARYNGOL, V122, P1201; DELAERE PR, 1995, J THORAC CARDIOV SUR, V110, P728, DOI 10.1016/S0022-5223(95)70105-2; GRILLO HC, 1995, J THORAC CARDIOV SUR, V109, P486, DOI 10.1016/S0022-5223(95)70279-2; Klepetko W, 2004, J THORAC CARDIOV SUR, V127, P862, DOI 10.1016/j.jtcvs.2003.07.050; LANGER F, 1974, J BONE JOINT SURG AM, VA 56, P297, DOI 10.2106/00004623-197456020-00007; Macchiarini P, 2009, LANCET, V373, P462; Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6; PEARSON FG, 1996, SEMIN THORAC CARDIOV, V8, P381; ROSE KG, 1979, LANCET, V1, P433; SALASSA JR, 1977, ANN THORAC SURG, V24, P100, DOI 10.1016/S0003-4975(10)63716-2; Strome M, 2001, NEW ENGL J MED, V344, P1676, DOI 10.1056/NEJM200105313442204; ten Hove WR, 2003, LIVER TRANSPLANT, V9, P552, DOI 10.1053/jlts.2003.50116; Wright CD, 2004, J THORAC CARDIOV SUR, V128, P731, DOI 10.1016/j.jtcvs.2004.07.005	17	215	225	3	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 14	2010	362	2					138	145		10.1056/NEJMoa0810653	http://dx.doi.org/10.1056/NEJMoa0810653			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	543FU	20071703	Bronze			2022-12-28	WOS:000273558500011
J	Novak, K				Novak, Kris			Stem Cell Therapies: California Dreamin'?	CELL			English	Editorial Material														Novak, Kristine/0000-0001-9314-1803					0	3	3	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 8	2010	140	1					10	12		10.1016/j.cell.2009.12.039	http://dx.doi.org/10.1016/j.cell.2009.12.039			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	541CY	20085697	Bronze			2022-12-28	WOS:000273391900006
J	Strom, T; Martinussen, T; Toft, P				Strom, Thomas; Martinussen, Torben; Toft, Palle			A protocol of no sedation for critically ill patients receiving mechanical ventilation: a randomised trial	LANCET			English	Article							INTENSIVE-CARE-UNIT; CONFUSION ASSESSMENT METHOD; DAILY INTERRUPTION; PROPOFOL; ANALGESICS; INFUSIONS; EFFICACY; DELIRIUM	Background Standard treatment of critically ill patients undergoing mechanical ventilation is continuous sedation. Daily interruption of sedation has a beneficial effect, and in the general intesive care unit of Odense University Hospital, Denmark, standard practice is a protocol of no sedation. We aimed to establish whether duration of mechanical ventilation could be reduced with a protocol of no sedation versus daily interruption of sedation. Methods Of 428 patients assessed for eligibility, we enrolled 140 critically ill adult patients who were undergoing mechanical ventilation and were expected to need ventilation for more than 24 h. Patients were randomly assigned in a 1:1 ratio (unblinded) to receive: no sedation (n=70 patients); or sedation (20 mg/mL propofal for 48 h, 1 mg/mL midazolam thereafter) with daily interruption until awake (n=70, control group). Both groups were treated with bolus doses of morphine (2.5 or 5 mg). The primary outcome was the number of days without mechanical ventilation in a 28-day period, and we also recorded the length of stay in the intensive care unit (from admission to 28 days) and in hospital (from admission to 90 days). Analysis was by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00466492. Findings 27 patients died or were successfully extubated within 48 h, and, as per our study design, were excluded from the study and statistical analysis. Patients receiving no sedation had significantly more days without ventilation (n=55; mean 13.8 days, SD 11.0) than did those receiving interrupted sedation (n=58; mean 9.6 days, SD 10.0; mean difference 4.2 days, 95% CI 0.3-8.1; p=0.0191). No sedation was also associated with a shorter stay in the intensive care unit (H R 1.86, 95% Cl 1.05-3.23; p=0.0316), and, for the first 30 days studied, in hospital (3.57, 1.52-9.09; p=0.0039), than was interrupted sedation. No difference was recorded in the occurrences of accidental extubations, the need for CT or MRI brain scans, or ventilator-associated pneumonia. Agitated delirium was more frequent in the intervention group than in the control group (n=11, 20% vs n=4, 7%; p=0.0400). Interpretation No sedation of critically ill patients receiving mechanical ventilation is associated with an increase in days without ventilation. A multicentre study is needed to establish whether this effect can be reproduced in other facilities.	[Strom, Thomas; Toft, Palle] Univ So Denmark, Odense Univ Hosp, Dept Anesthesia & Intens Care Med, DK-5000 Odense C, Denmark; [Martinussen, Torben] Univ So Denmark, Fac Hlth Sci, Dept Biostat, DK-5000 Odense C, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark	Strom, T (corresponding author), Univ So Denmark, Odense Univ Hosp, Dept Anesthesia & Intens Care Med, DK-5000 Odense C, Denmark.	t.s@dadlnet.dk		Toft, Palle/0000-0002-3188-449X; Strom, Thomas/0000-0002-1868-0978	Fund of Danielsen; Danish Society of Anesthesiology and Intensive Care Medicine; Fund of Kirsten Jensa la Cour; Fund of Holger og Ruth Hess	Fund of Danielsen; Danish Society of Anesthesiology and Intensive Care Medicine; Fund of Kirsten Jensa la Cour; Fund of Holger og Ruth Hess	PT and TS received research grants from the Fund of Danielsen; and TS received research grants from the Danish Society of Anesthesiology and Intensive Care Medicine, the Fund of Kirsten Jensa la Cour, and the Fund of Holger og Ruth Hess. None of these funding organisations affected the trial or publication. We thank the nurses and our colleagues in the Department of Anesthesia and intensive Care Medicine at Odense University Hospital for their participation and support in the study.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Arroliga A, 2005, CHEST, V128, P496, DOI 10.1378/chest.128.2.496; Brook AD, 1999, CRIT CARE MED, V27, P2609, DOI 10.1097/00003246-199912000-00001; Egerod I, 2006, INTENS CARE MED, V32, P60, DOI 10.1007/s00134-005-2856-1; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; Ely EW, 2001, CRIT CARE MED, V29, P1370, DOI 10.1097/00003246-200107000-00012; Girard TD, 2008, LANCET, V371, P126, DOI 10.1016/S0140-6736(08)60105-1; Girard TD, 2009, CRIT CARE MED, V37, P2654, DOI 10.1097/CCM.0b013e3181ad76f4; Hall Jesse B, 2009, Crit Care Med, V37, pS416, DOI 10.1097/CCM.0b013e3181b6f95b; Jacobi J, 2002, CRIT CARE MED, V30, P119, DOI 10.1097/00003246-200201000-00020; Jones C, 2001, CRIT CARE MED, V29, P573, DOI 10.1097/00003246-200103000-00019; Kam PCA, 2007, ANAESTHESIA, V62, P690, DOI 10.1111/j.1365-2044.2007.05055.x; Kollef MH, 1998, CHEST, V114, P541, DOI 10.1378/chest.114.2.541; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; Kress JP, 2003, AM J RESP CRIT CARE, V168, P1457, DOI 10.1164/rccm.200303-455OC; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; Martinussen T., 2006, STAT BIOL HEALTH; Mehta S, 2006, CRIT CARE MED, V34, P374, DOI 10.1097/01.CCM.0000196830.61965.F1; Peeters MMM, 2008, CLIN PHARMACOL THER, V83, P443, DOI 10.1038/sj.clpt.6100309; Petty TL, 1998, CHEST, V114, P360, DOI 10.1378/chest.114.2.360; RAMSAY MAE, 1974, BRIT MED J, V2, P656, DOI 10.1136/bmj.2.5920.656; Schoenfeld DA, 2002, CRIT CARE MED, V30, P1772, DOI 10.1097/00003246-200208000-00016; Schweickert WD, 2004, CRIT CARE MED, V32, P1272, DOI 10.1097/01.CCM.0000127263.54807.79; Vasile B, 2003, INTENS CARE MED, V29, P1417, DOI 10.1007/s00134-003-1905-x; Vincent Jean-Louis, 2009, Crit Care Med, V37, pS296, DOI 10.1097/CCM.0b013e3181b6f1e1	25	557	601	0	42	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 6	2010	375	9713					475	480		10.1016/S0140-6736(09)62072-9	http://dx.doi.org/10.1016/S0140-6736(09)62072-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	558PV	20116842				2022-12-28	WOS:000274757900030
J	Abersfelder, K; White, AJP; Rzepa, HS; Scheschkewitz, D				Abersfelder, Kai; White, Andrew J. P.; Rzepa, Henry S.; Scheschkewitz, David			A Tricyclic Aromatic Isomer of Hexasilabenzene	SCIENCE			English	Article							STABLE COMPOUND; CHEMISTRY; ELEMENTS; CLUSTER; EXPLORATION; DISILENES; MOLECULES; BOND	Benzene represents the showcase of Huckel aromaticity. The silicon analog, hexasilabenzene, has consequently been targeted for decades. We now report an intensely green isomer of Si6R6 (R being 2,4,6-triisopropylphenyl) with a tricyclic structure in the solid state featuring silicon atoms with two, one, and no substituents outside the ring framework. The highly dispersed Si-29 nuclear magnetic resonance shifts in solution ranging from +125 to -90 parts per million indicate an inhomogeneous electron distribution due to the dismutation of formal oxidation numbers as compared with that of benzene. Theoretical analysis reveals nonetheless the cyclic delocalization of six mobile electrons of the pi-, sigma- and non-bonding type across the central four-membered ring. For this alternative form of aromaticity, in principle applicable to many Huckel aromatic species, we propose the term dismutational aromaticity.	[Abersfelder, Kai; White, Andrew J. P.; Rzepa, Henry S.; Scheschkewitz, David] Univ London Imperial Coll Sci Technol & Med, Dept Chem, London SW7 2AZ, England	Imperial College London	Rzepa, HS (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Chem, London SW7 2AZ, England.	rzepa@imperial.ac.uk; d.scheschkewitz@imperial.ac.uk	Scheschkewitz, David/A-5050-2008; Rzepa, Henry/G-5782-2019; Abersfelder, Kai/AAP-9536-2021	Scheschkewitz, David/0000-0001-5600-8034; Rzepa, Henry/0000-0002-8635-8390; 	Deutsche Forschungsgemeinschaft [DFG SCHE 906/3-2]; Aventis Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Aventis Foundation	We thank the Deutsche Forschungsgemeinschaft (DFG SCHE 906/3-2) and the Karl-Winnacker-Fund of the Aventis Foundation for financial support. Crystallographic details were deposited with the Cambridge Crystallographic Data Centre as CCDC-745660 (2) and 745661 (3a).	Abersfelder K, 2008, J AM CHEM SOC, V130, P4114, DOI 10.1021/ja711169w; Allan CSM, 2008, J CHEM THEORY COMPUT, V4, P1841, DOI 10.1021/ct8001915; Bader R. F. W., 1990, ATOMS MOL QUANTUM TH; Balaban AT, 2005, CHEM REV, V105, P3436, DOI 10.1021/cr0300946; Baldridge KK, 2000, ORGANOMETALLICS, V19, P1477, DOI 10.1021/om9903745; Chen ZF, 2005, CHEM REV, V105, P3842, DOI 10.1021/cr030088+; Cotton F.A., 1972, ADV INORGANIC CHEM, Vthird, P1145; DEWAR MJS, 1975, J AM CHEM SOC, V97, P1311, DOI 10.1021/ja00839a005; Dinadayalane TC, 2004, J PHYS CHEM A, V108, P11433, DOI 10.1021/jp0467696; DOERING WV, 1951, J AM CHEM SOC, V73, P876, DOI 10.1021/ja01146a537; Downing J, 2008, J CHEM INF MODEL, V48, P1571, DOI 10.1021/ci7004737; Faraday M. Xx., 1825, PHILOS T R SOC LONDO, V115, P440; Fischer G, 2005, ANGEW CHEM INT EDIT, V44, P7884, DOI 10.1002/anie.200501289; Ichinohe M, 2005, J AM CHEM SOC, V127, P9978, DOI 10.1021/ja053202+; Kinjo R, 2007, J AM CHEM SOC, V129, P7766, DOI 10.1021/ja072759h; Kira M, 2006, ADV ORGANOMET CHEM, V54, P73, DOI 10.1016/S0065-3055(05)54003-6; Lee VY, 2007, ANGEW CHEM INT EDIT, V46, P6596, DOI 10.1002/anie.200604869; Lee VY, 2004, J AM CHEM SOC, V126, P4758, DOI 10.1021/ja030662z; NAGASE S, 1987, J CHEM PHYS, V86, P4513, DOI 10.1063/1.452726; NIECKE E, 1995, ANGEW CHEM INT EDIT, V34, P555, DOI 10.1002/anie.199505551; Sasamori T, 2008, J AM CHEM SOC, V130, P13856, DOI 10.1021/ja8061002; SAVIN A, 1992, ANGEW CHEM INT EDIT, V31, P187, DOI 10.1002/anie.199201871; Schepers T, 2002, J PHYS ORG CHEM, V15, P490, DOI 10.1002/poc.527; Scheschkewitz D, 2005, ANGEW CHEM INT EDIT, V44, P2954, DOI 10.1002/anie.200462730; Scheschkewitz D, 2004, ANGEW CHEM INT EDIT, V43, P2965, DOI 10.1002/anie.200353347; Schnepf A, 2007, CHEM SOC REV, V36, P745, DOI 10.1039/b516379j; Seierstad M, 2002, ANGEW CHEM INT EDIT, V41, P3894, DOI 10.1002/1521-3773(20021018)41:20<3894::AID-ANIE3894>3.0.CO;2-Z; Sekiguchi A, 2004, SCIENCE, V305, P1755, DOI 10.1126/science.1102209; SEKIGUCHI A, 1993, J AM CHEM SOC, V115, P5853, DOI 10.1021/ja00066a075; Shimoni-Livny L, 1998, INORG CHEM, V37, P1853, DOI 10.1021/ic970909r; Wakita K, 2000, ANGEW CHEM INT EDIT, V39, P634, DOI 10.1002/(SICI)1521-3773(20000204)39:3<634::AID-ANIE634>3.0.CO;2-#; Wannere CS, 2009, J PHYS CHEM A, V113, P11619, DOI 10.1021/jp902176a; WEST R, 1981, SCIENCE, V214, P1343, DOI 10.1126/science.214.4527.1343; Zhang Q, 2009, J AM CHEM SOC, V131, P9789, DOI 10.1021/ja9029285	34	187	187	2	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 29	2010	327	5965					564	566		10.1126/science.1181771	http://dx.doi.org/10.1126/science.1181771			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	549CT	20110501				2022-12-28	WOS:000274020500033
J	Silove, DM; Rees, SJ				Silove, Derrick M.; Rees, Susan J.			Assessing torture Interrogating the role of mental health professionals in assessing torture	BRITISH MEDICAL JOURNAL			English	Editorial Material							POSTTRAUMATIC-STRESS-DISORDER; DOCTORS		[Silove, Derrick M.] Univ New S Wales, Sch Psychiat, Sydney, NSW 2052, Australia	University of New South Wales Sydney	Silove, DM (corresponding author), Univ New S Wales, Sch Psychiat, Sydney, NSW 2052, Australia.	d.silove@unsw.edu.au						Andrews B, 2007, AM J PSYCHIAT, V164, P1319, DOI 10.1176/appi.ajp.2007.06091491; Annas GJ, 2005, NEW ENGL J MED, V352, P2127, DOI 10.1056/NEJMlim044131; [Anonymous], 2009, GUARDIAN        0904; BASOGLU M, 1994, AM J PSYCHIAT, V151, P76; Breslau N, 2002, CAN J PSYCHIAT, V47, P923, DOI 10.1177/070674370204701003; Coghill RC, 2003, P NATL ACAD SCI USA, V100, P8538, DOI 10.1073/pnas.1430684100; Greene C. H., 2009, CONSULT PSYCH J, V61, P25, DOI [10.1037/a0015102, DOI 10.1037/A0015102]; Hall P, 2004, BRIT MED J, V329, P66, DOI 10.1136/bmj.329.7457.66; Miles SH, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1088; *PHR, 2003, DUAL LOYALT HUM RIGH; Physicians for Human Rights, 2009, AID TORT HLTH PROF E; SANDS P, 2008, RUMSFELDS MEMO BETRA, P254; Steel Z, 2009, JAMA-J AM MED ASSOC, V302, P537, DOI 10.1001/jama.2009.1132; Summers F, 2009, NATURE, V460, P173, DOI 10.1038/460173a; van der Hart O, 2008, J TRAUMA DISSOCIATIO, V9, P481, DOI 10.1080/15299730802223362; 2009, NATURE, V459, P300	16	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 28	2010	340								c124	10.1136/bmj.c124	http://dx.doi.org/10.1136/bmj.c124			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	549YC	20110311				2022-12-28	WOS:000274089400002
J	Soderberg, AM; Chakraborti, S; Pignata, G; Chevalier, RA; Chandra, P; Ray, A; Wieringa, MH; Copete, A; Chaplin, V; Connaughton, V; Barthelmy, SD; Bietenholz, MF; Chugai, N; Stritzinger, MD; Hamuy, M; Fransson, C; Fox, O; Levesque, EM; Grindlay, JE; Challis, P; Foley, RJ; Kirshner, RP; Milne, PA; Torres, MAP				Soderberg, A. M.; Chakraborti, S.; Pignata, G.; Chevalier, R. A.; Chandra, P.; Ray, A.; Wieringa, M. H.; Copete, A.; Chaplin, V.; Connaughton, V.; Barthelmy, S. D.; Bietenholz, M. F.; Chugai, N.; Stritzinger, M. D.; Hamuy, M.; Fransson, C.; Fox, O.; Levesque, E. M.; Grindlay, J. E.; Challis, P.; Foley, R. J.; Kirshner, R. P.; Milne, P. A.; Torres, M. A. P.			A relativistic type Ibc supernova without a detected gamma-ray burst	NATURE			English	Article							IC SUPERNOVAE; EMISSION; 1998BW	Long duration gamma-ray bursts (GRBs) mark(1) the explosive death of some massive stars and are a rare sub-class of type Ibc supernovae. They are distinguished by the production of an energetic and collimated relativistic outflow powered(2) by a central engine (an accreting black hole or neutron star). Observationally, this outflow is manifested(3) in the pulse of gamma-rays and a long-lived radio afterglow. Until now, central-engine driven supernovae have been discovered exclusively through their gamma-ray emission, yet it is expected(4) that a larger population goes undetected because of limited satellite sensitivity or beaming of the collimated emission away from our line of sight. In this framework, the recovery of undetected GRBs may be possible through radio searches(5,6) for type Ibc supernovae with relativistic outflows. Here we report the discovery of luminous radio emission from the seemingly ordinary type Ibc SN 2009bb, which requires a substantial relativistic outflow powered by a central engine. A comparison with our radio survey of type Ibc supernovae reveals that the fraction harbouring central engines is low, about one per cent, measured independently from, but consistent with, the inferred(7) rate of nearby GRBs. Independently, a second mildly relativistic supernova has been reported(8).	[Soderberg, A. M.; Copete, A.; Levesque, E. M.; Grindlay, J. E.; Challis, P.; Foley, R. J.; Kirshner, R. P.; Torres, M. A. P.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Chakraborti, S.; Ray, A.] Tata Inst Fundamental Res, Mumbai 400005, Maharashtra, India; [Pignata, G.; Hamuy, M.] Univ Chile, Dept Astron, Santiago, Chile; [Chevalier, R. A.; Fox, O.] Univ Virginia, Dept Astron, Charlottesville, VA 22904 USA; [Chandra, P.] Royal Mil Coll Canada, Kingston, ON K7K 7B4, Canada; [Wieringa, M. H.] CSIRO, Australia Telescope Natl Facil, Epping, NSW 2121, Australia; [Chaplin, V.; Connaughton, V.] Univ Alabama, Huntsville, AL 35899 USA; [Barthelmy, S. D.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Bietenholz, M. F.] York Univ, Dept Phys & Astron, Toronto, ON M3J 1P3, Canada; [Bietenholz, M. F.] Hartebeestehoek Radio Observ, ZA-1740 Krugersdorp, South Africa; [Chugai, N.] RAS, Inst Astron, Moscow 119017, Russia; [Stritzinger, M. D.] Carnegie Observ, Las Campanas Observ, La Serena, Chile; [Stritzinger, M. D.] Univ Copenhagen, Niels Bohr Inst, Dark Cosmol Ctr, DK-2100 Copenhagen O, Denmark; [Fransson, C.] Stockholm Univ, Dept Astron, SE-10691 Stockholm, Sweden; [Levesque, E. M.] Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; [Milne, P. A.] Univ Arizona, Steward Observ, Tucson, AZ 85721 USA	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Tata Institute of Fundamental Research (TIFR); Universidad de Chile; University of Virginia; Royal Military College - Canada; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Alabama System; University of Alabama Huntsville; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; York University - Canada; National Research Foundation - South Africa; Hartebeesthoek Radio Astronomy Observatory; Institute of Astronomy of the Russian Academy of Sciences; Russian Academy of Sciences; Carnegie Institution for Science; University of Copenhagen; Niels Bohr Institute; Stockholm University; University of Hawaii System; University of Arizona	Soderberg, AM (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St,MS-51, Cambridge, MA 02138 USA.	asoderberg@cfa.harvard.edu	Barthelmy, Scott D/D-2943-2012; Chaplin, Vandiver/AAN-6228-2021; Hamuy, Mario/G-7541-2016; Torres, Manuel Angel Perez/AAE-5006-2019	Chaplin, Vandiver/0000-0002-4074-0391; Torres, Manuel Angel Perez/0000-0002-5297-2683; Chugai, Nikolai/0000-0003-2895-6066; Foley, Ryan/0000-0002-2445-5275	NASA; Ford Foundation; NSF; FONDECYT; Iniciativa Cientifica Milenio; FONDAP; CONICYT; 11th Five Year Plan Project	NASA(National Aeronautics & Space Administration (NASA)); Ford Foundation; NSF(National Science Foundation (NSF)); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Iniciativa Cientifica Milenio; FONDAP; CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); 11th Five Year Plan Project	The VLA is operated by the NRAO, a facility of the NSF operated under cooperative agreement by Associated Universities, Inc. GMRT is run by the National Centre for Radio Astrophysics of the Tata Institute of Fundamental Research. This research has made use of the NASA/IPAC Extragalactic Database (NED) which is operated by the Jet Propulsion Laboratory, California Institute of Technology, under contract with NASA. A. M. S. and O. F. acknowledge support by NASA through Hubble and GSRP grants, respectively. E. M. L. is funded through a Ford Foundation Predoctoral Fellowship. R. J. F. is a Clay fellow. R. A. C. and R. P. K. acknowledge support through NASA and NSF grants. G. P. and M. H. acknowledge support from FONDECYT, Iniciativa Cientifica Milenio, FONDAP and CONICYT. A. R. and S. C. are funded by an 11th Five Year Plan Project.	Berger E, 2003, ASTROPHYS J, V599, P408, DOI 10.1086/379214; BLANDFORD RD, 1976, PHYS FLUIDS, V19, P1130, DOI 10.1063/1.861619; Cappellaro E, 1999, ASTRON ASTROPHYS, V351, P459; Chevalier RA, 1998, ASTROPHYS J, V499, P810, DOI 10.1086/305676; Chevalier RA, 2006, ASTROPHYS J, V651, P381, DOI 10.1086/507606; Dahlen T, 2004, ASTROPHYS J, V613, P189, DOI 10.1086/422899; Folatelli G., 2009, CBET, V1751, P1; Hurley K, 2009, AIP CONF PROC, V1133, P55, DOI 10.1063/1.3155966; KAISER N, 2002, P SOC PHOTO-OPT INS, V4386, P154; Kulkarni SR, 1998, NATURE, V395, P663, DOI 10.1038/27139; LAW NM, 2009, PALOMAR TRANSIENT FA; LEVESQUE E, 2009, HIGH METALLICITY EXP; Li ZY, 1999, ASTROPHYS J, V526, P716, DOI 10.1086/308031; MacFadyen AI, 2001, ASTROPHYS J, V550, P410, DOI 10.1086/319698; Modjaz M, 2008, ASTRON J, V135, P1136, DOI 10.1088/0004-6256/135/4/1136; Perley RA, 2004, P SOC PHOTO-OPT INS, V5489, P784, DOI 10.1117/12.551557; Perna R, 1998, ASTROPHYS J, V509, pL85, DOI 10.1086/311784; Pian E, 2000, ASTROPHYS J, V536, P778, DOI 10.1086/308978; Pignata G, 2009, AIP CONF PROC, V1111, P551, DOI 10.1063/1.3141608; Pignata G., 2009, CBET, V1731, P1; Piran T, 1999, PHYS REP, V314, P575, DOI 10.1016/S0370-1573(98)00127-6; READHEAD ACS, 1994, ASTROPHYS J, V426, P51, DOI 10.1086/174038; Soderberg A., 2007, THESIS CALTECH; Soderberg AM, 2006, NATURE, V442, P1014, DOI 10.1038/nature05087; Soderberg AM, 2006, ASTROPHYS J, V638, P930, DOI 10.1086/499121; Soderberg AM, 2004, NATURE, V430, P648, DOI 10.1038/nature02757; Tan JC, 2001, ASTROPHYS J, V551, P946, DOI 10.1086/320245; Woosley SE, 2006, ASTROPHYS J, V637, P914, DOI 10.1086/498500	28	241	241	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 28	2010	463	7280					513	515		10.1038/nature08714	http://dx.doi.org/10.1038/nature08714			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	548QK	20110995	Green Accepted			2022-12-28	WOS:000273981100044
J	Snyderman, R; Dinan, MA				Snyderman, Ralph; Dinan, Michaela A.			Improving Health by Taking It Personally	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PRIMARY-CARE; MEDICINE; TRANSFORMATION; SUPPORT		[Snyderman, Ralph; Dinan, Michaela A.] Duke Univ, Med Ctr, Ctr Res Prospect Hlth Care, Durham, NC 27710 USA	Duke University	Snyderman, R (corresponding author), Duke Univ, Med Ctr, Ctr Res Prospect Hlth Care, DUMC 3059, Durham, NC 27710 USA.	ralph.snyderman@duke.edu						*DUK PROSP HLTH, DUK PROSP HLTH PROGR; Goroll AH, 2007, J GEN INTERN MED, V22, P410, DOI 10.1007/s11606-006-0083-2; Plomin R, 2009, NAT REV GENET, V10, P872, DOI 10.1038/nrg2670; Rosenthal TC, 2008, J AM BOARD FAM MED, V21, P427, DOI 10.3122/jabfm.2008.05.070287; Schoen C, 2007, HEALTH AFFAIR, V26, pW717, DOI 10.1377/hlthaff.26.6.w717; Snyderman R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-104; Snyderman R, 2003, ACAD MED, V78, P1079, DOI 10.1097/00001888-200311000-00002; Whellan DJ, 2001, ARCH INTERN MED, V161, P2223, DOI 10.1001/archinte.161.18.2223; Williams RS, 2003, SCIENCE, V300, P549, DOI 10.1126/science.300.5619.549; Yoediono Z, 2008, PERS MED, V5, P47, DOI 10.2217/17410541.5.1.47	10	19	20	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 27	2010	303	4					363	364		10.1001/jama.2010.34	http://dx.doi.org/10.1001/jama.2010.34			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	548IC	20103762				2022-12-28	WOS:000273952800027
J	Wang, Q; Mynar, JL; Yoshida, M; Lee, E; Lee, M; Okuro, K; Kinbara, K; Aida, T				Wang, Qigang; Mynar, Justin L.; Yoshida, Masaru; Lee, Eunji; Lee, Myongsoo; Okuro, Kou; Kinbara, Kazushi; Aida, Takuzo			High-water-content mouldable hydrogels by mixing clay and a dendritic molecular binder	NATURE			English	Article							NANOCOMPOSITE HYDROGELS; MEDICINE; POLYMER	With the world's focus on reducing our dependency on fossil-fuel energy, the scientific community can investigate new plastic materials that are much less dependent on petroleum than are conventional plastics. Given increasing environmental issues, the idea of replacing plastics with water-based gels, so-called hydrogels, seems reasonable. Here we report that water and clay (2-3 per cent by mass), when mixed with a very small proportion (<0.4 per cent by mass) of organic components, quickly form a transparent hydrogel. This material can be moulded into shape-persistent, free-standing objects owing to its exceptionally great mechanical strength, and rapidly and completely self-heals when damaged. Furthermore, it preserves biologically active proteins for catalysis. So far(1) no other hydrogels, including conventional ones formed by mixing polymeric cations and anions(2,3) or polysaccharides and borax(4), have been reported to possess all these features. Notably, this material is formed only by non-covalent forces resulting from the specific design of a telechelic dendritic macromolecule with multiple adhesive termini for binding to clay.	[Wang, Qigang; Mynar, Justin L.; Okuro, Kou; Kinbara, Kazushi; Aida, Takuzo] Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan; [Mynar, Justin L.; Aida, Takuzo] Natl Museum Emerging Sci & Innovat, Japan Sci & Technol Agcy, ERATO SORST Nanospace Project, Koto Ku, Tokyo 1350064, Japan; [Yoshida, Masaru] Natl Inst Adv Ind Sci & Technol, Nanotechnol Res Inst, Tsukuba, Ibaraki 3058565, Japan; [Lee, Eunji; Lee, Myongsoo] Seoul Natl Univ, Dept Chem, Seoul 151747, South Korea; [Lee, Eunji; Lee, Myongsoo] Seoul Natl Univ, Ctr Supramol Nanoassembly, Seoul 151747, South Korea	University of Tokyo; Japan Science & Technology Agency (JST); National Institute of Advanced Industrial Science & Technology (AIST); Seoul National University (SNU); Seoul National University (SNU)	Aida, T (corresponding author), Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	jmynar@berkeley.edu; aida@macro.t.u-tokyo.ac.jp	Wang, Qigang/G-1124-2010; Lee, Myongsoo/A-8106-2011; Kinbara, Kazushi/E-6347-2017; Aida, Takuzo/I-9117-2012; Lee, Eunji/H-1301-2011; Yoshida, Masaru/B-7380-2018	Wang, Qigang/0000-0002-4026-3337; Kinbara, Kazushi/0000-0002-5945-9612; Lee, Eunji/0000-0001-7494-1776; Yoshida, Masaru/0000-0002-9220-4312; Okuro, Kou/0000-0003-0445-6358	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Q. W. thanks the Japan Society for the Promotion of Science postdoctoral fellowship for foreign researchers. We thank Y. Arakawa for his support for the synthesis of PEG-G3-dendron.	Carnahan MA, 2002, J AM CHEM SOC, V124, P5291, DOI 10.1021/ja025576y; Crompton KE, 2007, BIOMATERIALS, V28, P441, DOI 10.1016/j.biomaterials.2006.08.044; Das AK, 2008, SMALL, V4, P279, DOI 10.1002/smll.200700889; Dong L, 2006, NATURE, V442, P551, DOI 10.1038/nature05024; Gong JP, 2003, ADV MATER, V15, P1155, DOI 10.1002/adma.200304907; Haraguchi K, 2002, ADV MATER, V14, P1120, DOI 10.1002/1521-4095(20020816)14:16<1120::AID-ADMA1120>3.0.CO;2-9; Hirst AR, 2008, ANGEW CHEM INT EDIT, V47, P8002, DOI 10.1002/anie.200800022; Ihre H, 2001, J AM CHEM SOC, V123, P5908, DOI 10.1021/ja010524e; Jayawarna V, 2006, ADV MATER, V18, P611, DOI 10.1002/adma.200501522; Kiyonaka S, 2004, NAT MATER, V3, P58, DOI 10.1038/nmat1034; Ladet S, 2008, NATURE, V452, P76, DOI 10.1038/nature06619; Li P, 2009, J APPL POLYM SCI, V111, P1786, DOI 10.1002/app.29061; Liu Y, 2006, POLYMER, V47, P1, DOI 10.1016/j.polymer.2005.11.030; Marsich E, 2008, J BIOMED MATER RES A, V84A, P364, DOI 10.1002/jbm.a.31307; Nowak AP, 2002, NATURE, V417, P424, DOI 10.1038/417424a; Okada A, 2006, MACROMOL MATER ENG, V291, P1449, DOI 10.1002/mame.200600260; Okay O, 2007, MACROMOLECULES, V40, P3378, DOI 10.1021/ma062929v; Okuro K, 2009, J AM CHEM SOC, V131, P1626, DOI 10.1021/ja800491v; Peppas NA, 2000, ANNU REV BIOMED ENG, V2, P9, DOI 10.1146/annurev.bioeng.2.1.9; PEZRON E, 1988, MACROMOLECULES, V21, P1121, DOI 10.1021/ma00182a045; *ROCKW ADD LTD, 1990, L21101G ROCKW ADD LT; Rokita B, 2009, MACROMOLECULES, V42, P3269, DOI 10.1021/ma802565p; Schnepp ZAC, 2006, ADV MATER, V18, P1869, DOI 10.1002/adma.200502545; Sijbesma RP, 1997, SCIENCE, V278, P1601, DOI 10.1126/science.278.5343.1601; Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783; Sreenivasachary N, 2005, P NATL ACAD SCI USA, V102, P5938, DOI 10.1073/pnas.0501663102; Wang QG, 2007, CHEM COMMUN, P1032, DOI 10.1039/b615223f; Wathier M, 2004, J AM CHEM SOC, V126, P12744, DOI 10.1021/ja045870l; Xing BG, 2002, J AM CHEM SOC, V124, P14846, DOI 10.1021/ja028539f; Yoshida M, 2007, J AM CHEM SOC, V129, P11039, DOI 10.1021/ja0738677	30	1276	1328	54	1944	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 21	2010	463	7279					339	343		10.1038/nature08693	http://dx.doi.org/10.1038/nature08693			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545PM	20090750				2022-12-28	WOS:000273748100040
J	Ogden, CL; Carroll, MD; Curtin, LR; Lamb, MM; Flegal, KM				Ogden, Cynthia L.; Carroll, Margaret D.; Curtin, Lester R.; Lamb, Molly M.; Flegal, Katherine M.			Prevalence of High Body Mass Index in US Children and Adolescents, 2007-2008	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OVERWEIGHT; OBESITY; ADULTS	Context The prevalence of high body mass index (BMI) among children and adolescents in the United States appeared to plateau between 1999 and 2006. Objectives To provide the most recent estimates of high BMI among children and adolescents and high weight for recumbent length among infants and toddlers and to analyze trends in prevalence between 1999 and 2008. Design, Setting, and Participants The National Health and Nutrition Examination Survey 2007-2008, a representative sample of the US population with measured heights and weights on 3281 children and adolescents (2 through 19 years of age) and 719 infants and toddlers (birth to 2 years of age). Main Outcome Measures Prevalence of high weight for recumbent length (>= 95th percentile of the Centers for Disease Control and Prevention growth charts) among infants and toddlers. Prevalence of high BMI among children and adolescents defined at 3 levels: BMI for age at or above the 97th percentile, at or above the 95th percentile, and at or above the 85th percentile of the BMI-for-age growth charts. Analyses of trends by age, sex, and race/ethnicity from 1999-2000 to 2007-2008. Results In 2007-2008, 9.5% of infants and toddlers (95% confidence interval [CI], 7.3%-11.7%) were at or above the 95th percentile of the weight-for-recumbent-length growth charts. Among children and adolescents aged 2 through 19 years, 11.9% (95% CI, 9.8%-13.9%) were at or above the 97th percentile of the BMI-for-age growth charts; 16.9% (95% CI, 14.1%-19.6%) were at or above the 95th percentile; and 31.7% (95% CI, 29.2%-34.1%) were at or above the 85th percentile of BMI for age. Prevalence estimates differed by age and by race/ethnic group. Trend analyses indicate no significant trend between 1999-2000 and 2007-2008 except at the highest BMI cut point (BMI for age >= 97th percentile) among all 6-through 19-year-old boys (odds ratio [OR], 1.52; 95% CI, 1.17-2.01) and among non-Hispanic white boys of the same age (OR, 1.87; 95% CI, 1.22-2.94). Conclusion No statistically significant linear trends in high weight for recumbent length or high BMI were found over the time periods 1999-2000, 2001-2002, 2003-2004, 2005-2006, and 2007-2008 among girls and boys except among the very heaviest 6-through 19-year-old boys. JAMA. 2010;303(3):242-249	[Ogden, Cynthia L.; Carroll, Margaret D.; Curtin, Lester R.; Lamb, Molly M.; Flegal, Katherine M.] Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Hyattsville, MD 20782 USA	Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS)	Ogden, CL (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, 3311 Toledo Rd,Room 4414, Hyattsville, MD 20782 USA.	cogden@cdc.gov	Flegal, Katherine M/A-4608-2013; Fruyt, Sofie/F-6843-2011	Flegal, Katherine/0000-0002-0838-469X; Lamb, Molly/0000-0002-2331-2555				Barlow SE, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.3.e29; *COMM PREV SERV, OB PREV BEH INT RED; Eaton Danice K., 2008, Morbidity and Mortality Weekly Report, V57, P1; Flegal KM, 2006, HEALTH EDUC RES, V21, P755, DOI 10.1093/her/cyl128; Freedman DS, 2008, OBESITY, V16, P1105, DOI 10.1038/oby.2008.30; Freedman DS, 2007, J PEDIATR-US, V150, P12, DOI 10.1016/j.jpeds.2006.08.042; Guo, 2002, VITAL HLTH STAT, V11, DOI DOI 10.1016/J.BBRC.2015.06.114; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; HIMES JH, 1994, AM J CLIN NUTR, V59, P307, DOI 10.1093/ajcn/59.2.307; Krebs NF, 2007, PEDIATRICS, V120, pS193, DOI 10.1542/peds.2007-2329D; *NAT CTR HLTH STAT, PREV OV INF CHILDR L; National Health and Nutrition Examination Survey, QUEST DAT REL DOC; *NHS INF CTR LIF S, 2009, STAT OB PHYS ACT DIE; Ogden CL, 2002, JAMA-J AM MED ASSOC, V288, P1728, DOI 10.1001/jama.288.14.1728; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; OGDEN CL, 2009, EPIDEMIOLOGY OBESITY; Ogden CL, 2008, JAMA-J AM MED ASSOC, V299, P2401, DOI 10.1001/jama.299.20.2401; Ogden Cynthia L, 2007, NCHS Data Brief, P1; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; SERDULA MK, 1993, PREV MED, V22, P167, DOI 10.1006/pmed.1993.1014; Sharma A. J., 2009, Morbidity and Mortality Weekly Report, V58, P769; Story M, 2009, J ADOLESCENT HEALTH, V45, pS1, DOI 10.1016/j.jadohealth.2009.06.022; Sundblom E, 2008, INT J OBESITY, V32, P1525, DOI 10.1038/ijo.2008.104; Velleman P. F., 1981, APPL BASICS COMPUTIN; YOUTH ONLINE COMPREH	25	2184	2213	4	150	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 20	2010	303	3					242	249		10.1001/jama.2009.2012	http://dx.doi.org/10.1001/jama.2009.2012			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	544WM	20071470	Bronze			2022-12-28	WOS:000273690600020
J	Iwasaki, A; Medzhitov, R				Iwasaki, Akiko; Medzhitov, Ruslan			Regulation of Adaptive Immunity by the Innate Immune System	SCIENCE			English	Review							TOLL-LIKE RECEPTORS; PATTERN-RECOGNITION RECEPTOR; DENDRITIC CELLS; RIG-I; VIRUS-INFECTION; CUTTING EDGE; RESPONSES; INDUCTION; PATHWAY; DIFFERENTIATION	Twenty years after the proposal that pattern recognition receptors detect invasion by microbial pathogens, the field of immunology has witnessed several discoveries that have elucidated receptors and signaling pathways of microbial recognition systems and how they control the generation of T and B lymphocyte-mediated immune responses. However, there are still many fundamental questions that remain poorly understood, even though sometimes the answers are assumed to be known. Here, we discuss some of these questions, including the mechanisms by which pathogen-specific innate immune recognition activates antigen-specific adaptive immune responses and the roles of different types of innate immune recognition in host defense from infection and injury.	[Iwasaki, Akiko; Medzhitov, Ruslan] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Medzhitov, Ruslan] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute; Yale University	Iwasaki, A (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.	akiko.iwasaki@yale.edu; ruslan.medzhitov@yale.edu	Iwasaki, Akiko/Z-1591-2019	Iwasaki, Akiko/0000-0002-7824-9856	NIH [R01AI055502, R37AI046688, R01DK071754, R01AI064705, R21AI083242, R01AI054359]; Howard Hughes Medical Institute; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054359, R21AI083242, R01AI081884, R01AI055502, R37AI046688, R01AI062428, U54AI057160, R01AI064705] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071754] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work in the authors' laboratories is supported by grants from the NIH [R01AI055502, R37AI046688, and R01DK071754 (R. M.) and R01AI064705, R21AI083242, and R01AI054359 (A. I.)], the Howard Hughes Medical Institute (R. M.), and the Investigators in Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund (A. I.).	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032; Bhoj VG, 2008, P NATL ACAD SCI USA, V105, P14046, DOI 10.1073/pnas.0804717105; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Browne EP, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000298; Carbone FR, 2004, TRENDS IMMUNOL, V25, P655, DOI 10.1016/j.it.2004.09.013; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; de Jong MAWP, 2009, J INTERN MED, V265, P18, DOI 10.1111/j.1365-2796.2008.02046.x; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; Fritz JH, 2007, IMMUNITY, V26, P445, DOI 10.1016/j.immuni.2007.03.009; Germain RN, 2004, CURR OPIN IMMUNOL, V16, P120, DOI 10.1016/j.coi.2003.11.001; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Johnson GB, 2002, J IMMUNOL, V168, P5233, DOI 10.4049/jimmunol.168.10.5233; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Koyama S, 2007, J IMMUNOL, V179, P4711, DOI 10.4049/jimmunol.179.7.4711; Kumar H, 2008, J IMMUNOL, V180, P683, DOI 10.4049/jimmunol.180.2.683; Li M, 2001, J IMMUNOL, V166, P7128, DOI 10.4049/jimmunol.166.12.7128; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; MacDonald GH, 2000, J VIROL, V74, P914, DOI 10.1128/JVI.74.2.914-922.2000; Macpherson AJ, 2008, MUCOSAL IMMUNOL, V1, P11, DOI 10.1038/mi.2007.6; Marshak-Rothstein A, 2007, ANNU REV IMMUNOL, V25, P419, DOI 10.1146/annurev.immunol.22.012703.104514; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; Minns LA, 2006, J IMMUNOL, V176, P7589, DOI 10.4049/jimmunol.176.12.7589; Ngoi SM, 2008, J IMMUNOL, V181, P7670, DOI 10.4049/jimmunol.181.11.7670; O'Riordan M, 2002, P NATL ACAD SCI USA, V99, P13861, DOI 10.1073/pnas.202476699; Palm NW, 2009, IMMUNOL REV, V227, P221, DOI 10.1111/j.1600-065X.2008.00731.x; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Reiling N, 2008, IMMUNOL LETT, V116, P15, DOI 10.1016/j.imlet.2007.11.015; Robinson MJ, 2009, J EXP MED, V206, P2037, DOI 10.1084/jem.20082818; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Sato A, 2004, P NATL ACAD SCI USA, V101, P16274, DOI 10.1073/pnas.0406268101; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; Schmid D, 2007, IMMUNITY, V27, P11, DOI 10.1016/j.immuni.2007.07.004; Smith CM, 2004, NAT IMMUNOL, V5, P1143, DOI 10.1038/ni1129; Sporri R, 2005, NAT IMMUNOL, V6, P163, DOI 10.1038/ni1162; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Stetson DB, 2009, CURR OPIN IMMUNOL, V21, P244, DOI 10.1016/j.coi.2009.05.005; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Taylor KR, 2007, J BIOL CHEM, V282, P18265, DOI 10.1074/jbc.M606352200; Torchinsky MB, 2009, NATURE, V458, P78, DOI 10.1038/nature07781; Tsung A, 2005, J EXP MED, V201, P1135, DOI 10.1084/jem.20042614; van Beijnum JR, 2008, ANGIOGENESIS, V11, P91, DOI 10.1007/s10456-008-9093-5; Way SS, 2003, J IMMUNOL, V171, P533, DOI 10.4049/jimmunol.171.2.533; Yarovinsky F, 2006, IMMUNITY, V25, P655, DOI 10.1016/j.immuni.2006.07.015; Yoneyama M, 2008, IMMUNITY, V29, P178, DOI 10.1016/j.immuni.2008.07.009; Zaph C, 2007, NATURE, V446, P552, DOI 10.1038/nature05590	58	1386	1490	6	381	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 15	2010	327	5963					291	295		10.1126/science.1183021	http://dx.doi.org/10.1126/science.1183021			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544CM	20075244	Green Accepted			2022-12-28	WOS:000273629700031
J	Arias-Santiago, SA; Naranjo-Sintes, R				Antonio Arias-Santiago, Salvador; Naranjo-Sintes, Ramon			Generalized Ostraceous Psoriasis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Antonio Arias-Santiago, Salvador; Naranjo-Sintes, Ramon] Univ Hosp San Cecilio, Granada, Spain	Hospital Universitario San Cecilio	Arias-Santiago, SA (corresponding author), Univ Hosp San Cecilio, Granada, Spain.	salvadorarias@hotmail.es	Arias-Santiago, Salvador/ABH-3162-2020						0	9	9	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 14	2010	362	2					155	155		10.1056/NEJMicm0810475	http://dx.doi.org/10.1056/NEJMicm0810475			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	543FU	20071705				2022-12-28	WOS:000273558500013
J	Mansfield, AJ; Kaufman, JS; Marshall, SW; Gaynes, BN; Morrissey, JP; Engel, CC				Mansfield, Alyssa J.; Kaufman, Jay S.; Marshall, Stephen W.; Gaynes, Bradley N.; Morrissey, Joseph P.; Engel, Charles C.			Deployment and the Use of Mental Health Services among US Army Wives	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STRESSFUL LIFE EVENTS; IRAQ; AFGHANISTAN; DISORDER; SEPARATION; REDUCTION; SYMPTOMS; TREAT; RISK	BACKGROUND Military operations in Iraq and Afghanistan have involved the frequent and extended deployment of military personnel, many of whom are married. The effect of deployment on mental health in military spouses is largely unstudied. METHODS We examined electronic medical-record data for outpatient care received between 2003 and 2006 by 250,626 wives of active-duty U. S. Army soldiers. After adjustment for the sociodemographic characteristics and the mental health history of the wives, as well as the number of deployments of the personnel, we compared mental health diagnoses according to the number of months of deployment in Operation Iraqi Freedom in the Iraq-Kuwait region and Operation Enduring Freedom in Afghanistan during the same period. RESULTS The deployment of spouses and the length of deployment were associated with mental health diagnoses. In adjusted analyses, as compared with wives of personnel who were not deployed, women whose husbands were deployed for 1 to 11 months received more diagnoses of depressive disorders (27.4 excess cases per 1000 women; 95% confidence interval [CI], 22.4 to 32.3), sleep disorders (11.6 excess cases per 1000; 95% CI, 8.3 to 14.8), anxiety (15.7 excess cases per 1000; 95% CI, 11.8 to 19.6), and acute stress reaction and adjustment disorders (12.0 excess cases per 1000; 95% CI, 8.6 to 15.4). Deployment for more than 11 months was associated with 39.3 excess cases of depressive disorders (95% CI, 33.2 to 45.4), 23.5 excess cases of sleep disorders (95% CI, 19.4 to 27.6), 18.7 excess cases of anxiety (95% CI, 13.9 to 23.5), and 16.4 excess cases of acute stress reaction and adjustment disorders (95% CI, 12.2 to 20.6). CONCLUSIONS Prolonged deployment was associated with more mental health diagnoses among U. S. Army wives, and these findings may have relevance for prevention and treatment efforts.	[Mansfield, Alyssa J.] RTI Int, Res Triangle Pk, NC 27709 USA; [Mansfield, Alyssa J.; Kaufman, Jay S.; Marshall, Stephen W.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Gaynes, Bradley N.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA; [Morrissey, Joseph P.] Univ N Carolina, Dept Hlth Policy & Management, Chapel Hill, NC USA; [Kaufman, Jay S.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Engel, Charles C.] Uniformed Serv Univ Hlth Sci, Dept Psychiat, Bethesda, MD 20814 USA	Research Triangle Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; McGill University; Uniformed Services University of the Health Sciences - USA	Mansfield, AJ (corresponding author), RTI Int, 3040 Cornwallis Rd, Res Triangle Pk, NC 27709 USA.	amansfield@rti.org		Kaufman, Jay/0000-0003-1606-401X; Gaynes, Bradley/0000-0002-8283-5030; Marshall, Stephen/0000-0002-2664-9233; Mansfield, Alyssa/0000-0001-7411-6397; Engel, Charles/0000-0002-9232-3389	Bristol-Myers Squibb; Novartis; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050924] Funding Source: NIH RePORTER	Bristol-Myers Squibb(Bristol-Myers Squibb); Novartis(Novartis); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Dr. Gaynes reports receiving consulting fees from Bristol-Myers Squibb and grant support from Bristol-Myers Squibb and Novartis and serving as an expert witness for Phillips Lytle in a case involving paroxetine, which did not go to trial. No other potential conflict of interest relevant to this article was reported.	Angrist JD, 2000, IND LABOR RELAT REV, V54, P41, DOI 10.2307/2696031; [Anonymous], 1994, PSYCHOL ADDICT BEHAV, DOI DOI 10.1037/0893-164X.8.2.59; BLACK WG, 1993, SOC WORK, V38, P273; Britt TW, 2007, MIL MED, V172, P157, DOI 10.7205/MILMED.172.2.157; COOK RJ, 1995, BRIT MED J, V310, P452, DOI 10.1136/bmj.310.6977.452; Dawes MA, 2000, DRUG ALCOHOL DEPEN, V61, P3, DOI 10.1016/S0376-8716(00)00120-4; *DEP ARM HUM RES P, 2007, ARM DEM FY07 ARM PRO; *DEP DEF DEF MANP, OP IR FREED CAS SUMM; *DEP DEF WASH HEAD, 2004, PERS GULF WAR CAS SU; Diala CC, 2001, AM J PUBLIC HEALTH, V91, P805, DOI 10.2105/AJPH.91.5.805; Friedman MJ, 2006, AM J PSYCHIAT, V163, P586, DOI 10.1176/appi.ajp.163.4.586; Hilbe JM, 2007, NEGATIVE BINOMIAL RE; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Jensen PS, 1996, J AM ACAD CHILD PSY, V35, P433, DOI 10.1097/00004583-199604000-00009; JOHNSON SL, 1995, PSYCHOL BULL, V117, P434, DOI 10.1037/0033-2909.117.3.434; Johnson SL, 1997, J ABNORM PSYCHOL, V106, P449, DOI 10.1037/0021-843X.106.3.449; Kendler KS, 1999, AM J PSYCHIAT, V156, P837, DOI 10.1176/ajp.156.6.837; Kessler RC, 1997, ANNU REV PSYCHOL, V48, P191, DOI 10.1146/annurev.psych.48.1.191; KOSTEN TR, 1986, ARCH GEN PSYCHIAT, V43, P733; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; *OFF UND DEF PERS, 2005, POP REPR MIL SERV; ORTHNER DK, 2005, DEPLOYMENT SEPARATIO; PAYKEL ES, 1994, ACTA PSYCHIAT SCAND, V89, P50, DOI 10.1111/j.1600-0447.1994.tb05803.x; PIANTA RC, 1994, J CONSULT CLIN PSYCH, V62, P1229, DOI 10.1037/0022-006X.62.6.1229; Poole C, 2001, EPIDEMIOLOGY, V12, P291, DOI 10.1097/00001648-200105000-00005; Schechtman E, 2002, VALUE HEALTH, V5, P431; Schumm WR, 2000, PSYCHOL REP, V87, P815, DOI 10.2466/PR0.87.7.815-821; Schwartz DA, 1997, JAMA-J AM MED ASSOC, V277, P238, DOI 10.1001/jama.277.3.238; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Sinha R, 2000, PSYCHOPHARMACOLOGY, V152, P140, DOI 10.1007/s002130000499; Unwin C, 1999, LANCET, V353, P169, DOI 10.1016/S0140-6736(98)11338-7; WACHOLDER S, 1986, AM J EPIDEMIOL, V123, P174, DOI 10.1093/oxfordjournals.aje.a114212	35	238	240	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 14	2010	362	2					101	109		10.1056/NEJMoa0900177	http://dx.doi.org/10.1056/NEJMoa0900177			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	543FU	20071699				2022-12-28	WOS:000273558500007
J	Horton, R				Horton, Richard			Offline: Do architects tell jokes?	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.								0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 2	2010	375	9708					14	14		10.1016/S0140-6736(09)62157-7	http://dx.doi.org/10.1016/S0140-6736(09)62157-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	539BZ	20109843				2022-12-28	WOS:000273229700009
J	Solomon, S; Rosenlof, KH; Portmann, RW; Daniel, JS; Davis, SM; Sanford, TJ; Plattner, GK				Solomon, Susan; Rosenlof, Karen H.; Portmann, Robert W.; Daniel, John S.; Davis, Sean M.; Sanford, Todd J.; Plattner, Gian-Kasper			Contributions of Stratospheric Water Vapor to Decadal Changes in the Rate of Global Warming	SCIENCE			English	Article							VARIABILITY; CLIMATE; TRENDS; VALIDATION; BOULDER; CLOUDS	Stratospheric water vapor concentrations decreased by about 10% after the year 2000. Here we show that this acted to slow the rate of increase in global surface temperature over 2000-2009 by about 25% compared to that which would have occurred due only to carbon dioxide and other greenhouse gases. More limited data suggest that stratospheric water vapor probably increased between 1980 and 2000, which would have enhanced the decadal rate of surface warming during the 1990s by about 30% as compared to estimates neglecting this change. These findings show that stratospheric water vapor is an important driver of decadal global surface climate change.	[Solomon, Susan; Rosenlof, Karen H.; Portmann, Robert W.; Daniel, John S.; Davis, Sean M.; Sanford, Todd J.] NOAA, Earth Syst Res Lab, Div Chem Sci, Boulder, CO USA; [Davis, Sean M.; Sanford, Todd J.] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Plattner, Gian-Kasper] Univ Bern, Inst Phys, CH-3012 Bern, Switzerland	National Oceanic Atmospheric Admin (NOAA) - USA; University of Colorado System; University of Colorado Boulder; University of Bern	Solomon, S (corresponding author), NOAA, Earth Syst Res Lab, Div Chem Sci, Boulder, CO USA.		Portmann, Robert W/C-4903-2009; Daniel, John S/D-9324-2011; Rosenlof, Karen H/B-5652-2008; Plattner, Gian-Kasper/A-5245-2016; Davis, Sean/C-9570-2011; Richards, Amber/K-8203-2015	Portmann, Robert W/0000-0002-0279-6087; Rosenlof, Karen H/0000-0002-0903-8270; Plattner, Gian-Kasper/0000-0002-3765-0045; Davis, Sean/0000-0001-9276-6158; 	National Oceanic and Atmospheric Administration Climate Program	National Oceanic and Atmospheric Administration Climate Program	This work was supported by the Atmospheric Composition and Climate Program of the National Oceanic and Atmospheric Administration Climate Program. We appreciate helpful comments on a draft manuscript by K. Shine, M. Geller, A. Gettelman, and A. Dessler.	BREWER AW, 1949, Q J ROY METEOR SOC, V75, P351, DOI 10.1002/qj.49707532603; Cordero EC, 2006, ATMOS CHEM PHYS, V6, P5369, DOI 10.5194/acp-6-5369-2006; Dessler AE, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035333; Easterling DR, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037810; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Forster PMD, 1999, GEOPHYS RES LETT, V26, P3309, DOI 10.1029/1999GL010487; Fueglistaler S, 2009, REV GEOPHYS, V47, DOI 10.1029/2008RG000267; Garcia RR, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007485; Geller MA, 2002, J ATMOS SCI, V59, P1076, DOI 10.1175/1520-0469(2002)059<1076:SOTIVO>2.0.CO;2; Gettelman A, 2009, ATMOS CHEM PHYS, V9, P1621, DOI 10.5194/acp-9-1621-2009; Gregory JM, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD010405; Harries JE, 1996, J GEOPHYS RES-ATMOS, V101, P10205, DOI 10.1029/95JD02933; HOLTON JR, 1995, REV GEOPHYS, V33, P403, DOI 10.1029/95RG02097; Kley D, 2000, 113 WCRP; Lambert A, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2007JD008724; Lean JL, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038932; Manney GL, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2007JD008709; Mote PW, 1996, J GEOPHYS RES-ATMOS, V101, P3989, DOI 10.1029/95JD03422; Murphy DM, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD012105; Oinas V, 2001, GEOPHYS RES LETT, V28, P2791, DOI 10.1029/2001GL013137; Oltmans SJ, 2000, GEOPHYS RES LETT, V27, P3453, DOI 10.1029/2000GL012133; Onogi K, 2007, J METEOROL SOC JPN, V85, P369, DOI 10.2151/jmsj.85.369; Plattner GK, 2008, J CLIMATE, V21, P2721, DOI 10.1175/2007JCLI1905.1; Portmann RW, 1997, J GEOPHYS RES-ATMOS, V102, P9409, DOI 10.1029/96JD04007; Randel WJ, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006744; RIND D, 1993, J GEOPHYS RES-ATMOS, V98, P4835, DOI 10.1029/92JD01174; Rohs S, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006877; Rosenlof KH, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009109; Rosenlof KH, 2001, GEOPHYS RES LETT, V28, P1195, DOI 10.1029/2000GL012502; Rossow WB, 1999, B AM METEOROL SOC, V80, P2261, DOI 10.1175/1520-0477(1999)080<2261:AIUCFI>2.0.CO;2; Scherer M, 2008, ATMOS CHEM PHYS, V8, P1391, DOI 10.5194/acp-8-1391-2008; Sherwood S, 2002, SCIENCE, V295, P1272, DOI 10.1126/science.1065080; Sherwood SC, 2001, J ATMOS SCI, V58, P765, DOI 10.1175/1520-0469(2001)058<0765:AMFTAT>2.0.CO;2; Shindell DT, 2001, GEOPHYS RES LETT, V28, P1551, DOI 10.1029/1999GL011197; Smith CA, 2001, GEOPHYS RES LETT, V28, P179, DOI 10.1029/2000GL011846; Solomon S., 2007, PHYS SCI BASIS WORKI; Stuber N, 2005, CLIM DYNAM, V24, P497, DOI 10.1007/s00382-004-0497-7; Trenberth KE, 2005, CLIM DYNAM, V24, P741, DOI 10.1007/s00382-005-0017-4; Trenberth KE, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P235; World Meteorological Organization, 2007, 50 WORLD MET ORG GLO	40	783	819	9	236	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 5	2010	327	5970					1219	1223		10.1126/science.1182488	http://dx.doi.org/10.1126/science.1182488			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563VD	20110466				2022-12-28	WOS:000275162100029
J	Sullivan, SR; Taylor, HOB; Pauyo, T; Steer, ML				Sullivan, Stephen R.; Taylor, Helena O. B.; Pauyo, Thierry; Steer, Michael L.			Surgeons' Dispatch from Cange, Haiti	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ACCESS; POOR		[Sullivan, Stephen R.; Taylor, Helena O. B.; Steer, Michael L.] Partners Hlth, Boston, MA USA; [Pauyo, Thierry; Steer, Michael L.] Harvard Univ, Sch Med, Boston, MA USA; [Sullivan, Stephen R.; Taylor, Helena O. B.] Brown Univ, Warren Alpert Med Sch, Div Plast Surg, Providence, RI 02912 USA; [Sullivan, Stephen R.; Taylor, Helena O. B.] Rhode Isl Hosp, Dept Plast Surg, Providence, RI USA; [Sullivan, Stephen R.; Taylor, Helena O. B.] Hasbro Childrens Hosp, Providence, RI USA	Partners Healthcare System; Harvard University; Harvard Medical School; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Hasbro Children's Hospital	Sullivan, SR (corresponding author), Partners Hlth, Boston, MA USA.		Sullivan, Stephen/C-6389-2013					*CHILDR HOSP BOST, 2009, ADDR GLOB BURD SURG; Farmer PE, 2008, WORLD J SURG, V32, P533, DOI 10.1007/s00268-008-9525-9; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Ivers LC, 2008, WORLD J SURG, V32, P537, DOI 10.1007/s00268-008-9527-7; Mukherjee JS, 2006, JAIDS-J ACQ IMM DEF, V43, pS123, DOI 10.1097/01.qai.0000248348.25630.74	5	13	13	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 18	2010	362	7								10.1056/NEJMp1000976	http://dx.doi.org/10.1056/NEJMp1000976			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	556ED	20130245	Bronze			2022-12-28	WOS:000274571200005
J	Hemmelgarn, BR; Manns, BJ; Lloyd, A; James, MT; Klarenbach, S; Quinn, RR; Wiebe, N; Tonelli, M				Hemmelgarn, Brenda R.; Manns, Braden J.; Lloyd, Anita; James, Matthew T.; Klarenbach, Scott; Quinn, Robert R.; Wiebe, Natasha; Tonelli, Marcello		Alberta Kidney Disease Network	Relation Between Kidney Function, Proteinuria, and Adverse Outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GLOMERULAR-FILTRATION-RATE; ADMINISTRATIVE DATA; CARDIOVASCULAR EVENTS; RENAL-INSUFFICIENCY; DISEASE; PREVALENCE; DEATH; MICROALBUMINURIA; POPULATION; EQUATION	Context The current staging system for chronic kidney disease is based primarily on estimated glomerular filtration rate (eGFR) with lower eGFR associated with higher risk of adverse outcomes. Although proteinuria is also associated with adverse outcomes, it is not used to refine risk estimates of adverse events in this current system. Objective To determine the association between reduced GFR, proteinuria, and adverse clinical outcomes. Design, Setting, and Participants Community-based cohort study with participants identified from a province-wide laboratory registry that includes eGFR and proteinuria measurements from Alberta, Canada, between 2002 and 2007. There were 920 985 adults who had at least 1 outpatient serum creatinine measurement and who did not require renal replacement treatment at baseline. Proteinuria was assessed by urine dipstick or albumin-creatinine ratio (ACR). Main Outcome Measures All-cause mortality, myocardial infarction, and progression to kidney failure. Results The majority of individuals (89.1%) had an eGFR of 60 mL/min/1.73 m(2) or greater. Over median follow-up of 35 months ( range, 0-59 months), 27 959 participants (3.0%) died. The fully adjusted rate of all-cause mortality was higher in study participants with lower eGFRs or heavier proteinuria. Adjusted mortality rates were more than 2-fold higher among individuals with heavy proteinuria measured by urine dipstick and eGFR of 60 mL/min/1.73 m(2) or greater, as compared with those with eGFR of 45 to 59.9 mL/min/1.73 m(2) and normal protein excretion (rate, 7.2 [95% CI, 6.6-7.8] vs 2.9 [95% CI, 2.7-3.0] per 1000 person-years, respectively; rate ratio, 2.5 [95% CI, 2.3-2.7]). Similar results were observed when proteinuria was measured by ACR (15.9 [ 95% CI, 14.0-18.1] and 7.0 [95% CI, 6.4-7.6] per 1000 person-years for heavy and absent proteinuria, respectively; rate ratio, 2.3 [95% CI, 2.0-2.6]) and for the outcomes of hospitalization with acute myocardial infarction, end-stage renal disease, and doubling of serum creatinine level. Conclusion The risks of mortality, myocardial infarction, and progression to kidney failure associated with a given level of eGFR are independently increased in patients with higher levels of proteinuria. JAMA. 2010;303(5):423-429 www.jama.com	[Hemmelgarn, Brenda R.; Manns, Braden J.; James, Matthew T.; Quinn, Robert R.] Foothills Med Ctr, Div Nephrol, Calgary, AB T2N 2T9, Canada; [Hemmelgarn, Brenda R.; Manns, Braden J.; James, Matthew T.; Quinn, Robert R.] Univ Calgary, Dept Med, Calgary, AB, Canada; [Hemmelgarn, Brenda R.; Manns, Braden J.; James, Matthew T.] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Lloyd, Anita; Klarenbach, Scott; Wiebe, Natasha; Tonelli, Marcello] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Klarenbach, Scott; Tonelli, Marcello] Univ Alberta, Dept Publ Hlth Sci, Edmonton, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Alberta; University of Alberta	Hemmelgarn, BR (corresponding author), Foothills Med Ctr, Div Nephrol, 1403 29th St NW, Calgary, AB T2N 2T9, Canada.	brenda.hemmelgarn@albertahealthservices.ca	Tonelli, Marcello/B-3028-2009; Hemmelgarn, Brenda R./I-6894-2012; Quinn, Robert R/E-7017-2011; Hug, Balthasar L./G-1568-2010; Manns, Braden J/I-8942-2012; Wiebe, Natasha/V-7803-2019	Tonelli, Marcello/0000-0002-0846-3187; Wiebe, Natasha/0000-0002-5613-1582	Alberta Heritage Foundation for Medical Research (AHFMR); Canadian Institutes of Health Research; Alberta Health and Wellness and the Universities of Alberta and Calgary; KRESCENT	Alberta Heritage Foundation for Medical Research (AHFMR)(Alberta Heritage Foundation for Medical Research); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Health and Wellness and the Universities of Alberta and Calgary; KRESCENT	Drs Hemmelgarn, Tonelli, and Klarenbach were supported by awards from the Alberta Heritage Foundation for Medical Research (AHFMR). Drs Hemmelgarn, Manns, and Tonelli were also supported by awards from the Canadian Institutes of Health Research. Drs Hemmelgarn, Manns, Klarenbach, and Tonelli were supported by a joint initiative between Alberta Health and Wellness and the Universities of Alberta and Calgary. Dr James was supported by a KRESCENT and AHFMR Fellowship. This work was supported by a grant from the AHFMR Interdisciplinary Team Grants Program to Drs Hemmelgarn, Manns, and Tonelli.	Akbari A, 2004, ARCH INTERN MED, V164, P1788, DOI 10.1001/archinte.164.16.1788; *ALB HLTH WELLN, PREM ASS PROGR PREM; Altman D.G., 1990, PRACTICAL STAT MED R, DOI DOI 10.1201/9780429258589; [Anonymous], 2002, AM J KIDNEY DIS S1, V39, pS1; Austin PC, 2002, AM HEART J, V144, P290, DOI 10.1067/mhj.2002.123839; Chen MLW, 2003, AM J KIDNEY DIS, V42, P623, DOI 10.1016/S0272-6386(03)00870-9; CIAVARELLA A, 1989, DIABETES RES CLIN PR, V7, P307, DOI 10.1016/0168-8227(89)90020-X; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; FEEST TG, 1993, BMJ-BRIT MED J, V306, P481, DOI 10.1136/bmj.306.6876.481; Garg AX, 2002, KIDNEY INT, V61, P2165, DOI 10.1046/j.1523-1755.2002.00356.x; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hemmelgarn BR, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-30; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Hossain MP, 2009, AM J KIDNEY DIS, V53, P166, DOI 10.1053/j.ajkd.2007.10.047; Hsu C, 2000, AM J KIDNEY DIS, V36, P415, DOI 10.1053/ajkd.2000.8996; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Klausen K, 2004, CIRCULATION, V110, P32, DOI 10.1161/01.CIR.0000133312.96477.48; Lamb EJ, 2009, ANN CLIN BIOCHEM, V46, P205, DOI 10.1258/acb.2009.009007; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Mann JFE, 2001, ANN INTERN MED, V134, P629, DOI 10.7326/0003-4819-134-8-200104170-00007; Manns BJ, 2001, CLIN INVEST MED, V24, P164; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Quan HD, 2009, HYPERTENSION, V54, P1423, DOI 10.1161/HYPERTENSIONAHA.109.139279; Shlipak MG, 2005, NEW ENGL J MED, V352, P2049, DOI 10.1056/NEJMoa043161; Sin DD, 2003, CHEST, V124, P51, DOI 10.1378/chest.124.1.51; Statistics Canada, ETHN PORTR CAN HIGHL	28	732	763	2	50	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 3	2010	303	5					423	429		10.1001/jama.2010.39	http://dx.doi.org/10.1001/jama.2010.39			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	550QR	20124537	Bronze			2022-12-28	WOS:000274143600017
J	Greenhalgh, T				Greenhalgh, Trisha			GMC Wakefield Verdict Why did the Lancet take so long?	BRITISH MEDICAL JOURNAL			English	Editorial Material									UCL, London WC1E 6BT, England	University of London; University College London	Greenhalgh, T (corresponding author), UCL, London WC1E 6BT, England.	p.greenhalgh@pcps.ucl.ac.uk	Greenhalgh, Trisha/B-1825-2015	Greenhalgh, Trisha/0000-0003-2369-8088				Chen RT, 1998, LANCET, V351, P611, DOI 10.1016/S0140-6736(05)78423-3; Horton R, 2004, LANCET, V363, P747, DOI 10.1016/S0140-6736(04)15714-0; Murch SH, 2004, LANCET, V363, P750, DOI 10.1016/S0140-6736(04)15715-2; Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0	4	3	3	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 2	2010	340								c644	10.1136/bmj.c644	http://dx.doi.org/10.1136/bmj.c644			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	553CU	20124363				2022-12-28	WOS:000274343400041
J	Steen, EJ; Kang, YS; Bokinsky, G; Hu, ZH; Schirmer, A; McClure, A; del Cardayre, SB; Keasling, JD				Steen, Eric J.; Kang, Yisheng; Bokinsky, Gregory; Hu, Zhihao; Schirmer, Andreas; McClure, Amy; del Cardayre, Stephen B.; Keasling, Jay D.			Microbial production of fatty-acid-derived fuels and chemicals from plant biomass	NATURE			English	Article							ESCHERICHIA-COLI; ACYL-COENZYME; BIODIESEL; ETHANOL; IDENTIFICATION; BIOSYNTHESIS; REDUCTASE; BIOFUELS; GENES; CDNA	Increasing energy costs and environmental concerns have emphasized the need to produce sustainable renewable fuels and chemicals(1). Major efforts to this end are focused on the microbial production of high-energy fuels by cost-effective 'consolidated bioprocesses'(2). Fatty acids are composed of long alkyl chains and represent nature's 'petroleum', being a primary metabolite used by cells for both chemical and energy storage functions. These energy-rich molecules are today isolated from plant and animal oils for a diverse set of products ranging from fuels to oleochemicals. A more scalable, controllable and economic route to this important class of chemicals would be through the microbial conversion of renewable feedstocks, such as biomass-derived carbohydrates. Here we demonstrate the engineering of Escherichia coli to produce structurally tailored fatty esters (biodiesel), fatty alcohols, and waxes directly from simple sugars. Furthermore, we show engineering of the biodiesel-producing cells to express hemi-cellulases, a step towards producing these compounds directly from hemicellulose, a major component of plant-derived biomass.	[Steen, Eric J.; Kang, Yisheng; Bokinsky, Gregory; Keasling, Jay D.] Joint BioEnergy Inst, Emeryville, CA 94608 USA; [Steen, Eric J.; Keasling, Jay D.] Synthet Biol Engn Res Ctr, Emeryville, CA 94608 USA; [Steen, Eric J.; Keasling, Jay D.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Kang, Yisheng; Bokinsky, Gregory; Keasling, Jay D.] Univ Calif Berkeley, Inst QB3, Berkeley, CA 94720 USA; [Keasling, Jay D.] Univ Calif Berkeley, Dept Chem Engn, Berkeley, CA 94720 USA; [Hu, Zhihao; Schirmer, Andreas; McClure, Amy; del Cardayre, Stephen B.] LS9 Inc, San Francisco, CA 94080 USA; [Keasling, Jay D.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Keasling, JD (corresponding author), Joint BioEnergy Inst, 5885 Hollis Ave, Emeryville, CA 94608 USA.	delc@ls9.com; keasling@berkeley.edu	Keasling, Jay D/J-9162-2012	Keasling, Jay D/0000-0003-4170-6088	Tien Scholar Environmental Fellowship; Synthetic Biology Engineering Research Center (SynBERC); LS9, Inc. (South San Francisco, California) through the University of California	Tien Scholar Environmental Fellowship; Synthetic Biology Engineering Research Center (SynBERC); LS9, Inc. (South San Francisco, California) through the University of California	E.J.S. was supported by the Tien Scholar Environmental Fellowship and the Synthetic Biology Engineering Research Center (SynBERC). Y.K. and G. B. were supported by a grant from LS9, Inc. (South San Francisco, California) through the University of California Discovery Grant program. This research was performed at the Joint BioEnergy Institute. We thank M. Rude with help on the manuscript and J. Cronan and the LS9 Scientific Advisory Board for technical insight and discussion.	Adelsberger H, 2004, MICROBIOL-SGM, V150, P2257, DOI 10.1099/mic.0.27066-0; Aldai N, 2006, J CHROMATOGR A, V1110, P133, DOI 10.1016/j.chroma.2006.01.049; Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450; Cheng JB, 2004, J BIOL CHEM, V279, P37789, DOI 10.1074/jbc.M406225200; CHO HS, 1995, J BIOL CHEM, V270, P4216, DOI 10.1074/jbc.270.9.4216; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dehesh K, 1996, PLANT J, V9, P167, DOI 10.1046/j.1365-313X.1996.09020167.x; Fortman JL, 2008, TRENDS BIOTECHNOL, V26, P375, DOI 10.1016/j.tibtech.2008.03.008; Hill J, 2006, P NATL ACAD SCI USA, V103, P11206, DOI 10.1073/pnas.0604600103; Hoover DM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e43; INGRAM LO, 1987, APPL ENVIRON MICROB, V53, P2420, DOI 10.1128/AEM.53.10.2420-2425.1987; International Energy Agency, 2008, OIL MARK REP; JIANG P, 1994, J BACTERIOL, V176, P2814, DOI 10.1128/JB.176.10.2814-2821.1994; Kalscheuer R, 2006, MICROBIOL-SGM, V152, P2529, DOI 10.1099/mic.0.29028-0; Knothe G, 2008, ENERG FUEL, V22, P1358, DOI 10.1021/ef700639e; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; Lu XF, 2008, METAB ENG, V10, P333, DOI 10.1016/j.ymben.2008.08.006; Lynd LR, 2005, CURR OPIN BIOTECH, V16, P577, DOI 10.1016/j.copbio.2005.08.009; MAGNUSON K, 1993, MICROBIOL REV, V57, P522, DOI 10.1128/MMBR.57.3.522-542.1993; Metz JG, 2000, PLANT PHYSIOL, V122, P635, DOI 10.1104/pp.122.3.635; Qian ZG, 2008, BIOTECHNOL BIOENG, V101, P587, DOI 10.1002/bit.21898; Reiser S, 1997, J BACTERIOL, V179, P2969, DOI 10.1128/jb.179.9.2969-2975.1997; Rude MA, 2009, CURR OPIN MICROBIOL, V12, P274, DOI 10.1016/j.mib.2009.04.004; Rupilius W., 2006, PALM OIL DEV, V44, P15; Sambrook J., 2002, MOL CLONING LAB MANU; Steen EJ, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-36; Tsuruta H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004489; WHITEHEAD TR, 1990, J BACTERIOL, V172, P2408, DOI 10.1128/jb.172.5.2408-2412.1990	29	988	1108	10	799	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 28	2010	463	7280					559	U182		10.1038/nature08721	http://dx.doi.org/10.1038/nature08721			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	548QK	20111002				2022-12-28	WOS:000273981100055
J	Agarwal, N; Bishai, WR				Agarwal, Nisheeth; Bishai, William R.			Subversion from the Sidelines	SCIENCE			English	Editorial Material							TUBERCULOSIS; MATRIX-METALLOPROTEINASE-9; INFECTION; VIRULENCE; GRANULOMA		[Agarwal, Nisheeth; Bishai, William R.] Johns Hopkins Sch Med, Div Infect Dis, Dept Med, Ctr TB Res, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Medicine	Agarwal, N (corresponding author), Johns Hopkins Sch Med, Div Infect Dis, Dept Med, Ctr TB Res, Baltimore, MD 21231 USA.	wbishai@jhmi.edu			NIAID NIH HHS [AI 30036] Funding Source: Medline; PHS HHS [36973, 37856] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030036] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agarwal N, 2009, NATURE, V460, P98, DOI 10.1038/nature08123; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Elkington PT, 2007, AM J RESP CELL MOL, V37, P431, DOI 10.1165/rcmb.2007-0011OC; Elkington PTG, 2006, THORAX, V61, P259, DOI 10.1136/thx.2005.051979; Ganguly N, 2008, TUBERCULOSIS, V88, P510, DOI 10.1016/j.tube.2008.05.002; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Hung DT, 2005, SCIENCE, V310, P670, DOI 10.1126/science.1116739; Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859; SMALL PLC, 1994, SCIENCE, V263, P637, DOI 10.1126/science.8303269; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; Taylor JL, 2006, INFECT IMMUN, V74, P6135, DOI 10.1128/IAI.02048-05; Volkman HE, 2010, SCIENCE, V327, P466, DOI 10.1126/science.1179663; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7	13	6	6	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 22	2010	327	5964					417	418		10.1126/science.1185569	http://dx.doi.org/10.1126/science.1185569			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546BS	20093460				2022-12-28	WOS:000273783100021
J	Shea, S; Hripcsak, G				Shea, Steven; Hripcsak, George			Accelerating the Use of Electronic Health Records in Physician Practices	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Shea, Steven; Hripcsak, George] Columbia Univ, Med Ctr, New York, NY 10027 USA	Columbia University	Shea, S (corresponding author), Columbia Univ, Med Ctr, New York, NY 10027 USA.				NLM NIH HHS [R01 LM006910] Funding Source: Medline	NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		*DEP HLTH HUM SERV, 2009, HLTH IT POL COUNC RE; DesRoches CM, 2008, NEW ENGL J MED, V359, P50, DOI 10.1056/NEJMsa0802005; Jha AK, 2009, NEW ENGL J MED, V360, P1628, DOI 10.1056/NEJMsa0900592; LOHR S, 2009, NY TIMES        0928; Shea S, 2009, J AM MED INFORM ASSN, V16, P446, DOI 10.1197/jamia.M3157	5	43	43	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 21	2010	362	3					192	195		10.1056/NEJMp0910140	http://dx.doi.org/10.1056/NEJMp0910140			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	545NE	20089969				2022-12-28	WOS:000273738400002
J	Yu, Q; Shan, ZW; Li, J; Huang, XX; Xiao, L; Sun, J; Ma, E				Yu, Qian; Shan, Zhi-Wei; Li, Ju; Huang, Xiaoxu; Xiao, Lin; Sun, Jun; Ma, Evan			Strong crystal size effect on deformation twinning	NATURE			English	Article							AL SINGLE-CRYSTALS; MATERIALS SCIENCE; METALS; TITANIUM; STRENGTH; BEHAVIOR; NUCLEATION; PLASTICITY; DEPENDENCE; MAXIMUM	Deformation twinning(1-6) in crystals is a highly coherent inelastic shearing process that controls the mechanical behaviour of many materials, but its origin and spatio-temporal features are shrouded in mystery. Using micro-compression and in situ nano-compression experiments, here we find that the stress required for deformation twinning increases drastically with decreasing sample size of a titanium alloy single crystal(7,8), until the sample size is reduced to one micrometre, below which the deformation twinning is entirely replaced by less correlated, ordinary dislocation plasticity. Accompanying the transition in deformation mechanism, the maximum flow stress of the submicrometre-sized pillars was observed to saturate at a value close to titanium's ideal strength(9,10). We develop a 'stimulated slip' model to explain the strong size dependence of deformation twinning. The sample size in transition is relatively large and easily accessible in experiments, making our understanding of size dependence(11-17) relevant for applications.	[Yu, Qian; Shan, Zhi-Wei; Xiao, Lin; Sun, Jun; Ma, Evan] Xi An Jiao Tong Univ, CAMP Nano, State Key Lab Mech Behav Mat, Xian 710049, Peoples R China; [Shan, Zhi-Wei] Hysitron Inc, Minneapolis, MN 55344 USA; [Li, Ju] Univ Penn, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA; [Huang, Xiaoxu] Tech Univ Denmark, Riso Natl Lab Sustainable Energy, Mat Res Div, Danish Chinese Ctr Nanomet, DK-4000 Roskilde, Denmark; [Ma, Evan] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA	Xi'an Jiaotong University; University of Pennsylvania; Technical University of Denmark; Johns Hopkins University	Sun, J (corresponding author), Xi An Jiao Tong Univ, CAMP Nano, State Key Lab Mech Behav Mat, Xian 710049, Peoples R China.	liju@seas.upenn.edu; junsun@mail.xjtu.edu.cn	xjtu, campnano/Q-1904-2015; Yu, Qian/C-5949-2013; Li, Ju/A-2993-2008; Shan, Zhiwei/B-8799-2014; Ma, En/A-3232-2010; Huang, Xiaoxu/AFV-2572-2022; Huang, Xiaoxu/N-2856-2017	Li, Ju/0000-0002-7841-8058; Huang, Xiaoxu/0000-0002-4635-6112	NSFC [50671077, 50720145101, 50831004, 50925104]; 973 Program of China [2004CB619303, 2007CB613804, 2010CB613003]; 111 Project of China [B06025]; ONR [N00014-05-1-0504]; NSF [CMMI-0728069]; MRSEC [DMR-0520020]; AFOSR [FA9550-08-1-0325]; Danish National Research Foundation; US Department of Energy [DE-AC02-05CH11231]	NSFC(National Natural Science Foundation of China (NSFC)); 973 Program of China(National Basic Research Program of China); 111 Project of China(Ministry of Education, China - 111 Project); ONR(Office of Naval Research); NSF(National Science Foundation (NSF)); MRSEC(National Science Foundation (NSF)); AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Danish National Research Foundation(Danmarks Grundforskningsfond); US Department of Energy(United States Department of Energy (DOE))	We thank Q. Liu for help with EBSD experiments. This work was supported by grants from the NSFC (50671077, 50720145101, 50831004 and 50925104), the 973 Program of China (2004CB619303, 2007CB613804 and 2010CB613003) and the 111 Project of China (B06025). J. L. was supported by ONR grant N00014-05-1-0504, NSF grant CMMI-0728069, MRSEC grant DMR-0520020 and AFOSR grant FA9550-08-1-0325. X. H. was supported by the Danish National Research Foundation. The in situ TEM work was performed at the National Center for Electron Microscopy, Lawrence Berkeley Laboratory, which is supported by the US Department of Energy under contract DE-AC02-05CH11231.	AKHTAR A, 1975, METALL TRANS, VA  6, P1105, DOI 10.1007/BF02661366; Argon AS, 2006, PHIL MAG LETT, V86, P713, DOI 10.1080/09500830600986091; Chen MW, 2003, SCIENCE, V300, P1275, DOI 10.1126/science.1083727; CHRISTIAN JW, 1995, PROG MATER SCI, V39, P1, DOI 10.1016/0079-6425(94)00007-7; COTTRELL AH, 1951, PHILOS MAG, V42, P573; El-Azab A, 2008, SCIENCE, V320, P1729, DOI 10.1126/science.1160003; Greer JR, 2005, ACTA MATER, V53, P1821, DOI 10.1016/j.actamat.2004.12.031; Lu L, 2009, SCIENCE, V323, P607, DOI 10.1126/science.1167641; Meyers MA, 2001, ACTA MATER, V49, P4025, DOI 10.1016/S1359-6454(01)00300-7; Niewczas M, 2002, PHILOS MAG A, V82, P167, DOI 10.1080/01418610110067725; Niewczas M, 2007, DISCLOC SOLIDS, V13, P263, DOI 10.1016/S1572-4859(07)80007-6; Ogata S, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.224102; Ogata S, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.104104; PATON NE, 1970, METALL TRANS, V1, P2839; Schiotz J, 2003, SCIENCE, V301, P1357, DOI 10.1126/science.1086636; Shan ZW, 2008, NAT MATER, V7, P115, DOI 10.1038/nmat2085; Shan ZW, 2004, SCIENCE, V305, P654, DOI 10.1126/science.1098741; SONG SG, 1995, ACTA METALL MATER, V43, P2325, DOI 10.1016/0956-7151(94)00433-1; SONG SG, 1995, PHILOS MAG A, V71, P661, DOI 10.1080/01418619508244473; Stanford N, 2008, METALL MATER TRANS A, V39A, P934, DOI 10.1007/s11661-007-9442-9; Suresh S, 2008, NATURE, V456, P716, DOI 10.1038/456716a; Svelto O., 1998, PRINCIPLES LASERS, Vvol 4; Uchic MD, 2004, SCIENCE, V305, P986, DOI 10.1126/science.1098993; Warner DH, 2007, NAT MATER, V6, P876, DOI 10.1038/nmat2030; Williams JC, 2002, METALL MATER TRANS A, V33, P837, DOI 10.1007/s11661-002-0153-y; Wu XL, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.025503; Xiao L, 2005, MAT SCI ENG A-STRUCT, V394, P168, DOI 10.1016/j.msea.2004.11.039; Yoo MH, 1998, INTERMETALLICS, V6, P597, DOI 10.1016/S0966-9795(98)00033-8; Zhu T, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.025502	30	478	493	27	857	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 21	2010	463	7279					335	338		10.1038/nature08692	http://dx.doi.org/10.1038/nature08692			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545PM	20090749				2022-12-28	WOS:000273748100039
J	Tinetti, ME; Kumar, C				Tinetti, Mary E.; Kumar, Chandrika			The Patient Who Falls "It's Always a Trade-off"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EYE CATARACT-SURGERY; ADVERSE DRUG EVENTS; OLDER-PEOPLE; RISK-FACTORS; AMERICAN-COLLEGE; ELDERLY-PEOPLE; PREVENT FALLS; HEALTH-STATUS; PRIMARY-CARE; COMMUNITY	Falls are common health events that cause discomfort and disability for older adults and stress for caregivers. Using the case of an older man who has experienced multiple falls and a hip fracture, this article, which focuses on community-living older adults, addresses the consequences and etiology of falls; summarizes the evidence on predisposing factors and effective interventions; and discusses how to translate this evidence into patient care. Previous falls; strength, gait, and balance impairments; and medications are the strongest risk factors for falling. Effective single interventions include exercise and physical therapy, cataract surgery, and medication reduction. Evidence suggests that the most effective strategy for reducing the rate of falling in community-living older adults may be intervening on multiple risk factors. Vitamin D has the strongest clinical trial evidence of benefit for preventing fractures among older men at risk. Issues involved in incorporating these evidence-based fall prevention interventions into outpatient practice are discussed, as are the trade-offs inherent in managing older patients at risk of falling. While challenges and barriers exist, fall prevention strategies can be incorporated into clinical practice. JAMA. 2010;303(3):258-266	[Tinetti, Mary E.; Kumar, Chandrika] Yale Univ, Sch Med, Dept Med, New Haven, CT 06520 USA; [Tinetti, Mary E.] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA	Yale University; Yale University	Tinetti, ME (corresponding author), Yale Univ, Sch Med, Sect Geriatr, Dept Internal Med, 333 Cedar St,POB 208025, New Haven, CT 06520 USA.	mary.tinetti@yale.edu			National Institute on Aging [P30AG21342]; SCAN Foundation; NATIONAL INSTITUTE ON AGING [P30AG021342] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); SCAN Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported in part by the Claude D. Pepper Older Americans Independence Center at Yale School of Medicine (#P30AG21342), from the National Institute on Aging. The Care of the Aging Patient series is made possible by funding from The SCAN Foundation.	Anonymous, 2008, Morbidity and Mortality Weekly Report, V57, P225; [Anonymous], FALLS OLD AD OV; Baker DI, 2005, J AM GERIATR SOC, V53, P675, DOI 10.1111/j.1532-5415.2005.53218.x; Bedard M, 2001, GERONTOLOGIST, V41, P652, DOI 10.1093/geront/41.5.652; Bischoff-Ferrari HA, 2009, ARCH INTERN MED, V169, P551, DOI 10.1001/archinternmed.2008.600; Bishop CE, 2002, HEALTH AFFAIR, V21, P215, DOI 10.1377/hlthaff.21.6.215; Blyth FM, 2007, EUR J PAIN, V11, P564, DOI 10.1016/j.ejpain.2006.08.001; Bonelli RM, 2008, NEUROLOGIST, V14, P100, DOI 10.1097/NRL.0b013e31815b0de2; Campbell AJ, 2007, AGE AGEING, V36, P656, DOI 10.1093/ageing/afm122; Campbell AJ, 1999, J AM GERIATR SOC, V47, P850, DOI 10.1111/j.1532-5415.1999.tb03843.x; Cauley JA, 2008, ARCH INTERN MED, V168, P793, DOI 10.1001/archinte.168.8.793; Chang JT, 2004, BRIT MED J, V328, P680, DOI 10.1136/bmj.328.7441.680; Cumming RG, 2007, J AM GERIATR SOC, V55, P175, DOI 10.1111/j.1532-5415.2007.01046.x; Ensrud KE, 2002, J AM GERIATR SOC, V50, P1629, DOI 10.1046/j.1532-5415.2002.50453.x; Ensrud KE, 2007, J GERONTOL A-BIOL, V62, P744, DOI 10.1093/gerona/62.7.744; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forbes D, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006489.pub2; Foss AJE, 2006, AGE AGEING, V35, P66, DOI 10.1093/ageing/afj005; Gandhi TK, 2003, NEW ENGL J MED, V348, P1556, DOI 10.1056/NEJMsa020703; Ganz DA, 2007, JAMA-J AM MED ASSOC, V297, P77, DOI 10.1001/jama.297.1.77; Gates S, 2008, BRIT MED J, V336, P130, DOI 10.1136/bmj.39412.525243.BE; Gill TM, 2001, ANN INTERN MED, V135, P313, DOI 10.7326/0003-4819-135-5-200109040-00007; Guideline for the prevention of falls in older persons, 2001, J AM GERIATR SOC, V49, P664, DOI DOI 10.1046/J.1532-5415.2001.49115.X; Gurwitz JH, 2003, JAMA-J AM MED ASSOC, V289, P1107, DOI 10.1001/jama.289.9.1107; Harwood RH, 2005, BRIT J OPHTHALMOL, V89, P53, DOI 10.1136/bjo.2004.049478; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kenny Rose Anne, 1999, Am J Geriatr Cardiol, V8, P87; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Kuzuya M, 2006, INT J GERIATR PSYCH, V21, P740, DOI 10.1002/gps.1554; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Leveille SG, 2002, J AM GERIATR SOC, V50, P671, DOI 10.1046/j.1532-5415.2002.50161.x; Liu H, 2008, ANN INTERN MED, V148, P685, DOI 10.7326/0003-4819-148-9-200805060-00009; MacLean C, 2008, ANN INTERN MED, V148, P197, DOI 10.7326/0003-4819-148-3-200802050-00198; Mahoney JE, 2007, J AM GERIATR SOC, V55, P489, DOI 10.1111/j.1532-5415.2007.01144.x; MATHIAS S, 1986, ARCH PHYS MED REHAB, V67, P387; MAYFIELD D, 1974, AM J PSYCHIAT, V131, P1121; National Osteoporosis Foundation, 2013, CLIN GUID PREV TREAT; NEVITT MC, 1989, JAMA-J AM MED ASSOC, V261, P2663, DOI 10.1001/jama.261.18.2663; Parker MJ, 2006, BMJ-BRIT MED J, V332, P571, DOI 10.1136/bmj.38753.375324.7C; Piccinelli M, 1997, BRIT MED J, V314, P420, DOI 10.1136/bmj.314.7078.420; Pit SW, 2007, MED J AUSTRALIA, V187, P23, DOI 10.5694/j.1326-5377.2007.tb01110.x; Qaseem A, 2008, ANN INTERN MED, V148, P680, DOI 10.7326/0003-4819-148-9-200805060-00008; Reuben DB, 2003, J AM GERIATR SOC, V51, P1787, DOI 10.1046/j.1532-5415.2003.51565.x; Royall DR, 2007, J NEUROPSYCH CLIN N, V19, P249, DOI 10.1176/appi.neuropsych.19.3.249; Scanlan J, 2001, INT J GERIATR PSYCH, V16, P216, DOI 10.1002/1099-1166(200102)16:2<216::AID-GPS316>3.0.CO;2-B; Shaw FE, 2003, BRIT MED J, V326, P73, DOI 10.1136/bmj.326.7380.73; Sheridan PL, 2007, DEMENT GERIATR COGN, V24, P125, DOI 10.1159/000105126; Steultjens EMJ, 2004, AGE AGEING, V33, P453, DOI 10.1093/ageing/afh174; Tinetti ME, 2008, J AM GERIATR SOC, V56, P1409, DOI 10.1111/j.1532-5415.2008.01815.x; Tinetti ME, 2006, GERONTOLOGIST, V46, P717, DOI 10.1093/geront/46.6.717; Tinetti ME, 1998, J GERONTOL A-BIOL, V53, pM112, DOI 10.1093/gerona/53A.2.M112; TINETTI ME, 1995, JAMA-J AM MED ASSOC, V273, P1348, DOI 10.1001/jama.273.17.1348; Tinetti ME, 1996, AM J EPIDEMIOL, V144, P389; TINETTI ME, 1993, JAMA-J AM MED ASSOC, V269, P65, DOI 10.1001/jama.269.1.65; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; TINETTI ME, 1995, J AM GERIATR SOC, V43, P1214, DOI 10.1111/j.1532-5415.1995.tb07396.x; Tinetti ME, 1997, NEW ENGL J MED, V337, P1279, DOI 10.1056/NEJM199710303371806; TINETTI ME, 1986, J AM GERIATR SOC, V34, P119, DOI 10.1111/j.1532-5415.1986.tb05480.x; WOLFKLEIN GP, 1989, J AM GERIATR SOC, V37, P730, DOI 10.1111/j.1532-5415.1989.tb02234.x; Woolcott JC, 2009, ARCH INTERN MED, V169, P1952, DOI 10.1001/archinternmed.2009.357; Ziere G, 2008, J CLIN PSYCHOPHARM, V28, P411, DOI 10.1097/JCP.0b013e31817e0ecb	61	570	595	3	116	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 20	2010	303	3					258	266		10.1001/jama.2009.2024	http://dx.doi.org/10.1001/jama.2009.2024			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	544WM	20085954	Green Accepted			2022-12-28	WOS:000273690600022
J	Brophy, J				Brophy, James			A model combining clinical assessment and NT-proBNP level accurately predicted heart failure in ED patients with dyspnea	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									McGill Univ, Montreal, PQ, Canada	McGill University	Brophy, J (corresponding author), McGill Univ, Montreal, PQ, Canada.		brophy, james/H-6673-2019	brophy, james/0000-0001-8049-6875					0	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 19	2010	152	2							JC1-13	10.7326/0003-4819-152-2-201001190-02013	http://dx.doi.org/10.7326/0003-4819-152-2-201001190-02013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	548IE	20083816				2022-12-28	WOS:000273953000025
J	Mumoli, N; Cei, M; Orlandi, F; Luschi, R; Niccoli, G				Mumoli, Nicola; Cei, Marco; Orlandi, Fabrizio; Luschi, Riccardo; Niccoli, Giovanni			An innocent gallbladder?	LANCET			English	Editorial Material							VARICELLA-ZOSTER-VIRUS		[Mumoli, Nicola; Cei, Marco; Orlandi, Fabrizio; Luschi, Riccardo; Niccoli, Giovanni] Osped Civile Livorno, Dept Internal Med, I-57100 Livorno, Italy		Mumoli, N (corresponding author), Osped Civile Livorno, Dept Internal Med, Viale Alfieri 36, I-57100 Livorno, Italy.	nimumoli@tiscali.it	Mumoli, Nicola/J-4652-2019	Mumoli, Nicola/0000-0001-7166-5630				Arvin AM, 1996, CLIN MICROBIOL REV, V9, P361, DOI 10.1128/CMR.9.3.361; Cunningham AL, 2008, MED J AUSTRALIA, V188, P171, DOI 10.5694/j.1326-5377.2008.tb01566.x; Gilden DH, 2003, ARCH NEUROL-CHICAGO, V60, P616, DOI 10.1001/archneur.60.4.616; Kurtovic J, 2005, INTERN MED J, V35, P69, DOI 10.1111/j.1445-5994.2004.00724.x; ROSS JS, 1980, AM J GASTROENTEROL, V74, P423	5	0	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 16	2010	375	9710					252	252		10.1016/S0140-6736(09)61673-1	http://dx.doi.org/10.1016/S0140-6736(09)61673-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	546ZH	20109926				2022-12-28	WOS:000273853800036
J	van de Beek, D; Drake, JM; Tunkel, AR				van de Beek, Diederik; Drake, James M.; Tunkel, Allan R.			CURRENT CONCEPTS Nosocomial Bacterial Meningitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CEREBROSPINAL-FLUID SHUNT; RESISTANT STAPHYLOCOCCUS-AUREUS; EXTERNAL VENTRICULAR DRAINS; RISK-FACTORS; NEUROSURGICAL PATIENTS; ASEPTIC-MENINGITIS; CARE PATIENTS; INFECTIONS; MANAGEMENT; DIAGNOSIS		[van de Beek, Diederik] Univ Amsterdam, Acad Med Ctr, Dept Neurol, CINIMA, NL-1100 DD Amsterdam, Netherlands; [Drake, James M.] Univ Toronto, Hosp Sick Children, Div Neurosurg, Dept Surg, Toronto, ON M5G 1X8, Canada; [Tunkel, Allan R.] Monmouth Med Ctr, Dept Med, Long Branch, NJ USA	University of Amsterdam; Academic Medical Center Amsterdam; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	van de Beek, D (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Neurol, CINIMA, POB 22660, NL-1100 DD Amsterdam, Netherlands.	d.vandebeek@amc.uva.nl	van de beek, diederik/A-2935-2010; van de Beek, Diederik/Y-2713-2019	van de Beek, Diederik/0000-0002-4571-044X	Netherlands Organization for Health Research and Development [916.76.023]; Academic Medical Center	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Academic Medical Center	Supported by grants from the Netherlands Organization for Health Research and Development (NWO-Veni grant 2006 [916.76.023]) and the Academic Medical Center (AMC Fellowship 2008), both to Dr. van de Beek.; No potential conflict of interest relevant to this article was reported.	Adriani KS, 2007, CLIN INFECT DIS, V45, pE46, DOI 10.1086/520682; Baer ET, 2006, ANESTHESIOLOGY, V105, P381, DOI 10.1097/00000542-200608000-00022; BALTAS I, 1994, NEUROSURGERY, V35, P422, DOI 10.1227/00006123-199409000-00009; Banks JT, 2005, NEUROSURGERY, V57, P1237, DOI 10.1227/01.NEU.0000186038.98817.72; Beer R, 2008, J NEUROL, V255, P1617, DOI 10.1007/s00415-008-0059-8; Beer R, 2007, ANTIMICROB AGENTS CH, V51, P379, DOI 10.1128/AAC.00515-06; Brown EM, 2006, NEUROSURGERY, V58, P657, DOI 10.1227/01.NEU.0000204126.54417.46; Brown EM, 2000, BRIT J NEUROSURG, V14, P7; Bullock M Ross, 2006, Neurosurgery, V58, pS56; Choi D, 1996, BRIT J NEUROSURG, V10, P571, DOI 10.1080/02688699646880; Conen A, 2008, CLIN INFECT DIS, V47, P73, DOI 10.1086/588298; Falagas ME, 2007, INT J ANTIMICROB AG, V29, P9, DOI 10.1016/j.ijantimicag.2006.08.024; Governale LS, 2008, NEUROSURGERY, V63, P379, DOI 10.1227/01.NEU.0000327023.18220.88; Guardado AR, 2008, J ANTIMICROB CHEMOTH, V61, P908, DOI 10.1093/jac/dkn018; Katragkou A, 2005, J CLIN MICROBIOL, V43, P4916, DOI 10.1128/JCM.43.9.4916-4917.2005; Kessler AT, 2007, INFECTION, V35, P271, DOI 10.1007/s15010-007-6211-z; Kestle JRW, 2006, J NEUROSURG, V105, P177, DOI 10.3171/ped.2006.105.3.177; Kim BN, 2009, LANCET INFECT DIS, V9, P245, DOI 10.1016/S1473-3099(09)70055-6; Korinek AM, 2006, NEUROSURGERY, V59, P126, DOI 10.1227/01.NEU.0000220477.47323.92; Kulkarni AV, 2001, J NEUROSURG, V94, P195, DOI 10.3171/jns.2001.94.2.0195; Lee DH, 2008, CLIN INFECT DIS, V47, P588, DOI 10.1086/590257; Leib SL, 1999, CLIN INFECT DIS, V29, P69, DOI 10.1086/520184; Lozier AP, 2008, NEUROSURGERY, V62, P688, DOI [10.1227/01.NEU.0000017465.78245.6C, 10.1227/01.neu.0000316273.35833.7c]; MAYHALL CG, 1984, NEW ENGL J MED, V310, P553, DOI 10.1056/NEJM198403013100903; McClelland S, 2007, CLIN INFECT DIS, V45, P55, DOI 10.1086/518580; Muttaiyah S, 2008, J MED MICROBIOL, V57, P207, DOI 10.1099/jmm.0.47518-0; Nathan BR, 2002, CURR CLIN TOPICS INF, V22, P155; Pfausler B, 2004, ACTA NEUROCHIR, V146, P477, DOI 10.1007/s00701-004-0258-8; Pfausler B, 2003, J NEUROSURG, V98, P1040, DOI 10.3171/jns.2003.98.5.1040; Schade RP, 2006, J NEUROSURG, V104, P101, DOI 10.3171/jns.2006.104.1.101; Schreffler RT, 2002, PEDIATR INFECT DIS J, V21, P632, DOI 10.1097/00006454-200207000-00006; Sorensen P, 2008, BRIT J NEUROSURG, V22, P675, DOI 10.1080/02688690802295645; TULIPAN N, 2006, J NEUROSURG S, V104, pS5; Tunkel AR, 2004, CLIN INFECT DIS, V39, P1267, DOI 10.1086/425368; Vinchon M, 2006, CHILD NERV SYST, V22, P692, DOI 10.1007/s00381-005-0037-8; Weisfelt M, 2007, J HOSP INFECT, V66, P71, DOI 10.1016/j.jhin.2007.02.017; Wen D Y, 1992, Neurosurg Clin N Am, V3, P343; Wong GKC, 2002, J NEUROL NEUROSUR PS, V73, P759, DOI 10.1136/jnnp.73.6.759; YOGEV R, 1985, PEDIATR INFECT DIS J, V4, P113, DOI 10.1097/00006454-198503000-00001; Zarrouk V, 2007, CLIN INFECT DIS, V44, P1555, DOI 10.1086/518169; Ziai WC, 2009, CURR OPIN NEUROL, V22, P277, DOI 10.1097/WCO.0b013e32832c1396	41	245	253	2	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 14	2010	362	2					146	154		10.1056/NEJMra0804573	http://dx.doi.org/10.1056/NEJMra0804573			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	543FU	20071704				2022-12-28	WOS:000273558500012
J	Dorsey, ER; de Roulet, J; Thompson, JP; Reminick, JI; Thai, A; White-Stellato, Z; Beck, CA; George, BP; Moses, H				Dorsey, E. Ray; de Roulet, Jason; Thompson, Joel P.; Reminick, Jason I.; Thai, Ashley; White-Stellato, Zachary; Beck, Christopher A.; George, Benjamin P.; Moses, Hamilton, III			Funding of US Biomedical Research, 2003-2008	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INFORMATION	Context With the exception of the American Recovery and Reinvestment Act, funding support for biomedical research in the United States has slowed after a decade of doubling. However, the extent and scope of slowing are largely unknown. Objective To quantify funding of biomedical research in the United States from 2003 to 2008. Design Publicly available data were used to quantify funding from government (federal, state, and local), private, and industry sources. Regression models were used to compare financial trends between 1994-2003 and 2003-2007. The numbers of new drug and device approvals by the US Food and Drug Administration over the same period were also evaluated. Main Outcome Measures Funding and growth rates by source; numbers of US Food and Drug Administration approvals. Results Biomedical research funding increased from $75.5 billion in 2003 to $101.1 billion in 2007. In 2008, funding from the National Institutes of Health and industry totaled $88.8 billion. In 2007, funding from these sources, adjusted for inflation, was $90.2 billion. Adjusted for inflation, funding from 2003 to 2007 increased by 14%, for a compound annual growth rate of 3.4%. By comparison, funding from 1994 to 2003 increased at an annual rate of 7.8% (P<.001). In 2007, industry (58%) was the largest funder, followed by the federal government (33%). Modest increase in funding was not accompanied by an increase in approvals for drugs or devices. In 2007, the United States spent an estimated 4.5% of its total health expenditures on biomedical research and 0.1% on health services research. Conclusion After a decade of doubling, the rate of increase in biomedical research funding slowed from 2003 to 2007, and after adjustment for inflation, the absolute level of funding from the National Institutes of Health and industry appears to have decreased by 2% in 2008. JAMA. 2010;303(2):137-143 www.jama.com	[Dorsey, E. Ray] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA; [Reminick, Jason I.; George, Benjamin P.] Univ Rochester, Sch Med & Dent, Rochester, NY 14642 USA; [Reminick, Jason I.] Univ Rochester, Simon Grad Sch Business, Rochester, NY 14642 USA; [White-Stellato, Zachary] Univ Rochester, Coll Arts & Sci, Rochester, NY 14642 USA; [Beck, Christopher A.] Univ Rochester, Dept Biostat & Computat Biol, Rochester, NY 14642 USA; [de Roulet, Jason] Univ Hosp Case Med Ctr, Cleveland, OH USA; [Thompson, Joel P.] Univ Buffalo, Sch Med & Biomed Sci, Buffalo, NY USA; [Thai, Ashley] Johns Hopkins Sleep Disorders Ctr, Div Pulm Med, Baltimore, MD USA; [Moses, Hamilton, III] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Moses, Hamilton, III] Alerion Inst, N Garden, VA USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester; Case Western Reserve University; Case Western Reserve University Hospital; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Dorsey, ER (corresponding author), 1351 Mt Hope Ave,Ste 223, Rochester, NY 14620 USA.	ray.dorsey@ctcc.rochester.edu		George, Benjamin/0000-0001-9966-5632	National Center for Research Resources, National Institutes of Health (NIH) [KL2 RR024136]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024136] Funding Source: NIH RePORTER	National Center for Research Resources, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was funded by grant KL2 RR024136 from the National Center for Research Resources, a component of the National Institutes of Health (NIH), and the NIH Roadmap for Medical Research.	*AM ASS ADV SCI, GUID R D FUND DAT IN; Anderson GF, 2003, HEALTH AFFAIR, V22, P89, DOI 10.1377/hlthaff.22.3.89; [Anonymous], NAT EC ACC; Blumenthal D, 2009, NEW ENGL J MED, V360, P1477, DOI 10.1056/NEJMp0901592; *BURR CO, BIOPH IND RES DEV TO; *BURR CO, BIOPH IND RES DEV ME; *BURR CO, R D SPEND US BIOPHAR; Butler D, 2008, NATURE, V453, P840, DOI 10.1038/453840a; Centers for Medicare Medicaid Services, NAT HLTH EXP DAT; *COAL HLTH SERV RE, REP FED FUND HLTH SE; *CTR MED MED SERV, 2005, SUMM BENCHM CHANG NH; DANZON PM, EC PHARM IND; Drews J, 2006, NAT REV DRUG DISCOV, V5, P635, DOI 10.1038/nrd2084; FitzGerald GA, 2008, SCIENCE, V320, P1563, DOI 10.1126/science.1161006; Goldston D, 2008, NATURE, V453, P838, DOI 10.1038/453838a; Hoffman A, 2009, HEALTH AFFAIR, V28, pW710, DOI 10.1377/hlthaff.28.4.w710; Moses H, 2005, JAMA-J AM MED ASSOC, V294, P1333, DOI 10.1001/jama.294.11.1333; *NAT SCI FDN DIV S, 2009, PUBL; *NAT SCI FDN DIV S, 2004, PUBL NAT SCI FDN DIV; Newhouse JP, 2002, HEALTH AFFAIR, V21, P13, DOI 10.1377/hlthaff.21.4.13; *NIH OFF BUDG, 2009, BIOM RES DEV PRIC IN; *NIH OFF BUDG, BIOM RES DEV PRIC IN; *PHRMA, 2009, PHARM IND PROF 2009; PISANO G, 2006, SCI BUSINESS, P122; *RW JOHNS FDN, ANN REP 2003 2008 RW; Schweitzer S.O, 2007, PHARM EC POLICY; United States Food and Drug Administration, MED DEV PMA APPR; *US DEP HHS, FUND GLOSS ACR LIST; *US FDA, DRUGS NME DRUG NEW B; *US SEC EXCH COMM, FIL FORMS; Wilensky GR, 2006, HEALTH AFFAIR, V25, pW572, DOI 10.1377/hlthaff.25.w572; Wood AJJ, 2006, NEW ENGL J MED, V355, P618, DOI 10.1056/NEJMsb055203	32	226	232	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 13	2010	303	2					137	143		10.1001/jama.2009.1987	http://dx.doi.org/10.1001/jama.2009.1987			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	542UI	20068207	Bronze, Green Accepted			2022-12-28	WOS:000273522600023
J	Li, NC; Lee, A; Whitmer, RA; Kivipelto, M; Lawler, E; Kazis, LE; Wolozin, B				Li, Nien-Chen; Lee, Austin; Whitmer, Rachel A.; Kivipelto, Miia; Lawler, Elizabeth; Kazis, Lewis E.; Wolozin, Benjamin			Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ALZHEIMER-DISEASE PROGRESSION; MILD COGNITIVE IMPAIRMENT; ENZYME ACE INHIBITORS; QUALITY-OF-LIFE; CARDIOVASCULAR-DISEASE; BLOOD-PRESSURE; HYPERTENSIVE PATIENTS; HEART-FAILURE; SYSTEM; LOSARTAN	Objective To investigate whether angiotensin receptor blockers protect against Alzheimer's disease and dementia or reduce the progression of both diseases. Design Prospective cohort analysis. Setting Administrative database of the US Veteran Affairs, 2002-6. Population 819 491 predominantly male participants (98%) aged 65 or more with cardiovascular disease. Main outcome measures Time to incident Alzheimer's disease or dementia in three cohorts (angiotensin receptor blockers, lisinopril, and other cardiovascular drugs, the "cardiovascular comparator") over a four year period (fiscal years 2003-6) using Cox proportional hazard models with adjustments for age, diabetes, stroke, and cardiovascular disease. Disease progression was the time to admission to a nursing home or death among participants with pre-existing Alzheimer's disease or dementia. Results Hazard rates for incident dementia in the angiotensin receptor blocker group were 0.76 (95% confidence interval 0.69 to 0.84) compared with the cardiovascular comparator and 0.81 (0.73 to 0.90) compared with the lisinopril group. Compared with the cardiovascular comparator, angiotensin receptor blockers in patients with pre-existing Alzheimer's disease were associated with a significantly lower risk of admission to a nursing home (0.51, 0.36 to 0.72) and death (0.83, 0.71 to 0.97). Angiotensin receptor blockers exhibited a dose-response as well as additive effects in combination with angiotensin converting enzyme inhibitors. This combination compared with angiotensin converting enzyme inhibitors alone was associated with a reduced risk of incident dementia (0.54, 0.51 to 0.57) and admission to a nursing home (0.33, 0.22 to 0.49). Minor differences were shown in mean systolic and diastolic blood pressures between the groups. Similar results were observed for Alzheimer's disease. Conclusions Angiotensin receptor blockers are associated with a significant reduction in the incidence and progression of Alzheimer's disease and dementia compared with angiotensin converting enzyme inhibitors or other cardiovascular drugs in a predominantly male population.	[Li, Nien-Chen; Lee, Austin; Kazis, Lewis E.; Wolozin, Benjamin] Vet Affairs Med Ctr, Ctr Hlth Qual Outcomes & Econ Res, Bedford, MA USA; [Li, Nien-Chen; Kazis, Lewis E.] Boston Univ, Sch Publ Hlth,Management & Policy Program, Ctr Assessment Pharmaceut Practices & Pharmaceut, Dept Hlth Policy & Management, Boston, MA USA; [Lee, Austin] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Whitmer, Rachel A.] Kaiser Permanente, Div Res Epidemiol Etiol & Prevent, Oakland, CA USA; [Kivipelto, Miia] Karolinska Inst, Aging Res Ctr, Stockholm, Sweden; [Lawler, Elizabeth] VA Cooperat Studies Program, MAVERIC, Boston, MA USA; [Wolozin, Benjamin] Boston Univ, Sch Med, Dept Pharmacol, Boston, MA 02118 USA; [Wolozin, Benjamin] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Boston University; Harvard University; Massachusetts General Hospital; Kaiser Permanente; Karolinska Institutet; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Boston University; Boston University	Wolozin, B (corresponding author), Vet Affairs Med Ctr, Ctr Hlth Qual Outcomes & Econ Res, Bedford, MA USA.	bwolozin@bu.edu	Kivipelto, Miia/AAS-3557-2021	Kivipelto, Miia/0000-0003-0992-3875; Kazis, Lewis/0000-0003-1800-5849	Retirement Research Foundation; Casten Foundation	Retirement Research Foundation; Casten Foundation	This work was supported by a grant award to BW from the Retirement Research Foundation and a donation from the Casten Foundation. The researchers operate independently of the funders of the study.; BW and RAW received a grant award from the Retirement Research Foundation to fund this research. BW received a donation from the Casten Foundation to fund this research.	Aisen PS, 2003, JAMA-J AM MED ASSOC, V289, P2819, DOI 10.1001/jama.289.21.2819; Andraws R, 2007, AM J CARDIOL, V99, P1006, DOI 10.1016/j.amjcard.2006.10.068; Biessels GJ, 2005, BIOCHEM SOC T, V33, P1041, DOI 10.1042/BST0331041; Braunwald E, 2004, NEW ENGL J MED, V351, P2058; BRETELER MMB, 1994, BRIT MED J, V308, P1604, DOI 10.1136/bmj.308.6944.1604; de la Torre JC, 2004, LANCET NEUROL, V3, P184, DOI 10.1016/S1474-4422(04)00683-0; Elliott WJ, 2007, LANCET, V369, P201, DOI 10.1016/S0140-6736(07)60108-1; Encinas M, 2003, EUR J NUCL MED MOL I, V30, P1473, DOI 10.1007/s00259-003-1277-z; Fogari R, 2003, J HUM HYPERTENS, V17, P781, DOI 10.1038/sj.jhh.1001613; Forette F, 2002, ARCH INTERN MED, V162, P2046, DOI 10.1001/archinte.162.18.2046; Gallinat S, 1998, MOL BRAIN RES, V57, P111, DOI 10.1016/S0169-328X(98)00079-5; Geldmacher DS, 2003, J AM GERIATR SOC, V51, P937, DOI 10.1046/j.1365-2389.2003.51306.x; Hamed A, 2004, MED CARE, V42, P551, DOI 10.1097/01.mlr.0000128002.73998.87; Hanon O, 2008, J HYPERTENS, V26, P1642, DOI 10.1097/HJH.0b013e328301a280; Inagami T, 1999, CLIN EXP PHARMACOL P, V26, P544, DOI 10.1046/j.1440-1681.1999.03086.x; Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X; Kehoe PG, 2007, LANCET NEUROL, V6, P373, DOI 10.1016/S1474-4422(07)70077-7; Kehoe PG, 2009, TRENDS NEUROSCI, V32, P619, DOI 10.1016/j.tins.2009.07.006; Khachaturian AS, 2006, ARCH NEUROL-CHICAGO, V63, P686, DOI 10.1001/archneur.63.5.noc60013; Kinosian B, 2007, GERONTOLOGIST, V47, P356, DOI 10.1093/geront/47.3.356; Kivipelto M, 2001, BMJ-BRIT MED J, V322, P1447, DOI 10.1136/bmj.322.7300.1447; Kivipelto M, 2006, LANCET NEUROL, V5, P735, DOI 10.1016/S1474-4422(06)70537-3; Krikov M, 2008, J HYPERTENS, V26, P544, DOI 10.1097/HJH.0b013e3282f2dac9; Launer LJ, 2000, NEUROBIOL AGING, V21, P49, DOI 10.1016/S0197-4580(00)00096-8; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Luchsinger JA, 2005, NEUROLOGY, V65, P545, DOI 10.1212/01.wnl.0000172914.08967.dc; Lucius R, 1998, J EXP MED, V188, P661, DOI 10.1084/jem.188.4.661; Majani G, 2005, J CARD FAIL, V11, P253, DOI 10.1016/j.cardfail.2004.11.004; Matchar DB, 2008, ANN INTERN MED, V148, P16, DOI 10.7326/0003-4819-148-1-200801010-00189; Nash DT, 2006, AM J CARDIOL, V97, P1262, DOI 10.1016/j.amjcard.2005.12.031; Newman AB, 2005, J AM GERIATR SOC, V53, P1101, DOI 10.1111/j.1532-5415.2005.53360.x; Niwa K, 2001, AM J PHYSIOL-HEART C, V281, pH2417, DOI 10.1152/ajpheart.2001.281.6.H2417; Ohrui T, 2004, NEUROLOGY, V63, P1324, DOI 10.1212/01.WNL.0000140705.23869.E9; Parhofer KG, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-36; Poon IO, 2008, PHARMACOTHERAPY, V28, P366, DOI 10.1592/phco.28.3.366; PROHOVNIK I, 1988, NEUROLOGY, V38, P931, DOI 10.1212/WNL.38.6.931; Qiu CX, 2005, LANCET NEUROL, V4, P487, DOI 10.1016/S1474-4422(05)70141-1; Raghavendra V, 1998, NEUROPEPTIDES, V32, P417, DOI 10.1016/S0143-4179(98)90065-8; Raghavendra V, 2001, NEUROPEPTIDES, V35, P65, DOI 10.1054/npep.2000.0845; RANADIVE SA, 1992, PHARM RES-DORDR, V9, P1480, DOI 10.1023/A:1015823315983; Rozzini L, 2006, INT J GERIATR PSYCH, V21, P550, DOI 10.1002/gps.1523; Ruitenberg A, 2005, ANN NEUROL, V57, P789, DOI 10.1002/ana.20493; Sjogren M, 2006, MECH AGEING DEV, V127, P138, DOI 10.1016/j.mad.2005.09.020; Skoog I, 2005, AM J HYPERTENS, V18, P1052, DOI 10.1016/j.amjhyper.2005.02.013; Smith F, 1996, J Biopharm Stat, V6, P395, DOI 10.1080/10543409608835152; Smith MW, 2003, MED CARE RES REV, V60, p92S, DOI 10.1177/1077558703256726; Stern Y, 1997, JAMA-J AM MED ASSOC, V277, P806, DOI 10.1001/jama.277.10.806; STERN Y, 1994, NEUROLOGY, V44, P2300, DOI 10.1212/WNL.44.12.2300; STOLL M, 1995, J CLIN INVEST, V95, P651, DOI 10.1172/JCI117710; Takeda S, 2009, HYPERTENSION, V54, P1345, DOI 10.1161/HYPERTENSIONAHA.109.138586; Tedesco MA, 1999, AM J HYPERTENS, V12, P1130, DOI 10.1016/S0895-7061(99)00156-9; Thone-Reineke C, 2006, J HYPERTENS, V24, pS115; Tsukuda K, 2009, HYPERTENSION, V54, P782, DOI 10.1161/HYPERTENSIONAHA.109.136879; Veld BAI, 2001, NEUROBIOL AGING, V22, P407, DOI 10.1016/S0197-4580(00)00241-4; Wang J, 2007, J CLIN INVEST, V117, P3393, DOI 10.1172/JCI31547; Weir RAP, 2008, EUR J HEART FAIL, V10, P157, DOI 10.1016/j.ejheart.2007.12.006; Whitmer RA, 2005, NEUROLOGY, V64, P277, DOI 10.1212/01.WNL.0000149519.47454.F2; Wilms Henrik, 2005, Am J Cardiovasc Drugs, V5, P245, DOI 10.2165/00129784-200505040-00004; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P1439, DOI 10.1001/archneur.57.10.1439; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317; Zaman MA, 2002, NAT REV DRUG DISCOV, V1, P621, DOI 10.1038/nrd873	61	328	341	1	24	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 12	2010	340								b5465	10.1136/bmj.b5465	http://dx.doi.org/10.1136/bmj.b5465			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	545CZ	20068258	Green Published, hybrid			2022-12-28	WOS:000273711400005
J	Rego, AT; Fronzes, R; Waksman, G				Rego, Ana Toste; Fronzes, Remi; Waksman, Gabriel			SnapShot: Bacterial Appendages I	CELL			English	Editorial Material							PILUS BIOGENESIS; OUTER-MEMBRANE; MICROSCOPY; PATHWAY; DOMAIN		[Rego, Ana Toste; Fronzes, Remi; Waksman, Gabriel] Birkbeck & Univ Coll London, Inst Struct Mol Biol, London WC1E 7HX, England	University of London; Birkbeck University London	Rego, AT (corresponding author), Birkbeck & Univ Coll London, Inst Struct Mol Biol, London WC1E 7HX, England.		Fronzes, Remi/T-2578-2019; Fronzes, Rémi/GLS-0406-2022	Toste Rego, Ana/0000-0002-8584-3386; Fronzes, Remi/0000-0003-3031-9824	MRC [G0800002] Funding Source: UKRI; Medical Research Council [G0800002] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Collins RF, 2004, J BIOL CHEM, V279, P39750, DOI 10.1074/jbc.M405971200; Collins RF, 2007, J BACTERIOL, V189, P6389, DOI 10.1128/JB.00648-07; Craig L, 2008, CURR OPIN STRUC BIOL, V18, P267, DOI 10.1016/j.sbi.2007.12.009; Craig L, 2006, MOL CELL, V23, P651, DOI 10.1016/j.molcel.2006.07.004; Golovanov AP, 2006, J MOL BIOL, V364, P186, DOI 10.1016/j.jmb.2006.08.078; Remaut H, 2008, CELL, V133, P640, DOI 10.1016/j.cell.2008.03.033; Satyshur KA, 2007, STRUCTURE, V15, P363, DOI 10.1016/j.str.2007.01.018; Waksman G, 2009, NAT REV MICROBIOL, V7, P765, DOI 10.1038/nrmicro2220	8	2	2	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 8	2010	140	1					162	U163	162.e1	10.1016/j.cell.2009.12.047	http://dx.doi.org/10.1016/j.cell.2009.12.047			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	541CY	20085708	Bronze			2022-12-28	WOS:000273391900023
J	Van den Bruel, A; Haj-Hassan, T; Thompson, M; Buntinx, F; Mant, D				Van den Bruel, Ann; Haj-Hassan, Tanya; Thompson, Matthew; Buntinx, Frank; Mant, David		European Res Network Recognising S	Diagnostic value of clinical features at presentation to identify serious infection in children in developed countries: a systematic review	LANCET			English	Review							C-REACTIVE PROTEIN; BACTERIAL-INFECTIONS; FEBRILE CHILDREN; OUTPATIENT MANAGEMENT; MENINGOCOCCAL DISEASE; OBSERVATION SCALES; PREDICTIVE MODEL; FEVER; EMERGENCY; BACTEREMIA	Background Our aim was to identify which clinical features have value in confirming or excluding the possibility of serious infection in children presenting to ambulatory care settings in developed countries. Methods In this systematic review, we searched electronic databases (Medline, Embase, DARE, CINAHL), reference lists of relevant studies, and contacted experts to identify articles assessing clinical features of serious infection in children. 1939 potentially relevant studies were identified. Studies were selected on the basis of six criteria: design (studies of diagnostic accuracy or prediction rules), participants (otherwise healthy children aged 1 month to 18 years), setting (ambulatory care), outcome (serious infection), features assessed (assessable in ambulatory care setting), and sufficient data reported. Quality assessment was based on the Quality Assessment of Diagnostic Accuracy Studies criteria. We calculated likelihood ratios for the presence (positive likelihood ratio) or absence (negative likelihood ratio) of each clinical feature and pre-test and post-test probabilities of the outcome. Clinical features with a positive likelihood ratio of more than 5.0 were deemed red flags (ie, warning signs for serious infection); features with a negative likelihood ratio of less than 0.2 were deemed rule-out signs. Findings 30 studies were included in the analysis. Cyanosis (positive likelihood ratio range 2.66-52.20), rapid breathing (1.26-9.78), poor peripheral perfusion (2.39-38.80), and petechial rash (6.18-83.70) were identified as red flags in several studies. Parental concern (positive likelihood ratio 14.40, 95% CI 9.30-22.10) and clinician instinct (positive likelihood ratio 23.50, 95% CI 16.80-32.70) were identified as strong red flags in one primary care study. Temperature of 40 C or more has value as a red flag in settings with a low prevalence of serious infection. No single clinical feature has rule-out value but some combinations can be used to exclude the possibility of serious infection for example, pneumonia is very unlikely (negative likelihood ratio 0.07, 95% CI 0.01-0.46) if the child is not short of breath and there is no parental concern. The Yale Observation Scale had little value in confirming (positive likelihood ratio range 1.10-6.70) or excluding (negative likelihood ratio range 0.16-0.97) the possibility of serious infection. Interpretation The red flags for serious infection that we identified should be used routinely, but serious illness will still be missed without effective use of precautionary measures. We now need to identify the level of risk at which clinical action should be taken.	[Van den Bruel, Ann; Buntinx, Frank] Katholieke Univ Leuven, Dept Gen Practice, B-3000 Louvain, Belgium; [Haj-Hassan, Tanya; Thompson, Matthew; Mant, David] Univ Oxford, Dept Primary Hlth Care, Oxford, England	KU Leuven; University of Oxford	Van den Bruel, A (corresponding author), Katholieke Univ Leuven, Dept Gen Practice, Kapucijnenvoer 33 Blok J, B-3000 Louvain, Belgium.	ann.vandenbruel@med.kuleuven.be	Buntinx, Frank/E-4950-2011; Van den Bruel, Ann/AAC-2442-2020	Van den Bruel, Ann/0000-0001-9012-2009; Aertgeerts, Bert/0000-0003-1142-5402	Health Technology Assessment [07/37/05]; National Institute for Health Research National School for Primary Care Research; Fonds Wetenschappelijk Onderzoek Vlaanderen; National Institute for Health Research [07/37/05, CL-2009-13-007] Funding Source: researchfish	Health Technology Assessment; National Institute for Health Research National School for Primary Care Research; Fonds Wetenschappelijk Onderzoek Vlaanderen(FWO); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by the Health Technology Assessment Project 07/37/05 (Systematic review and validation of clinical prediction rules for identifying children with serious infections in emergency departments and urgent-access primary care) and the National Institute for Health Research National School for Primary Care Research. We would like to thank Paul Glasziou (Centre for Evidence Based Medicine, Oxford, UK) for advising us on the tables and figures. The Fonds Wetenschappelijk Onderzoek Vlaanderen (Research Foundation-Flanders) initially funded the study by Van den Bruel and colleagues' and granted extension to pay for some of the work presented in this report.	Almond S, 2009, BRIT J GEN PRACT, V59, P872, DOI 10.3399/bjgp09X472971; Andreola B, 2007, PEDIATR INFECT DIS J, V26, P672, DOI 10.1097/INF.0b013e31806215e3; Armon K, 2001, ARCH DIS CHILD, V84, P390, DOI 10.1136/adc.84.5.390; Bachur RG, 2001, PEDIATRICS, V108, P311, DOI 10.1542/peds.108.2.311; BAKER MD, 1990, PEDIATRICS, V85, P1040; Baker MD, 1999, PEDIATRICS, V103, P627, DOI 10.1542/peds.103.3.627; BAKER MD, 1993, NEW ENGL J MED, V329, P1437, DOI 10.1056/NEJM199311113292001; Berger RMF, 1996, EUR J PEDIATR, V155, P468, DOI 10.1007/BF01955183; Bleeker SE, 2007, ACTA PAEDIATR, V96, P100, DOI 10.1111/j.1651-2227.2006.00033.x; BONADIO WA, 1993, CLIN PEDIATR, V32, P401, DOI 10.1177/000992289303200703; Bruijnzeels MA, 1998, BRIT J GEN PRACT, V48, P880; Carlin JB, 2008, LANCET, V371, P135, DOI 10.1016/S0140-6736(08)60106-3; Confidential Enquiry into Maternal and Child Health (CEMACH), 2008, WHY CHILDR DIE PIL S; CROCKER PJ, 1985, ANN EMERG MED, V14, P1172, DOI 10.1016/S0196-0644(85)81024-6; Duke T, 2005, ARCH DIS CHILD, V90, P200, DOI 10.1136/adc.2003.047951; Fleming D M, 2002, Commun Dis Public Health, V5, P7; Galetto-Lacour A, 2003, PEDIATRICS, V112, P1054, DOI 10.1542/peds.112.5.1054; Garra G, 2005, ACAD EMERG MED, V12, P921, DOI 10.1197/j.aem.2005.06.006; Gorelick MH, 1997, PEDIATRICS, V99, DOI 10.1542/peds.99.5.e6; GOVE S, 1977, B WHO S1, V75, P7; Grupo de Trabajo sobre el Nino Febril de la Sociedad Espanola de Urgencias de Pediatria, 2001, An Esp Pediatr, V55, P5; Haddon RA, 1999, MED J AUSTRALIA, V170, P475, DOI 10.5694/j.1326-5377.1999.tb127847.x; Hsiao AL, 2006, PEDIATRICS, V117, P1695, DOI 10.1542/peds.2005-1673; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; JAFFE DM, 1991, PEDIATRICS, V87, P670; JOFFE A, 1983, AM J DIS CHILD, V137, P1153, DOI 10.1001/archpedi.1983.02140380013005; Kai J, 1996, BRIT MED J, V313, P983; Lacour AG, 2001, EUR J PEDIATR, V160, P95, DOI 10.1007/s004310000681; Lacour AG, 2008, PEDIATR INFECT DIS J, V27, P654, DOI 10.1097/INF.0b013e318168d2b4; MACKENZIE A, 1989, LANCET, V2, P605; Mahabee-Gittens EM, 2005, CLIN PEDIATR, V44, P427, DOI 10.1177/000992280504400508; MCCARTHY PL, 1982, PEDIATRICS, V70, P802; MCCARTHY PL, 1987, J PEDIATR-US, V110, P26, DOI 10.1016/S0022-3476(87)80282-2; MORLEY CJ, 1991, ARCH DIS CHILD, V66, P111, DOI 10.1136/adc.66.1.111; Nademi Z, 2001, J INFECTION, V43, P221, DOI 10.1053/jinf.2001.0920; National Institute for Health and Clinical Excellence (NICE), 2007, UR TRACT INF CHILDR; NICE, 2007, FEV ILLN CHILDR ASS; Nielsen HE, 2001, ARCH DIS CHILD, V85, P160, DOI 10.1136/adc.85.2.160; OFFRINGA M, 1992, CLIN PEDIATR, V31, P514, DOI 10.1177/000992289203100901; Oostenbrink R, 2001, ACTA PAEDIATR, V90, P611, DOI 10.1080/080352501750258649; Osman O, 2002, Health Bull (Edinb), V60, P33; Riordan FAI, 1996, BRIT MED J, V313, P1255, DOI 10.1136/bmj.313.7067.1255; Shavit I, 2006, PEDIATRICS, V118, P2402, DOI 10.1542/peds.2006-1108; TAYLOR JA, 1995, ARCH PEDIAT ADOL MED, V149, P283, DOI 10.1001/archpedi.1995.02170150063011; TEELE DW, 1975, J PEDIATR-US, V87, P227, DOI 10.1016/S0022-3476(75)80584-1; Thayyil S, 2005, ACTA PAEDIATR, V94, P155, DOI 10.1080/08035250410025140; Thompson M, 2009, ARCH DIS CHILD, V94, P888, DOI 10.1136/adc.2009.159095; Thompson MJ, 2006, LANCET, V367, P397, DOI 10.1016/S0140-6736(06)67932-4; Trautner BW, 2006, PEDIATRICS, V118, P34, DOI 10.1542/peds.2005-2823; Van den Bruel A, 2007, BRIT J GEN PRACT, V57, P538; WASKERWITZ S, 1981, J PEDIATR-US, V99, P231, DOI 10.1016/S0022-3476(81)80458-1; Wells LC, 2001, ARCH DIS CHILD, V85, P218, DOI 10.1136/adc.85.3.218; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25	53	209	213	2	23	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 6	2010	375	9717					834	845		10.1016/S0140-6736(09)62000-6	http://dx.doi.org/10.1016/S0140-6736(09)62000-6			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	570MO	20132979				2022-12-28	WOS:000275682600033
J	Li, CK; Seguin, FH; Frenje, JA; Rosenberg, M; Petrasso, RD; Amendt, PA; Koch, JA; Landen, OL; Park, HS; Robey, HF; Town, RPJ; Casner, A; Philippe, F; Betti, R; Knauer, JP; Meyerhofer, DD; Back, CA; Kilkenny, JD; Nikroo, A				Li, C. K.; Seguin, F. H.; Frenje, J. A.; Rosenberg, M.; Petrasso, R. D.; Amendt, P. A.; Koch, J. A.; Landen, O. L.; Park, H. S.; Robey, H. F.; Town, R. P. J.; Casner, A.; Philippe, F.; Betti, R.; Knauer, J. P.; Meyerhofer, D. D.; Back, C. A.; Kilkenny, J. D.; Nikroo, A.			Charged-Particle Probing of X-ray-Driven Inertial-Fusion Implosions	SCIENCE			English	Article							PLASMAS; MATTER	Measurements of x-ray-driven implosions with charged particles have resulted in the quantitative characterization of critical aspects of indirect-drive inertial fusion. Three types of spontaneous electric fields differing in strength by two orders of magnitude, the largest being nearly one-tenth of the Bohr field, were discovered with time-gated proton radiographic imaging and spectrally resolved proton self-emission. The views of the spatial structure and temporal evolution of both the laser drive in a hohlraum and implosion properties provide essential insight into, and modeling validation of, x-ray-driven implosions.	[Li, C. K.; Seguin, F. H.; Frenje, J. A.; Rosenberg, M.; Petrasso, R. D.] MIT, Plasma Sci & Fus Ctr, Cambridge, MA 02139 USA; [Amendt, P. A.; Koch, J. A.; Landen, O. L.; Park, H. S.; Robey, H. F.; Town, R. P. J.] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; [Casner, A.; Philippe, F.] CEA, DAM, DIF, F-91297 Arpajon, France; [Betti, R.; Knauer, J. P.; Meyerhofer, D. D.] Univ Rochester, Laser Energet Lab, Rochester, NY 14623 USA; [Back, C. A.; Kilkenny, J. D.; Nikroo, A.] Gen Atom Co, San Diego, CA 92186 USA	Massachusetts Institute of Technology (MIT); United States Department of Energy (DOE); Lawrence Livermore National Laboratory; CEA; University of Rochester; General Atomics & Affiliated Companies	Li, CK (corresponding author), MIT, Plasma Sci & Fus Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	ckli@mit.edu	Landen, Otto/AEX-9890-2022; Casner, Alexis/O-9007-2019; CASNER, Alexis/B-7458-2014	Landen, Otto/0000-0002-1499-8217; CASNER, Alexis/0000-0003-2176-1389; Nikroo, Abbas/0000-0002-8855-0378	U.S. Department of Energy; Laboratory for Laser Energetics (LLE) National Laser User's Facility [DE-FG52-07NA28059, DE-FG03-03SF22691]; Lawrence Livermore National Laboratory [B543881, LDRD-ER-898988]; CEA/DIF (France) [DE-FC52-08NA28302]; LLE [414090-G]; Fusion Science Center at University of Rochester [412761-G]; General Atomics [DE-AC52-06NA27279]	U.S. Department of Energy(United States Department of Energy (DOE)); Laboratory for Laser Energetics (LLE) National Laser User's Facility; Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); CEA/DIF (France)(French Atomic Energy Commission); LLE; Fusion Science Center at University of Rochester; General Atomics	This work was supported in part by the U.S. Department of Energy and the Laboratory for Laser Energetics (LLE) National Laser User's Facility (DE-FG52-07NA28059 and DE-FG03-03SF22691), Lawrence Livermore National Laboratory (B543881 and LDRD-ER-898988), CEA/DIF (France, Cooperative agreement DE-FC52-08NA28302), LLE (414090-G), Fusion Science Center at University of Rochester (412761-G), and General Atomics (DE-AC52-06NA27279).	Amendt PA, 2009, PLASMA PHYS CONTR F, V51, DOI 10.1088/0741-3335/51/12/124048; Atzeni S, 2004, PHYS INERTIAL FUSION; BRAGINSKII SI, 1965, REV PLASMA PHYS, V1; Drake RP, 2006, SHOCK WAVE HIGH PRES, P1, DOI 10.1007/3-540-29315-9; Haines MG, 1997, PHYS REV LETT, V78, P254, DOI 10.1103/PhysRevLett.78.254; Jackson J., 1975, CLASSICAL ELECTRODYN; LASINSKI TA, 1973, REV MOD PHYS, V45, pS1, DOI 10.1103/RevModPhys.45.S1; Li CK, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.135003; Li CK, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016407; Li CK, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.205001; Li CK, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.225001; LI CK, 1993, PHYS REV LETT, V70, P3059, DOI 10.1103/PhysRevLett.70.3059; Lindl J. D., 1999, INERTIAL CONFINEMENT; MacFarlane JJ, 2003, J QUANT SPECTROSC RA, V81, P287, DOI 10.1016/S0022-4073(03)00081-5; Meyerhofer DD, 2001, PHYS PLASMAS, V8, P2251, DOI 10.1063/1.1350964; NUCKOLLS J, 1972, NATURE, V239, P139, DOI 10.1038/239139a0; Petrasso RD, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.085001; Petrasso RD, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.095002; Remington BA, 1999, SCIENCE, V284, P1488, DOI 10.1126/science.284.5419.1488; Rygg JR, 2006, PHYS PLASMAS, V13, DOI 10.1063/1.2192759; Rygg JR, 2008, SCIENCE, V319, P1223, DOI 10.1126/science.1152640; Seguin FH, 2003, REV SCI INSTRUM, V74, P975, DOI 10.1063/1.1518141; Soures JM, 1996, PHYS PLASMAS, V3, P2108, DOI 10.1063/1.871662	23	82	87	2	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 5	2010	327	5970					1231	1235		10.1126/science.1185747	http://dx.doi.org/10.1126/science.1185747			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563VD	20110464	Green Submitted			2022-12-28	WOS:000275162100032
J	Coggon, RM; Teagle, DAH; Smith-Duque, CE; Alt, JC; Cooper, MJ				Coggon, Rosalind M.; Teagle, Damon A. H.; Smith-Duque, Christopher E.; Alt, Jeffrey C.; Cooper, Matthew J.			Reconstructing Past Seawater Mg/Ca and Sr/Ca from Mid-Ocean Ridge Flank Calcium Carbonate Veins	SCIENCE			English	Article							BENTHIC FORAMINIFERAL CALCITE; DE-FUCA RIDGE; WEATHERING FLUXES; FLUID INCLUSIONS; EASTERN FLANK; CHEMISTRY; RATIOS; RECORD; GEOCHEMISTRY; OSCILLATIONS	Proxies for past seawater chemistry, such as Mg/Ca and Sr/Ca ratios, provide a record of the dynamic exchanges of elements between the solid Earth, the atmosphere, and the hydrosphere and the evolving influence of life. We estimated past oceanic Mg/Ca and Sr/Ca ratios from suites of 1.6- to 170-million-year-old calcium carbonate veins that had precipitated from seawater-derived fluids in ocean ridge flank basalts. Our data indicate that before the Neogene, oceanic Mg/Ca and Sr/Ca ratios were lower than in the modern ocean. Decreased ocean spreading since the Cretaceous and the resulting slow reduction in ocean crustal hydrothermal exchange throughout the early Tertiary may explain the recent rise in these ratios.	[Teagle, Damon A. H.; Smith-Duque, Christopher E.; Cooper, Matthew J.] Univ Southampton, Natl Oceanog Ctr, Sch Ocean & Earth Sci, Southampton SO14 3ZH, Hants, England; [Coggon, Rosalind M.] Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London SW7 2AZ, England; [Alt, Jeffrey C.] Univ Michigan, Dept Geol Sci, Ann Arbor, MI 48109 USA	NERC National Oceanography Centre; University of Southampton; Imperial College London; University of Michigan System; University of Michigan	Teagle, DAH (corresponding author), Univ Southampton, Natl Oceanog Ctr, Sch Ocean & Earth Sci, Southampton SO14 3ZH, Hants, England.	damon.teagle@soton.ac.uk	Cooper, Matthew/I-8573-2012; Coggon, Rosalind/M-8816-2017	Cooper, Matthew/0000-0002-2130-2759; Coggon, Rosalind/0000-0002-9228-9707	National Environment Research Council [NER/T/S/2003/00048, NE/E001971/1, NE/C513242/1]; Ocean Drilling Program (ODP); Integrated Ocean Drilling Program (IODP); NSF; Japan's Ministry of Education, Culture, Sports, Science and Technology; European Consortium for Ocean Drilling Research; People's Republic of China, Ministry of Science and Technology; NERC [NE/I006311/1, NE/E005640/1, NE/E005616/1, NE/E001971/1] Funding Source: UKRI; Natural Environment Research Council [NE/E005616/1, NE/E001971/1, NE/E005640/1, NE/I006311/1, NER/T/S/2003/00048] Funding Source: researchfish	National Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Ocean Drilling Program (ODP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Integrated Ocean Drilling Program (IODP); NSF(National Science Foundation (NSF)); Japan's Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); European Consortium for Ocean Drilling Research; People's Republic of China, Ministry of Science and Technology; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was supported by National Environment Research Council research grants NER/T/S/2003/00048 and NE/E001971/1 to D. A. H. T. and NE/C513242/1 to R. M. C. and D. A. H. T. This research used samples provided by the Ocean Drilling Program (ODP) and the Integrated Ocean Drilling Program (IODP). ODP was sponsored by NSF and participating countries under the management of Joint Oceanographic Institutions. IODP is supported by NSF; Japan's Ministry of Education, Culture, Sports, Science and Technology; the European Consortium for Ocean Drilling Research; and the People's Republic of China, Ministry of Science and Technology. We thank M. Palmer, P. Wilson, D. Vance, R. James, and three anonymous reviewers for insightful comments that greatly improved this manuscript.	Alt JC, 1999, GEOCHIM COSMOCHIM AC, V63, P1527, DOI 10.1016/S0016-7037(99)00123-4; BERNER RA, 1983, AM J SCI, V283, P641, DOI 10.2475/ajs.283.7.641; Brand U, 2003, CHEM GEOL, V198, P305, DOI 10.1016/S0009-2541(03)00032-9; CARPENTER SJ, 1991, GEOCHIM COSMOCHIM AC, V55, P1991, DOI 10.1016/0016-7037(91)90038-7; Coggon RM, 2004, EARTH PLANET SC LETT, V219, P111, DOI 10.1016/S0012-821X(03)00697-6; Cohen AL, 2002, SCIENCE, V296, P331, DOI 10.1126/science.1069330; Dickson JAD, 2002, SCIENCE, V298, P1222, DOI 10.1126/science.1075882; Elderfield H, 1999, EARTH PLANET SC LETT, V172, P151, DOI 10.1016/S0012-821X(99)00191-0; Fisher AT, 2003, NATURE, V421, P618, DOI 10.1038/nature01352; Freitas PS, 2006, GEOCHIM COSMOCHIM AC, V70, P5119, DOI 10.1016/j.gca.2006.07.029; Gaillardet J, 1999, CHEM GEOL, V159, P3, DOI 10.1016/S0009-2541(99)00031-5; GIBBS MT, 1994, PALEOCEANOGRAPHY, V9, P529, DOI 10.1029/94PA01009; Horita J, 2002, GEOCHIM COSMOCHIM AC, V66, P3733, DOI 10.1016/S0016-7037(01)00884-5; Lea DW, 1999, GEOCHIM COSMOCHIM AC, V63, P2369, DOI 10.1016/S0016-7037(99)00197-0; Lear CH, 2003, EARTH PLANET SC LETT, V208, P69, DOI 10.1016/S0012-821X(02)01156-1; Lear CH, 2002, GEOCHIM COSMOCHIM AC, V66, P3375, DOI 10.1016/S0016-7037(02)00941-9; Lear CH, 2000, SCIENCE, V287, P269, DOI 10.1126/science.287.5451.269; Lowenstein TK, 2001, SCIENCE, V294, P1086, DOI 10.1126/science.1064280; MACKENZIE FT, 1966, AM J SCI, V264, P507, DOI 10.2475/ajs.264.7.507; McArthur JM, 2001, J GEOL, V109, P155, DOI 10.1086/319243; Meybeck M., 1996, RIVER DISCHARGES OCE; Morse JW, 1997, GEOLOGY, V25, P85, DOI 10.1130/0091-7613(1997)025<0085:IOTAMC>2.3.CO;2; Muller RD, 2008, SCIENCE, V319, P1357, DOI 10.1126/science.1151540; Paul HJ, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001089; RICHTER FM, 1993, EARTH PLANET SC LETT, V117, P553, DOI 10.1016/0012-821X(93)90102-F; RICHTER FM, 1987, EARTH PLANET SC LETT, V83, P27, DOI 10.1016/0012-821X(87)90048-3; SANDBERG PA, 1983, NATURE, V305, P19, DOI 10.1038/305019a0; Seton M, 2009, GEOLOGY, V37, P687, DOI 10.1130/G25624A.1; Stanley SM, 1998, PALAEOGEOGR PALAEOCL, V144, P3, DOI 10.1016/S0031-0182(98)00109-6; Steuber T, 2002, GEOLOGY, V30, P1123, DOI 10.1130/0091-7613(2002)030<1123:PROPTC>2.0.CO;2; Steuber T, 1999, INT J EARTH SCI, V88, P551, DOI 10.1007/s005310050284; Timofeeff MN, 2006, GEOCHIM COSMOCHIM AC, V70, P1977, DOI 10.1016/j.gca.2006.01.020; Tripati AK, 2009, EARTH PLANET SC LETT, V282, P122, DOI 10.1016/j.epsl.2009.03.020; Vance D, 2009, NATURE, V458, P493, DOI 10.1038/nature07828; Von Damm KL, 1995, GEOPHYS MONOGR SER, V91, P222, DOI DOI 10.1029/GM091P0222	35	194	197	2	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2010	327	5969					1114	1117		10.1126/science.1182252	http://dx.doi.org/10.1126/science.1182252			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560KJ	20133522				2022-12-28	WOS:000274901100031
J	Doceul, V; Hollinshead, M; van der Linden, L; Smith, GL				Doceul, Virginie; Hollinshead, Michael; van der Linden, Lonneke; Smith, Geoffrey L.			Repulsion of Superinfecting Virions: A Mechanism for Rapid Virus Spread	SCIENCE			English	Article							EXTRACELLULAR ENVELOPED VIRUS; ACTIN TAIL FORMATION; TO-CELL SPREAD; VACCINIA VIRUS; SEQUENCE-ANALYSIS; A36R PROTEIN; A33R PROTEIN; GENE; FUSION; LOCALIZATION	Viruses are thought to spread across susceptible cells through an iterative process of infection, replication, and release, so that the rate of spread is limited by replication kinetics. Here, we show that vaccinia virus spreads across one cell every 75 minutes, fourfold faster than its replication cycle would permit. To explain this phenomenon, we found that newly infected cells express two surface proteins that mark cells as infected and, via exploitation of cellular machinery, induce the repulsion of superinfecting virions away toward uninfected cells. Mechanistically, early expression of proteins A33 and A36 was critical for virion repulsion and rapid spread, and cells expressing these proteins repelled exogenous virions rapidly. Additional spreading mechanisms may exist for other viruses that also spread faster than predicted by replication kinetics.	[Doceul, Virginie; Hollinshead, Michael; van der Linden, Lonneke; Smith, Geoffrey L.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Virol, London W2 1PG, England	Imperial College London	Smith, GL (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Virol, St Marys Campus,Norfolk Pl, London W2 1PG, England.	geoffrey.l.smith@imperial.ac.uk	Smith, Geoffrey L/G-2894-2012	Smith, Geoffrey L/0000-0002-3730-9955	UK Medical Research Council; MRC [G0501257] Funding Source: UKRI; Medical Research Council [G0501257] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Professor Rick E. Randall, University of St. Andrews for the lentivirus vectors. GLS is a Wellcome Trust Principal Research Fellow. This work was supported by the UK Medical Research Council.	BLASCO R, 1991, J VIROL, V65, P4598, DOI 10.1128/JVI.65.9.4598-4608.1991; Carter GC, 2003, J GEN VIROL, V84, P2443, DOI 10.1099/vir.0.19271-0; Condit RC, 2006, ADV VIRUS RES, V66, P31, DOI 10.1016/S0065-3527(06)66002-8; CUDMORE S, 1995, NATURE, V378, P636, DOI 10.1038/378636a0; DULBECCO R, 1952, P NATL ACAD SCI USA, V38, P747, DOI 10.1073/pnas.38.8.747; Elliott G, 1999, J VIROL, V73, P4110, DOI 10.1128/JVI.73.5.4110-4119.1999; ENGELSTAD M, 1993, VIROLOGY, V194, P627, DOI 10.1006/viro.1993.1302; HILLER G, 1979, VIROLOGY, V98, P142, DOI 10.1016/0042-6822(79)90533-6; LAW KM, 1992, J GEN VIROL, V73, P549, DOI 10.1099/0022-1317-73-3-549; Law M, 2002, J GEN VIROL, V83, P209, DOI 10.1099/0022-1317-83-1-209; Lorenzo MM, 2000, J VIROL, V74, P10535, DOI 10.1128/JVI.74.22.10535-10550.2000; McIntosh AAG, 1996, J VIROL, V70, P272, DOI 10.1128/JVI.70.1.272-281.1996; Moss B., 2007, FIELDS VIROLOGY, V2, P2905; PARKINSON JE, 1994, VIROLOGY, V204, P376, DOI 10.1006/viro.1994.1542; PAYNE LG, 1979, J VIROL, V32, P614, DOI 10.1128/JVI.32.2.614-622.1979; Perdiguero B, 2006, J VIROL, V80, P8763, DOI 10.1128/JVI.00598-06; Roberts KL, 2008, TRENDS MICROBIOL, V16, P472, DOI 10.1016/j.tim.2008.07.009; Roper RL, 1998, J VIROL, V72, P4192, DOI 10.1128/JVI.72.5.4192-4204.1998; Roper RL, 1996, J VIROL, V70, P3753, DOI 10.1128/JVI.70.6.3753-3762.1996; ROSEL J, 1985, J VIROL, V56, P830, DOI 10.1128/JVI.56.3.830-838.1985; Rottger S, 1999, J VIROL, V73, P2863; Sanderson CM, 1998, J VIROL, V72, P1235, DOI 10.1128/JVI.72.2.1235-1243.1998; Smith GL, 2002, J GEN VIROL, V83, P2915, DOI 10.1099/0022-1317-83-12-2915; STOKES GV, 1976, J VIROL, V18, P636, DOI 10.1128/JVI.18.2.636-643.1976; Turner PC, 2008, VIROLOGY, V380, P226, DOI 10.1016/j.virol.2008.07.020; van Eijl H, 2000, VIROLOGY, V271, P26, DOI 10.1006/viro.2000.0260; Wagenaar TR, 2007, J VIROL, V81, P6286, DOI 10.1128/JVI.00274-07; Wagenaar TR, 2009, J VIROL, V83, P1546, DOI 10.1128/JVI.01684-08; Wolffe EJ, 2001, J VIROL, V75, P303, DOI 10.1128/JVI.75.1.303-310.2001; Zhang WH, 2000, J VIROL, V74, P11654, DOI 10.1128/JVI.74.24.11654-11662.2000	30	155	160	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2010	327	5967					873	876		10.1126/science.1183173	http://dx.doi.org/10.1126/science.1183173			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554AQ	20093437	Green Accepted			2022-12-28	WOS:000274408300064
J	Cohen, JA; Barkhof, F; Comi, G; Hartung, HP; Khatri, BO; Montalban, X; Pelletier, J; Capra, R; Gallo, P; Izquierdo, G; Tiel-Wilck, K; de Vera, A; Jin, J; Stites, T; Wu, S; Aradhye, S; Kappos, L				Cohen, Jeffrey A.; Barkhof, Frederik; Comi, Giancarlo; Hartung, Hans-Peter; Khatri, Bhupendra O.; Montalban, Xavier; Pelletier, Jean; Capra, Ruggero; Gallo, Paolo; Izquierdo, Guillermo; Tiel-Wilck, Klaus; de Vera, Ana; Jin, James; Stites, Tracy; Wu, Stacy; Aradhye, Shreeram; Kappos, Ludwig		TRANSFORMS Study Grp	Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; PHASE-II EXTENSION; RECEPTOR AGONISTS; LYMPHOCYTE EGRESS; FTY720; BETA-1A; ORGANS; MS	BACKGROUND Fingolimod (FTY720), a sphingosine-1-phosphate-receptor modulator that prevents lymphocyte egress from lymph nodes, showed clinical efficacy and improvement on imaging in a phase 2 study involving patients with multiple sclerosis. METHODS In this 12-month, double-blind, double-dummy study, we randomly assigned 1292 patients with relapsing-remitting multiple sclerosis who had a recent history of at least one relapse to receive either oral fingolimod at a daily dose of either 1.25 or 0.5 mg or intramuscular interferon beta-1a ( an established therapy for multiple sclerosis) at a weekly dose of 30 mu g. The primary end point was the annualized relapse rate. Key secondary end points were the number of new or enlarged lesions on T-2-weighted magnetic resonance imaging (MRI) scans at 12 months and progression of disability that was sustained for at least 3 months. RESULTS A total of 1153 patients (89%) completed the study. The annualized relapse rate was significantly lower in both groups receiving fingolimod -0.20 (95% confidence interval [CI], 0.16 to 0.26) in the 1.25-mg group and 0.16 ( 95% CI, 0.12 to 0.21) in the 0.5-mg group - than in the interferon group (0.33; 95% CI, 0.26 to 0.42; P<0.001 for both comparisons). MRI findings supported the primary results. No significant differences were seen among the study groups with respect to progression of disability. Two fatal infections occurred in the group that received the 1.25-mg dose of fingolimod: disseminated primary varicella zoster and herpes simplex encephalitis. Other adverse events among patients receiving fingolimod were nonfatal herpesvirus infections, bradycardia and atrioventricular block, hypertension, macular edema, skin cancer, and elevated liver-enzyme levels. CONCLUSIONS This trial showed the superior efficacy of oral fingolimod with respect to relapse rates and MRI outcomes in patients with multiple sclerosis, as compared with intramuscular interferon beta-1a. Longer studies are needed to assess the safety and efficacy of treatment beyond 1 year.	[Cohen, Jeffrey A.] Cleveland Clin, Mellen Ctr, Cleveland, OH 44195 USA; [Barkhof, Frederik] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; [Comi, Giancarlo] Univ Vita & Salute, Hosp San Raffaele, Neurol Clin, Milan, Italy; [Capra, Ruggero] Presidio Osped Montichiari, Reg Multiple Sclerosis Ctr, Montichiari, Italy; [Gallo, Paolo] Univ Hosp Padua, Dept Neurosci, Multiple Sclerosis Ctr Veneto Reg, Padua, Italy; [Hartung, Hans-Peter] Univ Dusseldorf, Dept Neurol, D-4000 Dusseldorf, Germany; [Tiel-Wilck, Klaus] Klin Studienzentrum, Neurol Facharztzentrum Berlin, Berlin, Germany; [Khatri, Bhupendra O.] Reg MS Ctr, Ctr Neurol Disorders, Milwaukee, WI USA; [Montalban, Xavier] Hosp Gen Valle Hebron, Neuroimmunol Unit, Barcelona, Spain; [Izquierdo, Guillermo] Hosp Univ Virgen Macarena, Serv Neurol, MS Unit, Seville, Spain; [Pelletier, Jean] CHU Timone, Dept Neurol, Marseille, France; [Pelletier, Jean] CHU Timone, Dept Res CRMBM, Marseille, France; [de Vera, Ana] Novartis Pharmaceut, Basel, Switzerland; [Kappos, Ludwig] Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland; [Kappos, Ludwig] Univ Basel Hosp, Dept Res, CH-4031 Basel, Switzerland; [Jin, James; Stites, Tracy; Wu, Stacy; Aradhye, Shreeram] Novartis Pharmaceut, E Hanover, NJ USA	Cleveland Clinic Foundation; Vrije Universiteit Amsterdam; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Padua; Azienda Ospedaliera - Universita di Padova; Heinrich Heine University Dusseldorf; Hospital Universitari Vall d'Hebron; Hospital Universitario Virgen Macarena; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Novartis; University of Basel; University of Basel; Novartis	Cohen, JA (corresponding author), Cleveland Clin, Neurol Inst, Mellen Ctr U 10, 9500 Euclid Ave, Cleveland, OH 44195 USA.	cohenj@ccf.org	Barkhof, Frederik/AAJ-6226-2020; Bertolotto, Antonio/K-8346-2015; Montalban, Xavier/J-5938-2016; Bacellar, Aroldo S/U-6399-2018; amato, Maria Pia/AAL-5998-2020; Lugaresi, Alessandra/C-7743-2012	Barkhof, Frederik/0000-0003-3543-3706; Bertolotto, Antonio/0000-0002-7052-1907; Montalban, Xavier/0000-0002-0098-9918; Bacellar, Aroldo S/0000-0001-8452-0932; amato, Maria Pia/0000-0003-3325-3760; Lugaresi, Alessandra/0000-0003-2902-5589; Luetic, Geraldine/0000-0002-5716-6082; lebrun-frenay, christine/0000-0002-3713-2416; Sa, Maria Jose/0000-0003-0825-2977; Pozzilli, Carlo/0000-0002-6360-4798; antel, jack/0000-0002-5148-0636; Cunha, Luis/0000-0002-0828-3485; Beran, Roy/0000-0002-5884-0606	Novartis Pharma; Biogen Idec; Novartis; EMD Serono; Teva; Sanofi-Aventis and Waterfront Media; Genzyme; Bayer Schering; Serono; Sanofi-Aventis; AstraZeneca; Genentech; Lundbeck; Talecris; Roche; Wyeth; MediciNova; Merck Serono; Bayer; Biogen-Dompe; Medtronics; Pfizer; Bayer Schering Pharma; Biogen Dompe; Biogen; Bayer Healthcare; Accorda; Actelion; Allergan; Allozyne; Boehringer Ingelheim; Genmab; GlaxoSmithKline; Santhera; Teva Pharmaceuticals; UCB Pharma; Helvea; Mediservice; CSL Behring; Novartis Foundation	Novartis Pharma; Biogen Idec(Biogen); Novartis(Novartis); EMD Serono; Teva(Teva Pharmaceutical Industries); Sanofi-Aventis and Waterfront Media; Genzyme(Sanofi-AventisGenzyme Corporation); Bayer Schering(Bayer AG); Serono(Merck & Company); Sanofi-Aventis(Sanofi-Aventis); AstraZeneca(AstraZeneca); Genentech(Roche HoldingGenentech); Lundbeck(Lundbeck Corporation); Talecris; Roche(Roche Holding); Wyeth(Wyeth); MediciNova; Merck Serono(Merck & Company); Bayer(Bayer AG); Biogen-Dompe(Biogen); Medtronics; Pfizer(Pfizer); Bayer Schering Pharma(Bayer AG); Biogen Dompe(Biogen); Biogen(Biogen); Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); Accorda; Actelion; Allergan(AbbVieAllergan); Allozyne; Boehringer Ingelheim(Boehringer Ingelheim); Genmab(Genmab); GlaxoSmithKline(GlaxoSmithKline); Santhera; Teva Pharmaceuticals(Teva Pharmaceutical Industries); UCB Pharma(UCB Pharma SA); Helvea; Mediservice; CSL Behring; Novartis Foundation(Novartis)	Supported by Novartis Pharma.; Presented in part at the annual meetings of the American Academy of Neurology, Seattle, in April 2009, and of the European Committee for Treatment and Research in Multiple Sclerosis, Dusseldorf, Germany, in September 2009.; Dr. Cohen reports receiving consulting fees from Biogen Idec, Novartis, EMD Serono, and Teva, lecture fees from Sanofi-Aventis and Waterfront Media, and research support from Genzyme, Novartis, and Teva; Dr. Barkhof, receiving consulting fees from Bayer Schering, Serono, Sanofi-Aventis, AstraZeneca, Genentech, Novartis, Biogen Idec, Lundbeck, Talecris, Roche, Wyeth, and MediciNova and lecture fees from Bayer Schering and Serono; Dr. Comi, receiving consulting fees from Merck Serono, Novartis, Sanofi-Aventis, and Teva and lecture fees from Bayer, Biogen-Dompe, Novartis, Merck Serono, Sanofi-Aventis, and Teva; Dr. Hartung, receiving consulting and lecture fees from Bayer Schering, Biogen Idec, Merck Serono, and Teva, consulting fees from Novartis, and grant support from Biogen Idec and Bayer Schering; Dr. Khatri, receiving consulting fees from Bayer, Biogen Idec, Medtronics, Pfizer, Teva, and Serono and lecture fees from Bayer, Biogen Idec, and Serono; Dr. Montalban, receiving consulting and lecture fees from Bayer Schering, Biogen Idec, Novartis, Sanofi-Aventis, and Teva; Dr. Pelletier, receiving consulting and lecture fees from Bayer Schering Pharma, Biogen Idec, Merck Serono, Novartis, and Sanofi-Aventis and grant support from Bayer and Sanofi-Aventis; Dr. Capra, receiving consulting fees from Novartis and lecture fees from Bayer, Biogen Dompe, and Sanofi-Aventis; Dr. Gallo, receiving lecture fees from Biogen Dompe, Merck Serono, and Bayer Schering and grant support from Biogen, Sanofi-Aventis, and Merck Serono; Dr. Izquierdo, receiving consulting fees from Biogen Idec, Merck Serono, Novartis, and Teva and lecture fees from Biogen and Merck Serono; Dr. Tiel-Wilck, receiving consulting fees from Novartis and lecture fees from Bayer Healthcare, Biogen Idec, Sanofi-Aventis, and Teva; Dr. de Vera, being an employee of Novartis Pharma; Drs. Jin, Stites, Wu, and Aradhye, being employees of Novartis Pharmaceuticals; and Dr. Kappos, serving as a consultant or a member or chair of a steering committee, data and safety monitoring board, or advisory board in clinical trials sponsored by Accorda, Actelion, Allergan, Allozyne, Bayer Schering, Biogen Idec, Biogen-Dompe, Boehringer Ingelheim, Genmab, GlaxoSmithKline, MediciNova, Merck Serono, Novartis, Roche, Sanofi-Aventis, Santhera, Teva Pharmaceuticals, UCB Pharma, and Wyeth, receiving lecture fees from Biogen Idec, Helvea, GlaxoSmithKline, Mediservice and Merck Serono, and receiving grant support from Bayer Schering, Biogen Idec, CSL Behring, Genmab, Genzyme, GlaxoSmithKline, MediciNova, Merck Serono, Novartis, Novartis Foundation, Roche, Santhera, Sanofi-Aventis, and UCB Pharma. No other potential conflict of interest relevant to this article was reported.; We thank Dave Anderson of Novartis Pharmaceuticals and Tom Potter and Rowena Hughes of Oxford PharmaGenesis for their editorial assistance.	Barske C, 2008, NEUROLOGY, V70, pA28; Baum K, 2007, MULT SCLER J, V13, P1153, DOI 10.1177/1352458507079291; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Clanet M, 2002, NEUROLOGY, V59, P1507, DOI 10.1212/01.WNL.0000032256.35561.D6; Coelho RP, 2007, J PHARMACOL EXP THER, V323, P626, DOI 10.1124/jpet.107.123927; Cohen BA, 2007, INT J CLIN PRACT, V61, P1922, DOI 10.1111/j.1742-1241.2007.01561..x; Durelli L, 2002, LANCET, V359, P1453, DOI 10.1016/S0140-6736(02)08430-1; Fischer J.S., 2001, MULTIPLE SCLEROSIS F; Foster CA, 2007, J PHARMACOL EXP THER, V323, P469, DOI 10.1124/jpet.107.127183; Fujino M, 2003, J PHARMACOL EXP THER, V305, P70, DOI 10.1124/jpet.102.045658; Galetta SL, 2005, CNS DRUGS, V19, P239, DOI 10.2165/00023210-200519030-00005; Gergely P, 2009, MULT SCLER, V15, pS125; International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceutical for Human Use, 1996, ICH HARM TRIP GUID G; Jacobs LD, 1996, ANN NEUROL, V40, P480; Kappos L, 2006, NEW ENGL J MED, V355, P1124, DOI 10.1056/NEJMoa052643; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mehling M, 2008, NEUROLOGY, V71, P1261, DOI 10.1212/01.wnl.0000327609.57688.ea; Miron VE, 2008, ANN NEUROL, V63, P61, DOI 10.1002/ana.21227; Mont-Alban X, 2009, NEUROLOGY, V72, pA313; *NEUR, NEUR TRAIN DOC DVD S; O'Connor P, 2009, NEUROLOGY, V72, P73, DOI 10.1212/01.wnl.0000338569.32367.3d; O'Connor PW, 2006, NEUROLOGY, V66, P894, DOI 10.1212/01.wnl.0000203121.04509.31; Panitch H, 2002, NEUROLOGY, V59, P1496, DOI 10.1212/01.WNL.0000034080.43681.DA; Pinschewer DD, 2000, J IMMUNOL, V164, P5761, DOI 10.4049/jimmunol.164.11.5761; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Rudick RA, 2006, NEW ENGL J MED, V354, P911, DOI 10.1056/NEJMoa044396; SCHMOUDER RL, 2006, MULT SCLER S1, V12, pS228; Schmouder R, 2006, J CLIN PHARMACOL, V46, P895, DOI 10.1177/0091270006289853; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Webb M, 2004, J NEUROIMMUNOL, V153, P108, DOI 10.1016/j.jneuroim.2004.04.015; World Medical Association, DECL HELS ETH PRINC	34	1615	1665	3	129	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 4	2010	362	5					402	415		10.1056/NEJMoa0907839	http://dx.doi.org/10.1056/NEJMoa0907839			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551FV	20089954	Bronze			2022-12-28	WOS:000274193300006
J	Collini, E; Wong, CY; Wilk, KE; Curmi, PMG; Brumer, P; Scholes, GD				Collini, Elisabetta; Wong, Cathy Y.; Wilk, Krystyna E.; Curmi, Paul M. G.; Brumer, Paul; Scholes, Gregory D.			Coherently wired light-harvesting in photosynthetic marine algae at ambient temperature	NATURE			English	Article							RESONANCE ENERGY-TRANSFER; DYNAMICS; MOLECULES; EXCITONS; PROTEIN	Photosynthesis makes use of sunlight to convert carbon dioxide into useful biomass and is vital for life on Earth. Crucial components for the photosynthetic process are antenna proteins, which absorb light and transmit the resultant excitation energy between molecules to a reaction centre. The efficiency of these electronic energy transfers has inspired much work on antenna proteins isolated from photosynthetic organisms to uncover the basic mechanisms at play(1-5). Intriguingly, recent work has documented(6-8) that light-absorbing molecules in some photosynthetic proteins capture and transfer energy according to quantum-mechanical probability laws instead of classical laws(9) at temperatures up to 180 K. This contrasts with the long-held view that long-range quantum coherence between molecules cannot be sustained in complex biological systems, even at low temperatures. Here we present two-dimensional photon echo spectroscopy(10-13) measurements on two evolutionarily related light-harvesting proteins isolated from marine cryptophyte algae, which reveal exceptionally long-lasting excitation oscillations with distinct correlations and anti-correlations even at ambient temperature. These observations provide compelling evidence for quantum-coherent sharing of electronic excitation across the 5-nm-wide proteins under biologically relevant conditions, suggesting that distant molecules within the photosynthetic proteins are 'wired' together by quantum coherence for more efficient light-harvesting in cryptophyte marine algae.	[Collini, Elisabetta; Wong, Cathy Y.; Brumer, Paul; Scholes, Gregory D.] Univ Toronto, Dept Chem, Inst Opt Sci, Toronto, ON M5S 3H6, Canada; [Collini, Elisabetta; Wong, Cathy Y.; Brumer, Paul; Scholes, Gregory D.] Univ Toronto, Ctr Quantum Informat & Quantum Control, Toronto, ON M5S 3H6, Canada; [Wilk, Krystyna E.; Curmi, Paul M. G.] Univ New S Wales, Sch Phys, Sydney, NSW 2052, Australia; [Wilk, Krystyna E.; Curmi, Paul M. G.] Univ New S Wales, St Vincents Hosp, Ctr Appl Med Res, Sydney, NSW 2052, Australia	University of Toronto; University of Toronto; University of New South Wales Sydney; St Vincents Hospital Sydney; University of New South Wales Sydney	Scholes, GD (corresponding author), Univ Toronto, Dept Chem, Inst Opt Sci, 80 St George St, Toronto, ON M5S 3H6, Canada.	gscholes@chem.utoronto.ca	Collini, Elisabetta/F-1668-2010; Curmi, Paul/G-7185-2011	Collini, Elisabetta/0000-0002-1019-9100; Curmi, Paul/0000-0001-5762-7638	Natural Sciences and Engineering Research Council of Canada; Australian Research Council; EWR	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Australian Research Council(Australian Research Council); EWR	This work was supported by the Natural Sciences and Engineering Research Council of Canada and the Australian Research Council. G.D.S. acknowledges the support of an EWR Steacie Memorial Fellowship.	Abramavicius D, 2009, CHEM REV, V109, P2350, DOI 10.1021/cr800268n; Beljonne D, 2009, J PHYS CHEM B, V113, P6583, DOI 10.1021/jp900708f; Brixner T, 2004, J CHEM PHYS, V121, P4221, DOI 10.1063/1.1776112; Cheng YC, 2008, J PHYS CHEM A, V112, P4254, DOI 10.1021/jp7107889; Cheng YC, 2009, ANNU REV PHYS CHEM, V60, P241, DOI 10.1146/annurev.physchem.040808.090259; Cho MH, 2008, CHEM REV, V108, P1331, DOI 10.1021/cr078377b; Collini E, 2009, SCIENCE, V323, P369, DOI 10.1126/science.1164016; Doust AB, 2004, J MOL BIOL, V344, P135, DOI 10.1016/j.jmb.2004.09.044; Engel GS, 2007, NATURE, V446, P782, DOI 10.1038/nature05678; FEYNMAN RP, 1948, REV MOD PHYS, V20, P367, DOI 10.1103/RevModPhys.20.367; Franco I, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2940789; Green B. R., 2003, LIGHT HARVESTING ANT; Hwang H, 2004, J PHYS CHEM B, V108, P6723, DOI 10.1021/jp037031b; Jang S, 2007, J PHYS CHEM B, V111, P6807, DOI 10.1021/jp070111l; Jang S, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3247899; Jonas DM, 2003, ANNU REV PHYS CHEM, V54, P425, DOI 10.1146/annurev.physchem.54.011002.103907; LANGHOFF CA, 1974, CHEM PHYS, V6, P34, DOI 10.1016/0301-0104(74)80032-7; Lee H, 2007, SCIENCE, V316, P1462, DOI 10.1126/science.1142188; Mercer IP, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.057402; Mirkovic T, 2007, PHOTOCH PHOTOBIO SCI, V6, P964, DOI 10.1039/b704962e; RACKOVSKY S, 1973, MOL PHYS, V25, P61, DOI 10.1080/00268977300100081; RHODES W, 1969, J CHEM PHYS, V50, P2885, DOI 10.1063/1.1671480; Scholes GD, 2003, ANNU REV PHYS CHEM, V54, P57, DOI 10.1146/annurev.physchem.54.011002.103746; Scholes GD, 2007, J PHYS CHEM B, V111, P6978, DOI 10.1021/jp072540p; Scholes GD, 2006, NAT MATER, V5, P683, DOI 10.1038/nmat1714; SPEARBERNSTEIN L, 1989, J PHYCOL, V25, P412, DOI 10.1111/j.1529-8817.1989.tb00245.x; van der Weij-De Wit CD, 2008, BIOPHYS J, V94, P2423, DOI 10.1529/biophysj.107.113993; van Grondelle R, 2006, PHYS CHEM CHEM PHYS, V8, P793, DOI 10.1039/b514032c; WEDEMAYER GJ, 1992, J BIOL CHEM, V267, P7315; Wilk KE, 1999, P NATL ACAD SCI USA, V96, P8901, DOI 10.1073/pnas.96.16.8901	30	1231	1254	12	519	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 4	2010	463	7281					644	U69		10.1038/nature08811	http://dx.doi.org/10.1038/nature08811			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551GB	20130647				2022-12-28	WOS:000274193900032
J	Clarke, RT; Mitchell, C				Clarke, Rachel T.; Mitchell, Chris			Case report A toddler with pallor and recurrent infection	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LEUKEMIA		[Mitchell, Chris] John Radcliffe Hosp, Dept Paediat Haematol Oncol, Oxford OX3 9DU, England	University of Oxford	Mitchell, C (corresponding author), John Radcliffe Hosp, Dept Paediat Haematol Oncol, Oxford OX3 9DU, England.	chris.mitchell@paediatrics.ox.ac.uk						Alvaro F, 1996, J PAEDIATR CHILD H, V32, P466, DOI 10.1111/j.1440-1754.1996.tb00951.x; BOMKEN SN, 2009, PAEDIAT CHILD HLTH, V19, P345, DOI DOI 10.1016/j.paed.2009.04.003; Feltbower RG, 2004, BRIT J CANCER, V90, P1882, DOI 10.1038/sj.bjc.6601733; Flohr T, 2008, LEUKEMIA, V22, P771, DOI 10.1038/leu.2008.5; Frankfurt O, 2008, HEMATOL MALIG, P281, DOI 10.1007/978-3-540-72304-2_23; Goor Y, 2002, J CLIN GASTROENTEROL, V34, P485, DOI 10.1097/00004836-200204000-00023; Greaves M, 2002, BRIT MED J, V324, P283, DOI 10.1136/bmj.324.7332.283; Hann I. M., 2004, Annals of Hematology, V83, pS108; Howard SC, 2006, CHILDHOOD LEUKEMIAS, 2ND EDITION, P709; JONES DP, 1995, PEDIATR NEPHROL, V9, P206, DOI 10.1007/BF00860751; Kader A, 2004, EUR J PEDIATR, V163, P628, DOI 10.1007/s00431-004-1510-1; Mitchell C, 2009, BRIT MED J, V338, P1491; *NAT I HLTH CLIN E, 2007, UR TRACT INF DIAGN T; Patel KJ, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-12; Porcu P, 2000, LEUKEMIA LYMPHOMA, V39, P1, DOI 10.3109/10428190009053534; Pui CH, 1998, NEW ENGL J MED, V339, P605, DOI 10.1056/NEJM199808273390907; Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2; Redaelli A, 2005, EUR J CANCER CARE, V14, P53, DOI 10.1111/j.1365-2354.2005.00513.x; Saraswatula A, 2009, EUR J PEDIATR, V168, P1395, DOI 10.1007/s00431-009-0933-0; Shah A, 2008, BRIT J CANCER, V99, P219, DOI 10.1038/sj.bjc.6604466; THOMPSON MJ, 2009, BMJ-BRIT MED J, V338, P1006; Urschel S, 2009, J PEDIATR-US, V154, P888, DOI 10.1016/j.jpeds.2008.12.020; Wheatley K, 1999, BRIT J HAEMATOL, V107, P69, DOI 10.1046/j.1365-2141.1999.01684.x	23	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	2010	340								b5653	10.1136/bmj.b5653	http://dx.doi.org/10.1136/bmj.b5653			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	553CV	20130005				2022-12-28	WOS:000274343500002
J	Bakker, JJH; Verhoeven, CJM; Janssen, PF; van Lith, JM; van Oudgaarden, ED; Bloemenkamp, KWM; Papatsonis, DNM; Mol, BW; van der Post, JAM				Bakker, Jannet J. H.; Verhoeven, Corine J. M.; Janssen, Petra F.; van Lith, Jan M.; van Oudgaarden, Elisabeth D.; Bloemenkamp, Kitty W. M.; Papatsonis, Dimitri N. M.; Mol, Ben Willem J.; van der Post, Joris A. M.			Outcomes after Internal versus External Tocodynamometry for Monitoring Labor	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTRAUTERINE PRESSURE CATHETER; UTERINE RUPTURE; COMPLICATIONS; AUGMENTATION; TOCOGRAPHY	BACKGROUND It has been hypothesized that internal tocodynamometry, as compared with external monitoring, may provide a more accurate assessment of contractions and thus improve the ability to adjust the dose of oxytocin effectively, resulting in fewer operative deliveries and less fetal distress. However, few data are available to test this hypothesis. METHODS We performed a randomized, controlled trial in six hospitals in the Netherlands to compare internal tocodynamometry with external monitoring of uterine activity in women for whom induced or augmented labor was required. The primary outcome was the rate of operative deliveries, including both cesarean sections and instrumented vaginal deliveries. Secondary outcomes included the use of antibiotics during labor, time from randomization to delivery, and adverse neonatal outcomes (defined as any of the following: an Apgar score at 5 minutes of less than 7, umbilical-artery pH of less than 7.05, and neonatal hospital stay of longer than 48 hours). RESULTS We randomly assigned 1456 women to either internal tocodynamometry (734) or external monitoring (722). The operative-delivery rate was 31.3% in the internal-tocodynamometry group and 29.6% in the external-monitoring group (relative risk with internal monitoring, 1.1; 95% confidence interval [CI], 0.91 to 1.2). Secondary outcomes did not differ significantly between the two groups. The rate of adverse neonatal outcomes was 14.3% with internal monitoring and 15.0% with external monitoring (relative risk, 0.95; 95% CI, 0.74 to 1.2). No serious adverse events associated with use of the intrauterine pressure catheter were reported. CONCLUSIONS Internal tocodynamometry during induced or augmented labor, as compared with external monitoring, did not significantly reduce the rate of operative deliveries or of adverse neonatal outcomes. (Current Controlled Trials number, ISRCTN13667534; Netherlands Trial number, NTR285.)	[Bakker, Jannet J. H.; Mol, Ben Willem J.; van der Post, Joris A. M.] Acad Med Ctr, Dept Obstet & Gynecol, NL-1100 DD Amsterdam, Netherlands; [Verhoeven, Corine J. M.; Mol, Ben Willem J.] Maxima Med Ctr, Veldhoven, Netherlands; [Janssen, Petra F.] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands; [van Lith, Jan M.] Onze Lieve Vrouw Hosp, Amsterdam, Netherlands; [van Oudgaarden, Elisabeth D.] Slotervaart Hosp, Amsterdam, Netherlands; [van Lith, Jan M.; Bloemenkamp, Kitty W. M.] Leiden Univ, Med Ctr, Leiden, Netherlands; [Papatsonis, Dimitri N. M.] Amphia Hosp Breda, Breda, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Maxima Medical Center; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Onze Lieve Vrouwe Gasthuis Hospital; Slotervaart Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Amphia Hospital	Bakker, JJH (corresponding author), Acad Med Ctr, Dept Obstet & Gynecol, H3-107,Meibergdreef 9, NL-1100 DD Amsterdam, Netherlands.	j.j.bakker@amc.uva.nl	Verhoeven, C.J.M./E-8128-2018; van der Post, Joris A M/A-8991-2008; Mol, Ben/I-4526-2012; Verhoeven, Corine/N-8354-2019	Verhoeven, Corine/0000-0002-0001-0888; van der Post, Joris/0000-0003-3311-2116				*AM COLL OBST GYN, 2003, ACOG PRACTICE B, V49, P1445; CHAN WH, 1973, OBSTET GYNECOL, V41, P7; CHIA YT, 1993, AUST NZ J OBSTET GYN, V33, P159, DOI 10.1111/j.1479-828X.1993.tb02382.x; CHUA S, 1990, OBSTET GYNECOL, V76, P164; *DUTCH SOC OBST GY, 2008, 5 NVOG DUTCH SOC OBS; Kayani SI, 2005, BJOG-INT J OBSTET GY, V112, P528, DOI 10.1111/j.1471-0528.2005.00661.x; Liston R, 2007, J OBSTET GYNAECOL CA, V29, pS3, DOI 10.1016/S1701-2163(16)32615-9; Macones GA, 2008, OBSTET GYNECOL, V112, P661, DOI 10.1097/AOG.0b013e3181841395; MADANES AE, 1982, OBSTET GYNECOL, V59, P389; Matsuo K, 2008, AM J OBSTET GYNECOL, V198, pE8, DOI 10.1016/j.ajog.2007.09.035; Minino Arialdi M, 2007, Natl Vital Stat Rep, V55, P1; Panayotopoulos N, 1998, PRENAT NEONAT MED, V3, P464; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; RODRIGUEZ MH, 1989, AM J OBSTET GYNECOL, V161, P666; TRUDINGER BJ, 1978, BRIT J OBSTET GYNAEC, V85, P567, DOI 10.1111/j.1471-0528.1978.tb14921.x; Wilmink FA, 2008, J MATERN-FETAL NEO M, V21, P880, DOI 10.1080/14767050802220508; Wilson RD, 2007, J OBSTET GYNAECOL CA, V29, P972, DOI 10.1016/S1701-2163(16)32679-2; Zelop CM, 1999, AM J OBSTET GYNECOL, V181, P882, DOI 10.1016/S0002-9378(99)70319-4; 2006, STICHTING PERINATALE	19	42	44	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 28	2010	362	4					306	313		10.1056/NEJMoa0902748	http://dx.doi.org/10.1056/NEJMoa0902748			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	548OT	20107216				2022-12-28	WOS:000273975000006
J	Mayack, SR; Shadrach, JL; Kim, FS; Wagers, AJ				Mayack, Shane R.; Shadrach, Jennifer L.; Kim, Francis S.; Wagers, Amy J.			RETRACTED: Systemic signals regulate ageing and rejuvenation of blood stem cell niches (Retracted article. See vol. 467, pg. 872, 2010)	NATURE			English	Article; Retracted Publication							HEMATOPOIETIC-STEM; IGF-I; PROGENITOR CELLS; SKELETAL-MUSCLE; GROWTH; OSTEOBLASTS; PATHWAYS; BONE; IDENTIFICATION; REGENERATION	Ageing in multicellular organisms typically involves a progressive decline in cell replacement and repair processes, resulting in several physiological deficiencies, including inefficient muscle repair, reduced bone mass, and dysregulation of blood formation (haematopoiesis). Although defects in tissue-resident stem cells clearly contribute to these phenotypes, it is unclear to what extent they reflect stem cell intrinsic alterations or age-related changes in the stem cell supportive microenvironment, or niche. Here, using complementary in vivo and in vitro heterochronic models, we show that age-associated changes in stem cell supportive niche cells deregulate normal haematopoiesis by causing haematopoietic stem cell dysfunction. Furthermore, we find that age-dependent defects in niche cells are systemically regulated and can be reversed by exposure to a young circulation or by neutralization of the conserved longevity regulator, insulin-like growth factor-1, in the marrow microenvironment. Together, these results show a new and critical role for local and systemic factors in signalling age-related haematopoietic decline, and highlight a new model in which blood-borne factors in aged animals act through local niche cells to induce age-dependent disruption of stem cell function.	[Mayack, Shane R.; Shadrach, Jennifer L.; Kim, Francis S.; Wagers, Amy J.] Harvard Univ, Howard Hughes Med Inst, Dept Stem Cell & Regenerat Biol, Harvard Stem Cell Inst,Joslin Diabet Ctr, Boston, MA 02115 USA	Harvard University; Joslin Diabetes Center, Inc.; Howard Hughes Medical Institute	Wagers, AJ (corresponding author), Harvard Univ, Howard Hughes Med Inst, Dept Stem Cell & Regenerat Biol, Harvard Stem Cell Inst,Joslin Diabet Ctr, 1 Joslin Pl, Boston, MA 02115 USA.	amy.wagers@joslin.harvard.edu			Burroughs-Welcome Fund; WM Keck Foundation; Glenn Foundation; National Institutes of Health (NIH) [1 DP2 OD004345-01, T32DK07260-29]; Iacocca Foundation; Joslin Diabetes Center DERC [P30DK036836]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007260, P30DK036836] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004345] Funding Source: NIH RePORTER	Burroughs-Welcome Fund(Burroughs Wellcome Fund); WM Keck Foundation(W.M. Keck Foundation); Glenn Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Iacocca Foundation; Joslin Diabetes Center DERC; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by funding from the Burroughs-Welcome Fund, WM Keck Foundation, Glenn Foundation, and National Institutes of Health (NIH) 1 DP2 OD004345-01 (to A. J. W.), by fellowships from the NIH (T32DK07260-29) and the Iacocca Foundation (to S. R. M.), and by the Joslin Diabetes Center DERC (P30DK036836). We thank J. LaVecchio and G. Buruzula for expert cell sorting, C. J. Luckey for anti-IGF-1 antibody, and L. Zon, R. Lee, D. Rossi, L. P. Kane, S. Lowe and C. Dall'Osso for helpful advice and critical reading of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Arai F, 2005, TRENDS CARDIOVAS MED, V15, P75, DOI 10.1016/j.tcm.2005.03.002; Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Caspari R, 2004, P NATL ACAD SCI USA, V101, P10895, DOI 10.1073/pnas.0402857101; Cornish J, 2004, BIOCHEM BIOPH RES CO, V318, P240, DOI 10.1016/j.bbrc.2004.04.020; DiGirolamo DJ, 2007, J BIOL CHEM, V282, P31666, DOI 10.1074/jbc.M705219200; Eggan K, 2006, NATURE, V441, P1109, DOI 10.1038/nature04929; Ema H, 2006, NAT PROTOC, V1, P2979, DOI 10.1038/nprot.2006.447; Fisher MC, 2005, BONE, V37, P741, DOI 10.1016/j.bone.2005.07.024; Fulzele K, 2007, J BIOL CHEM, V282, P25649, DOI 10.1074/jbc.M700651200; GIBSON LF, 1993, BLOOD, V82, P3005; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Jones DL, 2008, NAT REV MOL CELL BIO, V9, P11, DOI 10.1038/nrm2319; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kuro-O M, 2008, BIOL CHEM, V389, P233, DOI 10.1515/BC.2008.028; Liang Y, 2005, BLOOD, V106, P1479, DOI 10.1182/blood-2004-11-4282; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; Mayack SR, 2008, BLOOD, V112, P519, DOI 10.1182/blood-2008-01-133710; Morrison SJ, 1997, DEVELOPMENT, V124, P1929; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Nakasaki M, 2008, BONE, V43, P869, DOI 10.1016/j.bone.2008.07.241; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Wagers AJ, 2005, CELL, V122, P659, DOI 10.1016/j.cell.2005.08.021; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Wang YM, 2007, J BONE MINER RES, V22, P1329, DOI 10.1359/JBMR.070517; Welniak LA, 2004, BIOL BLOOD MARROW TR, V10, P32, DOI 10.1016/j.bbmt.2003.09.008; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	37	104	112	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 28	2010	463	7280					495	U109		10.1038/nature08749	http://dx.doi.org/10.1038/nature08749			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	548QK	20110993				2022-12-28	WOS:000273981100041
J	Coleman, J; Spurling, G				Coleman, Justin; Spurling, Geoffrey			Easily missed? Constipation in people with learning disability	BRITISH MEDICAL JOURNAL			English	Editorial Material							INTELLECTUAL DISABILITIES; CHILDREN; MANAGEMENT		[Coleman, Justin; Spurling, Geoffrey] Inala Indigenous Hlth, Discipline Gen Practice, Inala, Qld 4077, Australia		Coleman, J (corresponding author), Inala Indigenous Hlth, Discipline Gen Practice, 64 Wirraway Parade, Inala, Qld 4077, Australia.	colross@tpg.com.au	Spurling, Geoffrey K/F-1783-2010	Spurling, Geoffrey K/0000-0002-3525-4663				Bohmer CJM, 2001, J INTELL DISABIL RES, V45, P212, DOI 10.1046/j.1365-2788.2001.00300.x; Carr E., 1995, MENTAL RETARDATION D, V1, P94, DOI DOI 10.1002/MRDD.1410010204; Del Giudice E, 1999, BRAIN DEV-JPN, V21, P307, DOI 10.1016/S0387-7604(99)00025-X; Elawad MA, 2001, DEV MED CHILD NEUROL, V43, P829, DOI 10.1017/S0012162201001505; JANCAR J, 1994, J INTELL DISABIL RES, V38, P413; Kamm MA, 2003, BMJ-BRIT MED J, V327, P459, DOI 10.1136/bmj.327.7413.459; Lantman-de Valk HMJV, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2507; MARSH L, 2008, BR J NURS, V17, P11; Pare P, 2001, AM J GASTROENTEROL, V96, P3130, DOI 10.1111/j.1572-0241.2001.05259.x; Ramkumar D, 2005, AM J GASTROENTEROL, V100, P936, DOI 10.1111/j.1572-0241.2005.40925.x; Rubin G, 2006, BMJ-BRIT MED J, V333, P1051, DOI 10.1136/bmj.39007.760174.47; Staiano A, 2000, J PEDIATR-US, V136, P41, DOI 10.1016/S0022-3476(00)90047-7; Starr JM, 2008, J INTELL DISABIL RES, V52, P483, DOI 10.1111/j.1365-2788.2008.01051.x; Sullivan PB, 2008, DEV DISABIL RES REV, V14, P128, DOI 10.1002/ddrr.18; 2004, DIRECTED ENHANCED SE	15	10	10	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 26	2010	340								c222	10.1136/bmj.c222	http://dx.doi.org/10.1136/bmj.c222			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	549YA	20103526				2022-12-28	WOS:000274089200002
J	Marwan, W				Marwan, Wolfgang			Amoeba-Inspired Network Design	SCIENCE			English	Editorial Material									Otto von Guericke Univ, Magdeburg Ctr Syst Biol, D-39106 Magdeburg, Germany	Otto von Guericke University	Marwan, W (corresponding author), Otto von Guericke Univ, Magdeburg Ctr Syst Biol, Sandtorstr 1, D-39106 Magdeburg, Germany.	marwan@mpi-magdeburg.mpg.de						Tero A, 2007, J THEOR BIOL, V244, P553, DOI 10.1016/j.jtbi.2006.07.015; Tero A, 2010, SCIENCE, V327, P439, DOI 10.1126/science.1177894	2	23	23	2	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 22	2010	327	5964					419	420		10.1126/science.1185570	http://dx.doi.org/10.1126/science.1185570			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546BS	20093462				2022-12-28	WOS:000273783100023
J	Engelen, M; Ofman, R; Dijkgraaf, MGW; Hijzen, M; van der Wardt, LA; van Geel, BM; de Visser, M; Wanders, RJA; Poll-The, BT; Kemp, S				Engelen, Marc; Ofman, Rob; Dijkgraaf, Marcel G. W.; Hijzen, Michiel; van der Wardt, Lucinda A.; van Geel, Bjorn M.; de Visser, Marianne; Wanders, Ronald J. A.; Poll-The, Bwee Tien; Kemp, Stephan			Lovastatin in X-Linked Adrenoleukodystrophy	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter							CHAIN FATTY-ACIDS; SIMVASTATIN		[Engelen, Marc; Ofman, Rob; Dijkgraaf, Marcel G. W.; Hijzen, Michiel; van der Wardt, Lucinda A.; de Visser, Marianne; Wanders, Ronald J. A.; Poll-The, Bwee Tien; Kemp, Stephan] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [van Geel, Bjorn M.] Med Ctr Alkmaar, Alkmaar, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Medical Center Of Alkmaar	Engelen, M (corresponding author), Univ Amsterdam, Acad Med Ctr, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	s.kemp@amc.uva.nl	Engelen, Marc/F-8433-2012; Kemp, Stephan/A-3935-2008; Dijkgraaf, Marcel GW/G-6663-2011	Engelen, Marc/0000-0002-5346-8497; Kemp, Stephan/0000-0003-2023-064X; Poll-The, Bwee Tien/0000-0002-8118-5419				Cartier N, 2000, FEBS LETT, V478, P205, DOI 10.1016/S0014-5793(00)01852-4; HO JK, 1995, J CLIN INVEST, V96, P1455, DOI 10.1172/JCI118182; Singh I, 1998, NEW ENGL J MED, V339, P702, DOI 10.1056/NEJM199809033391012; Valianpour F, 2003, MOL GENET METAB, V79, P189, DOI 10.1016/S1096-7192(03)00098-2; Verrips A, 2000, ANN NEUROL, V47, P552, DOI 10.1002/1531-8249(200004)47:4<552::AID-ANA28>3.3.CO;2-S	5	36	40	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 21	2010	362	3					276	277		10.1056/NEJMc0907735	http://dx.doi.org/10.1056/NEJMc0907735			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	545NE	20089986				2022-12-28	WOS:000273738400032
J	Schroder, K; Zhou, RB; Tschopp, J				Schroder, Kate; Zhou, Rongbin; Tschopp, Jurg			The NLRP3 Inflammasome: A Sensor for Metabolic Danger?	SCIENCE			English	Review							BETA-CELL APOPTOSIS; THIOREDOXIN-INTERACTING PROTEIN; TYPE-2 DIABETES-MELLITUS; HUMAN PANCREATIC-ISLETS; NALP3 INFLAMMASOME; CRYOPYRIN INFLAMMASOME; INNATE IMMUNITY; RECEPTOR; INTERLEUKIN-1-BETA; GLUCOSE	Interleukin-1 beta (IL-1 beta), reactive oxygen species (ROS), and thioredoxin-interacting protein (TXNIP) are all implicated in the pathogenesis of type 2 diabetes mellitus (T2DM). Here we review mechanisms directing IL-1 beta production and its pathogenic role in islet dysfunction during chronic hyperglycemia. In doing so, we integrate previously disparate disease-driving mechanisms for IL-1 beta, ROS, and TXNIP in T2DM into one unifying model in which the NLRP3 inflammasome plays a central role. The NLRP3 inflammasome also drives IL-1 beta maturation and secretion in another disease of metabolic dysregulation, gout. Thus, we propose that the NLRP3 inflammasome contributes to the pathogenesis of T2DM and gout by functioning as a sensor for metabolic stress.	[Schroder, Kate; Zhou, Rongbin; Tschopp, Jurg] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Schroder, Kate] Monash Univ, Monash Inst Med Res, Clayton, Vic 3800, Australia	University of Lausanne; Monash University	Tschopp, J (corresponding author), Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland.	jurg.tschopp@unil.ch	Schroder, Kate/C-6132-2008; Zhou, Rongbin/B-1430-2013	Schroder, Kate/0000-0001-9261-3805; 	Australian National Health and Medical Research Council [ID 490993]; Swiss National Science Foundation; European Union; Institute of Arthritis Research	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Union(European Commission); Institute of Arthritis Research	K. S. is supported by a C. J. Martin Fellowship from the Australian National Health and Medical Research Council (ID 490993). J. T. is supported by grants of the Swiss National Science Foundation, European Union grants (Hermione, Apo-train, Apo-SYS, and Mugene), and the Institute of Arthritis Research. We thank K. Irvine, A. Yazdi, and M. Donath for critical reading of the manuscript.	Boni-Schnetzler M, 2009, ENDOCRINOLOGY, V150, P5218, DOI 10.1210/en.2009-0543; Boni-Schnetzler M, 2008, J CLIN ENDOCR METAB, V93, P4065, DOI 10.1210/jc.2008-0396; Bryant C, 2009, TRENDS CELL BIOL, V19, P455, DOI 10.1016/j.tcb.2009.06.002; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Chen J, 2008, DIABETES, V57, P938, DOI 10.2337/db07-0715; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; Donath MY, 1999, DIABETES, V48, P738, DOI 10.2337/diabetes.48.4.738; Donath MY, 2003, J MOL MED-JMM, V81, P455, DOI 10.1007/s00109-003-0450-y; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; EIZIRIK DL, 1991, DIABETOLOGIA, V34, P445, DOI 10.1007/BF00403185; Feldmeyer L, 2007, CURR BIOL, V17, P1140, DOI 10.1016/j.cub.2007.05.074; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; HISCOTT J, 1993, MOL CELL BIOL, V13, P6231, DOI 10.1128/MCB.13.10.6231; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hui STY, 2008, P NATL ACAD SCI USA, V105, P3921, DOI 10.1073/pnas.0800293105; Kahlenberg JM, 2004, AM J PHYSIOL-CELL PH, V286, pC1100, DOI 10.1152/ajpcell.00494.2003; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; Lamkanfi M, 2009, J BIOL CHEM, V284, P20574, DOI 10.1074/jbc.M109.023689; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Larsen CM, 2009, DIABETES CARE, V32, P1663, DOI 10.2337/dc09-0533; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Maedler K, 2001, DIABETES, V50, P1683, DOI 10.2337/diabetes.50.8.1683; Maedler K, 2006, DIABETES, V55, P2713, DOI 10.2337/db05-1430; Maedler K, 2009, EXPERT OPIN BIOL TH, V9, P1177, DOI 10.1517/14712590903136688; MANDRUPPOULSEN T, 1986, DIABETOLOGIA, V29, P63, DOI 10.1007/BF02427283; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Meissner F, 2008, NAT IMMUNOL, V9, P866, DOI 10.1038/ni.1633; Minn AH, 2005, ENDOCRINOLOGY, V146, P2397, DOI 10.1210/en.2004-1378; Morgan D, 2007, DIABETOLOGIA, V50, P359, DOI 10.1007/s00125-006-0462-6; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Newman ZL, 2009, INFECT IMMUN, V77, P4327, DOI 10.1128/IAI.00730-09; Nishikawa T, 2007, ANTIOXID REDOX SIGN, V9, P343, DOI 10.1089/ars.2006.1458; Oka S, 2009, ENDOCRINOLOGY, V150, P1225, DOI 10.1210/en.2008-0646; Osborn O, 2008, CYTOKINE, V44, P141, DOI 10.1016/j.cyto.2008.07.004; Parikh H, 2007, PLOS MED, V4, P868, DOI 10.1371/journal.pmed.0040158; Pedra JHF, 2009, CURR OPIN IMMUNOL, V21, P10, DOI 10.1016/j.coi.2009.01.006; PLATASALAMAN CR, 1992, PHYSIOL BEHAV, V51, P1277, DOI 10.1016/0031-9384(92)90321-R; Sakuraba H, 2002, DIABETOLOGIA, V45, P85, DOI 10.1007/s125-002-8248-z; Sauter NS, 2008, ENDOCRINOLOGY, V149, P2208, DOI 10.1210/en.2007-1059; Schroder K, 2009, CURR BIOL, V19, pR262, DOI 10.1016/j.cub.2009.02.011; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; So A, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2143; SPINAS GA, 1986, ACTA ENDOCRINOL-COP, V113, P551, DOI 10.1530/acta.0.1130551; Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812; Tellez N, 2005, GENE THER, V12, P120, DOI 10.1038/sj.gt.3302351; Terkeltaub R, 2009, ANN RHEUM DIS, V68, P1613, DOI 10.1136/ard.2009.108936; Wolfs MGM, 2009, CURR GENOMICS, V10, P110, DOI 10.2174/138920209787847023; ZHOU R, 2009, NAT IMMUNOL, V11, P136, DOI DOI 10.1038/NI.1831	51	810	864	5	202	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 15	2010	327	5963					296	300		10.1126/science.1184003	http://dx.doi.org/10.1126/science.1184003			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544CM	20075245				2022-12-28	WOS:000273629700032
J	Ting, JPY; Duncan, JA; Lei, Y				Ting, Jenny P. Y.; Duncan, Joseph A.; Lei, Yu			How the Noninflammasome NLRs Function in the Innate Immune System	SCIENCE			English	Review							NF-KAPPA-B; ALPHA-DEFENSIN EXPRESSION; CROHNS-DISEASE; RIG-I; MURAMYL DIPEPTIDE; ADAPTIVE IMMUNITY; NOD2 MUTATION; SIGNALING PATHWAY; CUTTING EDGE; RNA VIRUSES	NLR (nucleotide-binding domain, leucine-rich repeat-containing) proteins have rapidly emerged as central regulators of immunity and inflammation with demonstrated relevance to human diseases. Much attention has focused on the ability of several NLRs to activate the inflammasome complex and drive proteolytic processing of inflammatory cytokines; however, NLRs also regulate important inflammasome-independent functions in the immune system. We discuss several of these functions, including the regulation of canonical and noncanonical NF-kappa B activation, mitogen-activated protein kinase activation, cytokine and chemokine production, antimicrobial reactive oxygen species production, type I interferon production, and ribonuclease L activity. We also explore the mechanistic basis of these functions and describe current challenges in the field.	[Ting, Jenny P. Y.] Univ N Carolina, Dept Microbiol Immunol, Chapel Hill, NC 27599 USA; [Ting, Jenny P. Y.; Lei, Yu] Univ N Carolina, Curriculum Oral Biol, Chapel Hill, NC 27599 USA; [Ting, Jenny P. Y.; Lei, Yu] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Duncan, Joseph A.] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Duncan, Joseph A.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Ting, JPY (corresponding author), Univ N Carolina, Dept Microbiol Immunol, Chapel Hill, NC 27599 USA.	jpyting@med.unc.edu	Lei, Yu Leo/ABF-1293-2020	Lei, Yu Leo/0000-0002-9868-9824	NIH [CA131645, AI057157, AI031496, AI063031, DE016326, U19AI077437, DK38108]; Burroughs Wellcome Fund; SERCEB; NATIONAL CANCER INSTITUTE [R21CA131645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057157, U19AI077437, R37AI029564, R01AI063031, U01AI031496, R01AI088255, U19AI031496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016326] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK038108] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); SERCEB; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We acknowledge the very large number of researchers who have contributed to this field whose work was not cited or was cited through others' review articles because of space limitations. Supported by NIH grants CA131645, AI057157, and AI031496 and the Burroughs Wellcome Fund Career Award for Medical Scientists (J. A. D.) and by NIH grants AI063031, DE016326, U19AI077437, DK38108, and SERCEB (J. P. T.).	Arnoult D, 2009, J CELL SCI, V122, P3161, DOI 10.1242/jcs.051193; Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Bertrand MJM, 2009, IMMUNITY, V30, P789, DOI 10.1016/j.immuni.2009.04.011; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Chamaillard M, 2003, P NATL ACAD SCI USA, V100, P3455, DOI 10.1073/pnas.0530276100; Coulombe F, 2009, J EXP MED, V206, P1709, DOI 10.1084/jem.20081779; Dugan JW, 2009, MOL IMMUNOL, V47, P560, DOI 10.1016/j.molimm.2009.09.025; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Fritz JH, 2008, TRENDS IMMUNOL, V29, P41, DOI 10.1016/j.it.2007.10.002; Hsu LC, 2008, P NATL ACAD SCI USA, V105, P7803, DOI 10.1073/pnas.0802726105; Jia YX, 2009, J IMMUNOL, V183, P4241, DOI 10.4049/jimmunol.0901646; Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Lecine P, 2007, J BIOL CHEM, V282, P15197, DOI 10.1074/jbc.M606242200; Lei Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005466; Li J, 2004, HUM MOL GENET, V13, P1715, DOI 10.1093/hmg/ddh182; Lich JD, 2007, J IMMUNOL, V178, P1256, DOI 10.4049/jimmunol.178.3.1256; Lipinski S, 2009, J CELL SCI, V122, P3522, DOI 10.1242/jcs.050690; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; Malathi K, 2005, P NATL ACAD SCI USA, V102, P14533, DOI 10.1073/pnas.0507551102; Mayor A, 2007, NAT IMMUNOL, V8, P497, DOI 10.1038/ni1459; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Noguchi E, 2009, NAT IMMUNOL, V10, P471, DOI 10.1038/ni.1722; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Pan QL, 2007, J LEUKOCYTE BIOL, V82, P177, DOI 10.1189/jlb.1006627; Pan QL, 2006, INFECT IMMUN, V74, P2121, DOI 10.1128/IAI.74.4.2121-2127.2006; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Simms LA, 2008, GUT, V57, P903, DOI 10.1136/gut.2007.142588; Tattoli I, 2008, EMBO REP, V9, P293, DOI 10.1038/sj.embor.7401161; Tattoli I, 2007, SEMIN IMMUNOPATHOL, V29, P289, DOI 10.1007/s00281-007-0083-2; Ting JPY, 2005, ANNU REV IMMUNOL, V23, P387, DOI 10.1146/annurev.immunol.23.021704.115616; Wang L, 2002, J BIOL CHEM, V277, P29874, DOI 10.1074/jbc.M203915200; Watanabe T, 2004, NAT IMMUNOL, V5, P800, DOI 10.1038/ni1092; Watanabe T, 2008, J CLIN INVEST, V118, P545, DOI [10.1172/JC133145, 10.1172/JCI33145]; Wehkamp J, 2004, GUT, V53, P1658, DOI 10.1136/gut.2003.032805; Williams KL, 2003, J IMMUNOL, V170, P5354, DOI 10.4049/jimmunol.170.11.5354; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Xu LJ, 2009, P NATL ACAD SCI USA, V106, P1530, DOI 10.1073/pnas.0811029106; Yasukawa K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000287; Yoneyama M, 2008, IMMUNITY, V29, P178, DOI 10.1016/j.immuni.2008.07.009; You FP, 2009, NAT IMMUNOL, V10, P1300, DOI 10.1038/ni.1815	48	229	239	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 15	2010	327	5963					286	290		10.1126/science.1184004	http://dx.doi.org/10.1126/science.1184004			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544CM	20075243	Green Accepted, Green Submitted			2022-12-28	WOS:000273629700030
J	Norris, JH; Carrim, ZI; Morrell, AJ				Norris, Jonathan H.; Carrim, Zia I.; Morrell, Andrew J.			Spiderman's eye	LANCET			English	Editorial Material							OPHTHALMIA NODOSA; TARANTULA HAIRS		[Norris, Jonathan H.; Carrim, Zia I.; Morrell, Andrew J.] St James Univ Hosp, Dept Ophthalmol, Leeds LS9 7TF, W Yorkshire, England	Saint James's University Hospital	Carrim, ZI (corresponding author), St James Univ Hosp, Dept Ophthalmol, Beckett St, Leeds LS9 7TF, W Yorkshire, England.	zia.carrim@doctors.org						CHANG PCT, 1991, BRIT J OPHTHALMOL, V75, P253, DOI 10.1136/bjo.75.4.253-b; Choi JTL, 2003, EYE, V17, P433, DOI 10.1038/sj.eye.6700335; HERED RW, 1988, OPHTHALMOLOGY, V95, P166, DOI 10.1016/S0161-6420(88)33191-X; SHULTZ SA, 1998, BARRONS ED SERIES; WATSON PG, 1966, BRIT J OPHTHALMOL, V50, P209, DOI 10.1136/bjo.50.4.209	5	3	4	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 2	2010	375	9708					92	92		10.1016/S0140-6736(09)61672-X	http://dx.doi.org/10.1016/S0140-6736(09)61672-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	539BZ	20109868				2022-12-28	WOS:000273229700036
J	Vierbuchen, T; Ostermeier, A; Pang, ZP; Kokubu, Y; Sudhof, TC; Wernig, M				Vierbuchen, Thomas; Ostermeier, Austin; Pang, Zhiping P.; Kokubu, Yuko; Suedhof, Thomas C.; Wernig, Marius			Direct conversion of fibroblasts to functional neurons by defined factors	NATURE			English	Article							EMBRYONIC STEM-CELLS; SOMATIC-CELLS; MATURE B; NUCLEAR TRANSFER; PLURIPOTENCY; EXPRESSION; PROTEINS; TRANSPLANTATION; PROGENITORS; GENERATION	Cellular differentiation and lineage commitment are considered to be robust and irreversible processes during development. Recent work has shown that mouse and human fibroblasts can be reprogrammed to a pluripotent state with a combination of four transcription factors. This raised the question of whether transcription factors could directly induce other defined somatic cell fates, and not only an undifferentiated state. We hypothesized that combinatorial expression of neural-lineage-specific transcription factors could directly convert fibroblasts into neurons. Starting from a pool of nineteen candidate genes, we identified a combination of only three factors, Ascl1, Brn2 ( also called Pou3f2) and Myt1l, that suffice to rapidly and efficiently convert mouse embryonic and postnatal fibroblasts into functional neurons in vitro. These induced neuronal (iN) cells express multiple neuron-specific proteins, generate action potentials and form functional synapses. Generation of iN cells from non-neural lineages could have important implications for studies of neural development, neurological disease modelling and regenerative medicine.	[Vierbuchen, Thomas; Ostermeier, Austin; Kokubu, Yuko; Wernig, Marius] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Dept Pathol, Palo Alto, CA 94304 USA; [Vierbuchen, Thomas; Ostermeier, Austin; Wernig, Marius] Stanford Univ, Sch Med, Program Canc Biol, Palo Alto, CA 94304 USA; [Pang, Zhiping P.; Suedhof, Thomas C.] Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Palo Alto, CA 94304 USA; [Suedhof, Thomas C.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Palo Alto, CA 94304 USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Wernig, M (corresponding author), Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Dept Pathol, 1050 Arastradero Rd, Palo Alto, CA 94304 USA.	wernig@stanford.edu	Wilson, Matthew H/K-3193-2013; Pang, Zhiping/AAF-5757-2020	Pang, Zhiping/0000-0002-6183-1233; Vierbuchen, Thomas/0000-0002-5690-5680	Institute for Stem Cell Biology and Regenerative Medicine at Stanford; Donald E. and Delia B. Baxter Foundation; William Stinehart Jr and the Reed Foundation; National Institute of Health [1018438-142-PABCA]; Ruth and Robert Halperin Stanford Graduate Fellowship; NARSAD; NIH/NINDS [5T32NS007280]; NATIONAL CANCER INSTITUTE [T32CA009302] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007280] Funding Source: NIH RePORTER	Institute for Stem Cell Biology and Regenerative Medicine at Stanford; Donald E. and Delia B. Baxter Foundation; William Stinehart Jr and the Reed Foundation; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth and Robert Halperin Stanford Graduate Fellowship; NARSAD(NARSAD); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank S. Marro and P. Lovelace for help with FACS sorting, S. Hafeez and Y. Huh for assistance with molecular cloning and mouse husbandry, and K. Jann for assistance with the diagram in Fig. 1. We would also like to thank I. Graef, R. Bajpai, J. Wysocka, J.-R. Lin and J.-Y. Chen for contributing reagents and help with analysis. This work was supported by start-up funds from the Institute for Stem Cell Biology and Regenerative Medicine at Stanford ( M. W.), the Donald E. and Delia B. Baxter Foundation ( M. W.), an award from William Stinehart Jr and the Reed Foundation ( M. W.), the National Institute of Health Training Grant 1018438-142-PABCA (A.O.) and the Ruth and Robert Halperin Stanford Graduate Fellowship ( T. V.). Z.P.P. is supported by NARSAD Young Investigator Award and NIH/NINDS Epilepsy Training Grant 5T32NS007280.	Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; BLAU HM, 1989, TRENDS GENET, V5, P268, DOI 10.1016/0168-9525(89)90100-5; BRIGGS R, 1952, P NATL ACAD SCI USA, V38, P455, DOI 10.1073/pnas.38.5.455; Bussmann LH, 2009, CELL STEM CELL, V5, P554, DOI 10.1016/j.stem.2009.10.004; Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Cobaleda C, 2007, NATURE, V449, P473, DOI 10.1038/nature06159; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Do JT, 2004, STEM CELLS, V22, P941, DOI 10.1634/stemcells.22-6-941; ESCURAT M, 1990, J NEUROSCI, V10, P764; Farah MH, 2000, DEVELOPMENT, V127, P693; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; Guillemot F, 2005, CURR OPIN CELL BIOL, V17, P639, DOI 10.1016/j.ceb.2005.09.006; GURDON JB, 1958, NATURE, V182, P64, DOI 10.1038/182064a0; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kondo M, 2000, NATURE, V407, P383, DOI 10.1038/35030112; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Maximov A, 2005, NEURON, V48, P547, DOI 10.1016/j.neuron.2005.09.006; Maximov A, 2007, J NEUROSCI METH, V161, P75, DOI 10.1016/j.jneumeth.2006.10.009; SCHAFER BW, 1990, NATURE, V344, P454, DOI 10.1038/344454a0; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Wernig M, 2002, J NEUROSCI RES, V69, P918, DOI 10.1002/jnr.10395; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wu H, 2007, P NATL ACAD SCI USA, V104, P13821, DOI 10.1073/pnas.0706199104; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Zhou Q, 2008, CELL STEM CELL, V3, P382, DOI 10.1016/j.stem.2008.09.015; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	37	2079	2276	4	409	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 25	2010	463	7284					1035	U50		10.1038/nature08797	http://dx.doi.org/10.1038/nature08797			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563DR	20107439	Green Accepted			2022-12-28	WOS:000275108400027
J	Fiete, GA; de Lozanne, A				Fiete, Gregory A.; de Lozanne, Alex			Seeing Quantum Fractals	SCIENCE			English	Editorial Material							TOPOLOGICAL INSULATORS; SEMICONDUCTORS; MICROSCOPY		[Fiete, Gregory A.; de Lozanne, Alex] Univ Texas Austin, Dept Phys, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Fiete, GA (corresponding author), Univ Texas Austin, Dept Phys, Austin, TX 78712 USA.	fiete@physics.utexas.edu; delozanne@physics.utexas.edu	de Lozanne, Alex L/C-9693-2013	de Lozanne, Alex L/0000-0003-2950-4707; Fiete, Gregory/0000-0001-9477-0804				ANDERSON PW, 1958, PHYS REV, V109, P1492, DOI 10.1103/PhysRev.109.1492; BINNIG G, 1987, REV MOD PHYS, V59, P615, DOI 10.1103/RevModPhys.59.615; CROMMIE MF, 1993, SCIENCE, V262, P218, DOI 10.1126/science.262.5131.218; Evers F, 2008, REV MOD PHYS, V80, P1355, DOI 10.1103/RevModPhys.80.1355; Foster MS, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.075101; Jungwirth T, 2006, REV MOD PHYS, V78, P809, DOI 10.1103/RevModPhys.78.809; Macdonald AH, 2005, NAT MATER, V4, P195, DOI 10.1038/nmat1325; Moca CP, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.137203; Moore J, 2009, NAT PHYS, V5, P378, DOI 10.1038/nphys1294; Ohno H, 1998, SCIENCE, V281, P951, DOI 10.1126/science.281.5379.951; Qi XL, 2010, PHYS TODAY, V63, P33, DOI 10.1063/1.3293411; Richardella A, 2010, SCIENCE, V327, P665, DOI 10.1126/science.1183640; SMITH AR, 1994, REV SCI INSTRUM, V65, P3216, DOI 10.1063/1.1144552; Zutic I, 2004, REV MOD PHYS, V76, P323, DOI 10.1103/RevModPhys.76.323	14	2	2	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 5	2010	327	5966					652	653		10.1126/science.1186118	http://dx.doi.org/10.1126/science.1186118			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551ZD	20133561	Green Submitted			2022-12-28	WOS:000274251800025
J	Swain, MR; Deroo, P; Griffith, CA; Tinetti, G; Thatte, A; Vasisht, G; Chen, P; Bouwman, J; Crossfield, IJ; Angerhausen, D; Afonso, C; Henning, T				Swain, Mark R.; Deroo, Pieter; Griffith, Caitlin A.; Tinetti, Giovanna; Thatte, Azam; Vasisht, Gautam; Chen, Pin; Bouwman, Jeroen; Crossfield, Ian J.; Angerhausen, Daniel; Afonso, Cristina; Henning, Thomas			A ground-based near-infrared emission spectrum of the exoplanet HD 189733b	NATURE			English	Article							ATMOSPHERIC CIRCULATION; TRANSMISSION SPECTRUM; EXTRASOLAR PLANET; DAYSIDE SPECTRUM; HOT JUPITERS; WATER; METHANE; ABSORPTION; 209458B; SODIUM	Detection of molecules using infrared spectroscopy probes the conditions and compositions of exoplanet atmospheres. Water (H(2)O), methane (CH(4)), carbon dioxide (CO(2)), and carbon monoxide (CO) have been detected(1-5) in two hot Jupiters. These previous results relied on space-based telescopes that do not provide spectroscopic capability in the 2.4-5.2 mu m spectral region. Here we report ground-based observations of the dayside emission spectrum for HD189733b between 2.0-2.4 mu m and 3.1-4.1 mu m, where we find a bright emission feature. Where overlap with space-based instruments exists, our results are in excellent agreement with previous measurements(2,6). A feature at similar to 3.25 mu m is unexpected and difficult to explain with models that assume local thermodynamic equilibrium (LTE) conditions at the 1 bar to 1 x 10(-6) bar pressures typically sampled by infrared measurements. The most likely explanation for this feature is that it arises fromnon-LTE emission from CH(4), similar to what is seen in the atmospheres of planets in our own Solar System(7-9). These results suggest that non-LTE effects may need to be considered when interpreting measurements of strongly irradiated exoplanets.	[Swain, Mark R.; Deroo, Pieter; Vasisht, Gautam; Chen, Pin] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Griffith, Caitlin A.] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Tinetti, Giovanna] UCL, Dept Phys & Astron, London WC1E 6BT, England; [Crossfield, Ian J.] Univ Calif Los Angeles, Dept Astron, Los Angeles, CA 90034 USA; [Thatte, Azam] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA; [Bouwman, Jeroen; Afonso, Cristina; Henning, Thomas] Max Planck Inst Astron, D-69117 Heidelberg, Germany; [Angerhausen, Daniel] German SOFIA Inst, Inst Space Syst, Stuttgart, Germany	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Arizona; University of London; University College London; University of California System; University of California Los Angeles; University System of Georgia; Georgia Institute of Technology; Max Planck Society	Swain, MR (corresponding author), CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.	mark.r.swain@jpl.nasa.gov	Vasisht, Gautam/AAP-3022-2020; Chen, Pin/B-1112-2008; Tinetti, Giovanna/G-7956-2017; Tinetti, Giovanna/Q-4697-2019	Vasisht, Gautam/0000-0002-1871-6264; Chen, Pin/0000-0003-1195-9666; Tinetti, Giovanna/0000-0001-6058-6654; Tinetti, Giovanna/0000-0001-6058-6654; Angerhausen, Daniel/0000-0001-6138-8633; Bouwman, Jeroen/0000-0003-4757-2500	UK Sciences and Technology Facilities Council; European Space Agency; National Aeronautics and Space Administration	UK Sciences and Technology Facilities Council; European Space Agency(European Space AgencyEuropean Commission); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA))	We thank S. Bus at the IRTF for several discussions regarding the operation of the SpeX instrument and for support during our observing runs. We thank the observing staff at the IRTF for their assistance and advice during observing runs. We thank L. Brown for making recommendations on molecular line lists and G. Orton for extensive discussions about the interpretation of these results. G. Tinetti was supported by the UK Sciences and Technology Facilities Council and the European Space Agency. The research described in this paper was carried out at the Jet Propulsion Laboratory, California Institute of Technology, under a contract with the National Aeronautics and Space Administration.	Barman TS, 2008, ASTROPHYS J LETT, V676, pL61, DOI 10.1086/587056; Brown RH, 2003, ICARUS, V164, P461, DOI 10.1016/S0019-1035(03)00134-9; Charbonneau D, 2008, ASTROPHYS J, V686, P1341, DOI 10.1086/591635; Drossart P, 1999, ESA SP PUBL, V427, P169; Grillmair CJ, 2008, NATURE, V456, P767, DOI 10.1038/nature07574; Kim SJ, 2000, ICARUS, V147, P588, DOI 10.1006/icar.2000.6481; Menou K, 2009, ASTROPHYS J, V700, P887, DOI 10.1088/0004-637X/700/1/887; Pagiatakis SD, 2007, PHYS EARTH PLANET IN, V160, P108, DOI 10.1016/j.pepi.2006.10.002; Rayner JT, 2003, PUBL ASTRON SOC PAC, V115, P362, DOI 10.1086/367745; Redfield S, 2008, ASTROPHYS J LETT, V673, pL87, DOI 10.1086/527475; Showman AP, 2008, ASTROPHYS J, V682, P559, DOI 10.1086/589325; Snellen IAG, 2008, ASTRON ASTROPHYS, V487, P357, DOI 10.1051/0004-6361:200809762; Swain MR, 2009, ASTROPHYS J, V704, P1616, DOI 10.1088/0004-637X/704/2/1616; Swain MR, 2009, ASTROPHYS J LETT, V690, pL114, DOI 10.1088/0004-637X/690/2/L114; Swain MR, 2008, NATURE, V452, P329, DOI 10.1038/nature06823; Tinetti G, 2007, NATURE, V448, P169, DOI 10.1038/nature06002	16	143	144	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 4	2010	463	7281					637	639		10.1038/nature08775	http://dx.doi.org/10.1038/nature08775			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551GB	20130645	Green Submitted			2022-12-28	WOS:000274193900030
J	Zheng, YM; Bai, H; Huang, ZB; Tian, XL; Nie, FQ; Zhao, Y; Zhai, J; Jiang, L				Zheng, Yongmei; Bai, Hao; Huang, Zhongbing; Tian, Xuelin; Nie, Fu-Qiang; Zhao, Yong; Zhai, Jin; Jiang, Lei			Directional water collection on wetted spider silk	NATURE			English	Article							MECHANICAL-PROPERTIES; SURFACES; CAPTURE; DROPLET; MOTION	Many biological surfaces in both the plant and animal kingdom possess unusual structural features at the micro-and nanometre-scale that control their interaction with water and hence wettability(1-5). An intriguing example is provided by desert beetles, which use micrometre-sized patterns of hydrophobic and hydrophilic regions on their backs to capture water from humid air(6). As anyone who has admired spider webs adorned with dew drops will appreciate, spider silk is also capable of efficiently collecting water from air. Here we show that the water-collecting ability of the capture silk of the cribellate spider Uloborus walckenaerius is the result of a unique fibre structure that forms after wetting, with the 'wet-rebuilt' fibres characterized by periodic spindle-knots made of random nanofibrils and separated by joints made of aligned nanofibrils. These structural features result in a surface energy gradient between the spindle-knots and the joints and also in a difference in Laplace pressure, with both factors acting together to achieve continuous condensation and directional collection of water drops around spindle-knots. Submillimetre-sized liquid drops have been driven by surface energy gradients(7-9) or a difference in Laplace pressure(10), but until now neither force on its own has been used to overcome the larger hysteresis effects that make the movement of micrometre-sized drops more difficult. By tapping into both driving forces, spider silk achieves this task. Inspired by this finding, we designed artificial fibres that mimic the structural features of silk and exhibit its directional water-collecting ability.	[Huang, Zhongbing; Tian, Xuelin; Nie, Fu-Qiang; Zhao, Yong; Jiang, Lei] Chinese Acad Sci, Inst Chem, BNLMS, Beijing 100190, Peoples R China; [Zheng, Yongmei; Zhai, Jin] Beijing Univ Aeronaut & Astronaut, Sch Chem & Environm, Beijing 100083, Peoples R China; [Bai, Hao] Natl Ctr Nanosci & Technol, Beijing 100190, Peoples R China	Chinese Academy of Sciences; Institute of Chemistry, CAS; Beihang University; Chinese Academy of Sciences; National Center for Nanoscience & Technology - China	Jiang, L (corresponding author), Chinese Acad Sci, Inst Chem, BNLMS, Beijing 100190, Peoples R China.	zhaoyong@iccas.ac.cn; jianglei@iccas.ac.cn	Bai, Hao/J-5255-2012; Bai, Hao/D-1713-2017; , 许永傲/AAC-2581-2019; Jiang, Lei/B-1066-2011; Tian, Xuelin/C-3424-2008; jiang, lei/E-8437-2010; Zhao, Yong/D-4523-2009	Bai, Hao/0000-0002-1707-4976; Bai, Hao/0000-0002-3348-6129; Tian, Xuelin/0000-0001-6178-2067; Zhao, Yong/0000-0002-2545-1620	State Basic Research Program of China [2007CB936403]; Key Program in the National Natural Science Foundation of China [119030601101]; Knowledge Innovation Program in the Chinese Academy of Sciences [2A200522222200301]	State Basic Research Program of China(National Basic Research Program of China); Key Program in the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program in the Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences)	We thank the State Basic Research Program of China (2007CB936403), the Key Program in the National Natural Science Foundation of China (119030601101), and the Knowledge Innovation Program in the Chinese Academy of Sciences (2A200522222200301).	Becker N, 2003, NAT MATER, V2, P278, DOI 10.1038/nmat858; Blossey R, 2003, NAT MATER, V2, P301, DOI 10.1038/nmat856; CHAUDHURY MK, 1992, SCIENCE, V256, P1539, DOI 10.1126/science.256.5063.1539; Daniel S, 2004, LANGMUIR, V20, P4085, DOI 10.1021/la036221a; Daniel S, 2001, SCIENCE, V291, P633, DOI 10.1126/science.291.5504.633; EDMONDS DT, 1992, P ROY SOC B-BIOL SCI, V248, P145, DOI 10.1098/rspb.1992.0055; Emile O, 2006, NATURE, V440, P621, DOI 10.1038/440621a; Fang GP, 2008, LANGMUIR, V24, P11651, DOI 10.1021/la802033q; Feng L, 2002, ADV MATER, V14, P1857, DOI 10.1002/adma.200290020; Gao XF, 2004, NATURE, V432, P36, DOI 10.1038/432036a; Gau H, 1999, SCIENCE, V283, P46, DOI 10.1126/science.283.5398.46; Li XM, 2007, CHEM SOC REV, V36, P1350, DOI 10.1039/b602486f; Liu Y, 2005, NAT MATER, V4, P901, DOI 10.1038/nmat1534; Lorenceau E, 2004, J FLUID MECH, V510, P29, DOI 10.1017/S0022112004009152; Parker AR, 2001, NATURE, V414, P33, DOI 10.1038/35102108; PETERS HM, 1984, ZOOMORPHOLOGY, V104, P96, DOI 10.1007/BF00312023; Porter D, 2007, NANO TODAY, V2, P6, DOI 10.1016/S1748-0132(07)70071-3; Quere D, 2008, ANNU REV MATER RES, V38, P71, DOI 10.1146/annurev.matsci.38.060407.132434; Sun TL, 2005, ACCOUNTS CHEM RES, V38, P644, DOI 10.1021/ar040224c; VOLLRATH F, 1990, NATURE, V345, P526, DOI 10.1038/345526a0; Vollrath F, 2000, J Biotechnol, V74, P67; VOLLRATH F, 1989, NATURE, V340, P305, DOI 10.1038/340305a0; Vollrath F, 2006, SOFT MATTER, V2, P377, DOI 10.1039/b600098n; Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024; Yang JT, 2008, LANGMUIR, V24, P9889, DOI 10.1021/la8004695; Yoshimitsu Z, 2002, LANGMUIR, V18, P5818, DOI 10.1021/la020088p; Zheng YM, 2007, SOFT MATTER, V3, P178, DOI 10.1039/b612667g	27	1366	1442	148	2663	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 4	2010	463	7281					640	643		10.1038/nature08729	http://dx.doi.org/10.1038/nature08729			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551GB	20130646				2022-12-28	WOS:000274193900031
J	Catterall, WA; Scott, JD				Catterall, William A.; Scott, John D.			Edwin G. Krebs (1918-2009)	SCIENCE			English	Biographical-Item									[Catterall, William A.; Scott, John D.] Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Catterall, WA (corresponding author), Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA.	wcatt@u.washington.edu							0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 29	2010	327	5965					537	537		10.1126/science.1186913	http://dx.doi.org/10.1126/science.1186913			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549CT	20110494				2022-12-28	WOS:000274020500025
J	Meng, GN; Arkus, N; Brenner, MP; Manoharan, VN				Meng, Guangnan; Arkus, Natalie; Brenner, Michael P.; Manoharan, Vinothan N.			The Free-Energy Landscape of Clusters of Attractive Hard Spheres	SCIENCE			English	Article							STATISTICAL THERMODYNAMICS; MONATOMIC SYSTEMS; LIQUIDS; PACKING; MECHANICS; SYMMETRY; STATICS; RANGE	The study of clusters has provided a tangible link between local geometry and bulk condensed matter, but experiments have not yet systematically explored the thermodynamics of the smallest clusters. Here we present experimental measurements of the structures and free energies of colloidal clusters in which the particles act as hard spheres with short-range attractions. We found that highly symmetric clusters are strongly suppressed by rotational entropy, whereas the most stable clusters have anharmonic vibrational modes or extra bonds. Many of these clusters are subsets of close-packed lattices. As the number of particles increases from 6 to 10, we observe the emergence of a complex free-energy landscape with a small number of ground states and many local minima.	[Meng, Guangnan; Manoharan, Vinothan N.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Arkus, Natalie; Brenner, Michael P.; Manoharan, Vinothan N.] Harvard Univ, Harvard Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Manoharan, VN (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	vnm@seas.harvard.edu	Manoharan, Vinothan N/C-1292-2008	Manoharan, Vinothan N/0000-0003-0370-6095	NSF [DMR-0820484, CBET-0747625, DMS-0907985]; Defense Advanced Research Projects Agency [BAA 07-21]; Kavli Institute for Bionano Science and Technology at Harvard University; Directorate For Engineering [0747625] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Kavli Institute for Bionano Science and Technology at Harvard University; Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	We thank F. Spaepen and Z. Cheng for helpful discussions. We acknowledge support from NSF under award numbers DMR-0820484, CBET-0747625, and DMS-0907985; from the Defense Advanced Research Projects Agency under contract BAA 07-21; and from the Kavli Institute for Bionano Science and Technology at Harvard University.	Anderson VJ, 2002, NATURE, V416, P811, DOI 10.1038/416811a; Arkus N, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.118303; ASAKURA S, 1954, J CHEM PHYS, V22, P1255, DOI 10.1063/1.1740347; BERNAL JD, 1960, NATURE, V185, P68, DOI 10.1038/185068a0; Biancaniello PL, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.058302; Brooks CL, 2001, SCIENCE, V293, P612, DOI 10.1126/science.1062559; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; Doye JPK, 2002, J CHEM PHYS, V116, P8307, DOI 10.1063/1.1469616; Doye JPK, 1996, SCIENCE, V271, P484, DOI 10.1126/science.271.5248.484; Doye JPK, 1997, J CHEM SOC FARADAY T, V93, P4233, DOI 10.1039/a706221d; FRANK FC, 1952, PROC R SOC LON SER-A, V215, P43, DOI 10.1098/rspa.1952.0194; FRANKE G, 1993, J CHEM PHYS, V98, P3496, DOI 10.1063/1.464070; HOARE MR, 1975, ADV PHYS, V24, P645, DOI 10.1080/00018737500101481; HOARE MR, 1983, ADV PHYS, V32, P791, DOI 10.1080/00018738300101611; HOARE MR, 1971, ADV PHYS, V20, P161, DOI 10.1080/00018737100101231; JOHNSON NW, 1966, CANADIAN J MATH, V18, P169, DOI 10.4153/CJM-1966-021-8; Johnston R.L., 2002, ATOMIC MOL CLUSTERS, DOI 10.1201/9780367805814d; Manoharan VN, 2003, SCIENCE, V301, P483, DOI 10.1126/science.1086189; NELSON DR, 1989, SOLID STATE PHYS, V42, P1; Reichert H, 2000, NATURE, V408, P839, DOI 10.1038/35048537; Royall CP, 2008, NAT MATER, V7, P556, DOI 10.1038/nmat2219; Sheng HW, 2006, NATURE, V439, P419, DOI 10.1038/nature04421; STILLINGER FH, 1984, SCIENCE, V225, P983, DOI 10.1126/science.225.4666.983; Stradner A, 2004, NATURE, V432, P492, DOI 10.1038/nature03109; VRIJ A, 1976, PURE APPL CHEM, V48, P471, DOI 10.1351/pac197648040471; Wales DJ, 2006, J PHYS CHEM B, V110, P20765, DOI 10.1021/jp0680544; WALES DJ, 2008, CAMBRIDGE CLUSTER DA	27	235	235	5	145	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 29	2010	327	5965					560	563		10.1126/science.1181263	http://dx.doi.org/10.1126/science.1181263			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549CT	20110500	Green Submitted			2022-12-28	WOS:000274020500032
J	Ang, CC				Ang, Chia Chun			Cutaneous Larva Migrans	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Changi Gen Hosp, Singapore, Singapore	Changi General Hospital	Ang, CC (corresponding author), Changi Gen Hosp, Singapore, Singapore.	angchiachun@gmail.com							0	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 28	2010	362	4					E10	E10		10.1056/NEJMicm0808714	http://dx.doi.org/10.1056/NEJMicm0808714			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	548OT	20107212				2022-12-28	WOS:000273975000011
J	Daou, R; Chang, J; LeBoeuf, D; Cyr-Choiniere, O; Laliberte, F; Doiron-Leyraud, N; Ramshaw, BJ; Liang, RX; Bonn, DA; Hardy, WN; Taillefer, L				Daou, R.; Chang, J.; LeBoeuf, David; Cyr-Choiniere, Olivier; Laliberte, Francis; Doiron-Leyraud, Nicolas; Ramshaw, B. J.; Liang, Ruixing; Bonn, D. A.; Hardy, W. N.; Taillefer, Louis			Broken rotational symmetry in the pseudogap phase of a high-T-c superconductor	NATURE			English	Article							HIGH-TEMPERATURE SUPERCONDUCTORS; CUPRATE SUPERCONDUCTORS; MAGNETIC ORDER; MOTT INSULATOR; FERMI-SURFACE; STRIPES; STATE	The nature of the pseudogap phase is a central problem in the effort to understand the high-transition-temperature (high-T-c) copper oxide superconductors(1). A fundamental question is what symmetries are broken when the pseudogap phase sets in, which occurs when the temperature decreases below a value T*. There is evidence from measurements of both polarized neutron diffraction(2,3) and the polar Kerr effect(4) that time-reversal symmetry is broken, but at temperatures that differ significantly from one another. Broken rotational symmetry was detected from both resistivity measurements(5) and inelastic neutron scattering(6-8) at low doping, and from scanning tunnelling spectroscopy(9,10) at low temperature, but showed no clear relation to T*. Here we report the observation of a large in-plane anisotropy of the Nernst effect in YBa2Cu3Oy that sets in precisely at T* throughout the doping phase diagram. We show that the CuO chains of the orthorhombic lattice are not responsible for this anisotropy, which is therefore an intrinsic property of the CuO2 planes. We conclude that the pseudogap phase is an electronic state that strongly breaks four-fold rotational symmetry. This narrows the range of possible states considerably, pointing to stripe or nematic order(11,12).	[Daou, R.; Chang, J.; LeBoeuf, David; Cyr-Choiniere, Olivier; Laliberte, Francis; Doiron-Leyraud, Nicolas; Taillefer, Louis] Univ Sherbrooke, Dept Phys, Sherbrooke, PQ J1K 2R1, Canada; [Daou, R.; Chang, J.; LeBoeuf, David; Cyr-Choiniere, Olivier; Laliberte, Francis; Doiron-Leyraud, Nicolas; Taillefer, Louis] Univ Sherbrooke, RQMP, Sherbrooke, PQ J1K 2R1, Canada; [Ramshaw, B. J.; Liang, Ruixing; Bonn, D. A.; Hardy, W. N.] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada; [Liang, Ruixing; Bonn, D. A.; Hardy, W. N.; Taillefer, Louis] Canadian Inst Adv Res, Toronto, ON M5G 1Z8, Canada	University of Sherbrooke; University of Sherbrooke; University of British Columbia; Canadian Institute for Advanced Research (CIFAR)	Taillefer, L (corresponding author), Univ Sherbrooke, Dept Phys, Sherbrooke, PQ J1K 2R1, Canada.	louis.taillefer@physique.usherbrooke.ca	Chang, Johan/F-1506-2014; Ramshaw, Brad/AAU-5603-2020; Hardy, Walter Newbold/AAN-7827-2020; Ramshaw, Brad/J-3121-2013	Chang, Johan/0000-0002-4655-1516; Ramshaw, Brad/0000-0002-3222-5007	Swiss National Science Foundation; Fonds quebecois de la recherche sur la nature et les technologies (FQRNT); Canadian Institute for Advanced Research; Canadian Natural Sciences and Engineering Research Council; FQRNT; the Canada Foundation for Innovation; Canada Research Chair	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Fonds quebecois de la recherche sur la nature et les technologies (FQRNT)(FQRNT); Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR)); Canadian Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); FQRNT(FQRNT); the Canada Foundation for Innovation(Canada Foundation for Innovation); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	We thank K. Behnia, R. L. Greene, C. Kallin, S. A. Kivelson, A. J. Millis, C. Proust, S. Sachdev, A.-M. S. Tremblay and M. Vojta for discussions, and J. Corbin for his assistance with the experiments. J. C. was supported by fellowships from the Swiss National Science Foundation and the Fonds quebecois de la recherche sur la nature et les technologies (FQRNT). L. T. acknowledges support from the Canadian Institute for Advanced Research and funding from the Canadian Natural Sciences and Engineering Research Council, the FQRNT, the Canada Foundation for Innovation and a Canada Research Chair.	Ando Y, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.267001; Ando Y, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.137005; Behnia K, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/11/113101; Borzi RA, 2007, SCIENCE, V315, P214, DOI 10.1126/science.1134796; CHANG J, 2009, THERMOELECTRIC STUDY; Cyr-Choiniere O, 2009, NATURE, V458, P743, DOI 10.1038/nature07931; Daou R, 2009, NAT PHYS, V5, P31, DOI [10.1038/nphys1109, 10.1038/NPHYS1109]; Hackl A, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.045102; Hackl A, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.220514; Hinkov V, 2008, SCIENCE, V319, P597, DOI 10.1126/science.1152309; Hinkov V, 2007, NAT PHYS, V3, P780, DOI 10.1038/nphys720; Ichikawa N, 2000, PHYS REV LETT, V85, P1738, DOI 10.1103/PhysRevLett.85.1738; Kivelson SA, 1998, NATURE, V393, P550, DOI 10.1038/31177; Kohsaka Y, 2008, NATURE, V454, P1072, DOI 10.1038/nature07243; Kohsaka Y, 2007, SCIENCE, V315, P1380, DOI 10.1126/science.1138584; LeBoeuf D, 2007, NATURE, V450, P533, DOI 10.1038/nature06332; Li Y, 2008, NATURE, V455, P372, DOI 10.1038/nature07251; Liang RX, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.180505; Matusiak M, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/17005; Norman MR, 2005, ADV PHYS, V54, P715, DOI [10.1080/00018730500459906, 10.1080/00018730500489906]; Ong NP, 2004, ANN PHYS-BERLIN, V13, P9, DOI 10.1002/andp.200310034; Rullier-Albenque F, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.067002; Stock C, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.014502; Taillefer L, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/16/164212; Timusk T, 1999, REP PROG PHYS, V62, P61, DOI 10.1088/0034-4885/62/1/002; Vojta M, 2009, ADV PHYS, V58, P699, DOI 10.1080/00018730903122242	30	439	442	3	231	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 28	2010	463	7280					519	522		10.1038/nature08716	http://dx.doi.org/10.1038/nature08716			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	548QK	20110997	Green Submitted			2022-12-28	WOS:000273981100046
J	Wu, J				Wu, Julie			Recertification	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												jwusauk@aol.com							0	11	11	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 27	2010	303	4					309	310		10.1001/jama.2009.1959	http://dx.doi.org/10.1001/jama.2009.1959			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	548IC	20103747				2022-12-28	WOS:000273952800001
J	Rotenberg, E; Yakir, D				Rotenberg, Eyal; Yakir, Dan			Contribution of Semi-Arid Forests to the Climate System	SCIENCE			English	Article							DROUGHT; BOREAL; DESERTIFICATION; EFFICIENCY; FEEDBACKS	Forests both take up CO2 and enhance absorption of solar radiation, with contrasting effects on global temperature. Based on a 9-year study in the forests' dry timberline, we show that substantial carbon sequestration (cooling effect) is maintained in the large dry transition zone (precipitation from 200 to 600 millimeters) by shifts in peak photosynthetic activities from summer to early spring, and this is counteracted by longwave radiation (L) suppression (warming effect), doubling the forestation shortwave (S) albedo effect. Several decades of carbon accumulation are required to balance the twofold S + L effect. Desertification over the past several decades, however, contributed negative forcing at Earth's surface equivalent to similar to 20% of the global anthropogenic CO2 effect over the same period, moderating warming trends.	[Rotenberg, Eyal; Yakir, Dan] Weizmann Inst Sci, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Yakir, D (corresponding author), Weizmann Inst Sci, IL-76100 Rehovot, Israel.	dan.yakir@weizmann.ac.il	Yakir, Dan/K-1500-2012		Israel Science Foundation; Minerva-Avron Center; Weizmann Institute	Israel Science Foundation(Israel Science Foundation); Minerva-Avron Center; Weizmann Institute	We thank the students, postdocs, and technicians of the Yatir team for making this project possible. The long-term operation of the Yatir Forest Research Field Site is supported by the Cathy Wills and Robert Lewis Program in Environmental Science. Financial support from the Israel Science Foundation, Global Change and the Hydrological Cycle-Jordan River (GLOWA-JR), Keren Kayemet L'Israel (KKL), Jewish National Fund (JNF), the Minerva-Avron Center, and the Weizmann Institute is gratefully acknowledged.	AFIK T, 2009, THESIS HEBREW U JERU; [Anonymous], 4 IPCC; Asner GP, 2003, GLOBAL ECOL BIOGEOGR, V12, P191, DOI 10.1046/j.1466-822X.2003.00026.x; Aubinet M, 2000, ADV ECOL RES, V30, P113, DOI 10.1016/S0065-2504(08)60018-5; Bala G, 2007, P NATL ACAD SCI USA, V104, P6550, DOI 10.1073/pnas.0608998104; Baldocchi D, 2001, B AM METEOROL SOC, V82, P2415, DOI 10.1175/1520-0477(2001)082<2415:FANTTS>2.3.CO;2; Bar Massada A, 2006, CAN J FOREST RES, V36, P2585, DOI 10.1139/X06-152; Betts RA, 2000, NATURE, V408, P187, DOI 10.1038/35041545; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Bowman DMJS, 2009, SCIENCE, V324, P481, DOI 10.1126/science.1163886; Campbell Gaylon S., 1998; Canadell JG, 2007, P NATL ACAD SCI USA, V104, P18866, DOI 10.1073/pnas.0702737104; CHARNEY J, 1977, J ATMOS SCI, V34, P1366, DOI 10.1175/1520-0469(1977)034<1366:ACSOTE>2.0.CO;2; CHARNEY JG, 1975, Q J ROY METEOR SOC, V101, P193, DOI 10.1002/qj.49710142802; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Claussen M, 2001, GEOPHYS RES LETT, V28, P1011, DOI 10.1029/2000GL012471; Davin EL, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029678; *FAO, 2004, WORLD SOILS RES REP, V102; Helliker BR, 2008, NATURE, V454, P511, DOI 10.1038/nature07031; Knorr W, 2001, GEOPHYS RES LETT, V28, P3489, DOI 10.1029/2001GL013283; Lal R, 2004, ENVIRON MANAGE, V33, P528, DOI 10.1007/s00267-003-9110-9; LeHouerou HN, 1996, J ARID ENVIRON, V34, P133, DOI 10.1006/jare.1996.0099; Luyssaert S, 2007, GLOBAL CHANGE BIOL, V13, P2509, DOI 10.1111/j.1365-2486.2007.01439.x; Maseyk K, 2008, GLOBAL CHANGE BIOL, V14, P1553, DOI 10.1111/j.1365-2486.2008.01604.x; Maseyk KS, 2008, NEW PHYTOL, V178, P603, DOI 10.1111/j.1469-8137.2008.02391.x; Masson V, 2003, J CLIMATE, V16, P1261, DOI 10.1175/1520-0442-16.9.1261; Myhre G, 1998, GEOPHYS RES LETT, V25, P2715, DOI 10.1029/98GL01908; *NAT CLIM DAT CTR, 1964, MEAN DAIL SOL RAD MO; OTTERMAN J, 1974, SCIENCE, V186, P531, DOI 10.1126/science.186.4163.531; Pacala S, 2004, SCIENCE, V305, P968, DOI 10.1126/science.1100103; Peixoto J.P., 1992, PHYS CLIMATE, P520; Penuelas J, 2003, GLOBAL CHANGE BIOL, V9, P131, DOI 10.1046/j.1365-2486.2003.00566.x; Reynolds JF, 2007, SCIENCE, V316, P847, DOI 10.1126/science.1131634; Schaeffer M, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002581; SHAW RH, 1982, AGR METEOROL, V26, P51, DOI 10.1016/0002-1571(82)90057-7; SHUTTLEWORTH WJ, 1984, Q J ROY METEOR SOC, V110, P1163, DOI 10.1002/qj.49711046623; Smith GL, 2002, J CLIMATE, V15, P1175, DOI 10.1175/1520-0442(2002)015&lt;1175:SRBACC&gt;2.0.CO;2; Warner T.T., 2009, DESERT METEOROLOGY; Xue YK, 1997, Q J ROY METEOR SOC, V123, P1483, DOI 10.1002/qj.49712354203	39	339	360	14	192	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 22	2010	327	5964					451	454		10.1126/science.1179998	http://dx.doi.org/10.1126/science.1179998			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546BS	20093470				2022-12-28	WOS:000273783100034
J	Tero, A; Takagi, S; Saigusa, T; Ito, K; Bebber, DP; Fricker, MD; Yumiki, K; Kobayashi, R; Nakagaki, T				Tero, Atsushi; Takagi, Seiji; Saigusa, Tetsu; Ito, Kentaro; Bebber, Dan P.; Fricker, Mark D.; Yumiki, Kenji; Kobayashi, Ryo; Nakagaki, Toshiyuki			Rules for Biologically Inspired Adaptive Network Design	SCIENCE			English	Article							TRANSPORT NETWORK; PHYSARUM; SHAPE	Transport networks are ubiquitous in both social and biological systems. Robust network performance involves a complex trade-off involving cost, transport efficiency, and fault tolerance. Biological networks have been honed by many cycles of evolutionary selection pressure and are likely to yield reasonable solutions to such combinatorial optimization problems. Furthermore, they develop without centralized control and may represent a readily scalable solution for growing networks in general. We show that the slime mold Physarum polycephalum forms networks with comparable efficiency, fault tolerance, and cost to those of real-world infrastructure networks-in this case, the Tokyo rail system. The core mechanisms needed for adaptive network formation can be captured in a biologically inspired mathematical model that may be useful to guide network construction in other domains.	[Tero, Atsushi; Takagi, Seiji; Ito, Kentaro; Nakagaki, Toshiyuki] Hokkaido Univ, Res Inst Elect Sci, Sapporo, Hokkaido 0600812, Japan; [Tero, Atsushi] JST, PRESTO, Saitama, Japan; [Saigusa, Tetsu] Hokkaido Univ, Grad Sch Engn, Sapporo, Hokkaido 0608628, Japan; [Bebber, Dan P.; Fricker, Mark D.] Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England; [Yumiki, Kenji; Kobayashi, Ryo] Hiroshima Univ, Dept Math & Life Sci, Higashihiroshima 7398526, Japan; [Kobayashi, Ryo; Nakagaki, Toshiyuki] JST, CREST, Chiyoda Ku, Tokyo 1020075, Japan	Hokkaido University; Japan Science & Technology Agency (JST); Hokkaido University; University of Oxford; Hiroshima University; Japan Science & Technology Agency (JST)	Nakagaki, T (corresponding author), Hokkaido Univ, Res Inst Elect Sci, Sapporo, Hokkaido 0600812, Japan.	nakagaki@es.hokudai.ac.jp	Nakagaki, Toshiyuki/L-3049-2013; Fricker, Mark/AAX-9245-2020; Fricker, Mark D/L-6627-2014; Kobayashi, Ryo/G-8714-2019	Nakagaki, Toshiyuki/0000-0002-3446-4888; Fricker, Mark D/0000-0002-8942-6897; Kobayashi, Ryo/0000-0003-0750-5848	MEXT KAKENHI [18650054, 20300105]; Human Frontier Science Program [RGP51/2007]; EU [12999]; NERC [A/S/882]; Natural Environment Research Council [NER/A/S/2002/00882] Funding Source: researchfish	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Human Frontier Science Program(Human Frontier Science Program); EU(European Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Supported by MEXT KAKENHI grants 18650054 and 20300105, Human Frontier Science Program grant RGP51/2007, EU Framework 6 contract 12999 (NEST), and NERC grant A/S/882.	Akyildiz IF, 2005, COMPUT NETW, V47, P445, DOI 10.1016/j.comnet.2004.12.001; Albert R, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.025103; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Bebber DP, 2007, P ROY SOC B-BIOL SCI, V274, P2307, DOI 10.1098/rspb.2007.0459; Buhl J, 2009, BEHAV ECOL SOCIOBIOL, V63, P451, DOI 10.1007/s00265-008-0680-7; Colorni A., 1996, International Transactions in Operational Research, V3, P1, DOI 10.1111/j.1475-3995.1996.tb00032.x; *IND INV BOARD OFF, 2006, TRAIN DER HATF; KAMBHU J, 2007, FEDERAL RESERVE BANK, V13, P1; May RM, 2008, NATURE, V451, P893, DOI 10.1038/451893a; Nakagaki T, 2000, NATURE, V407, P470, DOI 10.1038/35035159; Nakagaki T, 2000, BIOPHYS CHEM, V84, P195, DOI 10.1016/S0301-4622(00)00108-3; Nakagaki T, 2004, P ROY SOC B-BIOL SCI, V271, P2305, DOI 10.1098/rspb.2004.2856; Nakagaki T, 2004, BIOPHYS CHEM, V107, P1, DOI 10.1016/S0301-4622(03)00189-3; Nakagaki T, 2001, BIOPHYS CHEM, V92, P47, DOI 10.1016/S0301-4622(01)00179-X; NAKAGAKI T, 2007, TOPOLOGICAL ASPECTS, P94; Nakagaki T, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.068104; Sole RV, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.026102; Takamatsu A, 2009, J THEOR BIOL, V256, P29, DOI 10.1016/j.jtbi.2008.09.010; Tero A, 2006, PHYSICA A, V363, P115, DOI 10.1016/j.physa.2006.01.053; Tero A, 2008, THEOR BIOSCI, V127, P89, DOI 10.1007/s12064-008-0037-9; Tero A, 2007, J THEOR BIOL, V244, P553, DOI 10.1016/j.jtbi.2006.07.015	21	499	519	10	370	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 22	2010	327	5964					439	442		10.1126/science.1177894	http://dx.doi.org/10.1126/science.1177894			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546BS	20093467	Green Submitted			2022-12-28	WOS:000273783100030
J	Thapar, A; Collishaw, S; Potter, R; Thapar, AK				Thapar, Anita; Collishaw, Stephan; Potter, Robert; Thapar, Ajay K.			Managing and preventing depression in adolescents	BRITISH MEDICAL JOURNAL			English	Review							RANDOMIZED CONTROLLED-TRIAL; COGNITIVE-BEHAVIORAL THERAPY; PAST 10 YEARS; MAJOR DEPRESSION; RISK-FACTORS; CHILDREN; DISORDERS; CHILDHOOD; COMMUNITY; CARE		[Thapar, Anita; Collishaw, Stephan] Cardiff Univ, Sch Med, Dept Psychol Med & Neurol, Cardiff CF14 4XN, Wales; [Potter, Robert] Cwm Taf NHS Trust, Trehafod Child & Family Clin, Swansea SA2 0GB, W Glam, Wales	Cardiff University	Thapar, A (corresponding author), Cardiff Univ, Sch Med, Dept Psychol Med & Neurol, Cardiff CF14 4XN, Wales.	thapar@cf.ac.uk	Thapar, Anita/AAH-5555-2020; Collishaw, Stephan/H-4593-2019	Thapar, Anita/0000-0002-3689-737X; Collishaw, Stephan/0000-0002-4296-820X	Sir Jules Thorne Medical Trust; Medical Research Council [G0801418B] Funding Source: researchfish; The Sir Jules Thorn Charitable Trust [06JTA] Funding Source: researchfish	Sir Jules Thorne Medical Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Sir Jules Thorn Charitable Trust	The authors' research on depression is supported by Sir Jules Thorne Medical Trust.	Asarnow JR, 2005, JAMA-J AM MED ASSOC, V293, P311, DOI 10.1001/jama.293.3.311; Birmaher B, 1996, J AM ACAD CHILD PSY, V35, P1427, DOI 10.1097/00004583-199611000-00011; Birmaher B, 2007, J AM ACAD CHILD PSY, V46, P1503, DOI 10.1097/chi.0b013e318145ae1c; Brent D, 2008, JAMA-J AM MED ASSOC, V299, P901, DOI 10.1001/jama.299.8.901; Bridge JA, 2007, JAMA-J AM MED ASSOC, V63, P332; CDC, 2021, CTR DIS CONTROL PREV; Costello EJ, 2006, J CHILD PSYCHOL PSYC, V47, P1263, DOI 10.1111/j.1469-7610.2006.01682.x; Costello EJ, 2003, ARCH GEN PSYCHIAT, V60, P837, DOI 10.1001/archpsyc.60.8.837; Daviss WB, 2006, J CHILD PSYCHOL PSYC, V47, P927, DOI 10.1111/j.1469-7610.2006.01646.x; Egger HL, 1999, J AM ACAD CHILD PSY, V38, P852, DOI 10.1097/00004583-199907000-00015; Foley DL, 2006, ARCH GEN PSYCHIAT, V63, P1017, DOI 10.1001/archpsyc.63.9.1017; Garber J, 2009, JAMA-J AM MED ASSOC, V301, P2215, DOI 10.1001/jama.2009.788; Goodyer I, 2007, BMJ-BRIT MED J, V335, P142, DOI 10.1136/bmj.39224.494340.55; Gould MS, 2003, J AM ACAD CHILD PSY, V42, P386, DOI 10.1097/01.CHI.0000046821.95464.CF; Green H., 2005, J RES SPEC EDUC NEED; Hetrick S, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004851.pub2; Kessler RC, 2001, BIOL PSYCHIAT, V49, P1002, DOI 10.1016/S0006-3223(01)01129-5; Klein JB, 2007, J AM ACAD CHILD PSY, V46, P1403, DOI 10.1097/chi.0b013e3180592aaa; Leaf PJ, 1996, J AM ACAD CHILD PSY, V35, P889, DOI 10.1097/00004583-199607000-00014; Lewinsohn PM, 2000, AM J PSYCHIAT, V157, P1584, DOI 10.1176/appi.ajp.157.10.1584; Lewinsohn PM, 1998, CLIN PSYCHOL REV, V18, P765, DOI 10.1016/S0272-7358(98)00010-5; LEWINSOHN PM, 1994, J AM ACAD CHILD PSY, V33, P809, DOI 10.1097/00004583-199407000-00006; March J, 2009, AM J PSYCHIAT, V166, P1141, DOI 10.1176/appi.ajp.2009.08111620; Mufson L, 2004, ARCH GEN PSYCHIAT, V61, P577, DOI 10.1001/archpsyc.61.6.577; National Institute for Health and Clinical Excellence, 2005, DEPR CHILDR YOUNG PE; Rice F, 2002, J CHILD PSYCHOL PSYC, V43, P65, DOI 10.1111/1469-7610.00004; Stice E, 2009, J CONSULT CLIN PSYCH, V77, P486, DOI 10.1037/a0015168; Weissman MM, 2006, JAMA-J AM MED ASSOC, V295, P1389, DOI 10.1001/jama.295.12.1389; Weisz JR, 2006, PSYCHOL BULL, V132, P132, DOI 10.1037/0033-2909.132.1.132; Williams SB, 2009, PEDIATRICS, V123, pE716, DOI 10.1542/peds.2008-2415	30	40	40	0	13	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 22	2010	340								c209	10.1136/bmj.c209	http://dx.doi.org/10.1136/bmj.c209			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	548HQ	20097692				2022-12-28	WOS:000273951500001
J	Isselbacher, EM; Kligerman, SJ; Lam, KM; Hurtado, RM				Isselbacher, Eric M.; Kligerman, Seth J.; Lam, Kaitlyn M.; Hurtado, Rocio M.			A Man with Abdominal and Flank Pain Chronic infection with Trypanosoma cruzi (Chagas' disease) and cardiomyopathy, apical left ventricular aneurysm, and thromboembolic disease with renal infarctions	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEART-DISEASE; HYPERTROPHIC CARDIOMYOPATHY; ECHOCARDIOGRAPHY		[Isselbacher, Eric M.; Lam, Kaitlyn M.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Hurtado, Rocio M.] Massachusetts Gen Hosp, Infect Dis Unit, Boston, MA 02114 USA; [Kligerman, Seth J.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Kligerman, Seth J.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Isselbacher, Eric M.; Lam, Kaitlyn M.; Hurtado, Rocio M.] Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; [Kligerman, Seth J.] Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University	Isselbacher, EM (corresponding author), Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA.							Acquatella H, 2007, CIRCULATION, V115, P1124, DOI 10.1161/CIRCULATIONAHA.106.627323; Barbosa A. J. A., 1993, Revista do Instituto de Medicina Tropical de Sao Paulo, V35, P117, DOI 10.1590/S0036-46651993000200002; Bern C, 2008, CURR OPIN INFECT DIS, V21, P476, DOI 10.1097/QCO.0b013e32830ef5b6; Bern C, 2007, JAMA-J AM MED ASSOC, V298, P2171, DOI 10.1001/jama.298.18.2171; Frustaci A, 2000, CHEST, V118, P1696, DOI 10.1378/chest.118.6.1696; Hansen MW, 2007, AM J ROENTGENOL, V189, P1335, DOI 10.2214/AJR.07.2286; Kosuge H, 2001, JPN HEART J, V42, P265, DOI 10.1536/jhj.42.265; Kun H, 2009, CLIN INFECT DIS, V48, P1534, DOI 10.1086/598931; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; Maron MS, 2008, CIRCULATION, V118, P1541, DOI 10.1161/CIRCULATIONAHA.108.781401; OLIVEIRA JSM, 1981, BRIT HEART J, V46, P432, DOI 10.1136/hrt.46.4.432; Papagiannis J, 2001, AM HEART J, V141, P491, DOI 10.1067/mhj.2001.113076; Parthenakis FI, 2005, CHEST, V127, P1452, DOI 10.1378/chest.127.4.1452; Pektok E, 2008, J CARDIAC SURG, V23, P533, DOI 10.1111/j.1540-8191.2008.00574.x; Rassi A, 2007, CIRCULATION, V115, P1101, DOI 10.1161/CIRCULATIONAHA.106.627265; Reithinger R, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2141; ROSSI MA, 1995, AM HEART J, V129, P626, DOI 10.1016/0002-8703(95)90297-X; Sartori AMC, 2007, ANN TROP MED PARASIT, V101, P31, DOI 10.1179/136485907X154629; Simoes MV, 2007, ARQ BRAS CARDIOL, V89, P131, DOI 10.1590/S0066-782X2007001400010; Stevenson WG, 2000, NEW ENGL J MED, V342, P1979, DOI 10.1056/NEJM200006293422608; Tarleton RL, 1999, PARASITOL TODAY, V15, P94, DOI 10.1016/S0169-4758(99)01398-8; Vazquez-Jimenez JF, 1998, ANN THORAC SURG, V65, P1178, DOI 10.1016/S0003-4975(98)00089-7; Viotti RJ, 2004, HEART, V90, P655, DOI 10.1136/hrt.2003.018960; Viotti R, 2006, ANN INTERN MED, V144, P724, DOI 10.7326/0003-4819-144-10-200605160-00006; 2009, LANCET NEUROL, V8, P501	25	1	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 21	2010	362	3					254	262		10.1056/NEJMcpc0905548	http://dx.doi.org/10.1056/NEJMcpc0905548			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	545NE	20089976				2022-12-28	WOS:000273738400013
J	Graham, IA; Besser, K; Blumer, S; Branigan, CA; Czechowski, T; Elias, L; Guterman, I; Harvey, D; Isaac, PG; Khan, AM; Larson, TR; Li, Y; Pawson, T; Penfield, T; Rae, AM; Rathbone, DA; Reid, S; Ross, J; Smallwood, MF; Segura, V; Townsend, T; Vyas, D; Winzer, T; Bowles, D				Graham, Ian A.; Besser, Katrin; Blumer, Susan; Branigan, Caroline A.; Czechowski, Tomasz; Elias, Luisa; Guterman, Inna; Harvey, David; Isaac, Peter G.; Khan, Awais M.; Larson, Tony R.; Li, Yi; Pawson, Tanya; Penfield, Teresa; Rae, Anne M.; Rathbone, Deborah A.; Reid, Sonja; Ross, Joe; Smallwood, Margaret F.; Segura, Vincent; Townsend, Theresa; Vyas, Darshna; Winzer, Thilo; Bowles, Dianna			The Genetic Map of Artemisia annua L. Identifies Loci Affecting Yield of the Antimalarial Drug Artemisinin	SCIENCE			English	Article							BIOSYNTHESIS; ASTERACEAE; CLONING	Artemisinin is a plant natural product produced by Artemisia annua and the active ingredient in the most effective treatment for malaria. Efforts to eradicate malaria are increasing demand for an affordable, high-quality, robust supply of artemisinin. We performed deep sequencing on the transcriptome of A. annua to identify genes and markers for fast-track breeding. Extensive genetic variation enabled us to build a detailed genetic map with nine linkage groups. Replicated field trials resulted in a quantitative trait loci (QTL) map that accounts for a significant amount of the variation in key traits controlling artemisinin yield. Enrichment for positive QTLs in parents of new high-yielding hybrids confirms that the knowledge and tools to convert A. annua into a robust crop are now available.	[Graham, Ian A.; Besser, Katrin; Blumer, Susan; Branigan, Caroline A.; Czechowski, Tomasz; Elias, Luisa; Guterman, Inna; Harvey, David; Khan, Awais M.; Larson, Tony R.; Li, Yi; Pawson, Tanya; Penfield, Teresa; Rae, Anne M.; Rathbone, Deborah A.; Reid, Sonja; Ross, Joe; Smallwood, Margaret F.; Segura, Vincent; Townsend, Theresa; Vyas, Darshna; Winzer, Thilo; Bowles, Dianna] Univ York, Dept Biol, Ctr Novel Agr Prod, York YO10 5YW, N Yorkshire, England; [Isaac, Peter G.] IDna Genet Ltd, Norwich NR4 7UH, Norfolk, England	University of York - UK	Graham, IA (corresponding author), Univ York, Dept Biol, Ctr Novel Agr Prod, York YO10 5YW, N Yorkshire, England.	iag1@york.ac.uk; djb32@york.ac.uk	Larson, Tony/AAI-4782-2020; Segura, Vincent/B-4656-2013	Larson, Tony/0000-0003-1337-3482; Segura, Vincent/0000-0003-1860-2256; Khan, Muhammad Awais/0000-0002-0424-7727	Bill and Melinda Gates Foundation; Medicines for Malaria Venture; Garfield Weston Foundation for the Centre for Novel Agricultural Products	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medicines for Malaria Venture; Garfield Weston Foundation for the Centre for Novel Agricultural Products	We thank L. Doucet, H. Martin, N. Nattriss, M. Segura, and A. Czechowska for horticulture assistance; G. Chigeza for horticulture management; S. Graham, S. Heywood, B. Kowalik, S. Pandey, R. Simister, and C. Whitehead for laboratory assistance; C. Calvert, P. Dickes, W. Lawley, and D. Rotherham for project management; E. Bartlet for communications advice; and P. Roberts for graphic design. We thank T. Brewer, H. Klee, and K. Stuart for insightful advice on this project. We thank X. Simonnet and Mediplant for access to the Artemis pedigree. We acknowledge financial support for this project from The Bill and Melinda Gates Foundation and Medicines for Malaria Venture, as well as from The Garfield Weston Foundation for the Centre for Novel Agricultural Products.	Bertea CM, 2006, ARCH BIOCHEM BIOPHYS, V448, P3, DOI 10.1016/j.abb.2006.02.026; Bertea CM, 2005, PLANTA MED, V71, P40, DOI 10.1055/s-2005-837749; Chang MCY, 2007, NAT CHEM BIOL, V3, P274, DOI 10.1038/nchembio875; Covello PS, 2008, PHYTOCHEMISTRY, V69, P2881, DOI 10.1016/j.phytochem.2008.10.001; Delabays N, 2001, CURR MED CHEM, V8, P1795, DOI 10.2174/0929867013371635; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; DUKE MV, 1994, INT J PLANT SCI, V155, P365, DOI 10.1086/297173; FERREIRA JFS, 1995, INT J PLANT SCI, V156, P807, DOI 10.1086/297304; *NAT AC SCI, 2004, SAV LIV BUYING TIM E; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Teoh KH, 2006, FEBS LETT, V580, P1411, DOI 10.1016/j.febslet.2006.01.065; TEOH KH, 2009, CAN J BOT, V87, P635; Torrell M, 2001, GENOME, V44, P231, DOI 10.1139/gen-44-2-231; WORLDHEALTH ORGANIZATION (WHO), 2008, WORLD MAL REP 2008; Zhang Y, 2008, J BIOL CHEM, V283, P21501, DOI 10.1074/jbc.M803090200	15	253	306	1	146	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 15	2010	327	5963					328	331		10.1126/science.1182612	http://dx.doi.org/10.1126/science.1182612			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544CM	20075252				2022-12-28	WOS:000273629700042
J	Liang, BA; Mackey, T				Liang, Bryan A.; Mackey, Tim			Reforming Off-Label Promotion to Enhance Orphan Disease Treatment	SCIENCE			English	Editorial Material							DRUGS; FDA		[Liang, Bryan A.; Mackey, Tim] Calif Western Sch Law, Inst Hlth Law Studies, San Diego, CA 92101 USA; [Liang, Bryan A.] Univ Calif San Diego, San Diego Sch Med, San Diego Ctr Patient Safety, Dept Anesthesiol, San Diego, CA 92103 USA	University of California System; University of California San Diego	Liang, BA (corresponding author), Calif Western Sch Law, Inst Hlth Law Studies, San Diego, CA 92101 USA.	baliang@alum.mit.edu	Mackey, Tim/H-9156-2013	Mackey, Tim/0000-0002-2191-7833; Liang, Bryan/0000-0001-7801-5673				ABELSON R, 2009, NY TIMES        0127, pA22, DOI DOI 10.1007/S00228-005-0981-Y; Berenson Alex, 2006, N Y Times Web, pC2; Boos J, 2003, ANN ONCOL, V14, P1, DOI 10.1093/annonc/mdg035; Brewer GJ, 2009, TRANSL RES, V154, P314, DOI 10.1016/j.trsl.2009.03.008; Canadian Organization for Rare Disorders, 2005, CAN ORPH DRUG POL LE; *DHHS, 2001, OEI090000380 DHHS; FDA, 2009, GOOD REPR PRACT DIST; Hampton T, 2007, JAMA-J AM MED ASSOC, V297, P683, DOI 10.1001/jama.297.7.683; Krammer MG, 2003, NATL ORG RARE DISORD; Liang BA, 2007, HARVARD J LEGIS, V44, P363; Mello MM, 2009, NEW ENGL J MED, V360, P1557, DOI 10.1056/NEJMhle0807695; POLLACK A, 1990, NY TIMES        0116, pD1; Psaty BM, 2008, JAMA-J AM MED ASSOC, V299, P1949, DOI 10.1001/jama.299.16.1949; Radley DC, 2006, ARCH INTERN MED, V166, P1021, DOI 10.1001/archinte.166.9.1021; *RAR CANC FOR, 2009, OFF LIM INV NHS ORG; Richey EA, 2009, J CLIN ONCOL, V27, P4398, DOI 10.1200/JCO.2008.21.1961; SALBU SR, 1999, FLA L REV, V51, P181, DOI DOI 10.1377/HLTHAFF.2010.1032; Schlander M, 2009, CURR MED RES OPIN, V25, P1285, DOI [10.1185/03007990902892633, 10.1185/03007990902892633 ]; Stafford RS, 2008, NEW ENGL J MED, V358, P1427, DOI 10.1056/NEJMp0802107; 2008, NIH NEWS; 1997, FED REG, V62, P64073; 1996, FED REG, V61, P52800	22	24	24	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 15	2010	327	5963					273	274		10.1126/science.1181567	http://dx.doi.org/10.1126/science.1181567			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	544CM	20075234				2022-12-28	WOS:000273629700021
J	Henneberger, C; Papouin, T; Oliet, SHR; Rusakov, DA				Henneberger, Christian; Papouin, Thomas; Oliet, Stephane H. R.; Rusakov, Dmitri A.			Long-term potentiation depends on release of D-serine from astrocytes	NATURE			English	Article							GLUTAMATE RELEASE; SYNAPTIC-TRANSMISSION; TRANSPORTER CURRENTS; RECEPTOR ACTIVATION; GLYCINE SITE; IN-SITU; CALCIUM; HIPPOCAMPUS; SYNAPSES; BRAIN	Long-term potentiation (LTP) of synaptic transmission provides an experimental model for studying mechanisms of memory(1). The classical form of LTP relies on N-methyl-D-aspartate receptors (NMDARs), and it has been shown that astroglia can regulate their activation through Ca2+-dependent release of the NMDAR co-agonist D-serine(2-4). Release of D-serine from glia enables LTP in cultures(5) and explains a correlation between glial coverage of synapses and LTP in the supraoptic nucleus(4). However, increases in Ca2+ concentration in astroglia can also release other signalling molecules, most prominently glutamate(6-8), ATP(9) and tumour necrosis factor-alpha(10,11), whereas neurons themselves can synthesize and supply D-serine(12,13). Furthermore, loading an astrocyte with exogenous Ca2+ buffers does not suppress LTP in hippocampal area CA1 (refs 14-16), and the physiological relevance of experiments in cultures or strong exogenous stimuli applied to astrocytes has been questioned(17,18). The involvement of glia in LTP induction therefore remains controversial. Here we show that clamping internal Ca2+ in individual CA1 astrocytes blocks LTP induction at nearby excitatory synapses by decreasing the occupancy of the NMDAR co-agonist sites. This LTP blockade can be reversed by exogenous D-serine or glycine, whereas depletion of D-serine or disruption of exocytosis in an individual astrocyte blocks local LTP. We therefore demonstrate that Ca2+-dependent release of D-serine from an astrocyte controls NMDAR-dependent plasticity in many thousands of excitatory synapses nearby.	[Henneberger, Christian; Rusakov, Dmitri A.] UCL, UCL Inst Neurol, London WC1N 3BG, England; [Papouin, Thomas; Oliet, Stephane H. R.] INSERM, U862, Neuroctr Magendie, F-33077 Bordeaux, France; [Papouin, Thomas; Oliet, Stephane H. R.] Univ Bordeaux, F-33077 Bordeaux, France	University of London; University College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Rusakov, DA (corresponding author), UCL, UCL Inst Neurol, London WC1N 3BG, England.	stephane.oliet@inserm.fr; d.rusakov@ion.ucl.ac.uk	Rusakov, Dmitri/AAH-4529-2021; Papouin, Thomas/W-2769-2019; Henneberger, Christian/C-1557-2008; Rusakov, Dmitri A/E-1987-2011	Rusakov, Dmitri/0000-0001-9539-9947; Papouin, Thomas/0000-0001-5288-1944; Henneberger, Christian/0000-0002-5391-7387; Rusakov, Dmitri A/0000-0001-9539-9947; Oliet, Stephane/0000-0003-0595-9029	Human Frontier Science Programme; Wellcome Trust; Medical Research Council (UK); European Union (Promemoria), INSERM, Universite de Bordeaux; Fondation pour la Recherche Medicale; French Ministry of Research; Medical Research Council [G0900613, G0600368, G0802216] Funding Source: researchfish; MRC [G0802216, G0900613, G0600368] Funding Source: UKRI	Human Frontier Science Programme(Human Frontier Science Program); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union (Promemoria), INSERM, Universite de Bordeaux(Institut National de la Sante et de la Recherche Medicale (Inserm)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); French Ministry of Research(Ministry of Research, FranceEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Acknowledgements We thank D. Kullmann, J. Diamond, T. Bliss and K. Volynski for comments and suggestions. This work was supported by the Human Frontier Science Programme (D. A. R. and S.H.R.O.), the Wellcome Trust (Senior Fellowship to D. A. R.), the Medical Research Council (UK), the European Union (Promemoria), INSERM, Universite de Bordeaux, the Fondation pour la Recherche Medicale (Equipe FRM, to S.H.R.O.), National Alliance for Research on Schizophrenia and Depression (NARSAD; Independent Investigator, SHRO), Agence National de la Recherche, Federation pour la Recherche sur le Cerveau, Conseil Regional d'Aquitaine and a studentship from the French Ministry of Research to T. P.	Agulhon C, 2008, NEURON, V59, P932, DOI 10.1016/j.neuron.2008.09.004; BAKER PF, 1985, CELL CALCIUM, V6, P5, DOI 10.1016/0143-4160(85)90030-2; Bergles DE, 1998, J NEUROSCI, V18, P7709; Bezzi P, 2001, NAT NEUROSCI, V4, P702, DOI 10.1038/89490; Bezzi P, 1998, NATURE, V391, P281, DOI 10.1038/34651; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; Diamond JS, 1998, NEURON, V21, P425, DOI 10.1016/S0896-6273(00)80551-6; Duffy S, 2008, NEUROPSYCHOPHARMACOL, V33, P1004, DOI 10.1038/sj.npp.1301486; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Fellin T, 2009, P NATL ACAD SCI USA, V106, P15037, DOI 10.1073/pnas.0906419106; Fiacco TA, 2007, NEURON, V54, P611, DOI 10.1016/j.neuron.2007.04.032; Ge WP, 2007, J NEUROPHYSIOL, V97, P2564, DOI 10.1152/jn.00146.2006; Kartvelishvily E, 2006, J BIOL CHEM, V281, P14151, DOI 10.1074/jbc.M512927200; Li Y, 2009, J NEUROPHYSIOL, V102, P578, DOI 10.1152/jn.91342.2008; Luscher C, 1998, NEURON, V21, P435, DOI 10.1016/S0896-6273(00)80552-8; Martineau M, 2008, GLIA, V56, P1271, DOI 10.1002/glia.20696; Miya K, 2008, J COMP NEUROL, V510, P641, DOI 10.1002/cne.21822; Mothet JP, 2005, P NATL ACAD SCI USA, V102, P5606, DOI 10.1073/pnas.0408483102; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; Oertner TG, 2002, NAT NEUROSCI, V5, P657, DOI 10.1038/nn867; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Porter JT, 1996, J NEUROSCI, V16, P5073; Rouach N, 2008, SCIENCE, V322, P1551, DOI 10.1126/science.1164022; Rusakov DA, 2003, NEURON, V37, P287, DOI 10.1016/S0896-6273(03)00025-4; Rusakov DA, 1998, J NEUROSCI, V18, P3158; SCHELL MJ, 1995, P NATL ACAD SCI USA, V92, P3948, DOI 10.1073/pnas.92.9.3948; Scott R, 2008, J NEUROSCI, V28, P7765, DOI 10.1523/JNEUROSCI.1296-08.2008; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Strisovsky K, 2005, BIOCHEMISTRY-US, V44, P13091, DOI 10.1021/bi051201o; SZERB JC, 1987, BRAIN RES, V410, P116, DOI 10.1016/S0006-8993(87)80030-6; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Xu T, 1998, NAT NEUROSCI, V1, P192, DOI 10.1038/642; Yang YL, 2003, P NATL ACAD SCI USA, V100, P15194, DOI 10.1073/pnas.2431073100	37	917	939	4	170	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 14	2010	463	7278					232	U120		10.1038/nature08673	http://dx.doi.org/10.1038/nature08673			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543MQ	20075918	Green Accepted			2022-12-28	WOS:000273582700036
J	Berg, WA				Berg, Wendie A.			Benefits of Screening Mammography	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BREAST-CANCER; MORTALITY; WOMEN		Amer Radiol Serv, Lutherville Timonium, MD 21093 USA		Berg, WA (corresponding author), Amer Radiol Serv, Lutherville Timonium, MD 21093 USA.	wendieberg@gmail.com			NATIONAL CANCER INSTITUTE [U01CA079778] Funding Source: NIH RePORTER; NCI NIH HHS [U01 CA079778, U01 CA89008] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], FREQUENTLY ASKED QUE; Bancej C, 2003, J MED SCREEN, V10, P16, DOI 10.1258/096914103321610761; Berg WA, 2009, AM J ROENTGENOL, V192, P390, DOI 10.2214/AJR.08.1706; Board of Radiation Effects Research Division on Earth and Life Sciences National Research Council of the National Academies, 2006, HLTH RISKS EXP LOW L; Coldman A, 2007, INT J CANCER, V120, P1076, DOI 10.1002/ijc.22249; Nelson HD, 2009, ANN INTERN MED, V151, P727, DOI 10.7326/0003-4819-151-10-200911170-00009; Schwartz LM, 2000, BMJ-BRIT MED J, V320, P1635, DOI 10.1136/bmj.320.7250.1635; Shapiro S, 1988, PERIODIC SCREENING B; Tabar L, 1996, INT J CANCER, V68, P693; Tabar L, 2003, LANCET, V361, P1405, DOI 10.1016/S0140-6736(03)13143-1	10	34	34	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 13	2010	303	2					168	169		10.1001/jama.2009.1993	http://dx.doi.org/10.1001/jama.2009.1993			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	542UI	20068213	Green Submitted, Green Accepted			2022-12-28	WOS:000273522600030
J	Barnes, AM; Carter, EM; Cabral, WA; Weis, M; Chang, WZ; Makareeva, E; Leikin, S; Rotimi, CN; Eyre, DR; Raggio, CL; Marini, JC				Barnes, Aileen M.; Carter, Erin M.; Cabral, Wayne A.; Weis, MaryAnn; Chang, Weizhong; Makareeva, Elena; Leikin, Sergey; Rotimi, Charles N.; Eyre, David R.; Raggio, Cathleen L.; Marini, Joan C.			Lack of Cyclophilin B in Osteogenesis Imperfecta with Normal Collagen Folding	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TRIPLE-HELIX FORMATION; CIS-TRANS-ISOMERASE; PROLYL 3-HYDROXYLATION; FK506-BINDING PROTEIN; ENDOPLASMIC-RETICULUM; I COLLAGEN; MUTATIONS; LETHAL; CRTAP; DEFICIENCY	Osteogenesis imperfecta is a heritable disorder that causes bone fragility. Mutations in type I collagen result in autosomal dominant osteogenesis imperfecta, whereas mutations in either of two components of the collagen prolyl 3-hydroxylation complex (cartilage-associated protein [CRTAP] and prolyl 3-hydroxylase 1 [P3H1]) cause autosomal recessive osteogenesis imperfecta with rhizomelia (shortening of proximal segments of upper and lower limbs) and delayed collagen folding. We identified two siblings who had recessive osteogenesis imperfecta without rhizomelia. They had a homozygous start-codon mutation in the peptidyl-prolyl isomerase B gene (PPIB), which results in a lack of cyclophilin B (CyPB), the third component of the complex. The proband's collagen had normal collagen folding and normal prolyl 3-hydroxylation, suggesting that CyPB is not the exclusive peptidyl-prolyl cis-trans isomerase that catalyzes the rate-limiting step in collagen folding, as is currently thought.	[Barnes, Aileen M.; Cabral, Wayne A.; Chang, Weizhong; Makareeva, Elena; Leikin, Sergey; Marini, Joan C.] NICHHD, NIH, Bethesda, MD 20892 USA; [Rotimi, Charles N.] NHGRI, NIH, Bethesda, MD 20892 USA; [Carter, Erin M.; Raggio, Cathleen L.] Hosp Special Surg, New York, NY 10021 USA; [Weis, MaryAnn; Eyre, David R.] Univ Washington, Orthopaed Res Labs, Seattle, WA 98195 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Washington; University of Washington Seattle	Marini, JC (corresponding author), NICHD, Bone & Extracellular Matrix Branch, NIH, Bldg 10,Rm 10N260,9000 Rockville Pike, Bethesda, MD 20892 USA.	oidoc@helix.nih.gov	Makareeva, Elena/F-5183-2011; Leikin, Sergey/A-5518-2008	Makareeva, Elena/0000-0002-5815-0760; Leikin, Sergey/0000-0001-7095-0739; Barnes, Aileen/0000-0001-8021-4997	National Institute of Child Health and Human Development; National Human Genome Research Institute Center for Research on Genomics and Global Health; National Institutes of Health [AR37318, AR36794, HD22657, DK-54001]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000408, ZIAHD000256, ZIAHD008830] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200362] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR036794, R01AR036794, R01AR037318, R37AR037318] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Human Genome Research Institute Center for Research on Genomics and Global Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Supported by intramural funding from the National Institute of Child Health and Human Development (to Drs. Marini and Leikin) and the National Human Genome Research Institute Center for Research on Genomics and Global Health (to Dr. Rotimi) and by grants (AR37318, AR36794, and HD22657, to Dr. Eyre; and DK-54001, to Dr. Rotimi) from the National Institutes of Health.	BACHINGER HP, 1993, AM J MED GENET, V45, P152, DOI 10.1002/ajmg.1320450204; BACHINGER HP, 1987, J BIOL CHEM, V262, P17144; BACHINGER HP, 1980, EUR J BIOCHEM, V106, P619, DOI 10.1111/j.1432-1033.1980.tb04610.x; Baldridge D, 2008, HUM MUTAT, V29, P1435, DOI 10.1002/humu.20799; Barnes AM, 2006, NEW ENGL J MED, V355, P2757, DOI 10.1056/NEJMoa063804; Cabral WA, 2008, NAT GENET, V40, P927, DOI 10.1038/ng0708-927a; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; Ishikawa Y, 2008, J BIOL CHEM, V283, P31584, DOI 10.1074/jbc.M802535200; Ishikawa Y, 2009, J BIOL CHEM, V284, P17641, DOI 10.1074/jbc.M109.007070; Marini JC, 2004, NELSON TXB PEDIAT, P2336; Marini JC, 2007, CELL CYCLE, V6, P1675, DOI 10.4161/cc.6.14.4474; Marini JC, 2007, HUM MUTAT, V28, P209, DOI 10.1002/humu.20429; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Obafemi AA, 2008, AM J MED GENET A, V146A, P2725, DOI 10.1002/ajmg.a.32508; PRICE ER, 1991, P NATL ACAD SCI USA, V88, P1903, DOI 10.1073/pnas.88.5.1903; RAGHUNATH M, 1994, J MOL BIOL, V236, P940, DOI 10.1006/jmbi.1994.1199; SILLENCE DO, 1979, J MED GENET, V16, P101, DOI 10.1136/jmg.16.2.101; SMITH T, 1995, J BIOL CHEM, V270, P18323, DOI 10.1074/jbc.270.31.18323; STEINMANN B, 1991, J BIOL CHEM, V266, P1299; Tryon RC, 2007, GENOMICS, V90, P93, DOI 10.1016/j.ygeno.2007.03.009; Van Dijk FS, 2009, EUR J HUM GENET, V17, P1560, DOI 10.1038/ejhg.2009.75; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; Wang P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-226; Willaert A, 2009, J MED GENET, V46, P233, DOI 10.1136/jmg.2008.062729; Zeng BF, 1998, BIOCHEM J, V330, P109, DOI 10.1042/bj3300109	26	135	138	1	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 11	2010	362	6					521	528		10.1056/NEJMoa0907705	http://dx.doi.org/10.1056/NEJMoa0907705			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	553WJ	20089953	Green Accepted			2022-12-28	WOS:000274397200009
J	Gibbons, RJ; Antman, EM; Smith, SC				Gibbons, Raymond J.; Antman, Elliott M.; Smith, Sidney C.			Has guideline development gone astray? No	BRITISH MEDICAL JOURNAL			English	Editorial Material							ACUTE MYOCARDIAL-INFARCTION; CLINICAL-PRACTICE GUIDELINES; HEART-FAILURE; DISEASE; CARE		[Gibbons, Raymond J.] Mayo Clin, Div Cardiovasc Dis & Internal Med, Rochester, MN 55905 USA; [Antman, Elliott M.] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; [Smith, Sidney C.] Univ N Carolina, Div Cardiol, Chapel Hill, NC USA	Mayo Clinic; Harvard University; Brigham & Women's Hospital; University of North Carolina; University of North Carolina Chapel Hill	Gibbons, RJ (corresponding author), Mayo Clin, Div Cardiovasc Dis & Internal Med, 200 1st St SW, Rochester, MN 55905 USA.	gibbons.raymond@mayo.edu		Gibbons, Raymond/0000-0003-0704-1350				*AG HEALTHC QUAL R, 2007 NAT HEALTHC QUA; *AM HEART ASS, 2010, METH MAN ACCF AHA GU; Antman EM, 2009, JAMA-J AM MED ASSOC, V302, P143, DOI 10.1001/jama.2009.912; Arias Elizabeth, 2007, Natl Vital Stat Rep, V56, P1; *COMM REV EV ID HI, 2008, KNOW WHAT WORKS HLTH; Eagle KA, 2005, J AM COLL CARDIOL, V46, P1242, DOI 10.1016/j.jacc.2004.12.083; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Fox KAA, 2007, JAMA-J AM MED ASSOC, V297, P1892, DOI 10.1001/jama.297.17.1892; GREENSPAN AM, 1988, NEW ENGL J MED, V318, P158, DOI 10.1056/NEJM198801213180306; McCormick D, 1999, ARCH INTERN MED, V159, P561, DOI 10.1001/archinte.159.6.561; Mehta RH, 2002, JAMA-J AM MED ASSOC, V287, P1269, DOI 10.1001/jama.287.10.1269; Mosser G, 1996, Qual Manag Health Care, V4, P11; Shaneyfelt TM, 2009, JAMA-J AM MED ASSOC, V301, P868, DOI 10.1001/jama.2009.225; Sueta CA, 1999, AM J CARDIOL, V83, P1303, DOI 10.1016/S0002-9149(99)00117-4; Tricoci P, 2009, JAMA-J AM MED ASSOC, V301, P831, DOI 10.1001/jama.2009.205; Wennberg JE, 1999, DARTMOUTH ATLAS CARD	16	7	7	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 29	2010	340								c343	10.1136/bmj.c343	http://dx.doi.org/10.1136/bmj.c343			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	549YD	20118176				2022-12-28	WOS:000274089500002
J	Querfurth, HW; LaFerla, FM				Querfurth, Henry W.; LaFerla, Frank M.			MECHANISMS OF DISEASE Alzheimer's Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							AMYLOID-BETA-PROTEIN; NICOTINIC ACETYLCHOLINE-RECEPTOR; INSULIN-DEGRADING ENZYME; BLOOD-BRAIN-BARRIER; GENOME-WIDE ASSOCIATION; LONG-TERM POTENTIATION; NEURONAL CELL-DEATH; A-BETA; MOUSE MODEL; PRECURSOR PROTEIN		[Querfurth, Henry W.] Rhode Isl Hosp, Dept Neurol, Providence, RI 02903 USA; [Querfurth, Henry W.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Querfurth, Henry W.] Tufts Med Ctr, Dept Neurol, Boston, MA USA; [Querfurth, Henry W.] Caritas St Elizabeths Med Ctr, Dept Neurol, Brighton, MA USA; [LaFerla, Frank M.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA USA	Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Tufts Medical Center; St. Elizabeth's Medical Center; University of California System; University of California Irvine	Querfurth, HW (corresponding author), Rhode Isl Hosp, Dept Neurol, 563 Eddy St, Providence, RI 02903 USA.	henry_querfurth@brown.edu	Carvalho, Cristina IMM/J-3657-2012					Aisen PS, 2008, JAMA-J AM MED ASSOC, V300, P1774, DOI 10.1001/jama.300.15.1774; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P10573, DOI 10.1073/pnas.90.22.10573; Arispe N, 1996, P NATL ACAD SCI USA, V93, P1710, DOI 10.1073/pnas.93.4.1710; ARRIAGADA PV, 1992, NEUROLOGY, V42, P1681, DOI 10.1212/WNL.42.9.1681; Arvanitakis Z, 2004, ARCH NEUROL-CHICAGO, V61, P661, DOI 10.1001/archneur.61.5.661; Bertram L, 2008, AM J HUM GENET, V83, P623, DOI 10.1016/j.ajhg.2008.10.008; Bitner RS, 2009, BRAIN RES, V1265, P65, DOI 10.1016/j.brainres.2009.01.069; Bodick NC, 1997, ARCH NEUROL-CHICAGO, V54, P465, DOI 10.1001/archneur.1997.00550160091022; Busciglio J, 2002, NEURON, V33, P677, DOI 10.1016/S0896-6273(02)00604-9; Busser J, 1998, J NEUROSCI, V18, P2801; Butler D, 2007, EUR J PHARMACOL, V562, P20, DOI 10.1016/j.ejphar.2007.01.053; Caccamo A, 2006, NEURON, V49, P671, DOI 10.1016/j.neuron.2006.01.020; Cardoso SM, 2004, J NEUROCHEM, V89, P1417, DOI 10.1111/j.1471-4159.2004.02438.x; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; Chapman PF, 1999, NAT NEUROSCI, V2, P271, DOI 10.1038/6374; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Clifford PM, 2007, BRAIN RES, V1142, P223, DOI 10.1016/j.brainres.2007.01.070; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Combs CK, 2001, J NEUROSCI, V21, P1179; Connor B, 1997, MOL BRAIN RES, V49, P71, DOI 10.1016/S0169-328X(97)00125-3; Cook DG, 2003, AM J PATHOL, V162, P313, DOI 10.1016/S0002-9440(10)63822-9; Cooper JD, 2001, P NATL ACAD SCI USA, V98, P10439, DOI 10.1073/pnas.181219298; Cordle A, 2005, J NEUROSCI, V25, P299, DOI 10.1523/JNEUROSCI.2544-04.2005; Craft S, 1998, NEUROLOGY, V50, P164, DOI 10.1212/WNL.50.1.164; Csernansky JG, 2006, AM J PSYCHIAT, V163, P2164, DOI 10.1176/appi.ajp.163.12.2164; Cuajungco MP, 2003, BRAIN RES REV, V41, P44, DOI 10.1016/S0165-0173(02)00219-9; DAVIES CA, 1987, J NEUROL SCI, V78, P151, DOI 10.1016/0022-510X(87)90057-8; Dawson GR, 1999, NEUROSCIENCE, V90, P1, DOI 10.1016/S0306-4522(98)00410-2; de la Monte SM, 2006, J ALZHEIMERS DIS, V10, P89; Deane R, 2007, CURR ALZHEIMER RES, V4, P191, DOI 10.2174/156720507780362245; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; den Dunnen WFA, 2008, NEUROBIOL AGING, V29, P1127, DOI 10.1016/j.neurobiolaging.2008.04.010; Doody RS, 2008, LANCET, V372, P207, DOI 10.1016/S0140-6736(08)61074-0; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Ernfors P, 2003, TRENDS NEUROSCI, V26, P171, DOI 10.1016/S0166-2236(03)00064-X; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Fiala M, 2005, J ALZHEIMERS DIS, V7, P221, DOI 10.3233/jad-2005-7304; Garzon DJ, 2007, J NEUROSCI, V27, P2628, DOI 10.1523/JNEUROSCI.5053-06.2007; Gilman S, 2005, NEUROLOGY, V64, P1553, DOI 10.1212/01.WNL.0000159740.16984.3C; Goedert M, 2005, BBA-MOL BASIS DIS, V1739, P240, DOI 10.1016/j.bbadis.2004.08.007; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; Good PF, 1996, AM J PATHOL, V149, P21; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Gouras GK, 2005, NEUROBIOL AGING, V26, P1235, DOI 10.1016/j.neurobiolaging.2005.05.022; Greene PD, 2004, ASIAN MUSIC, V35, P1; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hachinski V, 2006, STROKE, V37, P2220, DOI 10.1161/01.STR.0000237236.88823.47; Hall CB, 2009, NEUROLOGY, V73, P356, DOI 10.1212/WNL.0b013e3181b04ae3; Hauptmann S, 2006, EXP GERONTOL, V41, P668, DOI 10.1016/j.exger.2006.03.012; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; Henderson VW, 2009, SEMIN REPROD MED, V27, P283, DOI 10.1055/s-0029-1216281; HENSLEY K, 1994, P NATL ACAD SCI USA, V91, P3270, DOI 10.1073/pnas.91.8.3270; Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; Hock C, 2003, NEURON, V38, P547, DOI 10.1016/S0896-6273(03)00294-0; Hoffman LB, 2009, NEUROLOGY, V72, P1720, DOI 10.1212/01.wnl.0000345881.82856.d5; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Holtzman DM, 2000, P NATL ACAD SCI USA, V97, P2892, DOI 10.1073/pnas.050004797; Hoozemans JJM, 2005, ACTA NEUROPATHOL, V110, P165, DOI 10.1007/s00401-005-1038-0; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Humphries KM, 1998, BIOCHEMISTRY-US, V37, P15835, DOI 10.1021/bi981512h; Hutter-Paier B, 2004, NEURON, V44, P227, DOI 10.1016/j.neuron.2004.08.043; Ikonomovic MD, 2009, ARCH NEUROL-CHICAGO, V66, P646, DOI 10.1001/archneurol.2009.46; Iqbal K, 2005, BBA-MOL BASIS DIS, V1739, P198, DOI 10.1016/j.bbadis.2004.09.008; Isaacs AM, 2006, J BIOL CHEM, V281, P27916, DOI 10.1074/jbc.M602061200; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; Jagust WJ, 2000, NEUROL CLIN, V18, P885, DOI 10.1016/S0733-8619(05)70231-0; Jones RW, 2008, ALZHEIMERS DEMENT, V4, P145, DOI 10.1016/j.jalz.2008.02.001; Kamal A, 2001, NATURE, V414, P643, DOI 10.1038/414643a; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kanemitsu H, 2003, NEUROSCI LETT, V350, P113, DOI 10.1016/S0304-3940(03)00898-X; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Keller JN, 1997, NEUROSCIENCE, V80, P685, DOI 10.1016/S0306-4522(97)00065-1; Khlistunova I, 2006, J BIOL CHEM, V281, P1205, DOI 10.1074/jbc.M507753200; Kivipelto M, 2001, BMJ-BRIT MED J, V322, P1447, DOI 10.1136/bmj.322.7300.1447; Klein JA, 2003, J CLIN INVEST, V111, P785, DOI 10.1172/JCI200318182; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Klyubin I, 2008, J NEUROSCI, V28, P4231, DOI 10.1523/JNEUROSCI.5161-07.2008; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Larson J, 1999, BRAIN RES, V840, P23, DOI 10.1016/S0006-8993(99)01698-4; Lazarov O, 2002, J NEUROSCI, V22, P9785; Lazarov O, 2005, J NEUROSCI, V25, P2386, DOI 10.1523/JNEUROSCI.3089-04.2005; Lee HG, 2005, TRENDS MOL MED, V11, P164, DOI 10.1016/j.molmed.2005.02.008; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Leissring MA, 2000, J CELL BIOL, V149, P793, DOI 10.1083/jcb.149.4.793; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Li GB, 2003, J NEUROCHEM, V84, P347, DOI 10.1046/j.1471-4159.2003.01526.x; Li YK, 2003, J NEUROSCI, V23, P1605; Lin H, 2002, FASEB J, V16; Lin H, 2001, FASEB J, V15, P2433, DOI 10.1096/fj.01-0377com; Lister JP, 2009, ARCH NEUROL-CHICAGO, V66, P829, DOI 10.1001/archneurol.2009.125; Liu DX, 2001, CELL TISSUE RES, V305, P217, DOI 10.1007/s004410100396; Lleo A, 2004, NAT MED, V10, P1065, DOI 10.1038/nm1112; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Luchsinger JA, 2007, ARCH NEUROL-CHICAGO, V64, P86, DOI 10.1001/archneur.64.1.86; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; Maelicke A, 2001, BIOL PSYCHIAT, V49, P279, DOI 10.1016/S0006-3223(00)01109-4; Mark RJ, 1997, J NEUROSCI, V17, P1046; Masliah E, 2001, NEUROLOGY, V56, P127, DOI 10.1212/WNL.56.1.127; Masliah E, 2006, J ALZHEIMERS DIS, V9, P91; Matsumoto Y, 2007, DEMENT GERIATR COGN, V23, P241, DOI 10.1159/000100019; Matsuoka Y, 2008, J PHARMACOL EXP THER, V325, P146, DOI 10.1124/jpet.107.130526; Mattsson N, 2009, JAMA-J AM MED ASSOC, V302, P385, DOI 10.1001/jama.2009.1064; McGeer EG, 2001, NEUROBIOL AGING, V22, P843, DOI 10.1016/S0197-4580(01)00288-3; McGeer PL, 2007, NEUROBIOL AGING, V28, P639, DOI 10.1016/j.neurobiolaging.2006.03.013; McGeer PL, 2003, NEUROBIOL AGING, V24, P391, DOI 10.1016/S0197-4580(02)00157-4; McLaurin J, 2006, NAT MED, V12, P801, DOI 10.1038/nm1423; Messier Claude, 2005, Neural Plasticity, V12, P311, DOI 10.1155/NP.2005.311; Mosch B, 2007, J NEUROSCI, V27, P6859, DOI 10.1523/JNEUROSCI.0379-07.2007; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Mungarro-Menchaca X, 2002, J NEUROSCI RES, V68, P89, DOI 10.1002/jnr.10193; Nagahara AH, 2009, NAT MED, V15, P331, DOI 10.1038/nm.1912; Nelson O, 2007, J CLIN INVEST, V117, P1230, DOI 10.1172/JCI30447; Nitsch RM, 1996, NEURODEGENERATION, V5, P477, DOI 10.1006/neur.1996.0066; Nitsch RM, 2000, ANN NEUROL, V48, P913, DOI 10.1002/1531-8249(200012)48:6<913::AID-ANA12>3.3.CO;2-J; Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759; OBRIEN JT, 2003, LANCET NEUROL, V2, P89, DOI [10.1016/S1474-4422(03)00305-3, DOI 10.1016/S1474-4422(03)00305-3]; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2006, J BIOL CHEM, V281, P39413, DOI 10.1074/jbc.M608485200; Ogawa O, 2003, AGING CELL, V2, P105, DOI 10.1046/j.1474-9728.2003.00042.x; Ono K, 2008, J BIOL CHEM, V283, P32176, DOI 10.1074/jbc.M806154200; Paris D, 2004, NEUROSCI LETT, V366, P80, DOI 10.1016/j.neulet.2004.05.017; Pedersen WA, 2006, EXP NEUROL, V199, P265, DOI 10.1016/j.expneurol.2006.01.018; Pedrini S, 2005, PLOS MED, V2, P69, DOI 10.1371/journal.pmed.0020018; Pierrot N, 2004, J NEUROCHEM, V88, P1140, DOI 10.1046/j.1471-4159.2003.02227.x; Planel E, 2009, FASEB J, V23, P2595, DOI 10.1096/fj.08-122424; Pratico D, 2008, TRENDS PHARMACOL SCI, V29, P609, DOI 10.1016/j.tips.2008.09.001; Price JM, 2001, NEUROL RES, V23, P506, DOI 10.1179/016164101101198758; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; QUINN JF, 2009, ALZHEIMERS DEMENTI S, V5, P84; Rapoport M, 2002, P NATL ACAD SCI USA, V99, P6364, DOI 10.1073/pnas.092136199; Reddy PH, 2008, TRENDS MOL MED, V14, P45, DOI 10.1016/j.molmed.2007.12.002; Reiman EM, 2009, P NATL ACAD SCI USA, V106, P6820, DOI 10.1073/pnas.0900345106; Ring S, 2007, J NEUROSCI, V27, P7817, DOI 10.1523/JNEUROSCI.1026-07.2007; Risner ME, 2006, PHARMACOGENOMICS J, V6, P246, DOI 10.1038/sj.tpj.6500369; RITCHIE CW, 2008, LANCET NEUROL, V7, P779; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Roher AE, 2004, STROKE, V35, P2623, DOI 10.1161/01.STR.0000143317.70478.b3; ROTHMAN SM, 1995, TRENDS NEUROSCI, V18, P57; Ruitenberg A, 2005, ANN NEUROL, V57, P789, DOI 10.1002/ana.20493; Sager KL, 2007, ANN NEUROL, V62, P640, DOI 10.1002/ana.21190; Salon ML, 2000, J NEUROSCI RES, V62, P302, DOI 10.1002/1097-4547(20001015)62:2<302::AID-JNR15>3.0.CO;2-L; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Savva GM, 2009, NEW ENGL J MED, V360, P2302, DOI 10.1056/NEJMoa0806142; Scheff SW, 2007, NEUROLOGY, V68, P1501, DOI 10.1212/01.wnl.0000260698.46517.8f; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shen Y, 2003, PROG NEUROBIOL, V70, P463, DOI 10.1016/j.pneurobio.2003.08.001; Siemers ER, 2006, NEUROLOGY, V66, P602, DOI 10.1212/01.WNL.0000198762.41312.E1; Sigurdsson EM, 2008, J ALZHEIMERS DIS, V15, P157; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Sink KM, 2009, ARCH INTERN MED, V169, P1195, DOI 10.1001/archinternmed.2009.175; Sisodia SS, 2002, SCIENCE, V295, P805, DOI 10.1126/science.1069661; Smith MA, 1997, J NEUROSCI, V17, P2653; Smith MA, 1996, NATURE, V382, P120, DOI 10.1038/382120b0; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Sparks DL, 2005, ARCH NEUROL-CHICAGO, V62, P753, DOI 10.1001/archneur.62.5.753; St George-Hyslop PH, 2000, BIOL PSYCHIAT, V47, P183, DOI 10.1016/S0006-3223(99)00301-7; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Strittmatter WJ, 1996, ANNU REV NEUROSCI, V19, P53, DOI 10.1146/annurev.ne.19.030196.000413; Szekely CA, 2008, NEUROLOGY, V70, P17, DOI 10.1212/01.wnl.0000284596.95156.48; Takashima A, 2006, J ALZHEIMERS DIS, V9, P309; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tuszynski MH, 2007, ALZ DIS ASSOC DIS, V21, P179, DOI 10.1097/WAD.0b013e318068d6d2; Van Nostrand WE, 1998, J NEUROCHEM, V70, P216; Vega GL, 2003, ARCH NEUROL-CHICAGO, V60, P510, DOI 10.1001/archneur.60.4.510; Vlad SC, 2008, NEUROLOGY, V70, P1672, DOI 10.1212/01.wnl.0000311269.57716.63; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wallin AK, 2006, DEMENT GERIATR COGN, V21, P131, DOI 10.1159/000090631; Walsh DM, 2005, J NEUROSCI, V25, P2455, DOI 10.1523/JNEUROSCI.4391-04.2005; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang HY, 2000, J BIOL CHEM, V275, P5626, DOI 10.1074/jbc.275.8.5626; Weggen S, 2003, J BIOL CHEM, V278, P31831, DOI 10.1074/jbc.M303592200; Wilcock DM, 2007, NEUROSCIENCE, V144, P950, DOI 10.1016/j.neuroscience.2006.10.020; Wu W, 2008, ANN NEUROL, V64, P698, DOI 10.1002/ana.21557; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8; Xie ZC, 2008, ANN NEUROL, V64, P618, DOI 10.1002/ana.21548; Yamamoto A, 2002, J NEUROCHEM, V82, P1137; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yang Y, 2003, J NEUROSCI, V23, P2557; Yang Y, 2007, BBA-MOL BASIS DIS, V1772, P457, DOI 10.1016/j.bbadis.2006.10.002; 2002, BIOCHEMISTRY, V41, P11080	193	3448	3604	50	1751	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 28	2010	362	4					329	344		10.1056/NEJMra0909142	http://dx.doi.org/10.1056/NEJMra0909142			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	548OT	20107219				2022-12-28	WOS:000273975000009
J	Hafiji, J; Batchelor, J				Hafiji, Juber; Batchelor, Jonathan			Picture quiz Red in the face	BRITISH MEDICAL JOURNAL			English	Editorial Material							DOXYCYCLINE; MANAGEMENT		[Hafiji, Juber; Batchelor, Jonathan] Addenbrookes Hosp, Dept Dermatol, Cambridge CB2 0QQ, England	Addenbrooke's Hospital; University of Cambridge	Hafiji, J (corresponding author), Addenbrookes Hosp, Dept Dermatol, Cambridge CB2 0QQ, England.	juber.hafiji@addenbrookes.nhs.uk						BONNETBLANC JM, 2003, ANN DERMATOL VENER, V130, P789; CHARTIER C, 1990, INT J DERMATOL, V29, P459, DOI 10.1111/j.1365-4362.1990.tb04833.x; Elsaie ML, 2009, POSTGRAD MED, V121, P178, DOI 10.3810/pgm.2009.09.2066; EPSTEIN JH, 1983, J AM ACAD DERMATOL, V8, P141, DOI 10.1016/S0190-9622(83)70016-2; Iannini P, 2006, J CHEMOTHERAPY, V18, P127, DOI 10.1179/joc.2006.18.2.127; LAYTON AM, 1993, CLIN EXP DERMATOL, V18, P425, DOI 10.1111/j.1365-2230.1993.tb02242.x; Lee JH, 2007, PHOTODERMATOL PHOTO, V23, P73, DOI 10.1111/j.1600-0781.2007.00279.x; LIM DS, 2003, BRIT J DERMATOL, V149, P193; LOWE NJ, 1994, CLIN PHARMACOL THER, V56, P587, DOI 10.1038/clpt.1994.180; Moore DE, 2002, DRUG SAFETY, V25, P345, DOI 10.2165/00002018-200225050-00004; Morris AD, 2008, CLIN EVID; Onoue S, 2009, CURR DRUG SAF, V4, P123, DOI 10.2174/157488609788173044; Scheinfeld Noah S, 2006, Skinmed, V5, P191, DOI 10.1111/j.1540-9740.2006.05017.x; Sloan B, 2008, EXPERT OPIN DRUG SAF, V7, P571, DOI 10.1517/14740338.7.5.571 ; Webster GF, 2009, MED CLIN N AM, V93, P1183, DOI 10.1016/j.mcna.2009.08.007	15	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 27	2010	340								b5643	10.1136/bmj.b5643	http://dx.doi.org/10.1136/bmj.b5643			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	549YB	20106883				2022-12-28	WOS:000274089300002
J	Lamont, T; Luettel, D; Scarpello, J; O'Driscoll, BR; Connew, S				Lamont, Tara; Luettel, Dagmar; Scarpello, John; O'Driscoll, B. Ronan; Connew, Steven			Safety Alerts Improving the safety of oxygen therapy in hospitals: summary of a safety report from the National Patient Safety Agency	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Lamont, Tara; Luettel, Dagmar; Scarpello, John] Natl Patient Safety Agcy, Natl Reporting & Learning Serv, London W1T 5HD, England; [O'Driscoll, B. Ronan] Salford Royal NHS Fdn Trust, Salford M6 8HD, Lancs, England; [Connew, Steven] Colchester Hosp Univ NHS Fdn Trust, Colchester CO4 5JL, Essex, England	Salford Royal NHS Foundation Trust	Lamont, T (corresponding author), Natl Patient Safety Agcy, Natl Reporting & Learning Serv, London W1T 5HD, England.	tara.lamont@npsa.nhs.uk						*BRIT THOR SOC, NAT AUD RES EM OX US; DAVIS R M, 1989, California Agriculture, V43, P4; Leach RM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a2790; *NAT I HLTH CLIN E, 2007, CLIN GUID NAT I HLTH, V50; National Patient Safety Agency, 2007, REC RESP APPR EARL S; O'Driscoll BR, 2008, THORAX, V63, DOI 10.1136/thx.2008.102947; SLUTSKY AS, 1994, INTENS CARE MED, V20, P64, DOI 10.1007/BF02425061	7	9	9	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 26	2010	340								c187	10.1136/bmj.c187	http://dx.doi.org/10.1136/bmj.c187			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	549YA	20103511				2022-12-28	WOS:000274089200001
J	Cannon, CP; Harrington, RA; James, S; Ardissino, D; Becker, RC; Emanuelsson, H; Husted, S; Katus, H; Keltai, M; Khurmi, NS; Kontny, F; Lewis, BS; Steg, PG; Storey, RF; Wojdyla, D; Wallentin, L				Cannon, Christopher P.; Harrington, Robert A.; James, Stefan; Ardissino, Diego; Becker, Richard C.; Emanuelsson, Hakan; Husted, Steen; Katus, Hugo; Keltai, Matyas; Khurmi, Nardev S.; Kontny, Frederic; Lewis, Basil S.; Steg, Philippe Gabriel; Storey, Robert F.; Wojdyla, Daniel; Wallentin, Lars		PLATO Investigators	Comparison of ticagrelor with clopidogrel in patients with planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study	LANCET			English	Article							ELEVATION MYOCARDIAL-INFARCTION; P2Y(12) RECEPTOR ANTAGONIST; ST-ELEVATION; PLATELET INHIBITION; UNSTABLE ANGINA; TASK-FORCE; INTERVENTION; ASPIRIN; PCI; PRETREATMENT	Background Variation in and irreversibility of platelet inhibition with clopiclogrel has led to controversy about its optimum dose and timing of administration in patients with acute coronary syndromes. We compared ticagrelor, a more potent reversible P2Y12 inhibitor with clopiclogrel in such patients. Methods At randomisation, an invasive strategy was planned for 13408 (72.0%) of 18624 patients hospitalised for acute coronary syndromes (with or without ST elevation). in a double-blind, double-dummy study, patients were randomly assigned in a one-to-one ratio to ticagrelor and placebo (180 mg loading dose followed by 90 mg twice a day), or to clopidogrel and placebo (300-600 mg loading dose or continuation with maintenance dose followed by 75 mg per day) for 6-12 months. All patients were given aspirin. The primary composite endpoint was cardiovascular death, myocardial infarction, or stroke. Analyses were by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT00391872. Findings 6732 patients were assigned to ticagrelor and 6676 to clopidogrel. The primary composite endpoint occurred in fewer patients in the ticagrelor group than in the clopiclogrel group (569 [event rate at 360 days 9.0%] vs 668 [10.7%], hazard ratio 0.84, 95% CI 0.75-0.94; p=0.0025). There was no difference between clopiclogrel and ticagrelor groups in the rates of total major bleeding (691 [11.6%] vs 689 [11.5%], 0.99 [0.89-1.10]; p=0.8803) or severe bleeding, as defined according to the Global Use of Strategies To Open occluded coronary arteries, (198 [3.2%] vs 185 [2.9%], 0.91 [0.74-1.12]; p=0.3785). Interpretation Ticagrelor seems to be a better option than clopidogrel for patients with acute coronary syndromes for whom an early invasive strategy is planned.	[Cannon, Christopher P.] Brigham & Womens Hosp, TIMI Study Grp, Div Cardiovasc, Boston, MA 02115 USA; [Harrington, Robert A.; Becker, Richard C.; Wojdyla, Daniel] Duke Clin Res Inst, Durham, NC USA; [James, Stefan; Wallentin, Lars] Uppsala Clin Res Ctr, Uppsala, Sweden; [James, Stefan; Wallentin, Lars] Dept Med Sci, Uppsala, Sweden; [Ardissino, Diego] Azienda Osped Univ Parma, Parma, Italy; [Emanuelsson, Hakan] AstraZeneca, Molndal, Sweden; [Khurmi, Nardev S.] AstraZeneca, Wilmington, DE USA; [Husted, Steen] Arhus Univ Hosp, Aarhus, Denmark; [Katus, Hugo] Univ Klinikum Heidelberg, Heidelberg, Germany; [Keltai, Matyas] Hungarian Inst Cardiol, Budapest, Hungary; [Kontny, Frederic] Volvat Med Ctr, Oslo, Norway; [Lewis, Basil S.] Lady Davis Carmel Med Ctr, Haifa, Israel; [Steg, Philippe Gabriel] APHP, INSERM, U698, Paris, France; [Steg, Philippe Gabriel] Univ Paris, F-75252 Paris, France; [Storey, Robert F.] Univ Sheffield, Sheffield, S Yorkshire, England	Harvard University; Brigham & Women's Hospital; Duke University; Uppsala University; University of Parma; University Hospital of Parma; AstraZeneca; AstraZeneca; Aarhus University; Ruprecht Karls University Heidelberg; Clalit Health Services; Carmel Medical Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Sheffield	Cannon, CP (corresponding author), Brigham & Womens Hosp, TIMI Study Grp, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA.	cpcannon@partners.org	Ardissino, Diego/AAC-4041-2022; STEG, Philippe Gabriel/Z-1567-2019; James, Stefan K/J-4554-2014; Cannon, Christopher P/AAY-7644-2020; Storey, Robert/AAA-6853-2019	Cannon, Christopher P/0000-0003-4596-2791; Storey, Robert/0000-0002-6677-6229; STEG, Philippe Gabriel/0000-0001-6896-2941; solinas, emilia/0000-0003-3532-1317	Accumetrics; AstraZeneca; Bristol-Myers Squibb; Sanofi-Aventis; GlaxoSmithlKline; Merck; Intekrin Therapeutics; Novartis; Takeda; Pfizer; Eli Lilly; Boehringer-Irigelheiin	Accumetrics; AstraZeneca(AstraZeneca); Bristol-Myers Squibb(Bristol-Myers Squibb); Sanofi-Aventis(Sanofi-Aventis); GlaxoSmithlKline; Merck(Merck & Company); Intekrin Therapeutics; Novartis(Novartis); Takeda(Takeda Pharmaceutical Company Ltd); Pfizer(Pfizer); Eli Lilly(Eli Lilly); Boehringer-Irigelheiin	CPC has received research or grant support from Accumetrics, AstraZeneca, Bristol-Myers Squibb, Sanofi-Aventis, GlaxoSmithlKline, Merck, Intekrin Therapeutics, Novartis, and Takeda; and owns equity in ALItomedics Medical Systems. RAH has received consulting fees from Bristol-Myers Squibb, Sanorfi-Aventis, Portola Pharmaceuticals, Schering-Plough, arid AstraZeneca; lecture fees from Schering-Plough, Bristol-Myers Squibb, Sanofi-Aventis, and Eli Lilly; and grant support from Millennium Phannaceuticals, Schering-Plough, Tlie Medicines Company, Portola Pharmaceuticals, AstraZeneca, and Bristol-Myers Squibb. SJ has received research grants arid advisory board fees from AstraZeneca; and honoraria from AstraZeneca, Bristol-Myers Squibb, Schering-Plough, and Eli Lilly. DA has received research grants from AstraZeneca, Eli Lilly, Pfizer, and Boston Scientific; speaker's bureau payments and honoraria from GIaxoSmithKline, Boehringer-Irigelheiin, Sanofi-Aventis, Pfizer, Eli Lilly, AstraZeneca. Schering-Plough, Daiichi Sankyo, Merck, arid Boston Scientific: and advisory board fees from Sanofi-Aventis, Pfizer, Eli Lillv AstraZeneca, Schering-Plough, Daiichi Sarikyo, and Mechionic. RCB has received consulting fees from Regado Biosciences, AstraZeneca, Eli Lilly, and Bristol-Myers Squibb; and grant support from Momenta Pharmaceuticals, The Medicines Company, and Bristol-Myers Squibb. H E has been an employee ofand owned equity in AstraZeneca. SH has received consulting fees from AstraZeneca, Sanofi-Aventis, and Eli Lilly; and lecture fees from AstraZeneca, Sanofi-Avenfis, and Bristol-Myers Squibb. H K has received consulting arid lecture fees from AstraZeneca, Bayer Healthcare, Abbott, Roche, and Menarim. MK has received consulting and lecture fees from AstraZeneca. NSK has been an employee ofAstraZeneca. FK has received advisory board fees from AstraZeneca and Boehringer-Ingelheim; consulting fees from AstraZeneca, Boeh ringer-I ngelheim, and Sanofi-Aventis; grant support froul Merck Sharp and Dohme, and Perseus Proteomics; and lecture fees from AstraZerieca, Bristol-Myers Squibb, Boehringer-Ingelheim, Eli Lilly, Pfizer, and Sanofi-Aventis. BSL has received consulting fees froni Bristol-Myers Squibb and Sanofi-Aventis; and grant support from AstraZeneca. PGS has received research grants from Sanofi-Aventis arid Servier; lecture fees from AstraZeneca, Boehringer-Ingelheirn ' Bristol-Myers Squibb, GlaxoSmith Kline, Menarim, Mechronic, Nyconied, Pierre Fabre, Sanofi-Averitis, Servier, and The Medicines Company; consulting or advisory board fees from Astellas, AstraZeneca, Bayer, Boehringer-Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Endotis, GlaxoSmith Kline, Medtronic, Merck Sharp and Dohme, Nycomed, Sanofi-Aventis, Servier, and The Medicines Company; and has been a stockholder ofAterovax. RFS has received consulting fees from AstraZeneca. Eli Lilly, Daiichi Sankyo, Teva, and Schering-Plough; lecture fees from Eli Lilly, Daiichi Sankyo, arid AstraZeneca; and grant support from AstraZeneca, Eli Lilly, Daiichi Sankyo, arid Schering-Plough. DW declares that he has no conflicts of interest. LW has received consulting fees from Regado Biosciences and Athera Biotechnologies; lecture fees from Boehringer-Ingelheim, AstraZeneca, and Eli Lilly; and grant support from AstraZeneca, Boehringer-Ingelheim, Bristol-Myers Squibb, GlaxoSmitliKline, and Schering-Plough.	Alexander D, 2008, AM HEART J, V156, P606, DOI 10.1016/j.ahj.2008.05.012; Anderson JL, 2007, J AM COLL CARDIOL, V50, P652, DOI 10.1016/j.jacc.2007.02.028; [Anonymous], 1988, LANCET, V2, P349; [Anonymous], J AM COLL CARDIOL, DOI DOI 10.1016/J.JACC.2007.10.001; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Bassand JP, 2007, EUR HEART J, V28, P1598, DOI 10.1093/eurheartj/ehm161; Berger PB, 2002, CIRCULATION, V106, P2284, DOI 10.1161/01.CIR.0000035924.70846.20; Bjorkman JA, 2007, CIRCULATION, V116, P28; Boersma E, 2006, EUR HEART J, V27, P779, DOI 10.1093/eurheartj/ehi810; Boersma E, 2002, LANCET, V359, P189, DOI 10.1016/S0140-6736(02)07442-1; Chen ZM, 2005, LANCET, V366, P1607, DOI 10.1016/s0140-6736(05)67660-x; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Eikelboom JW, 2000, LANCET, V355, P1936, DOI 10.1016/S0140-6736(00)02324-2; Gurbel PA, 2003, CIRCULATION, V107, P2908, DOI 10.1161/01.CIR.0000072771.11429.83; Gurbel PA, 2009, CIRCULATION, V120, P2577, DOI 10.1161/CIRCULATIONAHA.109.912550; Husted S, 2006, EUR HEART J, V27, P1038, DOI 10.1093/eurheartj/ehi754; Husted S, 2009, CARDIOVASC THER, V27, P259, DOI 10.1111/j.1755-5922.2009.00096.x; James S, 2009, AM HEART J, V157, P599, DOI 10.1016/j.ahj.2009.01.003; Kleiman NS, 2000, CIRCULATION, V101, P751, DOI 10.1161/01.CIR.101.7.751; Kushner FG, 2009, J AM COLL CARDIOL, V54, P2205, DOI [10.1016/j.jacc.2009.10.015, 10.1002/ccd.22351]; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P2908, DOI 10.1001/jama.293.23.2908; MEHTA SR, 2009, EUR SOC CARD SCI SES; Sabatine MS, 2005, NEW ENGL J MED, V352, P1179, DOI 10.1056/NEJMoa050522; Sabatine MS, 2005, JAMA-J AM MED ASSOC, V294, P1224, DOI 10.1001/jama.294.10.1224; Stone GW, 2008, NEW ENGL J MED, V358, P2218, DOI 10.1056/NEJMoa0708191; Storey RF, 2007, J AM COLL CARDIOL, V50, P1852, DOI 10.1016/j.jacc.2007.07.058; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; Van de Werf F, 2008, EUR HEART J, V29, P2909, DOI 10.1093/eurheartj/ehn416; van Giezen JJJ, 2009, J THROMB HAEMOST, V7, P1556, DOI 10.1111/j.1538-7836.2009.03527.x; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wiviott SD, 2007, CIRCULATION, V116, P2923, DOI 10.1161/CIRCULATIONAHA.107.740324; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Yusuf S, 2006, NEW ENGL J MED, V354, P1464; Yusuf S, 2001, NEW ENGL J MED, V345, P494	35	506	547	1	46	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 23	2010	375	9711					283	293		10.1016/S0140-6736(09)62191-7	http://dx.doi.org/10.1016/S0140-6736(09)62191-7			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	549QS	20079528				2022-12-28	WOS:000274069300029
J	Missmann, M; Tauscher, T; Jank, S; Kloss, F; Gassner, R				Missmann, Martin; Tauscher, Thomas; Jank, Siegfried; Kloss, Frank; Gassner, Robert			Impaled head	LANCET			English	Editorial Material									[Missmann, Martin; Jank, Siegfried; Kloss, Frank; Gassner, Robert] Univ Innsbruck Hosp, Dept Cranio Maxillofacial & Oral Surg, A-6020 Innsbruck, Austria; [Tauscher, Thomas] Univ Innsbruck Hosp, Dept Vasc Surg, A-6020 Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck	Gassner, R (corresponding author), Univ Innsbruck Hosp, Dept Cranio Maxillofacial & Oral Surg, A-6020 Innsbruck, Austria.	robert.gassner@uki.at							0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 23	2010	375	9711					317	317		10.1016/S0140-6736(09)60294-4	http://dx.doi.org/10.1016/S0140-6736(09)60294-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	549QS	20109959				2022-12-28	WOS:000274069300033
J	Kahan, D				Kahan, Dan			Fixing the communications failure	NATURE			English	Editorial Material							COGNITION; SELF		Yale Univ, Sch Law, New Haven, CT 06511 USA	Yale University	Kahan, D (corresponding author), Yale Univ, Sch Law, New Haven, CT 06511 USA.	dan.kahan@yale.edu						Cohen GL, 2007, J PERS SOC PSYCHOL, V93, P415, DOI 10.1037/0022-3514.93.3.415; Cohen GL, 2000, PERS SOC PSYCHOL B, V26, P1151, DOI 10.1177/01461672002611011; DiMaggio P, 1997, ANNU REV SOCIOL, V23, P263, DOI 10.1146/annurev.soc.23.1.263; Douglas M., 1982, RISK CULTURE ESSAY S; HASTORF AH, 1954, J ABNORM SOC PSYCH, V49, P129, DOI 10.1037/h0057880; Kahan D. M., 2007, J EMPIR LEGAL STUD, V4, P465, DOI DOI 10.1111/J.1740-1461.2007.00097.X; Kahan DM, 2009, NAT NANOTECHNOL, V4, P87, DOI [10.1038/nnano.2008.341, 10.1038/NNANO.2008.341]; KAHAN DM, LAW HUMAN B IN PRESS	8	329	333	1	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 21	2010	463	7279					296	297		10.1038/463296a	http://dx.doi.org/10.1038/463296a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	545PM	20090734				2022-12-28	WOS:000273748100022
J	Henriksson, M; Palmer, S; Chen, RL; Damant, J; Fitzpatrick, NK; Abrams, K; Hingorani, AD; Stenestrand, U; Janzon, M; Feder, G; Keogh, B; Shipley, MJ; Kaski, JC; Timmis, A; Sculpher, M; Hemingway, H				Henriksson, Martin; Palmer, Stephen; Chen, Ruoling; Damant, Jacqueline; Fitzpatrick, Natalie K.; Abrams, Keith; Hingorani, Aroon D.; Stenestrand, Ulf; Janzon, Magnus; Feder, Gene; Keogh, Bruce; Shipley, Martin J.; Kaski, Juan-Carlos; Timmis, Adam; Sculpher, Mark; Hemingway, Harry			Assessing the cost effectiveness of using prognostic biomarkers with decision models: case study in prioritising patients waiting for coronary artery surgery	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BYPASS GRAFT-SURGERY; STABLE ANGINA; CARDIOVASCULAR-DISEASE; CARDIAC-SURGERY; DEATH; RISK; REVASCULARIZATION; MANAGEMENT; OUTCOMES; IMPROVE	Objective To determine the effectiveness and cost effectiveness of using information from circulating biomarkers to inform the prioritisation process of patients with stable angina awaiting coronary artery bypass graft surgery. Design Decision analytical model comparing four prioritisation strategies without biomarkers (no formal prioritisation, two urgency scores, and a risk score) and three strategies based on a risk score using biomarkers: a routinely assessed biomarker (estimated glomerular filtration rate), a novel biomarker (C reactive protein), or both. The order in which to perform coronary artery bypass grafting in a cohort of patients was determined by each prioritisation strategy, and mean lifetime costs and quality adjusted life years (QALYs) were compared. Data sources Swedish Coronary Angiography and Angioplasty Registry (9935 patients with stable angina awaiting coronary artery bypass grafting and then followed up for cardiovascular events after the procedure for 3.8 years), and meta-analyses of prognostic effects (relative risks) of biomarkers. Results The observed risk of cardiovascular events while on the waiting list for coronary artery bypass grafting was 3 per 10 000 patients per day within the first 90 days (184 events in 9935 patients). Using a cost effectiveness threshold of 20 pound 000-30 pound 000 ((sic)22 000-(sic)33 000; $32 000-$48 000) per additional QALY, a prioritisation strategy using a risk score with estimated glomerular filtration rate was the most cost effective strategy (cost per additional QALY was <410 pound compared with the Ontario urgency score). The impact on population health of implementing this strategy was 800 QALYs per 100 000 patients at an additional cost of 245 pound 000 to the National Health Service. The prioritisation strategy using a risk score with C reactive protein was associated with lower QALYs and higher costs compared with a risk score using estimated glomerular filtration rate. Conclusion Evaluating the cost effectiveness of prognostic biomarkers is important even when effects at an individual level are small. Formal prioritisation of patients awaiting coronary artery bypass grafting using a routinely assessed biomarker (estimated glomerular filtration rate) along with simple, routinely collected clinical information was cost effective. Prioritisation strategies based on the prognostic information conferred by C reactive protein, which is not currently measured in this context, or a combination of C reactive protein and estimated glomerular filtration rate, is unlikely to be cost effective. The widespread practice of using only implicit or informal means of clinically ordering the waiting list may be harmful and should be replaced with formal prioritisation approaches.	[Chen, Ruoling; Damant, Jacqueline; Fitzpatrick, Natalie K.; Hingorani, Aroon D.; Keogh, Bruce; Shipley, Martin J.; Hemingway, Harry] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; [Sculpher, Mark] Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England; [Abrams, Keith] Univ Leicester, Dept Hlth Sci, Leicester LE1 7RH, Leics, England; [Stenestrand, Ulf; Janzon, Magnus] Linkoping Univ Hosp, Dept Cardiol, HeartCtr, Linkoping, Sweden; [Feder, Gene] Univ Bristol, Acad Unit Primary Hlth Care, Bristol BS8 1TH, Avon, England; [Kaski, Juan-Carlos] Univ London, Div Cardiac & Vasc Sci, London WC1E 7HU, England; [Timmis, Adam] Barts & London Med Sch, London, England	University of London; University College London; University of York - UK; University of Leicester; Linkoping University; University of Bristol; University of London; University of London; Queen Mary University London	Hemingway, H (corresponding author), UCL, Dept Epidemiol & Publ Hlth, Mortimer St, London WC1E 6BT, England.	h.hemingway@ucl.ac.uk	Henriksson, Martin/HDN-3507-2022; Abrams, Keith/AAA-2557-2020; Hemingway, Harry/C-1219-2009	Henriksson, Martin/0000-0003-1699-3185; Hemingway, Harry/0000-0003-2279-0624; Sculpher, Mark/0000-0003-3746-9913; Hingorani, Aroon/0000-0001-8365-0081; Abrams, Keith/0000-0002-7557-1567; Chen, Ruoling/0000-0002-3033-8753; Feder, Gene/0000-0002-7890-3926; Damant, Jacqueline/0000-0003-1425-272X	Health Technology Assessment programme [HTA 05-40]; National Institute for Health Research [RP-PG-0407-10314]; British Heart Foundation [RG/07/007, FS/05/125]	Health Technology Assessment programme(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation)	This study was funded by a grant from the Health Technology Assessment programme, HTA 05-40 and a National Institute for Health Research programme grant (RP-PG-0407-10314). The views expressed here are those of the authors and do not necessarily reflect those of the Department of Health. MJS is supported by the British Heart Foundation (RG/07/007). ADH is supported by a British Heart Foundation senior research fellowship (FS/05/125).	Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Bridgewater B, 2009, 6 NATL ADULT CARDIAC; Claxton K, 2002, LANCET, V360, P711, DOI 10.1016/S0140-6736(02)09832-X; Claxton K, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8310; Clayton TC, 2005, BMJ-BRIT MED J, V331, P869, DOI 10.1136/bmj.38603.656076.63; Cosin-Sales J, 2005, EUR HEART J, V26, P2093, DOI 10.1093/eurheartj/ehi433; *DEP HLTH, 2006, NHS REF COSTS 2005 0; *DEP HLTH, 2007, TRUST ASS SAF REG HL; Di Angelantonio E, 2007, PLOS MED, V4, P1497, DOI 10.1371/journal.pmed.0040270; Diamond GA, 2009, CIRC-CARDIOVASC QUAL, V2, P49, DOI 10.1161/CIRCOUTCOMES.108.793406; Emberson JR, 2007, J AM COLL CARDIOL, V49, P311; Fox K, 2006, EUR HEART J, V27, P1341, DOI 10.1093/eurheartj/ehl001; GRIFFIN SC, 2007, BRIT MED J, V334, pB624; Hadorn DC, 1997, BRIT MED J, V314, P135, DOI 10.1136/bmj.314.7074.135; Hemingway H, 2000, LANCET, V355, P985, DOI 10.1016/S0140-6736(00)90018-7; Hemingway H, 2001, NEW ENGL J MED, V344, P645, DOI 10.1056/NEJM200103013440906; HEMINGWAY H, 2010, HLTH TECHNO IN PRESS, V14; Hemingway H, 2006, J CLIN EPIDEMIOL, V59, P1229, DOI 10.1016/j.jclinepi.2006.02.005; Hemingway H, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4184; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; JOHANNESSON M, 1993, J HEALTH ECON, V12, P459, DOI 10.1016/0167-6296(93)90005-Y; Jones L, 2004, HEALTH TECHNOL ASSES, V8, P1; Lagerqvist B, 2007, NEW ENGL J MED, V356, P1009, DOI 10.1056/NEJMoa067722; Legare JF, 2005, CAN MED ASSOC J, V173, P371, DOI 10.1503/cmaj.050053; Martin S, 2008, J HEALTH ECON, V27, P826, DOI 10.1016/j.jhealeco.2007.12.002; Moons KGM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b375; Morgan CD, 1998, HEART, V79, P345, DOI 10.1136/hrt.79.4.345; Morgan K, 2004, HEALTH TECHNOL ASSES, V8, pIII; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; National Institute for Health and Clinical Excellence (NICE), 2008, GUID METH TECHN APPR; NAYLOR CD, 1990, LANCET, V335, P1070, DOI 10.1016/0140-6736(90)92640-4; *NCEPOD, 2008, DEATH FOLL 1 TIM IS; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Plomp J, 1999, HEART, V81, P593, DOI 10.1136/hrt.81.6.593; Robinson M, 2005, HEALTH TECHNOL ASSES, V9, P1; Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626; Vasan RS, 2006, CIRCULATION, V113, P2335, DOI 10.1161/CIRCULATIONAHA.104.482570; YUSUF, 1994, LANCET, V344, P1446; YUSUF S, 1994, LANCET, V344, P563, DOI 10.1016/S0140-6736(94)91963-1; Zethelius B, 2008, NEW ENGL J MED, V358, P2107, DOI 10.1056/NEJMoa0707064	41	31	34	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 19	2010	340								b5606	10.1136/bmj.b5606	http://dx.doi.org/10.1136/bmj.b5606			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	548HN	20085988	Green Submitted, Green Published, hybrid, Green Accepted			2022-12-28	WOS:000273951200002
J	Kelesidis, T; Kelesidis, I; Chou, S; Mantzoros, CS				Kelesidis, Theodore; Kelesidis, Iosif; Chou, Sharon; Mantzoros, Christos S.			Narrative Review: The Role of Leptin in Human Physiology: Emerging Clinical Applications	ANNALS OF INTERNAL MEDICINE			English	Review							RECOMBINANT HUMAN LEPTIN; ACTIVE ANTIRETROVIRAL THERAPY; REVERSES INSULIN-RESISTANCE; ANOREXIA-NERVOSA; HYPOTHALAMIC AMENORRHEA; METABOLIC SYNDROME; SEVERE LIPODYSTROPHY; REPLACEMENT THERAPY; DIABETES-MELLITUS; MISSENSE MUTATION	Leptin is a hormone secreted by adipose tissue in direct proportion to amount of body fat. The circulating leptin levels serve as a gauge of energy stores, thereby directing the regulation of energy homeostasis, neuroendocrine function, and metabolism. Persons with congenital deficiency are obese, and treatment with leptin results in dramatic weight loss through decreased food intake and possible increased energy expenditure. However, most obese persons are resistant to the weight-reducing effects of leptin. Recent studies suggest that leptin is physiologically more important as an indicator of energy deficiency, rather than energy excess, and may mediate adaptation by driving increased food intake and directing neuroendocrine function to converse energy, such as inducing hypothalamic hypogonadism to prevent fertilization. Current studies investigate the role of leptin in weight-loss management because persons who have recently lost weight have relative leptin deficiency that may drive them to regain weight. Leptin deficiency is also evident in patients with diet-or exercise-induced hypothalamic amenorrhea and lipoatrophy. Replacement of leptin in physiologic doses restores ovulatory menstruation in women with hypothalamic amenorrhea and improves metabolic dysfunction in patients with lipoatrophy, including lipoatrophy associated with HIV or highly active antiretroviral therapy. The applications of leptin continue to grow and will hopefully soon be used therapeutically.	[Mantzoros, Christos S.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Mantzoros, CS (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Endocrinol Diabet & Metab, 330 Brookline Ave,Stoneman 816, Boston, MA 02215 USA.	cmantzor@bidmc.harvard.edu	Mantzoros, Christos/Y-2902-2019; Kelesidis, Theodoros/AAE-1961-2020	Kelesidis, Theodoros/0000-0002-8463-3811	National Institute of Diabetes and Digestive and Kidney Diseases [DK58785, DK 79929, DK 81913]; Amgen; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK081913, R01DK058785, R56DK058785, R01DK079929] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Amgen(Amgen); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Grant Support: By the National Institute of Diabetes and Digestive and Kidney Diseases (grants DK58785, DK 79929, and DK 81913). Dr. Mantzoros received grant support from Amgen through the Beth Israel Deaconess Medical Center and has been using leptin provided by Amylin Pharmaceuticals for investigator-initiated studies.	Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; Audi L, 1998, MOL PSYCHIATR, V3, P544, DOI 10.1038/sj.mp.4000418; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Bjorbaek C, 1999, J BIOL CHEM, V274, P30059, DOI 10.1074/jbc.274.42.30059; Bjorbaek C, 1998, ENDOCRINOLOGY, V139, P3485, DOI 10.1210/en.139.8.3485; Boden G, 1996, J CLIN ENDOCR METAB, V81, P3419, DOI 10.1210/jc.81.9.3419; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Brennan AM, 2009, EUR J ENDOCRINOL, V160, P173, DOI 10.1530/EJE-08-0597; Chan JL, 2008, J CLIN ENDOCR METAB, V93, P2819, DOI 10.1210/jc.2008-0056; Chan JL, 2006, P NATL ACAD SCI USA, V103, P8481, DOI 10.1073/pnas.0505429103; Chan JL, 2007, CLIN ENDOCRINOL, V66, P49, DOI 10.1111/j.1365-2265.2006.02684.x; Chan JL, 2005, LANCET, V366, P74, DOI 10.1016/S0140-6736(05)66830-4; Chan JL, 2005, J CLIN ENDOCR METAB, V90, P1625, DOI 10.1210/jc.2004-1823; Chan JL, 2005, J CLIN ENDOCR METAB, V90, P1618, DOI 10.1210/jc.2004-1921; Collins S, 1996, NATURE, V380, P677, DOI 10.1038/380677a0; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Ebihara K, 2004, NEW ENGL J MED, V351, P615, DOI 10.1056/NEJM200408053510623; Elmquist JK, 1998, J COMP NEUROL, V395, P535; Farooqi IS, 2007, SCIENCE, V317, P1355, DOI 10.1126/science.1144599; Farooqi IS, 2007, NEW ENGL J MED, V356, P237, DOI 10.1056/NEJMoa063988; Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204; Farooqi IS, 2002, J CLIN INVEST, V110, P1093, DOI 10.1172/JCI200215693; Farooqi IS, 2001, NATURE, V414, P34, DOI 10.1038/35102112; Fei H, 1997, P NATL ACAD SCI USA, V94, P7001, DOI 10.1073/pnas.94.13.7001; Gavrilova O, 2000, J CLIN INVEST, V105, P271, DOI 10.1172/JCI7901; Grinspoon S, 2005, NEW ENGL J MED, V352, P48, DOI 10.1056/NEJMra041811; Harris RBS, 1998, ENDOCRINOLOGY, V139, P8, DOI 10.1210/en.139.1.8; Haynes WG, 1997, J CLIN INVEST, V100, P270, DOI 10.1172/JCI119532; Heiman ML, 1997, ENDOCRINOLOGY, V138, P3859, DOI 10.1210/en.138.9.3859; Heymsfield SB, 1999, JAMA-J AM MED ASSOC, V282, P1568, DOI 10.1001/jama.282.16.1568; Jacobson DL, 2005, CLIN INFECT DIS, V40, P1837, DOI 10.1086/430379; Javor ED, 2005, DIABETES, V54, P1994, DOI 10.2337/diabetes.54.7.1994; Javor ED, 2005, HEPATOLOGY, V41, P753, DOI 10.1002/hep.20672; Jimerson DC, 2000, J CLIN ENDOCR METAB, V85, P4511, DOI 10.1210/jc.85.12.4511; Keski-Rahkonen A, 2007, AM J PSYCHIAT, V164, P1259, DOI 10.1176/appi.ajp.2007.06081388; Kim JK, 2000, J BIOL CHEM, V275, P8456, DOI 10.1074/jbc.275.12.8456; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Lee JH, 2006, J CLIN ENDOCR METAB, V91, P2605, DOI 10.1210/jc.2005-1545; Licinio J, 1997, NAT MED, V3, P575, DOI 10.1038/nm0597-575; Mantzoros C, 1997, J CLIN ENDOCR METAB, V82, P1845, DOI 10.1210/jc.82.6.1845; Mantzoros CS, 2009, J CLIN ENDOCR METAB, V94, P1089, DOI 10.1210/jc.2009-0340; Mantzoros CS, 1997, J CLIN ENDOCR METAB, V82, P1066, DOI 10.1210/jc.82.4.1066; Miller KK, 1998, J CLIN ENDOCR METAB, V83, P2309, DOI 10.1210/jc.83.7.2309; Munzberg H, 2008, PHYSIOL BEHAV, V94, P664, DOI 10.1016/j.physbeh.2008.04.020; Mulligan K, 2009, J CLIN ENDOCR METAB, V94, P1137, DOI 10.1210/jc.2008-1588; Musso C, 2005, METABOLISM, V54, P255, DOI 10.1016/j.metabol.2004.08.021; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; Nagy GS, 2003, CLIN INFECT DIS, V36, P795, DOI 10.1086/367859; Nattiv Aurelia, 2007, Med Sci Sports Exerc, V39, P1867; Niswender KD, 2001, NATURE, V413, P794, DOI 10.1038/35101657; Oral EA, 2002, NEW ENGL J MED, V346, P570, DOI 10.1056/NEJMoa012437; Ozata M, 1999, J CLIN ENDOCR METAB, V84, P3686, DOI 10.1210/jc.84.10.3686; Pardini VC, 1998, J CLIN ENDOCR METAB, V83, P503, DOI 10.1210/jc.83.2.503; Petersen KF, 2002, J CLIN INVEST, V109, P1345, DOI [10.1172/JCI0215001, 10.1172/JCI200215001]; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Ravussin E, 2009, OBESITY, V17, P1736, DOI 10.1038/oby.2009.184; Robertson SA, 2008, PHYSIOL BEHAV, V94, P637, DOI 10.1016/j.physbeh.2008.04.005; Rosenbaum M, 1996, J CLIN ENDOCR METAB, V81, P3424, DOI 10.1210/jc.81.9.3424; Rosenbaum M, 2005, J CLIN INVEST, V115, P3579, DOI 10.1172/JCI25977; Roth JD, 2008, P NATL ACAD SCI USA, V105, P7257, DOI 10.1073/pnas.0706473105; Saad MF, 1997, J CLIN ENDOCR METAB, V82, P579, DOI 10.1210/jc.82.2.579; Scarpace PJ, 1997, AM J PHYSIOL-ENDOC M, V273, pE226, DOI 10.1152/ajpendo.1997.273.1.E226; Shimomura I, 1999, NATURE, V401, P73, DOI 10.1038/43448; Sinha MK, 1996, J CLIN INVEST, V97, P1344, DOI 10.1172/JCI118551; Strobel A, 1998, NAT GENET, V18, P213, DOI 10.1038/ng0398-213; Warren MP, 1996, J CLIN ENDOCR METAB, V81, P437, DOI 10.1210/jc.81.2.437; Welt CK, 2004, NEW ENGL J MED, V351, P987, DOI 10.1056/NEJMoa040388; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	69	397	421	0	51	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 19	2010	152	2					93	+		10.7326/0003-4819-152-2-201001190-00008	http://dx.doi.org/10.7326/0003-4819-152-2-201001190-00008			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	548IE	20083828	Green Accepted			2022-12-28	WOS:000273953000004
J	Mueller, KL				Mueller, Kristen L.			Recognizing the First Responders INTRODUCTION	SCIENCE			English	Editorial Material																			0	7	9	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 15	2010	327	5963					283	283		10.1126/science.327.5963.283	http://dx.doi.org/10.1126/science.327.5963.283			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544CM	20075241				2022-12-28	WOS:000273629700028
J	Peterson, WM; Mutel, RL; Gudel, M; Goss, WM				Peterson, W. M.; Mutel, R. L.; Guedel, M.; Goss, W. M.			A large coronal loop in the Algol system	NATURE			English	Article							POLARIZATION VLBI OBSERVATIONS; X-RAY; RADIO-EMISSION; UX-ARIETIS; SOLAR CORONA; CLOSE BINARY; STARS; REGION; FLARE; ASTROMETRY	The close binary Algol system contains a radio-bright KIV sub-giant star in a very close (0.062 astronomical units) and rapid (2.86 day) orbit with a main sequence B8 star. Because the rotation periods of the two stars are tidally locked to the orbital period, the rapid rotation drives a magnetic dynamo. A large body of evidence points to the existence of an extended, complex coronal magnetosphere originating at the cooler K subgiant(1-4). The detailed morphology of the subgiant's corona and its possible interaction with its companion are unknown, though theory predicts that the coronal plasma should be confined in a magnetic loop structure(5), as seen on the Sun. Here we report multi-epoch radio imaging of the Algol system, in which we see a large, persistent coronal loop approximately one subgiant diameter in height, whose base is straddling the subgiant and whose apex is oriented towards the B8 star. This suggests that a persistent asymmetric magnetic field structure is aligned between the two stars. The loop is larger than anticipated theoretically(6,7), but the size may be the result of a magnetic interaction between the two stars.	[Peterson, W. M.; Mutel, R. L.] Univ Iowa, Dept Phys & Astron, Iowa City, IA 52240 USA; [Guedel, M.] ETH, Inst Astron, CH-8093 Zurich, Switzerland; [Goss, W. M.] Natl Radio Astron Observ, Pete V Domenici Sci Operat Ctr, Socorro, NM 87801 USA	University of Iowa; Swiss Federal Institutes of Technology Domain; ETH Zurich; National Radio Astronomy Observatory (NRAO)	Peterson, WM (corresponding author), Univ Iowa, Dept Phys & Astron, Van Allen Hall, Iowa City, IA 52240 USA.	bmp@astro.physics.uiowa.edu	Guedel, Manuel/C-8486-2015	Guedel, Manuel/0000-0001-9818-0588	NRAO [GSSP08-0022]; Direct For Mathematical & Physical Scien [0908941] Funding Source: National Science Foundation	NRAO; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The NRAO is a facility of the NSF operated under cooperative agreement by Associated Universities, Inc. Support for this work was provided by the NSF through award GSSP08-0022 from the NRAO. R. L. M. is grateful to the Institute of Astronomy at ETH, Zurich, for logistic support during the preparation of this paper.	Albright GE, 1996, ASTROPHYS J, V459, pL99, DOI 10.1086/309957; Aschwanden MJ, 2001, ANNU REV ASTRON ASTR, V39, P175, DOI 10.1146/annurev.astro.39.1.175; Beasley AJ, 2000, ASTROPHYS J, V529, P961, DOI 10.1086/308292; Boboltz DA, 2007, ASTRON J, V133, P906, DOI 10.1086/510154; Chung SM, 2004, ASTROPHYS J, V606, P1184, DOI 10.1086/383195; DULK GA, 1985, ANNU REV ASTRON ASTR, V23, P169, DOI 10.1146/annurev.aa.23.090185.001125; Favata F, 2000, ASTRON ASTROPHYS, V362, P628; Fey AL, 2006, ASTRON J, V131, P1084, DOI 10.1086/498722; Franciosini E, 1999, ASTRON ASTROPHYS, V341, P595; GATEWOOD G, 1995, ASTRON J, V109, P434, DOI 10.1086/117288; LESTRADE JF, 1988, ASTROPHYS J, V328, P232, DOI 10.1086/166285; LESTRADE JF, 1993, ASTROPHYS J, V410, P808, DOI 10.1086/172798; MASSI M, 1999, ASTRON REV, V43, P539; Morin J, 2008, MON NOT R ASTRON SOC, V390, P567, DOI 10.1111/j.1365-2966.2008.13809.x; Mullan DJ, 2006, ASTROPHYS J SUPPL S, V164, P173, DOI 10.1086/502629; Mutel RL, 1998, ASTROPHYS J, V507, P371, DOI 10.1086/306311; MUTEL RL, 1985, ASTROPHYS J, V289, P262, DOI 10.1086/162886; Ness JU, 2004, ASTRON ASTROPHYS, V427, P667, DOI 10.1051/0004-6361:20040504; OTTMANN R, 1994, ASTRON ASTROPHYS, V286, pL27; PAN XP, 1993, ASTROPHYS J, V413, pL129, DOI 10.1086/186976; Petit P, 2008, MON NOT R ASTRON SOC, V388, P80, DOI 10.1111/j.1365-2966.2008.13411.x; Ransom RR, 2002, ASTROPHYS J, V572, P487, DOI 10.1086/340300; Retter A, 2005, ASTROPHYS J, V621, P417, DOI 10.1086/426667; Richards MT, 2003, ASTROPHYS J SUPPL S, V147, P337, DOI 10.1086/375835; ROGERS A, 1989, LECT NOTE PHYS, V330, P77; ROSNER R, 1978, ASTROPHYS J, V220, P643, DOI 10.1086/155949; Schmitt JHMM, 1999, NATURE, V401, P44, DOI 10.1038/43389; Schmitt JHMM, 2003, ASTRON ASTROPHYS, V412, P849, DOI 10.1051/0004-6361:20034057; Warren HP, 2003, ASTROPHYS J, V593, P1174, DOI 10.1086/376678	29	34	35	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 14	2010	463	7278					207	209		10.1038/nature08643	http://dx.doi.org/10.1038/nature08643			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543MQ	20075916				2022-12-28	WOS:000273582700030
J	Burrill, DR; Silver, PA				Burrill, Devin R.; Silver, Pamela A.			Making Cellular Memories	CELL			English	Article							TOGGLE SWITCH; CIRCUITRY; NETWORKS; MODEL		[Burrill, Devin R.; Silver, Pamela A.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Silver, PA (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	pamela_silver@hms.harvard.edu			NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM036373] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Special thanks to the Silver lab, J. Way, F. Winston, and A. Salic for helpful discussion. D. R. B. is supported by the NSF Synthetic Biology Engineering Research Center, and P. A. S. by grants from the NIH.	Ajo-Franklin CM, 2007, GENE DEV, V21, P2271, DOI 10.1101/gad.1586107; Alon U., 2006, INTRO SYSTEMS BIOL D; Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Barrett RM, 2008, LEARN MEMORY, V15, P460, DOI 10.1101/lm.917508; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chickarmane V, 2006, PLOS COMPUT BIOL, V2, P1080, DOI 10.1371/journal.pcbi.0020123; Demongeot L, 2000, CR ACAD SCI III-VIE, V323, P69, DOI 10.1016/S0764-4469(00)00112-8; Dodd IB, 2007, CELL, V129, P813, DOI 10.1016/j.cell.2007.02.053; EISEN H, 1970, P NATL ACAD SCI USA, V66, P855, DOI 10.1073/pnas.66.3.855; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Ingolia NT, 2007, CURR BIOL, V17, P668, DOI 10.1016/j.cub.2007.03.016; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; Kramer BP, 2004, NAT BIOTECHNOL, V22, P867, DOI 10.1038/nbt980; Kramer BP, 2003, BIOTECHNOL BIOENG, V83, P810, DOI 10.1002/bit.10731; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; M_uller-Hill B., 1996, LAC OPERON SHORT HIS; MONOD J, 1961, COLD SPRING HARB SYM, V26, P389, DOI 10.1101/SQB.1961.026.01.048; MORTENSEN R, 2006, CURR PROTOC MOL BIOL, V23; Muotri AR, 2006, NATURE, V441, P1087, DOI 10.1038/nature04959; NINFA AJ, 2004, SCI STKE, V232, pPE20; NOVAK B, 1993, J CELL SCI, V106, P1153; Ogasawara H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.256pe7; Ptashne M, 2004, GENETIC SWITCH PHAGE; Schulze A, 2001, GENE DEV, V15, P981, DOI 10.1101/gad.191101; Shetty Reshma P, 2008, J Biol Eng, V2, P5, DOI 10.1186/1754-1611-2-5; Stefanko DP, 2009, P NATL ACAD SCI USA, V106, P9447, DOI 10.1073/pnas.0903964106; Tanaka K, 2008, NEURON, V59, P608, DOI 10.1016/j.neuron.2008.06.026; Thron CD, 1996, BIOPHYS CHEM, V57, P239, DOI 10.1016/0301-4622(95)00075-5; Vermaak D, 2003, CURR OPIN CELL BIOL, V15, P266, DOI 10.1016/S0955-0674(03)00043-7; Weber W, 2007, BIOTECHNOL BIOENG, V98, P894, DOI 10.1002/bit.21463; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089	35	93	94	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 8	2010	140	1					13	18		10.1016/j.cell.2009.12.034	http://dx.doi.org/10.1016/j.cell.2009.12.034			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	541CY	20085698	Bronze, Green Accepted			2022-12-28	WOS:000273391900007
J	Bibbins-Domingo, K; Chertow, GM; Coxson, PG; Moran, A; Lightwood, JM; Pletcher, MJ; Goldman, L				Bibbins-Domingo, Kirsten; Chertow, Glenn M.; Coxson, Pamela G.; Moran, Andrew; Lightwood, James M.; Pletcher, Mark J.; Goldman, Lee			Projected Effect of Dietary Salt Reductions on Future Cardiovascular Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BLOOD-PRESSURE; SODIUM RESTRICTION; COST-EFFECTIVENESS; SUBGROUP ANALYSIS; HYPERTENSION; METAANALYSIS; PREVENTION; STRATEGIES; PREDICTION; STROKE	BACKGROUND The U. S. diet is high in salt, with the majority coming from processed foods. Reducing dietary salt is a potentially important target for the improvement of public health. METHODS We used the Coronary Heart Disease (CHD) Policy Model to quantify the benefits of potentially achievable, population-wide reductions in dietary salt of up to 3 g per day (1200 mg of sodium per day). We estimated the rates and costs of cardiovascular disease in subgroups defined by age, sex, and race; compared the effects of salt reduction with those of other interventions intended to reduce the risk of cardiovascular disease; and determined the cost-effectiveness of salt reduction as compared with the treatment of hypertension with medications. RESULTS Reducing dietary salt by 3 g per day is projected to reduce the annual number of new cases of CHD by 60,000 to 120,000, stroke by 32,000 to 66,000, and myocardial infarction by 54,000 to 99,000 and to reduce the annual number of deaths from any cause by 44,000 to 92,000. All segments of the population would benefit, with blacks benefiting proportionately more, women benefiting particularly from stroke reduction, older adults from reductions in CHD events, and younger adults from lower mortality rates. The cardiovascular benefits of reduced salt intake are on par with the benefits of population-wide reductions in tobacco use, obesity, and cholesterol levels. A regulatory intervention designed to achieve a reduction in salt intake of 3 g per day would save 194,000 to 392,000 quality-adjusted life-years and $10 billion to $24 billion in health care costs annually. Such an intervention would be cost-saving even if only a modest reduction of 1 g per day were achieved gradually between 2010 and 2019 and would be more cost-effective than using medications to lower blood pressure in all persons with hypertension. CONCLUSIONS Modest reductions in dietary salt could substantially reduce cardiovascular events and medical costs and should be a public health target.	[Bibbins-Domingo, Kirsten; Coxson, Pamela G.; Pletcher, Mark J.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Bibbins-Domingo, Kirsten; Pletcher, Mark J.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Lightwood, James M.] Univ Calif San Francisco, Sch Pharm, Dept Clin Pharm, San Francisco, CA 94143 USA; [Bibbins-Domingo, Kirsten; Coxson, Pamela G.] Univ Calif San Francisco, San Francisco Gen Hosp, Div Gen Internal Med, San Francisco, CA 94143 USA; [Bibbins-Domingo, Kirsten; Coxson, Pamela G.] Univ Calif San Francisco, San Francisco Gen Hosp, Ctr Vulnerable Populat, San Francisco, CA 94143 USA; [Chertow, Glenn M.] Stanford Univ, Dept Med, Palo Alto, CA 94304 USA; [Moran, Andrew; Goldman, Lee] Columbia Univ, Dept Med, Coll Phys & Surg, New York, NY USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Stanford University; Columbia University	Bibbins-Domingo, K (corresponding author), Univ Calif San Francisco, Dept Med, Box 1364 UCSF SFGH, San Francisco, CA 94143 USA.			Chertow, Glenn/0000-0002-7599-0534	American Heart Association Western States Affiliate [09GRNT2060096]; University of California, San Francisco Clinical and Translational Sciences Institute [UL1 RR024131]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER	American Heart Association Western States Affiliate(American Heart Association); University of California, San Francisco Clinical and Translational Sciences Institute(University of California System); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Supported in part by a grant-in-aid from the American Heart Association Western States Affiliate (09GRNT2060096) and an intramural pilot grant from the University of California, San Francisco Clinical and Translational Sciences Institute (NIH-NCRR UCSF-CTSI UL1 RR024131).	Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Ayala C., 2009, Morbidity and Mortality Weekly Report, V58, P281; Bibbins-Domingo K, 2007, NEW ENGL J MED, V357, P2371, DOI 10.1056/NEJMsa073166; Bibbins-Domingo K, 2009, NEW ENGL J MED, V360, P1179, DOI 10.1056/NEJMoa0807265; BLAIS CA, 1986, AM J CLIN NUTR, V44, P232, DOI 10.1093/ajcn/44.2.232; Bray GA, 2004, AM J CARDIOL, V94, P222, DOI 10.1016/j.amjcard.2004.03.070; Cappuccio FP, 1997, LANCET, V350, P850, DOI 10.1016/S0140-6736(97)02264-2; Chambless LE, 2004, AM J EPIDEMIOL, V160, P259, DOI 10.1093/aje/kwh189; Chobanian AV, 2009, NEW ENGL J MED, V361, P1516; Chobanian AV, 2009, NEW ARMEN MED J, V3, P60, DOI 10.1056/NEJMsa0903829; Cook NR, 2007, BMJ-BRIT MED J, V334, P885, DOI 10.1136/bmj.39147.604896.55; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; Food Standards Agency, 2008, DIET SOD LEV SURV; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; Griffith JL, 2003, JAMA-J AM MED ASSOC, V289, P178; Hajjar I, 2003, JAMA-J AM MED ASSOC, V290, P199, DOI 10.1001/jama.290.2.199; Havas S, 2007, JAMA-J AM MED ASSOC, V298, P1439, DOI 10.1001/jama.298.12.1439; He F, 2002, J HUM HYPERTENS, V16, P761, DOI 10.1038/sj.jhh.1001459; He FJ, 2009, J HUM HYPERTENS, V23, P363, DOI 10.1038/jhh.2008.144; He FJ, 2006, HYPERTENSION, V48, P861, DOI 10.1161/01.HYP.0000245672.27270.4a; He FJ, 2003, HYPERTENSION, V42, P1093, DOI 10.1161/01.HYP.0000102864.05174.E8; He FJ, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004937, DOI 10.1002/14651858.CD004937]; Heidenreich PA, 2008, J GEN INTERN MED, V23, P509, DOI 10.1007/s11606-008-0515-2; Hooper L., 2004, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD003656.PUB2; Institute of Medicine Panel on Dietary Reference Intakes for Electrolytes and Water, 2005, DIET REF INT WAT POT; Kissela B, 2004, STROKE, V35, P426, DOI 10.1161/01.STR.0000110982.74967.39; LAW MR, 1991, BRIT MED J, V302, P939; LAW MR, 1991, BMJ-BRIT MED J, V302, P819, DOI 10.1136/bmj.302.6780.819; Lightwood JM, 2009, AM J PREV MED, V36, P13, DOI 10.1016/j.amepre.2008.09.030; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; MACGREGOR GA, 1989, LANCET, V2, P1244, DOI 10.1016/S0140-6736(89)91852-7; Maruthur NM, 2009, CIRCULATION, V119, P2026, DOI 10.1161/CIRCULATIONAHA.108.809491; MATTES RD, 1991, J AM COLL NUTR, V10, P383; Otten J.J., 2006, DIETARY REFERENCE IN, DOI DOI 10.17226/11537; Palar K, 2009, AM J HEALTH PROMOT, V24, P49, DOI 10.4278/ajhp.080826-QUAN-164; Pletcher MJ, 2009, ANN INTERN MED, V150, P243, DOI 10.7326/0003-4819-150-4-200902170-00005; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; STAMLER J, 1989, HYPERTENSION, V14, P570, DOI 10.1161/01.HYP.14.5.570; Swift PA, 2005, HYPERTENSION, V46, P308, DOI 10.1161/01.HYP.0000172662.12480.7f; The AO, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; U.S. Department of Agriculture: Agricultural Research Service, 2008, NUTR INT FOOD MEAN A; Vollmer WM, 2001, ANN INTERN MED, V135, P1019, DOI 10.7326/0003-4819-135-12-200112180-00005; WHO, 2021, NEW WHO BENCHM HELP; Williams GR, 1999, STROKE, V30, P2523, DOI 10.1161/01.STR.30.12.2523; Wong MD, 2002, NEW ENGL J MED, V347, P1585, DOI 10.1056/NEJMsa012979	46	827	860	2	176	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 18	2010	362	7					590	599		10.1056/NEJMoa0907355	http://dx.doi.org/10.1056/NEJMoa0907355			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	556ED	20089957	Green Accepted			2022-12-28	WOS:000274571200007
J	Shi, DL; Xu, Y; Hopkinson, BM; Morel, FMM				Shi, Dalin; Xu, Yan; Hopkinson, Brian M.; Morel, Francois M. M.			Effect of Ocean Acidification on Iron Availability to Marine Phytoplankton	SCIENCE			English	Article							ACQUISITION; SEAWATER; LIGANDS; GROWTH; CARBON; CALCIFICATION; COMPLEXATION; TEMPERATURE; REDUCTION; IRON(III)	The acidification caused by the dissolution of anthropogenic carbon dioxide (CO(2)) in the ocean changes the chemistry and hence the bioavailability of iron (Fe), a limiting nutrient in large oceanic regions. Here, we show that the bioavailability of dissolved Fe may decline because of ocean acidification. Acidification of media containing various Fe compounds decreases the Fe uptake rate of diatoms and coccolithophores to an extent predicted by the changes in Fe chemistry. A slower Fe uptake by a model diatom with decreasing pH is also seen in experiments with Atlantic surface water. The Fe requirement of model phytoplankton remains unchanged with increasing CO(2). The ongoing acidification of seawater is likely to increase the Fe stress of phytoplankton populations in some areas of the ocean.	[Shi, Dalin; Xu, Yan; Hopkinson, Brian M.; Morel, Francois M. M.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA	Princeton University	Shi, DL (corresponding author), Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA.	dshi@princeton.edu	Shi, Dalin/E-6361-2011	Shi, Dalin/0000-0003-4432-1992	NSF; BP and Ford Motor Company; Directorate For Geosciences [0825192] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); BP and Ford Motor Company; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The authors wish to thank J.-P. Bellenger and T. Wichard for helpful discussions and supplying azotochelin. The authors gratefully acknowledge C. Haldeman and S. Glenn (Rutgers University) for assistance with water collection off the New Jersey coast and M. Lomas, K. Buck, M. Tiahlo (Bermuda Institute of Ocean Sciences), and the captain and crew of the R/V Atlantic Explorer for their help on the experiments conducted in the BATS region. Funding was provided by NSF and by a grant from BP and Ford Motor Company to the Princeton Environmental Institute.	Ramos JBE, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002898; Boyd PW, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2005GB002494; Breitbarth E., 2009, BIOGEOSCI DISCUSS, V6, P6781, DOI DOI 10.5194/BGD-6-6781-2009; Castruita M, 2006, APPL ENVIRON MICROB, V72, P2918, DOI 10.1128/AEM.72.4.2918-2924.2006; Castruita M, 2008, LIMNOL OCEANOGR, V53, P890, DOI 10.4319/lo.2008.53.3.0890; Coale KH, 1996, NATURE, V379, P621, DOI 10.1038/379621a0; Feng Y, 2008, EUR J PHYCOL, V43, P87, DOI 10.1080/09670260701664674; Gattuso JP, 1998, GLOBAL PLANET CHANGE, V18, P37, DOI 10.1016/S0921-8181(98)00035-6; Gledhill M, 1998, MAR CHEM, V59, P283, DOI 10.1016/S0304-4203(97)00097-2; GLEDHILL M, 1994, MAR CHEM, V47, P41, DOI 10.1016/0304-4203(94)90012-4; Kustka AB, 2007, J PHYCOL, V43, P715, DOI 10.1111/j.1529-8817.2007.00359.x; Macrellis HM, 2001, MAR CHEM, V76, P175, DOI 10.1016/S0304-4203(01)00061-5; Maldonado MT, 2001, J PHYCOL, V37, P298, DOI 10.1046/j.1529-8817.2001.037002298.x; Moffett J. W., 2001, BIOGEOCHEMISTRY IRON, P343; Reinfelder JR, 2000, NATURE, V407, P996, DOI 10.1038/35039612; RICH HW, 1990, LIMNOL OCEANOGR, V35, P652, DOI 10.4319/lo.1990.35.3.0652; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; Riebesell U, 2007, NATURE, V450, P545, DOI 10.1038/nature06267; Rost B, 2003, LIMNOL OCEANOGR, V48, P55, DOI 10.4319/lo.2003.48.1.0055; RUE EL, 1995, MAR CHEM, V50, P117, DOI 10.1016/0304-4203(95)00031-L; Shaked Y, 2005, LIMNOL OCEANOGR, V50, P872, DOI 10.4319/lo.2005.50.3.0872; Strzepek RF, 2004, NATURE, V431, P689, DOI 10.1038/nature02954; SULTEMEYER DF, 1987, PHOTOSYNTH RES, V12, P25, DOI 10.1007/BF00019148; Sunda W, 2003, MAR CHEM, V84, P35, DOI 10.1016/S0304-4203(03)00101-4; Sunda W.G., 2005, ALGAE CULTURING TECH, V4, P35, DOI [10.1016/b978-012088426-1/50005-6, DOI 10.1016/B978-012088426-1/50005-6]; SUNDA WG, 1995, MAR CHEM, V50, P189, DOI 10.1016/0304-4203(95)00035-P; Sunda WG, 1997, NATURE, V390, P389, DOI 10.1038/37093; Tortell PD, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032583; Xue XP, 1998, J PHYCOL, V34, P939, DOI 10.1046/j.1529-8817.1998.340939.x	29	243	261	13	372	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 5	2010	327	5966					676	679		10.1126/science.1183517	http://dx.doi.org/10.1126/science.1183517			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551ZD	20075213				2022-12-28	WOS:000274251800034
J	Doeller, CF; Barry, C; Burgess, N				Doeller, Christian F.; Barry, Caswell; Burgess, Neil			Evidence for grid cells in a human memory network	NATURE			English	Article							MEDIAL TEMPORAL-LOBE; ENTORHINAL CORTEX; SPATIAL NAVIGATION; PATH-INTEGRATION; HEAD-DIRECTION; HIPPOCAMPUS; MODEL; BRAIN; FMRI; REPRESENTATIONS	Grid cells in the entorhinal cortex of freely moving rats provide a strikingly periodic representation of self-location(1) which is indicative of very specific computational mechanisms(2-4). However, the existence of grid cells in humans and their distribution throughout the brain are unknown. Here we show that the preferred firing directions of directionally modulated grid cells in rat entorhinal cortex are aligned with the grids, and that the spatial organization of grid-cell firing is more strongly apparent at faster than slower running speeds. Because the grids are also aligned with each other(1,5), we predicted a macroscopic signal visible to functional magnetic resonance imaging (fMRI) in humans. We then looked for this signal as participants explored a virtual reality environment, mimicking the rats' foraging task: fMRI activation and adaptation showing a speed-modulated six-fold rotational symmetry in running direction. The signal was found in a network of entorhinal/subicular, posterior and medial parietal, lateral temporal and medial prefrontal areas. The effect was strongest in right entorhinal cortex, and the coherence of the directional signal across entorhinal cortex correlated with spatial memory performance. Our study illustrates the potential power of combining single-unit electrophysiology with fMRI in systems neuroscience. Our results provide evidence for grid-cell-like representations in humans, and implicate a specific type of neural representation in a network of regions which supports spatial cognition and also autobiographical memory.	[Doeller, Christian F.; Barry, Caswell; Burgess, Neil] UCL Inst Cognit Neurosci, London WC1N 3AR, England; [Doeller, Christian F.; Burgess, Neil] UCL Inst Neurol, London WC1N 3BG, England; [Barry, Caswell] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England; [Barry, Caswell] UCL, Inst Behav Neurosci, London WC1H 0AP, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London	Doeller, CF (corresponding author), UCL Inst Cognit Neurosci, London WC1N 3AR, England.	c.doeller@ucl.ac.uk; n.burgess@ucl.ac.uk	Doeller, Christian/E-6376-2012; Burgess, Neil/B-2420-2009	Burgess, Neil/0000-0003-0646-6584	UK Medical Research Council; European Union; MRC [G0501672] Funding Source: UKRI; Medical Research Council [G0501672] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We acknowledge K. Jeffery and J. O'Keefe for providing help and facilities for single-unit recording; the Wellcome Trust Centre for Neuroimaging at UCL for providing help and scanning facilities; J. Krupic and R. Hayman for help with single-unit data collection; A. Jeewajee for help with analyses; J. King for help with virtual reality programming; and useful discussions with P. Dayan, K. Friston, U. Frith, C. Hall, A. Jeewajee, J. O'Keefe and M. Witter. This work was funded by the UK Medical Research Council and the European Union (SpaceBrain grant).	Andersson JLR, 2001, NEUROIMAGE, V13, P903, DOI 10.1006/nimg.2001.0746; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Bakker A, 2008, SCIENCE, V319, P1640, DOI 10.1126/science.1152882; Barry C, 2007, NAT NEUROSCI, V10, P682, DOI 10.1038/nn1905; BOCCARA CN, 2008, FENS ABSTR, V4; Buchel C, 1998, NEUROIMAGE, V8, P140, DOI 10.1006/nimg.1998.0351; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; Byrne P, 2007, PSYCHOL REV, V114, P340, DOI 10.1037/0033-295X.114.2.340; CHEN LL, 1994, EXP BRAIN RES, V101, P8, DOI 10.1007/BF00243212; Doeller CF, 2008, P NATL ACAD SCI USA, V105, P5915, DOI 10.1073/pnas.0801489105; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Epstein R, 2003, NEURON, V37, P865, DOI 10.1016/S0896-6273(03)00117-X; Fernandez G, 1999, HIPPOCAMPUS, V9, P35, DOI 10.1002/(SICI)1098-1063(1999)9:1<35::AID-HIPO4>3.0.CO;2-Z; Fischl B, 2009, NEUROIMAGE, V47, P8, DOI 10.1016/j.neuroimage.2009.04.033; GAFFAN D, 1994, J COGNITIVE NEUROSCI, V6, P305, DOI 10.1162/jocn.1994.6.4.305; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hasselmo ME, 2009, NEUROBIOL LEARN MEM, V92, P559, DOI 10.1016/j.nlm.2009.07.005; Howard MW, 2005, PSYCHOL REV, V112, P75, DOI 10.1037/0033-295X.112.1.75; Hutton C, 2002, NEUROIMAGE, V16, P217, DOI 10.1006/nimg.2001.1054; INSAUSTI R, 1995, J COMP NEUROL, V355, P171, DOI 10.1002/cne.903550203; Jeewajee A, 2008, HIPPOCAMPUS, V18, P1175, DOI 10.1002/hipo.20510; Knierim JJ, 2006, LEARN MEMORY, V13, P405, DOI 10.1101/lm.224606; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Maguire EA, 2001, PHILOS T R SOC B, V356, P1441, DOI 10.1098/rstb.2001.0944; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Olsen RK, 2009, J NEUROSCI, V29, P11880, DOI 10.1523/JNEUROSCI.2245-09.2009; Park S, 2007, NEURON, V54, P335, DOI 10.1016/j.neuron.2007.04.006; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; RECCE M K, 1989, Society for Neuroscience Abstracts, V15, P1250; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; Taube JS, 1998, PROG NEUROBIOL, V55, P225, DOI 10.1016/S0301-0082(98)00004-5; Weiskopf N, 2006, NEUROIMAGE, V33, P493, DOI 10.1016/j.neuroimage.2006.07.029; Whitlock JR, 2008, P NATL ACAD SCI USA, V105, P14755, DOI 10.1073/pnas.0804216105; Wolbers T, 2007, J NEUROSCI, V27, P9408, DOI 10.1523/JNEUROSCI.2146-07.2007	38	411	424	6	127	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 4	2010	463	7281					657	U87		10.1038/nature08704	http://dx.doi.org/10.1038/nature08704			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551GB	20090680	Green Accepted, Green Published			2022-12-28	WOS:000274193900035
J	Shachak, A; Jadad, AR				Shachak, Aviv; Jadad, Alejandro R.			Electronic Health Records in the Age of Social Networks and Global Telecommunications	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Shachak, Aviv; Jadad, Alejandro R.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON M5T 3M6, Canada; [Jadad, Alejandro R.] Univ Toronto, Ctr Global eHlth Innovat, Toronto, ON M5T 3M6, Canada	University of Toronto; University of Toronto	Shachak, A (corresponding author), Univ Toronto, Dept Hlth Policy Management & Evaluat, 155 Coll St, Toronto, ON M5T 3M6, Canada.	aviv.shachak@utoronto.ca		Shachak, Aviv/0000-0002-1166-609X				Ahituv N, 2001, COMMUN ACM, V44, P48, DOI 10.1145/376134.376158; DAFT RL, 1987, MIS QUART, V11, P355, DOI 10.2307/248682; ENGEL GL, 1977, SCIENCE, V196, P129, DOI 10.1126/science.847460; Institute of Medicine, 2001, CROSSING QUALITY CHA; JADAD AR, PREVENTING MANAGING; Jain SH, 2009, NEW ENGL J MED, V361, P649, DOI 10.1056/NEJMp0901277; JARVINEN OP, 2009, PATIENT CTR E HLTH; KOERNER BI, 2009, WIRED MAGAZINE  0921; Zhou Yi Y, 2007, Am J Manag Care, V13, P418	9	26	26	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 3	2010	303	5					452	453		10.1001/jama.2010.63	http://dx.doi.org/10.1001/jama.2010.63			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	550QR	20124543				2022-12-28	WOS:000274143600023
J	Gribble, FM				Gribble, Fiona M.			alpha(2A)-Adrenergic Receptors and Type 2 Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Gribble, FM (corresponding author), Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge, England.			Gribble, Fiona/0000-0002-4232-2898	Wellcome Trust [088357] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		DEVRIES A, 1949, AM J MED, V6, P51, DOI 10.1016/0002-9343(49)90006-6; McCarthy MI, 2009, CURR DIABETES REP, V9, P164, DOI 10.1007/s11892-009-0027-4; ROSENGREN AH, 2009, SCIENCE         1119; Small KM, 2006, P NATL ACAD SCI USA, V103, P5472, DOI 10.1073/pnas.0601345103	4	20	21	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 28	2010	362	4					361	362		10.1056/NEJMcibr0911499	http://dx.doi.org/10.1056/NEJMcibr0911499			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	548OT	20107223				2022-12-28	WOS:000273975000014
J	Lowy, I; Molrine, DC; Leav, BA; Blair, BM; Baxter, R; Gerding, DN; Nichol, G; Thomas, WD; Leney, M; Sloan, S; Hay, CA; Ambrosino, DM				Lowy, Israel; Molrine, Deborah C.; Leav, Brett A.; Blair, Barbra M.; Baxter, Roger; Gerding, Dale N.; Nichol, Geoffrey; Thomas, William D., Jr.; Leney, Mark; Sloan, Susan; Hay, Catherine A.; Ambrosino, Donna M.			Treatment with Monoclonal Antibodies against Clostridium difficile Toxins	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RESTRICTION-ENDONUCLEASE ANALYSIS; INFECTION; DISEASE; PROTECTION; HAMSTERS; COLITIS; STRAIN; CANADA; HOSPITALS; MORTALITY	BACKGROUND New therapies are needed to manage the increasing incidence, severity, and high rate of recurrence of Clostridium difficile infection. METHODS We performed a randomized, double-blind, placebo-controlled study of two neutralizing, fully human monoclonal antibodies against C. difficile toxins A (CDA1) and B (CDB1). The antibodies were administered together as a single infusion, each at a dose of 10 mg per kilogram of body weight, in patients with symptomatic C. difficile infection who were receiving either metronidazole or vancomycin. The primary outcome was laboratory-documented recurrence of infection during the 84 days after the administration of monoclonal antibodies or placebo. RESULTS Among the 200 patients who were enrolled (101 in the antibody group and 99 in the placebo group), the rate of recurrence of C. difficile infection was lower among patients treated with monoclonal antibodies (7% vs. 25%; 95% confidence interval, 7 to 29; P<0.001). The recurrence rates among patients with the epidemic BI/NAP1/027 strain were 8% for the antibody group and 32% for the placebo group (P = 0.06); among patients with more than one previous episode of C. difficile infection, recurrence rates were 7% and 38%, respectively (P = 0.006). The mean duration of the initial hospitalization for inpatients did not differ significantly between the antibody and placebo groups (9.5 and 9.4 days, respectively). At least one serious adverse event was reported by 18 patients in the antibody group and by 28 patients in the placebo group (P = 0.09). CONCLUSIONS The addition of monoclonal antibodies against C. difficile toxins to antibiotic agents significantly reduced the recurrence of C. difficile infection. (ClinicalTrials.gov number, NCT00350298.)	[Molrine, Deborah C.; Leav, Brett A.; Blair, Barbra M.; Thomas, William D., Jr.; Leney, Mark; Sloan, Susan; Hay, Catherine A.; Ambrosino, Donna M.] Univ Massachusetts, Sch Med, Boston, MA 02126 USA; [Lowy, Israel; Nichol, Geoffrey] Medarex, Princeton, NJ USA; [Baxter, Roger] Kaiser Permanente Vaccine Study Ctr, Oakland, CA USA; [Gerding, Dale N.] Hines Vet Affairs Hosp, Res Serv, Hines, IL USA; [Gerding, Dale N.] Hines Vet Affairs Hosp, Div Infect Dis, Dept Med, Hines, IL USA; [Gerding, Dale N.] Loyola Univ, Stritch Sch Med, Chicago, IL 60611 USA	University of Massachusetts System; University of Massachusetts Boston; Kaiser Permanente; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; Loyola University Chicago	Molrine, DC (corresponding author), Univ Massachusetts, Sch Med, 460 Walk Hill St, Boston, MA 02126 USA.	deborah.molrine@umassmed.edu			MassBiologics; Medarex	MassBiologics; Medarex	Supported by MassBiologics and Medarex.	Babcock GJ, 2006, INFECT IMMUN, V74, P6339, DOI 10.1128/IAI.00982-06; Blossom DB, 2007, CLIN INFECT DIS, V45, P222, DOI 10.1086/518874; CLABOTS CR, 1993, J CLIN MICROBIOL, V31, P1870, DOI 10.1128/JCM.31.7.1870-1875.1993; FERNIE DS, 1982, DEV BIOLOGICALS, V53, P325; Giannasca PJ, 1999, INFECT IMMUN, V67, P527, DOI 10.1128/IAI.67.2.527-538.1999; Goorhuis A, 2008, CLIN INFECT DIS, V47, P1162, DOI 10.1086/592257; Gravel D, 2009, CLIN INFECT DIS, V48, P568, DOI 10.1086/596703; Hu MY, 2009, GASTROENTEROLOGY, V136, P1206, DOI 10.1053/j.gastro.2008.12.038; Killgore G, 2008, J CLIN MICROBIOL, V46, P431, DOI 10.1128/JCM.01484-07; KIM PH, 1987, INFECT IMMUN, V55, P2984, DOI 10.1128/IAI.55.12.2984-2992.1987; Kink JA, 1998, INFECT IMMUN, V66, P2018, DOI 10.1128/IAI.66.5.2018-2025.1998; Kyne L, 2000, NEW ENGL J MED, V342, P390, DOI 10.1056/NEJM200002103420604; Kyne L, 2001, LANCET, V357, P189, DOI 10.1016/S0140-6736(00)03592-3; LEUNG DYM, 1991, J PEDIATR-US, V118, P633, DOI 10.1016/S0022-3476(05)83393-1; Loo VG, 2006, NEW ENGL J MED, V354, P2200; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; Maroo S, 2006, GASTROENTEROLOGY, V130, P1311, DOI 10.1053/j.gastro.2006.02.044; McDonald LC, 2006, EMERG INFECT DIS, V12, P409, DOI 10.3201/eid1203.051064; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; McFarland LV, 2008, NAT CLIN PRACT GASTR, V5, P40, DOI 10.1038/ncpgasthep1029; Pepin J, 2006, CLIN INFECT DIS, V42, P758, DOI 10.1086/501126; Pepin J, 2005, CLIN INFECT DIS, V40, P1591, DOI 10.1086/430315; Salcedo J, 1997, GUT, V41, P366, DOI 10.1136/gut.41.3.366; Surawicz CM, 2009, GASTROENTEROLOGY, V136, P1152, DOI 10.1053/j.gastro.2009.02.023; Taylor CP, 2008, VACCINE, V26, P3404, DOI 10.1016/j.vaccine.2008.04.042; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X; Zilberberg MD, 2008, EMERG INFECT DIS, V14, P1756, DOI 10.3201/eid1411.080337	28	547	601	0	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 21	2010	362	3					197	205		10.1056/NEJMoa0907635	http://dx.doi.org/10.1056/NEJMoa0907635			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	545NE	20089970				2022-12-28	WOS:000273738400006
J	Raj, A; Saggurti, N; Winter, M; Labonte, A; Decker, MR; Balaiah, D; Silverman, JG				Raj, Anita; Saggurti, Niranjan; Winter, Michael; Labonte, Alan; Decker, Michele R.; Balaiah, Donta; Silverman, Jay G.			The effect of maternal child marriage on morbidity and mortality of children under 5 in India: cross sectional study of a nationally representative sample	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LONGITUDINAL DATA-ANALYSIS; INFANT-MORTALITY; HEALTH; RISK; PREGNANCY; DELIVERY; PARITY; DEATH; AGE	Objective To assess associations between maternal child marriage (marriage before age 18) and morbidity and mortality of infants and children under 5 in India. Design Cross-sectional analyses of nationally representative household sample. Generalised estimating equation models constructed to assess associations. Adjusted models included maternal and child demographics and maternal body mass index as covariates. Setting India. Population Women aged 15-49 years (n=124 385); data collected in 2005-6 through National Family Health Survey-3. Data about child morbidity and mortality reported by participants. Analyses restricted to births in past five years reported by ever married women aged 15-24 years (n=19 302 births to 13 396 mothers). Main outcome measures In under 5s: mortality related infectious diseases in the past two weeks (acute respiratory infection, diarrhoea); malnutrition (stunting, wasting, underweight); infant (age <1 year) and child (1-5 years) mortality; low birth weight (<2500 kg). Results The majority of births (73%; 13 042/19 302) were to mothers married as minors. Although bivariate analyses showed significant associations between maternal child marriage and infant and child diarrhoea, malnutrition (stunted, wasted, underweight), low birth weight, and mortality, only stunting (adjusted odds ratio 1.22, 95% CI 1.12 to 1.33) and underweight (1.24, 1.14 to 1.36) remained significant in adjusted analyses. We noted no effect of maternal child marriage on health of boys versus girls. Conclusions The risk of malnutrition is higher in young children born to mothers married as minors than in those born to women married at a majority age. Further research should examine how early marriage affects food distribution and access for children in India.	[Raj, Anita] Boston Univ Publ Hlth, Dept Social & Behav Sci, Boston, MA USA; [Saggurti, Niranjan] Populat Council, New Delhi, India; [Winter, Michael] Boston Univ Publ Hlth, Data Coordinating Ctr, Boston, MA USA; [Labonte, Alan] Boston Univ, Sch Management, Dept Operat & Technol Management, Boston, MA 02118 USA; [Decker, Michele R.; Silverman, Jay G.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA; [Balaiah, Donta] Indian Council Med Res, Natl Inst Res Reprod Hlth, Mumbai, Maharashtra, India	Boston University; Boston University; Boston University; Harvard University; Harvard T.H. Chan School of Public Health; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Reproductive Health (NIRRH)	Raj, A (corresponding author), Boston Univ, Sch Publ Hlth, Dept Social & Behav Sci, 801 Massachusetts Ave, Boston, MA 02118 USA.	anitaraj@bu.edu		Decker, Michele/0000-0002-7085-7080; Saggurti, Niranjan/0000-0002-5267-8425	US National Institutes of Health; Indian Council on Medical Research [1 R03 HD055120-01]; Boston University School of Public Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD055120] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indian Council on Medical Research; Boston University School of Public Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Analyses for this study and development of this paper were funded by the US National Institutes of Health and the Indian Council on Medical Research Indo-US Program on Maternal and Child Health and Human Development (Grant Number 1 R03 HD055120-01), as well as seed grant funding from Boston University School of Public Health. Researchers operated independently from the funders on this work, and funders neither provided nor were required to provide review and approval of this research.	Abdullah K, 2007, ACTA PAEDIATR, V96, P396, DOI 10.1111/j.1651-2227.2007.00117.x; Adhikari R., 2003, ADULTHOOD EXPLORING, P62; Alam N, 2000, J BIOSOC SCI, V32, P229, DOI 10.1017/S0021932000002297; AROKIASAMY P, 2006, GENDER BIAS FEMALE C; Awasthi Shally, 2003, Indian Pediatr, V40, P1145; BHAN MK, 1989, B WORLD HEALTH ORGAN, V67, P281; Bhutta ZA, 2004, BMJ-BRIT MED J, V328, P816, DOI 10.1136/bmj.328.7443.816; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Borooah VK, 2004, SOC SCI MED, V58, P1719, DOI 10.1016/S0277-9536(03)00342-3; Fronczak N, 2005, INT J GYNECOL OBSTET, V91, P271, DOI 10.1016/j.ijgo.2005.09.006; HELLERSTEDT WL, 1995, AM J PUBLIC HEALTH, V85, P1139, DOI 10.2105/AJPH.85.8_Pt_1.1139; IBRAHIM SA, 1994, PAEDIATR PERINAT EP, V8, P193, DOI 10.1111/j.1365-3016.1994.tb00450.x; ICRW, 2010, NEW INS PREV CHILD M; *INT I POP SCI, 2007, NFHS3 INT I POP SCI, V1; King JC, 2003, J NUTR, V133, p1732S, DOI 10.1093/jn/133.5.1732S; Lenders CM, 2000, CURR OPIN PEDIATR, V12, P291, DOI 10.1097/00008480-200006000-00021; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; MARKOVITZ BP, 2005, BMC PUBLIC HEALTH, V25, P79; Mayor S, 2004, BRIT MED J, V328, P1152, DOI 10.1136/bmj.328.7449.1152-a; Mehra Sunil, 2004, Indian Pediatr, V41, P137; Messer E, 1997, SOC SCI MED, V44, P1675, DOI 10.1016/S0277-9536(96)00370-X; Mishra V, 2004, POPUL DEV REV, V30, P269, DOI 10.1111/j.1728-4457.2004.013_1.x; Olausson PO, 1999, BRIT J OBSTET GYNAEC, V106, P116, DOI 10.1111/j.1471-0528.1999.tb08210.x; Osmani S, 2003, ECON HUM BIOL, V1, P105, DOI 10.1016/S1570-677X(02)00006-0; Phipps MG, 2002, J WOMEN HEALTH GEN-B, V11, P889, DOI 10.1089/154099902762203722; Raj A, 2009, LANCET, V373, P1883, DOI 10.1016/S0140-6736(09)60246-4; RAVALLION M, 2002, 2846 WORLD BANK; Reynolds HW, 2006, INT FAM PLAN PERSPEC, V32, P6, DOI 10.1363/3200606; Santhya K.G., 2007, ECON POLIT WEEKLY, p42(14), 1291; Saravanan P, 2004, Indian J Med Microbiol, V22, P212; Smith GCS, 2001, BRIT MED J, V323, P476, DOI 10.1136/bmj.323.7311.476; Stewart CP, 2007, MATERN CHILD NUTR, V3, P174, DOI 10.1111/j.1740-8709.2007.00097.x; Taffa Negussie, 2003, Int J Adolesc Med Health, V15, P321; *UN NEWS CTR, 2008, NUMB HUNGR PEOPL WOR; *UNFPA, STAT WORLD POP 2005; UNICEF, 2007, PROGR CHILDR PROT AB; UNICEF, 2001, EARL MARR CHILD SPOU; *UNICEF, STAT AS PAC CHILDR 2; *UNICEF, MILL DEV GOALS GOAL; United Nations Children's Fund (UNICEF), 2014, STATE WORLDS CHILDRE; United Nations Development Programme, MILL DEV GOALS GOAL; WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA; *WHO STAT INF SYST, UND 5 MORT RAT PROB; World Health Organisation, 1999, RED MAT MORT JOINT W; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	45	147	146	2	27	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 21	2010	340								b4258	10.1136/bmj.b4258	http://dx.doi.org/10.1136/bmj.b4258			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	548HP	20093277	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000273951400001
J	Harkins, C				Harkins, Claire			Lobby Watch The Portman Group	BRITISH MEDICAL JOURNAL			English	Editorial Material							INDUSTRY		Univ Strathclyde, Dept Geog & Sociol, Glasgow G1 1XN, Lanark, Scotland	University of Strathclyde	Harkins, C (corresponding author), Univ Strathclyde, Dept Geog & Sociol, Glasgow G1 1XN, Lanark, Scotland.	c.harkins@strath.ac.uk						*ALC, LEAD HLTH CHAR CALL; Babor TF, 1996, ADDICTION, V91, P5, DOI 10.1111/j.1360-0443.1996.tb03150.x; *BMA, UND INFL DAM EFF ALC; *BMA SCOTL, WRITT RESP SCOTT GOV; CAREY J, RECREATIONAL DRUG WA; Coussins J, 2004, BRIT MED J, V329, P404, DOI 10.1136/bmj.329.7462.404-b; Donaldson LJ, 2008, 150 YEARS ANN REPORT; EDWARDS G, 1992, ALCOHOL POLICY PUBLI; *FAME DAT, CO REP PORTM GROUP; *HOUS COMM HLTH CO, ALC REP 1 SESS 2009; *PORTM GROUP, BMA IGN WORLD CLASS; *PORTM GROUP, CHANG SCOTL REL ALC; *PORTM GROUP, HLTH COMM RESP; *PRIM MIN STRAT UN, ALC HARM RED STRAT E; *PROTM GROUP, US; *SCOTT GOV, CHANG SCOTL REL ALC; SMITH R, 1994, BRIT MED J, V309, P1597, DOI 10.1136/bmj.309.6969.1597; Stevens A, 2007, SOC POLICY SOC, V6, P25, DOI 10.1017/S1474746406003319; *U SHEFF SCH HLTH, MOD BAS APPR ALC MIN	19	6	6	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 20	2010	340								b5659	10.1136/bmj.b5659	http://dx.doi.org/10.1136/bmj.b5659			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	548HO	20089577				2022-12-28	WOS:000273951300005
J	Werren, JH; Richards, S; Desjardins, CA; Niehuis, O; Gadau, J; Colbourne, JK; Beukeboom, LW; Desplan, C; Elsik, CG; Grimmelikhuijzen, CJP; Kitts, P; Lynch, JA; Murphy, T; Oliveira, DCSG; Smith, CD; van de Zande, L; Worley, KC; Zdobnov, EM; Aerts, M; Albert, S; Anaya, VH; Anzola, JM; Barchuk, AR; Behura, SK; Bera, AN; Berenbaum, MR; Bertossa, RC; Bitondi, MMG; Bordenstein, SR; Bork, P; Bornberg-Bauer, E; Brunain, M; Cazzamali, G; Chaboub, L; Chacko, J; Chavez, D; Childers, CP; Choi, JH; Clark, ME; Claudianos, C; Clinton, RA; Cree, AG; Cristino, AS; Dang, PM; Darby, AC; de Graaf, DC; Devreese, B; Dinh, HH; Edwards, R; Elango, N; Elhaik, E; Ermolaeva, O; Evans, JD; Foret, S; Fowler, GR; Gerlach, D; Gibson, JD; Gilbert, DG; Graur, D; Grunder, S; Hagen, DE; Han, Y; Hauser, F; Hultmark, D; Hunter, HC; Jhangian, SN; Jiang, HY; Johnson, RM; Jones, AK; Junier, T; Kadowaki, T; Kamping, A; Kapustin, Y; Kechavarzi, B; Kim, J; Kim, J; Kiryutin, B; Koevoets, T; Kovar, CL; Kriventseva, EV; Kucharski, R; Lee, H; Lee, SL; Lees, K; Lewis, LR; Loehlin, DW; Logsdon, JM; Lopez, JA; Lozado, RJ; Maglott, D; Maleszka, R; Mayampurath, A; Mazur, DJ; McClure, MA; Moore, AD; Morgan, MB; Muller, J; Munoz-Torres, MC; Muzny, DM; Nazareth, LV; Neupert, S; Nguyen, NB; Nunes, FMF; Oakeshott, JG; Okwuonu, GO; Pannebakker, BA; Pejaver, VR; Peng, ZG; Pratt, SC; Predel, R; Pu, LL; Ranson, H; Raychoudhury, R; Rechtsteiner, A; Reese, JT; Reid, JG; Riddle, M; Robertson, IM; Romero-Severson, J; Rosenberg, M; Sackton, TB; Sattelle, DB; Schluns, H; Schmitt, T; Schneider, M; Schuler, A; Schurko, AM; Shuker, DM; Simoes, ZLP; Sinha, S; Smith, Z; Solovyev, V; Souvorov, A; Springauf, A; Stafflinger, E; Stage, DE; Stanke, M; Tanaka, Y; Telschow, A; Trent, C; Vattathil, S; Verhulst, EC; Viljakainen, L; Wanner, KW; Waterhouse, RM; Whitfield, JB; Wilkes, TE; Williamson, M; Willis, JH; Wolschin, F; Wyder, S; Yamada, T; Yi, SV; Zecher, CN; Zhang, L; Gibbs, RA				Werren, John H.; Richards, Stephen; Desjardins, Christopher A.; Niehuis, Oliver; Gadau, Juergen; Colbourne, John K.; Beukeboom, Leo W.; Desplan, Claude; Elsik, Christine G.; Grimmelikhuijzen, Cornelis J. P.; Kitts, Paul; Lynch, Jeremy A.; Murphy, Terence; Oliveira, Deodoro C. S. G.; Smith, Christopher D.; van de Zande, Louis; Worley, Kim C.; Zdobnov, Evgeny M.; Aerts, Maarten; Albert, Stefan; Anaya, Victor H.; Anzola, Juan M.; Barchuk, Angel R.; Behura, Susanta K.; Bera, Agata N.; Berenbaum, May R.; Bertossa, Rinaldo C.; Bitondi, Marcia M. G.; Bordenstein, Seth R.; Bork, Peer; Bornberg-Bauer, Erich; Brunain, Marleen; Cazzamali, Giuseppe; Chaboub, Lesley; Chacko, Joseph; Chavez, Dean; Childers, Christopher P.; Choi, Jeong-Hyeon; Clark, Michael E.; Claudianos, Charles; Clinton, Rochelle A.; Cree, Andrew G.; Cristino, Alexandre S.; Dang, Phat M.; Darby, Alistair C.; de Graaf, Dirk C.; Devreese, Bart; Dinh, Huyen H.; Edwards, Rachel; Elango, Navin; Elhaik, Eran; Ermolaeva, Olga; Evans, Jay D.; Foret, Sylvain; Fowler, Gerald R.; Gerlach, Daniel; Gibson, Joshua D.; Gilbert, Donald G.; Graur, Dan; Grunder, Stefan; Hagen, Darren E.; Han, Yi; Hauser, Frank; Hultmark, Dan; Hunter, Henry C.; Jhangian, Shalini N.; Jiang, Huaiyang; Johnson, Reed M.; Jones, Andrew K.; Junier, Thomas; Kadowaki, Tatsuhiko; Kamping, Albert; Kapustin, Yuri; Kechavarzi, Bobak; Kim, Jaebum; Kim, Jay; Kiryutin, Boris; Koevoets, Tosca; Kovar, Christie L.; Kriventseva, Evgenia V.; Kucharski, Robert; Lee, Heewook; Lee, Sandra L.; Lees, Kristin; Lewis, Lora R.; Loehlin, David W.; Logsdon, John M., Jr.; Lopez, Jacqueline A.; Lozado, Ryan J.; Maglott, Donna; Maleszka, Ryszard; Mayampurath, Anoop; Mazur, Danielle J.; McClure, Marcella A.; Moore, Andrew D.; Morgan, Margaret B.; Muller, Jean; Munoz-Torres, Monica C.; Muzny, Donna M.; Nazareth, Lynne V.; Neupert, Susanne; Nguyen, Ngoc B.; Nunes, Francis M. F.; Oakeshott, John G.; Okwuonu, Geoffrey O.; Pannebakker, Bart A.; Pejaver, Vikas R.; Peng, Zuogang; Pratt, Stephen C.; Predel, Reinhard; Pu, Ling-Ling; Ranson, Hilary; Raychoudhury, Rhitoban; Rechtsteiner, Andreas; Reese, Justin T.; Reid, Jeffrey G.; Riddle, Megan; Robertson, Il High M.; Romero-Severson, Jeanne; Rosenberg, Miriam; Sackton, Timothy B.; Sattelle, David B.; Schluens, Helge; Schmitt, Thomas; Schneider, Martina; Schueler, Andreas; Schurko, Andrew M.; Shuker, David M.; Simoes, Zila L. P.; Sinha, Saurabh; Smith, Zachary; Solovyev, Victor; Souvorov, Alexandre; Springauf, Andreas; Stafflinger, Elisabeth; Stage, Deborah E.; Stanke, Mario; Tanaka, Yoshiaki; Telschow, Arndt; Trent, Carol; Vattathil, Selina; Verhulst, Eveline C.; Viljakainen, Lumi; Wanner, Kevin W.; Waterhouse, Robert M.; Whitfield, James B.; Wilkes, Timothy E.; Williamson, Michael; Willis, Judith H.; Wolschin, Florian; Wyder, Stefan; Yamada, Takuji; Yi, Soojin V.; Zecher, Courtney N.; Zhang, Lan; Gibbs, Richard A.		Nasonia Genome Working Grp	Functional and Evolutionary Insights from the Genomes of Three Parasitoid Nasonia Species	SCIENCE			English	Article							WASP NASONIA; DNA METHYLATION; SOCIAL INSECTS; APIS-MELLIFERA; VITRIPENNIS; HYMENOPTERA; GENES; PTEROMALIDAE; DROSOPHILA; HONEYBEE	We report here genome sequences and comparative analyses of three closely related parasitoid wasps: Nasonia vitripennis, N. giraulti, and N. longicornis. Parasitoids are important regulators of arthropod populations, including major agricultural pests and disease vectors, and Nasonia is an emerging genetic model, particularly for evolutionary and developmental genetics. Key findings include the identification of a functional DNA methylation tool kit; hymenopteran-specific genes including diverse venoms; lateral gene transfers among Pox viruses, Wolbachia, and Nasonia; and the rapid evolution of genes involved in nuclear-mitochondrial interactions that are implicated in speciation. Newly developed genome resources advance Nasonia for genetic research, accelerate mapping and cloning of quantitative trait loci, and will ultimately provide tools and knowledge for further increasing the utility of parasitoids as pest insect-control agents.	[Werren, John H.; Desjardins, Christopher A.; Oliveira, Deodoro C. S. G.; Clark, Michael E.; Edwards, Rachel; Loehlin, David W.; Raychoudhury, Rhitoban; Stage, Deborah E.] Univ Rochester, Dept Biol, Rochester, NY 14627 USA; [Richards, Stephen; Worley, Kim C.; Chaboub, Lesley; Chacko, Joseph; Chavez, Dean; Cree, Andrew G.; Dinh, Huyen H.; Fowler, Gerald R.; Han, Yi; Jhangian, Shalini N.; Jiang, Huaiyang; Kamping, Albert; Kovar, Christie L.; Lee, Sandra L.; Lewis, Lora R.; Lozado, Ryan J.; Morgan, Margaret B.; Muzny, Donna M.; Nazareth, Lynne V.; Nguyen, Ngoc B.; Okwuonu, Geoffrey O.; Pu, Ling-Ling; Reid, Jeffrey G.; Vattathil, Selina; Zhang, Lan; Gibbs, Richard A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Niehuis, Oliver; Gadau, Juergen; Gibson, Joshua D.; Pratt, Stephen C.; Wolschin, Florian] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Colbourne, John K.; Choi, Jeong-Hyeon; Lopez, Jacqueline A.; Rechtsteiner, Andreas; Smith, Zachary] Indiana Univ, Ctr Genom & Bioinformat, Bloomington, IN 47405 USA; [Beukeboom, Leo W.; van de Zande, Louis; Koevoets, Tosca; Pannebakker, Bart A.; Verhulst, Eveline C.] Univ Groningen, Evolutionary Genet Ctr Ecol & Evolutionary Studie, NL-9750 AA Haren, Netherlands; [Desplan, Claude; Rosenberg, Miriam] NYU, Dept Biol, New York, NY 10003 USA; [Elsik, Christine G.; Childers, Christopher P.; Hagen, Darren E.; Munoz-Torres, Monica C.; Reese, Justin T.] Georgetown Univ, Dept Biol, Washington, DC 20057 USA; [Grimmelikhuijzen, Cornelis J. P.; Cazzamali, Giuseppe; Hauser, Frank; Schneider, Martina; Stafflinger, Elisabeth; Williamson, Michael] Univ Copenhagen, Dept Biol, Ctr Comparat & Funct Insect Genom, DK-2100 Copenhagen, Denmark; [Kitts, Paul; Murphy, Terence; Ermolaeva, Olga; Kapustin, Yuri; Kiryutin, Boris; Maglott, Donna; Souvorov, Alexandre] Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA; [Lynch, Jeremy A.] Univ Cologne, Inst Entwicklungsphysiol, D-50923 Cologne, Germany; [Smith, Christopher D.; Hunter, Henry C.; Kim, Jay] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA; [Smith, Christopher D.] Univ Calif Berkeley, Lawrence Berkeley Lab, Drosophila Heterochromatin Genome Project, Berkeley, CA 94720 USA; [Zdobnov, Evgeny M.; Gerlach, Daniel; Junier, Thomas; Wyder, Stefan] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Zdobnov, Evgeny M.; Gerlach, Daniel] Swiss Inst Bioinformat, CH-1211 Geneva, Switzerland; [Zdobnov, Evgeny M.; Waterhouse, Robert M.] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; [Aerts, Maarten; Devreese, Bart] Univ Ghent, Lab Prot Biochem & Biomol Engn, B-9000 Ghent, Belgium; [Albert, Stefan] Univ Wurzburg, BEEgrp, D-97082 Wurzburg, Germany; [Albert, Stefan] Univ Wurzburg, Inst Pharmaceut Biol, D-97082 Wurzburg, Germany; [Anaya, Victor H.] Humboldt Univ, Inst Theoret Biol, D-10115 Berlin, Germany; [Anzola, Juan M.] Texas A&M Univ, College Stn, TX 77843 USA; [Barchuk, Angel R.] Univ Fed Alfenas, Dept Ciencias Biomed, BR-37130000 Alfenas, MG, Brazil; [Behura, Susanta K.] Univ Notre Dame, Dept Biol Sci, Eck Inst Global Hlth, Notre Dame, IN 46556 USA; [Bera, Agata N.; Jones, Andrew K.; Lees, Kristin; Sattelle, David B.] Univ Oxford, Dept Physiol Anat & Genet, MRC, Funct Genom Unit, Oxford OX1 3QX, England; [Berenbaum, May R.; Robertson, Il High M.; Whitfield, James B.] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; [Bertossa, Rinaldo C.] Univ Groningen, Chronobiol Ctr Behav & Neurosci, NL-9750 AA Haren, Netherlands; [Bitondi, Marcia M. G.; Nunes, Francis M. F.; Simoes, Zila L. P.] Univ Sao Paulo, Dept Biol, Fac Filosofia Ciencias & Letras Ribeirao Pret, BR-14040901 Sao Paulo, Brazil; [Bordenstein, Seth R.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Bordenstein, Seth R.; Zecher, Courtney N.] Marine Biol Lab, Josephine Bay Paul Ctr Comparat Mol Biol & Evolut, Woods Hole, MA 02536 USA; [Bork, Peer; Muller, Jean; Yamada, Takuji] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Bornberg-Bauer, Erich; Moore, Andrew D.; Romero-Severson, Jeanne; Schueler, Andreas; Telschow, Arndt] Univ Munster, Inst Evolut & Biodivers, D-48143 Munster, Germany; [Brunain, Marleen; de Graaf, Dirk C.] Univ Ghent, Lab Zoophysiol, B-9000 Ghent, Belgium; [Claudianos, Charles; Cristino, Alexandre S.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Clinton, Rochelle A.; McClure, Marcella A.] Montana State Univ, Dept Microbiol, Bozeman, MT 59715 USA; [Clinton, Rochelle A.; McClure, Marcella A.] Montana State Univ, Ctr Computat Biol, Bozeman, MT 59715 USA; [Cristino, Alexandre S.] Univ Sao Paulo, Dept Fis & Informat, Inst Fis Sao Carlos, BR-13560970 Sao Paulo, Brazil; [Dang, Phat M.] ARS, Subtrop Insects Res Unit, USDA, US Hort Res Lab, Ft Pierce, FL 34945 USA; [Darby, Alistair C.; Wilkes, Timothy E.] Univ Liverpool, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England; [Elango, Navin; Peng, Zuogang; Yi, Soojin V.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Elhaik, Eran; Graur, Dan] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; [Evans, Jay D.] ARS, Bee Res Lab, USDA, Beltsville, MD 20705 USA; [Foret, Sylvain] James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Gilbert, Donald G.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Grunder, Stefan; Springauf, Andreas] Rhein Westfal TH Aachen, Inst Physiol, D-52074 Aachen, Germany; [Hultmark, Dan] Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden; [Johnson, Reed M.] Univ Nebraska, Dept Entomol, Lincoln, NE 68583 USA; [Kadowaki, Tatsuhiko] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Kechavarzi, Bobak; Lee, Heewook; Mayampurath, Anoop; Pejaver, Vikas R.] Indiana Univ, Sch Informat, Bloomington, IN 47405 USA; [Kim, Jaebum; Sinha, Saurabh] Univ Illinois, Dept Comp Sci, Urbana, IL 61801 USA; [Kriventseva, Evgenia V.] Univ Geneva, Sch Med, Dept Struct Biol & Bioinformat, CH-1211 Geneva, Switzerland; [Kucharski, Robert; Maleszka, Ryszard] Australian Natl Univ, Res Sch Biol, Canberra, ACT 2601, Australia; [Logsdon, John M., Jr.; Mazur, Danielle J.; Schurko, Andrew M.] Univ Iowa, Roy J Carver Ctr Comparat Genom, Iowa City, IA 52242 USA; [Logsdon, John M., Jr.; Mazur, Danielle J.; Schurko, Andrew M.] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; [Munoz-Torres, Monica C.] Clemson Univ, Dept Biochem & Genet, Clemson, SC 29634 USA; [Neupert, Susanne; Predel, Reinhard] Univ Jena, Inst Gen Zool, D-7743 Jena, Germany; [Nunes, Francis M. F.] Univ Sao Paulo, Dept Genet, Fac Med Ribeirao Preto, BR-14049900 Sao Paulo, Brazil; [Oakeshott, John G.] CSIRO, Div Entomol, Canberra, ACT 2601, Australia; [Pannebakker, Bart A.] Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland; [Ranson, Hilary] Univ Liverpool, Liverpool Sch Trop Med, Vector Grp, Liverpool L3 5QA, Merseyside, England; [Rechtsteiner, Andreas] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Reese, Justin T.] Reese Consulting, Amphur Muang, Nong Khai, Thailand; [Riddle, Megan; Trent, Carol] Western Washington Univ, Dept Biol, Bellingham, WA 98225 USA; [Romero-Severson, Jeanne] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Sackton, Timothy B.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Schluens, Helge] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Schluens, Helge] James Cook Univ, Ctr Comparat Genom, Townsville, Qld 4811, Australia; [Schmitt, Thomas] Univ Freiburg, Dept Evolutionary Biol & Anim Ecol, D-79104 Freiburg, Germany; [Shuker, David M.] Univ St Andrews, Sch Biol, St Andrews KY16 9TH, Fife, Scotland; [Solovyev, Victor] Univ London, Dept Comp Sci, Egham TW20 0EX, Surrey, England; [Stanke, Mario] Univ Gottingen, Inst Mikrobiol & Genet, D-37077 Gottingen, Germany; [Tanaka, Yoshiaki] Natl Inst Agrobiol Sci, Div Insect Sci, Tsukuba, Ibaraki 3058634, Japan; [Viljakainen, Lumi] Univ Oulu, Dept Biol, Oulu 90014, Finland; [Viljakainen, Lumi] Univ Oulu, Bioctr Oulu, Oulu 90014, Finland; [Wanner, Kevin W.] Montana State Univ, Dept Plant Sci & Plant Pathol, Bozeman, MT 59717 USA; [Willis, Judith H.] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [Wolschin, Florian] Norwegian Univ Life Sci, Dept Biotechnol Chem & Food Sci, N-1432 As, Norway	University of Rochester; Baylor College of Medicine; Arizona State University; Arizona State University-Tempe; Indiana University System; Indiana University Bloomington; University of Groningen; New York University; Georgetown University; University of Copenhagen; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); University of Cologne; California State University System; San Francisco State University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Geneva; Swiss Institute of Bioinformatics; Imperial College London; Ghent University; University of Wurzburg; University of Wurzburg; Humboldt University of Berlin; Texas A&M University System; Texas A&M University College Station; Universidade Federal de Alfenas; University of Notre Dame; University of Oxford; University of Illinois System; University of Illinois Urbana-Champaign; University of Groningen; Universidade de Sao Paulo; Vanderbilt University; Marine Biological Laboratory - Woods Hole; European Molecular Biology Laboratory (EMBL); University of Munster; Ghent University; University of Queensland; Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; Universidade de Sao Paulo; United States Department of Agriculture (USDA); University of Liverpool; University System of Georgia; Georgia Institute of Technology; University of Houston System; University of Houston; United States Department of Agriculture (USDA); James Cook University; Indiana University System; Indiana University Bloomington; RWTH Aachen University; Umea University; University of Nebraska System; University of Nebraska Lincoln; Nagoya University; Indiana University System; Indiana University Bloomington; University of Illinois System; University of Illinois Urbana-Champaign; University of Geneva; Australian National University; University of Iowa; University of Iowa; Clemson University; Friedrich Schiller University of Jena; Universidade de Sao Paulo; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Edinburgh; Liverpool School of Tropical Medicine; University of Liverpool; University of California System; University of California Santa Cruz; Western Washington University; University of Notre Dame; Harvard University; James Cook University; James Cook University; University of Freiburg; University of St Andrews; University of London; Royal Holloway University London; University of Gottingen; National Institute of Agrobiological Sciences - Japan; University of Oulu; University of Oulu; Montana State University System; Montana State University Bozeman; University System of Georgia; University of Georgia; Norwegian University of Life Sciences	Werren, JH (corresponding author), Univ Rochester, Dept Biol, Rochester, NY 14627 USA.	werr@mail.rochester.edu; stephenr@bcm.tmc.edu	Choi, Justin/F-8792-2014; Verhulst, Eveline/J-2641-2013; Oakeshott, John G/B-5365-2009; Devreese, Bart/B-2011-2009; Evans, Jay D/C-8408-2012; Foret, Sylvain/C-7661-2011; Bornberg-Bauer, Erich/A-1563-2013; Pratt, Stephen/C-5418-2011; FORET, Sylvain/B-9207-2012; Elhaik, Eran/H-6838-2019; Lopez, Jacqueline A/F-9712-2013; Pannebakker, Bart/D-1479-2010; Schluns, Helge/B-1753-2009; Darby, Alistair/I-6485-2012; Devreese, Bart/K-2841-2019; Bork, Peer/F-1813-2013; Gründer, Stefan/I-2495-2019; Johnson, Reed M./H-3742-2011; Muller, Jean/L-7412-2018; Peng, Zuogang/D-4448-2011; Choi, Jeong-Hyeon/E-3084-2010; Nguyen, Ngoc/HHZ-0886-2022; Cristino, Alexandre S/A-5834-2012; Bitondi, Marcia MG/E-8014-2012; Zdobnov, Evgeny/AAB-2745-2022; Simoes, Zila Luz Paulino/H-7314-2014; Romero-Severson, Jeanne/B-5259-2011; Hultmark, Dan/C-5058-2013; Elsik, Christine G/C-4120-2017; Zdobnov, Evgeny M/K-1133-2012; Beukeboom, L.W./D-1808-2012; Waterhouse, Robert M/A-1858-2010; Pannebakker, Bart A./D-3823-2012; Aerts, Maarten/O-6194-2014; Shuker, David M/E-8827-2013; Solovyev, Victor/C-4614-2013; Predel, Reinhard/O-5243-2015; Maleszka, Ryszard/A-6078-2008; Nunes, Francis M. F./F-5871-2010; Schmitt, Thomas/H-3033-2013; Stanke, Mario/P-7876-2019; Hauser, Frank/M-2952-2014; Junier, Thomas/A-6748-2011; Colbourne, John K/L-7748-2014; de Graaf, Dirk C./HGD-4017-2022	Verhulst, Eveline/0000-0002-4781-535X; Oakeshott, John G/0000-0001-8324-7874; Devreese, Bart/0000-0002-9764-2581; Evans, Jay D/0000-0002-0036-4651; Bornberg-Bauer, Erich/0000-0002-1826-3576; Elhaik, Eran/0000-0003-4795-1084; Darby, Alistair/0000-0002-3786-6209; Devreese, Bart/0000-0002-9764-2581; Bork, Peer/0000-0002-2627-833X; Gründer, Stefan/0000-0002-7635-9883; Johnson, Reed M./0000-0002-2431-0180; Muller, Jean/0000-0002-7682-559X; Peng, Zuogang/0000-0001-8810-2025; Cristino, Alexandre S/0000-0002-3468-0919; Bitondi, Marcia MG/0000-0002-5619-6378; Zdobnov, Evgeny/0000-0002-5178-1498; Romero-Severson, Jeanne/0000-0003-4112-7238; Hultmark, Dan/0000-0002-6506-5855; Elsik, Christine G/0000-0002-4248-7713; Waterhouse, Robert M/0000-0003-4199-9052; Pannebakker, Bart A./0000-0001-8503-3896; Aerts, Maarten/0000-0003-0125-6721; Solovyev, Victor/0000-0001-8885-493X; Maleszka, Ryszard/0000-0003-1855-555X; Nunes, Francis M. F./0000-0002-7769-3058; Stanke, Mario/0000-0001-8696-0384; Hauser, Frank/0000-0001-5563-2345; Colbourne, John K/0000-0002-6966-2972; Ranson, Hilary/0000-0003-2332-8247; Claudianos, Charles/0000-0002-9799-9572; Chaboub, Lesley/0000-0002-2773-8027; Lees, Kristin/0000-0002-9783-1227; Rosenberg, Miriam/0000-0001-5348-8247; Simoes, Zila Luz Paulino/0000-0003-2363-6178; Desjardins, Christopher/0000-0002-3160-4734; Childers, Chris/0000-0002-1253-5550; Anaya-Munoz, Victor Hugo/0000-0001-6136-7330; Desplan, Claude/0000-0002-6914-1413; Sackton, Timothy/0000-0003-1673-9216; Worley, Kim/0000-0002-0282-1000; Gibson, Joshua/0000-0002-0193-2307; Raychoudhury, Rhitoban/0000-0001-6835-1008; behura, Susanta/0000-0003-1057-2435; Kucharski, Robert/0000-0002-1708-1877; Viljakainen, Lumi/0000-0002-6587-6156; Werren, John/0000-0001-9353-2070; Jones, Andrew/0000-0002-7835-0890; Grimmelikhuijzen, Cornelis Johannes Pieter/0000-0001-6486-2046; Hagen, Darren/0000-0001-8295-020X; Gerlach, Daniel/0000-0001-9338-3765; Wyder, Stefan/0000-0002-3412-0292; Rechtsteiner, Andreas/0000-0001-6031-1087; van de Zande, Louis/0000-0001-5687-3220; Anzola, Juan/0000-0003-2677-6731	National Human Genome Research Institute [NHGRI U54 HG003273]; NERC [NE/D009979/2] Funding Source: UKRI; Natural Environment Research Council [NE/D009979/2] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000747, U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028309, R01AI055624] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085163, R01GM070026, R24GM084917, R01GM079484, R01GM064864, R01GM085233] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Genome sequencing, assembly and annotation were funded by the National Human Genome Research Institute (NHGRI U54 HG003273). The whole-genome shotgun project has been deposited at the DNA Databank of Japan (DDBJ)/European Molecular Biology Laboratory (EMBL)/GenBank under accession numbers AAZX00000000 (N. vitripennis), ADAO00000000 (N. giraulti), and ADAP00000000 (N. longicornis). Additional support, acknowledgments, and accession numbers are provided in the supporting online material.	Aquadro CF, 2001, CURR OPIN GENET DEV, V11, P627, DOI 10.1016/S0959-437X(00)00245-8; Beukeboom LW, 2007, SEMIN CELL DEV BIOL, V18, P371, DOI 10.1016/j.semcdb.2006.12.015; BREEUWER JAJ, 1995, EVOLUTION, V49, P705, DOI 10.1111/j.1558-5646.1995.tb02307.x; Brent AE, 2007, SCIENCE, V315, P1841, DOI 10.1126/science.1137528; Chang SJ, 2009, J VIROL, V83, P4140, DOI 10.1128/JVI.01835-08; de Graaf DC, 2010, INSECT MOL BIOL, V19, P11, DOI 10.1111/j.1365-2583.2009.00914.x; Desjardins CA, 2010, HEREDITY, V104, P270, DOI 10.1038/hdy.2009.145; Drapeau MD, 2006, GENOME RES, V16, P1385, DOI 10.1101/gr.5012006; Elango N, 2009, P NATL ACAD SCI USA, V106, P11206, DOI 10.1073/pnas.0900301106; Flowers JM, 2007, MOL BIOL EVOL, V24, P1347, DOI 10.1093/molbev/msm057; Gerlach D, 2009, NUCLEIC ACIDS RES, V37, pD111, DOI 10.1093/nar/gkn707; Heraty John, 2009, P445, DOI 10.1002/9781444308211.ch19; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; Jurkowski TP, 2008, RNA, V14, P1663, DOI 10.1261/rna.970408; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kucharski R, 2008, SCIENCE, V319, P1827, DOI 10.1126/science.1153069; Loehlin DW, 2010, HEREDITY, V104, P260, DOI 10.1038/hdy.2009.146; Loehlin DW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000821; Lynch JA, 2006, NATURE, V439, P728, DOI 10.1038/nature04445; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Niehuis O, 2008, GENETICS, V178, P413, DOI 10.1534/genetics.107.080523; Niehuis O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008597; Oliveira DCSG, 2008, MOL BIOL EVOL, V25, P2167, DOI 10.1093/molbev/msn159; Pannebakker BA, 2010, INSECT MOL BIOL, V19, P91, DOI 10.1111/j.1365-2583.2009.00915.x; Pultz MA, 2000, GENETICS, V154, P1213; Quicke D. L. J., 1997, PARASITIC WASPS; Rand DM, 2004, TRENDS ECOL EVOL, V19, P645, DOI 10.1016/j.tree.2004.10.003; Raychoudhury R, 2010, HEREDITY, V104, P278, DOI 10.1038/hdy.2009.147; RIVERS DB, 1999, TRENDS ENTOMOL, V2, P1; Robertson HM, 2010, INSECT MOL BIOL, V19, P121, DOI 10.1111/j.1365-2583.2009.00979.x; Smith CD, 2007, GENE, V389, P1, DOI 10.1016/j.gene.2006.09.011; van den Assem J, 1976, BIOL BEHAV, V1, P37; Velthuis BJ, 2005, ANIM BEHAV, V69, P1107, DOI 10.1016/j.anbehav.2004.06.032; Viljakainen L, 2010, INSECT MOL BIOL, V19, P27, DOI 10.1111/j.1365-2583.2009.00932.x; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; WERREN JH, 2009, COLD SPRING HARB PRO, V2009, DOI DOI 10.1101/PDB.EMO134; Wilfert L, 2007, HEREDITY, V98, P189, DOI 10.1038/sj.hdy.6800950; Yapici N, 2008, NATURE, V451, P33, DOI 10.1038/nature06483; Zdobnov EM, 2007, TRENDS GENET, V23, P16, DOI 10.1016/j.tig.2006.10.004	39	637	723	11	414	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 15	2010	327	5963					343	348		10.1126/science.1178028	http://dx.doi.org/10.1126/science.1178028			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544CM	20075255	Green Submitted, Green Accepted			2022-12-28	WOS:000273629700047
J	Rowe, HM; Jakobsson, J; Mesnard, D; Rougemont, J; Reynard, S; Aktas, T; Maillard, PV; Layard-Liesching, H; Verp, S; Marquis, J; Spitz, F; Constam, DB; Trono, D				Rowe, Helen M.; Jakobsson, Johan; Mesnard, Daniel; Rougemont, Jacques; Reynard, Severine; Aktas, Tugce; Maillard, Pierre V.; Layard-Liesching, Hillary; Verp, Sonia; Marquis, Julien; Spitz, Francois; Constam, Daniel B.; Trono, Didier			KAP1 controls endogenous retroviruses in embryonic stem cells	NATURE			English	Article							MURINE LEUKEMIA-VIRUS; RNAI SCREEN; BINDING; COREPRESSOR; GENOME; RETROTRANSPOSONS; METHYLATION; EXPRESSION; REPRESSION; HP1	More than forty per cent of the mammalian genome is derived from retroelements, of which about one-quarter are endogenous retroviruses (ERVs)(1). Some are still active, notably in mice the highly polymorphic early transposon (ETn)/MusD and intracisternal A-type particles (IAP)(2,3). ERVs are transcriptionally silenced during early embryogenesis by histone and DNA methylation(4-6) (and reviewed in ref. 7), although the initiators of this process, which is essential to protect genome integrity(8), remain largely unknown. KAP1 (KRAB-associated protein 1, also known as tripartite motif-containing protein 28, TRIM28) represses genes by recruiting the histone methyltransferase SETDB1, heterochromatin protein 1 (HP1) and the NuRD histone deacetylase complex(9), but few of its physiological targets are known. Two lines of evidence suggest that KAP1-mediated repression could contribute to the control of ERVs: first, KAP1 can trigger permanent gene silencing during early embryogenesis(10), and second, a KAP1 complex silences the retrovirus murine leukaemia virus in embryonic cells(11-13). Consistent with this hypothesis, here we show that KAP1 deletion leads to a marked upregulation of a range of ERVs, in particular IAP elements, in mouse embryonic stem (ES) cells and in early embryos. We further demonstrate that KAP1 acts synergistically with DNA methylation to silence IAP elements, and that it is enriched at the 5' untranslated region (5'UTR) of IAP genomes, where KAP1 deletion leads to the loss of histone 3 lysine 9 trimethylation (H3K9me3), a hallmark of KAP1-mediated repression. Correspondingly, IAP 5'UTR sequences can impose in cis KAP1-dependent repression on a heterologous promoter in ES cells. Our results establish that KAP1 controls endogenous retroelements during early embryonic development.	[Rowe, Helen M.; Jakobsson, Johan; Mesnard, Daniel; Rougemont, Jacques; Reynard, Severine; Maillard, Pierre V.; Layard-Liesching, Hillary; Verp, Sonia; Marquis, Julien; Constam, Daniel B.; Trono, Didier] Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Aktas, Tugce; Spitz, Francois] EMBL Heidelberg, D-69117 Heidelberg, Germany	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; European Molecular Biology Laboratory (EMBL)	Trono, D (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland.	didier.trono@epfl.ch	Jakobsson, Johan/E-7745-2014; Rowe, Helen/AAQ-7138-2021; Maillard, Pierre V/V-4305-2019	Jakobsson, Johan/0000-0003-0669-7673; Rowe, Helen/0000-0001-5881-0290; Maillard, Pierre V/0000-0003-4611-388X; Constam, Daniel B./0000-0002-6256-3891; Aktas, Tugce/0000-0003-1599-9454; Spitz, Francois/0000-0002-1960-829X	Swiss National Science Foundation; Infectigen Association and the Strauss Foundation; Swedish Research Council	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Infectigen Association and the Strauss Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	We thank P. Turelli and I. Barde for advice, F. Cammas and R. Losson for the Kap1<SUP>loxp/loxP</SUP> and Kap1<SUP>+/-</SUP> mice, D. Schultz for the KAP1-specific antibody, and K. Harshman at the genomics platform for the Illumina high throughput sequencing. This work was supported by grants from the Swiss National Science Foundation, the Infectigen Association and the Strauss Foundation to D. T., and by a post-doctoral fellowship from the Swedish Research Council to J.J.	Bryja V, 2006, NAT PROTOC, V1, P2082, DOI 10.1038/nprot.2006.355; Cammas F, 2004, GENE DEV, V18, P2147, DOI 10.1101/gad.302904; Dewannieux M, 2004, NAT GENET, V36, P534, DOI 10.1038/ng1353; Emerson RO, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000325; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Haas DL, 2003, J VIROL, V77, P9439, DOI 10.1128/JVI.77.17.9439-9450.2003; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Krebs CJ, 2005, GENOMICS, V85, P752, DOI 10.1016/j.ygeno.2005.03.004; Maillard PV, 2007, PLOS PATHOG, V3, P2052, DOI 10.1371/journal.ppat.0030200; Maksakova IA, 2008, CELL MOL LIFE SCI, V65, P3329, DOI 10.1007/s00018-008-8494-3; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; MIETZ JA, 1987, J VIROL, V61, P3020, DOI 10.1128/JVI.61.10.3020-3029.1987; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Modin C, 2000, VIROLOGY, V278, P368, DOI 10.1006/viro.2000.0683; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Riclet R, 2009, MOL BIOL CELL, V20, P296, DOI 10.1091/mbc.E08-05-0510; Sripathy SP, 2006, MOL CELL BIOL, V26, P8623, DOI 10.1128/MCB.00487-06; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Whitelaw E, 2001, NAT GENET, V27, P361, DOI 10.1038/86850; Wiznerowicz M, 2007, J BIOL CHEM, V282, P34535, DOI 10.1074/jbc.M705898200; Wolf D, 2008, J VIROL, V82, P4675, DOI 10.1128/JVI.02445-07; Wolf D, 2007, CELL, V131, P46, DOI 10.1016/j.cell.2007.07.026; Wolf D, 2009, NATURE, V458, P1201, DOI 10.1038/nature07844; Zhang Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000007	29	497	506	3	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 14	2010	463	7278					237	240		10.1038/nature08674	http://dx.doi.org/10.1038/nature08674			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543MQ	20075919				2022-12-28	WOS:000273582700037
J	Schuurman, MJ; Robben, SG; Been, JV				Schuurman, Marijn J.; Robben, Simon G.; Been, Jasper V.			Picture Quiz A congenital anomaly in a preterm newborn	BRITISH MEDICAL JOURNAL			English	Editorial Material							ESOPHAGEAL ATRESIA; APGAR SCORE; FISTULA		[Schuurman, Marijn J.; Been, Jasper V.] Maastricht Univ Med Ctr, Dept Paediat, NL-6202 AZ Maastricht, Netherlands; [Robben, Simon G.] Maastricht Univ Med Ctr, Dept Radiol, NL-6202 AZ Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC)	Been, JV (corresponding author), Maastricht Univ Med Ctr, Dept Paediat, NL-6202 AZ Maastricht, Netherlands.	jasper.been@mumc.nl						APGAR V, 1953, Curr Res Anesth Analg, V32, P260; Brantberg A, 2007, ULTRASOUND OBST GYN, V30, P180, DOI 10.1002/uog.4056; Casey BM, 2001, NEW ENGL J MED, V344, P467, DOI 10.1056/NEJM200102153440701; Genevieve D, 2007, CLIN GENET, V71, P392, DOI 10.1111/j.1399-0004.2007.00798.x; Houben CH, 2008, PRENATAL DIAG, V28, P667, DOI 10.1002/pd.1938; Keckler SJ, 2007, PEDIATR SURG INT, V23, P309, DOI 10.1007/s00383-007-1891-0; Kovesi T, 2004, CHEST, V126, P915, DOI 10.1378/chest.126.3.915; Lopez PJ, 2006, J PEDIATR SURG, V41, P331, DOI 10.1016/j.jpedsurg.2005.11.009; O'Donnell CPF, 2006, J PEDIATR-US, V149, P486, DOI 10.1016/j.jpeds.2006.05.040; Ringer SA, 2008, MANUAL NEONATAL CARE, P59; SCHUTTER I, 2007, EUR J PEDIATR, V166, P911; Spitz L, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-24	12	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 13	2010	340								b5241	10.1136/bmj.b5241	http://dx.doi.org/10.1136/bmj.b5241			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	545DA	20071436				2022-12-28	WOS:000273711500001
J	Abramson, J; Giraud, M; Benoist, C; Mathis, D				Abramson, Jakub; Giraud, Matthieu; Benoist, Christophe; Mathis, Diane			Aire's Partners in the Molecular Control of Immunological Tolerance	CELL			English	Article							THYMIC EPITHELIAL-CELLS; TRANSCRIPTIONAL ELONGATION; GENE-EXPRESSION; II TRANSCRIPTION; T-CELLS; BINDING; PROTEIN; PHOSPHORYLATION; AUTOIMMUNITY; BREAKS	Aire induces the expression of a battery of peripheral-tissue self-antigens (PTAs) in thymic stromal cells, promoting the clonal deletion of differentiating T cells that recognize them. Just how Aire targets and induces PTA transcripts remains largely undefined. Screening via Aire-targeted coimmunoprecipitation followed by mass spectrometry, and validating by multiple RNAi-mediated knockdown approaches, we identified a large set of proteins that associate with Aire. They fall into four major functional classes: nuclear transport, chromatin binding/structure, transcription and pre-mRNA processing. One set of Aire interactions centered on DNA protein kinase and a group of proteins it partners with to resolve DNA double-stranded breaks or promote transcriptional elongation. Another set of interactions was focused on the pre-mRNA splicing and maturation machinery, potentially explaining the markedly more effective processing of PTA transcripts in the presence of Aire. These findings suggest a model to explain Aire's widespread targeting and induction of weakly transcribed chromatin regions.	[Abramson, Jakub; Giraud, Matthieu; Benoist, Christophe; Mathis, Diane] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Benoist, Christophe; Mathis, Diane] Broad Inst, Boston, MA 02115 USA; [Mathis, Diane] Harvard Stem Cell Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Benoist, C (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	cbdm@hms.harvard.edu; cbdm@hms.harvard.edu	ABRAMSON, JAKUB/K-1348-2012; Giraud, Matthieu/E-4972-2017	Giraud, Matthieu/0000-0002-1208-9677	Joslin Diabetes Center's NIDDK; Juvenile Diabetes Research Foundation [10-2007-601, 03-2005-1138]; Campbell and Hall Charity Fund; Harold Whitworth Pierce Charitable Trust; Philippe Foundation	Joslin Diabetes Center's NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Campbell and Hall Charity Fund; Harold Whitworth Pierce Charitable Trust; Philippe Foundation	We thank Drs. N. Hacohen, D. Gray, D. Mayerova, S. Haxhinasto, and E. Husebye for materials, techniques, and/or discussions; and N. Asinovski, K. Leatherbee, Dr. A. Ortiz-Lopez, C. Campbell, G. Buruzula, J. LaVecchio, and J. Chen for technical assistance. This work was supported by the Joslin Diabetes Center's NIDDK-funded DERC core facilities. J. A. was supported by fellowships from the Juvenile Diabetes Research Foundation (JDRF#: 10-2007-601 and 03-2005-1138) and M. G. by fellowships from the Campbell and Hall Charity Fund, The Harold Whitworth Pierce Charitable Trust, and the Philippe Foundation.	Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Bottomley MJ, 2001, NAT STRUCT BIOL, V8, P626, DOI 10.1038/89675; Das R, 2007, MOL CELL, V26, P867, DOI 10.1016/j.molcel.2007.05.036; Derbinski J, 2008, P NATL ACAD SCI USA, V105, P657, DOI 10.1073/pnas.0707486105; Gray D, 2007, J EXP MED, V204, P2521, DOI 10.1084/jem.20070795; Guerau-De-Arellano M, 2008, P NATL ACAD SCI USA, V105, P14011, DOI 10.1073/pnas.0806616105; Halonen M, 2004, HUM MUTAT, V23, P245, DOI 10.1002/humu.20003; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Heessen S, 2007, EMBO REP, V8, P914, DOI 10.1038/sj.embor.7401075; Heo K, 2008, MOL CELL, V30, P86, DOI 10.1016/j.molcel.2008.02.029; Johnnidis JB, 2005, P NATL ACAD SCI USA, V102, P7233, DOI 10.1073/pnas.0502670102; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Koh AS, 2008, P NATL ACAD SCI USA, V105, P15878, DOI 10.1073/pnas.0808470105; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; Kyewski B, 2006, ANNU REV IMMUNOL, V24, P571, DOI 10.1146/annurev.immunol.23.021704.115601; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Liiv I, 2008, BBA-MOL CELL RES, V1783, P74, DOI 10.1016/j.bbamcr.2007.09.003; Lin SR, 2008, NAT STRUCT MOL BIOL, V15, P819, DOI 10.1038/nsmb.1461; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; Misteli T, 1999, MOL CELL, V3, P697, DOI 10.1016/S1097-2765(01)80002-2; Mondal N, 2001, NATURE, V413, P435, DOI 10.1038/35096590; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Muslimovic A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005859; Org T, 2008, EMBO REP, V9, P370, DOI [10.1038/embor.2008.11, 10.1038/sj.embor.2008.11]; Oven I, 2007, MOL CELL BIOL, V27, P8815, DOI 10.1128/MCB.01085-07; Pitkanen J, 2000, J BIOL CHEM, V275, P16802, DOI 10.1074/jbc.M908944199; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Su MA, 2008, J CLIN INVEST, V118, P1712, DOI 10.1172/JCI34523; SURH CD, 1992, J EXP MED, V176, P611, DOI 10.1084/jem.176.2.611; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; Villasenor J, 2008, P NATL ACAD SCI USA, V105, P15854, DOI 10.1073/pnas.0808069105	34	216	224	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 8	2010	140	1					123	135		10.1016/j.cell.2009.12.030	http://dx.doi.org/10.1016/j.cell.2009.12.030			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	541CY	20085707	Bronze			2022-12-28	WOS:000273391900020
J	Pece, S; Tosoni, D; Confalonieri, S; Mazzarol, G; Vecchi, M; Ronzoni, S; Bernard, L; Viale, G; Pelicci, PG; Di Fiore, PP				Pece, Salvatore; Tosoni, Daniela; Confalonieri, Stefano; Mazzarol, Giovanni; Vecchi, Manuela; Ronzoni, Simona; Bernard, Loris; Viale, Giuseppe; Pelicci, Pier Giuseppe; Di Fiore, Pier Paolo			Biological and Molecular Heterogeneity of Breast Cancers Correlates with Their Cancer Stem Cell Content	CELL			English	Article							MAMMARY-GLAND; IN-VIVO; DIFFERENTIATION; POPULATION; TUMORS; RECONSTRUCTION; MORPHOGENESIS; PROGENITORS; CARCINOMAS; DIVISIONS	Pathways that govern stem cell (SC) function are often subverted in cancer. Here, we report the isolation to near purity of human normal mammary SCs (hNMSCs), from cultured mammospheres, on the basis of their ability to retain the lipophilic dye PKH26 as a consequence of their quiescent nature. PKH26-positive cells possess all the characteristics of hNMSCs. The transcriptional profile of PKH26-positive cells (hNMSC signature) was able to predict biological and molecular features of breast cancers. By using markers of the hNMSC signature, we prospectively isolated SCs from the normal gland and from breast tumors. Poorly differentiated (G3) cancers displayed higher content of prospectively isolated cancer SCs (CSCs) than did well-differentiated (G1) cancers. By comparing G3 and G1 tumors in xenotransplantation experiments, we directly demonstrated that G3s are enriched in CSCs. Our data support the notion that the heterogeneous phenotypical and molecular traits of human breast cancers are a function of their CSC content.	[Pece, Salvatore; Tosoni, Daniela; Confalonieri, Stefano; Vecchi, Manuela; Di Fiore, Pier Paolo] Fdn Ist FIRC Oncol Mol, IFOM, I-20139 Milan, Italy; [Pece, Salvatore; Viale, Giuseppe; Pelicci, Pier Giuseppe; Di Fiore, Pier Paolo] Univ Milan, Dipartimento Med Chirurg & Odontoiatria, I-20122 Milan, Italy; [Pece, Salvatore; Tosoni, Daniela; Mazzarol, Giovanni; Ronzoni, Simona; Bernard, Loris; Viale, Giuseppe; Pelicci, Pier Giuseppe; Di Fiore, Pier Paolo] Ist Europeo Oncol, I-20141 Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; University of Milan; IRCCS European Institute of Oncology (IEO)	Pece, S (corresponding author), Fdn Ist FIRC Oncol Mol, IFOM, Via Adamello 16, I-20139 Milan, Italy.	salvatore.pece@ifom-ieo-campus.it; piergiuseppe.pelicci@ifom-ieo-campus.it; pierpaolo.difiore@ifom-ieo-campus.it	Pece, Salvatore/B-9609-2013; Ronzoni, Simona/AAQ-1669-2020; Di Fiore, Pier Paolo/K-2130-2012; Bernard, Loris/K-5953-2014; Confalonieri, Stefano/AAQ-6786-2020; Viale, Giuseppe/AAE-8921-2019; Pelicci, Pier Giuseppe/AAL-6572-2020; Tosoni, Daniela/K-4524-2014; Vecchi, Manuela/L-3502-2017	Pece, Salvatore/0000-0003-1764-3929; Di Fiore, Pier Paolo/0000-0002-2252-0950; Confalonieri, Stefano/0000-0001-6886-9851; Vecchi, Manuela/0000-0002-2750-9160	Associazione Italiana per la Ricerca sul Cancro; MIUR; European Community [FP6, FP7]; CARIPLO foundation; Ferrari Foundation; Monzino Foundation; Vollaro Foundation; European Research Commission	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); MIUR(Ministry of Education, Universities and Research (MIUR)); European Community(European Commission); CARIPLO foundation(Fondazione Cariplo); Ferrari Foundation; Monzino Foundation; Vollaro Foundation; European Research Commission(European CommissionEuropean Commission Joint Research Centre)	We thank the Division of Senology at IEO, in particular V. Galimberti, A. Luini, P. Naninato, and P. Arnone, for the collection of human samples; G. Dontu, R.B. Clarke, C. Streuli, and J. M. Verdi for generously providing reagents; A. Cocito for statistical consultation and assistance; G. Matera, D. Galvagno, A. Fiocchi, G. Taliento, O. Oldazzi, A. Cavallon, V. Stufano, D. Nicosia, and M. Garre; the IEO Biobank and the centralized facilities of the IFOM-IEO Campus for technical assistance; P. Nuciforo for histopathological analysis; and G. Bonizzi, A. Cicalese, E. Belloni, and P. R. Romano for insightful discussions. This work was supported by grants from the Associazione Italiana per la Ricerca sul Cancro and MIUR to S. P., P. G. P., and P. P. D. F.; the European Community (FP6 and FP7) and the CARIPLO foundation to P. P. D. F. and P. G. P.; the Ferrari Foundation and the Monzino Foundation to P. P. D. F.; the G. Vollaro Foundation to S. P.; and the European Research Commission to P. P. D.	Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; CARTER WG, 1990, J CELL BIOL, V111, P3141, DOI 10.1083/jcb.111.6.3141; Chepko G, 1997, TISSUE CELL, V29, P239, DOI 10.1016/S0040-8166(97)80024-9; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Eirew P, 2008, NAT MED, V14, P1384, DOI 10.1038/nm.1791; Gonczy P, 2008, NAT REV MOL CELL BIO, V9, P355, DOI 10.1038/nrm2388; Huang S, 1999, BLOOD, V94, P2595, DOI 10.1182/blood.V94.8.2595.420k37_2595_2604; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Jones C, 2004, CANCER RES, V64, P3037, DOI 10.1158/0008-5472.CAN-03-2028; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Lanzkron SM, 1999, BLOOD, V93, P1916, DOI 10.1182/blood.V93.6.1916.406k15_1916_1921; Liao MJ, 2007, CANCER RES, V67, P8131, DOI 10.1158/0008-5472.CAN-06-4493; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; McCaffrey LM, 2009, GENE DEV, V23, P1450, DOI 10.1101/gad.1795909; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Pece S, 2004, J CELL BIOL, V167, P215, DOI 10.1083/jcb.200406140; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Proia DA, 2006, NAT PROTOC, V1, P206, DOI 10.1038/nprot.2006.31; Raouf A, 2008, CELL STEM CELL, V3, P109, DOI 10.1016/j.stem.2008.05.018; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stingl J, 1998, DIFFERENTIATION, V63, P201, DOI 10.1111/j.1432-0436.1998.00201.x; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Stingl J, 2007, NAT REV CANCER, V7, P791, DOI 10.1038/nrc2212; Vecchi M, 2007, ONCOGENE, V26, P4284, DOI 10.1038/sj.onc.1210208; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; WILLIAMS JM, 1983, DEV BIOL, V97, P274, DOI 10.1016/0012-1606(83)90086-6	30	660	700	0	84	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 8	2010	140	1					62	73		10.1016/j.cell.2009.12.007	http://dx.doi.org/10.1016/j.cell.2009.12.007			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	541CY	20074520	Bronze			2022-12-28	WOS:000273391900015
J	Tischfield, MA; Baris, HN; Wu, C; Rudolph, G; Van Maldergem, L; He, W; Chan, WM; Andrews, C; Demer, JL; Robertson, RL; Mackey, DA; Ruddle, JB; Bird, TD; Gottlob, I; Pieh, C; Traboulsi, EI; Pomeroy, SL; Hunter, DG; Soul, JS; Newlin, A; Sabol, LJ; Doherty, EJ; de Uzcategui, CE; de Uzcategui, N; Collins, MLZ; Sener, EC; Wabbels, B; Hellebrand, H; Meitinger, T; de Berardinis, T; Magli, A; Schiavi, C; Pastore-Trossello, M; Koc, F; Wong, AM; Levin, AV; Geraghty, MT; Descartes, M; Flaherty, M; Jamieson, RV; Moller, HU; Meuthen, I; Callen, DF; Kerwin, J; Lindsay, S; Meindl, A; Gupta, ML; Pellman, D; Engle, EC				Tischfield, Max A.; Baris, Hagit N.; Wu, Chen; Rudolph, Guenther; Van Maldergem, Lionel; He, Wei; Chan, Wai-Man; Andrews, Caroline; Demer, Joseph L.; Robertson, Richard L.; Mackey, David A.; Ruddle, Jonathan B.; Bird, Thomas D.; Gottlob, Irene; Pieh, Christina; Traboulsi, Elias I.; Pomeroy, Scott L.; Hunter, David G.; Soul, Janet S.; Newlin, Anna; Sabol, Louise J.; Doherty, Edward J.; de Uzcategui, Clara E.; de Uzcategui, Nicolas; Collins, Mary Louise Z.; Sener, Emin C.; Wabbels, Bettina; Hellebrand, Heide; Meitinger, Thomas; de Berardinis, Teresa; Magli, Adriano; Schiavi, Costantino; Pastore-Trossello, Marco; Koc, Feray; Wong, Agnes M.; Levin, Alex V.; Geraghty, Michael T.; Descartes, Maria; Flaherty, Maree; Jamieson, Robyn V.; Moller, H. U.; Meuthen, Ingo; Callen, David F.; Kerwin, Janet; Lindsay, Susan; Meindl, Alfons; Gupta, Mohan L., Jr.; Pellman, David; Engle, Elizabeth C.			Human TUBB3 Mutations Perturb Microtubule Dynamics, Kinesin Interactions, and Axon Guidance	CELL			English	Article							CONGENITAL FIBROSIS; BETA-TUBULIN; EXTRAOCULAR-MUSCLES; ALPHA-TUBULIN; IN-VITRO; ISOTYPE; YEAST; IDENTIFICATION; TRANSPORT; PROTEIN	We report that eight heterozygous missense mutations in TUBB3, encoding the neuron-specific beta-tubulin isotype III, result in a spectrum of human nervous system disorders that we now call the TUBB3 syndromes. Each mutation causes the ocular motility disorder CFEOM3, whereas some also result in intellectual and behavioral impairments, facial paralysis, and/or later-onset axonal sensorimotor polyneuropathy. Neuroimaging reveals a spectrum of abnormalities including hypoplasia of oculomotor nerves and dysgenesis of the corpus callosum, anterior commissure, and corticospinal tracts. A knock-in disease mouse model reveals axon guidance defects without evidence of cortical cell migration abnormalities. We show that the disease-associated mutations can impair tubulin heterodimer formation in vitro, although folded mutant heterodimers can still polymerize into microtubules. Modeling each mutation in yeast tubulin demonstrates that all alter dynamic instability whereas a subset disrupts the interaction of microtubules with kinesin motors. These findings demonstrate that normal TUBB3 is required for axon guidance and maintenance in mammals.	[Tischfield, Max A.; Wu, Chen; He, Wei; Chan, Wai-Man; Andrews, Caroline; Pomeroy, Scott L.; Soul, Janet S.; Engle, Elizabeth C.] Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; [Tischfield, Max A.; Wu, Chen; He, Wei; Chan, Wai-Man; Andrews, Caroline; Pomeroy, Scott L.; Engle, Elizabeth C.] Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Tischfield, Max A.; Baris, Hagit N.; He, Wei; Chan, Wai-Man; Andrews, Caroline; Engle, Elizabeth C.] Childrens Hosp, Program Genom, Boston, MA 02115 USA; [Tischfield, Max A.; Engle, Elizabeth C.] Childrens Hosp, Manton Ctr Orphan Dis Res, Boston, MA 02115 USA; [Baris, Hagit N.; Engle, Elizabeth C.] Childrens Hosp, Dept Med Genet, Boston, MA 02115 USA; [Pellman, David] Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Hunter, David G.; Engle, Elizabeth C.] Childrens Hosp, Dept Ophthalmol, Boston, MA 02115 USA; [Robertson, Richard L.] Childrens Hosp, Dept Radiol, Boston, MA 02115 USA; [Tischfield, Max A.; Wu, Chen; Pomeroy, Scott L.; Engle, Elizabeth C.] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; [Gupta, Mohan L., Jr.; Pellman, David] Harvard Univ, Sch Med, Div Hematol Oncol, Boston, MA 02115 USA; [Pomeroy, Scott L.; Soul, Janet S.; Engle, Elizabeth C.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Gupta, Mohan L., Jr.; Pellman, David] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Rudolph, Guenther] Univ Munich, Univ Eye Hosp, D-80539 Munich, Germany; [Van Maldergem, Lionel] Univ Liege, Ctr Genet Humaine, B-4000 Liege, Belgium; [Wu, Chen; Chan, Wai-Man; Andrews, Caroline; Pellman, David; Engle, Elizabeth C.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Demer, Joseph L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Ophthalmol, Los Angeles, CA 90095 USA; [Demer, Joseph L.] Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; [Demer, Joseph L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Demer, Joseph L.] Univ Calif Los Angeles, David Geffen Sch Med, Neurosci Interdepartmental Program, Los Angeles, CA 90095 USA; [Demer, Joseph L.] Univ Calif Los Angeles, David Geffen Sch Med, Bioengn Interdepartmental Program, Los Angeles, CA 90095 USA; [Mackey, David A.; Ruddle, Jonathan B.] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Dept Ophthalmol, Ctr Eye Res Australia, Melbourne, Vic 3002, Australia; [Mackey, David A.] Univ Tasmania, Royal Hobart Hosp, Dept Ophthalmol, Hobart, Tas 7000, Australia; [Bird, Thomas D.] Univ Washington, Sch Med, Dept Neurol, Seattle, WA 98195 USA; [Bird, Thomas D.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [Bird, Thomas D.] VA Puget Sound Hlth Care Syst, GRECC, Seattle, WA 98195 USA; [Gottlob, Irene] Univ Leicester, Ophthalmol Grp, Leicester LE2 7LX, Leics, England; [Pieh, Christina] Univ Freiburg, Univ Eye Hosp, D-79106 Freiburg, Germany; [Traboulsi, Elias I.] Cleveland Clin i32, Cole Eye Inst, Cleveland, OH 44195 USA; [Newlin, Anna] NorthShore Univ HealthSyst, Ctr Genet Med, Evanston, IL 60201 USA; [Sabol, Louise J.] Geisinger Med Inst, Dept Ophthalmol, Danville, PA 17822 USA; [Doherty, Edward J.] St Johns Hosp, Atlantic Hlth Sci Ctr, St John, NB E2L 4L2, Canada; [de Uzcategui, Clara E.] Inst Oftalmol, Caracas 1010, Venezuela; [de Uzcategui, Nicolas] Upstate Med Univ SUNY, Dept Ophthalmol, Syracuse, NY 13210 USA; [Collins, Mary Louise Z.] Greater Baltimore Med Ctr, Dept Ophthalmol, Baltimore, MD 21204 USA; [Sener, Emin C.] Hacettepe Univ Hosp, Dept Ophthalmol, TR-06100 Ankara, Turkey; [Wabbels, Bettina] Univ Bonn, Dept Ophthalmol, D-53127 Bonn, Germany; [Hellebrand, Heide; Meindl, Alfons] Tech Univ Munich, Klinikum Rechts Isar, Dept Obstet & Gynaecol, D-81675 Munich, Germany; [Meitinger, Thomas] Tech Univ Munich, Klinikum Rechts Isar, Inst Human Genet, D-81675 Munich, Germany; [Meitinger, Thomas] Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [de Berardinis, Teresa; Magli, Adriano] Univ Naples Federico II, Dept Ophthalmol Sci, Fac Med & Surg, I-80138 Naples, Italy; [Schiavi, Costantino] Univ Bologna, Dept Ophthalmol, I-40126 Bologna, Italy; [Pastore-Trossello, Marco] St Orsola Marcello Malpighi Hosp, Dept Neuroradiol, I-40138 Bologna, Italy; [Koc, Feray] Acibadem Univ, Kocaeli Hosp, Dept Ophthalmol & Strabismus & Neuroophthalmol, TR-41100 Kocaeli, Turkey; [Wong, Agnes M.] Hosp Sick Children, Dept Ophthalmol & Vis Sci, Toronto, ON M5G 1X8, Canada; [Levin, Alex V.] Wills Eye Inst, Philadelphia, PA 19107 USA; [Geraghty, Michael T.] Childrens Hosp Eastern Ontario, Dept Genet, Ottawa, ON K1H 8L1, Canada; [Descartes, Maria] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA; [Flaherty, Maree] Childrens Hosp Westmead, Dept Ophthalmol, Sydney, NSW 2145, Australia; [Jamieson, Robyn V.] Childrens Hosp Westmead, Dept Clin Genet, Sydney, NSW 2145, Australia; [Jamieson, Robyn V.] Univ Sydney, Sydney, NSW 2008, Australia; [Moller, H. U.] Viborg Hosp, Dept Ophthalmol, DK-8000 Viborg, Denmark; [Meuthen, Ingo] Kliniken Stadt Koln, Dept Hematol Oncol, D-51067 Cologne, Germany; [Callen, David F.] Univ Adelaide, Sch Med, Breast Canc Genet Grp, Adelaide, SA 5005, Australia; [Kerwin, Janet; Lindsay, Susan] Newcastle Univ, Inst Human Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Lindsay, Susan] Newcastle Univ, MRC Wellcome Trust Human Dev Biol Resource Newcas, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; University of Munich; University of Liege; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; Royal Hobart Hospital; University of Tasmania; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Leicester; University of Freiburg; Cleveland Clinic Foundation; NorthShore University Health System; Geisinger Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Greater Baltimore Medical Center; Hacettepe University; University of Bonn; Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Naples Federico II; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; Acibadem University; Kocaeli State Hospital; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Jefferson University; University of Ottawa; Children's Hospital of Eastern Ontario; University of Alabama System; University of Alabama Birmingham; University of Sydney; University of Sydney; University of Sydney; Aarhus University; University of Adelaide; Newcastle University - UK; Newcastle University - UK	Gupta, ML (corresponding author), Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA.	mlgupta@uchicago.edu; elizabeth.engle@childrens.harvard.edu	Callen, David F/G-1975-2012; Traboulsi, Elias/AAY-7443-2020; Van Maldergem, Lionel/O-3242-2019; Wu, Chen/B-3932-2010; Van Maldergem, Lionel/G-9849-2017; Schiavi, Costantino/Q-8909-2019; Magli, Adriano/AAU-7380-2020; Jamieson, Robyn/M-5161-2019; Meitinger, Thomas/O-1318-2015; Wabbels, Bettina/AAT-4804-2021; Lindsay, Susan/B-3828-2013; Mackey, David A/H-5340-2014	Van Maldergem, Lionel/0000-0001-8880-5214; Van Maldergem, Lionel/0000-0001-8880-5214; Magli, Adriano/0000-0002-6490-2068; Jamieson, Robyn/0000-0002-7285-0253; Wabbels, Bettina/0000-0002-7767-114X; Lindsay, Susan/0000-0003-2980-4582; Mackey, David A/0000-0001-7914-4709; Robertson, Richard/0000-0001-8811-4405; schiavi, costantino/0000-0002-5753-6987; Soul, Janet/0000-0001-6998-7753; Hunter, David/0000-0002-4587-4794; DE BERARDINIS, Teresa/0000-0001-6872-0432; Callen, David/0000-0002-6189-9991; Meitinger, Thomas/0000-0002-8838-8403	NIH [R01 EY012498, R01 EY013583, HD18655, F32 EY016306, R01 GM061345-08]; MRC [G0700089, G9900837] Funding Source: UKRI; Medical Research Council [G0700089, G9900837] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012498, R01EY013583, T32EY007143, R01EY008313, F32EY016306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061345] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the families for their participation; Michelle DeLisle and Carrie Wu for technical assistance and members of the Engle lab for their thoughtful comments; A. Nurten Akarsu, Peter Kang, Lisa S Kearns, James Hoekel, Marijean Miller, Marilyn Miller, Peter Roggenkamper, and Sandra Staffieri for pedigree referrals and/or clinical exam data. This work was supported by NIH R01 EY012498, R01 EY013583, HD18655 (E. C. E.), F32 EY016306 (H. B.), R01 GM061345-08 (D. P.), and VA Research Funds (T. D. B.). E. C. E. and D. P. are investigators of the Howard Hughes Medical Institute.	Al-Bassam J, 2002, J CELL BIOL, V157, P1187, DOI 10.1083/jcb.200201048; BANERJEE A, 1990, J BIOL CHEM, V265, P1794; Carminati JL, 1997, J CELL BIOL, V138, P629, DOI 10.1083/jcb.138.3.629; Carvalho P, 2004, DEV CELL, V6, P815, DOI 10.1016/j.devcel.2004.05.001; Chevalier-Larsen E, 2006, BBA-MOL BASIS DIS, V1762, P1094, DOI 10.1016/j.bbadis.2006.04.002; CLEVELAND DW, 1978, CELL, V15, P1021, DOI 10.1016/0092-8674(78)90286-6; Coksaygan T, 2006, EXP NEUROL, V197, P475, DOI 10.1016/j.expneurol.2005.10.030; Demer JL, 2005, INVEST OPHTH VIS SCI, V46, P530, DOI 10.1167/iovs.04-1125; DeZwaan TM, 1997, J CELL BIOL, V138, P1023, DOI 10.1083/jcb.138.5.1023; Doherty EJ, 1999, INVEST OPHTH VIS SCI, V40, P1687; Gordon-Weeks PR, 2004, J NEUROBIOL, V58, P70, DOI 10.1002/neu.10266; Gupta ML, 2006, NAT CELL BIOL, V8, P913, DOI 10.1038/ncb1457; Jaglin XH, 2009, NAT GENET, V41, P746, DOI 10.1038/ng.380; JIANG YQ, 1992, J CELL SCI, V103, P643; JOSHI HC, 1990, CELL MOTIL CYTOSKEL, V16, P159, DOI 10.1002/cm.970160302; Kalil K, 2005, CURR OPIN NEUROBIOL, V15, P521, DOI 10.1016/j.conb.2005.08.005; Katsetos CD, 2003, J CHILD NEUROL, V18, P851, DOI 10.1177/088307380301801205; Keays DA, 2007, CELL, V128, P45, DOI 10.1016/j.cell.2006.12.017; Khan IA, 1996, BIOCHEMISTRY-US, V35, P3704, DOI 10.1021/bi951247p; Lewis SA, 1996, J CELL BIOL, V132, P1, DOI 10.1083/jcb.132.1.1; Li HL, 2002, STRUCTURE, V10, P1317, DOI 10.1016/S0969-2126(02)00827-4; Li L, 2007, GENESIS, V45, P560, DOI 10.1002/dvg.20325; LOPATA MA, 1987, J CELL BIOL, V105, P1707, DOI 10.1083/jcb.105.4.1707; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; LUDUENA RF, 1993, MOL BIOL CELL, V4, P445, DOI 10.1091/mbc.4.5.445; Mackey DA, 2002, HUM GENET, V110, P510, DOI 10.1007/s00439-002-0707-5; Miyake N, 2008, SCIENCE, V321, P839, DOI 10.1126/science.1156121; Nogales E, 2006, CURR OPIN CELL BIOL, V18, P179, DOI 10.1016/j.ceb.2006.02.009; PANDA D, 1994, P NATL ACAD SCI USA, V91, P11358, DOI 10.1073/pnas.91.24.11358; Poirier K, 2007, HUM MUTAT, V28, P1055, DOI 10.1002/humu.20572; REIJO RA, 1994, MOL BIOL CELL, V5, P29, DOI 10.1091/mbc.5.1.29; Uchimura S, 2006, EMBO J, V25, P5932, DOI 10.1038/sj.emboj.7601442; WEBSTER DR, 1987, P NATL ACAD SCI USA, V84, P9040, DOI 10.1073/pnas.84.24.9040; Yamada K, 2003, NAT GENET, V35, P318, DOI 10.1038/ng1261; Yamada K, 2004, INVEST OPHTH VIS SCI, V45, P2218, DOI 10.1167/iovs.03-1413	35	385	395	2	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 8	2010	140	1					74	87		10.1016/j.cell.2009.12.011	http://dx.doi.org/10.1016/j.cell.2009.12.011			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	541CY	20074521	Bronze, Green Accepted			2022-12-28	WOS:000273391900016
J	Horton, R				Horton, Richard			Offline: The rational irrationality of fear	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.								0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN-FEB	2010	375	9712					360	360		10.1016/S0140-6736(10)60106-7	http://dx.doi.org/10.1016/S0140-6736(10)60106-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	552PK	20113814				2022-12-28	WOS:000274305500011
J	Raman, S; Lange, OF; Rossi, P; Tyka, M; Wang, X; Aramini, J; Liu, GH; Ramelot, TA; Eletsky, A; Szyperski, T; Kennedy, MA; Prestegard, J; Montelione, GT; Baker, D				Raman, Srivatsan; Lange, Oliver F.; Rossi, Paolo; Tyka, Michael; Wang, Xu; Aramini, James; Liu, Gaohua; Ramelot, Theresa A.; Eletsky, Alexander; Szyperski, Thomas; Kennedy, Michael A.; Prestegard, James; Montelione, Gaetano T.; Baker, David			NMR Structure Determination for Larger Proteins Using Backbone-Only Data	SCIENCE			English	Article							RESIDUAL DIPOLAR COUPLINGS; STRUCTURE PREDICTION; AUTOMATED-ANALYSIS; CHEMICAL-SHIFTS; ASSIGNMENTS; ROSETTA	Conventional protein structure determination from nuclear magnetic resonance data relies heavily on side-chain proton-to-proton distances. The necessary side-chain resonance assignment, however, is labor intensive and prone to error. Here we show that structures can be accurately determined without nuclear magnetic resonance (NMR) information on the side chains for proteins up to 25 kilodaltons by incorporating backbone chemical shifts, residual dipolar couplings, and amide proton distances into the Rosetta protein structure modeling methodology. These data, which are too sparse for conventional methods, serve only to guide conformational search toward the lowest-energy conformations in the folding landscape; the details of the computed models are determined by the physical chemistry implicit in the Rosetta all-atom energy function. The new method is not hindered by the deuteration required to suppress nuclear relaxation processes for proteins greater than 15 kilodaltons and should enable routine NMR structure determination for larger proteins.	[Raman, Srivatsan; Lange, Oliver F.; Tyka, Michael; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Rossi, Paolo; Aramini, James; Liu, Gaohua; Montelione, Gaetano T.] Rutgers State Univ, Dept Mol Biol & Biochem, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Rossi, Paolo; Aramini, James; Liu, Gaohua; Montelione, Gaetano T.] Rutgers State Univ, NE Struct Genom Consortium, Piscataway, NJ 08854 USA; [Wang, Xu; Prestegard, James] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Ramelot, Theresa A.; Kennedy, Michael A.] Miami Univ, Dept Chem & Biochem, Oxford, OH 45056 USA; [Ramelot, Theresa A.; Kennedy, Michael A.] Miami Univ, NE Struct Genom Consortium, Oxford, OH 45056 USA; [Eletsky, Alexander; Szyperski, Thomas] SUNY Buffalo, Dept Chem, Buffalo, NY 14260 USA; [Baker, David] Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Rutgers State University New Brunswick; Rutgers State University New Brunswick; University System of Georgia; University of Georgia; University System of Ohio; Miami University; University System of Ohio; Miami University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Howard Hughes Medical Institute	Baker, D (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	dabaker@u.washington.edu	Lange, Oliver/K-5749-2012; Kennedy, Michael/ABE-6002-2021; Baker, David/K-8941-2012; Lange, Oliver/B-2861-2009; Lange, Oliver/G-1366-2010; Ramelot, Theresa A/V-1413-2017; Kennedy, Michael/M-2578-2019	Lange, Oliver/0000-0002-4018-7020; Baker, David/0000-0001-7896-6217; Ramelot, Theresa A/0000-0002-0335-1573; Tyka, Michael/0000-0003-0108-6558; Montelione, Gaetano/0000-0002-9440-3059	U.S. Department of Energy; Human Frontiers of Science Program; NIH [GM76222]; HHMI; National Institutes of General Medical Science Protein Structure Initiative [U54 GM074958]; Research Resource [RR005351]; Sir Henry Wellcome Postdoctoral Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095693, U54GM074958, P20GM076222, P41GM103390, R01GM092802] Funding Source: NIH RePORTER	U.S. Department of Energy(United States Department of Energy (DOE)); Human Frontiers of Science Program(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); National Institutes of General Medical Science Protein Structure Initiative; Research Resource; Sir Henry Wellcome Postdoctoral Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are thankful to the U.S. Department of Energy Innovative and Novel Computational Impact on Theory and Experiment Award for providing access to the Blue Gene/P supercomputer at the Argonne Leadership Computing Facility and to Rosetta@ home participants for their generous contributions of computing power. We thank Y. Shen and A. Bax for fruitful discussions; Y. J. Huang and Y. Tang for their contribution during preliminary studies using sparse NOE constraints with CS-Rosetta; S. Bansal, H.-w. Lee, and Y. Liu for collection of RDC data, A. Lemak for providing the Crystallography and NMR System RDC refinement protocol, and the NESG consortium for access to other unpublished NMR data that has facilitated methods development. S. R., O.F.L., P. R., G. T. M., and D. B. designed research; S. R. designed and tested the CS-RDC-Rosetta protocol; O.F.L. designed and tested the iterative CS-RDC-NOE-Rosetta protocol; M. T. developed the all-atom refinement protocol; S. R., O.F.L. and D. B. designed and performed research for energy based structure validation; X. W and J. P analyzed the ALG13 ensemble; J. A, G. L, T. R, A. E, M. K, and T. S provided blind NMR data sets; and S. R., O.F.L., P. R., G. T. M., and D. B. wrote the manuscript. This work was supported by the Human Frontiers of Science Program (O.F.L.), NIH grant GM76222 (D. B.), the HHMI, the National Institutes of General Medical Science Protein Structure Initiative program grant U54 GM074958 (G. T. M.), and the Research Resource grant RR005351 (J. P.). M. T. holds a Sir Henry Wellcome Postdoctoral Fellowship. RDC and Paramagnetic Relaxation Enhancement data as deposited in the Protein Data Bank (PDB) with accession code 2jzc.	Baran MC, 2004, CHEM REV, V104, P3541, DOI 10.1021/cr030408p; Bartels C, 1997, J COMPUT CHEM, V18, P139, DOI 10.1002/(SICI)1096-987X(19970115)18:1<139::AID-JCC13>3.0.CO;2-H; Berjanskii M, 2009, NUCLEIC ACIDS RES, V37, pW670, DOI 10.1093/nar/gkp280; Bertini I, 2008, DALTON T, P3782, DOI 10.1039/b719526e; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; Brunette TJ, 2008, PROTEINS, V73, P958, DOI 10.1002/prot.22123; Cavalli A, 2007, P NATL ACAD SCI USA, V104, P9615, DOI 10.1073/pnas.0610313104; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Gardner KH, 1997, BIOCHEMISTRY-US, V36, P1389, DOI 10.1021/bi9624806; GRZESIEK S, 1993, J BIOMOL NMR, V3, P627; Jung YS, 2004, J BIOMOL NMR, V30, P11, DOI 10.1023/B:JNMR.0000042954.99056.ad; Kontaxis G, 2005, METHOD ENZYMOL, V394, P42, DOI 10.1016/S0076-6879(05)94003-2; Lee W, 2009, BIOINFORMATICS, V25, P2085, DOI 10.1093/bioinformatics/btp345; LEMASTER DM, 1988, BIOCHEMISTRY-US, V27, P142, DOI 10.1021/bi00401a022; Losonczi JA, 1999, J MAGN RESON, V138, P334, DOI 10.1006/jmre.1999.1754; Prestegard JH, 2004, CHEM REV, V104, P3519, DOI 10.1021/cr030419i; Qian B, 2007, NATURE, V450, P259, DOI 10.1038/nature06249; Rohl CA, 2002, J AM CHEM SOC, V124, P2723, DOI 10.1021/ja016880e; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Snyder DA, 2005, PROTEINS, V59, P673, DOI 10.1002/prot.20402; van Ingen H, 2009, J PHYS CHEM B, V113, P9968, DOI 10.1021/jp902793y; WAGNER G, 1993, J BIOMOL NMR, V3, P375; Wang X, 2008, STRUCTURE, V16, P965, DOI 10.1016/j.str.2008.03.010; Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571; Zimmerman DE, 1997, J MOL BIOL, V269, P592, DOI 10.1006/jmbi.1997.1052	26	201	217	2	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2010	327	5968					1014	1018		10.1126/science.1183649	http://dx.doi.org/10.1126/science.1183649			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556XE	20133520	Green Accepted			2022-12-28	WOS:000274625800045
J	Van Bocxlaer, I; Loader, SP; Roelants, K; Biju, SD; Menegon, M; Bossuyt, F				Van Bocxlaer, Ines; Loader, Simon P.; Roelants, Kim; Biju, S. D.; Menegon, Michele; Bossuyt, Franky			Gradual Adaptation Toward a Range-Expansion Phenotype Initiated the Global Radiation of Toads	SCIENCE			English	Article							BUFO-MARINUS; CANE TOAD; EVOLUTION; AMPHIBIANS; DIVERSIFICATION; POPULATION; MORPHOLOGY; BUFONIDAE; FRONT; ANURA	Recent studies have identified range expansion as a potential driver of speciation. Yet it remains poorly understood how, under identical extrinsic settings, differential tendencies for geographic movement of taxa originate and subsequently affect diversification. We identified multiple traits that predict large distributional ranges in extant species of toads (Bufonidae) and used statistical methods to define and phylogenetically reconstruct an optimal range-expansion phenotype. Our results indicate that lineage-specific range-shifting abilities increased through an accumulation of adaptive traits that culminated in such a phenotype. This initiated the episode of global colonization and triggered the major radiation of toads. Evolution toward a range-expansion phenotype might be crucial to understanding both ancient widespread radiations and the evolutionary background of contemporary invasive species such as the cane toad.	[Van Bocxlaer, Ines; Roelants, Kim; Bossuyt, Franky] Vrije Univ Brussels, Dept Biol, Amphibian Evolut Lab, Unit Ecol & Systemat, B-1050 Brussels, Belgium; [Loader, Simon P.] Univ Basel, Sect Biogeog, Dept Environm Sci, CH-4056 Basel, Switzerland; [Biju, S. D.] Univ Delhi, Systemat Lab, CEMDE, Delhi 110007, India; [Menegon, Michele] Museo Tridentino Sci Nat, Sez Zool Vertebrati, I-38100 Trento, Italy	Vrije Universiteit Brussel; University of Basel; University of Delhi	Bossuyt, F (corresponding author), Vrije Univ Brussels, Dept Biol, Amphibian Evolut Lab, Unit Ecol & Systemat, Pleinlaan 2, B-1050 Brussels, Belgium.	fbossuyt@vub.ac.be	Menegon, Michele/F-9365-2011; Van Bocxlaer, Ines/L-4852-2015	Bossuyt, Franky/0000-0001-6804-9271; Roelants, Kim/0000-0001-5367-5958; Loader, Simon/0000-0003-4162-0575	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen); Fonds voor Wetenschappelijk Onderzoek-Vlaanderen [FWO 1.5.039.03N, FWO G.0056.03, FWO G.0307.04, VUB OZR834, ERC 204509]	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Fonds voor Wetenschappelijk Onderzoek-Vlaanderen(FWO)	We thank S. Bogaerts, R. O. de Sa, N. Poyarkov, M. Wilkinson, K. M. Howell, B. Vervust, B. P. Noonan, A. Channing, and J. V. Vindum for tissue samples; R. Verlinde (Vilda), P. Kok, B. Means, and E. Biggi for pictures; R. Ree for advice on Lagrange analyses; and two anonymous reviewers for valuable comments. Supported by the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen; I. V. B.); a postdoctoral fellowship from the Fonds voor Wetenschappelijk Onderzoek-Vlaanderen (F. B., K. R.); and grants FWO 1.5.039.03N, FWO G.0056.03, FWO G.0307.04, VUB OZR834, and ERC 204509 (project TAPAS). Sequences are deposited in GenBank with accession numbers GU183851 to GU183859 and GU226832 to GU226837.	BENTLEY PJ, 1966, SCIENCE, V152, P619, DOI 10.1126/science.152.3722.619; Bossuyt F, 2004, SCIENCE, V306, P479, DOI 10.1126/science.1100167; da Silva HR, 1999, HERPETOLOGICA, V55, P114; Excoffier L, 2008, TRENDS ECOL EVOL, V23, P347, DOI 10.1016/j.tree.2008.04.004; Garnica S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-1; Gavrilets S, 2009, SCIENCE, V323, P732, DOI 10.1126/science.1157966; Hallatschek O, 2007, P NATL ACAD SCI USA, V104, P19926, DOI 10.1073/pnas.0710150104; Leotard G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005377; Magallon S., 2009, TIMETREE LIFE, P133; Moore BR, 2007, AM NAT, V170, pS28, DOI 10.1086/519460; Moyle RG, 2009, P NATL ACAD SCI USA, V106, P1863, DOI 10.1073/pnas.0809861105; Noonan BP, 2006, AM NAT, V168, P730, DOI 10.1086/509052; Phillips BL, 2009, BIOL LETTERS, V5, P802, DOI 10.1098/rsbl.2009.0367; Phillips BL, 2008, AM NAT, V172, pS34, DOI 10.1086/588255; Phillips BL, 2007, AUSTRAL ECOL, V32, P169, DOI 10.1111/j.1442-9993.2007.01664.x; Phillips BL, 2005, ANIM CONSERV, V8, P407, DOI 10.1017/S1367943005002374; POUNDS JA, 1994, CONSERV BIOL, V8, P72, DOI 10.1046/j.1523-1739.1994.08010072.x; Pramuk JB, 2008, GLOBAL ECOL BIOGEOGR, V17, P72, DOI 10.1111/j.1466-8238.2007.00348.x; Ree RH, 2005, EVOLUTION, V59, P2299; ROFF RA, 2001, DISPERSAL, P191; SCHMID WD, 1965, ECOLOGY, V46, P261, DOI 10.2307/1936329; SZARSKI H, 1972, EVOLUTION GENUS BUFO, P71; THIBAUDEAU G, 1999, TADPOLES BIOL ANURAN, P295; TOLEDO RC, 1993, COMP BIOCHEM PHYS A, V105, P593, DOI 10.1016/0300-9629(93)90259-7; Travis JMJ, 2007, MOL BIOL EVOL, V24, P2334, DOI 10.1093/molbev/msm167; Van Bocxlaer I, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000074	26	184	192	2	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2010	327	5966					679	682		10.1126/science.1181707	http://dx.doi.org/10.1126/science.1181707			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551ZD	20133569				2022-12-28	WOS:000274251800035
J	Detsky, ME; Balter, MS; Sridhar, SK; Granton, J				Detsky, Michael E.; Balter, Meyer S.; Sridhar, S. Kavita; Granton, John			Under Pressure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PULMONARY VENOOCCLUSIVE DISEASE; CAPILLARY HEMANGIOMATOSIS; HYPERTENSION		[Detsky, Michael E.; Balter, Meyer S.; Granton, John] Univ Toronto, Fac Med, Toronto, ON, Canada; [Balter, Meyer S.; Granton, John] Mt Sinai & Univ Hlth Network, Dept Med, Toronto, ON, Canada; [Sridhar, S. Kavita] Univ Calgary, Dept Crit Care Med, Calgary, AB, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University Health Network Toronto; University of Calgary	Granton, J (corresponding author), Toronto Gen Hosp, 200 Elizabeth St,NCSB Rm 1170, Toronto, ON M5G 2C4, Canada.	john.granton@uhn.on.ca			Pfizer; Actelion	Pfizer(Pfizer); Actelion	Dr. Granton reports receiving consulting fees from and serving as an expert witness for Pfizer and receiving research support and speaking fees from Actelion. No other potential conflict of interest relevant to this article was reported.; We thank Dr. David Hwang for the pathological slides and Dr. Allan S. Detsky for his guidance and support of this project.	Almagro P, 2002, MEDICINE, V81, P417, DOI 10.1097/00005792-200211000-00002; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; Johnson SR, 2006, J RHEUMATOL, V33, P2347; Lantuejoul S, 2006, AM J SURG PATHOL, V30, P850, DOI 10.1097/01.pas.0000209834.69972.e5; Mandel J, 2000, AM J RESP CRIT CARE, V162, P1964, DOI 10.1164/ajrccm.162.5.9912045; Montani D, 2008, MEDICINE, V87, P220, DOI 10.1097/MD.0b013e31818193bb; Palmer SM, 1998, CHEST, V113, P237, DOI 10.1378/chest.113.1.237; Pietra GG, 2004, J AM COLL CARDIOL, V43, p25S, DOI 10.1016/j.jacc.2004.02.033; Resten A, 2004, AM J ROENTGENOL, V183, P65, DOI 10.2214/ajr.183.1.1830065; Simonneau G, 2004, J AM COLL CARDIOL, V43, p5S, DOI 10.1016/j.jacc.2004.02.037	10	1	2	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 4	2010	362	5					449	454		10.1056/NEJMcps0807342	http://dx.doi.org/10.1056/NEJMcps0807342			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551FV	20130255				2022-12-28	WOS:000274193300012
J	Sarewitz, D				Sarewitz, Daniel			Better all the time	NATURE			English	Editorial Material									Arizona State Univ, Washington, DC USA	Arizona State University	Sarewitz, D (corresponding author), Arizona State Univ, Washington, DC USA.	dsarewitz@gmail.com						De Clercq E, 2009, REV MED VIROL, V19, P287, DOI 10.1002/rmv.624; 2009, NATURE, V461, P1187	2	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 4	2010	463	7281					607	607		10.1038/463607a	http://dx.doi.org/10.1038/463607a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551GB	20130627	Bronze			2022-12-28	WOS:000274193900012
J	Solomatin, SV; Greenfeld, M; Chu, S; Herschlag, D				Solomatin, Sergey V.; Greenfeld, Max; Chu, Steven; Herschlag, Daniel			Multiple native states reveal persistent ruggedness of an RNA folding landscape	NATURE			English	Article							TETRAHYMENA RIBOZYME; ENERGY LANDSCAPE; SINGLE-MOLECULE; SUBSTRATE; BINDING; PATHWAYS; DYNAMICS; INTERMEDIATE; CATALYSIS	According to the 'thermodynamic hypothesis', the sequence of a biological macromolecule defines its folded, active (or 'native') structure as a global energy minimum in the folding landscape(1,2). However, the enormous complexity of folding landscapes of large macromolecules raises the question of whether there is in fact a unique global minimum corresponding to a unique native conformation or whether there are deep local minima corresponding to alternative active conformations(3). The folding of many proteins is well described by two-state models, leading to highly simplified representations of protein folding landscapes with a single native conformation(4,5). Nevertheless, accumulating experimental evidence suggests a more complex topology of folding landscapes with multiple active conformations that can take seconds or longer to interconvert(6-8). Here we demonstrate, using single-molecule experiments, that an RNA enzyme folds into multiple distinct native states that interconvert on a timescale much longer than that of catalysis. These data demonstrate that severe ruggedness of RNA folding landscapes extends into conformational space occupied by native conformations.	[Solomatin, Sergey V.; Herschlag, Daniel] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; [Greenfeld, Max] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Chu, Steven] Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA; [Chu, Steven] Univ Calif Berkeley, Dept Phys & Mol & Cell Biol, Berkeley, CA 94720 USA	Stanford University; Stanford University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Herschlag, D (corresponding author), Stanford Univ, Dept Biochem, Stanford, CA 94305 USA.	herschla@stanford.edu			US National Institutes of Health (NIH) [P01-GM-66275, GM49243]; Stanford Bio-X Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM049243, R01GM049243, P01GM066275] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Bio-X Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. H. Lee, B. Cui, H. Kim, W. Zhao and other current and former members of the Chu laboratory, and the Mabuchi laboratory, for technical assistance. We thank members of the Herschlag laboratory for discussions and comments on the manuscript. Financial support for this work was provided by US National Institutes of Health (NIH) programme project grant P01-GM-66275 and NIH grant GM49243, to D. H. We thank the Stanford Bio-X Program for fellowship support to S. V. S.	ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; BEVILACQUA PC, 1992, SCIENCE, V258, P1355, DOI 10.1126/science.1455230; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; Chen SJ, 2000, P NATL ACAD SCI USA, V97, P646, DOI 10.1073/pnas.97.2.646; DILL KA, 1997, NAT STRUCT BIOL, V4, P19, DOI DOI 10.1038/NSB0197-10; Dinner AR, 2000, TRENDS BIOCHEM SCI, V25, P331, DOI 10.1016/S0968-0004(00)01610-8; Ditzler MA, 2008, NUCLEIC ACIDS RES, V36, P7088, DOI 10.1093/nar/gkn871; English BP, 2006, NAT CHEM BIOL, V2, P168, DOI 10.1038/nchembio0306-168; Flomenbom O, 2005, P NATL ACAD SCI USA, V102, P2368, DOI 10.1073/pnas.0409039102; FRIEDEN C, 1979, ANNU REV BIOCHEM, V48, P471, DOI 10.1146/annurev.bi.48.070179.002351; HERSCHLAG D, 1992, BIOCHEMISTRY-US, V31, P1386, DOI 10.1021/bi00120a015; HERSCHLAG D, 1995, J BIOL CHEM, V270, P20871, DOI 10.1074/jbc.270.36.20871; James LC, 2003, TRENDS BIOCHEM SCI, V28, P361, DOI 10.1016/S0968-0004(03)00135-X; JENNINGS PA, 1993, BIOCHEMISTRY-US, V32, P3783, DOI 10.1021/bi00065a034; Kamagata K, 2003, J MOL BIOL, V332, P1143, DOI 10.1016/j.jmb.2003.07.002; Korennykh AV, 2007, BIOCHEMISTRY-US, V46, P12744, DOI 10.1021/bi700931y; LEVINTHAL C, 1968, J CHIM PHYS PCB, V65, P44, DOI 10.1051/jcp/1968650044; LINDAHL T, 1966, P NATL ACAD SCI USA, V55, P941, DOI 10.1073/pnas.55.4.941; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; Narlikar GJ, 1999, BIOCHEMISTRY-US, V38, P14192, DOI 10.1021/bi9914309; Pan J, 1997, J MOL BIOL, V273, P7, DOI 10.1006/jmbi.1997.1311; Russell R, 2002, P NATL ACAD SCI USA, V99, P155, DOI 10.1073/pnas.221593598; Russell R, 2001, J MOL BIOL, V308, P839, DOI 10.1006/jmbi.2001.4751; Sattint BD, 2008, J AM CHEM SOC, V130, P6085, DOI 10.1021/ja800919q; SCHMID FX, 1981, EUR J BIOCHEM, V114, P111; Tan E, 2003, P NATL ACAD SCI USA, V100, P9308, DOI 10.1073/pnas.1233536100; Treiber DK, 1999, CURR OPIN STRUC BIOL, V9, P339, DOI 10.1016/S0959-440X(99)80045-1; Zhuang XW, 2002, SCIENCE, V296, P1473, DOI 10.1126/science.1069013; Zhuang XW, 2000, SCIENCE, V288, P2048, DOI 10.1126/science.288.5473.2048; Zwanzig R, 1997, P NATL ACAD SCI USA, V94, P148, DOI 10.1073/pnas.94.1.148	30	155	159	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 4	2010	463	7281					681	U117		10.1038/nature08717	http://dx.doi.org/10.1038/nature08717			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551GB	20130651	Green Accepted			2022-12-28	WOS:000274193900040
J	Gerstein, HC				Gerstein, Hertzel C.			Does Insulin Therapy Promote, Reduce, or Have a Neutral Effect on Cancers?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RISK; WOMEN; MEN		[Gerstein, Hertzel C.] McMaster Univ & Hamilton Hlth Sci, Dept Med, Hamilton, ON L8N 3Z5, Canada; [Gerstein, Hertzel C.] McMaster Univ & Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON L8N 3Z5, Canada	McMaster University; McMaster University; Population Health Research Institute	Gerstein, HC (corresponding author), McMaster Univ & Hamilton Hlth Sci, Dept Med, Room 3V38,1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	gerstein@mcmaster.ca	Gerstein, Hertzel/ABB-8781-2020; Gerstein, Hertzel C/B-1235-2013	Gerstein, Hertzel/0000-0001-8072-2836; Gerstein, Hertzel C/0000-0001-8072-2836				Currie CJ, 2009, DIABETOLOGIA, V52, P1766, DOI 10.1007/s00125-009-1440-6; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hemkens LG, 2009, DIABETOLOGIA, V52, P1732, DOI 10.1007/s00125-009-1418-4; Home PD, 2009, DIABETOLOGIA, V52, P2499, DOI 10.1007/s00125-009-1530-5; Jee SH, 2005, JAMA-J AM MED ASSOC, V293, P194, DOI 10.1001/jama.293.2.194; Khaw KT, 2004, CANCER EPIDEM BIOMAR, V13, P915; Rosenstock J, 2009, DIABETOLOGIA, V52, P1971, DOI 10.1007/s00125-009-1452-2; Smith U, 2009, DIABETOLOGIA, V52, P1699, DOI 10.1007/s00125-009-1441-5; Vigneri P, 2009, ENDOCR-RELAT CANCER, V16, P1103, DOI 10.1677/ERC-09-0087; 2009, RES TEAM RESPONDS CO	10	41	42	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 3	2010	303	5					446	447		10.1001/jama.2010.60	http://dx.doi.org/10.1001/jama.2010.60			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	550QR	20124540				2022-12-28	WOS:000274143600020
J	Johnson, SA; Stevens, SM; Woller, SC; Lake, E; Donadini, M; Cheng, J; Labarere, J; Douketis, JD				Johnson, Stacy A.; Stevens, Scott M.; Woller, Scott C.; Lake, Erica; Donadini, Marco; Cheng, Ji; Labarere, Jose; Douketis, James D.			Risk of Deep Vein Thrombosis Following a Single Negative Whole-Leg Compression Ultrasound A Systematic Review and Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							VENOUS THROMBOSIS; WITHHOLDING ANTICOAGULATION; DIAGNOSTIC MANAGEMENT; PRIMARY-CARE; D-DIMER; ULTRASONOGRAPHY; CALF; THROMBOEMBOLISM; SONOGRAPHY; ACCURACY	Context In patients with suspected lower extremity deep vein thrombosis (DVT), compression ultrasound (CUS) is typically the initial test to confirm or exclude DVT. Patients with an initial negative CUS result often require repeat CUS after 5 to 7 days. Whole-leg CUS may exclude proximal and distal DVT in a single evaluation. Objective To determine the risk of venous thromboembolism after withholding anticoagulation in patients with suspected lower extremity DVT following a single negative whole-leg CUS result. Data Sources MEDLINE, EMBASE, CINAHL, LILACS, Cochrane, and Health Technology Assessments databases were searched for articles published from January 1970 through November 2009. Supplemental searches were performed of Internet resources, reference lists, and by contacting content experts. Study Selection Included studies were randomized controlled trials and prospective cohort studies of patients with suspected DVT and a negative whole-leg CUS result who did not receive anticoagulant therapy, and were followed up at least 90 days for venous thromboembolism events. Data Extraction Two authors independently reviewed and extracted data regarding a single positive or negative whole-leg CUS result, occurrence of venous thromboembolism during follow-up, and study quality. Results Seven studies were included totaling 4731 patients with negative whole-leg CUS examinations who did not receive anticoagulation. Of these, up to 647 patients (13.7%) had active cancer and up to 725 patients (15.3%) recently underwent a major surgery. Most participants were identified from an ambulatory setting. Venous thromboembolism or suspected venous thromboembolism-related death occurred in 34 patients (0.7%), including 11 patients with distal DVT (32.4%); 7 patients with proximal DVT (20.6%); 7 patients with nonfatal pulmonary emboli (20.6%); and 9 patients (26.5%) who died, possibly related to venous thromboembolism. Using a random-effects model with inverse variance weighting, the combined venous thromboembolism event rate at 3 months was 0.57% (95% confidence interval, 0.25%-0.89%). Conclusion Withholding anticoagulation following a single negative whole-leg CUS result was associated with a low risk of venous thromboembolism during 3-month follow-up. JAMA. 2010; 303(5):438-445 www.jama.com	[Stevens, Scott M.; Woller, Scott C.] Intermt Med Ctr, Dept Internal Med, Murray, UT 84157 USA; [Lake, Erica] Intermt Med Ctr, Med Lib, Murray, UT 84157 USA; [Lake, Erica] Intermt Med Ctr, Community Hlth Informat Ctr, Murray, UT 84157 USA; [Johnson, Stacy A.] Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT USA; [Donadini, Marco; Douketis, James D.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Cheng, Ji] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Cheng, Ji] St Josephs Healthcare Hamilton, Biostat Unit, Hamilton, ON, Canada; [Labarere, Jose] Grenoble Univ Hosp, Qual Care Unit, Grenoble, France	Intermountain Healthcare; Intermountain Medical Center; Intermountain Healthcare; Intermountain Medical Center; Intermountain Healthcare; Intermountain Medical Center; Utah System of Higher Education; University of Utah; McMaster University; McMaster University; McMaster University; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Stevens, SM (corresponding author), Intermt Med Ctr, Dept Internal Med, POB 57700, Murray, UT 84157 USA.	Scott.StevensMD@imail.org	Lake, Erica/L-6423-2019; Douketis, James/AAO-5659-2021; Labarère, José/N-1688-2014; Woller, Scott C./AAV-6187-2021; Donadini, Marco P/Q-9599-2016	Labarère, José/0000-0001-7621-6586; Woller, Scott C./0000-0002-2522-2705; Donadini, Marco/0000-0001-5065-318X; Lake, Erica/0000-0001-8468-4398	AGEN Biomedical; Janssen-Ortho; Boehringer-Ingelheim; Sanofi-Aventis; AstraZeneca; Pfizer; Leo Pharma	AGEN Biomedical; Janssen-Ortho; Boehringer-Ingelheim(Boehringer Ingelheim); Sanofi-Aventis(Sanofi-Aventis); AstraZeneca(AstraZeneca); Pfizer(Pfizer); Leo Pharma(LEO Pharma)	Dr Douketis reported receiving consulting fees from AGEN Biomedical, Janssen-Ortho, Boehringer-Ingelheim, Sanofi-Aventis, and AstraZeneca; and receiving speaker's fees from Pfizer, Leo Pharma, and Sanofi-Aventis. No other financial disclosures were reported.	Atri M, 1996, AM J ROENTGENOL, V166, P1361, DOI 10.2214/ajr.166.6.8633448; Bernardi E, 2008, JAMA-J AM MED ASSOC, V300, P1653, DOI 10.1001/jama.300.14.1653; Birdwell BG, 1998, ANN INTERN MED, V128, P1, DOI 10.7326/0003-4819-128-1-199801010-00001; Cogo A, 1998, BRIT MED J, V316, P17, DOI 10.1136/bmj.316.7124.17; Dauzat M, 1997, J CLIN ULTRASOUND, V25, P343, DOI 10.1002/(SICI)1097-0096(199709)25:7<343::AID-JCU1>3.0.CO;2-A; DEVALOIS JC, 1990, EUR J RADIOL, V11, P131, DOI 10.1016/0720-048X(90)90162-5; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elias A, 2003, THROMB HAEMOSTASIS, V89, P221; Gallus AS, 2000, MED J AUSTRALIA, V172, P600, DOI 10.5694/j.1326-5377.2000.tb124127.x; Goodacre S, 2005, BMC EMERG MED, V5, DOI 10.1186/1471-227X-5-6; Gottlieb RH, 2003, AM J ROENTGENOL, V180, P241, DOI 10.2214/ajr.180.1.1800241; Heit JA, 2002, ARCH INTERN MED, V162, P1245, DOI 10.1001/archinte.162.11.1245; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huerta C, 2007, ARCH INTERN MED, V167, P935, DOI 10.1001/archinte.167.9.935; Kearon C, 1998, ANN INTERN MED, V128, P663, DOI 10.7326/0003-4819-128-8-199804150-00011; Kearon C, 2008, CHEST, V133, p454S, DOI 10.1378/chest.08-0658; Krakow E, 2005, JAMA-J AM MED ASSOC, V294, P3088, DOI 10.1001/jama.294.24.3088-a; Labropoulos N, 2008, J VASC SURG, V48, P407, DOI 10.1016/j.jvs.2008.03.016; LAGERSTEDT CI, 1985, LANCET, V2, P515; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Martinelli I, 2001, THROMB HAEMOSTASIS, V86, P395; Qaseem A, 2007, ANN INTERN MED, V146, P454, DOI 10.7326/0003-4819-146-6-200703200-00013; Righini M, 2007, J THROMB HAEMOST, V5, P55, DOI 10.1111/j.1538-7836.2007.02468.x; Righini M, 2006, THROMB HAEMOSTASIS, V95, P56, DOI 10.1160/TH05-08-0588; Schellong SM, 2003, THROMB HAEMOSTASIS, V89, P228; Schwarz T, 2002, CLIN APPL THROMB-HEM, V8, P45, DOI 10.1177/107602960200800106; Sevestre MA, 2010, AM J MED, V123, P158, DOI 10.1016/j.amjmed.2009.05.034; Sevestre MA, 2009, THROMB HAEMOSTASIS, V102, P166, DOI 10.1160/TH09-01-0048; Stevens SM, 2004, ANN INTERN MED, V140, P985, DOI 10.7326/0003-4819-140-12-200406150-00007; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Subramaniam RM, 2005, RADIOLOGY, V237, P348, DOI 10.1148/radiol.2371041294; Wells GA, 2003, 11 INT COCHR C BARC, VO-63, P26; Wells PS, 2003, NEW ENGL J MED, V349, P1227, DOI 10.1056/NEJMoa023153; Wells PS, 1997, LANCET, V350, P1795, DOI 10.1016/S0140-6736(97)08140-3	34	132	138	1	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 3	2010	303	5					438	445		10.1001/jama.2010.43	http://dx.doi.org/10.1001/jama.2010.43			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	550QR	20124539	Bronze			2022-12-28	WOS:000274143600019
J	Goebel, A; Baranowski, A; Maurer, K; Ghiai, A; McCabe, C; Ambler, G				Goebel, Andreas; Baranowski, Andrew; Maurer, Konrad; Ghiai, Artemis; McCabe, Candy; Ambler, Gareth			Intravenous Immunoglobulin Treatment of the Complex Regional Pain Syndrome A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							REFLEX SYMPATHETIC DYSTROPHY; NEUROPATHIC PAIN; SYNDROME TYPE-1; IMMUNE; MECHANISMS; MAGNITUDE; CYTOKINES; PATTERNS; THERAPY	Background: Treatment of long-standing complex regional pain syndrome (CRPS) is empirical and often of limited efficacy. Preliminary data suggest that the immune system is involved in sustaining this condition and that treatment with low-dose intravenous immunoglobulin (IVIG) may substantially reduce pain in some patients. Objective: To evaluate the efficacy of IVIG in patients with long-standing CRPS under randomized, controlled conditions. Design: A randomized, double-blind, placebo-controlled crossover trial. (National Research Registry number: N0263177713; International Standard Randomised Controlled Trial Number Registry: 63918259) Setting: University College London Hospitals Pain Management Centre. Patients: Persons who had pain intensity greater than 4 on an 11-point (0 to 10) numerical rating scale and had CRPS for 6 to 30 months that was refractory to standard treatment. Intervention: IVIG, 0.5 g/kg, and normal saline in separate treatments, divided by a washout period of at least 28 days. Measurements: The primary outcome was pain intensity 6 to 19 days after the initial treatment and the crossover treatment. Results: 13 eligible participants were randomly assigned between November 2005 and May 2008; 12 completed the trial. The average pain intensity was 1.55 units lower after IVIG treatment than after saline (95% CI, 1.29 to 1.82; P < 0.001). In 3 patients, pain intensity after IVIG was less than after saline by 50% or more. No serious adverse reactions were reported. Limitation: The trial was small, and recruitment bias and chance variation could have influenced results and their interpretation. Conclusion: IVIG, 0.5 g/kg, can reduce pain in refractory CRPS. Studies are required to determine the best immunoglobulin dose, the duration of effect, and when repeated treatments are needed. Primary Funding Source: Association of Anaesthetists of Great Britain and Ireland, University College London Hospitals Charity, and CSL-Behring.	[Goebel, Andreas] Univ Liverpool, Pain Res Inst, Univ Hosp Aintree, Liverpool L9 7AL, Merseyside, England; Walton Ctr, Liverpool, Merseyside, England; Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England; UCL, Biomed Res Unit, Joint Univ Coll London Hosp, London, England; Natl Hosp Rheumat Dis, Bath, Avon, England	University of Liverpool; Walton Centre; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; Royal National Hospital for Rheumatic Diseases (RNHRD)	Goebel, A (corresponding author), Univ Liverpool, Pain Res Inst, Univ Hosp Aintree, Clin Sci Bldg, Liverpool L9 7AL, Merseyside, England.	andreasgoebel@rocketmail.com		McCabe, Candida/0000-0002-3593-0027	Association of Anaesthetists of Great Britain and Ireland; University College London Hospitals Trustees; CSL-Behring; Department of Health's National Institute for Health Research Biomedical Research Centres; University College London Hospitals/University College London	Association of Anaesthetists of Great Britain and Ireland; University College London Hospitals Trustees; CSL-Behring; Department of Health's National Institute for Health Research Biomedical Research Centres(National Institute for Health Research (NIHR)); University College London Hospitals/University College London	Grant Support: By the Association of Anaesthetists of Great Britain and Ireland, the University College London Hospitals Trustees, and CSL-Behring (drugs and contribution to general expenses). This work was undertaken at University College London Hospitals/University College London, which received a proportion of funding from the Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme. The sponsor under International Conference of Harmonisation Good Clinical Practice standards was University College London Hospitals/University College London.	Alexander GM, 2005, PAIN, V116, P213, DOI 10.1016/j.pain.2005.04.013; Arruda JL, 2000, BRAIN RES, V879, P216, DOI 10.1016/S0006-8993(00)02807-9; Birklein F, 2005, J NEUROL, V252, P131, DOI 10.1007/s00415-005-0737-8; Blaes F, 2007, ANN NY ACAD SCI, V1107, P168, DOI 10.1196/annals.1381.018; Blaes F, 2004, NEUROLOGY, V63, P1734, DOI 10.1212/01.WNL.0000143066.58498.BA; CLEELAND CS, 1989, ISSUES PAIN MEASUREM, P391; de Mos M, 2007, PAIN, V129, P12, DOI 10.1016/j.pain.2006.09.008; de Mos M, 2009, CLIN J PAIN, V25, P590, DOI 10.1097/AJP.0b013e3181a11623; DeLeo JA, 2001, PAIN, V90, P1, DOI 10.1016/S0304-3959(00)00490-5; *EUR UN, 2006, CPMPICH13595 EUR UN; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; Forouzanfar T, 2002, EUR J PAIN-LONDON, V6, P105, DOI 10.1053/eujp.2001.0304; Goebel A, 2005, J NEUROIMMUNOL, V162, P184, DOI 10.1016/j.jneuroim.2005.01.018; Goebel A, 2005, ANN NEUROL, V57, P463, DOI 10.1002/ana.20400; Goebel A, 2002, PAIN MED, V3, P119, DOI 10.1046/j.1526-4637.2002.02018.x; Harden RN, 2007, PAIN MED, V8, P326, DOI 10.1111/j.1526-4637.2006.00169.x; Huygen FJPM, 2002, MEDIAT INFLAMM, V11, P47, DOI 10.1080/09629350210307; Kemler MA, 2000, NEW ENGL J MED, V343, P618, DOI 10.1056/NEJM200008313430904; Kingery WS, 1997, PAIN, V73, P123, DOI 10.1016/S0304-3959(97)00049-3; Kohr D, 2009, PAIN, V143, P246, DOI 10.1016/j.pain.2009.03.009; Maihofner C, 2003, NEUROLOGY, V61, P1707, DOI 10.1212/01.WNL.0000098939.02752.8E; McCabe CS, 2003, RHEUMATOLOGY, V42, P97, DOI 10.1093/rheumatology/keg041; Moalem G, 2006, BRAIN RES REV, V51, P240, DOI 10.1016/j.brainresrev.2005.11.004; Moore RA, 1998, PAIN, V78, P209, DOI 10.1016/S0304-3959(98)00140-7; Moseley GL, 2004, PAIN, V108, P192, DOI 10.1016/j.pain.2004.01.006; Oerlemans HR, 1999, PAIN, V83, P77, DOI 10.1016/S0304-3959(99)00080-9; Price DD, 1998, CLIN J PAIN, V14, P216, DOI 10.1097/00002508-199809000-00008; RAUCK RL, 1993, ANESTHESIOLOGY, V79, P1163, DOI 10.1097/00000542-199312000-00005; RAUCK RL, 1993, ANESTHESIOLOGY, V79, pA27; Rowbotham MC, 2006, CLIN J PAIN, V22, P425, DOI 10.1097/01.ajp.0000194281.74379.01; Sigtermans MJ, 2009, PAIN, V145, P304, DOI 10.1016/j.pain.2009.06.023; Stangel M, 1997, CLIN NEUROPHARMACOL, V20, P385, DOI 10.1097/00002826-199710000-00002; Uceyler N, 2007, PAIN, V132, P195, DOI 10.1016/j.pain.2007.07.031; VELDMAN PHJM, 1993, LANCET, V342, P1012, DOI 10.1016/0140-6736(93)92877-V; Wasner G, 2003, SPINAL CORD, V41, P61, DOI 10.1038/sj.sc.3101404	35	125	128	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 2	2010	152	3					152	U7		10.7326/0003-4819-152-3-201002020-00006	http://dx.doi.org/10.7326/0003-4819-152-3-201002020-00006			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	552WN	20124231				2022-12-28	WOS:000274324600003
J	Renart, A; de la Rocha, J; Bartho, P; Hollender, L; Parga, N; Reyes, A; Harris, KD				Renart, Alfonso; de la Rocha, Jaime; Bartho, Peter; Hollender, Liad; Parga, Nestor; Reyes, Alex; Harris, Kenneth D.			The Asynchronous State in Cortical Circuits	SCIENCE			English	Article							FIRING RATES; NEURONS; DISCHARGE; NETWORKS; SYNCHRONY; DYNAMICS; CORTEX; MOTOR	Correlated spiking is often observed in cortical circuits, but its functional role is controversial. It is believed that correlations are a consequence of shared inputs between nearby neurons and could severely constrain information decoding. Here we show theoretically that recurrent neural networks can generate an asynchronous state characterized by arbitrarily low mean spiking correlations despite substantial amounts of shared input. In this state, spontaneous fluctuations in the activity of excitatory and inhibitory populations accurately track each other, generating negative correlations in synaptic currents which cancel the effect of shared input. Near-zero mean correlations were seen experimentally in recordings from rodent neocortex in vivo. Our results suggest a reexamination of the sources underlying observed correlations and their functional consequences for information processing.	[Renart, Alfonso; de la Rocha, Jaime; Bartho, Peter; Hollender, Liad; Harris, Kenneth D.] Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA; [de la Rocha, Jaime; Reyes, Alex] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Bartho, Peter] Hungarian Acad Sci, Inst Expt Med, H-1083 Budapest, Hungary; [Parga, Nestor] Univ Autonoma Madrid, Dept Fis Teor, E-28049 Madrid, Spain; [Harris, Kenneth D.] NYU, Sch Med, Smilow Res Ctr, New York, NY 10016 USA	Rutgers State University Newark; Rutgers State University New Brunswick; New York University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - UAM - Institut de Fisica Teorica (IFT); New York University	Renart, A (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA.	arenart@andromeda.rutgers.edu	de la Rocha, Jaime/I-2119-2015	de la Rocha, Jaime/0000-0002-3314-9384; Harris, Kenneth/0000-0002-5930-6456; Renart, Alfonso/0000-0001-7916-9930	NIH [MH073245, DC009947]; NSF [SBE-0542013]; NSF Science of Learning Center; National Institute on Deafness and Other Communication Disorders, NIH [DC-005787-01A1];  [FIS 2006-09294]; EPSRC [EP/I005102/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I005102/1] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073245] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009947, R01DC005787] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NSF Science of Learning Center(National Science Foundation (NSF)NSF - Office of the Director (OD)); National Institute on Deafness and Other Communication Disorders, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); ; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank A. Amarasingham, N. Brunel, G. Buzsaki, B. Doiron, A. Ecker, S. Fijisawa, A. Heimel, A. Kohn, D. Robbe, S. Sakata, E. Stark, and A. Tolias for comments on an earlier version of this manuscript; C. van Vreeswijk for discussions; and A. Compte, S. Ardid, and J. Manrique for sharing their codes. This study was supported by NIH grants MH073245 and DC009947; NSF grant SBE-0542013 to the Temporal Dynamics of Learning Center, an NSF Science of Learning Center; a National Institute on Deafness and Other Communication Disorders, NIH, grant DC-005787-01A1; and a Spanish grant FIS 2006-09294. K. D. H. is an Alfred P. Sloan fellow. We would like to dedicate this work to the memory of D. J. Amit.	Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Clement EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002004; Cohen MR, 2008, NEURON, V60, P162, DOI 10.1016/j.neuron.2008.08.007; Ecker AS, 2010, SCIENCE, V327, P584, DOI 10.1126/science.1179867; GAWNE TJ, 1993, J NEUROSCI, V13, P2758; GINZBURG I, 1994, PHYS REV E, V50, P3171, DOI 10.1103/PhysRevE.50.3171; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Kriener B, 2008, NEURAL COMPUT, V20, P2185, DOI 10.1162/neco.2008.02-07-474; Kumar A, 2008, J NEUROSCI, V28, P5268, DOI 10.1523/JNEUROSCI.2542-07.2008; Lee D, 1998, J NEUROSCI, V18, P1161; Moreno-Bote R, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.028101; Nienborg H, 2009, NATURE, V459, P89, DOI 10.1038/nature07821; Okun M, 2008, NAT NEUROSCI, V11, P535, DOI 10.1038/nn.2105; Riehle A, 1997, SCIENCE, V278, P1950, DOI 10.1126/science.278.5345.1950; Roelfsema PR, 2004, NAT NEUROSCI, V7, P982, DOI 10.1038/nn1304; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Sompolinsky H, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051904; STERIADE M, 1999, ELECTROENCEPHALOGRAP; Stern EA, 1998, NATURE, V394, P475, DOI 10.1038/28848; VAADIA E, 1995, NATURE, V373, P515, DOI 10.1038/373515a0; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Vogels TP, 2005, J NEUROSCI, V25, P10786, DOI 10.1523/JNEUROSCI.3508-05.2005; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	25	660	664	3	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 29	2010	327	5965					587	590		10.1126/science.1179850	http://dx.doi.org/10.1126/science.1179850			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549CT	20110507	Green Accepted			2022-12-28	WOS:000274020500040
J	Einstein, TL; Stasevich, TJ				Einstein, Theodore L.; Stasevich, Timothy J.			Epitaxial Growth Writ Large	SCIENCE			English	Editorial Material							FILM GROWTH; MODEL		[Einstein, Theodore L.] Univ Maryland, Dept Phys, College Pk, MD 20742 USA; [Stasevich, Timothy J.] NCI, Fluorescence Imaging Grp, Lab Receptor Biol & Gene Express, NIH, Bethesda, MD 20892 USA	University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Einstein, TL (corresponding author), Univ Maryland, Dept Phys, College Pk, MD 20742 USA.	einstein@umd.edu; stasevicht@mail.nih.gov	Einstein, Theodore L/F-7961-2011	Einstein, Theodore L./0000-0001-6031-4923				AMAR JG, 1994, PHYS REV B, V50, P8781, DOI 10.1103/PhysRevB.50.8781; Blackman JA, 1996, PHYS REV B, V54, P11681, DOI 10.1103/PhysRevB.54.11681; EHRLICH G, 1966, J CHEM PHYS, V44, P1039, DOI 10.1063/1.1726787; Evans JW, 2006, SURF SCI REP, V61, P1, DOI 10.1016/j.surfrep.2005.08.004; Ganapathy R, 2010, SCIENCE, V327, P445, DOI 10.1126/science.1179947; Marenduzzo D, 2006, J CELL BIOL, V175, P681, DOI 10.1083/jcb.200609066; Michely T., 2004, ISLANDS MOUNDS ATOMS, DOI [10.1007/978-3-642-18672-1, DOI 10.1007/978-3-642-18672-1]; PIMPINELLI A, 1989, PHYS CRYSTAL GROWTH; Pimpinelli A, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.226102; Qiu SR, 2004, P NATL ACAD SCI USA, V101, P1811, DOI 10.1073/pnas.0307900100; RAYMOND JA, 1989, P NATL ACAD SCI USA, V86, P881, DOI 10.1073/pnas.86.3.881; SCHWOEBEL RL, 1966, J APPL PHYS, V37, P3682, DOI 10.1063/1.1707904; Shim Y, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.046103; Stasevich TJ, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.085501; Voigt A., 2005, MULTISCALE MODELING	15	14	15	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 22	2010	327	5964					423	424		10.1126/science.1184947	http://dx.doi.org/10.1126/science.1184947			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546BS	20093465				2022-12-28	WOS:000273783100026
J	Hastings, G; Brooks, O; Stead, M; Angus, K; Anker, T; Farrell, T				Hastings, Gerard; Brooks, Oona; Stead, Martine; Angus, Kathryn; Anker, Thomas; Farrell, Tom			Failure of self regulation of UK alcohol advertising	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Hastings, Gerard; Brooks, Oona; Stead, Martine; Angus, Kathryn; Anker, Thomas] Univ Stirling, Inst Social Mkt, Stirling FK9 4LA, Scotland; [Farrell, Tom] Open Univ, Milton Keynes MK7 6AA, Bucks, England	University of Stirling; Open University - UK	Hastings, G (corresponding author), Univ Stirling, Inst Social Mkt, Stirling FK9 4LA, Scotland.	gerard.hastings@stir.ac.uk	Anker, Thomas/T-1542-2019	Stead, Martine/0000-0002-3066-4604; Brooks, Oona/0000-0002-8435-322X	Medical Research Council [G0501282] Funding Source: Medline; Economic and Social Research Council [ES/G007489/1] Funding Source: researchfish; MRC [G0501282] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Anderson P, 2009, ALCOHOL ALCOHOLISM, V44, P229, DOI 10.1093/alcalc/agn115; Booth A, 2008, INDEPENDENT REV EF A; *CAB OFF, 2003, STRAT UN ALC HARM RE, P129; CAIRNS G, 2009, EXTENT NATURE EFFECT; Hastings G., 2003, REV RES EFFECTS FOOD; Institute of Medicine, 2006, FOOD MARK CHILDR YOU; Lovato C, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003439; Smith LA, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-51	8	70	70	0	12	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 20	2010	340								b5650	10.1136/bmj.b5650	http://dx.doi.org/10.1136/bmj.b5650			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	548HO	20089576	Green Submitted, Green Accepted			2022-12-28	WOS:000273951300004
J	Hayward, RA; Krumholz, HM; Zulman, DM; Timbie, JW; Vijan, S				Hayward, Rodney A.; Krumholz, Harlan M.; Zulman, Donna M.; Timbie, Justin W.; Vijan, Sandeep			Optimizing Statin Treatment for Primary Prevention of Coronary Artery Disease	ANNALS OF INTERNAL MEDICINE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; TISSUE-PLASMINOGEN ACTIVATOR; TYPE-2 DIABETES-MELLITUS; C-REACTIVE PROTEIN; HEART-DISEASE; COST-EFFECTIVENESS; MYOCARDIAL-INFARCTION; CARDIOVASCULAR RISK; INDIVIDUAL PATIENTS; EDUCATION-PROGRAM	Background: Although treating to lipid targets ("treat to target") is widely recommended for coronary artery disease (CAD) prevention, some have advocated administering fixed doses of statins based on a person's estimated net benefit ("tailored treatment"). Objective: To examine how a tailored treatment approach to statin therapy compares with a treat-to-target approach. Design: Simulated model of population-level effects of treat-to-target and tailored treatment approaches to statin therapy. Data Sources: Statin trials from 1994 to 2009 and nationally representative CAD risk factor data. Target Population: U. S. persons aged 30 to 75 years with no history of myocardial infarction. Time Horizon: Lifetime effects of 5 years of treatment. Perspective: Societal and patient. Intervention: Tailored treatment based on a person's 5-year CAD risk (simvastatin, 40 mg, for 5% to 15% CAD risk and atorvastatin, 40 mg, for CAD risk >15%) versus treat-to-target approaches that escalate statin dose per National Cholesterol Education Program [NCEP] III guidelines (including an intensive approach that advances treatment whenever intensification is optional by NCEP III criteria). Outcome Measures: Quality-adjusted life-years (QALYs). Results of Base-Case Analysis: Compared with the standard NCEP III approach, the intensive NCEP III approach treated 15 million more persons and saved 570 000 more QALYs over 5 years. The tailored strategy treated a similar number of persons, as did the intensive NCEP III approach, but saved 500 000 more QALYs and treated fewer persons with high-dose statins. Results of Sensitivity Analysis: No circumstances were found in which a treat-to-target approach was preferable to tailored treatment. Limitation: Model assumptions were based on available clinical data, which included few persons 75 years or older. Conclusion: A tailored treatment strategy prevents more CAD events while treating fewer persons with high-dose statins than low-density lipoprotein cholesterol-based target approaches. Results were robust, even with assumptions favoring a treat-to-target approach.	[Hayward, Rodney A.] Univ Michigan, Sch Med, Robert Wood Johnson Clin Scholars Program, Ann Arbor, MI 48109 USA; Vet Affairs Ann Arbor Healthcare Syst, Ann Arbor, MI USA; Yale Univ, New Haven, CT USA; Yale New Haven Med Ctr, New Haven, CT 06504 USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; Yale University; Yale University	Hayward, RA (corresponding author), Univ Michigan, Sch Med, Robert Wood Johnson Clin Scholars Program, 6312 Med Sci Bldg 1,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	rhayward@umich.edu	, Harlan/AAI-2875-2020		Department of Veteran Affairs Health Services Research & Development Service's Quality Enhancement Research Initiative [QUERI DIB 98-001]; Measurement Core of the Michigan Diabetes Research & Training Center [P60 DK-20572]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572] Funding Source: NIH RePORTER	Department of Veteran Affairs Health Services Research & Development Service's Quality Enhancement Research Initiative; Measurement Core of the Michigan Diabetes Research & Training Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Primary Funding Source: Department of Veteran Affairs Health Services Research & Development Service's Quality Enhancement Research Initiative.; Grant Support: In part by the Department of Veteran Affairs Health Services Research & Development Service's Quality Enhancement Research Initiative (QUERI DIB 98-001). The Measurement Core of the Michigan Diabetes Research & Training Center (National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health [P60 DK-20572]) provided consultative support.	ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Brunzell JD, 2008, J AM COLL CARDIOL, V51, P1512, DOI 10.1016/j.jacc.2008.02.034; CAREY J, 2008, BUSINESSWEEK    0128; Chan PS, 2007, CIRCULATION, V115, P2398, DOI 10.1161/CIRCULATIONAHA.106.667683; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Glasziou PP, 2008, ANN INTERN MED, V148, P656, DOI 10.7326/0003-4819-148-9-200805060-00005; Gold MR, 1996, COST EFFECTIVENESS H; Gotto AM, 2000, EUR HEART J, V21, P1627, DOI 10.1053/euhj.2000.2288; Grundy Scott M, 2004, J Am Coll Cardiol, V44, P720, DOI 10.1016/j.jacc.2004.07.001; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Hayward RA, 2005, HEALTH AFFAIR, V24, P1571, DOI 10.1377/hlthaff.24.6.1571; Hayward RA, 2007, HEALTH SERV RES, V42, P1718, DOI 10.1111/j.1475-6773.2006.00661.x; Hayward RA, 2007, AM J MANAG CARE, V13, P126; Hayward RA, 2006, ANN INTERN MED, V145, P520, DOI 10.7326/0003-4819-145-7-200610030-00010; Kent DM, 2007, JAMA-J AM MED ASSOC, V298, P1209, DOI 10.1001/jama.298.10.1209; Kent DM, 2002, AM J MED, V113, P104, DOI 10.1016/S0002-9343(02)01160-9; Kravitz RL, 2004, MILBANK Q, V82, P661, DOI 10.1111/j.0887-378X.2004.00327.x; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; LaRosa JC, 1999, JAMA-J AM MED ASSOC, V282, P2340, DOI 10.1001/jama.282.24.2340; LAW MR, 1994, BMJ-BRIT MED J, V308, P367, DOI 10.1136/bmj.308.6925.367; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; LEITHA T, 1994, CLIN CARDIOL, V17, P123, DOI 10.1002/clc.4960170305; MARK DB, 1995, NEW ENGL J MED, V332, P1418, DOI 10.1056/NEJM199505253322106; National Center for Health Statistics, 3 NAT HLTH NUTR EX S; National Institute for Health and Clinical Excellence, 2006, STAT PREV CARD EV PA; *NIH, NIH PUBL; Pedersen TR, 2005, JAMA-J AM MED ASSOC, V294, P2437, DOI 10.1001/jama.294.19.2437; Pereira MA, 2004, INT J EPIDEMIOL, V33, P534, DOI 10.1093/ije/dyh057; Pitt B, 2005, NEW ENGL J MED, V352, P1483, DOI 10.1056/NEJMe058052; Pletcher MJ, 2009, ANN INTERN MED, V150, P243, DOI 10.7326/0003-4819-150-4-200902170-00005; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2008, CIRCULATION, V118, P2243, DOI 10.1161/CIRCULATIONAHA.108.814251; RIND DM, 2009, UPTODATE 17 2; Rothwell PM, 2005, LANCET, V365, P176, DOI 10.1016/S0140-6736(05)17709-5; Rothwell PM, 1999, LANCET, V353, P2105, DOI 10.1016/S0140-6736(98)11415-0; ROTTERDAM EP, 1987, CLIN CHEM, V33, P1913; Sacks FM, 1998, CIRCULATION, V97, P1446; Shepherd J, 2002, LANCET, V359, P2271, DOI 10.1016/S0140-6736(02)09299-1; Snow V, 2004, ANN INTERN MED, V140, P644, DOI 10.7326/0003-4819-140-8-200404200-00012; Ubbink Dirk T, 2008, Patient Prefer Adherence, V2, P315; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; Vijan S, 2004, ANN INTERN MED, V140, P650, DOI 10.7326/0003-4819-140-8-200404200-00013; Wenger NK, 2007, ANN INTERN MED, V147, P1, DOI 10.7326/0003-4819-147-1-200707030-00002; Wennberg J E, 1991, J Am Board Fam Pract, V4, P365; Whelan T, 2003, J NATL CANCER I, V95, P581, DOI 10.1093/jnci/95.8.581; Wilson PWF, 2008, CIRC-CARDIOVASC QUAL, V1, P92, DOI 10.1161/CIRCOUTCOMES.108.831198; Zulman DM, 2008, MILBANK Q, V86, P557, DOI 10.1111/j.1468-0009.2008.00534.x; UKPDS RISK ENGINE	50	104	107	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 19	2010	152	2					69	+		10.7326/0003-4819-152-2-201001190-00004	http://dx.doi.org/10.7326/0003-4819-152-2-201001190-00004			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	548IE	20083825				2022-12-28	WOS:000273953000001
J	Power, PP				Power, Philip P.			Main-group elements as transition metals	NATURE			English	Review							FREE CATALYTIC-HYDROGENATION; FRUSTRATED LEWIS PAIRS; HETEROLYTIC DIHYDROGEN ACTIVATION; STABLE COMPOUND; DOUBLE-BOND; DIRADICAL CHARACTER; MOLECULAR-STRUCTURE; AMBIENT CONDITIONS; MULTIPLE BONDS; TRIPLE BOND	The last quarter of the twentieth century and the beginning decade of the twenty-first witnessed spectacular discoveries in the chemistry of the heavier main-group elements. The new compounds that were synthesized highlighted the fundamental differences between their electronic properties and those of the lighter elements to a degree that was not previously apparent. This has led to new structural and bonding insights as well as a gradually increasing realization that the chemistry of the heavier main-group elements more resembles that of transition-metal complexes than that of their lighter main-group congeners. The similarity is underlined by recent work, which has shown that many of the new compounds react with small molecules such as H-2, NH3, C2H4 or CO under mild conditions and display potential for applications in catalysis.	Univ Calif Davis, Dept Chem, Davis, CA 95616 USA	University of California System; University of California Davis	Power, PP (corresponding author), Univ Calif Davis, Dept Chem, Davis, CA 95616 USA.	pppower@ucdavis.edu			US NSF; US Department of Energy Office of Basic Energy Sciences	US NSF(National Science Foundation (NSF)); US Department of Energy Office of Basic Energy Sciences(United States Department of Energy (DOE))	I thank the US NSF and the US Department of Energy Office of Basic Energy Sciences for financial support.	Albright T. A., 1985, ORBITAL INTERACTIONS, P166; Amii H, 2004, J AM CHEM SOC, V126, P1344, DOI 10.1021/ja039920i; BADER RFW, 1962, CAN J CHEM, V40, P1164, DOI 10.1139/v62-178; Breher F, 2007, COORDIN CHEM REV, V251, P1007, DOI 10.1016/j.ccr.2006.09.007; CARTER EA, 1986, J PHYS CHEM-US, V90, P998, DOI 10.1021/j100278a006; Chase PA, 2008, ANGEW CHEM INT EDIT, V47, P7433, DOI 10.1002/anie.200802596; Chase PA, 2007, ANGEW CHEM INT EDIT, V46, P8050, DOI 10.1002/anie.200702908; Chivers T, 2005, GUIDE TO CHALCOGEN-NITROGEN CHEMISTRY, P1, DOI 10.1142/9789812563118; Cui CM, 2004, J AM CHEM SOC, V126, P6510, DOI 10.1021/ja0492182; Dai XL, 2004, J AM CHEM SOC, V126, P4798, DOI 10.1021/ja036308i; Dasent W. E., 1965, NONEXISTENT COMPOUND; DAVIDSON PJ, 1973, J CHEM SOC CHEM COMM, P829, DOI 10.1039/c39730000829; DAVIDSON PJ, 1973, J CHEM SOC CHEM COMM, P317; Frey GD, 2007, SCIENCE, V316, P439, DOI 10.1126/science.1141474; Gaspar PP, 1998, CHEM FUNCT, V2, P2463, DOI 10.1002/0470857250.ch43; Gold PE, 2002, PSYCHOL SCI, P2, DOI 10.1111/1529-1006.00006; GOLDBERG DE, 1986, J CHEM SOC DALTON, P2387, DOI 10.1039/dt9860002387; GOLDBERG DE, 1976, J CHEM SOC CHEM COMM, P261, DOI 10.1039/c39760000261; Green SP, 2007, SCIENCE, V318, P1754, DOI 10.1126/science.1150856; GREV RS, 1991, ADV ORGANOMET CHEM, V33, P125, DOI 10.1016/S0065-3055(08)60695-4; Grutzmacher H, 2000, CHEM-EUR J, V6, P2317; GYNANE MJS, 1976, J CHEM SOC CHEM COMM, P623, DOI 10.1039/c39760000623; Hicks RG, 2007, ORG BIOMOL CHEM, V5, P1321, DOI 10.1039/b617142g; Holschumacher D, 2008, ANGEW CHEM INT EDIT, V47, P7428, DOI 10.1002/anie.200802705; JACOBSEN H, 1994, J AM CHEM SOC, V116, P3667, DOI 10.1021/ja00088a001; Jung Y, 2006, J AM CHEM SOC, V128, P7185, DOI 10.1021/ja055374c; Jung YS, 2003, J PHYS CHEM A, V107, P7475, DOI 10.1021/jp034467i; Kinjo R, 2007, J AM CHEM SOC, V129, P7766, DOI 10.1021/ja072759h; Kubas G.J., 2001, METAL DIHYDROGEN SIG; KUTZELNIGG W, 1984, ANGEW CHEM INT EDIT, V23, P272, DOI 10.1002/anie.198402721; Lee SC, 2003, P NATL ACAD SCI USA, V100, P3595, DOI 10.1073/pnas.0630028100; Lee VY, 2008, CHEM LETT, V37, P128, DOI 10.1246/cl.2008.128; Linti G, 2000, COORDIN CHEM REV, V206, P285, DOI 10.1016/S0010-8545(00)00339-8; McCahill JSJ, 2007, ANGEW CHEM INT EDIT, V46, P4968, DOI 10.1002/anie.200701215; Mizuhata Y, 2009, CHEM REV, V109, P3479, DOI 10.1021/cr900093s; Momming CM, 2009, ANGEW CHEM INT EDIT, V48, P6643, DOI 10.1002/anie.200901636; NIECKE E, 1995, ANGEW CHEM INT EDIT, V34, P555, DOI 10.1002/anie.199505551; Otten E, 2009, J AM CHEM SOC, V131, P9918, DOI 10.1021/ja904377v; PEARSON RG, 1975, P NATL ACAD SCI USA, V72, P2104, DOI 10.1073/pnas.72.6.2104; PEARSON RG, 1969, J AM CHEM SOC, V91, P4947, DOI 10.1021/ja01046a001; PEARSON RG, 1988, J AM CHEM SOC, V110, P2092, DOI 10.1021/ja00215a013; Peng Y, 2008, J AM CHEM SOC, V130, P12268, DOI 10.1021/ja805358u; Peng Y, 2009, SCIENCE, V325, P1668, DOI 10.1126/science.1176443; Peng Y, 2008, CHEM COMMUN, P6042, DOI 10.1039/b813442a; Phillips AD, 2002, J AM CHEM SOC, V124, P5930, DOI 10.1021/ja0257164; Power PP, 2007, ORGANOMETALLICS, V26, P4362, DOI 10.1021/om700365p; Power PP, 1999, CHEM REV, V99, P3463, DOI 10.1021/cr9408989; Power PP, 2003, CHEM REV, V103, P789, DOI 10.1021/cr020406p; Pu LH, 2000, J AM CHEM SOC, V122, P3524, DOI 10.1021/ja993346m; Resa I, 2004, SCIENCE, V305, P1136, DOI 10.1126/science.1101356; Scheschkewitz D, 2002, SCIENCE, V295, P1880, DOI 10.1126/science.1068167; Schoeller WW, 2003, CHEM-EUR J, V9, P3611, DOI 10.1002/chem.200204508; Seierstad M, 2002, ANGEW CHEM INT EDIT, V41, P3894, DOI 10.1002/1521-3773(20021018)41:20<3894::AID-ANIE3894>3.0.CO;2-Z; Sekiguchi A, 2004, SCIENCE, V305, P1755, DOI 10.1126/science.1102209; Seyferth D, 2001, ORGANOMETALLICS, V20, P2, DOI 10.1021/om000993+; Sita L.R., 1995, ADV ORGANOMET CHEM, VVolume 38, P189, DOI DOI 10.1016/S0065-3055(08)60429-3; SITA LR, 1988, J AM CHEM SOC, V110, P5208, DOI 10.1021/ja00223a059; Spies P, 2008, ANGEW CHEM INT EDIT, V47, P7543, DOI 10.1002/anie.200801432; Spikes GH, 2005, J AM CHEM SOC, V127, P12232, DOI 10.1021/ja053247a; Stender M, 2002, ANGEW CHEM INT EDIT, V41, P1785, DOI 10.1002/1521-3773(20020517)41:10<1785::AID-ANIE1785>3.0.CO;2-6; Stender M, 2002, CHEM COMMUN, P1312, DOI 10.1039/b203403d; Stephan DW, 2009, DALTON T, P3129, DOI 10.1039/b819621d; Sturmann M, 1998, ORGANOMETALLICS, V17, P4425, DOI 10.1021/om9804475; Su JR, 1997, J AM CHEM SOC, V119, P5471, DOI 10.1021/ja9700562; Sumerin V, 2008, J AM CHEM SOC, V130, P14117, DOI 10.1021/ja806627s; Sumerin V, 2008, ANGEW CHEM INT EDIT, V47, P6001, DOI 10.1002/anie.200800935; Taylor, 1975, METAL TO METAL BONDE; Tokitoh N, 1997, SCIENCE, V277, P78, DOI 10.1126/science.277.5322.78; TRINQUIER G, 1987, J AM CHEM SOC, V109, P5303, DOI 10.1021/ja00252a002; Wang HD, 2008, CHEM COMMUN, P5966, DOI 10.1039/b813286k; Wang XP, 2009, J AM CHEM SOC, V131, P14164, DOI 10.1021/ja906053y; Wang YZ, 2008, SCIENCE, V321, P1069, DOI 10.1126/science.1160768; Welch GC, 2006, SCIENCE, V314, P1124, DOI 10.1126/science.1134230; WELLS AF, 1986, STRUCTURAL INORGANIC, P1279; WEST R, 1981, SCIENCE, V214, P1343, DOI 10.1126/science.214.4527.1343; YOSHIFUJI M, 1981, J AM CHEM SOC, V103, P4587, DOI 10.1021/ja00405a054; Zhao J, 2005, SCIENCE, V307, P1080, DOI 10.1126/science.1109389; Zhu ZL, 2009, CHEM-EUR J, V15, P5263, DOI 10.1002/chem.200900201; Zhu ZL, 2009, ANGEW CHEM INT EDIT, V48, P2031, DOI 10.1002/anie.200805982	79	959	961	10	439	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 14	2010	463	7278					171	177		10.1038/nature08634	http://dx.doi.org/10.1038/nature08634			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543MQ	20075912				2022-12-28	WOS:000273582700024
J	Franklin, KA				Franklin, Keara A.			Plant Chromatin Feels the Heat	CELL			English	Editorial Material							TEMPERATURE		Univ Leicester, Dept Biol, Leicester LE1 7RH, Leics, England	University of Leicester	Franklin, KA (corresponding author), Univ Leicester, Dept Biol, Leicester LE1 7RH, Leics, England.	kaf5@le.ac.uk						Balasubramanian S, 2006, PLOS GENET, V2, P980, DOI 10.1371/journal.pgen.0020106; Falcone Deane L., 2004, BMC Plant Biology, V4, P17, DOI 10.1186/1471-2229-4-17; Gray WM, 1998, P NATL ACAD SCI USA, V95, P7197, DOI 10.1073/pnas.95.12.7197; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Kim DH, 2009, ANNU REV CELL DEV BI, V25, P277, DOI 10.1146/annurev.cellbio.042308.113411; Koini MA, 2009, CURR BIOL, V19, P408, DOI 10.1016/j.cub.2009.01.046; Li B, 2005, P NATL ACAD SCI USA, V102, P18385, DOI 10.1073/pnas.0507975102; Penfield S, 2008, NEW PHYTOL, V179, P615, DOI 10.1111/j.1469-8137.2008.02478.x; Stavang JA, 2009, PLANT J, V60, P589, DOI 10.1111/j.1365-313X.2009.03983.x	9	16	16	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 8	2010	140	1					26	28		10.1016/j.cell.2009.12.035	http://dx.doi.org/10.1016/j.cell.2009.12.035			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	541CY	20085701	Bronze			2022-12-28	WOS:000273391900010
J	Ludwig, LG; Akciz, SO; Noriega, GR; Zielke, O; Arrowsmith, JR				Ludwig, Lisa Grant; Akciz, Sinan O.; Noriega, Gabriela R.; Zielke, Olaf; Arrowsmith, J. Ramon			Climate-Modulated Channel Incision and Rupture History of the San Andreas Fault in the Carrizo Plain	SCIENCE			English	Article							1857 EARTHQUAKE; CALIFORNIA; SLIP	The spatial and temporal distribution of fault slip is a critical parameter in earthquake source models. Previous geomorphic and geologic studies of channel offset along the Carrizo section of the south central San Andreas Fault assumed that channels form more frequently than earthquakes occur and suggested that repeated large-slip earthquakes similar to the 1857 Fort Tejon earthquake illustrate typical fault behavior. We found that offset channels in the Carrizo Plain incised less frequently than they were offset by earthquakes. Channels have been offset by successive earthquakes with variable slip since similar to 1400. This nonuniform slip history reveals a more complex rupture history than previously assumed for the structurally simplest section of the San Andreas Fault.	[Ludwig, Lisa Grant; Akciz, Sinan O.; Noriega, Gabriela R.] Univ Calif Irvine, Program Publ Hlth, Irvine, CA 92697 USA; [Ludwig, Lisa Grant; Akciz, Sinan O.; Noriega, Gabriela R.] Univ Calif Irvine, Calif Inst Hazards Res, Irvine, CA 92697 USA; [Zielke, Olaf; Arrowsmith, J. Ramon] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; Arizona State University; Arizona State University-Tempe	Ludwig, LG (corresponding author), Univ Calif Irvine, Program Publ Hlth, Irvine, CA 92697 USA.	lgrant@uci.edu	Ludwig, Lisa Grant/G-6442-2012	Ludwig, Lisa Grant/0000-0001-6538-8067; Akciz, Sinan/0000-0003-3142-5215; zielke, olaf/0000-0002-4797-0034	NSF [EAR 0409500, EAR 0711518, EAR-0529922]; USGS [07HQGR0092, 07HQAG0008]; Southern California Earthquake Center (SCEC)	NSF(National Science Foundation (NSF)); USGS(United States Geological Survey); Southern California Earthquake Center (SCEC)	Supported by NSF grants EAR 0409500 and 0711518, USGS grant 07HQGR0092, and the Southern California Earthquake Center (SCEC). SCEC is funded by NSF Cooperative Agreement EAR-0529922 and USGS Cooperative Agreement 07HQAG0008. The SCEC contribution number for this paper is 1305. Thanks to anonymous reviewers, student field assistants, L. Bidart for access to field sites, and J. Southon, M. Kirby, D. Cayan, K. Whipple, A. Heimsath, and E. Vivoni for discussions.	Akciz SO, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2007JB005285; AKCIZ SO, 2006, EOS S, V87; Cayan DR, 1999, J CLIMATE, V12, P2881, DOI 10.1175/1520-0442(1999)012<2881:EAHEIT>2.0.CO;2; Engstrom WN, 1996, QUATERNARY RES, V46, P141, DOI 10.1006/qres.1996.0054; GRANT LB, 1993, B SEISMOL SOC AM, V83, P619; GRANT LB, 1994, J GEOPHYS RES-SOL EA, V99, P6819, DOI 10.1029/94JB00125; Grant LB, 1996, SCIENCE, V272, P826, DOI 10.1126/science.272.5263.826; Liu J, 2004, GEOLOGY, V32, P649, DOI 10.1130/G20478.1; Liu-Zeng J, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2004JB003601; Noriega GR, 2006, B SEISMOL SOC AM, V96, P33, DOI 10.1785/0120050094; NORIEGA GR, 2009, THESIS U CALIFORNIA; Schimmelmann A, 1998, QUATERNARY RES, V49, P51, DOI 10.1006/qres.1997.1937; Schimmelmann A, 2003, HOLOCENE, V13, P763, DOI 10.1191/0959683603hl661rp; Schmalzle G, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003843; Scholz C.H., 2002, MECH EARTHQUAKES FAU, DOI 10.1017/CBO9780511818516; SCHWARTZ DP, 1984, J GEOPHYS RES, V89, P5681, DOI 10.1029/JB089iB07p05681; SIEH KE, 1984, GEOL SOC AM BULL, V95, P883, DOI 10.1130/0016-7606(1984)95<883:HAOTSA>2.0.CO;2; SIEH KE, 1978, B SEISMOL SOC AM, V68, P1421; Working Group on California Earthquake Probabilities, 2008, UN CAL EARTHQ RUPT F; Zielke O, 2010, SCIENCE, V327, P1119, DOI 10.1126/science.1182781	20	48	48	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2010	327	5969					1117	1119		10.1126/science.1182837	http://dx.doi.org/10.1126/science.1182837			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560KJ	20093439				2022-12-28	WOS:000274901100032
J	Tennant, PWG; Pearce, MS; Bythell, M; Rankin, J				Tennant, Peter W. G.; Pearce, Mark S.; Bythell, Mary; Rankin, Judith			20-year survival of children born with congenital anomalies: a population-based study	LANCET			English	Article							NEW-YORK-STATE; PRENATAL-DIAGNOSIS; DOWNS-SYNDROME; HEART-DISEASE; SPINA-BIFIDA; 1ST-YEAR SURVIVAL; INFANTS BORN; ORAL CLEFTS; MORTALITY; MALFORMATIONS	Background Congenital anomalies are a leading cause of perinatal and infant mortality. Advances in care have improved the prognosis for some congenital anomaly groups and subtypes, but there remains a paucity of knowledge about survival for many others, especially beyond the first year of life. We estimated survival up to 20 years of age for a range of congenital anomaly groups and subtypes. Methods Information about children with at least one congenital anomaly, delivered between 1985 and 2003, was obtained from the UK Northern Congenital Abnormality Survey (NorCAS). Anomalies were categorised by group (the system affected), subtype (the individual disorder), and syndrome according to European Surveillance of Congenital Anomalies (EUROCAT) guidelines. Local hospital and national mortality records were used to identify the survival status of liveborn children. Survival up to 20 years of age was estimated by use of Kaplan-Meier methods. Cox proportional hazards regression was used to examine factors that affected survival. Findings 13758 cases of congenital anomaly were notified to NorCAS between 1985 and 2003. Survival status was available for 10 850 (99.0%) of 10 964 livebirths. 20-year survival was 85.5% (95% CI 84.8-86.3) in individuals born with at least one congenital anomaly, 89.5% (88.4-90.6) for cardiovascular system anomalies, 79.1% (76.7-81.3) for chromosomal anomalies, 93.2% (91.6-94.5) for urinary system anomalies, 83.2% (79.8-86.0) for digestive system anomalies, 97.6% (95.9-98.6) for orofacial clefts, and 66.2% (61.5-70.5) for nervous system anomalies. Survival varied between subtypes within the same congenital anomaly group. The proportion of terminations for fetal anomaly increased throughout the study period (from 12.4%, 9.8-15.5, in 1985 to 18.3%, 15.6-21.2, in 2003; p<0.0001) and, together with year of birth, was an independent predictor of survival (adjusted hazard ratio [HR] for proportion of terminations 0.95, 95% CI 0.91-0.99, p=0.023; adjusted HR for year of birth 0.94, 0.92-0.96, p<0.0001). Interpretation Estimates of survival for congenital anomaly groups and subtypes will be valuable for families and health professionals when a congenital anomaly is detected, and will assist in planning for the future care needs of affected individuals.	[Tennant, Peter W. G.; Pearce, Mark S.; Rankin, Judith] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Bythell, Mary; Rankin, Judith] Reg Matern Survey Off, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Rankin, J (corresponding author), Newcastle Univ, Inst Hlth & Soc, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	j.m.rankin@ncl.ac.uk		Tennant, Peter/0000-0003-1555-069X; Pearce, Mark/0000-0002-0583-3779	BDF Newlife; Healthcare Quality Improvement Partnership; National Institute of Health Research (Department of Health)	BDF Newlife; Healthcare Quality Improvement Partnership; National Institute of Health Research (Department of Health)(National Institute for Health Research (NIHR))	We are grateful to all the Link Clinicians in the northern region for their continued collaboration and support of NorCAS. We thank Danielle Crowder at the Regional Maternity Survey Office, Jane Salotti at Newcastle University, and staff at the Office for National Statistics. We thank Patricia Boyd (medical geneticist) and Chris Wright (paediatric pathologist) for their help with coding the congenital anomaly cases and commenting on the report. This study was funded by BDF Newlife. NorCAS is funded by the Healthcare Quality Improvement Partnership. JR is funded by a Personal Award Scheme Career Scientist Award from the National Institute of Health Research (Department of Health).	Agha MM, 2006, BIRTH DEFECTS RES A, V76, P46, DOI 10.1002/bdra.20218; ALTHOUSE R, 1980, ARCH DIS CHILD, V55, P845, DOI 10.1136/adc.55.11.845; Altman D.G., 1991, PRACTICAL STAT MED R; BAIRD PA, 1989, HUM GENET, V82, P291, DOI 10.1007/BF00291175; BAMFORTH SJ, 1989, AM J HUM GENET, V44, P225; BMJ, 1995, BMJ, V310, P7; Boneva RS, 2001, CIRCULATION, V103, P2376; Bourke J, 2005, PAEDIATR PERINAT EP, V19, P284, DOI 10.1111/j.1365-3016.2005.00666.x; Boyd PA, 2005, BMJ-BRIT MED J, V330, P27, DOI 10.1136/bmj.38300.665301.3A; Cleves MA, 2003, BIRTH DEFECTS RES A, V67, P662, DOI 10.1002/bdra.10119; Dastgiri S, 2003, ARCH DIS CHILD, V88, P391, DOI 10.1136/adc.88.5.391; Druschel C, 1996, PUBLIC HEALTH REP, V111, P359; Druschel CM, 1996, CLEFT PALATE-CRAN J, V33, P400, DOI 10.1597/1545-1569(1996)033<0400:FYOLMA>2.3.CO;2; EUROCAT, EUROCAT SYNDR GUID D; EUROCAT, COD EUROCAT SUBGR CO; *EUROCAT, ASS AN SURV DAT HYP; Forrester MB, 2003, AM J MED GENET A, V119A, P311, DOI 10.1002/ajmg.a.20151; Frid C, 1999, J INTELL DISABIL RES, V43, P234, DOI 10.1046/j.1365-2788.1999.00198.x; Fuchs IB, 2007, ULTRASOUND OBST GYN, V29, P38, DOI 10.1002/uog.3900; GILSTRAP LC, 1988, AM J OBSTET GYNECOL, V159, P579, DOI 10.1016/S0002-9378(88)80012-7; Glasson EJ, 2002, CLIN GENET, V62, P390, DOI 10.1034/j.1399-0004.2002.620506.x; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Hayes C, 1997, INT J EPIDEMIOL, V26, P822, DOI 10.1093/ije/26.4.822; KALTER H, 1991, INT J EPIDEMIOL, V20, P173, DOI 10.1093/ije/20.1.173; Leonard H, 2001, ARCH DIS CHILD-FETAL, V85, pF204, DOI 10.1136/fn.85.3.F204; Leonard S, 2000, PAEDIATR PERINAT EP, V14, P163; Nembhard WN, 2001, TERATOLOGY, V64, P267, DOI 10.1002/tera.1073; PALTA M, 1994, ARCH PEDIAT ADOL MED, V148, P1295, DOI 10.1001/archpedi.1994.02170120057009; Peller AJ, 2004, OBSTET GYNECOL, V104, P957, DOI 10.1097/01.AOG.0000142718.53380.8f; Perloff JK, 2001, CIRCULATION, V103, P2637; Rankin J, 2005, ARCH DIS CHILD-FETAL, V90, pF374, DOI 10.1136/adc.2003.047902; Rasmussen SA, 2006, J PEDIATR-US, V148, P806, DOI 10.1016/j.jpeds.2006.01.010; Richmond S, 2005, BJOG-INT J OBSTET GY, V112, P1349, DOI 10.1111/j.1471-0528.2005.00660.x; Rosano A, 2000, J EPIDEMIOL COMMUN H, V54, P660, DOI 10.1136/jech.54.9.660; SAMANEK M, 1992, PEDIATR CARDIOL, V13, P152; Smith NP, 2005, ARCH DIS CHILD, V90, P426, DOI 10.1136/adc.2003.045765; Stoll C, 2000, CLEFT PALATE-CRAN J, V37, P41, DOI 10.1597/1545-1569(2000)037<0041:AMICWO>2.3.CO;2; Wong LYC, 2001, PAEDIATR PERINAT EP, V15, P374, DOI 10.1046/j.1365-3016.2001.00371.x; World Health Organization, INT STAT CLASS DIS R, V10th; World Health Organization (WHO), 2009, LIF TABL WHO MEMB ST; Wren C, 2000, HEART, V83, P414, DOI 10.1136/heart.83.4.414	41	266	278	0	16	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 20	2010	375	9715					649	656		10.1016/S0140-6736(09)61922-X	http://dx.doi.org/10.1016/S0140-6736(09)61922-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	564JT	20092884				2022-12-28	WOS:000275210900033
J	Monti, MM; Vanhaudenhuyse, A; Coleman, MR; Boly, M; Pickard, JD; Tshibanda, L; Owen, AM; Laureys, S				Monti, Martin M.; Vanhaudenhuyse, Audrey; Coleman, Martin R.; Boly, Melanie; Pickard, John D.; Tshibanda, Luaba; Owen, Adrian M.; Laureys, Steven			Willful Modulation of Brain Activity in Disorders of Consciousness	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERSISTENT VEGETATIVE STATE; MEDICAL ASPECTS; FMRI; ACCURACY	BACKGROUND The differential diagnosis of disorders of consciousness is challenging. The rate of misdiagnosis is approximately 40%, and new methods are required to complement bedside testing, particularly if the patient's capacity to show behavioral signs of awareness is diminished. METHODS At two major referral centers in Cambridge, United Kingdom, and Liege, Belgium, we performed a study involving 54 patients with disorders of consciousness. We used functional magnetic resonance imaging (MRI) to assess each patient's ability to generate willful, neuroanatomically specific, blood-oxygenation-level-dependent responses during two established mental-imagery tasks. A technique was then developed to determine whether such tasks could be used to communicate yes-or-no answers to simple questions. RESULTS Of the 54 patients enrolled in the study, 5 were able to willfully modulate their brain activity. In three of these patients, additional bedside testing revealed some sign of awareness, but in the other two patients, no voluntary behavior could be detected by means of clinical assessment. One patient was able to use our technique to answer yes or no to questions during functional MRI; however, it remained impossible to establish any form of communication at the bedside. CONCLUSIONS These results show that a small proportion of patients in a vegetative or minimally conscious state have brain activation reflecting some awareness and cognition. Careful clinical examination will result in reclassification of the state of consciousness in some of these patients. This technique may be useful in establishing basic communication with patients who appear to be unresponsive.	[Monti, Martin M.; Owen, Adrian M.] Univ Cambridge, MRC, Cognit & Brain Sci Unit, Cambridge CB2 7EF, England; [Coleman, Martin R.] Univ Cambridge, Wolfson Brain Imaging Ctr, Impaired Consciousness Study Grp, Cambridge CB2 7EF, England; [Pickard, John D.] Addenbrookes Hosp, Div Acad Neurosurg, Cambridge, England; [Vanhaudenhuyse, Audrey; Boly, Melanie; Laureys, Steven] Univ Liege, Cyclotron Res Ctr, Coma Sci Grp, Liege, Belgium; [Boly, Melanie; Laureys, Steven] Univ Hosp Liege, Dept Neurol, Liege, Belgium; [Tshibanda, Luaba] Univ Hosp Liege, Dept Neuroradiol, Liege, Belgium; [Vanhaudenhuyse, Audrey; Boly, Melanie; Laureys, Steven] Fonds Natl Rech Sci, B-1050 Brussels, Belgium	University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Liege; University of Liege; University of Liege; Fonds de la Recherche Scientifique - FNRS	Owen, AM (corresponding author), Univ Cambridge, MRC, Cognit & Brain Sci Unit, 15 Chaucer Rd, Cambridge CB2 7EF, England.	adrian.owen@mrc-cbu.cam.ac.uk	Vanhaudenhuyse, Audrey/AAP-2455-2020; Laureys, Steven/AAN-2097-2021	Laureys, Steven/0000-0002-3096-3807; Monti, Martin M/0000-0001-5511-3780; Boly, Melanie/0000-0001-9584-0907	Medical Research Council [U.1055.01.002.00007.01, U.1055.01.002.00001.01]; European Commission; Fonds de la Recherche Scientifique; James S. McDonnell Foundation; Mind Science Foundation; Reine Elisabeth Medical Foundation; Belgian French-Speaking Community Concerted Research Action, University Hospital of Liege; University of Liege; National Institute for Health Research Biomedical Research Centre; Medical Research Council [G0600986, MC_EX_G0800771, G9439390, G0001237] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10327] Funding Source: researchfish; MRC [G0001237, G9439390, MC_EX_G0800771, G0600986] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); Fonds de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); James S. McDonnell Foundation; Mind Science Foundation; Reine Elisabeth Medical Foundation; Belgian French-Speaking Community Concerted Research Action, University Hospital of Liege; University of Liege(University of Liege); National Institute for Health Research Biomedical Research Centre(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by grants from the Medical Research Council (U.1055.01.002.00007.01 and U.1055.01.002.00001.01), the European Commission (Disorders and Coherence of the Embodied Self, Mindbridge, Deployment of Brain-Computer Interfaces for the Detection of Consciousness in Nonresponsive Patients, and Consciousness: A Transdisciplinary, Integrated Approach), Fonds de la Recherche Scientifique, the James S. McDonnell Foundation, the Mind Science Foundation, the Reine Elisabeth Medical Foundation, the Belgian French-Speaking Community Concerted Research Action, University Hospital of Liege, the University of Liege, and the National Institute for Health Research Biomedical Research Centre (Neurosciences Theme).	Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Boly M, 2007, NEUROIMAGE, V36, P979, DOI 10.1016/j.neuroimage.2007.02.047; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Coleman MR, 2007, BRAIN, V130, P2494, DOI 10.1093/brain/awm170; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; JENNETT B, 1972, LANCET, V1, P734; JENNETT B, 2002, VEGETATIVE STATE MED; Laureys S, 2005, TRENDS COGN SCI, V9, P556, DOI 10.1016/j.tics.2005.10.010; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Laureys S, 2002, NEUROIMAGE, V17, P732, DOI 10.1006/nimg.2002.1236; Monti MM, 2009, PROG BRAIN RES, V177, P249, DOI 10.1016/S0079-6123(09)17717-8; Monti MM, 2009, ANN NY ACAD SCI, V1157, P81, DOI 10.1111/j.1749-6632.2008.04121.x; *MULT TASK FORC PV, 1995, NEW ENGL J MED, V333, P130; Owen AM, 2008, NAT REV NEUROSCI, V9, P235, DOI 10.1038/nrn2330; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; *ROYAL COLL PHYS L, 2003, VEG STAT GUID DIAGN; Schnakers C, 2008, NEUROLOGY, V71, P1614, DOI 10.1212/01.wnl.0000334754.15330.69; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Smith SK, 2004, POPUL RES POLICY REV, V23, P1, DOI 10.1023/B:POPU.0000019918.24143.c9; Weiskopf N, 2004, IEEE T BIO-MED ENG, V51, P966, DOI 10.1109/TBME.2004.827063	22	816	846	3	238	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 18	2010	362	7					579	589		10.1056/NEJMoa0905370	http://dx.doi.org/10.1056/NEJMoa0905370			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	556ED	20130250				2022-12-28	WOS:000274571200006
J	Kollef, MH				Kollef, Marin H.			Will procalcitonin reduce antibiotic use in intensive care?	LANCET			English	Editorial Material							VENTILATOR-ASSOCIATED PNEUMONIA; HOSPITAL-ACQUIRED PNEUMONIA; THERAPY; IMPACT		Washington Univ, Sch Med, Div Pulm & Crit Care Med, St Louis, MO 63110 USA	Washington University (WUSTL)	Kollef, MH (corresponding author), Washington Univ, Sch Med, Div Pulm & Crit Care Med, St Louis, MO 63110 USA.	mkollef@dom.wustl.edu						Bouadma L, 2010, LANCET, V375, P463, DOI 10.1016/S0140-6736(09)61879-1; Hoo GWS, 2005, CHEST, V128, P2778, DOI 10.1378/chest.128.4.2778; Ibrahim EH, 2001, CRIT CARE MED, V29, P1109, DOI 10.1097/00003246-200106000-00003; Lancaster JW, 2008, PHARMACOTHERAPY, V28, P852, DOI 10.1592/phco.28.7.852; Micek S, 2004, CHEST, V125, P1791, DOI 10.1378/chest.125.5.1791; Rello J, 2004, CRIT CARE MED, V32, P2183, DOI 10.1097/01.CCM.0000145997.10438.28; Singh N, 2000, AM J RESP CRIT CARE, V162, P505, DOI 10.1164/ajrccm.162.2.9909095	7	9	9	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 6	2010	375	9713					435	436		10.1016/S0140-6736(10)60140-7	http://dx.doi.org/10.1016/S0140-6736(10)60140-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	558PV	20097416				2022-12-28	WOS:000274757900004
J	Richardella, A; Roushan, P; Mack, S; Zhou, B; Huse, DA; Awschalom, DD; Yazdani, A				Richardella, Anthony; Roushan, Pedram; Mack, Shawn; Zhou, Brian; Huse, David A.; Awschalom, David D.; Yazdani, Ali			Visualizing Critical Correlations Near the Metal-Insulator Transition in Ga1-xMnxAs	SCIENCE			English	Article							ANDERSON LOCALIZATION; FERROMAGNETISM; STATES; MODEL	Electronic states in disordered conductors on the verge of localization are predicted to exhibit critical spatial characteristics indicative of the proximity to a metal-insulator phase transition. We used scanning tunneling microscopy to visualize electronic states in Ga1-xMnxAs samples close to this transition. Our measurements show that doping-induced disorder produces strong spatial variations in the local tunneling conductance across a wide range of energies. Near the Fermi energy, where spectroscopic signatures of electron-electron interaction are the most prominent, the electronic states exhibit a diverging spatial correlation length. Power-law decay of the spatial correlations is accompanied by log-normal distributions of the local density of states and multifractal spatial characteristics.	[Richardella, Anthony; Roushan, Pedram; Zhou, Brian; Huse, David A.; Yazdani, Ali] Princeton Univ, Joseph Henry Labs, Princeton, NJ 08544 USA; [Richardella, Anthony; Roushan, Pedram; Zhou, Brian; Huse, David A.; Yazdani, Ali] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; [Richardella, Anthony] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Mack, Shawn; Awschalom, David D.] Univ Calif Santa Barbara, Ctr Spintron & Quantum Computat, Santa Barbara, CA 93106 USA	Princeton University; Princeton University; University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California Santa Barbara	Yazdani, A (corresponding author), Princeton Univ, Joseph Henry Labs, Princeton, NJ 08544 USA.	yazdani@princeton.edu	Mack, Shawn/F-4008-2011	Mack, Shawn/0000-0001-6696-0483; Yazdani, Ali/0000-0003-4996-8904; Zhou, Brian/0000-0001-8314-4488	Office of Naval Research; Army Research Office; Keck Foundation; NSF; NSF-Materials Research Science and Engineering Center program through the Princeton Center for Complex material	Office of Naval Research(Office of Naval Research); Army Research Office; Keck Foundation(W.M. Keck Foundation); NSF(National Science Foundation (NSF)); NSF-Materials Research Science and Engineering Center program through the Princeton Center for Complex material	This work was supported by grants from Office of Naval Research, Army Research Office, the Keck Foundation, NSF, and the NSF-Materials Research Science and Engineering Center program through the Princeton Center for Complex material. P. R. acknowledges a NSF graduate fellowship.	ALTSHULER BL, 1979, SOLID STATE COMMUN, V30, P115, DOI 10.1016/0038-1098(79)90967-0; ALTSHULER BL, 1989, PHYS LETT A, V134, P488, DOI 10.1016/0375-9601(89)90691-9; ANDERSON PW, 1958, PHYS REV, V109, P1492, DOI 10.1103/PhysRev.109.1492; Aspect A, 2009, PHYS TODAY, V62, P30, DOI 10.1063/1.3206092; Basko DM, 2006, ANN PHYS-NEW YORK, V321, P1126, DOI 10.1016/j.aop.2005.11.014; BELITZ D, 1994, REV MOD PHYS, V66, P261, DOI 10.1103/RevModPhys.66.261; Burch KS, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.087208; Chiba D, 2008, NATURE, V455, P515, DOI 10.1038/nature07318; Chun SH, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.100408; Dietl T, 2000, SCIENCE, V287, P1019, DOI 10.1126/science.287.5455.1019; Dietl T, 2008, J PHYS SOC JPN, V77, DOI 10.1143/JPSJ.77.031005; Evers F, 2008, REV MOD PHYS, V80, P1355, DOI 10.1103/RevModPhys.80.1355; Garleff JK, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.075313; Hashimoto K, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.256802; Ilani S, 2004, NATURE, V427, P328, DOI 10.1038/nature02230; Jungwirth T, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.125206; Kitchen D, 2006, NATURE, V442, P436, DOI 10.1038/nature04971; LEE PA, 1985, REV MOD PHYS, V57, P287, DOI 10.1103/RevModPhys.57.287; LERNER IV, 1988, PHYS LETT A, V133, P253, DOI 10.1016/0375-9601(88)91027-4; Moca CP, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.137203; Myers RC, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.155203; Neumaier D, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.116803; Ohno H, 2000, NATURE, V408, P944, DOI 10.1038/35050040; Rokhinson LP, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.161201; Sheu BL, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.227205; Strandberg TO, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.024425; Tang JM, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.047201	29	195	198	0	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2010	327	5966					665	669		10.1126/science.1183640	http://dx.doi.org/10.1126/science.1183640			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551ZD	20133566	Green Submitted			2022-12-28	WOS:000274251800031
J	Ali, JR; Huber, M				Ali, Jason R.; Huber, Matthew			Mammalian biodiversity on Madagascar controlled by ocean currents	NATURE			English	Article							MOZAMBIQUE CHANNEL; COLONIZATION; ORIGINS; DISPERSAL; PRIMATES; CLIMATE; NUCLEAR; AFRICA	Madagascar hosts one of the world's most unusual, endemic, diverse and threatened concentrations of fauna(1). To explain its unique, imbalanced biological diversity, G. G. Simpson proposed the 'sweepstakes hypothesis', according to which the ancestors of Madagascar's present-day mammal stock rafted there from Africa(2). This is an important hypothesis in biogeography and evolutionary theory for how animals colonize new frontiers(1,3-5), but its validity is questioned(5-9). Studies suggest that currents were inconsistent with rafting to Madagascar(9) and that land bridges provided the migrants' passage(5-8). Here we show that currents could have transported the animals to the island and highlight evidence inconsistent with the land-bridge hypothesis. Using palaeogeographic reconstructions and palaeo-oceanographic modelling, we find that strong surface currents flowed from northeast Mozambique and Tanzania eastward towards Madagascar during the Palaeogene period, exactly as required by the 'sweepstakes process'. Subsequently, Madagascar advanced north towards the equatorial gyre and the regional current system evolved into its modern configuration with flows westward(10) from Madagascar to Africa. This may explain why no fully non-aquatic land mammals have colonized Madagascar since the arrival of the rodents and carnivorans during the early-Miocene epoch. One implication is that rafting may be the dominant means of overseas dispersal in the Cenozoic era when palaeocurrent directions are properly considered.	[Huber, Matthew] Purdue Univ, Dept Earth & Atmospher Sci, W Lafayette, IN 47907 USA; [Huber, Matthew] Purdue Univ, Purdue Climate Change Res Ctr, W Lafayette, IN 47907 USA; [Ali, Jason R.] Univ Hong Kong, Dept Earth Sci, Hong Kong, Hong Kong, Peoples R China	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Hong Kong	Huber, M (corresponding author), Purdue Univ, Dept Earth & Atmospher Sci, W Lafayette, IN 47907 USA.	huberm@purdue.edu	Huber, Matthew/A-7677-2008; Ali, Jason/A-2738-2010	Huber, Matthew/0000-0002-2771-9977; Ali, Jason Richard/0000-0002-5214-620X	US National Science Foundation (NSF) [0927946-ATM]	US National Science Foundation (NSF)(National Science Foundation (NSF))	M. Nowak, W. de Ruijter, I. Tattersall and A. Yoder supplied reprints. J. Aitchison, R. Corlett and A. Switzer are thanked for sharing information. M. H. is supported by US National Science Foundation (NSF) grant 0927946-ATM and uses the US National Center for Atmospheric Research CCSM, which is supported by the NSF. M. H. acknowledges conversations with P. Koch and D. Raup on vicariance biogeography. All computing was performed at the Rosen Center for Advanced Computing, which is part of Information Technology at Purdue, Purdue University.	Ali JR, 2008, EARTH-SCI REV, V88, P145, DOI 10.1016/j.earscirev.2008.01.007; BASSIAS Y, 1992, J AFR EARTH SCI, V15, P321, DOI 10.1016/0899-5362(92)90018-8; De Ruijter WPM, 2005, PHILOS T R SOC A, V363, P63, DOI 10.1098/rsta.2004.1478; Godinot M, 2006, FOLIA PRIMATOL, V77, P446, DOI 10.1159/000095391; Goodman S.M., 2003, P1159; Heaney LR, 2007, J BIOGEOGR, V34, P753, DOI 10.1111/j.1365-2699.2007.01692.x; Huber M, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001014; Huber M, 2006, PALAEOGEOGR PALAEOCL, V231, P9, DOI 10.1016/j.palaeo.2005.07.037; Huber M., 2003, GEOLOGICAL SOC AM SP, V369, P25; Kappeler PM, 2000, FOLIA PRIMATOL, V71, P422, DOI 10.1159/000052741; Krause DW, 2006, ANN MO BOT GARD, V93, P178, DOI 10.3417/0026-6493(2006)93[178:LCTVFM]2.0.CO;2; Krause David W., 1997, P3; Krause DW, 2001, NATURE, V412, P497, DOI 10.1038/35087649; Liu ZH, 2009, SCIENCE, V323, P1187, DOI 10.1126/science.1166368; Masters JC, 2006, FOLIA PRIMATOL, V77, P399, DOI 10.1159/000095388; McCall RA, 1997, P ROY SOC B-BIOL SCI, V264, P663, DOI 10.1098/rspb.1997.0094; Nagy ZT, 2003, P ROY SOC B-BIOL SCI, V270, P2613, DOI 10.1098/rspb.2003.2547; Otto-Bliesner BL, 2006, J CLIMATE, V19, P2526, DOI 10.1175/JCLI3748.1; Poux C, 2005, SYST BIOL, V54, P719, DOI 10.1080/10635150500234534; Rabinowitz PD, 2006, J AFR EARTH SCI, V44, P270, DOI 10.1016/j.jafrearsci.2005.12.005; RABINOWITZ PD, 1983, SCIENCE, V220, P67, DOI 10.1126/science.220.4592.67; Schott FA, 2009, REV GEOPHYS, V47, DOI 10.1029/2007RG000245; SIMPSON GEORGE GAYLORD, 1940, JOUR WASHINGTON ACAD SCI, V30, P137; Stankiewicz J, 2006, J BIOGEOGR, V33, P221, DOI 10.1111/j.1365-2699.2005.01381.x; Stuenes S., 1989, Journal of Vertebrate Paleontology, V9, P241; Tattersall I, 2008, DEV PRIMATOL-PROG PR, P397, DOI 10.1007/978-0-387-73896-3_25; Tattersall I, 2006, FOLIA PRIMATOL, V77, P477, DOI 10.1159/000095393; Thiel M, 2006, OCEANOGR MAR BIOL, V44, P323, DOI 10.1201/9781420006391.ch7; Vences M, 2004, ITAL J ZOOL, V71, P217, DOI 10.1080/11250000409356639; von der Heydt A, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001149; Yeager SG, 2006, J CLIMATE, V19, P2545, DOI 10.1175/JCLI3744.1; Yoder AD, 2003, NATURE, V421, P734, DOI 10.1038/nature01303; Yoder AD, 2006, ANNU REV ECOL EVOL S, V37, P405, DOI 10.1146/annurev.ecolsys.37.091305.110239	33	206	209	3	129	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 4	2010	463	7281					653	U80		10.1038/nature08706	http://dx.doi.org/10.1038/nature08706			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551GB	20090678				2022-12-28	WOS:000274193900034
J	Layard, R				Layard, Richard			Measuring Subjective Well-Being	SCIENCE			English	Editorial Material							LIFE		London Sch Econ, London WC2A 2AE, England	University of London; London School Economics & Political Science	Layard, R (corresponding author), London Sch Econ, London WC2A 2AE, England.	r.layard@lse.ac.uk			ESRC [ES/H02123X/1] Funding Source: UKRI; Economic and Social Research Council [ES/H02123X/1] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Coghill RC, 2003, P NATL ACAD SCI USA, V100, P8538, DOI 10.1073/pnas.1430684100; Di Tella R, 2003, REV ECON STAT, V85, P809; KAHNEMAN D, 1999, WELL BEING FDN HEDON, pCH1; Oswald AJ, 2010, SCIENCE, V327, P576, DOI 10.1126/science.1180606; Steptoe A, 2005, NEUROBIOL AGING, V26, pS108, DOI 10.1016/j.neurobiolaging.2005.08.016; Stiglitz J. E., 2010, FREEFALL AM FREE MAR; Urry HL, 2004, PSYCHOL SCI, V15, P367, DOI 10.1111/j.0956-7976.2004.00686.x	7	157	161	7	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 29	2010	327	5965					534	535		10.1126/science.1186315	http://dx.doi.org/10.1126/science.1186315			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	549CT	20110492				2022-12-28	WOS:000274020500023
J	Binzel, RP; Morbidelli, A; Merouane, S; DeMeo, FE; Birlan, M; Vernazza, P; Thomas, CA; Rivkin, AS; Bus, SJ; Tokunaga, AT				Binzel, Richard P.; Morbidelli, Alessandro; Merouane, Sihane; DeMeo, Francesca E.; Birlan, Mirel; Vernazza, Pierre; Thomas, Cristina A.; Rivkin, Andrew S.; Bus, Schelte J.; Tokunaga, Alan T.			Earth encounters as the origin of fresh surfaces on near-Earth asteroids	NATURE			English	Article							SPECTROSCOPIC SURVEY; SPECTRAL PROPERTIES; POPULATION; EROS	Telescopic measurements of asteroids' colours rarely match laboratory reflectance spectra of meteorites owing to a 'space weathering'(1,2) process that rapidly(3) reddens asteroid surfaces in less than 10(6) years. 'Unweathered' asteroids (those having spectra matching the most commonly falling ordinary chondrite meteorites), however, are seen among small bodies the orbits of which cross inside Mars and the Earth. Various explanations have been proposed for the origin of these fresh surface colours, ranging from collisions(4) to planetary encounters(5). Less reddened asteroids seem to cross most deeply into the terrestrial planet region, strengthening(6) the evidence for the planetary-encounter theory(5), but encounter details within 10(6) years remain to be shown. Here we report that asteroids displaying unweathered spectra (so-called 'Q-types'(7)) have experienced orbital intersections closer than the Earth-Moon distance within the past 5 x 10(5) years. These Q-type asteroids are not currently found among asteroids showing no evidence of recent close planetary encounters. Our results substantiate previous work(5): tidal stress(8), strong enough to disturb and expose unweathered surface grains, is the most likely dominant short-term asteroid resurfacing process. Although the seismology details are yet to be worked out, the identification of rapid physical processes that can produce both fresh and weathered asteroid surfaces resolves the decades-long(9) puzzle of the difference in colour of asteroids and meteorites.	[Binzel, Richard P.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Binzel, Richard P.; Birlan, Mirel] Observ Paris, IMCCE, F-75014 Paris, France; [Morbidelli, Alessandro] Univ Nice Sophia Antipolis, CNRS, Dept Cassiopee, Observ Cote Azur, F-06304 Nice, France; [Merouane, Sihane; DeMeo, Francesca E.] Observ Paris, LESIA, F-92195 Meudon, France; [Vernazza, Pierre] ESA, ESTEC, NL-2200 AG Noordwijk, Netherlands; [Thomas, Cristina A.] No Arizona Univ, Dept Phys, Flagstaff, AZ 86011 USA; [Thomas, Cristina A.] No Arizona Univ, Dept Astron, Flagstaff, AZ 86011 USA; [Rivkin, Andrew S.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Bus, Schelte J.; Tokunaga, Alan T.] Univ Hawaii, Inst Astron, Hilo, HI 96720 USA	Massachusetts Institute of Technology (MIT); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Observatoire de la Cote d'Azur; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; European Space Agency; Northern Arizona University; Northern Arizona University; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; University of Hawaii System; University Hawaii Hilo	Binzel, RP (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.	rpb@mit.edu	Birlan, Mirel/X-8359-2019; Rivkin, Andrew S/B-7744-2016; BIRLAN, Mirel I/B-5283-2011	Rivkin, Andrew S/0000-0002-9939-9976; BIRLAN, Mirel I/0000-0003-3495-8535; Tokunaga, Alan/0000-0001-8136-9704; Thomas, Cristina/0000-0003-3091-5757	National Science Foundation [0506716]; NASA [NAG5-12355]	National Science Foundation(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA))	R. P. B. is a Chercheur Associe at the Observatoire de Paris IMCCE and thanks IMCCE and LESIA for their collaboration and hospitality during the initiation of this analysis. We thank C. Chapman, B. Clark, D. Richardson and D. Nesvorny for their constructive reviews and comments. Observations reported here were obtained at the Infrared Telescope Facility, which is operated by the University of Hawaii under Cooperative Agreement NCC 5-538 with the National Aeronautics and Space Administration, Science Mission Directorate, Planetary Astronomy Program. This paper includes data gathered with the 6.5 m Magellan Telescopes located at Las Campanas Observatory, Chile. F. E. D. acknowledges funding from the Fulbright Program. This material is based upon work supported by the National Science Foundation under grant 0506716 and NASA under grant NAG5-12355. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation or NASA.	Binzel RP, 2009, ICARUS, V200, P480, DOI 10.1016/j.icarus.2008.11.028; Binzel RP, 2004, ICARUS, V170, P259, DOI 10.1016/j.icarus.2004.04.004; Bonanno C, 2000, ASTRON ASTROPHYS, V360, P411; Burbine T.H., 2003, ANTARCTIC METEORITE, V16, P185; Bus SJ, 2002, ICARUS, V158, P106, DOI 10.1006/icar.2002.6857; Chapman CR, 2004, ANNU REV EARTH PL SC, V32, P539, DOI 10.1146/annurev.earth.32.101802.120453; Clark BE, 2002, ASTEROIDS, P585, DOI DOI 10.1016/0273-1177(91)90551-T; Demeo FE, 2009, ICARUS, V202, P160, DOI 10.1016/j.icarus.2009.02.005; Gaffey M.J., 2002, ASTEROIDS, VIII, P183; Grady M.M, 2000, CATALOGUE METEORITES, V5th; Holsapple KA, 2006, ICARUS, V183, P331, DOI 10.1016/j.icarus.2006.03.013; Lazzaro D, 2004, ICARUS, V172, P179, DOI 10.1016/j.icarus.2004.06.006; LEVISON HF, 1994, ICARUS, V108, P18, DOI 10.1006/icar.1994.1039; Marchi S, 2006, MON NOT R ASTRON SOC, V368, pL39, DOI 10.1111/j.1745-3933.2006.00152.x; MCFADDEN LA, 1985, SCIENCE, V229, P160, DOI 10.1126/science.229.4709.160; Murchie S, 2002, ICARUS, V155, P145, DOI 10.1006/icar.2001.6756; Nesvorny D, 2005, ICARUS, V173, P132, DOI 10.1016/j.icarus.2004.07.026; Richardson DC, 1998, ICARUS, V134, P47, DOI 10.1006/icar.1998.5954; Saito J, 2006, SCIENCE, V312, P1341, DOI 10.1126/science.1125722; Scheeres DJ, 2007, ICARUS, V188, P430, DOI 10.1016/j.icarus.2006.12.015; Scheeres DJ, 2005, ICARUS, V178, P281, DOI 10.1016/j.icarus.2005.06.002; Strazzulla G, 2005, ICARUS, V174, P31, DOI 10.1016/j.icarus.2004.09.013; Stuart JS, 2004, ICARUS, V170, P295, DOI 10.1016/j.icarus.2004.03.018; Trombka JI, 2000, SCIENCE, V289, P2101, DOI 10.1126/science.289.5487.2101; Vernazza P, 2009, NATURE, V458, P993, DOI 10.1038/nature07956; Wetherill G., 1988, METEORITES EARLY SOL, P35; ZELLNER B, 1985, ICARUS, V61, P355, DOI 10.1016/0019-1035(85)90133-2	28	118	119	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 21	2010	463	7279					331	334		10.1038/nature08709	http://dx.doi.org/10.1038/nature08709			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545PM	20090748				2022-12-28	WOS:000273748100038
J	Flegal, KM; Carroll, MD; Ogden, CL; Curtin, LR				Flegal, Katherine M.; Carroll, Margaret D.; Ogden, Cynthia L.; Curtin, Lester R.			Prevalence and Trends in Obesity Among US Adults, 1999-2008	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS INDEX; UNITED-STATES; OVERWEIGHT; MORTALITY; WHITE; COMMUNITIES; POPULATION; WEIGHT; HEALTH; FAT	Context The prevalence of obesity increased in the United States between 19761980 and 1988-1994 and again between 1988-1994 and 1999-2000. Objective To examine trends in obesity from 1999 through 2008 and the current prevalence of obesity and overweight for 2007-2008. Design, Setting, and Participants Analysis of height and weight measurements from 5555 adult men and women aged 20 years or older obtained in 2007-2008 as part of the National Health and Nutrition Examination Survey (NHANES), a nationally representative sample of the US population. Data from the NHANES obtained in 20072008 were compared with results obtained from 1999 through 2006. Main Outcome Measure Estimates of the prevalence of overweight and obesity in adults. Overweight was defined as a body mass index (BMI) of 25.0 to 29.9. Obesity was defined as a BMI of 30.0 or higher. Results In 2007-2008, the age-adjusted prevalence of obesity was 33.8% (95% confidence interval [CI], 31.6%-36.0%) overall, 32.2% (95% CI, 29.5%-35.0%) among men, and 35.5% (95% CI, 33.2%-37.7%) among women. The corresponding prevalence estimates for overweight and obesity combined (BMI >= 25) were 68.0% (95% CI, 66.3%-69.8%), 72.3% (95% CI, 70.4%-74.1%), and 64.1% (95% CI, 61.3%-66.9%). Obesity prevalence varied by age group and by racial and ethnic group for both men and women. Over the 10-year period, obesity showed no significant trend among women (adjusted odds ratio [AOR] for 2007-2008 vs 1999-2000, 1.12 [95% CI, 0.89-1.32]). For men, there was a significant linear trend (AOR for 2007-2008 vs 1999-2000, 1.32 [95% CI, 1.12-1.58]); however, the 3 most recent data points did not differ significantly from each other. Conclusions In 2007-2008, the prevalence of obesity was 32.2% among adult men and 35.5% among adult women. The increases in the prevalence of obesity previously observed do not appear to be continuing at the same rate over the past 10 years, particularly for women and possibly for men. JAMA. 2010;303(3):235-241	[Flegal, Katherine M.; Carroll, Margaret D.; Ogden, Cynthia L.; Curtin, Lester R.] Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Hyattsville, MD 20782 USA	Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS)	Flegal, KM (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, 3311 Toledo Rd,Room 4315, Hyattsville, MD 20782 USA.	kmf2@cdc.gov	Flegal, Katherine M/A-4608-2013; FENTON, MIRIAM C/B-6430-2011	Flegal, Katherine/0000-0002-0838-469X				Abell JE, 2008, AM J PUBLIC HEALTH, V98, P63, DOI 10.2105/AJPH.2006.093781; Aloia JF, 1999, OSTEOPOROSIS INT, V10, P114, DOI 10.1007/s001980050204; Berghofer A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-200; Bouchard C, 2008, INT J OBESITY, V32, pS2, DOI 10.1038/ijo.2008.231; Costa DL, 1997, NAT BUR EC, P47; Cowie CC, 2009, DIABETES CARE, V32, P287, DOI 10.2337/dc08-1296; Cutler JA, 2008, HYPERTENSION, V52, P818, DOI 10.1161/HYPERTENSIONAHA.108.113357; Ferndandez JR, 2003, AM J CLIN NUTR, V77, P71, DOI 10.1093/ajcn/77.1.71; Flegal C.L, OBESITY ADULTS US NO; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; Flegal KM, 2009, AM J CLIN NUTR, V89, P500, DOI 10.3945/ajcn.2008.26847; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Gallagher D, 1996, AM J EPIDEMIOL, V143, P228, DOI 10.1093/oxfordjournals.aje.a008733; Giang T, 2008, J PUBLIC HEALTH MAN, V14, P272, DOI 10.1097/01.PHH.0000316486.57512.bf; Glanz K, 2004, PREV MED, V39, pS75, DOI 10.1016/j.ypmed.2004.01.004; Gregg EW, 2005, JAMA-J AM MED ASSOC, V293, P1868, DOI 10.1001/jama.293.15.1868; Gu DF, 2006, JAMA-J AM MED ASSOC, V295, P776, DOI 10.1001/jama.295.7.776; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; KUCZMARSKI RJ, 1994, JAMA-J AM MED ASSOC, V272, P205, DOI 10.1001/jama.272.3.205; Kumanyika SK, 2008, CIRCULATION, V118, P428, DOI 10.1161/CIRCULATIONAHA.108.189702; Malnick SDH, 2006, QJM-INT J MED, V99, P565, DOI 10.1093/qjmed/hcl085; McKinlay J, 2000, LANCET, V356, P757, DOI 10.1016/S0140-6736(00)02641-6; Misra A, 2003, INT J OBESITY, V27, P1294, DOI 10.1038/sj.ijo.0802412; National Center for Health Statistics, 2008, HLTH US 2008 CHARTB; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Orpana HM, 2010, OBESITY, V18, P214, DOI 10.1038/oby.2009.191; Pi-Sunyer FX, 1998, AM J CLIN NUTR, V68, P899; Rahman M, 2009, METABOLISM, V58, P1329, DOI 10.1016/j.metabol.2009.04.017; Ross R, 2009, NAT REV ENDOCRINOL, V5, P319, DOI 10.1038/nrendo.2009.78; Sanchez Ana M., 2000, Ethnicity and Disease, V10, P24; Stevens J, 1998, OBES RES, V6, P268, DOI 10.1002/j.1550-8528.1998.tb00349.x; Stevens J, 2003, INT J OBESITY, V27, P287, DOI 10.1038/sj.ijo.0802255; Tjepkema Michael, 2006, Health Rep, V17, P9; Velleman P. F., 1981, APPL BASICS COMPUTIN; WHO, 2004, LANCET, V363, P902; WHO Expert Committee on Physical Status: the Use and Interpretation of Anthropometry (1993: Geneva S Organization WH, 1995, PHYS STAT US INT ANT	37	4664	4758	7	255	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 20	2010	303	3					235	241		10.1001/jama.2009.2014	http://dx.doi.org/10.1001/jama.2009.2014			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	544WM	20071471	Bronze			2022-12-28	WOS:000273690600019
J	Barkun, AN; Bardou, M; Kuipers, EJ; Sung, J; Hunt, RH; Martel, M; Sinclair, P				Barkun, Alan N.; Bardou, Marc; Kuipers, Ernst J.; Sung, Joseph; Hunt, Richard H.; Martel, Myriam; Sinclair, Paul		Int Consensus Upper Gastrointestin	International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding	ANNALS OF INTERNAL MEDICINE			English	Review							HELICOBACTER-PYLORI INFECTION; PROTON-PUMP INHIBITORS; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; TRANSCATHETER ARTERIAL EMBOLIZATION; DOSE OMEPRAZOLE INFUSION; RAPID UREASE TEST; LOW-RISK PATIENTS; ENDOSCOPIC INJECTION THERAPY; NONBLEEDING VISIBLE VESSELS; COST-EFFECTIVENESS ANALYSIS	Description: A multidisciplinary group of 34 experts from 15 countries developed this update and expansion of the recommendations on the management of acute nonvariceal upper gastrointestinal bleeding (UGIB) from 2003. ethods: The Appraisal of Guidelines for Research and Evaluation (AGREE) process and independent ethics protocols were used. Sources of data included original and published systematic reviews; randomized, controlled trials; and abstracts up to October 2008. Quality of evidence and strength of recommendations have been rated by using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) criteria. Recommendations: Recommendations emphasize early risk stratification, by using validated prognostic scales, and early endoscopy (within 24 hours). Endoscopic hemostasis remains indicated for high-risk lesions, whereas data support attempts to dislodge clots with hemostatic, pharmacologic, or combination treatment of the underlying stigmata. Clips or thermocoagulation, alone or with epinephrine injection, are effective methods; epinephrine injection alone is not recommended. Second-look endoscopy may be useful in selected high-risk patients but is not routinely recommended. Preendoscopy proton-pump inhibitor (PPI) therapy may downstage the lesion; intravenous high-dose PPI therapy after successful endoscopic hemostasis decreases both rebleeding and mortality in patients with high-risk stigmata. Although selected patients can be discharged promptly after endoscopy, high-risk patients should be hospitalized for at least 72 hours after endoscopic hemostasis. For patients with UGIB who require a nonsteroidal anti-inflammatory drug, a PPI with a cyclooxygenase-2 inhibitor is preferred to reduce rebleeding. Patients with UGIB who require secondary cardiovascular prophylaxis should start receiving acetylsalicylic acid (ASA) again as soon as cardiovascular risks outweigh gastrointestinal risks (usually within 7 days); ASA plus PPI therapy is preferred over clopidogrel alone to reduce rebleeding.	[Barkun, Alan N.] McGill Univ, Ctr Hlth, Montreal Gen Hosp Site, Div Gastroenterol, Montreal, PQ H3G 1A4, Canada; Ctr Hosp Univ Dijon, Serv Pharmacol, F-21004 Dijon, France; Ctr Hosp Univ Dijon, CIC P 803, INSERM, F-21004 Dijon, France; Erasmus MC Univ Med Ctr, Rotterdam, Netherlands; Chinese Univ Hong Kong, Shatin, Hong Kong, Peoples R China; McMaster Univ, Hlth Sci Ctr, Hamilton, ON, Canada; Canadian Assoc Gastroenterol, Oakville, ON, Canada	McGill University; CHU Dijon Bourgogne; CHU Dijon Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); Erasmus University Rotterdam; Erasmus MC; Chinese University of Hong Kong; McMaster University; University of Manitoba; Children's Hospital Research Institute of Manitoba	Barkun, AN (corresponding author), McGill Univ, Ctr Hlth, Montreal Gen Hosp Site, Div Gastroenterol, 1650 Cedar Ave,Room D7-148, Montreal, PQ H3G 1A4, Canada.		Kuipers, Ernst J/H-3293-2019; Sung, Joseph J. Y./R-3203-2018; Martel, Myriam/ABB-3862-2020; Calvet, Xavier/H-3288-2019; Moayyedi, Paul/M-6178-2014	Kuipers, Ernst J/0000-0002-0633-3098; Sung, Joseph J. Y./0000-0003-3125-5199; Calvet, Xavier/0000-0002-6278-9663; Moayyedi, Paul/0000-0002-3616-9292; Calvet, Xavier/0000-0002-4413-4209; Romagnuolo, Joseph/0000-0002-5630-3022; QUENOT, Jean-Pierre/0000-0003-2351-682X	Canadian Association of Gastroenterology; European Association for Gastroenterology and Endoscopy; Asian Pacific Society of Digestive Endoscopy; Canadian Institutes of Health Research; AstraZeneca Molndal; Abbott Canada; Olympus Canada	Canadian Association of Gastroenterology; European Association for Gastroenterology and Endoscopy; Asian Pacific Society of Digestive Endoscopy; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); AstraZeneca Molndal(AstraZeneca); Abbott Canada(Abbott Laboratories); Olympus Canada	Grant Support: By the Canadian Association of Gastroenterology; European Association for Gastroenterology and Endoscopy; Asian Pacific Society of Digestive Endoscopy; and Institute of Diabetes, Metabolism, and Nutrition ( of the Canadian Institutes of Health Research), and at-arms-length contributions to these societies from AstraZeneca Molndal, Abbott Canada, and Olympus Canada.	*ACC, 2008, JOINT COMM STUD REG; Adamopoulos AB, 2003, EUR J GASTROEN HEPAT, V15, P381, DOI 10.1097/00042737-200304000-00008; Aguejouf O, 2009, CLIN APPL THROMB-HEM, V15, P523, DOI 10.1177/1076029608319945; Al-Sabah S, 2008, CLIN GASTROENTEROL H, V6, P418, DOI 10.1016/j.cgh.2007.12.037; Almela P, 2004, GASTROINTEST ENDOSC, V59, P772, DOI 10.1016/S0016-5107(04)00362-1; *AM ACCR COUNC CON, 2007, ACCME STAND COMM SUP; Amer Soc Anesthesiologists Task Fo, 2006, ANESTHESIOLOGY, V105, P198; Ananthakrishnan AN, 2009, CLIN GASTROENTEROL H, V7, P296, DOI 10.1016/j.cgh.2008.08.013; Archimandritis A, 2000, J GASTROEN HEPATOL, V15, P369, DOI 10.1046/j.1440-1746.2000.02171.x; Armstrong D, 2005, CAN J GASTROENTEROL, V19, P15, DOI 10.1155/2005/836030; Aseeri M, 2008, AM J GASTROENTEROL, V103, P2308, DOI 10.1111/j.1572-0241.2008.01975.x; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Bajaj JS, 2007, DIGEST DIS SCI, V52, P2190, DOI 10.1007/s10620-006-9282-2; Baradarian R, 2004, AM J GASTROENTEROL, V99, P619, DOI 10.1111/j.1572-0241.2004.04073.x; Barkun A, 2003, ANN INTERN MED, V139, P843, DOI 10.7326/0003-4819-139-10-200311180-00012; Barkun A, 2004, AM J GASTROENTEROL, V99, P1238, DOI 10.1111/j.1572-0241.2004.30272.x; BARKUN A, 2006, CAN J GASTROENTEROL, V20, pA80; BARKUN A, 2009, GASTROENTEROLOGY, V134; Barkun AN, 2008, GASTROINTEST ENDOSC, V67, P1064, DOI 10.1016/j.gie.2008.02.040; Barkun A, 2008, GASTROENTEROLOGY, V134, pA167; Barkun AN, 2009, GASTROINTEST ENDOSC, V69, P786, DOI 10.1016/j.gie.2008.05.031; Barkun AN, 2004, ALIMENT PHARM THER, V19, P591, DOI 10.1046/j.1365-2036.2004.01808.x; Bellotto F, 2005, AM J MED, V118, P548, DOI 10.1016/j.amjmed.2005.01.026; Bensoussan K, 2005, CAN J GASTROENTEROL, V19, P487, DOI 10.1155/2005/198387; Bhatt DL, 2008, CIRCULATION, V118, P1894, DOI 10.1161/CIRCULATIONAHA.108.191087; Biondi-Zoccai GGL, 2006, EUR HEART J, V27, P2667, DOI 10.1093/eurheartj/ehl334; Bjorkman DJ, 2004, GASTROINTEST ENDOSC, V60, P1, DOI 10.1016/S0016-5107(04)01287-8; Blatchford O, 2000, LANCET, V356, P1318, DOI 10.1016/S0140-6736(00)02816-6; Bleau BL, 2002, GASTROINTEST ENDOSC, V56, P1, DOI 10.1067/mge.2002.125365; Bracey AW, 1999, TRANSFUSION, V39, P1070, DOI 10.1046/j.1537-2995.1999.39101070.x; Brullet E, 2004, GASTROINTEST ENDOSC, V60, P15, DOI 10.1016/S0016-5107(04)01314-8; Brullet E, 1996, GUT, V39, P155, DOI 10.1136/gut.39.2.155; Burger W, 2005, J INTERN MED, V257, P399, DOI 10.1111/j.1365-2796.2005.01477.x; Calvet X, 2004, GASTROENTEROLOGY, V126, P441, DOI 10.1053/j.gastro.2003.11.006; CALVET X, 2009, GASTROENTEROLOGY, V134; Camellini L, 2004, DIGEST LIVER DIS, V36, P271, DOI 10.1016/j.dld.2003.10.017; *CAN ASS GASTR, POL APPL IMPL CLIN P; *CAN MED ASS, 2007, GUID PHYS INT IND; Carbonell N, 2006, AM J GASTROENTEROL, V101, P1211, DOI 10.1111/j.1572-0241.2006.00582.x; Castro-Fernandez M, 2004, REV ESP ENFERM DIG, V96, P395; Chan AT, 2008, GASTROENTEROLOGY, V134, pA113; Chan FKL, 2005, NEW ENGL J MED, V352, P238, DOI 10.1056/NEJMoa042087; Chan FKL, 2004, GASTROENTEROLOGY, V127, P1038, DOI 10.1053/j.gastro.2004.07.010; Chan FKL, 2002, NEW ENGL J MED, V347, P2104, DOI 10.1056/NEJMoa021907; Chan FKL, 2008, AM J GASTROENTEROL, V103, P2908, DOI 10.1111/j.1572-0241.2008.02200.x; Chan FKL, 2007, LANCET, V369, P1621, DOI 10.1016/S0140-6736(07)60749-1; Chen GC, 2007, AM J EMERG MED, V25, P774, DOI 10.1016/j.ajem.2006.12.024; Chiu PW, 2006, GASTROENTEROLOGY, V130, pA121; Chiu PWY, 2009, CLIN GASTROENTEROL H, V7, P311, DOI 10.1016/j.cgh.2008.08.044; Chiu PW, 2009, CLIN GASTROENTEROL H, V7, P253; Chiu PWY, 2003, GUT, V52, P1403, DOI 10.1136/gut.52.10.1403; CHIU PWY, 2003, ANN COLL SURG HONG K, V7, P106; Chong E, 2003, PHARMACOTHERAPY, V23, P460, DOI 10.1592/phco.23.4.460.32128; CHOUDARI CP, 1994, GUT, V35, P464, DOI 10.1136/gut.35.4.464; Chung Il-Kwun, 2001, Korean Journal of Internal Medicine, V16, P147; CHUNG SCS, 1991, GASTROENTEROLOGY, V100, P33, DOI 10.1016/0016-5085(91)90579-A; Church NI, 2006, GASTROINTEST ENDOSC, V63, P606, DOI 10.1016/j.gie.2005.06.042; Cipolletta L, 2002, GASTROINTEST ENDOSC, V55, P1, DOI 10.1067/mge.2002.119219; Coffin B, 2002, GASTROINTEST ENDOSC, V56, P174, DOI 10.1067/mge.2002.126135; Colin R, 2000, GASTROEN CLIN BIOL, V24, P31; Cook DJ, 1997, ANN INTERN MED, V127, P210, DOI 10.7326/0003-4819-127-3-199708010-00006; Cooper GS, 2009, GASTROINTEST ENDOSC, V70, P229, DOI 10.1016/j.gie.2008.10.052; Cooper GS, 2009, GASTROENTEROLOGY, V136, P108, DOI 10.1053/j.gastro.2008.09.030; DALKEY N, 1969, FUTURES, V1, P408, DOI 10.1016/S0016-3287(69)80025-X; DALTON D, 2007, UK COMP AUDIT UPPER; Defreyne L, 2001, RADIOLOGY, V218, P739, DOI 10.1148/radiology.218.3.r01mr05739; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Demiray E, 2006, WORLD J GASTROENTERO, V12, P4206, DOI 10.3748/wjg.v12.i26.4206; Dial S, 2005, JAMA-J AM MED ASSOC, V294, P2989, DOI 10.1001/jama.294.23.2989; Dial S, 2004, CAN MED ASSOC J, V171, P33, DOI 10.1503/cmaj.1040876; Dorward S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005415.pub2; Dunn SP, 2008, CIRCULATION, V118, pS815; El-Serag HB, 2002, ARCH INTERN MED, V162, P2105, DOI 10.1001/archinte.162.18.2105; Ell C, 1998, GASTROINTEST ENDOSC, V47, pAB83; Elmunzer BJ, 2008, AM J GASTROENTEROL, V103, P2625, DOI 10.1111/j.1572-0241.2008.02070.x; Enns RA, 2006, WORLD J GASTROENTERO, V12, P7779, DOI 10.3748/wjg.v12.i48.7779; Erstad BL, 2004, CRIT CARE MED, V32, P1277, DOI 10.1097/01.CCM.0000127261.09066.6E; Focareta R, 2004, DIGEST LIVER DIS, V36, pS250; Frossard JL, 2002, GASTROENTEROLOGY, V123, P17, DOI 10.1053/gast.2002.34230; Gevers AM, 2002, GASTROINTEST ENDOSC, V55, P466, DOI 10.1067/mge.2002.112613; Gilard M, 2008, J AM COLL CARDIOL, V51, P256, DOI 10.1016/j.jacc.2007.06.064; Gisbert JP, 2007, HELICOBACTER, V12, P231, DOI 10.1111/j.1523-5378.2007.00492.x; Gisbert JP, 2006, AM J GASTROENTEROL, V101, P848, DOI 10.1111/j.1572-0241.2006.00528.x; Gisbert JP, 2006, J CLIN GASTROENTEROL, V40, P129, DOI 10.1097/01.mcg.0000196187.19426.03; Gisbert JP, 2004, ALIMENT PHARM THER, V19, P617, DOI 10.1111/j.1365-2036.2004.01898.x; Gisbert JP, 2004, ALIMENT PHARM THER, V19, P923, DOI 10.1111/j.1365-2036.2004.01932.x; Gralnek IM, 2008, NEW ENGL J MED, V359, P928, DOI 10.1056/NEJMra0706113; Grino P, 2003, EUR J GASTROEN HEPAT, V15, P525, DOI [10.1097/00042737-200305000-00011, 10.1097/01.meg.0000059114.41030.a9]; Grino P, 2001, SCAND J GASTROENTERO, V36, P1254, DOI 10.1080/003655201317097083; Guell M, 2006, ALIMENT PHARM THER, V23, P53, DOI 10.1111/j.1365-2036.2006.02726.x; Guyatt GH, 2008, CHEST, V133, p123S, DOI 10.1378/chest.08-0654; Habashi SL, 2007, AM J GASTROENTEROL, V102, pS526, DOI 10.14309/00000434-200709002-01114; Hanvivatvong Orrawadee, 2006, J Med Assoc Thai, V89 Suppl 3, pS98; Hay JA, 1997, JAMA-J AM MED ASSOC, V278, P2151, DOI 10.1001/jama.278.24.2151; HAYES S, 2007, AM COLL GASTR ANN M; HEARNSHAW S, 2009, GUT IN PRESS; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Ho PM, 2009, JAMA-J AM MED ASSOC, V301, P937, DOI 10.1001/jama.2009.261; Holme JB, 2006, ACTA RADIOL, V47, P244, DOI 10.1080/02841850600550690; HSU PI, 1994, GUT, V35, P746, DOI 10.1136/gut.35.6.746; Hsu PI, 1996, GASTROINTEST ENDOSC, V44, P382, DOI 10.1016/S0016-5107(96)70085-8; Hsu PI, 2004, WORLD J GASTROENTERO, V10, P3666, DOI 10.3748/wjg.v10.i24.3666; Imperiale TF, 2007, ARCH INTERN MED, V167, P1291, DOI 10.1001/archinte.167.12.1291; Jang JY, 2006, GASTROENTEROLOGY, V130, pA467; Jensen DM, 2006, AM J GASTROENTEROL, V101, P1991, DOI 10.1111/j.1572-0241.2006.00773.x; Jensen DM, 2002, GASTROENTEROLOGY, V123, P407, DOI 10.1053/gast.2002.34782; JENSEN DM, 2006, AM J GASTROENTEROL, V101, P2170; Juurlink DN, 2009, CAN MED ASSOC J, V180, P713, DOI 10.1503/cmaj.082001; Kahi CJ, 2005, GASTROENTEROLOGY, V129, P855, DOI 10.1053/j.gastro.2005.06.070; Kearney PM, 2006, BMJ-BRIT MED J, V332, P1302, DOI 10.1136/bmj.332.7553.1302; Khoshbaten M, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-2; Kim SK, 2005, TECH GASTROINTEST EN, V7, P148, DOI 10.1016/j.tgie.2005.04.012; Klok RM, 2003, ALIMENT PHARM THER, V17, P1237, DOI 10.1046/j.1365-2036.2003.01562.x; Lai KC, 2006, CLIN GASTROENTEROL H, V4, P860, DOI 10.1016/j.cgh.2006.04.019; Lai KC, 2005, AM J MED, V118, P1271, DOI 10.1016/j.amjmed.2005.04.031; Lai KC, 1997, GASTROINTEST ENDOSC, V45, P26, DOI 10.1016/S0016-5107(97)70299-2; LAI KC, 1996, GASTROENTEROLOGY S, V110, pA167; LAI KH, 1994, ENDOSCOPY, V26, P338, DOI 10.1055/s-2007-1008987; Laine L, 2005, GASTROENTEROLOGY, V129, P2127, DOI 10.1053/j.gastro.2005.10.039; Laine L, 1996, GASTROINTEST ENDOSC, V43, P107, DOI 10.1016/S0016-5107(06)80109-4; Laine L, 2007, LANCET, V369, P465, DOI 10.1016/S0140-6736(07)60234-7; Laine L, 2009, CLIN GASTROENTEROL H, V7, P33, DOI 10.1016/j.cgh.2008.08.016; Lanas A, 2009, AM J GASTROENTEROL, V104, P1633, DOI 10.1038/ajg.2009.164; Lassen A, 2006, AM J GASTROENTEROL, V101, P945, DOI 10.1111/j.1572-0241.2006.00518.x; Lau JY, 2007, NEW ENGL J MED, V356, P1631, DOI 10.1056/NEJMoa065703; Lau JYW, 2000, NEW ENGL J MED, V343, P310, DOI 10.1056/NEJM200008033430501; Lau JYW, 1999, NEW ENGL J MED, V340, P751, DOI 10.1056/NEJM199903113401002; Lau JYW, 1998, ENDOSCOPY, V30, P513, DOI 10.1055/s-2007-1001336; Lee JG, 1999, GASTROINTEST ENDOSC, V50, P755, DOI 10.1016/S0016-5107(99)70154-9; Lee JM, 2000, AM J GASTROENTEROL, V95, P1166, DOI 10.1111/j.1572-0241.2000.02004.x; Lee KKC, 2003, GASTROINTEST ENDOSC, V57, P160, DOI 10.1067/mge.2003.74; Lee SY, 2005, GASTROENTEROLOGY, V128, pA639; LEONTIADIS G, 2009, GASTROENTEROLOGY, V134; Leontiadis GI, 2007, HEALTH TECHNOL ASSES, V11, P1; Leontiadis GI, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002094.pub3; Lewis JD, 2002, AM J GASTROENTEROL, V97, P2540; Liao CC, 2003, CHINESE MED J-PEKING, V116, P1821; Liao CC, 2001, GUT, V49, pA102; Lin CK, 1996, GASTROENTEROLOGY, V110, pA177; Lin HJ, 1998, ARCH INTERN MED, V158, P54, DOI 10.1001/archinte.158.1.54; Lin HJ, 1996, GASTROINTEST ENDOSC, V43, P470; Lin HJ, 2006, AM J GASTROENTEROL, V101, P500, DOI 10.1111/j.1572-0241.2006.00399.x; LIN HJ, 1994, GUT, V35, P1389, DOI 10.1136/gut.35.10.1389; Lin HJ, 2004, HELICOBACTER, V9, P663, DOI 10.1111/j.1083-4389.2004.00276.x; Lin HJ, 1996, J CLIN GASTROENTEROL, V22, P267, DOI 10.1097/00004836-199606000-00005; Ljungdahl M, 2002, EUR J SURG, V168, P384, DOI 10.1080/110241502320789050; Lo CC, 2005, WORLD J GASTROENTERO, V11, P3909; Loffroy R, 2008, J CLIN GASTROENTEROL, V42, P361, DOI 10.1097/MCG.0b013e3180319177; Longstreth GF, 1998, GASTROINTEST ENDOSC, V47, P219, DOI 10.1016/S0016-5107(98)70316-5; Maetzel A, 2003, ARTHRIT RHEUM-ARTHR, V49, P283, DOI 10.1002/art.11121; Marik PE, 2008, CRIT CARE MED, V36, P2667, DOI 10.1097/CCM.0b013e3181844677; Marmo R, 2003, GASTROINTEST ENDOSC, V57, P62, DOI 10.1067/mge.2003.48; Marmo R, 2007, AM J GASTROENTEROL, V102, P469; Marmo R, 2007, AM J GASTROENTEROL, V102, P279, DOI 10.1111/j.1572-0241.2006.01023.x; Masaoka T, 2007, J GASTROEN HEPATOL, V22, P1404, DOI 10.1111/j.1440-1746.2006.04762.x; Messmann H, 1998, ENDOSCOPY, V30, P583, DOI 10.1055/s-2007-1001360; Moayyedi P, 2009, CAN J GASTROENTEROL, V23, P251, DOI 10.1155/2009/868946; Moreno P, 1998, AM J MED, V105, P176, DOI 10.1016/S0002-9343(98)00243-5; Naumovski-Mihalic S, 2005, GASTROENTEROLOGY, V128, pA641; NAUMOVSKIMIHALI.S, 2007, GUT, V56, pA234; Ng FH, 2004, ALIMENT PHARM THER, V19, P359, DOI 10.1111/j.1365-2036.2004.01857.x; O'Donoghue ML, 2009, LANCET, V374, P989, DOI 10.1016/S0140-6736(09)61525-7; Oei TT, 2002, AM J GASTROENTEROL, V97, P2271; Okazaki K, 2002, GUT, V51, P1, DOI 10.1136/gut.51.1.1; Palda VA, 2007, CAN MED ASSOC J, V177, P1221, DOI 10.1503/cmaj.070880; Peitz U, 2003, ALIMENT PHARM THER, V17, P1075, DOI 10.1046/j.1365-2036.2003.01548.x; Poultsides GA, 2008, ARCH SURG-CHICAGO, V143, P457, DOI 10.1001/archsurg.143.5.457; Rahme E, 2007, ARTHRIT RHEUM-ARTHR, V57, P748, DOI 10.1002/art.22764; Ripoll C, 2004, J VASC INTERV RADIOL, V15, P447; Robins GG, 2007, POSTGRAD MED J, V83, P768, DOI 10.1136/pgmj.2007.061614; Rockall TA, 1996, LANCET, V347, P1138, DOI 10.1016/S0140-6736(96)90607-8; Rockall TA, 1996, GUT, V38, P316, DOI 10.1136/gut.38.3.316; Romagnuolo J, 2005, INT J QUAL HEALTH C, V17, P249, DOI 10.1093/intqhc/mzi023; Romagnuolo J, 2004, CAN J GASTROENTEROL, V18, P401, DOI 10.1155/2004/454252; Romagnuolo J, 2007, ARCH INTERN MED, V167, P265, DOI 10.1001/archinte.167.3.265; Rostom A, 2009, ALIMENT PHARM THER, V29, P481, DOI 10.1111/j.1365-2036.2008.03905.x; Rostom A, 2007, ANN INTERN MED, V146, P376, DOI 10.7326/0003-4819-146-5-200703060-00010; Roughead EE, 2009, MED J AUSTRALIA, V190, P114, DOI 10.5694/j.1326-5377.2009.tb02307.x; Rutgeerts P, 1997, LANCET, V350, P692, DOI 10.1016/S0140-6736(97)03233-9; SADOWSKI DC, 2009, PROTON PUMP INHIBITO; Saeed ZA, 1996, ENDOSCOPY, V28, P288, DOI 10.1055/s-2007-1005455; Schacher GM, 2005, ENDOSCOPY, V37, P324, DOI 10.1055/s-2004-826237; Scheiman JM, 2006, AM J GASTROENTEROL, V101, P701, DOI 10.1111/j.1572-0241.2006.00499.x; Schilling D, 2003, DIGEST LIVER DIS, V35, P217, DOI 10.1016/S1590-8658(03)00058-6; Shi SJ, 2008, EUR J CLIN PHARMACOL, V64, P935, DOI 10.1007/s00228-008-0538-y; Sibon I, 2004, NEUROLOGY, V62, P1187, DOI 10.1212/01.WNL.0000118288.04483.02; Simon T, 2009, NEW ENGL J MED, V360, P363, DOI 10.1056/NEJMoa0808227; Small DS, 2008, J CLIN PHARMACOL, V48, P475, DOI 10.1177/0091270008315310; Soncini M, 2007, EUR J GASTROEN HEPAT, V19, P543, DOI 10.1097/MEG.0b013e3281532b89; Spiegel BMR, 2005, ARTHRIT RHEUM-ARTHR, V53, P185, DOI 10.1002/art.21065; Spiegel BMR, 2003, AM J GASTROENTEROL, V98, P86; Spiegel BMR, 2001, ARCH INTERN MED, V161, P1393, DOI 10.1001/archinte.161.11.1393; SREEDHARAN A, 2009, GASTROENTEROLOGY, V134; Stanley AJ, 2009, LANCET, V373, P42, DOI 10.1016/S0140-6736(08)61769-9; SUNG J, 2007, GUT, V56, pA27; Sung JJY, 2003, ANN INTERN MED, V139, P237, DOI 10.7326/0003-4819-139-4-200308190-00005; Sung JJY, 2007, GUT, V56, P1364, DOI 10.1136/gut.2007.123976; Sung JJY, 2009, ANN INTERN MED, V150, P455, DOI 10.7326/0003-4819-150-7-200904070-00105; Sussman DA., 2008, GASTROINTEST ENDOSC, V67, pAB247; Tai CM, 2007, AM J EMERG MED, V25, P273, DOI 10.1016/j.ajem.2006.07.014; Targownik LE, 2008, CAN MED ASSOC J, V179, P319, DOI 10.1503/cmaj.071330; Targownik LE, 2008, GASTROENTEROLOGY, V134, P937, DOI 10.1053/j.gastro.2008.01.010; Targownik LE, 2007, CAN J GASTROENTEROL, V21, P425, DOI 10.1155/2007/636032; Targownik LE, 2006, CLIN GASTROENTEROL H, V4, P1459, DOI 10.1016/j.cgh.2006.08.018; The AGREE Collaboration, 2001, APPR GUID RES EV AGR; TOYODA H, 1995, ENDOSCOPY, V27, P304, DOI 10.1055/s-2007-1005697; Tripodi A, 2007, ALIMENT PHARM THERAP, V26, P141, DOI 10.1111/j.1365-2036.2007.03369.x; TSOI K, 2008, GUT, V57, pA355; Tsoi KKF, 2008, GASTROINTEST ENDOSC, V67, P1056, DOI 10.1016/j.gie.2007.11.056; Tu TC, 1999, GASTROINTEST ENDOSC, V49, P302, DOI 10.1016/S0016-5107(99)70005-2; US FDA, 2009, PLAV CLOP BIS 75 MG; van Leerdam ME, 2003, AM J GASTROENTEROL, V98, P1494, DOI 10.1016/S0002-9270(03)00299-5; van Leerdam ME, 2003, AM J GASTROENTEROL, V98, P798, DOI [10.1016/S0002-9270(03)00051-0, 10.1111/j.1572-0241.2003.07387.x]; Vergara M, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005584.pub2; VILLANUEVA C, 1994, GASTROINTEST ENDOSC, V40, P34, DOI 10.1016/S0016-5107(94)70006-0; VILLANUEVA C, 1993, DIGEST DIS SCI, V38, P2062, DOI 10.1007/BF01297086; Viviane A, 2008, VALUE HEALTH, V11, P1, DOI 10.1111/j.1524-4733.2007.00208.x; Vreeburg EM, 1999, GUT, V44, P331, DOI 10.1136/gut.44.3.331; Wei KL, 2007, J GASTROEN HEPATOL, V22, P43, DOI 10.1111/j.1440-1746.2006.04354.x; Wildner-Christensen M, 2002, DIGESTION, V66, P9, DOI 10.1159/000064421; Winiarski M, 2003, J CLIN GASTROENTEROL, V37, P34, DOI 10.1097/00004836-200307000-00010; Winstead NS, 2007, ALIMENT PHARM THERAP, V26, P1371, DOI 10.1111/j.1365-2036.2007.03516.x; Wolf AT, 2007, AM J GASTROENTEROL, V102, P290, DOI 10.1111/j.1572-0241.2006.00969.x; Yuan Y, 2008, GASTROINTEST ENDOSC, V68, P339, DOI 10.1016/j.gie.2008.03.1122; Zargar SA, 2006, J GASTROEN HEPATOL, V21, P716, DOI 10.1111/j.1440-1746.2006.04292.x	225	749	831	3	76	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 19	2010	152	2					101	+		10.7326/0003-4819-152-2-201001190-00009	http://dx.doi.org/10.7326/0003-4819-152-2-201001190-00009			21	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	548IE	20083829				2022-12-28	WOS:000273953000005
J	Reynolds, T				Reynolds, Tim			A lifestyle intervention improved obstructive sleep apnea more than support and education in obese patients with diabetes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Queens Hosp, Burton Upon Trent, England		Reynolds, T (corresponding author), Queens Hosp, Burton Upon Trent, England.							Grunstein RR, 2007, SLEEP, V30, P703, DOI 10.1093/sleep/30.6.703; STRADLING JR, 1991, THORAX, V46, P85, DOI 10.1136/thx.46.2.85; Torgerson JS, 2004, DIABETES CARE, V27, P155, DOI 10.2337/diacare.27.1.155; Wadden TA, 2004, OBES RES, V12, p151S, DOI 10.1038/oby.2004.282	4	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 19	2010	152	2							JC1-5	10.7326/0003-4819-152-2-201001190-02005	http://dx.doi.org/10.7326/0003-4819-152-2-201001190-02005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	548IE	20083820				2022-12-28	WOS:000273953000029
J	Eckel, RH; Alberti, KGMM; Grundy, SM; Zimmet, PZ				Eckel, Robert H.; Alberti, K. G. M. M.; Grundy, Scott M.; Zimmet, Paul Z.			The metabolic syndrome	LANCET			English	Editorial Material							CARDIORESPIRATORY FITNESS; CARDIOVASCULAR EVENTS; RISK-FACTORS; MEN; MORTALITY		[Eckel, Robert H.] Univ Colorado, Denver Sch Med, Denver, CO 80045 USA; [Alberti, K. G. M. M.] Univ London Imperial Coll Sci Technol & Med, London, England; [Grundy, Scott M.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Zimmet, Paul Z.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Imperial College London; University of Texas System; University of Texas Southwestern Medical Center Dallas; Baker Heart and Diabetes Institute	Eckel, RH (corresponding author), Univ Colorado, Denver Sch Med, Anschutz Med Campus, Denver, CO 80045 USA.	robert.eckel@ucdenver.edu						Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Cameron AJ, 2008, OBESITY, V16, P2707, DOI 10.1038/oby.2008.412; Cornier MA, 2008, ENDOCR REV, V29, P777, DOI 10.1210/er.2008-0024; Cubbon RM, 2009, CLIN SCI, V117, P173, DOI 10.1042/CS20080263; Ford ES, 2008, DIABETES CARE, V31, P1898, DOI 10.2337/dc08-0423; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Garaulet M, 2009, CURR OPIN LIPIDOL, V20, P127, DOI 10.1097/MOL.0b013e3283292399; Grundy SM, 2006, NAT REV DRUG DISCOV, V5, P294, DOI 10.1038/nrd2005; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Junyent M, 2009, J NUTR, V139, P842, DOI 10.3945/jn.108.101196; Kahn R, 2005, DIABETES CARE, V28, P2289, DOI 10.2337/diacare.28.9.2289; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Koskinen J, 2009, CIRCULATION, V120, P229, DOI 10.1161/CIRCULATIONAHA.108.845065; LaMonte MJ, 2005, CIRCULATION, V112, P505, DOI 10.1161/CIRCULATIONAHA.104.503805; Reis JP, 2009, PEDIATRICS, V124, pE371, DOI 10.1542/peds.2009-0213; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Tabak AG, 2009, LANCET, V373, P2215, DOI 10.1016/S0140-6736(09)60619-X; Wannamethee SG, 2005, ARCH INTERN MED, V165, P2644, DOI 10.1001/archinte.165.22.2644	19	568	593	0	103	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 16	2010	375	9710					181	183		10.1016/S0140-6736(09)61794-3	http://dx.doi.org/10.1016/S0140-6736(09)61794-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	546ZH	20109902				2022-12-28	WOS:000273853800009
J	Bloom, AA; Palmer, PI; Fraser, A; Reay, DS; Frankenberg, C				Bloom, A. Anthony; Palmer, Paul I.; Fraser, Annemarie; Reay, David S.; Frankenberg, Christian			Large-Scale Controls of Methanogenesis Inferred from Methane and Gravity Spaceborne Data	SCIENCE			English	Article							EMISSIONS; VARIABILITY; CONSUMPTION; BASIN	Wetlands are the largest individual source of methane (CH4), but the magnitude and distribution of this source are poorly understood on continental scales. We isolated the wetland and rice paddy contributions to spaceborne CH4 measurements over 2003-2005 using satellite observations of gravity anomalies, a proxy for water-table depth Gamma, and surface temperature analyses T-S. We find that tropical and higher-latitude CH4 variations are largely described by Gamma and T-S variations, respectively. Our work suggests that tropical wetlands contribute 52 to 58% of global emissions, with the remainder coming from the extra-tropics, 2% of which is from Arctic latitudes. We estimate a 7% rise in wetland CH4 emissions over 2003-2007, due to warming of mid-latitude and Arctic wetland regions, which we find is consistent with recent changes in atmospheric CH4.	[Bloom, A. Anthony; Palmer, Paul I.; Fraser, Annemarie; Reay, David S.] Univ Edinburgh, Sch Geosci, Edinburgh, Midlothian, Scotland; [Frankenberg, Christian] SRON Netherlands Inst Space Res, Utrecht, Netherlands	University of Edinburgh	Palmer, PI (corresponding author), Univ Edinburgh, Sch Geosci, Edinburgh, Midlothian, Scotland.	pip@ed.ac.uk	Bloom, A Anthony/G-8072-2017; Fraser, Annemarie/D-3874-2012; Palmer, Paul I/F-7008-2010; Frankenberg, Christian/A-2944-2013; Reay, David/F-4054-2010	Palmer, Paul I/0000-0002-1487-0969; Frankenberg, Christian/0000-0002-0546-5857; Reay, Dave/0000-0001-5829-9007	United Kingdom Natural Environmental Research Council [NE/F007973/1]; National Centre for Earth Observation	United Kingdom Natural Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); National Centre for Earth Observation	We thank J. Melack for providing feedback on the manuscript and R. Hipkin and F. Simons for assistance with GRACE gravity data. This work is funded by United Kingdom Natural Environmental Research Council studentship NE/F007973/1 and the National Centre for Earth Observation.	Bousquet P, 2006, NATURE, V443, P439, DOI 10.1038/nature05132; Bovensmann H, 1999, J ATMOS SCI, V56, P127, DOI 10.1175/1520-0469(1999)056<0127:SMOAMM>2.0.CO;2; Cao MK, 1996, J GEOPHYS RES-ATMOS, V101, P14399, DOI 10.1029/96JD00219; Chen JL, 2007, J GEODESY, V81, P237, DOI 10.1007/s00190-006-0104-2; Dlugokencky EJ, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018126; Evans JR, 2007, NEW PHYTOL, V175, P1, DOI 10.1111/j.1469-8137.2007.02114.x; Fiore A, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003855; Frankenberg C, 2008, ATMOS CHEM PHYS, V8, P5061, DOI 10.5194/acp-8-5061-2008; Frankenberg C, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034300; FUNG I, 1991, J GEOPHYS RES-ATMOS, V96, P13033, DOI 10.1029/91JD01247; Gedney N, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020919; Joabsson A, 1999, TRENDS ECOL EVOL, V14, P385, DOI 10.1016/S0169-5347(99)01649-3; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Le Mer J, 2001, EUR J SOIL BIOL, V37, P25, DOI 10.1016/S1164-5563(01)01067-6; Lemoine JM, 2007, ADV SPACE RES, V39, P1620, DOI 10.1016/j.asr.2007.03.062; Matthews E, 1991, GLOBAL BIOGEOCHEM CY, V5, P3, DOI 10.1029/90GB02311; Matthews E, 1987, GLOBAL BIOGEOCHEM CY, V1, P61, DOI 10.1029/GB001i001p00061; McLeod AR, 2008, NEW PHYTOL, V180, P124, DOI 10.1111/j.1469-8137.2008.02571.x; Melack JM, 2004, GLOBAL CHANGE BIOL, V10, P530, DOI 10.1111/j.1365-2486.2004.00763.x; Oki T, 1998, EARTH INTERACT, V2, P1; Rigby M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL036037; Segers R, 1998, BIOGEOCHEMISTRY, V41, P23, DOI 10.1023/A:1005929032764; Smith P, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P497; Tapley BD, 2004, SCIENCE, V305, P503, DOI 10.1126/science.1099192; van der Werf GR, 2006, ATMOS CHEM PHYS, V6, P3423, DOI 10.5194/acp-6-3423-2006; Walter BP, 2001, J GEOPHYS RES-ATMOS, V106, P34189, DOI 10.1029/2001JD900165; Ward D. M., 1985, Advances in Aquatic Microbiology, V3, P141	27	226	243	7	182	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 15	2010	327	5963					322	325		10.1126/science.1175176	http://dx.doi.org/10.1126/science.1175176			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544CM	20075250				2022-12-28	WOS:000273629700040
J	Raine, R; Wong, W; Scholes, S; Ashton, C; Obichere, A; Ambler, G				Raine, Rosalind; Wong, Wun; Scholes, Shaun; Ashton, Charlotte; Obichere, Austin; Ambler, Gareth			Social variations in access to hospital care for patients with colorectal, breast, and lung cancer between 1999 and 2006: retrospective analysis of hospital episode statistics	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SOUTH EAST ENGLAND; CALMAN-HINE REPORT; SOCIOECONOMIC DEPRIVATION; RESECTION RATE; SURVIVAL; INEQUALITIES; MANAGEMENT; SURGERY; WOMEN; STAGE	Objectives To determine the extent to which type of hospital admission (emergency compared with elective) and surgical procedure varied by socioeconomic circumstances, age, sex, and year of admission for colorectal, breast, and lung cancer. Design Repeated cross sectional study with data from individual patients, 1 April 1999 to 31 March 2006. Setting Hospital episode statistics (HES) dataset. Participants 564 821 patients aged 50 and over admitted with a diagnosis of colorectal, breast, or lung cancer. Main outcome measures Proportion of patients admitted as emergencies, and the proportion receiving the recommended surgical treatment. Results Patients from deprived areas, older people, and women were more likely to be admitted as emergencies. For example, the adjusted odds ratio for patients with breast cancer in the least compared with most deprived fifth of deprivation was 0.63 (95% confidence interval 0.60 to 0.66) and the adjusted odds ratio for patients with lung cancer aged 80-89 compared with those aged 50-59 was 3.13 (2.93 to 3.34). There were some improvements in disparities between age groups but not for patients living in deprived areas over time. Patients from deprived areas were less likely to receive preferred procedures for rectal, breast, and lung cancer. These findings did not improve with time. For example, 67.4% (3529/5237) of patients in the most deprived fifth of deprivation had anterior resection for rectal cancer compared with 75.5% (4497/5959) of patients in the least deprived fifth (1.34, 1.22 to 1.47). Over half (54.0%, 11256/20849) of patients in the most deprived fifth of deprivation had breast conserving surgery compared with 63.7% (18445/28960) of patients in the least deprived fifth (1.21, 1.16 to 1.26). Men were less likely than women to undergo anterior resection and lung cancer resection and older people were less likely to receive breast conserving surgery and lung cancer resection. For example, the adjusted odds ratio for lung cancer patients aged 80-89 compared with those aged 50-59 was 0.52 (0.46 to 0.59). Conclusions Despite the implementation of the NHS Cancer Plan, social factors still strongly influence access to and the provision of care.	[Raine, Rosalind; Ashton, Charlotte] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; [Obichere, Austin] Univ Coll London Hosp, London NW1 2PG, England; [Ambler, Gareth] UCL, Dept Stat Sci, London WC1E 6BT, England	University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London	Raine, R (corresponding author), UCL, Dept Epidemiol & Publ Hlth, Mortimer St, London WC1E 6BT, England.	r.raine@ucl.ac.uk		Raine, Rosalind/0000-0003-0904-749X	National Institute for Health; National Institute for Health Research University College London Hospital/University College London Comprehensive Biomedical Research Centre; Legal and General Group; CRUK; Institute of Actuaries in England and Wales and the Faculty of Actuaries in Scotland	National Institute for Health; National Institute for Health Research University College London Hospital/University College London Comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); Legal and General Group; CRUK(Cancer Research UK); Institute of Actuaries in England and Wales and the Faculty of Actuaries in Scotland	RR is partly funded by a National Institute for Health Research public health career scientist award and by the National Institute for Health Research University College London Hospital/University College London Comprehensive Biomedical Research Centre. WW and SS are funded by Legal and General Group. AO is partly funded by CRUK. The research was funded in part by the actuarial profession (Institute of Actuaries in England and Wales and the Faculty of Actuaries in Scotland). The authors' work was independent of the funders.	Battersby J, 2004, J EPIDEMIOL COMMUN H, V58, P623, DOI 10.1136/jech.2003.013391; Berrino F, 2007, LANCET ONCOL, V8, P773, DOI 10.1016/S1470-2045(07)70245-0; Brown SBF, 2007, BREAST CANCER RES TR, V103, P233, DOI 10.1007/s10549-006-9361-2; *CANC RES UK, 2009, UK LUNG CANC INC STA; Coleman MP, 2004, BRIT J CANCER, V90, P1367, DOI 10.1038/sj.bjc.6601696; Collins ED, 2009, J CLIN ONCOL, V27, P519, DOI 10.1200/JCO.2008.16.6215; Cooper ZN, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3264; Damhuis RAM, 1996, EUR RESPIR J, V9, P7, DOI 10.1183/09031936.96.09010007; *DEP HLTH, 1997, GUID COMM CANC SERV; *DEP HLTH, 2003, NHS CANC PLAN 3 YEAR; Department of Health, 2000, NHS CANC PLAN PLAN I; Devbhandari Mohan P, 2007, Interact Cardiovasc Thorac Surg, V6, P712, DOI 10.1510/icvts.2007.157289; Dixon J, 1998, J PUBLIC HEALTH MED, V20, P63, DOI 10.1093/oxfordjournals.pubmed.a024721; Downing A, 2007, BRIT J CANCER, V96, P836, DOI 10.1038/sj.bjc.6603622; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Garout M, 2008, INT J COLORECTAL DIS, V23, P155, DOI 10.1007/s00384-007-0390-z; Graham H, 2004, J SOC POLICY, V33, P115, DOI 10.1017/S0047279403007220; Gulliford M, 2003, ACCESS HLTH CARE; Harris AR, 2009, BRIT J SURG, V96, P763, DOI 10.1002/bjs.6621; health W., 2008, STAT INJ DEATHS RIS; Henley NC, 2005, BRIT J CANCER, V92, P631, DOI 10.1038/sj.bjc.6602390; *HES ONL, 2009, HES US GUID; Hole DJ, 2002, BRIT J SURG, V89, P586, DOI 10.1046/j.1365-2168.2002.02073.x; Imperatori A, 2006, THORAX, V61, P232, DOI 10.1136/thx.2005.040477; Jack RH, 2003, BRIT J CANCER, V88, P1025, DOI 10.1038/sj.bjc.6600831; Jack RH, 2006, J EVAL CLIN PRACT, V12, P573, DOI 10.1111/j.1365-2753.2006.00644.x; Janssen-Heijnen MLG, 1998, EUR J CANCER, V34, P2191, DOI 10.1016/S0959-8049(98)00312-8; Katz JN, 2001, JAMA-J AM MED ASSOC, V286, P1506, DOI 10.1001/jama.286.12.1506; Laroche C, 1998, THORAX, V53, P445, DOI 10.1136/thx.53.6.445; Martin-Ucar AE, 2004, LUNG CANCER, V46, P227, DOI 10.1016/j.lungcan.2004.03.010; McCarthy M, 2008, J EPIDEMIOL COMMUN H, V62, P650, DOI 10.1136/jech.2007.066258; Morris E, 2008, GUT, V57, P1690, DOI 10.1136/gut.2007.137877; Morris E, 2008, ANN ONCOL, V19, P284, DOI 10.1093/annonc/mdm432; Morris E, 2006, BRIT J CANCER, V95, P979, DOI 10.1038/sj.bjc.6603372; Myrdal G, 2009, LUNG CANCER, V63, P16, DOI 10.1016/j.lungcan.2008.05.011; *NAT I HLTH CLIN E, 2005, LUNG CANC DIAGN TREA; National Audit Office, 2005, NHS CANC PLAN PROGR; National Institute for Clinical Excellence, 2004, GUID CANC SERV IMPR; National Institute of Health and Clinical Excellence, 2002, GUID CANC SERV IMPR; Neal RD, 2005, BRIT J CANCER, V92, P1971, DOI 10.1038/sj.bjc.6602623; *NHS INF CTR HLTH, 2009, NAT LUNG CANC AUD; NOBLE M, 2009, ENGLISH INDICES DEPR; NUR U, 2008, CANC SURVIVAL ENGLAN; *OFF NAT STAT, 2008, CANC STAT REG; Office of Population Censuses and Surveys, 1990, TAB LIST CLASS SURG; Peake MD, 2003, AGE AGEING, V32, P171, DOI 10.1093/ageing/32.2.171; Pollock AM, 1998, BMJ-BRIT MED J, V317, P245, DOI 10.1136/bmj.317.7153.245; Rachet B, 2009, LANCET ONCOL, V10, P351, DOI 10.1016/S1470-2045(09)70028-2; Richards M, 2009, LANCET ONCOL, V10, P311, DOI 10.1016/S1470-2045(09)70086-5; *ROYAL COLL SURG E, 2008, 1 ROYAL COLL SURG EN; Sant M, 2003, ANN ONCOL, V14, pV61, DOI 10.1093/annonc/mdg754; SCHRIJVERS CTM, 1995, INT J CANCER, V63, P324, DOI 10.1002/ijc.2910630303; Snijders T, 1999, MULTILEVEL ANAL; Taylor A, 2003, J PUBLIC HEALTH MED, V25, P228, DOI 10.1093/pubmed/fdg072; The Expert Advisory Group on Cancer to the Chief Medical Officers of England and Wales, 1995, POL FRAM COMM CANC S; Tilney HS, 2008, ANN SURG, V247, P77, DOI 10.1097/SLA.0b013e31816076c3; Verdecchia A, 2007, LANCET ONCOL, V8, P784, DOI 10.1016/S1470-2045(07)70246-2; Wyld L, 2004, BRIT J CANCER, V90, P1486, DOI 10.1038/sj.bjc.6601742; Wyld L, 2007, EUR J CANCER, V43, P2253, DOI 10.1016/j.ejca.2007.07.035	59	74	76	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 14	2010	340								b5479	10.1136/bmj.b5479	http://dx.doi.org/10.1136/bmj.b5479			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	545DC	20075152	Green Published, hybrid			2022-12-28	WOS:000273711700004
J	Lacomba, MT; Sanchez, MJY; Goni, AZ; Merino, DP; del Moral, OM; Tellez, EC; Mogollon, EM				Lacomba, Maria Torres; Yuste Sanchez, Maria Jose; Zapico Goni, Alvaro; Merino, David Prieto; Mayoral del Moral, Orlando; Cerezo Tellez, Ester; Minayo Mogollon, Elena			Effectiveness of early physiotherapy to prevent lymphoedema after surgery for breast cancer: randomised, single blinded, clinical trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							AXILLARY WEB SYNDROME; QUALITY-OF-LIFE; EARLY REHABILITATION; CONSERVING THERAPY; NODE DISSECTION; ARM MORBIDITY; SURVIVORS; RELIABILITY; DIAGNOSIS; VALIDITY	Objective To determine the effectiveness of early physiotherapy in reducing the risk of secondary lymphoedema after surgery for breast cancer. Design Randomised, single blinded, clinical trial. Setting University hospital in Alcala de Henares, Madrid, Spain. Participants 120 women who had breast surgery involving dissection of axillary lymph nodes between May 2005 and June 2007. Intervention The early physiotherapy group was treated by a physiotherapist with a physiotherapy programme including manual lymph drainage, massage of scar tissue, and progressive active and action assisted shoulder exercises. This group also received an educational strategy. The control group received the educational strategy only. Main outcome measure Incidence of clinically significant secondary lymphoedema (>2 cm increase in arm circumference measured at two adjacent points compared with the non-affected arm). Results 116 women completed the one year follow-up. Of these, 18 developed secondary lymphoedema (16%): 14 in the control group (25%) and four in the intervention group (7%). The difference was significant (P=0.01); risk ratio 0.28 (95% confidence interval 0.10 to 0.79). A survival analysis showed a significant difference, with secondary lymphoedema being diagnosed four times earlier in the control group than in the intervention group (intervention/control, hazard ratio 0.26, 95% confidence interval 0.09 to 0.79). Conclusion Early physiotherapy could be an effective intervention in the prevention of secondary lymphoedema in women for at least one year after surgery for breast cancer involving dissection of axillary lymph nodes.	[Lacomba, Maria Torres; Yuste Sanchez, Maria Jose; Zapico Goni, Alvaro] Univ Alcala de Henares, Sch Physiotherapy, Physiotherapy Dept, E-28871 Madrid, Spain; [Zapico Goni, Alvaro] Principe Asturias Univ Hosp, Madrid, Spain; [Merino, David Prieto] London Sch Hyg & Trop Med, Med Stat Unit, Dept Epidemiol & Populat Hlth, London WC1, England; [Mayoral del Moral, Orlando] Prov Hosp, Physiotherapy Dept, Toledo, Spain	Universidad de Alcala; Prince of Asturias University Hospital; University of London; London School of Hygiene & Tropical Medicine	Lacomba, MT (corresponding author), Univ Alcala de Henares, Sch Physiotherapy, Physiotherapy Dept, E-28871 Madrid, Spain.	maria.torres@uah.es	Torres-Lacomba, María/A-5896-2017	Torres-Lacomba, María/0000-0002-7051-3130; Mayoral del Moral, Orlando/0000-0001-5329-3415; Yuste Sanchez, Maria Jose/0000-0002-0059-4991; Cerezo-Tellez, Ester/0000-0001-8197-1420; Prieto-Merino, David/0000-0001-5001-0061	Spanish Health Ministry [PI071124]	Spanish Health Ministry(Instituto de Salud Carlos IIISpanish Government)	This study was funded by the Health Institute Carlos III (Protocol PI071124) of the Spanish Health Ministry.	ADLER SS, 2002, FACILITACION NEUROMU; Armer Jane M., 2005, Lymphatic Research and Biology, V3, P208, DOI 10.1089/lrb.2005.3.208; Bani HA, 2007, PATIENT EDUC COUNS, V66, P311, DOI 10.1016/j.pec.2007.01.004; Batiston AP, 2005, FISIOTER PESQUI, V12, P30; Beaulac SM, 2002, ARCH SURG-CHICAGO, V137, P1253, DOI 10.1001/archsurg.137.11.1253; Box RC, 2002, BREAST CANCER RES TR, V75, P51, DOI 10.1023/A:1016591121762; Chen YW, 2008, AM J PHYS MED REHAB, V87, P33, DOI 10.1097/PHM.0b013e31815b6199; Cheville AL, 2003, SEMIN RADIAT ONCOL, V13, P214, DOI 10.1016/S1053-4296(03)00038-9; Cheville AL, 2007, J SURG ONCOL, V95, P409, DOI 10.1002/jso.20782; Cinar N, 2008, CANCER NURS, V31, P160, DOI 10.1097/01.NCC.0000305696.12873.0e; CORUNA A, 2006, XUNTA GALLCIA; FERRANDEZ J, 2006, REEDUCATION CANC SEI; FERRANDEZ J, 1999, ANN KINESITHER, V26, P265; Ferrandez JC, 1996, B CANCER, V83, P989; FERRANDEZ JC, 2005, ONCOLOGIE, V7, P316; FERRANDEZ JC, 2008, CUEST FISIOTER, V37, P187; FERRANDEZ JC, 1995, ANN KINESITHER, V22, P253; FERRANDEZ JC, 2007, CANC SEIN TRAITE MED, P119; FOLDI E, 1989, ANN PLAS SURG, V22, P505; Foldi M., 2005, PRINCIPES DRAINAGE L; Gergich NLS, 2008, CANCER-AM CANCER SOC, V112, P2809, DOI 10.1002/cncr.23494; Hack TF, 1999, J CLIN ONCOL, V17, P143, DOI 10.1200/JCO.1999.17.1.143; Harris SR, 2001, CAN MED ASSOC J, V164, P191; Hayes S, 2005, BREAST CANCER RES TR, V94, P1, DOI 10.1007/s10549-005-5991-z; Hayes S, 2005, BREAST CANCER RES TR, V89, P221, DOI 10.1007/s10549-004-2045-x; Johansson K, 2002, LYMPHOLOGY, V35, P59; Karges JR, 2003, PHYS THER, V83, P134, DOI 10.1093/ptj/83.2.134; KILBREATH SL, 2006, REHABIL ONCOL, V24, P9; Kitamura Yuko, 2005, Breast Cancer, V12, P130, DOI 10.2325/jbcs.12.130; KOAK Z, 2000, ACTA ONCOL, V39, P389; Kosir MA, 2001, J SURG RES, V95, P147, DOI 10.1006/jsre.2000.6021; Kwan W, 2002, J CLIN ONCOL, V20, P4242, DOI 10.1200/JCO.2002.09.018; LACOMBA MT, 2008, KINESITHER SCI, V494, P25; Leidenius M, 2003, AM J SURG, V185, P127, DOI 10.1016/S0002-9610(02)01214-X; LeVu B, 1997, B CANCER, V84, P957; Liu NF, 2004, LYMPHOLOGY, V37, P6; MARTINEZ I, 1999, 98267 U CAST MANCH J; MASMOUDI A, 2004, DERMATOLOGY ONLINE J, V12; McTiernan A, 2005, ONCOLOGY-NY, V19, P871; MEESKE K, 2008, BREAST CANC RES TREA, V14, P982; MORTIMER P, 1998, PROGR LYMPHOLOGY, P36; Moskovitz AH, 2001, AM J SURG, V181, P434, DOI 10.1016/S0002-9610(01)00602-X; Na YM, 1999, YONSEI MED J, V40, P1; Nardone Luigia, 2005, Rays, V30, P149; NEIGER H, 1998, ESTIRAMIENTOS ANALIT; Nesvold IL, 2008, ACTA ONCOL, V47, P835, DOI 10.1080/02841860801961257; Ocana A, 2006, J CLIN ONCOL, V24, P1477, DOI 10.1200/JCO.2005.01.8473; Ozaslan C, 2004, AM J SURG, V187, P69, DOI 10.1016/j.amjsurg.2002.12.003; Petrek JA, 1998, CANCER-AM CANCER SOC, V83, P2776, DOI 10.1002/(SICI)1097-0142(19981215)83:12B+<2776::AID-CNCR25>3.0.CO;2-V; POURQUIER H, 2007, CANC SEIN TRAITE MED, P46; Powell SN, 2003, INT J RADIAT ONCOL, V55, P1209, DOI 10.1016/S0360-3016(02)04273-6; Ridner SH, 2006, PATIENT EDUC COUNS, V61, P72, DOI 10.1016/j.pec.2005.02.009; Rietman J, 2004, DISABIL REHABIL, V26, P78, DOI 10.1080/09638280310001629642; ROMAY H, 2006, GUIA MASOTERAPIA FIS, P311; RUNOWICK C, 1998, AM CANC SOC LYMPH WO, P2874; SALVAT I, 2006, GUIA MASOTERAPIA DIS, P152; SANDER AP, 2005, Q J MED, V98, P343; Shamley DR, 2005, BREAST CANCER RES TR, V90, P263, DOI 10.1007/s10549-004-4727-9; Shih YCT, 2009, J CLIN ONCOL, V27, P2007, DOI 10.1200/JCO.2008.18.3517; Soerjomataram I, 2008, BREAST CANCER RES TR, V107, P309, DOI 10.1007/s10549-007-9556-1; *STATACORP, 2008, STATA SOFTW 10 0 VER; Taylor R, 2006, PHYS THER, V86, P205, DOI 10.1093/ptj/86.2.205; Tengrup I, 2000, ACTA ONCOL, V39, P393, DOI 10.1080/028418600750013177; Tobbia D, 2009, J VASC RES, V46, P426, DOI 10.1159/000194273; Todd J, 2008, PHYSIOTHERAPY, V94, P265, DOI 10.1016/j.physio.2008.09.005; Lacomba MT, 2009, BREAST CANCER RES TR, V117, P625, DOI 10.1007/s10549-009-0371-8; TORRES M, 2009, CUEST FISIOTER, V38, P170; TORRES M, 2006, GUIA MASOTERAPIA DIS, P239; TORRES M, 2006, GUIA MASOTERAPIA FIS, P337; TORRES M, 2010, CUEST FISIO IN PRESS, V39; Weir HK, 2003, JNCI-J NATL CANCER I, V95, P1276, DOI 10.1093/jnci/djg040	71	222	228	3	48	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 12	2010	340								b5396	10.1136/bmj.b5396	http://dx.doi.org/10.1136/bmj.b5396			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	545CZ	20068255	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000273711400002
J	Chandrashekar, J; Kuhn, C; Oka, Y; Yarmolinsky, DA; Hummler, E; Ryba, NJP; Zuker, CS				Chandrashekar, Jayaram; Kuhn, Christina; Oka, Yuki; Yarmolinsky, David A.; Hummler, Edith; Ryba, Nicholas J. P.; Zuker, Charles S.			The cells and peripheral representation of sodium taste in mice	NATURE			English	Article							SINGLE CHORDA TYMPANI; GLOSSOPHARYNGEAL NERVE; RECEPTOR-CELLS; BITTER TASTE; SALT TASTE; AMILORIDE; CHANNEL; MOUSE; NACL; RAT	Salt taste in mammals can trigger two divergent behavioural responses. In general, concentrated saline solutions elicit robust behavioural aversion, whereas low concentrations of NaCl are typically attractive, particularly after sodium depletion(1-5). Notably, the attractive salt pathway is selectively responsive to sodium and inhibited by amiloride, whereas the aversive one functions as a nonselective detector for a wide range of salts(1-3,6-9). Because amiloride is a potent inhibitor of the epithelial sodium channel (ENaC), ENaC has been proposed to function as a component of the salt-taste-receptor system(1,3,6-14). Previously, we showed that four of the five basic taste qualities-sweet, sour, bitter and umami-are mediated by separate taste-receptor cells (TRCs) each tuned to a single taste modality, and wired to elicit stereotypical behavioural responses(5,15-18). Here we show that sodium sensing is also mediated by a dedicated population of TRCs. These taste cells express the epithelial sodium channel ENaC19,20, and mediate behavioural attraction to NaCl. We genetically engineered mice lacking ENaC alpha in TRCs, and produced animals exhibiting a complete loss of salt attraction and sodium taste responses. Together, these studies substantiate independent cellular substrates for all five basic taste qualities, and validate the essential role of ENaC for sodium taste in mice.	[Chandrashekar, Jayaram; Oka, Yuki; Yarmolinsky, David A.; Zuker, Charles S.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Chandrashekar, Jayaram; Oka, Yuki; Yarmolinsky, David A.; Zuker, Charles S.] Univ Calif San Diego, Dept Neurobiol, La Jolla, CA 92093 USA; [Chandrashekar, Jayaram; Oka, Yuki; Yarmolinsky, David A.; Zuker, Charles S.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Kuhn, Christina; Ryba, Nicholas J. P.] Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA; [Hummler, Edith] Univ Lausanne, Fac Biol & Med, Dept Pharmacol & Toxicol, CH-1005 Lausanne, Switzerland	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of Lausanne	Zuker, CS (corresponding author), Columbia Univ, Columbia Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem, New York, NY 10032 USA.	cz2195@columbia.edu		Oka, Yuki/0000-0003-2686-0677; Chandrashekar, jayaram/0000-0001-6412-0114; Ryba, Nicholas/0000-0002-2060-8393	NIH, NIDCR; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003160] Funding Source: NIH RePORTER	NIH, NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank W. Guo and A. Becker for generation and maintenance of mouse lines, and K. Scott and members of our laboratories for valuable comments. This research was supported in part by the intramural research program of the NIH, NIDCR (N.J.P.R.). C.S.Z. is an investigator of the Howard Hughes Medical Institute.	BEAUCHAMP GK, 1990, AM J CLIN NUTR, V51, P881, DOI 10.1093/ajcn/51.5.881; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Chandrashekar J, 2009, SCIENCE, V326, P443, DOI 10.1126/science.1174601; Contreras RJ, 1989, NEURAL MECHANISMS TA, P119; DETHIER VG, 1977, AM SCI, V65, P744; Doolin RE, 1996, J GEN PHYSIOL, V107, P545, DOI 10.1085/jgp.107.4.545; DUNCAN C. J., 1962, PHYSIOL ZOOL, V35, P120; Eylam S, 2005, AM J PHYSIOL-REG I, V288, pR1361, DOI 10.1152/ajpregu.00796.2004; FRANK ME, 1991, J NEUROPHYSIOL, V65, P1452, DOI 10.1152/jn.1991.65.6.1452; Halpern BP, 1998, NEUROSCI BIOBEHAV R, V23, P5, DOI 10.1016/S0149-7634(97)00063-8; HECK GL, 1984, SCIENCE, V223, P403, DOI 10.1126/science.6691151; Hellekant G, 1997, J NEUROPHYSIOL, V77, P978, DOI 10.1152/jn.1997.77.2.978; HELLEKANT G, 1994, PHYSIOL BEHAV, V56, P1185, DOI 10.1016/0031-9384(94)90364-6; HETTINGER TP, 1990, BRAIN RES, V513, P24, DOI 10.1016/0006-8993(90)91085-U; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Hummler E, 2000, J AM SOC NEPHROL, V11, pS129; Hummler E, 2002, GENESIS, V32, P169, DOI 10.1002/gene.10041; Kretz O, 1999, J HISTOCHEM CYTOCHEM, V47, P51, DOI 10.1177/002215549904700106; Lindemann B, 2001, NATURE, V413, P219, DOI 10.1038/35093032; Mueller KL, 2005, NATURE, V434, P225, DOI 10.1038/nature03352; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Ninomiya Y, 1998, P NATL ACAD SCI USA, V95, P5347, DOI 10.1073/pnas.95.9.5347; Oka Y, 2006, NEURON, V52, P857, DOI 10.1016/j.neuron.2006.10.019; SCHIFFMAN SS, 1983, P NATL ACAD SCI-BIOL, V80, P6136, DOI 10.1073/pnas.80.19.6136; Strazzullo P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4567; Vandenbeuch A, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-1; Yarmolinsky DA, 2009, CELL, V139, P234, DOI 10.1016/j.cell.2009.10.001; Yoshida R, 2009, NEUROSCIENCE, V159, P795, DOI 10.1016/j.neuroscience.2008.12.052; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	30	408	427	12	191	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 11	2010	464	7286					297	U182		10.1038/nature08783	http://dx.doi.org/10.1038/nature08783			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	566JO	20107438	Green Accepted			2022-12-28	WOS:000275366100051
J	Glenzer, SH; MacGowan, BJ; Michel, P; Meezan, NB; Suter, LJ; Dixit, SN; Kline, JL; Kyrala, GA; Bradley, DK; Callahan, DA; Dewald, EL; Divol, L; Dzenitis, E; Edwards, MJ; Hamza, AV; Haynam, CA; Hinkel, DE; Kalantar, DH; Kilkenny, JD; Landen, OL; Lindl, JD; LePape, S; Moody, JD; Nikroo, A; Parham, T; Schneider, MB; Town, RPJ; Wegner, P; Widmann, K; Whitman, P; Young, BKF; Van Wonterghem, B; Atherton, LJ; Moses, EI				Glenzer, S. H.; MacGowan, B. J.; Michel, P.; Meezan, N. B.; Suter, L. J.; Dixit, S. N.; Kline, J. L.; Kyrala, G. A.; Bradley, D. K.; Callahan, D. A.; Dewald, E. L.; Divol, L.; Dzenitis, E.; Edwards, M. J.; Hamza, A. V.; Haynam, C. A.; Hinkel, D. E.; Kalantar, D. H.; Kilkenny, J. D.; Landen, O. L.; Lindl, J. D.; LePape, S.; Moody, J. D.; Nikroo, A.; Parham, T.; Schneider, M. B.; Town, R. P. J.; Wegner, P.; Widmann, K.; Whitman, P.; Young, B. K. F.; Van Wonterghem, B.; Atherton, L. J.; Moses, E. I.			Symmetric Inertial Confinement Fusion Implosions at Ultra-High Laser Energies	SCIENCE			English	Article							NATIONAL-IGNITION-FACILITY; HOHLRAUM PLASMAS; BEAMS; PERFORMANCE	Indirect-drive hohlraum experiments at the National Ignition Facility have demonstrated symmetric capsule implosions at unprecedented laser drive energies of 0.7 megajoule. One hundred and ninety-two simultaneously fired laser beams heat ignition-emulate hohlraums to radiation temperatures of 3.3 million kelvin, compressing 1.8-millimeter-diameter capsules by the soft x-rays produced by the hohlraum. Self-generated plasma optics gratings on either end of the hohlraum tune the laser power distribution in the hohlraum, which produces a symmetric x-ray drive as inferred from the shape of the capsule self-emission. These experiments indicate that the conditions are suitable for compressing deuterium-tritium-filled capsules, with the goal of achieving burning fusion plasmas and energy gain in the laboratory.	[Glenzer, S. H.; MacGowan, B. J.; Michel, P.; Meezan, N. B.; Suter, L. J.; Dixit, S. N.; Bradley, D. K.; Callahan, D. A.; Dewald, E. L.; Divol, L.; Dzenitis, E.; Edwards, M. J.; Hamza, A. V.; Haynam, C. A.; Hinkel, D. E.; Kalantar, D. H.; Landen, O. L.; Lindl, J. D.; LePape, S.; Moody, J. D.; Parham, T.; Schneider, M. B.; Town, R. P. J.; Wegner, P.; Widmann, K.; Whitman, P.; Young, B. K. F.; Van Wonterghem, B.; Atherton, L. J.; Moses, E. I.] Lawrence Livermore Natl Lab, Livermore, CA 94551 USA; [Kline, J. L.; Kyrala, G. A.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [Kilkenny, J. D.; Nikroo, A.] Gen Atom Co, San Diego, CA 92121 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; General Atomics & Affiliated Companies	Glenzer, SH (corresponding author), Lawrence Livermore Natl Lab, POB 808, Livermore, CA 94551 USA.	glenzer1@llnl.gov	Michel, Pierre/J-9947-2012; Kline, John/ABH-9654-2020; Whitman, Pamela K/B-2336-2013; Landen, Otto/AEX-9890-2022	Michel, Pierre/0000-0002-7584-7420; Landen, Otto/0000-0002-1499-8217; Kline, John/0000-0002-2271-9919; Nikroo, Abbas/0000-0002-8855-0378; Widmann, Klaus/0000-0001-5623-6619	U. S. Department of Energy by Lawrence Livermore National Laboratory [DE-AC52-07NA27344]	U. S. Department of Energy by Lawrence Livermore National Laboratory(United States Department of Energy (DOE))	This work was performed under the auspices of the U. S. Department of Energy by Lawrence Livermore National Laboratory under contract DE-AC52-07NA27344.	Atzeni S, 2004, PHYS INERTIAL FUSION; Berger RL, 1998, PHYS PLASMAS, V5, P4337, DOI 10.1063/1.873171; Clery D, 2009, SCIENCE, V324, P326, DOI 10.1126/science.324.5925.326; Dewald EL, 2004, REV SCI INSTRUM, V75, P3759, DOI 10.1063/1.1788872; Drake RP, 2006, SHOCK WAVE HIGH PRES, P1, DOI 10.1007/3-540-29315-9; Fernandez JC, 1997, PHYS PLASMAS, V4, P1849, DOI 10.1063/1.872328; Froula DH, 2004, REV SCI INSTRUM, V75, P4168, DOI 10.1063/1.1789592; Garcia RA, 2007, SCIENCE, V316, P1591, DOI 10.1126/science.1140598; Glenzer SH, 1998, PHYS REV LETT, V80, P2845, DOI 10.1103/PhysRevLett.80.2845; Gough DO, 1996, SCIENCE, V272, P1296, DOI 10.1126/science.272.5266.1296; HAUER AA, 1995, PHYS PLASMAS, V2, P2488, DOI 10.1063/1.871210; Haynam CA, 2007, APPL OPTICS, V46, P3276, DOI 10.1364/AO.46.003276; KAUFFMAN RL, 1994, PHYS REV LETT, V73, P2320, DOI 10.1103/PhysRevLett.73.2320; Kirkwood RK, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.215003; Krauser WJ, 1996, PHYS PLASMAS, V3, P2084, DOI 10.1063/1.872006; Kruer W.L., 1988, PHYS LASER PLASMA IN; Kruer WL, 1996, PHYS PLASMAS, V3, P382, DOI 10.1063/1.871863; Landen OL, 1999, PHYS PLASMAS, V6, P2137, DOI 10.1063/1.873465; Lindl JD, 2004, PHYS PLASMAS, V11, P339, DOI 10.1063/1.1578638; MacGowan BJ, 1996, PHYS PLASMAS, V3, P2029, DOI 10.1063/1.872000; Mackinnon AJ, 2004, REV SCI INSTRUM, V75, P4183, DOI 10.1063/1.1789594; McCrory RL, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.2837048; Michel P, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3103788; Michel P, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.025004; Moses EI, 2005, FUSION SCI TECHNOL, V47, P314, DOI 10.13182/FST47-314; NUCKOLLS J, 1972, NATURE, V239, P139, DOI 10.1038/239139a0; Oertel JA, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2227439; Remington BA, 2006, REV MOD PHYS, V78, P755, DOI 10.1103/RevModPhys.78.755; SUTER LJ, 1994, PHYS REV LETT, V73, P2328, DOI 10.1103/PhysRevLett.73.2328; Wharton KB, 1998, PHYS REV LETT, V81, P2248, DOI 10.1103/PhysRevLett.81.2248; Zimmerman G. B., 1975, COMMENTS PLASMA PHYS, V2, P85	31	289	304	4	108	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 5	2010	327	5970					1228	1231		10.1126/science.1185634	http://dx.doi.org/10.1126/science.1185634			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563VD	20110465	Green Submitted			2022-12-28	WOS:000275162100031
J	Butler, SM				Butler, Stuart M.			Risking Big Changes with Small Reforms	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Heritage Fdn, Washington, DC 20002 USA		Butler, SM (corresponding author), Heritage Fdn, Washington, DC 20002 USA.							COLLINS SR, 2010, HLTH INSURANCE PROVI	1	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 25	2010	362	8					673	675		10.1056/NEJMp1001054	http://dx.doi.org/10.1056/NEJMp1001054			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	559SA	20130246				2022-12-28	WOS:000274845600003
J	Timmins, N				Timmins, Nicholas			Social Partnership Forum The unions are back in town	BRITISH MEDICAL JOURNAL			English	Editorial Material									Financial Times, London, England		Timmins, N (corresponding author), Financial Times, London, England.	Nick.timmins@ft.com							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 2	2010	340								c565	10.1136/bmj.c565	http://dx.doi.org/10.1136/bmj.c565			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	553CU	20124369				2022-12-28	WOS:000274343400039
J	Barr, RG; Bluemke, DA; Ahmed, FS; Carr, JJ; Enright, PL; Hoffman, EA; Jiang, R; Kawut, SM; Kronmal, RA; Lima, JAC; Shahar, E; Smith, LJ; Watson, KE				Barr, R. Graham; Bluemke, David A.; Ahmed, Firas S.; Carr, J. Jeffery; Enright, Paul L.; Hoffman, Eric A.; Jiang, Rui; Kawut, Steven M.; Kronmal, Richard A.; Lima, Joao A. C.; Shahar, Eyal; Smith, Lewis J.; Watson, Karol E.			Percent Emphysema, Airflow Obstruction, and Impaired Left Ventricular Filling	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PULMONARY BLOOD-FLOW; CHRONIC COR-PULMONALE; RAY CT IMAGES; ATHEROSCLEROSIS MESA; MYOCARDIAL MASS; LUNG-DISEASE; CARDIAC CT; MILD COPD; HYPERTENSION; SMOKERS	BACKGROUND Very severe chronic obstructive pulmonary disease causes cor pulmonale with elevated pulmonary vascular resistance and secondary reductions in left ventricular filling, stroke volume, and cardiac output. We hypothesized that emphysema, as detected on computed tomography (CT), and airflow obstruction are inversely related to left ventricular end-diastolic volume, stroke volume, and cardiac output among persons without very severe lung disease. METHODS We measured left ventricular structure and function with the use of magnetic resonance imaging in 2816 persons who were 45 to 84 years of age. The extent of emphysema (expressed as percent emphysema) was defined as the percentage of voxels below -910 Hounsfield units in the lung windows on cardiac computed tomographic scans. Spirometry was performed according to American Thoracic Society guidelines. Generalized additive models were used to test for threshold effects. RESULTS Of the study participants, 13% were current smokers, 38% were former smokers, and 49% had never smoked. A 10-point increase in percent emphysema was linearly related to reductions in left ventricular end-diastolic volume (-4.1 ml; 95% confidence interval [CI], -3.3 to -4.9; P<0.001), stroke volume (-2.7 ml; 95% CI, -2.2 to -3.3; P<0.001), and cardiac output (-0.19 liters per minute; 95% CI, -0.14 to -0.23; P<0.001). These associations were of greater magnitude among current smokers than among former smokers and those who had never smoked. The extent of airflow obstruction was similarly associated with left ventricular structure and function, and smoking status had similar modifying effects on these associations. Percent emphysema and airflow obstruction were not associated with the left ventricular ejection fraction. CONCLUSIONS In a population-based study, a greater extent of emphysema on CT scanning and more severe airflow obstruction were linearly related to impaired left ventricular filling, reduced stroke volume, and lower cardiac output without changes in the ejection fraction.	[Barr, R. Graham; Ahmed, Firas S.; Jiang, Rui] Columbia Univ, Dept Med, Coll Phys & Surg, New York, NY 10032 USA; [Barr, R. Graham; Jiang, Rui] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10032 USA; [Bluemke, David A.] NIH, Dept Radiol & Imaging Sci, Ctr Clin, Bethesda, MD 20892 USA; [Carr, J. Jeffery] Wake Forest Univ, Dept Radiol, Winston Salem, NC 27109 USA; [Enright, Paul L.; Shahar, Eyal] Univ Arizona, Div Epidemiol & Biostat, Tucson, AZ USA; [Hoffman, Eric A.] Univ Iowa, Dept Radiol, Iowa City, IA 52242 USA; [Kawut, Steven M.] Univ Penn, Sch Med, Penn Cardiovasc Inst, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Kawut, Steven M.] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Kronmal, Richard A.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Lima, Joao A. C.] Johns Hopkins Univ, Dept Med, Baltimore, MD USA; [Lima, Joao A. C.] Johns Hopkins Univ, Dept Radiol, Baltimore, MD USA; [Smith, Lewis J.] Northwestern Univ, Dept Med, Chicago, IL 60611 USA; [Watson, Karol E.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA	Columbia University; Columbia University; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Wake Forest University; University of Arizona; University of Iowa; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Washington; University of Washington Seattle; Johns Hopkins University; Johns Hopkins University; Northwestern University; University of California System; University of California Los Angeles	Barr, RG (corresponding author), Columbia Univ, Med Ctr, Div Gen Med, 630 W 168th St,PH 9 E,Rm 105, New York, NY 10032 USA.	rgb9@columbia.edu	Carr, John/AAN-7531-2021; Carr, John Jeffrey/A-1938-2012; Watson, Karol/ABD-7425-2021; Bluemke, David/GYU-8169-2022	Carr, John/0000-0002-4398-8237; Carr, John Jeffrey/0000-0002-4398-8237; Smith, Lewis J/0000-0002-4728-1562; Hoffman, Eric/0000-0001-8456-9437; Bluemke, David/0000-0002-8323-8086	National Heart, Lung, and Blood Institute [N01-HC95159, N01HC95169]; Pfizer; Toshiba Medical Systems and General Electric;  [R01-HL077612];  [R01-HL075476];  [R01-HL093081];  [UL1-RR02415]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095160, N01HC095163, N01HC095164, N01HC095165, N01HC095168, N01HC095169, N01HC095162, N01HC095161, N01HC095166, N01HC095159, N01HC095167] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR002415] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077612, R01HL086719, R01HL093081, R44HL095169, R01HL075476, R43HL095169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZIAEB000072] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL090019] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Pfizer(Pfizer); Toshiba Medical Systems and General Electric(General Electric); ; ; ; ; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); CLINICAL CENTER	Supported by grants (R01-HL077612, R01-HL075476, and R01-HL093081) and contracts (N01-HC95159 through N01HC95169) from the National Heart, Lung, and Blood Institute, with additional support from UL1-RR02415.; Dr. Enright reports receiving consulting fees from Pfizer and Gilead; Dr. Hoffman, having equity ownership in and being a founder of VIDA Diagnostics and receiving lecture fees from Sanofi-Aventis, AstraZeneca, and Chiesi Pharmaceuticals; Dr. Kawut, receiving grant support from Pfizer; Dr. Lima, receiving grant support from Toshiba Medical Systems and General Electric; and Dr. Smith, receiving consulting fees from Merck and KarmelSonix. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 2008, MESA MAN OP FIELD CT; BARBERA JA, 1994, AM J RESP CRIT CARE, V149, P423, DOI 10.1164/ajrccm.149.2.8306040; Barbera JA, 2003, EUR RESPIR J, V21, P892, DOI 10.1183/09031936.03.00115402; Barr RG, 2007, AM J RESP CRIT CARE, V176, P1200, DOI 10.1164/rccm.200707-980OC; BAUM GL, 1971, NEW ENGL J MED, V285, P361, DOI 10.1056/NEJM197108122850701; Bertoni AG, 2009, AM J EPIDEMIOL, V169, P444, DOI 10.1093/aje/kwn350; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Boussuges A, 2000, AM J RESP CRIT CARE, V162, P670, DOI 10.1164/ajrccm.162.2.9908056; Bristow J D, 1966, Prog Cardiovasc Dis, V9, P239, DOI 10.1016/S0033-0620(66)80026-9; BUDA AJ, 1979, NEW ENGL J MED, V301, P453, DOI 10.1056/NEJM197908303010901; BURROWS B, 1972, NEW ENGL J MED, V286, P912, DOI 10.1056/NEJM197204272861703; CABANES LR, 1989, NEW ENGL J MED, V320, P1317, DOI 10.1056/NEJM198905183202005; Capderou A, 2000, AM J RESP CRIT CARE, V162, P2073, DOI 10.1164/ajrccm.162.6.2005077; Carmo M M, 1994, Rev Port Cardiol, V13, P763; Carr JJ, 2005, RADIOLOGY, V234, P35, DOI 10.1148/radiol.2341040439; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Chaouat A, 2005, AM J RESP CRIT CARE, V172, P189, DOI 10.1164/rccm.200401-006OC; COXSON HO, 1995, J APPL PHYSIOL, V79, P1525, DOI 10.1152/jappl.1995.79.5.1525; Demedts IK, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-53; FAGGIANO P, 1993, CARDIOLOGY, V83, P30, DOI 10.1159/000175944; FISHMAN AP, 1976, AM REV RESPIR DIS, V114, P775; FRANK MJ, 1973, CIRCULATION, V47, P798, DOI 10.1161/01.CIR.47.4.798; Gan CTJ, 2006, AM J PHYSIOL-HEART C, V290, pH1528, DOI 10.1152/ajpheart.01031.2005; GLENNY RW, 1991, J APPL PHYSIOL, V71, P620, DOI 10.1152/jappl.1991.71.2.620; Guo J, 2002, 2002 IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING, PROCEEDINGS, P871, DOI 10.1109/ISBI.2002.1029398; HAKIM TS, 1987, J APPL PHYSIOL, V63, P1114, DOI 10.1152/jappl.1987.63.3.1114; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hankinson JL, 2010, CHEST, V137, P138, DOI 10.1378/chest.09-0919; HARVEY RM, 1951, AM J MED, V10, P719, DOI 10.1016/0002-9343(51)90340-3; Heckbert SR, 2006, J AM COLL CARDIOL, V48, P2285, DOI 10.1016/j.jacc.2006.03.072; Hoffman EA, 2009, ACAD RADIOL, V16, P689, DOI 10.1016/j.acra.2008.12.024; Hu SY, 2001, IEEE T MED IMAGING, V20, P490, DOI 10.1109/42.929615; Jemal A, 2005, JAMA-J AM MED ASSOC, V294, P1255, DOI 10.1001/jama.294.10.1255; Jiang R, 2008, AM J EPIDEMIOL, V168, P602, DOI 10.1093/aje/kwn174; Jorgensen K, 2007, CHEST, V131, P1050, DOI 10.1378/chest.06-2245; Kasahara Y, 2001, AM J RESP CRIT CARE, V163, P737, DOI 10.1164/ajrccm.163.3.2002117; KATZ J, 1988, RADIOLOGY, V169, P495, DOI 10.1148/radiology.169.2.2971985; KELLER AM, 1986, J AM COLL CARDIOL, V8, P113, DOI 10.1016/S0735-1097(86)80100-0; KLINE LE, 1977, CHEST, V72, P558, DOI 10.1378/chest.72.5.558; Lichodziejewska B, 2007, CHEST, V131, P1142, DOI 10.1378/chest.06-2056; LIEBOW AA, 1959, AM REV RESPIR DIS, V80, P67; Macklem PT, 2006, EUR RESPIR REV, V15, P80, DOI 10.1183/09059180.00010005; MACNEE W, 1994, AM J RESP CRIT CARE, V150, P833, DOI 10.1164/ajrccm.150.3.8087359; MARZLUF BA, 2007, EUR RESPIR J, V30, pS608; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Natori S, 2006, AM J ROENTGENOL, V186, pS357, DOI 10.2214/AJR.04.1868; Noordegraaf AV, 1997, CHEST, V112, P640, DOI 10.1378/chest.112.3.640; Peinado VI, 1998, AM J PHYSIOL-LUNG C, V274, pL908, DOI 10.1152/ajplung.1998.274.6.L908; Petrache I, 2005, NAT MED, V11, P491, DOI 10.1038/nm1238; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Santos S, 2002, EUR RESPIR J, V19, P632, DOI 10.1183/09031936.02.00245902; Scharf SM, 2002, AM J RESP CRIT CARE, V166, P314, DOI 10.1164/rccm.2107027; STEELE P, 1975, AM J MED, V59, P21, DOI 10.1016/0002-9343(75)90317-4; Thabut G, 2005, CHEST, V127, P1531, DOI 10.1378/chest.127.5.1531; Tschirren J, 2005, IEEE T MED IMAGING, V24, P1540, DOI 10.1109/TMI.2005.857653; Vonk-Noordegraaf A, 2005, CHEST, V127, P1898, DOI 10.1378/chest.127.6.1898; Zhang L, 2006, IEEE T MED IMAGING, V25, P1, DOI 10.1109/TMI.2005.859209	57	388	401	0	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 21	2010	362	3					217	227		10.1056/NEJMoa0808836	http://dx.doi.org/10.1056/NEJMoa0808836			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	545NE	20089972	Green Accepted			2022-12-28	WOS:000273738400008
J	Zhang, JJ; Baker, ML; Schroder, GF; Douglas, NR; Reissmann, S; Jakana, J; Dougherty, M; Fu, CJ; Levitt, M; Ludtke, SJ; Frydman, J; Chiu, W				Zhang, Junjie; Baker, Matthew L.; Schroeder, Gunnar F.; Douglas, Nicholai R.; Reissmann, Stefanie; Jakana, Joanita; Dougherty, Matthew; Fu, Caroline J.; Levitt, Michael; Ludtke, Steven J.; Frydman, Judith; Chiu, Wah			Mechanism of folding chamber closure in a group II chaperonin	NATURE			English	Article							PARTICLE ELECTRON CRYOMICROSCOPY; CRYSTAL-STRUCTURE; ARCHAEAL CHAPERONIN; MOLECULAR CHAPERONES; GROEL; RESOLUTION; PROTEIN; RECONSTRUCTION; AGGREGATION; STATE	Group II chaperonins are essential mediators of cellular protein folding in eukaryotes and archaea. These oligomeric protein machines, similar to 1 megadalton, consist of two back-to-back rings encompassing a central cavity that accommodates polypeptide substrates(1-3). Chaperonin-mediated protein folding is critically dependent on the closure of a built-in lid(4,5), which is triggered by ATP hydrolysis(6). The structural rearrangements and molecular events leading to lid closure are still unknown. Here we report four single particle cryo-electron microscopy (cryo-EM) structures of Mm-cpn, an archaeal group II chaperonin(5,7), in the nucleotide-free (open) and nucleotide-induced (closed) states. The 4.3 angstrom resolution of the closed conformation allowed building of the first ever atomic model directly from the single particle cryo-EM density map, in which we were able to visualize the nucleotide and more than 70% of the side chains. The model of the open conformation was obtained by using the deformable elastic network modelling with the 8 angstrom resolution open-state cryo-EM density restraints. Together, the open and closed structures show how local conformational changes triggered by ATP hydrolysis lead to an alteration of intersubunit contacts within and across the rings, ultimately causing a rocking motion that closes the ring. Our analyses show that there is an intricate and unforeseen set of interactions controlling allosteric communication and inter-ring signalling, driving the conformational cycle of group II chaperonins. Beyond this, we anticipate that our methodology of combining single particle cryo-EM and computational modelling will become a powerful tool in the determination of atomic details involved in the dynamic processes of macromolecular machines in solution.	[Zhang, Junjie; Ludtke, Steven J.; Chiu, Wah] Baylor Coll Med, Grad Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA; [Zhang, Junjie; Baker, Matthew L.; Jakana, Joanita; Dougherty, Matthew; Fu, Caroline J.; Ludtke, Steven J.; Chiu, Wah] Baylor Coll Med, Natl Ctr Macromol Imaging, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Schroeder, Gunnar F.; Levitt, Michael] Stanford Univ, Dept Biol Struct, Stanford, CA 94305 USA; [Douglas, Nicholai R.; Reissmann, Stefanie; Frydman, Judith] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Douglas, Nicholai R.; Reissmann, Stefanie; Frydman, Judith] Stanford Univ, BioX Program, Stanford, CA 94305 USA	Baylor College of Medicine; Baylor College of Medicine; Stanford University; Stanford University; Stanford University	Chiu, W (corresponding author), Baylor Coll Med, Grad Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA.	jfrydman@stanford.edu; wah@bcm.edu	Levitt, Michael/E-4582-2012; Zhang, Junjie/V-3855-2019; Schröder, Gunnar F/H-5261-2013; Ludtke, Steven/A-4478-2008	Levitt, Michael/0000-0002-8414-7397; Zhang, Junjie/0000-0002-7912-0819; Schröder, Gunnar F/0000-0003-1803-5431; Ludtke, Steven/0000-0002-1903-1574; , judith/0000-0003-2302-6943; /0000-0003-3905-8085	National Institutes of Health through the Nanomedicine Development Center Roadmap Initiative; Biomedical Technology Research Center for Structural Biology in National Center for Research Resources; Nanobiology Training Fellowship; National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002250] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY016525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R90DK071504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063817, R01GM079429, T32GM007276, R01GM080139] Funding Source: NIH RePORTER	National Institutes of Health through the Nanomedicine Development Center Roadmap Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biomedical Technology Research Center for Structural Biology in National Center for Research Resources; Nanobiology Training Fellowship; National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge the support of grants from the National Institutes of Health through the Nanomedicine Development Center Roadmap Initiative, Biomedical Technology Research Center for Structural Biology in National Center for Research Resources, Nanobiology Training Fellowship administered by the Keck Center of the Gulf Coast Consortia and the National Science Foundation.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Blow D, 2002, OUTLINE CRYSTALLOGRA; Boisvert DC, 1996, NAT STRUCT BIOL, V3, P170, DOI 10.1038/nsb0296-170; Booth CR, 2008, NAT STRUCT MOL BIOL, V15, P746, DOI 10.1038/nsmb.1436; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; BRAIG K, 1995, NAT STRUCT BIOL, V2, P1083, DOI 10.1038/nsb1295-1083; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Clare DK, 2008, STRUCTURE, V16, P528, DOI 10.1016/j.str.2008.01.016; Ditzel L, 1998, CELL, V93, P125, DOI 10.1016/S0092-8674(00)81152-6; Dobson CM, 2004, SEMIN CELL DEV BIOL, V15, P3, DOI 10.1016/j.semcdb.2003.12.008; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandez JJ, 2008, J STRUCT BIOL, V164, P170, DOI 10.1016/j.jsb.2008.05.010; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; HARAUZ G, 1986, OPTIK, V73, P146; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Jiang W, 2008, NATURE, V451, P1130, DOI 10.1038/nature06665; Kitamura A, 2006, NAT CELL BIOL, V8, P1163, DOI 10.1038/ncb1478; Kusmierczyk AR, 2003, FEBS LETT, V547, P201, DOI 10.1016/S0014-5793(03)00722-1; Kusmierczyk AR, 2003, BIOCHEM J, V371, P669, DOI 10.1042/BJ20030230; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Ludtke SJ, 2001, J MOL BIOL, V314, P253, DOI 10.1006/jmbi.2001.5133; Ludtke SJ, 2008, STRUCTURE, V16, P441, DOI 10.1016/j.str.2008.02.007; Meyer AS, 2003, CELL, V113, P369, DOI 10.1016/S0092-8674(03)00307-6; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reissmann S, 2007, NAT STRUCT MOL BIOL, V14, P432, DOI 10.1038/nsmb1236; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; SAIBIL HR, 1993, CURR BIOL, V3, P265, DOI 10.1016/0960-9822(93)90176-O; Schoehn G, 2000, J MOL BIOL, V301, P323, DOI 10.1006/jmbi.2000.3952; Schroder GF, 2007, STRUCTURE, V15, P1630, DOI 10.1016/j.str.2007.09.021; Suzuki M, 2008, J BIOL CHEM, V283, P23931, DOI 10.1074/jbc.M804090200; Tam S, 2006, NAT CELL BIOL, V8, P1155, DOI 10.1038/ncb1477; Tang YC, 2006, CELL, V125, P903, DOI 10.1016/j.cell.2006.04.027; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Yam AY, 2008, NAT STRUCT MOL BIOL, V15, P1255, DOI 10.1038/nsmb.1515; Yang C, 2009, J MICROSC-OXFORD, V233, P391, DOI 10.1111/j.1365-2818.2009.03137.x; Yu XK, 2008, NATURE, V453, P415, DOI 10.1038/nature06893; Zhang X, 2008, P NATL ACAD SCI USA, V105, P1867, DOI 10.1073/pnas.0711623105	39	161	163	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 21	2010	463	7279					379	U130		10.1038/nature08701	http://dx.doi.org/10.1038/nature08701			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545PM	20090755	Green Accepted			2022-12-28	WOS:000273748100049
J	Christensen, CH; Norskov, JK				Christensen, Claus Hviid; Norskov, Jens K.			Green Gold Catalysis	SCIENCE			English	Editorial Material							CO OXIDATION; NANOPARTICLES		[Christensen, Claus Hviid] Haldor Topsoe Res Labs, DK-2800 Lyngby, Denmark; [Norskov, Jens K.] Tech Univ Denmark, Dept Phys, Ctr Atom Scale Mat Design, DK-2800 Lyngby, Denmark	Haldor Topsoe; Technical University of Denmark	Christensen, CH (corresponding author), Haldor Topsoe Res Labs, Nymollevej 55, DK-2800 Lyngby, Denmark.	chc@topsoe.dk	Norskov, Jens K/D-2539-2017	Norskov, Jens K/0000-0002-4427-7728				Biella S, 2002, J CATAL, V206, P242, DOI 10.1006/jcat.2001.3497; Bond GC, 1999, CATAL REV, V41, P319, DOI 10.1081/CR-100101171; Christensen CH, 2006, ANGEW CHEM INT EDIT, V45, P4648, DOI 10.1002/anie.200601180; Corma A, 2008, CHEM SOC REV, V37, P2096, DOI 10.1039/b707314n; Falsig H, 2008, ANGEW CHEM INT EDIT, V47, P4835, DOI 10.1002/anie.200801479; HARUTA M, 1987, CHEM LETT, P405, DOI 10.1246/cl.1987.405; Hutchings GJ, 2004, GOLD BULL, V37, P3, DOI 10.1007/BF03215511; Jacobsen CJH, 2001, J AM CHEM SOC, V123, P8404, DOI 10.1021/ja010963d; Lopez N, 2004, J CATAL, V223, P232, DOI 10.1016/j.jcat.2004.01.001; Meyer R, 2004, GOLD BULL, V37, P72, DOI 10.1007/BF03215519; Min BK, 2004, J PHYS CHEM B, V108, P14609, DOI 10.1021/jp0492974; Sakurai H, 2005, APPL CATAL A-GEN, V291, P179, DOI 10.1016/j.apcata.2005.02.043; Sanchez A, 1999, J PHYS CHEM A, V103, P9573, DOI 10.1021/jp9935992; Sinha AK, 2004, TOP CATAL, V29, P95, DOI 10.1023/B:TOCA.0000029791.69935.53; Wittstock A, 2010, SCIENCE, V327, P319, DOI 10.1126/science.1183591	15	76	78	2	133	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 15	2010	327	5963					278	279		10.1126/science.1184203	http://dx.doi.org/10.1126/science.1184203			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544CM	20075237				2022-12-28	WOS:000273629700024
J	Solow, RM				Solow, Robert M.			Paul A. Samuelson (1915-2009)	SCIENCE			English	Biographical-Item									MIT, Dept Econ, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Solow, RM (corresponding author), MIT, Dept Econ, Cambridge, MA 02139 USA.								0	0	0	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 15	2010	327	5963					282	282		10.1126/science.1186205	http://dx.doi.org/10.1126/science.1186205			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544CM	20075240				2022-12-28	WOS:000273629700027
J	Talmud, PJ; Hingorani, AD; Cooper, JA; Marmot, MG; Brunner, EJ; Kumari, M; Kivimaki, M; Humphries, SE				Talmud, Philippa J.; Hingorani, Aroon D.; Cooper, Jackie A.; Marmot, Michael G.; Brunner, Eric J.; Kumari, Meena; Kivimaeki, Mika; Humphries, Steve E.			Utility of genetic and non-genetic risk factors in prediction of type 2 diabetes: Whitehall II prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GENOME-WIDE ASSOCIATION; INSULIN CONCENTRATIONS; PROSPECTIVE DERIVATION; ROC CURVE; VARIANTS; LOCI; POLYMORPHISMS; METAANALYSIS; POPULATION; DISEASE	Objectives To assess the performance of a panel of common single nucleotide polymorphisms (genotypes) associated with type 2 diabetes in distinguishing incident cases of future type 2 diabetes (discrimination), and to examine the effect of adding genetic information to previously validated non-genetic (phenotype based) models developed to estimate the absolute risk of type 2 diabetes. Design Workplace based prospective cohort study with three 5 yearly medical screenings. Participants 5535 initially healthy people (mean age 49 years; 33% women), of whom 302 developed new onset type 2 diabetes over 10 years. Outcome measures Non-genetic variables included in two established risk models-the Cambridge type 2 diabetes risk score (age, sex, drug treatment, family history of type 2 diabetes, body mass index, smoking status) and the Framingham offspring study type 2 diabetes risk score (age, sex, parental history of type 2 diabetes, body mass index, high density lipoprotein cholesterol, triglycerides, fasting glucose)-and 20 single nucleotide polymorphisms associated with susceptibility to type 2 diabetes. Cases of incident type 2 diabetes were defined on the basis of a standard oral glucose tolerance test, self report of a doctor's diagnosis, or the use of anti-diabetic drugs. Results A genetic score based on the number of risk alleles carried (range 0-40; area under receiver operating characteristics curve 0.54, 95% confidence interval 0.50 to 0.58) and a genetic risk function in which carriage of risk alleles was weighted according to the summary odds ratios of their effect from meta-analyses of genetic studies (area under receiver operating characteristics curve 0.55, 0.51 to 0.59) did not effectively discriminate cases of diabetes. The Cambridge risk score (area under curve 0.72, 0.69 to 0.76) and the Framingham offspring risk score (area under curve 0.78, 0.75 to 0.82) led to better discrimination of cases than did genotype based tests. Adding genetic information to phenotype based risk models did not improve discrimination and provided only a small improvement in model calibration and a modest net reclassification improvement of about 5% when added to the Cambridge risk score but not when added to the Framingham offspring risk score. Conclusion The phenotype based risk models provided greater discrimination for type 2 diabetes than did models based on 20 common independently inherited diabetes risk alleles. The addition of genotypes to phenotype based risk models produced only minimal improvement in accuracy of risk estimation assessed by recalibration and, at best, a minor net reclassification improvement. The major translational application of the currently known common, small effect genetic variants influencing susceptibility to type 2 diabetes is likely to come from the insight they provide on causes of disease and potential therapeutic targets.	[Talmud, Philippa J.; Cooper, Jackie A.; Humphries, Steve E.] UCL, Dept Med, Ctr Cardiovasc Genet, London WC1E 6JF, England; [Hingorani, Aroon D.; Marmot, Michael G.; Brunner, Eric J.; Kivimaeki, Mika] UCL, Dept Epidemiol & Publ Hlth, Genet Epidemiol Grp, London WC1E 6BT, England; [Hingorani, Aroon D.] UCL, Ctr Clin Pharmacol, London WC1E 6JF, England	University of London; University College London; University of London; University College London; University of London; University College London	Talmud, PJ (corresponding author), UCL, Dept Med, Ctr Cardiovasc Genet, London WC1E 6JF, England.	p.talmud@ucl.ac.uk	Marmot, M G/Y-3920-2019; Kivimaki, Mika/B-3607-2012; Brunner, Eric/H-2114-2011	Marmot, M G/0000-0002-2431-6419; Kivimaki, Mika/0000-0002-4699-5627; Brunner, Eric/0000-0002-0595-4474; Talmud, Philippa/0000-0002-5560-1933; Humphries, Stephen E/0000-0002-8221-6547; Hingorani, Aroon/0000-0001-8365-0081; Kumari, Meena/0000-0001-9716-1035	Medical Research Council [G8802774]; British Heart Foundation [RG/02/005, FS05/125, RG/05/014, PG/07/133]; Health and Safety Executive; Department of Health; National Institute on Aging, US, NIH [AG13196]; Agency for Health Care Policy Research [HS06516]; John D and Catherine T MacArthur Foundation; Academy of Finland; BUPA Foundation; Stroke Association [TSA 2008/05]; British Heart Foundation [RG/07/008/23674] Funding Source: researchfish; Medical Research Council [G0100222, G0902037, G19/35] Funding Source: researchfish; Stroke Association [TSA2008/05] Funding Source: researchfish; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS006516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG013196, R01AG013196] Funding Source: NIH RePORTER; MRC [G0902037] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Health and Safety Executive; Department of Health; National Institute on Aging, US, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Agency for Health Care Policy Research(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); John D and Catherine T MacArthur Foundation; Academy of Finland(Academy of Finland); BUPA Foundation; Stroke Association; British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Stroke Association; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by the Medical Research Council (G8802774); British Heart Foundation (RG/02/005); Health and Safety Executive; Department of Health; National Institute on Aging (AG13196), US, NIH; Agency for Health Care Policy Research (HS06516); and John D and Catherine T MacArthur Foundation Research Networks on Successful Midlife Development and Socio-economic Status and Health. SEH is a British Heart Foundation research professor, and ADH has a British Heart Foundation senior research fellowship (FS05/125). PJT, JAC, and SEH are supported by a British Heart Foundation research grant (RG/05/014). Genotyping in the Whitehall II study was supported in part by a British Heart Foundation project grant (PG/07/133). M Kivimaki is supported by the Academy of Finland and a BUPA Foundation specialist research grant. MGM is supported by a Medical Research Council research professorship. EJB is supported by a Stroke Association grant (TSA 2008/05). The funders had no role in the design and conduct of the study; the collection, management, analysis, and interpretation of data; the writing of the manuscript; or the decision to submit the manuscript for publication.	ALPERT L, 1976, LAB WORLD, V27, P8; Assmann G, 2002, CIRCULATION, V105, P310, DOI 10.1161/hc0302.102575; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bonora E, 2004, DIABETES, V53, P1782, DOI 10.2337/diabetes.53.7.1782; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cauchi S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002031; Cook NR, 2008, STAT MED, V27, P191, DOI 10.1002/sim.2987; Cooper G R, 1973, CRC Crit Rev Clin Lab Sci, V4, P101, DOI 10.3109/10408367309151554; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gavin JR, 1997, DIABETES CARE, V20, P1183; Gillies CL, 2007, BMJ-BRIT MED J, V334, P299, DOI 10.1136/bmj.39063.689375.55; HANNING I, 1985, DIABETOLOGIA, V28, P831, DOI 10.1007/BF00291073; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Hippisley-Cox J, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b880; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; HOSHINO T, 1990, J CHROMATOGR, V515, P531, DOI 10.1016/S0021-9673(01)89351-1; HOSMER DW, 1992, EPIDEMIOLOGY, V3, P452, DOI 10.1097/00001648-199209000-00012; Keating BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003583; Lango H, 2008, DIABETES, V57, P3129, DOI 10.2337/db08-0504; Lin X, 2009, DIABETOLOGIA, V52, P600, DOI 10.1007/s00125-008-1254-y; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Lyssenko V, 2009, CURR OPIN LIPIDOL, V20, P87, DOI 10.1097/MOL.0b013e32832923af; Marmot M, 2005, INT J EPIDEMIOL, V34, P251, DOI 10.1093/ije/dyh372; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Perry JRB, 2008, CURR OPIN CLIN NUTR, V11, P371, DOI 10.1097/MCO.0b013e32830349a1; Rahman M, 2008, FAM PRACT, V25, P191, DOI 10.1093/fampra/cmn024; Rose G, 1982, CARDIOVASCULAR SURVE; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Scott LJ, 2006, DIABETES, V55, P2649, DOI 10.2337/db06-0341; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Song YQ, 2004, AM J HUM GENET, V74, P208, DOI 10.1086/381400; Sparso T, 2009, DIABETOLOGIA, V52, P1308, DOI 10.1007/s00125-009-1362-3; Talmud PJ, 2008, CLIN CHEM, V54, P467, DOI 10.1373/clinchem.2007.095489; Thakkinstian A, 2006, HUM MOL GENET, V15, P2784, DOI 10.1093/hmg/ddl220; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; van Hoek M, 2008, DIABETES, V57, P3122, DOI 10.2337/db08-0425; Vaxillaire M, 2008, DIABETES, V57, P244, DOI 10.2337/db07-0615; Weedon MN, 2006, PLOS MED, V3, P1877, DOI 10.1371/journal.pmed.0030374; Weedon MN, 2005, DIABETES, V54, P2487, DOI 10.2337/diabetes.54.8.2487; Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	49	213	218	0	25	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 14	2010	340								b4838	10.1136/bmj.b4838	http://dx.doi.org/10.1136/bmj.b4838			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	545DC	20075150	Green Published, hybrid			2022-12-28	WOS:000273711700002
J	Holtz, WJ; Keasling, JD				Holtz, William J.; Keasling, Jay D.			Engineering Static and Dynamic Control of Synthetic Pathways	CELL			English	Article							ESCHERICHIA-COLI; MEVALONATE PATHWAY; MESSENGER-RNA; GENE NETWORKS; OPTIMIZATION; EXPRESSION; BIOSYNTHESIS; METABOLISM; FRAMEWORK; TARGETS		[Keasling, Jay D.] Univ Calif Berkeley, Dept Chem Engn, Berkeley, CA 94720 USA; [Keasling, Jay D.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Holtz, William J.] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA; [Keasling, Jay D.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Holtz, William J.; Keasling, Jay D.] Synthet Biol Engn Res Ctr, Emeryville, CA 94608 USA; [Keasling, Jay D.] Joint BioEnergy Inst, Emeryville, CA 94608 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI	Keasling, JD (corresponding author), Univ Calif Berkeley, Dept Chem Engn, Berkeley, CA 94720 USA.	keasling@berkeley.edu	Keasling, Jay D/J-9162-2012	Keasling, Jay D/0000-0003-4170-6088; Holtz, William/0000-0001-5281-1794				Alper H, 2005, METAB ENG, V7, P155, DOI 10.1016/j.ymben.2004.12.003; Alper H, 2005, NAT BIOTECHNOL, V23, P612, DOI 10.1038/nbt1083; Amanullah A., 2004, HDB IND MIXING SCI P, P1071, DOI [10.1002/0471451452.ch18., DOI 10.1002/0471451452.CH18]; Anesiadis N, 2008, METAB ENG, V10, P255, DOI 10.1016/j.ymben.2008.06.004; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Burgard AP, 2003, BIOTECHNOL BIOENG, V84, P647, DOI 10.1002/bit.10803; Chin CS, 2008, PLOS BIOL, V6, P1343, DOI 10.1371/journal.pbio.0060146; Dueber JE, 2009, NAT BIOTECHNOL, V27, P753, DOI 10.1038/nbt.1557; Farmer WR, 2000, NAT BIOTECHNOL, V18, P533, DOI 10.1038/75398; Gadkar KG, 2005, BIOTECHNOL BIOENG, V89, P243, DOI 10.1002/bit.20349; Grant GA, 1996, PROTEIN SCI, V5, P34; Kelly Jason R, 2009, J Biol Eng, V3, P4, DOI 10.1186/1754-1611-3-4; Kimura S, 2005, J BIOCHEM, V137, P523, DOI 10.1093/jb/mvi065; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; Llaneras F, 2008, J BIOSCI BIOENG, V105, P1, DOI 10.1263/jbb.105.1; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Nakamura CE, 2003, CURR OPIN BIOTECH, V14, P454, DOI 10.1016/j.copbio.2003.08.005; Pharkya P, 2006, METAB ENG, V8, P1, DOI 10.1016/j.ymben.2005.08.003; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Schmidt FR, 2005, APPL MICROBIOL BIOT, V68, P425, DOI 10.1007/s00253-005-0003-0; SCHONER BE, 1986, P NATL ACAD SCI USA, V83, P8506, DOI 10.1073/pnas.83.22.8506; Yoon SH, 2009, J BIOTECHNOL, V140, P218, DOI 10.1016/j.jbiotec.2009.01.008; Zhang KC, 2008, P NATL ACAD SCI USA, V105, P20653, DOI 10.1073/pnas.0807157106	24	172	184	4	72	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 8	2010	140	1					19	23		10.1016/j.cell.2009.12.029	http://dx.doi.org/10.1016/j.cell.2009.12.029			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	541CY	20085699	Bronze			2022-12-28	WOS:000273391900008
J	Fryatt, R; Mills, A; Nordstrom, A				Fryatt, Robert; Mills, Anne; Nordstrom, Anders			Financing of health systems to achieve the health Millennium Development Goals in low-income countries	LANCET			English	Article							UNIVERSAL COVERAGE; GLOBAL HEALTH; INTERVENTIONS; COSTS; IMMUNIZATION; PREVENTION; STRATEGIES; THAILAND; DISEASE; NEWBORN	Concern that underfunded and weak health systems are impeding the achievement of the health Millennium Development Goals in low-income countries led to the creation of a High Level Taskforce on innovative International Financing for Health Systems in September, 2008. This report summarises the key challenges faced by the Taskforce and its Working Groups. Working Group 1 examined the constraints to scaling up and costs. Challenges included: difficulty in generalisation because of scarce and context-specific health-systems knowledge; no consensus for optimum service-delivery approaches, leading to wide cost differences; no consensus for health benefits; difficulty in quantification of likely efficiency gains; and challenges in quantification of the financing gap owing to uncertainties about financial commitments for health. Working Group 2 reviewed the different innovative mechanisms for raising and channelling funds. Challenges included: variable definitions of innovative finance; small evidence base for many innovative finance mechanisms; insufficient experience in harmonisation of global health initiatives; and inadequate experience in use of international investments to improve maternal, newborn, and child health. The various mechanisms reviewed and finally recommended all had different characteristics, some focusing on specific problems and some on raising resources generally. Contentious issues included the potential role of the private sector, the rights-based approach to health, and the move to results-based aid. The challenges and disagreements that arose during the work of the Taskforce draw attention to the many issues facing decision makers in low-income countries. International donors and recipient governments should work together to improve the evidence base for strengthening health systems, increase long-term commitments, and improve accountability through transparent and inclusive national approaches.	[Fryatt, Robert] WHO, Hlth Syst & Serv, CH-1211 Geneva, Switzerland; [Mills, Anne] London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1, England; [Nordstrom, Anders] Swedish Int Dev Agcy, Stockholm, Sweden	World Health Organization; University of London; London School of Hygiene & Tropical Medicine	Fryatt, R (corresponding author), 451 Millers Dr, ZA-0081 Pretoria, South Africa.	bobfryatt@yahoo.com		Mills, Anne/0000-0001-9863-9950				Adam T, 2005, BMJ-BRIT MED J, V331, P1107, DOI 10.1136/bmj.331.7525.1107; [Anonymous], 2008, ACCRA AGENDA ACTION; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Becerra-Posada F, 2004, LANCET, V364, P997, DOI 10.1016/S0140-6736(04)17026-8; BROOK PJ, 2009, CONTRACTING PUBLIC S; Bryce J, 2008, LANCET, V371, P1247, DOI 10.1016/S0140-6736(08)60559-0; Chisholm D, 2007, BRIT J PSYCHIAT, V191, P528, DOI 10.1192/bjp.bp.107.038463; Cometto G, 2009, LANCET, V374, P1146, DOI 10.1016/S0140-6736(09)61740-2; *COMM MACR HLTH WO, 2002, IMPR HLTH OUTC POOR; Eichler R, 2009, PERFORMANCE BASED IN; Floyd K, 2008, B WORLD HEALTH ORGAN, V86, P568, DOI 10.2471/BLT.07.049767; Girishankar N., 2009, INNOVATING DEV FINAN; *GLOB FUND FIGHT A, 2009, TUB MAL 5 YEAR EV GL; Hanson K, 2003, J INT DEV, V15, P1, DOI DOI 10.1002/JID.963; *INT HLTH PARTN RE, 2009, WORK GROUP COST; Johns B, 2007, B WORLD HEALTH ORGAN, V85, P256, DOI 10.2471/BLT.06.032037; Kiszewski A, 2007, B WORLD HEALTH ORGAN, V85, P623, DOI 10.2471/BLT.06.039529; KRISHNAN N, 2009, THESIS U CAMBRIDGE; Lagarde M, 2007, JAMA-J AM MED ASSOC, V298, P1900, DOI 10.1001/jama.298.16.1900; Leading group on Innovative Financing for Development, 2009, WHAT IS INN FIN; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Lim SS, 2008, LANCET, V372, P2031, DOI 10.1016/S0140-6736(08)61869-3; Limwattananon S, 2007, B WORLD HEALTH ORGAN, V85, P600, DOI 10.2471/BLT.06.033720; Moyo Dambisa., 2009, DEAD AID WHY AID IS; *OECD, 2008, EFF AID BETT HLTH; Prakongsai P, 2009, ADV HEALTH ECON HEAL, V21, P57, DOI 10.1108/S0731-2199(2009)0000021006; Ravishankar N, 2009, LANCET, V373, P2113, DOI 10.1016/S0140-6736(09)60881-3; Shiffman J, 2008, HEALTH POLICY PLANN, V23, P95, DOI 10.1093/heapol/czm045; Sridhar D, 2008, LANCET, V372, P1185, DOI 10.1016/S0140-6736(08)61485-3; Stenberg K, 2007, B WORLD HEALTH ORGAN, V85, P305, DOI 10.2471/BLT.06.032052; *TASKF INN INT FIN, 2003, MOR MON HLTH MOR HLT; Taskforce on Innovative International Financing for Health Systems, 2009, CONSTR SCAL COSTS; Taskforce on Innovative International Financing for Health systems, 2009, RAIS CHANN FUNDS; *WHO, 2008, PRIM HLTH CAR MOR TH; WHO, 2009, CONSTR SCAL HLTH REL; Wolfson LJ, 2008, B WORLD HEALTH ORGAN, V86, P27, DOI 10.2471/BLT.07.045096; *WORLD BANK, 2009, HLTH SYST MDGS COUNT; World Health Organization (WHO), 2006, WORLD HLTH REP 2006	38	47	49	0	20	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN-FEB	2010	375	9712					419	426		10.1016/S0140-6736(09)61833-X	http://dx.doi.org/10.1016/S0140-6736(09)61833-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	552PK	20113826				2022-12-28	WOS:000274305500029
J	Levine, JA				Levine, James A.			Deafness	LANCET			English	Editorial Material									Mayo Clin, Endocrine Res Unit, Rochester, MN 55905 USA	Mayo Clinic	Levine, JA (corresponding author), Mayo Clin, Endocrine Res Unit, 5-194 Joseph, Rochester, MN 55905 USA.	levine.james@mayo.edu							0	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC-JAN	2009	374	9707					2126	2127		10.1016/S0140-6736(09)61995-4	http://dx.doi.org/10.1016/S0140-6736(09)61995-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	537OO	20109836				2022-12-28	WOS:000273122900037
J	Friedmann, T; Rabin, O; Frankel, MS				Friedmann, Theodore; Rabin, Olivier; Frankel, Mark S.			Gene Doping and Sport	SCIENCE			English	Editorial Material							SEVERE COMBINED IMMUNODEFICIENCY; MURINE C2C12 MYOBLASTS; IN-VITRO; EXPRESSION; THERAPY; PERFORMANCE; CELLS		[Frankel, Mark S.] Amer Assoc Advancement Sci, Washington, DC 20005 USA; [Friedmann, Theodore] Univ Calif San Diego, La Jolla, CA 92093 USA; [Rabin, Olivier] WADA, Montreal, PQ H4Z 1B7, Canada	University of California System; University of California San Diego	Frankel, MS (corresponding author), Amer Assoc Advancement Sci, Washington, DC 20005 USA.	mfrankel@aaas.org						Aartsma-Rus A, 2006, MOL THER, V14, P401, DOI 10.1016/j.ymthe.2006.02.022; Abranches E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006286; Aiuti A, 2009, NEW ENGL J MED, V360, P447, DOI 10.1056/NEJMoa0805817; Alper J, 2009, NAT BIOTECHNOL, V27, P213, DOI 10.1038/nbt0309-213a; Anguiano A, 2009, J CLIN ONCOL, V27, P4197, DOI 10.1200/JCO.2008.19.1916; [Anonymous], 2008, NATURE, V454, P667, DOI 10.1038/454667a; Barton-Davis ER, 1999, J CLIN INVEST, V104, P375, DOI 10.1172/JCI7866; Bhasker CR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-535; Brenner MK, 2008, ADV EXP MED BIOL, V610, P88, DOI 10.1007/978-0-387-73898-7_7; Carroll D, 2008, GENE THER, V15, P1463, DOI 10.1038/gt.2008.145; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Catlin DH, 1996, JAMA-J AM MED ASSOC, V276, P231, DOI 10.1001/jama.276.3.231; Dressel U, 2003, MOL ENDOCRINOL, V17, P2477, DOI 10.1210/me.2003-0151; Engel BC, 2007, BLOOD, V109, P503, DOI 10.1182/blood-2006-06-031476; Fedoruk MN, 2008, SCAND J MED SCI SPOR, V18, P123, DOI 10.1111/j.1600-0838.2007.00759.x; Grimm D, 2007, J CLIN INVEST, V117, P3633, DOI 10.1172/JCI34129; Hacein-Bey-Abina S, 2002, NEW ENGL J MED, V346, P1185, DOI 10.1056/NEJMoa012616; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314; Hoberman J., 1984, MORTAL ENGINES SCI P; Kayser Bengt, 2007, BMC Med Ethics, V8, P2, DOI 10.1186/1472-6939-8-2; King CC, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-28; Kohn DB, 2009, NEW ENGL J MED, V360, P518, DOI 10.1056/NEJMe0809614; Kota J, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000112; Lee S, 2004, J APPL PHYSIOL, V96, P1097, DOI 10.1152/japplphysiol.00479.2003; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; McClorey G, 2006, GENE THER, V13, P1373, DOI 10.1038/sj.gt.3302800; MIAH A, 2008, WASHINGTON POST 0803; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Rauscher FJ, 2009, CANCER RES, V69, P1, DOI 10.1158/0008-5472.CAN-69-1-ED; REYNOLDS G, 2007, NY TIMES        0603; Rivera VM, 2005, BLOOD, V105, P1424, DOI 10.1182/blood-2004-06-2501; SLOT O, 2006, TIMES ONLINE    0202; Thrasher AJ, 2006, NATURE, V443, pE5, DOI 10.1038/nature05219; Tokish JM, 2004, AM J SPORT MED, V32, P1543, DOI 10.1177/0363546504268041; WENNER M, 2008, SCI AM ONLINE   0815; WILLIAMS EA, 2007, GOOD BETTER BEST HUM; 2009, ASS PRESS       0723	37	29	29	2	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 5	2010	327	5966					647	648		10.1126/science.1177801	http://dx.doi.org/10.1126/science.1177801			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	551ZD	20133558				2022-12-28	WOS:000274251800022
J	Petta, JR; Lu, H; Gossard, AC				Petta, J. R.; Lu, H.; Gossard, A. C.			A Coherent Beam Splitter for Electronic Spin States	SCIENCE			English	Article							QUANTUM DOTS; INTERFEROMETRY; SPECTROSCOPY; MANIPULATION	Rapid coherent control of electron spin states is required for implementation of a spin-based quantum processor. We demonstrated coherent control of electronic spin states in a double quantum dot by sweeping an initially prepared spin-singlet state through a singlet-triplet anticrossing in the energy-level spectrum. The anticrossing serves as a beam splitter for the incoming spin-singlet state. When performed within the spin-dephasing time, consecutive crossings through the beam splitter result in coherent quantum oscillations between the singlet state and a triplet state. The all-electrical method for quantum control relies on electron-nuclear spin coupling and drives single-electron spin rotations on nanosecond time scales.	[Petta, J. R.] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; [Lu, H.; Gossard, A. C.] Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA	Princeton University; University of California System; University of California Santa Barbara	Petta, JR (corresponding author), Princeton Univ, Dept Phys, Princeton, NJ 08544 USA.	petta@princeton.edu	Petta, Jason R/J-6663-2013; LU, Hong/D-3658-2013	Petta, Jason R/0000-0002-6416-0789; LU, Hong/0000-0002-8340-2739	Sloan Foundation; Packard Foundation; NSF through the Princeton Center for Complex Materials [DMR-0819860]; CAREER [DMR-0846341]; Defense Advanced Research Projects Agency [N66001-09-1-2020]; UCSB National Science Foundation DMR Materials Research Science and Engineering Center	Sloan Foundation(Alfred P. Sloan Foundation); Packard Foundation(The David & Lucile Packard Foundation); NSF through the Princeton Center for Complex Materials; CAREER(National Science Foundation (NSF)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); UCSB National Science Foundation DMR Materials Research Science and Engineering Center	We thank G. Burkard, B. Coish, D. Haldane, D. Huse, D. Loss, and H. Ribeiro for useful discussions and C. Laumann for technical contributions. Research at Princeton Univ. was supported by the Sloan Foundation, the Packard Foundation, and the NSF through the Princeton Center for Complex Materials (grant DMR-0819860) and CAREER award (grant DMR-0846341). Work at UCSB was supported by the Defense Advanced Research Projects Agency grant N66001-09-1-2020 and the UCSB National Science Foundation DMR Materials Research Science and Engineering Center.	Berezovsky J, 2008, SCIENCE, V320, P349, DOI 10.1126/science.1154798; Berns DM, 2008, NATURE, V455, P51, DOI 10.1038/nature07262; COHENTANNOUDJI R, 1977, QUANTUM MECH, V1, pCH4; Coish WA, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.125337; Gaudreau L, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.036807; Hanson R, 2007, REV MOD PHYS, V79, P1217, DOI 10.1103/RevModPhys.79.1217; Hund F, 1927, Z PHYS, V40, P742, DOI 10.1007/BF01400234; Izmalkov A, 2004, EUROPHYS LETT, V65, P844, DOI 10.1209/epl/i2003-10200-6; Izmalkov A, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.017003; Koppens FHL, 2006, NATURE, V442, P766, DOI 10.1038/nature05065; Lang F, 2008, NAT PHYS, V4, P223, DOI 10.1038/nphys838; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; Nakamura Y., 2001, NONADIABATIC TRANSIT; Nowack KC, 2007, SCIENCE, V318, P1430, DOI 10.1126/science.1148092; Oliver WD, 2005, SCIENCE, V310, P1653, DOI 10.1126/science.1119678; Petta JR, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.067601; Petta JR, 2005, SCIENCE, V309, P2180, DOI 10.1126/science.1116955; Pioro-Ladriere M, 2008, NAT PHYS, V4, P776, DOI 10.1038/nphys1053; Press D, 2008, NATURE, V456, P218, DOI 10.1038/nature07530; Ribeiro H, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.216802; SHEVCHENKO SN, 2009, PREPRINT; SHIMSHONI E, 1991, ANN PHYS-NEW YORK, V210, P16, DOI 10.1016/0003-4916(91)90275-D; Shytov AV, 2003, EUR PHYS J B, V36, P263, DOI 10.1140/epjb/e2003-00343-8; Sillanpaa M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.187002; Taylor JM, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.035315; Taylor JM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.236803; von Neumann J, 1929, PHYS Z, V30, P467; Zumbuhl DM, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.256801	28	205	208	1	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 5	2010	327	5966					669	672		10.1126/science.1183628	http://dx.doi.org/10.1126/science.1183628			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551ZD	20133567	Green Submitted			2022-12-28	WOS:000274251800032
J	Naka, K; Hoshii, T; Muraguchi, T; Tadokoro, Y; Ooshio, T; Kondo, Y; Nakao, S; Motoyama, N; Hirao, A				Naka, Kazuhito; Hoshii, Takayuki; Muraguchi, Teruyuki; Tadokoro, Yuko; Ooshio, Takako; Kondo, Yukio; Nakao, Shinji; Motoyama, Noboru; Hirao, Atsushi			TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia	NATURE			English	Article							HEMATOPOIETIC STEM-CELLS; CHRONIC MYELOGENOUS LEUKEMIA; ABL-EXPRESSING CELLS; BCR-ABL; TRANSCRIPTION FACTOR; OXIDATIVE STRESS; MURINE MODEL; BONE-MARROW; APOPTOSIS; MICE	Chronic myeloid leukaemia (CML) is caused by a defined genetic abnormality that generates BCR-ABL, a constitutively active tyrosine kinase(1). It is widely believed that BCR-ABL activates Akt signalling that suppresses the forkhead O transcription factors (FOXO), supporting the proliferation or inhibiting the apoptosis of CML cells(2-4). Although the use of the tyrosine kinase inhibitor imatinib is a breakthrough for CML therapy, imatinib does not deplete the leukaemia-initiating cells (LICs) that drive the recurrence of CML(5-8). Here, using a syngeneic transplantation system and a CML-like myeloproliferative disease mouse model, we show that Foxo3a has an essential role in the maintenance of CML LICs. We find that cells with nuclear localization of Foxo3a and decreased Akt phosphorylation are enriched in the LIC population. Serial transplantation of LICs generated from Foxo3a(+/+) and Foxo3a(-/-) mice shows that the ability of LICs to cause disease is significantly decreased by Foxo3a deficiency. Furthermore, we find that TGF-beta is a critical regulator of Akt activation in LICs and controls Foxo3a localization. A combination of TGF-beta inhibition, Foxo3a deficiency and imatinib treatment led to efficient depletion of CML in vivo. Furthermore, the treatment of human CML LICs with a TGF-beta inhibitor impaired their colony-forming ability in vitro. Our results demonstrate a critical role for the TGF-beta-FOXO pathway in the maintenance of LICs, and strengthen our understanding of the mechanisms that specifically maintain CML LICs in vivo.	[Naka, Kazuhito; Hoshii, Takayuki; Muraguchi, Teruyuki; Tadokoro, Yuko; Ooshio, Takako; Hirao, Atsushi] Kanazawa Univ, Div Mol Genet, Ctr Canc & Stem Cell Res, Canc Res Inst, Kanazawa, Ishikawa 9200934, Japan; [Ooshio, Takako; Hirao, Atsushi] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo 1020075, Japan; [Kondo, Yukio; Nakao, Shinji] Kanazawa Univ, Grad Sch Med Sci, Div Canc Med, Kanazawa, Ishikawa 9208641, Japan; [Motoyama, Noboru] Natl Ctr Gerontol & Geriatr, Natl Inst Longev Sci, Dept Geriatr Med, Aichi 4748522, Japan	Kanazawa University; Japan Science & Technology Agency (JST); Kanazawa University	Naka, K (corresponding author), Kanazawa Univ, Div Mol Genet, Ctr Canc & Stem Cell Res, Canc Res Inst, Kanazawa, Ishikawa 9200934, Japan.	kazunaka@kenroku.kanazawa-u.ac.jp; ahirao@kenroku.kanazawa-u.ac.jp	Naka, Kazuhito/X-3756-2019	Naka, Kazuhito/0000-0001-6646-6004; Ooshio, Takako/0000-0001-6508-8152	Ministry of Education, Culture, Sports, Science and Technology, Japan [17GS0419]; Grants-in-Aid for Scientific Research [21390290] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank H. Honda for BCR-ABL cDNA, C. A. Schmitt for MSCV-dnFoxo-ires-GFP, T. Nakamura for MSCV-NUP98-HOXA9, T. Kitamura for Plat-E retroviral packaging cells, T. Suda, N. Komatsu and K. Miyazono for discussions, and M. Sakae and T. Hatakeyama for expert technical support. We also thank Novartis International AG for imatinib (STI571). K. N. was supported by a grant-in-aid for Scientific Research (C), and A. H. was supported by grants-in-aid for Scientific Research (B) and Creative Scientific Research (17GS0419) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Bouchard C, 2007, GENE DEV, V21, P2775, DOI 10.1101/gad.453107; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Dash AB, 2002, P NATL ACAD SCI USA, V99, P7622, DOI 10.1073/pnas.102583199; Ema H, 2006, NAT PROTOC, V1, P2979, DOI 10.1038/nprot.2006.447; Essafi A, 2005, ONCOGENE, V24, P2317, DOI 10.1038/sj.onc.1208421; Ghaffari S, 2003, P NATL ACAD SCI USA, V100, P6523, DOI 10.1073/pnas.0731871100; Graham SM, 2002, BLOOD, V99, P319, DOI 10.1182/blood.V99.1.319; Hu YG, 2006, P NATL ACAD SCI USA, V103, P16870, DOI 10.1073/pnas.0606509103; Ito K, 2008, NATURE, V453, P1072, DOI 10.1038/nature07016; Jorgensen HG, 2007, BLOOD, V109, P4016, DOI 10.1182/blood-2006-11-057521; KODAMA H, 1994, EXP HEMATOL, V22, P979; Komatsu N, 2003, J BIOL CHEM, V278, P6411, DOI 10.1074/jbc.M211562200; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Michor F, 2005, NATURE, V435, P1267, DOI 10.1038/nature03669; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Moller GMO, 2007, FEBS LETT, V581, P1329, DOI 10.1016/j.febslet.2007.02.048; Neering SJ, 2007, BLOOD, V110, P2578, DOI 10.1182/blood-2007-02-073031; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; PELLICANO F, 2009, BLOOD           1201, DOI DOI 10.1182/BLOOD-2009-06-226621; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Roeder I, 2006, NAT MED, V12, P1181, DOI 10.1038/nm1487; Sawyer JS, 2003, J MED CHEM, V46, P3953, DOI 10.1021/jm0205705; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Yalcin S, 2008, J BIOL CHEM, V283, P25692, DOI 10.1074/jbc.M800517200; Yamazaki S, 2006, EMBO J, V25, P3515, DOI 10.1038/sj.emboj.7601236; Yamazaki S, 2009, BLOOD, V113, P1250, DOI 10.1182/blood-2008-04-146480; Zhao C, 2009, NATURE, V458, P776, DOI 10.1038/nature07737	28	437	461	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 4	2010	463	7281					676	U111		10.1038/nature08734	http://dx.doi.org/10.1038/nature08734			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551GB	20130650	Green Submitted			2022-12-28	WOS:000274193900039
J	Baldwin, A; Howlett, D; Maxwell, D				Baldwin, Andrew; Howlett, David; Maxwell, David			Picture quiz Gradually worsening shortness of breath	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DEFICIENCY		[Baldwin, Andrew; Howlett, David; Maxwell, David] E Sussex Hosp Trust, Eastbourne Dist Gen Hosp, Eastbourne BN21 2UD, England		Baldwin, A (corresponding author), E Sussex Hosp Trust, Eastbourne Dist Gen Hosp, Eastbourne BN21 2UD, England.	a.baldwin@doctors.org.uk						Amer Thoracic Soc European Respir, 2003, AM J RESP CRIT CARE, V168, P818, DOI 10.1164/rccm.168.7.818; FAIRMAN P, 2009, EMEDICINE; Kohnlein T, 2008, AM J MED, V121, P3, DOI 10.1016/j.amjmed.2007.07.025; LONGMORE M, 2004, OXFORD HDB CLIN MED; Needham M, 2004, THORAX, V59, P441, DOI 10.1136/thx.2003.006510; Stoller JK, 2005, LANCET, V365, P2225, DOI 10.1016/S0140-6736(05)66781-5	6	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	2010	340								c396	10.1136/bmj.c396	http://dx.doi.org/10.1136/bmj.c396			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	553CV	20130006				2022-12-28	WOS:000274343500008
J	Bridgens, J; Kiely, N				Bridgens, Joshua; Kiely, Nigel			Current management of clubfoot (congenital talipes equinovarus)	BRITISH MEDICAL JOURNAL			English	Review							2 DIFFERENT PROTOCOLS; PONSETI METHOD; IDIOPATHIC CLUBFOOT; FOLLOW-UP; FOOT; PHYSIOTHERAPY; DEFORMITY; CLUBFEET; RELEASE		[Kiely, Nigel] Robert Jones & Agnes Hunt Orthopaed Hosp, Oswestry SY10 7AG, Shrops, England	Keele University		jpbridgens@doctors.org.uk						ADBELGAWAD AA, 2007, J PEDIAT ORTHOP B, V16, P98; Bar-On E, 2005, J BONE JOINT SURG BR, V87B, P990, DOI 10.1302/0301-620X.87B7.16076; Changulani M, 2006, J BONE JOINT SURG BR, V88B, P1385, DOI 10.1302/0301-620X.88B10.17578; CHUNG CS, 1969, HUM HERED, V19, P321, DOI 10.1159/000152236; COOPER DM, 1995, J BONE JOINT SURG AM, V77, P1477, DOI 10.2106/00004623-199510000-00002; Cosma D, 2007, J PEDIATR ORTHOP B, V16, P317, DOI 10.1097/BPB.0b013e32826d18a6; Dobbs MB, 2006, J BONE JOINT SURG AM, V88A, P986, DOI 10.2106/JBJS.E.00114; Dobbs MB, 2004, J PEDIATR ORTHOPED, V24, P353, DOI 10.1097/01241398-200407000-00002; Dyer PJ, 2006, J BONE JOINT SURG BR, V88B, P1082, DOI 10.1302/0301-620X.88B8.17482; Freedman JA, 2006, J PEDIATR ORTHOPED, V26, P432, DOI 10.1097/01.bpo.0000226276.70706.0e; Ippolito E, 2003, J BONE JOINT SURG AM, V85A, P1286, DOI 10.2106/00004623-200307000-00015; Janicki JA, 2009, J BONE JOINT SURG AM, V91A, P1101, DOI 10.2106/JBJS.H.00178; Karol LA, 2005, J PEDIATR ORTHOPED, V25, P236, DOI 10.1097/01.bpo.0000150815.56790.b0; LAAVEG SJ, 1980, J BONE JOINT SURG AM, V62, P23, DOI 10.2106/00004623-198062010-00004; Lourenco AF, 2007, J BONE JOINT SURG BR, V89B, P378, DOI 10.1302/0301-620X.89B3.18313; Morcuende JA, 2004, PEDIATRICS, V113, P376, DOI 10.1542/peds.113.2.376; Morcuende Jose A, 2003, Iowa Orthop J, V23, P83; Paton RW, 2009, J BONE JOINT SURG BR, V91B, P655, DOI 10.1302/0301-620X.91B5.22117; PONSETI IV, 1963, J BONE JOINT SURG AM, V45, P261, DOI 10.2106/00004623-196345020-00004; Richards BS, 2008, J BONE JOINT SURG AM, V90A, P2313, DOI 10.2106/JBJS.G.01621; Tindall AJ, 2005, J PEDIATR ORTHOPED, V25, P627, DOI 10.1097/01.bpo.0000164876.97949.6b; Uglow MG, 2007, J CHILD ORTHOP, V1, P115, DOI 10.1007/s11832-007-0024-6; WYNNEDAVIES R, 1964, J BONE JOINT SURG BR, V46, P445, DOI 10.1302/0301-620X.46B3.445; CLUBFOOT PONSETI MAN	24	15	17	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 2	2010	340								c355	10.1136/bmj.c355	http://dx.doi.org/10.1136/bmj.c355			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	553CU	20124368				2022-12-28	WOS:000274343400011
J	Bloom, K; Joglekar, A				Bloom, Kerry; Joglekar, Ajit			Towards building a chromosome segregation machine	NATURE			English	Review							SPINDLE ASSEMBLY CHECKPOINT; BUDDING YEAST; KINETOCHORE COMPLEX; MITOTIC SPINDLE; CENTROMERIC NUCLEOSOMES; PERICENTRIC CHROMATIN; STRUCTURAL INTEGRITY; PLASMID PARTITION; DISTINCT PATHWAYS; MICROTUBULE TIPS	All organisms, from bacteria to humans, face the daunting task of replicating, packaging and segregating up to two metres (about 6 x 10(9) base pairs) of DNA when each cell divides. This task is carried out up to a trillion times during the development of a human from a single fertilized cell. The strategy by which DNA is replicated is now well understood. But when it comes to packaging and segregating a genome, the mechanisms are only beginning to be understood and are often as variable as the organisms in which they are studied.	[Bloom, Kerry; Joglekar, Ajit] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Bloom, K (corresponding author), Univ N Carolina, Dept Biol, 622 Fordham Hall,CB3280, Chapel Hill, NC 27599 USA.	kerry_bloom@unc.edu	Bloom, Kerry/AAE-5336-2019	Bloom, Kerry/0000-0002-3457-004X; Joglekar, Ajit/0000-0002-0607-5332	NIGMS NIH HHS [R01 GM032238-23, R01 GM032238] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032238] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Asbury CL, 2006, P NATL ACAD SCI USA, V103, P9873, DOI 10.1073/pnas.0602249103; AUSTIN S, 1983, J MOL BIOL, V169, P373, DOI 10.1016/S0022-2836(83)80056-4; Bancaud A, 2007, MOL CELL, V27, P135, DOI 10.1016/j.molcel.2007.05.037; Bianco PR, 2001, NATURE, V409, P374, DOI 10.1038/35053131; Blat Y, 1999, CELL, V98, P249, DOI 10.1016/S0092-8674(00)81019-3; BLOOM KS, 1982, CELL, V29, P305, DOI 10.1016/0092-8674(82)90147-7; Bouck DC, 2007, CURR BIOL, V17, P741, DOI 10.1016/j.cub.2007.03.033; Bowman GR, 2008, CELL, V134, P945, DOI 10.1016/j.cell.2008.07.015; Callaway E, 2008, NATURE, V451, P124, DOI 10.1038/451124a; CLARKE L, 1980, NATURE, V287, P504, DOI 10.1038/287504a0; Collins KA, 2005, MOL BIOL CELL, V16, P5649, DOI 10.1091/mbc.E05-08-0771; CORDOVA NJ, 1992, P NATL ACAD SCI USA, V89, P339, DOI 10.1073/pnas.89.1.339; Cottingham FR, 1999, J CELL BIOL, V147, P335, DOI 10.1083/jcb.147.2.335; Dalai Y, 2007, P NATL ACAD SCI USA, V104, P15974, DOI 10.1073/pnas.0707648104; Dalal Y, 2007, PLOS BIOL, V5, P1798, DOI 10.1371/journal.pbio.0050218; DANEHOLT B, 1977, J CELL BIOL, V73, P149, DOI 10.1083/jcb.73.1.149; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Doi M, 1992, THEORY POLYM DYNAMIC; Dworkin J, 2002, P NATL ACAD SCI USA, V99, P14089, DOI 10.1073/pnas.182539899; Ebersbach G, 2008, CELL, V134, P956, DOI 10.1016/j.cell.2008.07.016; Eckert CA, 2007, GENE DEV, V21, P278, DOI 10.1101/gad.1498707; Efremov A, 2007, P NATL ACAD SCI USA, V104, P19017, DOI 10.1073/pnas.0709524104; Emanuel M, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/2/025008; FINZI L, 1995, SCIENCE, V267, P378, DOI 10.1126/science.7824935; Fisher JK, 2009, P NATL ACAD SCI USA, V106, P9250, DOI 10.1073/pnas.0812723106; Folco HD, 2008, SCIENCE, V319, P94, DOI 10.1126/science.1150944; Furuyama T, 2009, CELL, V138, P104, DOI 10.1016/j.cell.2009.04.049; GALL JG, 1966, METHOD CELL PHYSIOL, V2, P37; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; Gerlich D, 2006, CURR BIOL, V16, P333, DOI 10.1016/j.cub.2005.12.040; Grishchuk EL, 2008, P NATL ACAD SCI USA, V105, P6918, DOI 10.1073/pnas.0801811105; Grishchuk EL, 2008, P NATL ACAD SCI USA, V105, P15423, DOI 10.1073/pnas.0807859105; Guimaraes GJ, 2008, CURR BIOL, V18, P1778, DOI 10.1016/j.cub.2008.08.012; Haldar D, 2006, NAT STRUCT MOL BIOL, V13, P192, DOI 10.1038/nsmb0306-192; Hamiche A, 1996, P NATL ACAD SCI USA, V93, P7588, DOI 10.1073/pnas.93.15.7588; Harrison BD, 2009, CHROMOSOMA, V118, P633, DOI 10.1007/s00412-009-0224-6; He XW, 2000, CELL, V101, P763, DOI 10.1016/S0092-8674(00)80888-0; Hertwig O, 1906, LEHRBUCH ENTWICKLUNG; HILL A, 1987, MOL CELL BIOL, V7, P2397, DOI 10.1128/MCB.7.7.2397; HILL TL, 1985, P NATL ACAD SCI USA, V82, P4404, DOI 10.1073/pnas.82.13.4404; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; HOLM C, 1985, CELL, V41, P553, DOI 10.1016/S0092-8674(85)80028-3; Hori T, 2008, CELL, V135, P1039, DOI 10.1016/j.cell.2008.10.019; Joglekar AP, 2009, CURR BIOL, V19, P694, DOI 10.1016/j.cub.2009.02.056; Jun S, 2006, P NATL ACAD SCI USA, V103, P12388, DOI 10.1073/pnas.0605305103; Kiermaier E, 2009, NAT CELL BIOL, V11, P1109, DOI 10.1038/ncb1924; Lacefield S, 2009, NAT CELL BIOL, V11, P1116, DOI 10.1038/ncb1925; LYNCH AS, 1994, J MOL BIOL, V236, P679, DOI 10.1006/jmbi.1994.1179; Maresca TJ, 2009, J CELL BIOL, V184, P373, DOI 10.1083/jcb.200808130; Marquis KA, 2008, GENE DEV, V22, P1786, DOI 10.1101/gad.1684008; Mazumder A, 2008, BIOPHYS J, V95, P3028, DOI 10.1529/biophysj.108.132274; Mazumder A, 2007, BIOPHYS J, V93, P2209, DOI 10.1529/biophysj.106.102202; McIntosh JR, 2008, CELL, V135, P322, DOI 10.1016/j.cell.2008.08.038; Meaburn KJ, 2007, NATURE, V445, P379, DOI 10.1038/445379a; Mehta S, 2002, J CELL BIOL, V158, P625, DOI 10.1083/jcb.200204136; Miller SA, 2008, CURR BIOL, V18, P1785, DOI 10.1016/j.cub.2008.11.007; Miranda JJL, 2005, NAT STRUCT MOL BIOL, V12, P138, DOI 10.1038/nsmb896; Mogilner A, 2003, CURR BIOL, V13, pR721, DOI 10.1016/j.cub.2003.08.050; NICKLAS RB, 1988, ANNU REV BIOPHYS BIO, V17, P431, DOI 10.1146/annurev.bb.17.060188.002243; Obermayer B, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.021804; Ocampo-Hafalla MT, 2007, CHROMOSOMA, V116, P531, DOI 10.1007/s00412-007-0118-4; OGURA T, 1983, CELL, V32, P351, DOI 10.1016/0092-8674(83)90454-3; Okumura Y, 2001, ADV MATER, V13, P485, DOI 10.1002/1521-4095(200104)13:7<485::AID-ADMA485>3.0.CO;2-T; Oliveira RA, 2005, MOL CELL BIOL, V25, P8971, DOI 10.1128/MCB.25.20.8971-8984.2005; Paliulis LV, 2004, CURR BIOL, V14, P2124, DOI 10.1016/j.cub.2004.11.052; PAULSON JR, 1977, CELL, V12, P817, DOI 10.1016/0092-8674(77)90280-X; Pearson CG, 2001, J CELL BIOL, V152, P1255, DOI 10.1083/jcb.152.6.1255; Pope LH, 2006, MOL BIOL CELL, V17, P104, DOI 10.1091/mbc.e05-04-0321; Powers AF, 2009, CELL, V136, P865, DOI 10.1016/j.cell.2008.12.045; Ptacin JL, 2008, NAT STRUCT MOL BIOL, V15, P485, DOI 10.1038/nsmb.1412; Ramamurthi KS, 2008, CELL, V134, P916, DOI 10.1016/j.cell.2008.09.004; Rao VB, 2008, ANNU REV GENET, V42, P647, DOI 10.1146/annurev.genet.42.110807.091545; Ribeiro SA, 2009, MOL BIOL CELL, V20, P2371, DOI 10.1091/mbc.E08-11-1127; Schumacher MA, 2008, BIOCHEM J, V412, P1, DOI 10.1042/BJ20080359; SELVIN PR, 1992, SCIENCE, V255, P82, DOI 10.1126/science.1553534; SKIBBENS RV, 1993, J CELL BIOL, V122, P859, DOI 10.1083/jcb.122.4.859; Storlazzi A, 2008, GENE DEV, V22, P796, DOI 10.1101/gad.459308; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sullivan NL, 2009, CELL, V137, P697, DOI 10.1016/j.cell.2009.04.044; Towles KB, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/2/025001; Uchida KSK, 2009, J CELL BIOL, V184, P383, DOI 10.1083/jcb.200811028; Walczak CE, 2008, INT REV CYTOL, V265, P111, DOI 10.1016/S0074-7696(07)65003-7; Wan XH, 2009, CELL, V137, P672, DOI 10.1016/j.cell.2009.03.035; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Weber SA, 2004, PLOS BIOL, V2, P1340, DOI 10.1371/journal.pbio.0020260; Welburn JPI, 2008, DEV CELL, V15, P645, DOI 10.1016/j.devcel.2008.10.011; Westermann S, 2005, MOL CELL, V17, P277, DOI 10.1016/j.molcel.2004.12.019; Wolgemuth CW, 2004, EUR BIOPHYS J BIOPHY, V33, P146, DOI 10.1007/s00249-003-0344-5; Yeh E, 2008, CURR BIOL, V18, P81, DOI 10.1016/j.cub.2007.12.019; YIN H, 1995, SCIENCE, V270, P1653, DOI 10.1126/science.270.5242.1653; Zelin E, 2007, CHEMBIOCHEM, V8, P1907, DOI 10.1002/cbic.200700437; ZINKOWSKI RP, 1991, J CELL BIOL, V113, P1091, DOI 10.1083/jcb.113.5.1091; Zocchi G, 2009, ANNU REV BIOPHYS, V38, P75, DOI 10.1146/annurev.biophys.050708.133637	95	57	58	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 28	2010	463	7280					446	456		10.1038/nature08912	http://dx.doi.org/10.1038/nature08912			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	548QK	20110988	Green Submitted, Green Accepted			2022-12-28	WOS:000273981100036
J	Checchi, F				Checchi, Francesco			Estimating the number of civilian deaths from armed conflicts	LANCET			English	Editorial Material							MORTALITY; NUTRITION		Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Checchi, F (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Keppel St, London WC1E 7HT, England.	Francesco.checchi@lshtm.ac.uk		Checchi, Francesco/0000-0001-9030-5382				Aiga H, 2007, B WORLD HEALTH ORGAN, V85, P823; Bostoen K, 2007, EMERG THEMES EPIDEMI, V4, DOI 10.1186/1742-7622-4-13; BRENNAN RJ, 2006, HUMANITARIAN EXCHANG, V35, P27; Brown V, 2007, EMERG THEMES EPIDEMI, V4, DOI 10.1186/1742-7622-4-9; Connolly MA, 2005, COMMUNICABLE DIS CON; *CTR RES EP DIS, 2009, COMPL EM DAT; Degomme O, 2010, LANCET, V375, P294, DOI 10.1016/S0140-6736(09)61967-X; Degomme O, 2007, EMERG THEMES EPIDEMI, V4, DOI 10.1186/1742-7622-4-11; Grais Rebecca F, 2009, Confl Health, V3, P8, DOI 10.1186/1752-1505-3-8; NIELSEN J, 2009, TRENDS NUTR MORTALIT; Prudhon C, 2007, EMERG THEMES EPIDEMI, V4, DOI 10.1186/1742-7622-4-10; Ratnayake Ruwan, 2009, Confl Health, V3, P2, DOI 10.1186/1752-1505-3-2; Ronald C, 1999, BMJ, V318; SALIGNON P, 2009, SRI LANKA CLOSED DOO; *SPHER PROJ, 2004, SPHER HDB; Tapp Christine, 2008, Confl Health, V2, P1, DOI 10.1186/1752-1505-2-1; *UN STAND COMM, UN STAND COMM NUTR D; World Health Organization, 2006, WORKSH TRACK HLTH PE	18	7	7	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 23	2010	375	9711					255	257		10.1016/S0140-6736(09)62128-0	http://dx.doi.org/10.1016/S0140-6736(09)62128-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	549QS	20109930				2022-12-28	WOS:000274069300004
J	Connelly, JN				Connelly, J. N.			Adjusting the Solar System's Absolute Clock	SCIENCE			English	Editorial Material							ANGRITE; AGES		Univ Copenhagen, Nat Hist Museum Denmark, Ctr Star & Planet Format, DK-1350 Copenhagen, Denmark	University of Copenhagen	Connelly, JN (corresponding author), Univ Copenhagen, Nat Hist Museum Denmark, Ctr Star & Planet Format, DK-1350 Copenhagen, Denmark.	connelly@snm.ku.dk	Connelly, James/O-7996-2015					Amelin Y, 2002, SCIENCE, V297, P1678, DOI 10.1126/science.1073950; Amelin Y, 2008, GEOCHIM COSMOCHIM AC, V72, P221, DOI 10.1016/j.gca.2007.09.034; Brennecka GA, 2010, SCIENCE, V327, P449, DOI 10.1126/science.1180871; Connelly JN, 2008, GEOCHIM COSMOCHIM AC, V72, P4813, DOI 10.1016/j.gca.2008.06.007; Glavin DP, 2004, METEORIT PLANET SCI, V39, P693, DOI 10.1111/j.1945-5100.2004.tb00112.x; Stirling CH, 2005, GEOCHIM COSMOCHIM AC, V69, P1059, DOI 10.1016/j.gca.2004.06.034; Trinquier A, 2009, SCIENCE, V324, P374, DOI 10.1126/science.1168221	7	1	1	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 22	2010	327	5964					422	423		10.1126/science.1183755	http://dx.doi.org/10.1126/science.1183755			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546BS	20093464				2022-12-28	WOS:000273783100025
J	Buekens, P; Althabe, F				Buekens, Pierre; Althabe, Fernando			Post-partum haemorrhage: beyond the confrontation between misoprostol and oxytocin	LANCET			English	Editorial Material									[Buekens, Pierre] Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA 70112 USA; [Althabe, Fernando] Inst Clin Effectiveness & Hlth Policy, Buenos Aires, DF, Argentina	Tulane University	Buekens, P (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA 70112 USA.	pbuekens@tulane.edu						Althabe F, 2008, NEW ENGL J MED, V358, P1929, DOI 10.1056/NEJMsa071456; Blum J, 2010, LANCET, V375, P217, DOI 10.1016/S0140-6736(09)61923-1; COTTER A, 2001, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001808, DOI 10.1002/14651858.CD001808]; *DEP MAK PREGN SAF, WHO REC PREV POSTP H; Derman RJ, 2006, LANCET, V368, P1248, DOI 10.1016/S0140-6736(06)69522-6; Gulmezoglu AM, 2001, LANCET, V358, P689, DOI 10.1016/S0140-6736(01)05835-4; Hofmeyr GJ, 2009, B WORLD HEALTH ORGAN, V87, P666, DOI [10.2471/BLT.08.062562, 10.2471/BLT.08.055715]; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Prendiville WJ, 2000, COCHRANE DB SYST REV, V3; Tsu VD, 2003, INT J GYNECOL OBSTET, V83, P103, DOI 10.1016/S0020-7292(03)00186-3; WINIKOFF B, 2010, LANCET, V375, P320	11	7	7	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 16	2010	375	9710					176	178		10.1016/S0140-6736(10)60066-9	http://dx.doi.org/10.1016/S0140-6736(10)60066-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	546ZH	20109901				2022-12-28	WOS:000273853800006
J	Sanders, AE; Wang, CL; Katz, M; Derby, CA; Barzilai, N; Ozelius, L; Lipton, RB				Sanders, Amy E.; Wang, Cuiling; Katz, Mindy; Derby, Carol A.; Barzilai, Nir; Ozelius, Laurie; Lipton, Richard B.			Association of a Functional Polymorphism in the Cholesteryl Ester Transfer Protein (CETP) Gene With Memory Decline and Incidence of Dementia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENOME-WIDE ASSOCIATION; ALZHEIMERS-DISEASE; IDENTIFIES VARIANTS; TASK-FORCE; GENOTYPE; RISK; APOE; SENSITIVITY; LONGEVITY; TESTS	Context Polymorphisms in the cholesteryl ester transfer protein ( CETP) gene have been associated with exceptional longevity and lower cardiovascular risk, but associations with memory decline and dementia risk are unclear. Objective To test the hypothesis that a single-nucleotide polymorphism ( SNP) at CETP codon 405 ( isoleucine to valine V405; SNP rs5882) is associated with a lower rate of memory decline and lower risk of incident dementia, including Alzheimer disease ( AD). Design, Setting, and Participants Prospective cohort study comprising 608 community-dwelling adults without dementia aged 70 years or older from the Einstein Aging Study with CETP genotype available. Fifteen participants with prevalent dementia were excluded, and 70 without follow-up-63 lost to follow-up and 7 new to the study-were excluded from the Cox proportional hazards model, which included 523 participants in the analysis. Standardized neuropsychological and neurological measures were administered annually from 1994-2009. Linear mixed-effects models adjusted for sex, education, race, medical comorbidities, and apolipoprotein (APOE) epsilon 4 examined associations of V405 genotype with longitudinal performance on cognitive tests of episodic memory ( Free and Cued Selective Reminding Test [FCSRT], possible scores of 0-48), attention ( Digit Span), and psychomotor speed ( Digit Symbol Substitution). The V405 genotype was the main predictor of incident dementia or AD in similarly adjusted Cox proportional hazards models with age as the time scale. Main Outcome Measures Memory decline and incident dementia. Results Valine allele frequency was 43.5%. A total of 40 cases of incident dementia occurred during follow-up (mean[(SD], 4.3 [3.1] years). Compared with isoleucine homozygotes, valine homozygotes had significantly slower memory decline on the FCSRT (0.43 points per year of age for isoleucine; 95% confidence interval [CI], -0.58 to -0.29 vs 0.21 points per year of age for valine; 95% CI, -0.39 to -0.04; difference in linear age slope, 0.22; 95% CI, 0.02 to 0.41; P=.03) and no significant differences on the Digit Span or Digit Symbol Substitution tests. Valine homozygotes also had lower risk of dementia ( hazard ratio, 0.28; 95% CI, 0.10-0.85; P=.02) and AD ( hazard ratio, 0.31; 95% CI, 0.10-0.95; P=.04). Conclusion This preliminary report suggests that CETP V405 valine homozygosity is associated with slower memory decline and lower incident dementia and AD risk. JAMA. 2010;303(2):150-158 www.jama.com	[Sanders, Amy E.; Katz, Mindy; Derby, Carol A.; Lipton, Richard B.] Yeshiva Univ Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10461 USA; [Wang, Cuiling; Derby, Carol A.; Lipton, Richard B.] Yeshiva Univ Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA; [Barzilai, Nir; Lipton, Richard B.] Yeshiva Univ Albert Einstein Coll Med, Inst Aging Res, Bronx, NY 10461 USA; [Ozelius, Laurie] Mt Sinai Sch Med, Dept Genet, New York, NY USA; [Ozelius, Laurie] Mt Sinai Sch Med, Dept Genom Sci & Neurol, New York, NY USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Lipton, RB (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Neurol, 1165 Morris Pk Ave,Rousso Bldg,Room 346, Bronx, NY 10461 USA.	richard.lipton@einstein.yu.edu	Lipton, Richard B/B-5060-2011; Sanders, Amy/AAF-6601-2020; Lipton, Richard Bruce/AAY-2818-2021; Sanders, Amy/AAI-2633-2019		National Institute on Aging [AG03949, AG03949-24S1, AG-027734, AG-18728]; National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) [UL1 RR025750, KL2 RR025749, TL1 RR025748]; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR025748, KL2RR025749, UL1RR025750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018728, P01AG027734, P01AG003949] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Einstein Aging Study is supported by the National Institute on Aging program project grant AG03949 and Supplement (Biorepository) AG03949-24S1. Dr Barzilai is supported by grants AG-027734 and AG-18728 from the National Institute on Aging. Dr Sanders is supported by the Einstein Clinical and Translation Science Award grant UL1 RR025750 and KL2 RR025749 and TL1 RR025748 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research.	ALBERS JJ, 1992, INT J CLIN LAB RES, V21, P264, DOI 10.1007/BF02591657; *AM PSYCH ASS, 1994, DIAGN STAT MAN MENT, P133; Arias-Vasquez A, 2007, NEUROGENETICS, V8, P189, DOI 10.1007/s10048-007-0089-x; Barzilai N, 2006, NEUROLOGY, V67, P2170, DOI 10.1212/01.wnl.0000249116.50854.65; Barzilai N, 2003, JAMA-J AM MED ASSOC, V290, P2030, DOI 10.1001/jama.290.15.2030; Bennett DA, 2009, NEUROLOGY, V72, P1495, DOI 10.1212/WNL.0b013e3181a2e87d; BLESSED G, 1968, BRIT J PSYCHIAT, V114, P797, DOI 10.1192/bjp.114.512.797; BUSCHKE H, 1984, J CLIN NEUROPSYCHOL, V6, P433, DOI 10.1080/01688638408401233; Carter CJ, 2007, NEUROCHEM INT, V50, P12, DOI 10.1016/j.neuint.2006.07.007; Coon KD, 2007, J CLIN PSYCHIAT, V68, P613, DOI 10.4088/JCP.v68n0419; Dullaart RPF, 2008, PHARMACOGENOMICS, V9, P747, DOI 10.2217/14622416.9.6.747; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Grober E, 1999, NEUROBIOL AGING, V20, P573, DOI 10.1016/S0197-4580(99)00063-9; GROBER E, 1988, NEUROLOGY, V38, P900, DOI 10.1212/WNL.38.6.900; GROBER E, ALZHEIMER D IN PRESS; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Johnson W, 2007, NEUROSCI LETT, V420, P189, DOI 10.1016/j.neulet.2007.05.013; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lipton RB, 2003, J AM GERIATR SOC, V51, P1382, DOI 10.1046/j.1532-5415.2003.51455.x; Martin GM, 2007, PLOS GENET, V3, P1121, DOI 10.1371/journal.pgen.0030125; MASUR DM, 1994, NEUROLOGY, V44, P1427, DOI 10.1212/WNL.44.8.1427; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Proust-Lima C, 2007, AM J EPIDEMIOL, V165, P344, DOI 10.1093/aje/kwk017; Qureischie H, 2009, J NEURAL TRANSM, V116, P467, DOI 10.1007/s00702-008-0180-y; Rodriguez E, 2006, J NEUROL, V253, P181, DOI 10.1007/s00415-005-0945-2; Sanders AE, 2008, J GERONTOL A-BIOL, V63, P1356, DOI 10.1093/gerona/63.12.1356; Scarmeas N, 2009, JAMA-J AM MED ASSOC, V302, P627, DOI 10.1001/jama.2009.1144; SCHACHTER F, 1994, NAT GENET, V6, P29, DOI 10.1038/ng0194-29; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Suribhatla S, 2004, INT J GERIATR PSYCH, V19, P1140, DOI 10.1002/gps.1196; Tan QH, 2004, BIOGERONTOLOGY, V5, P89, DOI 10.1023/B:BGEN.0000025072.30441.1c; Thiebaut ACM, 2004, STAT MED, V23, P3803, DOI 10.1002/sim.2098; Thompson A, 2008, JAMA-J AM MED ASSOC, V299, P2777, DOI 10.1001/jama.299.23.2777; Thompson JF, 2005, ATHEROSCLEROSIS, V181, P45, DOI 10.1016/j.atherosclerosis.2005.01.015; Tounsi H, 1999, ALZ DIS ASSOC DIS, V13, P38, DOI 10.1097/00002093-199903000-00006; Vellas B, 2011, LANCET NEUROL, V10, P297, DOI 10.1016/S1474-4422(08)70087-5; Verghese J, 2006, J AM GERIATR SOC, V54, P255, DOI 10.1111/j.1532-5415.2005.00580.x; Verghese J, 2010, J NEUROL, V257, P392, DOI 10.1007/s00415-009-5332-y; Wechsler D., 2008, WECHSLER ADULT INTEL, P257; YAMADA T, 1995, ACTA NEUROPATHOL, V90, P633	41	75	82	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 13	2010	303	2					150	158		10.1001/jama.2009.1988	http://dx.doi.org/10.1001/jama.2009.1988			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	542UI	20068209	Green Accepted, Bronze			2022-12-28	WOS:000273522600025
J	Warrell, DA				Warrell, David A.			Snake bite	LANCET			English	Article							RANDOMIZED COMPARATIVE TRIAL; VIPER CALLOSELASMA-RHODOSTOMA; VENOM ANTIGEN LEVELS; NAJA-NIGRICOLLIS; SPITTING COBRA; SRI-LANKA; HYPERSENSITIVITY REACTIONS; ANTIVENOM REACTIONS; SOUTHEASTERN NEPAL; ECHIS-CARINATUS	Snake bite is a common and frequently devastating environmental and occupational disease, especially in rural areas of tropical developing countries. Its public health importance has been largely ignored by medical science. Snake venoms are rich in protein and peptide toxins that have specificity for a wide range of tissue receptors, making them clinically challenging and scientifically fascinating, especially for drug design. Although the full burden of human suffering attributable to snake bite remains obscure, hundreds of thousands of people are known to be envenomed and tens of thousands are killed or maimed by snakes every year. Preventive efforts should be aimed towards education of affected communities to use proper footwear and to reduce the risk of contact with snakes to a minimum through understanding of snakes' behaviour. To treat envenoming, the production and clinical use of antivenom must be improved. Increased collaboration between clinicians, epidemiologists, and laboratory toxinologists should enhance the understanding and treatment of envenoming.	Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England	University of Oxford	Warrell, DA (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England.	david.warrell@ndm.ox.ac.uk						Abubakar SB, 2010, TOXICON, V55, P719, DOI 10.1016/j.toxicon.2009.10.024; ANKER RL, 1982, MED J AUSTRALIA, V1, P212, DOI 10.5694/j.1326-5377.1982.tb132272.x; Ariaratnam CA, 1999, AM J TROP MED HYG, V61, P259, DOI 10.4269/ajtmh.1999.61.259; Ariaratnam CA, 2008, AM J TROP MED HYG, V79, P458, DOI 10.4269/ajtmh.2008.79.458; Ariaratnam CA, 2009, AM J TROP MED HYG, V81, P725, DOI 10.4269/ajtmh.2009.09-0225; AUDEBERT F, 1994, HUM EXP TOXICOL, V13, P683, DOI 10.1177/096032719401301006; Barlow A, 2009, P ROY SOC B-BIOL SCI, V276, P2443, DOI 10.1098/rspb.2009.0048; BEVAN P, 1983, J BIOL CHEM, V258, P5319; Bon C, 1996, ENVENOMINGS THEIR TR, P3; Bos MHA, 2009, BLOOD, V114, P2563, DOI 10.1182/blood-2009-07-229716; Boyer LV, 1999, ARCH INTERN MED, V159, P706, DOI 10.1001/archinte.159.7.706; BROWN AE, 1987, T ROY SOC TROP MED H, V81, P548, DOI 10.1016/0035-9203(87)90401-9; Brunda G, 2007, INDIAN J MED RES, V125, P661; Campbell C H, 1966, Med J Aust, V2, P922; Canale E, 2009, EMERG MED AUSTRALAS, V21, P184, DOI 10.1111/j.1742-6723.2009.01180.x; CARDOSO JLC, 1993, Q J MED, V86, P315; Caron EJ, 2009, TOXICON, V54, P779, DOI 10.1016/j.toxicon.2009.06.001; Chappuis F, 2007, AM J TROP MED HYG, V77, P197, DOI 10.4269/ajtmh.2007.77.197; Chen TB, 2002, ANAL BIOCHEM, V311, P152, DOI 10.1016/S0003-2697(02)00404-9; Chippaux JP, 1998, B WORLD HEALTH ORGAN, V76, P515; COULTER AR, 1974, J IMMUNOL METHODS, V4, P297, DOI 10.1016/0022-1759(74)90072-6; CUPO P, 1991, REV I MED TROP, V33, P115, DOI 10.1590/S0036-46651991000200005; Daltry JC, 1996, NATURE, V379, P537, DOI 10.1038/379537a0; Dong LV, 2003, J IMMUNOL METHODS, V282, P13, DOI 10.1016/S0022-1759(03)00277-1; Ducancel F, 2005, CELL MOL LIFE SCI, V62, P2828, DOI 10.1007/s00018-005-5286-x; Fayrer J., 1882, NATURE, V27, P205; Fry BG, 2005, GENOME RES, V15, P403, DOI 10.1101/gr.3228405; Fry BG, 2009, J PROTEOMICS, V72, P127, DOI 10.1016/j.jprot.2009.01.009; GATINEAU E, 1988, EUR J BIOCHEM, V171, P535, DOI 10.1111/j.1432-1033.1988.tb13822.x; GREENWOOD BM, 1974, BRIT MED J, V4, P743, DOI 10.1136/bmj.4.5947.743; GUBENSEK F, 1982, TOXICON, V20, P191, DOI 10.1016/0041-0101(82)90191-X; Harrison RA, 2006, TOXICON, V47, P364, DOI 10.1016/j.toxicon.2005.10.017; Harrison RA, 2003, TOXICON, V41, P441, DOI 10.1016/S0041-0101(02)00360-4; Hati A K, 1992, J Indian Med Assoc, V90, P145; HO M, 1986, AM J TROP MED HYG, V35, P579, DOI 10.4269/ajtmh.1986.35.579; HO M, 1986, TOXICON, V24, P211, DOI 10.1016/0041-0101(86)90147-9; Hughes BW, 2006, MUSCLE NERVE, V33, P445, DOI 10.1002/mus.20440; HUTTON RA, 1990, T ROY SOC TROP MED H, V84, P866, DOI 10.1016/0035-9203(90)90111-Q; Isbell LA, 2006, J HUM EVOL, V51, P1, DOI 10.1016/j.jhevol.2005.12.012; Isbister GK, 2009, QJM-INT J MED, V102, P563, DOI 10.1093/qjmed/hcp081; Isbister GK, 2008, MED J AUSTRALIA, V188, P473, DOI 10.5694/j.1326-5377.2008.tb01721.x; Isbister GK, 2010, TOXICON, V55, P646, DOI 10.1016/j.toxicon.2009.07.034; Jha P, 2006, PLOS MED, V3, P191, DOI 10.1371/journal.pmed.0030018; Joseph JK, 2007, T ROY SOC TROP MED H, V101, P85, DOI 10.1016/j.trstmh.2006.03.008; KAMINSKI HJ, 1990, NEUROLOGY, V40, P1663, DOI 10.1212/WNL.40.11.1663; Kasturiratne A, 2008, PLOS MED, V5, P1591, DOI 10.1371/journal.pmed.0050218; Kitchens CS, 2008, J MED TOXICOL, V4, P180, DOI 10.1007/BF03161198; Klaewsongkram J, 2009, ACTA TROP, V109, P84, DOI 10.1016/j.actatropica.2008.09.007; Kuch U, 2006, NATURWISSENSCHAFTEN, V93, P84, DOI 10.1007/s00114-005-0065-y; LALLOO DG, 1995, BLOOD COAGUL FIBRIN, V6, P65, DOI 10.1097/00001721-199502000-00011; Lisy O, 2008, J AM COLL CARDIOL, V52, P60, DOI 10.1016/j.jacc.2008.02.077; Lu Q, 2005, J THROMB HAEMOST, V3, P1791, DOI 10.1111/j.1538-7836.2005.01358.x; MALASIT P, 1986, BRIT MED J, V292, P17, DOI 10.1136/bmj.292.6512.17; Malhotra A, 2004, MOL PHYLOGENET EVOL, V32, P83, DOI 10.1016/j.ympev.2004.02.008; Gutierrez JM, 2009, TOXICON, V54, P958, DOI 10.1016/j.toxicon.2009.01.038; MENEZ A, 1984, J PHYSIOLOGY PARIS, V79, P196; Meyer WP, 1997, AM J TROP MED HYG, V56, P291, DOI 10.4269/ajtmh.1997.56.291; MUELLING RJ, 1957, AM J CLIN PATHOL, V28, P489, DOI 10.1093/ajcp/28.5.489; Munez A., 2003, SUBTLE BEAST SNAKES; O'Leary MA, 2006, TOXICON, V48, P4, DOI 10.1016/j.toxicon.2006.04.001; Ohman A, 2007, P NATL ACAD SCI USA, V104, P16396, DOI 10.1073/pnas.0707885104; Pardal PPD, 2004, T ROY SOC TROP MED H, V98, P28, DOI 10.1016/S0035-9203(03)00005-1; PHILLIPS RE, 1988, Q J MED, V68, P691; Pook CE, 2009, MOL PHYLOGENET EVOL, V53, P792, DOI 10.1016/j.ympev.2009.08.002; PUGH RNH, 1980, ANN TROP MED PARASIT, V74, P523, DOI 10.1080/00034983.1980.11687380; REID HA, 1963, LANCET, V1, P617; REID HA, 1963, LANCET, V1, P621; Riviere G, 1997, J PHARMACOL EXP THER, V281, P1; ROJAS G, 1994, TOXICON, V32, P351, DOI 10.1016/0041-0101(94)90087-6; Ruff RL, 2002, MUSCLE NERVE, V25, P311, DOI 10.1002/mus.10063; Saha A, 2006, TOXICON, V47, P296, DOI 10.1016/j.toxicon.2005.11.006; SANOMARTINS IS, 1994, TOXICON, V32, P1045, DOI 10.1016/0041-0101(94)90388-3; Sclater W.L., 1891, LIST SNAKES INDIAN M; Sharma SK, 2004, AM J TROP MED HYG, V71, P234, DOI 10.4269/ajtmh.2004.71.234; SILVA MRE, 1949, AM J PHYSIOL, V156, P261, DOI 10.1152/ajplegacy.1949.156.2.261; Smalligan R, 2004, BMJ-BRIT MED J, V329, P1129, DOI 10.1136/bmj.329.7475.1129; SNOW RW, 1994, ANN TROP MED PARASIT, V88, P665, DOI 10.1080/00034983.1994.11812919; SWAROOP S, 1954, Bull World Health Organ, V10, P35; Tanos PP, 2008, TOXICON, V52, P769, DOI 10.1016/j.toxicon.2008.08.013; THALLEY BS, 1990, BIO-TECHNOL, V8, P934, DOI 10.1038/nbt1090-934; THEAKSTON RDG, 1977, LANCET, V2, P639; Trape JF, 2001, T ROY SOC TROP MED H, V95, P420, DOI 10.1016/S0035-9203(01)90202-0; Vidal N, 2002, CR BIOL, V325, P987, DOI 10.1016/S1631-0691(02)01509-3; Warrell D.A., 1999, SE ASIAN J TROP MED, V30, P1; Warrell D.A., 2004, VENOMOUS REPTILES W, P709; WARRELL DA, 1974, BMJ-BRIT MED J, V4, P437, DOI 10.1136/bmj.4.5942.437; Warrell DA, 1996, QJM-MON J ASSOC PHYS, V89, P523; WARRELL DA, 1977, Q J MED, V46, P33; WARRELL DA, 1983, BRIT MED J, V286, P678, DOI 10.1136/bmj.286.6366.678; WARRELL DA, 1986, AM J TROP MED HYG, V35, P1235, DOI 10.4269/ajtmh.1986.35.1235; WARRELL DA, 1976, Q J MED, V45, P1; WARRELL DA, 1976, ACTA TROP, V0033, P00307; Warrell DA, 2006, TOXICON, V48, P718, DOI 10.1016/j.toxicon.2006.07.012; Warrell DA, 2008, TOXICON, V52, P833, DOI 10.1016/j.toxicon.2008.11.004; Warrell David A., 1995, P433; WATT G, 1986, NEW ENGL J MED, V315, P1444, DOI 10.1056/NEJM198612043152303; WHO, 2007, RAB ENV NEGL PUBL HL; Williams D, 2010, LANCET, V375, P89, DOI 10.1016/S0140-6736(09)61159-4; World Health Organization, SNAK; World Health Organization, 2016, WHO GUID PROD CONTR; World Health Organization, INT STAT CLASS DIS R, V10th; WUSTER W, 1989, BIOL J LINN SOC, V36, P391, DOI 10.1111/j.1095-8312.1989.tb00503.x; Wuster W, 1997, J ZOOL, V243, P771, DOI 10.1111/j.1469-7998.1997.tb01975.x; WUSTER W, 1992, BIOL J LINN SOC, V47, P97, DOI 10.1111/j.1095-8312.1992.tb00658.x; Wuster W, 2008, MOL PHYLOGENET EVOL, V49, P445, DOI 10.1016/j.ympev.2008.08.019; Wuster W, 2007, MOL PHYLOGENET EVOL, V45, P437, DOI 10.1016/j.ympev.2007.07.021; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	117	458	471	3	61	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 2	2010	375	9708					77	88		10.1016/S0140-6736(09)61754-2	http://dx.doi.org/10.1016/S0140-6736(09)61754-2			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	539BZ	20109866				2022-12-28	WOS:000273229700034
J	Hatzivassiliou, G; Song, K; Yen, I; Brandhuber, BJ; Anderson, DJ; Alvarado, R; Ludlam, MJC; Stokoe, D; Gloor, SL; Vigers, G; Morales, T; Aliagas, I; Liu, B; Sideris, S; Hoeflich, KP; Jaiswal, BS; Seshagiri, S; Koeppen, H; Belvin, M; Friedman, LS; Malek, S				Hatzivassiliou, Georgia; Song, Kyung; Yen, Ivana; Brandhuber, Barbara J.; Anderson, Daniel J.; Alvarado, Ryan; Ludlam, Mary J. C.; Stokoe, David; Gloor, Susan L.; Vigers, Guy; Morales, Tony; Aliagas, Ignacio; Liu, Bonnie; Sideris, Steve; Hoeflich, Klaus P.; Jaiswal, Bijay S.; Seshagiri, Somasekar; Koeppen, Hartmut; Belvin, Marcia; Friedman, Lori S.; Malek, Shiva			RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth	NATURE			English	Article							B-RAF; SELECTIVE INHIBITOR; C-RAF; KINASE; PHOSPHORYLATION; EFFICACY; POTENT; MUTATIONS; MECHANISM; PROTEINS	Activating mutations in KRAS and BRAF are found in more than 30% of all human tumours and 40% of melanoma, respectively, thus targeting this pathway could have broad therapeutic effects(1). Small molecule ATP-competitive RAF kinase inhibitors have potent antitumour effects on mutant BRAF(V600E) tumours but, in contrast to mitogen-activated protein kinase kinase (MEK) inhibitors, are not potent against RAS mutant tumour models, despite RAF functioning as a key effector downstream of RAS and upstream of MEK2,3. Here we show that ATP-competitive RAF inhibitors have two opposing mechanisms of action depending on the cellular context. In BRAF(V600E) tumours, RAF inhibitors effectively block the mitogen-activated protein kinase (MAPK) signalling pathway and decrease tumour growth. Notably, in KRAS mutant and RAS/RAF wild-type tumours, RAF inhibitors activate the RAF-MEK-ERK pathway in a RAS-dependent manner, thus enhancing tumour growth in some xenograft models. Inhibitor binding activates wild-type RAF isoforms by inducing dimerization, membrane localization and interaction with RAS-GTP. These events occur independently of kinase inhibition and are, instead, linked to direct conformational effects of inhibitors on the RAF kinase domain. On the basis of these findings, we demonstrate that ATP-competitive kinase inhibitors can have opposing functions as inhibitors or activators of signalling pathways, depending on the cellular context. Furthermore, this work provides new insights into the therapeutic use of ATP-competitive RAF inhibitors.	[Hatzivassiliou, Georgia; Song, Kyung; Yen, Ivana; Anderson, Daniel J.; Alvarado, Ryan; Ludlam, Mary J. C.; Stokoe, David; Aliagas, Ignacio; Liu, Bonnie; Sideris, Steve; Hoeflich, Klaus P.; Jaiswal, Bijay S.; Seshagiri, Somasekar; Koeppen, Hartmut; Belvin, Marcia; Friedman, Lori S.; Malek, Shiva] Genentech Inc, San Francisco, CA 94080 USA; [Brandhuber, Barbara J.; Gloor, Susan L.; Vigers, Guy; Morales, Tony] Array BioPharma, Boulder, CO 80301 USA	Roche Holding; Genentech; Pfizer; Array BioPharma	Hatzivassiliou, G (corresponding author), Genentech Inc, San Francisco, CA 94080 USA.	hatzivassiliou.georgia@gene.com; malek.shiva@gene.com		Malek, Shiva/0000-0002-9526-7968; Vigers, Guy/0000-0003-4451-8453; Seshagiri, Somasekar/0000-0003-4272-6443; Anderson, Daniel/0000-0002-3249-2439				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Cameron AJM, 2009, NAT STRUCT MOL BIOL, V16, P624, DOI 10.1038/nsmb.1606; Chapman P, 2009, EJC SUPPL, V7, P5, DOI 10.1016/S1359-6349(09)72036-1; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cho DC, 2009, J CLIN ONCOL, V27; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Goetz CA, 2003, J BIOL CHEM, V278, P51184, DOI 10.1074/jbc.M309183200; Hansen JD, 2008, BIOORG MED CHEM LETT, V18, P4692, DOI 10.1016/j.bmcl.2008.07.002; Hindie V, 2009, NAT CHEM BIOL, V5, P758, DOI 10.1038/nchembio.208; Hoeflich KP, 2009, CANCER RES, V69, P3042, DOI 10.1158/0008-5472.CAN-08-3563; Jaiswal BS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005717; JELINEK T, 1994, MOL CELL BIOL, V14, P8212, DOI 10.1128/MCB.14.12.8212; Khazak V, 2007, EXPERT OPIN THER TAR, V11, P1587, DOI 10.1517/14728222.11.12.1587; Kim JS, 2004, CANCER RES, V64, P1932, DOI 10.1158/0008-5472.CAN-03-3862; Lukyanov KA, 2000, J BIOL CHEM, V275, P25879, DOI 10.1074/jbc.C000338200; Malek S, 2006, EJC SUPPL, V4, P184, DOI 10.1016/S1359-6349(06)70614-0; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Okuzumi T, 2009, NAT CHEM BIOL, V5, P484, DOI 10.1038/nchembio.183; Rajakulendran T, 2009, NATURE, V461, P542, DOI 10.1038/nature08314; Rushworth LK, 2006, MOL CELL BIOL, V26, P2262, DOI 10.1128/MCB.26.6.2262-2272.2006; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Schwartz GK, 2009, J CLIN ONCOL, V27; Stokoe D, 1997, EMBO J, V16, P2384, DOI 10.1093/emboj/16.9.2384; Terai K, 2005, EMBO REP, V6, P251, DOI 10.1038/sj.embor.7400349; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Wallace EM, 2006, J MED CHEM, V49, P441, DOI 10.1021/jm050834y; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Weber CK, 2001, CANCER RES, V61, P3595; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Xiang XQ, 2002, J BIOL CHEM, V277, P44996, DOI 10.1074/jbc.M203953200; Yeh JJ, 2009, MOL CANCER THER, V8, P834, DOI 10.1158/1535-7163.MCT-08-0972; Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229; Zang MW, 2008, J BIOL CHEM, V283, P31429, DOI 10.1074/jbc.M802855200	33	1191	1238	0	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 18	2010	464	7287					431	U132		10.1038/nature08833	http://dx.doi.org/10.1038/nature08833			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570FG	20130576	Bronze			2022-12-28	WOS:000275657100051
J	Wang, F; Wang, XH; Yuan, CG; Ma, JY				Wang, Fei; Wang, Xinhe; Yuan, Chong-Gang; Ma, Jiyan			Generating a Prion with Bacterially Expressed Recombinant Prion Protein	SCIENCE			English	Article							IN-VITRO; SCRAPIE; RESISTANT; PRP; CONFORMATION; PROPAGATION; MOLECULES; STRAINS; MICE	The prion hypothesis posits that a misfolded form of prion protein (PrP) is responsible for the infectivity of prion disease. Using recombinant murine PrP purified from Escherichia coli, we created a recombinant prion with the attributes of the pathogenic PrP isoform: aggregated, protease-resistant, and self-perpetuating. After intracerebral injection of the recombinant prion, wild-type mice developed neurological signs in similar to 130 days and reached the terminal stage of disease in similar to 150 days. Characterization of diseased mice revealed classic neuropathology of prion disease, the presence of protease-resistant PrP, and the capability of serially transmitting the disease; these findings confirmed that the mice succumbed to prion disease. Thus, as postulated by the prion hypothesis, the infectivity in mammalian prion disease results from an altered conformation of PrP.	[Wang, Fei; Wang, Xinhe; Ma, Jiyan] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Yuan, Chong-Gang; Ma, Jiyan] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China	University System of Ohio; Ohio State University; East China Normal University	Ma, JY (corresponding author), Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA.	ma.131@osu.edu	Wang, Fei/D-9550-2013	Ma, Jiyan/0000-0001-7150-1898	Ellison Medical Foundation; NIH [R01NS060729]; Ministry of Education of China [985]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060729] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education of China(Ministry of Education, China); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank. A. Aguzzi, M.-S. Sy, and B. Wainer for reagents and A. Steele for comments on the manuscript. Supported by the Ellison Medical Foundation, NIH grant R01NS060729, and Ministry of Education of China project 985.	Aguzzi A, 2008, ANNU REV NEUROSCI, V31, P439, DOI 10.1146/annurev.neuro.31.060407.125620; Baron GS, 2006, J VIROL, V80, P2106, DOI 10.1128/JVI.80.5.2106-2117.2006; BESSEN RA, 1995, NATURE, V375, P698, DOI 10.1038/375698a0; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Castilla J, 2008, EMBO J, V27, P2557, DOI 10.1038/emboj.2008.181; Caughey B, 2006, NATURE, V443, P803, DOI 10.1038/nature05294; Caughey B, 2009, ANNU REV BIOCHEM, V78, P177, DOI 10.1146/annurev.biochem.78.082907.145410; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2005, J BIOL CHEM, V280, P26873, DOI 10.1074/jbc.M503973200; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; GABIZON R, 1987, P NATL ACAD SCI USA, V84, P4017, DOI 10.1073/pnas.84.12.4017; Geoghegan JC, 2007, J BIOL CHEM, V282, P36341, DOI 10.1074/jbc.M704447200; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Manuelidis L, 2007, J CELL BIOCHEM, V100, P897, DOI 10.1002/jcb.21090; Pan T, 2005, J VIROL, V79, P12355, DOI 10.1128/JVI.79.19.12355-12364.2005; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Raeber AJ, 1999, P NATL ACAD SCI USA, V96, P3987, DOI 10.1073/pnas.96.7.3987; Tamguney G, 2008, J GEN VIROL, V89, P1777, DOI 10.1099/vir.0.2008/001255-0; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Wang F, 2007, BIOCHEMISTRY-US, V46, P7045, DOI 10.1021/bi700299h; Weissmann C, 2005, CELL, V122, P165, DOI 10.1016/j.cell.2005.07.001; White SH, 2001, J BIOL CHEM, V276, P32395, DOI 10.1074/jbc.R100008200	25	517	531	2	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2010	327	5969					1132	1135		10.1126/science.1183748	http://dx.doi.org/10.1126/science.1183748			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560KJ	20110469	Green Accepted			2022-12-28	WOS:000274901100037
J	Bajpai, R; Chen, DA; Rada-Iglesias, A; Zhang, JM; Xiong, YQ; Helms, J; Chang, CP; Zhao, YM; Swigut, T; Wysocka, J				Bajpai, Ruchi; Chen, Denise A.; Rada-Iglesias, Alvaro; Zhang, Junmei; Xiong, Yiqin; Helms, Jill; Chang, Ching-Pin; Zhao, Yingming; Swigut, Tomek; Wysocka, Joanna			CHD7 cooperates with PBAF to control multipotent neural crest formation	NATURE			English	Article							EMBRYONIC STEM-CELLS; CHARGE-SYNDROME; POLYMERASE-II; CHROMATIN; EXPRESSION; MUTATIONS; TRANSCRIPTION; NETWORK; COMPLEX; PROTEIN	Heterozygous mutations in the gene encoding the CHD (chromo-domain helicase DNA-binding domain) member CHD7, an ATP-dependent chromatin remodeller homologous to the Drosophila trithorax-group protein Kismet(1,2), result in a complex constellation of congenital anomalies called CHARGE syndrome, which is a sporadic, autosomal dominant disorder characterized by malformations of the craniofacial structures, peripheral nervous system, ears, eyes and heart(3,4). Although it was postulated 25 years ago that CHARGE syndrome results from the abnormal development of the neural crest, this hypothesis remained untested(5). Here we show that, in both humans and Xenopus, CHD7 is essential for the formation of multipotent migratory neural crest (NC), a transient cell population that is ectodermal in origin but undergoes a major transcriptional reprogramming event to acquire a remarkably broad differentiation potential and ability to migrate throughout the body, giving rise to craniofacial bones and cartilages, the peripheral nervous system, pigmentation and cardiac structures(6,7). We demonstrate that CHD7 is essential for activation of the NC transcriptional circuitry, including Sox9, Twist and Slug. In Xenopus embryos, knockdown of Chd7 or overexpression of its catalytically inactive form recapitulates all major features of CHARGE syndrome. In human NC cells CHD7 associates with PBAF (polybromo-and BRG1-associated factor-containing complex) 8 and both remodellers occupy a NC-specific distal SOX9 enhancer(9) and a conserved genomic element located upstream of the TWIST1 gene. Consistently, during embryogenesis CHD7 and PBAF cooperate to promote NC gene expression and cell migration. Our work identifies an evolutionarily conserved role for CHD7 in orchestrating NC gene expression programs, provides insights into the synergistic control of distal elements by chromatin remodellers, illuminates the pathoembryology of CHARGE syndrome, and suggests a broader function for CHD7 in the regulation of cell motility.	[Bajpai, Ruchi; Chen, Denise A.; Rada-Iglesias, Alvaro; Swigut, Tomek; Wysocka, Joanna] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Xiong, Yiqin] Stanford Univ, Sch Med, Dept Med, Div Cardiovasc Med, Stanford, CA 94305 USA; [Helms, Jill; Chang, Ching-Pin] Stanford Univ, Sch Med, Dept Surg, Stanford, CA 94305 USA; [Wysocka, Joanna] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Zhang, Junmei] Univ Texas SW Med Ctr Dallas, Prot Chem Technol Ctr, Dallas, TX 75390 USA; [Zhao, Yingming] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA	Stanford University; Stanford University; Stanford University; Stanford University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Chicago	Wysocka, J (corresponding author), Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	wysocka@stanford.edu	Xiong, Yiqin/H-1710-2012	Bajpai, Ruchi/0000-0001-7737-3567; Swigut, Tomek/0000-0002-7649-6781; Rada-Iglesias, Alvaro/0000-0001-7137-1341	CIRM SEED [RS1-00323]; Keck Foundation; Searle Scholar Award; EMBO; National Institutes of Health (NIH) [R01DK082664, R01HL085345]; March of Dimes [6-FY06-335]; Oak Foundation; NATIONAL CANCER INSTITUTE [R01CA126832] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082664] Funding Source: NIH RePORTER	CIRM SEED; Keck Foundation(W.M. Keck Foundation); Searle Scholar Award; EMBO(European Molecular Biology Organization (EMBO)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); Oak Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank laboratory members for input during the course of this work; S. Brugmann and A. C. Foley for sharing expertise in Xenopus and chick embryology, B. Bedogni, L. Ho and I. Shestopalov for reagents; A. Sanchez-Alvarado for the cartilage staining protocol; G. Crump and S. Cox for sharing unpublished information; and S. Brugmann, E. Duncan, Z. Ma, J. Peng, A. M. Ring and R. A. Roth for comments on the manuscript. This work was supported by CIRM SEED grant RS1-00323, a W. M. Keck Foundation Distinguished Young Scholar Award, a Searle Scholar Award to J. W., an EMBO long-term fellowship to A. R-I., National Institutes of Health (NIH) grant R01DK082664 to Y.Z., March of Dimes grant 6-FY06-335 to J. H., NIH grant R01HL085345 to C-P. C., and an Oak Foundation Fellowship to Y.X.	Bagheri-Fam S, 2006, DEV BIOL, V291, P382, DOI 10.1016/j.ydbio.2005.11.013; Bajpai R, 2009, CELL DEATH DIFFER, V16, P807, DOI 10.1038/cdd.2009.18; Bajpai R, 2008, MOL REPROD DEV, V75, P818, DOI 10.1002/mrd.20809; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Del Barrio MG, 2004, DEV DYNAM, V229, P136, DOI 10.1002/dvdy.10456; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dupin E, 2006, ADV EXP MED BIOL, V589, P96; Eccles MR, 1999, CLIN GENET, V56, P1, DOI 10.1034/j.1399-0004.1999.560101.x; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Fu YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000138; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Ho LN, 2009, P NATL ACAD SCI USA, V106, P5187, DOI 10.1073/pnas.0812888106; Kaeser MD, 2008, J BIOL CHEM, V283, P32254, DOI 10.1074/jbc.M806061200; KENNISON JA, 1988, P NATL ACAD SCI USA, V85, P8136, DOI 10.1073/pnas.85.21.8136; Kwon CS, 2007, TRENDS GENET, V23, P403, DOI 10.1016/j.tig.2007.05.010; Lee G, 2007, NAT BIOTECHNOL, V25, P1468, DOI 10.1038/nbt1365; Lemon B, 2001, NATURE, V414, P924, DOI 10.1038/414924a; Loring JF, 2007, HUMAN STEM CELL MANUAL: A LABORATORY GUIDE, P1; Minarcik J C, 2003, Orthod Craniofac Res, V6, P210, DOI 10.1046/j.1601-6335.2003.00268.x; Mohrmann L, 2005, BBA-GENE STRUCT EXPR, V1681, P59, DOI 10.1016/j.bbaexp.2004.10.005; Sanlaville D, 2007, EUR J HUM GENET, V15, P389, DOI 10.1038/sj.ejhg.5201778; Sauka-Spengler T, 2008, NAT REV MOL CELL BIO, V9, P557, DOI 10.1038/nrm2428; Schnetz MP, 2009, GENOME RES, V19, P590, DOI 10.1101/gr.086983.108; Seo S, 2005, DEVELOPMENT, V132, P105, DOI 10.1242/dev.01548; SHIMADA T, 1991, J CLIN INVEST, V88, P1043, DOI 10.1172/JCI115365; Shimizu K, 1999, P NATL ACAD SCI USA, V96, P6791, DOI 10.1073/pnas.96.12.6791; SIEBERT JR, 1985, TERATOLOGY, V31, P331, DOI 10.1002/tera.1420310303; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Srinivasan S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000217; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; Wu JI, 2009, CELL, V136, P200, DOI 10.1016/j.cell.2009.01.009; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	35	390	408	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 18	2010	463	7283					958	U135		10.1038/nature08733	http://dx.doi.org/10.1038/nature08733			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556HZ	20130577	Green Accepted			2022-12-28	WOS:000274582700048
J	Hilser, VJ				Hilser, Vincent J.			An Ensemble View of Allostery	SCIENCE			English	Editorial Material							PROTEINS; BINDING; TRANSITIONS		[Hilser, Vincent J.] Univ Texas Med Branch Galveston, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Hilser, Vincent J.] Univ Texas Med Branch Galveston, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Hilser, VJ (corresponding author), Univ Texas Med Branch Galveston, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.	vjhilser@utmb.edu			NIGMS NIH HHS [GM63747, R01 GM063747] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063747] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bai F, 2010, SCIENCE, V327, P685, DOI 10.1126/science.1182105; Changeux JP, 2005, SCIENCE, V308, P1424, DOI 10.1126/science.1108595; Clarkson MW, 2006, BIOCHEMISTRY-US, V45, P7693, DOI 10.1021/bi060652l; Duke TAJ, 1999, P NATL ACAD SCI USA, V96, P10104, DOI 10.1073/pnas.96.18.10104; Duke TAJ, 2001, J MOL BIOL, V308, P541, DOI 10.1006/jmbi.2001.4610; Gunasekaran K, 2004, PROTEINS, V57, P433, DOI 10.1002/prot.20232; Hilser VJ, 2007, P NATL ACAD SCI USA, V104, P8311, DOI 10.1073/pnas.0700329104; KANTROWITZ ER, 1988, SCIENCE, V241, P669, DOI 10.1126/science.3041592; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Laine O, 2008, J MOL BIOL, V381, P89, DOI 10.1016/j.jmb.2008.05.018; Miyashita O, 2003, P NATL ACAD SCI USA, V100, P12570, DOI 10.1073/pnas.2135471100; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; MONOD J, 1963, J MOL BIOL, V6, P306, DOI 10.1016/S0022-2836(63)80091-1; Ostermeier M, 2005, PROTEIN ENG DES SEL, V18, P359, DOI 10.1093/protein/gzi048; Pan H, 2000, P NATL ACAD SCI USA, V97, P12020, DOI 10.1073/pnas.220240297; Perutz M, 1990, COOPERATIVITY ALLOST; Popovych N, 2006, NAT STRUCT MOL BIOL, V13, P831, DOI 10.1038/nsmb1132; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Strickland D, 2008, P NATL ACAD SCI USA, V105, P10709, DOI 10.1073/pnas.0709610105; Wyman J., 1972, CURR TOP CELL REGUL, V6, P207	20	98	98	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 5	2010	327	5966					653	654		10.1126/science.1186121	http://dx.doi.org/10.1126/science.1186121			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551ZD	20133562	Green Accepted			2022-12-28	WOS:000274251800026
J	Angier, E; Sheikh, A				Angier, Elizabeth; Sheikh, Aziz			10-Minute Consultation Pollen food syndrome in a teenage student	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sheikh, Aziz] Univ Edinburgh, Ctr Populat Hlth Sci, Allergy & Resp Res Grp, Edinburgh EH8 9DX, Midlothian, Scotland; [Angier, Elizabeth] No Gen Hosp, Allergy & Clin Immunol Unit, Sheffield S5 7AU, S Yorkshire, England	University of Edinburgh; Northern General Hospital	Sheikh, A (corresponding author), Univ Edinburgh, Ctr Populat Hlth Sci, Allergy & Resp Res Grp, Edinburgh EH8 9DX, Midlothian, Scotland.	Aziz.sheikh@ed.ac.uk	Sheikh, Aziz/D-2818-2009	Sheikh, Aziz/0000-0001-7022-3056				Vieths S, 2002, ANN NY ACAD SCI, V964, P47	1	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 1	2010	340								b3405	10.1136/bmj.b3405	http://dx.doi.org/10.1136/bmj.b3405			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	553CT	20123832				2022-12-28	WOS:000274343300012
J	Fletcher, DA; Mullins, D				Fletcher, Daniel A.; Mullins, Dyche			Cell mechanics and the cytoskeleton	NATURE			English	Review							PROKARYOTIC ACTIN HOMOLOG; ARP2/3 COMPLEX; DYNAMIC INSTABILITY; IN-VITRO; EXTRACELLULAR-MATRIX; MICROTUBULE GROWTH; SELF-ORGANIZATION; EPITHELIAL-CELLS; SHEAR-STRESS; 3T3 CELLS	The ability of a eukaryotic cell to resist deformation, to transport intracellular cargo and to change shape during movement depends on the cytoskeleton, an interconnected network of filamentous polymers and regulatory proteins. Recent work has demonstrated that both internal and external physical forces can act through the cytoskeleton to affect local mechanical properties and cellular behaviour. Attention is now focused on how cytoskeletal networks generate, transmit and respond to mechanical signals over both short and long timescales. An important insight emerging from this work is that long-lived cytoskeletal structures may act as epigenetic determinants of cell shape, function and fate.	[Fletcher, Daniel A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA; [Mullins, Dyche] Univ Calif San Francisco, San Francisco, CA 94143 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Fletcher, DA (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA.	fletch@berkeley.edu; dyche@mullinslab.ucsf.edu			National Institutes of Health (NIH) [R01]; Cell Propulsion Lab, an NIH Nanomedicine Development Center; NATIONAL EYE INSTITUTE [PN2EY016546] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cell Propulsion Lab, an NIH Nanomedicine Development Center; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank O. Chaudhuri, D. Richmond, V. Risca and other members of the Fletcher laboratory for discussion and assistance with this Review. We also benefited from interactions with the researchers and students in the 2009 Physiology course at the Marine Biological Laboratory, Woods Hole, Massachusetts. Work in our laboratories is supported by R01 grants from the National Institutes of Health (NIH) and by the Cell Propulsion Lab, an NIH Nanomedicine Development Center. We apologize to those colleagues whose work could not be cited because of space constraints.	ALBRECHTBUEHLER G, 1977, CELL, V12, P333, DOI 10.1016/0092-8674(77)90109-X; ALBRECHTBUEHLER G, 1977, J CELL BIOL, V72, P595, DOI 10.1083/jcb.72.3.595; Anderson CT, 2009, CURR BIOL, V19, P1498, DOI 10.1016/j.cub.2009.07.034; Ausmees N, 2003, CELL, V115, P705, DOI 10.1016/S0092-8674(03)00935-8; Bailly M, 1999, J CELL BIOL, V145, P331, DOI 10.1083/jcb.145.2.331; Basu A, 2008, EUR PHYS J E, V27, P149, DOI 10.1140/epje/i2008-10364-9; BEISSON J, 1965, P NATL ACAD SCI USA, V53, P275, DOI 10.1073/pnas.53.2.275; Berdyyeva TK, 2005, PHYS MED BIOL, V50, P81, DOI 10.1088/0031-9155/50/1/007; Bieling P, 2007, NATURE, V450, P1100, DOI 10.1038/nature06386; Brangwynne CP, 2006, J CELL BIOL, V173, P733, DOI 10.1083/jcb.200601060; Burns JM, 2006, JPN J APPL PHYS 1, V45, P2341, DOI 10.1143/JJAP.45.2341; Bursac P, 2005, NAT MATER, V4, P557, DOI 10.1038/nmat1404; Campellone KG, 2008, CELL, V134, P148, DOI 10.1016/j.cell.2008.05.032; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; Chaudhuri O, 2007, NATURE, V445, P295, DOI 10.1038/nature05459; Chaudhuri O, 2009, NAT METHODS, V6, P383, DOI [10.1038/NMETH.1320, 10.1038/nmeth.1320]; Chen CS, 2008, J CELL SCI, V121, P3285, DOI 10.1242/jcs.023507; Cheng G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004632; Cooper JA, 2008, INT REV CEL MOL BIO, V267, P183, DOI 10.1016/S1937-6448(08)00604-7; DELHANTY P, 1991, EUR J CELL BIOL, V56, P443; Derman AI, 2009, MOL MICROBIOL, V73, P534, DOI 10.1111/j.1365-2958.2009.06771.x; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Dogterom M, 1997, SCIENCE, V278, P856, DOI 10.1126/science.278.5339.856; Dos Remedios CG, 2003, PHYSIOL REV, V83, P433, DOI 10.1152/physrev.00026.2002; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Flitney EW, 2009, FASEB J, V23, P2110, DOI 10.1096/fj.08-124453; Footer MJ, 2007, P NATL ACAD SCI USA, V104, P2181, DOI 10.1073/pnas.0607052104; Fygenson DK, 1997, PHYS REV E, V55, P850, DOI 10.1103/PhysRevE.55.850; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Henson JH, 1999, MOL BIOL CELL, V10, P4075, DOI 10.1091/mbc.10.12.4075; Herant M, 2005, J CELL SCI, V118, P1789, DOI 10.1242/jcs.02275; HOLY TE, 1994, P NATL ACAD SCI USA, V91, P5682, DOI 10.1073/pnas.91.12.5682; Hsiung F, 2005, NATURE, V437, P560, DOI 10.1038/nature03951; Janmey PA, 1998, PHYSIOL REV, V78, P763, DOI 10.1152/physrev.1998.78.3.763; Janmey PA, 2007, ANNU REV BIOMED ENG, V9, P1, DOI 10.1146/annurev.bioeng.9.060906.151927; Janmey PA, 2009, CELL MOTIL CYTOSKEL, V66, P597, DOI 10.1002/cm.20382; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Kato S, 2008, TISSUE CELL, V40, P95, DOI 10.1016/j.tice.2007.09.007; Keren K, 2008, NATURE, V453, P475, DOI 10.1038/nature06952; Koenderink GH, 2009, P NATL ACAD SCI USA, V106, P15192, DOI 10.1073/pnas.0903974106; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; Liu AP, 2008, NAT PHYS, V4, P789, DOI 10.1038/nphys1071; Liu AP, 2009, NAT REV MOL CELL BIO, V10, P644, DOI 10.1038/nrm2746; LOCKE M, 1990, J CELL SCI, V96, P563; Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739; MACKINTOSH FC, 1995, PHYS REV LETT, V75, P4425, DOI 10.1103/PhysRevLett.75.4425; Mammoto A, 2009, NATURE, V457, P1103, DOI 10.1038/nature07765; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Naumanen P, 2008, J MICROSC-OXFORD, V231, P446, DOI 10.1111/j.1365-2818.2008.02057.x; Nedelec FJ, 1997, NATURE, V389, P305, DOI 10.1038/38532; Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319; Parekh SH, 2005, NAT CELL BIOL, V7, P1219, DOI 10.1038/ncb1336; Parent CA, 2004, CURR OPIN CELL BIOL, V16, P4, DOI 10.1016/j.ceb.2003.11.008; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pontani LL, 2009, BIOPHYS J, V96, P192, DOI 10.1016/j.bpj.2008.09.029; Prass M, 2006, J CELL BIOL, V174, P767, DOI 10.1083/jcb.200601159; Rochlin MW, 1999, MOL BIOL CELL, V10, P2309, DOI 10.1091/mbc.10.7.2309; Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217; SATO M, 1987, ARTERIOSCLEROSIS, V7, P276, DOI 10.1161/01.ATV.7.3.276; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; SONNEBORN TM, 1964, P NATL ACAD SCI USA, V51, P915, DOI 10.1073/pnas.51.5.915; Stachowiak JC, 2008, P NATL ACAD SCI USA, V105, P4697, DOI 10.1073/pnas.0710875105; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; Svitkina TM, 1995, J STRUCT BIOL, V115, P290, DOI 10.1006/jsbi.1995.1054; Tharmann R, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.088103; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; Tsai MY, 2006, SCIENCE, V311, P1887, DOI 10.1126/science.1122771; WACHSSTOCK DH, 1994, BIOPHYS J, V66, P801, DOI 10.1016/S0006-3495(94)80856-2; Wagner B, 2006, P NATL ACAD SCI USA, V103, P13974, DOI 10.1073/pnas.0510190103; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; Waterman-Storer CM, 1999, NAT CELL BIOL, V1, P45, DOI 10.1038/9018; Weiner OD, 2007, PLOS BIOL, V5, P2053, DOI 10.1371/journal.pbio.0050221; Weiss P., 1961, MOLECULAR CONTROL CE, P1; Weiss P. A., 1939, PRINCIPLES DEV TEXT; Wiche G, 1998, J CELL SCI, V111, P2477	88	1673	1723	22	865	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 28	2010	463	7280					485	492		10.1038/nature08908	http://dx.doi.org/10.1038/nature08908			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	548QK	20110992	Green Accepted			2022-12-28	WOS:000273981100040
J	Ali, MK; Koplan, JP				Ali, Mohammed K.; Koplan, Jeffrey P.			Promoting Health Through Tobacco Taxation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SMOKING		[Koplan, Jeffrey P.] Emory Univ, Global Hlth Inst, Atlanta, GA 30322 USA; [Ali, Mohammed K.] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA	Emory University; Emory University; Rollins School Public Health	Koplan, JP (corresponding author), Emory Univ, Global Hlth Inst, 1599 Clifton Rd NE,Room 6-101, Atlanta, GA 30322 USA.	jkoplan@emory.edu	Ali, Mohammed K/N-9833-2013	Ali, Mohammed/0000-0001-7266-2503				Brownell KD, 2009, NEW ENGL J MED, V361, P1599, DOI 10.1056/NEJMhpr0905723; Chaloupka F J, 1999, Nicotine Tob Res, V1 Suppl 1, pS105; Chaloupka FJ, 2003, DIS MANAG HEALTH OUT, V11, P647, DOI 10.2165/00115677-200311100-00004; *CIT COMM CHILDR N, 2008, VOT PREF CLOS NEW YO; Fichtenberg CM, 2002, BMJ-BRIT MED J, V325, P188, DOI 10.1136/bmj.325.7357.188; JHA P, CURBING EPIDEMIC GOV, pCH4; Kenkel Donald, 2000, THBACCO CONTROL DEVE, P177; Lang McGrew J, HIST TOBACCO REGULAT; Pierce JP, 2001, TOB CONTROL, V10, P145, DOI 10.1136/tc.10.2.145	9	3	3	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 27	2010	303	4					357	358		10.1001/jama.2010.23	http://dx.doi.org/10.1001/jama.2010.23			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	548IC	20103759				2022-12-28	WOS:000273952800024
J	Clark, CJ; Everson-Rose, SA; Suglia, SF; Btoush, R; Alonso, A; Haj-Yahia, MM				Clark, Cari Jo; Everson-Rose, Susan A.; Suglia, Shakira Franco; Btoush, Rula; Alonso, Alvaro; Haj-Yahia, Muhammad M.			Association between exposure to political violence and intimate-partner violence in the occupied Palestinian territory: a cross-sectional study	LANCET			English	Article							DOMESTIC VIOLENCE; FAMILY VIOLENCE; WAR TRAUMA; PERPETRATION; HUMILIATION; CHILDREN; TACTICS; MEN	Background Intimate-partner violence might increase during and after exposure to collective violence. We assessed whether political violence was associated with male-to-female intimate-partner violence in the occupied Palestinian territory. Methods A nationally representative, cross-sectional survey was done between Dec 18, 2005, and Jan 18, 2006, by the Palestinian Central Bureau of Statistics. 4156 households were randomly selected with a multistage random cluster design, from which 3815 ever-married women aged 15-64 years were identified. We restricted our analysis to presently married women (n=3510, 92% participation rate), who completed a short version of the revised conflict tactics scales and exposure to political violence inventory Exposure to political violence was characterised as the husband's direct exposure, his indirect exposure via his family's experiences, and economic effects of exposure on the household. We used adjusted multinomial logistic regression models to estimate odds ratios (ORs) for association between political violence and intimate-partner violence. Findings Political violence was significantly related to higher odds of intimate-partner violence. ORs were 1.89 (95% CI 1.29-2.76) for physical and 2.23 (1.49-3.35) for sexual intimate. partner violence in respondents whose husbands were directly exposed to political violence compared with those whose husbands were not directly exposed. For women whose husbands were indirectly exposed, ORs were 1.61 (1.25-2.07) for physical and 1.97 (1.49-2.60) for sexual violence, compared with those whose husbands were not indirectly exposed. Economic effects of exposure were associated with increased odds of intimate-partner violence in the Gaza Strip only. Interpretation Because exposure to political violence is associated with increased odds of intimate-partner violence, and exposure to many traumas is associated with poor health, a range of violent exposures should be assessed when establishing the need for psychosocial interventions in conflict settings.	[Clark, Cari Jo; Everson-Rose, Susan A.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Clark, Cari Jo; Everson-Rose, Susan A.] Univ Minnesota, Program Hlth Dispar Res, Minneapolis, MN USA; [Alonso, Alvaro] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Suglia, Shakira Franco] Boston Univ, Sch Med, Dept Pediat, Boston, MA 02118 USA; [Btoush, Rula] Univ Med & Dent New Jersey, Sch Nursing, Newark, NJ 07103 USA; [Haj-Yahia, Muhammad M.] Hebrew Univ Jerusalem, Paul Baerwald Sch Social Work & Social Welf, Jerusalem, Israel	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Boston University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Hebrew University of Jerusalem	Clark, CJ (corresponding author), Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA.	carijoclark@post.harvard.edu; mshajyah@mscc.huji.ac.il	Everson-Rose, Susan A/L-7582-2017; Alonso, Alvaro/A-4917-2010; Btoush, Rula/C-9084-2016	Alonso, Alvaro/0000-0002-2225-8323; Btoush, Rula/0000-0002-2702-5326; Everson-Rose, Susan/0000-0002-9839-2537	Palestinian National Authority (PNA); Program in Health Disparities Research at the University of Minnesota	Palestinian National Authority (PNA); Program in Health Disparities Research at the University of Minnesota	We thank the Palestinian Central Bureau of Statistics for data collection. Financial support for the design and undertaking of the Domestic Violence Survey, the data on which this analysis was based, was provided by the Palestinian National Authority (PNA) and the Core Funding Group represented by the Representative Office of Norway,ay to PNA, the Representative Office of Netherlands to PNA, the Swiss Agency for Development and Cooperation, the UK Department for International Development, the European Commission, and the World Bank. CJC and SAE-R were supported by the Program in Health Disparities Research at the University of Minnesota for the secondary data analysis.	Al-Krenawi A, 2007, AM J ORTHOPSYCHIAT, V77, P427, DOI 10.1037/0002-9432.77.3.427; Bandura A., 1977, SOCIAL LEARNING THEO, V1; Batniji R, 2009, LANCET, V373, P1133, DOI 10.1016/S0140-6736(09)60110-0; Berkowitz L., 1993, AGGRESSION ITS CAUSE, DOI 3.0.CO;2-9; Catani C, 2008, J MARITAL FAM THER, V34, P165, DOI 10.1111/j.1752-0606.2008.00062.x; Catani C, 2009, J TRAUMA STRESS, V22, P163, DOI 10.1002/jts.20415; Catani C, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-33; *CENTR BUR STAT IS, 2006, TABL 2 7 LOC POP DIS; Dobash R.E., 1979, VIOLENCE WIVES CASE; Giacaman R, 2007, PUBLIC HEALTH, V121, P576, DOI 10.1016/j.puhe.2006.10.020; Giacaman R, 2007, PUBLIC HEALTH, V121, P563, DOI 10.1016/j.puhe.2006.10.021; GOODE WJ, 1971, J MARRIAGE FAM, V33, P624, DOI 10.2307/349435; Green BL, 2000, J TRAUMA STRESS, V13, P271, DOI 10.1023/A:1007758711939; Gupta J, 2009, AM J PUBLIC HEALTH, V99, P462, DOI 10.2105/AJPH.2007.120634; Haj-Yahia M, 2003, CHILD ABUSE NEGLECT, V27, P781, DOI 10.1016/S0145-2134(03)00119-4; Haj-Yahia MM, 2000, J FAM VIOLENCE, V15, P347, DOI 10.1023/A:1007554229592; HAJYAHIA MM, 1994, J FAM VIOLENCE, V9, P47, DOI 10.1007/BF01531968; Heise L., 2002, WORLD REPORT VIOLENC, V1, P87, DOI DOI 10.1503/CMAJ.1150071; Hynes M, 2004, DISASTERS, V28, P294, DOI 10.1111/j.0361-3666.2004.00260.x; *I WOM STUD BIRZ U, 2008, IMP ISR MOB RESTR VI; *INT RESC COMM WOM, 2004, SURV PREV GEN BAS VI; Inter-agency Standing Committee, 2005, GUID GEND BAS VIOL I; Kendler KS, 2003, ARCH GEN PSYCHIAT, V60, P789, DOI 10.1001/archpsyc.60.8.789; KHAMIS V, 2000, POLITICAL VIOLENCE P; Marshall AD, 2005, CLIN PSYCHOL REV, V25, P862, DOI 10.1016/j.cpr.2005.05.009; *PAL CENTR BUR STA, 2006, DOM VIOL SURV DEC 20; Riggs DS, 2000, J CLIN PSYCHOL, V56, P1289, DOI 10.1002/1097-4679(200010)56:10<1289::AID-JCLP4>3.0.CO;2-Z; Shalhoub-Kevorkian Nadera., 2009, MILITARIZATION VIOLE; Straus M.M.A., 1980, CLOSED DOORS VIOLENC; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; *UN OFF COORD HUM, 2005, HUM UPD OCC PAL TERR; Usta J, 2008, J WOMENS HEALTH, V17, P793, DOI 10.1089/jwh.2007.0602; Ward J, 2002, ADDRESSING GENDER BA; *WOM WELLN CTR, 2006, PREV GEND BAS VIOL P; World Bank, 2004, 4 YEARS INT CLOS PAL; Zwi A.B., 2002, WORLD REPORT VIOLENC, P213	36	114	114	0	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 23	2010	375	9711					310	316		10.1016/S0140-6736(09)61827-4	http://dx.doi.org/10.1016/S0140-6736(09)61827-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	549QS	20109958				2022-12-28	WOS:000274069300032
J	Schimel, DS				Schimel, David S.			Drylands in the Earth System	SCIENCE			English	Editorial Material									Natl Ecol Observ Inc, Boulder, CO 80301 USA		Schimel, DS (corresponding author), Natl Ecol Observ Inc, 5340 Airport Blvd, Boulder, CO 80301 USA.	dschimel@naeoninc.org						Bonan G.B., 2008, ECOLOGICAL CLIMATOLO, DOI [10.1017/CBO9781107339200, DOI 10.1017/CBO9781107339200]; BONAN GB, 1992, NATURE, V359, P716, DOI 10.1038/359716a0; Churkina G, 2005, GLOBAL CHANGE BIOL, V11, P1777, DOI 10.1111/j.1365-2486.2005.001012.x; Hillel Daniel, 2006, NATURAL HIST BIBLE E; Rotenberg E, 2010, SCIENCE, V327, P451, DOI 10.1126/science.1179998	5	174	192	12	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 22	2010	327	5964					418	419		10.1126/science.1184946	http://dx.doi.org/10.1126/science.1184946			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546BS	20093461				2022-12-28	WOS:000273783100022
J	Balemans, W; Lounis, N; Gilissen, R; Guillemont, J; Simmen, K; Andries, K; Koul, A				Balemans, Wendy; Lounis, Nacer; Gilissen, Ron; Guillemont, Jerome; Simmen, Kenny; Andries, Koen; Koul, Anil			Essentiality of FASII pathway for Staphylococcus aureus	NATURE			English	Letter							FATTY-ACID SYNTHESIS; ANTIBACTERIAL AGENTS; TARGET; RESISTANCE; PATHOGENS; INHIBITOR; VIRULENCE; MPRF		[Balemans, Wendy; Lounis, Nacer; Andries, Koen; Koul, Anil] Johnson & Johnson, Tibotec BVBA, Dept Antimicrobial Res, B-2340 Beerse, Belgium; [Gilissen, Ron] Johnson & Johnson, Pharmaceut Res & Dev, Dept ADMETox, B-2340 Beerse, Belgium; [Guillemont, Jerome] Johnson & Johnson, Ctr Rech Janssen Cilag, Dept Antimicrobial Res, F-27106 Val De Reuil, France; [Simmen, Kenny] Johnson & Johnson, Tibotec BVBA, Dept Antimicrobial Res, B-2800 Mechelen, Belgium	Johnson & Johnson; Johnson & Johnson; Johnson & Johnson; Johnson & Johnson	Balemans, W (corresponding author), Johnson & Johnson, Tibotec BVBA, Dept Antimicrobial Res, Turnhoutseweg 30, B-2340 Beerse, Belgium.	akoul@its.jnj.com						Altabe S, 2007, J BACTERIOL, V189, P8139, DOI 10.1128/JB.01275-07; Brinster S, 2009, NATURE, V458, P83, DOI 10.1038/nature07772; Finlay BB, 1997, SCIENCE, V276, P718, DOI 10.1126/science.276.5313.718; Heath RJ, 2001, PROG LIPID RES, V40, P467, DOI 10.1016/S0163-7827(01)00012-1; Ji YD, 2004, FEMS MICROBIOL LETT, V231, P177, DOI 10.1016/S0378-1097(03)00931-5; Koul A, 2004, NAT REV MICROBIOL, V2, P189, DOI 10.1038/nrmicro840; Marrakchi H, 2002, BIOCHEM SOC T, V30, P1050, DOI 10.1042/bst0301050; Omura S, 1981, Methods Enzymol, V72, P520; Payne DJ, 2002, ANTIMICROB AGENTS CH, V46, P3118, DOI 10.1128/AAC.46.10.3118-3124.2002; Peschel A, 2001, J EXP MED, V193, P1067, DOI 10.1084/jem.193.9.1067; Vilcheze C, 2006, NAT MED, V12, P1027, DOI 10.1038/nm1466; Wang J, 2006, NATURE, V441, P358, DOI 10.1038/nature04784; Weidenmaier C, 2005, INFECT IMMUN, V73, P8033, DOI 10.1128/IAI.73.12.8033-8038.2005; Yum JH, 2007, ANTIMICROB AGENTS CH, V51, P2591, DOI 10.1128/AAC.01562-06; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839	15	112	115	1	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 21	2010	463	7279					E3	E4		10.1038/nature08667	http://dx.doi.org/10.1038/nature08667			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545PM	20090698	Bronze			2022-12-28	WOS:000273748100055
J	Dobson, R; Shannon, C				Dobson, Ruth; Shannon, Clare			Picture quiz A 56 year old man with headache, fever, and neurological symptoms	BRITISH MEDICAL JOURNAL			English	Editorial Material							BACTERIAL-MENINGITIS; ADULTS		[Dobson, Ruth] Leicester Gen Hosp, Leicester LE5 4PW, Leics, England; [Shannon, Clare] Univ Hosp, Leicester, Leics, England	University Hospitals of Leicester NHS Trust; Leicester General Hospital; University Hospitals of Leicester NHS Trust	Dobson, R (corresponding author), Leicester Gen Hosp, Gwendolen Rd, Leicester LE5 4PW, Leics, England.	ruthdobson@doctors.org.uk						Bartt R, 2000, SEMIN NEUROL, V20, P361, DOI 10.1055/s-2000-9398; Bille J, 2006, Euro Surveill, V11, P91, DOI 10.2807/esm.11.06.00633-en; Britton D, 2008, VOICES, V34, P3; de Gans J, 2002, NEW ENGL J MED, V347, P1549, DOI 10.1056/NEJMoa021334; Drnda Alija, 2009, Med Arh, V63, P112; Goulet V, 2008, EMERG INFECT DIS, V14, P734, DOI 10.3201/eid1405.071395; ROOS K, 2005, BACTERIAL MENINGITIS, P13; Schut Ewout S, 2008, Pract Neurol, V8, P8, DOI 10.1136/jnnp.2007.139725; van de Beek D, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004405.pub2; van de Beek D, 2006, NEW ENGL J MED, V354, P44, DOI 10.1056/NEJMra052116	10	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 20	2010	340								b5603	10.1136/bmj.b5603	http://dx.doi.org/10.1136/bmj.b5603			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	548HO	20089575				2022-12-28	WOS:000273951300003
J	Fried, TR; Drickamer, M				Fried, Terri R.; Drickamer, Margaret			Garnering Support for Advance Care Planning	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DIRECTIVES; ILL		[Fried, Terri R.] VA Connecticut Healthcare Syst, Clin Epidemiol Res Ctr, West Haven, CT 06516 USA; [Fried, Terri R.; Drickamer, Margaret] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University	Fried, TR (corresponding author), VA Connecticut Healthcare Syst, Clin Epidemiol Res Ctr, CERC 151B,950 Campbell Ave, West Haven, CT 06516 USA.	terri.fried@yale.edu			NATIONAL INSTITUTE ON AGING [K24AG028443] Funding Source: NIH RePORTER; NIA NIH HHS [K24 AG028443-01A2, K24 AG028443] Funding Source: Medline; PHS HHS [K24 AGAG028443] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Finucane TE, 1999, JAMA-J AM MED ASSOC, V282, P1670, DOI 10.1001/jama.282.17.1670; Fried TR, 2009, J AM GERIATR SOC, V57, P1547, DOI 10.1111/j.1532-5415.2009.02396.x; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; LAPUMA J, 1991, JAMA-J AM MED ASSOC, V266, P402, DOI 10.1001/jama.266.3.402; Levinsky NG, 1996, NEW ENGL J MED, V335, P741, DOI 10.1056/NEJM199609053351012; RUTENBERG J, 2009, NY TIMES        0814; Tulsky JA, 1998, ANN INTERN MED, V129, P441, DOI 10.7326/0003-4819-129-6-199809150-00003; Zimmermann C, 2004, PALLIATIVE MED, V18, P121, DOI 10.1191/0269216304pm858oa	8	27	27	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 20	2010	303	3					269	270		10.1001/jama.2009.1956	http://dx.doi.org/10.1001/jama.2009.1956			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	544WM	20085956	Green Accepted			2022-12-28	WOS:000273690600024
J	Horton, R				Horton, Richard			Offline: The hottest date in town	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.								0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 16	2010	375	9710					184	184		10.1016/S0140-6736(10)60074-8	http://dx.doi.org/10.1016/S0140-6736(10)60074-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	546ZH	20109903				2022-12-28	WOS:000273853800010
J	Farmer, CG; Sanders, K				Farmer, C. G.; Sanders, Kent			Unidirectional Airflow in the Lungs of Alligators	SCIENCE			English	Article							AMERICAN ALLIGATOR; THEROPOD DINOSAURS; PELVIC ASPIRATION; NILE CROCODILE; GAS-EXCHANGE; VENTILATION; EVOLUTION; MISSISSIPPIENSIS	The lungs of birds move air in only one direction during both inspiration and expiration through most of the tubular gas-exchanging bronchi (parabronchi), whereas in the lungs of mammals and presumably other vertebrates, air moves tidally into and out of terminal gas-exchange structures, which are cul-de-sacs. Unidirectional flow purportedly depends on bellowslike ventilation by air sacs and may have evolved to meet the high aerobic demands of sustained flight. Here, we show that air flows unidirectionally through parabronchi in the lungs of the American alligator, an amphibious ectotherm without air sacs, which suggests that this pattern dates back to the basal archosaurs of the Triassic and may have been present in their nondinosaur descendants (phytosaurs, aetosaurs, rauisuchians, crocodylomorphs, and pterosaurs) as well as in dinosaurs.	[Farmer, C. G.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Sanders, Kent] Univ Utah, Hlth Sci Ctr, Dept Radiol, Musculoskeletal Div, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Farmer, CG (corresponding author), Univ Utah, Dept Biol, 257 South 1400 East, Salt Lake City, UT 84112 USA.	cg.frmr@gmail.com			NSF [IOS-0818973]	NSF(National Science Foundation (NSF))	This work was supported by NSF (grant IOS-0818973 to C. G. F.).	Berner RA, 2007, SCIENCE, V316, P557, DOI 10.1126/science.1140273; BICKLER PE, 1985, AM J PHYSIOL, V249, pR477, DOI 10.1152/ajpregu.1985.249.4.R477; Brusatte SL, 2008, SCIENCE, V321, P1485, DOI 10.1126/science.1161833; Carrier DR, 2000, PALEOBIOLOGY, V26, P271, DOI 10.1666/0094-8373(2000)026<0271:TEOPAI>2.0.CO;2; Claessens LPAM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004497; Crompton A.W., 1979, P59; Dotterweich H., 1936, Zeitschrift fuer Vergleichende Physiologie, V23, P744, DOI 10.1007/BF00341105; Farmer CG, 2000, J EXP BIOL, V203, P1679; HAZELHOFF EH, 1951, POULTRY SCI, V30, P3, DOI 10.3382/ps.0300003; HICKS JW, 1992, RESP PHYSIOL, V88, P23, DOI 10.1016/0034-5687(92)90026-S; MOSER F, 1902, ARCH MIKROSK ANAT EN, V60, P587, DOI DOI 10.1007/BF02978399; O'Connor PM, 2005, NATURE, V436, P253, DOI 10.1038/nature03716; Perreau J, 1998, CRYPTOGAMIE MYCOL, V19, P1; PERRY SF, 1990, J COMP PHYSIOL B, V159, P761, DOI 10.1007/BF00691722; PERRY SF, 1988, J EXP BIOL, V134, P99; Perry SF, 1989, COMP PULMONARY PHYSL, P193; POWELL FL, 1989, RESP PHYSIOL, V78, P83, DOI 10.1016/0034-5687(89)90144-8; Ruben JA, 1999, SCIENCE, V283, P514, DOI 10.1126/science.283.5401.514; SCHEID P, 1987, BIRD RESPIRATION, V1, P97; WOLF SIEGFRIED, 1933, ZOOL JAHRB ABT ANAT U ONT, V57, P139; [No title captured]	21	98	99	2	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 15	2010	327	5963					338	340		10.1126/science.1180219	http://dx.doi.org/10.1126/science.1180219			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544CM	20075253				2022-12-28	WOS:000273629700045
J	Geha, M				Geha, Marla			GALAXY FORMATION Gone with the wind?	NATURE			English	Editorial Material							COLD DARK-MATTER; HALOS		Yale Univ, Dept Astron, New Haven, CT 06520 USA	Yale University	Geha, M (corresponding author), Yale Univ, Dept Astron, New Haven, CT 06520 USA.							Blanton MR, 2005, ASTROPHYS J, V631, P208, DOI 10.1086/431416; DAVIS M, 1985, ASTROPHYS J, V292, P371, DOI 10.1086/163168; de Blok WJG, 2010, ADV ASTRON, V2010, DOI 10.1155/2010/789293; Governato F, 2010, NATURE, V463, P203, DOI 10.1038/nature08640; Navarro JF, 1996, ASTROPHYS J, V462, P563, DOI 10.1086/177173; Simon JD, 2005, ASTROPHYS J, V621, P757, DOI 10.1086/427684; Swaters RA, 2003, ASTROPHYS J, V583, P732, DOI 10.1086/345426	8	1	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 14	2010	463	7278					167	168		10.1038/463167a	http://dx.doi.org/10.1038/463167a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543MQ	20075909				2022-12-28	WOS:000273582700021
J	Shimizu, Y; Kodama, K; Nishi, N; Kasagi, F; Suyama, A; Soda, M; Grant, EJ; Sugiyama, H; Sakata, R; Moriwaki, H; Hayashi, M; Konda, M; Shore, RE				Shimizu, Yukiko; Kodama, Kazunori; Nishi, Nobuo; Kasagi, Fumiyoshi; Suyama, Akihiko; Soda, Midori; Grant, Eric J.; Sugiyama, Hiromi; Sakata, Ritsu; Moriwaki, Hiroko; Hayashi, Mikiko; Konda, Manami; Shore, Roy E.			Radiation exposure and circulatory disease risk: Hiroshima and Nagasaki atomic bomb survivor data, 1950-2003	BMJ-BRITISH MEDICAL JOURNAL			English	Article							IONIZING-RADIATION; CARDIOVASCULAR-DISEASES; NONCANCER MORTALITY; CANCER-MORTALITY; BREAST-CANCER; HEART-DISEASE; SOLID CANCER; MALE WORKERS; COHORT; STROKE	Objective To investigate the degree to which ionising radiation confers risk of mortality from heart disease and stroke. Design Prospective cohort study with more than 50 years of follow-up. Setting Atomic bomb survivors in Hiroshima and Nagasaki, Japan. Participants 86 611 Life Span Study cohort members with individually estimated radiation doses from 0 to >3 Gy (86% received <0.2 Gy). Main outcome measures Mortality from stroke or heart disease as the underlying cause of death and dose-response relations with atomic bomb radiation. Results About 9600 participants died of stroke and 8400 died of heart disease between 1950 and 2003. For stroke, the estimated excess relative risk per gray was 9% (95% confidence interval 1% to 17%, P=0.02) on the basis of a linear dose-response model, but an indication of possible upward curvature suggested relatively little risk at low doses. For heart disease, the estimated excess relative risk per gray was 14% (6% to 23%, P<0.001); a linear model provided the best fit, suggesting excess risk even at lower doses. However, the dose-response effect over the restricted dose range of 0 to 0.5 Gy was not significant. Prospective data on smoking, alcohol intake, education, occupation, obesity, and diabetes had almost no impact on the radiation risk estimates for either stroke or heart disease, and misdiagnosis of cancers as circulatory diseases could not account for the associations seen. Conclusion Doses above 0.5 Gy are associated with an elevated risk of both stroke and heart disease, but the degree of risk at lower doses is unclear. Stroke and heart disease together account for about one third as many radiation associated excess deaths as do cancers among atomic bomb survivors.	[Shimizu, Yukiko; Nishi, Nobuo; Kasagi, Fumiyoshi; Grant, Eric J.; Sugiyama, Hiromi; Sakata, Ritsu; Moriwaki, Hiroko; Hayashi, Mikiko; Konda, Manami] Radiat Effects Res Fdn, Dept Epidemiol, Minami Ku, Hiroshima 7320815, Japan; [Suyama, Akihiko; Soda, Midori] Radiat Effects Res Fdn, Dept Epidemiol, Nagasaki 8500013, Japan	Radiation Effects Research Foundation - Japan; Radiation Effects Research Foundation - Japan	Shimizu, Y (corresponding author), Radiat Effects Res Fdn, Dept Epidemiol, Minami Ku, 5-2 Hijiyama Pk, Hiroshima 7320815, Japan.	shimizu@rerf.or.jp	Kunzendorf, Ulrich/A-8257-2010; NISHI, NOBUO/S-6195-2019; Sugiyama, Hiromi/AAX-1736-2020; Sakata, Ritsu/ABI-1805-2020; Klinghammer, Lutz/B-7682-2011	Sugiyama, Hiromi/0000-0003-2536-0865; Klinghammer, Lutz/0000-0001-8082-9190; Shore, Roy/0000-0002-6842-2248	Japanese Ministry of Health, Labour and Welfare (MHLW); US Department of Energy (DOE); National Academy of Sciences	Japanese Ministry of Health, Labour and Welfare (MHLW)(Ministry of Health, Labour and Welfare, Japan); US Department of Energy (DOE)(United States Department of Energy (DOE)); National Academy of Sciences	The Radiation Effects Research Foundation (RERF), Hiroshima and Nagasaki, Japan is a private, non-profit foundation funded by the Japanese Ministry of Health, Labour and Welfare (MHLW) and the US Department of Energy (DOE), the latter in part through the National Academy of Sciences. This publication was supported by RERF research protocol 1-75. The views expressed in this paper are those of the authors alone.	Abe O, 2005, LANCET, V366, P2087; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ALDERSON MR, 1971, BRIT J RADIOL, V44, P295, DOI 10.1259/0007-1285-44-520-295; AZIZOVA TV, 2009, LATE HLTH EFFECTS IO, P46; Basavaraju SR, 2002, MED PHYS, V29, P2391, DOI 10.1118/1.1509442; Berrington A, 2001, BRIT J RADIOL, V74, P507, DOI 10.1259/bjr.74.882.740507; BOLOTNIKOVA MG, 1994, SCI TOTAL ENVIRON, V142, P29, DOI 10.1016/0048-9697(94)90070-1; Bowers DC, 2006, J CLIN ONCOL, V24, P5277, DOI 10.1200/JCO.2006.07.2884; Bowers DC, 2005, J CLIN ONCOL, V23, P6508, DOI 10.1200/JCO.2005.15.107; Breslow NE., 1987, STAT METHODS CANC RE, P81; Carr ZA, 2005, INT J RADIAT ONCOL, V61, P842, DOI 10.1016/j.ijrobp.2004.07.708; Cullings HM, 2006, RADIAT RES, V166, P219, DOI 10.1667/RR3546.1; Darby S, 2003, BRIT MED J, V326, P256, DOI 10.1136/bmj.326.7383.256; Darby SC, 2005, LANCET ONCOL, V6, P557, DOI 10.1016/S1470-2045(05)70251-5; DARBY SC, 1994, INT J CANCER, V56, P793, DOI 10.1002/ijc.2910560606; DAVIS FG, 1989, CANCER RES, V49, P6130; De Bruin ML, 2009, JNCI-J NATL CANCER I, V101, P928, DOI 10.1093/jnci/djp147; Doody MM, 2000, SPINE, V25, P2052; Fajardo L F, 1999, Cardiovasc Radiat Med, V1, P108; Hall EJ, 2008, BRIT J RADIOL, V81, P362, DOI 10.1259/bjr/01948454; HANCOCK SL, 1993, JAMA-J AM MED ASSOC, V270, P1949, DOI 10.1001/jama.270.16.1949; Hauptmann M, 2003, AM J EPIDEMIOL, V157, P239, DOI 10.1093/aje/kwf189; Hayashi T, 2005, AM J MED, V118, P83, DOI 10.1016/j.amjmed.2004.06.045; Hayashi T, 2003, INT J RADIAT BIOL, V79, P129, DOI 10.1080/0955300021000038662; Hendry JH, 2008, RADIAT ENVIRON BIOPH, V47, P189, DOI 10.1007/s00411-007-0155-7; Ivanov VK, 2007, HEALTH PHYS, V93, P470, DOI 10.1097/01.HP.0000282195.34508.b0; Kaczmarek A, 2004, STRUCT CHEM, V15, P517, DOI 10.1023/B:STUC.0000037910.26456.59; Kasagi F, 1992, NAGASAKI MED J, V67, P479; Kreuzer M, 2006, RADIAT ENVIRON BIOPH, V45, P159, DOI 10.1007/s00411-006-0056-1; Kusunoki Y, 1999, RADIAT RES, V152, P539, DOI 10.2307/3580151; Kusunoki Y, 1998, RADIAT RES, V150, P227, DOI 10.2307/3579858; Kusunoki Y, 2008, INT J RADIAT BIOL, V84, P1, DOI 10.1080/09553000701616106; Little MP, 2008, RADIAT RES, V169, P99, DOI 10.1667/RR1070.1; MATANOSKI GM, 1975, AM J EPIDEMIOL, V101, P199, DOI 10.1093/oxfordjournals.aje.a112087; McGeoghegan D, 2008, INT J EPIDEMIOL, V37, P506, DOI 10.1093/ije/dyn018; Mettler Fred A. Jr., 2000, Journal of Radiological Protection, V20, P353, DOI 10.1088/0952-4746/20/4/301; Muirhead CR, 2009, BRIT J CANCER, V100, P206, DOI 10.1038/sj.bjc.6604825; Neriishi K, 2001, INT J RADIAT BIOL, V77, P475, DOI 10.1080/09553000010024911; Pierce DA, 2007, RADIAT RES, V167, P735, DOI 10.1667/RR0349.1; Preston D, 1991, EPICURE RISK REGRESS; Preston DL, 2007, RADIAT RES, V168, P1, DOI 10.1667/RR0763.1; Preston DL, 2003, RADIAT RES, V160, P381, DOI 10.1667/RR3049; Preston DL, 2004, RADIAT RES, V162, P377, DOI 10.1667/RR3232; REED DM, 1990, AM J EPIDEMIOL, V131, P579, DOI 10.1093/oxfordjournals.aje.a115542; ROBERTSON TL, 1979, 1279 RERF; RON E, 1994, EPIDEMIOLOGY, V5, P48, DOI 10.1097/00001648-199401000-00009; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sasaki H, 2002, J CLIN EPIDEMIOL, V55, P974, DOI 10.1016/S0895-4356(02)00439-0; Schultz-Hector S, 2007, INT J RADIAT ONCOL, V67, P10, DOI 10.1016/j.ijrobp.2006.08.071; Shimizu Y, 1999, RADIAT RES, V152, P374, DOI 10.2307/3580222; SHIMIZU Y, 1992, RADIAT RES, V130, P249, DOI 10.2307/3578283; Smith GL, 2008, J CLIN ONCOL, V26, P5119, DOI 10.1200/JCO.2008.16.6546; Stewart FA, 2006, AM J PATHOL, V168, P649, DOI 10.2353/ajpath.2006.050409; Swerdlow AJ, 2007, J NATL CANCER I, V99, P206, DOI 10.1093/jnci/djk029; *UNSCEAR, 2008, ANN B EP EV CARD DIS; Vrijheid M, 2007, INT J EPIDEMIOL, V36, P1126, DOI 10.1093/ije/dym138; Wong FL, 1999, RADIAT RES, V151, P736, DOI 10.2307/3580213; Yamada M, 2005, INT J RADIAT BIOL, V81, P821, DOI 10.1080/09553000600555504; Yamada M, 2004, RADIAT RES, V161, P622, DOI 10.1667/RR3183	59	305	331	1	25	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 14	2010	340								b5349	10.1136/bmj.b5349	http://dx.doi.org/10.1136/bmj.b5349			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	545DC	20075151	hybrid, Green Published			2022-12-28	WOS:000273711700003
J	Ulijasz, AT; Cornilescu, G; Cornilescu, CC; Zhang, JR; Rivera, M; Markley, JL; Vierstra, RD				Ulijasz, Andrew T.; Cornilescu, Gabriel; Cornilescu, Claudia C.; Zhang, Junrui; Rivera, Mario; Markley, John L.; Vierstra, Richard D.			Structural basis for the photoconversion of a phytochrome to the activated Pfr form	NATURE			English	Article							CHROMOPHORE-BINDING DOMAIN; PSEUDOMONAS-AERUGINOSA BACTERIOPHYTOCHROME; INDUCED PROTON RELEASE; TETRAPYRROLE CHROMOPHORE; SIGNAL-TRANSDUCTION; DIPOLAR COUPLINGS; CRYSTAL-STRUCTURE; GROUND-STATE; GAF DOMAIN; CYANOBACTERIAL	Phytochromes are a collection of bilin-containing photoreceptors that regulate numerous photoresponses in plants and microorganisms through their ability to photointerconvert between a red-light-absorbing, ground state (Pr) and a far-red-light-absorbing, photoactivated state (Pfr)(1,2). Although the structures of several phytochromes as Pr have been determined(3-7), little is known about the structure of Pfr and how it initiates signalling. Here we describe the three-dimensional solution structure of the bilin-binding domain as Pfr, using the cyanobacterial phytochrome from Synechococcus OSB'. Contrary to predictions, light-induced rotation of the A pyrrole ring but not the D ring is the primary motion of the chromophore during photoconversion. Subsequent rearrangements within the protein then affect intradomain and interdomain contact sites within the phytochrome dimer. On the basis of our models, we propose that phytochromes act by propagating reversible light-driven conformational changes in the bilin to altered contacts between the adjacent output domains, which in most phytochromes direct differential phosphotransfer.	[Ulijasz, Andrew T.; Zhang, Junrui; Vierstra, Richard D.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Cornilescu, Gabriel; Cornilescu, Claudia C.; Markley, John L.] Univ Wisconsin, Natl Magnet Resonance Facil Madison, Madison, WI 53706 USA; [Rivera, Mario] Univ Kansas, Lawrence, KS 66057 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Kansas	Vierstra, RD (corresponding author), Univ Wisconsin, Dept Genet, Madison, WI 53706 USA.	vierstra@wisc.edu	Cornilescu, Claudia/H-1959-2012; Zhang, Junrui/J-2684-2012; Cornilescu, Gabriel/H-3113-2011; Cornilescu, Claudia/K-1981-2015	Cornilescu, Gabriel/0000-0002-1204-8904; Cornilescu, Claudia/0000-0002-2401-7806; Ulijasz, Andrew/0000-0003-0739-1297	US National Science Foundation; American Heart Association; U. S. National Institutes of Health; US National Institute of Health; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074901] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1022010] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); American Heart Association(American Heart Association); U. S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Acknowledgements We thank K. T. Forest and W. M. Westler for technical advice. This work was supported by a grant from the US National Science Foundation (R. D. V.) and a postdoctoral fellowship from the American Heart Association (A. T. U.). C. C. C. was supported by the U. S. National Institutes of Health. This study was a collaboration with the National Magnetic Resonance Facility at Madison, which is supported by the US National Institute of Health.	BISHOP JE, 1986, J BIOL CHEM, V261, P6790; Borucki B, 2005, J BIOL CHEM, V280, P34358, DOI 10.1074/jbc.M505493200; Cornilescu G, 2000, J AM CHEM SOC, V122, P10143, DOI 10.1021/ja0016194; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cornilescu G, 2008, J MOL BIOL, V383, P403, DOI 10.1016/j.jmb.2008.08.034; Essen LO, 2008, P NATL ACAD SCI USA, V105, P14709, DOI 10.1073/pnas.0806477105; Fischer AJ, 2005, BIOCHEMISTRY-US, V44, P15203, DOI 10.1021/bi051633z; FODOR SPA, 1990, BIOCHEMISTRY-US, V29, P11141, DOI 10.1021/bi00502a018; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; Inomata K, 2005, J BIOL CHEM, V280, P24491, DOI 10.1074/jbc.M504710200; Inomata K, 2006, J BIOL CHEM, V281, P28162, DOI 10.1074/jbc.M603983200; Inomata K, 2009, BIOCHEMISTRY-US, V48, P2817, DOI 10.1021/bi802334u; Karniol B, 2005, BIOCHEM J, V392, P103, DOI 10.1042/BJ20050826; Kneip C, 1999, BIOCHEMISTRY-US, V38, P15185, DOI 10.1021/bi990688w; LAGARIAS JC, 1979, J AM CHEM SOC, V101, P5030, DOI 10.1021/ja00511a038; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Oka Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000158; Ottiger M, 1998, J MAGN RESON, V134, P365, DOI 10.1006/jmre.1998.1546; Ottiger M, 1999, J BIOMOL NMR, V13, P187, DOI 10.1023/A:1008395916985; Quail PH, 2002, NAT REV MOL CELL BIO, V3, P85, DOI 10.1038/nrm728; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; Rohmer T, 2008, P NATL ACAD SCI USA, V105, P15229, DOI 10.1073/pnas.0805696105; RUDIGER W, 1983, P NATL ACAD SCI-BIOL, V80, P6244, DOI 10.1073/pnas.80.20.6244; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Seibeck S, 2007, FEBS LETT, V581, P5425, DOI 10.1016/j.febslet.2007.10.043; Strauss HM, 2005, BIOCHEMISTRY-US, V44, P8244, DOI 10.1021/bi050457r; Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111; Ulijasz AT, 2008, J BIOL CHEM, V283, P21251, DOI 10.1074/jbc.M801592200; Ulmer TS, 2003, J AM CHEM SOC, V125, P9179, DOI 10.1021/ja0350684; van Thor JJ, 2006, BIOPHYS J, V91, P1811, DOI 10.1529/biophysj.106.084335; van Thor JJ, 2001, BIOCHEMISTRY-US, V40, P11460, DOI 10.1021/bi002651d; Vierstra RD, 2005, HANDBOOK OF PHOTOSENSORY RECEPTORS, P171, DOI 10.1002/352760510X.ch8; von Stetten D, 2007, J BIOL CHEM, V282, P2116, DOI 10.1074/jbc.M608878200; Vreede J, 2005, BIOPHYS J, V88, P3525, DOI 10.1529/biophysj.104.055103; Wagner JR, 2008, J BIOL CHEM, V283, P12212, DOI 10.1074/jbc.M709355200; Wagner JR, 2007, J BIOL CHEM, V282, P12298, DOI 10.1074/jbc.M611824200; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yang X, 2008, P NATL ACAD SCI USA, V105, P14715, DOI 10.1073/pnas.0806718105; Yang X, 2007, P NATL ACAD SCI USA, V104, P12571, DOI 10.1073/pnas.0701737104; Yang XJ, 2009, P NATL ACAD SCI USA, V106, P15639, DOI 10.1073/pnas.0902178106	43	106	114	1	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 14	2010	463	7278					250	U143		10.1038/nature08671	http://dx.doi.org/10.1038/nature08671			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543MQ	20075921	Green Submitted, Green Accepted			2022-12-28	WOS:000273582700040
J	de Vos, RJ; Weir, A; van Schie, HTM; Bierma-Zeinstra, SMA; Verhaar, JAN; Weinans, H; Tol, JL				de Vos, Robert J.; Weir, Adam; van Schie, Hans T. M.; Bierma-Zeinstra, Sita M. A.; Verhaar, Jan A. N.; Weinans, Harrie; Tol, Johannes L.			Platelet-Rich Plasma Injection for Chronic Achilles Tendinopathy A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TENDINOSIS; OSTEOARTHRITIS; MANAGEMENT; SURGERY; TENDON; PAIN	Context Tendon disorders comprise 30% to 50% of all activity-related injuries; chronic degenerative tendon disorders (tendinopathy) occur frequently and are difficult to treat. Tendon regeneration might be improved by injecting platelet-rich plasma (PRP), an increasingly used treatment for releasing growth factors into the degenerative tendon. Objective To examine whether a PRP injection would improve outcome in chronic midportion Achilles tendinopathy. Design, Setting, and Patients A stratified, block-randomized, double-blind, placebo-controlled trial at a single center ( The Hague Medical Center, Leidschendam, the Netherlands) of 54 randomized patients aged 18 to 70 years with chronic tendinopathy 2 to 7 cm above the Achilles tendon insertion. The trial was conducted between August 28, 2008, and January 29, 2009, with follow-up until July 16, 2009. Intervention Eccentric exercises ( usual care) with either a PRP injection ( PRP group) or saline injection ( placebo group). Randomization was stratified by activity level. Main Outcome Measures The validated Victorian Institute of Sports Assessment-Achilles (VISA-A) questionnaire, which evaluated pain score and activity level, was completed at baseline and 6, 12, and 24 weeks. The VISA-A score ranged from 0 to 100, with higher scores corresponding with less pain and increased activity. Treatment group effects were evaluated using general linear models on the basis of intention-to-treat. Results After randomization into the PRP group (n=27) or placebo group (n=27), there was complete follow-up of all patients. The mean VISA-A score improved significantly after 24 weeks in the PRP group by 21.7 points (95% confidence interval [CI], 13.0-30.5) and in the placebo group by 20.5 points ( 95% CI, 11.6-29.4). The increase was not significantly different between both groups ( adjusted between-group difference from baseline to 24 weeks, -0.9; 95% CI, -12.4 to 10.6). This CI did not include the predefined relevant difference of 12 points in favor of PRP treatment. Conclusion Among patients with chronic Achilles tendinopathy who were treated with eccentric exercises, a PRP injection compared with a saline injection did not result in greater improvement in pain and activity. Trial Registration clinicaltrials. gov Identifier: NCT00761423 JAMA. 2010;303(2):144-149 www.jama.com	[de Vos, Robert J.; van Schie, Hans T. M.; Verhaar, Jan A. N.; Weinans, Harrie] Erasmus Univ, Med Ctr, Dept Orthoped, NL-3000 CA Rotterdam, Netherlands; [Bierma-Zeinstra, Sita M. A.] Erasmus Univ, Med Ctr, Dept Gen Practice, NL-3000 CA Rotterdam, Netherlands; [Weir, Adam; Tol, Johannes L.] Hague Med Ctr Antoniushove, Dept Sports Med, Leidschendam, Netherlands; [van Schie, Hans T. M.] Univ Utrecht, Dept Equine Sci, Utrecht, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Utrecht University	de Vos, RJ (corresponding author), Erasmus Univ, Med Ctr, Dept Orthoped, Room Ee1614,POB 2040,Dr Molenwaterpl 50, NL-3000 CA Rotterdam, Netherlands.	r.devos@erasmusmc.nl	Verhaar, Jan/AAH-1372-2020; Bierma-Zeinstra, Sita/AAF-2122-2019	de Vos, Robert-Jan/0000-0003-0372-0188; Weinans, Harrie/0000-0002-2275-6170; Verhaar, Jan/0000-0003-3016-9600	Biomet Biologics LLC, Warsaw, Indiana	Biomet Biologics LLC, Warsaw, Indiana	This work was funded by Biomet Biologics LLC, Warsaw, Indiana.	Alfredson H, 2003, CLIN SPORT MED, V22, P727, DOI 10.1016/S0278-5919(03)00010-3; Alsousou J, 2009, J BONE JOINT SURG BR, V91B, P987, DOI 10.1302/0301-620X.91B8.22546; BOSCH G, J ORTHOP RES, DOI DOI 10.1002/JOR.20980; Brown R, 2006, BRIT J SPORT MED, V40, P275, DOI 10.1136/bjsm.2005.021931; de Mos M, 2008, AM J SPORT MED, V36, P1171, DOI 10.1177/0363546508314430; de Vos RJ, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2006.032532; Ehrenfest DMD, 2009, TRENDS BIOTECHNOL, V27, P158, DOI 10.1016/j.tibtech.2008.11.009; Eppley BL, 2004, PLAST RECONSTR SURG, V114, P1502, DOI 10.1097/01.PRS.0000138251.07040.51; Halasi T, 2004, AM J SPORT MED, V32, P899, DOI 10.1177/0363546503262181; James SLJ, 2007, BRIT J SPORT MED, V41, P518, DOI 10.1136/bjsm.2006.034686; Jarvinen Tero A H, 2005, Foot Ankle Clin, V10, P255, DOI 10.1016/j.fcl.2005.01.013; Kingma JJ, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2006.030916; Kon E, 2009, INJURY, V40, P598, DOI 10.1016/j.injury.2008.11.026; Langberg H, 2007, SCAND J MED SCI SPOR, V17, P61, DOI 10.1111/j.1600-0838.2006.00522.x; Maffulli N, 2003, CLIN SPORT MED, V22, P675, DOI 10.1016/S0278-5919(03)00004-8; Maffulli N, 2004, J ROY SOC MED, V97, P472, DOI 10.1258/jrsm.97.10.472; McCarrel T, 2009, J ORTHOP RES, V27, P1033, DOI 10.1002/jor.20853; Mishra A, 2006, AM J SPORT MED, V34, P1774, DOI 10.1177/0363546506288850; Mishra A, 2009, CLIN SPORT MED, V28, P113, DOI 10.1016/j.csm.2008.08.007; Ostelo RWJG, 2008, SPINE, V33, P90, DOI 10.1097/BRS.0b013e31815e3a10; Pham T, 2004, OSTEOARTHR CARTILAGE, V12, P389, DOI 10.1016/j.joca.2004.02.001; Rees JD, 2009, AM J SPORT MED, V37, P1855, DOI 10.1177/0363546508324283; Robinson JM, 2001, BRIT J SPORT MED, V35, P335, DOI 10.1136/bjsm.35.5.335; Rompe JD, 2007, AM J SPORT MED, V35, P374, DOI 10.1177/0363546506295940; Rozendaal RM, 2008, ANN INTERN MED, V148, P268, DOI 10.7326/0003-4819-148-4-200802190-00005; Sampson S, 2008, CURR REV MUSCULOSKE, V1, P165, DOI 10.1007/s12178-008-9032-5; Sanchez M, 2009, SPORTS MED, V39, P345, DOI 10.2165/00007256-200939050-00002; Sayana MK, 2007, J SCI MED SPORT, V10, P52, DOI 10.1016/j.jsams.2006.05.008; Tallon C, 2001, AM J SPORT MED, V29, P315, DOI 10.1177/03635465010290031101; Virchenko O, 2006, ACTA ORTHOP, V77, P806, DOI 10.1080/17453670610013033; Wasielewski NJ, 2007, J ATHL TRAINING, V42, P409; WOO SL, 2007, ENCY SPORTS MED, V12; Zafar MS, 2009, SPORTS MED ARTHROSC, V17, P190, DOI 10.1097/JSA.0b013e3181b37eb7; Zhang W, 2008, ANN RHEUM DIS, V67, P1716, DOI 10.1136/ard.2008.092015	34	528	536	8	109	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 13	2010	303	2					144	149		10.1001/jama.2009.1986	http://dx.doi.org/10.1001/jama.2009.1986			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	542UI	20068208				2022-12-28	WOS:000273522600024
J	Lane, R				Lane, Richard			A protocol for labrador retrievers?	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Lane, R (corresponding author), The Lancet, London NW1 7BY, England.							Church J, 2001, LANCET, V358, P930, DOI 10.1016/S0140-6736(01)06065-2; 2009, GUARDIAN        0427; 2002, US TODAY        0724	3	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC-JAN	2009	374	9707					2038	2039		10.1016/S0140-6736(09)62134-6	http://dx.doi.org/10.1016/S0140-6736(09)62134-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	537OO	20109816				2022-12-28	WOS:000273122900009
J	Peterson, S				Peterson, Stefan			Assessing the scale-up of child survival interventions	LANCET			English	Editorial Material							DEATHS		[Peterson, Stefan] Karolinska Inst, Global Hlth IHCAR, S-17177 Stockholm, Sweden; [Peterson, Stefan] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Kampala, Uganda	Karolinska Institutet; Makerere University	Peterson, S (corresponding author), Karolinska Inst, Global Hlth IHCAR, S-17177 Stockholm, Sweden.	Stefan.Peterson@ki.se						Berwick DM, 2008, JAMA-J AM MED ASSOC, V299, P1182, DOI 10.1001/jama.299.10.1182; Bryce J, 2010, LANCET, V375, P572, DOI 10.1016/S0140-6736(09)62060-2; DeSavigny D, 2009, SYSTEMS THINKING FOR HEALTH SYSTEMS STRENGTHENING, P1; Gapminder, UNV BEAUT STAT FACT; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Leroy JL, 2007, AM J PUBLIC HEALTH, V97, P219, DOI 10.2105/AJPH.2005.083287; Leykum LK, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-69; Schepker R, 2007, Z KINDER JUG-PSYCH, V35, P9, DOI 10.1024/1422-4917.35.1.9; Tomlinson M, 2007, PLOS MED, V4, P1293, DOI 10.1371/journal.pmed.0040259; *WHO, 2009, CONS P GEN 26 27 MAR	10	11	11	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 13	2010	375	9714					530	531		10.1016/S0140-6736(09)62193-0	http://dx.doi.org/10.1016/S0140-6736(09)62193-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	560YO	20071022				2022-12-28	WOS:000274941900006
J	Pronovost, PJ; Goeschel, CA; Colantuoni, E; Watson, S; Lubomski, LH; Berenholtz, SM; Thompson, DA; Sinopoli, DJ; Cosgrove, S; Sexton, JB; Marsteller, JA; Hyzy, RC; Welsh, R; Posa, P; Schumacher, K; Needham, D				Pronovost, Peter J.; Goeschel, Christine A.; Colantuoni, Elizabeth; Watson, Sam; Lubomski, Lisa H.; Berenholtz, Sean M.; Thompson, David A.; Sinopoli, David J.; Cosgrove, Sara; Sexton, J. Bryan; Marsteller, Jill A.; Hyzy, Robert C.; Welsh, Robert; Posa, Patricia; Schumacher, Kathy; Needham, Dale			Sustaining reductions in catheter related bloodstream infections in Michigan intensive care units: observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PREVENTION; CHLORHEXIDINE; OUTCOMES; SYSTEMS; SAFETY	Objectives To evaluate the extent to which intensive care units participating in the initial Keystone ICU project sustained reductions in rates of catheter related bloodstream infections. Design Collaborative cohort study to implement and evaluate interventions to improve patients' safety. Setting Intensive care units predominantly in Michigan, USA. Intervention Conceptual model aimed at improving clinicians' use of five evidence based recommendations to reduce rates of catheter related bloodstream infections rates, with measurement and feedback of infection rates. During the sustainability period, intensive care unit teams were instructed to integrate this intervention into staff orientation, collect monthly data from hospital infection control staff, and report infection rates to appropriate stakeholders. Main outcome measures Quarterly rate of catheter related bloodstream infections per 1000 catheter days during the sustainability period (19-36 months after implementation of the intervention). Results Ninety (87%) of the original 103 intensive care units participated, reporting 1532 intensive care unit months of data and 300 310 catheter days during the sustainability period. The mean and median rates of catheter related bloodstream infection decreased from 7.7 and 2.7 (interquartile range 0.6-4.8) at baseline to 1.3 and 0 (0-2.4) at 16-18 months and to 1.1 and 0 (0.0-1.2) at 34-36 months post-implementation. Multilevel regression analysis showed that incidence rate ratios decreased from 0.68 (95% confidence interval 0.53 to 0.88) at 0-3 months to 0.38 (0.26 to 0.56) at 16-18 months and 0.34 (0.24-0.48) at 34-36 months post-implementation. During the sustainability period, the mean bloodstream infection rate did not significantly change from the initial 18 month post-implementation period (-1%, 95% confidence interval -9% to 7%). Conclusions The reduced rates of catheter related bloodstream infection achieved in the initial 18 month post-implementation period were sustained for an additional 18 months as participating intensive care units integrated the intervention into practice. Broad use of this intervention with achievement of similar results could substantially reduce the morbidity and costs associated with catheter related bloodstream infections.	[Pronovost, Peter J.; Goeschel, Christine A.] Johns Hopkins Univ, Dept Anesthesiol & Crit Care Med, Qual & Safety Res Grp, Patient Safety & Qual Initiat, Baltimore, MD 21231 USA; [Watson, Sam] Michigan Hlth & Hosp Assoc Keystone Ctr, Lansing, MI 48917 USA; [Sinopoli, David J.] Johns Hopkins Univ, Carey Business Sch, Baltimore, MD 21201 USA; [Cosgrove, Sara] Div Infect Dis, Baltimore, MD 21287 USA; [Marsteller, Jill A.] Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD 21205 USA; [Hyzy, Robert C.] Univ Michigan, Dept Internal Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA; [Welsh, Robert; Schumacher, Kathy] William Beaumont Hosp, Royal Oak, MI 48072 USA; [Posa, Patricia] St Joseph Mercy Hlth Syst, Ann Arbor, MI 48106 USA; [Needham, Dale] Div Pulm & Crit Care Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Michigan System; University of Michigan; Beaumont Health; Saint Joseph Mercy Health System (SJMHS)	Pronovost, PJ (corresponding author), Johns Hopkins Univ, Dept Anesthesiol & Crit Care Med, Qual & Safety Res Grp, Patient Safety & Qual Initiat, 1909 Thames St, Baltimore, MD 21231 USA.	ppronovo@jhmi.edu	Goeschel, Christine/AAA-6783-2020		Agency for Healthcare Research and Quality [1UC1HS14246]; MHA; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [UC1HS014246] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); MHA; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Support for this project, for the period from October 2003 to September 2005, was provided by the Agency for Healthcare Research and Quality (1UC1HS14246) and the MHA. The Agency for Healthcare Research and Quality provided financial support, and the MHA provided support for the biannual statewide meetings. The researchers were independent of the sponsors, and neither sponsor had any influence over the study design; collection, analysis, or interpretation of the data; writing of the manuscript; or decision to submit it for publication.	Alexander JA, 2003, MED CARE RES REV, V60, p130S, DOI 10.1177/1077558703259069; Berenholtz SM, 2004, CRIT CARE MED, V32, P2014, DOI 10.1097/01.CCM.0000142399.70913.2F; Berwick DM, 2005, ANN INTERN MED, V142, P121, DOI 10.7326/0003-4819-142-2-200501180-00011; Burke JP, 2003, NEW ENGL J MED, V348, P651, DOI 10.1056/NEJMhpr020557; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; Chin MH, 2004, DIABETES CARE, V27, P2, DOI 10.2337/diacare.27.1.2; Climo MW, 2009, CRIT CARE MED, V37, P1858, DOI 10.1097/CCM.0b013e31819ffe6d; Dietrich AJ, 2004, ANN FAM MED, V2, P301, DOI 10.1370/afm.102; Friedman C, 2008, AM J INFECT CONTROL, V36, P385, DOI 10.1016/j.ajic.2008.04.246; Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x; Gustafson DH, 2003, HEALTH SERV RES, V38, P751, DOI 10.1111/1475-6773.00143; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; Hockenhull JC, 2009, CRIT CARE MED, V37, P702, DOI 10.1097/CCM.0b013e3181958915; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; Lyder Courtney H, 2004, Jt Comm J Qual Saf, V30, P205; Mermel LA, 2000, ANN INTERN MED, V132, P391, DOI 10.7326/0003-4819-132-5-200003070-00009; Neily J, 2005, JT COMM J QUAL PATIE, V31, P275, DOI 10.1016/S1553-7250(05)31035-X; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Panageas KS, 2003, ANN INTERN MED, V139, P658, DOI 10.7326/0003-4819-139-8-200310210-00009; Pronovost P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1714; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Pronovost PJ, 2008, J CRIT CARE, V23, P207, DOI 10.1016/j.jcrc.2007.09.002; PRONOVOST PJ, 2005, J PATIENT SAF, V1, P33; Rabe-Hesketh S.S.A., 2005, MULTILEVEL LONGITUDI; Roger E.M, 2003, DIFFUSION INNOVATION, V5th; Skrondal A., 2004, GEN LATENT VARIABLE; Timsit JF, 2009, JAMA-J AM MED ASSOC, V301, P1231, DOI 10.1001/jama.2009.376; Weick KE, 1999, ANNU REV PSYCHOL, V50, P361, DOI 10.1146/annurev.psych.50.1.361; Womer RB, 2002, J CLIN ONCOL, V20, P4705, DOI 10.1200/JCO.2002.04.108; Yates Gary R, 2004, Jt Comm J Qual Saf, V30, P534	30	328	336	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 4	2010	340								c309	10.1136/bmj.c309	http://dx.doi.org/10.1136/bmj.c309			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	553CW	20133365	hybrid, Green Published			2022-12-28	WOS:000274343600002
J	Rosenthal, RL; Grimsley, BR				Rosenthal, Robert L.; Grimsley, Bradley R.			Kinked Carotids	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rosenthal, Robert L.; Grimsley, Bradley R.] Baylor Jack & Jane Hamilton Heart & Vasc Hosp, Dallas, TX USA		Rosenthal, RL (corresponding author), Baylor Jack & Jane Hamilton Heart & Vasc Hosp, Dallas, TX USA.	robert.rosenthal@heartplace.com							0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 4	2010	362	5					448	448		10.1056/NEJMicm0901403	http://dx.doi.org/10.1056/NEJMicm0901403			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551FV	20130254				2022-12-28	WOS:000274193300010
J	Shelly, DR				Shelly, David R.			Migrating tremors illuminate complex deformation beneath the seismogenic San Andreas fault	NATURE			English	Article							NON-VOLCANIC TREMOR; EPISODIC TREMOR; PARKFIELD; CALIFORNIA; SUBDUCTION; SLIP	The San Andreas fault is one of the most extensively studied faults in the world, yet its physical character and deformation mode beneath the relatively shallow earthquake-generating portion remain largely unconstrained. Tectonic 'non-volcanic' tremor, a recently discovered seismic signal(1) probably generated by shear slip on the deep extension of some major faults(2-4), can provide new insight into the deep fate of such faults, including that of the San Andreas fault near Parkfield, California(5). Here I examine continuous seismic data from mid-2001 to 2008, identifying tremor and decomposing the signal into different families of activity based on the shape and timing of the waveforms at multiple stations(6). This approach allows differentiation between activities from nearby patches of the deep fault and begins to unveil rich and complex patterns of tremor occurrence. I find that tremor exhibits nearly continuous migration, with the most extensive episodes propagating more than 20 kilometres along fault strike at rates of 15-80 kilometres per hour. This suggests that the San Andreas fault remains a localized through-going structure, at least to the base of the crust, in this area. Tremor rates and recurrence behaviour changed markedly in the wake of the 2004 magnitude-6.0 Parkfield earthquake(6,7), but these changes were far from uniform within the tremor zone, probably reflecting heterogeneous fault properties and static and dynamic stresses decaying away from the rupture. The systematic recurrence of tremor demonstrated here suggests the potential to monitor detailed time-varying deformation on this portion of the deep San Andreas fault, deformation which unsteadily loads the shallower zone that last ruptured in the 1857 magnitude-7.9 Fort Tejon earthquake(8).	US Geol Survey, Menlo Pk, CA 94025 USA	United States Department of the Interior; United States Geological Survey	Shelly, DR (corresponding author), US Geol Survey, 345 Middlefield Rd,MS 977, Menlo Pk, CA 94025 USA.	dshelly@usgs.gov		Shelly, David/0000-0003-2783-5158				Agnew D.C., 2003, LONG BASE LASER STRA; Brudzinski MR, 2007, GEOLOGY, V35, P907, DOI 10.1130/G23740A.1; Gibbons SJ, 2006, GEOPHYS J INT, V165, P149, DOI 10.1111/j.1365-246X.2006.02865.x; Gomberg J, 2008, SCIENCE, V319, P173, DOI 10.1126/science.1149164; Ide S, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028890; Johnston MJS, 2006, B SEISMOL SOC AM, V96, pS56, DOI 10.1785/0120050822; Katsumata A, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL015981; KIRBY S, 2002, EOS S, V83; Murray J, 2006, B SEISMOL SOC AM, V96, pS283, DOI 10.1785/0120050820; Nadeau RM, 2005, SCIENCE, V307, P389, DOI 10.1126/science.1107142; Nadeau RM, 2009, SCIENCE, V325, P191, DOI 10.1126/science.1174155; Obara K, 2006, TECTONOPHYSICS, V417, P33, DOI 10.1016/j.tecto.2005.04.013; Obara K, 2002, SCIENCE, V296, P1679, DOI 10.1126/science.1070378; Ozacar AA, 2009, GEOPHYS J INT, V178, P1098, DOI [10.1111/J.1365-246X.2009.04198.x, 10.1111/j.1365-246X.2009.04198.x]; Page BM, 1998, GEOL SOC AM BULL, V110, P846, DOI 10.1130/0016-7606(1998)110<0846:OLCTOT>2.3.CO;2; Peng ZG, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL036080; Peng ZG, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB006049; Rogers G, 2003, SCIENCE, V300, P1942, DOI 10.1126/science.1084783; Rubinstein JL, 2010, INT YEAR PLANET EART, P287, DOI 10.1007/978-90-481-2737-5_8; Sass JH, 1997, J GEOPHYS RES-SOL EA, V102, P27575, DOI 10.1029/97JB02350-B; Shelly DR, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2007GC001640; Shelly DR, 2007, NATURE, V446, P305, DOI 10.1038/nature05666; Shelly DR, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039589; Shelly DR, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036367; SIEH KE, 1978, B SEISMOL SOC AM, V68, P1731; SMITH EF, J GEOPHYS R IN PRESS, DOI DOI 10.1029/2008JB005848; Thomas AM, 2009, NATURE, V462, P1048, DOI 10.1038/nature08654; Thurber C, 2006, B SEISMOL SOC AM, V96, pS38, DOI 10.1785/0120050825; TREHU AM, 1987, GEOLOGY, V15, P254, DOI 10.1130/0091-7613(1987)15<254:PEFSSM>2.0.CO;2; Wech AG, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031167	30	123	126	2	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 4	2010	463	7281					648	U75		10.1038/nature08755	http://dx.doi.org/10.1038/nature08755			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551GB	20130648				2022-12-28	WOS:000274193900033
J	Bezemer, ID; Bare, LA; Arellano, AR; Reitsma, PH; Rosendaal, FR				Bezemer, Irene D.; Bare, Lance A.; Arellano, Andre R.; Reitsma, Pieter H.; Rosendaal, Frits R.			Updated Analysis of Gene Variants Associated With Deep Vein Thrombosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Bezemer, Irene D.; Rosendaal, Frits R.] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands; [Reitsma, Pieter H.] Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, Leiden, Netherlands; [Bare, Lance A.; Arellano, Andre R.] Celera, Alameda, CA USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Bezemer, ID (corresponding author), Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands.	f.r.rosendaal@lumc.nl	Rosendaal, Frits/Q-3842-2017	Rosendaal, Frits/0000-0003-2558-7496				Bezemer ID, 2008, JAMA-J AM MED ASSOC, V299, P1306, DOI 10.1001/jama.299.11.1306; Bezemer ID, 2009, HAEMATOL-HEMATOL J, V94, P693, DOI 10.3324/haematol.2008.003020; Smith NL, 2007, JAMA-J AM MED ASSOC, V297, P489, DOI 10.1001/jama.297.5.489	3	20	20	2	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 3	2010	303	5					421	422		10.1001/jama.2010.57	http://dx.doi.org/10.1001/jama.2010.57			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	550QR	20124536	Bronze			2022-12-28	WOS:000274143600013
J	Wu, M; Pastor-Pareja, JC; Xu, T				Wu, Ming; Pastor-Pareja, Jose Carlos; Xu, Tian			Interaction between Ras(V12) and scribbled clones induces tumour growth and invasion	NATURE			English	Article							DROSOPHILA JAK/STAT PATHWAY; SIGNALING PATHWAY; CELL POLARITY; JNK; CANCER; ACTIVATION; RAS; OVERGROWTH; EXPRESSION; TISSUES	Human tumours have a large degree of cellular and genetic heterogeneity(1). Complex cell interactions in the tumour and its microenvironment are thought to have an important role in tumorigenesis and cancer progression(2). Furthermore, cooperation between oncogenic genetic lesions is required for tumour development(3); however, it is not known how cell interactions contribute to oncogenic cooperation. The genetic techniques available in the fruitfly Drosophila melanogaster allow analysis of the behaviour of cells with distinct mutations(4), making this the ideal model organism with which to study cell interactions and oncogenic cooperation. In Drosophila eye-antennal discs, cooperation between the oncogenic protein Ras(V12) (ref.5) and loss-of-function mutations in the conserved tumour suppressor scribbled (scrib)(6,7) gives rise to metastatic tumours that display many characteristics observed in human cancers(8-11). Here we show that clones of cells bearing different mutations can cooperate to promote tumour growth and invasion in Drosophila. We found that the Ras(V12) and scrib(-) mutations can also cause tumours when they affect different adjacent epithelial cells. We show that this interaction between Ras(V12) and scrib(-) clones involves JNK signalling propagation and JNK-induced upregulation of JAK/STAT-activating cytokines, a compensatory growth mechanism for tissue homeostasis. The development of Ras(V12) tumours can also be triggered by tissue damage, a stress condition that activates JNK signalling. Given the conservation of the pathways examined here, similar cooperative mechanisms could have a role in the development of human cancers.	[Wu, Ming; Pastor-Pareja, Jose Carlos; Xu, Tian] Yale Univ, Sch Med, Dept Genet, Howard Hughes Med Inst, New Haven, CT 06519 USA; [Xu, Tian] Fudan Univ, Sch Life Sci, Inst Dev Biol & Mol Med, Fudan Yale Biomed Res Ctr, Shanghai 20043, Peoples R China	Howard Hughes Medical Institute; Yale University; Fudan University	Xu, T (corresponding author), Yale Univ, Sch Med, Dept Genet, Howard Hughes Med Inst, 295 Congress Ave, New Haven, CT 06519 USA.	tian.xu@yale.edu	Pastor-Pareja, Jose Carlos/ABE-6917-2021	Pastor-Pareja, Jose Carlos/0000-0002-3823-4473; Wu, Ming/0000-0002-2193-8271	Spanish Ministry of Education; NIH/NCI; NATIONAL CANCER INSTITUTE [R01CA069408] Funding Source: NIH RePORTER	Spanish Ministry of Education(Spanish Government); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank E. Bach, D. Harrison, J. Castelli-Gair Hombria, M. Zeidler, T. Adachi-Yamada, M. Mlodzik, E. Matunis, D. Montell, H. Agaisse, the Bloomington Stock Center and the National Institute of Genetics (Kyoto) for fly strains, and T. Ni, S. Landrette and M. Rojas for comments. R. Pagliarini and S. Landrette helped with microarray analysis and RT-PCR. We thank T. Igaki for discussing the manuscript and providing FRT82B, tub-Gal80, scrib 1/TM6B flies. M. W. is a Yale predoctoral fellow. J. C. P.-P. was funded by a Spanish Ministry of Education postdoctoral fellowship. This work was supported by a grant from NIH/NCI to T. X. T. X. is a Howard Hughes Medical Institute Investigator.	Agaisse H, 2003, DEV CELL, V5, P441, DOI 10.1016/S1534-5807(03)00244-2; Bach EA, 2007, GENE EXPR PATTERNS, V7, P323, DOI 10.1016/j.modgep.2006.08.003; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Bosch M, 2005, DEV BIOL, V280, P73, DOI 10.1016/j.ydbio.2005.01.002; Brown S, 2001, CURR BIOL, V11, P1700, DOI 10.1016/S0960-9822(01)00524-3; Brumby AM, 2003, EMBO J, V22, P5769, DOI 10.1093/emboj/cdg548; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hariharan IK, 2006, ANNU REV GENET, V40, P335, DOI 10.1146/annurev.genet.39.073003.100738; Harrison DA, 1998, GENE DEV, V12, P3252, DOI 10.1101/gad.12.20.3252; HEPPNER GH, 1984, CANCER RES, V44, P2259; Hombria JCG, 2005, DEV BIOL, V288, P420, DOI 10.1016/j.ydbio.2005.09.040; Igaki T, 2006, CURR BIOL, V16, P1139, DOI 10.1016/j.cub.2006.04.042; Igaki T, 2009, DEV CELL, V16, P458, DOI 10.1016/j.devcel.2009.01.002; Karim FD, 1998, DEVELOPMENT, V125, P1; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Martin FA, 2009, INT J DEV BIOL, V53, P1341, DOI 10.1387/ijdb.072447fm; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Pastor-Pareja JC, 2008, DIS MODEL MECH, V1, P144, DOI 10.1242/dmm.000950; Ryoo HD, 2004, DEV CELL, V7, P491, DOI 10.1016/j.devcel.2004.08.019; Srivastava A, 2007, P NATL ACAD SCI USA, V104, P2721, DOI 10.1073/pnas.0611666104; Uhlirova M, 2005, P NATL ACAD SCI USA, V102, P13123, DOI 10.1073/pnas.0504170102; Uhlirova M, 2006, EMBO J, V25, P5294, DOI 10.1038/sj.emboj.7601401; XU T, 1993, DEVELOPMENT, V117, P1223; Zeidler MP, 2000, ONCOGENE, V19, P2598, DOI 10.1038/sj.onc.1203482; Zhan LX, 2008, CELL, V135, P865, DOI 10.1016/j.cell.2008.09.045	30	268	271	2	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 28	2010	463	7280					545	U165		10.1038/nature08702	http://dx.doi.org/10.1038/nature08702			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	548QK	20072127	Green Accepted, Green Submitted			2022-12-28	WOS:000273981100052
J	Wilber, DJ; Pappone, C; Neuzil, P; De Paola, A; Marchlinski, F; Natale, A; Macle, L; Daoud, EG; Calkins, H; Hall, B; Reddy, V; Augello, G; Reynolds, MR; Vinekar, C; Liu, CY; Berry, SM; Berry, DA				Wilber, David J.; Pappone, Carlo; Neuzil, Petr; De Paola, Angelo; Marchlinski, Frank; Natale, Andrea; Macle, Laurent; Daoud, Emile G.; Calkins, Hugh; Hall, Burr; Reddy, Vivek; Augello, Giuseppe; Reynolds, Matthew R.; Vinekar, Chandan; Liu, Christine Y.; Berry, Scott M.; Berry, Donald A.		ThermoCool AF Trial Investigators	Comparison of Antiarrhythmic Drug Therapy and Radiofrequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; PULMONARY VEIN ABLATION; FOLLOW-UP; CLINICAL-TRIALS; SINUS RHYTHM; MANAGEMENT; RISK; AMIODARONE; MORTALITY; OUTCOMES	Context Antiarrhythmic drugs are commonly used for prevention of recurrent atrial fibrillation (AF) despite inconsistent efficacy and frequent adverse effects. Catheter ablation has been proposed as an alternative treatment for paroxysmal AF. Objective To determine the efficacy of catheter ablation compared with antiarrhythmic drug therapy (ADT) in treating symptomatic paroxysmal AF. Design, Setting, and Participants A prospective, multicenter, randomized (2: 1), unblinded, Bayesian-designed study conducted at 19 hospitals of 167 patients who did not respond to at least 1 antiarrhythmic drug and who experienced at least 3 AF episodes within 6 months before randomization. Enrollment occurred between October 25, 2004, and October 11, 2007, with the last follow-up on January 19, 2009. Intervention Catheter ablation (n = 106) or ADT (n = 61), with assessment for effectiveness in a comparable 9-month follow-up period. Main Outcome Measures Time to protocol-defined treatment failure. The proportion of patients who experienced major treatment-related adverse events within 30 days of catheter ablation or ADT was also reported. Results At the end of the 9-month effectiveness evaluation period, 66% of patients in the catheter ablation group remained free from protocol-defined treatment failure compared with 16% of patients treated with ADT. The hazard ratio of catheter ablation to ADT was 0.30 (95% confidence interval, 0.19-0.47; P < .001). Major 30-day treatment-related adverse events occurred in 5 of 57 patients (8.8%) treated with ADT and 5 of 103 patients (4.9%) treated with catheter ablation. Mean quality of life scores improved significantly in patients treated by catheter ablation compared with ADT at 3 months; improvement was maintained during the course of the study. Conclusion Among patients with paroxysmal AF who had not responded to at least 1 antiarrhythmic drug, the use of catheter ablation compared with ADT resulted in a longer time to treatment failure during the 9-month follow-up period. Trial Registration clinicaltrials.gov Identifier: NCT00116428 JAMA. 2010;303(4):333-340	[Wilber, David J.] Loyola Univ, Med Ctr, Dept Med, Cardiovasc Inst, Maywood, IL 60153 USA; [Pappone, Carlo; Augello, Giuseppe] Hosp San Raffaele, Dept Med, I-20132 Milan, Italy; [Neuzil, Petr; Reddy, Vivek] Na Homolce Hosp, Dept Med, Prague, Czech Republic; [De Paola, Angelo] Hosp Sao Paulo, UNIFESP, Dept Med, Sao Paulo, Brazil; [Marchlinski, Frank] Hosp Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Natale, Andrea] Cleveland Clin Fdn, Dept Med, Cleveland, OH 44195 USA; [Macle, Laurent] Montreal Heart Inst, Dept Med, Montreal, PQ H1T 1C8, Canada; [Daoud, Emile G.] Ohio State Univ, Dept Med, Columbus, OH 43210 USA; [Calkins, Hugh] Johns Hopkins Univ Hosp, Dept Med, Baltimore, MD 21287 USA; [Hall, Burr] Univ Rochester, Med Ctr, Dept Med, Rochester, NY 14642 USA; [Reynolds, Matthew R.] Harvard Clin Res Inst, Boston, MA USA; [Vinekar, Chandan; Liu, Christine Y.] Biosense Webster, Diamond Bar, CA USA; [Berry, Scott M.] Berry Consultants, College Stn, TX USA; [Berry, Donald A.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	Loyola University Chicago; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Na Homolce Hospital; Universidade Federal de Sao Paulo (UNIFESP); University of Pennsylvania; Pennsylvania Medicine; Cleveland Clinic Foundation; Universite de Montreal; University System of Ohio; Ohio State University; Johns Hopkins University; Johns Hopkins Medicine; University of Rochester; Harvard University; Harvard Medical School; University of Texas System; UTMD Anderson Cancer Center	Wilber, DJ (corresponding author), Loyola Univ, Med Ctr, Dept Med, Cardiovasc Inst, 2160 S 1st Ave,Bldg 110,Room 6232, Maywood, IL 60153 USA.	dwilber@lumc.edu	Macle, laurent/AAA-4675-2021; Natale, Andrea/ABE-7273-2020; Augello, Giuseppe/AAM-2338-2021; Pappone, Carlo/J-9853-2016	Macle, laurent/0000-0002-3328-5239; Sala, Simone/0000-0003-3303-8892; Wilkoff, Bruce/0000-0001-8905-9233; Reddy, Vivek/0000-0002-5638-4993; Marchlinski, Francis/0000-0001-7962-9423; Talajic, Mario/0000-0001-8469-4748; Pappone, Carlo/0000-0002-0901-6135	Biosense Webster; Boston Scientific; Medtronic; St Jude Medical; Blackwell/Futura; Johnson Johnson; Cardiofocus; Cyrocath Technologies; Hansen Medical; NIH [BARI 2D]; Bristol-Myers Squibb; GE Healthcare; BARD; Atritech; CryoCath Technologies; Endosense Hansen Medical; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Biosense Webster; Boston Scientific(Boston Scientific); Medtronic(Medtronic); St Jude Medical(St. Jude Medical); Blackwell/Futura; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Cardiofocus; Cyrocath Technologies; Hansen Medical; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bristol-Myers Squibb(Bristol-Myers Squibb); GE Healthcare(General ElectricGE Healthcare); BARD(US-Israel Binational Science Foundation); Atritech; CryoCath Technologies; Endosense Hansen Medical; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Dr Wilber reported receiving grants from Biosense Webster, Boston Scientific, Medtronic, and St Jude Medical; consulting fees from Biosense Webster, Medtronic, and Sanofi-Aventis; honoraria from Biosense Webster, Boston Scientific, Medtronic, and St Jude Medical; and royalties from Blackwell/Futura. Dr Pappone reported receiving grants and consulting fees from St Jude Medical and Johnson & Johnson, and honorarium from Biosense Webster. Dr Neuzil reported receiving grants from Biosense Webster, Cardiofocus, Cyrocath Technologies, Hansen Medical, NIH BARI 2D, and St Jude Medical; consulting fees from Stereotaxis; and honorarium from Biosense Webster. Dr De Paola reported receiving a grant from Bristol-Myers Squibb. Dr Marchlinski reported receiving grants and honoraria from Biosense Webster, Boston Scientific, and St Jude Medical; consulting fees from Biosense Webster, Boston Scientific, GE Healthcare, Medtronic, and St Jude Medical; and speakers' bureau fees from Biosense Webster. Dr Natale reported receiving grants from Biosense Webster and St Jude Medical, and speakers' bureau fees from Biosense Webster, Boston Scientific, Medtronic, and St Jude Medical. Dr Macle reported receiving consulting fees and honorarium from Biosense Webster. Dr Daoud reported receiving consulting fees from BARD and Biosense Webster, and honorarium from Biosense Webster. Dr Calkins reported receiving consulting fees from Ablation Frontiers, Atricure, BARD, Biosense Webster, Boston Scientific, CryoCor, CyberHeart, Medtronic, ProRhythm, Sanofi-Aventis, and TASER International; a grant and honorarium from Biosense Webster; speakers' bureau fees from Atricure, BARD, Biosense Webster, Boston Scientific, Medtronic, and Reliant; and fellowship fees from BARD, Boston Scientific, and Medtronic. Dr Hall reported receiving consulting fees from Biosense Webster. Dr Reddy reported receiving grants from Atritech, Boston Scientific, Biosense Webster, Cardiofocus, CryoCath Technologies, Endosense Hansen Medical, St Jude Medical, and Stereotaxis; consulting fees from Biosense Webster and St Jude Medical; and honoraria from Boston Scientific, Biosense Webster, Medtronic, and St Jude Medical. Dr Augello reported receiving honoraria from BARD, Biosense Webster, and St Jude Medical. Dr Reynolds reported receiving consulting fees from Biosense Webster, Cardiome Pharma Corp, and Sanofi-Aventis. Mr Vinekar and Ms Liu are employees of Biosense Webster. Drs S. Berry and D. Berry reported receiving consulting fees from Biosense Webster, Veridex LLC, Boston Scientific, Endologix, R. R. Bard, W. L. Gore, Medtronic, Bristol-Myers Squibb, Pfizer, and Teva Pharmaceuticals.; This study was funded by Biosense Webster, who provided the catheters used.	Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Berry DA, 2006, NAT REV DRUG DISCOV, V5, P27, DOI 10.1038/nrd1927; Berry DA, 2005, CLIN TRIALS, V2, P295, DOI 10.1191/1740774505cn100oa; Berry DA, 2004, STAT SCI, V19, P175, DOI 10.1214/088342304000000044; Bubien RS, 1996, CIRCULATION, V94, P1585, DOI 10.1161/01.CIR.94.7.1585; Calkins H, 2007, HEART RHYTHM, V4, P816, DOI 10.1016/j.hrthm.2007.04.005; Cappato R, 2005, CIRCULATION, V111, P1100, DOI 10.1161/01.CIR.0000157153.30978.67; Curtis AB, 2005, AM HEART J, V149, P304, DOI 10.1016/j.ahj.2004.08.012; Dorian P, 2002, AM HEART J, V143, P984, DOI 10.1067/mhj.2002.122518; Fuster V, 2006, J AM COLL CARDIOL, V48, P854, DOI 10.1016/j.jacc.2006.07.009; Greene HL, 2003, J AM COLL CARDIOL, V42, P20, DOI 10.1016/S0735-1097(03)00559-X; HAMER ME, 1994, AM J CARDIOL, V74, P826, DOI 10.1016/0002-9149(94)90448-0; Jais P, 2008, CIRCULATION, V118, P2498, DOI 10.1161/CIRCULATIONAHA.108.772582; KRAHN AD, 1995, AM J MED, V98, P476, DOI 10.1016/S0002-9343(99)80348-9; Nademanee K, 2008, J AM COLL CARDIOL, V51, P843, DOI 10.1016/j.jacc.2007.10.044; Pappone C, 2003, J AM COLL CARDIOL, V42, P185, DOI 10.1016/S0735-1097(03)00577-1; Pappone C, 2008, HEART RHYTHM, V5, P1501, DOI 10.1016/j.hrthm.2008.08.011; Pappone C, 2006, J AM COLL CARDIOL, V48, P2340, DOI 10.1016/j.jacc.2006.08.037; Reynolds MR, 2007, J CARDIOVASC ELECTR, V18, P628, DOI 10.1111/j.1540-8167.2007.00819.x; Roy D, 2000, NEW ENGL J MED, V342, P913, DOI 10.1056/NEJM200003303421302; Singh BN, 2005, NEW ENGL J MED, V352, P1861, DOI 10.1056/NEJMoa041705; Singh SN, 2006, J AM COLL CARDIOL, V48, P721, DOI 10.1016/j.jacc.2006.03.051; Stabile G, 2006, EUR HEART J, V27, P216, DOI 10.1093/eurheartj/ehi583; Vasamreddy CR, 2006, J CARDIOVASC ELECTR, V17, P134, DOI 10.1111/j.1540-8167.2006.00359.x; Wang TJ, 2003, CIRCULATION, V107, P2920, DOI 10.1161/01.CIR.0000072767.89944.6E; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wazni OM, 2005, JAMA-J AM MED ASSOC, V293, P2634, DOI 10.1001/jama.293.21.2634; Yokoyama K, 2006, CIRCULATION, V113, P11, DOI 10.1161/CIRCULATIONAHA.105.540062	28	781	813	0	45	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 27	2010	303	4					333	340		10.1001/jama.2009.2029	http://dx.doi.org/10.1001/jama.2009.2029			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	548IC	20103757	Bronze			2022-12-28	WOS:000273952800021
J	Ganapathy, R; Buckley, MR; Gerbode, SJ; Cohen, I				Ganapathy, Rajesh; Buckley, Mark R.; Gerbode, Sharon J.; Cohen, Itai			Direct Measurements of Island Growth and Step-Edge Barriers in Colloidal Epitaxy	SCIENCE			English	Article							THIN-FILM GROWTH; NUCLEATION; CRYSTALS; NANOSTRUCTURES; DIFFUSION; PARTICLES; DYNAMICS; SURFACES; VIEW	Epitaxial growth, a bottom-up self-assembly process for creating surface nano-and microstructures, has been extensively studied in the context of atoms. This process, however, is also a promising route to self-assembly of nanometer- and micrometer-scale particles into microstructures that have numerous technological applications. To determine whether atomic epitaxial growth laws are applicable to the epitaxy of larger particles with attractive interactions, we investigated the nucleation and growth dynamics of colloidal crystal films with single-particle resolution. We show quantitatively that colloidal epitaxy obeys the same two-dimensional island nucleation and growth laws that govern atomic epitaxy. However, we found that in colloidal epitaxy, step-edge and corner barriers that are responsible for film morphology have a diffusive origin. This diffusive mechanism suggests new routes toward controlling film morphology during epitaxy.	[Ganapathy, Rajesh; Buckley, Mark R.; Gerbode, Sharon J.; Cohen, Itai] Cornell Univ, Dept Phys, Ithaca, NY 14853 USA	Cornell University	Ganapathy, R (corresponding author), Jawaharlal Nehru Ctr Adv Sci Res, Int Ctr Mat Sci, Bangalore 560064, Karnataka, India.	rajeshg@jncasr.ac.in	Ganapathy, Rajesh/B-8657-2013	Buckley, Mark/0000-0002-6938-2110; Cohen, Itai/0000-0001-9218-043X	NSF Division of Materials Research; Cornell NanoScale Science and Technology Facility, King Abdullah University of Science and Technology (KAUST) [KUS-C1-018-02]	NSF Division of Materials Research(National Science Foundation (NSF)); Cornell NanoScale Science and Technology Facility, King Abdullah University of Science and Technology (KAUST)(King Abdullah University of Science & Technology)	We thank L. Ristroph, J. Savage, T. Arias, J. Machta, and A. Woll for useful discussions. We would like to especially thank J. Sethna for helping us set up the numerical calculations for residence times. This research was supported by grants from the NSF Division of Materials Research, the Cornell NanoScale Science and Technology Facility, and in part by award no. KUS-C1-018-02 from King Abdullah University of Science and Technology (KAUST).	Alsayed AM, 2005, SCIENCE, V309, P1207, DOI 10.1126/science.1112399; ASAKURA S, 1954, J CHEM PHYS, V22, P1255, DOI 10.1063/1.1740347; Barth JV, 2005, NATURE, V437, P671, DOI 10.1038/nature04166; Brune H, 1999, PHYS REV B, V60, P5991, DOI 10.1103/PhysRevB.60.5991; Brune H, 1998, SURF SCI REP, V31, P121, DOI 10.1016/S0167-5729(99)80001-6; Cheng ZD, 1999, NATURE, V401, P893, DOI 10.1038/44785; Dufresne ER, 1998, REV SCI INSTRUM, V69, P1974, DOI 10.1063/1.1148883; EHRLICH G, 1966, J CHEM PHYS, V44, P1039, DOI 10.1063/1.1726787; El-Shehawey MA, 2000, J PHYS A-MATH GEN, V33, P9005, DOI 10.1088/0305-4470/33/49/301; Evans JW, 2006, SURF SCI REP, V61, P1, DOI 10.1016/j.surfrep.2005.08.004; Hlawacek G, 2008, SCIENCE, V321, P108, DOI 10.1126/science.1159455; Hong L, 2006, LANGMUIR, V22, P9495, DOI 10.1021/la062716z; Leunissen ME, 2005, NATURE, V437, P235, DOI 10.1038/nature03946; LEWIS B, 1967, J VAC SCI TECHNOL, V4, P209, DOI 10.1116/1.1492548; Manoharan VN, 2003, SCIENCE, V301, P483, DOI 10.1126/science.1086189; Michely T., 2004, ISLANDS MOUNDS ATOMS, DOI [10.1007/978-3-642-18672-1, DOI 10.1007/978-3-642-18672-1]; Polya G., 1921, Math. Ann., V84, P149, DOI DOI 10.1007/BF01458701; Redner S, 2001, GUIDE 1 PASSAGE PROC; Savage JR, 2006, SCIENCE, V314, P795, DOI 10.1126/science.1128649; Schall P, 2006, NATURE, V440, P319, DOI 10.1038/nature04557; Schall P, 2004, SCIENCE, V305, P1944, DOI 10.1126/science.1102186; SCHWOEBEL RL, 1966, J APPL PHYS, V37, P3682, DOI 10.1063/1.1707904; Shevchenko EV, 2006, NATURE, V439, P55, DOI 10.1038/nature04414; Teichert C, 2002, PHYS REP, V365, P335, DOI 10.1016/S0370-1573(02)00009-1; vanBlaaderen A, 1997, NATURE, V385, P321, DOI 10.1038/385321a0; VENABLES JA, 1973, PHILOS MAG, V27, P697, DOI 10.1080/14786437308219242; Zhang ZY, 1997, SCIENCE, V276, P377, DOI 10.1126/science.276.5311.377	27	86	87	3	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 22	2010	327	5964					445	448		10.1126/science.1179947	http://dx.doi.org/10.1126/science.1179947			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546BS	20093469	Green Published, Green Submitted			2022-12-28	WOS:000273783100032
J	Shah, NR; Ogedegbe, G				Shah, Nirav R.; Ogedegbe, Gbenga			Review: First-line low-dose thiazides and ACE inhibitors reduce mortality and morbidity in adults with hypertension	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Shah, Nirav R.; Ogedegbe, Gbenga] NYU, Sch Med, New York, NY 10016 USA	New York University	Shah, NR (corresponding author), NYU, Sch Med, New York, NY 10016 USA.		Shah, Nirav R./B-6622-2008	Shah, Nirav R./0000-0003-2044-7865				Fretheim A, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-21; Fretheim A, 2003, BMC HEALTH SERV RES, V3, DOI 10.1186/1472-6963-3-18; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; Furmaga EM, 2008, J CLIN HYPERTENS, V10, P770, DOI 10.1111/j.1751-7176.2008.00019.x	4	2	2	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 19	2010	152	2							JC1-4	10.7326/0003-4819-152-2-201001190-02004	http://dx.doi.org/10.7326/0003-4819-152-2-201001190-02004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	548IE	20083819				2022-12-28	WOS:000273953000028
J	Gornall, J				Gornall, Jonathan			Medical Research A very public break-up	BRITISH MEDICAL JOURNAL			English	Editorial Material							PATENT FORAMEN OVALE; MIGRAINE INTERVENTION; DECOMPRESSION ILLNESS; CLOSURE; HEADACHE; DEVICE; TRIAL					Jgornall@mac.com						Carroll JD, 2008, CIRCULATION, V117, P1358, DOI 10.1161/CIRCULATIONAHA.107.758748; Carroll JD, 2009, CIRC-CARDIOVASC INTE, V2, P475, DOI 10.1161/CIRCINTERVENTIONS.109.860031; Dowson, 2009, CIRCULATION, V120, pE71, DOI 10.1161/CIRCULATIONAHA.109.192626; Dowson A, 2008, CIRCULATION, V117, P1397, DOI 10.1161/CIRCULATIONAHA.107.727271; HAGEN PT, 1984, MAYO CLIN PROC, V59, P17, DOI 10.1016/S0025-6196(12)60336-X; *HEALTHWATCH, HEALTHWATCH AW 2003; Nugent AW, 2006, J AM COLL CARDIOL, V48, P538, DOI 10.1016/j.jacc.2006.03.049; Reisman M, 2005, J AM COLL CARDIOL, V45, P493, DOI 10.1016/j.jacc.2004.10.055; Schwerzmann M, 2004, NEUROLOGY, V62, P1399, DOI 10.1212/01.WNL.0000120677.64217.A9; Wilmshurst P, 1996, LANCET, V348, P752, DOI 10.1016/S0140-6736(05)65638-3; Wilmshurst PT, 2000, LANCET, V356, P1648, DOI 10.1016/S0140-6736(00)03160-3; WILMSHURST PT, 1986, BRIT MED J, V293, P1277, DOI 10.1136/bmj.293.6557.1277	12	5	5	1	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 18	2010	340								c110	10.1136/bmj.c110	http://dx.doi.org/10.1136/bmj.c110			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	548HM	20083545				2022-12-28	WOS:000273951100002
J	Angamuthu, R; Byers, P; Lutz, M; Spek, AL; Bouwman, E				Angamuthu, Raja; Byers, Philip; Lutz, Martin; Spek, Anthony L.; Bouwman, Elisabeth			Electrocatalytic CO2 Conversion to Oxalate by a Copper Complex	SCIENCE			English	Article							CARBON-DIOXIDE; FIXATION; TRANSFORMATION; SPECTROSCOPY; REDUCTION; CATALYSIS; BINDING; ZINC	Global warming concern has dramatically increased interest in using CO2 as a feedstock for preparation of value-added compounds, thereby helping to reduce its atmospheric concentration. Here, we describe a dinuclear copper(I) complex that is oxidized in air by CO2 rather than O-2; the product is a tetranuclear copper(II) complex containing two bridging CO2-derived oxalate groups. Treatment of the copper(II) oxalate complex in acetonitrile with a soluble lithium salt results in quantitative precipitation of lithium oxalate. The copper(II) complex can then be nearly quantitatively electrochemically reduced at a relatively accessible potential, regenerating the initial dinuclear copper(I) compound. Preliminary results demonstrate six turnovers (producing 12 equivalents of oxalate) during 7 hours of catalysis at an applied potential of -0.03 volts versus the normal hydrogen electrode.	[Angamuthu, Raja; Byers, Philip; Bouwman, Elisabeth] Leiden Univ, Leiden Inst Chem, Gorlaeus Labs, NL-2300 RA Leiden, Netherlands; [Lutz, Martin; Spek, Anthony L.] Univ Utrecht, Bijvoet Ctr Biomol Res Crystal & Struct Chem, NL-3584 CH Utrecht, Netherlands	Leiden University; Leiden University - Excl LUMC; Utrecht University	Bouwman, E (corresponding author), Leiden Univ, Leiden Inst Chem, Gorlaeus Labs, POB 9502, NL-2300 RA Leiden, Netherlands.	bouwman@chem.leidenuniv.nl	Bouwman, Elisabeth/D-1637-2010; Angamuthu, Raja/W-4533-2019; Angamuthu, Raja/J-2060-2012	Bouwman, Elisabeth/0000-0001-7762-3968; Angamuthu, Raja/0000-0002-5152-0837	Leiden Institute of Chemistry; Council for the Chemical Sciences of The Netherlands Organization for Scientific Research (CW-NWO)	Leiden Institute of Chemistry; Council for the Chemical Sciences of The Netherlands Organization for Scientific Research (CW-NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Leiden Institute of Chemistry. X-ray crystallographic work was supported (M. L. and A. L. S.) by the Council for the Chemical Sciences of The Netherlands Organization for Scientific Research (CW-NWO). J. Reedijk and M. T. M. Koper are gratefully acknowledged for stimulating discussions. P. B. (Ithaca College, New York) was involved in the project through a summer exchange program. Crystallographic data for [2](BF<INF>4</INF>)<INF>4</INF> and [3](BF<INF>4</INF>)<INF>4</INF> have been deposited with the Cambridge Crystallographic Data Center under reference numbers 717726 and 717727.	AMATORE C, 1981, J AM CHEM SOC, V103, P5021, DOI 10.1021/ja00407a008; Angulo IM, 2001, EUR J INORG CHEM, P1465; Aresta M, 2007, DALTON T, P2975, DOI 10.1039/b700658f; Benson EE, 2009, CHEM SOC REV, V38, P89, DOI 10.1039/b804323j; Chen JM, 2007, CHEM-ASIAN J, V2, P710, DOI 10.1002/asia.200700042; Company A, 2007, INORG CHEM, V46, P9098, DOI 10.1021/ic700692t; Doyle RP, 2007, DALTON T, P5140, DOI 10.1039/b711655a; Garcia-Espana E, 2004, J AM CHEM SOC, V126, P5082, DOI 10.1021/ja039577h; Himmel HJ, 2007, EUR J INORG CHEM, P675, DOI 10.1002/ejic.200600840; Johansson R, 2005, ORGANOMETALLICS, V24, P4500, DOI 10.1021/om0505561; KUSHI Y, 1995, J CHEM SOC CHEM COMM, P1223, DOI 10.1039/c39950001223; Notni J, 2008, INORG CHEM, V47, P1382, DOI 10.1021/ic701899u; Reda T, 2008, P NATL ACAD SCI USA, V105, P10654, DOI 10.1073/pnas.0801290105; Sakakura T, 2007, CHEM REV, V107, P2365, DOI 10.1021/cr068357u; Sarkar B, 2008, INORG CHEM, V47, P2777, DOI 10.1021/ic702126k; Saveant JM, 2008, CHEM REV, V108, P2348, DOI 10.1021/cr068079z; Schrag DP, 2007, SCIENCE, V315, P812, DOI 10.1126/science.1137632; Song CS, 2006, CATAL TODAY, V115, P2, DOI 10.1016/j.cattod.2006.02.029; van Albada GA, 2002, INORG CHIM ACTA, V331, P208, DOI 10.1016/S0020-1693(01)00808-8; Verdejo B, 2006, INORG CHEM, V45, P3803, DOI 10.1021/ic060278d; Verdejo B, 2008, EUR J INORG CHEM, P84, DOI 10.1002/ejic.200700767; Youngme S, 2001, INORG CHIM ACTA, V324, P232, DOI 10.1016/S0020-1693(01)00610-7	22	413	437	14	563	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 15	2010	327	5963					313	315		10.1126/science.1177981	http://dx.doi.org/10.1126/science.1177981			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	544CM	20075248				2022-12-28	WOS:000273629700037
J	Vats, A; Vincent, CA; Nagpal, K; Davies, RW; Darzi, A; Moorthy, K				Vats, A.; Vincent, C. A.; Nagpal, K.; Davies, R. W.; Darzi, A.; Moorthy, K.			Practical challenges of introducing WHO surgical checklist: UK pilot experience	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Vincent, C. A.] Univ London Imperial Coll Sci Technol & Med, Acad Dept Surg, Clin Safety Res Unit, London W2 1NY, England; [Darzi, A.] Univ London Imperial Coll Sci Technol & Med, Acad Dept Surg, Div Surg, London W2 1NY, England	Imperial College London; Imperial College London		amit.vats@imperial.ac.uk	Vincent, Charles A/D-1134-2010	Vincent, Charles A/0000-0003-0270-0222; Moorthy, Krishna/0000-0001-8960-465X				[Anonymous], 1983, HDB HUMAN RELIABILIT; [Anonymous], NOT DO WHO SAF SURG; DEGANI A, 1993, HUM FACTORS, V35, P345, DOI 10.1177/001872089303500209; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; Lingard L, 2005, QUAL SAF HEALTH CARE, V14, P340, DOI 10.1136/qshc.2004.012377; McCulloch P, 2009, QUAL SAF HEALTH CARE, V18, P109, DOI 10.1136/qshc.2008.032045; National Patient Safety Agency, WHO SURG SAF CHECKL; National Patient Safety Agency, DO WHO SAF SURG CHEC; World Health Organization, SAF SURG SAV LIV	9	150	150	0	14	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 13	2010	340								b5433	10.1136/bmj.b5433	http://dx.doi.org/10.1136/bmj.b5433			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	545DA	20071413				2022-12-28	WOS:000273711500002
J	Samb, B				Samb, Badara			Reforming country health systems for women's health	LANCET			English	Editorial Material									WHO, Hlth Syst & Serv, CH-1211 Geneva, Switzerland	World Health Organization	Samb, B (corresponding author), WHO, Hlth Syst & Serv, CH-1211 Geneva, Switzerland.	sambb@who.int						[Anonymous], 2008, PRIM HLTH CAR NOW MO; Freedman LP, 2005, LANCET, V365, P997, DOI 10.1016/S0140-6736(05)71090-4; *HIGH LEV TASKF IN, 2009, INV OUR COMM FUT HLT; Kumar S, 2005, Indian J Public Health, V49, P45; Nanda P, 2002, REPROD HEALTH MATTER, V10, P127, DOI 10.1016/S0968-8080(02)00083-6; Samb B, 2009, LANCET, V373, P2137, DOI 10.1016/S0140-6736(09)60919-3; UN Millennium Project, 2005, WHOS GOT POW TRANSF; WHO, 2007, EV BUS STRENGTH HLTH; Wolfe CV, 2005, ARCH PHYS MED REHAB, V86, P1283, DOI 10.1016/j.apmr.2005.05.001; World Health Organization, 2009, WOMEN AND HEALTH: TODAY'S EVIDENCE TOMORROW'S AGENDA, P1; 2009, UN NEWS CTR     0915; 2009, THEWHITE HOUSE STATE	12	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN-FEB	2010	375	9712					354	355		10.1016/S0140-6736(10)60102-X	http://dx.doi.org/10.1016/S0140-6736(10)60102-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	552PK	20113811				2022-12-28	WOS:000274305500007
J	Saha, S; Coffman, DD; Smits, AK				Saha, Somnath; Coffman, Darren D.; Smits, Ariel K.			Giving Teeth to Comparative-Effectiveness Research - The Oregon Experience	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Saha, Somnath] Oregon Hlth & Sci Univ, Portland VA Med Ctr, Gen Internal Med Sect, Portland, OR 97201 USA; [Saha, Somnath] Oregon Hlth & Sci Univ, Div Gen Internal Med & Geriatr, Portland, OR 97201 USA; [Smits, Ariel K.] Oregon Hlth & Sci Univ, Dept Family Med, Portland, OR 97201 USA; [Saha, Somnath; Coffman, Darren D.; Smits, Ariel K.] Oregon Hlth Serv Commiss, Salem, OR USA	Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Saha, S (corresponding author), Oregon Hlth & Sci Univ, Portland VA Med Ctr, Gen Internal Med Sect, Portland, OR 97201 USA.							*DEP HUM SERV, 2009, ESS BEN PACK REC OR; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; *RAND CORP, 2009, AN COMP EFF; Schoen C, 2007, BENDING CURVE OPTION; Truog RD, 2009, NEW ENGL J MED, V361, P2501, DOI 10.1056/NEJMp0911447	5	13	13	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 18	2010	362	7								10.1056/NEJMp0912938	http://dx.doi.org/10.1056/NEJMp0912938			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	556ED	20130249				2022-12-28	WOS:000274571200004
J	Glasier, AF; Cameron, ST; Fine, PM; Logan, SJS; Casale, W; Van Horn, J; Sogor, L; Blithe, DL; Scherrer, B; Mathe, H; Jaspart, A; Ulmann, A; Gainer, E				Glasier, Anna F.; Cameron, Sharon T.; Fine, Paul M.; Logan, Susan J. S.; Casale, William; Van Horn, Jennifer; Sogor, Laszlo; Blithe, Diana L.; Scherrer, Bruno; Mathe, Henri; Jaspart, Amelie; Ulmann, Andre; Gainer, Erin			Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis	LANCET			English	Article							PROGESTERONE-RECEPTOR MODULATOR; INCREASED ACCESS; INTERCOURSE; PREGNANCY; WOMEN; MIFEPRISTONE; CONCEPTION; OVULATION; ABORTION; REGIMEN	Background Emergency contraception can prevent unintended pregnancies, but current methods are only effective if used as soon as possible after sexual intercourse and before ovulation. We compared the efficacy and safety of ulipristal acetate with levonorgestrel for emergency contraception. Methods Women with regular menstrual cycles who presented to a participating family planning clinic requesting emergency contraception within 5 days of unprotected sexual intercourse were eligible for enrolment in this randomised, multicentre, non-inferiority trial. 2221 women were randomly assigned to receive a single, supervised dose of 30 mg ulipristal acetate (n=1104) or 1.5 mg levonorgestrel (n=1117) orally. Allocation was by block randomisation stratified by Centre and time from unprotected sexual intercourse to treatment, with allocation concealment by identical opaque boxes labelled with a unique treatment number. participants were masked to treatment assignment whereas investigators were not. Follow-up was done 5-7 days after expected onset of next menses. The primary endpoint was pregnancy rate in women who received emergency contraception within 72 h of unprotected sexual intercourse, with a non-inferiority margin of 1% point difference between groups (limit of 1.6 for odds ratio). Analysis was done on the efficacy-evaluable population, which excluded women lost to follow-up, those aged over 35 years, women with unknown follow-up pregnancy status, and those who had re-enrolled in the study. Additionally, we undertook a meta-analysis of our trial and an earlier study to assess the efficacy of ulipristal acetate compared with levonorgestrel. This trial is registered with ClinicalTrials.gov, number NCT00551616. Findings In the efficacy-evaluable population, 1696 women received emergency contraception within 72 h of sexual intercourse (ulipristal acetate, n=844; levonorgestrel, n=852). There were 15 pregnancies in the ulipristal acetate group (1.8%, 95% CI 1.0-3.0) and 22 in the levonorgestrel group (2.6%, 1.7-3.9; odds ratio [OR] 0.68, 95% CI 0.35-1.31). In 203 women who received emergency contraception between 72 In and 120 h after sexual intercourse, there were three pregnancies, all of which were in the levonorgestrel group. The most frequent adverse event was headache (ulipristal acetate, 213 events [19.3%] in 1104 women; levonorgestrel, 211 events [18.9%] in 1117 women). Two serious adverse events were judged possibly related to use of emergency contraception; a case of dizziness in the ulipristal acetate group and a molar pregnancy in the levonorgestrel group. In the meta-analysis (0-72 h), there were 22 (1.4%) pregnancies in 1617 women in the ulipristal acetate group and 35 (2.2%) in 1625 women in the levonorgestrel group (OR 0.58, 0.33-0.99; p=0.046). Interpretation Ulipristal acetate provides women and health-care providers with an effective alternative for emergency contraception that can be used up to 5 days after unprotected sexual intercourse. Funding HRA Pharma.	[Glasier, Anna F.; Cameron, Sharon T.] Natl Hlth Serv Lothian, Edinburgh, Midlothian, Scotland; [Glasier, Anna F.; Cameron, Sharon T.] Univ Edinburgh, Dept Reprod & Dev Sci, Edinburgh, Midlothian, Scotland; [Fine, Paul M.] Planned Parenthood Houston & SE Texas, Houston, TX USA; [Logan, Susan J. S.] Natl Hlth Serv Grampian, Aberdeen, Scotland; [Casale, William] Palm Beach & Treasure Coast, Planned Parenthood Greater Miami, W Palm Beach, FL USA; [Van Horn, Jennifer] Planned Parenthood Assoc Utah, Salt Lake City, UT USA; [Sogor, Laszlo] Planned Parenthood NE Ohio, Akron, OH USA; [Blithe, Diana L.] NICHHD, Bethesda, MD 20892 USA; [Scherrer, Bruno] Bruno Scherrer Conseil, St Arnoult En Yvelines, France; [Mathe, Henri; Jaspart, Amelie; Ulmann, Andre; Gainer, Erin] HRA Pharma, Paris, France	University of Edinburgh; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Glasier, AF (corresponding author), NHS Lothian, Dean Terrace Ctr, Family Planning & Well Woman Serv, 18 Dean Terrace, Edinburgh EH4 1NL, Midlothian, Scotland.	Anna.Glasier@nhslothian.scot.nhs.uk			HRA Pharma	HRA Pharma	This study was funded by HRA Pharma.	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Cameron S, 2010, J FAM PLAN REPROD H, V36, P3, DOI 10.1783/147118910790290911; Cheng L, 2008, COCHRANE DB SYST REV, V2; Creinin MD, 2006, OBSTET GYNECOL, V108, P1089, DOI 10.1097/01.AOG.0000239440.02284.45; Croxatto H, 2009, 8 C EUR SOC GYN ROM; Croxatto HB, 2004, CONTRACEPTION, V70, P442, DOI 10.1016/j.contraception.2004.05.007; *EMEA, ICH TOP E 2 A CLIN S; *EUR MED AG, 2009, EMEAHC1027 EUR MED A; *FAC FAM PLANN REP, FFPRHC GUID APR 2006; *FDA, 1995, GUID DEV VAG CONTR D; FINE PM, OBSTET GYNE IN PRESS; Gardner JS, 2001, FAM PLANN PERSPECT, V33, P172, DOI 10.2307/2673721; Glasier A, 2004, CONTRACEPTION, V69, P361, DOI 10.1016/j.contraception.2004.01.002; Glasier A, 2008, J FAM PLAN REPROD H, V34, P213, DOI 10.1783/147118908786000497; Grimes D, 1998, LANCET, V352, P428; Lakha F, 2006, LANCET, V368, P1782, DOI 10.1016/S0140-6736(06)69737-7; Moreau C, 2005, CONTRACEPTION, V71, P202, DOI 10.1016/j.contraception.2004.09.004; Piaggio G, 1999, LANCET, V353, P721, DOI 10.1016/S0140-6736(98)05718-3; Polis CB, 2007, COCHRANE DB SYST REV, V2; Raymond E, 2004, CONTRACEPTION, V69, P79, DOI 10.1016/j.contraception.2003.09.013; Raymond EG, 2007, OBSTET GYNECOL, V109, P181, DOI 10.1097/01.AOG.0000250904.06923.4a; Raymond EG, 2006, OBSTET GYNECOL, V108, P1098, DOI 10.1097/01.AOG.0000235708.91572.db; Sitruk-Ware R, 2003, CONTRACEPTION, V68, P409, DOI 10.1016/S0010-7824(03)00171-9; Stirling A, 2002, CONTRACEPTION, V66, P19, DOI 10.1016/S0010-7824(02)00310-4; Stratton P, 2010, FERTIL STERIL, V93, P2035, DOI 10.1016/j.fertnstert.2008.12.057; TAYLOR T, 2006, 30 OFF NAT STAT; Trussell J, 1998, CONTRACEPTION, V57, P363, DOI 10.1016/S0010-7824(98)00042-0; Trussell J, 2003, CONTRACEPTION, V67, P259, DOI 10.1016/S0010-7824(02)00535-8; von Hertzen H, 1998, LANCET, V352, P1939, DOI 10.1016/S0140-6736(05)60440-0; von Hertzen H, 2002, LANCET, V360, P1803, DOI 10.1016/S0140-6736(02)11767-3; Wilcox AJ, 2004, HUM REPROD, V19, P1539, DOI 10.1093/humrep/deh305; WILCOX AJ, 1995, NEW ENGL J MED, V333, P1517, DOI 10.1056/NEJM199512073332301; Wilcox AJ, 2001, CONTRACEPTION, V63, P211, DOI 10.1016/S0010-7824(01)00191-3; Williams ARW, 2007, HUM REPROD, V22, P1696, DOI 10.1093/humrep/dem026	34	330	349	1	49	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 13	2010	375	9714					555	562		10.1016/S0140-6736(10)60101-8	http://dx.doi.org/10.1016/S0140-6736(10)60101-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	560YO	20116841				2022-12-28	WOS:000274941900029
J	Lin, YM; Dimitrakopoulos, C; Jenkins, KA; Farmer, DB; Chiu, HY; Grill, A; Avouris, P				Lin, Y. -M.; Dimitrakopoulos, C.; Jenkins, K. A.; Farmer, D. B.; Chiu, H. -Y.; Grill, A.; Avouris, Ph.			100-GHz Transistors from Wafer-Scale Epitaxial Graphene	SCIENCE			English	Article									[Lin, Y. -M.; Dimitrakopoulos, C.; Jenkins, K. A.; Farmer, D. B.; Chiu, H. -Y.; Grill, A.; Avouris, Ph.] IBM Corp, Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA	International Business Machines (IBM)	Lin, YM (corresponding author), IBM Corp, Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA.	yming@us.ibm.com; avouris@us.ibm.com		Chiu, Hsin-Ying/0000-0002-6753-3261; Avouris, Phaedon/0000-0001-9902-8000; Dimitrakopoulos, Christos/0000-0003-1059-3498				Farmer DB, 2009, NANO LETT, V9, P4474, DOI 10.1021/nl902788u; Lin YM, 2009, NANO LETT, V9, P422, DOI 10.1021/nl803316h; Meric I, 2008, INT EL DEVICES MEET, P513; Moon JS, 2009, IEEE ELECTR DEVICE L, V30, P650, DOI 10.1109/LED.2009.2020699	4	2067	2160	20	952	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2010	327	5966					662	662		10.1126/science.1184289	http://dx.doi.org/10.1126/science.1184289			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551ZD	20133565				2022-12-28	WOS:000274251800029
J	Cady, SD; Schmidt-Rohr, K; Wang, J; Soto, CS; DeGrado, WF; Hong, M				Cady, Sarah D.; Schmidt-Rohr, Klaus; Wang, Jun; Soto, Cinque S.; DeGrado, William F.; Hong, Mei			Structure of the amantadine binding site of influenza M2 proton channels in lipid bilayers	NATURE			English	Article							SOLID-STATE NMR; ANTIVIRAL DRUG AMANTADINE; SIDE-CHAIN CONFORMATION; SELECTIVE ION-CHANNEL; A VIRUS; TRANSMEMBRANE PEPTIDE; DISTANCE MEASUREMENTS; PROTEIN; INHIBITION; DOMAIN	The M2 protein of influenza A virus is a membrane-spanning tetrameric proton channel targeted by the antiviral drugs amantadine and rimantadine(1). Resistance to these drugs has compromised their effectiveness against many influenza strains, including pandemic H1N1. A recent crystal structure of M2(22-46) showed electron densities attributed to a single amantadine in the amino-terminal half of the pore(2), indicating a physical occlusion mechanism for inhibition. However, a solution NMR structure of M2(18-60) showed four rimantadines bound to the carboxy-terminal lipid-facing surface of the helices(3), suggesting an allosteric mechanism. Here we show by solid-state NMR spectroscopy that two amantadine-binding sites exist in M2 in phospholipid bilayers. The high-affinity site, occupied by a single amantadine, is located in the N-terminal channel lumen, surrounded by residues mutated in amantadine-resistant viruses. Quantification of the protein-amantadine distances resulted in a 0.3 angstrom-resolution structure of the high-affinity binding site. The second, low-affinity, site was observed on the C-terminal protein surface, but only when the drug reaches high concentrations in the bilayer. The orientation and dynamics of the drug are distinct in the two sites, as shown by H-2 NMR. These results indicate that amantadine physically occludes the M2 channel, thus paving the way for developing new antiviral drugs against influenza viruses. The study demonstrates the ability of solid-state NMR to elucidate small-molecule interactions with membrane proteins and determine high-resolution structures of their complexes.	[Cady, Sarah D.; Schmidt-Rohr, Klaus; Hong, Mei] Iowa State Univ, Dept Chem, Ames, IA 50011 USA; [Wang, Jun; Soto, Cinque S.; DeGrado, William F.] Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Wang, Jun; Soto, Cinque S.; DeGrado, William F.] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA	Iowa State University; University of Pennsylvania; University of Pennsylvania	Hong, M (corresponding author), Iowa State Univ, Dept Chem, Ames, IA 50011 USA.	mhong@iastate.edu	Cady, Sarah D./AAL-8810-2020; Wang, Jun/G-6504-2010	Cady, Sarah D./0000-0002-8310-7422; Wang, Jun/0000-0002-4845-4621; Hong, Mei/0000-0001-5255-5858	NSF [MCB-0543473]; NIH [GM088204, GM56423, AI74571]; Iowa State University Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI074571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056423, R01GM088204] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Iowa State University Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a NSF grant MCB-0543473 and an NIH grant GM088204 to M. H., the Iowa State University Foundation, and NIH grants GM56423 and AI74571 to W. F. D.	Cady SD, 2008, P NATL ACAD SCI USA, V105, P1483, DOI 10.1073/pnas.0711500105; Cady SD, 2009, BIOCHEMISTRY-US, V48, P7356, DOI 10.1021/bi9008837; Cady SD, 2009, J MOL BIOL, V385, P1127, DOI 10.1016/j.jmb.2008.11.022; Chen HN, 2007, BIOPHYS J, V93, P3470, DOI 10.1529/biophysj.107.105742; Cristian L, 2003, P NATL ACAD SCI USA, V100, P14772, DOI 10.1073/pnas.2536751100; GULLION T, 1989, J MAGN RESON, V81, P196, DOI 10.1016/0022-2364(89)90280-1; Gullion T, 2000, J MAGN RESON, V146, P220, DOI 10.1006/jmre.2000.2164; HOLSINGER LJ, 1994, J VIROL, V68, P1551, DOI 10.1128/JVI.68.3.1551-1563.1994; Hong M, 2009, J AM CHEM SOC, V131, P7806, DOI 10.1021/ja901550q; Hu J, 2007, BIOPHYS J, V92, P4335, DOI 10.1529/biophysj.106.090183; Hu J, 2007, BIOPHYS J, V93, P276, DOI 10.1529/biophysj.106.102103; Jaroniec CP, 2001, J AM CHEM SOC, V123, P3507, DOI 10.1021/ja003266e; Jing XH, 2008, P NATL ACAD SCI USA, V105, P10967, DOI 10.1073/pnas.0804958105; Li C, 2008, BIOPHYS J, V94, P1295, DOI 10.1529/biophysj.107.112482; Li C, 2007, BBA-BIOMEMBRANES, V1768, P3162, DOI 10.1016/j.bbamem.2007.08.025; Lin TI, 1997, J GEN VIROL, V78, P767, DOI 10.1099/0022-1317-78-4-767; Luo WB, 2007, J PHYS CHEM B, V111, P10825, DOI 10.1021/jp073823k; Luo W, 2006, J AM CHEM SOC, V128, P7242, DOI 10.1021/ja0603406; Luo WB, 2009, BIOCHEMISTRY-US, V48, P6361, DOI 10.1021/bi900716s; Ma CL, 2009, P NATL ACAD SCI USA, V106, P12283, DOI 10.1073/pnas.0905726106; Pinto LH, 2006, J BIOL CHEM, V281, P8997, DOI 10.1074/jbc.R500020200; Sack I, 1999, J MAGN RESON, V138, P54, DOI 10.1006/jmre.1999.1710; Salom D, 2000, BIOCHEMISTRY-US, V39, P14160, DOI 10.1021/bi001799u; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Stouffer AL, 2008, STRUCTURE, V16, P1067, DOI 10.1016/j.str.2008.04.011; Stouffer AL, 2008, NATURE, V451, P596, DOI 10.1038/nature06528; Tang YJ, 2002, J BIOL CHEM, V277, P39880, DOI 10.1074/jbc.M206582200; WANG C, 1993, J VIROL, V67, P5585, DOI 10.1128/JVI.67.9.5585-5594.1993; Wang J, 2009, J AM CHEM SOC, V131, P8066, DOI 10.1021/ja900063s; Yi M, 2008, J PHYS CHEM B, V112, P7977, DOI 10.1021/jp800171m	30	501	506	7	212	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 4	2010	463	7281					689	U127		10.1038/nature08722	http://dx.doi.org/10.1038/nature08722			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551GB	20130653	Green Accepted, Green Submitted			2022-12-28	WOS:000274193900042
J	Kappos, L; Radue, EW; O'Connor, P; Polman, C; Hohlfeld, R; Calabresi, P; Selmaj, K; Agoropoulou, C; Leyk, M; Zhang-Auberson, L; Burtin, P				Kappos, Ludwig; Radue, Ernst-Wilhelm; O'Connor, Paul; Polman, Chris; Hohlfeld, Reinhard; Calabresi, Peter; Selmaj, Krzysztof; Agoropoulou, Catherine; Leyk, Malgorzata; Zhang-Auberson, Lixin; Burtin, Pascale		FREEDOMS Study Grp	A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SPHINGOSINE 1-PHOSPHATE RECEPTORS; CENTRAL-NERVOUS-SYSTEM; PHASE-II EXTENSION; FTY720; AGONISTS; IMMUNE	BACKGROUND Oral fingolimod, a sphingosine-1-phosphate-receptor modulator that prevents the egress of lymphocytes from lymph nodes, significantly improved relapse rates and end points measured on magnetic resonance imaging (MRI), as compared with either placebo or intramuscular interferon beta-1a, in phase 2 and 3 studies of multiple sclerosis. METHODS In our 24-month, double-blind, randomized study, we enrolled patients who had relapsing-remitting multiple sclerosis, were 18 to 55 years of age, had a score of 0 to 5.5 on the Expanded Disability Status Scale ( which ranges from 0 to 10, with higher scores indicating greater disability), and had had one or more relapses in the previous year or two or more in the previous 2 years. Patients received oral fingolimod at a dose of 0.5 mg or 1.25 mg daily or placebo. End points included the annualized relapse rate ( the primary end point) and the time to disability progression ( a secondary end point). RESULTS A total of 1033 of the 1272 patients (81.2%) completed the study. The annualized relapse rate was 0.18 with 0.5 mg of fingolimod, 0.16 with 1.25 mg of fingolimod, and 0.40 with placebo (P<0.001 for either dose vs. placebo). Fingolimod at doses of 0.5 mg and 1.25 mg significantly reduced the risk of disability progression over the 24-month period (hazard ratio, 0.70 and 0.68, respectively; P = 0.02 vs. placebo, for both comparisons). The cumulative probability of disability progression (confirmed after 3 months) was 17.7% with 0.5 mg of fingolimod, 16.6% with 1.25 mg of fingolimod, and 24.1% with placebo. Both fingolimod doses were superior to placebo with regard to MRI-related measures (number of new or enlarged lesions on T(2)-weighted images, gadolinium-enhancing lesions, and brain-volume loss; P<0.001 for all comparisons at 24 months). Causes of study discontinuation and adverse events related to fingolimod included bradycardia and atrioventricular conduction block at the time of fingolimod initiation, macular edema, elevated liver-enzyme levels, and mild hypertension. CONCLUSIONS As compared with placebo, both doses of oral fingolimod improved the relapse rate, the risk of disability progression, and end points on MRI. These benefits will need to be weighed against possible long-term risks.	[Kappos, Ludwig] Univ Basel, Univ Hosp, Dept Neurol, CH-4031 Basel, Switzerland; [Kappos, Ludwig] Univ Basel, Univ Hosp, Dept Biomed, CH-4031 Basel, Switzerland; [Radue, Ernst-Wilhelm] Univ Basel, Univ Hosp, Med Image Anal Ctr, CH-4031 Basel, Switzerland; [Agoropoulou, Catherine; Leyk, Malgorzata; Zhang-Auberson, Lixin; Burtin, Pascale] Novartis Pharmaceut, Basel, Switzerland; [Polman, Chris] Free Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; [O'Connor, Paul] St Michaels Hosp, Toronto, ON M5B 1W8, Canada; [Hohlfeld, Reinhard] Inst Klin Neuroimmunol, Munich, Germany; [Calabresi, Peter] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA; [Selmaj, Krzysztof] Med Univ Lodz, Lodz, Poland	University of Basel; University of Basel; University of Basel; Novartis; Vrije Universiteit Amsterdam; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Johns Hopkins University; Johns Hopkins Medicine; Medical University Lodz	Kappos, L (corresponding author), Univ Basel, Univ Hosp, Dept Neurol, CH-4031 Basel, Switzerland.	lkappos@uhbs.ch	Kocaman, Ayse S/D-2363-2015; LICEND, CEMND/F-1296-2015; Zipp, Frauke/C-9968-2015; Pazdera, Ladislav/S-6779-2018; Kremenchutzky, Marcelo/B-6413-2015; Weissert, Robert/B-2585-2009; De Seze, Jerome/M-8316-2016; Kotov, Sergey V./E-4451-2017; Calabresi, Peter A./AAF-2288-2019; Dubois, Benedicte/A-4338-2019	Kocaman, Ayse S/0000-0002-5621-9453; Zipp, Frauke/0000-0002-1231-1928; Pazdera, Ladislav/0000-0003-0053-7003; Weissert, Robert/0000-0002-1295-1271; De Seze, Jerome/0000-0002-7197-7578; Kotov, Sergey V./0000-0002-8706-7317; Wiertlewki, Sandrine/0000-0002-8678-3661; Milo, Ron/0000-0001-8556-2579; Dubois, Benedicte/0000-0003-0604-8702; Sevim, Serhan/0000-0002-0518-3374; Airas, Laura/0000-0002-9751-5881; Wiendl, Heinz/0000-0003-4310-3432; Turcani, Peter/0000-0002-4868-6836; Lycke, Jan/0000-0002-7891-8466; Beran, Roy/0000-0002-5884-0606; Gugleta, Konstantin/0000-0002-3520-2791; Selmaj, Krzysztof/0000-0003-1213-7218	Novartis Pharma; Accorda; Actelion; Allergan; Allozyne; Bayer Schering; Biogen Idec; Biogen-Dompe; Boehringer Ingelheim; Genmab; GlaxoSmithKline; Medicinova; Merck Serono; Novartis; Roche; Sanofi Aventis; Santhera; Teva Pharmaceuticals; UCB Pharma; Wyeth; Helvea; Mediservice; CSL Behring; European Community; Genzyme; Novartis Foundation; Rubato Foundation; Antisense Therapeutics; Teva; Genetech; Vertex; Ono Pharma	Novartis Pharma; Accorda; Actelion; Allergan(AbbVieAllergan); Allozyne; Bayer Schering(Bayer AG); Biogen Idec(Biogen); Biogen-Dompe(Biogen); Boehringer Ingelheim(Boehringer Ingelheim); Genmab(Genmab); GlaxoSmithKline(GlaxoSmithKline); Medicinova; Merck Serono(Merck & Company); Novartis(Novartis); Roche(Roche Holding); Sanofi Aventis(Sanofi-Aventis); Santhera; Teva Pharmaceuticals(Teva Pharmaceutical Industries); UCB Pharma(UCB Pharma SA); Wyeth(Wyeth); Helvea; Mediservice; CSL Behring; European Community(European Commission); Genzyme(Sanofi-AventisGenzyme Corporation); Novartis Foundation(Novartis); Rubato Foundation; Antisense Therapeutics; Teva(Teva Pharmaceutical Industries); Genetech; Vertex(Vertex Pharmaceuticals); Ono Pharma	Supported by Novartis Pharma.; Financial and other disclosures provided by the authors are available with the full text of this article at NEJM.org. Dr. Kappos reports receiving consulting or advisory fees from Accorda, Actelion, Allergan, Allozyne, Bayer Schering, Biogen Idec, Biogen-Dompe, Boehringer Ingelheim, Genmab, GlaxoSmithKline, Medicinova, Merck Serono, Novartis, Roche, Sanofi Aventis, Santhera, Teva Pharmaceuticals, UCB Pharma, and Wyeth; lecture fees from Biogen Idec, Helvea, GlaxoSmithKline, Mediservice, and Merck Serono; and grant support from Bayer Schering, Biogen Idec, CSL Behring, the European Community Research Fund, Genmab, Genzyme, GlaxoSmithKline, Medicinova, Merck Serono, Novartis, Novartis Foundation, the Rubato Foundation, Roche, Santhera, Sanofi Aventis, and UCB Pharma; Dr. Radue, receiving consulting or advisory fees from Actelion, Biogen Idec, Novartis, and Merck Serono and lecture fees from Actelion and Merck Serono; Dr. O'Connor, receiving consulting or advisory fees and grant support from Novartis; Dr. Polman, receiving consulting or lecture fees from Actelion, Antisense Therapeutics, Biogen Idec, Bayer Schering, GlaxoSmithKline, Merck Serono, Novartis, Roche, Teva, and UCB Pharma and grant support from Bayer Schering, Biogen Idec, GlaxoSmithKline, Merck Serono, Novartis, Teva, and UCB Pharma; Dr. Hohlfeld, receiving consulting, advisory, or lecture fees from Bayer, Biogen Idec, Novartis, Sanofi Aventis, and Teva and grant support from Novartis; Dr. Calabresi, receiving consulting fees from Biogen Idec, Genetech, Merck Serono, Novartis, Teva, and Vertex; lecture fees from Novartis; and grant support from Bayer Schering, Biogen Idec, Genetech, Merck Serono, Teva, and Vertex; Dr. Selmaj, receiving advisory fees from Biogen Idec, Genzyme, Ono Pharma, and Novartis and lecture fees from Biogen Idec, Merck Serono, and Genzyme; and Drs Agoropoulou, Leyk, Zhang-Auderson and Burtin report being employees of Novartis Pharma. No other potential conflict of interest relevant to this article was reported. Financial and other disclosures provided by the authors are available with the full text of this article at NEJM.org.	Barkhof F, 2009, NAT REV NEUROL, V5, P256, DOI 10.1038/nrneurol.2009.41; Barske C, 2008, NEUROLOGY, V70, pA28; Bartholomaus I, 2009, NATURE, V462, P94, DOI 10.1038/nature08478; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brinkmann V, 2007, PHARMACOL THERAPEUT, V115, P84, DOI 10.1016/j.pharmthera.2007.04.006; Brinkmann V, 2009, BRIT J PHARMACOL, V158, P1173, DOI 10.1111/j.1476-5381.2009.00451.x; Coelho RP, 2007, J PHARMACOL EXP THER, V323, P626, DOI 10.1124/jpet.107.123927; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Foster CA, 2007, J PHARMACOL EXP THER, V323, P469, DOI 10.1124/jpet.107.127183; Jackson SJ, 2009, NEUROLOGY, V72, pA377; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kappos L, 2009, J NEUROL, V256, pS9; Kappos L, 2006, NEW ENGL J MED, V355, P1124, DOI 10.1056/NEJMoa052643; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Marsolais D, 2009, NAT REV DRUG DISCOV, V8, P297, DOI 10.1038/nrd2356; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Miron VE, 2008, ANN NEUROL, V63, P61, DOI 10.1002/ana.21227; *NAT MULT SCLER SO, ADM SCOR MAN MULT SC; *NEUR, 2006, NEUR TRAIN DOC DVD S; O'Connor P, 2009, NEUROLOGY, V72, P73, DOI 10.1212/01.wnl.0000338569.32367.3d; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Rudick RA, 2009, MULT SCLER J, V15, P984, DOI 10.1177/1352458509106212; Schmouder R, 2006, J CLIN PHARMACOL, V46, P895, DOI 10.1177/0091270006289853; US Dept of Health and Human Services (HHS) Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) Center for Veterinary Medicine (CVM), ICH HARM TRIP GUID G; *WORLD MED ASS, 2006, DECL HELS ETH PRINC	28	1868	1932	4	171	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 4	2010	362	5					387	401		10.1056/NEJMoa0909494	http://dx.doi.org/10.1056/NEJMoa0909494			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551FV	20089952	Green Published, Bronze			2022-12-28	WOS:000274193300005
J	Walters, RG; Jacquemont, S; Valsesia, A; de Smith, AJ; Martinet, D; Andersson, J; Falchi, M; Chen, F; Andrieux, J; Lobbens, S; Delobel, B; Stutzmann, F; Moustafa, JSES; Chevre, JC; Lecoeur, C; Vatin, V; Bouquillon, S; Buxton, JL; Boute, O; Holder-Espinasse, M; Cuisset, JM; Lemaitre, MP; Ambresin, AE; Brioschi, A; Gaillard, M; Giusti, V; Fellmann, F; Ferrarini, A; Hadjikhani, N; Campion, D; Guilmatre, A; Goldenberg, A; Calmels, N; Mandel, JL; Le Caignec, C; David, A; Isidor, B; Cordier, MP; Dupuis-Girod, S; Labalme, A; Sanlaville, D; Beri-Dexheimer, M; Jonveaux, P; Leheup, B; Ounap, K; Bochukova, EG; Henning, E; Keogh, J; Ellis, RJ; MacDermot, KD; van Haelst, MM; Vincent-Delorme, C; Plessis, G; Touraine, R; Philippe, A; Malan, V; Mathieu-Dramard, M; Chiesa, J; Blaumeiser, B; Kooy, RF; Caiazzo, R; Pigeyre, M; Balkau, B; Sladek, R; Bergmann, S; Mooser, V; Waterworth, D; Reymond, A; Vollenweider, P; Waeber, G; Kurg, A; Palta, P; Esko, T; Metspalu, A; Nelis, M; Elliott, P; Hartikainen, AL; McCarthy, MI; Peltonen, L; Carlsson, L; Jacobson, P; Sjostrom, L; Huang, N; Hurles, ME; O'Rahilly, S; Farooqi, IS; Mannik, K; Jarvelin, MR; Pattou, F; Meyre, D; Walley, AJ; Coin, LJM; Blakemore, AIF; Froguel, P; Beckmann, JS				Walters, R. G.; Jacquemont, S.; Valsesia, A.; de Smith, A. J.; Martinet, D.; Andersson, J.; Falchi, M.; Chen, F.; Andrieux, J.; Lobbens, S.; Delobel, B.; Stutzmann, F.; Moustafa, J. S. El-Sayed; Chevre, J. -C.; Lecoeur, C.; Vatin, V.; Bouquillon, S.; Buxton, J. L.; Boute, O.; Holder-Espinasse, M.; Cuisset, J. -M.; Lemaitre, M. -P.; Ambresin, A. -E.; Brioschi, A.; Gaillard, M.; Giusti, V.; Fellmann, F.; Ferrarini, A.; Hadjikhani, N.; Campion, D.; Guilmatre, A.; Goldenberg, A.; Calmels, N.; Mandel, J. -L.; Le Caignec, C.; David, A.; Isidor, B.; Cordier, M. -P.; Dupuis-Girod, S.; Labalme, A.; Sanlaville, D.; Beri-Dexheimer, M.; Jonveaux, P.; Leheup, B.; Ounap, K.; Bochukova, E. G.; Henning, E.; Keogh, J.; Ellis, R. J.; MacDermot, K. D.; van Haelst, M. M.; Vincent-Delorme, C.; Plessis, G.; Touraine, R.; Philippe, A.; Malan, V.; Mathieu-Dramard, M.; Chiesa, J.; Blaumeiser, B.; Kooy, R. F.; Caiazzo, R.; Pigeyre, M.; Balkau, B.; Sladek, R.; Bergmann, S.; Mooser, V.; Waterworth, D.; Reymond, A.; Vollenweider, P.; Waeber, G.; Kurg, A.; Palta, P.; Esko, T.; Metspalu, A.; Nelis, M.; Elliott, P.; Hartikainen, A. -L.; McCarthy, M. I.; Peltonen, L.; Carlsson, L.; Jacobson, P.; Sjostrom, L.; Huang, N.; Hurles, M. E.; O'Rahilly, S.; Farooqi, I. S.; Maennik, K.; Jarvelin, M. -R.; Pattou, F.; Meyre, D.; Walley, A. J.; Coin, L. J. M.; Blakemore, A. I. F.; Froguel, P.; Beckmann, J. S.			A new highly penetrant form of obesity due to deletions on chromosome 16p11.2	NATURE			English	Article							GENOME-WIDE ASSOCIATION; CIRCULAR BINARY SEGMENTATION; COPY NUMBER VARIATION; FRAMESHIFT MUTATION; RISK LOCI; MICRODELETION; AUTISM; SAMPLE; BIRTH; MC4R	Obesity has become a major worldwide challenge to public health, owing to an interaction between the Western 'obesogenic' environment and a strong genetic contribution(1). Recent extensive genome-wide association studies (GWASs) have identified numerous single nucleotide polymorphisms associated with obesity, but these loci together account for only a small fraction of the known heritable component(1). Thus, the 'common disease, common variant' hypothesis is increasingly coming under challenge(2). Here we report a highly penetrant form of obesity, initially observed in 31 subjects who were heterozygous for deletions of at least 593 kilobases at 16p11.2 and whose ascertainment included cognitive deficits. Nineteen similar deletions were identified from GWAS data in 16,053 individuals from eight European cohorts. These deletions were absent from healthy non-obese controls and accounted for 0.7% of our morbid obesity cases (body mass index (BMI) >= 40 kg m(-2) or BMI standard deviation score >= 4; P = 6.43 x 10(-8), odds ratio 43.0), demonstrating the potential importance in common disease of rare variants with strong effects. This highlights a promising strategy for identifying missing heritability in obesity and other complex traits: cohorts with extreme phenotypes are likely to be enriched for rare variants, thereby improving power for their discovery. Subsequent analysis of the loci so identified may well reveal additional rare variants that further contribute to the missing heritability, as recently reported for SIM1 (ref. 3). The most productive approach may therefore be to combine the 'power of the extreme'(4) in small, well-phenotyped cohorts, with targeted follow-up in case-control and population cohorts.	[Walters, R. G.; de Smith, A. J.; Andersson, J.; Falchi, M.; Moustafa, J. S. El-Sayed; Buxton, J. L.; Walley, A. J.; Blakemore, A. I. F.; Froguel, P.] Univ London Imperial Coll Sci Technol & Med, Sect Genom Med, London W12 0NN, England; [Walters, R. G.; Elliott, P.; Jarvelin, M. -R.; Coin, L. J. M.] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London W2 1PG, England; [Jacquemont, S.; Martinet, D.; Gaillard, M.; Fellmann, F.; Ferrarini, A.; Beckmann, J. S.] CHU Vaudois, Serv Genet Med, CH-1011 Lausanne, Switzerland; [Valsesia, A.; Bergmann, S.; Beckmann, J. S.] Univ Lausanne, Dept Med Genet, CH-1015 Lausanne, Switzerland; [Valsesia, A.] Univ Lausanne, Ludwig Inst Canc Res, CH-1015 Lausanne, Switzerland; [Valsesia, A.; Bergmann, S.] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Chen, F.; Hadjikhani, N.] Ecole Polytech Fed Lausanne, Brain Mind Inst, CH-1015 Lausanne, Switzerland; [Andrieux, J.; Bouquillon, S.] Ctr Hosp Reg Univ, Med Genet Lab, F-59000 Lille, France; [Lobbens, S.; Stutzmann, F.; Chevre, J. -C.; Lecoeur, C.; Vatin, V.; Meyre, D.; Froguel, P.] Inst Pasteur, Inst Biol 8090, CNRS, F-59800 Lille, France; [Delobel, B.] Hop St Vincent de Paul, Ctr Genet Chromosom, GHICL, F-59020 Lille, France; [Boute, O.; Holder-Espinasse, M.] CHU Lille, Serv Genet Clin, Hop Jeanne Flandre, F-59000 Lille, France; [Cuisset, J. -M.; Lemaitre, M. -P.] Ctr Hosp Reg Univ, Serv Neuropediat, F-59000 Lille, France; [Ambresin, A. -E.] CHU Vaudois, Unite Multidisciplinaire Sante Adolescents, CH-1011 Lausanne, Switzerland; [Brioschi, A.] CHU Vaudois, Serv Neuropsychol & Neurorehabil, CH-1011 Lausanne, Switzerland; [Giusti, V.] CHU Vaudois, Serv Endocrinol, CH-1011 Lausanne, Switzerland; [Hadjikhani, N.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA; [Campion, D.; Guilmatre, A.] Fac Med, INSERM, U614, F-76183 Rouen, France; [Goldenberg, A.] CHU Rouen, Serv Genet, F-76031 Rouen, France; [Calmels, N.; Mandel, J. -L.] Nouvel Hop Civil, Lab Diagnost Genet, F-67091 Strasbourg, France; [Le Caignec, C.; David, A.; Isidor, B.] CHU Nantes, Serv Genet Med, F-44093 Nantes, France; [Le Caignec, C.] Inst Thorax, UMR915, INSERM, F-44007 Nantes, France; [Cordier, M. -P.; Dupuis-Girod, S.; Labalme, A.; Sanlaville, D.] Hop Hotel Dieu, Hosp Civils Lyon, Serv Genet, F-69288 Lyon, France; [Sanlaville, D.] Univ Lyon 1, EA 4171, F-69622 Villeurbanne, France; [Beri-Dexheimer, M.; Jonveaux, P.; Leheup, B.] Nancy Univ, Ctr Hosp Univ, Genet Lab, F-54511 Vandoeuvre Les Nancy, France; [Leheup, B.] Univ Henri Poincare, Med Sch Nancy EA4368, F-54003 Nancy, France; [Ounap, K.] Univ Tartu, Childrens Hosp, United Labs, Dept Genet, EE-50406 Tartu, Estonia; [Bochukova, E. G.; Henning, E.; Keogh, J.; O'Rahilly, S.; Farooqi, I. S.] Univ Cambridge, Metab Res Labs, Inst Metab Sci, Addenbrookes Hosp, Cambridge CB2 0QQ, England; [Ellis, R. J.; MacDermot, K. D.; van Haelst, M. M.] Northwick Pk & St Marks Hosp, NW Thames Reg Genet Serv, Harrow HA1 3UJ, Middx, England; [Vincent-Delorme, C.] Ctr Hosp Arras, F-62000 Arras, France; [Plessis, G.] Ctr Hosp Univ Clemenceau, Serv Genet Med, F-14033 Caen, France; [Touraine, R.] Ctr Hosp Univ Hop Nord, Serv Genet, F-42055 St Etienne, France; [Philippe, A.; Malan, V.] Univ Paris 05, Hop Necker Enfants Malad, Dept Genet, F-75015 Paris, France; [Philippe, A.; Malan, V.] Univ Paris 05, Hop Necker Enfants Malad, INSERM, U781, F-75015 Paris, France; [Mathieu-Dramard, M.] Ctr Hosp Univ, Serv Genet Clin, F-80054 Amiens, France; [Chiesa, J.] Ctr Hosp Univ Caremeau, Lab Cytogenet, F-30029 Nimes, France; [Blaumeiser, B.; Kooy, R. F.] Univ Hosp & Univ Antwerp, Dept Med Genet, B-2650 Edegem, Belgium; [Caiazzo, R.; Pattou, F.] INSERM, U859, F-59045 Lille, France; [Caiazzo, R.; Pigeyre, M.; Pattou, F.] Univ Lille Nord France, CHU Lille, F-59037 Lille, France; [Balkau, B.] INSERM, U780, IFR69, F-94807 Villejuif, France; [Sladek, R.] McGill Univ, Montreal, PQ H3A 1A4, Canada; [Sladek, R.] Genome Quebec Innovat Ctr, Montreal, PQ H3A 1A4, Canada; [Sladek, R.] McGill Univ, Dept Med & Human Genet, Montreal, PQ H3A 1B1, Canada; [Mooser, V.; Waterworth, D.] GlaxoSmithKline, Div Genet, Philadelphia, PA 19101 USA; [Reymond, A.] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; [Vollenweider, P.; Waeber, G.] CHU Vaudois, Dept Med, CH-1011 Lausanne, Switzerland; [Kurg, A.; Palta, P.; Maennik, K.] Univ Tartu, Inst Mol & Cell Biol, EE-51010 Tartu, Estonia; [Esko, T.; Metspalu, A.; Nelis, M.] Univ Tartu, Estonian Genome Project, EE-50410 Tartu, Estonia; [Esko, T.; Metspalu, A.; Nelis, M.] Estonian Bioctr, EE-51010 Tartu, Estonia; [Hartikainen, A. -L.] Univ Oulu, Dept Obstet & Gynaecol, SF-90220 Oulu, Finland; [McCarthy, M. I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [McCarthy, M. I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Peltonen, L.; Huang, N.; Hurles, M. E.] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; [Peltonen, L.] Biomedicum, Inst Mol Med, Helsinki 00290, Finland; [Peltonen, L.] MIT, Broad Inst, Cambridge, MA 02142 USA; [Carlsson, L.; Jacobson, P.; Sjostrom, L.] Sahlgrens Acad, Dept Mol & Clin Med, S-41345 Gothenburg, Sweden; [Carlsson, L.; Jacobson, P.; Sjostrom, L.] Sahlgrens Acad, Ctr Cardiovasc & Metab Res, S-41345 Gothenburg, Sweden; [Jarvelin, M. -R.] Natl Publ Hlth Inst, Dept Child & Adolescent Hlth, Oulu 90101, Finland; [Jarvelin, M. -R.] Univ Oulu, Inst Hlth Sci, SF-90220 Oulu, Finland; [Jarvelin, M. -R.] Univ Oulu, Bioctr Oulu, SF-90220 Oulu, Finland	Imperial College London; Imperial College London; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Ludwig Institute for Cancer Research; University of Lausanne; Swiss Institute of Bioinformatics; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Universite de Lille - ISITE; CHU Lille; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Harvard University; Massachusetts General Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Rouen; CHU Strasbourg; Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU de Nancy; Universite de Lorraine; Universite de Lorraine; University of Tartu; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Imperial College London; CHU de Caen NORMANDIE; CHU de St Etienne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Universite de Montpellier; CHU de Nimes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); McGill University; McGill University; GlaxoSmithKline; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Tartu; University of Tartu; Estonian Biocentre; University of Oulu; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Wellcome Trust Sanger Institute; University of Helsinki; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Gothenburg; University of Gothenburg; Finland National Institute for Health & Welfare; University of Oulu; University of Oulu	Froguel, P (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sect Genom Med, London W12 0NN, England.	p.froguel@imperial.ac.uk; jacques.beckmann@chuv.ch	Kooy, Frank/F-5276-2014; Sanlaville, Damien/M-4716-2014; Sladek, Robert/R-2391-2019; Kurg, Ants/AAM-1292-2020; Isidor, Bertrand/AAJ-3456-2021; Farooqi, Ismaa Sadaf/AAZ-3046-2020; FROGUEL, Philippe/O-6799-2017; Coin, Lachlan JM/A-9001-2014; Colaus, PsyColaus/K-6607-2013; Nelis, Mari/ABG-7775-2020; Blakemore, Alexandra I F/D-2253-2009; Palta, Priit/W-2477-2019; Andersson-Assarsson, Johanna/M-2524-2019; Malan, Valerie/H-7423-2017; Kurg, Ants/J-2616-2015; O'Rahilly, Stephen/ABF-6509-2020; Caiazzo, Robert/D-1958-2013; Ounap, Katrin/Q-1103-2016; Philippe, Anne/E-5587-2017; Buxton, Jessica L/I-4033-2014; Touraine, Renaud/AAV-1605-2020; Chèvre, Jean-Claude/C-3943-2015; Walley, Andrew J/D-2573-2009; Hadjikhani, Nouchine/C-2018-2008; Coin, Lachlan/O-4976-2019; caiazzo, robert/Y-9692-2019; Isidor, Bertrand/L-2435-2015; Dupuis-Girod, Sophie/D-6268-2014; Meyre, David/D-7315-2011; Falchi, Mario/F-5956-2013; Le Caignec, Cedric/K-8467-2015; Jacquemont, Sebastien/AAS-5060-2021; Carlsson, Lena/F-7570-2018; Pattou, Francois/O-6151-2017; Walters, Robin G/E-6069-2010; Valsesia, Armand/F-1724-2010; Kutalik, Zoltan/HHZ-5697-2022; Beckmann, Jacques S/A-9772-2008; Buxton, Jessica/L-9849-2019; McCarthy, Mark/M-3763-2015; Mandel, Jean Louis/Q-2668-2016	Kooy, Frank/0000-0003-2024-0485; Sanlaville, Damien/0000-0001-9939-2849; Sladek, Robert/0000-0002-2730-1204; Kurg, Ants/0000-0002-0829-1987; Isidor, Bertrand/0000-0001-6480-126X; FROGUEL, Philippe/0000-0003-2972-0784; Coin, Lachlan JM/0000-0002-4300-455X; Nelis, Mari/0000-0001-9748-1020; Blakemore, Alexandra I F/0000-0003-0661-564X; Palta, Priit/0000-0001-9320-7008; Andersson-Assarsson, Johanna/0000-0001-9082-8589; Malan, Valerie/0000-0002-3450-4958; O'Rahilly, Stephen/0000-0003-2199-4449; Ounap, Katrin/0000-0002-4594-6364; Buxton, Jessica L/0000-0002-0918-9335; Chèvre, Jean-Claude/0000-0002-5329-5231; Walley, Andrew J/0000-0001-7707-7549; Hadjikhani, Nouchine/0000-0003-4075-3106; Coin, Lachlan/0000-0002-4300-455X; caiazzo, robert/0000-0001-5383-0540; Isidor, Bertrand/0000-0001-6480-126X; Meyre, David/0000-0003-4850-7444; Le Caignec, Cedric/0000-0002-0598-653X; Jacquemont, Sebastien/0000-0001-6838-8767; Carlsson, Lena/0000-0003-4145-6242; Pattou, Francois/0000-0001-8388-3766; Walters, Robin G/0000-0002-9179-0321; Kutalik, Zoltan/0000-0001-8285-7523; Beckmann, Jacques S/0000-0002-9741-1900; Waeber, Gerard/0000-0003-4193-788X; Farooqi, Sadaf/0000-0001-7609-3504; Bochukova, Elena/0000-0003-0275-1548; de Smith, Adam/0000-0003-4880-7543; Dupuis-Girod, Sophie/0000-0002-8834-5526; El-Sayed Moustafa, Julia Sarah/0000-0001-6963-6654; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Falchi, Mario/0000-0002-5646-1004; CALMELS, Nadege/0000-0001-8516-8184; Bergmann, Sven/0000-0002-6785-9034; Jacobson, Peter/0000-0002-1769-1827; PHILIPPE, Anne/0000-0001-8746-0576; Ambresin, Anne-emmanuelle/0000-0001-8386-4231; Valsesia, Armand/0000-0003-0746-9664; Fellmann, Florence/0000-0003-3156-4768; McCarthy, Mark/0000-0002-4393-0510; Pigeyre, Marie/0000-0003-2984-8366; Elliott, Paul/0000-0002-7511-5684; Reymond, Alexandre/0000-0003-1030-8327; CHEN, Fei/0000-0003-2077-3812; Mandel, Jean Louis/0000-0002-0535-6589	Wellcome Trust; Medical Research Council (MRC) [G0500539]; Swiss National Foundation [310000-112552, 33CSCO-122661]; RCUK; Swiss National Fund [320030_122674]; Synapsis Foundation; University of Lausanne; Ludwig Institute for Cancer Research; Swiss Institute of Bioinformatics; le Conseil Regional Nord Pas de Calais/FEDER; GlaxoSmithKline; Faculty of Biology and Medicine of Lausanne; Estonian Government [SF0180142s08]; EU; FP7 [201413 ENGAGE, 212111 BBMRI]; ECOGENE [205419]; Genome Canada; Genome Quebec; Swedish Research Council [K2008-65X-20753-01-4, K2007-55X-11285-13, 529-2002-6671]; Swedish Foundation for Strategic Research; Swedish Diabetes Foundation; Ake Wiberg Foundation; Foundations of the National Board of Health and Welfare; Jeansson Foundations; Magn Bergvall Foundation; Tore Nilson Foundation; Royal Physiographic Society; INNOVA-VINNMER; Swedish federal government; INSERM; CNAMTS; Lilly; Novartis Pharma; Sanofi-Aventis; Association Diabete Risque Vasculaire; Federation Francaise de Cardiologie; La Fondation de France; ALFEDIAM; ONIVINS; Ardix Medical, Bayer Diagnostics; Becton Dickinson; Cardionics; Merck Sante; Novo Nordisk; Pierre Fabre; Roche and Topcon; Academy of Finland [104781, 120315]; University Hospital Oulu; Biocenter, University of Oulu, Finland; European Commission [QLG1-CT-2000-01643]; NHLBI [5R01HL087679-02, 1RL1MH083268-01]; NIH/NIMH [5R01MH63706: 02]; ENGAGE [HEALTH-F4-2007-201413];  [SF0180026s09]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RL1MH083268, R01MH063706] Funding Source: NIH RePORTER; MRC [G0600331, G0900554] Funding Source: UKRI; Medical Research Council [G0600331, G0900554] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swiss National Foundation(Swiss National Science Foundation (SNSF)); RCUK(UK Research & Innovation (UKRI)); Swiss National Fund(Swiss National Science Foundation (SNSF)); Synapsis Foundation; University of Lausanne; Ludwig Institute for Cancer Research; Swiss Institute of Bioinformatics; le Conseil Regional Nord Pas de Calais/FEDER(Region Hauts-de-FranceEuropean Commission); GlaxoSmithKline(GlaxoSmithKline); Faculty of Biology and Medicine of Lausanne; Estonian Government; EU(European Commission); FP7; ECOGENE; Genome Canada(Genome Canada); Genome Quebec; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Diabetes Foundation; Ake Wiberg Foundation; Foundations of the National Board of Health and Welfare; Jeansson Foundations; Magn Bergvall Foundation; Tore Nilson Foundation; Royal Physiographic Society; INNOVA-VINNMER; Swedish federal government; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNAMTS; Lilly(Eli Lilly); Novartis Pharma; Sanofi-Aventis(Sanofi-Aventis); Association Diabete Risque Vasculaire; Federation Francaise de Cardiologie; La Fondation de France(Fondation de France); ALFEDIAM; ONIVINS; Ardix Medical, Bayer Diagnostics(Bayer AG); Becton Dickinson; Cardionics; Merck Sante; Novo Nordisk(Novo Nordisk); Pierre Fabre; Roche and Topcon; Academy of Finland(Academy of Finland); University Hospital Oulu; Biocenter, University of Oulu, Finland; European Commission(European CommissionEuropean Commission Joint Research Centre); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); ENGAGE; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	A.J.W., A. I. F. B. and P. F. are supported by grants from the Wellcome Trust and the Medical Research Council (MRC). J.S.B. is supported by a grant from the Swiss National Foundation (310000-112552). L.J.M.C. is supported by an RCUK Fellowship. S.J. is funded by Swiss National Fund 320030_122674 and the Synapsis Foundation, University of Lausanne. A. V. is funded by the Ludwig Institute for Cancer Research. S. B. is supported by the Swiss Institute of Bioinformatics. I. S. F. and M. E. H. are funded by the Wellcome Trust and the MRC. We thank the DHOS (Direction de l'Hospitalisation et de l'Organisation des Soins) from the French Ministry of Health for their support in the development of several array CGH platforms in France. We thank le Conseil Regional Nord Pas de Calais/FEDER' for their financial support. Part of the CoLaus computation was performed at the Vital-IT center for high-performance computing of the Swiss Institute of Bioinformatics. The CoLaus authors thank Y. Barreau, M. Firmann, V. Mayor, A.-L. Bastian, B. Ramic, M. Moranville, M. Baumer, M. Sagette, J. Ecoffey and S. Mermoud for data collection. The CoLaus study was supported by grants from GlaxoSmithKline, the Faculty of Biology and Medicine of Lausanne and by the Swiss National Foundation (33CSCO-122661). K. M., A. K., T. E., M.N. and A. M. received support from targeted financing from Estonian Government SF0180142s08, and P. P. from SF0180026s09; and from the EU through the European Regional Development Fund. T. E., M.N. and A. M. received support from FP7 grants (201413 ENGAGE, 212111 BBMRI, ECOGENE (no. 205419, EBC)). The genotyping of the Estonian Genome Project samples were performed in the Estonian Biocentre Genotyping Core Facility. The EGPUT authors thank V. Soo for technical help in genotyping. The Northwick Park authors acknowledge support from the NIHR Biomedical Research Centre Scheme and the Hammersmith Hospital Charity Trustees. Genome Canada and Genome Quebec funded the genotyping of DESIR subjects. Work on the SOS sib pair cohort was supported by grants from the Swedish Research Council (K2008-65X-20753-01-4, K2007-55X-11285-13, 529-2002-6671), the Swedish Foundation for Strategic Research to Sahlgrenska Center for Cardiovascular and Metabolic Research, the Swedish Diabetes Foundation, the Ake Wiberg Foundation, Foundations of the National Board of Health and Welfare, the Jeansson Foundations, the Magn Bergvall Foundation, the Tore Nilson Foundation, the Royal Physiographic Society (Nilsson-Ehle Foundation), VINNOVA-VINNMER, and the Swedish federal government under the LUA/ALF agreement. The DESIR study has been supported by INSERM, CNAMTS, Lilly, Novartis Pharma and Sanofi-Aventis, by INSERM (Reseaux en Sante Publique, Interactions entre les determinants de la sante), by the Association Diabete Risque Vasculaire, the Federation Francaise de Cardiologie, La Fondation de France, ALFEDIAM, ONIVINS, Ardix Medical, Bayer Diagnostics, Becton Dickinson, Cardionics, Merck Sante, Novo Nordisk, Pierre Fabre, Roche and Topcon. Northern Finland Birth Cohort 1966 (NFBC1966) was supported by the Academy of Finland (project grants 104781, 120315 and Center of Excellence in Complex Disease Genetics), University Hospital Oulu, Biocenter, University of Oulu, Finland, the European Commission (EURO-BLCS, Framework 5 award QLG1-CT-2000-01643), NHLBI grant 5R01HL087679-02 through the STAMPEED program (1RL1MH083268-01), NIH/NIMH (5R01MH63706: 02), the ENGAGE project and grant agreement HEALTH-F4-2007-201413, and the MRC (studentship grant G0500539).; The NFBC authors than P. Rantakallio for the launch of NFBC1966 and initial data collection, S. Vaara for data collection, T. Ylitalo for administration, M. Koiranen for data management, and O. Tornwall and M. Jussila for DNA biobanking.	Balkau B, 1997, DIABETES METAB, V23, P428; Bengtsson H, 2008, BIOINFORMATICS, V24, P759, DOI 10.1093/bioinformatics/btn016; Bengtsson H., 2008, 745 U CAL DEP STAT; Bengtsson H, 2009, BIOINFORMATICS, V25, P861, DOI 10.1093/bioinformatics/btp074; Bijlsma EK, 2009, EUR J MED GENET, V52, P77, DOI 10.1016/j.ejmg.2009.03.006; Boeka AG, 2008, ARCH CLIN NEUROPSYCH, V23, P467, DOI 10.1016/j.acn.2008.03.003; Chen AY, 2010, OBESITY, V18, P210, DOI 10.1038/oby.2009.185; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; CONRAD DF, 2009, NATURE          1007, DOI DOI 10.1038/NATURE08516; Farooqi IS, 2000, ARCH DIS CHILD, V83, P31, DOI 10.1136/adc.83.1.31; Fernandez BA, 2010, J MED GENET, V47, P195, DOI 10.1136/jmg.2009.069369; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Froguel P, 2008, NEW ENGL J MED, V359, P891, DOI 10.1056/NEJMp0805396; Ghebranious N, 2007, AM J MED GENET A, V143A, P1462, DOI 10.1002/ajmg.a.31837; Huang Jing, 2004, Human Genomics, V1, P287; Jernas M, 2009, BIOCHEM BIOPH RES CO, V383, P63, DOI 10.1016/j.bbrc.2009.03.120; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marioni JC, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r228; Marques-Vidal P, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-330; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Nelis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005472; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; POSKITT EME, 1995, ACTA PAEDIATR, V84, P961, DOI 10.1111/j.1651-2227.1995.tb13806.x; ROLLANDCACHERA MF, 1991, EUR J CLIN NUTR, V45, P13; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Shimojima K, 2009, EUR J MED GENET, V52, P433, DOI 10.1016/j.ejmg.2009.09.007; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Stutzmann F, 2009, DIABETOLOGIA, V52, pS104; Vaisse C, 1998, NAT GENET, V20, P113, DOI 10.1038/2407; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Walley AJ, 2009, NAT REV GENET, V10, P431, DOI 10.1038/nrg2594; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; Yeo GSH, 1998, NAT GENET, V20, P111, DOI 10.1038/2404	41	355	375	1	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 4	2010	463	7281					671	U104		10.1038/nature08727	http://dx.doi.org/10.1038/nature08727			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551GB	20130649	Green Accepted, Green Submitted			2022-12-28	WOS:000274193900038
J	Rosenbloom, J; Castro, SV; Jimenez, SA				Rosenbloom, Joel; Castro, Susan V.; Jimenez, Sergio A.			Narrative Review: Fibrotic Diseases: Cellular and Molecular Mechanisms and Novel Therapies	ANNALS OF INTERNAL MEDICINE			English	Review							GROWTH-FACTOR-BETA; IDIOPATHIC PULMONARY-FIBROSIS; FIBRONECTIN MESSENGER-RNAS; VERSUS-HOST-DISEASE; LATENT TGF-BETA; KINASE-C-DELTA; IMATINIB MESYLATE; SYSTEMIC-SCLEROSIS; GENE-EXPRESSION; ANGIOTENSIN-II	Abnormal and exaggerated deposition of extracellular matrix is the hallmark of many fibrotic diseases, including systemic sclerosis and pulmonary, liver, and kidney fibrosis. The spectrum of affected organs, the usually progressive nature of the fibrotic process, the large number of affected persons, and the absence of effective treatment pose an enormous challenge when treating fibrotic diseases. Delineation of the central role of transforming growth factor-beta (TGF-beta) and identification of the specific cellular receptors, kinases, and other mediators involved in the fibrotic process have provided a sound basis for development of effective therapies. The inhibition of signaling pathways activated by TGF-beta represents a novel therapeutic approach for the fibrotic disorders. One of these TGF-beta pathways results in the activation of the nonreceptor tyrosine kinase cellular Abelson (c-Abl), and c-Abl inhibitors, including imatinib mesylate, diminishing the fibrogenic effects of TGF-beta. Thus, recently acquired basic knowledge about the pathogenesis of the fibrotic process has enabled the development of novel therapeutic agents capable of modifying the deleterious effects of the fibrotic diseases.	[Jimenez, Sergio A.] Thomas Jefferson Univ, Jefferson Inst Mol Med, Philadelphia, PA 19107 USA	Jefferson University	Jimenez, SA (corresponding author), Thomas Jefferson Univ, Jefferson Inst Mol Med, 233 S 10th St,Room 509,Bluemle Life Sci Bldg, Philadelphia, PA 19107 USA.	sergio.jimenez@jefferson.edu		Jimenez, Sergio/0000-0001-5213-1203	National Institutes of Health [RO1 AR019616]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Grant Support: By the National Institutes of Health (grant RO1 AR019616; Dr. Jimenez).	Afshar K, 2008, CURR OPIN PULM MED, V14, P427, DOI 10.1097/MCP.0b013e3283043e58; Akhmetshina A, 2009, ARTHRITIS RHEUM-US, V60, P219, DOI 10.1002/art.24186; Antoniu Sabina A, 2006, Expert Opin Investig Drugs, V15, P823, DOI 10.1517/13543784.15.7.823; Aono Y, 2005, AM J RESP CRIT CARE, V171, P1279, DOI 10.1164/rccm.200404-531OC; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; BARTHOLOMEW LG, 1963, NEW ENGL J MED, V269, P8, DOI 10.1056/NEJM196307042690102; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Beham-Schmid C, 2002, BLOOD, V99, P381, DOI 10.1182/blood.V99.1.381; Bhattacharyya S, 2009, ONCOGENE, V28, P1285, DOI 10.1038/onc.2008.479; Bibi Y, 2008, J AM ACAD DERMATOL, V59, P654, DOI 10.1016/j.jaad.2008.04.034; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Brook NR, 2005, J SURG RES, V125, P137, DOI 10.1016/j.jss.2004.12.007; Budas GR, 2007, BIOCHEM SOC T, V35, P1021, DOI 10.1042/BST0351021; Bueso-Ramos CE, 2004, CANCER-AM CANCER SOC, V101, P332, DOI 10.1002/cncr.20380; Chandran S, 2009, AM J KIDNEY DIS, V53, P129, DOI 10.1053/j.ajkd.2008.08.029; Chen YG, 2009, CELL RES, V19, P58, DOI 10.1038/cr.2008.315; Churchill EN, 2009, TRENDS ENDOCRIN MET, V20, P25, DOI 10.1016/j.tem.2008.10.002; Cowper Shawn E, 2008, J Am Coll Radiol, V5, P23, DOI 10.1016/j.jacr.2007.08.013; Cowper SE, 2008, EUR J RADIOL, V66, P191, DOI 10.1016/j.ejrad.2008.01.016; Daniels CE, 2004, J CLIN INVEST, V114, P1308, DOI 10.1175/JCI200419603; Deacon SW, 2008, CHEM BIOL, V15, P322, DOI 10.1016/j.chembiol.2008.03.005; Del Gaido F, 2008, ARTHRITIS RHEUM-US, V58, P2854, DOI 10.1002/art.23791; Del Galdo F, 2008, CURR OPIN RHEUMATOL, V20, P713, DOI 10.1097/BOR.0b013e3283103d27; Denton CP, 2006, NAT CLIN PRACT RHEUM, V2, P134, DOI 10.1038/ncprheum0115; Denton CP, 2004, BEST PRACT RES CL RH, V18, P271, DOI 10.1016/j.berh.2004.03.001; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Ding HM, 2008, INT J CANCER, V123, P2931, DOI 10.1002/ijc.23895; Distler JHW, 2008, RHEUMATOLOGY, V47, pV10, DOI 10.1093/rheumatology/ken276; Distler JHW, 2009, RHEUMATOLOGY, V48, P2, DOI 10.1093/rheumatology/ken431; Distler JHW, 2007, ARTHRITIS RHEUM-US, V56, P311, DOI 10.1002/art.22314; Dong CM, 2002, P NATL ACAD SCI USA, V99, P3908, DOI 10.1073/pnas.062010399; Dosanjh A, 2002, PULM PHARMACOL THER, V15, P433, DOI 10.1006/pupt.2002.0367; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; EDWARDS DR, 1987, EMBO J, V6, P1899, DOI 10.1002/j.1460-2075.1987.tb02449.x; Garcia L, 2002, J HEPATOL, V37, P797, DOI 10.1016/S0168-8278(02)00272-6; Gharaee-Kermani M, 2005, CURR PHARM DESIGN, V11, P3943, DOI 10.2174/138161205774580561; GLEESON MH, 1970, P ROY SOC MED, V63, P1309, DOI 10.1177/003591577006301240; Goumans MJ, 2009, CELL RES, V19, P116, DOI 10.1038/cr.2008.326; Grobner T, 2007, KIDNEY INT, V72, P260, DOI 10.1038/sj.ki.5002338; Gross TJ, 2001, NEW ENGL J MED, V345, P517, DOI 10.1056/NEJMra003200; Hahm K, 2007, AM J PATHOL, V170, P110, DOI 10.2353/ajpath.2007.060158; Hasserjian RP, 2002, AM J CLIN PATHOL, V117, P360; Horan GS, 2008, AM J RESP CRIT CARE, V177, P56, DOI 10.1164/rccm.200706-805OC; IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337; IGNOTZ RA, 1987, J BIOL CHEM, V262, P6443; Itoh S, 2000, EUR J BIOCHEM, V267, P6954, DOI 10.1046/j.1432-1327.2000.01828.x; Iyer SN, 1999, J PHARMACOL EXP THER, V291, P367; Jimenez SA, 2001, J CLIN INVEST, V108, P1395, DOI 10.1172/JCI200112347; Jimenez SA, 2004, ANN INTERN MED, V140, P37, DOI 10.7326/0003-4819-140-1-200401060-00010; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kay J, 2008, ANN RHEUM DIS, V67, P66, DOI 10.1136/ard.2008.102475; Kay J, 2008, ARTHRITIS RHEUM, V58, P2543, DOI 10.1002/art.23696; Kheifets V, 2007, PHARMACOL RES, V55, P467, DOI 10.1016/j.phrs.2007.04.014; Kheifets V, 2006, J BIOL CHEM, V281, P23218, DOI 10.1074/jbc.M602075200; Kim Dong Soon, 2006, Proc Am Thorac Soc, V3, P285, DOI 10.1513/pats.200601-005TK; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Magro L, 2009, BLOOD, V114, P719, DOI 10.1182/blood-2009-02-204750; Maher TM, 2007, EUR RESPIR J, V30, P835, DOI 10.1183/09031936.00069307; Marshall RP, 2004, AM J PHYSIOL-LUNG C, V286, pL156, DOI 10.1152/ajplung.00313.2002; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; MCANULTY RJ, 1991, BIOCHIM BIOPHYS ACTA, V1091, P231, DOI 10.1016/0167-4889(91)90066-7; Medsger TA, 2003, RHEUM DIS CLIN N AM, V29, P255, DOI 10.1016/S0889-857X(03)00023-1; Mendoza FA, 2006, SEMIN ARTHRITIS RHEU, V35, P238, DOI 10.1016/j.semarthrit.2005.08.002; MIYAZONO K, 1991, EMBO J, V10, P1091, DOI 10.1002/j.1460-2075.1991.tb08049.x; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Moustakas A, 2001, J CELL SCI, V114, P4359; Murphy-Ullrich JE, 2000, CYTOKINE GROWTH F R, V11, P59, DOI 10.1016/S1359-6101(99)00029-5; Nainani N, 2009, AM J NEPHROL, V29, P1, DOI 10.1159/000149628; Naito T, 2004, AM J PHYSIOL-RENAL, V286, pF278, DOI 10.1152/ajprenal.00139.2003; Neild GH, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-23; Olivieri A, 2009, BLOOD, V114, P709, DOI 10.1182/blood-2009-02-204156; Pannu J, 2008, ARTHRITIS RHEUM-US, V58, P2528, DOI 10.1002/art.23698; Pannu J, 2006, ARTHRITIS RHEUM-US, V54, P3011, DOI 10.1002/art.22063; Prud'homme GJ, 2007, LAB INVEST, V87, P1077, DOI 10.1038/labinvest.3700669; Puthawala K, 2008, AM J RESP CRIT CARE, V177, P82, DOI 10.1164/rccm.200706-806OC; RAGHOW R, 1987, J CLIN INVEST, V79, P1285, DOI 10.1172/JCI112950; Rahimi RA, 2007, J CELL BIOCHEM, V102, P593, DOI 10.1002/jcb.21501; ROBERTS AB, 1986, P NATL ACAD SCI USA, V83, P4167, DOI 10.1073/pnas.83.12.4167; Rosenbloom J, 2008, ARTHRITIS RHEUM, V58, P2219, DOI 10.1002/art.23634; Ross S, 2008, INT J BIOCHEM CELL B, V40, P383, DOI 10.1016/j.biocel.2007.09.006; Schnaper HW, 2005, METH MOLEC MED, V117, P45; Schnaper HW, 2003, FRONT BIOSCI-LANDMRK, V8, pE68, DOI 10.2741/925; Sheppard D, 2005, CANCER METAST REV, V24, P395, DOI 10.1007/s10555-005-5131-6; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shigeki TA, 2006, CLIN CHIM ACTA, V364, P33, DOI 10.1016/j.cca.2005.06.014; Shihab FS, 2002, AM J TRANSPLANT, V2, P111, DOI 10.1034/j.1600-6143.2002.020201.x; Shimizu T, 1998, KIDNEY INT, V54, P99, DOI 10.1046/j.1523-1755.1998.00962.x; TAIPALE J, 1994, J CELL BIOL, V124, P171, DOI 10.1083/jcb.124.1.171; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Thomsen HS, 2008, MAGN RESON IMAGING C, V16, P551, DOI 10.1016/j.mric.2008.07.011; Tower CL, 2005, MOL HUM REPROD, V11, P847, DOI 10.1093/molehr/gah242; Trojanowska M, 2007, CURR OPIN RHEUMATOL, V19, P568, DOI 10.1097/BOR.0b013e3282e6f495; Tseng PH, 2005, BLOOD, V105, P4021, DOI 10.1182/blood-2004-07-2967; VANOBBERGHENSCHILLING E, 1988, J BIOL CHEM, V263, P7741; VARGA J, 1987, BIOCHEM J, V247, P597, DOI 10.1042/bj2470597; Varga J, 2002, ARTHRITIS RHEUM-US, V46, P1703, DOI 10.1002/art.10413; Varga J, 2007, J CLIN INVEST, V117, P557, DOI 10.1172/JCI31139; Varga J, 2008, BULL HOSP JT DIS, V66, P198; Verma S, 2007, NEW ENGL J MED, V356, P1370, DOI 10.1056/NEJMcibr070490; Viaud J, 2009, MOL CANCER THER, V8, P2559, DOI 10.1158/1535-7163.MCT-09-0102; Vittal R, 2007, J PHARMACOL EXP THER, V321, P35, DOI 10.1124/jpet.106.113407; Vuorinen K, 2007, EXP LUNG RES, V33, P357, DOI 10.1080/01902140701634827; Wang SN, 2005, FASEB J, V19, P1, DOI 10.1096/fj.04-2370com; Wang XM, 2006, J EXP MED, V203, P2895, DOI 10.1084/jem.20061536; White JML, 2007, BRIT J DERMATOL, V156, P1032, DOI 10.1111/j.1365-2133.2007.07827.x; Wilkes MC, 2006, J BIOL CHEM, V281, P27846, DOI 10.1074/jbc.M603721200; Wilson MS, 2009, MUCOSAL IMMUNOL, V2, P103, DOI 10.1038/mi.2008.85; Wipff PJ, 2008, EUR J CELL BIOL, V87, P601, DOI 10.1016/j.ejcb.2008.01.012; Wolf G, 2006, KIDNEY INT, V70, P1914, DOI 10.1038/sj.ki.5001846; Wolf G, 1998, NEPHROLOGIE, V19, P451; Yoshiji H, 2005, AM J PHYSIOL-GASTR L, V288, pG907, DOI 10.1152/ajpgi.00420.2004; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zhu JX, 2004, CANCER RES, V64, P4309, DOI 10.1158/0008-5472.CAN-03-4063; Zisman DA, 2005, METH MOLEC MED, V117, P3	117	170	181	1	23	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 2	2010	152	3					159	U8		10.7326/0003-4819-152-3-201002020-00007	http://dx.doi.org/10.7326/0003-4819-152-3-201002020-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	552WN	20124232				2022-12-28	WOS:000274324600004
J	Sterry, W; Ortonne, JP; Kirkham, B; Brocq, O; Robertson, D; Pedersen, RD; Estojak, J; Molta, CT; Freundlich, B				Sterry, Wolfram; Ortonne, Jean-Paul; Kirkham, Bruce; Brocq, Olivier; Robertson, Deborah; Pedersen, Ronald D.; Estojak, Joanne; Molta, Charles T.; Freundlich, Bruce			Comparison of two etanercept regimens for treatment of psoriasis and psoriatic arthritis: PRESTA randomised double blind multicentre trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							50 MG; MANAGEMENT; GUIDELINES; INFLIXIMAB; SEVERITY; BENEFITS; EFFICACY; THERAPY; SAFETY; CARE	Objectives To compare the efficacy over 12 weeks of two different etanercept regimens in treating the skin manifestations of psoriasis in patients who also have psoriatic arthritis and to evaluate efficacy and safety over an additional 12 weeks of open label etanercept treatment. Design Randomised double blind multicentre outpatient study. Setting 98 outpatient facilities in Europe, Latin America, and the Asia Pacific region. Participants 752 patients with both psoriasis (evaluated by dermatologists) and psoriatic arthritis (evaluated by rheumatologists). Interventions During the blinded portion of the study, participants were randomised to receive etanercept 50 mg twice weekly (n=379) or 50 mg once weekly (n=373) for 12 weeks by subcutaneous injection. All participants then received open label etanercept 50 mg once weekly for 12 additional weeks, while remaining blinded to the regimen. Main outcome measures The primary efficacy end point was the proportion of participants achieving "clear" or "almost clear" on the physician's global assessment of psoriasis at week 12. Secondary efficacy analyses included psoriasis area and severity index, American College of Rheumatology responses, psoriatic arthritis response criteria, and improvement in joint and tendon disease manifestations. Results At week 12, 46% (176/379) of participants receiving etanercept 50 mg twice weekly achieved a physician's global assessment of psoriasis of "clear" or "almost clear" compared with 32% (119/373) in the group treated with 50 mg once weekly (P<0.001). In contrast, an equally high percentage of participants in both groups achieved psoriatic arthritis response criteria (77% (284/371) in the twice weekly/once weekly group versus 76% (282/371) in the once weekly/once weekly group). Participants treated with 50 mg twice weekly/once weekly had greater mean reductions from baseline in the psoriasis area and severity index at week 12 compared with those who received 50 mg once weekly/once weekly (71% v 62%, P<0.001), with less difference at week 24 (78% v 74%, P<0.110). Joint and tendon disease manifestations improved from baseline in both groups to a similar extent. No new safety signals were seen in either etanercept treatment group, and no significant difference in the safety profiles was observed. Conclusions In participants with active psoriasis and psoriatic arthritis, initial treatment of the psoriasis with etanercept 50 mg twice weekly may allow for more rapid clearance of skin lesions than with 50 mg once weekly. A regimen of 50 mg once weekly seems to be appropriate for treatment of joint and tendon rheumatic symptoms. The choice of regimen should be determined by the clinical needs of the individual patient.	[Sterry, Wolfram] Charite, Dept Dermatol & Allergy, D-10117 Berlin, Germany; [Ortonne, Jean-Paul] Hop Archet, Dept Dermatol, Nice, France; [Kirkham, Bruce] GStT, NIHR Biomed Res Ctr, Guys & St Thomas NHS Fdn Trust, Dept Rheumatol, London, England; [Brocq, Olivier] Princesse Grace Hosp, Monaco, Monaco; [Molta, Charles T.] Pfizer Inc, Dept Inflammat, Collegeville, PA USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; CHU Nice; Guy's & St Thomas' NHS Foundation Trust; Pfizer	Sterry, W (corresponding author), Charite, Dept Dermatol & Allergy, D-10117 Berlin, Germany.	wolfram.sterry@charite.de			Pfizer; Wyeth; Abbott; Schering-Plough; Janssen-Cilag; Merck-Serono; Centocor; MedPharma; Laboratorios Pierre-Fabre; Galderma Laboratories; Leo Pharma; Roche; Bristol-Myers Squibb; Chugai	Pfizer(Pfizer); Wyeth(Wyeth); Abbott(Abbott Laboratories); Schering-Plough(Merck & CompanySchering Plough Corporation); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck-Serono(Merck & Company); Centocor; MedPharma; Laboratorios Pierre-Fabre; Galderma Laboratories; Leo Pharma(LEO Pharma); Roche(Roche Holding); Bristol-Myers Squibb(Bristol-Myers Squibb); Chugai	Wyeth Research, which was acquired by Pfizer in October 2009, sponsored this clinical trial and was responsible for the collection and analysis of data. The authors and the sponsor were involved in the study design, interpretation of data, manuscript preparation, and decision to publish. All statistical analyses were done by the Global Biostatistics and Programming Department of Wyeth Research.; Competing interests: WS has received fees for speaking/consulting from Abbott, Schering-Plough, Wyeth, and Janssen-Cilag. J-PO has received fees for speaking/conferences/consulting from Schering-Plough, Abbott, Merck-Serono, Centocor, Wyeth, Janssen-Cilag, MedPharma, Laboratorios Pierre-Fabre, Galderma Laboratories, and Leo Pharma. BK has served on advisory boards for Schering-Plough and Roche; has received funds for research/travel/conferences from Wyeth, Centocor, Abbott, Schering-Plough, Roche, and Bristol-Myers Squibb; and has served on a speaker panel for Bristol-Myers Squibb. OB has received fees from Wyeth, Schering-Plough, Abbott, Roche, Chugai, and Bristol-Myers Squibb. DR, RDP, JE, CM, and BF are all employees of Pfizer.	*AMG INC WYETH PHA, 2008, ENBR ET PRESCR INF; Antoni CE, 2005, ARTHRITIS RHEUM, V52, P1227, DOI 10.1002/art.20967; Ashcroft DM, 1999, BRIT J DERMATOL, V141, P185; Clegg DO, 1996, ARTHRITIS RHEUM, V39, P2013, DOI 10.1002/art.1780391210; Driessen RJB, 2009, BRIT J DERMATOL, V160, P670, DOI 10.1111/j.1365-2133.2008.09019.x; Feldman SR, 2005, ANN RHEUM DIS, V64, P65, DOI 10.1136/ard.2004.031237; FELSON DT, 1993, ARTHRITIS RHEUM-US, V36, P729, DOI 10.1002/art.1780360601; FERNANDEZSUEIRO JL, 2007, ANN RHEUM DIS S, V66, P99; Feuchtenberger M, 2008, CLIN DERMATOL, V26, P460, DOI 10.1016/j.clindermatol.2007.11.005; Finlay AY, 2005, BRIT J DERMATOL, V152, P861, DOI 10.1111/j.1365-2133.2005.06502.x; FREDRIKSSON T, 1978, DERMATOLOGICA, V157, P238, DOI 10.1159/000250839; Gladman Dafna D, 2004, Dermatol Ther, V17, P350, DOI 10.1111/j.1396-0296.2004.04038.x; Gottlieb A, 2008, J AM ACAD DERMATOL, V58, P851, DOI 10.1016/j.jaad.2008.02.040; Gottlieb AB, 2008, J DERMATOL TREAT, V19, P5, DOI 10.1080/09546630701364768; Kwoh CK, 2002, ARTHRITIS RHEUM-US, V46, P328; Langley RG, 2004, J AM ACAD DERMATOL, V51, P563, DOI 10.1016/j.jaad.2004.04.012; Mease Philip, 2006, Curr Rheumatol Rep, V8, P348, DOI 10.1007/s11926-006-0064-9; Mease PJ, 2004, ARTHRITIS RHEUM-US, V50, P2264, DOI 10.1002/art.20335; Mease PJ, 2000, LANCET, V356, P385, DOI 10.1016/S0140-6736(00)02530-7; Menter A, 2008, J AM ACAD DERMATOL, V58, P826, DOI 10.1016/j.jaad.2008.02.039; Ortonne JP, 2008, EXP REV DERM, V3, P657, DOI 10.1586/17469872.3.6.657; Ritchlin CT, 2009, ANN RHEUM DIS, V68, P1387, DOI 10.1136/ard.2008.094946; Saad AA, 2008, J RHEUMATOL, V35, P883; Tyring S, 2007, ARCH DERMATOL, V143, P719, DOI 10.1001/archderm.143.6.719; van de Kerkhof PCM, 2008, BRIT J DERMATOL, V159, P1177, DOI 10.1111/j.1365-2133.2008.08771.x; Vergel YB, 2007, RHEUMATOLOGY, V46, P1729, DOI 10.1093/rheumatology/kem221	26	166	170	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 2	2010	340								c147	10.1136/bmj.c147	http://dx.doi.org/10.1136/bmj.c147			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	553CU	20124563	hybrid			2022-12-28	WOS:000274343400008
J	Boilard, E; Nigrovic, PA; Larabee, K; Watts, GFM; Coblyn, JS; Weinblatt, ME; Massarotti, EM; Remold-O'Donnell, E; Farndale, RW; Ware, J; Lee, DM				Boilard, Eric; Nigrovic, Peter A.; Larabee, Katherine; Watts, Gerald F. M.; Coblyn, Jonathan S.; Weinblatt, Michael E.; Massarotti, Elena M.; Remold-O'Donnell, Eileen; Farndale, Richard W.; Ware, Jerry; Lee, David M.			Platelets Amplify Inflammation in Arthritis via Collagen-Dependent Microparticle Production	SCIENCE			English	Article							RHEUMATOID-ARTHRITIS; GLYCOPROTEIN-VI; ACTIVATION; DISEASE; COMPLEXES; MECHANISM; RECEPTOR; PLASMA; CHAIN	In addition to their pivotal role in thrombosis and wound repair, platelets participate in inflammatory responses. We investigated the role of platelets in the autoimmune disease rheumatoid arthritis. We identified platelet microparticles-submicrometer vesicles elaborated by activated platelets-in joint fluid from patients with rheumatoid arthritis and other forms of inflammatory arthritis, but not in joint fluid from patients with osteoarthritis. Platelet microparticles were proinflammatory, eliciting cytokine responses from synovial fibroblasts via interleukin-1. Consistent with these findings, depletion of platelets attenuated murine inflammatory arthritis. Using both pharmacologic and genetic approaches, we identified the collagen receptor glycoprotein VI as a key trigger for platelet microparticle generation in arthritis pathophysiology. Thus, these findings demonstrate a previously unappreciated role for platelets and their activation-induced microparticles in inflammatory joint diseases.	[Boilard, Eric; Nigrovic, Peter A.; Larabee, Katherine; Watts, Gerald F. M.; Coblyn, Jonathan S.; Weinblatt, Michael E.; Massarotti, Elena M.; Lee, David M.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Nigrovic, Peter A.] Childrens Hosp Boston, Div Immunol, Boston, MA 02115 USA; [Remold-O'Donnell, Eileen] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Farndale, Richard W.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Ware, Jerry] Univ Arkansas Med Sci, Little Rock, AR 72205 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; University of Cambridge; University of Arkansas System; University of Arkansas Medical Sciences	Lee, DM (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA.	dlee@rics.bwh.harvard.edu		Watts, Gerald/0000-0003-2276-1524	NIH [P01 AI065858, K08AR051321, HL091269]; Arthritis Foundation; Cogan Family Foundation; British Heart Foundation and Medical Research Council, UK; National Heart, Lung, and Blood Institute [HL50545]; MRC [G0500707] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL091269, R01HL050545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI065858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR051321] Funding Source: NIH RePORTER; British Heart Foundation [RG/09/003/27122] Funding Source: researchfish; Medical Research Council [G0500707] Funding Source: researchfish	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Foundation; Cogan Family Foundation; British Heart Foundation and Medical Research Council, UK; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Financial support for this work was provided by NIH grant P01 AI065858, an Arthritis Foundation Investigator Award, and the Cogan Family Foundation (D. M. L.); an Arthritis Foundation Postdoctoral Fellowship Award (E. B.); NIH grants K08AR051321 (P. A. N.) and HL091269 (E. R.-O.); the British Heart Foundation and Medical Research Council, UK (R. W. F.); and National Heart, Lung, and Blood Institute grant HL50545 (J. W.). D. M. L., E. B., and J. W. have filed a provisional patent application for glycoprotein VI as a target for treatment for inflammatory arthritis.	Berckmans RJ, 2002, ARTHRITIS RHEUM-US, V46, P2857, DOI 10.1002/art.10587; Binstadt BA, 2006, NAT IMMUNOL, V7, P284, DOI 10.1038/ni1306; Chen M, 2008, ARTHRITIS RHEUM, V58, P1354, DOI 10.1002/art.23453; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; FARR M, 1983, ANN RHEUM DIS, V42, P545, DOI 10.1136/ard.42.5.545; GARTNER LP, 2006, BRS CELL BIOL HISTOL; George JN, 2000, LANCET, V355, P1531, DOI 10.1016/S0140-6736(00)02175-9; GINSBERG MH, 1978, ARTHRITIS RHEUM, V21, P994, DOI 10.1002/art.1780210825; Helmick CG, 2008, ARTHRITIS RHEUM-US, V58, P15, DOI 10.1002/art.23177; Iannacone M, 2005, NAT MED, V11, P1167, DOI 10.1038/nm1317; Joseph JE, 2001, BRIT J HAEMATOL, V115, P451, DOI 10.1046/j.1365-2141.2001.03101.x; Knijff-Dutmer EAJ, 2002, ARTHRITIS RHEUM-US, V46, P1498, DOI 10.1002/art.10312; Kyburz D, 2003, SPRINGER SEMIN IMMUN, V25, P79, DOI 10.1007/s00281-003-0131-5; Lee DM, 2007, SCIENCE, V315, P1006, DOI 10.1126/science.1137306; Lee DM, 2001, LANCET, V358, P903, DOI 10.1016/S0140-6736(01)06075-5; LEE DM, 2004, KELLEY TXB RHEUMATOL, P175; LEVENE RB, 1986, BLOOD, V67, P207; Lindemann S, 2001, J CELL BIOL, V154, P485, DOI 10.1083/jcb.200105058; Mertens M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005121.pub3; Moroi M, 2004, THROMB RES, V114, P221, DOI 10.1016/j.thromres.2004.06.046; Nieswandt B, 2000, J BIOL CHEM, V275, P23998, DOI 10.1074/jbc.M003803200; Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882; Pastakia KB, 1996, J CLIN PATHOL-CL MOL, V49, pM17; Perez-Pujol S, 2007, CYTOM PART A, V71A, P38, DOI 10.1002/cyto.a.20354; Poduval P, 2007, ARTHRITIS RHEUM, V56, P3959, DOI 10.1002/art.23072; SCHUMACHER H R JR, 1975, Annals of Clinical and Laboratory Science, V5, P489; Shin K, 2009, J IMMUNOL, V182, P647, DOI 10.4049/jimmunol.182.1.647; Smethurst PA, 2007, J BIOL CHEM, V282, P1296, DOI 10.1074/jbc.M606479200; THIAGARAJAN P, 1991, J BIOL CHEM, V266, P24302; Valant PA, 1998, BRIT J HAEMATOL, V100, P24, DOI 10.1046/j.1365-2141.1998.00526.x; WOLF P, 1967, BRIT J HAEMATOL, V13, P269, DOI 10.1111/j.1365-2141.1967.tb08741.x	31	779	834	4	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 29	2010	327	5965					580	583		10.1126/science.1181928	http://dx.doi.org/10.1126/science.1181928			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549CT	20110505	Green Accepted			2022-12-28	WOS:000274020500038
J	Safinya, CR; Li, YL				Safinya, Cyrus R.; Li, Youli			Bundling with X-rays	SCIENCE			English	Editorial Material									[Safinya, Cyrus R.] Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA; [Safinya, Cyrus R.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Safinya, Cyrus R.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Li, Youli] Univ Calif Santa Barbara, Mat Res Lab, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Safinya, CR (corresponding author), Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA.	safinya@mrl.ucsb.edu; youli@mrl.ucsb		Safinya, Cyrus/0000-0002-3295-7128				ALSNIELSEN J, 1995, PHYS TODAY, V48, P34, DOI 10.1063/1.881457; [Anonymous], 2007, PRINCIPLES CONDENSED; BENKA SG, 1995, PHYS TODAY, V48, P23, DOI 10.1063/1.881455; Bray D, 2001, CELL MOVEMENTS MOL M; Cui HG, 2010, SCIENCE, V327, P555, DOI 10.1126/science.1182340; de Gennes P. G., 1993, PHYS LIQUID CRYSTALS; Gelbart WM, 2000, PHYS TODAY, V53, P38, DOI 10.1063/1.1325230; Kandel E., 2000, PRINCIPLES NEURAL SC; Needleman DJ, 2004, P NATL ACAD SCI USA, V101, P16099, DOI 10.1073/pnas.0406076101; Safinya CR, 2006, NEW PHYS 21 CENTURY	10	7	7	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 29	2010	327	5965					529	530		10.1126/science.1185868	http://dx.doi.org/10.1126/science.1185868			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549CT	20110489				2022-12-28	WOS:000274020500020
J	Zimmerman, GA; Weyrich, AS				Zimmerman, Guy A.; Weyrich, Andrew S.			Arsonists in Rheumatoid Arthritis	SCIENCE			English	Editorial Material							PLATELET MICROPARTICLES; SIGNAL; ACTIVATION; PATHWAYS; DISEASE; FLUID		[Zimmerman, Guy A.; Weyrich, Andrew S.] Univ Utah, Dept Med, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Zimmerman, GA (corresponding author), Univ Utah, Dept Med, Salt Lake City, UT 84112 USA.	guy.zimmerman@hmbg.utah.edu		Weyrich, Andrew/0000-0001-9622-4647	NHLBI NIH HHS [R01 HL066277, R37 HL044525] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066277, R37HL044525] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; Choy EHS, 2001, NEW ENGL J MED, V344, P907, DOI 10.1056/NEJM200103223441207; Denis MM, 2005, CELL, V122, P379, DOI 10.1016/j.cell.2005.06.015; DIAZGONZALEZ F, 2005, KELLYS TXB RHEUMATOL, V1, P252; Fausto, 2010, ROBBINS COTRAN PATHO; HERD C, 1995, IMMUNOPHARMACOLOGY P; Joseph JE, 2001, BRIT J HAEMATOL, V115, P451, DOI 10.1046/j.1365-2141.2001.03101.x; Knijff-Dutmer EAJ, 2002, ARTHRITIS RHEUM-US, V46, P1498, DOI 10.1002/art.10312; Perez-Pujol S, 2007, CYTOM PART A, V71A, P38, DOI 10.1002/cyto.a.20354; Sprague DL, 2008, BLOOD, V111, P5028, DOI 10.1182/blood-2007-06-097410; Weissmuller T, 2008, J CLIN INVEST, V118, P3682, DOI 10.1172/JCI35874; Weyrich AS, 2004, TRENDS IMMUNOL, V25, P489, DOI 10.1016/j.it.2004.07.003; YARON M, 1978, ARTHRITIS RHEUM, V21, P607, DOI 10.1002/art.1780210509; Zimmerman GA, 2008, ARTERIOSCL THROM VAS, V28, pS17, DOI 10.1161/ATVBAHA.107.160218	14	26	27	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 29	2010	327	5965					528	529		10.1126/science.1185869	http://dx.doi.org/10.1126/science.1185869			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549CT	20110488	Green Accepted			2022-12-28	WOS:000274020500019
J	Lieberman, DE; Venkadesan, M; Werbel, WA; Daoud, AI; D'Andrea, S; Davis, IS; Mang'Eni, RO; Pitsiladis, Y				Lieberman, Daniel E.; Venkadesan, Madhusudhan; Werbel, William A.; Daoud, Adam I.; D'Andrea, Susan; Davis, Irene S.; Mang'Eni, Robert Ojiambo; Pitsiladis, Yannis			Foot strike patterns and collision forces in habitually barefoot versus shod runners	NATURE			English	Article							RUNNING INJURIES; FEMALE RUNNERS; STANCE PHASE; EVOLUTION; WALKING; HOMO; MASS	Humans have engaged in endurance running for millions of years(1), but the modern running shoe was not invented until the 1970s. For most of human evolutionary history, runners were either barefoot or wore minimal footwear such as sandals or moccasins with smaller heels and little cushioning relative to modern running shoes. We wondered how runners coped with the impact caused by the foot colliding with the ground before the invention of the modern shoe. Here we show that habitually barefoot endurance runners often land on the fore-foot (fore-foot strike) before bringing down the heel, but they sometimes land with a flat foot (mid-foot strike) or, less often, on the heel (rear-foot strike). In contrast, habitually shod runners mostly rear-foot strike, facilitated by the elevated and cushioned heel of the modern running shoe. Kinematic and kinetic analyses show that even on hard surfaces, barefoot runners who fore-foot strike generate smaller collision forces than shod rear-foot strikers. This difference results primarily from a more plantarflexed foot at landing and more ankle compliance during impact, decreasing the effective mass of the body that collides with the ground. Fore-foot-and mid-foot-strike gaits were probably more common when humans ran barefoot or in minimal shoes, and may protect the feet and lower limbs from some of the impact-related injuries now experienced by a high percentage of runners.	[Lieberman, Daniel E.; Venkadesan, Madhusudhan; Daoud, Adam I.] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Venkadesan, Madhusudhan] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Werbel, William A.] Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA; [D'Andrea, Susan] Providence Vet Affairs Med Ctr, Ctr Restorat & Regenerat Med, Providence, RI 02906 USA; [Davis, Irene S.] Univ Delaware, Dept Phys Therapy, Newark, DE 19716 USA; [Mang'Eni, Robert Ojiambo; Pitsiladis, Yannis] Moi Univ, Sch Med, Dept Med Physiol, Eldoret 30100, Kenya; [Mang'Eni, Robert Ojiambo; Pitsiladis, Yannis] Univ Glasgow, Fac Biomed Life Sci, Glasgow G12 8QQ, Lanark, Scotland	Harvard University; Harvard University; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center; University of Delaware; Moi University; University of Glasgow	Lieberman, DE (corresponding author), Harvard Univ, Dept Human Evolutionary Biol, 11 Divin Ave, Cambridge, MA 02138 USA.	danlieb@fas.harvard.edu	Venkadesan, Madhusudhan/B-4697-2008; Daoud-Gray, Adam I/O-3183-2015	Venkadesan, Madhusudhan/0000-0001-5754-7478; Daoud-Gray, Adam I/0000-0003-3792-7881; Pitsiladis, Yannis/0000-0001-6210-2449	US National Science Foundation; American School of Prehistoric Research; Goelet Fund; Harvard University; Vibram USA	US National Science Foundation(National Science Foundation (NSF)); American School of Prehistoric Research; Goelet Fund; Harvard University; Vibram USA	We are grateful to the many volunteer runners who donated their time and patience. For help in Kenya, we thank M. Sang; E. Anjilla; Moi University Medical School; E. Maritim; and the students and teachers of Pemja, Union and AIC Chebisaas schools, in Kenya. For laboratory assistance in Cambridge, we thank A. Biewener, S. Chester, C. M. Eng, K. Duncan, C. Moreno, P. Mulvaney, N. T. Roach, C. P. Rolian, I. Ros, K. Whitcome and S. Wright. We are grateful to A. Biewener, D. Bramble, J. Hamill, H. Herr, L. Mahadevan and D. Raichlen for discussions and comments. Funding was provided by the US National Science Foundation, the American School of Prehistoric Research, The Goelet Fund, Harvard University and Vibram USA.	BOBBERT MF, 1991, J BIOMECH, V24, P1095, DOI 10.1016/0021-9290(91)90002-5; Bramble DM, 2004, NATURE, V432, P345, DOI 10.1038/nature03052; Chatterjee A, 2000, DYNAM STABIL SYST, V15, P139, DOI 10.1080/02681110050032128; Chi KJ, 2005, J BIOMECH, V38, P1387, DOI 10.1016/j.jbiomech.2004.06.020; De Wit B, 2000, J BIOMECH, V33, P269, DOI 10.1016/S0021-9290(99)00192-X; DECLERCQ D, 1994, J BIOMECH, V27, P1213, DOI 10.1016/0021-9290(94)90275-5; DEMPSTER WT, 1955, 55159 WADC US AIR FO; DICKINSON JA, 1985, J BIOMECH, V18, P415, DOI 10.1016/0021-9290(85)90276-3; Divert C, 2008, INT J SPORTS MED, V29, P512, DOI 10.1055/s-2007-989233; Divert C, 2005, INT J SPORTS MED, V26, P593, DOI 10.1055/s-2004-821327; Dixon SJ, 2000, MED SCI SPORT EXER, V32, P1919, DOI 10.1097/00005768-200011000-00016; Eslami M, 2007, CLIN BIOMECH, V22, P74, DOI 10.1016/j.clinbiomech.2006.08.002; Hasegawa H, 2007, J STRENGTH COND RES, V21, P888, DOI 10.1519/R-22096.1; Jungers WL, 2009, NATURE, V459, P81, DOI 10.1038/nature07989; Ker R F, 1989, Proc Inst Mech Eng H, V203, P191, DOI 10.1243/PIME_PROC_1989_203_038_01; KER RF, 1987, NATURE, V325, P147, DOI 10.1038/325147a0; Kerr BA, 1983, P INT S BIOM ASP SPO, P135; LATIMER B, 1989, AM J PHYS ANTHROPOL, V78, P369, DOI 10.1002/ajpa.1330780306; Laughton CA, 2003, J APPL BIOMECH, V19, P153, DOI 10.1123/jab.19.2.153; MARTI B, 1989, SHOE SPORT, P256; Milner CE, 2006, MED SCI SPORT EXER, V38, P323, DOI 10.1249/01.mss.0000183477.75808.92; Nigg B.M., 1986, BIOMECHANICS RUNNING; Onywera VO, 2006, J SPORT SCI, V24, P415, DOI 10.1080/02640410500189033; Pohl MB, 2009, CLIN J SPORT MED, V19, P372, DOI 10.1097/JSM.0b013e3181b8c270; Richards CE, 2009, BRIT J SPORT MED, V43, P159, DOI 10.1136/bjsm.2008.046680; ROBBINS SE, 1987, MED SCI SPORT EXER, V19, P148; Squadrone R, 2009, J SPORT MED PHYS FIT, V49, P6; van Gent RN, 2007, BRIT J SPORT MED, V41, P469, DOI 10.1136/bjsm.2006.033548; VANMECHELEN W, 1992, SPORTS MED, V14, P320, DOI 10.2165/00007256-199214050-00004; Williams DS, 2000, J APPL BIOMECH, V16, P210, DOI 10.1123/jab.16.2.210	30	811	848	24	644	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 28	2010	463	7280					531	U149		10.1038/nature08723	http://dx.doi.org/10.1038/nature08723			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	548QK	20111000				2022-12-28	WOS:000273981100049
J	Patel, NC; Hertel, PM; Estes, MK; de la Morena, M; Petru, AM; Noroski, LM; Revell, PA; Hanson, IC; Paul, ME; Rosenblatt, HM; Abramson, SL				Patel, Niraj C.; Hertel, Paula M.; Estes, Mary K.; de la Morena, Maite; Petru, Ann M.; Noroski, Lenora M.; Revell, Paula A.; Hanson, I. Celine; Paul, Mary E.; Rosenblatt, Howard M.; Abramson, Stuart L.			Vaccine-Acquired Rotavirus in Infants with Severe Combined Immunodeficiency	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DISSEMINATED BCG INFECTION; VIRAL GASTROENTERITIS; CHILDREN; VIREMIA; RISK; WC3	Live pentavalent human-bovine reassortant rotavirus vaccine is recommended in the United States for routine immunization of infants. We describe three infants, two with failure to thrive, who had dehydration and diarrhea within 1 month after their first or second rotavirus immunization and subsequently received a diagnosis of severe combined immunodeficiency. Rotavirus was detected, by means of reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assay, in stool specimens obtained from all three infants, and gene-sequence analysis revealed the presence of vaccine rotavirus. These infections raise concerns regarding the safety of rotavirus vaccine in severely immunocompromised patients.	[Patel, Niraj C.; Noroski, Lenora M.; Hanson, I. Celine; Paul, Mary E.; Abramson, Stuart L.] Texas Childrens Hosp, Baylor Coll Med, Sect Allergy & Immunol, Dept Pediat, Houston, TX 77030 USA; [Hertel, Paula M.] Texas Childrens Hosp, Baylor Coll Med, Gastroenterol Sect, Houston, TX 77030 USA; [Estes, Mary K.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [de la Morena, Maite] Univ Texas SW, Dept Pediat, Dallas, TX USA; [Revell, Paula A.] Univ Texas SW, Dept Pathol, Dallas, TX USA; [Rosenblatt, Howard M.] Dell Childrens Med Ctr Cent Texas, Austin, TX USA; [Patel, Niraj C.] Levine Childrens Hosp, Carolinas Med Ctr, Dept Pediat, Charlotte, NC USA; [Petru, Ann M.] Childrens Hosp & Res Ctr, Oakland, CA USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Carolinas Medical Center	Abramson, SL (corresponding author), Texas Childrens Hosp, Baylor Coll Med, Sect Allergy & Immunol, Dept Pediat, 1102 Bates,FC 330-01, Houston, TX 77030 USA.	abramson@bcm.edu	Paul, Mary/AAA-2722-2021		National Institutes of Health (General Clinical Research Centers) [M01 RR-00188, K12 HD41648]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K12HD041648] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000188] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211, R01AI080656] Funding Source: NIH RePORTER	National Institutes of Health (General Clinical Research Centers)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by grants from the National Institutes of Health (General Clinical Research Centers grant M01 RR-00188, K12 HD41648 to Dr. Hertel, and an unrestricted grant to Dr. Estes).	Anderson EJ, 2008, LANCET INFECT DIS, V8, P642, DOI 10.1016/S1473-3099(08)70231-7; BISHOP RF, 1983, NEW ENGL J MED, V309, P72, DOI 10.1056/NEJM198307143090203; Blutt SE, 2003, LANCET, V362, P1445, DOI 10.1016/S0140-6736(03)14687-9; BREARD J, 1980, J IMMUNOL, V124, P1943; *CDCP, 2008, PINK BOOK EP PREV VA; Chiappini E, 2006, J INFECT DIS, V193, P1333, DOI 10.1086/501374; Ciarlet M, 2002, VIRUS GENES, V24, P107, DOI 10.1023/A:1014512314545; Cortese Margaret M., 2009, Morbidity and Mortality Weekly Report, V58, P1; Culic S, 2004, PEDIATR HEMAT ONCOL, V21, P563, DOI 10.1080/08880010490477257; GILGER MA, 1992, J PEDIATR-US, V120, P912, DOI 10.1016/S0022-3476(05)81959-6; Jean-Philippe P, 2007, PEDIATRICS, V120, pE1345, DOI 10.1542/peds.2004-1681; Khetsuriani N, 2003, J INFECT DIS, V188, P1845, DOI 10.1086/379791; LOSONSKY GA, 1985, J CLIN INVEST, V76, P2362, DOI 10.1172/JCI112248; MONAFO WJ, 1994, J PEDIATR-US, V124, P273, DOI 10.1016/S0022-3476(94)70318-3; Newman RD, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.1.e3; Parashar UD, 2006, EMERG INFECT DIS, V12, P304; Pariyaprasert W, 2008, ASIAN PAC J ALLERGY, V26, P71; Puck JM, 2007, J ALLERGY CLIN IMMUN, V120, P760, DOI 10.1016/j.jaci.2007.08.043; Rayani A, 2007, SCAND J GASTROENTERO, V42, P81, DOI 10.1080/00365520600842179; SAHOO GC, HUMAN GROUP A ROTAVI; SAULSBURY FT, 1980, J PEDIATR-US, V97, P61, DOI 10.1016/S0022-3476(80)80131-4; Shearer WT, 2003, J ALLERGY CLIN IMMUN, V112, P973, DOI 10.1016/j.jaci.2003.07.003; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; 2008, MMWR MORB MORTAL WKL, V57, P697	24	139	148	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 28	2010	362	4					314	319		10.1056/NEJMoa0904485	http://dx.doi.org/10.1056/NEJMoa0904485			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	548OT	20107217	Green Accepted, Bronze			2022-12-28	WOS:000273975000007
J	Hill, J; Treasure, T				Hill, Jennifer; Treasure, Tom		Natl Clinical Guideline Ctr Acute	Guidelines Reducing the risk of venous thromboembolism in patients admitted to hospital: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HIP		[Hill, Jennifer] Royal Coll Physicians, Natl Clin Guideline Ctr Acute & Chron Condit, London NW1 4LE, England; [Treasure, Tom] UCL, Clin Operat Res Unit, Guideline Dev Grp, London WC1H 0BT, England	Royal College of Physicians; University of London; University College London	Hill, J (corresponding author), Royal Coll Physicians, Natl Clin Guideline Ctr Acute & Chron Condit, London NW1 4LE, England.	tom.treasure@gmail.com		Stansby, Gerard/0000-0001-5539-3049; Wonderling, David/0000-0003-0315-6273	National Institute for Health and Clinical Excellence	National Institute for Health and Clinical Excellence	The National Clinical Guideline Centre for Acute and Chronic Conditions was commissioned and funded by the National Institute for Health and Clinical Excellence to write this summary.	Choudhry NK, 2006, BMJ-BRIT MED J, V332, P141, DOI 10.1136/bmj.38698.709572.55; Cohen AT, 2007, THROMB HAEMOSTASIS, V98, P756, DOI 10.1160/TH07-03-0212; Department of Health, 2007, REP IND EXP WORK GRO; Department of Health, RISK ASS VEN THROMB; Eikelboom JW, 2009, CHEST, V135, P513, DOI 10.1378/chest.08-2655; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Haas SB, 2008, J BONE JOINT SURG AM, V90A, P2764; Hill J, 2007, BMJ-BRIT MED J, V334, P1053, DOI 10.1136/bmj.39174.678032.AD; House of Commons Health Select Committee, 2005, PREV VEN THROMB HOSP; Hunt BJ, 2008, ARTERIOSCL THROM VAS, V28, P398, DOI 10.1161/ATVBAHA.108.162586; *NAT I HLTH CLIN E, 2008, STROK DIAGN MAN AC S; Sharrock NE, 2008, CLIN ORTHOP RELAT R, V466, P714, DOI 10.1007/s11999-007-0092-4	12	56	71	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 27	2010	340								c95	10.1136/bmj.c95	http://dx.doi.org/10.1136/bmj.c95			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	549YB	20106897				2022-12-28	WOS:000274089300016
J	Epsztein, J; Lee, AK; Chorev, E; Brecht, M				Epsztein, Jerome; Lee, Albert K.; Chorev, Edith; Brecht, Michael			Impact of Spikelets on Hippocampal CA1 Pyramidal Cell Activity During Spatial Exploration	SCIENCE			English	Article							FIELD BURST ACTIVITY; FREELY MOVING RATS; PLACE CELLS; IN-VITRO; FREQUENCY OSCILLATIONS; ELECTRICAL SYNAPSES; FAST PREPOTENTIALS; ECTOPIC SPIKES; GAP-JUNCTIONS; NEURONS	In vivo intracellular recordings of hippocampal neurons reveal the occurrence of fast events of small amplitude called spikelets or fast prepotentials. Because intracellular recordings have been restricted to anesthetized or head-fixed animals, it is not known how spikelet activity contributes to hippocampal spatial representations. We addressed this question in CA1 pyramidal cells by using in vivo whole-cell recording in freely moving rats. We observed a high incidence of spikelets that occurred either in isolation or in bursts and could drive spiking as fast prepotentials of action potentials. Spikelets strongly contributed to spiking activity, driving similar to 30% of all action potentials. CA1 pyramidal cell firing and spikelet activity were comodulated as a function of the animal's location in the environment. We conclude that spikelets have a major impact on hippocampal activity during spatial exploration.	[Epsztein, Jerome; Lee, Albert K.; Chorev, Edith; Brecht, Michael] Humboldt Univ, Bernstein Ctr Computat Neurosci, D-10115 Berlin, Germany	Humboldt University of Berlin	Epsztein, J (corresponding author), INSERM, Inst Neurobiol Mediterranee, U801, Parc Sci & Technol Luminy,Boite Postale 13, F-13273 Marseille 9, France.	epsztein@inmed.univ-mrs.fr	Epsztein, Jerome/O-7922-2016	Epsztein, Jerome/0000-0002-5344-3986; Chorev, Edith/0000-0002-7170-8327; Brecht, Michael/0000-0002-5387-0953	Neurocure, Bernstein Center for Computational Neuroscience (BMBF), Humboldt University; Neuro-behavior European Research Council; European Molecular Biology Organization; Human Frontier Science Program	Neurocure, Bernstein Center for Computational Neuroscience (BMBF), Humboldt University(Federal Ministry of Education & Research (BMBF)); Neuro-behavior European Research Council; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Human Frontier Science Program(Human Frontier Science Program)	We would like to thank B. Geue, R. Karpinski, and A. Stern at Humboldt University for technical assistance and D. Schmitz for comments on the manuscript. This work was supported by Neurocure, Bernstein Center for Computational Neuroscience (BMBF), Humboldt University, and Neuro-behavior European Research Council grants (M. B.), a European Molecular Biology Organization Long Term Fellowship (A. K. L.), and a Human Frontier Science Program Long Term Fellowship (J.E.).	Avoli M, 1998, EUR J NEUROSCI, V10, P2714, DOI 10.1046/j.1460-9568.1998.t01-1-00275.x; Crochet S, 2004, CEREB CORTEX, V14, P1110, DOI 10.1093/cercor/bhh071; Draguhn A, 1998, NATURE, V394, P189, DOI 10.1038/28184; Dugue GP, 2009, NEURON, V61, P126, DOI 10.1016/j.neuron.2008.11.028; EPSZTEIN J, 2008, SOC NEUR ABSTR; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Hamzei-Sichani F, 2007, P NATL ACAD SCI USA, V104, P12548, DOI 10.1073/pnas.0705281104; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; JEFFERYS JGR, 1982, NATURE, V300, P448, DOI 10.1038/300448a0; Landisman CE, 2002, J NEUROSCI, V22, P1002, DOI 10.1523/JNEUROSCI.22-03-01002.2002; LEE AK, 2008, SOC NEUR ABSTR; Lee AK, 2006, NEURON, V51, P399, DOI 10.1016/j.neuron.2006.07.004; Lee AK, 2009, NAT PROTOC, V4, P385, DOI 10.1038/nprot.2009.5; LLINAS R, 1974, J NEUROPHYSIOL, V37, P560, DOI 10.1152/jn.1974.37.3.560; MACVICAR BA, 1981, SCIENCE, V213, P782, DOI 10.1126/science.6266013; Mann-Metzer P, 1999, J NEUROSCI, V19, P3298; Mercer A, 2006, BRAIN CELL BIOL, V35, P13, DOI 10.1007/s11068-006-9005-9; Muller R, 1996, NEURON, V17, P813, DOI 10.1016/S0896-6273(00)80214-7; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; PEREZVELAZQUEZ JL, 1994, J NEUROSCI, V14, P4308; Schmitz D, 2001, NEURON, V31, P831, DOI 10.1016/S0896-6273(01)00410-X; Simon A, 2005, J NEUROSCI, V25, P6278, DOI 10.1523/JNEUROSCI.1431-05.2005; SPENCER WA, 1961, J NEUROPHYSIOL, V24, P272, DOI 10.1152/jn.1961.24.3.272; STASHEFF SF, 1993, J NEUROPHYSIOL, V70, P961, DOI 10.1152/jn.1993.70.3.961; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; TAYLOR CP, 1982, SCIENCE, V218, P810, DOI 10.1126/science.7134978; THOMPSON LT, 1989, J NEUROSCI, V9, P2382; Traub RD, 2001, J NEUROPHYSIOL, V85, P1246, DOI 10.1152/jn.2001.85.3.1246; TRAUB RD, 1995, J PHYSIOL-LONDON, V489, P127, DOI 10.1113/jphysiol.1995.sp021036; VALIANTE TA, 1995, J NEUROSCI, V15, P6946; Zsiros V, 2005, J NEUROSCI, V25, P8686, DOI 10.1523/JNEUROSCI.2810-05.2005	32	84	86	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 22	2010	327	5964					474	477		10.1126/science.1182773	http://dx.doi.org/10.1126/science.1182773			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546BS	20093475				2022-12-28	WOS:000273783100040
J	Macilwain, C				Macilwain, Colin			Wild goose chase	NATURE			English	Editorial Material												cfmworldview@gmail.com							0	6	6	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 21	2010	463	7279					291	291		10.1038/463291a	http://dx.doi.org/10.1038/463291a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	545PM	20090727	Bronze			2022-12-28	WOS:000273748100015
J	Smits, P; Bolton, AD; Funari, V; Hong, M; Boyden, ED; Lu, L; Manning, DK; Dwyer, ND; Moran, JL; Prysak, M; Merriman, B; Nelson, SF; Bonafe, L; Superti-Furga, A; Ikegawa, S; Krakow, D; Cohn, DH; Kirchhausen, T; Warman, ML; Beier, DR				Smits, Patrick; Bolton, Andrew D.; Funari, Vincent; Hong, Minh; Boyden, Eric D.; Lu, Lei; Manning, Danielle K.; Dwyer, Noelle D.; Moran, Jennifer L.; Prysak, Mary; Merriman, Barry; Nelson, Stanley F.; Bonafe, Luisa; Superti-Furga, Andrea; Ikegawa, Shiro; Krakow, Deborah; Cohn, Daniel H.; Kirchhausen, Tom; Warman, Matthew L.; Beier, David R.			Lethal Skeletal Dysplasia in Mice and Humans Lacking the Golgin GMAP-210	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							THYROID-HORMONE RECEPTOR; RIBBON FORMATION; ER STRESS; PROTEIN; APPARATUS; MOUSE; MECHANISMS; MUTATIONS; PHENOTYPE; CARTILAGE	BACKGROUND Establishing the genetic basis of phenotypes such as skeletal dysplasia in model organisms can provide insights into biologic processes and their role in human disease. METHODS We screened mutagenized mice and observed a neonatal lethal skeletal dysplasia with an autosomal recessive pattern of inheritance. Through genetic mapping and positional cloning, we identified the causative mutation. RESULTS Affected mice had a nonsense mutation in the thyroid hormone receptor interactor 11 gene (Trip11), which encodes the Golgi microtubule-associated protein 210 (GMAP-210); the affected mice lacked this protein. Golgi architecture was disturbed in multiple tissues, including cartilage. Skeletal development was severely impaired, with chondrocytes showing swelling and stress in the endoplasmic reticulum, abnormal cellular differentiation, and increased cell death. Golgi-mediated glycosylation events were altered in fibroblasts and chondrocytes lacking GMAP-210, and these chondrocytes had intracellular accumulation of perlecan, an extracellular matrix protein, but not of type II collagen or aggrecan, two other extracellular matrix proteins. The similarities between the skeletal and cellular phenotypes in these mice and those in patients with achondrogenesis type 1A, a neonatal lethal form of skeletal dysplasia in humans, suggested that achondrogenesis type 1A may be caused by GMAP-210 deficiency. Sequence analysis revealed loss-of-function mutations in the 10 unrelated patients with achondrogenesis type 1A whom we studied. CONCLUSIONS GMAP-210 is required for the efficient glycosylation and cellular transport of multiple proteins. The identification of a mutation affecting GMAP-210 in mice, and then in humans, as the cause of a lethal skeletal dysplasia underscores the value of screening for abnormal phenotypes in model organisms and identifying the causative mutations.	[Smits, Patrick; Hong, Minh; Boyden, Eric D.; Warman, Matthew L.] Childrens Hosp, Dept Orthoped Surg, Orthoped Res Labs, Boston, MA 02115 USA; [Warman, Matthew L.] Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; [Lu, Lei; Kirchhausen, Tom] Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Bolton, Andrew D.; Manning, Danielle K.; Dwyer, Noelle D.; Moran, Jennifer L.; Prysak, Mary; Beier, David R.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Lu, Lei; Kirchhausen, Tom] Brigham & Womens Hosp, Immune Dis Inst, Boston, MA 02115 USA; [Lu, Lei; Kirchhausen, Tom] Brigham & Womens Hosp, Dept Cell Biol, Boston, MA 02115 USA; [Warman, Matthew L.] Brigham & Womens Hosp, Dept Genet, Boston, MA 02115 USA; [Funari, Vincent; Krakow, Deborah; Cohn, Daniel H.] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Funari, Vincent; Merriman, Barry; Nelson, Stanley F.; Krakow, Deborah; Cohn, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90048 USA; [Bonafe, Luisa] Univ Lausanne, CHU Vaudois, Div Mol Pediat, Lausanne, Switzerland; [Superti-Furga, Andrea] Univ Freiburg, Dept Pediat, D-7800 Freiburg, Germany; [Ikegawa, Shiro] RIKEN, Ctr Genom Med, Tokyo, Japan	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Freiburg; RIKEN	Warman, ML (corresponding author), Childrens Hosp, Dept Orthoped Surg, Orthoped Res Labs, Enders 907-2,320 Longwood Ave, Boston, MA 02115 USA.	matthew.warman@childrens.harvard.edu	Lu, Lei/A-2225-2011; superti-furga, andrea/E-9162-2015; Ikegawa, Shiro/N-6895-2015; Nelson, Stanley F/D-4771-2009; Krakow, Deborah/B-5778-2009	Lu, Lei/0000-0002-8192-1471; superti-furga, andrea/0000-0002-3543-7531; Ikegawa, Shiro/0000-0003-0316-2147; Nelson, Stanley F/0000-0002-2082-3114; Krakow, Deborah/0000-0001-9906-4968; Moran, Jennifer/0000-0002-5664-4716; Dwyer, Noelle/0000-0002-1995-7203	National Institutes of Health [HD36404, UO1 HD43430, GM075252, A1063430, AR050180]; Swiss National Research Foundation [320000-116506]; Arthritis Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD036404] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD043430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075252] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Research Foundation(Swiss National Science Foundation (SNSF)); Arthritis Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by grants from the National Institutes of Health (HD36404 and UO1 HD43430, to Dr. Beier; GM075252 and A1063430, to Dr. Kirchhausen; and AR050180, to Dr. Warman) and the Swiss National Research Foundation (320000-116506, to Dr. Bonafe) and by an Arthritis Foundation Investigator Award to Dr. Smits.	Aigner T, 2007, PEDIATR DEVEL PATHOL, V10, P328, DOI 10.2350/06-07-0134.1; Aszodi A, 2000, CELL STRUCT FUNCT, V25, P73, DOI 10.1247/csf.25.73; Barr FA, 2003, CURR OPIN CELL BIOL, V15, P405, DOI 10.1016/S0955-0674(03)00054-1; Beischlag TV, 2004, J BIOL CHEM, V279, P54620, DOI 10.1074/jbc.M410456200; Boyadjiev SA, 2006, NAT GENET, V38, P1192, DOI 10.1038/ng1876; Chang KH, 1997, P NATL ACAD SCI USA, V94, P9040, DOI 10.1073/pnas.94.17.9040; DALTON AJ, 1954, AM J ANAT, V94, P171, DOI 10.1002/aja.1000940202; Diao A, 2003, J CELL BIOL, V160, P201, DOI 10.1083/jcb.200207045; Dimitrov A, 2009, HUM MOL GENET, V18, P440, DOI 10.1093/hmg/ddn371; Feng Y, 2003, P NATL ACAD SCI USA, V100, P6469, DOI 10.1073/pnas.0631766100; Follit JA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000315; Fromme JC, 2007, DEV CELL, V13, P623, DOI 10.1016/j.devcel.2007.10.005; Gedeon AK, 2001, AM J HUM GENET, V68, P1386, DOI 10.1086/320592; Golgi C, 1898, B SOC MED CHIR PA, V13, P3; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Haycraft CJ, 2008, CURR TOP DEV BIOL, V85, P303, DOI 10.1016/S0070-2153(08)00811-9; HEINEGARD D, 1985, BIOCHEM J, V225, P95, DOI 10.1042/bj2250095; Herron BJ, 2002, NAT GENET, V30, P185, DOI 10.1038/ng812; Hsia CCW, 2004, AM J RESP CRIT CARE, V170, P319, DOI 10.1164/rccm.200209-1062ST; Lang MR, 2006, NAT GENET, V38, P1198, DOI 10.1038/ng1880; LEE JW, 1995, MOL ENDOCRINOL, V9, P243; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Lieu ZZ, 2008, P NATL ACAD SCI USA, V105, P3351, DOI 10.1073/pnas.0800137105; Lisse TS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040007; Lock JG, 2005, TRAFFIC, V6, P1142, DOI 10.1111/j.1600-0854.2005.00349.x; Marra P, 2007, MOL BIOL CELL, V18, P1595, DOI 10.1091/mbc.E06-10-0886; MOLZ G, 1980, EUR J PEDIATR, V134, P69, DOI 10.1007/BF00442406; Moran JL, 2006, GENOME RES, V16, P436, DOI 10.1101/gr.4563306; Osipovich AB, 2008, P NATL ACAD SCI USA, V105, P16171, DOI 10.1073/pnas.0804259105; Pfeffer SR, 2007, ANNU REV BIOCHEM, V76, P629, DOI 10.1146/annurev.biochem.76.061705.130002; Pirog-Garcia KA, 2007, HUM MOL GENET, V16, P2072, DOI 10.1093/hmg/ddm155; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; Rios RM, 2004, CELL, V118, P323; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Seegmiller RE, 2008, J HISTOCHEM CYTOCHEM, V56, P1003, DOI 10.1369/jhc.2008.951673; SupertiFurga A, 1996, NAT GENET, V12, P100, DOI 10.1038/ng0196-100; SUZAKI E, 1992, J HISTOCHEM CYTOCHEM, V40, P379, DOI 10.1177/40.3.1552177; Sztul E, 2006, AM J PHYSIOL-CELL PH, V290, pC11, DOI 10.1152/ajpcell.00293.2005; Tsang KY, 2007, PLOS BIOL, V5, P568, DOI 10.1371/journal.pbio.0050044; Wong SY, 2008, CURR TOP DEV BIOL, V85, P225, DOI 10.1016/S0070-2153(08)00809-0	40	99	104	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 21	2010	362	3					206	216		10.1056/NEJMoa0900158	http://dx.doi.org/10.1056/NEJMoa0900158			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	545NE	20089971	Green Accepted			2022-12-28	WOS:000273738400007
J	Luther, J; Chey, WD				Luther, Jay; Chey, William D.			Psyllium increased symptom relief in patients with the irritable bowel syndrome more than bran or placebo	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Luther, Jay; Chey, William D.] Univ Michigan, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Luther, J (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.		Chey, William/AAY-7766-2021					Brandt LJ, 2009, AM J GASTROENTEROL, V104, pS1, DOI 10.1038/ajg.2008.122; Ma YS, 2008, J AM DIET ASSOC, V108, P240, DOI 10.1016/j.jada.2007.10.047; Rivellese AA, 2008, EUR J CLIN NUTR, V62, P660, DOI 10.1038/sj.ejcn.1602755; Simren M, 2001, DIGESTION, V63, P108, DOI 10.1159/000051878	4	5	5	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 19	2010	152	2							JC1-11	10.7326/0003-4819-152-2-201001190-02011	http://dx.doi.org/10.7326/0003-4819-152-2-201001190-02011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	548IE	20083814				2022-12-28	WOS:000273953000023
J	Raoult, D				Raoult, Didier			The post-Darwinist rhizome of life	LANCET			English	Editorial Material									URMITE CNRS IRD, UMR 6236, Fac Med, Unite Rickettsies, F-13385 Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD)	Raoult, D (corresponding author), URMITE CNRS IRD, UMR 6236, Fac Med, Unite Rickettsies, F-13385 Marseille, France.	didier.raoult@gmail.com	RAOULT, Didier/A-8434-2008	RAOULT, Didier/0000-0002-0633-5974				[Anonymous], 1861, ORIGIN SPECIES MEANS; [Anonymous], 1976, RHIZOME INTRO; Callaway E, 2007, NATURE, V449, P6, DOI 10.1038/449006b; Dawkins R, 2006, SELFISH GENE; Doolittle WF, 2007, P NATL ACAD SCI USA, V104, P2043, DOI 10.1073/pnas.0610699104; Fraser CM, 2000, NATURE, V406, P799, DOI 10.1038/35021244; Koonin EV, 2009, NUCLEIC ACIDS RES, V37, P1011, DOI 10.1093/nar/gkp089; Raoult D, 2008, NAT REV MICROBIOL, V6, P315, DOI 10.1038/nrmicro1858	8	64	67	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 9	2010	375	9709					104	105		10.1016/S0140-6736(09)61958-9	http://dx.doi.org/10.1016/S0140-6736(09)61958-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	544NM	20109873				2022-12-28	WOS:000273664500009
J	Woo, CJ; Kharchenko, PV; Daheron, L; Park, PJ; Kingston, RE				Woo, Caroline J.; Kharchenko, Peter V.; Daheron, Laurence; Park, Peter J.; Kingston, Robert E.			A Region of the Human HOXD Cluster that Confers Polycomb-Group Responsiveness	CELL			English	Article							EMBRYONIC STEM-CELLS; POLYCOMB/TRITHORAX RESPONSE ELEMENTS; TRANSCRIPTION FACTOR YY1; DNA-BINDING PROTEIN; DROSOPHILA-MELANOGASTER; DEVELOPMENTAL REGULATORS; PCG PROTEINS; GROUP GENES; IN-VIVO; COMPLEXES	Polycomb group (PcG) proteins are essential for accurate axial body patterning during embryonic development. PcG-mediated repression is conserved in metazoans and is targeted in Drosophila by Polycomb response elements (PREs). However, targeting sequences in humans have not been described. While analyzing chromatin architecture in the context of human embryonic stem cell (hESC) differentiation, we discovered a 1.8kb region between HOXD11 and HOXD12(D11.12) that is associated with PcG proteins, becomes nuclease hypersensitive, and then shows alteration in nuclease sensitivity as hESCs differentiate. The D11.12 element repressed luciferase expression from a reporter construct and full repression required a highly conserved region and YY1 binding sites. Furthermore, repression was dependent on the PcG proteins BMI1 and EED and a YY1-interacting partner, RYBP. We conclude that D11.12 is a Polycomb-dependent regulatory region with similarities to Drosophila PREs, indicating conservation in the mechanisms that target PcG function in mammals and flies.	[Woo, Caroline J.; Kingston, Robert E.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Kharchenko, Peter V.; Park, Peter J.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA; [Kharchenko, Peter V.; Park, Peter J.] Childrens Hosp, Informat Program, Boston, MA 02115 USA; [Daheron, Laurence] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Regenerat Med, Boston, MA 02114 USA; [Daheron, Laurence] Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University	Kingston, RE (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	kingston@molbio.mgh.harvard.edu		Park, Peter/0000-0001-9378-960X	NIH [GM43901, HG003141, GM082798]; NRSA [GM072265]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043901, R01GM082798, R37GM048405, F32GM072265] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. K. Bowman and M. D. Simon for discussions and critical reading of the manuscript. Funding for this work for R. E. K. and C. J. W. was provided by NIH (GM43901 and HG003141). C. J. W. was supported by NRSA GM072265. P. J. K. and P. V. K. were supported by NIH grant GM082798.	Atchison L, 2003, EMBO J, V22, P1347, DOI 10.1093/emboj/cdg124; Barberi T, 2005, PLOS MED, V2, P554, DOI 10.1371/journal.pmed.0020161; Beckers J, 1998, DEV DYNAM, V213, P1; Bejarano F, 2005, MECH DEVELOP, V122, P1118, DOI 10.1016/j.mod.2005.06.001; Beuchle D, 2001, DEVELOPMENT, V128, P993; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Brown JL, 2003, DEVELOPMENT, V130, P285, DOI 10.1242/dev.00204; Brown JL, 1998, MOL CELL, V1, P1057, DOI 10.1016/S1097-2765(00)80106-9; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Cavalli G, 1998, CELL, V93, P505, DOI 10.1016/S0092-8674(00)81181-2; Dejardin J, 2005, NATURE, V434, P533, DOI 10.1038/nature03386; Dennis JH, 2007, GENOME RES, V17, P928, DOI 10.1101/gr.5636607; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Garcia E, 1999, EMBO J, V18, P3404, DOI 10.1093/emboj/18.12.3404; Grimaud C, 2006, CHROMOSOME RES, V14, P363, DOI 10.1007/s10577-006-1069-y; Hanson RD, 1999, P NATL ACAD SCI USA, V96, P14372, DOI 10.1073/pnas.96.25.14372; Henikoff S, 2009, GENOME RES, V19, P460, DOI 10.1101/gr.087619.108; Kahn TG, 2006, J BIOL CHEM, V281, P29064, DOI 10.1074/jbc.M605430200; Kallin EM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000506; Kharchenko PV, 2008, GENOME RES, V18, P1554, DOI 10.1101/gr.075952.107; Kim SY, 2006, DEVELOPMENT, V133, P4957, DOI 10.1242/dev.02677; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lessard J, 1999, GENE DEV, V13, P2691, DOI 10.1101/gad.13.20.2691; Mishra RK, 2001, MOL CELL BIOL, V21, P1311, DOI 10.1128/MCB.21.4.1311-1318.2001; Mito Y, 2007, SCIENCE, V315, P1408, DOI 10.1126/science.1134004; Mohd-Sarip A, 2006, MOL CELL, V24, P91, DOI 10.1016/j.molcel.2006.08.007; Muller J, 2006, CURR OPIN GENET DEV, V16, P476, DOI 10.1016/j.gde.2006.08.005; Negre N, 2006, PLOS BIOL, V4, P917, DOI 10.1371/journal.pbio.0040170; Oktaba K, 2008, DEV CELL, V15, P877, DOI 10.1016/j.devcel.2008.10.005; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Ringrose L, 2004, MOL CELL, V16, P641, DOI 10.1016/j.molcel.2004.10.015; Ringrose L, 2003, DEV CELL, V5, P759, DOI 10.1016/S1534-5807(03)00337-X; Ringrose L, 2007, DEVELOPMENT, V134, P223, DOI 10.1242/dev.02723; Schmitt S, 2005, GENE DEV, V19, P697, DOI 10.1101/gad.326205; Schmitt S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-218; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Sengupta AK, 2004, DEVELOPMENT, V131, P1959, DOI 10.1242/dev.01084; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Sing A, 2009, CELL, V138, P885, DOI 10.1016/j.cell.2009.08.020; Soshnikova N, 2009, SCIENCE, V324, P1320, DOI 10.1126/science.1171468; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Srinivasan L, 2005, J CELL BIOCHEM, V96, P689, DOI 10.1002/jcb.20562; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Tigli RS, 2009, J TISSUE ENG REGEN M, V3, P348, DOI 10.1002/term.169; Tiwari VK, 2008, GENOME RES, V18, P1171, DOI 10.1101/gr.073452.107; Tolhuis B, 2006, NAT GENET, V38, P694, DOI 10.1038/ng1792; vanderLugt NMT, 1996, MECH DEVELOP, V58, P153, DOI 10.1016/S0925-4773(96)00570-9; Wang L, 2004, MOL CELL, V14, P637, DOI 10.1016/j.molcel.2004.05.009	53	244	259	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 8	2010	140	1					99	110		10.1016/j.cell.2009.12.022	http://dx.doi.org/10.1016/j.cell.2009.12.022			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	541CY	20085705	Green Accepted, Bronze			2022-12-28	WOS:000273391900018
J	Ma, RCW; Cockram, CS				Ma, Ronald C. W.; Cockram, Clive S.			Pseudopseudohypoparathyroidism	LANCET			English	Editorial Material									[Ma, Ronald C. W.; Cockram, Clive S.] Chinese Univ Hong Kong, Dept Med & Therapeut, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital	Ma, RCW (corresponding author), Chinese Univ Hong Kong, Dept Med & Therapeut, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China.	rcwma@cuhk.edu.hk	Ma, Ronald/C-2788-2009	Ma, Ronald/0000-0002-1227-803X					0	3	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC-JAN	2009	374	9707					2090	2090		10.1016/S0140-6736(09)60293-2	http://dx.doi.org/10.1016/S0140-6736(09)60293-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	537OO	20109835	Bronze			2022-12-28	WOS:000273122900032
J	Li, QG; Gao, KQ; Vinther, J; Shawkey, MD; Clarke, JA; D'Alba, L; Meng, QJ; Briggs, DEG; Prum, RO				Li, Quanguo; Gao, Ke-Qin; Vinther, Jakob; Shawkey, Matthew D.; Clarke, Julia A.; D'Alba, Liliana; Meng, Qingjin; Briggs, Derek E. G.; Prum, Richard O.			Plumage Color Patterns of an Extinct Dinosaur	SCIENCE			English	Article							FEATHERS	For as long as dinosaurs have been known to exist, there has been speculation about their appearance. Fossil feathers can preserve the morphology of color-imparting melanosomes, which allow color patterns in feathered dinosaurs to be reconstructed. Here, we have mapped feather color patterns in a Late Jurassic basal paravian theropod dinosaur. Quantitative comparisons with melanosome shape and density in extant feathers indicate that the body was gray and dark and the face had rufous speckles. The crown was rufous, and the long limb feathers were white with distal black spangles. The evolution of melanin-based within-feather pigmentation patterns may coincide with that of elongate pennaceous feathers in the common ancestor of Maniraptora, before active powered flight. Feathers may thus have played a role in sexual selection or other communication.	[Vinther, Jakob; Briggs, Derek E. G.] Yale Univ, Dept Geol & Geophys, New Haven, CT 06511 USA; [Li, Quanguo; Meng, Qingjin] Beijing Museum Nat Hist, Beijing 100050, Peoples R China; [Gao, Ke-Qin] Peking Univ, Sch Earth & Space Sci, Beijing 100871, Peoples R China; [Vinther, Jakob; Briggs, Derek E. G.; Prum, Richard O.] Yale Univ, Peabody Museum Nat Hist, New Haven, CT 06511 USA; [Shawkey, Matthew D.; D'Alba, Liliana] Univ Akron, Dept Biol, Akron, OH 44325 USA; [Shawkey, Matthew D.; D'Alba, Liliana] Univ Akron, Integrated Biosci Program, Akron, OH 44325 USA; [Clarke, Julia A.] Univ Texas Austin, Dept Geol Sci, Austin, TX 78712 USA; [Prum, Richard O.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06511 USA	Yale University; Peking University; Yale University; University System of Ohio; University of Akron; University System of Ohio; University of Akron; University of Texas System; University of Texas Austin; Yale University	Vinther, J (corresponding author), Yale Univ, Dept Geol & Geophys, POB 6666, New Haven, CT 06511 USA.	jakob.vinther@yale.edu	Meng, Q./GSI-6185-2022; Vinther, Jakob/GZG-4679-2022; /B-4978-2011; Li, Quanguo/ABE-9756-2021; D'Alba, Liliana/AAC-4969-2022	/0000-0003-2218-2637; D'Alba, Liliana/0000-0002-2478-3455; Vinther, Jakob/0000-0002-3584-9616; Prum, Richard/0000-0002-4741-7132; Shawkey, Matthew/0000-0002-5131-8209	NSF [EAR-0720062, EAR-0719758]; Air Force Office of Scientific Research [FA9550-09-10159]; University of Akron; National Geographic Society; Yale University	NSF(National Science Foundation (NSF)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); University of Akron; National Geographic Society(National Geographic Society); Yale University	E. Champion and S. Nesbitt helped produce the figures. N. Vitek, J. A. Cundiff, and C. L. Canter made initial investigations of modern feathers. The research was funded by NSF (EAR-0720062 and EAR-0719758), the Air Force Office of Scientific Research (FA9550-09-10159), University of Akron startup funds, the National Geographic Society, and the Yale University W. R. Coe Fund. K. J. McGraw and R. J. Safran provided modern feather samples. The studied specimen is accessioned at Beijing Museum of Natural History (BMNHC). The color plate in Fig. 4 was painted by M. D. DiGiorgio.	Bortolotti G. R., 2006, BIRD COLORATION, V2, P3, DOI DOI 10.2307/J.CTV22JNR8K.4; Burtt E.H. Jr, 1979, P75; Hill G. E., 2006, BIRD COLORATION, V2; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Jablonski PG, 1999, BEHAV ECOL, V10, P7, DOI 10.1093/beheco/10.1.7; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; JI Q, 1996, CHIN GEOL, V23, P30; Mumme RL, 2002, AUK, V119, P1024, DOI 10.1642/0004-8038(2002)119[1024:STIANW]2.0.CO;2; Norell MA, 2005, ANNU REV EARTH PL SC, V33, P277, DOI 10.1146/annurev.earth.33.092203.122511; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; Vinther J, 2008, BIOL LETTERS, V4, P522, DOI 10.1098/rsbl.2008.0302; Vinther J, 2010, BIOL LETTERS, V6, P128, DOI 10.1098/rsbl.2009.0524; Willson SK., 2004, ORNITHOL MONOGR, V55, P1, DOI 10.2307/40166802; Xu X, 2003, NATURE, V421, P335, DOI 10.1038/nature01342; Xu X, 2009, CHINESE SCI BULL, V54, P430, DOI 10.1007/s11434-009-0009-6; Xu Xing, 2009, Vertebrata Palasiatica, V47, P311; Zhang FC, 2004, NATURE, V431, P925, DOI 10.1038/431925a; Zhang FC, 2010, NATURE, V463, P1075, DOI 10.1038/nature08740; Zhou Z, 2000, VERTEBRAT PALASIATIC, V38, P113; Zhou Zhong-He, 2000, Vertebrata Palasiatica, V38, P241	20	176	181	1	164	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 12	2010	327	5971					1369	1372		10.1126/science.1186290	http://dx.doi.org/10.1126/science.1186290			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	567CA	20133521	Green Published			2022-12-28	WOS:000275418700039
J	Miller, E; Hoschler, K; Hardelid, P; Stanford, E; Andrews, N; Zambon, M				Miller, Elizabeth; Hoschler, Katja; Hardelid, Pia; Stanford, Elaine; Andrews, Nick; Zambon, Maria			Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study	LANCET			English	Article							ANTIBODY	Background Knowledge of the age-specific prevalence of immunity from, and incidence of infection with, 2009 pandemic influenza A H1N1 virus is essential for modelling the future burden of disease and the effectiveness of interventions such as vaccination. Methods In this cross-sectional serological survey, we obtained 1403 serum samples taken in 2008 (before the first wave of H1N1 infection) and 1954 serum samples taken in August and September, 2009 (after the first wave of infection) as part of the annual collection for the Health Protection Agency seroepidemiology programme from patients accessing health care in England. Antibody titres were measured by use of haemagglutination inhibition and microneutralisation assays. We calculated the proportion of samples with antibodies to pandemic H1N1 virus in 2008 by age group and compared the proportion of samples with haemagglutination inhibition titre 1:32 or more (deemed a protective response) before the first wave of infection with the proportion after the first wave. Findings In the baseline serum samples from 2008, haemagglutination inhibition and microneutralisation antibody titres increased significantly with age (F test p<0.0001). The proportion of samples with haemagglutination inhibition litre 1:32 or more ranged from 1.8% (three of 171; 95% CI 0.6-5.0) in children aged 0-4 years to 31.3% (52 of 166; 24.8-38.7) in adults aged 80 years or older. In London and the West Midlands, the difference in the proportion of samples with haemagglutination inhibition titre equal to or above 1:32 between baseline and September, 2009, was 21.3% (95% CI 8.8-40.3) for children younger than 5 years of age, 42.0% (26.3-58.2) for 5-14-year-olds, and 20.6% (1.6-42.4) for 15-24-year-olds, with no difference between baseline and September in older age groups. In other regions, only children younger than 15 years showed a significant increase from baseline (6.3%, 1.8-12.9). Interpretation Around one child in every three was infected with 2009 pandemic H1N1 in the first wave of infection in regions with a high incidence, ten times more than estimated from clinical surveillance. Pre-existing antibody in older age groups protects against infection. Children have an important role in transmission of influenza and would be a key target group for vaccination both for their protection and for the protection of others through herd immunity.	[Miller, Elizabeth] Hlth Protect Agcy Ctr Infect, Immunisat Hepatitis & Blood Safety Dept, London NW9 6BT, England; [Hoschler, Katja; Zambon, Maria] Hlth Protect Agcy Ctr Infect, Resp Virus Unit, London NW9 6BT, England; [Hardelid, Pia; Andrews, Nick] Hlth Protect Agcy Ctr Infect, Stat Unit, London NW9 6BT, England; [Stanford, Elaine] Manchester Royal Infirm, Hlth Protect Agcy, Vaccine Evaluat Seroepidemiol Unit, Manchester M13 9WL, Lancs, England	Health Protection Agency; Health Protection Agency; Health Protection Agency; Health Protection Agency; University of Manchester	Miller, E (corresponding author), Hlth Protect Agcy Ctr Infect, Immunisat Hepatitis & Blood Safety Dept, 61 Colindale Ave, London NW9 6BT, England.	liz.miller@hpa.org.uk	Hardelid, Pia/K-3353-2013; Hardelid, Pia/B-3575-2011	Hardelid, Pia/0000-0002-0154-1306; 	Novartis; Sanofi Pasteur; Baxter; CSL Australia; National Institute for Health Research Health Technology [09/95/01]	Novartis(Novartis); Sanofi Pasteur; Baxter; CSL Australia; National Institute for Health Research Health Technology	MZ and KH have received research grants from Novartis, Sanofi Pasteur, Baxter, and CSL Australia. KH has received travel expenses from Sanofi Pasteur. All other authors declare that they have no conflicts of interest.; We thank Pauline Kaye for collation for data on serological responses in confirmed cases, Albert Jan Van Hoek and Stefan Flasche for their assistance in data analysis and presentation, and the HPA and National Health Service laboratories that collect samples for the HPA seroepidemiology programme. We also thank the chemical pathology laboratories in the participating regions for their collaboration in the collection of the August and September seroincidence samples and the Royal College of Pathologists and HPA regional epidemiologists for their support in recruitment of these laboratories. This study was funded by a grant to the Health Protection Agency from the National Institute for Health Research Health Technology Assessment Programme (09/95/01) under its Pandemic Influenza call.	BAGUELIN M, VACCINE IN PRESS; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Clark TW, 2009, NEW ENGL J MED, V361, P2424, DOI 10.1056/NEJMoa0907650; Dietz K, 1993, Stat Methods Med Res, V2, P23, DOI 10.1177/096228029300200103; Ellis J, 2009, EUROSURVEILLANCE, V14; *FLUS, UK FLU SURV; Hall IM, 2007, EPIDEMIOL INFECT, V135, P372, DOI 10.1017/S0950268806007084; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Health Protection Agency, SER PROGR; Health Protection Agency, 2009, HPA WEEKL NAT INFL R; *HLTH PROT AG, METH US EST NEW PAND; *HLTH PROT AG, 2009, WEEKL INT SUMM; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Johnson BF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007671; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Office for National Statistics, POP EST UK ENGL WAL; Osborne K, 2000, INT J EPIDEMIOL, V29, P362, DOI 10.1093/ije/29.2.362; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999	18	581	592	0	66	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR-APR	2010	375	9720					1100	1108		10.1016/S0140-6736(09)62126-7	http://dx.doi.org/10.1016/S0140-6736(09)62126-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	578ZB	20096450				2022-12-28	WOS:000276334600033
J	Zhang, FC; Kearns, SL; Orr, PJ; Benton, MJ; Zhou, ZH; Johnson, D; Xu, X; Wang, XL				Zhang, Fucheng; Kearns, Stuart L.; Orr, Patrick J.; Benton, Michael J.; Zhou, Zhonghe; Johnson, Diane; Xu, Xing; Wang, Xiaolin			Fossilized melanosomes and the colour of Cretaceous dinosaurs and birds	NATURE			English	Article							INTEGUMENTARY STRUCTURES; FEATHERED DINOSAURS; THEROPOD DINOSAUR; YIXIAN FORMATION; COLLAGEN-FIBERS; CHINA; EVOLUTION; ORIGIN; PROTOFEATHERS	Spectacular fossils from the Early Cretaceous Jehol Group(1,2) of northeastern China have greatly expanded our knowledge of the diversity and palaeobiology of dinosaurs and early birds, and contributed to our understanding of the origin of birds, of flight, and of feathers. Pennaceous (vaned) feathers and integumentary filaments are preserved in birds(3-5) and non-avian theropod dinosaurs(6-12), but little is known of their microstructure. Here we report that melanosomes (colour-bearing organelles) are not only preserved in the pennaceous feathers of early birds, but also in an identical manner in integumentary filaments of non-avian dinosaurs, thus refuting recent claims(13-16) that the filaments are partially decayed dermal collagen fibres. Examples of both eumelanosomes and phaeomelanosomes have been identified, and they are often preserved in life position within the structure of partially degraded feathers and filaments. Furthermore, the data here provide empirical evidence for reconstructing the colours and colour patterning of these extinct birds and theropod dinosaurs: for example, the dark-coloured stripes on the tail of the theropod dinosaur Sinosauropteryx can reasonably be inferred to have exhibited chestnut to reddish-brown tones.	[Kearns, Stuart L.; Benton, Michael J.] Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England; [Zhang, Fucheng; Zhou, Zhonghe; Xu, Xing; Wang, Xiaolin] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Evolutionary Systemat Vertebrates, Beijing 100044, Peoples R China; [Orr, Patrick J.] Univ Coll Dublin, Sch Geol Sci, Dublin 4, Ireland; [Johnson, Diane] Open Univ, Planetary & Space Sci Res Inst, Milton Keynes MK7 6AA, Bucks, England	University of Bristol; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; University College Dublin; Open University - UK	Benton, MJ (corresponding author), Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England.	mike.benton@bristol.ac.uk; zhonghe@yeah.net	Benton, Michael J/A-5639-2008	Benton, Michael J/0000-0002-4323-1824; Orr, Patrick/0000-0002-6740-1656	NERC; MST of China; National Natural Science Foundation of China; NERC [NE/E011055/1] Funding Source: UKRI; Natural Environment Research Council [NE/E011055/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); MST of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank M. McNamara (University College Dublin), R. Prum (Yale University) and J. Simon (Duke University) for comments, and L. Leonard and N. Monaghan (National Museum of Ireland) for materials. This work was supported by the NERC, the Major Basic Research Projects of MST of China, and the National Natural Science Foundation of China.	Benton MJ, 2008, P GEOLOGIST ASSOC, V119, P209, DOI 10.1016/S0016-7878(08)80302-1; Chen PJ, 1998, NATURE, V391, P147, DOI 10.1038/34356; DURRER H, 1986, BIOL INTEGUMENT, V2, P239; Feduccia A, 2005, J MORPHOL, V266, P125, DOI 10.1002/jmor.10382; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Lingham-Soliar T, 2003, NATURWISSENSCHAFTEN, V90, P563, DOI 10.1007/s00114-003-0483-7; Lingham-Soliar T, 2003, NATURWISSENSCHAFTEN, V90, P428, DOI 10.1007/s00114-003-0448-x; Lingham-Soliar T, 2007, P ROY SOC B-BIOL SCI, V274, P1823, DOI 10.1098/rspb.2007.0352; McGraw KJ., 2006, BIRD COLORATION, P243; Ortolani-Machado CF, 2009, TISSUE CELL, V41, P239, DOI 10.1016/j.tice.2008.11.005; Prum RO, 2005, J EXP ZOOL PART B, V304B, P570, DOI 10.1002/jez.b.21073; Prum RO, 2003, J EXP BIOL, V206, P2409, DOI 10.1242/jeb.00431; Prum RO, 2002, Q REV BIOL, V77, P261, DOI 10.1086/341993; Prum RO, 2002, P ROY SOC B-BIOL SCI, V269, P781, DOI 10.1098/rspb.2001.1896; Prum RO, 2006, BIRD COLORATION, V1, P295; Sawyer RH, 2003, J EXP ZOOL PART B, V297B, P27, DOI 10.1002/jez.b.00017; Vinther J, 2008, BIOL LETTERS, V4, P522, DOI 10.1098/rsbl.2008.0302; Vinther J, 2010, BIOL LETTERS, V6, P128, DOI 10.1098/rsbl.2009.0524; WUTTKE M, 1983, Senckenbergiana Lethaea, V64, P509; Xu X, 2003, NATURE, V421, P335, DOI 10.1038/nature01342; Xu X, 1999, NATURE, V401, P262, DOI 10.1038/45769; Xu X, 2005, NATURWISSENSCHAFTEN, V92, P173, DOI 10.1007/s00114-004-0604-y; Xu Xing, 2003, Vertebrata Palasiatica, V41, P195; Xu X, 2009, P NATL ACAD SCI USA, V106, P832, DOI 10.1073/pnas.0810055106; Zhang FC, 2000, SCIENCE, V290, P1955, DOI 10.1126/science.290.5498.1955; Zhang FC, 2004, NATURE, V431, P925, DOI 10.1038/431925a; Zhang FC, 2008, SCI CHINA SER D, V51, P625, DOI 10.1007/s11430-008-0050-3; Zhang FC, 2006, GEOL J, V41, P395, DOI 10.1002/gj.1057; Zheng XT, 2009, NATURE, V458, P333, DOI 10.1038/nature07856; Zhou ZH, 2003, NATURE, V421, P807, DOI 10.1038/nature01420	30	180	195	3	182	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 25	2010	463	7284					1075	1078		10.1038/nature08740	http://dx.doi.org/10.1038/nature08740			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563DR	20107440	Green Accepted			2022-12-28	WOS:000275108400035
J	Neumann, PJ; Tunis, SR				Neumann, Peter J.; Tunis, Sean R.			Medicare and Medical Technology - The Growing Demand for Relevant Outcomes	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Neumann, Peter J.] Tufts Med Ctr, Ctr Evaluat Value & Risk Hlth, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA; [Tunis, Sean R.] Ctr Med Technol Policy, Baltimore, MD USA	Tufts Medical Center	Neumann, PJ (corresponding author), Tufts Med Ctr, Ctr Evaluat Value & Risk Hlth, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA.							Dhruva SS, 2009, NEW ENGL J MED, V360, P2699, DOI 10.1056/NEJMp0904408; FUCHS VR, 1990, NEW ENGL J MED, V323, P673, DOI 10.1056/NEJM199009063231011; Neumann PJ, 2008, HEALTH AFFAIR, V27, P1620, DOI 10.1377/hlthaff.27.6.1620; Redberg RF, 2008, NEW ENGL J MED, V359, P2309, DOI 10.1056/NEJMp0805920	4	53	55	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 4	2010	362	5					377	379		10.1056/NEJMp0912062	http://dx.doi.org/10.1056/NEJMp0912062			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	551FV	20089955				2022-12-28	WOS:000274193300001
J	Sack, RL				Sack, Robert L.			Jet Lag	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PHASE RESPONSE CURVE; LIGHT MELATONIN ONSET; CIRCADIAN-RHYTHMS; WESTWARD FLIGHT; BRIGHT LIGHT; SLEEP; SHIFT; ALLEVIATION; ADAPTATION; CAFFEINE	A 55-year-old physician is planning a trip from Los Angeles to London to attend a scientific conference. His previous trip to Europe was complicated by sleepiness during meetings and difficulty falling asleep and remaining asleep at night. He wants to know what he can do to avoid jet lag. What would you advise?	Oregon Hlth & Sci Univ, Dept Psychiat, Sleep Disorders Med Program, Portland, OR 97201 USA	Oregon Health & Science University	Sack, RL (corresponding author), Oregon Hlth & Sci Univ, Dept Psychiat, Sleep Disorders Med Program, Mail Code CR139,3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.	sackr@ohsu.edu			Takeda Pharmaceuticals North America; Mini Mitter	Takeda Pharmaceuticals North America(Takeda Pharmaceutical Company Ltd); Mini Mitter	Dr. Sack reports receiving consulting fees from Takeda Pharmaceuticals North America and Mini Mitter, a subsidiary of Philips Respironics. No other potential conflict of interest relevant to this article was reported.	American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS; ARENDT J, 1986, BRIT MED J, V292, P1170, DOI 10.1136/bmj.292.6529.1170; ARENDT J, 1988, ANN REV CHRONOPHARMA, V5, P53; ASCHOFF J, 1975, CHRONOBIOLOGIA, V2, P23; Baehr EK, 1999, AM J PHYSIOL-REG I, V277, pR1598, DOI 10.1152/ajpregu.1999.277.6.R1598; Beaumont M, 2004, J APPL PHYSIOL, V96, P50, DOI 10.1152/japplphysiol.00940.2002; BOGAN R, 2009, 23 ANN M ASS PROF SL; Burgess HJ, 2008, J PHYSIOL-LONDON, V586, P639, DOI 10.1113/jphysiol.2007.143180; Buxton OM, 2000, SLEEP, V23, P915; Buxton OM, 2003, AM J PHYSIOL-REG I, V284, pR714, DOI 10.1152/ajpregu.00355.2002; CLAUSTRAT B, 1992, BIOL PSYCHIAT, V32, P705, DOI 10.1016/0006-3223(92)90300-O; DAAN S, 1984, PSYCHOPHARMACOL BULL, V20, P566; Daurat A, 2000, PSYCHOPHARMACOLOGY, V149, P241, DOI 10.1007/s002139900367; Dolder CR, 2008, CNS DRUGS, V22, P1021, DOI 10.2165/0023210-200822120-00005; Dubocovich ML, 1996, BEHAV BRAIN RES, V73, P141; DWARDS BJ, 2000, ERGONOMICS, V43, P1501; Eastman CI, 2009, SLEEP MED CLIN, V4, P241, DOI 10.1016/j.jsmc.2009.02.006; Herxheimer A, 2002, COCHRANE DB SYST REV, V2, DOI [10.1002/14651858.CD001520, DOI 10.1002/14651858.CD001520]; Jamieson AO, 2001, SLEEP MED, V2, P423, DOI 10.1016/S1389-9457(00)00073-3; Khalsa SBS, 2003, J PHYSIOL-LONDON, V549, P945, DOI 10.1113/jphysiol.2003.040477; LAVIE P, 1990, PSYCHOPHARMACOLOGY, V101, P250, DOI 10.1007/BF02244135; Lewy AJ, 1998, CHRONOBIOL INT, V15, P71, DOI 10.3109/07420529808998671; LEWY AJ, 1989, CHRONOBIOL INT, V6, P93, DOI 10.3109/07420528909059144; Lowden A, 1998, CHRONOBIOL INT, V15, P365, DOI 10.3109/07420529808998696; Morgenthaler TI, 2007, SLEEP, V30, P1445, DOI 10.1093/sleep/30.11.1445; MORRIS HH, 1987, JAMA-J AM MED ASSOC, V258, P945, DOI 10.1001/jama.258.7.945; Nickelsen T, 2002, CHRONOBIOL INT, V19, P915, DOI 10.1081/CBI-120014108; NICKELSEN T, 1991, ADV PINEAL, V5, P303; Pandi-Perumal SR, 2007, PROG NEURO-PSYCHOPH, V31, P1, DOI 10.1016/j.pnpbp.2006.06.020; PETRIE K, 1989, BRIT MED J, V298, P705, DOI 10.1136/bmj.298.6675.705; PETRIE K, 1993, BIOL PSYCHIAT, V33, P526, DOI 10.1016/0006-3223(93)90007-Z; Pierard C, 2001, EUR J APPL PHYSIOL, V85, P144, DOI 10.1007/s004210100418; Rajaratnam SMW, 2009, LANCET, V373, P482, DOI 10.1016/S0140-6736(08)61812-7; Reilly T, 2001, INT J SPORTS MED, V22, P166, DOI 10.1055/s-2001-16379; Reynolds NC, 2002, MIL MED, V167, P451, DOI 10.1093/milmed/167.6.451; Sack RL, 2007, SLEEP, V30, P1460, DOI 10.1093/sleep/30.11.1460; Silverman D, 2009, LANCET, V373, P2067, DOI 10.1016/S0140-6736(09)60209-9; Smith MR, 2008, PHYSIOL BEHAV, V95, P449, DOI 10.1016/j.physbeh.2008.07.012; Spitzer RL, 1999, AM J PSYCHIAT, V156, P1392; Suhner A, 2001, AVIAT SPACE ENVIR MD, V72, P638; Suhner A, 1998, CHRONOBIOL INT, V15, P655, DOI 10.3109/07420529808993201; Takahashi T, 2002, PSYCHIAT CLIN NEUROS, V56, P301, DOI 10.1046/j.1440-1819.2002.00988.x; Takahashi T, 1999, PSYCHIAT CLIN NEUROS, V53, P257, DOI 10.1046/j.1440-1819.1999.00537.x; Waterhouse J, 2007, LANCET, V369, P1117, DOI 10.1016/S0140-6736(07)60529-7; PROFILE US RESIDENT	45	89	94	1	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 4	2010	362	5					440	447		10.1056/NEJMcp0909838	http://dx.doi.org/10.1056/NEJMcp0909838			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551FV	20130253				2022-12-28	WOS:000274193300009
J	Horikoshi, M; Nakajima, S; Ueda, M; Mukaiyama, T				Horikoshi, Munekazu; Nakajima, Shuta; Ueda, Masahito; Mukaiyama, Takashi			Measurement of Universal Thermodynamic Functions for a Unitary Fermi Gas	SCIENCE			English	Article								Thermodynamic properties of matter generally depend on the details of interactions between its constituent parts. However, in a unitary Fermi gas where the scattering length diverges, thermodynamics is determined through universal functions that depend only on the particle density and temperature. By using only the general form of the equation of state and the equation of force balance, we measured the local internal energy of the trapped gas as a function of these parameters. Other universal functions, such as those corresponding to the Helmholtz free energy, chemical potential, and entropy, were calculated through general thermodynamic relations. The critical parameters were also determined at the superfluid transition temperature. These results apply to all strongly interacting fermionic systems, including neutron stars and nuclear matter.	[Horikoshi, Munekazu; Ueda, Masahito; Mukaiyama, Takashi] Japan Sci & Technol Agcy, Exploratory Res Adv Technol ERATO, Macroscop Quantum Control Project, Bunkyo Ku, Tokyo 1138656, Japan; [Nakajima, Shuta; Ueda, Masahito] Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; [Mukaiyama, Takashi] Univ Electrocommun, Ctr Frontier Sci & Engn, Tokyo 1828585, Japan	Japan Science & Technology Agency (JST); University of Tokyo; University of Electro-Communications - Japan	Horikoshi, M (corresponding author), Japan Sci & Technol Agcy, Exploratory Res Adv Technol ERATO, Macroscop Quantum Control Project, Bunkyo Ku, 2-11-16 Yayoi, Tokyo 1138656, Japan.	hori@sogo.t.u-tokyo.ac.jp	Mukaiyama, Takashi/AGB-2290-2022; Ueda, Masahito/G-3046-2012; Nakajima, Shuta/L-2745-2017	Mukaiyama, Takashi/0000-0002-2828-9702; Nakajima, Shuta/0000-0002-8479-8552; Ueda, Masahito/0000-0002-5367-1436	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank Y. Inada and S. Pradhan for experimental assistance. S. N. acknowledges support from the Japan Society for the Promotion of Science.	Baker GA, 1999, PHYS REV C, V60, DOI 10.1103/PhysRevC.60.054311; Bartenstein M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.103201; Bourdel T, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.020402; Bulgac A, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.120401; Bulgac A, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.023625; Burovski E, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.160402; Capuzzi P, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.021603; Chen QJ, 2005, PHYS REP, V412, P1, DOI 10.1016/j.physrep.2005.02.005; Haussmann R, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.023610; Heiselberg H, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.043606; Ho TL, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.160404; Ho TL, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.090402; Hu H, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.023617; Hu H, 2007, NAT PHYS, V3, P469, DOI 10.1038/nphys598; Inouye S, 1998, NATURE, V392, P151, DOI 10.1038/32354; Joseph J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.170401; Ketterle W, 2008, RIV NUOVO CIMENTO, V31, P247, DOI 10.1393/ncr/i2008-10033-1; Kinast J, 2005, SCIENCE, V307, P1296, DOI 10.1126/science.1109220; Luo L, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.080402; Luo L, 2009, J LOW TEMP PHYS, V154, P1, DOI 10.1007/s10909-008-9850-2; O'Hara KM, 2002, SCIENCE, V298, P2179, DOI 10.1126/science.1079107; Partridge GB, 2006, SCIENCE, V311, P503, DOI 10.1126/science.1122876; PETHICK CJ, 1995, ANNU REV NUCL PART S, V45, P429; Regal CA, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.040403; Riedl S, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.053609; Shuryak E, 2004, PROG PART NUCL PHYS, V53, P273, DOI 10.1016/j.ppnp.2004.02.025; Stewart JT, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.220406; Thomas JE, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.120402; Zwierlein MW, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.120403	30	160	160	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 22	2010	327	5964					442	445		10.1126/science.1183012	http://dx.doi.org/10.1126/science.1183012			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546BS	20093468				2022-12-28	WOS:000273783100031
J	Chen, PH; Lin, XZ				Chen, Ping-Hsien; Lin, Xi-Zhang			Hydropneumothorax	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Chen, Ping-Hsien; Lin, Xi-Zhang] Natl Cheng Kung Univ, Tainan 70101, Taiwan	National Cheng Kung University	Chen, PH (corresponding author), Natl Cheng Kung Univ, Tainan 70101, Taiwan.	bing_tw@hotmail.com	lin, xi/GZL-4959-2022						0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 21	2010	362	3					e9	e9		10.1056/NEJMicm0810434	http://dx.doi.org/10.1056/NEJMicm0810434			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	545NE	20089968				2022-12-28	WOS:000273738400012
J	Draghi, JA; Parsons, TL; Wagner, GP; Plotkin, JB				Draghi, Jeremy A.; Parsons, Todd L.; Wagner, Guenter P.; Plotkin, Joshua B.			Mutational robustness can facilitate adaptation	NATURE			English	Article							GENE NETWORKS; PROMOTES EVOLVABILITY; DIGITAL ORGANISMS; EVOLUTION; INNOVATION; SELECTION; RNA	Robustness seems to be the opposite of evolvability. If phenotypes are robust against mutation, we might expect that a population will have difficulty adapting to an environmental change, as several studies have suggested(1-4). However, other studies contend that robust organisms are more adaptable(5-8). A quantitative understanding of the relationship between robustness and evolvability will help resolve these conflicting reports and will clarify outstanding problems in molecular and experimental evolution, evolutionary developmental biology and protein engineering. Here we demonstrate, using a general population genetics model, that mutational robustness can either impede or facilitate adaptation, depending on the population size, the mutation rate and the structure of the fitness landscape. In particular, neutral diversity in a robust population can accelerate adaptation as long as the number of phenotypes accessible to an individual by mutation is smaller than the total number of phenotypes in the fitness landscape. These results provide a quantitative resolution to a significant ambiguity in evolutionary theory.	[Draghi, Jeremy A.; Parsons, Todd L.; Plotkin, Joshua B.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Plotkin, Joshua B.] Univ Penn, Program Appl Math & Computat Sci, Philadelphia, PA 19104 USA; [Wagner, Guenter P.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA	University of Pennsylvania; University of Pennsylvania; Yale University	Plotkin, JB (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	jplotkin@sas.upenn.edu	Plotkin, Joshua B/E-6947-2013	Wagner, Gunter/0000-0002-3097-002X	Burroughs Wellcome Fund; David and Lucile Packard Foundation; James S. McDonnell Foundation; Alfred P. Sloan Foundation; Defense Advanced Research Projects Agency [HR0011-05-1-0057]; US National Institute of Allergy and Infectious Diseases [2U54AI057168]; John Templeton Foundation; Perinatology Research Branch of the US National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057168] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); James S. McDonnell Foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); US National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); John Templeton Foundation; Perinatology Research Branch of the US National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank P. Turner and members of the Plotkin laboratory for advice and feedback. J.B.P. acknowledges funding from the Burroughs Wellcome Fund, the David and Lucile Packard Foundation, the James S. McDonnell Foundation, the Alfred P. Sloan Foundation, the Defense Advanced Research Projects Agency (HR0011-05-1-0057) and the US National Institute of Allergy and Infectious Diseases (2U54AI057168). G. P. W. acknowledges funding from the John Templeton Foundation and the Perinatology Research Branch of the US National Institutes of Health.	Aldana M, 2007, J THEOR BIOL, V245, P433, DOI 10.1016/j.jtbi.2006.10.027; Ancel LW, 2000, J EXP ZOOL, V288, P242, DOI 10.1002/1097-010X(20001015)288:3<242::AID-JEZ5>3.0.CO;2-O; Bergman A, 2003, NATURE, V424, P549, DOI 10.1038/nature01765; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Blount ZD, 2008, P NATL ACAD SCI USA, V105, P7899, DOI 10.1073/pnas.0803151105; Cambray G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000256; Carter AJR, 2005, THEOR POPUL BIOL, V68, P179, DOI 10.1016/j.tpb.2005.05.002; Ciliberti S, 2007, P NATL ACAD SCI USA, V104, P13591, DOI 10.1073/pnas.0705396104; Cowperthwaite MC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000110; Daniels BC, 2008, CURR OPIN BIOTECH, V19, P389, DOI 10.1016/j.copbio.2008.06.008; de Visser JAGM, 2003, EVOLUTION, V57, P1959, DOI 10.1554/02-750R; Elena SF, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-284; Fontana W, 1998, SCIENCE, V280, P1451, DOI 10.1126/science.280.5368.1451; Forster R, 2006, J THEOR BIOL, V243, P181, DOI 10.1016/j.jtbi.2006.06.020; Isalan M, 2008, NATURE, V452, P840, DOI 10.1038/nature06847; Kirschner M, 2005, PLAUSIBILITY LIFE RE; Koelle K, 2006, SCIENCE, V314, P1898, DOI 10.1126/science.1132745; Krakauer DC, 2002, P NATL ACAD SCI USA, V99, P1405, DOI 10.1073/pnas.032668599; Lenski RE, 2006, PLOS BIOL, V4, P2190, DOI 10.1371/journal.pbio.0040428; McBride RC, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-231; Meyers LA, 2005, PLOS COMPUT BIOL, V1, P236, DOI 10.1371/journal.pcbi.0010032; Parter M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000206; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Sumedha, 2007, BIOSYSTEMS, V90, P475, DOI 10.1016/j.biosystems.2006.11.007; van Nimwegen E, 1999, P NATL ACAD SCI USA, V96, P9716, DOI 10.1073/pnas.96.17.9716; van Nimwegen E, 2006, SCIENCE, V314, P1884, DOI 10.1126/science.1137300; Wagner A., 2005, ROBUSTNESS EVOLVABIL; Wagner A, 2008, P ROY SOC B-BIOL SCI, V275, P91, DOI 10.1098/rspb.2007.1137; Wilds R, 2008, CHAOS, V18, DOI 10.1063/1.2962223; Wilke CO, 2001, NATURE, V412, P331, DOI 10.1038/35085569	30	226	229	0	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 21	2010	463	7279					353	355		10.1038/nature08694	http://dx.doi.org/10.1038/nature08694			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545PM	20090752	Green Accepted			2022-12-28	WOS:000273748100043
J	McDonald, CF				McDonald, Christine F.			An updated BODE index and a simplified ADO index predicted 3-year mortality in COPD better than the original BODE index	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Austin Hosp, Heidelberg, Vic 3084, Australia	Austin Research Institute; Florey Institute of Neuroscience & Mental Health	McDonald, CF (corresponding author), Austin Hosp, Heidelberg, Vic 3084, Australia.		McDonald, Christine Faye/AAU-9083-2021					Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322	1	1	1	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 19	2010	152	2							JC1-12	10.7326/0003-4819-152-2-201001190-02012	http://dx.doi.org/10.7326/0003-4819-152-2-201001190-02012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	548IE	20083815				2022-12-28	WOS:000273953000024
J	Paulseth, JER				Paulseth, J. E. Rick			Glatiramer acetate delayed conversion to multiple sclerosis in patients with clinically isolated syndrome	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							DEFINITE		Hamilton Hlth Sci, Hamilton, ON, Canada	McMaster University	Paulseth, JER (corresponding author), Hamilton Hlth Sci, Hamilton, ON, Canada.							Coles A, 2007, LANCET NEUROL, V6, P753, DOI 10.1016/S1474-4422(07)70201-6; Comi G, 2001, LANCET, V357, P1576, DOI 10.1016/S0140-6736(00)04725-5; Jacobs LD, 2000, NEW ENGL J MED, V343, P898, DOI 10.1056/NEJM200009283431301; Kappos L, 2006, NEUROLOGY, V67, P1242, DOI 10.1212/01.wnl.0000237641.33768.8d	4	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 19	2010	152	2							JC1-10	10.7326/0003-4819-152-2-201001190-02010	http://dx.doi.org/10.7326/0003-4819-152-2-201001190-02010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	548IE	20083813				2022-12-28	WOS:000273953000022
J	Conteh, L; Engels, T; Molyneux, DH				Conteh, Lesong; Engels, Thomas; Molyneux, David H.			Neglected Tropical Diseases 4 Socioeconomic aspects of neglected tropical diseases	LANCET			English	Review							COMMUNITY-DIRECTED TREATMENT; SCHOOL DEWORMING PROGRAM; COST-EFFECTIVENESS; ONCHOCERCIASIS CONTROL; HEMORRHAGIC-FEVER; INCOME COUNTRIES; AFRICAN PROGRAM; ECONOMIC-IMPACT; BURULI ULCER; HEALTH	Although many examples of highly cost-effective interventions to control neglected tropical diseases exist, our understanding of the full economic effect that these diseases have on individuals, households, and nations needs to be improved to target interventions more effectively and equitably. We review data for the effect of neglected tropical diseases on a population's health and economy. We also present evidence on the costs, cost-effectiveness, and financing of strategies to monitor, control, or reduce morbidity and mortality associated with these diseases. We explore the potential for economies of scale and scope in terms of the costs and benefits of successfully delivering large-scale and integrated interventions. The low cost of neglected tropical disease control is driven by four factors: the commitment of pharmaceutical companies to provide free drugs; the scale of programmes; the opportunities for synergising delivery modes; and the often non-remunerated volunteer contribution of communities and teachers in drug distribution. Finally, we make suggestions for future economic research.	[Conteh, Lesong] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Engels, Thomas] Int Consulting, Brussels, Belgium; [Molyneux, David H.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	University of London; London School of Hygiene & Tropical Medicine; Liverpool School of Tropical Medicine; University of Liverpool	Conteh, L (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	lesong.conteh@lshtm.ac.uk	Conteh, Lesong/ABE-9550-2020	Conteh, Lesong/0000-0002-0719-3672	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	DHM is the executive secretary of the Global Alliance to Eliminate Lymphatic Filariasis. Since 2000, he has received grants from the UK Department for International Development, which includes a 25% contribution from GlaxoSmithKline to the Liverpool School of Tropical Medicine. He attends meetings of the Mectizan Donation Program and is supported by GlaxoSmithKline and Merck to provide independent scientific advice to programmes. The other authors declare that they have no conflicts of interest.	Alvar J, 2006, TRENDS PARASITOL, V22, P552, DOI 10.1016/j.pt.2006.09.004; Amazigo U, 2008, ANN TROP MED PARASIT, V102, P1, DOI 10.1179/136485908X311885; Amazigo U, 2007, SOC SCI MED, V64, P2070, DOI 10.1016/j.socscimed.2007.01.018; *APOC, 2006, ONCH CONTR PARTN M S; *APOC, 2006, 11 SESS JOINT ACT FO; Blackburn BG, 2006, AM J TROP MED HYG, V75, P650, DOI 10.4269/ajtmh.2006.75.650; Blas B. L., 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P26; Bleakley H, 2007, Q J ECON, V122, P73, DOI 10.1162/qjec.121.1.73; BOATIN BA, 2006, ADV PARASIT, P349; Brady MA, 2006, TRENDS PARASITOL, V22, P285, DOI 10.1016/j.pt.2006.05.007; Brooker S, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000291; Brooker S, 2008, HEALTH POLICY PLANN, V23, P24, DOI 10.1093/heapol/czm041; Brooker S, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-99; Budke CM, 2005, AM J TROP MED HYG, V73, P2, DOI 10.4269/ajtmh.2005.73.2; Bundy DAP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000362; Canning D, 2006, T ROY SOC TROP MED H, V100, P499, DOI 10.1016/j.trstmh.2006.02.001; CARABIN H, MONETARY BURDEN TAEN; Castillo-Riquelme M, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000336; Clark DV, 2005, AM J TROP MED HYG, V72, P786, DOI 10.4269/ajtmh.2005.72.786; Clarke SE, 2008, LANCET, V372, P127, DOI 10.1016/S0140-6736(08)61034-X; CROMPTON D, DFID SUPPORT CONTROL; *DEP CONTR NEGL TR, 2006, NEGL TROP DIS PREV T; Dixon S, 2002, BRIT MED J, V324, P232, DOI 10.1136/bmj.324.7331.232; Engels D, 2006, TRENDS PARASITOL, V22, P363, DOI 10.1016/j.pt.2006.06.004; Fenwick A, 2005, LANCET, V365, P1029, DOI 10.1016/s0140-6736(05)71134-x; Fevre EM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-96; Frick KD, 2003, AM J TROP MED HYG, V69, P1; Gallup JL, 2001, AM J TROP MED HYG, V64, P85, DOI 10.4269/ajtmh.2001.64.85; Garg P, 2008, T ROY SOC TROP MED H, V102, P570, DOI 10.1016/j.trstmh.2008.02.015; Gilgen D, 2001, TROP MED INT HEALTH, V6, P449, DOI 10.1046/j.1365-3156.2001.00729.x; Goldman AS, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000067; Grietens KP, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000321; Guinness Lorna, 2007, Cost Eff Resour Alloc, V5, P13, DOI 10.1186/1478-7547-5-13; Guyatt HL, 2001, B WORLD HEALTH ORGAN, V79, P695; HADDIX A, 1999, JOINT SESS HAG DEC 8; Harving ML, 2007, DAN MED BULL, V54, P170; Hodgkin C, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000074; Homeida M, 2002, ANN TROP MED PARASIT, V96, P93, DOI 10.1179/000349802125000673; Hotez P, 2006, LANCET, V367, P563, DOI 10.1016/S0140-6736(06)68213-5; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; Hotez PJ, 2006, VACCINE, V24, P5787, DOI 10.1016/j.vaccine.2006.05.008; Hotez PJ, 2006, PLOS MED, V3, P576, DOI 10.1371/journal.pmed.0030102; Hotez PJ, 2009, LANCET, V373, P1570, DOI 10.1016/S0140-6736(09)60233-6; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000430; Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000230; International Monetary Fund, WORLD EC OUTL DAT; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P3, DOI 10.1596/978-0-8213-6179-5/Chpt-1; Jha P, 2002, SCIENCE, V295, P2036, DOI 10.1126/science.295.5562.2036; Kabatereine NB, 2006, TRENDS PARASITOL, V22, P332, DOI 10.1016/j.pt.2006.05.001; Kamel M. I., 2001, Journal of the Egyptian Society of Parasitology, V31, P153; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; King CH, 2008, CHRONIC ILLN, V4, P65, DOI 10.1177/1742395307084407; Kirigia J M, 2000, Afr J Health Sci, V7, P55; Kumaranayake L, 2000, HEALTH POLICY PLANN, V15, P230, DOI 10.1093/heapol/15.2.230; Laxminarayan R, 2006, LANCET, V367, P1193, DOI 10.1016/S0140-6736(06)68440-7; Laxminarayan R, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P35; MAUMMA GA, 2006, ANN M WHO GLOB BUR U; MCFARLAND DA, COST EVALUATION CDTI; Miguel E, 2004, ECONOMETRICA, V72, P159, DOI 10.1111/j.1468-0262.2004.00481.x; Molyneux DH, 2008, T ROY SOC TROP MED H, V102, P509, DOI 10.1016/j.trstmh.2008.02.024; Molyneux DH, 2009, LANCET, V373, P296, DOI 10.1016/S0140-6736(09)60089-1; Molyneux DH, 2005, PLOS MED, V2, P1064, DOI 10.1371/journal.pmed.0020336; Molyneux DH, 2005, EYE, V19, P1050, DOI 10.1038/sj.eye.6701961; Molyneux DH, 2004, LANCET, V364, P380, DOI 10.1016/S0140-6736(04)16728-7; Montresor A, 2007, T ROY SOC TROP MED H, V101, P461, DOI 10.1016/j.trstmh.2006.07.008; Morel CM, 2005, BMJ-BRIT MED J, V331, P1299, DOI 10.1136/bmj.38639.702384.AE; Mulder AA, 2008, T ROY SOC TROP MED H, V102, P912, DOI 10.1016/j.trstmh.2008.05.026; MURRAY CJL, 1996, GLOBAL BURDEN DIS AX; Ndhlovu P, 2007, T ROY SOC TROP MED H, V101, P433, DOI 10.1016/j.trstmh.2006.08.008; Ottesen EA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000317; OVER M, 1992, HLTH ADULTS DEV WORL, P161; Perera M, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000128; Phommasack B, 2008, T ROY SOC TROP MED H, V102, P1201, DOI 10.1016/j.trstmh.2008.04.036; Ramzy Reda M R, 2005, Filaria J, V4, P7, DOI 10.1186/1475-2883-4-7; Raso G, 2004, INT J EPIDEMIOL, V33, P1092, DOI 10.1093/ije/dyh241; Remme JHF, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P433; Rheingans Richard D, 2004, Filaria J, V3, P2, DOI 10.1186/1475-2883-3-2; Sachs JD, 2006, SCIENCE, V311, P1521, DOI 10.1126/science.1126851; Sakti H, 1999, TROP MED INT HEALTH, V4, P322, DOI 10.1046/j.1365-3156.1999.00410.x; Sauerborn R, 1996, SOC SCI MED, V43, P291, DOI 10.1016/0277-9536(95)00375-4; Seketeli A., 2002, Annals of Tropical Medicine and Parasitology, V96, pS15, DOI 10.1179/000349802125000628; Shillcutt SD, 2009, PHARMACOECONOMICS, V27, P903, DOI 10.2165/10899580-000000000-00000; Sinuon M, 2005, T ROY SOC TROP MED H, V99, P664, DOI 10.1016/j.trstmh.2004.12.004; Smith RD, 2005, J HEALTH ECON, V24, P1055, DOI 10.1016/j.jhealeco.2005.02.003; *STAT BOL, CPI INFL CALC; Stoever K, 2009, LANCET, V373, P2025, DOI 10.1016/S0140-6736(09)61111-9; STROSBERG AM, 2007, CHAGAS DIS LATIN AM, P1; TAN-TORRES TE, 2003, MAKING CHOICES HLTH; Teklehaimanot A, 2007, LANCET, V369, P2143, DOI 10.1016/S0140-6736(07)60951-9; Torgerson PR, 2003, ACTA TROP, V85, P113, DOI 10.1016/S0001-706X(02)00228-0; Valdmanis V, 2003, INT J TECHNOL ASSESS, V19, P692, DOI 10.1017/S0266462303000655; Wang LD, 2008, LANCET, V372, P1793, DOI 10.1016/S0140-6736(08)61358-6; Waters HR, 2004, TROP MED INT HEALTH, V9, pA16, DOI 10.1111/j.1365-3156.2004.01210.x; Weiss MG, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000237; Whitehead M, 2001, LANCET, V358, P833, DOI 10.1016/S0140-6736(01)05975-X; *WHO, FIN CRIS GLOB HLTH; WHO, 2007, GLOB PLAN COMB NEGL; WHO, 2006, COORD US ANTH DRUGS; *WHO, COMM DIR INT MAJ HLT; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; INT DRUG PRICE INDIC	101	169	173	0	41	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 16	2010	375	9710					239	247		10.1016/S0140-6736(09)61422-7	http://dx.doi.org/10.1016/S0140-6736(09)61422-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	546ZH	20109925				2022-12-28	WOS:000273853800034
J	Frommer, WB				Frommer, Wolf B.			CO(2)mmon Sense	SCIENCE			English	Editorial Material									Carnegie Inst Sci, Stanford, CA 94305 USA	Carnegie Institution for Science	Frommer, WB (corresponding author), Carnegie Inst Sci, 260 Panama St, Stanford, CA 94305 USA.	wfrommer@stanford.edu	Frommer, Wolf B/K-5042-2017; Frommer, Wolf B/A-8256-2008	Frommer, Wolf B/0000-0001-6465-0115; Frommer, Wolf B/0000-0001-6465-0115	NIDDK NIH HHS [R01 DK079109, R01 DK079109-04] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079109] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Chandrashekar J, 2009, SCIENCE, V326, P443, DOI 10.1126/science.1174601; Cho YH, 2006, CELL, V127, P579, DOI 10.1016/j.cell.2006.09.028; Elleuche S, 2009, CURR GENET, V55, P211, DOI 10.1007/s00294-009-0238-x; Ho CH, 2009, CELL, V138, P1184, DOI 10.1016/j.cell.2009.07.004; Hu HH, 2010, NAT CELL BIOL, V12, P87, DOI 10.1038/ncb2009; Luo MM, 2009, CURR OPIN NEUROBIOL, V19, P354, DOI 10.1016/j.conb.2009.06.010; Rowlett RS, 2010, BBA-PROTEINS PROTEOM, V1804, P362, DOI 10.1016/j.bbapap.2009.08.002	7	38	38	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 15	2010	327	5963					275	276		10.1126/science.1186022	http://dx.doi.org/10.1126/science.1186022			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544CM	20075235	Green Accepted			2022-12-28	WOS:000273629700022
J	England, J				England, John			Canada needs a polar policy	NATURE			English	Editorial Material									Univ Alberta, Edmonton, AB T6G 2E3, Canada	University of Alberta	England, J (corresponding author), Univ Alberta, Edmonton, AB T6G 2E3, Canada.	john.england@ualberta.ca							0	5	5	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 14	2010	463	7278					159	159		10.1038/463159a	http://dx.doi.org/10.1038/463159a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543MQ	20075900	Bronze			2022-12-28	WOS:000273582700017
J	Oxman, AD; Bjorndal, A; Becerra-Posada, F; Gibson, M; Block, MAG; Haines, A; Hamid, M; Odom, CH; Lei, HC; Levin, B; Lipsey, MW; Littell, JH; Mshinda, H; Ongolo-Zogo, P; Pang, T; Sewankambo, N; Songane, F; Soydan, H; Torgerson, C; Weisburd, D; Whitworth, J; Wibulpolprasert, S				Oxman, Andrew D.; Bjorndal, Arild; Becerra-Posada, Francisco; Gibson, Mark; Gonzalez Block, Miguel Angel; Haines, Andy; Hamid, Maimunah; Odom, Carmen Hooker; Lei, Haichao; Levin, Ben; Lipsey, Mark W.; Littell, Julia H.; Mshinda, Hasson; Ongolo-Zogo, Pierre; Pang, Tikki; Sewankambo, Nelson; Songane, Francisco; Soydan, Haluk; Torgerson, Carole; Weisburd, David; Whitworth, Judith; Wibulpolprasert, Suwit			A framework for mandatory impact evaluation to ensure well informed public policy decisions	LANCET			English	Editorial Material							EVIPNET		[Oxman, Andrew D.; Bjorndal, Arild] Norwegian Knowledge Ctr Hlth Serv, N-0130 Oslo, Norway; [Bjorndal, Arild] Univ Oslo, Oslo, Norway; [Becerra-Posada, Francisco] Council Hlth Res Dev, Mexico City, DF, Mexico; [Gibson, Mark] Oregon Hlth & Sci Univ, Ctr Evidence Based Policy, Portland, OR 97201 USA; [Gonzalez Block, Miguel Angel] Natl Inst Publ Hlth, Ctr Hlth Syst Res, Cuernavaca, Morelos, Mexico; [Haines, Andy] London Sch Hyg & Trop Med, London WC1, England; [Hamid, Maimunah] Minist Hlth, Inst Hlth Syst Res, Kuala Lumpur, Malaysia; [Odom, Carmen Hooker] Milbank Mem Fund, New York, NY USA; [Lei, Haichao] Minist Hlth, Dept Policy & Regulat, Beijing, Peoples R China; [Levin, Ben] Univ Toronto, Toronto, ON, Canada; [Lipsey, Mark W.] Vanderbilt Univ, Peabody Res Inst, Nashville, TN USA; [Littell, Julia H.] Bryn Mawr Coll, Bryn Mawr, PA 19010 USA; [Mshinda, Hasson] Commiss Sci & Technol, Dar Es Salaam, Tanzania; [Ongolo-Zogo, Pierre] Yaounde Cent Hosp, Ctr Dev Best Practices Hlth, Yaounde, Cameroon; [Pang, Tikki] WHO, Res Policy & Cooperat Dept, CH-1211 Geneva, Switzerland; [Sewankambo, Nelson] Makerere Univ, Coll Hlth Sci, Off Principal, Kampala, Uganda; [Songane, Francisco] Partnership Maternal Newborn & Child Hlth, Geneva, Switzerland; [Soydan, Haluk] Univ So Calif, Sch Social Work, Hamovitch Ctr Sci Human Serv, Los Angeles, CA 90089 USA; [Torgerson, Carole] Univ York, Inst Effect Educ, York YO10 5DD, N Yorkshire, England; [Weisburd, David] Hebrew Univ Jerusalem, Inst Criminol, Jerusalem, Israel; [Weisburd, David] George Mason Univ, Fairfax, VA 22030 USA; [Whitworth, Judith] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia; [Wibulpolprasert, Suwit] Minist Publ Hlth, Nonthaburi, Thailand	Norwegian Knowledge Centre for Health Services; University of Oslo; Oregon Health & Science University; Instituto Nacional de Salud Publica; University of London; London School of Hygiene & Tropical Medicine; Kementerian Kesihatan Malaysia; University of Toronto; Vanderbilt University; Vanderbilt University Peabody College; Bryn Mawr College; World Health Organization; Makerere University; University of Southern California; University of York - UK; Hebrew University of Jerusalem; George Mason University; Australian National University; John Curtin School of Medical Research; Ministry of Public Health - Thailand	Oxman, AD (corresponding author), Norwegian Knowledge Ctr Hlth Serv, POB 7004, N-0130 Oslo, Norway.	oxman@online.no	Gonzalez-Block, Miguel/N-6526-2019; Weisburd, David/GRR-9877-2022; Oxman, Andrew/Y-3004-2019	Weisburd, David/0000-0003-3778-5190; Oxman, Andrew/0000-0002-5608-5061; Littell, Julia/0000-0002-2623-9728; Gonzalez-Block, Miguel Angel/0000-0002-7215-4768; Sewankambo, Nelson/0000-0001-9362-053X; Haines, Andy/0000-0002-8053-4605				Alliance for Health Policy and Systems Research, 2004, STRENGTH HLTH SYST R; Beane Billy, 2008, NY TIMES        1024; Becerra-Posada F, 2004, LANCET, V364, P997, DOI 10.1016/S0140-6736(04)17026-8; Cabinet Office, 1999, CM4310 CAB OFF; Chalmers I, 2003, ANN AM ACAD POLIT SS, V589, P22, DOI 10.1177/0002716203254762; Corkum S, 2008, LANCET, V372, P1130, DOI 10.1016/S0140-6736(08)61459-2; Fong GT, 2006, TOB CONTROL, V15, P3, DOI 10.1136/tc.2005.015438; *GOV US MEX PRES R, 2007, NAT DEV PLAN 2007 20; *GOV US MEX PRES R, 2005, DECR REG NAT COUNC E; Hamid M, 2005, LANCET, V366, P1758, DOI 10.1016/S0140-6736(05)67709-4; *IND EV GROP, 2007, ECD WORK PAP SER, V17; Macintyre S, 2000, J EPIDEMIOL COMMUN H, V54, P802, DOI 10.1136/jech.54.11.802; Moynihan R, 2008, EVIDENCE INFORM HLTH; Moynihan R, 2008, 12008 NASJ KUNNSK HE; PEAR R, 2009, NY TIMES        0215; *SECR FIN PUBL CRE, 2008, EXP BUDG FED FISC YE; van Kammen J, 2006, B WORLD HEALTH ORGAN, V84, P608, DOI 10.2471/BLT.05.028308; Volmink J, 2004, B WORLD HEALTH ORGAN, V82, P778; World Health Organization, 2004, MEX STAT HLTH RES; World Health Organization, 2008, BAM CALL ACT RES HLT	20	72	72	1	31	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN-FEB	2010	375	9712					427	431		10.1016/S0140-6736(09)61251-4	http://dx.doi.org/10.1016/S0140-6736(09)61251-4			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	552PK	20113827	Green Accepted			2022-12-28	WOS:000274305500030
J	Balkau, B; Simon, D				Balkau, Beverley; Simon, Dominique			Survival in people with type 2 diabetes as a function of HbA(1c)	LANCET			English	Editorial Material							GLUCOSE CONTROL; HYPOGLYCEMIA		[Balkau, Beverley; Simon, Dominique] INSERM, U1018, CESP Ctr Res Epidemiol & Populat Hlth, Epidemiol Diabet Obes & Chron Kidney Dis Lifecour, F-94807 Villejuif, France; [Balkau, Beverley] Univ Paris 11, UMRS 1018, Villejuif, France; [Simon, Dominique] Grp Hosp Pitie Salpetriere, F-75634 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Balkau, B (corresponding author), INSERM, U1018, CESP Ctr Res Epidemiol & Populat Hlth, Epidemiol Diabet Obes & Chron Kidney Dis Lifecour, F-94807 Villejuif, France.	beverley.balkau@inserm.fr						Amiel SA, 2008, DIABETIC MED, V25, P245, DOI 10.1111/j.1464-5491.2007.02341.x; Amiel SA, 2009, DIABETES CARE, V32, P1364, DOI 10.2337/dc09-0113; Currie CJ, 2010, LANCET, V375, P481, DOI 10.1016/S0140-6736(09)61969-3; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; GAMBLE JM, 2009, LANCET, DOI DOI 10.1111/J.1463-1326.2009.01125.X; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Mannucci E, 2009, NUTR METAB CARDIOVAS, V19, P604, DOI 10.1016/j.numecd.2009.03.021; Miller CD, 2001, ARCH INTERN MED, V161, P1653, DOI 10.1001/archinte.161.13.1653; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; Turnbull FM, 2009, DIABETOLOGIA, V52, P2288, DOI 10.1007/s00125-009-1470-0; TZOULAKI I, 2009, BMJ-BRIT MED J, V339, pb4731, DOI DOI 10.1136/BMJ.B4731	13	7	7	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 6	2010	375	9713					438	440		10.1016/S0140-6736(09)62192-9	http://dx.doi.org/10.1016/S0140-6736(09)62192-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	558PV	20110122	Green Submitted			2022-12-28	WOS:000274757900006
J	Chong, YS; Kwek, KYC				Chong, Yap-Seng; Kwek, Kenneth Y. C.			Safer childbirth: avoiding medical interventions for non-medical reasons	LANCET			English	Editorial Material							UNNECESSARY CESAREAN-SECTIONS; DELIVERY RATES; LATIN-AMERICA; CHOICE; MODE		[Chong, Yap-Seng] Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, Singapore 119074, Singapore; [Kwek, Kenneth Y. C.] KK Womens & Childrens Hosp, Dept Maternal Fetal Med, Singapore, Singapore	National University of Singapore; KK Women's & Children's Hospital	Chong, YS (corresponding author), Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, Singapore 119074, Singapore.	obgcys@nus.edu.sg		Chong, Yap Seng/0000-0002-7232-8473				Ali Unzila A, 2009, Rev Obstet Gynecol, V2, P5; AlMufti R, 1996, LANCET, V347, P544, DOI 10.1016/S0140-6736(96)91176-9; Althabe F, 2004, LANCET, V363, P1934, DOI 10.1016/S0140-6736(04)16406-4; Kingdon C, 2009, BJOG-INT J OBSTET GY, V116, P886, DOI 10.1111/j.1471-0528.2009.02119.x; Koch R, 2001, 80 20 PRINCIPLE SECR; Lee SI, 2004, BIRTH-ISS PERINAT C, V31, P108, DOI 10.1111/j.0730-7659.2004.00288.x; Lin HC, 2004, OBSTET GYNECOL, V103, P128, DOI 10.1097/01.AOG.0000102935.91389.53; Lumbiganon P, 2010, LANCET, V375, P490, DOI 10.1016/S0140-6736(09)61870-5; Ronsmans C, 2006, LANCET, V368, P1516, DOI 10.1016/S0140-6736(06)69639-6; The Lancet, 1997, LANCET, V349, P815; Victora CG, 2006, LANCET, V367, P1796, DOI 10.1016/S0140-6736(06)68780-1; Villar J, 2006, LANCET, V367, P1819, DOI 10.1016/S0140-6736(06)68704-7; Walker R, 2002, BIRTH-ISS PERINAT C, V29, P28, DOI 10.1046/j.1523-536X.2002.00153.x	13	12	12	4	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 6	2010	375	9713					440	442		10.1016/S0140-6736(10)60055-4	http://dx.doi.org/10.1016/S0140-6736(10)60055-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	558PV	20071023				2022-12-28	WOS:000274757900007
J	Currie, CJ; Peters, JR; Tynan, A; Evans, M; Heine, RJ; Bracco, OL; Zagar, T; Poole, CD				Currie, Craig J.; Peters, John R.; Tynan, Aodan; Evans, Marc; Heine, Robert J.; Bracco, Oswaldo L.; Zagar, Tony; Poole, Chris D.			Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study	LANCET			English	Article							GLUCOSE CONTROL; CARDIOVASCULAR EVENTS; RISK; COMPLICATIONS; HYPOGLYCEMIA; ASSOCIATION; THERAPIES; MORTALITY; VETERANS; MELLITUS	Background Results of intervention studies in patients with type 2 diabetes have led to concerns about the safety of aiming for normal blood glucose concentrations. We assessed survival as a function of HbA(1c) in people with type 2 diabetes. Methods Two cohorts of patients aged 50 years and older with type 2 diabetes were generated from the UK General Practice Research Database from November 1986 to November 2008. We identified 27965 patients whose treatment had been intensified from oral monotherapy to combination therapy with oral blood-glucose lowering agents, and 20005 who had changed to regimens that included insulin. Those with diabetes secondary to other causes were excluded. All-cause mortality was the primary outcome. Age, sex, smoking status, cholesterol, cardiovascular risk, and general morbidity were identified as important confounding factors, and Cox survival models were adjusted for these factors accordingly. Findings For combined cohorts, compared with the glycated haemoglobin (HbA(1c)) decile with the lowest hazard (median HbA(1c) 7.5%, IQR 7.5-7.6%), the adjusted hazard ratio (HR) of all-cause mortality in the lowest HbA(1c) decile (6.4%, 6.1-6.6) was 1.52 (95% Cl 1.32-1.76), and in the highest HbA(1c) decile (median 10.5%, IQR 10.1-11.2%) was 1.79 (95% Cl 1.56-2.06). Results showed a general U-shaped association, with the lowest HR at an HbA(1c) of about 7.5%. HR for all-cause mortality in people given insulin-based regimens (2834 deaths) versus those given combination oral agents (2035) was 1.49 (95% Cl 1.39-1.59). Interpretation Low and high mean HbA(1c) values were associated with increased all-cause mortality and cardiac events. If confirmed, diabetes guidelines might need revision to include a minimum HbA(1c) value.	[Currie, Craig J.] Cardiff Univ, Sch Med, Pharma Res Ctr, Cardiff MediCtr,Dept Med, Cardiff CF14 4UJ, S Glam, Wales; [Peters, John R.; Evans, Marc] Univ Wales Hosp, Dept Med, Cardiff CF4 4XW, S Glam, Wales; [Tynan, Aodan; Heine, Robert J.; Bracco, Oswaldo L.; Zagar, Tony] Eli Lilly & Co, Indianapolis, IN 46285 USA; [Poole, Chris D.] Pharmatelligence, Dept Epidemiol, Cardiff, S Glam, Wales	Cardiff University; Cardiff University; Eli Lilly	Currie, CJ (corresponding author), Cardiff Univ, Sch Med, Pharma Res Ctr, Cardiff MediCtr,Dept Med, Cardiff CF14 4UJ, S Glam, Wales.	currie@cardiff.ac.uk			Astellas; Diabetes UK; European Association for the Study of Diabetes; Engineering and Physical Sciences Research Council; Ferring; GSK; Lilly; Medtronic; Medical Research Council; Pfizer; Sanofi-Aventis; National Health Service; Wyeth	Astellas(Astellas Pharmaceuticals); Diabetes UK(Diabetes UK); European Association for the Study of Diabetes; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Ferring(Ferring Pharmaceuticals); GSK(GlaxoSmithKline); Lilly(Eli Lilly); Medtronic(Medtronic); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Pfizer(Pfizer); Sanofi-Aventis(Sanofi-Aventis); National Health Service; Wyeth(Wyeth)	CJC has received research grants from various health-related organisations, including Astellas, Diabetes UK, the European Association for the Study of Diabetes, the Engineering and Physical Sciences Research Council, Ferring, GSK, Lilly, Medtronic, the Medical Research Council, Pfizer, Sanofi-Aventis, the National Health Service, and Wyeth, and consults for Amylin, Aryx, Astellas, Boeringher Ingelheim. Bristol-Myers Squibb, Diabetes UK, Eisel, Ferring, GSK, Ipsen, Lilly, Medtronic, Merck, Pfizer, Sanofi-Aventis, Takeda, and Wyeth. AT, RJH, OLB, and TZ are employed by Eli Lilly and Company. M E consults for Abbott. Allergan, BMS, GSK, Lilly, Novartis, Novo Nordisk, MSD, Roche, Sanofi-Aventis, and Takeda. CDP consults for Astellas, Ferring, Lilly, Medtronic, Sanofi-Aventis, and Wyeth (pfizer). JRP declares that he has no conflicts of interest.	Abraira C, 1997, ARCH INTERN MED, V157, P181, DOI 10.1001/archinte.157.2.181; American Diabetes Association, 2009, DIABETES CARE, V32, P13; Bowker SL, 2006, DIABETES CARE, V29, P254, DOI 10.2337/diacare.29.02.06.dc05-1558; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Choi SW, 2008, FREE RADICAL BIO MED, V44, P1217, DOI 10.1016/j.freeradbiomed.2007.12.005; CLAYTON D, 1993, STAT MODELS EPIDEMIO, P307; Currie CJ, 2009, DIABETOLOGIA, V52, P1766, DOI 10.1007/s00125-009-1440-6; Currie CJ, 2006, HEART, V92, P196, DOI 10.1136/hrt.2004.058339; Davies JS, 1998, CLIN ENDOCRINOL, V49, P217, DOI 10.1046/j.1365-2265.1998.00508.x; Deaton C, 2009, EUR J CARDIOVASC NUR, V8, P48, DOI 10.1016/j.ejcnurse.2008.04.003; DONAHOE SM, 2007, JAMA-J AM MED ASSOC, V287, P765; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; *GAN PRACT RES DAT, 1996, INFORM RES, P1; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Giorda CB, 2008, DIABETES CARE, V31, P2154, DOI 10.2337/dc08-1013; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Home P, 2008, BMJ-BRIT MED J, V336, P458, DOI 10.1136/bmj.39499.514410.80; JICK H, 1991, BRIT MED J, V302, P766, DOI 10.1136/bmj.302.6779.766; KLEINBAUM DG, 2005, SURVIVAL ANAL A SELF, P522; Koenig W, 2007, ARTERIOSCL THROM VAS, V27, P15, DOI 10.1161/01.ATV.0000251503.35795.4f; Mann JFE, 2005, PRESSE MED, V34, P1303, DOI 10.1016/S0755-4982(05)84178-8; Margolis DJ, 2008, PHARMACOEPIDEM DR S, V17, P753, DOI 10.1002/pds.1630; Miller CD, 2001, ARCH INTERN MED, V161, P1653, DOI 10.1001/archinte.161.13.1653; Mulnier HE, 2006, DIABETIC MED, V23, P516, DOI 10.1111/j.1464-5491.2006.01838.x; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Needham DM, 2005, J CRIT CARE, V20, P12, DOI 10.1016/j.jcrc.2004.09.007; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Turnbull FM, 2009, DIABETOLOGIA, V52, P2288, DOI 10.1007/s00125-009-1470-0; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1999, JAMA-J AM MED ASSOC, V281, P2005, DOI 10.1001/jama.281.21.2005; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Vaag Allan A, 2006, Endocr Pract, V12 Suppl 1, P89; 2009, GEN PRACTICE RES DAT	36	619	635	1	71	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 6	2010	375	9713					481	489		10.1016/S0140-6736(09)61969-3	http://dx.doi.org/10.1016/S0140-6736(09)61969-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	558PV	20110121				2022-12-28	WOS:000274757900031
J	Chu, K; Trelles, M; Ford, N				Chu, Kathryn; Trelles, Miguel; Ford, Nathan			Rethinking surgical care in conflict	LANCET			English	Editorial Material							MORTALITY		[Chu, Kathryn; Ford, Nathan] Med Sans Frontieres, Johannesburg, Gauteng, South Africa; [Trelles, Miguel] Med Sans Frontieres, Brussels, Belgium	Doctors Without Borders	Ford, N (corresponding author), Med Sans Frontieres, Braamfontein 2017, Johannesburg, Gauteng, South Africa.	nathan.ford@joburg.msf.org						[Anonymous], 2004, SPHER PROJ HUM CHART; Blackbourne LH, 2009, J TRAUMA, V66, pS27, DOI 10.1097/TA.0b013e31819cdf83; Chu K, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000078; Coghlan B, 2009, DISASTER MED PUBLIC, V3, P88, DOI 10.1097/DMP.0b013e3181a6e952; Debas HT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1245; Depoortere E, 2004, LANCET, V364, P1315, DOI 10.1016/S0140-6736(04)17187-0; Mellor S G, 2006, J R Nav Med Serv, V92, P109; Spiegel P, 2002, LANCET, V360, P1927, DOI 10.1016/S0140-6736(02)11915-5; Spiegel PB, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000093; Vassallo D J, 1994, J R Army Med Corps, V140, P146; Weber Michael A, 2006, Perspect Vasc Surg Endovasc Ther, V18, P141, DOI 10.1177/1531003506293451; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8	12	23	24	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 23	2010	375	9711					262	263		10.1016/S0140-6736(10)60107-9	http://dx.doi.org/10.1016/S0140-6736(10)60107-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	549QS	20109934				2022-12-28	WOS:000274069300008
J	Dalal, HM; Zawada, A; Jolly, K; Moxham, T; Taylor, RS				Dalal, Hasnain M.; Zawada, Anna; Jolly, Kate; Moxham, Tiffany; Taylor, Rod S.			Home based versus centre based cardiac rehabilitation: Cochrane systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							HOSPITAL-BASED REHABILITATION; QUALITY-OF-LIFE; MYOCARDIAL-INFARCTION; COST-EFFECTIVENESS; EXERCISE; PROGRAMS; PARTICIPATION; OUTCOMES; DISEASE; TRIAL	Objective To compare the effect of home based and supervised centre based cardiac rehabilitation on mortality and morbidity, health related quality of life, and modifiable cardiac risk factors in patients with coronary heart disease. Design Systematic review. Data sources Cochrane Central Register of Controlled Trials (CENTRAL) in the Cochrane Library, Medline, Embase, CINAHL, and PsycINFO, without language restriction, searched from 2001 to January 2008. Review methods Reference lists checked and advice sought from authors. Included randomised controlled trials that compared centre based cardiac rehabilitation with home based programmes in adults with acute myocardial infarction, angina, or heart failure or who had undergone coronary revascularisation. Two reviewers independently assessed the eligibility of the identified trials and extracted data independently. Authors were contacted when possible to obtain missing information. Results 12 studies (1938 participants) were included. Most studies recruited patients with a low risk of further events after myocardial infarction or revascularisation. No difference was seen between home based and centre based cardiac rehabilitation in terms of mortality (relative risk 1.31, 95% confidence interval 0.65 to 2.66), cardiac events, exercise capacity (standardised mean difference -0.11, -0.35 to 0.13), modifiable risk factors (weighted mean difference systolic blood pressure (0.58 mm Hg, -3.29 mm Hg to 4.44 mm Hg), total cholesterol (-0.13 mmol/l, -0.31 mmol/l to 0.05 mmol/l), low density lipoprotein cholesterol (-0.15 mmol/l, -0.31 mmol/l to 0.01 mmol/l), or relative risk for proportion of smokers at follow-up (0.98, 0.73 to 1.31)), or health related quality of life, with the exception of high density lipoprotein cholesterol (-0.06, -0.11 to -0.02) mmol/l). In the home based participants, there was evidence of superior adherence. No consistent difference was seen in the healthcare costs of the two forms of cardiac rehabilitation. Conclusions Home and centre based forms of cardiac rehabilitation seem to be equally effective in improving clinical and health related quality of life outcomes in patients with a low risk of further events after myocardial infarction or revascularisation. This finding, together with the absence of evidence of differences in patients' adherence and healthcare costs between the two approaches, supports the further provision of evidence based, home based cardiac rehabilitation programmes such as the "Heart Manual." The choice of participating in a more traditional supervised centre based or evidence based home based programme should reflect the preference of the individual patient.	[Dalal, Hasnain M.] Peninsula Med Sch Primary Care, Truro TR1 3HD, Cornwall, England; [Dalal, Hasnain M.] Three Spires Med Practice, Truro TR1 2LZ, Cornwall, England; [Zawada, Anna] Agcy Hlth Technol Assessment, Warsaw, Poland; [Jolly, Kate] Univ Birmingham, Birmingham B15 2TT, W Midlands, England; [Moxham, Tiffany; Taylor, Rod S.] Peninsula Med Sch Primary Care, Exeter EX2 5DW, Devon, England	University of Birmingham; University of Exeter	Dalal, HM (corresponding author), Peninsula Med Sch Primary Care, Truro TR1 3HD, Cornwall, England.	hmdalal@doctors.net.uk	Jolly, Kate/AAA-1341-2019	Jolly, Kate/0000-0002-6224-2115	National Institute for Health, UK; European Union; South West Primary Care Trust	National Institute for Health, UK; European Union(European Commission); South West Primary Care Trust	The study was funded by the National Institute for Health Research Cochrane Heart Programme, UK, and the European Union under transparency of the National Health System Drug Reimbursement Decisions, Poland. RST was also partly funded by South West Primary Care Trust.	ADES PA, 1992, ARCH INTERN MED, V152, P1033, DOI 10.1001/archinte.152.5.1033; ANDREW GM, 1981, MED SCI SPORT EXER, V13, P164; Arthur HM, 2002, MED SCI SPORT EXER, V34, P1544, DOI 10.1097/00005768-200210000-00003; Balady GJ, 2007, CIRCULATION, V115, P2675, DOI 10.1161/CIRCULATIONAHA.106.180945; Bell J, 1998, THESIS U LONDON; Beswick AD, 2004, HEALTH TECHNOL ASSES, V8, P1; CAMPBELL N, 1994, HLTH ED J, V53, P409; CANNISTRA LB, 1992, AM J CARDIOL, V69, P1274, DOI 10.1016/0002-9149(92)91220-X; Carlson JJ, 2000, AM J CARDIOL, V86, P17, DOI 10.1016/S0002-9149(00)00822-5; Dalal HM, 2007, INT J CARDIOL, V119, P202, DOI 10.1016/j.ijcard.2006.11.018; Dalal HM, 2003, BRIT MED J, V326, P481, DOI 10.1136/bmj.326.7387.481; Daskapan A, 2005, SAUDI MED J, V26, P842; DEBUSK RF, 1985, AM J CARDIOL, V55, P251, DOI 10.1016/0002-9149(85)90355-8; Evenson K R, 2000, J Cardiopulm Rehabil, V20, P241, DOI 10.1097/00008483-200007000-00005; FERGUSON EE, 2006, US CARDIOVASCULAR DI; Gordon NF, 2002, AM J CARDIOL, V89, P1263, DOI 10.1016/S0002-9149(02)02323-8; Grace Sherry L, 2005, J Cardiopulm Rehabil, V25, P24, DOI 10.1097/00008483-200501000-00006; Graham I, 2007, EUR J CARDIOV PREV R, V14, pE1, DOI 10.1097/01.hjr.0000277984.31558.c4; Jolliffe JA, 2000, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001800, DOI 10.1093/eurheartj/ehm316, DOI 10.1002/14651858.CD001800]; Jolly K, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11350; Jolly K, 2009, HEART, V95, P36, DOI 10.1136/hrt.2007.127209; Jolly K, 2006, INT J CARDIOL, V111, P343, DOI 10.1016/j.ijcard.2005.11.002; Kassaian M, 2000, IRANIAN HEART J, V1, P95; Law MR, 2002, ARCH INTERN MED, V162, P2405, DOI 10.1001/archinte.162.21.2405; LEWIN B, 1992, LANCET, V339, P1036, DOI 10.1016/0140-6736(92)90547-G; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Marchionni N, 2003, CIRCULATION, V107, P2201, DOI 10.1161/01.CIR.0000066322.21016.4A; MILLER NH, 1984, CIRCULATION, V70, P645, DOI 10.1161/01.CIR.70.4.645; National Institute of Health and Clinical Excellence, 2007, SEC PREV PRIM SEC CA; Neal B., 2004, PRIORITY MED EUROPE; NOHARA R, 1990, JPN CIRC J, V54, P1443, DOI 10.1253/jcj.54.11_1443; Pell J, 1996, BRIT MED J, V313, P267, DOI 10.1136/bmj.313.7052.267; Smith KM, 2004, EUR J CARDIOV PREV R, V11, P313, DOI 10.1097/01.hjr.0000136414.40017.10; SPARKS KE, 1993, HEART LUNG, V22, P298; Stone JA, 2005, CAN J CARDIOL, V21, p5D; TAYLOR CB, 1986, J PSYCHOSOM RES, V30, P581, DOI 10.1016/0022-3999(86)90031-0; Taylor RS, 2007, INT J CARDIOL, V119, P196, DOI 10.1016/j.ijcard.2006.07.218; Taylor RS, 2004, AM J MED, V116, P682, DOI 10.1016/j.amjmed.2004.01.009; Wenger NK, 2008, J AM COLL CARDIOL, V51, P1619, DOI 10.1016/j.jacc.2008.01.030; Wingham Jenny, 2006, Eur J Cardiovasc Nurs, V5, P289, DOI 10.1016/j.ejcnurse.2006.02.002; World Health Organisation (WHO), 1997, WORLD HLTH REP CONQ; Wu SK, 2006, AM J PHYS MED REHAB, V85, P711, DOI 10.1097/01.phm.0000228597.64057.66	42	199	209	2	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 19	2010	340								b5631	10.1136/bmj.b5631	http://dx.doi.org/10.1136/bmj.b5631			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	548HN	20085991	hybrid, Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000273951200003
J	Rihel, J; Prober, DA; Arvanites, A; Lam, K; Zimmerman, S; Jang, S; Haggarty, SJ; Kokel, D; Rubin, LL; Peterson, RT; Schier, AF				Rihel, Jason; Prober, David A.; Arvanites, Anthony; Lam, Kelvin; Zimmerman, Steven; Jang, Sumin; Haggarty, Stephen J.; Kokel, David; Rubin, Lee L.; Peterson, Randall T.; Schier, Alexander F.			Zebrafish Behavioral Profiling Links Drugs to Biological Targets and Rest/Wake Regulation	SCIENCE			English	Article							SLEEP; STRATEGIES; INHIBITORS; DISORDERS; DISCOVERY; EMBRYOS; HERG; MICE; QT	A major obstacle for the discovery of psychoactive drugs is the inability to predict how small molecules will alter complex behaviors. We report the development and application of a high-throughput, quantitative screen for drugs that alter the behavior of larval zebrafish. We found that the multidimensional nature of observed phenotypes enabled the hierarchical clustering of molecules according to shared behaviors. Behavioral profiling revealed conserved functions of psychotropic molecules and predicted the mechanisms of action of poorly characterized compounds. In addition, behavioral profiling implicated new factors such as ether-a-go-go-related gene ( ERG) potassium channels and immunomodulators in the control of rest and locomotor activity. These results demonstrate the power of high-throughput behavioral profiling in zebrafish to discover and characterize psychotropic drugs and to dissect the pharmacology of complex behaviors.	[Rihel, Jason; Prober, David A.; Zimmerman, Steven; Jang, Sumin; Schier, Alexander F.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Arvanites, Anthony; Lam, Kelvin; Rubin, Lee L.; Schier, Alexander F.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Haggarty, Stephen J.] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Haggarty, Stephen J.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Kokel, David; Peterson, Randall T.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Dev Biol Lab, Charlestown, MA 02129 USA; [Peterson, Randall T.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Schier, Alexander F.] Harvard Univ, Sch Med, Div Sleep Med, Boston, MA 02215 USA; [Schier, Alexander F.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University	Rihel, J (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	rihel@fas.harvard.edu; schier@fas.harvard.edu	Rihel, Jason/G-7106-2011; Zebrafish, UCL/A-3125-2009; Haggarty, Stephen J/M-9495-2016	Haggarty, Stephen J/0000-0002-7872-168X; Schier, Alexander Franz/0000-0001-7645-5325; Rubin, Lee/0000-0002-8658-841X; Rihel, Jason/0000-0003-4067-2066; Peterson, Randall/0000-0003-0727-3469	Life Sciences Research Foundation; Helen Hay Whitney Foundation; NIH [MH086867, MH085205]; Stanley Medical Research Institute; Harvard Stem Cell Institute; McKnight Endowment Fund for Neuroscience; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085357] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086867, R21MH085205, K01MH091449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS060996, R00NS060996] Funding Source: NIH RePORTER	Life Sciences Research Foundation; Helen Hay Whitney Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanley Medical Research Institute; Harvard Stem Cell Institute; McKnight Endowment Fund for Neuroscience; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Dowling, D. Milan, and G. Vanderlaan for suggestions and reagents and D. Schoppik, G. Uhl, and I. Woods for critical reading of the manuscript. Supported by a Bristol-Myers Squibb postdoctoral fellowship of the Life Sciences Research Foundation (J. R.), a Helen Hay Whitney Foundation postdoctoral fellowship (D. A. P.), a NIH Pathway to Independence grant (D. A. P.), the Stanley Medical Research Institute (S. J. H.), the Harvard Stem Cell Institute (L. L. R.), NIH grants MH086867 and MH085205 (R. T. P.), and grants from NIH and the McKnight Endowment Fund for Neuroscience (A. F. S.). L. L. R. is a founder of iPierian Inc., a biotechnology company, and is a member of its scientific advisory board.	Agid Y, 2007, NAT REV DRUG DISCOV, V6, P189, DOI 10.1038/nrd2217; Bar-Meir E, 2007, CRIT REV TOXICOL, V37, P279, DOI 10.1080/10408440601177855; Cirelli C, 2005, NATURE, V434, P1087, DOI 10.1038/nature03486; Douglas CL, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-42; FOWLER CJ, 1982, BIOCHEM PHARMACOL, V31, P3555, DOI 10.1016/0006-2952(82)90575-5; Imeri L, 2009, NAT REV NEUROSCI, V10, P199, DOI 10.1038/nrn2576; Jacobson KA, 1997, NEUROPHARMACOLOGY, V36, P1157, DOI 10.1016/S0028-3908(97)00104-4; Jorens PG, 1997, HUM EXP TOXICOL, V16, P600, DOI 10.1177/096032719701601008; Langheinrich U, 2003, TOXICOL APPL PHARM, V193, P370, DOI 10.1016/j.taap.2003.07.012; Matteucci A, 2005, EXP BRAIN RES, V167, P641, DOI 10.1007/s00221-005-0068-0; Murphey RD, 2006, CHEM BIOL DRUG DES, V68, P213, DOI 10.1111/j.1747-0285.2006.00439.x; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; North TE, 2009, CELL, V137, P736, DOI 10.1016/j.cell.2009.04.023; Pangalos MN, 2007, NAT REV DRUG DISCOV, V6, P521, DOI 10.1038/nrd2094; Peterson RT, 2004, METHOD CELL BIOL, V76, P569; Prober DA, 2006, J NEUROSCI, V26, P13400, DOI 10.1523/JNEUROSCI.4332-06.2006; Raschi E, 2008, PHARMACOL RES, V57, P181, DOI 10.1016/j.phrs.2008.01.009; Wie MB, 1997, NEUROSCI LETT, V225, P93, DOI 10.1016/S0304-3940(97)00195-X; Yoon BH, 2007, LIFE SCI, V81, P234, DOI 10.1016/j.lfs.2007.05.007	19	511	523	3	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 15	2010	327	5963					348	351		10.1126/science.1183090	http://dx.doi.org/10.1126/science.1183090			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544CM	20075256	Green Accepted			2022-12-28	WOS:000273629700048
J	Huang, JT; Witte, ON				Huang, Jiaoti; Witte, Owen N.			A Seminal Finding for Prostate Cancer?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CELL		[Huang, Jiaoti; Witte, Owen N.] Univ Calif Los Angeles, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Huang, JT (corresponding author), Univ Calif Los Angeles, Los Angeles, CA 90095 USA.			Huang, Jiaoti/0000-0003-1195-1998				EVANS GS, 1987, PROSTATE, V11, P339, DOI 10.1002/pros.2990110406; Mulholland DJ, 2009, CANCER RES, V69, P8555, DOI 10.1158/0008-5472.CAN-08-4673; OKADA H, 1992, VIRCHOWS ARCH A, V421, P157, DOI 10.1007/BF01607049; Prat A, 2009, NAT MED, V15, P842, DOI 10.1038/nm0809-842; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361	5	5	7	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 14	2010	362	2					175	176		10.1056/NEJMcibr0909965	http://dx.doi.org/10.1056/NEJMcibr0909965			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	543FU	20071710				2022-12-28	WOS:000273558500019
J	Geddes, JR; Goodwin, GM; Rendell, J; Azorin, JM; Cipriani, A; Ostacher, MJ; Morriss, R; Alder, N; Juszczak, E; Lewis, S; Attenburrow, MJ; Carter, B; Hainsworth, J; Healey, C; Stevens, W; Van der Cucht, E; Young, H; Davies, C; Peto, R; Barnes, TRE; Curtis, V; Johnson, T; de Silva, A; Marven, M; Berry, D; Arif, M; Bruce, J; Drybala, G; Hayden, E; Jhingan, HP; Marudkar, M; Hillier, R; Barrett, S; Lidder, JS; McCartney, M; Middleton, H; Ononve, F; Solanki, RD; Agell, I; Anjum, R; Hunt, N; Jones, P; Ramana, R; Chase, J; Ayuba, L; Macmillan, I; Michael, A; Frangou, S; Gijsman, H; Parker, E; Phillips, M; Behr, G; Tyrer, P; Conway, A; Ferrier, N; Oakley, T; Tower, N; Young, A; Chitty, R; Littlejohns, C; Suri, A; Iqbal, M; Zikis, P; Anderson, I; O'Driscoll, D; Robbins, N; Ash, G; Chaudhry, I; Duddu, V; Reed, P; Van Wyk, S; Vohra, A; Zingela, Z; Mahmood, T; Diedricks, H; Faizal, MA; McCarthy, J; Morriss, R; Briess, D; Ceccherini-Nelli, A; Clifford, E; Croos, R; Davis, JDR; De Silva, L; Eranti, S; Mahmoud, R; Maurya, A; Partovi-Tabar, P; Rahim, Y; Tuson, J; Greening, J; Campbell, C; Grewal, JS; Kumar, A; Schultewolter, D; Baldwin, D; Best, N; Herod, N; Polson, R; Shawcross, C; Khan, U; Almoshmosh, N; El-Adl, M; Rao, C; Timmins, B; Attenburrow, MJ; Bale, R; Bansal, S; Bhagwagar, Z; Carre, A; Cartright, J; Chalmers, J; Chisuse, A; Davison, P; Elwell, D; Fazel, S; Geaney, D; Hampson, S; Harrison, P; Henderson, E; Johnson, S; Massey, C; Ogilvie, A; O'Leary, D; Oppenheimer, C; Orr, M; Quested, D; Sargent, P; Wilkinson, P; Hussain, T; Franklin, S; King, J; White, J; Anagnosti, O; Bruce-Jones, B; Evans, J; Woodin, G; Kirov, G; Laugharne, R; Blewett, AE; Gupta, S; Saluja, B; Kelly, C; Leeman, T; Macauley, M; Shields, D; Anderson, J; McRae, A; Taylor, M; Carrick, L; Hare, E; Morrison, D; Azorin, JM; Maurel, M; Derouet, J; le Garzic, N; Millet, B; Droulout, T; Henry, C; Leboyer, M; Meary, A; Barbui, C; Cipriani, A; Imperadore, G; Tansella, M; Ostacher, M; Sachs, G				Geddes, John R.; Goodwin, Guy M.; Rendell, Jennifer; Azorin, Jean-Michel; Cipriani, Andrea; Ostacher, Michael J.; Morriss, Richard; Alder, Nicola; Juszczak, Ed; Lewis, Shon; Attenburrow, Mary-Jane; Carter, Brigid; Hainsworth, Jane; Healey, Christine; Stevens, Will; Van der Cucht, Emma; Young, Heather; Davies, Christina; Peto, Richard; Barnes, Thomas R. E.; Curtis, Vivienne; Johnson, Tony; de Silva, Asita; Marven, Michael; Berry, David; Arif, Mohammed; Bruce, Janet; Drybala, Gary; Hayden, Enda; Jhingan, Harsh P.; Marudkar, Mangesh; Hillier, Richard; Barrett, Sara; Lidder, Jasvinder Sing; McCartney, Mark; Middleton, Hugh; Ononve, Frank; Solanki, Ramesh D.; Agell, Ignasi; Anjum, Rubina; Hunt, Neil; Jones, Peter; Ramana, Rajim; Chase, Jeremy; Ayuba, Larry; Macmillan, Iain; Michael, Albert; Frangou, Sophia; Gijsman, Harm; Parker, Elizabeth; Phillips, Mary; Behr, Graham; Tyrer, Peter; Conway, Alison; Ferrier, Nicol; Oakley, Tim; Tower, Nicholas; Young, Allan; Chitty, Roger; Littlejohns, Carl; Suri, Anil; Iqbal, Mohammad; Zikis, Panayiotis; Anderson, Ian; O'Driscoll, David; Robbins, Natalie; Ash, Graham; Chaudhry, Imran; Duddu, Venu; Reed, Paul; Van Wyk, Stephan; Vohra, Adarsh; Zingela, Zukiswa; Mahmood, Tariq; Diedricks, Heidi; Faizal, Mohammad A.; McCarthy, James; Morriss, Richard; Briess, David; Ceccherini-Nelli, Alfonso; Clifford, Elizabeth; Croos, Robert; Davis, Jane Da Rosa; De Silva, Lalitha; Eranti, Savitha; Mahmoud, Rafi; Maurya, Anil; Partovi-Tabar, Peter; Rahim, Yousuf; Tuson, Jacqueline; Greening, Jayne; Campbell, Colin; Grewal, Jasdey Singh; Kumar, Ashok; Schultewolter, Dieter; Baldwin, David; Best, Nick; Herod, Nicola; Polson, Richard; Shawcross, Charles; Khan, Umama; Almoshmosh, Nadim; El-Adl, Mamdouh; Rao, Chandrashekar; Timmins, Bryan; Attenburrow, Mary-Jane; Bale, Rob; Bansal, Sandeep; Bhagwagar, Zubin; Carre, Ali; Cartright, Julia; Chalmers, Julie; Chisuse, Apa; Davison, Phil; Elwell, David; Fazel, Seena; Geaney, David; Hampson, Simon; Harrison, Paul; Henderson, Emma; Johnson, Sophie; Massey, Christopher; Ogilvie, Alan; O'Leary, Denis; Oppenheimer, Catherine; Orr, Michael; Quested, Digby; Sargent, Peter; Wilkinson, Philip; Hussain, Tafazul; Franklin, Steve; King, John; White, Janet; Anagnosti, Ourania; Bruce-Jones, Bill; Evans, Jonathan; Woodin, Geoffrey; Kirov, George; Laugharne, Richard; Blewett, Andrew E.; Gupta, Subhash; Saluja, Bharat; Kelly, Chris; Leeman, Timothy; Macauley, Mark; Shields, Deidre; Anderson, Jacqui; McRae, Alison; Taylor, Mark; Carrick, Lucy; Hare, Elizabeth; Morrison, Diana; Azorin, Jean-Michel; Maurel, Muriele; Derouet, Jacques; le Garzic, Natalie; Millet, Bruno; Droulout, Tiphaine; Henry, Chantal; Leboyer, Marion; Meary, Alexandre; Barbui, Corrado; Cipriani, Andrea; Imperadore, Giuseppe; Tansella, Michele; Ostacher, Michael; Sachs, Gary		BALANCE Investigators Collaborator	Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial	LANCET			English	Article							DOUBLE-BLIND; MAINTENANCE TRIAL; RUN-IN; DIVALPROEX; METAANALYSIS; LAMOTRIGINE; MORTALITY; PATIENT; BURDEN; TRENDS	Background Lithium carbonate and valproate semisodium are both recommended as monotherapy for prevention of relapse in bipolar disorder, but are not individually fully effective in many patients. If combination therapy with both agents is better than monotherapy, many relapses and consequent disability could be avoided. We aimed to establish whether lithium plus valproate was better than monotherapy with either drug alone for relapse prevention in bipolar I disorder. Methods 330 patients aged 16 years and older with bipolar I disorder from 41 sites in the UK, France, USA, and Italy were randomly allocated to open-label lithium monotherapy (plasma concentration 0.4-1.0 mmol/L, n=110), valproate monotherapy (750-1250 mg, n=110), or both agents in combination (n=110), after an active run-in of 4-8 weeks on the combination. Randomisation was by computer program, and investigators and participants were informed of treatment allocation. All outcome events were considered by the trial management team, who were masked to treatment assignment. Participants were followed up for up to 24 months. The primary outcome was initiation of new intervention for an emergent mood episode, which was compared between groups by Cox regression. Analysis was by intention to treat. This study is registered, number ISRCTN 55261332. Findings 59 (54%) of 110 people in the combination therapy group, 65 (59%) of 110 in the lithium group, and 76 (69%) of 110 in the valproate group had a primary outcome event during follow-up. Hazard ratios for the primary outcome were 0.59 (95% CI 0.42-0.83, p=0.0023) for combination therapy versus valproate, 0.82 (0.58-1.17, p=0.27) for combination therapy versus lithium, and 0.71 (0.51-1.00, p=0.0472) for lithium versus valproate. 16 participants had serious adverse events after randomisation: seven receiving valproate monotherapy (three deaths); five lithium monotherapy (two deaths); and four combination therapy (one death). Interpretation For people with bipolar I disorder, for whom long-term therapy is clinically indicated, both combination therapy with lithium plus valproate and lithium monotherapy are more likely to prevent relapse than is valproate monotherapy. This benefit seems to be irrespective of baseline severity of illness and is maintained for up to 2 years. BALANCE could neither reliably confirm nor refute a benefit of combination therapy compared with lithium monotherapy.	[Geddes, John R.; Goodwin, Guy M.; Rendell, Jennifer; Juszczak, Ed; Attenburrow, Mary-Jane; Carter, Brigid; Hainsworth, Jane; Healey, Christine; Stevens, Will; Van der Cucht, Emma; Young, Heather] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford Clin Trials Unit Mental Illness,Trial Mana, Oxford OX3 7JX, England; [Davies, Christina; Peto, Richard] Univ Oxford, MRC Canc Res UK BHF Clin Trial Serv Unit, Oxford, England; [Davies, Christina; Peto, Richard] Univ Oxford, Epidemiol Studies Unit, Oxford, England; [Marven, Michael] Oxford & Buckinghamshire NHS Fdn Trust, Oxford, England; [Berry, David] Guys & St Thomas NHS Fdn Trust, Med Toxicol Unit, London, England; [Arif, Mohammed; Bruce, Janet; Drybala, Gary; Hayden, Enda; Jhingan, Harsh P.; Marudkar, Mangesh] Leicestershire Partnership NHS Trust, Leicester, Leics, England; [Hillier, Richard] Lincolnshire Partnership NHS Fdn Trust, Lincoln, England; [Barrett, Sara; Lidder, Jasvinder Sing; McCartney, Mark; Middleton, Hugh; Ononve, Frank; Solanki, Ramesh D.] Nottinghamshire Healthcare NHS Trust, Nottingham, England; [Agell, Ignasi; Anjum, Rubina] S Staffordshire & Shropshire Healthcare NHS Fdn T, Stafford, England; [Hunt, Neil; Jones, Peter; Ramana, Rajim] Cambridgeshire & Peterborough NHS Fdn Trust, Cambridge, England; [Chase, Jeremy] Hertfordshire Partnership NHS Fdn Trust, Hertford, England; [Ayuba, Larry; Macmillan, Iain] Norfolk & Waveney Mental Hlth NHS Fdn Trust, Norfolk, England; [Michael, Albert] Suffolk Mental Hlth Partnership NHS Trust, Suffolk, England; [Frangou, Sophia; Gijsman, Harm; Parker, Elizabeth; Phillips, Mary] S London & Maudsley NHS Fdn Trust, London, England; [Behr, Graham; Tyrer, Peter] W London Mental Hlth NHS Trust, London, England; [Iqbal, Mohammad; Zikis, Panayiotis] Dudley Primary Care Trust, Dudley, England; [Anderson, Ian; O'Driscoll, David; Robbins, Natalie] Greater Manchester W Mental Hlth NHS Fdn Trust, Manchester, Lancs, England; [Mahmood, Tariq] Mersey Care NHS Trust, Liverpool, Merseyside, England; [Morriss, Richard; Diedricks, Heidi; Faizal, Mohammad A.; McCarthy, James] Leeds Partnerships NHS Fdn Trust, Leeds, W Yorkshire, England; [Greening, Jayne] Birmingham & Solihull Mental Hlth NHS Fdn Trust, Birmingham, W Midlands, England; [Campbell, Colin; Grewal, Jasdey Singh; Kumar, Ashok; Schultewolter, Dieter] Coventry & Warwickshire Partnership NHS Trust, Coventry, W Midlands, England; [Baldwin, David; Best, Nick; Herod, Nicola; Polson, Richard; Shawcross, Charles] Hampshire Partnership NHS Trust, Southampton, Hants, England; [Almoshmosh, Nadim; El-Adl, Mamdouh; Rao, Chandrashekar; Timmins, Bryan] Northamptonshire Healthcare NHS Trust, Northampton, England; [Geddes, John R.; Goodwin, Guy M.; Attenburrow, Mary-Jane; Bale, Rob; Bansal, Sandeep; Bhagwagar, Zubin; Carre, Ali; Cartright, Julia; Chalmers, Julie; Chisuse, Apa; Davison, Phil; Elwell, David; Fazel, Seena; Geaney, David; Hampson, Simon; Harrison, Paul; Henderson, Emma; Johnson, Sophie; Massey, Christopher; Ogilvie, Alan; O'Leary, Denis; Oppenheimer, Catherine; Orr, Michael; Quested, Digby; Sargent, Peter; Wilkinson, Philip] Oxford & Buckinghamshire NHS Fdn Trust, Oxford, England; [Hussain, Tafazul] Oxfordshire Learning Disabil NHS Trust, Oxford, England; [Franklin, Steve; King, John; White, Janet] Worcestershire Mental Hlth Partnership NHS Trust, Worcester, England; [Kirov, George] Cardiff & Vale NHS Trust, Cardiff, S Glam, Wales; [Laugharne, Richard] Cornwall Partnership NHS Trust, Cornwall, England; [Kelly, Chris] Belfast City Hosp Trust, Belfast, Antrim, North Ireland; [Azorin, Jean-Michel; Maurel, Muriele] CHU St Marguerite, Marseille, France; [Ostacher, Michael; Sachs, Gary] Massachusetts Gen Hosp, Boston, MA 02114 USA	University of Oxford; University of Oxford; University of Oxford; Guy's & St Thomas' NHS Foundation Trust; Leicestershire Partnership NHS Trust; Keele University; South London & Maudsley NHS Trust; Cardiff University; Belfast City Hospital; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Harvard University; Massachusetts General Hospital	Geddes, JR (corresponding author), Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford Clin Trials Unit Mental Illness,Trial Mana, Oxford OX3 7JX, England.	john.geddes@psych.ox.ac.uk	Cipriani, Andrea/P-6944-2015; Suri, Anil/P-5128-2016; Cipriani, Andrea/E-5951-2010; Frangou, Sophia/A-2672-2013; Barbui, Corrado/E-7146-2010; Fazel, Seena/B-5307-2008; Tansella, Michele/B-4106-2010; Bhagwagar, Zubin/H-1071-2012; Almoshmosh, Nadim/ABA-4310-2020; Leboyer, Marion/AAW-3648-2021; Geddes, John/B-8240-2011; Goodwin, Guy/ABE-6084-2020; Macmillan, Iain C/L-8933-2013	Cipriani, Andrea/0000-0001-5179-8321; Suri, Anil/0000-0001-5231-5555; Fazel, Seena/0000-0002-5383-5365; Bhagwagar, Zubin/0000-0002-1101-768X; Leboyer, Marion/0000-0001-5473-3697; Geddes, John/0000-0002-5281-5960; Macmillan, Iain C/0000-0002-7909-1560; Lewis, Shon/0000-0003-1861-4652; Harrison, Paul/0000-0002-6719-1126; Taylor, Andrew Mark/0000-0002-1159-6810; Laugharne, Richard/0000-0001-9916-343X; Ostacher, Michael/0000-0003-0353-7535; Young, Allan/0000-0003-2291-6952; Attenburrow, mary jane/0000-0002-1248-8248; Jones, Peter Brian/0000-0002-0387-880X; Kirov, George/0000-0002-3427-3950; curtis, vivienne/0000-0001-5976-525X	Stanley Medical Research Institute; Sanofi-Aventis; MRC [G0700477, MC_U137686861] Funding Source: UKRI; Medical Research Council [MC_U137686861, G0801418B, G0700477] Funding Source: researchfish	Stanley Medical Research Institute; Sanofi-Aventis(Sanofi-Aventis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the participants and the clinical and administrative staff in all four countries who assisted with the trial. BALANCE was funded by the Stanley Medical Research Institute, with French centres funded by Sanofi-Aventis. All study drugs for the UK and France were donated by Sanofi-Aventis, the manufacturers of lithium carbonate (Priadel) and valproate semisodium (Depakote). In the UK, the study was adopted by the Mental Health Research Network in February, 2005.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Blanco C, 2002, AM J PSYCHIAT, V159, P1005, DOI 10.1176/appi.ajp.159.6.1005; Calabrese JR, 2005, AM J PSYCHIAT, V162, P2152, DOI 10.1176/appi.ajp.162.11.2152; Cipriani A, 2005, AM J PSYCHIAT, V162, P1805, DOI 10.1176/appi.ajp.162.10.1805; Citrome L, 1998, PSYCHIAT QUART, V69, P283, DOI 10.1023/A:1022130130855; COOK RJ, 1995, BRIT MED J, V310, P452, DOI 10.1136/bmj.310.6977.452; Fenn HH, 1996, AM J PSYCHIAT, V153, P711; Findling RL, 2005, J AM ACAD CHILD PSY, V44, P409, DOI 10.1097/01.chi.0000155981.83865.ea; Freeman MP, 1998, AM J PSYCHIAT, V155, P12, DOI 10.1176/ajp.155.1.12; Geddes J, 2001, BRIT J PSYCHIAT, V178, pS191, DOI 10.1192/bjp.178.41.s191; Geddes JR, 2009, BRIT J PSYCHIAT, V194, P4, DOI 10.1192/bjp.bp.107.048504; Geddes John R, 2002, World Psychiatry, V1, P48; Geddes JR, 2004, AM J PSYCHIAT, V161, P217, DOI 10.1176/appi.ajp.161.2.217; Goodwin GM, 2009, J PSYCHOPHARMACOL, V23, P346, DOI 10.1177/0269881109102919; Goodwin GM, 2004, J CLIN PSYCHIAT, V65, P432; JONES SH, 1995, BRIT J PSYCHIAT, V166, P654, DOI 10.1192/bjp.166.5.654; Kane JM, 2002, AM J PSYCHIAT, V159, P1, DOI 10.1176/appi.ajp.159.1.1; Kemp DE, 2009, J CLIN PSYCHIAT, V70, P113, DOI 10.4088/JCP.07m04022; Kind P., 1996, QUAL LIFE PHARMACOEC, V25, P3110, DOI [10.1097/00007632-200012150-00005, DOI 10.1097/00007632-200012150-00005]; LANG JM, 1990, STAT MED, V9, P87, DOI 10.1002/sim.4780090115; MACRITCHIE K, 2004, COCHRANE DB SYST REV, V4; Macritchie KA, 2001, COCHRANE DB SYST REV, V3, DOI [10.1002/14651858, 10.1002/14651858.CD003196, DOI 10.1002/14651858.CD003196]; Meador KJ, 2009, NEW ENGL J MED, V360, P1597, DOI 10.1056/NEJMoa0803531; Merikangas KR, 2007, ARCH GEN PSYCHIAT, V64, P543, DOI 10.1001/archpsyc.64.5.543; Muller-Oerlinghausen B, 2002, LANCET, V359, P241, DOI 10.1016/S0140-6736(02)07450-0; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; National Institute for Health and Clinical Excellence, BIP DIS MAN BIP DIS; Ostacher MJ, 2008, ACTA PSYCHIAT SCAND, V118, P49, DOI 10.1111/j.1600-0447.2008.01201.x; Pablos-Mendez A, 1998, JAMA-J AM MED ASSOC, V279, P222, DOI 10.1001/jama.279.3.222; Rendell JM, 2004, BIPOLAR DISORD, V6, P26, DOI 10.1046/j.1399-5618.2003.00088.x; Sachs GS, 2007, NEW ENGL J MED, V356, P1711, DOI 10.1056/NEJMoa064135; Sanderson DR, 1998, PSYCHIATR SERV, V49, P1145, DOI 10.1176/ps.49.9.1145; Soares-Weiser K, 2007, HEALTH TECHNOL ASSES, V11, P1; STEPHENSON BJ, 1993, JAMA-J AM MED ASSOC, V269, P2779, DOI 10.1001/jama.269.21.2779; SUPPES T, 1991, ARCH GEN PSYCHIAT, V48, P1082; Williams RSB, 2002, NATURE, V417, P292, DOI 10.1038/417292a; Zarate CA, 2006, BIOL PSYCHIAT, V59, P1006, DOI 10.1016/j.biopsych.2005.10.021	37	347	352	3	52	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2010	375	9712					385	395		10.1016/S0140-6736(09)61828-6	http://dx.doi.org/10.1016/S0140-6736(09)61828-6			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	552PK	20092882	Green Submitted			2022-12-28	WOS:000274305500026
J	Gianni, L; Eiermann, W; Semiglazov, V; Manikhas, A; Lluch, A; Tjulandin, S; Zambetti, M; Vazquez, F; Byakhow, M; Lichinitser, M; Climent, MA; Ciruelos, E; Ojeda, B; Mansutti, M; Bozhok, A; Baronio, R; Feyereislova, A; Barton, C; Valagussa, P; Baselga, J				Gianni, Luca; Eiermann, Wolfgang; Semiglazov, Vladimir; Manikhas, Alexey; Lluch, Ana; Tjulandin, Sergey; Zambetti, Milvia; Vazquez, Federico; Byakhow, Mikhail; Lichinitser, Mikhail; Angel Climent, Miguel; Ciruelos, Eva; Ojeda, Belen; Mansutti, Mauro; Bozhok, Alla; Baronio, Roberta; Feyereislova, Andrea; Barton, Claire; Valagussa, Pinuccia; Baselga, Jose			Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort	LANCET			English	Article							COMPARING DOXORUBICIN; MONOCLONAL-ANTIBODY; PHASE-II; CYCLOPHOSPHAMIDE; PACLITAXEL; EFFICACY; RECEPTOR; THERAPY; SAFETY; PLUS	Background The monoclonal antibody trastuzumab has survival benefit when given with chemotherapy to patients with early, operable, and metastatic breast cancer that has HER2 (also known as ERBB2) overexpression or amplification. We aimed to assess event-free survival in patients with HER2-positive locally advanced or inflammatory breast cancer receiving neoadjuvant chemotherapy with or without 1 year of trastuzumab. Methods We compared I year of treatment with trastuzumab (given as neoadjuvant and adjuvant treatment; n=117) with no trastuzumab (118), in women with HER2-positive locally advanced or inflammatory breast cancer treated with a neoadjuvant chemotherapy regimen consisting of doxorubicin, paclitaxel, cyclophosphamide, methotrexate, and fluorouracil. Randomisation was done with a computer program and minimisation technique, taking account of geographical area, disease stage, and hormone receptor status. investigators were informed of treatment allocation. A parallel cohort of 99 patients with HER2-negative disease was included and treated with the same chemotherapy regimen. Primary endpoint was event-free survival. Analysis was by intention to treat. This study is registered, number ISRCTN86043495. Findings Trastuzumab significantly improved event-free survival in patients with HER2-positive breast cancer (3-year event-free survival, 71% [95% CI 61-78; n=36 events] with trastuzumab, vs 56% [46-65; n=51 events] without; hazard ratio 0.59 [95% CI 0.38-0.90]; p=0.013). Trastuzumab was well tolerated and, despite concurrent administration with doxorubicin, only two patients (2%) developed symptomatic cardiac failure. Both responded to cardiac drugs. Interpretation The addition of neoadjuvant and adjuvant trastuzumab to neoadjuvant chemotherapy should be considered for women with HER2-positive locally advanced or inflammatory breast cancer to improve event-free survival, survival, and clinical and pathological turnout responses.	[Gianni, Luca; Zambetti, Milvia] Fdn IRCCS Ist Nazl Tumori, I-20133 Milan, Italy; [Eiermann, Wolfgang] Frauenklin vom Roten Kreuz, Munich, Germany; [Semiglazov, Vladimir; Bozhok, Alla] NN Petrov Oncol Res Inst, St Petersburg, Russia; [Manikhas, Alexey] City Oncol Hosp, St Petersburg, Russia; [Lluch, Ana] Hosp Clin Univ Valencia, Valencia, Spain; [Tjulandin, Sergey; Lichinitser, Mikhail] NN Blokhin Russian Canc Ctr, Moscow, Russia; [Vazquez, Federico; Baselga, Jose] Vall dHebron Univ Hosp, Barcelona, Spain; [Byakhow, Mikhail] Cent Clin Hosp, Moscow, Russia; [Angel Climent, Miguel] Ist Valenciano Oncol, Valencia, Spain; [Ciruelos, Eva] Hosp Univ 12 Octubre, Madrid, Spain; [Ojeda, Belen] Hosp San Pau, Barcelona, Spain; [Mansutti, Mauro] Osped S Maria Misericordia, Udine, Italy; [Baronio, Roberta; Valagussa, Pinuccia] Fdn Michelangelo, Milan, Italy; [Feyereislova, Andrea; Barton, Claire] F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland	Fondazione IRCCS Istituto Nazionale Tumori Milan; N.N. Petrov Research Institute of Oncology; Hospital Clinic Universitari de Valencia; N.N. Blokhin Russian Cancer Research Center; Hospital Universitari Vall d'Hebron; Instituto Valenciano De Oncologia; Hospital Universitario 12 de Octubre; Hospital Santa Maria della Misericordia; Roche Holding	Gianni, L (corresponding author), Fdn IRCCS Ist Nazl Tumori, 1 Via Venezian, I-20133 Milan, Italy.	luca.gianni@istitutotumori.mi.it	Lluch, Ana/R-5493-2019; Manikhas, Alexey/ABI-7193-2020; Mieszkowska, Magdalena/O-6753-2017	Lluch, Ana/0000-0003-2766-407X; Semiglazov, Vladimir/0000-0003-0077-9619; Ciruelos, Eva/0000-0002-2796-1042; Valagussa, Pinuccia/0000-0003-3590-7916; Manikhas, Alexey/0000-0001-9616-6635; GIANNI, LUCA/0000-0002-2372-9625	GlaxoSmithKline; F Hoffmann-La Roche	GlaxoSmithKline(GlaxoSmithKline); F Hoffmann-La Roche(Hoffmann-La Roche)	LG has served on scientific advisory boards for Roche, Genentech, GlaxoSimthKline, Wyeth, Novartis, Millennium, Biogenldec, and Eisai. I B has had consultant or advisory roles for Exelixis, Merck, Novartis, and Roche, and has received research Funding from GlaxoSmithKline. AF is employed by Roche. CB has been employed by Roche, has held consultancies for ONO Pharma, Cellact, Acacia, Michelangelo, BTG Ltd, Kuros Biosurgery, Micromet AG, Bioenvision, Norgine, and Piramed, and has field stock in GlaxoSmithKline. WE, VS, AM, AL, ST MZ, FV, MB, ML, MAC, EC, BO, MM, AB, RB, and PV declare that they have no conflicts of interest.; F Hoffmann-La Roche provided trasnizurnalk and financial support. We thank all the patients who have participated in our trial, the many associates, in particular medical oncologists, surgeons, radiation therapists, pathologists, research nurses, and data managers for their cooperation, and Alberto Berti, Lidia Mariani, and Claudia Tomezzoli from the Michelangelo operations office and Viviana Beritata from SOLTI for study coordination and data management. Data from this trial have previously been presented at international conferences (Baselga et al, ECCO 2007; Eiermann et al, EBCC7 2008; Semiglazov et al, EBCC7 2008).	Baselga J, 2007, EJC SUPPL, V5, P193, DOI 10.1016/S1359-6349(07)70792-9; Baselga J, 2005, J CLIN ONCOL, V23, P2162, DOI 10.1200/JCO.2005.01.014; Bear HD, 2006, J CLIN ONCOL, V24, P2019, DOI 10.1200/JCO.2005.04.1665; Bianchi G, 2003, CLIN CANCER RES, V9, P5944; Bonadonna G, 1998, J CLIN ONCOL, V16, P93, DOI 10.1200/JCO.1998.16.1.93; Buzdar AU, 2005, J CLIN ONCOL, V23, P3676, DOI 10.1200/JCO.2005.07.032; Chia S, 2008, J CLIN ONCOL, V26, P786, DOI 10.1200/JCO.2008.15.0243; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; Collett D, 1994, MODELLING SURVIVAL D; Eiermann W, 2008, EJC SUPPL, V6, P115, DOI 10.1016/S1359-6349(08)70544-5; Gianni L, 2001, ANN ONCOL, V12, P1067, DOI 10.1023/A:1011655503511; Gianni L, 2007, J CLIN ONCOL, V25, P3389, DOI 10.1200/JCO.2007.10.9504; Gianni L, 2009, J CLIN ONCOL, V27, P2474, DOI 10.1200/JCO.2008.19.2567; Gluck Stefan, 2008, Int J Med Sci, V5, P341; Hance KW, 2005, JNCI-J NATL CANCER I, V97, P966, DOI 10.1093/jnci/dji172; Marty M, 2005, J CLIN ONCOL, V23, P4265, DOI 10.1200/JCO.2005.04.173; *NAT CANC I, COMM TOX CRIT VERS 2; Perez EA, 2008, J CLIN ONCOL, V26, P1231, DOI 10.1200/JCO.2007.13.5467; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Ross JS, 2009, ONCOLOGIST, V14, P320, DOI 10.1634/theoncologist.2008-0230; Rouzier R, 2005, CLIN CANCER RES, V11, P5678, DOI 10.1158/1078-0432.CCR-04-2421; Sant M, 2004, CANCER-AM CANCER SOC, V100, P715, DOI 10.1002/cncr.20038; SEMINGLAZOV V, 2008, EJC SUPPL, V6, P115; Shaye OS, 2007, J CLIN ONCOL, V25; Slamon D, 2005, BREAST CANCER RES TR, V94, pS5; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Smith I, 2007, LANCET, V369, P29, DOI 10.1016/S0140-6736(07)60028-2; Tan-Chiu E, 2005, J CLIN ONCOL, V23, P7811, DOI 10.1200/JCO.2005.02.4091; TAVES DR, 1974, CLIN PHARMACOL THER, V15, P443; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Untch M, 2008, 6 EUR BREAST CANC C; Zell JA, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2225	32	845	901	3	78	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2010	375	9712					377	384		10.1016/S0140-6736(09)61964-4	http://dx.doi.org/10.1016/S0140-6736(09)61964-4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	552PK	20113825				2022-12-28	WOS:000274305500025
J	Pekic, S; Arsenijevic, VA; Gazibara, MS; Milojevic, T; Pendjer, I; Stojanovic, M; Popovic, V				Pekic, Sandra; Arsenijevic, Valentina Arsic; Gazibara, Milica Skender; Milojevic, Toplica; Pendjer, Ivica; Stojanovic, Marko; Popovic, Vera			What lurks in the sellar?	LANCET			English	Article									[Pekic, Sandra; Stojanovic, Marko; Popovic, Vera] Univ Clin Ctr, Neuroendocrine Unit, Inst Endocrinol, Belgrade 11000, Serbia; [Milojevic, Toplica] Univ Clin Ctr, Inst Neurosurg, Belgrade 11000, Serbia; [Pendjer, Ivica] Univ Clin Ctr, Inst Otorhinolaryngol, Belgrade 11000, Serbia; [Arsenijevic, Valentina Arsic] Inst Microbiol, Reference Med Mycol Lab, Belgrade, Serbia; [Gazibara, Milica Skender] Univ Belgrade, Sch Med, Inst Pathol, Belgrade, Serbia	University of Belgrade	Popovic, V (corresponding author), Univ Clin Ctr, Neuroendocrine Unit, Inst Endocrinol, Dr Subotica 13, Belgrade 11000, Serbia.	popver@eunet.rs	Pekic, Sandra/S-7175-2016	Skender-Gazibara, Milica/0000-0001-7538-2742				Breuel KF, 2004, NEUROIMMUNOMODULAT, V11, P1, DOI 10.1159/000072963; Cestari DM, 2008, NEW ENGL J MED, V359, P2825, DOI 10.1056/NEJMcpc0805311; KERN ME, 1986, J CLIN MICROBIOL, V23, P1001, DOI 10.1128/JCM.23.6.1001-1005.1986; Ponikau JU, 1999, MAYO CLIN PROC, V74, P877, DOI 10.4065/74.9.877; Shin SH, 2004, J ALLERGY CLIN IMMUN, V114, P1369, DOI 10.1016/j.jaci.2004.08.012	5	14	14	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN-FEB	2010	375	9712					432	432		10.1016/S0140-6736(09)61835-3	http://dx.doi.org/10.1016/S0140-6736(09)61835-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	552PK	20113828				2022-12-28	WOS:000274305500031
J	Veselka, N; McErlain, DD; Holdsworth, DW; Eger, JL; Chhem, RK; Mason, MJ; Brain, KL; Faure, PA; Fenton, MB				Veselka, Nina; McErlain, David D.; Holdsworth, David W.; Eger, Judith L.; Chhem, Rethy K.; Mason, Matthew J.; Brain, Kirsty L.; Faure, Paul A.; Fenton, M. Brock			A bony connection signals laryngeal echolocation in bats	NATURE			English	Article							COMPUTED-TOMOGRAPHY; MIDDLE-EAR; EVOLUTION; MAMMALS; APPARATUS; REGION; FLIGHT	Echolocation is an active form of orientation in which animals emit sounds and then listen to reflected echoes of those sounds to form images of their surroundings in their brains(1). Although echolocation is usually associated with bats, it is not characteristic of all bats(2,3). Most echolocating bats produce signals in the larynx, but within one family of mainly non-echolocating species (Pteropodidae), a few species use echolocation sounds produced by tongue clicks(4,5). Here we demonstrate, using data obtained from micro-computed tomography scans of 26 species (n = 35 fluid-preserved bats), that proximal articulation of the stylohyal bone (part of the mammalian hyoid apparatus) with the tympanic bone always distinguishes laryngeally echolocating bats from all other bats (that is, non-echolocating pteropodids and those that echo-locate with tongue clicks). In laryngeally echolocating bats, the proximal end of the stylohyal bone directly articulates with the tympanic bone and is often fused with it. Previous research on the morphology of the stylohyal bone in the oldest known fossil bat (Onychonycteris finneyi) suggested that it did not echolocate(6), but our findings suggest that O. finneyi may have used laryngeal echolocation because its stylohyal bones may have articulated with its tympanic bones. The present findings reopen basic questions about the timing and the origin of flight and echolocation in the early evolution of bats. Our data also provide an independent anatomical character by which to distinguish laryngeally echolocating bats from other bats.	[Veselka, Nina; Fenton, M. Brock] Univ Western Ontario, Dept Biol, London, ON N6A 5B7, Canada; [McErlain, David D.; Holdsworth, David W.] Univ Western Ontario, Robarts Res Inst, Imaging Res Labs, London, ON N6A 5B7, Canada; [McErlain, David D.] Univ Western Ontario, Dept Med Biophys, London, ON N6A 5B7, Canada; [Holdsworth, David W.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Surg, London, ON N6A 5K8, Canada; [Eger, Judith L.] Royal Ontario Museum, Dept Nat Hist, Toronto, ON M5S 2C6, Canada; [Chhem, Rethy K.] Med Univ Vienna, Div Human Hlth, Dept Radiol, A-1090 Vienna, Austria; [Chhem, Rethy K.] IAEA, Div Human Hlth, A-1400 Vienna, Austria; [Mason, Matthew J.; Brain, Kirsty L.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England; [Faure, Paul A.] McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON L8S 4K1, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Royal Ontario Museum; Medical University of Vienna; International Atomic Energy Agency; University of Cambridge; McMaster University	Fenton, MB (corresponding author), Univ Western Ontario, Dept Biol, London, ON N6A 5B7, Canada.	bfenton@uwo.ca	Holdsworth, David W/F-6315-2012; Mason, Matthew James/AAX-9783-2021	Holdsworth, David W/0000-0002-0603-5322; Mason, Matthew James/0000-0001-7845-0720	Canadian Institutes of Health Research [CIHR MOP-89852]; Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation; Ontario Innovation Trust	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Innovation Trust	We thank B. Clare, E. Fraser, B. Galef, L. Jakobsen, D. S. Johnston, L. Lazure, J. McNeil, S. Peters, J. Ratcliffe, D. Riskin, K. Seymour, J. A. Simmons, N. Simmons, J. Szewczak and H. The wissen for comments on earlier versions of the manuscript, and K. Seymour, who arranged access to the O. finneyi specimen. We are particularly grateful to S. I. Pollmann, who assisted in the preparation of the Supplementary Movies. Our research was supported by an Operating Grant from the Canadian Institutes of Health Research (CIHR MOP-89852), and by Discovery Grants from the Natural Sciences and Engineering Research Council of Canada. The McMaster Bat Lab is also supported by grants from the Canada Foundation for Innovation and the Ontario Innovation Trust.	Cranford TW, 1996, J MORPHOL, V228, P223; FELDKAMP LA, 1989, J BONE MINER RES, V4, P3, DOI 10.1002/jbmr.5650040103; FENTON MB, 1995, PALEOBIOLOGY, V21, P229, DOI 10.1017/S0094837300013221; GOULD E, 1988, J MAMMAL, V69, P378, DOI 10.2307/1381392; Griffin DR, 1958, LISTENING DARK; HABERSETZER J, 1992, NATURWISSENSCHAFTEN, V79, P462, DOI 10.1007/BF01139198; HOFFMEISTER RG, 1991, AN I BIOL U NAC AU Z, V52, P219; Holderied MW, 2005, J EXP BIOL, V208, P1321, DOI 10.1242/jeb.01528; Holland RA, 2005, ACTA CHIROPTEROL, V7, P83, DOI 10.3161/1733-5329(2005)7[83:ESAPMI]2.0.CO;2; JEN PHS, 1976, SCIENCE, V191, P950, DOI 10.1126/science.1251206; Jones G, 2006, TRENDS ECOL EVOL, V21, P149, DOI 10.1016/j.tree.2006.01.001; Mason MJ, 2006, J MORPHOL, V267, P678, DOI 10.1002/jmor.10430; McErlain DD, 2008, OSTEOARTHR CARTILAGE, V16, P458, DOI 10.1016/j.joca.2007.08.006; Moss CF, 2001, J ACOUST SOC AM, V110, P2207, DOI 10.1121/1.1398051; Muller R, 2004, J ACOUST SOC AM, V116, P3701, DOI 10.1121/1.1815133; Nickel R., 1984, LEHRBUCH ANATOMIE HA; REIDENBERG JS, 1994, ANAT RECORD, V240, P598, DOI 10.1002/ar.1092400417; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; Siemers BM, 2009, BIOL LETTERS, V5, P593, DOI 10.1098/rsbl.2009.0378; Simmons NB, 2008, NATURE, V451, P818, DOI 10.1038/nature06549; Simmons NB, 1998, B AM MUS NAT HIST, P1; SPEAKMAN JR, 1991, NATURE, V350, P421, DOI 10.1038/350421a0; SPRAGUE JAMES M., 1941, JOUR MAMMAL, V22, P296, DOI 10.2307/1374956; Sprague JM, 1943, AM J ANAT, V72, P385, DOI 10.1002/aja.1000720304; Springer MS, 2004, TRENDS ECOL EVOL, V19, P430, DOI 10.1016/j.tree.2004.05.006; SUTHERS RA, 1988, J COMP PHYSIOL A, V162, P799, DOI 10.1007/BF00610969; Teeling EC, 2009, TRENDS ECOL EVOL, V24, P351, DOI 10.1016/j.tree.2009.02.012; Thomas JA, 2004, ECHOLOCATION BATS DO; van der Klaauw CJ, 1931, B AM MUS NAT HIST, V62, P1; Wible JR, 2008, ANN CARNEGIE MUS, V77, P321, DOI 10.2992/0097-4463-77.3.321	30	83	85	1	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 18	2010	463	7283					939	942		10.1038/nature08737	http://dx.doi.org/10.1038/nature08737			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556HZ	20098413				2022-12-28	WOS:000274582700044
J	Boddey, JA; Hodder, AN; Gunther, S; Gilson, PR; Patsiouras, H; Kapp, EA; Pearce, JA; de Koning-Ward, TF; Simpson, RJ; Crabb, BS; Cowman, AF				Boddey, Justin A.; Hodder, Anthony N.; Guenther, Svenja; Gilson, Paul R.; Patsiouras, Heather; Kapp, Eugene A.; Pearce, J. Andrew; de Koning-Ward, Tania F.; Simpson, Richard J.; Crabb, Brendan S.; Cowman, Alan F.			An aspartyl protease directs malaria effector proteins to the host cell	NATURE			English	Article							FALCIPARUM-INFECTED ERYTHROCYTES; PLASMODIUM EXPORT ELEMENT; ENDOPLASMIC-RETICULUM; PARASITE PROTEINS; HIV-1 PROTEASE; TRAFFICKING; EXPRESSION; VIRULENCE; CYTOADHERENCE; INVASION	Plasmodium falciparum causes the virulent form of malaria and disease manifestations are linked to growth inside infected erythrocytes. To survive and evade host responses the parasite remodels the erythrocyte by exporting several hundred effector proteins beyond the surrounding parasitophorous vacuole membrane. A feature of exported proteins is a pentameric motif (RxLxE/Q/D) that is a substrate for an unknown protease. Here we show that the protein responsible for cleavage of this motif is plasmepsin V (PMV), an aspartic acid protease located in the endoplasmic reticulum. PMV cleavage reveals the export signal (xE/Q/D) at the amino terminus of cargo proteins. Expression of an identical mature protein with xQ at the N terminus generated by signal peptidase was not exported, demonstrating that PMV activity is essential and linked with other key export events. Identification of the protease responsible for export into erythrocytes provides a novel target for therapeutic intervention against this devastating disease.	[Boddey, Justin A.; Hodder, Anthony N.; Guenther, Svenja; Pearce, J. Andrew; Simpson, Richard J.; Cowman, Alan F.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia; [Gilson, Paul R.; Crabb, Brendan S.] Macfarlane Burnet Inst Med Res & Publ Hlth, Melbourne, Vic 3004, Australia; [Patsiouras, Heather; Kapp, Eugene A.; Simpson, Richard J.] Ludwig Inst Canc Res, Joint Prote Facil, Melbourne, Vic 3050, Australia; [de Koning-Ward, Tania F.] Deakin Univ, Waurn Ponds 3217, Australia	Walter & Eliza Hall Institute; Burnet Institute; Ludwig Institute for Cancer Research; Deakin University	Cowman, AF (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia.	cowman@wehi.edu.au	de Koning-Ward, Tania F/N-3572-2017; Simpson, Richard/A-6947-2012; Cowman, Alan F/C-7642-2013; Crabb, Brendan/F-5287-2013	de Koning-Ward, Tania F/0000-0001-5810-8063; Cowman, Alan F/0000-0001-5145-9004; Boddey, Justin/0000-0001-7322-2040; Simpson, Richard/0000-0002-9834-0796	National Health and Medical Research Council; National Institutes of Health [RO1 AI44008]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044008] Funding Source: NIH RePORTER	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the Australian Red Cross Blood Bank for the provision of human blood and serum, the AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH for providing HIV protease inhibitors and MR4 (ATCC) for plasmepsin V antibodies, contributed by D. Goldberg. This work was supported by the National Health and Medical Research Council, and a grant from the National Institutes of Health (RO1 AI44008). J.A.B. is an NHMRC Peter Doherty postdoctoral Fellow and A. F. C. is an International Research Scholar of the Howard Hughes Medical Institute and an Australia Fellow.	BARNWELL JW, 1989, J CLIN INVEST, V84, P765, DOI 10.1172/JCI114234; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Baum J, 2008, CELL HOST MICROBE, V3, P188, DOI 10.1016/j.chom.2008.02.006; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Boddey JA, 2009, TRAFFIC, V10, P285, DOI 10.1111/j.1600-0854.2008.00864.x; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Chang HH, 2008, MOL BIOCHEM PARASIT, V160, P107, DOI 10.1016/j.molbiopara.2008.04.011; de Koning-Ward TF, 2009, NATURE, V459, P945, DOI 10.1038/nature08104; Duraisingh MT, 2002, INT J PARASITOL, V32, P81, DOI 10.1016/S0020-7519(01)00345-9; Gilson PR, 2008, MOL MICROBIOL, V68, P124, DOI 10.1111/j.1365-2958.2008.06140.x; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Hodder AN, 2009, J MOL BIOL, V392, P154, DOI 10.1016/j.jmb.2009.07.007; Klemba M, 2005, MOL BIOCHEM PARASIT, V143, P183, DOI 10.1016/j.molbiopara.2005.05.015; Knuepfer E, 2005, MOL BIOCHEM PARASIT, V142, P258, DOI 10.1016/j.molbiopara.2005.04.005; LaGreca N, 1997, MOL BIOCHEM PARASIT, V89, P283, DOI 10.1016/S0166-6851(97)00134-5; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Maier AG, 2009, NAT REV MICROBIOL, V7, P341, DOI 10.1038/nrmicro2110; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Meissner M, 2005, P NATL ACAD SCI USA, V102, P2980, DOI 10.1073/pnas.0500112102; MILLER LH, 1994, SCIENCE, V264, P1878, DOI 10.1126/science.8009217; MILLER M, 1989, SCIENCE, V246, P1149, DOI 10.1126/science.2686029; Pain A, 2008, NATURE, V455, P799, DOI 10.1038/nature07306; Pei XH, 2005, J BIOL CHEM, V280, P31166, DOI 10.1074/jbc.M505298200; Przyborski JM, 2005, EMBO J, V24, P2306, DOI 10.1038/sj.emboj.7600720; RAVENTOSSUAREZ C, 1985, P NATL ACAD SCI USA, V82, P3829, DOI 10.1073/pnas.82.11.3829; Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; van Ooij C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000084; Waller RF, 2000, EMBO J, V19, P1794, DOI 10.1093/emboj/19.8.1794; WEBER IT, 1989, SCIENCE, V243, P928, DOI 10.1126/science.2537531	34	227	232	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 4	2010	463	7281					627	U52		10.1038/nature08728	http://dx.doi.org/10.1038/nature08728			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551GB	20130643	Green Accepted			2022-12-28	WOS:000274193900028
J	Torrazza-Perez, E; Carreno, N				Torrazza-Perez, Euriko; Carreno, Norberto			Bleeding Esophageal Varices	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Torrazza-Perez, Euriko] Wayne State Univ, Sch Med, Detroit, MI 48202 USA; [Carreno, Norberto] Complejo Hosp Metropolitano, Panama City, Panama	Wayne State University	Torrazza-Perez, E (corresponding author), Wayne State Univ, Sch Med, Detroit, MI 48202 USA.	etorrazza@med.wayne.edu							0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 4	2010	362	5					e13	e13		10.1056/NEJMicm0807812	http://dx.doi.org/10.1056/NEJMicm0807812			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551FV	20130251				2022-12-28	WOS:000274193300011
J	Mirabito, AM; Berry, LL				Mirabito, Ann M.; Berry, Leonard L.			Lessons That Patient-Centered Medical Homes Can Learn From the Mistakes of HMOs	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							MANAGED-CARE; PLAN PERFORMANCE; QUALITY	Patient-centered medical homes (PCMHs) have been endorsed by primary and specialty care medical associations, payers, and patient groups as an innovative structure for transforming health care delivery. The cornerstone principle of the PCMH is the primary care physician's coordination of a patient's use of health care services, including visits to specialists, to improve effectiveness and efficiency. This principle aligns with the vision behind the creation of HMOs, managed care organizations that were once embraced by physicians, patients, and policy analysts but have since lost much of their luster. Many patients and physicians rejected HMOs as too restrictive, objecting particularly to the concept of gatekeeping. This article reviews the HMO experience and identifies lessons applicable to PCMHs that build on the strengths of HMOs while avoiding their mistakes.	[Mirabito, Ann M.] Baylor Univ, Hankamer Sch Business, Waco, TX 76798 USA; Texas A&M Univ, Mays Business Sch, College Stn, TX USA; Texas A&M Univ, Coll Med, Hlth Sci Ctr, College Stn, TX 77843 USA	Baylor University; Texas A&M University System; Texas A&M University College Station; Mays Business School; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Mirabito, AM (corresponding author), Baylor Univ, Hankamer Sch Business, 1 Bear Pl 98007, Waco, TX 76798 USA.	Ann_Mirabito@Baylor.edu		Mirabito, Ann/0000-0002-7506-0206				Barry MJ, 2002, ANN INTERN MED, V136, P127, DOI 10.7326/0003-4819-136-2-200201150-00010; BAUCUS M, 2008, CALL ACTION HEALTHCA; Berwick DM, 2009, HEALTH AFFAIR, V28, pW555, DOI 10.1377/hlthaff.28.4.w555; Carroll A, 2002, J HEALTH POLIT POLIC, V27, P927, DOI 10.1215/03616878-27-6-927; COOMBS JG, 2005, RISE FALL HMOS; Ellwood P M Jr, 1971, Med Care, V9, P291, DOI 10.1097/00005650-197105000-00008; FOUBISTER V, 2008, FOCUS ARE MED HOMES; Friedberg MW, 2009, J GEN INTERN MED, V24, P162, DOI 10.1007/s11606-008-0856-x; Goldberg DG, 2009, ANN FAM MED, V7, P301, DOI 10.1370/afm.1021; Grumbach K, 1998, NEW ENGL J MED, V339, P1516, DOI 10.1056/NEJM199811193392106; Grumbach K, 1999, JAMA-J AM MED ASSOC, V282, P261, DOI 10.1001/jama.282.3.261; GRUMBACH K, 2009, PATIENT CTR PRIMARY, P78; Kao AC, 1998, JAMA-J AM MED ASSOC, V280, P1708, DOI 10.1001/jama.280.19.1708; MCCARTHY D, 2009, COMMUNITY CARE N CAR; Mechanic D, 2004, J HEALTH SOC BEHAV, V45, P76; Miller RH, 1997, HEALTH AFFAIR, V16, P7, DOI 10.1377/hlthaff.16.5.7; Miller RH, 2002, HEALTH AFFAIR, V21, P63, DOI 10.1377/hlthaff.21.4.63; Milstein A, 2009, HEALTH AFFAIR, V28, P1317, DOI 10.1377/hlthaff.28.5.1317; Nutting PA, 2009, ANN FAM MED, V7, P254, DOI 10.1370/afm.1002; *OFF PAT ADV, 2009, HMO RAT GLANC; Oke A, 2009, ORGAN DYN, V38, P64, DOI 10.1016/j.orgdyn.2008.10.005; *PAT CTR PRIM CAR, 2008, PAT CTR MED HOM BUIL; Pearson SD, 1999, J GEN INTERN MED, V14, pS13, DOI 10.1046/j.1525-1497.1999.00259.x; Petersen LA, 2006, ANN INTERN MED, V145, P265, DOI 10.7326/0003-4819-145-4-200608150-00006; Rittenhouse DR, 2008, HEALTH AFFAIR, V27, P1246, DOI 10.1377/hlthaff.27.5.1246; Rittenhouse DR, 2009, JAMA-J AM MED ASSOC, V301, P2038, DOI 10.1001/jama.2009.691; Rittenhouse DR, 2004, HEALTH AFFAIR, V23, P51, DOI 10.1377/hlthaff.23.6.51; Robinson JC, 2001, JAMA-J AM MED ASSOC, V285, P2622, DOI 10.1001/jama.285.20.2622; Rosenthal TC, 2008, J AM BOARD FAM MED, V21, P427, DOI 10.3122/jabfm.2008.05.070287; Wallack S S, 1991, Health Care Financ Rev Annu Suppl, P27	30	4	4	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 2	2010	152	3					182	185		10.7326/0003-4819-152-3-201002020-00011	http://dx.doi.org/10.7326/0003-4819-152-3-201002020-00011			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	552WN	20124235				2022-12-28	WOS:000274324600007
J	Mackenzie, M; O'Donnell, C; Halliday, E; Sridharan, S; Platt, S				Mackenzie, Mhairi; O'Donnell, Catherine; Halliday, Emma; Sridharan, Sanjeev; Platt, Stephen			Do health improvement programmes fit with MRC guidance on evaluating complex interventions?	BRITISH MEDICAL JOURNAL			English	Editorial Material							CARE; REALITY; ENGLAND		[Mackenzie, Mhairi] Univ Glasgow, Dept Urban Studies, Glasgow, Lanark, Scotland; [O'Donnell, Catherine] Univ Glasgow, Div Community Based Sci, Glasgow, Lanark, Scotland; [Halliday, Emma] NHS Hlth Scotland, Policy Evaluat & Appraisal, Edinburgh EH12 5HE, Midlothian, Scotland; [Sridharan, Sanjeev] Univ Toronto, St Michaels Hosp, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Platt, Stephen] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh EH8 9AG, Midlothian, Scotland	University of Glasgow; University of Glasgow; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Edinburgh	Mackenzie, M (corresponding author), Univ Glasgow, Dept Urban Studies, Glasgow, Lanark, Scotland.	m.mackenzie@lbss.gla.ac.uk		Halliday, Emma Catherine/0000-0002-2216-9259; O'Donnell, Kate/0000-0002-5368-3779				Brown C, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2764; Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694; Campbell S, 2007, NEW ENGL J MED, V357, P181, DOI 10.1056/NEJMsr065990; Connell J., 1995, NEW APPROACHES EVALU, V1; Craig P., 2008, DEV EVALUATING COMPL; Crebolder HFJM, 1996, PATIENT EDUC COUNS, V28, P51, DOI 10.1016/0738-3991(96)00869-5; HART JT, 1991, BMJ-BRIT MED J, V302, P1509, DOI 10.1136/bmj.302.6791.1509; Hawe P, 2004, BMJ-BRIT MED J, V328, P1561, DOI 10.1136/bmj.328.7455.1561; Hawe P, 2009, AM J COMMUN PSYCHOL, V43, P267, DOI 10.1007/s10464-009-9229-9; *HOUS COMM HLTH CO, 2009, HLTH IN 3 REP SESS 2; May C, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-148; Oakley A, 1998, BRIT MED J, V317, P1239, DOI 10.1136/bmj.317.7167.1239; ODONNELL K, 2008, NATL EVALUATION KEEP; Pawson R., 1997, REALISTIC EVALUATION; Petticrew M, 2004, J EPIDEMIOL COMMUN H, V58, P811, DOI 10.1136/jech.2003.015289; Rogers P., 2008, EVALUATION-US, V14, P29, DOI [DOI 10.1177/1356389007084674, 10.1177/1356389007084674]; Shiell A, 2008, BMJ-BRIT MED J, V336, P1281, DOI 10.1136/bmj.39569.510521.AD; Sowden SL, 2008, J EPIDEMIOL COMMUN H, V62, P835, DOI 10.1136/jech.2007.069781; The Scottish Government, 2005, DEL HLTH; Weiss C. H., 1998, EVALUATION METHODS S	20	51	51	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 1	2010	340								c185	10.1136/bmj.c185	http://dx.doi.org/10.1136/bmj.c185			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	553CT	20123834				2022-12-28	WOS:000274343300006
J	Blackstock, JJ; Long, JCS				Blackstock, Jason J.; Long, Jane C. S.			The Politics of Geoengineering	SCIENCE			English	Editorial Material									[Blackstock, Jason J.] Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria; [Blackstock, Jason J.] Ctr Int Governance Innovat, Waterloo, ON N2L 6C2, Canada; [Long, Jane C. S.] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA	International Institute for Applied Systems Analysis (IIASA); United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Blackstock, JJ (corresponding author), Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria.	jjb@iiasa.ac.at						Blackstock J. J., 2009, CLIMATE ENG RESPONSE; Buesseler KO, 2008, SCIENCE, V319, P162, DOI 10.1126/science.1154305; Izrael YA, 2009, RUSS METEOROL HYDROL, V34, P265, DOI 10.3103/S106837390905001X; Keith DW, 2009, SCIENCE, V325, P1654, DOI 10.1126/science.1175680; KINTISCH E, 2009, SCIENCEINSIDER; McMullen C., 2009, CLIMATE CHANGE SCI C; Rahmstorf S, 2007, SCIENCE, V316, P709, DOI 10.1126/science.1136843; Robock A, 2010, SCIENCE, V327, P530, DOI 10.1126/science.1186237; Shepherd J, 2009, GEOENGINEERING CLIMA; Victor DG, 2009, FOREIGN AFF, V88, P64; 2009, NATURE GEOSCI, V2, P153	11	58	58	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 29	2010	327	5965					527	527		10.1126/science.1183877	http://dx.doi.org/10.1126/science.1183877			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	549CT	20110487				2022-12-28	WOS:000274020500018
J	Liu, TM; Chiu, HH				Liu, Te-Ming; Chiu, Hsin-Hui			Gallstone Ileus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Liu, Te-Ming; Chiu, Hsin-Hui] Kuo Gen Hosp, Tainan, Taiwan		Liu, TM (corresponding author), Kuo Gen Hosp, Tainan, Taiwan.	shchiu@kgh.com.tw							0	1	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 28	2010	362	4					345	345		10.1056/NEJMicm0809541	http://dx.doi.org/10.1056/NEJMicm0809541			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	548OT	20107220				2022-12-28	WOS:000273975000010
J	Marraffini, LA; Sontheimer, EJ				Marraffini, Luciano A.; Sontheimer, Erik J.			Self versus non-self discrimination during CRISPR RNA-directed immunity	NATURE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; PROVIDES ACQUIRED-RESISTANCE; IDENTIFICATION; PROKARYOTES; REPEATS; SYSTEM; PLASMID; DEFENSE; GENE; DNA	All immune systems must distinguish self from non-self to repel invaders without inducing autoimmunity. Clustered, regularly interspaced, short palindromic repeat (CRISPR) loci protect bacteria and archaea from invasion by phage and plasmid DNA through a genetic interference pathway(1-9). CRISPR loci are present in similar to 40% and similar to 90% of sequenced bacterial and archaeal genomes, respectively(10), and evolve rapidly, acquiring new spacer sequences to adapt to highly dynamic viral populations(1,11-13). Immunity requires a sequence match between the invasive DNA and the spacers that lie between CRISPR repeats(1-9). Each cluster is genetically linked to a subset of the cas (CRISPR-associated) genes(14-16) that collectively encode >40 families of proteins involved in adaptation and interference. CRISPR loci encode small CRISPR RNAs (crRNAs) that contain a full spacer flanked by partial repeat sequences(2,17-19). CrRNA spacers are thought to identify targets by direct Watson-Crick pairing with invasive 'protospacer' DNA(2,3), but how they avoid targeting the spacer DNA within the encoding CRISPR locus itself is unknown. Here we have defined the mechanism of CRISPR self/non-self discrimination. In Staphylococcus epidermidis, target/crRNA mismatches at specific positions outside of the spacer sequence license foreign DNA for interference, whereas extended pairing between crRNA and CRISPR DNA repeats prevents autoimmunity. Hence, this CRISPR system uses the base-pairing potential of crRNAs not only to specify a target, but also to spare the bacterial chromosome from interference. Differential complementarity outside of the spacer sequence is a built-in feature of all CRISPR systems, indicating that this mechanism is a broadly applicable solution to the self/non-self dilemma that confronts all immune pathways.	[Marraffini, Luciano A.; Sontheimer, Erik J.] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA	Northwestern University	Marraffini, LA (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2205 Tech Dr, Evanston, IL 60208 USA.	l-marraffini@northwestern.edu; erik@northwestern.edu		Sontheimer, Erik/0000-0002-0881-0310	National Institutes of Health, USA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI079722] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank N. Fang for cloning assistance and members of our laboratory for critical reading of the manuscript. We thank V. Gerbasi and J. Marques for experimental advice. L. A. M. is a Fellow of The Jane Coffin Childs Memorial Fund for Medical Research. This work was supported by a grant from the National Institutes of Health, USA, to E. J. S.	Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Climo MW, 1996, J BACTERIOL, V178, P4975, DOI 10.1128/jb.178.16.4975-4983.1996; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hale C, 2008, RNA, V14, P2572, DOI 10.1261/rna.1246808; HORINOUCHI S, 1982, J BACTERIOL, V150, P815, DOI 10.1128/JB.150.2.815-825.1982; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Lillestol Reidun K., 2006, Archaea, V2, P59, DOI 10.1155/2006/542818; Lillestol RK, 2009, MOL MICROBIOL, V72, P259, DOI 10.1111/j.1365-2958.2009.06641.x; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; MORTON TM, 1995, ANTIMICROB AGENTS CH, V39, P1272, DOI 10.1128/AAC.39.6.1272; Pall GS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm112; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; SCHNEEWIND O, 1992, CELL, V70, P267, DOI 10.1016/0092-8674(92)90101-H; Semenova E, 2009, FEMS MICROBIOL LETT, V296, P110, DOI 10.1111/j.1574-6968.2009.01626.x; Shah SA, 2009, BIOCHEM SOC T, V37, P23, DOI 10.1042/BST0370023; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Sugimoto N, 2000, BIOCHEMISTRY-US, V39, P11270, DOI 10.1021/bi000819p; Tang TH, 2005, MOL MICROBIOL, V55, P469, DOI 10.1111/j.1365-2958.2004.04428.x; Tang TH, 2002, P NATL ACAD SCI USA, V99, P7536, DOI 10.1073/pnas.112047299; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002; van der Ploeg JR, 2009, MICROBIOL-SGM, V155, P1966, DOI 10.1099/mic.0.027508-0; Weigel LM, 2003, SCIENCE, V302, P1569, DOI 10.1126/science.1090956	34	417	489	4	171	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 28	2010	463	7280					568	U194		10.1038/nature08703	http://dx.doi.org/10.1038/nature08703			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	548QK	20072129	Green Accepted			2022-12-28	WOS:000273981100057
J	Zhang, JM; Adrian, FJ; Jahnke, W; Cowan-Jacob, SW; Li, AG; Iacob, RE; Sim, T; Powers, J; Dierks, C; Sun, FX; Guo, GR; Ding, Q; Okram, B; Choi, Y; Wojciechowski, A; Deng, XM; Liu, GX; Fendrich, G; Strauss, A; Vajpai, N; Grzesiek, S; Tuntland, T; Liu, Y; Bursulaya, B; Azam, M; Manley, PW; Engen, JR; Daley, GQ; Warmuth, M; Gray, NS				Zhang, Jianming; Adrian, Francisco J.; Jahnke, Wolfgang; Cowan-Jacob, Sandra W.; Li, Allen G.; Iacob, Roxana E.; Sim, Taebo; Powers, John; Dierks, Christine; Sun, Fangxian; Guo, Gui-Rong; Ding, Qiang; Okram, Barun; Choi, Yongmun; Wojciechowski, Amy; Deng, Xianming; Liu, Guoxun; Fendrich, Gabriele; Strauss, Andre; Vajpai, Navratna; Grzesiek, Stephan; Tuntland, Tove; Liu, Yi; Bursulaya, Badry; Azam, Mohammad; Manley, Paul W.; Engen, John R.; Daley, George Q.; Warmuth, Markus; Gray, Nathanael S.			Targeting Bcr-Abl by combining allosteric with ATP-binding-site inhibitors	NATURE			English	Article							CHRONIC MYELOID-LEUKEMIA; CELL LUNG-CANCER; KINASE-INHIBITOR; C-ABL; TYROSINE KINASE; LYMPHOBLASTIC-LEUKEMIA; IMATINIB RESISTANCE; SELECTIVE INHIBITOR; MUTATIONS; DYNAMICS	In an effort to find new pharmacological modalities to overcome resistance to ATP-binding-site inhibitors of Bcr-Abl, we recently reported the discovery of GNF-2, a selective allosteric Bcr-Abl inhibitor. Here, using solution NMR, X-ray crystallography, mutagenesis and hydrogen exchange mass spectrometry, we show that GNF-2 binds to the myristate-binding site of Abl, leading to changes in the structural dynamics of the ATP-binding site. GNF-5, an analogue of GNF-2 with improved pharmacokinetic properties, when used in combination with the ATP-competitive inhibitors imatinib or nilotinib, suppressed the emergence of resistance mutations in vitro, displayed additive inhibitory activity in biochemical and cellular assays against T315I mutant human Bcr-Abl and displayed in vivo efficacy against this recalcitrant mutant in a murine bone-marrow transplantation model. These results show that therapeutically relevant inhibition of Bcr-Abl activity can be achieved with inhibitors that bind to the myristate-binding site and that combining allosteric and ATP-competitive inhibitors can overcome resistance to either agent alone.	[Adrian, Francisco J.; Li, Allen G.; Dierks, Christine; Sun, Fangxian; Guo, Gui-Rong; Ding, Qiang; Liu, Guoxun; Tuntland, Tove; Liu, Yi; Bursulaya, Badry] Novartis Res Fdn, Dept Chem, Genom Inst, San Diego, CA 92121 USA; [Zhang, Jianming; Sim, Taebo; Choi, Yongmun; Wojciechowski, Amy; Deng, Xianming; Gray, Nathanael S.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Zhang, Jianming; Sim, Taebo; Powers, John; Choi, Yongmun; Wojciechowski, Amy; Deng, Xianming; Azam, Mohammad; Daley, George Q.; Gray, Nathanael S.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Jahnke, Wolfgang; Cowan-Jacob, Sandra W.; Fendrich, Gabriele; Strauss, Andre; Manley, Paul W.] Novartis Inst Biomed Res, CH-4056 Basel, Switzerland; [Iacob, Roxana E.; Engen, John R.] Northwestern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA; [Iacob, Roxana E.; Engen, John R.] Northwestern Univ, Barnett Inst Chem & Biol Anal, Boston, MA 02115 USA; [Sim, Taebo] Korea Inst Sci & Technol, Life Sci Res Div, Seoul 136791, South Korea; [Powers, John; Azam, Mohammad; Daley, George Q.] Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Powers, John; Azam, Mohammad; Daley, George Q.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Powers, John; Azam, Mohammad; Daley, George Q.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Okram, Barun] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Okram, Barun] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Vajpai, Navratna; Grzesiek, Stephan] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Warmuth, Markus] Novartis Inst BioMed Res Inc, Cambridge, MA 02139 USA	Novartis; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Novartis; Northwestern University; Northwestern University; Korea Institute of Science & Technology (KIST); Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute; Scripps Research Institute; Scripps Research Institute; University of Basel; Novartis	Adrian, FJ (corresponding author), Novartis Res Fdn, Dept Chem, Genom Inst, 10675 John Jay Hopkins Dr, San Diego, CA 92121 USA.	fadrian@gnf.org; markus.warmuth@novartis.com; nathanael_gray@dfci.harvard.edu	Dierks, Christine/L-4358-2013; Powers, John/AAO-1018-2020; manley, paul william/GVT-9482-2022	Manley, Paul William/0000-0002-9722-7863; Engen, John R./0000-0002-6918-9476; Grzesiek, Stephan/0000-0003-1998-4225; Deng, Xianming/0000-0002-9354-5864; Zhang, Jianming/0000-0001-6326-3906	NCI NIH HHS [R01 CA130876-03, R01 CA130876] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA130876] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adrian FJ, 2006, NAT CHEM BIOL, V2, P95, DOI 10.1038/nchembio760; Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; Azam M, 2006, P NATL ACAD SCI USA, V103, P9244, DOI 10.1073/pnas.0600001103; Barnett SF, 2005, BIOCHEM J, V385, P399, DOI 10.1042/BJ20041140; Blencke S, 2004, CHEM BIOL, V11, P691, DOI 10.1016/j.chembiol.2004.02.029; Bradeen HA, 2006, BLOOD, V108, P2332, DOI 10.1182/blood-2006-02-004580; Branford S, 2002, BLOOD, V99, P3472, DOI 10.1182/blood.V99.9.3472; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Burke JR, 2003, J BIOL CHEM, V278, P1450, DOI 10.1074/jbc.M209677200; Choi Y, 2009, J BIOL CHEM, V284, P29005, DOI 10.1074/jbc.M109.026633; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Converso A, 2009, BIOORG MED CHEM LETT, V19, P1240, DOI 10.1016/j.bmcl.2008.12.076; Cools J, 2004, CANCER RES, V64, P6385, DOI 10.1158/0008-5472.CAN-04-2148; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7689; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Hantschel O, 2003, CELL, V112, P845, DOI 10.1016/S0092-8674(03)00191-0; Iacob RE, 2009, P NATL ACAD SCI USA, V106, P1386, DOI 10.1073/pnas.0811912106; Jahnke W, 2004, CELL MOL LIFE SCI, V61, P580, DOI 10.1007/s00018-003-3382-3; Joensuu H, 2001, NEW ENGL J MED, V344, P1052, DOI 10.1056/NEJM200104053441404; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; KORNBERG A, 1951, J BIOL CHEM, V189, P123; Lee TS, 2008, CANCER-AM CANCER SOC, V112, P1744, DOI 10.1002/cncr.23355; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mishra S, 2006, CANCER RES, V66, P5387, DOI 10.1158/0008-5472.CAN-05-3058; Nagar B, 2002, CANCER RES, V62, P4236; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; OPPI C, 1987, P NATL ACAD SCI USA, V84, P8200, DOI 10.1073/pnas.84.23.8200; Quintas-Cardama A, 2007, NAT REV DRUG DISCOV, V6, P834, DOI 10.1038/nrd2324; Ray A, 2007, BLOOD, V109, P5011, DOI 10.1182/blood-2006-01-015347; Seeliger MA, 2005, PROTEIN SCI, V14, P3135, DOI 10.1110/ps.051750905; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Strauss A, 2005, J BIOMOL NMR, V31, P343, DOI 10.1007/s10858-005-2451-3; TOKUMITSU H, 1990, J BIOL CHEM, V265, P4315; Vajpai N, 2008, J BIOL CHEM, V283, P18292, DOI 10.1074/jbc.M801337200; VANETTEN RA, 1993, LEUKEMIA LYMPHOMA, V11, P239, DOI 10.3109/10428199309047893; von Bubnoff N, 2005, BLOOD, V105, P1652, DOI 10.1182/blood-2004-06-2445; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; Wales TE, 2008, ANAL CHEM, V80, P6815, DOI 10.1021/ac8008862; Weis DD, 2006, J AM SOC MASS SPECTR, V17, P1700, DOI 10.1016/j.jasms.2006.07.025; Weisberg E, 2005, CANCER CELL, V7, P129, DOI 10.1016/j.ccr.2005.01.007	41	444	461	3	137	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 28	2010	463	7280					501	U116		10.1038/nature08675	http://dx.doi.org/10.1038/nature08675			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	548QK	20072125	Green Accepted			2022-12-28	WOS:000273981100042
J	Kamerow, D				Kamerow, Douglas			Yankee Doodling US healthcare reform is in the dustbin	BRITISH MEDICAL JOURNAL			English	Editorial Material									RTI Int, Res Triangle Pk, NC 27709 USA	Research Triangle Institute	Kamerow, D (corresponding author), RTI Int, Res Triangle Pk, NC 27709 USA.	dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957					0	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 27	2010	340								c500	10.1136/bmj.c500	http://dx.doi.org/10.1136/bmj.c500			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	549YB	20106891				2022-12-28	WOS:000274089300009
J	Epshtein, V; Dutta, D; Wade, J; Nudler, E				Epshtein, Vitaly; Dutta, Dipak; Wade, Joseph; Nudler, Evgeny			An allosteric mechanism of Rho-dependent transcription termination	NATURE			English	Article							RNA-POLYMERASE-II; ESCHERICHIA-COLI; ELONGATION COMPLEX; STRUCTURAL BASIS; TRIGGER LOOP; DNA HYBRID; IN-VITRO; SUBUNITS	Rho is the essential RNA helicase that sets the borders between transcription units and adjusts transcriptional yield to translational needs in bacteria(1-3). Although Rho was the first termination factor to be discovered(4), the actual mechanism by which it reaches and disrupts the elongation complex (EC) is unknown. Here we show that the termination-committed Rho molecule associates with RNA polymerase (RNAP) throughout the transcription cycle; that is, it does not require the nascent transcript for initial binding. Moreover, the formation of the RNAP-Rho complex is crucial for termination. We show further that Rho-dependent termination is a two-step process that involves rapid EC inactivation (trap) and a relatively slow dissociation. Inactivation is the critical rate-limiting step that establishes the position of the termination site. The trap mechanism depends on the allosterically induced rearrangement of the RNAP catalytic centre by means of the evolutionarily conserved mobile trigger-loop domain, which is also required for EC dissociation. The key structural and functional similarities, which we found between Rho-dependent and intrinsic (Rho-independent) termination pathways, argue that the allosteric mechanism of termination is general and likely to be preserved for all cellular RNAPs throughout evolution.	[Epshtein, Vitaly; Dutta, Dipak; Nudler, Evgeny] NYU, Sch Med, Dept Biochem, New York, NY 10016 USA; [Wade, Joseph] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY 12201 USA	New York University; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Nudler, E (corresponding author), NYU, Sch Med, Dept Biochem, New York, NY 10016 USA.	evgeny.nudler@nyumc.org		Nudler, Evgeny/0000-0002-8811-3071; Wade, Joseph/0000-0002-9779-3160	National Institutes of Health [R01GM58750]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072814, R01GM058750] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank I. Artsimovitch, S. Borukhov, K. Severinov, B. Stitt, D. Vassylyev and R. Weisberg for materials and discussions. This work was supported by a grant from the National Institutes of Health (R01GM58750, to E. N.).	Adelman JL, 2006, MOL CELL, V22, P611, DOI 10.1016/j.molcel.2006.04.022; ADHYA S, 1978, ANNU REV BIOCHEM, V47, P967, DOI 10.1146/annurev.bi.47.070178.004535; Banerjee S, 2006, J MICROBIOL, V44, P11; Bar-Nahum G, 2005, CELL, V120, P183, DOI 10.1016/j.cell.2004.11.045; BORUKHOV S, 1993, PROTEIN EXPRES PURIF, V4, P503, DOI 10.1006/prep.1993.1066; BRENNAN CA, 1987, CELL, V48, P945, DOI 10.1016/0092-8674(87)90703-3; Browne RJ, 2005, J BIOL CHEM, V280, P13292, DOI 10.1074/jbc.M500221200; Cardinale CJ, 2008, SCIENCE, V320, P935, DOI 10.1126/science.1152763; Chalissery J, 2007, J MOL BIOL, V371, P855, DOI 10.1016/j.jmb.2007.06.013; Epshtein V, 2007, MOL CELL, V28, P991, DOI 10.1016/j.molcel.2007.10.011; GEISELMANN J, 1992, BIOCHEMISTRY-US, V31, P111, DOI 10.1021/bi00116a017; Guerin M, 1998, NUCLEIC ACIDS RES, V26, P4895, DOI 10.1093/nar/26.21.4895; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; JIN DJ, 1992, P NATL ACAD SCI USA, V89, P1453, DOI 10.1073/pnas.89.4.1453; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Kim DE, 2001, J BIOL CHEM, V276, P13902, DOI 10.1074/jbc.M011043200; Komissarova N, 2002, MOL CELL, V10, P1151, DOI 10.1016/S1097-2765(02)00738-4; Mentesana PE, 2000, J MOL BIOL, V302, P1049, DOI 10.1006/jmbi.2000.4114; Naryshkina T, 2006, J MOL BIOL, V361, P634, DOI 10.1016/j.jmb.2006.05.034; Nudler E, 2003, METHOD ENZYMOL, V371, P160; Nudler E, 1998, SCIENCE, V281, P424, DOI 10.1126/science.281.5375.424; PLATT T, 1994, MOL MICROBIOL, V11, P983, DOI 10.1111/j.1365-2958.1994.tb00376.x; RICHARDSON JP, 1991, CELL, V64, P1047, DOI 10.1016/0092-8674(91)90257-Y; Roberts JW, 2008, ANNU REV MICROBIOL, V62, P211, DOI 10.1146/annurev.micro.61.080706.093422; ROBERTS JW, 1969, NATURE, V224, P1168, DOI 10.1038/2241168a0; Schwartz A, 2007, J BIOL CHEM, V282, P31469, DOI 10.1074/jbc.M706935200; Skordalakes E, 2006, CELL, V127, P553, DOI 10.1016/j.cell.2006.08.051; Toulokhonov I, 2007, MOL CELL, V27, P406, DOI 10.1016/j.molcel.2007.06.008; Vassylyev DG, 2005, NAT STRUCT MOL BIOL, V12, P1086, DOI 10.1038/nsmb1015; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Westover KD, 2004, SCIENCE, V303, P1014, DOI 10.1126/science.1090839; WRIGHT DJ, 1989, J BIOL CHEM, V264, P11816; Zhu AQ, 1998, BIOCHEMISTRY-US, V37, P11215, DOI 10.1021/bi972912s	34	127	129	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 14	2010	463	7278					245	U136		10.1038/nature08669	http://dx.doi.org/10.1038/nature08669			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543MQ	20075920	Green Accepted			2022-12-28	WOS:000273582700039
J	Schmutz, J; Cannon, SB; Schlueter, J; Ma, JX; Mitros, T; Nelson, W; Hyten, DL; Song, QJ; Thelen, JJ; Cheng, JL; Xu, D; Hellsten, U; May, GD; Yu, Y; Sakurai, T; Umezawa, T; Bhattacharyya, MK; Sandhu, D; Valliyodan, B; Lindquist, E; Peto, M; Grant, D; Shu, SQ; Goodstein, D; Barry, K; Futrell-Griggs, M; Abernathy, B; Du, JC; Tian, ZX; Zhu, LC; Gill, N; Joshi, T; Libault, M; Sethuraman, A; Zhang, XC; Shinozaki, K; Nguyen, HT; Wing, RA; Cregan, P; Specht, J; Grimwood, J; Rokhsar, D; Stacey, G; Shoemaker, RC; Jackson, SA				Schmutz, Jeremy; Cannon, Steven B.; Schlueter, Jessica; Ma, Jianxin; Mitros, Therese; Nelson, William; Hyten, David L.; Song, Qijian; Thelen, Jay J.; Cheng, Jianlin; Xu, Dong; Hellsten, Uffe; May, Gregory D.; Yu, Yeisoo; Sakurai, Tetsuya; Umezawa, Taishi; Bhattacharyya, Madan K.; Sandhu, Devinder; Valliyodan, Babu; Lindquist, Erika; Peto, Myron; Grant, David; Shu, Shengqiang; Goodstein, David; Barry, Kerrie; Futrell-Griggs, Montona; Abernathy, Brian; Du, Jianchang; Tian, Zhixi; Zhu, Liucun; Gill, Navdeep; Joshi, Trupti; Libault, Marc; Sethuraman, Anand; Zhang, Xue-Cheng; Shinozaki, Kazuo; Nguyen, Henry T.; Wing, Rod A.; Cregan, Perry; Specht, James; Grimwood, Jane; Rokhsar, Dan; Stacey, Gary; Shoemaker, Randy C.; Jackson, Scott A.			Genome sequence of the palaeopolyploid soybean	NATURE			English	Article							PHYLOGENETIC ANALYSIS; GLYCINE-MAX; GENES; EVOLUTION; IDENTIFICATION; PROTEIN; PLANTS; DNA; DIVERSIFICATION; RESISTANCE	Soybean (Glycine max) is one of the most important crop plants for seed protein and oil content, and for its capacity to fix atmospheric nitrogen through symbioses with soil-borne microorganisms. We sequenced the 1.1-gigabase genome by a whole-genome shotgun approach and integrated it with physical and high-density genetic maps to create a chromosome-scale draft sequence assembly. We predict 46,430 protein-coding genes, 70% more than Arabidopsis and similar to the poplar genome which, like soybean, is an ancient polyploid (palaeopolyploid). About 78% of the predicted genes occur in chromosome ends, which comprise less than one-half of the genome but account for nearly all of the genetic recombination. Genome duplications occurred at approximately 59 and 13 million years ago, resulting in a highly duplicated genome with nearly 75% of the genes present in multiple copies. The two duplication events were followed by gene diversification and loss, and numerous chromosome rearrangements. An accurate soybean genome sequence will facilitate the identification of the genetic basis of many soybean traits, and accelerate the creation of improved soybean varieties.	[Schlueter, Jessica; Ma, Jianxin; Futrell-Griggs, Montona; Abernathy, Brian; Du, Jianchang; Tian, Zhixi; Zhu, Liucun; Gill, Navdeep; Jackson, Scott A.] Purdue Univ, Dept Agron, W Lafayette, IN 47906 USA; [Schmutz, Jeremy; Sethuraman, Anand; Grimwood, Jane] HudsonAlpha Genome Sequencing Ctr, Huntsville, AL 35806 USA; [Schmutz, Jeremy; Hellsten, Uffe; Lindquist, Erika; Shu, Shengqiang; Goodstein, David; Barry, Kerrie; Grimwood, Jane; Rokhsar, Dan] Joint Genome Inst, Walnut Creek, CA 94598 USA; [Cannon, Steven B.; Peto, Myron; Grant, David; Shoemaker, Randy C.] ARS, USDA, Corn Insects & Crop Genet Res Unit, Ames, IA 50011 USA; [Schlueter, Jessica] Univ N Carolina, Dept Bioinformat & Genom, Charlotte, NC 28223 USA; [Mitros, Therese] Univ Calif Berkeley, Ctr Integrat Genom, Berkeley, CA 94720 USA; [Nelson, William] Univ Arizona, Inst BIO5, Arizona Genom Computat Lab, Tucson, AZ 85721 USA; [Hyten, David L.; Song, Qijian; Cregan, Perry] ARS, USDA, Soybean Genom & Improvement Lab, Beltsville, MD 20705 USA; [Song, Qijian] Univ Maryland, Dept Plant Sci & Landscape Architecture, College Pk, MD 20742 USA; [Thelen, Jay J.; Stacey, Gary] Univ Missouri, Christopher S Bond Life Sci Ctr 109, Div Biochem, Columbia, MO 65211 USA; [Thelen, Jay J.; Stacey, Gary] Univ Missouri, Christopher S Bond Life Sci Ctr 109, Interdisciplinary Plant Grp, Columbia, MO 65211 USA; [Cheng, Jianlin; Xu, Dong; Joshi, Trupti] Univ Missouri, Dept Comp Sci, Columbia, MO 65211 USA; [May, Gregory D.] Natl Ctr Genome Resources, Santa Fe, NM 87505 USA; [Yu, Yeisoo; Wing, Rod A.] Univ Arizona, Sch Plant Sci, Arizona Genom Inst, Tucson, AZ 85721 USA; [Sakurai, Tetsuya; Umezawa, Taishi; Shinozaki, Kazuo] RIKEN, Plant Sci Ctr, Yokohama, Kanagawa 2300045, Japan; [Bhattacharyya, Madan K.] Iowa State Univ, Dept Agron, Ames, IA 50011 USA; [Sandhu, Devinder] Univ Wisconsin, Dept Biol, Stevens Point, WI 54481 USA; [Valliyodan, Babu; Libault, Marc; Zhang, Xue-Cheng; Nguyen, Henry T.; Stacey, Gary] Univ Missouri, Div Plant Sci, Natl Ctr Soybean Biotechnol, Columbia, MO 65211 USA; [Specht, James] Univ Nebraska, Dept Agron & Hort, Lincoln, NE 68583 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; HudsonAlpha Institute for Biotechnology; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; United States Department of Agriculture (USDA); University of North Carolina; University of North Carolina Charlotte; University of California System; University of California Berkeley; University of Arizona; United States Department of Agriculture (USDA); University System of Maryland; University of Maryland College Park; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; National Center for Genome Resources (NCGR); University of Arizona; RIKEN; Iowa State University; University of Wisconsin System; University of Wisconsin Stevens Point; University of Missouri System; University of Missouri Columbia; University of Nebraska System; University of Nebraska Lincoln	Jackson, SA (corresponding author), Purdue Univ, Dept Agron, 915 W State St, W Lafayette, IN 47906 USA.	sjackson@purdue.edu	Schmutz, Jeremy/N-3173-2013; Cheng, Jianlin/N-8209-2013; Wing, Rod A/Z-2885-2019; Umezawa, Taishi/E-3028-2010; Grimwood, Jane/ABD-5737-2021; Shinozaki, Kazuo/AAB-4945-2019; Sakurai, Tetsuya/B-2690-2010; Grant, David/HGU-0154-2022; Barry, Kerrie Whitelaw/AAA-5500-2020; Shinozaki, Kazuo/G-4202-2013	Schmutz, Jeremy/0000-0001-8062-9172; Wing, Rod A/0000-0001-6633-6226; Umezawa, Taishi/0000-0003-3750-0503; Shinozaki, Kazuo/0000-0002-6317-9867; Sakurai, Tetsuya/0000-0003-2046-8973; Barry, Kerrie Whitelaw/0000-0002-8999-6785; Shinozaki, Kazuo/0000-0002-6317-9867; Thelen, Jay/0000-0001-5995-1562; Goodstein, David/0000-0001-6287-2697; Shu, Shengqiang/0000-0002-4336-8994; jackson, scott/0000-0002-3172-1607; Rokhsar, Daniel/0000-0002-8704-2224; zhu, liucun/0000-0002-8334-0216; Sandhu, Devinder/0000-0003-4193-3408; Hyten, David/0000-0001-6324-9389; Cheng, Jianlin/0000-0003-0305-2853; Yu, Yeisoo/0000-0002-8410-0310; Valliyodan, Babu/0000-0001-9457-9508	National Science Foundation [DBI-0421620, DBI-0501877, 082225]; United Soybean Board	National Science Foundation(National Science Foundation (NSF)); United Soybean Board	We thank N. Weeks for informatics support and C. Gunter for critical reading of the manuscript. We acknowledge funding from the National Science Foundation (DBI-0421620 to G. S.; DBI-0501877 and 082225 to S. A. J.) and the United Soybean Board.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Barkoulas M, 2007, CURR OPIN PLANT BIOL, V10, P660, DOI 10.1016/j.pbi.2007.07.012; Beckstette M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-389; Beisson F, 2003, PLANT PHYSIOL, V132, P681, DOI 10.1104/pp.103.022988; Bertioli DJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-45; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Bruggmann R, 2006, GENOME RES, V16, P1241, DOI 10.1101/gr.5338906; Choi IY, 2007, GENETICS, V176, P685, DOI 10.1534/genetics.107.070821; Fridborg I, 1999, PLANT CELL, V11, P1019, DOI 10.1105/tpc.11.6.1019; Gill N, 2009, PLANT PHYSIOL, V151, P1167, DOI 10.1104/pp.109.137935; Haas BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/nar/gkg770; Herve C, 2009, PLANT PHYSIOL, V149, P1462, DOI 10.1104/pp.108.126136; HYTEN DL, BMC GENOMIC IN PRESS; HYTEN DL, CROP SCI IN PRESS; Jaffe DB, 2003, GENOME RES, V13, P91, DOI 10.1101/gr.828403; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lai CP, 2004, PLANT PHYSIOL, V134, P1586, DOI 10.1104/pp.103.037820; Lavin M, 2005, SYST BIOL, V54, P575, DOI 10.1080/10635150590947131; Lin JY, 2005, GENETICS, V170, P1221, DOI 10.1534/genetics.105.041616; Ma JX, 2004, GENOME RES, V14, P860, DOI 10.1101/gr.1466204; Maroof MAS, 2009, CROP SCI, V49, P69, DOI 10.2135/cropsci2008.06.0362; McCarthy EM, 2003, BIOINFORMATICS, V19, P362, DOI 10.1093/bioinformatics/btf878; Meyer JDF, 2009, PLANT PHYSIOL, V150, P295, DOI 10.1104/pp.108.134551; Michelmore RW, 1998, GENOME RES, V8, P1113, DOI 10.1101/gr.8.11.1113; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Pfeil BE, 2005, SYST BIOL, V54, P441, DOI 10.1080/10635150590945359; Roy SW, 2007, MOL BIOL EVOL, V24, P171, DOI 10.1093/molbev/msl159; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Schlueter JA, 2004, GENOME, V47, P868, DOI [10.1139/g04-047, 10.1139/G04-047]; Schlueter JA, 2008, J HERED, V99, P390, DOI 10.1093/jhered/esn010; Simillion C, 2008, BIOINFORMATICS, V24, P127, DOI 10.1093/bioinformatics/btm449; Skoneczka JA, 2009, CROP SCI, V49, P247, DOI 10.2135/cropsci2008.07.0403; Song QJ, 2004, THEOR APPL GENET, V109, P122, DOI 10.1007/s00122-004-1602-3; Stone SL, 2001, P NATL ACAD SCI USA, V98, P11806, DOI 10.1073/pnas.201413498; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Umezawa T, 2008, DNA RES, V15, P333, DOI 10.1093/dnares/dsn024; Vahedian M, 1995, PLANT MOL BIOL, V29, P857, DOI 10.1007/BF00041174; Wang BB, 2006, P NATL ACAD SCI USA, V103, P7175, DOI 10.1073/pnas.0602039103; Wang HC, 2009, P NATL ACAD SCI USA, V106, P3853, DOI 10.1073/pnas.0813376106; Yeh RF, 2001, GENOME RES, V11, P803, DOI 10.1101/gr.175701	44	2867	3170	41	581	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 14	2010	463	7278					178	183		10.1038/nature08670	http://dx.doi.org/10.1038/nature08670			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543MQ	20075913	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000273582700025
J	Onder, M; Glenn, G; Adisen, E; Keseroglu, O; Sahin, S; Ataoglu, O; Akkaya, B; Toro, JR				Onder, Meltem; Glenn, Gladys; Adisen, Esra; Keseroglu, Ozge; Sahin, Sedef; Ataoglu, Omur; Akkaya, Bahar; Toro, Jorge R.			Cutaneous papules, uterine fibroids, and renal cell cancer: one family's tale	LANCET			English	Editorial Material							FUMARATE-HYDRATASE GENE; HEREDITARY LEIOMYOMATOSIS; GERMLINE MUTATIONS		[Glenn, Gladys; Toro, Jorge R.] NCI, Genet Epidemiol Branch, Rockville, MD 20892 USA; [Onder, Meltem; Adisen, Esra; Keseroglu, Ozge] Gazi Univ, Dept Dermatol, Ankara, Turkey; [Ataoglu, Omur] Gazi Univ, Dept Pathol, Ankara, Turkey; [Sahin, Sedef] Hacettepe Univ, Dept Dermatol, Ankara, Turkey; [Akkaya, Bahar] Akdeniz Univ, Dept Pathol, TR-07058 Antalya, Turkey	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Gazi University; Gazi University; Hacettepe University; Akdeniz University	Toro, JR (corresponding author), NCI, Genet Epidemiol Branch, 6120 Execut Blvd,Execut Plaza S,Room 7012, Rockville, MD 20892 USA.	toroj@mail.nih.gov						Alam M, 2002, J AM ACAD DERMATOL, V46, pS27, DOI 10.1067/mjd.2002.107970; Launonen V, 2001, P NATL ACAD SCI USA, V98, P3387, DOI 10.1073/pnas.051633798; Stewart L, 2008, ARCH DERMATOL, V144, P1584, DOI 10.1001/archdermatol.2008.517; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; Toro JR, 2003, AM J HUM GENET, V73, P95, DOI 10.1086/376435	5	3	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 9	2010	375	9709					170	170		10.1016/S0140-6736(09)61499-9	http://dx.doi.org/10.1016/S0140-6736(09)61499-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	544NM	20109895				2022-12-28	WOS:000273664500035
J	Kiel, C; Yus, E; Serrano, L				Kiel, Christina; Yus, Eva; Serrano, Luis			Engineering Signal Transduction Pathways	CELL			English	Review							CELL-CELL COMMUNICATION; SYNTHETIC BIOLOGY; ESCHERICHIA-COLI; COMPUTATIONAL DESIGN; GENE-EXPRESSION; LOCALIZED TRANSFECTION; RATIONAL DESIGN; IN-VIVO; PROTEIN; BACTERIAL		[Kiel, Christina; Yus, Eva; Serrano, Luis] Ctr Regulacio Genom, EMBL CRG Syst Biol Unit, Barcelona 08003, Spain; [Serrano, Luis] ICREA, Barcelona 08010, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); ICREA	Serrano, L (corresponding author), Ctr Regulacio Genom, EMBL CRG Syst Biol Unit, Dr Aiguader 88, Barcelona 08003, Spain.	luis.serrano@crg.es	Serrano, Luis/B-3355-2013	Serrano, Luis/0000-0002-5276-1392; Kiel, Christina/0000-0001-8454-6008	European Union [HEALTH-F4-2008-201648]; Celldoctor-ERC [232913]; ICREA Funding Source: Custom	European Union(European Commission); Celldoctor-ERC; ICREA(ICREA)	We thank J. A. Leigh-Bell, K. Michalodimitrakis, and T. Ferrar for their contributions and their comments on the manuscript. Research on signal transduction engineering in L. S.'s lab is supported by the European Union (Proteomics Specification in Time and Space [PROSPECTS], grant agreement number HEALTH-F4-2008-201648). Research on engineering in Mycoplasma is supported by Celldoctor-ERC advanced grant number 232913.	Airan RD, 2009, NATURE, V458, P1025, DOI 10.1038/nature07926; Alm E, 2006, PLOS COMPUT BIOL, V2, P1329, DOI 10.1371/journal.pcbi.0020143; Aloy P, 2004, SCIENCE, V303, P2026, DOI 10.1126/science.1092645; Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Anderson JC, 2006, J MOL BIOL, V355, P619, DOI 10.1016/j.jmb.2005.10.076; Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; Antunes MS, 2006, PLANT BIOTECHNOL J, V4, P605, DOI 10.1111/j.1467-7652.2006.00205.x; Antunes MS, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.28; Aravind L, 2003, CURR OPIN MICROBIOL, V6, P490, DOI 10.1016/j.mib.2003.09.003; Ashworth J, 2006, NATURE, V441, P656, DOI 10.1038/nature04818; Balagadde FK, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.24; Bashor CJ, 2008, SCIENCE, V319, P1539, DOI 10.1126/science.1151153; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Batchelor E, 2003, P NATL ACAD SCI USA, V100, P691, DOI 10.1073/pnas.0234782100; BAUMGARTNER JW, 1994, J BACTERIOL, V176, P1157, DOI 10.1128/JB.176.4.1157-1163.1994; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Belshaw PJ, 1996, CHEM BIOL, V3, P731, DOI 10.1016/S1074-5521(96)90249-5; Benner SA, 2005, NAT REV GENET, V6, P533, DOI 10.1038/nrg1637; Bermudes D, 2002, CURR OPIN DRUG DISC, V5, P194; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Bourret RB, 2008, MOL MICROBIOL, V69, P1336, DOI 10.1111/j.1365-2958.2008.06379.x; Bowen TA, 2008, NEW PHYTOL, V179, P583, DOI 10.1111/j.1469-8137.2008.02433.x; Brenner K, 2007, P NATL ACAD SCI USA, V104, P17300, DOI 10.1073/pnas.0704256104; Brocchieri L, 2005, NUCLEIC ACIDS RES, V33, P3390, DOI 10.1093/nar/gki615; Bulter T, 2004, P NATL ACAD SCI USA, V101, P2299, DOI 10.1073/pnas.0306484101; Campagna A, 2008, FEBS LETT, V582, P1231, DOI 10.1016/j.febslet.2008.02.019; Chen MT, 2005, NAT BIOTECHNOL, V23, P1551, DOI 10.1038/nbt1162; Chen WW, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.74; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Collins CH, 2006, NAT BIOTECHNOL, V24, P708, DOI 10.1038/nbt1209; Corson TW, 2008, ACS CHEM BIOL, V3, P677, DOI 10.1021/cb8001792; Czyzyk J, 2003, P NATL ACAD SCI USA, V100, P6003, DOI 10.1073/pnas.1031494100; Dahiyat BI, 2006, METH MOL B, V316, P359; de la Paz ML, 2002, P NATL ACAD SCI USA, V99, P16052, DOI 10.1073/pnas.252340199; Deans TL, 2007, CELL, V130, P363, DOI 10.1016/j.cell.2007.05.045; Di Ventura B, 2006, NATURE, V443, P527, DOI 10.1038/nature05127; Di Ventura B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001507; Dougan DA, 2002, FEBS LETT, V529, P6, DOI 10.1016/S0014-5793(02)03179-4; Drubin DA, 2007, GENE DEV, V21, P242, DOI 10.1101/gad.1507207; Dueber JE, 2004, CURR OPIN STRUC BIOL, V14, P690, DOI 10.1016/j.sbi.2004.10.004; Dueber JE, 2003, SCIENCE, V301, P1904, DOI 10.1126/science.1085945; Dwyer MA, 2003, P NATL ACAD SCI USA, V100, P11255, DOI 10.1073/pnas.2032284100; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; England PM, 1997, P NATL ACAD SCI USA, V94, P11025, DOI 10.1073/pnas.94.20.11025; Ferrell JE, 2008, CURR BIOL, V18, pR244, DOI 10.1016/j.cub.2008.02.035; FINN RD, 2008, NUCLEIC ACIDS RES, V81, pD81; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Fung E, 2005, NATURE, V435, P118, DOI 10.1038/nature03508; Galperin MY, 2005, ASM NEWS, V71, P326; Galperin MY, 2004, ENVIRON MICROBIOL, V6, P552, DOI 10.1111/j.1462-2920.2004.00633.x; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Gibson DG, 2008, P NATL ACAD SCI USA, V105, P20404, DOI 10.1073/pnas.0811011106; Gossen M, 2002, ANNU REV GENET, V36, P153, DOI 10.1146/annurev.genet.36.041002.120114; Greber D, 2007, J BIOTECHNOL, V130, P329, DOI 10.1016/j.jbiotec.2007.05.014; Grilly C, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100168; Guell M, 2009, SCIENCE, V326, P1268, DOI 10.1126/science.1176951; Harris K, 2001, CURR BIOL, V11, P1815, DOI 10.1016/S0960-9822(01)00567-X; Haruki H, 2008, MOL CELL, V31, P925, DOI 10.1016/j.molcel.2008.07.020; Haseltine EL, 2008, APPL ENVIRON MICROB, V74, P437, DOI 10.1128/AEM.01688-07; Howard PL, 2003, P NATL ACAD SCI USA, V100, P11267, DOI 10.1073/pnas.1934711100; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Isalan M, 2005, NAT METHODS, V2, P113, DOI 10.1038/NMETH732; Isalan M, 2008, NATURE, V452, P840, DOI 10.1038/nature06847; Jenal U, 2003, CURR OPIN MICROBIOL, V6, P163, DOI 10.1016/S1369-5274(03)00029-8; Jenal U, 2002, CURR OPIN MICROBIOL, V5, P558, DOI 10.1016/S1369-5274(02)00378-8; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Jordan JD, 2000, CELL, V103, P193, DOI 10.1016/S0092-8674(00)00112-4; Kamalakkannan S, 2004, PROTEIN ENG DES SEL, V17, P721, DOI 10.1093/protein/gzh087; KEMPIAK SJ, 2004, SCI STKE, pPL1; Kiel C, 2004, P NATL ACAD SCI USA, V101, P9223, DOI 10.1073/pnas.0401160101; Kiel C, 2008, ANNU REV BIOCHEM, V77, P415, DOI 10.1146/annurev.biochem.77.062706.133317; Kiel C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000397; Kim PM, 2006, SCIENCE, V314, P1938, DOI 10.1126/science.1136174; Kitano H, 2007, E SCHERING RES FDN W, V61, P69; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; Kollmann M, 2005, NATURE, V438, P504, DOI 10.1038/nature04228; Kortemme T, 2004, NAT STRUCT MOL BIOL, V11, P371, DOI 10.1038/nsmb749; Kuhner S, 2009, SCIENCE, V326, P1235, DOI 10.1126/science.1176343; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Kurosaki T, 2002, NAT REV IMMUNOL, V2, P354, DOI 10.1038/nri801; Lartigue C, 2007, SCIENCE, V317, P632, DOI 10.1126/science.1144622; Lartigue C, 2009, SCIENCE, V325, P1693, DOI 10.1126/science.1173759; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Levskaya A, 2005, NATURE, V438, P441, DOI 10.1038/nature04405; Liu WS, 2007, NAT METHODS, V4, P239, DOI 10.1038/NMETH1016; Lobato MN, 2003, TRENDS MOL MED, V9, P390, DOI 10.1016/S1471-4914(03)00163-1; Looger LL, 2003, NATURE, V423, P185, DOI 10.1038/nature01556; Lyon GJ, 2000, P NATL ACAD SCI USA, V97, P13330, DOI 10.1073/pnas.97.24.13330; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Mathonet P, 2004, CURR OPIN STRUC BIOL, V14, P505, DOI 10.1016/j.sbi.2004.06.007; Mayawala K, 2004, BIOPHYS J, V87, pL1, DOI 10.1529/biophysj.104.051888; McGinness KE, 2006, MOL CELL, V22, P701, DOI 10.1016/j.molcel.2006.04.027; Meinhardt H, 2001, P NATL ACAD SCI USA, V98, P14202, DOI 10.1073/pnas.251216598; METZGER H, 1981, ARZNEIMITTEL-FORSCH, V31-2, P1248; Michalodimitrakis K, 2009, FEMS MICROBIOL REV, V33, P27, DOI 10.1111/j.1574-6976.2008.00139.x; MOE GR, 1989, P NATL ACAD SCI USA, V86, P5683, DOI 10.1073/pnas.86.15.5683; Mukai Y, 2009, J MOL BIOL, V385, P1221, DOI 10.1016/j.jmb.2008.11.053; Northey JGB, 2002, NAT STRUCT BIOL, V9, P126, DOI 10.1038/nsb748; Park SH, 2003, SCIENCE, V299, P1061, DOI 10.1126/science.1076979; Pedraza JM, 2008, SCIENCE, V319, P339, DOI 10.1126/science.1144331; Peters FB, 2009, CHEM BIOL, V16, P148, DOI 10.1016/j.chembiol.2009.01.013; Picotti P, 2009, CELL, V138, P795, DOI 10.1016/j.cell.2009.05.051; Porter SL, 2008, TRENDS MICROBIOL, V16, P251, DOI 10.1016/j.tim.2008.02.006; Pryciak PM, 2009, CHEM BIOL, V16, P249, DOI 10.1016/j.chembiol.2009.01.011; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Ramamurthi KS, 2009, P NATL ACAD SCI USA, V106, P13541, DOI 10.1073/pnas.0906851106; Redondo P, 2008, NATURE, V456, P107, DOI 10.1038/nature07343; Reina J, 2002, NAT STRUCT BIOL, V9, P621, DOI 10.1038/nsb815; Reis CR, 2009, BIOCHEMISTRY-US, V48, P2180, DOI 10.1021/bi801927x; Rieker JD, 2000, METHOD ENZYMOL, V328, P282, DOI 10.1016/S0076-6879(00)28403-6; Rivera VM, 1996, NAT MED, V2, P1028, DOI 10.1038/nm0996-1028; Rowlinson SW, 2008, NAT CELL BIOL, V10, P740, DOI 10.1038/ncb1737; Saito H, 2004, CHEM BIOL, V11, P765, DOI 10.1016/j.chembiol.2004.03.032; Saito H, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm017; Sakamoto KM, 2001, P NATL ACAD SCI USA, V98, P8554, DOI 10.1073/pnas.141230798; Santori MI, 2006, NAT PROTOC, V1, P526, DOI 10.1038/nprot.2006.74; Seeliger MA, 2005, PROTEIN SCI, V14, P3135, DOI 10.1110/ps.051750905; Selzer T, 2000, NAT STRUCT BIOL, V7, P537; Serrano L, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100202; Shetty Reshma P, 2008, J Biol Eng, V2, P5, DOI 10.1186/1754-1611-2-5; Sia Samuel K., 2007, Birth Defects Research, V81, P354, DOI 10.1002/bdrc.20105; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Skerker JM, 2008, CELL, V133, P1043, DOI 10.1016/j.cell.2008.04.040; Slaughter BD, 2007, P NATL ACAD SCI USA, V104, P20320, DOI 10.1073/pnas.0710336105; Smits WK, 2006, NAT REV MICROBIOL, V4, P259, DOI 10.1038/nrmicro1381; SPENCER DM, 1993, SCIENCE, V262, P1019, DOI 10.1126/science.7694365; Suzuki T, 2001, PLANT CELL PHYSIOL, V42, P37, DOI 10.1093/pcp/pce011; Swinburne IA, 2008, GENE DEV, V22, P2342, DOI 10.1101/gad.1696108; Tanaka T, 2007, EMBO J, V26, P3250, DOI 10.1038/sj.emboj.7601744; Teruel MN, 2000, CELL, V103, P181, DOI 10.1016/S0092-8674(00)00109-4; Tigges M, 2009, NATURE, V457, P309, DOI 10.1038/nature07616; Townsend JA, 2009, NATURE, V459, P442, DOI 10.1038/nature07845; Trager JB, 1997, INT J BIOCHEM CELL B, V29, P635, DOI 10.1016/S1357-2725(96)00162-8; Tur V, 2008, J BIOL CHEM, V283, P20560, DOI 10.1074/jbc.M800457200; UTSUMI R, 1989, SCIENCE, V245, P1246, DOI 10.1126/science.2476847; Van der Sloot AM, 2006, P NATL ACAD SCI USA, V103, P8634, DOI 10.1073/pnas.0510187103; Vats P, 2009, CELL MOL LIFE SCI, V66, P3353, DOI 10.1007/s00018-009-0092-5; Ward SM, 2002, MOL MICROBIOL, V44, P709, DOI 10.1046/j.1365-2958.2002.02902.x; Weber W, 2008, P NATL ACAD SCI USA, V105, P9994, DOI 10.1073/pnas.0800663105; Yeh BJ, 2007, NATURE, V447, P596, DOI 10.1038/nature05851; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491; Yus E, 2009, SCIENCE, V326, P1263, DOI 10.1126/science.1177263	145	91	92	0	57	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 8	2010	140	1					33	47		10.1016/j.cell.2009.12.028	http://dx.doi.org/10.1016/j.cell.2009.12.028			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	541CY	20085704	Bronze			2022-12-28	WOS:000273391900013
J	Molyneux, DH				Molyneux, David H.			Neglected tropical diseases-beyond the tipping point?	LANCET			English	Editorial Material									Univ Liverpool, Liverpool Sch Trop Med, Ctr Neglected Trop Dis, Liverpool L3 5QA, Merseyside, England	Liverpool School of Tropical Medicine; University of Liverpool	Molyneux, DH (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Ctr Neglected Trop Dis, Liverpool L3 5QA, Merseyside, England.	david.molyneux@liv.ac.uk						[Anonymous], 2006, PREV CHEM HUM HELM C; Brady MA, 2006, TRENDS PARASITOL, V22, P285, DOI 10.1016/j.pt.2006.05.007; CONTEH L, LANCET IN PRESS; *GLOB NETW NEGL TR, 2009, GLOB NETW NEGL TROP; *GLOB NETW NEGL TR, 2009, SPEC ANN GLOB NETW N; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; Hotez PJ, 2009, LANCET, V373, P1570, DOI 10.1016/S0140-6736(09)60233-6; Kasturiratne A, 2008, PLOS MED, V5, P1591, DOI 10.1371/journal.pmed.0050218; Laxminarayan R, 2006, LANCET, V367, P1193, DOI 10.1016/S0140-6736(06)68440-7; Liese B, 2010, LANCET, V375, P67, DOI 10.1016/S0140-6736(09)61749-9; Liese BH, 2009, INT HEALTH, V1, P141, DOI 10.1016/j.inhe.2009.08.004; Molyneux DH, 2008, T ROY SOC TROP MED H, V102, P509, DOI 10.1016/j.trstmh.2008.02.024; Molyneux DH, 2009, LANCET, V373, P296, DOI 10.1016/S0140-6736(09)60089-1; Molyneux DH, 2004, LANCET, V364, P380, DOI 10.1016/S0140-6736(04)16728-7; Stoever K, 2009, LANCET, V373, P2025, DOI 10.1016/S0140-6736(09)61111-9	15	31	32	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 2	2010	375	9708					3	4		10.1016/S0140-6736(09)61914-0	http://dx.doi.org/10.1016/S0140-6736(09)61914-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	539BZ	20109840				2022-12-28	WOS:000273229700004
J	Godfray, HCJ; Beddington, JR; Crute, IR; Haddad, L; Lawrence, D; Muir, JF; Pretty, J; Robinson, S; Thomas, SM; Toulmin, C				Godfray, H. Charles J.; Beddington, John R.; Crute, Ian R.; Haddad, Lawrence; Lawrence, David; Muir, James F.; Pretty, Jules; Robinson, Sherman; Thomas, Sandy M.; Toulmin, Camilla			Food Security: The Challenge of Feeding 9 Billion People	SCIENCE			English	Review							LAND; AGRICULTURE; SUSTAINABILITY; IMPACT; YIELDS	Continuing population and consumption growth will mean that the global demand for food will increase for at least another 40 years. Growing competition for land, water, and energy, in addition to the overexploitation of fisheries, will affect our ability to produce food, as will the urgent requirement to reduce the impact of the food system on the environment. The effects of climate change are a further threat. But the world can produce more food and can ensure that it is used more efficiently and equitably. A multifaceted and linked global strategy is needed to ensure sustainable and equitable food security, different components of which are explored here.	[Godfray, H. Charles J.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Godfray, H. Charles J.] Univ Oxford, Inst Biodivers, James Martin 21st Century Sch, Oxford OX1 3PS, England; [Beddington, John R.; Thomas, Sandy M.] UK Govt Off Sci, London SW1H OET, England; [Crute, Ian R.] Agr & Hort Dev Board, Kenilworth CV8 2TL, Warwick, England; [Haddad, Lawrence; Robinson, Sherman] Univ Sussex, Inst Dev Studies, Brighton BN1 9RE, E Sussex, England; [Lawrence, David] Syngenta AG, CH-4002 Basel, Switzerland; [Muir, James F.] Univ Stirling, Dept Biol Sci, Stirling FK9 4LA, Scotland; [Pretty, Jules] Univ Essex, Dept Biol Sci, Colchester CO4 3SQ, Essex, England; [Toulmin, Camilla] Int Inst Environm & Develop, London WC1H 0DD, England	University of Oxford; University of Oxford; Agriculture & Horticulture Development Board (AHDB); University of Sussex; Syngenta; University of Stirling; University of Essex	Godfray, HCJ (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	charles.godfray@zoo.ox.ac.uk	Cuadros, Renzo/B-8684-2012; Zhong, Hong Lin/C-2633-2012; Pretty, Jules/D-4071-2012	Pretty, Jules/0000-0002-3897-6581				Anderson K., 2009, DISTORTIONS AGR INCE; [Anonymous], 2009, RETURN MASTER; Balmford A, 2005, GLOBAL CHANGE BIOL, V11, P1594, DOI 10.1111/j.1365-2486.2005.001035.x; Braun J.V., 2007, FOOD POLICY REP, V25, P37; Cabinet Office, 2008, FOOD MATT STRAT 21 C; Cassman KG, 1999, P NATL ACAD SCI USA, V96, P5952, DOI 10.1073/pnas.96.11.5952; Collier P, 2008, FOREIGN AFF, V87, P67; Conway G., 1997, DOUBLY GREEN REVOLUT; Cotula L., 2009, LAND GRAB DEV OPPORT; Day W, 2008, PHILOS T R SOC B, V363, P527, DOI 10.1098/rstb.2007.2168; Deininger K, 2009, WORLD BANK RES OBSER, V24, P233, DOI 10.1093/wbro/lkp007; Evans A, 2009, FEEDING 9 BILLION GL; Evenson RE, 2003, SCIENCE, V300, P758, DOI 10.1126/science.1078710; FAO, 2006, WORLD AGR 2030 2050; FAO, 2006, LIV LONG SHAD; FAO, 2003, WORLD AGR 2030 2050; Fargione J, 2008, SCIENCE, V319, P1235, DOI 10.1126/science.1152747; Food and Agriculture Organization of the United Nations (FAO), 2009, STAT FOOD INS WORLD; Gilbert RA, 2006, FIELD CROP RES, V95, P156, DOI 10.1016/j.fcr.2005.02.006; Gressel J., 2008, GENETIC GLASS CEILIN; Hazell P., 2001, Food, Agriculture and the Environment Discussion Paper - International Food Policy Research Institute; Hazell P, 2008, PHILOS T R SOC B, V363, P495, DOI 10.1098/rstb.2007.2166; Hobbs PR, 2008, PHILOS T R SOC B, V363, P543, DOI 10.1098/rstb.2007.2169; IAASTD, 2008, INT ASS AGR KNOWL SC; Lea D, 2008, ETHICAL THEORY MORAL, V11, P37, DOI 10.1007/s10677-007-9084-4; Lemaux PG, 2009, ANNU REV PLANT BIOL, V60, P511, DOI 10.1146/annurev.arplant.043008.092013; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING; NELLEMANN CM, 2009, ENV FOOD CRISIS; Nelson J, 2009, CLIMATE CHANGE AND GLOBAL POVERTY: A BILLION LIVES IN THE BALANCE, P223; Parry M. L., 2007, CLIMATE CHANGE 2007; Piesse J, 2009, FOOD POLICY, V34, P119, DOI 10.1016/j.foodpol.2009.01.001; Pretty JN, 2006, ENVIRON SCI TECHNOL, V40, P1114, DOI 10.1021/es051670d; Pretty JN, 2005, FOOD POLICY, V30, P1, DOI 10.1016/j.foodpol.2005.02.001; Pretty J, 2008, PHILOS T R SOC B, V363, P447, DOI 10.1098/rstb.2007.2163; Reij CP, 2008, LAND USE POLICY, V25, P410, DOI 10.1016/j.landusepol.2007.10.001; Schmidhuber J, 2007, P NATL ACAD SCI USA, V104, P19703, DOI 10.1073/pnas.0701976104; Smith MD, 2010, SCIENCE, V327, P784, DOI 10.1126/science.1185345; Society R., 2009, RS POL DOC; Stern Nicholas, 2007, EC CLIMATE CHANGE; Tacon AGJ, 2008, AQUACULTURE, V285, P146, DOI 10.1016/j.aquaculture.2008.08.015; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; UNEP (United Nations Environment Programme), 2008, AFR ATL OUR CHANG EN; Whitmarsh David, 2008, P251, DOI 10.1007/978-1-4020-6810-2_8; World Bank, 2008, INT TRADE CLIMATE CH; WRAP, 2008, THE FOOD WE WAST; [No title captured]; [No title captured]; [No title captured]; [No title captured]	49	6048	6333	290	4896	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2010	327	5967					812	818		10.1126/science.1185383	http://dx.doi.org/10.1126/science.1185383			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	554AQ	20110467				2022-12-28	WOS:000274408300045
J	Soliman, F; Glatt, CE; Bath, KG; Levita, L; Jones, RM; Pattwell, SS; Jing, DQ; Tottenham, N; Amso, D; Somerville, LH; Voss, HU; Glover, G; Ballon, DJ; Liston, C; Teslovich, T; Van Kempen, T; Lee, FS; Casey, BJ				Soliman, Fatima; Glatt, Charles E.; Bath, Kevin G.; Levita, Liat; Jones, Rebecca M.; Pattwell, Siobhan S.; Jing, Deqiang; Tottenham, Nim; Amso, Dima; Somerville, Leah H.; Voss, Henning U.; Glover, Gary; Ballon, Douglas J.; Liston, Conor; Teslovich, Theresa; Van Kempen, Tracey; Lee, Francis S.; Casey, B. J.			A Genetic Variant BDNF Polymorphism Alters Extinction Learning in Both Mouse and Human	SCIENCE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; VAL66MET POLYMORPHISM; NEUROTROPHIC FACTOR; PREFRONTAL CORTEX; FEAR EXTINCTION; CONDITIONED FEAR; HUMAN-MEMORY; AMYGDALA; ANXIETY; RECALL	Mouse models are useful for studying genes involved in behavior, but whether they are relevant to human behavior is unclear. Here, we identified parallel phenotypes in mice and humans resulting from a common single-nucleotide polymorphism in the brain-derived neurotrophic factor (BDNF) gene, which is involved in anxiety-related behavior. An inbred genetic knock-in mouse strain expressing the variant BDNF recapitulated the phenotypic effects of the human polymorphism. Both were impaired in extinguishing a conditioned fear response, which was paralleled by atypical frontoamygdala activity in humans. Thus, this variant BDNF allele may play a role in anxiety disorders showing impaired learning of cues that signal safety versus threat and in the efficacy of treatments that rely on extinction mechanisms, such as exposure therapy.	[Soliman, Fatima; Levita, Liat; Jones, Rebecca M.; Tottenham, Nim; Amso, Dima; Somerville, Leah H.; Liston, Conor; Teslovich, Theresa; Van Kempen, Tracey; Casey, B. J.] Weill Cornell Med Coll, Sackler Inst Dev Psychobiol, New York, NY 10065 USA; [Soliman, Fatima; Glatt, Charles E.; Bath, Kevin G.; Levita, Liat; Jones, Rebecca M.; Pattwell, Siobhan S.; Jing, Deqiang; Tottenham, Nim; Amso, Dima; Somerville, Leah H.; Liston, Conor; Teslovich, Theresa; Van Kempen, Tracey; Lee, Francis S.; Casey, B. J.] Weill Cornell Med Coll, Dept Psychiat, New York, NY 10065 USA; [Voss, Henning U.; Ballon, Douglas J.] Weill Cornell Med Coll, Citigrp Biomed Imaging Ctr, Dept Radiol, New York, NY 10065 USA; [Glover, Gary] Stanford Univ, Lucas Ctr Imaging, Dept Radiol, Stanford, CA 94305 USA	Cornell University; Cornell University; Cornell University; Stanford University	Soliman, F (corresponding author), Weill Cornell Med Coll, Sackler Inst Dev Psychobiol, New York, NY 10065 USA.	fas2002@med.cornell.edu; fslee@med.cornell.edu; bjc2002@med.cornell.edu	Van Kempen, Tracey/GOG-9322-2022; Van Kempen, Tracey/D-2450-2010; , Conor Liston/GQH-8931-2022; Voss, Henning/C-2194-2009	Voss, Henning/0000-0003-2811-2074; Ballon, Douglas/0000-0002-7162-9020; Levita, Liat/0000-0001-6002-6817	NIH [MH079513, MH060478, NS052819, HD055177, GM07739]; United Negro College; Burroughs Wellcome Foundation; International Mental Health Research Organization; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD055177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091864, R25MH060478, P50MH079513] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052819] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United Negro College; Burroughs Wellcome Foundation(Burroughs Wellcome Fund); International Mental Health Research Organization; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We acknowledge two anonymous reviewers for their thoughtful comments, resources and staff at the Biomedical Imaging Core Facility of the Citigroup Biomedical Imaging Center at Weill Cornell Medical College, Rafael Oania, a generous gift by the Dr. Mortimer D. Sackler family and support from NIH grants MH079513 (B.J.C., F. S. L.), MH060478 (B.J.C.), NS052819 (F. S. L.), HD055177 (B.J.C., S. S. P.), GM07739 (F. S.), and United Negro College Fund-Merck Graduate Science Research Dissertation Fellowship (F. S.), Burroughs Wellcome Foundation (F. S. L.), and International Mental Health Research Organization (F. S. L.).	Charney Dennis S, 2004, Sci STKE, V2004, pre5, DOI 10.1126/stke.2252004re5; Charney DS, 2004, AM J PSYCHIAT, V161, P195, DOI 10.1176/appi.ajp.161.2.195; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; Chhatwal JP, 2006, NAT NEUROSCI, V9, P870, DOI 10.1038/nn1718; Delgado MR, 2006, BIOL PSYCHOL, V73, P39, DOI 10.1016/j.biopsycho.2006.01.006; Delgado MR, 2008, NEURON, V59, P829, DOI 10.1016/j.neuron.2008.06.029; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Gatt JM, 2008, BIOL PSYCHOL, V79, P275, DOI 10.1016/j.biopsycho.2008.07.004; Gottfried JA, 2004, NAT NEUROSCI, V7, P1145, DOI 10.1038/nn1314; Gratacos M, 2007, BIOL PSYCHIAT, V61, P911, DOI 10.1016/j.biopsych.2006.08.025; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Jiang XY, 2005, NEUROPSYCHOPHARMACOL, V30, P1353, DOI 10.1038/sj.npp.1300703; Kalisch R, 2006, J NEUROSCI, V26, P9503, DOI 10.1523/JNEUROSCI.2021-06.2006; KIM M, 1993, BEHAV NEUROSCI, V107, P580, DOI 10.1037/0735-7044.107.4.580; LaBar KS, 1998, NEURON, V20, P937, DOI 10.1016/S0896-6273(00)80475-4; Lebron K, 2004, LEARN MEMORY, V11, P544, DOI 10.1101/lm.78604; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Liberzon I, 1999, BIOL PSYCHIAT, V45, P817, DOI 10.1016/S0006-3223(98)00246-7; Lissek S, 2005, BEHAV RES THER, V43, P1391, DOI 10.1016/j.brat.2004.10.007; Milad MR, 2007, BIOL PSYCHIAT, V62, P446, DOI 10.1016/j.biopsych.2006.10.011; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; Myers KM, 2002, NEURON, V36, P567, DOI 10.1016/S0896-6273(02)01064-4; Nader K, 1999, BEHAV NEUROSCI, V113, P152, DOI 10.1037/0735-7044.113.1.152; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Quirk GJ, 2003, J NEUROSCI, V23, P8800, DOI 10.1523/jneurosci.23-25-08800.2003; Rattiner LM, 2005, NEUROSCIENTIST, V11, P323, DOI 10.1177/1073858404272255; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Rauch SL, 2000, BIOL PSYCHIAT, V47, P769, DOI 10.1016/S0006-3223(00)00828-3; Rothbaum BO, 2003, ANN NY ACAD SCI, V1008, P112, DOI 10.1196/annals.1301.012; Schiller D, 2008, J NEUROSCI, V28, P11517, DOI 10.1523/JNEUROSCI.2265-08.2008; Sotres-Bayon F, 2006, BIOL PSYCHIAT, V60, P329, DOI 10.1016/j.biopsych.2005.10.012; Yu H, 2009, J NEUROSCI, V29, P4056, DOI 10.1523/JNEUROSCI.5539-08.2009	33	434	446	0	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2010	327	5967					863	866		10.1126/science.1181886	http://dx.doi.org/10.1126/science.1181886			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554AQ	20075215	Green Accepted			2022-12-28	WOS:000274408300061
J	Russo, I; Babbitt, S; Muralidharan, V; Butler, T; Oksman, A; Goldberg, DE				Russo, Ilaria; Babbitt, Shalon; Muralidharan, Vasant; Butler, Tamira; Oksman, Anna; Goldberg, Daniel E.			Plasmepsin V licenses Plasmodium proteins for export into the host erythrocyte	NATURE			English	Article							ENDOPLASMIC-RETICULUM; PARASITE PROTEINS; FOOD VACUOLE; FALCIPARUM; TRAFFICKING; VIRULENCE; CALPAIN; REVEALS	During their intraerythrocytic development, malaria parasites export hundreds of proteins to remodel their host cell. Nutrient acquisition, cytoadherence and antigenic variation are among the key virulence functions effected by this erythrocyte takeover. Proteins destined for export are synthesized in the endoplasmic reticulum (ER) and cleaved at a conserved (PEXEL) motif, which allows translocation into the host cell via an ATP-driven translocon called the PTEX complex. We report that plasmepsin V, an ER aspartic protease with distant homology to the mammalian processing enzyme BACE, recognizes the PEXEL motif and cleaves it at the correct site. This enzyme is essential for parasite viability and ER residence is essential for its function. We propose that plasmepsin V is the PEXEL protease and is an attractive enzyme for antimalarial drug development.	[Goldberg, Daniel E.] Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Microbiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	Howard Hughes Medical Institute; Washington University (WUSTL); Washington University (WUSTL)	Goldberg, DE (corresponding author), Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Microbiol, St Louis, MO 63110 USA.	Goldberg@borcim.wustl.edu	russo, ilaria/D-4674-2014; Russo, Ilaria/GNP-2328-2022	russo, ilaria/0000-0002-2269-7078; Russo, Ilaria/0000-0002-2269-7078; Muralidharan, Vasant/0000-0001-6367-6284	NIH [AI-047798]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047798] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant AI-047798. We thank A. Cowman, B. Crabb and S. Lindquist for suggestions, J. Adams and ATCC (MR4) for BiP antibody, D. Taylor for HRPII antibody, R. Anders for RESA antibody, A. Miller and M. Ndonwi for HRPII protein, P. Hruz for HIV protease inhibitors, J. Tang and S. Romeo for BACE inhibitors, W. Beatty for fluorescence analysis, S. Beverley for fluorimeter access, B. Vaupel for technical assistance and J. Turk for mass spectrometer access. Proteomics analysis was carried out at the 'Fingerprints' Proteomics Facility, College of Life Sciences, University of Dundee.	Bhattacharjee Souvik, 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020050; Boddey JA, 2009, TRAFFIC, V10, P285, DOI 10.1111/j.1600-0854.2008.00864.x; Chang HH, 2008, MOL BIOCHEM PARASIT, V160, P107, DOI 10.1016/j.molbiopara.2008.04.011; de Koning-Ward TF, 2009, NATURE, V459, P945, DOI 10.1038/nature08104; Drew ME, 2008, J BIOL CHEM, V283, P12870, DOI 10.1074/jbc.M708949200; Haldar K, 2007, CURR OPIN HEMATOL, V14, P203, DOI 10.1097/MOH.0b013e3280f31b2d; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Kim JH, 1998, P NATL ACAD SCI USA, V95, P2997, DOI 10.1073/pnas.95.6.2997; Klemba M, 2004, J CELL BIOL, V164, P47, DOI 10.1083/jcb200307147; Klemba M, 2005, MOL BIOCHEM PARASIT, V143, P183, DOI 10.1016/j.molbiopara.2005.05.015; Klemba M, 2004, J BIOL CHEM, V279, P43000, DOI 10.1074/jbc.M408123200; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Maier AG, 2009, NAT REV MICROBIOL, V7, P341, DOI 10.1038/nrmicro2110; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Parikh S, 2005, ANTIMICROB AGENTS CH, V49, P2983, DOI 10.1128/AAC.49.7.2983-2985.2005; Russo I, 2009, P NATL ACAD SCI USA, V106, P1554, DOI 10.1073/pnas.0806926106; Russo I, 2009, MOL MICROBIOL, V72, P229, DOI 10.1111/j.1365-2958.2009.06639.x; Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Skinner-Adams TS, 2004, J INFECT DIS, V190, P1998, DOI 10.1086/425584; Sullivan DJ, 1996, SCIENCE, V271, P219, DOI 10.1126/science.271.5246.219; TANG J, 2004, HDB PROTEOLYTIC ENZY, V1, pCH13; van Ooij C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000084	23	213	218	0	27	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 4	2010	463	7281					632	636		10.1038/nature08726	http://dx.doi.org/10.1038/nature08726			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551GB	20130644	Green Accepted			2022-12-28	WOS:000274193900029
J	Spence, D				Spence, Des			From the Frontline Bad medicine: osteoporosis	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 3	2010	340								c643	10.1136/bmj.c643	http://dx.doi.org/10.1136/bmj.c643			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	553CV	20130012				2022-12-28	WOS:000274343500004
J	Ho, L; Crabtree, GR				Ho, Lena; Crabtree, Gerald R.			Chromatin remodelling during development	NATURE			English	Review							CELL SELF-RENEWAL; HISTONE VARIANT H2A.Z; GENE-EXPRESSION; COMPLEX; TRANSCRIPTION; COMPONENT; PROTEIN; SUBUNIT; PLURIPOTENCY; FAMILY	New methods for the genome-wide analysis of chromatin are providing insight into its roles in development and their underlying mechanisms. Current studies indicate that chromatin is dynamic, with its structure and its histone modifications undergoing global changes during transitions in development and in response to extracellular cues. In addition to DNA methylation and histone modification, ATP-dependent enzymes that remodel chromatin are important controllers of chromatin structure and assembly, and are major contributors to the dynamic nature of chromatin. Evidence is emerging that these chromatin-remodelling enzymes have instructive and programmatic roles during development. Particularly intriguing are the findings that specialized assemblies of ATP-dependent remodellers are essential for establishing and maintaining pluripotent and multipotent states in cells.	[Ho, Lena; Crabtree, Gerald R.] Stanford Univ, Sch Med, Beckman Ctr, Stanford, CA 94305 USA	Stanford University	Crabtree, GR (corresponding author), Stanford Univ, Sch Med, Beckman Ctr, Room B211,279 Campus Dr, Stanford, CA 94305 USA.	crabtree@stanford.edu		Ho, Lena/0000-0002-9358-621X	Agency for Science, Technology and Research (Singapore); National Institutes of Health; Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046789] Funding Source: NIH RePORTER	Agency for Science, Technology and Research (Singapore)(Agency for Science Technology & Research (A*STAR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Yoo, A. Shalizi and J. Ronan for comment and critique throughout the preparation of this article. L. H. is funded by the Agency for Science, Technology and Research (Singapore). G. R. C. is funded by grants from the National Institutes of Health and the Howard Hughes Medical Institute.	Armstrong JA, 2002, EMBO J, V21, P5245, DOI 10.1093/emboj/cdf517; Badenhorst P, 2002, GENE DEV, V16, P3186, DOI 10.1101/gad.1032202; Bagchi A, 2007, CELL, V128, P459, DOI 10.1016/j.cell.2006.11.052; Banting GS, 2005, HUM MOL GENET, V14, P513, DOI 10.1093/hmg/ddi048; Bao YH, 2007, MUTAT RES-FUND MOL M, V618, P18, DOI 10.1016/j.mrfmmm.2006.10.006; Barak O, 2003, EMBO J, V22, P6089, DOI 10.1093/emboj/cdg582; Bowen NJ, 2004, BBA-GENE STRUCT EXPR, V1677, P52, DOI 10.1016/j.bbaexp.2003.10.010; Brown E, 2007, BIOCHEM CELL BIOL, V85, P444, DOI 10.1139/O07-059; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Bultman SJ, 2006, GENE DEV, V20, P1744, DOI 10.1101/gad.1435106; Bultman SJ, 2005, GENE DEV, V19, P2849, DOI 10.1101/gad.1364105; Chalkley GE, 2008, MOL CELL BIOL, V28, P2920, DOI 10.1128/MCB.02217-07; Chi TH, 2003, IMMUNITY, V19, P169, DOI 10.1016/S1074-7613(03)00199-7; Chi TH, 2002, NATURE, V418, P195, DOI 10.1038/nature00876; Corona DFV, 2007, PLOS BIOL, V5, P2011, DOI 10.1371/journal.pbio.0050232; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; COTE J, 1994, SCIENCE, V265, P53, DOI 10.1126/science.8016655; Creyghton MP, 2008, CELL, V135, P649, DOI 10.1016/j.cell.2008.09.056; de la Serna IL, 2001, NAT GENET, V27, P187, DOI 10.1038/84826; de la Serna IL, 2006, NAT REV GENET, V7, P461, DOI 10.1038/nrg1882; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Deuring R, 2000, MOL CELL, V5, P355, DOI 10.1016/S1097-2765(00)80430-X; DINGWALL AK, 1995, MOL BIOL CELL, V6, P777, DOI 10.1091/mbc.6.7.777; Dirscherl SS, 2004, BIOCHEM CELL BIOL, V82, P482, DOI 10.1139/O04-044; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Feng Q, 2001, GENE DEV, V15, P827; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Francke U, 1999, HUM MOL GENET, V8, P1947, DOI 10.1093/hmg/8.10.1947; Gao XL, 2008, P NATL ACAD SCI USA, V105, P6656, DOI 10.1073/pnas.0801802105; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Hall JA, 2007, BIOCHEM CELL BIOL, V85, P463, DOI 10.1139/O07-063; Hansis C, 2004, CURR BIOL, V14, P1475, DOI 10.1016/j.cub.2004.08.031; Herceg Z, 2001, NAT GENET, V29, P206, DOI 10.1038/ng725; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Ho LN, 2009, P NATL ACAD SCI USA, V106, P5187, DOI 10.1073/pnas.0812888106; Hodl M, 2009, CURR BIOL, V19, P1221, DOI 10.1016/j.cub.2009.05.048; Huang XL, 2008, DEV BIOL, V319, P258, DOI 10.1016/j.ydbio.2008.04.020; Hurd EA, 2007, MAMM GENOME, V18, P94, DOI 10.1007/s00335-006-0107-6; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kaeser MD, 2008, J BIOL CHEM, V283, P32254, DOI 10.1074/jbc.M806061200; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kaji K, 2007, DEVELOPMENT, V134, P1123, DOI 10.1242/dev.02802; KENNISON JA, 1988, P NATL ACAD SCI USA, V85, P8136, DOI 10.1073/pnas.85.21.8136; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; Kidder BL, 2009, STEM CELLS, V27, P317, DOI 10.1634/stemcells.2008-0710; Kim JK, 2001, MOL CELL BIOL, V21, P7787, DOI 10.1128/MCB.21.22.7787-7795.2001; Klochendler-Yeivin A, 2000, EMBO REP, V1, P500, DOI 10.1093/embo-reports/kvd129; Konev AY, 2007, SCIENCE, V317, P1087, DOI 10.1126/science.1145339; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Landry J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000241; Lange M, 2008, GENE DEV, V22, P2370, DOI 10.1101/gad.471408; Layman WS, 2009, HUM MOL GENET, V18, P1909, DOI 10.1093/hmg/ddp112; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Lickert H, 2004, NATURE, V432, P107, DOI 10.1038/nature03071; Lim DA, 2009, NATURE, V458, P529, DOI 10.1038/nature07726; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Marfella CGA, 2006, J CELL PHYSIOL, V209, P162, DOI 10.1002/jcp.20718; McDaniel IE, 2008, GENETICS, V178, P583, DOI 10.1534/genetics.107.079038; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Morrison AJ, 2009, NAT REV MOL CELL BIO, V10, P373, DOI 10.1038/nrm2693; Parrish JZ, 2006, GENE DEV, V20, P820, DOI 10.1101/gad.1391006; Pedersen TA, 2001, GENE DEV, V15, P3208, DOI 10.1101/gad.209901; Reyes JC, 1998, EMBO J, V17, P6979, DOI 10.1093/emboj/17.23.6979; Ruhl DD, 2006, BIOCHEMISTRY-US, V45, P5671, DOI 10.1021/bi060043d; Sapountzi V, 2006, INT J BIOCHEM CELL B, V38, P1496, DOI 10.1016/j.biocel.2006.03.003; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; SCHANIEL C, 2009, STEM CELLS      0925, DOI DOI 10.1002/STEM.223; Schnetz MP, 2009, GENOME RES, V19, P590, DOI 10.1101/gr.086983.108; Schones DE, 2008, NAT REV GENET, V9, P179, DOI 10.1038/nrg2270; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Shur I, 2006, J CELL PHYSIOL, V207, P374, DOI 10.1002/jcp.20586; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Siriaco G, 2009, GENETICS, V182, P661, DOI 10.1534/genetics.109.102053; Srinivasan S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000217; Stankunas K, 2008, DEV CELL, V14, P298, DOI 10.1016/j.devcel.2007.11.018; Stopka T, 2003, P NATL ACAD SCI USA, V100, P14097, DOI 10.1073/pnas.2336105100; Strohner R, 2001, EMBO J, V20, P4892, DOI 10.1093/emboj/20.17.4892; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Takeuchi JK, 2007, P NATL ACAD SCI USA, V104, P846, DOI 10.1073/pnas.0608118104; Takeuchi JK, 2009, NATURE, V459, P708, DOI 10.1038/nature08039; Toh Y, 2009, CLIN EXP METASTAS, V26, P215, DOI 10.1007/s10585-008-9233-8; Trotter Kevin W, 2008, Nucl Recept Signal, V6, pe004, DOI 10.1621/nrs.06004; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100; Wan M, 2009, EUR J IMMUNOL, V39, P580, DOI 10.1002/eji.200838909; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; Wang Y, 2004, COLD SPRING HARB SYM, V69, P161, DOI 10.1101/sqb.2004.69.161; Wang Z, 2004, GENE DEV, V18, P3106, DOI 10.1101/gad.1238104; White PS, 2005, ONCOGENE, V24, P2684, DOI 10.1038/sj.onc.1208306; Williams CJ, 2004, IMMUNITY, V20, P719, DOI 10.1016/j.immuni.2004.05.005; Wong MM, 2007, J BIOL CHEM, V282, P26132, DOI 10.1074/jbc.M703418200; Wu JI, 2007, NEURON, V56, P94, DOI 10.1016/j.neuron.2007.08.021; Wu JI, 2009, CELL, V136, P200, DOI 10.1016/j.cell.2009.01.009; Xi RW, 2005, SCIENCE, V310, P1487, DOI 10.1126/science.1120140; Yan Z, 2008, STEM CELLS, V26, P1155, DOI 10.1634/stemcells.2007-0846; Yoo AS, 2009, CURR OPIN NEUROBIOL, V19, P120, DOI 10.1016/j.conb.2009.04.006; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139; Yoshida T, 2008, GENE DEV, V22, P1174, DOI 10.1101/gad.1642808; Yoshimura K, 2009, P NATL ACAD SCI USA, V106, P9280, DOI 10.1073/pnas.0901184106; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4	103	762	787	3	151	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 28	2010	463	7280					474	484		10.1038/nature08911	http://dx.doi.org/10.1038/nature08911			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	548QK	20110991	Green Accepted			2022-12-28	WOS:000273981100039
J	Hughes, JF; Skaletsky, H; Pyntikova, T; Graves, TA; van Daalen, SKM; Minx, PJ; Fulton, RS; McGrath, SD; Locke, DP; Friedman, C; Trask, BJ; Mardis, ER; Warren, WC; Repping, S; Rozen, S; Wilson, RK; Page, DC				Hughes, Jennifer F.; Skaletsky, Helen; Pyntikova, Tatyana; Graves, Tina A.; van Daalen, Saskia K. M.; Minx, Patrick J.; Fulton, Robert S.; McGrath, Sean D.; Locke, Devin P.; Friedman, Cynthia; Trask, Barbara J.; Mardis, Elaine R.; Warren, Wesley C.; Repping, Sjoerd; Rozen, Steve; Wilson, Richard K.; Page, David C.			Chimpanzee and human Y chromosomes are remarkably divergent in structure and gene content	NATURE			English	Article							SEX-CHROMOSOME; X-CHROMOSOME; HUMAN GENOME; EVOLUTION; SEQUENCE; PALINDROMES; REGION; RECOMBINATION; DEGENERATION; POLYMORPHISM	The human Y chromosome began to evolve from an autosome hundreds of millions of years ago, acquiring a sex-determining function and undergoing a series of inversions that suppressed crossing over with the X chromosome(1,2). Little is known about the recent evolution of the Y chromosome because only the human Y chromosome has been fully sequenced. Prevailing theories hold that Y chromosomes evolve by gene loss, the pace of which slows over time, eventually leading to a paucity of genes, and stasis(3,4). These theories have been buttressed by partial sequence data from newly emergent plant and animal Y chromosomes(5-8), but they have not been tested in older, highly evolved Y chromosomes such as that of humans. Here we finished sequencing of the male-specific region of the Y chromosome (MSY) in our closest living relative, the chimpanzee, achieving levels of accuracy and completion previously reached for the human MSY. By comparing the MSYs of the two species we show that they differ radically in sequence structure and gene content, indicating rapid evolution during the past 6 million years. The chimpanzee MSY contains twice as many massive palindromes as the human MSY, yet it has lost large fractions of the MSY protein-coding genes and gene families present in the last common ancestor. We suggest that the extraordinary divergence of the chimpanzee and human MSYs was driven by four synergistic factors: the prominent role of the MSY in sperm production, 'genetic hitchhiking' effects in the absence of meiotic crossing over, frequent ectopic recombination within the MSY, and species differences in mating behaviour. Although genetic decay may be the principal dynamic in the evolution of newly emergent Y chromosomes, wholesale renovation is the paramount theme in the continuing evolution of chimpanzee, human and perhaps other older MSYs.	[Hughes, Jennifer F.; Skaletsky, Helen; Pyntikova, Tatyana; Rozen, Steve; Page, David C.] Whitehead Inst, Howard Hughes Med Inst, Cambridge, MA 02142 USA; [Hughes, Jennifer F.; Skaletsky, Helen; Pyntikova, Tatyana; Rozen, Steve; Page, David C.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Graves, Tina A.; Minx, Patrick J.; Fulton, Robert S.; McGrath, Sean D.; Locke, Devin P.; Mardis, Elaine R.; Warren, Wesley C.; Wilson, Richard K.] Washington Univ, Sch Med, Genome Ctr, St Louis, MO 63108 USA; [van Daalen, Saskia K. M.; Repping, Sjoerd] Univ Amsterdam, Acad Med Ctr, Dept Obstet & Gynecol, Ctr Reprod Med, NL-1105 AZ Amsterdam, Netherlands; [Friedman, Cynthia; Trask, Barbara J.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Washington University (WUSTL); University of Amsterdam; Academic Medical Center Amsterdam; Fred Hutchinson Cancer Center	Page, DC (corresponding author), Whitehead Inst, Howard Hughes Med Inst, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	dcpage@wi.mit.edu	Mardis, Elaine/W-2202-2019; McGrath, Sean David/AAT-3540-2020; Wilson, Richard K./AAF-4139-2019; Rozen, Steven G./J-5939-2013	McGrath, Sean David/0000-0001-9064-8449; Wilson, Richard K./0000-0002-1992-1358; Locke, Devin/0000-0002-2527-0475; Repping, Sjoerd/0000-0002-6959-149X; Rozen, Steven G./0000-0002-4288-0056	National Institutes of Health; Howard Hughes Medical Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000257] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank L. Brown, V. Frazzoni, G. Rogers and A. Berger for technical assistance, and L. Brown, M. Carmell, G. Dokshin, M. Gill, J. Mueller, K. Romer and Y. Soh for comments on the manuscript. This work was supported by the National Institutes of Health and the Howard Hughes Medical Institute.	Bachtrog D, 2002, NATURE, V416, P323, DOI 10.1038/416323a; Bachtrog D, 2008, GENETICS, V179, P1513, DOI 10.1534/genetics.107.084012; CHARLESWORTH B, 1991, SCIENCE, V251, P1030, DOI 10.1126/science.1998119; Charlesworth B, 2000, PHILOS T R SOC B, V355, P1563, DOI 10.1098/rstb.2000.0717; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; DIXSON AF, 1998, PRIMATE SEXUALITY CO, P37; Filatov DA, 2000, NATURE, V404, P388, DOI 10.1038/35006057; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hughes JF, 2006, NAT GENET, V38, P853, DOI 10.1038/ng0806-853b; Hughes JF, 2005, NATURE, V437, P101, DOI 10.1038/nature04101; Kawaguchi TK, 2001, NAT GENET, V29, P279, DOI 10.1038/ng757; Kuroki Y, 2006, NAT GENET, V38, P158, DOI 10.1038/ng1729; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; Lange J, 2009, CELL, V138, P855, DOI 10.1016/j.cell.2009.07.042; Liu ZY, 2004, NATURE, V427, P348, DOI 10.1038/nature02228; Mefford HC, 2001, HUM MOL GENET, V10, P2363, DOI 10.1093/hmg/10.21.2363; Murphy WJ, 2006, PLOS GENET, V2, P353, DOI 10.1371/journal.pgen.0020043; PAGE DC, 1984, NATURE, V311, P119, DOI 10.1038/311119a0; Peichel CL, 2004, CURR BIOL, V14, P1416, DOI 10.1016/j.cub.2004.08.030; Repping S, 2002, AM J HUM GENET, V71, P906, DOI 10.1086/342928; Repping S, 2006, NAT GENET, V38, P463, DOI 10.1038/ng1754; Repping S, 2003, NAT GENET, V35, P247, DOI 10.1038/ng1250; Rice WR, 1996, BIOSCIENCE, V46, P331, DOI 10.2307/1312947; Rozen S, 2003, NATURE, V423, P873, DOI 10.1038/nature01723; Saxena R, 2000, GENOMICS, V67, P256, DOI 10.1006/geno.2000.6260; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Steinemann S, 2005, CYTOGENET GENOME RES, V110, P134, DOI 10.1159/000084945; Watanabe H, 2004, NATURE, V429, P382, DOI 10.1038/nature02564; Yeh RF, 2001, GENOME RES, V11, P803, DOI 10.1101/gr.175701; Yohn CT, 2005, PLOS BIOL, V3, P577, DOI 10.1371/journal.pbio.0030110	30	265	272	0	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 28	2010	463	7280					536	539		10.1038/nature08700	http://dx.doi.org/10.1038/nature08700			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	548QK	20072128	Green Accepted, Green Submitted			2022-12-28	WOS:000273981100050
J	Kirkegaard, T; Roth, AG; Petersen, NHT; Mahalka, AK; Olsen, OD; Moilanen, I; Zylicz, A; Knudsen, J; Sandhoff, K; Arenz, C; Kinnunen, PKJ; Nylandsted, J; Jaattela, M				Kirkegaard, Thomas; Roth, Anke G.; Petersen, Nikolaj H. T.; Mahalka, Ajay K.; Olsen, Ole Dines; Moilanen, Irina; Zylicz, Alicja; Knudsen, Jens; Sandhoff, Konrad; Arenz, Christoph; Kinnunen, Paavo K. J.; Nylandsted, Jesper; Jaattela, Marja			Hsp70 stabilizes lysosomes and reverts Niemann-Pick disease-associated lysosomal pathology	NATURE			English	Article							ACID SPHINGOMYELINASE; HEAT-SHOCK-PROTEIN-70 FAMILY; CELL-DEATH; STIMULATION; INVOLVEMENT; ACTIVATION; CATHEPSINS; APOPTOSIS; MEMBRANES; PROTEINS	Heat shock protein 70 (Hsp70) is an evolutionarily highly conserved molecular chaperone that promotes the survival of stressed cells by inhibiting lysosomal membrane permeabilization(1-5), a hallmark of stress-induced cell death(6-10). Clues to its molecular mechanism of action may lay in the recently reported stress-and cancer-associated translocation of a small portion of Hsp70 to the lysosomal compartment(1,11). Here we show that Hsp70 stabilizes lysosomes by binding to an endolysosomal anionic phospholipid bis(monoacylglycero) phosphate (BMP), an essential co-factor for lysosomal sphingomyelin metabolism(12-14). In acidic environments Hsp70 binds with high affinity and specificity to BMP, thereby facilitating the BMP binding and activity of acid sphingomyelinase (ASM). The inhibition of the Hsp70-BMP interaction by BMP antibodies or a point mutation in Hsp70 (Trp90Phe), as well as the pharmacological and genetic inhibition of ASM, effectively revert the Hsp70-mediated stabilization of lysosomes. Notably, the reduced ASM activity in cells from patients with Niemann-Pick disease (NPD) A and B-severe lysosomal storage disorders caused by mutations in the sphingomyelin phosphodiesterase 1 gene (SMPD1) encoding for ASM(15)-is also associated with a marked decrease in lysosomal stability, and this phenotype can be effectively corrected by treatment with recombinant Hsp70. Taken together, these data open exciting possibilities for the development of new treatments for lysosomal storage disorders and cancer with compounds that enter the lysosomal lumen by the endocytic delivery pathway.	[Kirkegaard, Thomas; Petersen, Nikolaj H. T.; Olsen, Ole Dines; Nylandsted, Jesper; Jaattela, Marja] Danish Canc Soc, Inst Canc Biol, Apoptosis Dept, DK-2100 Copenhagen, Denmark; [Kirkegaard, Thomas; Petersen, Nikolaj H. T.; Olsen, Ole Dines; Nylandsted, Jesper; Jaattela, Marja] Danish Canc Soc, Inst Canc Biol, Ctr Genotox Stress Res, DK-2100 Copenhagen, Denmark; [Roth, Anke G.; Arenz, Christoph] Humboldt Univ, Inst Chem, D-10099 Berlin, Germany; [Mahalka, Ajay K.; Moilanen, Irina; Kinnunen, Paavo K. J.] Univ Helsinki, Inst Biomed, Helsinki Biophys & Biomembrane Grp, FIN-00014 Helsinki, Finland; [Olsen, Ole Dines; Knudsen, Jens] Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense, Denmark; [Zylicz, Alicja] Int Inst Mol & Cell Biol, PL-02109 Warsaw, Poland; [Sandhoff, Konrad] Univ Bonn, Kekule Inst Organ Chem & Biochem, LIMES, D-53121 Bonn, Germany	Danish Cancer Society; Danish Cancer Society; Humboldt University of Berlin; University of Helsinki; University of Southern Denmark; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; University of Bonn	Jaattela, M (corresponding author), Danish Canc Soc, Inst Canc Biol, Apoptosis Dept, DK-2100 Copenhagen, Denmark.	mj@cancer.dk	Jäättelä, Marja/AAT-7932-2021; Nylandsted, Jesper/ABE-7192-2021; Resource Center, NINDS Human Genetics/AGF-2474-2022; Mahalka, Ajay Kumar/G-6875-2012; Mahalka, Ajay/K-3993-2015; Arenz, Christoph/D-1841-2010; Sander-Effron, Samuel/AAX-2231-2020	Jäättelä, Marja/0000-0001-5950-7111; Mahalka, Ajay Kumar/0000-0002-0716-9947; Arenz, Christoph/0000-0001-7613-9437; Zylicz, Alicja/0000-0003-4174-3073; Nylandsted, Jesper/0000-0001-6474-5093	Danish Cancer Society; Danish National Research Foundation; Danish Medical Research Council; European Commission; Meyer Foundation; Novo Nordisk Foundation; Association for International Cancer Research; Finnish Academy; Sigrid Juselius Foundation; Volkswagenstiftung; Deutsche Forschungsgemeinschaft [SFB 645, SPP 1267]; EU; Polish Ministry of Science and High Education	Danish Cancer Society(Danish Cancer Society); Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); Meyer Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Association for International Cancer Research; Finnish Academy(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Volkswagenstiftung(Volkswagen); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EU(European Commission); Polish Ministry of Science and High Education(Ministry of Science and Higher Education, Poland)	We thank E. Gulbins and A. Riehle for the NPD A (no. 2) cells, the Charite Berlin and the Johannes Gutenberg-Universitat Mainz for the NPD B fibroblasts, C. Ejsing and H. Schulze for advice, and J. Gruenberg, B. Margulis and the Developmental Studies Hybridoma Bank for antibodies. This work was supported by grants from the Danish Cancer Society, the Danish National Research Foundation, the Danish Medical Research Council, the European Commission FP7 (APO-SYS), the Meyer Foundation, the Novo Nordisk Foundation, and the Association for International Cancer Research for M. J., the Finnish Academy and the Sigrid Juselius Foundation for P. K. J. K., Volkswagenstiftung for A. G. R. and C. A., Deutsche Forschungsgemeinschaft (SFB 645, SPP 1267) and EU (LipidomicNet) for K. S., and the Polish Ministry of Science and High Education for A.Z.	Bivik C, 2007, CARCINOGENESIS, V28, P537, DOI 10.1093/carcin/bgl152; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brunk UT, 1997, FREE RADICAL BIO MED, V23, P616, DOI 10.1016/S0891-5849(97)00007-5; Brunk UT, 2001, REDOX REP, V6, P91, DOI 10.1179/135100001101536094; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; Doulias PT, 2007, FREE RADICAL BIO MED, V42, P567, DOI 10.1016/j.freeradbiomed.2006.11.022; FERLINZ K, 1991, BIOCHEM BIOPH RES CO, V179, P1187, DOI 10.1016/0006-291X(91)91697-B; Flerov MA, 2003, B EXP BIOL MED+, V136, P120, DOI 10.1023/A:1026394218471; Goni FM, 2002, FEBS LETT, V531, P38, DOI 10.1016/S0014-5793(02)03482-8; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guicciardi ME, 2004, ONCOGENE, V23, P2881, DOI 10.1038/sj.onc.1207512; Gyrd-Hansen M, 2006, MOL CELL BIOL, V26, P7880, DOI 10.1128/MCB.00716-06; Holopainen JM, 2000, EUR J BIOCHEM, V267, P6231, DOI 10.1046/j.1432-1327.2000.01708.x; Holopainen JM, 1998, BIOCHEMISTRY-US, V37, P17562, DOI 10.1021/bi980915e; Hwang JH, 2005, PANCREAS, V31, P332, DOI 10.1097/01.mpa.0000183377.04295.c3; Kirkegaard T, 2009, BBA-MOL CELL RES, V1793, P746, DOI 10.1016/j.bbamcr.2008.09.008; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; Kolter T, 2005, ANNU REV CELL DEV BI, V21, P81, DOI 10.1146/annurev.cellbio.21.122303.120013; Kolzer M, 2004, FEBS LETT, V559, P96, DOI 10.1016/S0014-5793(04)00033-X; Leist M, 2001, NAT REV MOL CELL BIO, V2, P589, DOI 10.1038/35085008; Linke T, 2001, BIOL CHEM, V382, P283, DOI 10.1515/BC.2001.035; Mambula SS, 2006, J IMMUNOL, V177, P7849, DOI 10.4049/jimmunol.177.11.7849; Morshauser RC, 1999, J MOL BIOL, V289, P1387, DOI 10.1006/jmbi.1999.2776; Nylandsted J, 2004, J EXP MED, V200, P425, DOI 10.1084/jem.20040531; QUINTERN LE, 1987, BIOCHIM BIOPHYS ACTA, V922, P323, DOI 10.1016/0005-2760(87)90055-5; Rohde M, 2005, GENE DEV, V19, P570, DOI 10.1101/gad.305405; Smith EL, 2008, FASEB J, V22, P3419, DOI 10.1096/fj.08-108043; Sriram M, 1997, STRUCTURE, V5, P403, DOI 10.1016/S0969-2126(97)00197-4; Stoka V, 2007, BIOL CHEM, V388, P555, DOI 10.1515/BC.2007.064; Tidwell JL, 2004, CELL STRESS CHAPERON, V9, P88, DOI 10.1379/CSC-9R.1; Utermohlen O, 2008, IMMUNOBIOLOGY, V213, P307, DOI 10.1016/j.imbio.2007.10.016; Yu Q, 2001, MOL VIS, V7, P48; Zhao HX, 2002, J BIOL CHEM, V277, P25170, DOI 10.1074/jbc.M203186200	33	346	361	7	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 28	2010	463	7280					549	U171		10.1038/nature08710	http://dx.doi.org/10.1038/nature08710			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	548QK	20111001				2022-12-28	WOS:000273981100053
J	Krishnamoorthy, KS; Eichler, FS; Goyal, NA; Small, JE; Snuderl, M				Krishnamoorthy, Kalpathy S.; Eichler, Florian S.; Goyal, Namita A.; Small, Juan E.; Snuderl, Matija			A Boy with Developmental Delay and Irritability Infantile Krabbe disease (globoid-cell leukodystrophy)	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CEREBRAL-PALSY; PERIPHERAL NEUROPATHY; TERM INFANTS; OPTIC-NERVE; CLASSIFICATION; ENLARGEMENT; MRI		[Krishnamoorthy, Kalpathy S.] Massachusetts Gen Hosp, Div Pediat Neurol, Boston, MA 02114 USA; [Eichler, Florian S.; Goyal, Namita A.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Small, Juan E.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Snuderl, Matija] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Krishnamoorthy, Kalpathy S.] Harvard Univ, Sch Med, Dept Pediat, Cambridge, MA 02138 USA; [Eichler, Florian S.; Goyal, Namita A.] Harvard Univ, Sch Med, Dept Neurol, Cambridge, MA 02138 USA; [Small, Juan E.] Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; [Snuderl, Matija] Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University; Harvard University	Krishnamoorthy, KS (corresponding author), Massachusetts Gen Hosp, Div Pediat Neurol, Boston, MA 02114 USA.			Snuderl, Matija/0000-0003-0752-0917				Ashwal S, 2004, NEUROLOGY, V62, P851, DOI 10.1212/01.WNL.0000117981.35364.1B; Barkovich J., 2005, PEDIAT NEUROIMAGING; Brockmann K, 2003, NEUROLOGY, V60, P819, DOI 10.1212/01.WNL.0000049469.29011.E9; CANDY EJ, 1993, PEDIATR NEUROL, V9, P421, DOI 10.1016/0887-8994(93)90020-D; Escolar ML, 2006, PEDIATRICS, V118, pE879, DOI 10.1542/peds.2006-0747; FENICHEL GM, 2005, CLIN PEDIAT NEUROLOG, P117; Formichi P, 2007, J CELL PHYSIOL, V212, P737, DOI 10.1002/jcp.21070; HARDING BH, 2008, GREENFIELDS NEUROPAT, P488; HITTMAIR K, 1994, AM J NEURORADIOL, V15, P1454; HOGAN GR, 1969, NEUROLOGY, V19, P1094, DOI 10.1212/WNL.19.11.1094; Jones BV, 1999, AM J NEURORADIOL, V20, P1228; Kulak W, 2007, J CHILD NEUROL, V22, P8, DOI 10.1177/0883073807299953; LEWIS RA, 1982, NEUROLOGY, V32, P592, DOI 10.1212/WNL.32.6.592; Loes DJ, 1999, AM J NEURORADIOL, V20, P316; MILLER RG, 1985, MUSCLE NERVE, V8, P205, DOI 10.1002/mus.880080305; Patel B, 2008, PEDIATR RADIOL, V38, P697, DOI 10.1007/s00247-008-0849-2; Redline RW, 2008, PEDIATR DEVEL PATHOL, V11, P456, DOI 10.2350/08-05-0468.1; Redline RW, 2005, AM J OBSTET GYNECOL, V192, P452, DOI 10.1016/j.ajog.2004.07.030; Sanger TD, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.1.e89; SASAKI M, 1991, PEDIATR NEUROL, V7, P283, DOI 10.1016/0887-8994(91)90046-N; Scriver C.R., 2001, METABOLIC MOL BASES, P3669; Siddiqi ZA, 2006, NEUROLOGY, V67, P263, DOI 10.1212/01.wnl.0000230153.34613.84; SUZUKI K, 2008, GREENFIELDS NEUROPAT, P535; Swaiman KF, 2006, PEDIAT NEUROLOGY PRI, V1, P491; TRUWIT CL, 1992, AM J NEURORADIOL, V13, P67; Wu YW, 2003, JAMA-J AM MED ASSOC, V290, P2677, DOI 10.1001/jama.290.20.2677; Zarifi MK, 2001, J CHILD NEUROL, V16, P522, DOI 10.1177/088307380101600713	27	4	4	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 28	2010	362	4					346	356		10.1056/NEJMcpc0907806	http://dx.doi.org/10.1056/NEJMcpc0907806			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	548OT	20107221				2022-12-28	WOS:000273975000012
J	Li, WK; Schulman, S; Dutton, RJ; Boyd, D; Beckwith, J; Rapoport, TA				Li, Weikai; Schulman, Sol; Dutton, Rachel J.; Boyd, Dana; Beckwith, Jon; Rapoport, Tom A.			Structure of a bacterial homologue of vitamin K epoxide reductase	NATURE			English	Article							DISULFIDE BOND FORMATION; ACTIVE-SITE; VKORC1; DSBB; MODEL; RESISTANCE; CONVERSION; MUTATIONS; MECHANISM; CYCLE	Vitamin K epoxide reductase (VKOR) generates vitamin K hydroquinone to sustain c-carboxylation of many blood coagulation factors. Here, we report the 3.6 angstrom crystal structure of a bacterial homologue of VKOR from Synechococcus sp. The structure shows VKOR in complex with its naturally fused redox partner, a thioredoxin-like domain, and corresponds to an arrested state of electron transfer. The catalytic core of VKOR is a four transmembrane helix bundle that surrounds a quinone, connected through an additional transmembrane segment with the periplasmic thioredoxin-like domain. We propose a pathway for how VKOR uses electrons from cysteines of newly synthesized proteins to reduce a quinone, a mechanism confirmed by in vitro reconstitution of vitamin K-dependent disulphide bridge formation. Our results have implications for the mechanism of the mammalian VKOR and explain how mutations can cause resistance to the VKOR inhibitor warfarin, the most commonly used oral anticoagulant.	[Li, Weikai; Schulman, Sol; Rapoport, Tom A.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Li, Weikai; Schulman, Sol; Rapoport, Tom A.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Dutton, Rachel J.; Boyd, Dana; Beckwith, Jon] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Rapoport, TA (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, 240 Longwood Ave, Boston, MA 02115 USA.	weikai@crystal.harvard.edu; tom_rapoport@hms.harvard.edu		schulman, sol/0000-0002-5229-3592	NIH; National Institute of General Medical Sciences [GMO41883]; Charles King Trust; National Heart, Lung, and Blood Institute (NIH) [K99, 1K99HL097083]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL097083, R00HL097083] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753, R01GM041883] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Charles King Trust; National Heart, Lung, and Blood Institute (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Jao for help with mass spectroscopy, S. Harrison for insightful comments on the structure, B. Furie, B. C. Furie and Y. Yu. for discussion, A. Osborne, B. van den Berg, J. Zimmer, and Y. Chen for critical reading of the manuscript, R. Zhang for help with the figures, the staff at Advanced Photon Source beamline ID-24C, and the SBGrid consortium at Harvard Medical School. S. S. is supported by an NIH Medical Scientist Training Program fellowship. J. B. is supported by grant GMO41883 from the National Institute of General Medical Sciences. W. L. is supported by a Charles King Trust fellowship and K99 grant 1K99HL097083 from the National Heart, Lung, and Blood Institute (NIH). T. A. R. is an HHMI investigator.	Bader M, 1998, J BIOL CHEM, V273, P10302, DOI 10.1074/jbc.273.17.10302; BARDWELL JCA, 1993, P NATL ACAD SCI USA, V90, P1038, DOI 10.1073/pnas.90.3.1038; Chu PH, 2006, P NATL ACAD SCI USA, V103, P19308, DOI 10.1073/pnas.0609401103; Cowtan KD, 1996, ACTA CRYSTALLOGR D, V52, P43, DOI 10.1107/S090744499500761X; D'Ambrosio RL, 2007, J THROMB HAEMOST, V5, P191, DOI 10.1111/j.1538-7836.2006.02261.x; Dutton RJ, 2008, P NATL ACAD SCI USA, V105, P11933, DOI 10.1073/pnas.0804621105; Dutton RJ, 2010, P NATL ACAD SCI USA, V107, P297, DOI 10.1073/pnas.0912952107; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Furie B, 1999, BLOOD, V93, P1798, DOI 10.1182/blood.V93.6.1798.406k22_1798_1808; Gebauer M, 2007, BIOORGAN MED CHEM, V15, P2414, DOI 10.1016/j.bmc.2007.01.014; Goodstadt L, 2004, TRENDS BIOCHEM SCI, V29, P289, DOI 10.1016/j.tibs.2004.04.004; Gross E, 2004, CELL, V117, P601, DOI 10.1016/S0092-8674(04)00418-0; Gross E, 2002, NAT STRUCT BIOL, V9, P61, DOI 10.1038/nsb740; Inaba K, 2004, J BIOL CHEM, V279, P6761, DOI 10.1074/jbc.M310765200; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Inaba K, 2009, EMBO J, V28, P779, DOI 10.1038/emboj.2009.21; Jin DY, 2007, BIOCHEMISTRY-US, V46, P7279, DOI 10.1021/bi700527j; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KISHIGAMI S, 1995, J BIOL CHEM, V270, P17072, DOI 10.1074/jbc.270.29.17072; Klein TE, 2009, NEW ENGL J MED, V360, P753, DOI 10.1056/NEJMoa0809329; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Malojcic G, 2008, FEBS LETT, V582, P3301, DOI 10.1016/j.febslet.2008.07.063; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oldenburg J, 2008, VITAM HORM, V78, P35, DOI 10.1016/S0083-6729(07)00003-9; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pelz HJ, 2005, GENETICS, V170, P1839, DOI 10.1534/genetics.104.040360; Regeimbal J, 2003, P NATL ACAD SCI USA, V100, P13779, DOI 10.1073/pnas.1935988100; Rost S, 2005, THROMB HAEMOSTASIS, V94, P780, DOI 10.1160/TH05-02-0082; Rost S, 2004, NATURE, V427, P537, DOI 10.1038/nature02214; Rost S, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-4; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; SILVERMAN RB, 1981, J AM CHEM SOC, V103, P5939, DOI 10.1021/ja00409a068; Singh AK, 2008, J BIOL CHEM, V283, P15762, DOI 10.1074/jbc.M800982200; SOUTE BAM, 1992, BIOCHEM J, V281, P255, DOI 10.1042/bj2810255; STENFLO J, 1977, ANNU REV BIOCHEM, V46, P157, DOI 10.1146/annurev.bi.46.070177.001105; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tie JK, 2008, VITAM HORM, V78, P103, DOI 10.1016/S0083-6729(07)00006-4; Tie JK, 2005, J BIOL CHEM, V280, P16410, DOI 10.1074/jbc.M500765200; Tu BP, 2000, SCIENCE, V290, P1571, DOI 10.1126/science.290.5496.1571; Wajih N, 2007, J BIOL CHEM, V282, P2626, DOI 10.1074/jbc.M608954200; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Zhang KYJ, 1997, METHOD ENZYMOL, V277, P53, DOI 10.1016/S0076-6879(97)77006-X; Zhou YP, 2008, MOL CELL, V31, P896, DOI 10.1016/j.molcel.2008.08.028	43	149	153	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 28	2010	463	7280					507	U123		10.1038/nature08720	http://dx.doi.org/10.1038/nature08720			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	548QK	20110994	Green Accepted			2022-12-28	WOS:000273981100043
J	Costanzo, M; Baryshnikova, A; Bellay, J; Kim, Y; Spear, ED; Sevier, CS; Ding, HM; Koh, JLY; Toufighi, K; Mostafavi, S; Prinz, J; Onge, RPS; VanderSluis, B; Makhnevych, T; Vizeacoumar, FJ; Alizadeh, S; Bahr, S; Brost, RL; Chen, YQ; Cokol, M; Deshpande, R; Li, ZJ; Lin, ZY; Liang, WD; Marback, M; Paw, J; Luis, BJS; Shuteriqi, E; Tong, AHY; van Dyk, N; Wallace, IM; Whitney, JA; Weirauch, MT; Zhong, GQ; Zhu, HW; Houry, WA; Brudno, M; Ragibizadeh, S; Papp, B; Pal, C; Roth, FP; Giaever, G; Nislow, C; Troyanskaya, OG; Bussey, H; Bader, GD; Gingras, AC; Morris, QD; Kim, PM; Kaiser, CA; Myers, CL; Andrews, BJ; Boone, C				Costanzo, Michael; Baryshnikova, Anastasia; Bellay, Jeremy; Kim, Yungil; Spear, Eric D.; Sevier, Carolyn S.; Ding, Huiming; Koh, Judice L. Y.; Toufighi, Kiana; Mostafavi, Sara; Prinz, Jeany; Onge, Robert P. St.; VanderSluis, Benjamin; Makhnevych, Taras; Vizeacoumar, Franco J.; Alizadeh, Solmaz; Bahr, Sondra; Brost, Renee L.; Chen, Yiqun; Cokol, Murat; Deshpande, Raamesh; Li, Zhijian; Lin, Zhen-Yuan; Liang, Wendy; Marback, Michaela; Paw, Jadine; Luis, Bryan-Joseph San; Shuteriqi, Ermira; Tong, Amy Hin Yan; van Dyk, Nydia; Wallace, Iain M.; Whitney, Joseph A.; Weirauch, Matthew T.; Zhong, Guoqing; Zhu, Hongwei; Houry, Walid A.; Brudno, Michael; Ragibizadeh, Sasan; Papp, Balazs; Pal, Csaba; Roth, Frederick P.; Giaever, Guri; Nislow, Corey; Troyanskaya, Olga G.; Bussey, Howard; Bader, Gary D.; Gingras, Anne-Claude; Morris, Quaid D.; Kim, Philip M.; Kaiser, Chris A.; Myers, Chad L.; Andrews, Brenda J.; Boone, Charles			The Genetic Landscape of a Cell	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; INTERACTION NETWORKS; TRANSFER-RNA; PROTEIN; EVOLUTION; INTERACTOME; EXOCYTOSIS; PATHWAYS; REVEALS; MAP	A genome-scale genetic interaction map was constructed by examining 5.4 million gene-gene pairs for synthetic genetic interactions, generating quantitative genetic interaction profiles for similar to 75% of all genes in the budding yeast, Saccharomyces cerevisiae. A network based on genetic interaction profiles reveals a functional map of the cell in which genes of similar biological processes cluster together in coherent subsets, and highly correlated profiles delineate specific pathways to define gene function. The global network identifies functional cross-connections between all bioprocesses, mapping a cellular wiring diagram of pleiotropy. Genetic interaction degree correlated with a number of different gene attributes, which may be informative about genetic network hubs in other organisms. We also demonstrate that extensive and unbiased mapping of the genetic landscape provides a key for interpretation of chemical-genetic interactions and drug target identification.	[Bellay, Jeremy; Kim, Yungil; Deshpande, Raamesh; Myers, Chad L.] Univ Minnesota, Dept Comp Sci & Engn, Minneapolis, MN 55455 USA; [Costanzo, Michael; Baryshnikova, Anastasia; Ding, Huiming; Koh, Judice L. Y.; Toufighi, Kiana; Prinz, Jeany; Vizeacoumar, Franco J.; Alizadeh, Solmaz; Bahr, Sondra; Brost, Renee L.; Chen, Yiqun; Li, Zhijian; Liang, Wendy; Marback, Michaela; Paw, Jadine; Luis, Bryan-Joseph San; Shuteriqi, Ermira; Tong, Amy Hin Yan; van Dyk, Nydia; Wallace, Iain M.; Zhong, Guoqing; Zhu, Hongwei; Giaever, Guri; Nislow, Corey; Bader, Gary D.; Morris, Quaid D.; Kim, Philip M.; Andrews, Brenda J.; Boone, Charles] Univ Toronto, Dept Mol Genet, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Costanzo, Michael; Baryshnikova, Anastasia; Ding, Huiming; Koh, Judice L. Y.; Toufighi, Kiana; Mostafavi, Sara; Prinz, Jeany; Vizeacoumar, Franco J.; Alizadeh, Solmaz; Bahr, Sondra; Brost, Renee L.; Chen, Yiqun; Li, Zhijian; Liang, Wendy; Marback, Michaela; Paw, Jadine; Luis, Bryan-Joseph San; Shuteriqi, Ermira; Tong, Amy Hin Yan; van Dyk, Nydia; Wallace, Iain M.; Whitney, Joseph A.; Zhong, Guoqing; Zhu, Hongwei; Brudno, Michael; Nislow, Corey; Bader, Gary D.; Morris, Quaid D.; Kim, Philip M.; Andrews, Brenda J.; Boone, Charles] Univ Toronto, Banting & Best Dept Med Res, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Spear, Eric D.; Sevier, Carolyn S.; Kaiser, Chris A.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Mostafavi, Sara; Whitney, Joseph A.; Brudno, Michael; Morris, Quaid D.] Univ Toronto, Dept Comp Sci, Toronto, ON M5S 2E4, Canada; [Onge, Robert P. St.] Stanford Univ, Dept Biochem, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA; [Makhnevych, Taras] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Cokol, Murat; Roth, Frederick P.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Lin, Zhen-Yuan; Gingras, Anne-Claude] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Wallace, Iain M.; Giaever, Guri] Univ Toronto, Dept Pharm, Toronto, ON M5S 3E1, Canada; [Weirauch, Matthew T.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Ragibizadeh, Sasan] S&P Robot Inc, N York, ON M3J 2V8, Canada; [Papp, Balazs; Pal, Csaba] Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary; [Troyanskaya, Olga G.] Princeton Univ, Dept Comp Sci, Lewis Sigler Inst Integrat Genom, Carl Icahn Lab, Princeton, NJ 08544 USA; [Bussey, Howard] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	University of Minnesota System; University of Minnesota Twin Cities; University of Toronto; University of Toronto; Massachusetts Institute of Technology (MIT); University of Toronto; Stanford University; University of Toronto; Harvard University; Harvard Medical School; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of California System; University of California Santa Cruz; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Princeton University; McGill University	Myers, CL (corresponding author), Univ Minnesota, Dept Comp Sci & Engn, Minneapolis, MN 55455 USA.	cmyers@cs.umn.edu; brenda.andrews@utoronto.ca; charlie.boone@utoronto.ca	Weirauch, Matthew/M-5459-2019; Bader, Gary/C-1176-2009; Morris, Quaid/ABE-8343-2020; Gingras, Anne-Claude/E-9982-2010; Troyanskaya, Olga G/B-1968-2010; Califano, Andrea/F-7239-2012; Vizeacoumar, Franco/GLS-7161-2022; Gingras, Anne-Claude/ABA-8341-2020; Roth, Frederick P/H-6308-2011; Wallace, Iain/B-9464-2009	Bader, Gary/0000-0003-0185-8861; Gingras, Anne-Claude/0000-0002-6090-4437; Gingras, Anne-Claude/0000-0002-6090-4437; Morris, Quaid/0000-0002-2760-6999; Papp, Balazs/0000-0003-3093-8852; Troyanskaya, Olga/0000-0002-5676-5737; Roth, Frederick/0000-0002-6628-649X; Sevier, Carolyn/0000-0003-3245-6988; Wallace, Iain/0000-0002-9491-7025	Genome Canada through the Ontario Genomics Institute [2004-OGI-3-01]; Canadian Institutes of Health Research [GSP-41567]; University of Minnesota; Minnesota Supercomputing Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003224] Funding Source: NIH RePORTER	Genome Canada through the Ontario Genomics Institute(Genome Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Minnesota(University of Minnesota System); Minnesota Supercomputing Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank S. Dixon, T. Hughes, P. Jorgensen, and M. Tyers for critical comments. Supported by Genome Canada through the Ontario Genomics Institute (2004-OGI-3-01) and the Canadian Institutes of Health Research (GSP-41567) (C. B., B. A.), the University of Minnesota Biomedical Informatics and Computational Biology program (J.B., R. D.), and a seed grant from the Minnesota Supercomputing Institute (J.B., B. V.).	Chen EJ, 2003, J CELL BIOL, V161, P333, DOI 10.1083/jcb.200210141; de Visser JAGM, 2003, EVOLUTION, V57, P1959, DOI 10.1554/02-750R; Dixon SJ, 2009, ANNU REV GENET, V43, P601, DOI 10.1146/annurev.genet.39.073003.114751; Dunham MJ, 2002, P NATL ACAD SCI USA, V99, P16144, DOI 10.1073/pnas.242624799; Esberg A, 2006, MOL CELL, V24, P139, DOI 10.1016/j.molcel.2006.07.031; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Fraser HB, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-11; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Hartwell L, 2004, SCIENCE, V303, P774, DOI 10.1126/science.1094731; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Johansen LD, 2008, J CELL SCI, V121, P854, DOI 10.1242/jcs.013722; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Kim PM, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.16; Kim PM, 2006, SCIENCE, V314, P1938, DOI 10.1126/science.1136174; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lehar J, 2008, NAT CHEM BIOL, V4, P674, DOI 10.1038/nchembio.120; Lehner B, 2006, NAT GENET, V38, P896, DOI 10.1038/ng1844; Leidel S, 2009, NATURE, V458, P228, DOI 10.1038/nature07643; Levy SF, 2008, PLOS BIOL, V6, P2588, DOI 10.1371/journal.pbio.0060264; Mani R, 2008, P NATL ACAD SCI USA, V105, P3461, DOI 10.1073/pnas.0712255105; Meiklejohn CD, 2002, TRENDS ECOL EVOL, V17, P468, DOI 10.1016/S0169-5347(02)02596-X; Metzger MB, 2009, MOL BIOL CELL, V20, P1006, DOI 10.1091/mbc.E08-02-0140; Naumanen T, 2008, CELL ADHES MIGR, V2, P236, DOI 10.4161/cam.2.4.6630; Pal C, 2001, GENETICS, V158, P927; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; Rahl PB, 2005, MOL CELL, V17, P841, DOI 10.1016/j.molcel.2005.02.018; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Sevier CS, 2007, CELL, V129, P333, DOI 10.1016/j.cell.2007.02.039; St Onge RP, 2007, NAT GENET, V39, P199, DOI 10.1038/ng1948; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Waddington CH., 1957, STRATEGY GENE, V1st; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684	34	1527	1568	2	266	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 22	2010	327	5964					425	431		10.1126/science.1180823	http://dx.doi.org/10.1126/science.1180823			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546BS	20093466	Green Accepted			2022-12-28	WOS:000273783100027
J	Roberts, RG; Brook, BW				Roberts, Richard G.; Brook, Barry W.			And Then There Were None?	SCIENCE			English	Editorial Material							PLEISTOCENE AUSTRALIA; MEGAFAUNA; EXTINCTION; COLLAPSE; HUMANS		[Roberts, Richard G.] Univ Wollongong, Sch Earth & Environm Sci, Ctr Archaeol Sci, Wollongong, NSW 2522, Australia; [Brook, Barry W.] Univ Adelaide, Sch Earth & Environm Sci, Inst Environm, Adelaide, SA 5005, Australia	University of Wollongong; University of Adelaide	Roberts, RG (corresponding author), Univ Wollongong, Sch Earth & Environm Sci, Ctr Archaeol Sci, Wollongong, NSW 2522, Australia.	rgrob@uow.edu.au; barry.brook@adelaide.edu.au	Brook, Barry W./G-2686-2011; Roberts, Richard Graham/B-8245-2013	Brook, Barry W./0000-0002-2491-1517; Roberts, Richard Graham/0000-0002-0128-4119				Ayliffe LK, 2008, QUATERNARY SCI REV, V27, P1784, DOI 10.1016/j.quascirev.2008.07.008; Brook B. W., 2006, ALCHERINGA, V1, P39; Field J, 2008, EARTH-SCI REV, V89, P97, DOI 10.1016/j.earscirev.2008.04.006; Fillios M, 2010, QUATERN INT, V211, P123, DOI 10.1016/j.quaint.2009.04.003; Gill JL, 2009, SCIENCE, V326, P1100, DOI 10.1126/science.1179504; Gillespie R, 2006, ARCHAEOL OCEAN, V41, P1; Grun R, 2010, QUATERNARY SCI REV, V29, P596, DOI 10.1016/j.quascirev.2009.11.004; Grun R, 2008, AUST J EARTH SCI, V55, P917, DOI 10.1080/08120090802097419; Haile J, 2009, P NATL ACAD SCI USA, V106, P22352, DOI 10.1073/pnas.0912510106; Miller GH, 1999, SCIENCE, V283, P205, DOI 10.1126/science.283.5399.205; Miller GH, 2005, SCIENCE, V309, P287, DOI 10.1126/science.1111288; Prideaux GJ, 2007, GEOLOGY, V35, P33, DOI 10.1130/G23070A.1; Prideaux GJ, 2009, P NATL ACAD SCI USA, V106, P11646, DOI 10.1073/pnas.0900956106; Roberts RG, 2001, SCIENCE, V292, P1888, DOI 10.1126/science.1060264; Trueman CNG, 2005, P NATL ACAD SCI USA, V102, P8381, DOI 10.1073/pnas.0408975102; Turney CSM, 2008, P NATL ACAD SCI USA, V105, P12150, DOI 10.1073/pnas.0801360105	16	14	14	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 22	2010	327	5964					420	422		10.1126/science.1185517	http://dx.doi.org/10.1126/science.1185517			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	546BS	20093463				2022-12-28	WOS:000273783100024
J	Danino, T; Mondragon-Palomino, O; Tsimring, L; Hasty, J				Danino, Tal; Mondragon-Palomino, Octavio; Tsimring, Lev; Hasty, Jeff			A synchronized quorum of genetic clocks	NATURE			English	Article							BACILLUS-THURINGIENSIS; QUENCHING LACTONASE; CELL COMMUNICATION; ESCHERICHIA-COLI; TOGGLE SWITCH; EXPRESSION; NETWORK; BEHAVIOR; OSCILLATORS; RHYTHMS	The engineering of genetic circuits with predictive functionality in living cells represents a defining focus of the expanding field of synthetic biology. This focus was elegantly set in motion a decade ago with the design and construction of a genetic toggle switch and an oscillator, with subsequent highlights that have included circuits capable of pattern generation, noise shaping, edge detection and event counting. Here we describe an engineered gene network with global intercellular coupling that is capable of generating synchronized oscillations in a growing population of cells. Using microfluidic devices tailored for cellular populations at differing length scales, we investigate the collective synchronization properties along with spatiotemporal waves occurring at millimetre scales. We use computational modelling to describe quantitatively the observed dependence of the period and amplitude of the bulk oscillations on the flow rate. The synchronized genetic clock sets the stage for the use of microbes in the creation of a macroscopic biosensor with an oscillatory output. Furthermore, it provides a specific model system for the generation of a mechanistic description of emergent coordinated behaviour at the colony level.	[Danino, Tal; Mondragon-Palomino, Octavio; Hasty, Jeff] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Tsimring, Lev; Hasty, Jeff] Univ Calif San Diego, BioCircuits Inst, La Jolla, CA 92093 USA; [Hasty, Jeff] Univ Calif, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Hasty, J (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	hasty@bioeng.ucsd.edu		Tsimring, Lev/0000-0003-0709-3548	National Institutes of Health and General Medicine [GM69811]; DOE CSGF; CONACyT (Mexico) [184646]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069811] Funding Source: NIH RePORTER	National Institutes of Health and General Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE CSGF(United States Department of Energy (DOE)); CONACyT (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Stricker for helpful discussions on plasmid construction, and M. Bennett, K. Wiesenfeld and J. Collins for stimulating discussions during the preparation of the manuscript. This work was supported by the National Institutes of Health and General Medicine (GM69811), the DOE CSGF fellowship (to T. D.), and CONACyT (Mexico, grant 184646, to O. M.-P.).	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Austin DW, 2006, NATURE, V439, P608, DOI 10.1038/nature04194; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Bennett MR, 2009, NAT REV GENET, V10, P628, DOI 10.1038/nrg2625; Chabot JR, 2007, NATURE, V450, P1249, DOI 10.1038/nature06395; Cookson NA, 2009, FEBS LETT, V583, P3931, DOI 10.1016/j.febslet.2009.10.089; Cookson S, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100032; DUNLAP PV, 1985, J BACTERIOL, V164, P45, DOI 10.1128/JB.164.1.45-50.1985; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Elson RC, 1998, PHYS REV LETT, V81, P5692, DOI 10.1103/PhysRevLett.81.5692; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Fung E, 2005, NATURE, V435, P118, DOI 10.1038/nature03508; Garcia-Ojalvo J, 2004, P NATL ACAD SCI USA, V101, P10955, DOI 10.1073/pnas.0307095101; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Glass L, 2001, NATURE, V410, P277, DOI 10.1038/35065745; Glossop NRJ, 1999, SCIENCE, V286, P766, DOI 10.1126/science.286.5440.766; Grenier F, 2003, J NEUROPHYSIOL, V89, P841, DOI 10.1152/jn.00420.2002; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; Huygens C., 1932, OEUVRES COMPLETES CH, V17; Isalan M, 2008, NATURE, V452, P840, DOI 10.1038/nature06847; Jiang YJ, 2000, NATURE, V408, P475, DOI 10.1038/35044091; Kerckhoffs RCP, 2009, MED IMAGE ANAL, V13, P362, DOI 10.1016/j.media.2008.06.013; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; Lakin-Thomas PL, 2004, ANNU REV MICROBIOL, V58, P489, DOI 10.1146/annurev.micro.58.030603.123744; Lewandowski W, 1999, P IEEE, V87, P163, DOI 10.1109/5.736348; Li D, 2002, IEEE SIGNAL PROC MAG, V19, P17, DOI 10.1109/79.985674; Liu D, 2008, BIOCHEMISTRY-US, V47, P7706, DOI 10.1021/bi800368y; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Mather W, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.068105; McMillen D, 2002, P NATL ACAD SCI USA, V99, P679, DOI 10.1073/pnas.022642299; MIROLLO RE, 1990, SIAM J APPL MATH, V50, P1645, DOI 10.1137/0150098; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Pikovsky A, 2001, SYNCHRONIZATION UNIV; Reading NC, 2006, FEMS MICROBIOL LETT, V254, P1, DOI 10.1111/j.1574-6968.2005.00001.x; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Strogatz S. H., 2004, SYNC; Tabor JJ, 2009, CELL, V137, P1272, DOI 10.1016/j.cell.2009.04.048; Thomas PW, 2005, BIOCHEMISTRY-US, V44, P7559, DOI 10.1021/bi050050m; Tigges M, 2009, NATURE, V457, P309, DOI 10.1038/nature07616; Vladimirov AG, 2003, EUROPHYS LETT, V61, P613, DOI 10.1209/epl/i2003-00115-8; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Wiesenfeld K, 1996, PHYS REV LETT, V76, P404, DOI 10.1103/PhysRevLett.76.404; WINFREE AT, 1967, J THEOR BIOL, V16, P15, DOI 10.1016/0022-5193(67)90051-3; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576	49	689	724	14	313	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 21	2010	463	7279					326	330		10.1038/nature08753	http://dx.doi.org/10.1038/nature08753			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545PM	20090747	Green Accepted, Green Submitted			2022-12-28	WOS:000273748100037
J	Gay, EB				Gay, Elizabeth B.			Insight	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												eg3d@hscmail.mcc.virginia.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 20	2010	303	3					205	205		10.1001/jama.2009.2026	http://dx.doi.org/10.1001/jama.2009.2026			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	544WM	20085944				2022-12-28	WOS:000273690600001
J	Relph, RA; Guasco, TL; Elliott, BM; Kamrath, MZ; McCoy, AB; Steele, RP; Schofield, DP; Jordan, KD; Viggiano, AA; Ferguson, EE; Johnson, MA				Relph, Rachael A.; Guasco, Timothy L.; Elliott, Ben M.; Kamrath, Michael Z.; McCoy, Anne B.; Steele, Ryan P.; Schofield, Daniel P.; Jordan, Kenneth D.; Viggiano, Albert A.; Ferguson, Eldon E.; Johnson, Mark A.			How the Shape of an H-Bonded Network Controls Proton-Coupled Water Activation in HONO Formation	SCIENCE			English	Article							MOLECULAR-ORBITAL CALCULATIONS; NITROUS-ACID FORMATION; CLUSTER IONS; INFRARED-SPECTROSCOPY; BASIS-SETS; NO+(H2O)(N); MECHANISM; SINGLES; CCSD	Many chemical reactions in atmospheric aerosols and bulk aqueous environments are influenced by the surrounding solvation shell, but the precise molecular interactions underlying such effects have rarely been elucidated. We exploited recent advances in isomer-specific cluster vibrational spectroscopy to explore the fundamental relation between the hydrogen (H)-bonding arrangement of a set of ion-solvating water molecules and the chemical activity of this ensemble. We find that the extent to which the nitrosonium ion (NO+) and water form nitrous acid (HONO) and a hydrated proton cluster in the critical trihydrate depends sensitively on the geometrical arrangement of the water molecules in the network. Theoretical analysis of these data details the role of the water network in promoting charge delocalization.	[Relph, Rachael A.; Guasco, Timothy L.; Elliott, Ben M.; Kamrath, Michael Z.; Steele, Ryan P.; Johnson, Mark A.] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [McCoy, Anne B.] Ohio State Univ, Dept Chem, Columbus, OH 43210 USA; [Schofield, Daniel P.; Jordan, Kenneth D.] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA; [Viggiano, Albert A.] USAF, Res Lab, Space Vehicles Directorate, Hanscom AFB, MA 01731 USA; [Ferguson, Eldon E.] NOAA, Climate Monitoring & Diagnost Lab, Boulder, CO 80305 USA	Yale University; University System of Ohio; Ohio State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; United States Department of Defense; United States Air Force; National Oceanic Atmospheric Admin (NOAA) - USA	Johnson, MA (corresponding author), Yale Univ, Dept Chem, POB 208107, New Haven, CT 06520 USA.	mark.johnson@yale.edu		Schofield, Daniel/0000-0001-7790-1497	Air Force Office of Scientific Research [FA-9550-09-1-0139, 2303EP]; NSF [CHE-0616198, CHE-0911199, CHE-0809457, CHE-0615882, OISE-0730114, CHE-0515627/CHE-0848242]; New Zealand Foundation for Research, Science and Technology	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NSF(National Science Foundation (NSF)); New Zealand Foundation for Research, Science and Technology(New Zealand Foundation for Research, Science and Technology)	M. A. J. thanks the Air Force Office of Scientific Research (grant FA-9550-09-1-0139). We also thank the NSF for support under grants CHE-0616198 and CHE-0911199 (M. A. J.), CHE-0809457 (K. D. J.), CHE-0615882 and OISE-0730114 (R. P. S.), and CHE-0515627/CHE-0848242 (A. B. M.). D. P. S. thanks the New Zealand Foundation for Research, Science and Technology for funding, and A. A. V. thanks the Air Force Office of Scientific Research under project 2303EP.	AGMON N, 1995, CHEM PHYS LETT, V244, P456, DOI 10.1016/0009-2614(95)00905-J; Beyer M, 1999, J AM CHEM SOC, V121, P1565, DOI 10.1021/ja982653+; Buck U, 2000, CHEM REV, V100, P3863, DOI 10.1021/cr990054v; C?ek, 1969, ADV CHEM PHYS, P35, DOI DOI 10.1002/9780470143599.CH2; CHOI JH, 1994, J CHEM PHYS, V100, P7153, DOI 10.1063/1.466914; DUNNING TH, 1989, J CHEM PHYS, V90, P1007, DOI 10.1063/1.456153; Elliott BM, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2966002; FEHSENFE.FC, 1969, J GEOPHYS RES, V74, P2217, DOI 10.1029/JA074i009p02217; FEHSENFELD FC, 1971, J CHEM PHYS, V55, P2120, DOI 10.1063/1.1676383; Hammam E, 2001, J PHYS CHEM A, V105, P5528, DOI 10.1021/jp003847q; Hammam E, 2000, J PHYS CHEM A, V104, P4571, DOI 10.1021/jp994278t; Headrick JM, 2005, SCIENCE, V308, P1765, DOI 10.1126/science.1113094; Huber K.P., 1979, MOL SPECTRA MOL STRU; Jacox ME, NIST CHEM WEBBOOK; KENDALL RA, 1992, J CHEM PHYS, V96, P6796, DOI 10.1063/1.462569; Miller DJ, 2008, J AM CHEM SOC, V130, P15381, DOI 10.1021/ja803665q; NARCISI RS, 1965, J GEOPHYS RES, V70, P3687, DOI 10.1029/JZ070i015p03687; Niedner-Schatteburg G, 2000, CHEM REV, V100, P4059, DOI 10.1021/cr990065o; OKUMURA M, 1986, J CHEM PHYS, V85, P2328, DOI 10.1063/1.451079; PURVIS GD, 1982, J CHEM PHYS, V76, P1910, DOI 10.1063/1.443164; SCUSERIA GE, 1989, J CHEM PHYS, V90, P3700, DOI 10.1063/1.455827; SCUSERIA GE, 1988, J CHEM PHYS, V89, P7382, DOI 10.1063/1.455269; Shimanouchi T., NIST CHEM WEBBOOK; STACE AJ, 1994, J PHYS CHEM-US, V98, P2012, DOI 10.1021/j100059a005; TSAI CJ, 1993, CHEM PHYS LETT, V213, P181, DOI 10.1016/0009-2614(93)85438-T; Wales DJ, 1998, NATURE, V394, P758, DOI 10.1038/29487	26	88	88	5	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 15	2010	327	5963					308	312		10.1126/science.1177118	http://dx.doi.org/10.1126/science.1177118			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544CM	20075247				2022-12-28	WOS:000273629700036
J	Pasini, D; Cloos, PAC; Walfridsson, J; Olsson, L; Bukowski, JP; Johansen, JV; Bak, M; Tommerup, N; Rappsilber, J; Helin, K				Pasini, Diego; Cloos, Paul A. C.; Walfridsson, Julian; Olsson, Linda; Bukowski, John-Paul; Johansen, Jens V.; Bak, Mads; Tommerup, Niels; Rappsilber, Juri; Helin, Kristian			JARID2 regulates binding of the Polycomb repressive complex 2 to target genes in ES cells	NATURE			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; DEVELOPMENTAL REGULATORS; CARDIAC DEVELOPMENT; JUMONJI; EZH2; DIFFERENTIATION; GASTRULATION; METHYLATION; PROTEINS; ENHANCER	The Polycomb group (PcG) proteins have an important role in controlling the expression of genes essential for development, differentiation and maintenance of cell fates(1,2). The Polycomb repressive complex 2 (PRC2) is believed to regulate transcriptional repression by catalysing the di- and tri-methylation of lysine 27 on histone H3 (H3K27me2/3)(2). At present, it is unknown how the PcG proteins are recruited to their target promoters in mammalian cells(3). Here we show that PRC2 forms a stable complex with the Jumonji- and ARID-domain-containing protein, JARID2 (ref. 4). Using genome-wide location analysis, we show that JARID2 binds to more than 90% of previously mapped PcG target genes. Notably, we show that JARID2 is sufficient to recruit PcG proteins to a heterologous promoter, and that inhibition of JARID2 expression leads to a major loss of PcG binding and to a reduction of H3K27me3 levels on target genes. Consistent with an essential role for PcG proteins in early development(5-8), we demonstrate that JARID2 is required for the differentiation of mouse embryonic stem cells. Thus, these results demonstrate that JARID2 is essential for the binding of PcG proteins to target genes and, consistent with this, for the proper differentiation of embryonic stem cells and normal development.	[Pasini, Diego; Cloos, Paul A. C.; Walfridsson, Julian; Olsson, Linda; Bukowski, John-Paul; Johansen, Jens V.; Helin, Kristian] Univ Copenhagen, BRIC, DK-2200 Copenhagen N, Denmark; [Pasini, Diego; Cloos, Paul A. C.; Walfridsson, Julian; Olsson, Linda; Bukowski, John-Paul; Helin, Kristian] Univ Copenhagen, Ctr Epigenet, DK-2200 Copenhagen N, Denmark; [Bak, Mads; Tommerup, Niels] Univ Copenhagen, Dept Cellular & Mol Med, Wilhelm Johannsen Ctr Funct Genome Res, DK-2200 Copenhagen N, Denmark; [Rappsilber, Juri] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Edinburgh	Helin, K (corresponding author), Univ Copenhagen, BRIC, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark.	kristian.helin@bric.ku.dk	Tommerup, Niels/T-8776-2017; Helin, Kristian/K-2526-2019; Pasini, Diego/J-9674-2012; Helin, Kristian/HDM-8306-2022; Rappsilber, Juri/ABF-3328-2020; Rappsilber, Juri/B-7265-2015	Tommerup, Niels/0000-0003-2304-0112; Pasini, Diego/0000-0002-9879-6486; Helin, Kristian/0000-0003-1975-6097; Rappsilber, Juri/0000-0001-5999-1310; Cloos, Paul/0000-0001-5863-0054; Vilstrup Johansen, Jens/0000-0001-7094-6801; Bak, Mads/0000-0003-2762-1002	Danish Medical Research Council; Benzon Foundation; NordForsk (Nordic Union); Danish National Research Foundation; Lundbeck Foundation; Danish Cancer Society; Novo Nordisk Foundation; Danish Natural Science Research Council; Lundbeck Foundation [R67-2010-6206, R13-2007-1172] Funding Source: researchfish	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Benzon Foundation; NordForsk (Nordic Union); Danish National Research Foundation(Danmarks Grundforskningsfond); Lundbeck Foundation(Lundbeckfonden); Danish Cancer Society(Danish Cancer Society); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Natural Science Research Council(Danish Natural Science Research Council); Lundbeck Foundation(Lundbeckfonden)	We thank K. Hansen for the RING1B antibody, J. Vikesaa for bioinformatics support, and F. de Lima Alves for assistance during mass spectrometry analyses. We thank L. Morey for critical reading of the manuscript, and members of the Helin laboratory for discussions, technical advice and support. D. P. was supported by a post-doctoral fellowship from the Danish Medical Research Council, P. A. C. C. by a grant from the Benzon Foundation and J. W. by a post-doctoral fellowship from NordForsk (Nordic Union). J. R. is a Senior Research Fellow of the Wellcome Trust. The Wilhelm Johannsen Center is supported by the Danish National Research Foundation and the Lundbeck Foundation. The work in the Helin laboratory was supported by grants from the Danish National Research Foundation, the Danish Cancer Society, the Novo Nordisk Foundation, the Danish Medical Research Council, and the Danish Natural Science Research Council.	Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Faust C, 1998, DEVELOPMENT, V125, P4495; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Kim T, 2004, MOL CELL BIOL, V24, P10151, DOI 10.1128/MCB.24.23.10151-10160.2004; Kim TG, 2003, J BIOL CHEM, V278, P42247, DOI 10.1074/jbc.M307386200; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasini D, 2008, COLD SH Q B, V73, P253, DOI 10.1101/sqb.2008.73.009; Pasini D, 2008, GENE DEV, V22, P1345, DOI 10.1101/gad.470008; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Takeuchi T, 1999, MECH DEVELOP, V86, P29, DOI 10.1016/S0925-4773(99)00100-8; TAKEUCHI T, 1995, GENE DEV, V9, P1211, DOI 10.1101/gad.9.10.1211; Villa R, 2007, CANCER CELL, V11, P513, DOI 10.1016/j.ccr.2007.04.009; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0	33	416	425	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 11	2010	464	7286					306	U193		10.1038/nature08788	http://dx.doi.org/10.1038/nature08788			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	566JO	20075857				2022-12-28	WOS:000275366100053
J	Zheng, Y; Josefowicz, S; Chaudhry, A; Peng, XP; Forbush, K; Rudensky, AY				Zheng, Ye; Josefowicz, Steven; Chaudhry, Ashutosh; Peng, Xiao P.; Forbush, Katherine; Rudensky, Alexander Y.			Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate	NATURE			English	Article							TRANSCRIPTION FACTOR FOXP3; HUMAN GENOME; EXPRESSION; METHYLATION; LINEAGE	Immune homeostasis is dependent on tight control over the size of a population of regulatory T (T-reg) cells capable of suppressing over-exuberant immune responses. The T-reg cell subset is comprised of cells that commit to the T-reg lineage by upregulating the transcription factor Foxp3 either in the thymus (tT(reg)) or in the periphery (iT(reg))(1,2). Considering a central role for Foxp3 in T-reg cell differentiation and function(3,4), we proposed that conserved non-coding DNA sequence (CNS) elements at the Foxp3 locus encode information defining the size, composition and stability of the T-reg cell population. Here we describe the function of three Foxp3 CNS elements (CNS1-3) in T-reg cell fate determination in mice. The pioneer element CNS3, which acts to potently increase the frequency of T-reg cells generated in the thymus and the periphery, binds c-Rel in in vitro assays. In contrast, CNS1, which contains a TGF-beta-NFAT response element, is superfluous for tT(reg) cell differentiation, but has a prominent role in iT(reg) cell generation in gut-associated lymphoid tissues. CNS2, although dispensable for Foxp3 induction, is required for Foxp3 expression in the progeny of dividing T-reg cells. Foxp3 binds to CNS2 in a Cbf-beta-Runx1 and CpG DNA demethylation-dependent manner, suggesting that Foxp3 recruitment to this 'cellular memory module' facilitates the heritable maintenance of the active state of the Foxp3 locus and, therefore, T-reg lineage stability. Together, our studies demonstrate that the composition, size and maintenance of the T-reg cell population are controlled by Foxp3 CNS elements engaged in response to distinct cell-extrinsic or -intrinsic cues.	[Zheng, Ye; Josefowicz, Steven; Chaudhry, Ashutosh; Forbush, Katherine; Rudensky, Alexander Y.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Zheng, Ye; Josefowicz, Steven; Chaudhry, Ashutosh; Forbush, Katherine; Rudensky, Alexander Y.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Zheng, Ye; Josefowicz, Steven; Chaudhry, Ashutosh; Peng, Xiao P.; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA; [Zheng, Ye; Josefowicz, Steven; Chaudhry, Ashutosh; Peng, Xiao P.; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Rudensky, AY (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	rudenska@mskcc.org	Zheng, Ye/G-4866-2015; Josefowicz, Steven Z/B-8716-2011	Zheng, Ye/0000-0001-5012-4309; Chaudhry, Ashutosh/0000-0003-3379-5236; josefowicz, steven/0000-0001-7453-779X	National Institutes of Health; CRI-Irvington Institute; CRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI034206] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CRI-Irvington Institute; CRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank T.-T. Chu and L. Karpik for expert technical assistance and mouse colony management, S. Roh for embryonic stem cell culture and screening, J. Rasmussen and A. Kas for bioinformatics support, A. Beg for providing c-Rel knockout mice, P. Treuting for histopathology analysis, J. Gerard for assistance in luciferase reporter assays, and C. Wilson, S. Tarakhovsky and L.-F. Lu for critical comments on the manuscript. This work was supported by grants from the National Institutes of Health (to A.Y.R.). Y.Z. and A. C. were supported by the CRI-Irvington Institute postdoctoral fellowship. S.Z.J. was supported by the CRI pre-doctoral training grant. A.Y.R. is an investigator with the Howard Hughes Medical Institute.	Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bruno L, 2009, J EXP MED, V206, P2329, DOI 10.1084/jem.20090226; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Dubchak Inna, 2006, V338, P69; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Kim HP, 2007, J EXP MED, V204, P1543, DOI 10.1084/jem.20070109; Kitoh A, 2009, IMMUNITY, V31, P609, DOI 10.1016/j.immuni.2009.09.003; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; Maurange C, 2002, GENE DEV, V16, P2672, DOI 10.1101/gad.242702; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Polansky JK, 2008, EUR J IMMUNOL, V38, P1654, DOI 10.1002/eji.200838105; Rao S, 2003, J IMMUNOL, V170, P3724, DOI 10.4049/jimmunol.170.7.3724; Rudra D, 2009, NAT IMMUNOL, V10, P1170, DOI 10.1038/ni.1795; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sather BD, 2007, J EXP MED, V204, P1335, DOI 10.1084/jem.20070081; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Williams DB, 2007, SURG OBES RELAT DIS, V3, P8, DOI 10.1016/j.soard.2006.10.003; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455	24	838	872	0	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 11	2010	463	7282					808	U120		10.1038/nature08750	http://dx.doi.org/10.1038/nature08750			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	553VG	20072126	Green Accepted			2022-12-28	WOS:000274394300040
J	Meurin, P; Tabet, JY; Thabut, G; Cristofini, P; Farrokhi, T; Fischbach, M; Pierre, B; Ben Driss, A; Renaud, N; Iliou, MC; Weber, H				Meurin, Philippe; Tabet, Jean Yves; Thabut, Gabriel; Cristofini, Pascal; Farrokhi, Titi; Fischbach, Michel; Pierre, Bernard; Ben Driss, Ahmed; Renaud, Nathalie; Iliou, Marie Christine; Weber, Helene		French Soc Cardiology	Nonsteroidal Anti-inflammatory Drug Treatment for Postoperative Pericardial Effusion A Multicenter Randomized, Double-Blind Trial	ANNALS OF INTERNAL MEDICINE			English	Article							CARDIAC-SURGERY; PREVENTION; MANAGEMENT; INHIBITORS; ASSOCIATION; DISEASE; RISK	Background: The incidence of asymptomatic pericardial effusion is high after cardiac surgery. Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely prescribed in this setting, but no study has assessed their efficacy. Objective: To assess whether the NSAID diclofenac is effective in reducing postoperative pericardial effusion volume. Design: Multicenter randomized, double-blind, placebo-controlled study. (Clinical trials.gov registration number: NCT00247052) Setting: 5 postoperative cardiac rehabilitation centers. Patients: 196 patients at high risk for tamponade because of moderate to large persistent pericardial effusion (grade 2, 3, or 4 on a scale of 0 to 4, as measured by echocardiography) more than 7 days after cardiac surgery. Intervention: Random assignment at each site in blocks of 4 to diclofenac, 50 mg, or placebo twice daily for 14 days. Measurements: The main end point was change in effusion grade after 14 days of treatment. Secondary end points included frequency of late cardiac tamponade. Results: The initial mean pericardial effusion grade was 2.58 (SD, 0.73) for the placebo group and 2.75 (SD, 0.81) for the diclofenac group. The 2 groups showed similar mean decreases from baseline after treatment (-1.08 grades [SD, 1.20] for the placebo group vs. -1.36 (SD, 1.25) for the diclofenac group). The mean difference between groups was -0.28 grade (95% CI, -0.63 to 0.06 grade; P = 0.105). Eleven cases of late cardiac tamponade occurred in the placebo group and 9 in the diclofenac group (P = 0.64). These differences persisted after adjustment for grade of pericardial effusion at baseline, treatment site, and type of surgery. Limitation: The sample was not large enough to find small beneficial effects of diclofenac or assess the cardiovascular tolerance of diclofenac. Conclusion: In patients with pericardial effusion after cardiac surgery, diclofenac neither reduced the size of the effusions nor prevented late cardiac tamponade.	Les Grands Pres CRCB, Villeneuve St Denis, France; Hop Xavier Bichat, Paris, France; Broussais Hosp Paris, Paris, France; Bligny Hosp, Briis Sous Forges, France; IRIS, Marcy Letoile, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP	Meurin, P (corresponding author), Les Grands Pres, 27 Rue Sainte Christine, F-77174 Villeneuve St Denis, France.	philippemeurin@hotmail.com			French Society of Cardiology and Association Chirurgicale pour le Developpement et l'Amelioration des Techniques de Depistage et de Traitement des Maladies Cardiovasculaires	French Society of Cardiology and Association Chirurgicale pour le Developpement et l'Amelioration des Techniques de Depistage et de Traitement des Maladies Cardiovasculaires	Grant Support: By the French Society of Cardiology and Association Chirurgicale pour le Developpement et l'Amelioration des Techniques de Depistage et de Traitement des Maladies Cardiovasculaires.	Antman EM, 2007, CIRCULATION, V115, P1634, DOI 10.1161/CIRCULATIONAHA.106.181424; BELAND MJ, 1990, AM J CARDIOL, V65, P1238, DOI 10.1016/0002-9149(90)90980-F; Catella-Lawson F, 2001, NEW ENGL J MED, V345, P1809, DOI 10.1056/NEJMoa003199; Gislason GH, 2006, CIRCULATION, V113, P2906, DOI 10.1161/CIRCULATIONAHA.106.616219; Hernandez-Diaz S, 2000, ARCH INTERN MED, V160, P2093, DOI 10.1001/archinte.160.14.2093; Hoit BD, 2002, CIRCULATION, V105, P2939, DOI 10.1161/01.CIR.0000019421.07529.C5; Huerta C, 2005, AM J KIDNEY DIS, V45, P531, DOI 10.1053/j.ajkd.2004.12.005; Imazio M, 2007, INT J CARDIOL, V121, P198, DOI 10.1016/j.ijcard.2006.08.071; Kuvin JT, 2002, ANN THORAC SURG, V74, P1148, DOI 10.1016/S0003-4975(02)03837-7; Little WC, 2006, CIRCULATION, V113, P1622, DOI 10.1161/CIRCULATIONAHA.105.561514; Loboz KK, 2005, BRIT J CLIN PHARMACO, V59, P239, DOI 10.1111/j.0306-5251.2004.2188.x; Maisch B, 2004, EUR HEART J, V25, P587, DOI 10.1016/j.ehj.2004.02.002; Meurin P, 2004, CHEST, V125, P2182, DOI 10.1378/chest.125.6.2182; Niva M, 2002, J CARDIOVASC SURG, V43, P449; Nussmeier NA, 2005, NEW ENGL J MED, V352, P1081, DOI 10.1056/NEJMoa050330; Ong CKS, 2007, CLIN MED RES, V5, P17, DOI 10.3121/cmr.2007.698; PEPI M, 1994, BRIT HEART J, V72, P327; Tsang TSM, 1999, CHEST, V116, P322, DOI 10.1378/chest.116.2.322; WEITZMAN LB, 1984, CIRCULATION, V69, P506, DOI 10.1161/01.CIR.69.3.506	19	28	30	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 2	2010	152	3					137	+		10.7326/0003-4819-152-3-201002020-00004	http://dx.doi.org/10.7326/0003-4819-152-3-201002020-00004			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	552WN	20124229				2022-12-28	WOS:000274324600001
J	Khandelwal, A; Cho, SH; Marella, H; Sakata, Y; Perroud, PF; Pan, A; Quatrano, RS				Khandelwal, A.; Cho, S. H.; Marella, H.; Sakata, Y.; Perroud, P. -F.; Pan, A.; Quatrano, R. S.			Role of ABA and ABI3 in Desiccation Tolerance	SCIENCE			English	Article							PHYSCOMITRELLA-PATENS; STRESS; MOSS		[Perroud, P. -F.; Quatrano, R. S.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Khandelwal, A.; Pan, A.] Monsanto Co, St Louis, MO 63017 USA; [Cho, S. H.] Penn State Univ, Dept Biol, State Coll, PA 16802 USA; [Marella, H.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA; [Sakata, Y.] Tokyo Univ Agr, Dept Biosci, Tokyo 1568502, Japan	Washington University (WUSTL); Monsanto; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Donald Danforth Plant Science Center; Tokyo University of Agriculture	Quatrano, RS (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	rsq@wustl.edu	Yoichi, Sakata/M-7482-2013	Yoichi, Sakata/0000-0002-9625-4966; Perroud, Pierre-Francois/0000-0001-7607-3618	NSF [EF-0425749]; Washington University	NSF(National Science Foundation (NSF)); Washington University	We thank L. Gunther and L. Maines for technical support and D. Cove and S. McDaniel for many helpful discussions. Supported by funds from NSF (EF-0425749) and Washington University.	[Anonymous], 1997, MECH ENV STRESS RESI; Finkelstein R, 2008, ANNU REV PLANT BIOL, V59, P387, DOI 10.1146/annurev.arplant.59.032607.092740; Frank W, 2005, PLANTA, V220, P384, DOI 10.1007/s00425-004-1351-1; Johri M. M., 2008, Physiology and Molecular Biology of Plants, V14, P23, DOI 10.1007/s12298-008-0003-5; KNIGHT CD, 1995, PLANT CELL, V7, P499, DOI 10.1105/tpc.7.5.499; Marella HH, 2006, PLANT J, V46, P1032, DOI 10.1111/j.1365-313X.2006.02764.x; Oliver MJ, 2005, INTEGR COMP BIOL, V45, P788, DOI 10.1093/icb/45.5.788; Perroud PF, 2008, PLANT CELL, V20, P411, DOI 10.1105/tpc.107.053256; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646	9	151	162	1	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 29	2010	327	5965					546	546		10.1126/science.1183672	http://dx.doi.org/10.1126/science.1183672			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549CT	20110497				2022-12-28	WOS:000274020500028
J	Wang, ZH; Wei, J; Morse, P; Dash, JG; Vilches, OE; Cobden, DH				Wang, Zenghui; Wei, Jiang; Morse, Peter; Dash, J. Gregory; Vilches, Oscar E.; Cobden, David H.			Phase Transitions of Adsorbed Atoms on the Surface of a Carbon Nanotube	SCIENCE			English	Article							SOLID KRYPTON MONOLAYERS; MECHANICAL RESONATORS; QUANTUM DOTS; GRAPHITE; ADSORPTION; TRANSPORT	Phase transitions of adsorbed atoms and molecules on two-dimensional substrates are well explored, but similar transitions in the one-dimensional limit have been more difficult to study experimentally. Suspended carbon nanotubes can act as nanoscale resonators with remarkable electromechanical properties and the ability to detect adsorption at the level of single atoms. We used single-walled carbon nanotube resonators to study the phase behavior of adsorbed argon and krypton atoms as well as their coupling to the substrate electrons. By monitoring the resonance frequency in the presence of gases, we observed the formation of monolayers on the cylindrical surface, phase transitions within them, and simultaneous modification of the electrical conductance.	[Wang, Zenghui; Wei, Jiang; Morse, Peter; Dash, J. Gregory; Vilches, Oscar E.; Cobden, David H.] Univ Washington, Dept Phys, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Cobden, DH (corresponding author), Univ Washington, Dept Phys, Seattle, WA 98195 USA.	cobden@u.washington.edu	wang, zenghui/H-8367-2012; wei, jiang/GRX-7907-2022	Wang, Zenghui/0000-0003-3743-7567	NSF [DMR 0606078, 0907690]; American Chemical Society; University of Washington (UW)	NSF(National Science Foundation (NSF)); American Chemical Society(American Chemical Society); University of Washington (UW)(University of Washington)	We acknowledge useful discussions with M. Bockrath, H.-Y. Chiu, M. W. Cole, M. den Nijs, M. Schick, and A. van der Zande. This work was supported by grants from NSF (DMR 0606078 and 0907690), the American Chemical Society Petroleum Research Fund, the University of Washington (UW) Royalty Research Fund, and a UW University Initiatives Fund fellowship. Portions of this work were done in the University of California at Santa Barbara Nanofabrication Facility and in the UW Nanotechnology Center, which are parts of the NSF-funded National Nanotechnology Infrastructure Network.	Bruch L. W., 1997, PHYS ADSORPTION FORC; Cao H, 2005, SMALL, V1, P138, DOI 10.1002/smll.200400015; Cao J, 2005, NAT MATER, V4, P745, DOI 10.1038/nmat1478; Charlier JC, 2007, REV MOD PHYS, V79, P677, DOI 10.1103/RevModPhys.79.677; CHINN MD, 1977, PHYS REV LETT, V39, P146, DOI 10.1103/PhysRevLett.39.146; Chiu HY, 2008, NANO LETT, V8, P4342, DOI 10.1021/nl802181c; DASH JG, 1980, NATO ADV STUDY I B, V51; Deshpande VV, 2009, SCIENCE, V323, P106, DOI 10.1126/science.1165799; FAIN SC, 1980, PHYS REV B, V21, P4170, DOI 10.1103/PhysRevB.21.4170; Huttel AK, 2009, NANO LETT, V9, P2547, DOI 10.1021/nl900612h; Jensen K, 2008, NAT NANOTECHNOL, V3, P533, DOI 10.1038/nnano.2008.200; Johnson MR, 2003, CHEM PHYS, V293, P217, DOI 10.1016/S0301-0104(03)00316-1; Lasjaunias JC, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.025901; Lassagne B, 2008, NANO LETT, V8, P3735, DOI 10.1021/nl801982v; Lassagne B, 2009, SCIENCE, V325, P1107, DOI 10.1126/science.1174290; Leturcq R, 2009, NAT PHYS, V5, P327, DOI 10.1038/NPHYS1234; MIGONE AD, 1984, PHYS REV LETT, V53, P810, DOI 10.1103/PhysRevLett.53.810; MILLOT F, 1979, J PHYS LETT-PARIS, V40, pL9, DOI 10.1051/jphyslet:019790040010900; Peng HB, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.087203; Sazonova V, 2004, NATURE, V431, P284, DOI 10.1038/nature02905; Shi W, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.015504; SPECHT ED, 1987, Z PHYS B CON MAT, V69, P347, DOI 10.1007/BF01307294; Stan G, 1998, SURF SCI, V395, P280, DOI 10.1016/S0039-6028(97)00632-8; Steele GA, 2009, SCIENCE, V325, P1103, DOI 10.1126/science.1176076; Steele GA, 2009, NAT NANOTECHNOL, V4, P363, DOI [10.1038/NNANO.2009.71, 10.1038/nnano.2009.71]; THOMY A, 1969, J CHIM PHYS PCB, V66, P1966, DOI 10.1051/jcp/196966s21966; Witkamp B, 2006, NANO LETT, V6, P2904, DOI 10.1021/nl062206p	27	96	97	2	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 29	2010	327	5965					552	555		10.1126/science.1182507	http://dx.doi.org/10.1126/science.1182507			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549CT	20110499	Green Submitted			2022-12-28	WOS:000274020500030
J	Keith, DW; Parson, E; Morgan, MG				Keith, David W.; Parson, Edward; Morgan, M. Granger			Research on global sun block needed now	NATURE			English	Editorial Material									[Keith, David W.] Univ Calgary, Energy & Environm Syst Grp, Calgary, AB T2N 1N4, Canada; [Parson, Edward] Univ Michigan, Ann Arbor, MI 48109 USA; [Morgan, M. Granger] Carnegie Mellon Univ, Dept Engn & Publ Policy, Pittsburgh, PA 15213 USA	University of Calgary; University of Michigan System; University of Michigan; Carnegie Mellon University	Keith, DW (corresponding author), Univ Calgary, Energy & Environm Syst Grp, Calgary, AB T2N 1N4, Canada.	keith@ucalgary.ca	Keith, David W/E-9777-2010	Keith, David W/0000-0002-8224-3780	Direct For Social, Behav & Economic Scie [0949710] Funding Source: National Science Foundation	Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))		Heckendorn P, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/4/045108; Robock A, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1175/2779.1; Tilmes S, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD011420	3	141	143	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 28	2010	463	7280					426	427		10.1038/463426a	http://dx.doi.org/10.1038/463426a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	548QK	20110972				2022-12-28	WOS:000273981100022
J	Aspinall, W				Aspinall, Willy			A route to more tractable expert advice	NATURE			English	Editorial Material									[Aspinall, Willy] Univ Bristol, Bristol BS8 1RJ, Avon, England; [Aspinall, Willy] Aspinall & Associates, Tisbury SP3 6HF, England	University of Bristol	Aspinall, W (corresponding author), Univ Bristol, Bristol BS8 1RJ, Avon, England.	Willy.Aspinall@Bristol.ac.uk	Aspinall, Willy/AAW-1022-2020	Aspinall, Willy/0000-0001-6014-6042				Aspinall W, 1998, PROBABILISTIC SAFETY ASSESSMENT AND MANAGEMENT (PSAM 4), VOLS 1-4, P2113; Cooke R. M., 1991, EXPERTS UNCERTAINTY; Cooke RM, 2008, RELIAB ENG SYST SAFE, V93, P745, DOI 10.1016/j.ress.2007.03.017; Krupnick A., 2006, NOT SURE THING MAKIN; Oppenheimer M, 2007, SCIENCE, V317, P1505, DOI 10.1126/science.1144831; TYSHENKO MG, 2009, EXP EL WORKSH RES LA	6	200	204	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 21	2010	463	7279					294	295		10.1038/463294a	http://dx.doi.org/10.1038/463294a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	545PM	20090733				2022-12-28	WOS:000273748100021
J	Parsons, A; Daley, A; Begh, R; Aveyard, P				Parsons, A.; Daley, A.; Begh, R.; Aveyard, P.			Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CORONARY-HEART-DISEASE; 2ND PRIMARY CANCERS; CIGARETTE-SMOKING; SURVIVAL; BEHAVIOR; ANGIOGENESIS; ABSTINENCE; MORTALITY; EFFICACY	Objective To systematically review the evidence that smoking cessation after diagnosis of a primary lung tumour affects prognosis. Design Systematic review with meta-analysis. Data sources CINAHL (from 1981), Embase (from 1980), Medline (from 1966), Web of Science (from 1966), CENTRAL (from 1977) to December 2008, and reference lists of included studies. Study selection Randomised controlled trials or observational longitudinal studies that measured the effect of quitting smoking after diagnosis of lung cancer on prognostic outcomes, regardless of stage at presentation or tumour histology, were included. Data extraction Two researchers independently identified studies for inclusion and extracted data. Estimates were combined by using a random effects model, and the I-2 statistic was used to examine heterogeneity. Life tables were used to model five year survival for early stage non-small cell lung cancer and limited stage small cell lung cancer, using death rates for continuing smokers and quitters obtained from this review. Results In 9/10 included studies, most patients studied were diagnosed as having an early stage lung tumour. Continued smoking was associated with a significantly increased risk of all cause mortality (hazard ratio 2.94, 95% confidence interval 1.15 to 7.54) and recurrence (1.86, 1.01 to 3.41) in early stage non-small cell lung cancer and of all cause mortality (1.86, 1.33 to 2.59), development of a second primary tumour (4.31, 1.09 to 16.98), and recurrence (1.26, 1.06 to 1.50) in limited stage small cell lung cancer. No study contained data on the effect of quitting smoking on cancer specific mortality or on development of a second primary tumour in non-small cell lung cancer. Life table modelling on the basis of these data estimated 33% five year survival in 65 year old patients with early stage non-small cell lung cancer who continued to smoke compared with 70% in those who quit smoking. In limited stage small cell lung cancer, an estimated 29% of continuing smokers would survive for five years compared with 63% of quitters on the basis of the data from this review. Conclusions This review provides preliminary evidence that smoking cessation after diagnosis of early stage lung cancer improves prognostic outcomes. From life table modelling, the estimated number of deaths prevented is larger than would be expected from reduction of cardiorespiratory deaths after smoking cessation, so most of the mortality gain is likely to be due to reduced cancer progression. These findings indicate that offering smoking cessation treatment to patients presenting with early stage lung cancer may be beneficial.	[Begh, R.; Aveyard, P.] Univ Birmingham, UK Ctr Tobacco Control Studies, Birmingham B15 2TT, W Midlands, England	University of Birmingham		a.c.parsons@bham.ac.uk		Aveyard, Paul/0000-0002-1802-4217; Begh, Rachna/0000-0003-0822-9689	British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Medical Research Council; National Institute for Health Research; Economic and Social Research Council [ES/G007489/1] Funding Source: researchfish; National Institute for Health Research [CSA/02/06/001] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Institute for Health Research(National Institute for Health Research (NIHR))	The work was undertaken by the UK Centre for Tobacco Control Studies, a UKCRC Public Health Research centre of excellence. Funding came from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, and National Institute for Health Research, under the auspices of the UK Clinical Research Collaboration. PA and AD are supported by National Institute for Health Research career scientist fellowship awards. The views expressed in this publication are those of the authors and have not been influenced by the funding bodies.	ALBERG AJ, 2003, CHEST S1, V123, P21; Altman DG, 2001, BMJ-BRIT MED J, V323, P224, DOI 10.1136/bmj.323.7306.224; Aveyard P, 2002, BJU INT, V90, P228, DOI 10.1046/j.1464-410X.2002.02880.x; Baser S, 2006, CHEST, V130, P1784, DOI 10.1016/S0012-3692(15)50902-1; BROWMAN GP, 1993, NEW ENGL J MED, V328, P159, DOI 10.1056/NEJM199301213280302; Cancer Research UK, 2007, CANCERSTATS; Cooke JP, 2007, LIFE SCI, V80, P2347, DOI 10.1016/j.lfs.2007.01.061; Cox LS, 2002, PSYCHO-ONCOLOGY, V11, P472, DOI 10.1002/pon.612; Critchley JA, 2003, JAMA-J AM MED ASSOC, V290, P86, DOI 10.1001/jama.290.1.86; Department of Health, 2007, CANC REF STRAT; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Dresler CM, 1996, CHEST, V110, P1199, DOI 10.1378/chest.110.5.1199; GRITZ ER, 1991, CANCER CAUSE CONTROL, V2, P105, DOI 10.1007/BF00053129; Hecht SS, 1999, JNCI-J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194; Heeschen C, 2001, NAT MED, V7, P833, DOI 10.1038/89961; Hughes JR, 2004, ADDICTION, V99, P29, DOI 10.1111/j.1360-0443.2004.00540.x; International Agency for Research on Cancer, 2007, IARC HDB CANC PREV; Janssen-Heijnen MLG, 1998, LUNG CANCER, V21, P105, DOI 10.1016/S0169-5002(98)00039-7; JOHNSTONEARLY A, 1980, JAMA-J AM MED ASSOC, V244, P2175, DOI 10.1001/jama.244.19.2175; KAWACHI I, 1994, ARCH INTERN MED, V154, P169, DOI 10.1001/archinte.154.2.169; Kawaguchi T, 2006, JPN J CLIN ONCOL, V36, P7, DOI 10.1093/jjco/hyi208; Kawahara M, 1998, BRIT J CANCER, V78, P409, DOI 10.1038/bjc.1998.507; Khuder SA, 2001, CHEST, V120, P1577, DOI 10.1378/chest.120.5.1577; Nia PS, 2005, LUNG CANCER-J IASLC, V47, P351, DOI 10.1016/j.lungcan.2004.08.011; OCKENE JK, 1990, AM J PUBLIC HEALTH, V80, P954, DOI 10.2105/AJPH.80.8.954; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Peto R, 1986, IARC Sci Publ, P23; Peto R, 1994, MORTALITY SMOKING DE; Pinto BM, 2005, CANCER-AM CANCER SOC, V104, P2614, DOI 10.1002/cncr.21248; Saito-Nakaya K, 2006, CANCER SCI, V97, P206, DOI 10.1111/j.1349-7006.2006.00159.x; Shiba M, 2000, CANCER, V89, P1457, DOI 10.1002/1097-0142(20001001)89:7<1457::AID-CNCR7>3.0.CO;2-L; SILVERMAN S, 1983, J AM DENT ASSOC, V106, P33, DOI 10.14219/jada.archive.1983.0004; Song FJ, 2000, CONTROL CLIN TRIALS, V21, P488, DOI 10.1016/S0197-2456(00)00055-6; STEVENS MH, 1983, ARCH OTOLARYNGOL, V109, P746; Stull VB, 2007, J NUTR, V137, p243S, DOI 10.1093/jn/137.1.243S; Sugimura H, 2006, CHEST, V129, P1088, DOI 10.1378/chest.129.4.1088; Taylor T, 2006, SMOKING RELATED BEHA; Tucker MA, 1997, J NATL CANCER I, V89, P1782, DOI 10.1093/jnci/89.23.1782; *UK NAT STAT, 2009, PUBL HUB GAT UK NAT; Videtic GMM, 2003, J CLIN ONCOL, V21, P1544, DOI 10.1200/JCO.2003.10.089; West R, 2005, ADDICTION, V100, P299, DOI 10.1111/j.1360-0443.2004.00995.x; Yoshida T, 1996, Nihon Kyobu Shikkan Gakkai Zasshi, V34, P741; Yoshino I, 2007, SURG TODAY, V37, P725, DOI 10.1007/s00595-007-3516-6	43	458	469	0	66	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 21	2010	340								b5569	10.1136/bmj.b5569	http://dx.doi.org/10.1136/bmj.b5569			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	548HP	20093278	Green Published, hybrid			2022-12-28	WOS:000273951400003
J	Farzaneh-Far, R; Lin, J; Epel, ES; Harris, WS; Blackburn, EH; Whooley, MA				Farzaneh-Far, Ramin; Lin, Jue; Epel, Elissa S.; Harris, William S.; Blackburn, Elizabeth H.; Whooley, Mary A.			Association of Marine Omega-3 Fatty Acid Levels With Telomeric Aging in Patients With Coronary Heart Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POLYUNSATURATED FATTY-ACIDS; DEPRESSIVE SYMPTOMS; OXIDATIVE-STRESS; QUANTITATIVE PCR; OMEGA-3 INDEX; RISK-FACTOR; LENGTH; BLOOD; DEATH; LIFE	Context Increased dietary intake of marine omega-3 fatty acids is associated with prolonged survival in patients with coronary heart disease. However, the mechanisms underlying this protective effect are poorly understood. Objective To investigate the association of omega-3 fatty acid blood levels with temporal changes in telomere length, an emerging marker of biological age. Design, Setting, and Participants Prospective cohort study of 608 ambulatory outpatients in California with stable coronary artery disease recruited from the Heart and Soul Study between September 2000 and December 2002 and followed up to January 2009 (median, 6.0 years; range, 5.0-8.1 years). Main Outcome Measures We measured leukocyte telomere length at baseline and again after 5 years of follow-up. Multivariable linear and logistic regression models were used to investigate the association of baseline levels of omega-3 fatty acids (docosahexaenoic acid [DHA] and eicosapentaenoic acid [EPA]) with subsequent change in telomere length. Results Individuals in the lowest quartile of DHA + EPA experienced the fastest rate of telomere shortening (0.13 telomere-to-single-copy gene ratio [T/S] units over 5 years; 95% confidence interval [CI], 0.09-0.17), whereas those in the highest quartile experienced the slowest rate of telomere shortening (0.05 T/S units over 5 years; 95% CI, 0.02-0.08; P < .001 for linear trend across quartiles). Levels of DHA + EPA were associated with less telomere shortening before (unadjusted beta coefficient x 10(-3) = 0.06; 95% CI, 0.02-0.10) and after (adjusted beta coefficient x 10(-3) = 0.05; 95% CI, 0.01-0.08) sequential adjustment for established risk factors and potential confounders. Each 1-SD increase in DHA + EPA levels was associated with a 32% reduction in the odds of telomere shortening (adjusted odds ratio, 0.68; 95% CI, 0.47-0.98). Conclusion Among this cohort of patients with coronary artery disease, there was an inverse relationship between baseline blood levels of marine omega-3 fatty acids and the rate of telomere shortening over 5 years. JAMA. 2010;303(3):250-257	[Farzaneh-Far, Ramin] Univ Calif San Francisco, Div Cardiol, San Francisco Gen Hosp, San Francisco, CA 94110 USA; [Farzaneh-Far, Ramin; Whooley, Mary A.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Lin, Jue; Blackburn, Elizabeth H.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Whooley, Mary A.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Whooley, Mary A.] Vet Affairs Med Ctr, San Francisco, CA 94121 USA; [Harris, William S.] Univ S Dakota, Sanford Res USD, Sioux Falls, SD USA; [Harris, William S.] Univ S Dakota, Sanford Sch Med, Sioux Falls, SD USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); Sanford Health; University of South Dakota; University of South Dakota	Farzaneh-Far, R (corresponding author), Univ Calif San Francisco, Div Cardiol, San Francisco Gen Hosp, Room 5G1,1001 Potrero Ave, San Francisco, CA 94110 USA.	rfarzanehfar@medicine.ucsf.edu	Harris, William Stephen/T-1674-2019	Harris, William Stephen/0000-0003-3042-9353	GlaxoSmithKline; Monsanto; American Heart Association [0875014N]; Department of Veterans Affairs; National Heart, Lung, and Blood Institute [R01 HL079235]; Robert Wood Johnson Foundation; American Federation for Aging Research; Ischemia Research and Education Foundation; Nancy Kirwan Heart Research Fund; Bernard and Barbro Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079235] Funding Source: NIH RePORTER	GlaxoSmithKline(GlaxoSmithKline); Monsanto; American Heart Association(American Heart Association); Department of Veterans Affairs(US Department of Veterans Affairs); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); American Federation for Aging Research; Ischemia Research and Education Foundation; Nancy Kirwan Heart Research Fund; Bernard and Barbro Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr Harris reports that he is an advisor to, a speaker for, and has received research grants from companies with interests in omega-3 fatty acids, including GlaxoSmithKline and Monsanto. In addition, he has recently founded a company (OmegaQuant Analytics) to offer blood omega-3 fatty acid testing. No other disclosures were reported.; Dr Farzaneh-Far is supported by an American Heart Association Fellow-to-Faculty Transition Award (grant 0875014N). The Heart and Soul Study was supported by the Department of Veterans Affairs (Epidemiology Merit Review Program), the National Heart, Lung, and Blood Institute (grant R01 HL079235), the Robert Wood Johnson Foundation (Generalist Physician Faculty Scholars Program), the American Federation for Aging Research (Paul Beeson Faculty Scholars in Aging Research Program), the Ischemia Research and Education Foundation, and the Nancy Kirwan Heart Research Fund. Dr Lin is supported by the Bernard and Barbro Foundation.	Albanese E, 2009, AM J CLIN NUTR, V90, P392, DOI 10.3945/ajcn.2009.27580; Albert CM, 2002, NEW ENGL J MED, V346, P1113, DOI 10.1056/NEJMoa012918; Aviv A, 2008, J GERONTOL A-BIOL, V63, P979, DOI 10.1093/gerona/63.9.979; Aviv A, 2009, AM J CLIN NUTR, V89, P1721, DOI 10.3945/ajcn.2009.27807; Aviv A, 2009, AM J EPIDEMIOL, V169, P323, DOI 10.1093/aje/kwn338; Bekaert S, 2007, AGING CELL, V6, P639, DOI 10.1111/j.1474-9726.2007.00321.x; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Brouilette S, 2003, ARTERIOSCL THROM VAS, V23, P842, DOI 10.1161/01.ATV.0000067426.96344.32; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; BURR ML, 1989, LANCET, V2, P757; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chan SRWL, 2004, PHILOS T R SOC B, V359, P109, DOI 10.1098/rstb.2003.1370; Eitsuka T, 2005, BBA-MOL CELL BIOL L, V1737, P1, DOI 10.1016/j.bbalip.2005.08.017; Epel ES, 2009, HORM-INT J ENDOCRINO, V8, P7, DOI 10.14310/horm.2002.1217; Epel ES, 2009, AGING-US, V1, P81; Farzaneh-Far R, 2008, ARTERIOSCL THROM VAS, V28, P1379, DOI 10.1161/ATVBAHA.108.167049; Furumoto K, 1998, LIFE SCI, V63, P935, DOI 10.1016/S0024-3205(98)00351-8; Fuster JJ, 2006, CIRC RES, V99, P1167, DOI 10.1161/01.RES.0000251281.00845.18; Gao L, 2007, J BIOL CHEM, V282, P2529, DOI 10.1074/jbc.M607622200; Gil ME, 2004, MOL BIOTECHNOL, V27, P169, DOI 10.1385/MB:27:2:169; Hamazaki K, 2009, CLIN NEPHROL, V71, P508; Harris WS, 2008, AM J CLIN NUTR, V87, p1997S, DOI 10.1093/ajcn/87.6.1997S; Harris WS, 2008, ATHEROSCLEROSIS, V197, P12, DOI 10.1016/j.atherosclerosis.2007.11.008; Harris WS, 2004, PREV MED, V39, P212, DOI 10.1016/j.ypmed.2004.02.030; Hunt SC, 2008, AGING CELL, V7, P451, DOI 10.1111/j.1474-9726.2008.00397.x; Jolly CA, 2001, J NUTR, V131, P2753, DOI 10.1093/jn/131.10.2753; Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94; Lee JH, 2008, MAYO CLIN PROC, V83, P324, DOI 10.4065/83.3.324; Lin J, 2010, J IMMUNOL METHODS, V352, P71, DOI 10.1016/j.jim.2009.09.012; Marchioli R, 2002, CIRCULATION, V105, P1897, DOI 10.1161/01.CIR.0000014682.14181.F2; Milne GL, 2008, J BIOL CHEM, V283, P15533, DOI 10.1074/jbc.R700047200; Nettleton JA, 2008, AM J CLIN NUTR, V88, P1405, DOI 10.3945/ajcn.2008.26429; Njajou OT, 2009, J GERONTOL A-BIOL, V64, P860, DOI 10.1093/gerona/glp061; Nordfjall K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000375; Olovnikov AM, 1996, EXP GERONTOL, V31, P443, DOI 10.1016/0531-5565(96)00005-8; Ornish D, 2008, LANCET ONCOL, V9, P1048, DOI 10.1016/S1470-2045(08)70234-1; Paul L, 2009, J NUTR, V139, P1273, DOI 10.3945/jn.109.104984; Pepe S, 2007, ANN NY ACAD SCI, V1114, P381, DOI 10.1196/annals.1396.046; Richards JB, 2007, AM J CLIN NUTR, V86, P1420, DOI 10.1093/ajcn/86.5.1420; Romieu I, 2008, ENVIRON HEALTH PERSP, V116, P1237, DOI 10.1289/ehp.10578; Ruo B, 2003, JAMA-J AM MED ASSOC, V290, P215, DOI 10.1001/jama.290.2.215; Satoh M, 2009, CLIN SCI, V116, P827, DOI 10.1042/CS20080404; Shrier I, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-70; Spyridopoulos I, 2004, CIRCULATION, V110, P3136, DOI 10.1161/01.CIR.0000142866.50300.EB; Tan JSL, 2009, ARCH OPHTHALMOL-CHIC, V127, P656, DOI 10.1001/archophthalmol.2009.76; Tanaka Y, 2007, J CELL BIOCHEM, V102, P689, DOI 10.1002/jcb.21322; Tomiyama H, 2005, HYPERTENS RES, V28, P651, DOI 10.1291/hypres.28.651; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Visioli F, 2007, PHARMACOL RES, V55, P199, DOI 10.1016/j.phrs.2007.01.008; Weng NP, 1996, J EXP MED, V183, P2471, DOI 10.1084/jem.183.6.2471; Whooley MA, 2008, JAMA-J AM MED ASSOC, V300, P2379, DOI 10.1001/jama.2008.711; Wong JMY, 2003, LANCET, V362, P983, DOI 10.1016/S0140-6736(03)14369-3; Xu Q, 2009, AM J CLIN NUTR, V89, P1857, DOI 10.3945/ajcn.2008.26986	55	224	236	0	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 20	2010	303	3					250	257		10.1001/jama.2009.2008	http://dx.doi.org/10.1001/jama.2009.2008			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	544WM	20085953	Green Accepted, Bronze			2022-12-28	WOS:000273690600021
J	Pini, P; Palmer, J; Barrett, T				Pini, Pia; Palmer, Joanna; Barrett, Tamara			Stunned deaf	LANCET			English	Editorial Material									[Pini, Pia; Palmer, Joanna; Barrett, Tamara] The Lancet, London NW1 7BY, England		Pini, P (corresponding author), The Lancet, London NW1 7BY, England.							LEVINE J, 2009, BLUE NOTEBOOK; Levine JA, 2009, LANCET, V374, P2126, DOI 10.1016/S0140-6736(09)61995-4; Office of the UN High Commissioner for Human Rights, 2002, OPT PROT CONV RIGHTS; Pini P, 2009, LANCET, V373, P1932, DOI 10.1016/S0140-6736(09)61048-5	4	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC-JAN	2009	374	9707					2040	2040		10.1016/S0140-6736(09)62129-2	http://dx.doi.org/10.1016/S0140-6736(09)62129-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	537OO	20109818				2022-12-28	WOS:000273122900011
